Citrus Sinensis ID: 018640
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 352 | 2.2.26 [Sep-21-2011] | |||||||
| Q6NLQ6 | 538 | Calcium-dependent protein | yes | no | 1.0 | 0.654 | 0.837 | 1e-176 | |
| Q38873 | 535 | Calcium-dependent protein | no | no | 1.0 | 0.657 | 0.799 | 1e-172 | |
| Q42438 | 533 | Calcium-dependent protein | no | no | 1.0 | 0.660 | 0.795 | 1e-170 | |
| P93759 | 530 | Calcium-dependent protein | no | no | 0.991 | 0.658 | 0.781 | 1e-168 | |
| Q8W4I7 | 528 | Calcium-dependent protein | no | no | 0.982 | 0.655 | 0.732 | 1e-155 | |
| Q9SSF8 | 541 | Calcium-dependent protein | no | no | 0.988 | 0.643 | 0.709 | 1e-146 | |
| Q9M9V8 | 545 | Calcium-dependent protein | no | no | 0.985 | 0.636 | 0.705 | 1e-144 | |
| Q9SIQ7 | 582 | Calcium-dependent protein | no | no | 0.877 | 0.530 | 0.686 | 1e-132 | |
| Q9FMP5 | 528 | Calcium-dependent protein | no | no | 0.875 | 0.583 | 0.631 | 1e-118 | |
| Q38870 | 646 | Calcium-dependent protein | no | no | 0.846 | 0.461 | 0.640 | 1e-116 |
| >sp|Q6NLQ6|CDPKW_ARATH Calcium-dependent protein kinase 32 OS=Arabidopsis thaliana GN=CPK32 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 616 bits (1589), Expect = e-176, Method: Compositional matrix adjust.
Identities = 300/358 (83%), Positives = 324/358 (90%), Gaps = 6/358 (1%)
Query: 1 MGNCCVTPAAAKQG--KKKTNKKKQNPFSIDYGTHHQGNGGH----KLCVLKEPTGREIE 54
MGNCC T + Q K K +KKQNPFSIDYG HH G G KL VL +PTGREIE
Sbjct: 1 MGNCCGTAGSLAQNDNKPKKGRKKQNPFSIDYGLHHGGGDGGGRPLKLIVLNDPTGREIE 60
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+Y LGRELGRGEFG+TYLCTD+E D FACKSI KKKLRTAVDIEDVRREV+IMRH+P+
Sbjct: 61 SKYTLGRELGRGEFGVTYLCTDKETDDVFACKSILKKKLRTAVDIEDVRREVEIMRHMPE 120
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H N+V LK+TYED+ AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI+EVVQ+CHK
Sbjct: 121 HPNVVTLKETYEDEHAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIMEVVQVCHK 180
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNY 234
HGVMHRDLKPENFLF NKKETAPLKAIDFGLSVFFKPGE+F+EIVGSPYYMAPEVLKRNY
Sbjct: 181 HGVMHRDLKPENFLFGNKKETAPLKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLKRNY 240
Query: 235 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK 294
GPEVD+WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL+RK
Sbjct: 241 GPEVDIWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLIRK 300
Query: 295 MLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVMS 352
MLDPD KRRLTAQQVL+HPWLQNAK APNVSLGETV+ARLKQF+VMNKLKKRAL+V++
Sbjct: 301 MLDPDQKRRLTAQQVLDHPWLQNAKTAPNVSLGETVRARLKQFTVMNKLKKRALRVIA 358
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Functions as regulator of the calcium-mediated abscisic acid (ABA) signaling pathway. Phosphorylates ABA-responsive transcription factor ABF4 in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q38873|CDPK7_ARATH Calcium-dependent protein kinase 7 OS=Arabidopsis thaliana GN=CPK7 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 604 bits (1557), Expect = e-172, Method: Compositional matrix adjust.
Identities = 283/354 (79%), Positives = 320/354 (90%), Gaps = 2/354 (0%)
Query: 1 MGNCCVTPAAA-KQGKKKTNKKKQNPF-SIDYGTHHQGNGGHKLCVLKEPTGREIEERYE 58
MGNCC P++A Q K+ K K NPF S +Y T + G KL VLK+PTG +I +Y+
Sbjct: 1 MGNCCGNPSSATNQSKQGKPKNKNNPFYSNEYATTDRSGAGFKLSVLKDPTGHDISLQYD 60
Query: 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI 118
LGRE+GRGEFGITYLCTD+E G+ +ACKSISKKKLRTAVDIEDVRREV+IM+H+PKH N+
Sbjct: 61 LGREVGRGEFGITYLCTDKETGEKYACKSISKKKLRTAVDIEDVRREVEIMKHMPKHPNV 120
Query: 119 VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVM 178
V LKD++EDD AVH+VMELCEGGELFDRIVARGHYTERAAAAV KTIVEVVQ+CHK GVM
Sbjct: 121 VSLKDSFEDDDAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQICHKQGVM 180
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEV 238
HRDLKPENFLFANKKET+ LKAIDFGLSVFFKPGE+F+EIVGSPYYMAPEVL+RNYGPE+
Sbjct: 181 HRDLKPENFLFANKKETSALKAIDFGLSVFFKPGEQFNEIVGSPYYMAPEVLRRNYGPEI 240
Query: 239 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298
DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWP+VS++AKDLVRKML+P
Sbjct: 241 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPRVSDSAKDLVRKMLEP 300
Query: 299 DPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVMS 352
DPK+RLTA QVLEH W+ NAKKAPNVSLGETVKARLKQFSVMNKLKKRAL+V++
Sbjct: 301 DPKKRLTAAQVLEHTWILNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRVIA 354
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q42438|CDPK8_ARATH Calcium-dependent protein kinase 8 OS=Arabidopsis thaliana GN=CPK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 598 bits (1543), Expect = e-170, Method: Compositional matrix adjust.
Identities = 280/352 (79%), Positives = 313/352 (88%)
Query: 1 MGNCCVTPAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELG 60
MGNCC +P + KK K K NPF + T + G KL VLK+PTG +I Y+LG
Sbjct: 1 MGNCCASPGSETGSKKGKPKIKSNPFYSEAYTTNGSGTGFKLSVLKDPTGHDISLMYDLG 60
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
RE+GRGEFGITYLCTD + G+ +ACKSISKKKLRTAVDIEDVRREV+IM+H+P+H NIV
Sbjct: 61 REVGRGEFGITYLCTDIKTGEKYACKSISKKKLRTAVDIEDVRREVEIMKHMPRHPNIVS 120
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
LKD +EDD AVH+VMELCEGGELFDRIVARGHYTERAAAAV KTI+EVVQ+CHKHGVMHR
Sbjct: 121 LKDAFEDDDAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTILEVVQICHKHGVMHR 180
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDV 240
DLKPENFLFANKKET+ LKAIDFGLSVFFKPGE F+EIVGSPYYMAPEVL+RNYGPEVD+
Sbjct: 181 DLKPENFLFANKKETSALKAIDFGLSVFFKPGEGFNEIVGSPYYMAPEVLRRNYGPEVDI 240
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
WSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWP+VSE AKDLVRKML+PDP
Sbjct: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPRVSETAKDLVRKMLEPDP 300
Query: 301 KRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVMS 352
K+RL+A QVLEH W+QNAKKAPNVSLGETVKARLKQFSVMNKLKKRAL+V++
Sbjct: 301 KKRLSAAQVLEHSWIQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRVIA 352
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P93759|CDPKE_ARATH Calcium-dependent protein kinase 14 OS=Arabidopsis thaliana GN=CPK14 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 592 bits (1527), Expect = e-168, Method: Compositional matrix adjust.
Identities = 275/352 (78%), Positives = 316/352 (89%), Gaps = 3/352 (0%)
Query: 1 MGNCCVTPAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELG 60
MGNCC T + Q K+K K NPFS +YG HH G KL VLKEPTG EI+++Y+LG
Sbjct: 1 MGNCCGTAGSLIQDKQKKGFKLPNPFSNEYGNHHDG---LKLIVLKEPTGHEIKQKYKLG 57
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
RELGRGEFG+TYLCT+ E G+ FACKSI KKKL+T++DIEDV+REV+IMR +P+H NIV
Sbjct: 58 RELGRGEFGVTYLCTEIETGEIFACKSILKKKLKTSIDIEDVKREVEIMRQMPEHPNIVT 117
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
LK+TYEDD AVHLVMELCEGGELFDRIVARGHYTERAAA+V KTI+EVVQMCHKHGVMHR
Sbjct: 118 LKETYEDDKAVHLVMELCEGGELFDRIVARGHYTERAAASVIKTIIEVVQMCHKHGVMHR 177
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDV 240
DLKPENFLFANKKETA LKAIDFGLSVFFKPGE+F+EIVGSPYYMAPEVL+R+YG E+D+
Sbjct: 178 DLKPENFLFANKKETASLKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLRRSYGQEIDI 237
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
WSAGVILYILLCGVPPFWAETE GVA+AI++SV+DF+RDPWPKVS+NAKDL++KML PDP
Sbjct: 238 WSAGVILYILLCGVPPFWAETEHGVAKAILKSVIDFKRDPWPKVSDNAKDLIKKMLHPDP 297
Query: 301 KRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVMS 352
+RRLTAQQVL+HPW+QN K A NVSLGETV+ARLKQFSVMNKLKKRAL+V++
Sbjct: 298 RRRLTAQQVLDHPWIQNGKNASNVSLGETVRARLKQFSVMNKLKKRALRVIA 349
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8W4I7|CDPKD_ARATH Calcium-dependent protein kinase 13 OS=Arabidopsis thaliana GN=CPK13 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 548 bits (1411), Expect = e-155, Method: Compositional matrix adjust.
Identities = 260/355 (73%), Positives = 300/355 (84%), Gaps = 9/355 (2%)
Query: 1 MGNCCVTPAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHK---LCVLKEPTGREIEERY 57
MGNCC +PAA + K+N +S GG K + VL + IE+RY
Sbjct: 1 MGNCCRSPAAVAREDVKSN------YSGHDHARKDAAGGKKSAPIRVLSDVPKENIEDRY 54
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
L RELGRGEFG+TYLC +R + D ACKSISK+KLRTAVDIEDV+REV IM+HLPK +
Sbjct: 55 LLDRELGRGEFGVTYLCIERSSRDLLACKSISKRKLRTAVDIEDVKREVAIMKHLPKSSS 114
Query: 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGV 177
IV LK+ EDD AVHLVMELCEGGELFDRIVARGHYTERAAA VTKTIVEVVQ+CHKHGV
Sbjct: 115 IVTLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAGVTKTIVEVVQLCHKHGV 174
Query: 178 MHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPE 237
+HRDLKPENFLFANKKE +PLKAIDFGLS+FFKPGEKFSEIVGSPYYMAPEVLKRNYGPE
Sbjct: 175 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGEKFSEIVGSPYYMAPEVLKRNYGPE 234
Query: 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297
+D+WSAGVILYILLCGVPPFWAE+EQGVAQAI+R V+DF+R+PWP +SE AK+LVR+ML+
Sbjct: 235 IDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGVIDFKREPWPNISETAKNLVRQMLE 294
Query: 298 PDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVMS 352
PDPKRRLTA+QVLEHPW+QNAKKAPNV LG+ VK+RLKQFSVMN+ K++AL+V++
Sbjct: 295 PDPKRRLTAKQVLEHPWIQNAKKAPNVPLGDVVKSRLKQFSVMNRFKRKALRVIA 349
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SSF8|CDPKU_ARATH Calcium-dependent protein kinase 30 OS=Arabidopsis thaliana GN=CPK30 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 519 bits (1337), Expect = e-146, Method: Compositional matrix adjust.
Identities = 254/358 (70%), Positives = 295/358 (82%), Gaps = 10/358 (2%)
Query: 1 MGNC--CV--TPAAAK--QGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIE 54
MGNC CV P +K Q KK +++NP+ G L V+ +I
Sbjct: 1 MGNCIACVKFDPDNSKPNQKKKPPRGRQRNPYDDPDGLRTHA----PLRVIPMSHQSQIS 56
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
++Y LGRELGRGEFGITYLCTDRE +A ACKSISK+KLRTAVD+EDVRREV IM LP+
Sbjct: 57 DKYILGRELGRGEFGITYLCTDRETREALACKSISKRKLRTAVDVEDVRREVTIMSTLPE 116
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H N+V LK TYED+ VHLVMELCEGGELFDRIVARGHYTERAAA V +TI EVV+MCH
Sbjct: 117 HPNVVKLKATYEDNENVHLVMELCEGGELFDRIVARGHYTERAAATVARTIAEVVRMCHV 176
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNY 234
+GVMHRDLKPENFLFANKKE + LKAIDFGLSV FKPGE+F+EIVGSPYYMAPEVLKRNY
Sbjct: 177 NGVMHRDLKPENFLFANKKENSALKAIDFGLSVLFKPGERFTEIVGSPYYMAPEVLKRNY 236
Query: 235 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK 294
GPEVDVWSAGVILYILLCGVPPFWAETEQGVA AI+R VLDF+RDPW ++SE+AK LV++
Sbjct: 237 GPEVDVWSAGVILYILLCGVPPFWAETEQGVALAILRGVLDFKRDPWSQISESAKSLVKQ 296
Query: 295 MLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVMS 352
ML+PD +RLTAQQVL+HPW+QNAKKAPNV LG+ V++RLKQFS+MN+LKK+AL+V++
Sbjct: 297 MLEPDSTKRLTAQQVLDHPWIQNAKKAPNVPLGDIVRSRLKQFSMMNRLKKKALRVIA 354
|
May play a role in signal transduction pathways that involve calcium as a second messenger. May be a positive regulator controlling stress signal transduction. Acts as a calcium sensor involved in the hormone-signaling pathways. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M9V8|CDPKA_ARATH Calcium-dependent protein kinase 10 OS=Arabidopsis thaliana GN=CPK10 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 512 bits (1319), Expect = e-144, Method: Compositional matrix adjust.
Identities = 256/363 (70%), Positives = 297/363 (81%), Gaps = 16/363 (4%)
Query: 1 MGNC--CVTP-----AAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKE----PT 49
MGNC CV P + + KK +K NPF+ D+ + VLK+
Sbjct: 1 MGNCNACVRPDSKESKPSSKPKKPNRDRKLNPFAGDFT-----RSPAPIRVLKDVIPMSN 55
Query: 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIM 109
+I ++Y LGRELGRGEFGITYLCTDRE +A ACKSISK+KLRTAVDIEDVRREV IM
Sbjct: 56 QTQISDKYILGRELGRGEFGITYLCTDRETHEALACKSISKRKLRTAVDIEDVRREVAIM 115
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV 169
LP+H N+V LK +YED+ VHLVMELCEGGELFDRIVARGHYTERAAAAV +TI EVV
Sbjct: 116 STLPEHPNVVKLKASYEDNENVHLVMELCEGGELFDRIVARGHYTERAAAAVARTIAEVV 175
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEV 229
MCH +GVMHRDLKPENFLFANKKE +PLKAIDFGLSVFFKPG+KF+EIVGSPYYMAPEV
Sbjct: 176 MMCHSNGVMHRDLKPENFLFANKKENSPLKAIDFGLSVFFKPGDKFTEIVGSPYYMAPEV 235
Query: 230 LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289
LKR+YGP VDVWSAGVI+YILLCGVPPFWAETEQGVA AI+R VLDF+RDPWP++SE+AK
Sbjct: 236 LKRDYGPGVDVWSAGVIIYILLCGVPPFWAETEQGVALAILRGVLDFKRDPWPQISESAK 295
Query: 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALK 349
LV++MLDPDP +RLTAQQVL HPW+QNAKKAPNV LG+ V++RLKQFS+MN+ KK+ L+
Sbjct: 296 SLVKQMLDPDPTKRLTAQQVLAHPWIQNAKKAPNVPLGDIVRSRLKQFSMMNRFKKKVLR 355
Query: 350 VMS 352
V++
Sbjct: 356 VIA 358
|
May play a role in signal transduction pathways that involve calcium as a second messenger. May be a positive regulator controlling stress signal transduction. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SIQ7|CDPKO_ARATH Calcium-dependent protein kinase 24 OS=Arabidopsis thaliana GN=CPK24 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 473 bits (1217), Expect = e-132, Method: Compositional matrix adjust.
Identities = 212/309 (68%), Positives = 266/309 (86%)
Query: 44 VLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR 103
VL EP G I +Y+LG+ELGRGEFG+T+ C + + FACK ISK+KLRT +D+EDVR
Sbjct: 53 VLPEPIGDGIHLKYDLGKELGRGEFGVTHECIEISTRERFACKRISKEKLRTEIDVEDVR 112
Query: 104 REVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
REV+IMR LPKH NIV K+ +ED AV+LVME+CEGGELFDRIV+RGHYTERAAA+V K
Sbjct: 113 REVEIMRCLPKHPNIVSFKEAFEDKDAVYLVMEICEGGELFDRIVSRGHYTERAAASVAK 172
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY 223
TI+EVV++CH+HGV+HRDLKPENFLF+N ETA LKAIDFGLS+FFKP ++F+EIVGSPY
Sbjct: 173 TILEVVKVCHEHGVIHRDLKPENFLFSNGTETAQLKAIDFGLSIFFKPAQRFNEIVGSPY 232
Query: 224 YMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283
YMAPEVL+RNYGPE+DVWSAGVILYILLCGVPPFWAETE+G+A AI+R +DF RDPWPK
Sbjct: 233 YMAPEVLRRNYGPEIDVWSAGVILYILLCGVPPFWAETEEGIAHAIVRGNIDFERDPWPK 292
Query: 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKL 343
VS AK+LV+ MLD +P RLT Q+VLEHPW++NA++APNV+LG+ V+ +++QF +MN+
Sbjct: 293 VSHEAKELVKNMLDANPYSRLTVQEVLEHPWIRNAERAPNVNLGDNVRTKIQQFLLMNRF 352
Query: 344 KKRALKVMS 352
KK+ L++++
Sbjct: 353 KKKVLRIVA 361
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FMP5|CDPKH_ARATH Calcium-dependent protein kinase 17 OS=Arabidopsis thaliana GN=CPK17 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 423 bits (1088), Expect = e-118, Method: Compositional matrix adjust.
Identities = 195/309 (63%), Positives = 238/309 (77%), Gaps = 1/309 (0%)
Query: 44 VLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR 103
VL P +++ Y LG+ELGRG+FG+T+LCT + G FACK+I+K+KL DIEDVR
Sbjct: 61 VLGRPM-EDVKASYSLGKELGRGQFGVTHLCTQKATGHQFACKTIAKRKLVNKEDIEDVR 119
Query: 104 REVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
REV IM HL NIV LK YED +VHLVMELC GGELFDRI+A+GHY+ERAAA++ +
Sbjct: 120 REVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSERAAASLLR 179
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY 223
TIV++V CH GV+HRDLKPENFL NK E +PLKA DFGLSVF+KPGE F +IVGS Y
Sbjct: 180 TIVQIVHTCHSMGVIHRDLKPENFLLLNKDENSPLKATDFGLSVFYKPGEVFKDIVGSAY 239
Query: 224 YMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283
Y+APEVLKR YGPE D+WS GV+LYILLCGVPPFWAE+E G+ AI+R +DF DPWP
Sbjct: 240 YIAPEVLKRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILRGHVDFSSDPWPS 299
Query: 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKL 343
+S AKDLV+KML+ DPK+RLTA QVL HPW++ +AP+V L V +RLKQF MN
Sbjct: 300 ISPQAKDLVKKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNAVMSRLKQFKAMNNF 359
Query: 344 KKRALKVMS 352
KK AL+V++
Sbjct: 360 KKVALRVIA 368
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q38870|CDPK2_ARATH Calcium-dependent protein kinase 2 OS=Arabidopsis thaliana GN=CPK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 418 bits (1074), Expect = e-116, Method: Compositional matrix adjust.
Identities = 191/298 (64%), Positives = 235/298 (78%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E Y LGR+LG+G+FG T+LC ++ G+ +ACKSISK+KL T D+EDVRRE+ IM HL
Sbjct: 184 EFYSLGRKLGQGQFGTTFLCLEKGTGNEYACKSISKRKLLTDEDVEDVRREIQIMHHLAG 243
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H N++ +K YED AVHLVMELC GGELFDRI+ RGHYTER AA + +TIV V++ CH
Sbjct: 244 HPNVISIKGAYEDVVAVHLVMELCSGGELFDRIIQRGHYTERKAAELARTIVGVLEACHS 303
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNY 234
GVMHRDLKPENFLF +++E + LK IDFGLS+FFKP E F+++VGSPYY+APEVL++ Y
Sbjct: 304 LGVMHRDLKPENFLFVSREEDSLLKTIDFGLSMFFKPDEVFTDVVGSPYYVAPEVLRKRY 363
Query: 235 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK 294
GPE DVWSAGVI+YILL GVPPFWAETEQG+ + ++ LDF DPWP +SE+AKDLVRK
Sbjct: 364 GPESDVWSAGVIVYILLSGVPPFWAETEQGIFEQVLHGDLDFSSDPWPSISESAKDLVRK 423
Query: 295 MLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVMS 352
ML DPKRRLTA QVL HPW+Q AP+ L V +R+KQFS MNK KK AL+V++
Sbjct: 424 MLVRDPKRRLTAHQVLCHPWVQIDGVAPDKPLDSAVLSRMKQFSAMNKFKKMALRVIA 481
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 352 | ||||||
| 337729587 | 530 | calcium-dependent protein kinase [Hevea | 0.994 | 0.660 | 0.894 | 0.0 | |
| 317106768 | 531 | JMS10C05.3 [Jatropha curcas] | 0.991 | 0.657 | 0.878 | 0.0 | |
| 260408334 | 550 | calcium dependent protein kinase 32 [Gos | 1.0 | 0.64 | 0.878 | 0.0 | |
| 359481709 | 526 | PREDICTED: calcium-dependent protein kin | 0.988 | 0.661 | 0.877 | 0.0 | |
| 224138018 | 532 | calcium dependent protein kinase 7 [Popu | 0.997 | 0.659 | 0.857 | 1e-180 | |
| 356504799 | 534 | PREDICTED: calcium-dependent protein kin | 1.0 | 0.659 | 0.855 | 1e-178 | |
| 255577483 | 529 | calcium-dependent protein kinase, putati | 0.988 | 0.657 | 0.866 | 1e-178 | |
| 343126682 | 534 | calcium-dependent protein kinase [Dimoca | 1.0 | 0.659 | 0.867 | 1e-178 | |
| 449466099 | 535 | PREDICTED: calcium-dependent protein kin | 1.0 | 0.657 | 0.845 | 1e-177 | |
| 356572042 | 535 | PREDICTED: calcium-dependent protein kin | 1.0 | 0.657 | 0.847 | 1e-176 |
| >gi|337729587|gb|AEI70328.1| calcium-dependent protein kinase [Hevea brasiliensis] | Back alignment and taxonomy information |
|---|
Score = 650 bits (1678), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 315/352 (89%), Positives = 331/352 (94%), Gaps = 2/352 (0%)
Query: 1 MGNCCVTPAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELG 60
MGNCCVTP+ A + + K NKKKQNPF+IDYG H HKL VLK+PTGREIE+RYELG
Sbjct: 1 MGNCCVTPSTASKHEHKKNKKKQNPFAIDYG--HSNGVQHKLTVLKDPTGREIEQRYELG 58
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
RELGRGEFGITYLCTD+E D FACKSISKKKLRTAVDIEDVRREV IMRHLPKH NIV
Sbjct: 59 RELGRGEFGITYLCTDKETRDTFACKSISKKKLRTAVDIEDVRREVQIMRHLPKHPNIVS 118
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
LKDTYEDD AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR
Sbjct: 119 LKDTYEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 178
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDV 240
DLKPENFLFANKKETA LKAIDFGLSVFFKPGEKF+EIVGSPYYMAPEVLKRNYGPEVDV
Sbjct: 179 DLKPENFLFANKKETAALKAIDFGLSVFFKPGEKFNEIVGSPYYMAPEVLKRNYGPEVDV 238
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
WSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWPKVS+NAKDLV+KMLDPDP
Sbjct: 239 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSDNAKDLVKKMLDPDP 298
Query: 301 KRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVMS 352
KRRLTAQQVL+HPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRAL+V++
Sbjct: 299 KRRLTAQQVLDHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRVIA 350
|
Source: Hevea brasiliensis Species: Hevea brasiliensis Genus: Hevea Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|317106768|dbj|BAJ53260.1| JMS10C05.3 [Jatropha curcas] | Back alignment and taxonomy information |
|---|
Score = 647 bits (1668), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 310/353 (87%), Positives = 328/353 (92%), Gaps = 4/353 (1%)
Query: 1 MGNCCVTPAAAKQGKKKTNKKKQNPFSIDYGTHHQGNG-GHKLCVLKEPTGREIEERYEL 59
MGNCCVTP+A K +KKKQNPF+IDYG Q NG HKL VLKEPTGREIE+RYEL
Sbjct: 1 MGNCCVTPSAVPSPDNKKHKKKQNPFAIDYG---QNNGVHHKLTVLKEPTGREIEQRYEL 57
Query: 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIV 119
G ELGRGEFGITYLCTD+E + +ACKSISKKKLRTAVDIEDVRREV IMRHLPKH NIV
Sbjct: 58 GGELGRGEFGITYLCTDKETAEKYACKSISKKKLRTAVDIEDVRREVQIMRHLPKHPNIV 117
Query: 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMH 179
LKDTYEDD AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK GVMH
Sbjct: 118 SLKDTYEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKQGVMH 177
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVD 239
RDLKPENFLFANKKETA LKAIDFGLSVFFKPGE+F+EIVGSPYYMAPEVLKRNYGPEVD
Sbjct: 178 RDLKPENFLFANKKETAALKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLKRNYGPEVD 237
Query: 240 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPD 299
VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWPKVS+NAKDLV+KMLDPD
Sbjct: 238 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSDNAKDLVKKMLDPD 297
Query: 300 PKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVMS 352
P RRLTAQQVL+HPWLQNAKKAPNVSLGETVKARLKQFS+MNKLKKRAL+V++
Sbjct: 298 PNRRLTAQQVLDHPWLQNAKKAPNVSLGETVKARLKQFSLMNKLKKRALRVIA 350
|
Source: Jatropha curcas Species: Jatropha curcas Genus: Jatropha Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|260408334|gb|ACX37460.1| calcium dependent protein kinase 32 [Gossypium hirsutum] | Back alignment and taxonomy information |
|---|
Score = 645 bits (1664), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 311/354 (87%), Positives = 332/354 (93%), Gaps = 2/354 (0%)
Query: 1 MGNCCVTPA--AAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYE 58
MGNCC TP+ A+ + K+K KKKQNPFS+DYG H GNGGHKL VL +PTG EIE+RYE
Sbjct: 1 MGNCCATPSTTASHEKKEKKGKKKQNPFSLDYGQRHHGNGGHKLTVLNDPTGGEIEQRYE 60
Query: 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI 118
LGRELGRGEFGIT+LCTD+E GD FACKSISKKKLRTAVDIEDVRREV+IM+HLP H NI
Sbjct: 61 LGRELGRGEFGITFLCTDKETGDTFACKSISKKKLRTAVDIEDVRREVEIMKHLPHHPNI 120
Query: 119 VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVM 178
V LKDTYEDD AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ+CHKHGVM
Sbjct: 121 VTLKDTYEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQVCHKHGVM 180
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEV 238
HRDLKPENFLFANKKETA LK+IDFGLSVFFKPGE F+EIVGSPYYMAPEVLKRNYG EV
Sbjct: 181 HRDLKPENFLFANKKETAALKSIDFGLSVFFKPGEIFTEIVGSPYYMAPEVLKRNYGREV 240
Query: 239 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298
DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWPKVSENAKDLVRKML+P
Sbjct: 241 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVRKMLNP 300
Query: 299 DPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVMS 352
DPKRRLTAQ+VL+HPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKV++
Sbjct: 301 DPKRRLTAQEVLDHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIA 354
|
Source: Gossypium hirsutum Species: Gossypium hirsutum Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359481709|ref|XP_002283549.2| PREDICTED: calcium-dependent protein kinase 32-like isoform 1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 642 bits (1656), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 309/352 (87%), Positives = 333/352 (94%), Gaps = 4/352 (1%)
Query: 1 MGNCCVTPAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELG 60
MGNCCVTP +++ K KKKQNPFS+DY + QGNGG KL VLK+PTGREIE RYELG
Sbjct: 1 MGNCCVTPVPSEK---KKGKKKQNPFSLDYAAN-QGNGGSKLSVLKDPTGREIELRYELG 56
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
RELGRGEFGIT+LCTD+ GD +ACKSISKKKLRTAVDI+DVRREV+IM+HLPKH NIV
Sbjct: 57 RELGRGEFGITHLCTDKSTGDVYACKSISKKKLRTAVDIDDVRREVEIMKHLPKHPNIVT 116
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
LKDTYEDD AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR
Sbjct: 117 LKDTYEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 176
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDV 240
DLKPENFLFANKKETAPLKAIDFGLSVFFKPGE+F+EIVGSPYYMAPEVLKRNYGPEVDV
Sbjct: 177 DLKPENFLFANKKETAPLKAIDFGLSVFFKPGERFTEIVGSPYYMAPEVLKRNYGPEVDV 236
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF+RDPWPKVSENAKDLV+KMLDPDP
Sbjct: 237 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFKRDPWPKVSENAKDLVKKMLDPDP 296
Query: 301 KRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVMS 352
KRRL+AQ+VL+HPWLQNAKKAPNVSLGETV+ARLKQFS+MNKLKKRAL+V++
Sbjct: 297 KRRLSAQEVLDHPWLQNAKKAPNVSLGETVRARLKQFSMMNKLKKRALRVIA 348
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224138018|ref|XP_002322709.1| calcium dependent protein kinase 7 [Populus trichocarpa] gi|222867339|gb|EEF04470.1| calcium dependent protein kinase 7 [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 636 bits (1640), Expect = e-180, Method: Compositional matrix adjust.
Identities = 302/352 (85%), Positives = 332/352 (94%), Gaps = 1/352 (0%)
Query: 1 MGNCCVTPAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELG 60
MGNCCVTP +KK +KKKQNPF++D+G H++G HKL VL++PTG+EIE+RYELG
Sbjct: 1 MGNCCVTPPGVPDHEKKKHKKKQNPFALDFGHHNRGTN-HKLIVLRDPTGKEIEQRYELG 59
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
RELGRGEFGITYLCTD+E G+ FACKSISKKKLRTAVDIEDVRREV+IM+ +P+H N+V
Sbjct: 60 RELGRGEFGITYLCTDKETGENFACKSISKKKLRTAVDIEDVRREVEIMKQMPQHPNLVT 119
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
LKDTYEDD+AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ+CH+HGVMHR
Sbjct: 120 LKDTYEDDSAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQICHEHGVMHR 179
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDV 240
DLKPENFLF NKKE APLKAIDFGLSVFFKPGE+F+EIVGSPYYMAPEVLKRNYGPEVDV
Sbjct: 180 DLKPENFLFGNKKENAPLKAIDFGLSVFFKPGERFTEIVGSPYYMAPEVLKRNYGPEVDV 239
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
WSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWPKVSENAKDLVRKMLDPDP
Sbjct: 240 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVRKMLDPDP 299
Query: 301 KRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVMS 352
KRRLTAQQVL+HPWLQNAKKAPNVSLGETV+ RLKQFSVMNKLKKRAL+V++
Sbjct: 300 KRRLTAQQVLDHPWLQNAKKAPNVSLGETVRTRLKQFSVMNKLKKRALRVIA 351
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356504799|ref|XP_003521182.1| PREDICTED: calcium-dependent protein kinase 32-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 632 bits (1629), Expect = e-178, Method: Compositional matrix adjust.
Identities = 302/353 (85%), Positives = 323/353 (91%), Gaps = 1/353 (0%)
Query: 1 MGNCCVTPAAAKQGKKKTNKKK-QNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYEL 59
MGNCC TP+ + KK K K +NPF+IDYG + G KL VLK PTGREIE RYEL
Sbjct: 1 MGNCCATPSTDETANKKGKKGKKENPFAIDYGFNATAANGSKLTVLKSPTGREIEARYEL 60
Query: 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIV 119
GRELGRGEFGITYLCTD+ G+ ACKSISKKKLRTA+DIEDVRREV+IMRHLP+H NIV
Sbjct: 61 GRELGRGEFGITYLCTDKGTGEELACKSISKKKLRTAIDIEDVRREVEIMRHLPQHANIV 120
Query: 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMH 179
LKDTYEDD AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK GVMH
Sbjct: 121 TLKDTYEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKQGVMH 180
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVD 239
RDLKPENFLFANKKETA LKAIDFGLSVFFKPGEKF+EIVGSPYYMAPEVLKRNYGPEVD
Sbjct: 181 RDLKPENFLFANKKETAALKAIDFGLSVFFKPGEKFNEIVGSPYYMAPEVLKRNYGPEVD 240
Query: 240 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPD 299
+WSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWPKVS+NAKDLV+KMLDPD
Sbjct: 241 IWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVVDFKRDPWPKVSDNAKDLVKKMLDPD 300
Query: 300 PKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVMS 352
PKRRLTAQ VL+HPWLQNAKKAPNVSLGETV+ARLKQFSVMNKLKKRAL+V++
Sbjct: 301 PKRRLTAQDVLDHPWLQNAKKAPNVSLGETVRARLKQFSVMNKLKKRALRVIA 353
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255577483|ref|XP_002529620.1| calcium-dependent protein kinase, putative [Ricinus communis] gi|223530905|gb|EEF32765.1| calcium-dependent protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 630 bits (1625), Expect = e-178, Method: Compositional matrix adjust.
Identities = 306/353 (86%), Positives = 329/353 (93%), Gaps = 5/353 (1%)
Query: 1 MGNCCVTPAAAKQGKKKTNKKKQNPFSIDYGTHHQGNG-GHKLCVLKEPTGREIEERYEL 59
MGNCC TP + + K KKK NPFSIDYG + NG H+L VLK+PTGREIE+RYEL
Sbjct: 1 MGNCCATPPSDPH-ENKKYKKKPNPFSIDYGLN---NGVSHRLTVLKDPTGREIEQRYEL 56
Query: 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIV 119
G ELGRGEFG+TYLCTD+E+G+ FACKSISKKKLRTAVDIEDVRREV IM+HLPKH NIV
Sbjct: 57 GGELGRGEFGVTYLCTDKESGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIV 116
Query: 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMH 179
LKDTYEDD AVHLVMELCEGGELFDRIV+RGHYTERAAAAVTKTIVEVVQMCHKHGVMH
Sbjct: 117 SLKDTYEDDNAVHLVMELCEGGELFDRIVSRGHYTERAAAAVTKTIVEVVQMCHKHGVMH 176
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVD 239
RDLKPENFLFANKKE+A LKAIDFGLSVFFKPGE+F+EIVGSPYYMAPEVLKRNYGPEVD
Sbjct: 177 RDLKPENFLFANKKESAALKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLKRNYGPEVD 236
Query: 240 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPD 299
VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWPKVS+NAKDLV+KMLDPD
Sbjct: 237 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVVDFKRDPWPKVSDNAKDLVKKMLDPD 296
Query: 300 PKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVMS 352
PKRRLTAQQVL+HPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRAL+V++
Sbjct: 297 PKRRLTAQQVLDHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRVIA 349
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|343126682|gb|AEL88279.1| calcium-dependent protein kinase [Dimocarpus longan] | Back alignment and taxonomy information |
|---|
Score = 630 bits (1624), Expect = e-178, Method: Compositional matrix adjust.
Identities = 307/354 (86%), Positives = 326/354 (92%), Gaps = 2/354 (0%)
Query: 1 MGNCCVTPAAAKQGKKKTNKKKQ-NPFSIDYG-THHQGNGGHKLCVLKEPTGREIEERYE 58
MG CC +PAA KK+ +KK+ N FSIDYG HH GN GHKLCVLKEPTGREIE+RYE
Sbjct: 1 MGICCGSPAADNHHKKQKKQKKKPNQFSIDYGVNHHHGNDGHKLCVLKEPTGREIEQRYE 60
Query: 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI 118
LGREL RGEFG+TYLCTD+ N + FACKSISKKKLRTAVDIEDVRREV IMRHLP+H NI
Sbjct: 61 LGRELRRGEFGVTYLCTDKSNAETFACKSISKKKLRTAVDIEDVRREVAIMRHLPQHPNI 120
Query: 119 VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVM 178
V LKDTYEDD AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVM
Sbjct: 121 VTLKDTYEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVM 180
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEV 238
HRDLKPENF FANK+ETA LKAIDFG S+FFKPGE+FSE VGSPYYMA EVLKRNYGPEV
Sbjct: 181 HRDLKPENFFFANKQETAALKAIDFGCSIFFKPGERFSERVGSPYYMALEVLKRNYGPEV 240
Query: 239 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298
DVWSAGVILYILL GVPPFWAETEQGVAQAIIRSV+DF+RDPWPKVS+NAKDLVRKMLDP
Sbjct: 241 DVWSAGVILYILLSGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSDNAKDLVRKMLDP 300
Query: 299 DPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVMS 352
DPKRRLTAQQVLEHPWLQNAKKAPNVSLGETV+ARLKQFSVMNKLKKRAL+V++
Sbjct: 301 DPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVRARLKQFSVMNKLKKRALRVIA 354
|
Source: Dimocarpus longan Species: Dimocarpus longan Genus: Dimocarpus Family: Sapindaceae Order: Sapindales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449466099|ref|XP_004150764.1| PREDICTED: calcium-dependent protein kinase 7-like [Cucumis sativus] gi|449508351|ref|XP_004163290.1| PREDICTED: calcium-dependent protein kinase 7-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 625 bits (1612), Expect = e-177, Method: Compositional matrix adjust.
Identities = 301/356 (84%), Positives = 323/356 (90%), Gaps = 4/356 (1%)
Query: 1 MGNCCVTPAAAKQGKKKTNKKKQ-NPFSIDYGTHH--QGNGG-HKLCVLKEPTGREIEER 56
MGNCCV P + + K +KK+ NPFS+DYG +H GNGG HKL VL PTG EI +
Sbjct: 1 MGNCCVAPPRNPEDQNKGKRKKKPNPFSVDYGVNHFAGGNGGSHKLTVLTNPTGCEIGLQ 60
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
YELGRELGRGEFGIT+LCTD+ G+ FACKSISKKKLRTA+DIEDVRREV IMRHLPKHQ
Sbjct: 61 YELGRELGRGEFGITHLCTDKVTGEKFACKSISKKKLRTAIDIEDVRREVQIMRHLPKHQ 120
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
NIV LKDT+EDD AVHLVMELCEGGELFDRIVARGHYTERAAA VTKTIVEVVQMCHK G
Sbjct: 121 NIVSLKDTFEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAVVTKTIVEVVQMCHKQG 180
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGP 236
VMHRDLKPENFLF NKKE APLKAIDFGLSVFFKPGE+F+EIVGSPYYMAPEVLKRNYGP
Sbjct: 181 VMHRDLKPENFLFGNKKENAPLKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLKRNYGP 240
Query: 237 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKML 296
EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWPKVS+NAKDLVRKML
Sbjct: 241 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSDNAKDLVRKML 300
Query: 297 DPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVMS 352
DPDPKRRLTAQ VL+HPWLQN KKAPNVSLGETV+ARLKQFSVMNKLKKRAL+V++
Sbjct: 301 DPDPKRRLTAQGVLDHPWLQNVKKAPNVSLGETVRARLKQFSVMNKLKKRALRVIA 356
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356572042|ref|XP_003554179.1| PREDICTED: calcium-dependent protein kinase 8-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 625 bits (1611), Expect = e-176, Method: Compositional matrix adjust.
Identities = 300/354 (84%), Positives = 324/354 (91%), Gaps = 2/354 (0%)
Query: 1 MGNCCVTPAAAKQGKKKTNKKK-QNPFSIDYG-THHQGNGGHKLCVLKEPTGREIEERYE 58
MGNCC TP+ + KK K K +NPF+IDYG G KL VLK PTGREIE RYE
Sbjct: 1 MGNCCATPSTDETANKKGKKGKKENPFAIDYGFNAAAAANGSKLTVLKSPTGREIEARYE 60
Query: 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI 118
LGRELGRGEFGITYLCTD+E G+ ACKSISKKKLRTA+DI+DVRREV+IMRHLP+H NI
Sbjct: 61 LGRELGRGEFGITYLCTDKETGEELACKSISKKKLRTAIDIDDVRREVEIMRHLPQHPNI 120
Query: 119 VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVM 178
V LKDTYEDD AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK GVM
Sbjct: 121 VTLKDTYEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKQGVM 180
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEV 238
HRDLKPENFLFANKKETA LKAIDFGLSVFFKPGE+F+EIVGSPYYMAPEVLKRNYGPEV
Sbjct: 181 HRDLKPENFLFANKKETAALKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLKRNYGPEV 240
Query: 239 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298
D+WSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWPKVS+NAKDLV+KMLDP
Sbjct: 241 DIWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVVDFKRDPWPKVSDNAKDLVKKMLDP 300
Query: 299 DPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVMS 352
DP+RRLTAQ+VL+HPWLQNAKKAPNVSLGETV+ARLKQFSVMNKLKKRAL+V++
Sbjct: 301 DPRRRLTAQEVLDHPWLQNAKKAPNVSLGETVRARLKQFSVMNKLKKRALRVIA 354
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 352 | ||||||
| TAIR|locus:2103498 | 538 | CPK32 "calcium-dependent prote | 1.0 | 0.654 | 0.782 | 2.1e-148 | |
| TAIR|locus:505006616 | 535 | CPK7 "calmodulin-domain protei | 1.0 | 0.657 | 0.754 | 4.2e-143 | |
| TAIR|locus:2150230 | 533 | CDPK19 "calcium-dependent prot | 0.997 | 0.658 | 0.756 | 1.8e-142 | |
| TAIR|locus:2054386 | 530 | CPK14 "calcium-dependent prote | 0.991 | 0.658 | 0.730 | 6.3e-140 | |
| TAIR|locus:2074338 | 528 | CPK13 "calcium-dependent prote | 0.982 | 0.655 | 0.692 | 1e-130 | |
| TAIR|locus:2011201 | 545 | CDPK1 "calcium-dependent prote | 0.809 | 0.522 | 0.8 | 3.4e-125 | |
| TAIR|locus:2027227 | 541 | CPK30 "calcium-dependent prote | 0.809 | 0.526 | 0.796 | 3.9e-124 | |
| TAIR|locus:2061290 | 582 | CPK24 "AT2G31500" [Arabidopsis | 0.809 | 0.489 | 0.691 | 3.2e-113 | |
| TAIR|locus:2177023 | 528 | CPK17 "calcium-dependent prote | 0.809 | 0.539 | 0.645 | 7.9e-101 | |
| TAIR|locus:2075885 | 646 | CPK2 "calmodulin-domain protei | 0.809 | 0.441 | 0.642 | 3.4e-100 |
| TAIR|locus:2103498 CPK32 "calcium-dependent protein kinase 32" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1449 (515.1 bits), Expect = 2.1e-148, P = 2.1e-148
Identities = 280/358 (78%), Positives = 301/358 (84%)
Query: 1 MGNCCVTPA--AAXXXXXXXXXXXXXPFSIDYGTHHQGN--GGH--KLCVLKEPTXXXXX 54
MGNCC T A PFSIDYG HH G GG KL VL +PT
Sbjct: 1 MGNCCGTAGSLAQNDNKPKKGRKKQNPFSIDYGLHHGGGDGGGRPLKLIVLNDPTGREIE 60
Query: 55 XXXXXXXXXXXXXFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
FG+TYLCTD+E D FACKSI KKKLRTAVDIEDVRREV+IMRH+P+
Sbjct: 61 SKYTLGRELGRGEFGVTYLCTDKETDDVFACKSILKKKLRTAVDIEDVRREVEIMRHMPE 120
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H N+V LK+TYED+ AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI+EVVQ+CHK
Sbjct: 121 HPNVVTLKETYEDEHAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIMEVVQVCHK 180
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNY 234
HGVMHRDLKPENFLF NKKETAPLKAIDFGLSVFFKPGE+F+EIVGSPYYMAPEVLKRNY
Sbjct: 181 HGVMHRDLKPENFLFGNKKETAPLKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLKRNY 240
Query: 235 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK 294
GPEVD+WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL+RK
Sbjct: 241 GPEVDIWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLIRK 300
Query: 295 MLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVMS 352
MLDPD KRRLTAQQVL+HPWLQNAK APNVSLGETV+ARLKQF+VMNKLKKRAL+V++
Sbjct: 301 MLDPDQKRRLTAQQVLDHPWLQNAKTAPNVSLGETVRARLKQFTVMNKLKKRALRVIA 358
|
|
| TAIR|locus:505006616 CPK7 "calmodulin-domain protein kinase 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1399 (497.5 bits), Expect = 4.2e-143, P = 4.2e-143
Identities = 267/354 (75%), Positives = 299/354 (84%)
Query: 1 MGNCCVTPAAAXXXXXXXX-XXXXXPF-SIDYGTHHQGNGGHKLCVLKEPTXXXXXXXXX 58
MGNCC P++A PF S +Y T + G KL VLK+PT
Sbjct: 1 MGNCCGNPSSATNQSKQGKPKNKNNPFYSNEYATTDRSGAGFKLSVLKDPTGHDISLQYD 60
Query: 59 XXXXXXXXXFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI 118
FGITYLCTD+E G+ +ACKSISKKKLRTAVDIEDVRREV+IM+H+PKH N+
Sbjct: 61 LGREVGRGEFGITYLCTDKETGEKYACKSISKKKLRTAVDIEDVRREVEIMKHMPKHPNV 120
Query: 119 VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVM 178
V LKD++EDD AVH+VMELCEGGELFDRIVARGHYTERAAAAV KTIVEVVQ+CHK GVM
Sbjct: 121 VSLKDSFEDDDAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQICHKQGVM 180
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEV 238
HRDLKPENFLFANKKET+ LKAIDFGLSVFFKPGE+F+EIVGSPYYMAPEVL+RNYGPE+
Sbjct: 181 HRDLKPENFLFANKKETSALKAIDFGLSVFFKPGEQFNEIVGSPYYMAPEVLRRNYGPEI 240
Query: 239 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298
DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWP+VS++AKDLVRKML+P
Sbjct: 241 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPRVSDSAKDLVRKMLEP 300
Query: 299 DPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVMS 352
DPK+RLTA QVLEH W+ NAKKAPNVSLGETVKARLKQFSVMNKLKKRAL+V++
Sbjct: 301 DPKKRLTAAQVLEHTWILNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRVIA 354
|
|
| TAIR|locus:2150230 CDPK19 "calcium-dependent protein kinase 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1393 (495.4 bits), Expect = 1.8e-142, P = 1.8e-142
Identities = 267/353 (75%), Positives = 296/353 (83%)
Query: 1 MGNCCVTPAAAXXXXXXXXXXXXXPF-SIDYGTHHQGNGGHKLCVLKEPTXXXXXXXXXX 59
MGNCC +P + PF S Y T+ G G KL VLK+PT
Sbjct: 1 MGNCCASPGSETGSKKGKPKIKSNPFYSEAYTTNGSGTG-FKLSVLKDPTGHDISLMYDL 59
Query: 60 XXXXXXXXFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIV 119
FGITYLCTD + G+ +ACKSISKKKLRTAVDIEDVRREV+IM+H+P+H NIV
Sbjct: 60 GREVGRGEFGITYLCTDIKTGEKYACKSISKKKLRTAVDIEDVRREVEIMKHMPRHPNIV 119
Query: 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMH 179
LKD +EDD AVH+VMELCEGGELFDRIVARGHYTERAAAAV KTI+EVVQ+CHKHGVMH
Sbjct: 120 SLKDAFEDDDAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTILEVVQICHKHGVMH 179
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVD 239
RDLKPENFLFANKKET+ LKAIDFGLSVFFKPGE F+EIVGSPYYMAPEVL+RNYGPEVD
Sbjct: 180 RDLKPENFLFANKKETSALKAIDFGLSVFFKPGEGFNEIVGSPYYMAPEVLRRNYGPEVD 239
Query: 240 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPD 299
+WSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWP+VSE AKDLVRKML+PD
Sbjct: 240 IWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPRVSETAKDLVRKMLEPD 299
Query: 300 PKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVMS 352
PK+RL+A QVLEH W+QNAKKAPNVSLGETVKARLKQFSVMNKLKKRAL+V++
Sbjct: 300 PKKRLSAAQVLEHSWIQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRVIA 352
|
|
| TAIR|locus:2054386 CPK14 "calcium-dependent protein kinase 14" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1369 (487.0 bits), Expect = 6.3e-140, P = 6.3e-140
Identities = 257/352 (73%), Positives = 293/352 (83%)
Query: 1 MGNCCVTPAAAXXXXXXXXXXXXXPFSIDYGTHHQGNGGHKLCVLKEPTXXXXXXXXXXX 60
MGNCC T + PFS +YG HH G KL VLKEPT
Sbjct: 1 MGNCCGTAGSLIQDKQKKGFKLPNPFSNEYGNHHDGL---KLIVLKEPTGHEIKQKYKLG 57
Query: 61 XXXXXXXFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
FG+TYLCT+ E G+ FACKSI KKKL+T++DIEDV+REV+IMR +P+H NIV
Sbjct: 58 RELGRGEFGVTYLCTEIETGEIFACKSILKKKLKTSIDIEDVKREVEIMRQMPEHPNIVT 117
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
LK+TYEDD AVHLVMELCEGGELFDRIVARGHYTERAAA+V KTI+EVVQMCHKHGVMHR
Sbjct: 118 LKETYEDDKAVHLVMELCEGGELFDRIVARGHYTERAAASVIKTIIEVVQMCHKHGVMHR 177
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDV 240
DLKPENFLFANKKETA LKAIDFGLSVFFKPGE+F+EIVGSPYYMAPEVL+R+YG E+D+
Sbjct: 178 DLKPENFLFANKKETASLKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLRRSYGQEIDI 237
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
WSAGVILYILLCGVPPFWAETE GVA+AI++SV+DF+RDPWPKVS+NAKDL++KML PDP
Sbjct: 238 WSAGVILYILLCGVPPFWAETEHGVAKAILKSVIDFKRDPWPKVSDNAKDLIKKMLHPDP 297
Query: 301 KRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVMS 352
+RRLTAQQVL+HPW+QN K A NVSLGETV+ARLKQFSVMNKLKKRAL+V++
Sbjct: 298 RRRLTAQQVLDHPWIQNGKNASNVSLGETVRARLKQFSVMNKLKKRALRVIA 349
|
|
| TAIR|locus:2074338 CPK13 "calcium-dependent protein kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1282 (456.3 bits), Expect = 1.0e-130, P = 1.0e-130
Identities = 246/355 (69%), Positives = 283/355 (79%)
Query: 1 MGNCCVTPAAAXXXXXXXXXXXXXPFSIDYGTHHQGNGGHK---LCVLKEPTXXXXXXXX 57
MGNCC +PAA D+ GG K + VL +
Sbjct: 1 MGNCCRSPAAVAREDVKSNYSGH-----DHA-RKDAAGGKKSAPIRVLSDVPKENIEDRY 54
Query: 58 XXXXXXXXXXFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
FG+TYLC +R + D ACKSISK+KLRTAVDIEDV+REV IM+HLPK +
Sbjct: 55 LLDRELGRGEFGVTYLCIERSSRDLLACKSISKRKLRTAVDIEDVKREVAIMKHLPKSSS 114
Query: 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGV 177
IV LK+ EDD AVHLVMELCEGGELFDRIVARGHYTERAAA VTKTIVEVVQ+CHKHGV
Sbjct: 115 IVTLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAGVTKTIVEVVQLCHKHGV 174
Query: 178 MHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPE 237
+HRDLKPENFLFANKKE +PLKAIDFGLS+FFKPGEKFSEIVGSPYYMAPEVLKRNYGPE
Sbjct: 175 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGEKFSEIVGSPYYMAPEVLKRNYGPE 234
Query: 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297
+D+WSAGVILYILLCGVPPFWAE+EQGVAQAI+R V+DF+R+PWP +SE AK+LVR+ML+
Sbjct: 235 IDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGVIDFKREPWPNISETAKNLVRQMLE 294
Query: 298 PDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVMS 352
PDPKRRLTA+QVLEHPW+QNAKKAPNV LG+ VK+RLKQFSVMN+ K++AL+V++
Sbjct: 295 PDPKRRLTAKQVLEHPWIQNAKKAPNVPLGDVVKSRLKQFSVMNRFKRKALRVIA 349
|
|
| TAIR|locus:2011201 CDPK1 "calcium-dependent protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1230 (438.0 bits), Expect = 3.4e-125, P = 3.4e-125
Identities = 228/285 (80%), Positives = 259/285 (90%)
Query: 68 FGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127
FGITYLCTDRE +A ACKSISK+KLRTAVDIEDVRREV IM LP+H N+V LK +YED
Sbjct: 74 FGITYLCTDRETHEALACKSISKRKLRTAVDIEDVRREVAIMSTLPEHPNVVKLKASYED 133
Query: 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENF 187
+ VHLVMELCEGGELFDRIVARGHYTERAAAAV +TI EVV MCH +GVMHRDLKPENF
Sbjct: 134 NENVHLVMELCEGGELFDRIVARGHYTERAAAAVARTIAEVVMMCHSNGVMHRDLKPENF 193
Query: 188 LFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVIL 247
LFANKKE +PLKAIDFGLSVFFKPG+KF+EIVGSPYYMAPEVLKR+YGP VDVWSAGVI+
Sbjct: 194 LFANKKENSPLKAIDFGLSVFFKPGDKFTEIVGSPYYMAPEVLKRDYGPGVDVWSAGVII 253
Query: 248 YILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQ 307
YILLCGVPPFWAETEQGVA AI+R VLDF+RDPWP++SE+AK LV++MLDPDP +RLTAQ
Sbjct: 254 YILLCGVPPFWAETEQGVALAILRGVLDFKRDPWPQISESAKSLVKQMLDPDPTKRLTAQ 313
Query: 308 QVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVMS 352
QVL HPW+QNAKKAPNV LG+ V++RLKQFS+MN+ KK+ L+V++
Sbjct: 314 QVLAHPWIQNAKKAPNVPLGDIVRSRLKQFSMMNRFKKKVLRVIA 358
|
|
| TAIR|locus:2027227 CPK30 "calcium-dependent protein kinase 30" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1220 (434.5 bits), Expect = 3.9e-124, P = 3.9e-124
Identities = 227/285 (79%), Positives = 259/285 (90%)
Query: 68 FGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127
FGITYLCTDRE +A ACKSISK+KLRTAVD+EDVRREV IM LP+H N+V LK TYED
Sbjct: 70 FGITYLCTDRETREALACKSISKRKLRTAVDVEDVRREVTIMSTLPEHPNVVKLKATYED 129
Query: 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENF 187
+ VHLVMELCEGGELFDRIVARGHYTERAAA V +TI EVV+MCH +GVMHRDLKPENF
Sbjct: 130 NENVHLVMELCEGGELFDRIVARGHYTERAAATVARTIAEVVRMCHVNGVMHRDLKPENF 189
Query: 188 LFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVIL 247
LFANKKE + LKAIDFGLSV FKPGE+F+EIVGSPYYMAPEVLKRNYGPEVDVWSAGVIL
Sbjct: 190 LFANKKENSALKAIDFGLSVLFKPGERFTEIVGSPYYMAPEVLKRNYGPEVDVWSAGVIL 249
Query: 248 YILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQ 307
YILLCGVPPFWAETEQGVA AI+R VLDF+RDPW ++SE+AK LV++ML+PD +RLTAQ
Sbjct: 250 YILLCGVPPFWAETEQGVALAILRGVLDFKRDPWSQISESAKSLVKQMLEPDSTKRLTAQ 309
Query: 308 QVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVMS 352
QVL+HPW+QNAKKAPNV LG+ V++RLKQFS+MN+LKK+AL+V++
Sbjct: 310 QVLDHPWIQNAKKAPNVPLGDIVRSRLKQFSMMNRLKKKALRVIA 354
|
|
| TAIR|locus:2061290 CPK24 "AT2G31500" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1117 (398.3 bits), Expect = 3.2e-113, P = 3.2e-113
Identities = 197/285 (69%), Positives = 248/285 (87%)
Query: 68 FGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127
FG+T+ C + + FACK ISK+KLRT +D+EDVRREV+IMR LPKH NIV K+ +ED
Sbjct: 77 FGVTHECIEISTRERFACKRISKEKLRTEIDVEDVRREVEIMRCLPKHPNIVSFKEAFED 136
Query: 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENF 187
AV+LVME+CEGGELFDRIV+RGHYTERAAA+V KTI+EVV++CH+HGV+HRDLKPENF
Sbjct: 137 KDAVYLVMEICEGGELFDRIVSRGHYTERAAASVAKTILEVVKVCHEHGVIHRDLKPENF 196
Query: 188 LFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVIL 247
LF+N ETA LKAIDFGLS+FFKP ++F+EIVGSPYYMAPEVL+RNYGPE+DVWSAGVIL
Sbjct: 197 LFSNGTETAQLKAIDFGLSIFFKPAQRFNEIVGSPYYMAPEVLRRNYGPEIDVWSAGVIL 256
Query: 248 YILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQ 307
YILLCGVPPFWAETE+G+A AI+R +DF RDPWPKVS AK+LV+ MLD +P RLT Q
Sbjct: 257 YILLCGVPPFWAETEEGIAHAIVRGNIDFERDPWPKVSHEAKELVKNMLDANPYSRLTVQ 316
Query: 308 QVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVMS 352
+VLEHPW++NA++APNV+LG+ V+ +++QF +MN+ KK+ L++++
Sbjct: 317 EVLEHPWIRNAERAPNVNLGDNVRTKIQQFLLMNRFKKKVLRIVA 361
|
|
| TAIR|locus:2177023 CPK17 "calcium-dependent protein kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1000 (357.1 bits), Expect = 7.9e-101, P = 7.9e-101
Identities = 184/285 (64%), Positives = 222/285 (77%)
Query: 68 FGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127
FG+T+LCT + G FACK+I+K+KL DIEDVRREV IM HL NIV LK YED
Sbjct: 84 FGVTHLCTQKATGHQFACKTIAKRKLVNKEDIEDVRREVQIMHHLTGQPNIVELKGAYED 143
Query: 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENF 187
+VHLVMELC GGELFDRI+A+GHY+ERAAA++ +TIV++V CH GV+HRDLKPENF
Sbjct: 144 KHSVHLVMELCAGGELFDRIIAKGHYSERAAASLLRTIVQIVHTCHSMGVIHRDLKPENF 203
Query: 188 LFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVIL 247
L NK E +PLKA DFGLSVF+KPGE F +IVGS YY+APEVLKR YGPE D+WS GV+L
Sbjct: 204 LLLNKDENSPLKATDFGLSVFYKPGEVFKDIVGSAYYIAPEVLKRKYGPEADIWSIGVML 263
Query: 248 YILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQ 307
YILLCGVPPFWAE+E G+ AI+R +DF DPWP +S AKDLV+KML+ DPK+RLTA
Sbjct: 264 YILLCGVPPFWAESENGIFNAILRGHVDFSSDPWPSISPQAKDLVKKMLNSDPKQRLTAA 323
Query: 308 QVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVMS 352
QVL HPW++ +AP+V L V +RLKQF MN KK AL+V++
Sbjct: 324 QVLNHPWIKEDGEAPDVPLDNAVMSRLKQFKAMNNFKKVALRVIA 368
|
|
| TAIR|locus:2075885 CPK2 "calmodulin-domain protein kinase cdpk isoform 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 994 (355.0 bits), Expect = 3.4e-100, P = 3.4e-100
Identities = 183/285 (64%), Positives = 224/285 (78%)
Query: 68 FGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127
FG T+LC ++ G+ +ACKSISK+KL T D+EDVRRE+ IM HL H N++ +K YED
Sbjct: 197 FGTTFLCLEKGTGNEYACKSISKRKLLTDEDVEDVRREIQIMHHLAGHPNVISIKGAYED 256
Query: 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENF 187
AVHLVMELC GGELFDRI+ RGHYTER AA + +TIV V++ CH GVMHRDLKPENF
Sbjct: 257 VVAVHLVMELCSGGELFDRIIQRGHYTERKAAELARTIVGVLEACHSLGVMHRDLKPENF 316
Query: 188 LFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVIL 247
LF +++E + LK IDFGLS+FFKP E F+++VGSPYY+APEVL++ YGPE DVWSAGVI+
Sbjct: 317 LFVSREEDSLLKTIDFGLSMFFKPDEVFTDVVGSPYYVAPEVLRKRYGPESDVWSAGVIV 376
Query: 248 YILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQ 307
YILL GVPPFWAETEQG+ + ++ LDF DPWP +SE+AKDLVRKML DPKRRLTA
Sbjct: 377 YILLSGVPPFWAETEQGIFEQVLHGDLDFSSDPWPSISESAKDLVRKMLVRDPKRRLTAH 436
Query: 308 QVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVMS 352
QVL HPW+Q AP+ L V +R+KQFS MNK KK AL+V++
Sbjct: 437 QVLCHPWVQIDGVAPDKPLDSAVLSRMKQFSAMNKFKKMALRVIA 481
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q6NLQ6 | CDPKW_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8379 | 1.0 | 0.6542 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00025568001 | SubName- Full=Chromosome chr8 scaffold_34, whole genome shotgun sequence; (526 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
 | GSVIVG00027665001 | SubName- Full=Chromosome chr19 scaffold_4, whole genome shotgun sequence; (769 aa) | • | 0.800 | |||||||
 | GSVIVG00022728001 | SubName- Full=Chromosome chr14 scaffold_27, whole genome shotgun sequence; (873 aa) | • | 0.800 | |||||||
 | GSVIVG00006233001 | SubName- Full=Chromosome chr1 scaffold_166, whole genome shotgun sequence; (805 aa) | • | 0.800 | |||||||
 | GSVIVG00002525001 | SubName- Full=Chromosome chr2 scaffold_132, whole genome shotgun sequence; (943 aa) | • | 0.800 | |||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 352 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-106 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-96 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-69 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-63 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-60 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-59 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-58 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-57 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-55 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-54 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-51 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-50 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-49 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-48 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-47 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-47 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-45 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-45 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-45 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-44 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-44 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-43 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-42 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-41 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-41 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-41 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-39 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-39 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-38 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-38 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-38 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-37 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-37 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-36 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-36 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-36 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-36 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-36 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-36 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-35 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-35 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-34 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-34 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-34 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 7e-34 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-34 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-33 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-33 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-33 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-33 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-33 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-33 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-33 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-33 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-33 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-32 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-32 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-32 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-32 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-32 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-32 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-32 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-31 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-31 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-31 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-31 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-31 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-31 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-31 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-31 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-31 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-30 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-30 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-30 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-30 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-30 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-30 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-30 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-29 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-29 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-29 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-29 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-29 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-29 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-29 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-29 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-28 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-28 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-28 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-28 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-28 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-28 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-28 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-27 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-27 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-27 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-27 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-27 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-27 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-27 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-27 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-27 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-27 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-26 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-26 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-26 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-26 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-26 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-26 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-26 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-26 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-26 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-26 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-25 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-25 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-25 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-25 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-25 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-25 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-25 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-25 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-25 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-25 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-25 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-25 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-25 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-25 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-25 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-25 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-24 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-24 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-24 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-24 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-24 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-24 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-24 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-24 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-24 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-24 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-24 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-24 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-23 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-23 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-23 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-23 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-23 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-23 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-22 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-22 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-22 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-22 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-22 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-22 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-21 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-21 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-21 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-21 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-21 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-21 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-21 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-21 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-21 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-20 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-20 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-20 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-20 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-20 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-20 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-20 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-20 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-20 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-20 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-19 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-19 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-19 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-19 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-19 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-19 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-19 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-18 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-18 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-18 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-18 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-18 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-18 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-17 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-17 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-17 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-16 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-16 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-16 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 8e-16 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-15 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-15 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-15 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-15 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-15 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-14 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-14 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-13 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-13 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-13 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-11 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-11 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-10 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-10 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-10 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-09 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-09 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-09 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-09 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-09 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-08 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-08 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-08 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-08 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-08 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-07 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-07 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-07 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 4e-07 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-07 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-06 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-06 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-06 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-06 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-05 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 3e-05 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-05 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-05 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-05 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 9e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-04 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-04 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-04 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-04 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 6e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-04 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 7e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 0.002 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.002 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.002 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.003 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 0.003 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 310 bits (797), Expect = e-106
Identities = 114/260 (43%), Positives = 153/260 (58%), Gaps = 7/260 (2%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
YE+ +LG G FG YL D++ G A K I KKK++ D E + RE+ I++ L KH
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKK--DRERILREIKILKKL-KHP 57
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
NIV L D +ED+ ++LVME CEGG+LFD + RG +E A + I+ ++ H G
Sbjct: 58 NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN-YG 235
++HRDLKPEN L +K DFGL+ PGEK + VG+P YMAPEVL YG
Sbjct: 118 IVHRDLKPENILLDEDGH---VKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYG 174
Query: 236 PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKM 295
VD+WS GVILY LL G PPF + + I P +S AKDL+RK+
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234
Query: 296 LDPDPKRRLTAQQVLEHPWL 315
L DP++RLTA++ L+HP+
Sbjct: 235 LVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 286 bits (735), Expect = 1e-96
Identities = 113/266 (42%), Positives = 151/266 (56%), Gaps = 13/266 (4%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
YEL R+LG G FG Y + G A K + K+ ++ D RRE+ I+R L H
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTA-RREIRILRRL-SHP 58
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
NIV L D +ED ++LVME CEGG+LFD + G +E A + I+ ++ H +G
Sbjct: 59 NIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG 118
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKFSEIVGSPYYMAPEVLK--RN 233
++HRDLKPEN L +K DFGL+ K + VG+P+YMAPEVL
Sbjct: 119 IIHRDLKPENILLDENGV---VKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNG 175
Query: 234 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL----DFRRDPWPKVSENAK 289
YGP+VDVWS GVILY LL G PPF E +IR +L +F W SE AK
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQ-LQLIRRILGPPLEFDEPKWSSGSEEAK 234
Query: 290 DLVRKMLDPDPKRRLTAQQVLEHPWL 315
DL++K L+ DP +R TA+++L+HPW
Sbjct: 235 DLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 217 bits (555), Expect = 2e-69
Identities = 89/257 (34%), Positives = 137/257 (53%), Gaps = 13/257 (5%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG L ++ G +A K + KKK+ ++E E +I+ + H IV L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLH 59
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
++ + ++LV+E GGELF + G ++E A IV ++ H G+++RDL
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDL 119
Query: 183 KPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDV 240
KPEN L +K DFGL+ G + + G+P Y+APEVL YG VD
Sbjct: 120 KPENILL---DADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDW 176
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
WS GV+LY +L G PPF+AE + + + I++ L F P +S A+DL+ +L DP
Sbjct: 177 WSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRF---P-EFLSPEARDLISGLLQKDP 232
Query: 301 KRRLT---AQQVLEHPW 314
+RL A+++ HP+
Sbjct: 233 TKRLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 200 bits (512), Expect = 2e-63
Identities = 91/255 (35%), Positives = 127/255 (49%), Gaps = 44/255 (17%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG G FG YL D++ G A K I K+ + + E++ RE++I++ L H NIV L
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLL--EELLREIEILKKL-NHPNIVKLY 57
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRD 181
+ED+ ++LVME CEGG L D + G +E + I+E ++ H +G++HRD
Sbjct: 58 GVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 182 LKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIVGSPYYMAPEVLKRN--YGPEV 238
LKPEN L + +K DFGLS IVG+P YMAPEVL Y +
Sbjct: 118 LKPENILLDSDNGK--VKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 239 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298
D+WS GVILY L KDL+RKML
Sbjct: 176 DIWSLGVILYEL-----------------------------------PELKDLIRKMLQK 200
Query: 299 DPKRRLTAQQVLEHP 313
DP++R +A+++LEH
Sbjct: 201 DPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 2e-60
Identities = 80/272 (29%), Positives = 138/272 (50%), Gaps = 30/272 (11%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
+YE+ +++G+G FG YL + +G + K I + + ED EV I++ L H
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEK-EREDALNEVKILKKL-NH 58
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTKTIVEV-VQ 170
NI+ +++E+ + +VME +GG+L +I + + E + I++ VQ
Sbjct: 59 PNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPE-------EQILDWFVQ 111
Query: 171 MC------HKHGVMHRDLKPEN-FLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSP 222
+C H ++HRD+KP+N FL +N +K DFG+S V + +VG+P
Sbjct: 112 LCLALKYLHSRKILHRDIKPQNIFLTSNGL----VKLGDFGISKVLSSTVDLAKTVVGTP 167
Query: 223 YYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281
YY++PE+ + Y + D+WS G +LY L PF E +A I++ + P
Sbjct: 168 YYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKG--QYPPIP- 224
Query: 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHP 313
+ S ++LV +L DP+ R + Q+L+ P
Sbjct: 225 SQYSSELRNLVSSLLQKDPEERPSIAQILQSP 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 192 bits (491), Expect = 1e-59
Identities = 87/268 (32%), Positives = 137/268 (51%), Gaps = 19/268 (7%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+ +G +G +L + GD +A K I K + ++ V E DI+ + +V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVKLY 59
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
+++ ++LVME GG+L + G E A IV ++ H +G++HRDL
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDL 119
Query: 183 KPENFLFANKKETAPLKAIDFGLSVF---------FKPGEKFSEIVGSPYYMAPEV-LKR 232
KP+N L + LK DFGLS ++ IVG+P Y+APEV L +
Sbjct: 120 KPDNILIDSNGH---LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176
Query: 233 NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
+ VD WS G ILY L G+PPF ET + + Q I+ +++ D +VS+ A DL+
Sbjct: 177 GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEAIDLI 234
Query: 293 RKMLDPDPKRRLTA---QQVLEHPWLQN 317
K+L PDP++RL A +++ HP+ +
Sbjct: 235 SKLLVPDPEKRLGAKSIEEIKNHPFFKG 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 188 bits (480), Expect = 8e-58
Identities = 77/284 (27%), Positives = 125/284 (44%), Gaps = 33/284 (11%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
++ G+ +G G F L ++E +A K + K++L ++ V+ E +++ L H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
I+ L T++D+ ++ V+E GEL I G E+ I+ ++ H G
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI------------------ 218
++HRDLKPEN L +K DFG + P
Sbjct: 123 IIHRDLKPENILLDKDMH---IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179
Query: 219 ---VGSPYYMAPEVLKRNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL 274
VG+ Y++PE+L G D+W+ G I+Y +L G PPF E Q I++
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239
Query: 275 DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTA----QQVLEHPW 314
F P +AKDL+ K+L DP+ RL ++ HP+
Sbjct: 240 SFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 1e-57
Identities = 86/267 (32%), Positives = 132/267 (49%), Gaps = 14/267 (5%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
+ G LGRG FG YL D++ G+ A KS+ + + ++E + RE+ I+ L +H
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSV-ELSGDSEEELEALEREIRILSSL-QH 58
Query: 116 QNIVCLKDTYEDDTAVHL--VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
NIV + D+ L +E GG L + G E T+ I+E + H
Sbjct: 59 PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLH 118
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE---IVGSPYYMAPEVL 230
+G++HRD+K N L + +K DFG + E + G+PY+MAPEV+
Sbjct: 119 SNGIVHRDIKGANILVDSDGV---VKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 231 KRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-VSENA 288
+ YG D+WS G + + G PP W+E A+ + P+ +SE A
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPP-WSELGN-PMAALYKIGSSGEPPEIPEHLSEEA 233
Query: 289 KDLVRKMLDPDPKRRLTAQQVLEHPWL 315
KD +RK L DPK+R TA ++L+HP+L
Sbjct: 234 KDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 182 bits (463), Expect = 1e-55
Identities = 85/262 (32%), Positives = 137/262 (52%), Gaps = 14/262 (5%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+E+ ++G+G FG Y + G A K I KL + E + E+ I++ KH
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVI---KLESKEKKEKIINEIQILKKC-KHP 57
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIVEVVQMCHKH 175
NIV +Y + +VME C GG L D + + TE A V K +++ ++ H +
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR-NY 234
G++HRD+K N L + E +K IDFGLS + + +VG+PY+MAPEV+ Y
Sbjct: 118 GIIHRDIKAANILLTSDGE---VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPY 174
Query: 235 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR-SVLDFRRDPWP-KVSENAKDLV 292
+ D+WS G+ L G PP+ +E +A+ + + P K S+ KD +
Sbjct: 175 DYKADIWSLGITAIELAEGKPPY---SELPPMKALFKIATNGPPGLRNPEKWSDEFKDFL 231
Query: 293 RKMLDPDPKRRLTAQQVLEHPW 314
+K L +P++R TA+Q+L+HP+
Sbjct: 232 KKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 182 bits (461), Expect = 3e-54
Identities = 94/293 (32%), Positives = 140/293 (47%), Gaps = 28/293 (9%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
Y + R+LG G FG YL DR+ A K ++KK + ++E RE+ I+ L
Sbjct: 2 YRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH---YTERAAAAVTKTIVEVVQMCH 173
NIV L D ++D+ +++LVME +GG L D + G +E A + I+ ++ H
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-------EKFSEIVGSPYYMA 226
G++HRD+KPEN L ++ +K IDFGL+ S VG+P YMA
Sbjct: 119 SKGIIHRDIKPENILL--DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 227 PEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL-------- 274
PEVL D+WS G+ LY LL G+PPF E ++ +L
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236
Query: 275 -DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSL 326
+S+ A DL++K+L DPK RL++ L H L + K +
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLS 289
|
Length = 384 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 7e-51
Identities = 86/293 (29%), Positives = 133/293 (45%), Gaps = 41/293 (13%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
RY++ +G G GI + DRE G+ A K ++ ++L + RE+ ++ +H
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIP-NQALREIKALQAC-QH 58
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIVEVVQMCHK 174
+V L D + + LVME +L + + E + + +++ V H
Sbjct: 59 PYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA 117
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK--FSEIVGSPYYMAPEVL-- 230
+G+MHRDLKP N L + LK DFGL+ F E +S V + +Y APE+L
Sbjct: 118 NGIMHRDLKPANLLIS---ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG 174
Query: 231 KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ-AIIRSVL--------------- 274
R Y P VD+W+ G I LL G P F E + + Q AI+ L
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGSPLFPGEND--IEQLAIVFRTLGTPNEETWPGLTSLP 232
Query: 275 DF--------RRDPW----PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
D+ + P P S A DL++ +L DP +RL+A + L HP+
Sbjct: 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 8e-50
Identities = 83/265 (31%), Positives = 131/265 (49%), Gaps = 18/265 (6%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG G FG L + FA K + K+ + E + E +I+ H IV L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLY 59
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
T++D ++++ME C GGEL+ + RG + E A +V + H G+++RDL
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDL 119
Query: 183 KPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEV-LKRNYGPEVDVW 241
KPEN L + +K +DFG + K G+K G+P Y+APE+ L + Y VD W
Sbjct: 120 KPENLLLDSN---GYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYW 176
Query: 242 SAGVILYILLCGVPPFWAETE--QGVAQAIIRSV--LDFRRDPWPKVSENAKDLVRKMLD 297
S G++LY LL G PPF + E + I++ L+F + + AKDL++++L
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPN----YIDKAAKDLIKQLLR 232
Query: 298 PDPKRRLTAQQ-----VLEHPWLQN 317
+P+ RL + + +H W
Sbjct: 233 RNPEERLGNLKGGIKDIKKHKWFNG 257
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 9e-49
Identities = 86/264 (32%), Positives = 139/264 (52%), Gaps = 14/264 (5%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
Y+LG +GRG FG+ Y + E GD A K IS +K++ ++ + +E+D++++L KH
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEE-ALKSIMQEIDLLKNL-KH 58
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH 175
NIV + E ++++++E E G L I G + E A +++ + H+
Sbjct: 59 PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ 118
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKFSEIVGSPYYMAPEVLKRNY 234
GV+HRD+K N L K L DFG++ + + +VG+PY+MAPEV+
Sbjct: 119 GVIHRDIKAANILT-TKDGVVKLA--DFGVATKLNDVSKDDASVVGTPYWMAPEVI-EMS 174
Query: 235 GPEV--DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-VSENAKDL 291
G D+WS G + LL G PP++ + A+ R V D P P+ +S KD
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPYY---DLNPMAALFRIVQD-DHPPLPEGISPELKDF 230
Query: 292 VRKMLDPDPKRRLTAQQVLEHPWL 315
+ + DP R TA+Q+L+HPW+
Sbjct: 231 LMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 2e-48
Identities = 92/295 (31%), Positives = 142/295 (48%), Gaps = 37/295 (12%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+ +E+ + +GRG FG +L D++ G +A K + K + I VR E DI+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD-AD 59
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
IV L +++D+ ++LVME GG+L + ++ + + E A +V + HK
Sbjct: 60 SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHK 119
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLS--------------------------VF 208
G +HRD+KP+N L +K DFGL V
Sbjct: 120 LGFIHRDIKPDNILID---ADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176
Query: 209 FKPGEK----FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQ 263
+ ++ + VG+P Y+APEVL+ YG E D WS GVILY +L G PPF+++T Q
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236
Query: 264 GVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLT-AQQVLEHPWLQN 317
II R P P VS A DL+ ++L DP+ RL +++ HP+ +
Sbjct: 237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLL-CDPEDRLGSFEEIKSHPFFKG 290
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 161 bits (411), Expect = 2e-47
Identities = 87/274 (31%), Positives = 138/274 (50%), Gaps = 24/274 (8%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACK--SISKKKLRTAVDIEDVRREVDIMRH 111
E Y+ ++G G G Y TDR G A K + K+ + E+ IM+
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII------NEILIMKD 71
Query: 112 LPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHY---TERAAAAVTKTIVEV 168
KH NIV D+Y + +VME +GG L D + ++ E A V + +++
Sbjct: 72 C-KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTD--IITQNFVRMNEPQIAYVCREVLQG 128
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYYMAP 227
++ H V+HRD+K +N L + +K DFG + K K + +VG+PY+MAP
Sbjct: 129 LEYLHSQNVIHRDIKSDNILLSKDGS---VKLADFGFAAQLTKEKSKRNSVVGTPYWMAP 185
Query: 228 EVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI--IRSVLDFRRDPWPKV 284
EV+KR YGP+VD+WS G++ + G PP+ E +A+ I + K
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP---LRALFLITTKGIPPLKNPEKW 242
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318
S KD + K L DP++R +A+++L+HP+L+ A
Sbjct: 243 SPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 4e-47
Identities = 84/264 (31%), Positives = 135/264 (51%), Gaps = 16/264 (6%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+E + LG G FG L + +G +A K +SK K+ +E V E I++ + +H
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHP 61
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
+V L +++DD+ ++LVME GGELF + G + E A +V ++ H
Sbjct: 62 FLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD 121
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEV-LKRNYG 235
+++RDLKPEN L + +K DFG + K + G+P Y+APE+ L + YG
Sbjct: 122 IVYRDLKPENLLLDS---DGYIKITDFGFAKRVKGRTY--TLCGTPEYLAPEIILSKGYG 176
Query: 236 PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKM 295
VD W+ G+++Y +L G PPF+ + + + I+ + F P S +AKDL+R +
Sbjct: 177 KAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRF---P-SFFSPDAKDLIRNL 232
Query: 296 LDPDPKRRL-----TAQQVLEHPW 314
L D +RL + HPW
Sbjct: 233 LQVDLTKRLGNLKNGVNDIKNHPW 256
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 1e-45
Identities = 77/262 (29%), Positives = 124/262 (47%), Gaps = 8/262 (3%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+EL R +G+G FG + R+ FA K ++K+K + +V E I++ L H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHP 60
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
+V L +++D+ ++LV++L GG+L + + ++E IV ++ H G
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG 120
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR-NYG 235
++HRD+KP+N L E + DF ++ P + G+P YMAPEVL R Y
Sbjct: 121 IIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYS 177
Query: 236 PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKM 295
VD WS GV Y L G P+ + Q I S A D + K+
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ-IRAKQETADVLYPATWSTEAIDAINKL 236
Query: 296 LDPDPKRRL--TAQQVLEHPWL 315
L+ DP++RL + + HP+
Sbjct: 237 LERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 3e-45
Identities = 81/293 (27%), Positives = 138/293 (47%), Gaps = 45/293 (15%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMRHL 112
YE +LG G +G+ Y D++ G+ A K K+R + E + RE+ +++ L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALK-----KIRLDNEEEGIPSTALREISLLKEL 55
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTKTIVEVVQ 170
KH NIV L D + ++LV E C+ + D+ G + ++ ++ +
Sbjct: 56 -KHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLA 112
Query: 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIVGSPYYMAPEV 229
CH H ++HRDLKP+N + N+ LK DFGL+ F P ++ V + +Y APE+
Sbjct: 113 YCHSHRILHRDLKPQN-ILINRDGV--LKLADFGLARAFGIPLRTYTHEVVTLWYRAPEI 169
Query: 230 L--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR-------------SVL 274
L ++Y VD+WS G I ++ G P F ++E I + + L
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL 229
Query: 275 DFRRDPWPK------------VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
+ +PK + DL+ KML +P +R++A++ L+HP+
Sbjct: 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 4e-45
Identities = 82/263 (31%), Positives = 129/263 (49%), Gaps = 10/263 (3%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
+ + +G FG YL R GD FA K + K + + +V+ E IM + +
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
L +++ ++LVME GG+ I G E A +V V+ H+ G++HR
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHR 121
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPE-VD 239
D+KPEN L +T LK DFGLS + G + + VG+P Y+APE + + D
Sbjct: 122 DIKPENLLI---DQTGHLKLTDFGLS---RNGLENKKFVGTPDYLAPETILGVGDDKMSD 175
Query: 240 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPD 299
WS G +++ L G PPF AET V I+ +++ + S A DL+ ++L D
Sbjct: 176 WWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235
Query: 300 PKRRLTA---QQVLEHPWLQNAK 319
P +RL A Q++ HP+ ++
Sbjct: 236 PAKRLGANGYQEIKSHPFFKSIN 258
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 5e-44
Identities = 84/292 (28%), Positives = 127/292 (43%), Gaps = 42/292 (14%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR--REVDIMRHLPK 114
Y+ ++G G +G+ Y D+ G+ A K I KLR + RE+ +++ L
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKI---KLRFESEGIPKTALREIKLLKEL-N 56
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTKTIVEVVQMC 172
H NI+ L D + ++LV E + +L + E + +++ + C
Sbjct: 57 HPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFC 114
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVL- 230
H HG++HRDLKPEN L LK DFGL+ F P ++ V + +Y APE+L
Sbjct: 115 HSHGILHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLL 171
Query: 231 -KRNYGPEVDVWSAGVILYILLCGVPPFWAETE-------------------QGVAQAII 270
+ Y VD+WS G I LL P F ++E
Sbjct: 172 GDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231
Query: 271 RSVLDFR---RDPWPKV----SENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
F P PK+ S A DL+ +ML DP +R+TA+Q L HP+
Sbjct: 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 6e-44
Identities = 86/262 (32%), Positives = 131/262 (50%), Gaps = 13/262 (4%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCL 121
++G+G +G +L ++ G+ A K + K L ++ V E DI+ K + +V L
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT-TKSEWLVKL 66
Query: 122 KDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRD 181
++DD ++L ME GG+ + G +E A + E V H+ G +HRD
Sbjct: 67 LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRD 126
Query: 182 LKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDV 240
LKPENFL + +K DFGLS + +VGSP YMAPEVL+ + Y VD
Sbjct: 127 LKPENFLI---DASGHIKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRGKGYDFTVDY 181
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR----DPWPKVSENAKDLVRKML 296
WS G +LY LCG PPF T + + +R DP +S+ A DL+ K++
Sbjct: 182 WSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLI 241
Query: 297 DPDPKRRLTA-QQVLEHPWLQN 317
+ DP RR + + + HP+ +
Sbjct: 242 N-DPSRRFGSLEDIKNHPFFKE 262
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 3e-43
Identities = 95/297 (31%), Positives = 143/297 (48%), Gaps = 52/297 (17%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR--REVDIMRHLPK 114
Y++ ++LG G FG YL ++E G+ A K + KKK + E+ REV +R L +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYS---WEECMNLREVKSLRKLNE 56
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMC 172
H NIV LK+ + ++ ++ V E EG L+ + R ++E ++ I++ +
Sbjct: 57 HPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR 232
HKHG HRDLKPEN L + E +K DFGL+ + +++ V + +Y APE+L R
Sbjct: 116 HKHGFFHRDLKPENLLVSG-PEV--VKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLR 172
Query: 233 --NYGPEVDVWSAGVI---LYIL---------------LCGV-----PPFWAETEQGVAQ 267
+Y VD+W+ G I LY L +C V W E + +A
Sbjct: 173 STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK-LAS 231
Query: 268 AIIRSVLDFR---------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
L FR P S A DL++ ML DPK+R TA Q L+HP+
Sbjct: 232 K-----LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 4e-42
Identities = 87/296 (29%), Positives = 141/296 (47%), Gaps = 41/296 (13%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSI---SKKKLRTAVDIEDVRREVDIMRHL 112
RYE G++LG G + + Y D+E G A K I +K+ + ++ RE+ +++ L
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINF-TALREIKLLQEL 59
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEG---GELFDRIVARGHYTERAAAAVTKTIVEVV 169
KH NI+ L D + + ++LV E E + D+ + T + + +
Sbjct: 60 -KHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIV---LTPADIKSYMLMTLRGL 115
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKFSEIVGSPYYMAPE 228
+ H + ++HRDLKP N L A+ LK DFGL+ F P K + V + +Y APE
Sbjct: 116 EYLHSNWILHRDLKPNNLLIASDGV---LKLADFGLARSFGSPNRKMTHQVVTRWYRAPE 172
Query: 229 VL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV-- 284
+L R+YG VD+WS G I LL VP +++ I ++ + WP V
Sbjct: 173 LLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232
Query: 285 ----------------------SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318
S++A DL++++L +P +R+TA+Q LEHP+ N
Sbjct: 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 4e-41
Identities = 79/272 (29%), Positives = 131/272 (48%), Gaps = 20/272 (7%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
R++ G ++G G FG Y + + G+ A K I + I+++ E+ ++ L KH
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKT-IKEIADEMKVLELL-KH 58
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH 175
N+V V++ ME C GG L + + E T ++E + H H
Sbjct: 59 PNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH 118
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-----GEKFSEIVGSPYYMAPEVL 230
G++HRD+KP N + +K DFG +V K GE+ + G+P YMAPEV+
Sbjct: 119 GIVHRDIKPANIFLDHN---GVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 231 KRN----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP---K 283
+G D+WS G ++ + G P W+E + I+ V + P P +
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKRP-WSELDN--EFQIMFHVGAGHKPPIPDSLQ 232
Query: 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
+S KD + + L+ DPK+R TA ++L+HP++
Sbjct: 233 LSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 7e-41
Identities = 72/272 (26%), Positives = 125/272 (45%), Gaps = 20/272 (7%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMRHLP 113
E + LG+G G+ Y + G +A K I E+ R RE+ +R
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKI------HVDGDEEFRKQLLRELKTLRSCE 57
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
+V + + + +V+E +GG L D + G E A + + I++ + H
Sbjct: 58 -SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLH 116
Query: 174 -KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-EKFSEIVGSPYYMAPEVLK 231
K ++HRD+KP N L +K E +K DFG+S + ++ + VG+ YM+PE ++
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGE---VKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQ 173
Query: 232 -RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK--VSENA 288
+Y D+WS G+ L G PF Q +++++ D P S
Sbjct: 174 GESYSYAADIWSLGLTLLECALGKFPF-LPPGQPSFFELMQAICDGPPPSLPAEEFSPEF 232
Query: 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320
+D + L DPK+R +A ++L+HP+++ A
Sbjct: 233 RDFISACLQKDPKKRPSAAELLQHPFIKKADN 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 8e-41
Identities = 91/276 (32%), Positives = 139/276 (50%), Gaps = 23/276 (8%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDA---FACKSISK----KKLRTAVDIEDVRREVDIM 109
+EL R LG G +G +L DA +A K + K +K +TA E R E ++
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTA---EHTRTERQVL 58
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV 169
+ + +V L ++ DT +HL+++ GGELF + R H+TE IV +
Sbjct: 59 EAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLAL 118
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS--EIVGSPYYMAP 227
H+ G+++RD+K EN L + DFGLS F E+ G+ YMAP
Sbjct: 119 DHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175
Query: 228 EVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK- 283
EV++ + VD WS GV+ + LL G PF + EQ I R +L + P+PK
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK-SKPPFPKT 234
Query: 284 VSENAKDLVRKMLDPDPKRRL---TAQQVLEHPWLQ 316
+S A+D ++K+L+ DPK+RL A ++ HP+ Q
Sbjct: 235 MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 2e-39
Identities = 78/270 (28%), Positives = 133/270 (49%), Gaps = 20/270 (7%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+ E + +G G FG +L DR + +A K ++ ++ + V E +++ +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-S 59
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H I+ L T D ++++ME GGELF + G ++ IV ++ H
Sbjct: 60 HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHS 119
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN- 233
+++RDLKPEN L + +K DFG + K ++ + G+P Y+APEV++
Sbjct: 120 KEIVYRDLKPENILLDKEGH---IKLTDFGFAK--KLRDRTWTLCGTPEYLAPEVIQSKG 174
Query: 234 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR--DPWPKVSENAKDL 291
+ VD W+ G+++Y +L G PPF+ + G+ + I+ L+F R D + AKDL
Sbjct: 175 HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLY------AKDL 228
Query: 292 VRKMLDPDPKRRL-----TAQQVLEHPWLQ 316
++K+L D RRL A V H W +
Sbjct: 229 IKKLLVVDRTRRLGNMKNGADDVKNHRWFK 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 4e-39
Identities = 85/271 (31%), Positives = 131/271 (48%), Gaps = 23/271 (8%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
YE+ +G+G FG + +G K I + T + + + EV+I+R L KH
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILREL-KHP 59
Query: 117 NIV--CLKDTYEDDTAVHLVMELCEGGELFDRI----VARGHYTERAAAAVTKTIVEVVQ 170
NIV + + +++VME CEGG+L I R + E + ++ +
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 171 MCH-----KHGVMHRDLKPEN-FLFANKKETAPLKAIDFGLSVFFKPGEKF-SEIVGSPY 223
CH + V+HRDLKP N FL AN +K DFGL+ F VG+PY
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNN----VKLGDFGLAKILGHDSSFAKTYVGTPY 175
Query: 224 YMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282
YM+PE L Y + D+WS G ++Y L PPF A + +A I FRR P
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG--KFRRIP-Y 232
Query: 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLEHP 313
+ S ++++ ML+ DP +R + +++L+ P
Sbjct: 233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 3e-38
Identities = 93/273 (34%), Positives = 134/273 (49%), Gaps = 25/273 (9%)
Query: 56 RYELGR--ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
R L ++G G GI + TD+ G A K K LR E + EV IMR
Sbjct: 18 RSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVK---KMDLRKQQRRELLFNEVVIMRDYQ 74
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
H NIV + +Y + +VME EGG L D IV E A V +++ + H
Sbjct: 75 -HPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLH 132
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVLKR 232
GV+HRD+K ++ L +K DFG + K + +VG+PY+MAPEV+ R
Sbjct: 133 AQGVIHRDIKSDSILL---TSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISR 189
Query: 233 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP------KVS 285
YG EVD+WS G+++ ++ G PP++ E QA+ R R + P KVS
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP---LQAMKR----IRDNLPPKLKNLHKVS 242
Query: 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318
+ + +ML DP +R TA ++L HP+L A
Sbjct: 243 PRLRSFLDRMLVRDPAQRATAAELLNHPFLAKA 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 5e-38
Identities = 94/307 (30%), Positives = 143/307 (46%), Gaps = 65/307 (21%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMR 110
+YE+ +G G +G+ C ++ G+ A K K + + D EDV+ REV ++R
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIK-----KFKESEDDEDVKKTALREVKVLR 55
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTER-----AAAAVTKTI 165
L +H+NIV LK+ + ++LV E E L E AV I
Sbjct: 56 QL-RHENIVNLKEAFRRKGRLYLVFEYVERTLL--------ELLEASPGGLPPDAVRSYI 106
Query: 166 VEVVQ---MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF--KPGEKFSEIVG 220
+++Q CH H ++HRD+KPEN L E+ LK DFG + +P ++ V
Sbjct: 107 WQLLQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPASPLTDYVA 163
Query: 221 SPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQA-IIRSVL--- 274
+ +Y APE+L NYG VDVW+ G I+ LL G P F +++ + Q +I+ L
Sbjct: 164 TRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD--IDQLYLIQKCLGPL 221
Query: 275 ------DFRRDP------WP--------------KVSENAKDLVRKMLDPDPKRRLTAQQ 308
F +P +P KVS A D ++ L DPK RLT +
Sbjct: 222 PPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDE 281
Query: 309 VLEHPWL 315
+L+HP+
Sbjct: 282 LLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 8e-38
Identities = 94/310 (30%), Positives = 136/310 (43%), Gaps = 66/310 (21%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR---REVDIMRHL 112
RYEL + +G G +G+ D+ G A K IS D+ D + RE+ ++RHL
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKIS----NVFDDLIDAKRILREIKLLRHL 56
Query: 113 PKHQNIVCLKD-----TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE 167
+H+NI+ L D + ED V++V EL E +L I + T+
Sbjct: 57 -RHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFL----- 109
Query: 168 VVQMC------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK----FSE 217
Q+ H V+HRDLKP N + N LK DFGL+ P E +E
Sbjct: 110 -YQILRGLKYLHSANVIHRDLKPSN-ILVNSNCD--LKICDFGLARGVDPDEDEKGFLTE 165
Query: 218 IVGSPYYMAPEVL--KRNYGPEVDVWSAGVIL--------------YI----LLC---GV 254
V + +Y APE+L Y +D+WS G I YI L+ G
Sbjct: 166 YVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGT 225
Query: 255 PPFWAETEQGV----AQAIIRSVLDFRRDPW----PKVSENAKDLVRKMLDPDPKRRLTA 306
P E + + A+ ++S+ + P P S A DL+ KML DPK+R+TA
Sbjct: 226 PS--EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITA 283
Query: 307 QQVLEHPWLQ 316
+ L HP+L
Sbjct: 284 DEALAHPYLA 293
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 4e-37
Identities = 88/288 (30%), Positives = 146/288 (50%), Gaps = 26/288 (9%)
Query: 57 YELGRELGRGEFGITYLC---TDRENGDAFACKSISKKKL-RTAVDIEDVRREVDIMRHL 112
+EL + LG G +G +L + ++G +A K + K + + A E R E ++ H+
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC 172
+ +V L ++ DT +HL+++ GGELF + R + E+ + IV ++
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF--KPGEKFSEIVGSPYYMAPEVL 230
HK G+++RD+K EN L + DFGLS F E+ G+ YMAP+++
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVV---LTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 231 K---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-VSE 286
+ + VD WS GV++Y LL G PF + E+ I R +L P+P+ +S
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYPQEMSA 237
Query: 287 NAKDLVRKMLDPDPKRRL-----TAQQVLEHPWLQN-------AKKAP 322
AKD+++++L DPK+RL A ++ +HP+ Q AKK P
Sbjct: 238 LAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKKVP 285
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 5e-37
Identities = 82/268 (30%), Positives = 131/268 (48%), Gaps = 18/268 (6%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACK--SISKKKLRTAVDIEDVRREVDIMRHLP 113
R+ G LG G FG Y + ++GD FA K S++ ++ + +E+ ++ L
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL- 59
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
+H NIV T ++ +++ +EL GG L + G + E T+ I+ ++ H
Sbjct: 60 QHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLH 119
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI---VGSPYYMAPEVL 230
+HRD+K N L +K DFG++ K +FS GSPY+MAPEV+
Sbjct: 120 DRNTVHRDIKGANILVDTNGV---VKLADFGMA---KQVVEFSFAKSFKGSPYWMAPEVI 173
Query: 231 KR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-VSEN 287
+ YG D+WS G + + G PP W++ E A+ + P P +S+
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGKPP-WSQLEG--VAAVFKIGRSKELPPIPDHLSDE 230
Query: 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
AKD + K L DP R TA ++LEHP++
Sbjct: 231 AKDFILKCLQRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-36
Identities = 82/285 (28%), Positives = 138/285 (48%), Gaps = 33/285 (11%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD-IEDVRREVDIMRHLP 113
E + L +G+G FG Y D+ A K I L A D IED+++E+ +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID---LEEAEDEIEDIQQEIQFLSQC- 56
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
+ I ++ + + ++ME C GG D ++ G E A + + ++ ++ H
Sbjct: 57 RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDETYIAFILREVLLGLEYLH 115
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE------KFSEIVGSPYYMAP 227
+ G +HRD+K N L + E +K DFG+S G+ K + VG+P++MAP
Sbjct: 116 EEGKIHRDIKAANILLS---EEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAP 167
Query: 228 EVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV-- 284
EV+K++ Y + D+WS G+ L G PP V I + +P P +
Sbjct: 168 EVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP------KNNP-PSLEG 220
Query: 285 ---SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSL 326
S+ KD V L+ DPK R +A+++L+H +++ AKK ++L
Sbjct: 221 NKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKTSYLTL 265
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 2e-36
Identities = 81/266 (30%), Positives = 124/266 (46%), Gaps = 16/266 (6%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
Y R LG+G FG L E+ K ++ +L D E+ I+ L +H
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKER-RDALNEIVILSLL-QH 58
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCH 173
NI+ + + DD + + ME GG L+D+IV + + E IV V H
Sbjct: 59 PNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH 118
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS---EIVGSPYYMAPEVL 230
K G++HRD+K N +F K +K DFG+S G ++S +VG+PYYM+PE+
Sbjct: 119 KAGILHRDIKTLN-IFLTK--AGLIKLGDFGISK--ILGSEYSMAETVVGTPYYMSPELC 173
Query: 231 K-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289
+ Y + D+W+ G +LY LL F A + I++ + S
Sbjct: 174 QGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVY---SSELI 230
Query: 290 DLVRKMLDPDPKRRLTAQQVLEHPWL 315
LV +L DP++R TA +VL+ P L
Sbjct: 231 SLVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 3e-36
Identities = 89/259 (34%), Positives = 139/259 (53%), Gaps = 11/259 (4%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCL 121
++G G GI + T + +G A K K LR E + EV IMR +H+N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDY-QHENVVEM 82
Query: 122 KDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRD 181
++Y + +VME EGG L D IV E AAV +++ + + H GV+HRD
Sbjct: 83 YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRD 141
Query: 182 LKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVD 239
+K ++ L + +K DFG K + +VG+PY+MAPE++ R YGPEVD
Sbjct: 142 IKSDSILLTHDGR---VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVD 198
Query: 240 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPD 299
+WS G+++ ++ G PP++ E A +IR L + KVS + K + ++L D
Sbjct: 199 IWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRD 257
Query: 300 PKRRLTAQQVLEHPWLQNA 318
P +R TA ++L+HP+L A
Sbjct: 258 PAQRATAAELLKHPFLAKA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 3e-36
Identities = 83/275 (30%), Positives = 141/275 (51%), Gaps = 18/275 (6%)
Query: 57 YELGRELGRGEFGITYL---CTDRENGDAFACKSISKKKL-RTAVDIEDVRREVDIMRHL 112
+EL + LG G +G +L T + G +A K + K L + A +E R E +++ H+
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC 172
+ +V L ++ + +HL+++ GGE+F + R +++E + I+ ++
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEV 229
HK G+++RD+K EN L ++ DFGLS F EK +S G+ YMAPE+
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVV---LTDFGLSKEFLSEEKERTYS-FCGTIEYMAPEI 177
Query: 230 L--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287
+ K +G VD WS G++++ LL G PF E E+ + R +L +
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPE 237
Query: 288 AKDLVRKMLDPDPKRRL-----TAQQVLEHPWLQN 317
A+DL+ K+L DPK+RL A ++ EHP+ +
Sbjct: 238 AQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 3e-36
Identities = 83/282 (29%), Positives = 132/282 (46%), Gaps = 28/282 (9%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
+ +E+ ELG G FG Y +E G A K I ++ + ++ED E+DI+
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKII---QIESEEELEDFMVEIDILSEC- 59
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIVEVVQMC 172
KH NIV L + Y + + +++E C+GG L ++ TE V + ++E +
Sbjct: 60 KHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFL 119
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-EKFSEIVGSPYYMAPEVL- 230
H H V+HRDLK N L + +K DFG+S K +K +G+PY+MAPEV+
Sbjct: 120 HSHKVIHRDLKAGNILLTLDGD---VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVA 176
Query: 231 -----KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV- 284
Y + D+WS G+ L L PP E +R +L + P +
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIELAQMEPPH-HELN------PMRVLLKILKSEPPTLD 229
Query: 285 -----SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKA 321
S + D ++ L DP R TA ++L+HP++ +
Sbjct: 230 QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDN 271
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 7e-36
Identities = 86/280 (30%), Positives = 137/280 (48%), Gaps = 20/280 (7%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD-IEDVRREVDIMRHLPK 114
R EL +GRG +G Y G A K I+ L T D + D++REV ++ L +
Sbjct: 5 RLEL---IGRGAYGAVYRGKHVPTGRVVALKIIN---LDTPDDDVSDIQREVALLSQLRQ 58
Query: 115 HQ--NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQM 171
Q NI +Y + ++ME EGG + R + + G E+ + + + ++ ++
Sbjct: 59 SQPPNITKYYGSYLKGPRLWIIMEYAEGGSV--RTLMKAGPIAEKYISVIIREVLVALKY 116
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVL 230
HK GV+HRD+K N L N T +K DFG++ K S VG+PY+MAPEV+
Sbjct: 117 IHKVGVIHRDIKAANILVTN---TGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVI 173
Query: 231 K--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288
+ Y + D+WS G+ +Y + G PP+ I +S R S+
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPP--RLEDNGYSKLL 231
Query: 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGE 328
++ V LD +PK RL+A+++L+ W++ K P L E
Sbjct: 232 REFVAACLDEEPKERLSAEELLKSKWIKAHSKTPVSILKE 271
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 1e-35
Identities = 85/298 (28%), Positives = 135/298 (45%), Gaps = 52/298 (17%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
YE ++G G +G Y +++ G+ A K I + + I +R E+ +++ L +H
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR-EIKLLQKL-RHP 58
Query: 117 NIVCLKD--TYEDDTAVHLVMELCEGGELFD--RIVARG--HYTERAAAAVTKTIVEVVQ 170
NIV LK+ T + ++++V E + D ++ +TE K ++E +Q
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMD----HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQ 114
Query: 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP--GEKFSEIVGSPYYMAPE 228
H +G++HRD+K N L N LK DFGL+ + ++ V + +Y PE
Sbjct: 115 YLHSNGILHRDIKGSNILINNDGV---LKLADFGLARPYTKRNSADYTNRVITLWYRPPE 171
Query: 229 VL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR---SVLDFRRDPWPK 283
+L YGPEVD+WS G IL L G P F TE + I S D + WP
Sbjct: 172 LLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTD---ENWPG 228
Query: 284 V---------------------------SENAKDLVRKMLDPDPKRRLTAQQVLEHPW 314
V +A DL+ K+L DPK+R++A Q L+H +
Sbjct: 229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 6e-35
Identities = 81/268 (30%), Positives = 134/268 (50%), Gaps = 16/268 (5%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+E+G LG G FG + + G+ +A K + K+++ ++ V +E I+ L H
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHP 78
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
IV + +++D+ V+ ++E GGELF + G + A +V + H
Sbjct: 79 FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD 138
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYG 235
+++RDLKPEN L NK +K DFG + K ++ + G+P Y+APEV++ + +G
Sbjct: 139 IIYRDLKPENLLLDNKGH---VKVTDFGFAK--KVPDRTFTLCGTPEYLAPEVIQSKGHG 193
Query: 236 PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKM 295
VD W+ GV+LY + G PPF+ +T + + I+ L F W A+DLV+ +
Sbjct: 194 KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN--W--FDGRARDLVKGL 249
Query: 296 LDPDPKRRLTA-----QQVLEHPWLQNA 318
L D +RL V HP+ A
Sbjct: 250 LQTDHTKRLGTLKGGVADVKNHPYFHGA 277
|
Length = 329 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 2e-34
Identities = 73/265 (27%), Positives = 127/265 (47%), Gaps = 13/265 (4%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
EE +++ +LG G +G Y +E G A K + ++ D++++ +E+ I++
Sbjct: 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQC- 55
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIVEVVQMC 172
IV +Y +T + +VME C G + D + TE AA+ ++ ++
Sbjct: 56 DSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYL 115
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLK 231
H + +HRD+K N L + + K DFG+S K + ++G+P++MAPEV++
Sbjct: 116 HSNKKIHRDIKAGNILLNEEGQ---AKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQ 172
Query: 232 R-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290
Y + D+WS G+ + G PP+ I DP K S D
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDP-EKWSPEFND 231
Query: 291 LVRKMLDPDPKRRLTAQQVLEHPWL 315
V+K L DP+ R +A Q+L+HP++
Sbjct: 232 FVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 4e-34
Identities = 81/266 (30%), Positives = 131/266 (49%), Gaps = 17/266 (6%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL--RTAVDIEDVRREVDIMRHLPK 114
+ G+ LG+G FG YLC D + G A K + T ++ + E+ ++++L +
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-Q 62
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H+ IV DD + + ME GG + D++ A G TE T+ I+E V+ H
Sbjct: 63 HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHS 122
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFG----LSVFFKPGEKFSEIVGSPYYMAPEVL 230
+ ++HRD+K N L + +K DFG L G + G+PY+M+PEV+
Sbjct: 123 NMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179
Query: 231 K-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW--PKVSEN 287
YG + DVWS G + +L PP WAE E A A I + +P VS +
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEKPP-WAEFE---AMAAIFKIATQPTNPQLPSHVSPD 235
Query: 288 AKDLVRKMLDPDPKRRLTAQQVLEHP 313
A++ +R+ + K+R +A+++L H
Sbjct: 236 ARNFLRRTFVENAKKRPSAEELLRHF 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 6e-34
Identities = 86/262 (32%), Positives = 141/262 (53%), Gaps = 23/262 (8%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCL 121
++G G GI + ++ +G A K + LR E + EV IMR +HQN+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDY-QHQNVVEM 83
Query: 122 KDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRD 181
+Y + ++ME +GG L D IV++ E A V +++++ + H GV+HRD
Sbjct: 84 YKSYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRD 142
Query: 182 LKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVD 239
+K ++ L +K DFG K K +VG+PY+MAPEV+ R YG EVD
Sbjct: 143 IKSDSILLTLDGR---VKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVD 199
Query: 240 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP------KVSENAKDLVR 293
+WS G+++ ++ G PP+++++ QA+ R R P P K+S +D +
Sbjct: 200 IWSLGIMVIEMVDGEPPYFSDSP---VQAMKR----LRDSPPPKLKNAHKISPVLRDFLE 252
Query: 294 KMLDPDPKRRLTAQQVLEHPWL 315
+ML +P+ R TAQ++L+HP+L
Sbjct: 253 RMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 7e-34
Identities = 84/297 (28%), Positives = 132/297 (44%), Gaps = 52/297 (17%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+GRG FG L ++ G +A K + K ++ + VR E DI+ + +V L
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAE-ADNPWVVKLY 67
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
+++D+ ++L+ME GG++ ++ + +TE + + HK G +HRD+
Sbjct: 68 YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDI 127
Query: 183 KPENFLFANKKETAPLKAIDFGLSVFFK---------------PGEKFSEI--------- 218
KP+N L K +K DFGL K P I
Sbjct: 128 KPDNLLLDAKGH---IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRK 184
Query: 219 ---------------VGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETE 262
VG+P Y+APEV L+ Y E D WS GVI+Y +L G PPF ++
Sbjct: 185 AETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNP 244
Query: 263 QGVAQAII--RSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE---HPW 314
Q + II + L F + +S AKDL++++ + +RRL V E HP+
Sbjct: 245 QETYRKIINWKETLQFPDE--VPLSPEAKDLIKRLC-CEAERRLGNNGVNEIKSHPF 298
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 8e-34
Identities = 83/294 (28%), Positives = 134/294 (45%), Gaps = 49/294 (16%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR--REVDIMRHLPK 114
Y++ ++G G F R+ G +A K + KK + +E V RE+ +R L
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFK---SLEQVNNLREIQALRRLSP 56
Query: 115 HQNIVCLKDTYEDDTA--VHLVMELCEGGELFDRIVARGHY-TERAAAAVTKTIVEVVQM 171
H NI+ L + D + LV EL + L++ I R E+ + +++ +
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDH 115
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFG--LSVFFKPGEKFSEIVGSPYYMAPEV 229
H++G+ HRD+KPEN L K + LK DFG ++ KP ++E + + +Y APE
Sbjct: 116 MHRNGIFHRDIKPENILI--KDDI--LKLADFGSCRGIYSKP--PYTEYISTRWYRAPEC 169
Query: 230 LKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ-AIIRSVL-------DFRRD 279
L + YGP++D+W+ G + + +L P F E + Q A I VL +
Sbjct: 170 LLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVLGTPDAEVLKKFR 227
Query: 280 PW-------------------PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPW 314
P S DL++K+L DP R+TA+Q L HP+
Sbjct: 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 2e-33
Identities = 82/296 (27%), Positives = 136/296 (45%), Gaps = 43/296 (14%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
+ LG+G+ G +L + G FA K + KK++ ++ V E +I+ L H +
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPT 65
Query: 121 LKDTYEDDTAVHLVMELCEGGELFD-RIVARGHY-TERAAAAVTKTIVEVVQMCHKHGVM 178
L +++ +T + LVM+ C GGELF G +E A ++ ++ H G++
Sbjct: 66 LYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIV 125
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLS------------------------------VF 208
+RDLKPEN L E+ + DF LS
Sbjct: 126 YRDLKPENILL---HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFS 182
Query: 209 FKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ 267
+P + + VG+ Y+APEV+ + +G VD W+ G++LY +L G PF
Sbjct: 183 EEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFS 242
Query: 268 AIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRL----TAQQVLEHPWLQNAK 319
I++ + F P VS +A+DL+RK+L DP +RL A ++ +HP+ +
Sbjct: 243 NILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN 296
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 2e-33
Identities = 85/273 (31%), Positives = 126/273 (46%), Gaps = 37/273 (13%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+GRG FG + ++ GD +A K + K L + E DI+ + I L+
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILS-ISNSPWIPQLQ 67
Query: 123 DTYEDDTAVHLVMELCEGGEL----------FDRIVARGHYTERAAAAVTKTIVEVVQMC 172
++D ++LVME GG+L FD +A+ + E +V +
Sbjct: 68 YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAE---------LVLAIHSV 118
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK-FSEI-VGSPYYMAPEVL 230
H+ G +HRD+KPEN L T +K DFG + + S++ VG+P Y+APEVL
Sbjct: 119 HQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVL 175
Query: 231 -------KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII--RSVLDFRRDPW 281
K YG E D WS GVI Y ++ G PF T I+ + L F D
Sbjct: 176 TTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPED-- 233
Query: 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPW 314
PKVS + DL++ +L K RL + + HP+
Sbjct: 234 PKVSSDFLDLIQSLL-CGQKERLGYEGLCCHPF 265
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-33
Identities = 79/267 (29%), Positives = 138/267 (51%), Gaps = 21/267 (7%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH--LPKHQNIVC 120
+G+G FG Y ++ +A K +SKK++ ++ E +I+ L + IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
LK +++ D+ ++LV + GGELF + G ++E A +V ++ HK+ +++R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFKP----GEKFSEIVGSPYYMAPEVL--KRNY 234
DLKPEN L T + DFGLS K + + G+ Y+APEVL ++ Y
Sbjct: 121 DLKPENILL---DATGHIALCDFGLS---KANLTDNKTTNTFCGTTEYLAPEVLLDEKGY 174
Query: 235 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK 294
VD WS GV+++ + CG PF+AE Q + + I + F ++ +S+ + V+
Sbjct: 175 TKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKN---VLSDEGRQFVKG 231
Query: 295 MLDPDPKRRL----TAQQVLEHPWLQN 317
+L+ +P+ RL A ++ EHP+ +
Sbjct: 232 LLNRNPQHRLGAHRDAVELKEHPFFAD 258
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-33
Identities = 77/272 (28%), Positives = 128/272 (47%), Gaps = 24/272 (8%)
Query: 57 YELGRELGRGEFGITY--LCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
YEL +G G + Y +C N + A K I +K +T ++++R+EV M
Sbjct: 3 YELIEVIGVGATAVVYAAICLP--NNEKVAIKRIDLEKCQT--SVDELRKEVQAM-SQCN 57
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFD---RIVARGHYTERAAAAVTKTIVEVVQM 171
H N+V ++ + LVM GG L D RG E A V K +++ ++
Sbjct: 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF-FKPGEKFSE----IVGSPYYMA 226
H +G +HRD+K N L E +K DFG+S G++ + VG+P +MA
Sbjct: 118 LHSNGQIHRDIKAGNILLG---EDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 227 PEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS---VLDFRRDPW 281
PEV++ Y + D+WS G+ L G P+ V +++ L+ D +
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGAD-Y 233
Query: 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHP 313
K S++ + ++ L DP +R TA+++L+H
Sbjct: 234 KKYSKSFRKMISLCLQKDPSKRPTAEELLKHK 265
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-33
Identities = 82/289 (28%), Positives = 127/289 (43%), Gaps = 48/289 (16%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIED-----VRREVDIMRHLPKHQ 116
+LG G + Y +R G+ A K I +D E+ RE+ +M+ L KH+
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIH-------LDAEEGTPSTAIREISLMKEL-KHE 58
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAV---TKTIVEVVQMCH 173
NIV L D + + LV E + +L + G V T +++ + CH
Sbjct: 59 NIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVL-- 230
++ V+HRDLKP+N L + E LK DFGL+ F P FS V + +Y AP+VL
Sbjct: 118 ENRVLHRDLKPQNLLINKRGE---LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLG 174
Query: 231 KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE---- 286
R Y +D+WS G I+ ++ G P F + I R + WP +S+
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234
Query: 287 ---------------------NAKDLVRKMLDPDPKRRLTAQQVLEHPW 314
DL+ ++L +P+ R++A L+HPW
Sbjct: 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 3e-33
Identities = 90/259 (34%), Positives = 134/259 (51%), Gaps = 11/259 (4%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCL 121
++G G GI + T++ G A K K LR E + EV IMR H+N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVK---KMDLRKQQRRELLFNEVVIMRDY-HHENVVDM 84
Query: 122 KDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRD 181
++Y + +VME EGG L D IV E A V +++ + H GV+HRD
Sbjct: 85 YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRD 143
Query: 182 LKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVD 239
+K ++ L + +K DFG K K +VG+PY+MAPEV+ R YG EVD
Sbjct: 144 IKSDSILLTSDGR---IKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVD 200
Query: 240 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPD 299
+WS G+++ ++ G PP++ E A IR L R KVS + + ML +
Sbjct: 201 IWSLGIMVIEMIDGEPPYFNEPPLQ-AMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVRE 259
Query: 300 PKRRLTAQQVLEHPWLQNA 318
P +R TAQ++L+HP+L+ A
Sbjct: 260 PSQRATAQELLQHPFLKLA 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 3e-33
Identities = 75/296 (25%), Positives = 124/296 (41%), Gaps = 46/296 (15%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMRHL 112
YE E+G G +G Y D G + ++ KK+R + E + RE+ +++ L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTG-----RFVALKKVRVPLSEEGIPLSTLREIALLKQL 55
Query: 113 PK--HQNIV-----CLKDTYEDDTAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTK 163
H NIV C + + + LV E + + G + +
Sbjct: 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-LPPETIKDLMR 114
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY 223
++ V H H ++HRDLKP+N L + + +K DFGL+ + + +V + +
Sbjct: 115 QLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ---VKIADFGLARIYSFEMALTSVVVTLW 171
Query: 224 YMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII------------ 270
Y APEVL ++ Y VD+WS G I L P F +E I
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP 231
Query: 271 ------RSVLDFR-----RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
RS + P++ E DL++KML +P +R++A + L+HP+
Sbjct: 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 6e-33
Identities = 85/269 (31%), Positives = 134/269 (49%), Gaps = 23/269 (8%)
Query: 61 RELGRGEFGITYLC---TDRENGDAFACKSISKKKL-RTAVDIEDVRREVDIMRHLPKHQ 116
+ LG+G +G + T + G FA K + K + R D + E +I+ + KH
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHP 60
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
IV L ++ ++L++E GGELF + G + E A I ++ H+ G
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGL---SVFFKPGEKFSEIVGSPYYMAPEVLKRN 233
+++RDLKPEN L + +K DFGL S+ G G+ YMAPE+L R+
Sbjct: 121 IIYRDLKPENILLDAQGH---VKLTDFGLCKESIH--EGTVTHTFCGTIEYMAPEILMRS 175
Query: 234 -YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
+G VD WS G ++Y +L G PPF AE + I++ L+ P P ++ A+DL+
Sbjct: 176 GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL---P-PYLTPEARDLL 231
Query: 293 RKMLDPDPKRRL-----TAQQVLEHPWLQ 316
+K+L +P RL A +V HP+ +
Sbjct: 232 KKLLKRNPSSRLGAGPGDAAEVQSHPFFR 260
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 7e-33
Identities = 85/268 (31%), Positives = 140/268 (52%), Gaps = 11/268 (4%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
+++Y ++G+G G Y D G A K ++ L+ E + E+ +MR
Sbjct: 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN---LQQQPKKELIINEILVMREN- 73
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
KH NIV D+Y + +VME GG L D +V E AAV + ++ ++ H
Sbjct: 74 KHPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLH 132
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVLKR 232
+ V+HRD+K +N L +K DFG P + K S +VG+PY+MAPEV+ R
Sbjct: 133 SNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189
Query: 233 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291
YGP+VD+WS G++ ++ G PP+ E I + ++P K+S +D
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAIFRDF 248
Query: 292 VRKMLDPDPKRRLTAQQVLEHPWLQNAK 319
+ + L+ D ++R +A+++L+HP+L+ AK
Sbjct: 249 LNRCLEMDVEKRGSAKELLQHPFLKIAK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-32
Identities = 76/267 (28%), Positives = 126/267 (47%), Gaps = 22/267 (8%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIE--DVRREVDIMRHLP 113
+++ ++LG+G +G Y + +A K + L + E D E+ I+ +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALK---EVDLGSMSQKEREDAVNEIRILASV- 56
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH----YTERAAAAVTKTIVEVV 169
H NI+ K+ + D + +VME G+L I R E+ + ++ +
Sbjct: 57 NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGL 116
Query: 170 QMCHKHGVMHRDLKPEN-FLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPE 228
Q H+ ++HRDLK N L AN +K D G+S K ++I G+P+YMAPE
Sbjct: 117 QALHEQKILHRDLKSANILLVANDL----VKIGDLGISKVLKKNMAKTQI-GTPHYMAPE 171
Query: 229 VLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV-SE 286
V K R Y + D+WS G +LY + PPF A + Q + + R + P P + S+
Sbjct: 172 VWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG----KYPPIPPIYSQ 227
Query: 287 NAKDLVRKMLDPDPKRRLTAQQVLEHP 313
+ ++ +R ML PK R ++L P
Sbjct: 228 DLQNFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 1e-32
Identities = 88/302 (29%), Positives = 132/302 (43%), Gaps = 51/302 (16%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+++ ++G G +G Y D++ G+ A K + + I +R E+ I+R L H+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQL-NHR 66
Query: 117 NIVCLKDTYEDDT----------AVHLVMELCEG---GELFDRIVARGHYTERAAAAVTK 163
NIV LK+ D A +LV E + G L +V H++E + K
Sbjct: 67 NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLV---HFSEDHIKSFMK 123
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK--FSEIVGS 221
++E + CHK +HRD+K N L NK + +K DFGL+ + E ++ V +
Sbjct: 124 QLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ---IKLADFGLARLYNSEESRPYTNKVIT 180
Query: 222 PYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279
+Y PE+L + YGP +DVWS G IL L P F A E + I R
Sbjct: 181 LWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA 240
Query: 280 PWPKVSE--------------------------NAKDLVRKMLDPDPKRRLTAQQVLEHP 313
WP V + A DL+ ML DP +R TA++ L P
Sbjct: 241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSP 300
Query: 314 WL 315
WL
Sbjct: 301 WL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-32
Identities = 83/268 (30%), Positives = 141/268 (52%), Gaps = 11/268 (4%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
+++Y ++G+G G + D G A K I+ +K E + E+ +M+ L
Sbjct: 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK---ELIINEILVMKEL- 73
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
K+ NIV D++ + +VME GG L D +V E AAV + ++ ++ H
Sbjct: 74 KNPNIVNFLDSFLVGDELFVVMEYLAGGSLTD-VVTETCMDEAQIAAVCRECLQALEFLH 132
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVLKR 232
+ V+HRD+K +N L +K DFG P + K S +VG+PY+MAPEV+ R
Sbjct: 133 ANQVIHRDIKSDNVLLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189
Query: 233 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291
YGP+VD+WS G++ ++ G PP+ E I + ++P K+S +D
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSPIFRDF 248
Query: 292 VRKMLDPDPKRRLTAQQVLEHPWLQNAK 319
+ + L+ D ++R +A+++L+HP+L+ AK
Sbjct: 249 LNRCLEMDVEKRGSAKELLQHPFLKLAK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 6e-32
Identities = 83/261 (31%), Positives = 124/261 (47%), Gaps = 16/261 (6%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKL--RTAVDIEDVRREVDIMRHLPKHQNIVC 120
LG+G FG C + G +ACK + KK+L R + +++ IV
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSR---FIVS 57
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVM 178
L +E + LVM L GG+L I G + E A I+ ++ H+ ++
Sbjct: 58 LAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIV 117
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPE 237
+RDLKPEN L + ++ D GL+V K G+K G+P YMAPEVL+ Y
Sbjct: 118 YRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS 174
Query: 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297
VD ++ G LY ++ G PF E+ + + R L+ + K S AKDL +L
Sbjct: 175 VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQ 234
Query: 298 PDPKRRL-----TAQQVLEHP 313
DP++RL +A +V EHP
Sbjct: 235 KDPEKRLGCRGGSADEVREHP 255
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 7e-32
Identities = 94/299 (31%), Positives = 139/299 (46%), Gaps = 49/299 (16%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
EI RY + +G G FG+ D+ G A K I K T V + RE+ +++H
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKP-FSTPVLAKRTYRELKLLKH 65
Query: 112 LPKHQNIVCLKDTY----EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE 167
L +H+NI+ L D + ED ++ V EL G R++ ++ I+
Sbjct: 66 L-RHENIISLSDIFISPLED---IYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILR 119
Query: 168 VVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAP 227
++ H GV+HRDLKP N L E LK DFGL+ P + + V + YY AP
Sbjct: 120 GLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLARIQDP--QMTGYVSTRYYRAP 174
Query: 228 EVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ-AIIRSVL-----DF--- 276
E++ + Y EVD+WSAG I +L G P F + V Q +II +L D
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH--VNQFSIITDLLGTPPDDVINT 232
Query: 277 --------------RRDPWP------KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
+R+P P +A DL+ KML DP++R++A + L HP+L
Sbjct: 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 8e-32
Identities = 80/298 (26%), Positives = 134/298 (44%), Gaps = 51/298 (17%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIED-------VRREVD 107
E+YE ++G G +G+ + C +RE G A K V+ ED RE+
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKF--------VESEDDPVIKKIALREIR 52
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIV 166
+++ L KH N+V L + + +HLV E C+ + + + E + +
Sbjct: 53 MLKQL-KHPNLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTL 110
Query: 167 EVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK-FSEIVGSPYYM 225
+ V CHKH +HRD+KPEN L + + +K DFG + +++ V + +Y
Sbjct: 111 QAVNFCHKHNCIHRDVKPENILITKQGQ---IKLCDFGFARILTGPGDDYTDYVATRWYR 167
Query: 226 APEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF------- 276
APE+L YGP VDVW+ G + LL G P + +++ I +++ D
Sbjct: 168 APELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI 227
Query: 277 ----------------RRDP----WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPW 314
R+P +P +S A ++ L DP RL+ +++LEHP+
Sbjct: 228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 9e-32
Identities = 79/267 (29%), Positives = 129/267 (48%), Gaps = 20/267 (7%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
+ LG+G FG L + + +A K + K + D+E E ++ KH +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
L ++ + VME GG+L I G + E A IV +Q H+ G+++R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFK----PGEKFSEIVGSPYYMAPEVLK-RNYG 235
DLK +N L ++ +K DFG+ K G S G+P Y+APE+L + YG
Sbjct: 121 DLKLDNVLLDSEGH---IKIADFGMC---KEGILGGVTTSTFCGTPDYIAPEILSYQPYG 174
Query: 236 PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKM 295
P VD W+ GV+LY +L G PF + E + Q+I+ + + R W +S+ AK +++
Sbjct: 175 PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR--W--LSKEAKSILKSF 230
Query: 296 LDPDPKRRLTA-----QQVLEHPWLQN 317
L +P++RL Q + HP+ +
Sbjct: 231 LTKNPEKRLGCLPTGEQDIKGHPFFRE 257
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-31
Identities = 84/268 (31%), Positives = 138/268 (51%), Gaps = 11/268 (4%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
+++Y ++G+G G Y D G A I + L+ E + E+ +MR
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVA---IRQMNLQQQPKKELIINEILVMRE-N 74
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
K+ NIV D+Y + +VME GG L D +V E AAV + ++ ++ H
Sbjct: 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVLKR 232
+ V+HRD+K +N L +K DFG P + K S +VG+PY+MAPEV+ R
Sbjct: 134 SNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190
Query: 233 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291
YGP+VD+WS G++ ++ G PP+ E I + ++P K+S +D
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAIFRDF 249
Query: 292 VRKMLDPDPKRRLTAQQVLEHPWLQNAK 319
+ + LD D ++R +A+++L+H +L+ AK
Sbjct: 250 LNRCLDMDVEKRGSAKELLQHQFLKIAK 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-31
Identities = 86/272 (31%), Positives = 129/272 (47%), Gaps = 24/272 (8%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
+E YEL + +G G +G Y D G+ A K I KL D E +++E+ +++
Sbjct: 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKEC- 57
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTKTIVEVVQMC 172
+H NIV +Y + +VME C GG L D V RG +E A V + ++ +
Sbjct: 58 RHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYL 117
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVL- 230
H+ G +HRD+K N L E +K DFG+S K +G+PY+MAPEV
Sbjct: 118 HETGKIHRDIKGANILLT---EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAA 174
Query: 231 ---KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287
K Y + D+W+ G+ L PP + I +S P PK+ +
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKS----NFPP-PKLKDK 229
Query: 288 AK------DLVRKMLDPDPKRRLTAQQVLEHP 313
K D ++K L DPK+R TA ++L+HP
Sbjct: 230 EKWSPVFHDFIKKCLTKDPKKRPTATKLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-31
Identities = 87/296 (29%), Positives = 140/296 (47%), Gaps = 53/296 (17%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E +E + + G +G YL +E FA K I+K+ L I+ V E DI+ +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILT-FAE 59
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGE---LFDRI------VARGHYTERAAAAVTKTI 165
+ +V + ++E + +VME EGG+ L I +AR ++ E A
Sbjct: 60 NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLA------ 113
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF--------------KP 211
++ H +G++HRDLKP+N L + +K DFGLS K
Sbjct: 114 ---LEYLHNYGIVHRDLKPDNLLITS---MGHIKLTDFGLSKIGLMSLTTNLYEGHIEKD 167
Query: 212 GEKFS--EIVGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAET-EQGVAQ 267
+F ++ G+P Y+APEV L++ YG VD W+ G+ILY L G PF+ +T E+ Q
Sbjct: 168 TREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ 227
Query: 268 AIIRSVLDFRRDPWPK----VSENAKDLVRKMLDPDPKRRL---TAQQVLEHPWLQ 316
I + WP+ + +A+DL+ ++L +P RL A +V +H +
Sbjct: 228 VISDDIE------WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 87/274 (31%), Positives = 137/274 (50%), Gaps = 18/274 (6%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E +++ + +GRG FG L + + +A K +SK ++ D E DIM H
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAH-AN 101
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
+ IV L ++DD +++VME GG+L + +++ E+ A T +V + H
Sbjct: 102 SEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVLALDAIHS 160
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKFSEI-VGSPYYMAPEVLKR 232
G +HRD+KP+N L ++ LK DFG + G + VG+P Y++PEVLK
Sbjct: 161 MGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKS 217
Query: 233 N-----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII--RSVLDFRRDPWPKVS 285
YG E D WS GV LY +L G PF+A++ G I+ ++ L F D ++S
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDD--IEIS 275
Query: 286 ENAKDLVRKMLDPDPKR--RLTAQQVLEHPWLQN 317
+ AKDL+ L R R ++ HP+ +N
Sbjct: 276 KQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 72/261 (27%), Positives = 123/261 (47%), Gaps = 10/261 (3%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
+YE R +GRG FGI +LC + + K I +++ T + + E +++ L H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLL-SH 58
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCH 173
NI+ + + +D A+ +VME GG L + I R + E I+ + H
Sbjct: 59 PNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH 118
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-R 232
++HRDLK +N L +K + +K DFG+S K +VG+P Y++PE+ + +
Sbjct: 119 TKLILHRDLKTQNILL-DKHKMV-VKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGK 176
Query: 233 NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
Y + D+W+ G +LY L F A + I+ D + S + + L+
Sbjct: 177 PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISD---RYSPDLRQLI 233
Query: 293 RKMLDPDPKRRLTAQQVLEHP 313
ML+ DP +R Q++ P
Sbjct: 234 LSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 2e-31
Identities = 77/294 (26%), Positives = 133/294 (45%), Gaps = 42/294 (14%)
Query: 45 LKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRR 104
L +PTG +EL +G G +G Y ++ G A K + + E+++
Sbjct: 1 LPDPTGI-----FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE----EEEIKE 51
Query: 105 EVDIMRHLPKHQNIV------CLKDTYEDDTAVHLVMELCEGG---ELFDRIVARGH-YT 154
E +I+R H NI K+ +D + LVMELC GG +L + +G
Sbjct: 52 EYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLK 111
Query: 155 ERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGE 213
E A + + + + H++ V+HRD+K +N L + A +K +DFG+S
Sbjct: 112 EEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT---KNAEVKLVDFGVSAQLDSTLG 168
Query: 214 KFSEIVGSPYYMAPEVLKRNYGPEV------DVWSAGVILYILLCGVPPFWAETEQGVAQ 267
+ + +G+PY+MAPEV+ + P+ DVWS G+ L G PP
Sbjct: 169 RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL-------CDM 221
Query: 268 AIIRSVLDFRRDPWPKVSENAK------DLVRKMLDPDPKRRLTAQQVLEHPWL 315
+R++ R+P P + D + + L + ++R +++LEHP++
Sbjct: 222 HPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 3e-31
Identities = 84/268 (31%), Positives = 138/268 (51%), Gaps = 11/268 (4%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
+++Y ++G+G G Y D G A K ++ L+ E + E+ +MR
Sbjct: 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN---LQQQPKKELIINEILVMRE-N 73
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
K+ NIV D+Y + +VME GG L D +V E AAV + ++ + H
Sbjct: 74 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALDFLH 132
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVLKR 232
+ V+HRD+K +N L +K DFG P + K S +VG+PY+MAPEV+ R
Sbjct: 133 SNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189
Query: 233 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291
YGP+VD+WS G++ ++ G PP+ E I + ++P ++S +D
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP-ERLSAVFRDF 248
Query: 292 VRKMLDPDPKRRLTAQQVLEHPWLQNAK 319
+ + L+ D RR +A+++L+HP+L+ AK
Sbjct: 249 LNRCLEMDVDRRGSAKELLQHPFLKLAK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 4e-31
Identities = 82/269 (30%), Positives = 134/269 (49%), Gaps = 22/269 (8%)
Query: 60 GRELGRGEFGITYLCTDRENGDAFACKSIS--KKKLRTAVDIEDVRREVDIMRHLPKHQN 117
G+ LG+G FG YLC D + G A K + + T+ ++ + E+ ++++L +H+
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHER 65
Query: 118 IV----CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
IV CL+D E + + ME GG + D++ A G TE T+ I+E + H
Sbjct: 66 IVQYYGCLRDRAE--KTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH 123
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFG----LSVFFKPGEKFSEIVGSPYYMAPEV 229
+ ++HRD+K N L + +K DFG L G + G+PY+M+PEV
Sbjct: 124 SNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180
Query: 230 LK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-VSEN 287
+ YG + DVWS G + +L PP WAE E AI + P +SE+
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPP-WAEYE--AMAAIFKIATQPTNPQLPSHISEH 237
Query: 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
A+D + + + + R +A+++L HP+ Q
Sbjct: 238 ARDFLGCIF-VEARHRPSAEELLRHPFAQ 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 4e-31
Identities = 82/269 (30%), Positives = 136/269 (50%), Gaps = 24/269 (8%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSI--SKKKLRTAVDIEDVRREVDIMRHLPK 114
+ LG+ LG+G FG YLC D + G A K + + T+ ++ + E+ ++++L
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-L 62
Query: 115 HQNIV----CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ 170
H+ IV CL+D E + + ME GG + D++ + G TE T+ I+E V
Sbjct: 63 HERIVQYYGCLRDPME--RTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVS 120
Query: 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK----PGEKFSEIVGSPYYMA 226
H + ++HRD+K N L + +K DFG S + G + G+PY+M+
Sbjct: 121 YLHSNMIVHRDIKGANIL---RDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 177
Query: 227 PEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW--PK 283
PEV+ YG + D+WS G + +L PP WAE E A A I + +P P
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEKPP-WAEFE---AMAAIFKIATQPTNPVLPPH 233
Query: 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEH 312
VS++ +D ++++ + K R +A ++L H
Sbjct: 234 VSDHCRDFLKRIF-VEAKLRPSADELLRH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-30
Identities = 76/268 (28%), Positives = 138/268 (51%), Gaps = 24/268 (8%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+++ +++G+G+F + Y +G A K + ++ A +D +E+D+++ L H
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHP 62
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE-VVQMC--- 172
N++ ++ ++ +++V+EL + G+L I H+ ++ +TI + VQ+C
Sbjct: 63 NVIKYLASFIENNELNIVLELADAGDLSRMI---KHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 173 ---HKHGVMHRDLKPEN-FLFANKKETAPLKAIDFGLSVFF--KPGEKFSEIVGSPYYMA 226
H +MHRD+KP N F+ A +K D GL FF K S +VG+PYYM+
Sbjct: 120 EHMHSKRIMHRDIKPANVFITATGV----VKLGDLGLGRFFSSKTTAAHS-LVGTPYYMS 174
Query: 227 PEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQ--GVAQAIIRSVLDFRRDPWPK 283
PE + N Y + D+WS G +LY + PF+ + + + I + D+ P
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC--DYPPLPADH 232
Query: 284 VSENAKDLVRKMLDPDPKRRLTAQQVLE 311
SE +DLV + ++PDP++R VL+
Sbjct: 233 YSEELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-30
Identities = 84/295 (28%), Positives = 140/295 (47%), Gaps = 34/295 (11%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIE-DVRREVDIMRHLPKHQ 116
EL R LG G G C + G FA K+I+ D++ + RE++I + K
Sbjct: 5 ELSR-LGEGAGGSVTKCRLKNTGMIFALKTITT---DPNPDLQKQILRELEINKSC-KSP 59
Query: 117 NIVCLKDTY--EDDTAVHLVMELCEGGEL---FDRIVARGHYT-ERAAAAVTKTIVEVVQ 170
IV + E +++ + ME CEGG L + ++ RG E+ + +++++ +
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI----VGSPYYMA 226
H ++HRD+KP N L K + +K DFG+S GE + + G+ +YMA
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQ---VKLCDFGVS-----GELVNSLAGTFTGTSFYMA 171
Query: 227 PEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA-----QAIIR-SVLDFRRD 279
PE ++ + Y DVWS G+ L + PF E E + I+ + + +
Sbjct: 172 PERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDE 231
Query: 280 PWPKV--SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKA 332
P + SE KD +++ L+ DP RR T +LEHPW++ K V++ + V
Sbjct: 232 PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKK-VNMAKFVAQ 285
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 83/261 (31%), Positives = 129/261 (49%), Gaps = 19/261 (7%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP--KHQNIVC 120
LG+G FG L ++ G +A K I KK++ A D +V + R L +H +
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMK-ILKKEVIIAKD--EVAHTLTESRVLQNTRHPFLTA 59
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
LK +++ + VME GGELF + ++E A IV + H V++R
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYR 119
Query: 181 DLKPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEV 238
DLK EN + + +K DFGL G G+P Y+APEVL+ N YG V
Sbjct: 120 DLKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 176
Query: 239 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298
D W GV++Y ++CG PF+ + + + + I+ + F R +S AK L+ +L
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLAGLLKK 232
Query: 299 DPKRRL-----TAQQVLEHPW 314
DPK+RL A++++EH +
Sbjct: 233 DPKQRLGGGPEDAKEIMEHRF 253
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 3e-30
Identities = 84/265 (31%), Positives = 126/265 (47%), Gaps = 12/265 (4%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
R LG+G FG C R G +ACK + KK+++ E I+ + Q +V
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVN 64
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVM 178
L YE A+ LV+ + GG+L I G+ + E A I+ ++ H+ +
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTV 124
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPE 237
+RDLKPEN L + ++ D GL+V GE VG+ YMAPEVL + Y
Sbjct: 125 YRDLKPENILL---DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLS 181
Query: 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297
D W G ++Y ++ G PF E+ + + R VL+ K SE AK + + +L
Sbjct: 182 PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLT 241
Query: 298 PDPKRRLTAQ-----QVLEHPWLQN 317
DPK+RL Q +V HP+ +N
Sbjct: 242 KDPKQRLGCQEEGAGEVKRHPFFRN 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-30
Identities = 92/305 (30%), Positives = 139/305 (45%), Gaps = 55/305 (18%)
Query: 56 RYELGRELGRGEFGITYLC----TDRENGDAFACKSISK---KKLRTAVDIEDVRREVDI 108
RYEL +ELG+G +GI +C + + A K I+ KK+ + RE+ +
Sbjct: 1 RYELIKELGQGAYGI--VCSARNAETSEEETVAIKKITNVFSKKILAKRAL----RELKL 54
Query: 109 MRHLPKHQNIVCLKD----TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKT 164
+RH H+NI CL D + ++L EL E +L I + T+ +
Sbjct: 55 LRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQ 113
Query: 165 IVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-----EKFSEIV 219
I+ ++ H V+HRDLKP N L E LK DFGL+ F +E V
Sbjct: 114 ILCGLKYIHSANVLHRDLKPGNLLVNADCE---LKICDFGLARGFSENPGENAGFMTEYV 170
Query: 220 GSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWA------------------ 259
+ +Y APE++ ++Y +DVWS G IL LL P F
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPD 230
Query: 260 -ETEQGV----AQAIIRSVLDFRRDP----WPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
ET + AQ IRS+ + + P +P + A DL+ K+L DP +R++ ++ L
Sbjct: 231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290
Query: 311 EHPWL 315
EHP+L
Sbjct: 291 EHPYL 295
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 4e-30
Identities = 82/299 (27%), Positives = 134/299 (44%), Gaps = 41/299 (13%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
R + E +L R +G G +GI Y D +G+ A K + R + I +R E+ ++
Sbjct: 4 RSVTEFEKLNR-IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLL 61
Query: 111 HLPKHQNIVCLKDTYEDD--TAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTKTIV 166
+L +H NIV LK+ ++ LVME CE L D + ++E + ++
Sbjct: 62 NL-RHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLL 118
Query: 167 EVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYM 225
+Q H++ ++HRDLK N L +K LK DFGL+ + P + + V + +Y
Sbjct: 119 RGLQYLHENFIIHRDLKVSNLLLTDKGC---LKIADFGLARTYGLPAKPMTPKVVTLWYR 175
Query: 226 APEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR------------ 271
APE+L Y +D+W+ G IL LL P ++E II+
Sbjct: 176 APELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG 235
Query: 272 -------SVLDFRRDPW-------PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
+ P+ P +SE L+ +L DPK+R TA++ LE + +
Sbjct: 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 5e-30
Identities = 82/282 (29%), Positives = 132/282 (46%), Gaps = 22/282 (7%)
Query: 47 EPTGREIEERYE---LGRELGRGEFGITYLCTDR-ENGDAFACKSISKKKLRTAVDIEDV 102
+ R+ + +YE R LG G FG L T + E+ A K K K+ ++ V
Sbjct: 19 KEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHV 78
Query: 103 RREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVT 162
E I+ ++ H V L +++D++ ++LV+E GGE F + +
Sbjct: 79 FSERKILNYI-NHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYA 137
Query: 163 KTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSP 222
IV + + +++RDLKPEN L + +K DFG + + + G+P
Sbjct: 138 AQIVLIFEYLQSLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVVD--TRTYTLCGTP 192
Query: 223 YYMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281
Y+APE+L +G D W+ G+ +Y +L G PPF+A + Q I+ ++ F
Sbjct: 193 EYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYF----- 247
Query: 282 PK-VSENAKDLVRKMLDPDPKRRL-----TAQQVLEHPWLQN 317
PK + N K L++K+L D +R AQ V EHPW N
Sbjct: 248 PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289
|
Length = 340 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 1e-29
Identities = 80/271 (29%), Positives = 121/271 (44%), Gaps = 25/271 (9%)
Query: 60 GRELGRGEFGITYLCTDRENGDAFACKSI---SKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
G LG+G +G Y C G A K + + L + E ++ EVD+++ L KH
Sbjct: 5 GEVLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHV 62
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
NIV T DD + + ME GG + + G E TK I++ V H +
Sbjct: 63 NIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFG-------LSVFFKPGEKFSEIVGSPYYMAPEV 229
V+HRD+K N + +K IDFG + + + G+PY+MAPEV
Sbjct: 123 VVHRDIKGNNVMLM---PNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 230 LKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV---- 284
+ + YG + D+WS G ++ + G PP A ++ A I + R P++
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPP-LASMDRLAAMFYIGA----HRGLMPRLPDSF 234
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
S A D V L D R +A Q+L H +L
Sbjct: 235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 94/343 (27%), Positives = 146/343 (42%), Gaps = 73/343 (21%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
+ I +YE+ ++LG+G +GI + DR + A K I R A D + RE+ ++
Sbjct: 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDA-FRNATDAQRTFREIMFLQ 61
Query: 111 HLPKHQNIVCLKDTY--EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV 168
L H NIV L + E+D ++LV E E +L H A + I+E
Sbjct: 62 ELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DL--------H------AVIRANILED 106
Query: 169 VQMC-------------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK- 214
V H V+HRDLKP N L + +K DFGL+ E+
Sbjct: 107 VHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSD---CRVKLADFGLARSLSELEEN 163
Query: 215 -----FSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF---------- 257
++ V + +Y APE+L Y VD+WS G IL +L G P F
Sbjct: 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLE 223
Query: 258 ------WAETEQGVAQ-------AIIRSVLDFRRDP----WPKVSENAKDLVRKMLDPDP 300
+ + + ++ S+ R P PK S++A DL++K+L +P
Sbjct: 224 KIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNP 283
Query: 301 KRRLTAQQVLEHPWLQNAKK-APNVSLGETVKARL---KQFSV 339
+RLTA++ LEHP++ + L + L + SV
Sbjct: 284 NKRLTAEEALEHPYVAQFHNPSDEPVLPYPITIPLDDNVKLSV 326
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 71/272 (26%), Positives = 114/272 (41%), Gaps = 36/272 (13%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAF----ACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
LG++LG G FG Y + G A K++ K+ + IE+ RE IMR L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL--KEDASEQQIEEFLREARIMRKL- 58
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC- 172
H N+V L ++ +++VME EGG+L + ++ +++
Sbjct: 59 DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKL---------SLSDLLSFAL 109
Query: 173 ---------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG-SP 222
+HRDL N L +K DFGLS + + + G P
Sbjct: 110 QIARGMEYLESKNFIHRDLAARNCLVGENLV---VKISDFGLSRDLYDDDYYRKRGGKLP 166
Query: 223 Y-YMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279
+MAPE LK + + DVWS GV+L+ I G P+ + + V + + +R
Sbjct: 167 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKN---GYRLP 223
Query: 280 PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311
P DL+ + DP+ R T +++E
Sbjct: 224 QPPNCPPELYDLMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-29
Identities = 78/262 (29%), Positives = 128/262 (48%), Gaps = 15/262 (5%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG L ++ G +A K + K+ + ++ E ++++ +H + LK
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 61
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
++ + VME GGELF + +TE A IV ++ H V++RD+
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 121
Query: 183 KPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDV 240
K EN + +K DFGL G G+P Y+APEVL+ N YG VD
Sbjct: 122 KLENLMLDKDGH---IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 178
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
W GV++Y ++CG PF+ + + + + I+ + F R +S AK L+ +L DP
Sbjct: 179 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKKDP 234
Query: 301 KRRL-----TAQQVLEHPWLQN 317
K+RL A++V+EH + +
Sbjct: 235 KQRLGGGPSDAKEVMEHRFFLS 256
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 4e-29
Identities = 81/299 (27%), Positives = 139/299 (46%), Gaps = 44/299 (14%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
E+ +RY+ +G G +G D + G A K +S+ ++A+ + RE+ +++H
Sbjct: 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP-FQSAIHAKRTYRELRLLKH 70
Query: 112 LPKHQNIVCLKDTY------EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
+ H+N++ L D + ED V+LV L G +L + IV ++ + I
Sbjct: 71 M-DHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHIQFLVYQI 127
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
+ ++ H G++HRDLKP N + N E LK +DFGL+ ++ + V + +Y
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSN-IAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYR 182
Query: 226 APEVL--KRNYGPEVDVWSAGVILYILL---------------------CGVPP--FWAE 260
APE++ +Y VD+WS G I+ LL G P +
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK 242
Query: 261 TEQGVAQAIIRSVLDFRR----DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
A+ I+S+ + + + + A DL+ KML DP +R+TA + L HP+L
Sbjct: 243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL 301
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 5e-29
Identities = 74/270 (27%), Positives = 130/270 (48%), Gaps = 21/270 (7%)
Query: 60 GRELGRGEFGITYLCTDRENGDAFACKSI------SKKKLRTAVDIEDVRREVDIMRHLP 113
G +G G FG YL + +G+ A K + + K R ++ + RE+ +++ L
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL- 63
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
+H+NIV + D +++ +E GG + + G + E + I++ + H
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLH 123
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-------VFFKPGEKFSEIVGSPYYMA 226
G++HRD+K N L NK +K DFG+S + K + GS ++MA
Sbjct: 124 NRGIIHRDIKGANILVDNK---GGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 227 PEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285
PEV+K+ Y + D+WS G ++ +L G P + + Q QAI + + + +S
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHP-FPDCTQ--LQAIFKIGENASPEIPSNIS 237
Query: 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
A D + K + D +R TA ++L+HP+L
Sbjct: 238 SEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 5e-29
Identities = 84/308 (27%), Positives = 134/308 (43%), Gaps = 56/308 (18%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKK-----LRTAVDIEDVRREV 106
++ RY+ +G G +G+ T + G A K IS + RT RE+
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL-------REI 54
Query: 107 DIMRHLPKHQNIVCLKD-----TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAV 161
I+R KH+NI+ + D ++E V++V EL E +L+ +++ H +
Sbjct: 55 KILRRF-KHENIIGILDIIRPPSFESFNDVYIVQELMET-DLY-KLIKTQHLSNDHIQYF 111
Query: 162 TKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS----E 217
I+ ++ H V+HRDLKP N L LK DFGL+ P + E
Sbjct: 112 LYQILRGLKYIHSANVLHRDLKPSNLLL---NTNCDLKICDFGLARIADPEHDHTGFLTE 168
Query: 218 IVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF------------------ 257
V + +Y APE++ + Y +D+WS G IL +L P F
Sbjct: 169 YVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT 228
Query: 258 -WAETEQGV----AQAIIRSVLDFRRDPW----PKVSENAKDLVRKMLDPDPKRRLTAQQ 308
E + A+ I+S+ + PW P A DL+ KML +P +R+T ++
Sbjct: 229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEE 288
Query: 309 VLEHPWLQ 316
L HP+L+
Sbjct: 289 ALAHPYLE 296
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 9e-29
Identities = 77/273 (28%), Positives = 142/273 (52%), Gaps = 30/273 (10%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
+Y +++G G FG L +E+G + K I+ K+ + E+ R+EV ++ ++ KH
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK-EREESRKEVAVLSNM-KH 58
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE-VVQMC-- 172
NIV ++++E++ +++VM+ CEGG+L+ +I A+ R I++ VQ+C
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQ-----RGVLFPEDQILDWFVQICLA 113
Query: 173 ----HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAP 227
H ++HRD+K +N +F K T L DFG++ V E +G+PYY++P
Sbjct: 114 LKHVHDRKILHRDIKSQN-IFLTKDGTIKLG--DFGIARVLNSTVELARTCIGTPYYLSP 170
Query: 228 EVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV-- 284
E+ + R Y + D+W+ G +LY + F A + + IIR +P V
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG-------SYPPVSS 223
Query: 285 --SENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
S + ++LV ++ +P+ R + +LE ++
Sbjct: 224 HYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 1e-28
Identities = 79/264 (29%), Positives = 127/264 (48%), Gaps = 15/264 (5%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
R LG+G FG L +E+G +A K + K + D+E E I+ H +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
L ++ + VME GG+L I + E A I + H G+++R
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 181 DLKPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEV 238
DLK +N L ++ K DFG+ G+ S G+P Y+APE+L+ YGP V
Sbjct: 121 DLKLDNVLLDHEGHC---KLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSV 177
Query: 239 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298
D W+ GV+LY +LCG PF AE E + +AI+ + + W +S++A D+++ +
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY--PTW--LSQDAVDILKAFMTK 233
Query: 299 DPKRRLTA------QQVLEHPWLQ 316
+P RL + + +L HP+ +
Sbjct: 234 NPTMRLGSLTLGGEEAILRHPFFK 257
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 83/260 (31%), Positives = 127/260 (48%), Gaps = 17/260 (6%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKL--RTAVDIEDVRREVDIMRHLPKHQNIVC 120
+G+G FG R+ +A K+I K + R+ V R V + P IV
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCP---FIVP 57
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
LK +++ ++LV+ GGELF + G + A T ++ ++ HK V++R
Sbjct: 58 LKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYR 117
Query: 181 DLKPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEV 238
DLKPEN L + DFGL + K +K + G+P Y+APE+L Y V
Sbjct: 118 DLKPENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAV 174
Query: 239 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298
D W+ GV+LY +L G+PPF+ E + + I++ L F +AKDL+ +L
Sbjct: 175 DWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDG----FDRDAKDLLIGLLSR 230
Query: 299 DPKRRL---TAQQVLEHPWL 315
DP RRL AQ++ HP+
Sbjct: 231 DPTRRLGYNGAQEIKNHPFF 250
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 85/266 (31%), Positives = 132/266 (49%), Gaps = 27/266 (10%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
+Y + R +G G FG L + +A K I K ++ +ED R+E ++ + KH
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKM-KH 57
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE-VVQMC-- 172
NIV K+++E D +++VME C+GG+L +I +R TI++ VQMC
Sbjct: 58 PNIVAFKESFEADGHLYIVMEYCDGGDLMQKI-----KLQRGKLFPEDTILQWFVQMCLG 112
Query: 173 ----HKHGVMHRDLKPEN-FLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMA 226
H+ V+HRD+K +N FL N K +K DFG + + PG VG+PYY+
Sbjct: 113 VQHIHEKRVLHRDIKSKNIFLTQNGK----VKLGDFGSARLLTSPGAYACTYVGTPYYVP 168
Query: 227 PEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP-KV 284
PE+ + Y + D+WS G ILY L PF A + +I V P P
Sbjct: 169 PEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA----NSWKNLILKVCQGSYKPLPSHY 224
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQVL 310
S + L+++M +P+ R +A +L
Sbjct: 225 SYELRSLIKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 83/271 (30%), Positives = 132/271 (48%), Gaps = 22/271 (8%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSI--SKKKLRTAVDIEDVRREVDIMRHL 112
+ LG+ LGRG FG YLC D + G A K + T+ ++ + E+ ++++L
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 113 PKHQNIV----CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV 168
+H IV CL+D E ++ +E GG + D++ A G TE T+ I++
Sbjct: 62 -RHDRIVQYYGCLRDPEEKKLSI--FVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQG 118
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS----VFFKPGEKFSEIVGSPYY 224
V H + ++HRD+K N L + +K DFG S G + G+PY+
Sbjct: 119 VSYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175
Query: 225 MAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283
M+PEV+ YG + DVWS + +L PP WAE E AI + + P
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLTEKPP-WAEYE--AMAAIFKIATQPTKPMLPD 232
Query: 284 -VSENAKDLVRKMLDPDPKRRLTAQQVLEHP 313
VS+ +D ++++ + KRR TA+ +L HP
Sbjct: 233 GVSDACRDFLKQIF-VEEKRRPTAEFLLRHP 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-28
Identities = 80/288 (27%), Positives = 133/288 (46%), Gaps = 43/288 (14%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMRHLPKHQN 117
++G G +G+ Y +++ G + ++ KK+R + E V RE+ +++ L +H N
Sbjct: 7 KIGEGTYGVVYKGRNKKTG-----QIVAMKKIRLESEEEGVPSTAIREISLLKEL-QHPN 60
Query: 118 IVCLKDTYEDDTAVHLVMEL--CEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH 175
IVCL+D ++ ++L+ E + + D + + + I++ + CH
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVL--KR 232
V+HRDLKP+N L NK +K DFGL+ F P ++ V + +Y APEVL
Sbjct: 121 RVLHRDLKPQNLLIDNK---GVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSP 177
Query: 233 NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS------- 285
Y VD+WS G I + P F ++E I R + D WP V+
Sbjct: 178 RYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237
Query: 286 ------------------ENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
E+ DL+ KML DP +R++A++ L HP+
Sbjct: 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 5e-28
Identities = 75/272 (27%), Positives = 127/272 (46%), Gaps = 33/272 (12%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSI---SKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
ELG G G+ R G A K+I + ++ + RE+DI+
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQI-----LRELDILHKC-NSPY 60
Query: 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRI--VARGHYTERAAAAVTKTIVE-VVQMCHK 174
IV + ++ + + ME +GG L D+I +G ER + +++ + + K
Sbjct: 61 IVGFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI----VGSPYYMAPEVL 230
H ++HRD+KP N L ++ + +K DFG+S G+ + + VG+ YMAPE +
Sbjct: 120 HKIIHRDVKPSNILVNSRGQ---IKLCDFGVS-----GQLVNSLAKTFVGTSSYMAPERI 171
Query: 231 KRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVA-----QAIIRSVLDFRRDPWPKV 284
+ N Y + D+WS G+ L L G P+ E + Q I+ R P K
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE--PPPRLPSGKF 229
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
S + +D V L DP+ R + +++LEHP+++
Sbjct: 230 SPDFQDFVNLCLIKDPRERPSYKELLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-28
Identities = 87/304 (28%), Positives = 137/304 (45%), Gaps = 49/304 (16%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
E++ +Y + +GRG +GI + E + A K I+ +D + RE+ ++RH
Sbjct: 2 EVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANA-FDNRIDAKRTLREIKLLRH 60
Query: 112 LPKHQNIVCLKD--------TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
L H+N++ +KD + D V++V EL + +L I + ++
Sbjct: 61 L-DHENVIAIKDIMPPPHREAFND---VYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLY 115
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLF-ANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGS 221
++ ++ H V+HRDLKP N L AN LK DFGL+ + G+ +E V +
Sbjct: 116 QLLRGLKYIHSANVLHRDLKPSNLLLNAN----CDLKICDFGLARTTSEKGDFMTEYVVT 171
Query: 222 PYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWA------------------ET 261
+Y APE+L Y +DVWS G I LL P F E
Sbjct: 172 RWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEE 231
Query: 262 EQGV-----AQAIIRSVLDFRRDP----WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312
+ G A+ IRS+ R +P + A DL+ KML DP +R+T ++ L H
Sbjct: 232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291
Query: 313 PWLQ 316
P+L
Sbjct: 292 PYLA 295
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 86/274 (31%), Positives = 134/274 (48%), Gaps = 18/274 (6%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E YE+ + +GRG FG L + +A K +SK ++ D E DIM
Sbjct: 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FAN 101
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
+V L ++DD +++VME GG+L + +++ E+ A T +V + H
Sbjct: 102 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHS 160
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSV-FFKPGE-KFSEIVGSPYYMAPEVLKR 232
G +HRD+KP+N L ++ LK DFG + K G + VG+P Y++PEVLK
Sbjct: 161 MGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 217
Query: 233 N-----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII--RSVLDFRRDPWPKVS 285
YG E D WS GV LY +L G PF+A++ G I+ ++ L F D +S
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD--NDIS 275
Query: 286 ENAKDLVRKMLDPDPKR--RLTAQQVLEHPWLQN 317
+ AK+L+ L R R +++ H + +N
Sbjct: 276 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 78/262 (29%), Positives = 122/262 (46%), Gaps = 15/262 (5%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG C R G +ACK ++KK+L+ E E I+ + + IV L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLA 59
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGH----YTERAAAAVTKTIVEVVQMCHKHGVM 178
++ T + LVM + GG+L I + E A T I+ ++ H+ ++
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRII 119
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-EKFSEIVGSPYYMAPEVLK-RNYGP 236
+RDLKPEN L N ++ D GL+V K G K G+P +MAPE+L+ Y
Sbjct: 120 YRDLKPENVLLDNDGN---VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDF 176
Query: 237 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKML 296
VD ++ GV LY ++ PF A E+ + + + +L+ K S +K +L
Sbjct: 177 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL 236
Query: 297 DPDPKRRL-----TAQQVLEHP 313
DP++RL + HP
Sbjct: 237 AKDPEKRLGFRDGNCDGLRTHP 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 73/286 (25%), Positives = 130/286 (45%), Gaps = 46/286 (16%)
Query: 66 GEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKD-- 123
G +G+ Y D++ G+ A K + +K + I +R E++I+ L +H NIV +K+
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKL-QHPNIVTVKEVV 73
Query: 124 TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIV----EVVQMCHKHGVMH 179
+ +++VME E +L + + + K ++ V H + ++H
Sbjct: 74 VGSNLDKIYMVMEYVEH-DLKSLM---ETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILH 129
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKFSEIVGSPYYMAPEVL--KRNYGP 236
RDLK N L N+ LK DFGL+ + P + ++++V + +Y APE+L + Y
Sbjct: 130 RDLKTSNLLLNNRGI---LKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYST 186
Query: 237 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP-------------- 282
+D+WS G I LL P F ++E I + + WP
Sbjct: 187 AIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFT 246
Query: 283 --------------KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPW 314
+S+N DL+ ++L DP +R++A+ L+HP+
Sbjct: 247 KYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-27
Identities = 86/308 (27%), Positives = 138/308 (44%), Gaps = 55/308 (17%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMR 110
++YE ++G G +G+ Y DR + +I+ KK+R + E V RE+ +++
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNE-----TIALKKIRLEQEDEGVPSTAIREISLLK 56
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV-- 168
+ +H NIV L+D + ++LV E + + + H A +++
Sbjct: 57 EM-QHGNIVRLQDVVHSEKRLYLVFEYLD-------LDLKKHMDSSPDFAKNPRLIKTYL 108
Query: 169 ------VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGS 221
+ CH H V+HRDLKP+N L + T LK DFGL+ F P F+ V +
Sbjct: 109 YQILRGIAYCHSHRVLHRDLKPQNLLI--DRRTNALKLADFGLARAFGIPVRTFTHEVVT 166
Query: 222 PYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279
+Y APE+L R+Y VD+WS G I ++ P F ++E I R + +
Sbjct: 167 LWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEE 226
Query: 280 PWPKVSE-------------------------NAKDLVRKMLDPDPKRRLTAQQVLEHPW 314
WP V+ DL+ KML DP +R+TA+ LEH +
Sbjct: 227 TWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEY 286
Query: 315 LQNAKKAP 322
++ AP
Sbjct: 287 FKDLGDAP 294
|
Length = 294 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-27
Identities = 71/272 (26%), Positives = 110/272 (40%), Gaps = 35/272 (12%)
Query: 58 ELGRELGRGEFGITYLCT----DRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
LG++LG G FG Y T A K++ K+ + IE+ RE IMR L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL--KEDASEQQIEEFLREARIMRKL- 58
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC- 172
H NIV L ++ + +VME GG+L D + ++ +++
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKEL--------SLSDLLSFAL 110
Query: 173 ---------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG-SP 222
+HRDL N L +K DFGLS + + G P
Sbjct: 111 QIARGMEYLESKNFIHRDLAARNCLVGENLV---VKISDFGLSRDLYDDDYYKVKGGKLP 167
Query: 223 Y-YMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279
+MAPE LK + + DVWS GV+L+ I G P+ + V + + + +R
Sbjct: 168 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKK---GYRLP 224
Query: 280 PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311
P L+ + DP+ R T +++E
Sbjct: 225 KPPNCPPELYKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-27
Identities = 77/258 (29%), Positives = 129/258 (50%), Gaps = 16/258 (6%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG L ++ G +A K + K+ + ++ E ++++ +H + LK
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 61
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH-KHGVMHRD 181
+++ + VME GGELF + ++E A IV + H + V++RD
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 121
Query: 182 LKPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVD 239
LK EN + + +K DFGL K G G+P Y+APEVL+ N YG VD
Sbjct: 122 LKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 178
Query: 240 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPD 299
W GV++Y ++CG PF+ + + + + I+ + F R P+ AK L+ +L D
Sbjct: 179 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPE----AKSLLSGLLKKD 234
Query: 300 PKRRL-----TAQQVLEH 312
PK+RL A+++++H
Sbjct: 235 PKQRLGGGPDDAKEIMQH 252
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-27
Identities = 79/309 (25%), Positives = 138/309 (44%), Gaps = 29/309 (9%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
E+ + RE+G G FG Y D + A K +S ++ +D+ +EV ++ L
Sbjct: 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL- 72
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTKTIVEVVQM 171
+H N + K Y + LVME C G ++ + V + E AA+ ++ +
Sbjct: 73 RHPNTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAY 130
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVL- 230
H H +HRD+K N L E +K DFG + P F VG+PY+MAPEV+
Sbjct: 131 LHSHERIHRDIKAGNILLT---EPGTVKLADFGSASLVSPANSF---VGTPYWMAPEVIL 184
Query: 231 ---KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287
+ Y +VDVWS G+ L PP + I ++ D P +S N
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN------DS-PTLSSN 237
Query: 288 A-----KDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNK 342
++ V L P+ R +++++L+H ++ ++ P + + ++ ++
Sbjct: 238 DWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVL--RERPPTVIIDLIQRTKDAVRELDN 295
Query: 343 LKKRALKVM 351
L+ R +K +
Sbjct: 296 LQYRKMKKI 304
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-27
Identities = 79/265 (29%), Positives = 126/265 (47%), Gaps = 12/265 (4%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
R LG+G FG C R G +ACK + KK+++ E I+ + + +V
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVS 64
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVM 178
L YE A+ LV+ + GG+L I G+ + E+ A + ++ + ++
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIV 124
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPE 237
+RDLKPEN L ++ ++ D GL+V GE VG+ YMAPEV+ Y
Sbjct: 125 YRDLKPENILLDDRGH---IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFS 181
Query: 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297
D W G ++Y ++ G PF E+ + + R V + + + K SE+AK + R +L
Sbjct: 182 PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLT 241
Query: 298 PDPKRRL-----TAQQVLEHPWLQN 317
+PK RL A V +HP +N
Sbjct: 242 KNPKERLGCRGNGAAGVKQHPIFKN 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 7e-27
Identities = 84/308 (27%), Positives = 129/308 (41%), Gaps = 61/308 (19%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN--I 118
+ +G G FG L + +A K++ K + V+ E DI L + N +
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDI---LAEADNEWV 63
Query: 119 VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVM 178
V L +++D ++ VM+ GG++ ++ G + E A + ++ HK G +
Sbjct: 64 VKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFI 123
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFK--------------------PGEKFSEI 218
HRD+KP+N L +K DFGL F+ P E++SEI
Sbjct: 124 HRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEI 180
Query: 219 ------------------------VGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCG 253
VG+P Y+APEVL R Y D WS GVILY +L G
Sbjct: 181 DRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240
Query: 254 VPPFWAETEQGVAQAII--RSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRL---TAQQ 308
PPF A+T +I + L K+S A DL+ + L + RL A +
Sbjct: 241 QPPFLADTPAETQLKVINWETTLHI--PSQAKLSREASDLILR-LCCGAEDRLGKNGADE 297
Query: 309 VLEHPWLQ 316
+ HP+ +
Sbjct: 298 IKAHPFFK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 8e-27
Identities = 79/263 (30%), Positives = 126/263 (47%), Gaps = 23/263 (8%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAF-ACKSIS-------KKKLRTAVDIEDVRREVDI 108
Y + LG G FG Y + NG A K I+ K K I D+ EV I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 109 MRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG---GELFDRIVARG-HYTERAAAAVTKT 164
++ +H NIV T+ ++ +++VM+L EG GE F+ + + +TE +
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 165 IVEVVQMCHKHG-VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY 223
+V ++ HK ++HRDL P N + + DFGL+ +P K + +VG+
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVT---ITDFGLAKQKQPESKLTSVVGTIL 178
Query: 224 YMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282
Y PE++K YG + DVW+ G ILY + PPF++ +A I+ +V +P P
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVY----EPLP 234
Query: 283 K--VSENAKDLVRKMLDPDPKRR 303
+ SE+ D++ L PD + R
Sbjct: 235 EGMYSEDVTDVITSCLTPDAEAR 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 81/261 (31%), Positives = 125/261 (47%), Gaps = 12/261 (4%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
R LG+G FG C R G +ACK + KK+++ E I+ + + +V
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVS 64
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVM 178
L YE A+ LV+ L GG+L I G + E A I ++ H+ ++
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIV 124
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPE 237
+RDLKPEN L + ++ D GL+V G+ VG+ YMAPEV+K Y
Sbjct: 125 YRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 181
Query: 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297
D W+ G +LY ++ G PF ++ + + R V + + + K S +A+ L + +L
Sbjct: 182 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLC 241
Query: 298 PDPKRRL-----TAQQVLEHP 313
DPK RL A++V EHP
Sbjct: 242 KDPKERLGCQGGGAREVKEHP 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 82/266 (30%), Positives = 127/266 (47%), Gaps = 12/266 (4%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
R LG+G FG C R G +ACK + KK+++ E I+ + + +V
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVS 64
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVM 178
L YE A+ LV+ L GG+L I G+ + E A I ++ H+ ++
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIV 124
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPE 237
+RDLKPEN L + ++ D GL+V GE VG+ YMAPEV+K Y
Sbjct: 125 YRDLKPENILLDDYGH---IRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFS 181
Query: 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297
D W G ++Y ++ G PF E+ + + R V + + + K SE A+ + R++L
Sbjct: 182 PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLT 241
Query: 298 PDPKRRL-----TAQQVLEHPWLQNA 318
DP RL A++V HP+ + A
Sbjct: 242 KDPGFRLGCRGEGAEEVKAHPFFRTA 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-26
Identities = 70/264 (26%), Positives = 124/264 (46%), Gaps = 14/264 (5%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+E+ ++G+G FG+ + + + +A K I K+ + E+ E ++ L
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR-EREEAIDEARVLAKL-DSS 59
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVA-RGH-YTERAAAAVTKTIVEVVQMCHK 174
I+ +++ D +++VME E G+L + RG E I+ + H
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE-IVGSPYYMAPEVLK-R 232
++HRD+K N LF + + +K D G++ F+ IVG+PYY++PE+ + +
Sbjct: 120 KKILHRDIKSLN-LFLDAYDN--VKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDK 176
Query: 233 NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP-KVSENAKDL 291
Y + DVW+ GV+LY G PF A QG A+I ++ P S+ L
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFDANN-QG---ALILKIIRGVFPPVSQMYSQQLAQL 232
Query: 292 VRKMLDPDPKRRLTAQQVLEHPWL 315
+ + L D ++R Q+L +P L
Sbjct: 233 IDQCLTKDYRQRPDTFQLLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-26
Identities = 74/263 (28%), Positives = 128/263 (48%), Gaps = 21/263 (7%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG L ++ +G +A K + K+ + ++ E ++++ +H + LK
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKN-TRHPFLTSLK 61
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
+++ + VME GGELF + ++E IV + H +++RDL
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121
Query: 183 KPENFLFANKKETAPLKAIDFGLSVFFKPG----EKFSEIVGSPYYMAPEVLKRN-YGPE 237
K EN + + +K DFGL K G G+P Y+APEVL+ N YG
Sbjct: 122 KLENLML---DKDGHIKITDFGLC---KEGITDAATMKTFCGTPEYLAPEVLEDNDYGRA 175
Query: 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297
VD W GV++Y ++CG PF+ + + + + I+ + F R +S +AK L+ +L
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR----TLSADAKSLLSGLLI 231
Query: 298 PDPKRRL-----TAQQVLEHPWL 315
DP +RL A++++ H +
Sbjct: 232 KDPNKRLGGGPDDAKEIMRHSFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 1e-26
Identities = 83/286 (29%), Positives = 145/286 (50%), Gaps = 19/286 (6%)
Query: 44 VLKEPTGREIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDV 102
++++ +++ E Y++ + +GRG FG L + + +A K +SK ++ D
Sbjct: 31 IVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFF 90
Query: 103 RREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVT 162
E DIM +V L ++DD +++VME GG+L + +++ E+ A T
Sbjct: 91 WEERDIMA-FANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYT 148
Query: 163 KTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE--KFSEIVG 220
+V + H G++HRD+KP+N L + LK DFG + + VG
Sbjct: 149 AEVVLALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDETGMVRCDTAVG 205
Query: 221 SPYYMAPEVLKRN-----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII--RSV 273
+P Y++PEVLK YG E D WS GV L+ +L G PF+A++ G I+ ++
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNS 265
Query: 274 LDFRRDPWPKVSENAKDLVRKMLDPDPKR--RLTAQQVLEHPWLQN 317
L+F D ++S++AK+L+ L R R +++ +HP+ +N
Sbjct: 266 LNFPED--VEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 84/294 (28%), Positives = 132/294 (44%), Gaps = 46/294 (15%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMRH 111
+YE ++G G +G + +RE + A K ++R D E V RE+ +++
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALK-----RVRLDDDDEGVPSSALREICLLKE 55
Query: 112 LPKHQNIVCLKDTYEDDTAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTKTIVEVV 169
L KH+NIV L D D + LV E C+ + FD G + +++ +
Sbjct: 56 L-KHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSC--NGDIDPEIVKSFMFQLLKGL 112
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIVGSPYYMAPE 228
CH H V+HRDLKP+N L E LK DFGL+ F P +S V + +Y P+
Sbjct: 113 AFCHSHNVLHRDLKPQNLLINKNGE---LKLADFGLARAFGIPVRCYSAEVVTLWYRPPD 169
Query: 229 VL--KRNYGPEVDVWSAGVILYILL-CGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285
VL + Y +D+WSAG I L G P F + I R + + WP VS
Sbjct: 170 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVS 229
Query: 286 E-------------------------NAKDLVRKMLDPDPKRRLTAQQVLEHPW 314
+ +DL++ +L +P +R++A++ L+HP+
Sbjct: 230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 77/267 (28%), Positives = 132/267 (49%), Gaps = 23/267 (8%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK--HQNIVC 120
LGRG FG L ++ G+ +A K++ K + ++E + E I H +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
L ++ + V VME GG+L I ++E A +V +Q H++ +++R
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFK----PGEKFSEIVGSPYYMAPEVL-KRNYG 235
DLK +N L + +K DFGL K G++ S G+P ++APEVL + +Y
Sbjct: 126 DLKLDNLLLDTE---GFVKIADFGLC---KEGMGFGDRTSTFCGTPEFLAPEVLTETSYT 179
Query: 236 PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKM 295
VD W GV++Y +L G PF + E+ V +I+ + + R +S A ++R++
Sbjct: 180 RAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSREAISIMRRL 235
Query: 296 LDPDPKRRL-----TAQQVLEHPWLQN 317
L +P+RRL A+ V + P+ ++
Sbjct: 236 LRRNPERRLGSGEKDAEDVKKQPFFRD 262
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 5e-26
Identities = 88/288 (30%), Positives = 135/288 (46%), Gaps = 18/288 (6%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
EE +E+ ELG G FG Y ++E G A K I K + ++ED E+DI+
Sbjct: 4 EEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASC- 59
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQM 171
H NIV L D + + + +++E C GG + D ++ TE V K +E +
Sbjct: 60 DHPNIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEALNY 118
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYYMAPEVL 230
H++ ++HRDLK N LF + +K DFG+S + ++ +G+PY+MAPEV+
Sbjct: 119 LHENKIIHRDLKAGNILFTLDGD---IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVV 175
Query: 231 ------KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284
R Y + DVWS G+ L + PP V I +S P +
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQP-SRW 234
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKA 332
S KD ++K L+ + R T Q+L+HP++ P L KA
Sbjct: 235 SSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKPIRELIAEAKA 282
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 7e-26
Identities = 83/257 (32%), Positives = 128/257 (49%), Gaps = 10/257 (3%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG L + + FA K++ K + D+E E ++ +H + L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
T++ + VME GG+L I + G + E A I+ +Q HK G+++RDL
Sbjct: 63 CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDL 122
Query: 183 KPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVLK-RNYGPEVDV 240
K +N L + +K DFG+ GE K S G+P Y+APE+LK + Y VD
Sbjct: 123 KLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDW 179
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
WS GV+LY +L G PF E E + +I+ F R W +S+ AKD + K+ + DP
Sbjct: 180 WSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR--W--ISKEAKDCLSKLFERDP 235
Query: 301 KRRL-TAQQVLEHPWLQ 316
+RL + +HP+ +
Sbjct: 236 TKRLGVDGDIRQHPFFR 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 7e-26
Identities = 74/264 (28%), Positives = 127/264 (48%), Gaps = 19/264 (7%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+G+G FG L + +G +A K + KK + + + + E +++ KH +V L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
+++ ++ V++ GGELF + + E A I + H +++RDL
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDL 122
Query: 183 KPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIV----GSPYYMAPEVLKRN-YGPE 237
KPEN L ++ DFGL K G S+ G+P Y+APEV+++ Y
Sbjct: 123 KPENILLDSQGHVV---LTDFGLC---KEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNT 176
Query: 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297
VD W G +LY +L G+PPF+ + I+ L R P S A ++ ++L+
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEELLE 232
Query: 298 PDPKRRLTAQ----QVLEHPWLQN 317
D +RRL A+ ++ EHP+ ++
Sbjct: 233 KDRQRRLGAKEDFLEIQEHPFFES 256
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 8e-26
Identities = 71/256 (27%), Positives = 126/256 (49%), Gaps = 16/256 (6%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+++ +++GRG+F Y T + A K + ++ A +D +E+D+++ L H
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHP 62
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE-VVQMC--- 172
N++ D++ +D +++V+EL + G+L I ++ ++ +T+ + VQ+C
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIK---YFKKQKRLIPERTVWKYFVQLCSAV 119
Query: 173 ---HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE-IVGSPYYMAPE 228
H VMHRD+KP N T +K D GL FF + +VG+PYYM+PE
Sbjct: 120 EHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 229 VLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287
+ N Y + D+WS G +LY + PF+ + + D+ P SE
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEK 236
Query: 288 AKDLVRKMLDPDPKRR 303
++LV + PDP +R
Sbjct: 237 LRELVSMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-25
Identities = 84/302 (27%), Positives = 133/302 (44%), Gaps = 62/302 (20%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMRHL 112
Y+ ++G G +G+ Y D+ G+ A K K+R + E V RE+ +++ L
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALK-----KIRLETEDEGVPSTAIREISLLKEL 55
Query: 113 PKHQNIVCLKDTYEDDTAVHLV-----------MELCEGGELFDRIVARGHYTERAAAAV 161
H NIV L D + ++LV M+ L ++ Y
Sbjct: 56 -NHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQ------- 107
Query: 162 TKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVG 220
+++ + CH H V+HRDLKP+N L +++ LK DFGL+ F P ++ V
Sbjct: 108 ---LLQGIAYCHSHRVLHRDLKPQNLLI-DREGA--LKLADFGLARAFGVPVRTYTHEVV 161
Query: 221 SPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR------- 271
+ +Y APE+L R Y VD+WS G I ++ P F ++E I R
Sbjct: 162 TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDE 221
Query: 272 -------SVLDF-------RRDPWPKV----SENAKDLVRKMLDPDPKRRLTAQQVLEHP 313
S+ D+ R KV E+ DL+ KML DP +R++A+ L+HP
Sbjct: 222 DVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHP 281
Query: 314 WL 315
+
Sbjct: 282 YF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-25
Identities = 87/286 (30%), Positives = 134/286 (46%), Gaps = 22/286 (7%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E +E+ ELG G FG Y ++E G A K I K + ++ED E++I+
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATC-N 67
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVA---RGHYTERAAAAVTKTIVEVVQM 171
H IV L + D + +++E C GG + D I+ RG TE + + ++E +Q
Sbjct: 68 HPYIVKLLGAFYWDGKLWIMIEFCPGGAV-DAIMLELDRG-LTEPQIQVICRQMLEALQY 125
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYYMAPEVL 230
H ++HRDLK N L + +K DFG+S K ++ +G+PY+MAPEV+
Sbjct: 126 LHSMKIIHRDLKAGNVLLTLDGD---IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVV 182
Query: 231 ------KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284
Y + D+WS G+ L + PP V I +S P K
Sbjct: 183 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQP-SKW 241
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETV 330
S +D ++ LD P+ R +A Q+LEHP++ + N L E V
Sbjct: 242 SMEFRDFLKTALDKHPETRPSAAQLLEHPFV--SSVTSNRPLRELV 285
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 70/246 (28%), Positives = 119/246 (48%), Gaps = 9/246 (3%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+G+G FG L + +G +A K + KK + + + + E +++ KH +V L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
+++ ++ V++ GGELF + + E A I + H +++RDL
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDL 122
Query: 183 KPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVL-KRNYGPEVDV 240
KPEN L ++ + DFGL + + S G+P Y+APEVL K+ Y VD
Sbjct: 123 KPENILLDSQGH---VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDW 179
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
W G +LY +L G+PPF++ + I+ L + P +S +A+ L+ +L D
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLEGLLQKDR 235
Query: 301 KRRLTA 306
+RL A
Sbjct: 236 TKRLGA 241
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 80/277 (28%), Positives = 128/277 (46%), Gaps = 23/277 (8%)
Query: 53 IEERYELGRE-----LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVD 107
+E YE LG+G +GI Y D A K I ++ R ++ + E+
Sbjct: 1 LEYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR---YVQPLHEEIA 57
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG---HYTERAAAAVTKT 164
+ +L KH+NIV + ++ + ME GG L + ++ E+ TK
Sbjct: 58 LHSYL-KHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ 116
Query: 165 IVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE-IVGSPY 223
I+E ++ H + ++HRD+K +N L + +K DFG S +E G+
Sbjct: 117 ILEGLKYLHDNQIVHRDIKGDNVLV--NTYSGVVKISDFGTSKRLAGINPCTETFTGTLQ 174
Query: 224 YMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP 280
YMAPEV+ R YG D+WS G + + G PPF E G QA + V F+ P
Sbjct: 175 YMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF---IELGEPQAAMFKVGMFKIHP 231
Query: 281 W--PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
+S AK+ + + +PDP +R +A +L+ P+L
Sbjct: 232 EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-25
Identities = 84/300 (28%), Positives = 133/300 (44%), Gaps = 47/300 (15%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMR 110
+ YE ++G G +G Y D+ G K ++ KK R +D E + RE+ +++
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTG-----KLVALKKTRLEMDEEGIPPTALREISLLQ 55
Query: 111 HLPKHQNIV---CLKDTYEDD--TAVHLVME-LCEGGELFDRIVARGHYTERAAAAVTKT 164
L + IV ++ E + +++LV E L + F RG A +
Sbjct: 56 MLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 165 IVEVVQ---MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIVG 220
+ ++++ CHKHGVMHRDLKP+N L +K LK D GL F P + ++ +
Sbjct: 116 MYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGL--LKIADLGLGRAFSIPVKSYTHEIV 173
Query: 221 SPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR 278
+ +Y APEVL +Y VD+WS G I + P F ++E I + +
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE 233
Query: 279 DPWPKV------------------------SENAKDLVRKMLDPDPKRRLTAQQVLEHPW 314
WP V S DL++KML DP +R++A+ L HP+
Sbjct: 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-25
Identities = 74/256 (28%), Positives = 124/256 (48%), Gaps = 16/256 (6%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+ + +++GRG+F Y T +G A K + L A D +E+D+++ L H
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHP 62
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE-VVQMC--- 172
N++ ++ +D +++V+EL + G+L I H+ ++ KT+ + VQ+C
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMI---KHFKKQKRLIPEKTVWKYFVQLCSAL 119
Query: 173 ---HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE-IVGSPYYMAPE 228
H VMHRD+KP N T +K D GL FF + +VG+PYYM+PE
Sbjct: 120 EHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 229 VLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287
+ N Y + D+WS G +LY + PF+ + + D+ P SE
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE 236
Query: 288 AKDLVRKMLDPDPKRR 303
+ LV ++PDP++R
Sbjct: 237 LRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 68/247 (27%), Positives = 117/247 (47%), Gaps = 9/247 (3%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+G+G FG L + +A K + KK + + + + E +++ KH +V L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
+++ ++ V++ GGELF + + E A I + H +++RDL
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 122
Query: 183 KPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVL-KRNYGPEVDV 240
KPEN L ++ + DFGL + S G+P Y+APEVL K+ Y VD
Sbjct: 123 KPENILLDSQGH---IVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDW 179
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
W G +LY +L G+PPF++ + I+ L + P ++ +A+ L+ +L D
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQKDR 235
Query: 301 KRRLTAQ 307
+RL A+
Sbjct: 236 TKRLGAK 242
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 76/305 (24%), Positives = 129/305 (42%), Gaps = 54/305 (17%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
+YE ++G+G FG + ++ A K + + + I +R E+ I++ L KH
Sbjct: 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLL-KH 70
Query: 116 QNIVCLKD--------TYEDDTAVHLVMELCE---GGELFDRIVARGHYTERAAAAVTKT 164
+N+V L + + +LV E CE G L ++ V +T V K
Sbjct: 71 ENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNV---KFTLSEIKKVMKM 127
Query: 165 IVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-----KFSEIV 219
++ + H++ ++HRD+K N L + LK DFGL+ F + +++ V
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILIT---KDGILKLADFGLARAFSLSKNSKPNRYTNRV 184
Query: 220 GSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR 277
+ +Y PE+L +R+YGP +D+W AG I+ + P TEQ I +
Sbjct: 185 VTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244
Query: 278 RDPWPKV----------------------------SENAKDLVRKMLDPDPKRRLTAQQV 309
+ WP V +A DL+ K+L DP +R+ A
Sbjct: 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTA 304
Query: 310 LEHPW 314
L H +
Sbjct: 305 LNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-25
Identities = 80/294 (27%), Positives = 133/294 (45%), Gaps = 17/294 (5%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
RE+G G FG Y D N + A K +S ++ +D+ +EV ++ L +H N +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQ 79
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
+ Y + LVME C G V + E AAVT ++ + H H ++HR
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVL----KRNYGP 236
D+K N L + E +K DFG + P F VG+PY+MAPEV+ + Y
Sbjct: 140 DVKAGNILLS---EPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYDG 193
Query: 237 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD-FRRDPWPKVSENAKDLVRKM 295
+VDVWS G+ L PP + I ++ + W SE ++ V
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRNFVDSC 250
Query: 296 LDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALK 349
L P+ R T++ +L+H ++ ++ P + + ++ ++ L+ R +K
Sbjct: 251 LQKIPQDRPTSEVLLKHRFVL--RERPPTVIMDLIQRTKDAVRELDNLQYRKMK 302
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-25
Identities = 70/263 (26%), Positives = 121/263 (46%), Gaps = 16/263 (6%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG L + + +A K + K + D++ E I+ KH + L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
++ + VME GG+L +I + E + + + H+HGV++RDL
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDL 122
Query: 183 KPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDV 240
K +N L K DFG+ G + G+P Y+APE+L+ YGP VD
Sbjct: 123 KLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDW 179
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
W+ GV++Y ++ G PPF A+ E + ++I+ D W +S+ A +++ + +P
Sbjct: 180 WALGVLMYEMMAGQPPFEADNEDDLFESILHD--DVLYPVW--LSKEAVSILKAFMTKNP 235
Query: 301 KRRL-------TAQQVLEHPWLQ 316
+RL + +HP+ +
Sbjct: 236 NKRLGCVASQGGEDAIKQHPFFK 258
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-25
Identities = 87/311 (27%), Positives = 130/311 (41%), Gaps = 54/311 (17%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
++ RY R LG G G+ + D + A K I L ++ RE+ I+R
Sbjct: 2 DLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIV---LTDPQSVKHALREIKIIRR 58
Query: 112 LPKHQNIV----CLKDTYEDDT----------AVHLVMELCEGGELFDRIVARGHYTERA 157
L H NIV L + D T +V++V E E ++ +G +E
Sbjct: 59 L-DHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEH 115
Query: 158 AAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK--- 214
A ++ ++ H V+HRDLKP N +F N E LK DFGL+ P
Sbjct: 116 ARLFMYQLLRGLKYIHSANVLHRDLKPAN-VFINT-EDLVLKIGDFGLARIVDPHYSHKG 173
Query: 215 -FSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR 271
SE + + +Y +P +L NY +D+W+AG I +L G P F E Q I+
Sbjct: 174 YLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233
Query: 272 SVLDFR--------------------------RDPWPKVSENAKDLVRKMLDPDPKRRLT 305
SV R RD P V+ A D + ++L +P RLT
Sbjct: 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT 293
Query: 306 AQQVLEHPWLQ 316
A++ L HP++
Sbjct: 294 AEEALMHPYMS 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-25
Identities = 75/286 (26%), Positives = 127/286 (44%), Gaps = 42/286 (14%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMRHLPKHQN 117
++G G +G+ Y ++ G + ++ KK+R + E V RE+ +++ L H N
Sbjct: 7 KIGEGTYGVVYKARNKLTG-----EVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPN 60
Query: 118 IVCLKDTYEDDTAVHLVME-LCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
IV L D + ++LV E L + + F + +++ + CH H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVL--KRN 233
V+HRDLKP+N L +K DFGL+ F P ++ V + +Y APE+L +
Sbjct: 121 VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 177
Query: 234 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS-------- 285
Y VD+WS G I ++ F ++E I R++ WP V+
Sbjct: 178 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237
Query: 286 -----------------ENAKDLVRKMLDPDPKRRLTAQQVLEHPW 314
E+ +DL+ +ML DP +R++A+ L HP+
Sbjct: 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 6e-25
Identities = 85/307 (27%), Positives = 132/307 (42%), Gaps = 52/307 (16%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVD 107
++ RY+ +G G +G+ D +G A K I A D+ + RE+
Sbjct: 2 DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPH-----AFDVPTLAKRTLRELK 56
Query: 108 IMRHLPKHQNIVCLKDTY----EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
I+RH KH NI+ ++D D V++VM+L E +L I + TE
Sbjct: 57 ILRHF-KHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLY 114
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL--SVFFKPGEK---FSEI 218
++ ++ H V+HRDLKP N L E L+ DFG+ + P E +E
Sbjct: 115 QLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARGLSSSPTEHKYFMTEY 171
Query: 219 VGSPYYMAPEVL--KRNYGPEVDVWSAGVI---------------------LYILLCGVP 255
V + +Y APE+L Y +D+WS G I L + + G P
Sbjct: 172 VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSP 231
Query: 256 P--FWAETEQGVAQAIIRSVLDFRRDPW----PKVSENAKDLVRKMLDPDPKRRLTAQQV 309
+ I+++ + PW PK S A DL+ +ML DP+ R+T +Q
Sbjct: 232 SEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQA 291
Query: 310 LEHPWLQ 316
L+HP+L
Sbjct: 292 LQHPFLA 298
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 6e-25
Identities = 72/265 (27%), Positives = 129/265 (48%), Gaps = 13/265 (4%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
RYE+ +++G G FG YL + + + K I K+ + E ++EV ++ + KH
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVK-EKEASKKEVILLAKM-KH 58
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRI-VARG-HYTERAAAAVTKTIVEVVQMCH 173
NIV +++++ + +VME C+GG+L RI RG ++E + I ++ H
Sbjct: 59 PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH 118
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI-VGSPYYMAPEVLK- 231
++HRD+K +N + A L DFG++ + + VG+PYY++PE+ +
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLG--DFGIARQLNDSMELAYTCVGTPYYLSPEICQN 176
Query: 232 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW-PKVSENAKD 290
R Y + D+WS G +LY L PF + I + P P S + +
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQG----YFAPISPNFSRDLRS 232
Query: 291 LVRKMLDPDPKRRLTAQQVLEHPWL 315
L+ ++ P+ R + +L+ P+L
Sbjct: 233 LISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 8e-25
Identities = 83/283 (29%), Positives = 138/283 (48%), Gaps = 38/283 (13%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+ +E+ + +GRG FG + + G +A K ++K ++ + R E D++ +
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVN-GD 59
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELF-------DRI---VARGHYTERAAAAVTKT 164
+ I L ++D+ ++LVM+ GG+L DR+ +AR + E
Sbjct: 60 RRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAE--------- 110
Query: 165 IVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEI-VGSP 222
+V + H+ G +HRD+KP+N L + ++ DFG + G S + VG+P
Sbjct: 111 MVLAIDSVHQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADGTVQSNVAVGTP 167
Query: 223 YYMAPEVL------KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII--RSVL 274
Y++PE+L K YGPE D WS GV +Y +L G PF+AE+ I+ +
Sbjct: 168 DYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHF 227
Query: 275 DFRRDPWPKVSENAKDLVRKMLDPDPKRRL---TAQQVLEHPW 314
F D VSE AKDL+R+++ P+ RL Q +HP+
Sbjct: 228 QFPPDV-TDVSEEAKDLIRRLICS-PETRLGRNGLQDFKDHPF 268
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 8e-25
Identities = 76/260 (29%), Positives = 125/260 (48%), Gaps = 16/260 (6%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG +L + FA K++ K + D+E E ++ +H + L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
T++ + VME GG+L I + + A I+ +Q H G+++RDL
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDL 122
Query: 183 KPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVL-KRNYGPEVDV 240
K +N L +K DFG+ G+ K G+P Y+APE+L + Y VD
Sbjct: 123 KLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDW 179
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP--WPK-VSENAKDLVRKMLD 297
WS GV+LY +L G PF E+ + Q+I R D +P+ ++ AKD++ K+
Sbjct: 180 WSFGVLLYEMLIGQSPFHGHDEEELFQSI-------RMDNPCYPRWLTREAKDILVKLFV 232
Query: 298 PDPKRRLTAQ-QVLEHPWLQ 316
+P+RRL + + +HP+ +
Sbjct: 233 REPERRLGVKGDIRQHPFFR 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 87/320 (27%), Positives = 132/320 (41%), Gaps = 58/320 (18%)
Query: 51 REIEERYE-LGRELGRGEFGITYLCTDRENGDAFACK-------SISKKKLRTAVDIEDV 102
I ERY G LG G +G D G A K S K R V + +
Sbjct: 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGI 63
Query: 103 R----REVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAA 158
RE+ IM + KH+NI+ L D Y + ++LVM++ +L + + TE
Sbjct: 64 HFTTLRELKIMNEI-KHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQV 121
Query: 159 AAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF--------- 209
+ I+ + + HK MHRDL P N +F N K K DFGL+ +
Sbjct: 122 KCILLQILNGLNVLHKWYFMHRDLSPAN-IFINSKGIC--KIADFGLARRYGYPPYSDTL 178
Query: 210 ------KPGEKFSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAET 261
+ E+ + V + +Y APE+L Y VD+WS G I LL G P F E
Sbjct: 179 SKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238
Query: 262 EQGVAQAIIRSVLDFRRDPWPKV------------------------SENAKDLVRKMLD 297
E I + D WP+ S++A DL++ +L
Sbjct: 239 EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLK 298
Query: 298 PDPKRRLTAQQVLEHPWLQN 317
+P R++A++ L+H + ++
Sbjct: 299 LNPLERISAKEALKHEYFKS 318
|
Length = 335 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 77/278 (27%), Positives = 121/278 (43%), Gaps = 47/278 (16%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E +E + +GRG FG L ++ G +A K + K + + +R E DI+
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
+V + +++D ++L+ME GG++ ++ + TE V + H+
Sbjct: 61 LW-VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQ 119
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK-------------------- 214
G +HRD+KP+N L +K +K DFGL K +
Sbjct: 120 LGFIHRDIKPDNLLLDSKGH---VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176
Query: 215 -----------------FSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPP 256
FS VG+P Y+APEV + Y D WS GVI+Y +L G PP
Sbjct: 177 NSKRKAETWKRNRRQLAFS-TVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
Query: 257 FWAETEQGVAQAII--RSVLDFRRDPWPKVSENAKDLV 292
F +ET Q + ++ + L F P +SE AKDL+
Sbjct: 236 FCSETPQETYKKVMNWKETLIF--PPEVPISEKAKDLI 271
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 81/275 (29%), Positives = 127/275 (46%), Gaps = 23/275 (8%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
R +E +EL + +G G +G Y + G+ A K I KL D V++E+ +M+
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEIIMMK 61
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ 170
KH NIV +Y + + ME C GG L D G +E A V++ ++ +
Sbjct: 62 DC-KHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLY 120
Query: 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-EKFSEIVGSPYYMAPEV 229
H G MHRD+K N L + +K DFG+S K +G+PY+MAPEV
Sbjct: 121 YLHSKGKMHRDIKGANILLT---DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEV 177
Query: 230 L----KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285
K Y D+W+ G+ L PP + + +S +F+ PK+
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS--NFQP---PKLK 232
Query: 286 ENAK------DLVRKMLDPDPKRRLTAQQVLEHPW 314
+ K V+ L +PK+R TA+++L+HP+
Sbjct: 233 DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 70/247 (28%), Positives = 116/247 (46%), Gaps = 9/247 (3%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+G+G FG L + +G +A K + KK + + + E +++ KH +V L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
+++ ++ V++ GGELF + + E A + + H +++RDL
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDL 122
Query: 183 KPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDV 240
KPEN L ++ DFGL +P E S G+P Y+APEVL++ Y VD
Sbjct: 123 KPENILLDSQGHVV---LTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDW 179
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
W G +LY +L G+PPF++ + I+ L + A DL+ +L D
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVGLLHKDQ 235
Query: 301 KRRLTAQ 307
+RRL A+
Sbjct: 236 RRRLGAK 242
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 83/304 (27%), Positives = 133/304 (43%), Gaps = 53/304 (17%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+E + +GRG FG L ++ G +A K + K + + +R E DI+
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
+V + +++D ++L+ME GG++ ++ + +E A V + H+ G
Sbjct: 63 -VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG 121
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK--------------PGEKFS------ 216
+HRD+KP+N L K +K DFGL K P FS
Sbjct: 122 FIHRDIKPDNLLLDAKGH---VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178
Query: 217 ----------------EIVGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWA 259
VG+P Y+APEV ++ Y D WS GVI+Y +L G PPF +
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238
Query: 260 ETEQGVAQAIIRSVLDFRRD----PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE---H 312
ET Q R V++++ P +SE AKDL+ + D + R+ + V E H
Sbjct: 239 ET----PQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293
Query: 313 PWLQ 316
P+ +
Sbjct: 294 PFFE 297
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 70/280 (25%), Positives = 122/280 (43%), Gaps = 39/280 (13%)
Query: 60 GRELGRGEFGITYLCTDRENGDAFACK-------SISKKKLRTAVDIEDVRREVDIMRHL 112
G +G+G +G YL + G+ A K + R ++ +R E++ ++ L
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC 172
H NIV + + + +E GG + + G + E+ T+ ++E +
Sbjct: 66 -DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIV----------GSP 222
H G++HRDLK +N L K DFG+S K S+ + GS
Sbjct: 125 HSKGILHRDLKADNLLV---DADGICKISDFGIS-------KKSDDIYDNDQNMSMQGSV 174
Query: 223 YYMAPEVL---KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279
++MAPEV+ + Y +VD+WS G ++ + G P W++ E A+ +
Sbjct: 175 FWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP-WSDEEA--IAAMFKLGNKRSAP 231
Query: 280 PWP-----KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPW 314
P P +S A D + +P R TA+++L+HP+
Sbjct: 232 PIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 6e-24
Identities = 72/264 (27%), Positives = 121/264 (45%), Gaps = 20/264 (7%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG L + + +A K + K + D+E E ++ K + L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
++ ++ VME GG+L I G + E A I + H G+++RDL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 183 KPENFLFANKKETAPLKAIDFGL---SVFFKPGEKFSEIVGSPYYMAPE-VLKRNYGPEV 238
K +N + +K DFG+ ++F G+ G+P Y+APE + + YG V
Sbjct: 128 KLDNVML---DAEGHIKIADFGMCKENIF--GGKTTRTFCGTPDYIAPEIIAYQPYGKSV 182
Query: 239 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-VSENAKDLVRKMLD 297
D W+ GV+LY +L G PPF E E + Q+I+ + + PK +S+ A + + +L
Sbjct: 183 DWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSY-----PKSLSKEAVSICKGLLT 237
Query: 298 PDPKRRLTA-----QQVLEHPWLQ 316
P +RL + + EH + +
Sbjct: 238 KHPAKRLGCGPTGERDIREHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 6e-24
Identities = 91/298 (30%), Positives = 130/298 (43%), Gaps = 43/298 (14%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSI----SKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
ELG+G +G Y R G A K I + K + E+DI+ H
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQII------MELDIL-HKAVSPY 60
Query: 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK--- 174
IV + + AV++ ME + G L D++ A G TE V + I V K
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK 119
Query: 175 --HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI----VGSPYYMAPE 228
H ++HRD+KP N L + +K DFG+S G + + +G YMAPE
Sbjct: 120 EEHNIIHRDVKPTNVLVNGNGQ---VKLCDFGVS-----GNLVASLAKTNIGCQSYMAPE 171
Query: 229 VLKR-------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGV---AQAIIRSVLDFRR 278
+K Y + DVWS G+ + + G P+ ET + AI+ D
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDG--DPPT 229
Query: 279 DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQ 336
P S++A+D V K L+ P RR T Q+LEHPWL K +V + E V LK+
Sbjct: 230 LP-SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLV-KYKNADVDMAEWVTGALKR 285
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 6e-24
Identities = 75/257 (29%), Positives = 125/257 (48%), Gaps = 10/257 (3%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG L + G+ FA K++ K + D+E E ++ ++ + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
T++ + VME GG+L I +G + A IV +Q H G+++RDL
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDL 122
Query: 183 KPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVLK-RNYGPEVDV 240
K +N + +K DFG+ G+ + S G+P Y+APE+L+ Y VD
Sbjct: 123 KLDNVML---DRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDW 179
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
WS GV+LY +L G PF + E + ++I + R W +++ +KD++ K+ + DP
Sbjct: 180 WSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR--W--ITKESKDILEKLFERDP 235
Query: 301 KRRL-TAQQVLEHPWLQ 316
RRL + HP+ +
Sbjct: 236 TRRLGVVGNIRGHPFFK 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 99.8 bits (248), Expect = 7e-24
Identities = 84/316 (26%), Positives = 142/316 (44%), Gaps = 23/316 (7%)
Query: 45 LKEPTGREI------EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD 98
LK+P E+ E+ + RE+G G FG Y D + A K +S ++
Sbjct: 9 LKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEK 68
Query: 99 IEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAA 158
+D+ +EV ++ + KH N + K Y + LVME C G V + E
Sbjct: 69 WQDIIKEVKFLQRI-KHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEI 127
Query: 159 AAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI 218
AA+T ++ + H H ++HRD+K N L E +K DFG + P F
Sbjct: 128 AAITHGALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASIASPANSF--- 181
Query: 219 VGSPYYMAPEVL----KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS-V 273
VG+PY+MAPEV+ + Y +VDVWS G+ L PP + I ++
Sbjct: 182 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES 241
Query: 274 LDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKAR 333
+ + W S+ ++ V L P+ R T++++L+H ++ ++ P L + ++
Sbjct: 242 PTLQSNEW---SDYFRNFVDSCLQKIPQDRPTSEELLKHMFV--LRERPETVLIDLIQRT 296
Query: 334 LKQFSVMNKLKKRALK 349
++ L+ R +K
Sbjct: 297 KDAVRELDNLQYRKMK 312
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 8e-24
Identities = 79/287 (27%), Positives = 123/287 (42%), Gaps = 34/287 (11%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSI---SKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
+LG G G G A K + +K +R + + RE+ IM +
Sbjct: 11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVR-----KQILRELQIMHEC-RSPY 64
Query: 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVE-VVQMCHKH 175
IV + ++ + + ME + G L DRI + G + +VE + + + H
Sbjct: 65 IVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI----VGSPYYMAPEVLK 231
+MHRD+KP N L ++ + +K DFG+S GE + I VG+ YM+PE ++
Sbjct: 124 RIMHRDIKPSNILVNSRGQ---IKLCDFGVS-----GELINSIADTFVGTSTYMSPERIQ 175
Query: 232 -RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR----DPWPKV-- 284
Y + DVWS G+ + L G PF Q +LD + +P P++
Sbjct: 176 GGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS 235
Query: 285 ---SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGE 328
E+ +D V L DP R T QQ+ P A +A NV L
Sbjct: 236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNVDLQA 282
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 9e-24
Identities = 78/294 (26%), Positives = 135/294 (45%), Gaps = 43/294 (14%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMR 110
E+YE +G G +G+ C +E G A K K + D + V+ RE+ +++
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIK-----KFLESEDDKMVKKIAMREIRMLK 55
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ 170
L +H+N+V L + + ++LV E + L D E I+ ++
Sbjct: 56 QL-RHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIE 114
Query: 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIVGSPYYMAPEV 229
CH H ++HRD+KPEN L + K DFG + PGE +++ V + +Y APE+
Sbjct: 115 FCHSHNIIHRDIKPENILVSQSGVV---KLCDFGFARTLAAPGEVYTDYVATRWYRAPEL 171
Query: 230 LKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD--------FRRD 279
L + YG VD+W+ G ++ +L G P F +++ II+ + + F+++
Sbjct: 172 LVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231
Query: 280 P-------------------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPW 314
P +PK+S DL ++ L DP R ++ Q+L H +
Sbjct: 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 1e-23
Identities = 76/267 (28%), Positives = 127/267 (47%), Gaps = 19/267 (7%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIED--VRREVDIMRHLPK 114
Y R +G+G +G L R +G + I K LR A E +E ++ L K
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYV---IKKLNLRNASRRERKAAEQEAQLLSQL-K 57
Query: 115 HQNIVCLKDTYE-DDTAVHLVMELCEGGELFDRIV-ARGHY-TERAAAAVTKTIVEVVQM 171
H NIV ++++E +D +++VM CEGG+L+ ++ +G E I +Q
Sbjct: 58 HPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQY 117
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVL 230
H+ ++HRDLK +N T +K D G++ V + S ++G+PYYM+PE+
Sbjct: 118 LHEKHILHRDLKTQNVFLT---RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELF 174
Query: 231 -KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-VSENA 288
+ Y + DVW+ G +Y + F A+ + II L P PK S
Sbjct: 175 SNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL----PPMPKDYSPEL 230
Query: 289 KDLVRKMLDPDPKRRLTAQQVLEHPWL 315
+L+ ML P++R + + +L P++
Sbjct: 231 GELIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 1e-23
Identities = 84/309 (27%), Positives = 129/309 (41%), Gaps = 57/309 (18%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
+ LG G FG L + +A K++ KK + + V+ E DI+ ++ +V
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAE-ADNEWVVR 65
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
L +++D ++ VM+ GG++ ++ G + E A + V+ HK G +HR
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHR 125
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFF------------------------------- 209
D+KP+N L +K DFGL F
Sbjct: 126 DIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 210 -------KPGEKFS----------EIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILL 251
KP E+ + +VG+P Y+APEVL R Y D WS GVILY +L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 252 CGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRL---TAQQ 308
G PPF A+T +I P K+S A DL+ K+ P+ RL A +
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCR-GPEDRLGKNGADE 301
Query: 309 VLEHPWLQN 317
+ HP+ +
Sbjct: 302 IKAHPFFKT 310
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 1e-23
Identities = 70/274 (25%), Positives = 127/274 (46%), Gaps = 24/274 (8%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
R +GRG + L ++ +A K + K+ + DI+ V+ E + H +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
L ++ ++ + V+E GG+L + + E A + I + H+ G+++R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 181 DLKPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEV 238
DLK +N L ++ +K D+G+ +PG+ S G+P Y+APE+L+ +YG V
Sbjct: 121 DLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177
Query: 239 DVWSAGVILYILLCGVPPF---------WAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289
D W+ GV+++ ++ G PF TE + Q I+ + R +S A
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAA 233
Query: 290 DLVRKMLDPDPKRRLTA------QQVLEHPWLQN 317
+++ L+ DPK RL + HP+ +N
Sbjct: 234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 2e-23
Identities = 75/255 (29%), Positives = 124/255 (48%), Gaps = 20/255 (7%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E +E+ + +GRG FG + + FA K ++K ++ + R E D++ +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-GD 59
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCH 173
+Q I L ++D+ ++LVM+ GG+L + E A +V + H
Sbjct: 60 NQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH 119
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFG--LSVFFKPGEKFSEIVGSPYYMAPEVL- 230
+ +HRD+KP+N L ++ DFG L + + S VG+P Y++PE+L
Sbjct: 120 QLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 176
Query: 231 -----KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP--- 282
K YGPE D WS GV +Y +L G PF+AE+ I+ F+ +P
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ---FPAQV 233
Query: 283 -KVSENAKDLVRKML 296
VSE+AKDL+R+++
Sbjct: 234 TDVSEDAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 2e-23
Identities = 74/265 (27%), Positives = 119/265 (44%), Gaps = 15/265 (5%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCL 121
E+G G FG Y T+ + A K +S +T +D+ +EV ++ L KH N +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTIEY 86
Query: 122 KDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRD 181
K Y + LVME C G V + E AA+T ++ + H H ++HRD
Sbjct: 87 KGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 146
Query: 182 LKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVL----KRNYGPE 237
+K N L E +K DFG + P F VG+PY+MAPEV+ + Y +
Sbjct: 147 IKAGNILLT---EPGQVKLADFGSASKSSPANSF---VGTPYWMAPEVILAMDEGQYDGK 200
Query: 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS-VLDFRRDPWPKVSENAKDLVRKML 296
VDVWS G+ L PP + I ++ + + W +++ + V L
Sbjct: 201 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEW---TDSFRGFVDYCL 257
Query: 297 DPDPKRRLTAQQVLEHPWLQNAKKA 321
P+ R + ++L H +++ + A
Sbjct: 258 QKIPQERPASAELLRHDFVRRDRPA 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 6e-23
Identities = 69/256 (26%), Positives = 118/256 (46%), Gaps = 16/256 (6%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
R +GRG + L ++N +A K + K+ + DI+ V+ E + + +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
L ++ + + LV+E GG+L + + E A I + H+ G+++R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 181 DLKPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEV 238
DLK +N L +K D+G+ PG+ S G+P Y+APE+L+ YG V
Sbjct: 121 DLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSV 177
Query: 239 DVWSAGVILYILLCGVPPF-------WAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291
D W+ GV+++ ++ G PF TE + Q I+ + R +S A +
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR----FLSVKASHV 233
Query: 292 VRKMLDPDPKRRLTAQ 307
++ L+ DPK RL Q
Sbjct: 234 LKGFLNKDPKERLGCQ 249
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 1e-22
Identities = 85/294 (28%), Positives = 140/294 (47%), Gaps = 41/294 (13%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
YE+ +++G G FG +L + + F K+IS + L+ + V EV++MR L KH+
Sbjct: 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV-IEVNVMREL-KHK 72
Query: 117 NIVCLKDTY--EDDTAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQ 170
NIV D + + + ++++ME C+ G+L I G E A +T+ ++ +
Sbjct: 73 NIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALA 132
Query: 171 MCH--KHG-----VMHRDLKPENFLF-------------ANKKETAPLKAI-DFGLSVFF 209
CH K G V+HRDLKP+N AN P+ I DFGLS
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI 192
Query: 210 KPGEKFSEIVGSPYYMAPEVL---KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA 266
VG+PYY +PE+L ++Y + D+W+ G I+Y L G PF A
Sbjct: 193 GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK------A 246
Query: 267 QAIIRSVLDFRRDPWPKVSENAKD---LVRKMLDPDPKRRLTAQQVLEHPWLQN 317
+ + + +R P + +K+ L++ +L+ K R +A Q L + ++N
Sbjct: 247 NNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300
|
Length = 1021 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 1e-22
Identities = 86/319 (26%), Positives = 125/319 (39%), Gaps = 90/319 (28%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR----TAVDIEDVRREVDIMR 110
E Y+ +LG G + Y + G A K I + TA+ RE +++
Sbjct: 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI------REASLLK 58
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLV-----------MELCEGG------ELFDRIVARGHY 153
L KH NIV L D + LV M+ C GG LF + RG
Sbjct: 59 DL-KHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRG-- 115
Query: 154 TERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL----SVFF 209
+ CH+ V+HRDLKP+N L + + E LK DFGL SV
Sbjct: 116 ---------------LAYCHQRRVLHRDLKPQNLLISERGE---LKLADFGLARAKSV-- 155
Query: 210 KPGEKFSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAET---EQG 264
P + +S V + +Y P+VL Y +D+W G I Y + G P F T +Q
Sbjct: 156 -PSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ- 213
Query: 265 VAQAIIRSVLDFRRDPWPKVSENAK----------------------------DLVRKML 296
I R + + WP VS N + +L K L
Sbjct: 214 -LHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFL 272
Query: 297 DPDPKRRLTAQQVLEHPWL 315
+PK+R++A + ++HP+
Sbjct: 273 QYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 1e-22
Identities = 80/320 (25%), Positives = 135/320 (42%), Gaps = 66/320 (20%)
Query: 56 RYELGRELGRGEFGITYLCTDREN--GDAFACKSI-SKKKLRTAVDIEDVRREVDIMRHL 112
+YE+ +GRG +G Y + G +A K K+ T + R E+ ++R L
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR-EIALLREL 59
Query: 113 PKHQNIVCLKDTYEDDTA--VHLVMELCEGGELFDRIVARGHYTERAAAAVTKT------ 164
KH+N+V L + + + V+L+ + E +L+ I + H + +
Sbjct: 60 -KHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQII--KFHRQAKRVSIPPSMVKSLLW 115
Query: 165 -IVEVVQMCHKHGVMHRDLKPEN-FLFANKKETAPLKAIDFGLS-VFFKPGEKFSE---I 218
I+ V H + V+HRDLKP N + E +K D GL+ +F P + ++ +
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175
Query: 219 VGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA---------Q 267
V + +Y APE+L R+Y +D+W+ G I LL P F + +
Sbjct: 176 VVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235
Query: 268 AII---------------------RSVLDFRRDPWP------------KVSENAKDLVRK 294
I + DF+ +P K DL+RK
Sbjct: 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRK 295
Query: 295 MLDPDPKRRLTAQQVLEHPW 314
+L+ DP +R+TA++ LEHP+
Sbjct: 296 LLEYDPTKRITAEEALEHPY 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 2e-22
Identities = 72/266 (27%), Positives = 117/266 (43%), Gaps = 39/266 (14%)
Query: 66 GEFGITYLCTDRENGDAFACKSISKKKLRTAVDIE-DVRREVDIMRHLPKHQNIVCLKDT 124
G+FG + + F K I K IE V +M+ + N + L +
Sbjct: 27 GKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---IEPMVH---QLMKD---NPNFIKLYYS 77
Query: 125 YEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKP 184
L+M+ + G+LFD + G +E + + +VE + HKH ++H D+K
Sbjct: 78 VTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKL 137
Query: 185 ENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY-------YMAPE-VLKRNYGP 236
EN L+ K+ L D+GL +I+G+P Y +PE + NY
Sbjct: 138 ENVLYDRAKDRIYL--CDYGL----------CKIIGTPSCYDGTLDYFSPEKIKGHNYDV 185
Query: 237 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR-RDPWPK---VSENAKDLV 292
D W+ GV+ Y LL G PF ++ + + L R + P VS+NA D V
Sbjct: 186 SFDWWAVGVLTYELLTGKHPF----KEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFV 241
Query: 293 RKMLDPDPKRRLTA-QQVLEHPWLQN 317
+ ML + RLT ++++HP+L+
Sbjct: 242 QSMLKYNINYRLTNYNEIIKHPFLKI 267
|
Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 3e-22
Identities = 71/266 (26%), Positives = 127/266 (47%), Gaps = 17/266 (6%)
Query: 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDV----RREVDIMRHLPKH 115
G++LG G F Y D + G A K ++ + T+ + E+V R+E+ +M L H
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVR-NTSSEQEEVVEALRKEIRLMARL-NH 62
Query: 116 QNIV-CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
+I+ L T ED + +L +E GG + + G + E T+ ++ + H+
Sbjct: 63 PHIIRMLGATCED-SHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHE 121
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSV-----FFKPGEKFSEIVGSPYYMAPEV 229
+ ++HRD+K N L + + L+ DFG + GE +++G+ +MAPEV
Sbjct: 122 NQIIHRDVKGANLLIDSTGQR--LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 230 LK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-VSEN 287
L+ YG DVWS G ++ + PP+ AE I + P+ +S
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239
Query: 288 AKDLVRKMLDPDPKRRLTAQQVLEHP 313
+D+ + L+ P+ R ++++L+HP
Sbjct: 240 LRDVTLRCLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 3e-22
Identities = 81/309 (26%), Positives = 139/309 (44%), Gaps = 41/309 (13%)
Query: 30 YGTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSIS 89
YG + L L +PT +E+ +G+G +G Y T++++G A K +
Sbjct: 2 YGLFPYNSSMLGLESLGDPTDT-----WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD 56
Query: 90 KKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDT-YEDDTAVH----LVMELCEGG--- 141
VD E++ E +I++ LP H N+V Y+ D V LV+ELC GG
Sbjct: 57 PIS---DVD-EEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVT 112
Query: 142 ELFDRIVARGHYTERAAAA-VTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKA 200
EL ++ G + A + + + +Q H + ++HRD+K N L + +K
Sbjct: 113 ELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTE---GGVKL 169
Query: 201 IDFGLSVFFKPGE-KFSEIVGSPYYMAPEVL------KRNYGPEVDVWSAGVILYILLCG 253
+DFG+S + + VG+P++MAPEV+ +Y DVWS G+ L G
Sbjct: 170 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
Query: 254 VPPFWAETEQGVAQAIIRSVLDFRRDPWP------KVSENAKDLVRKMLDPDPKRRLTAQ 307
PP + ++++ R+P P K + + + L D + R +
Sbjct: 230 DPPLFDMHP-------VKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVT 282
Query: 308 QVLEHPWLQ 316
+LEHP+++
Sbjct: 283 HLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 5e-22
Identities = 77/293 (26%), Positives = 126/293 (43%), Gaps = 38/293 (12%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK- 114
+YE E+G G +G Y D +G A KS+ + + + VR EV +++ L
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRLEAF 59
Query: 115 -HQNIVCLKDT-----YEDDTAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTKTIV 166
H NIV L D + +T V LV E + D++ G E + + +
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKD-LMRQFL 118
Query: 167 EVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMA 226
+ H + ++HRDLKPEN L + + +K DFGL+ + + +V + +Y A
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQ---VKLADFGLARIYSCQMALTPVVVTLWYRA 175
Query: 227 PEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW---- 281
PEV L+ Y VD+WS G I + P F +E I + D W
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235
Query: 282 -------------------PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
P++ E+ L+ +ML +P +R++A + L+HP+
Sbjct: 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 2e-21
Identities = 75/250 (30%), Positives = 121/250 (48%), Gaps = 16/250 (6%)
Query: 63 LGRGEFGITYLC---TDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIV 119
LG+G FG +L T + G +A K + K L+ D + E DI+ + H IV
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVR-DRVRTKMERDILAEV-NHPFIV 61
Query: 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMH 179
L ++ + ++L+++ GG+LF R+ +TE + + H G+++
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY 121
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS-EIVGSPYYMAPEVL-KRNYGPE 237
RDLKPEN L E +K DFGLS EK + G+ YMAPEV+ +R +
Sbjct: 122 RDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 178
Query: 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-VSENAKDLVRKML 296
D WS GV+++ +L G PF + + I+++ L P+ +S A+ L+R +
Sbjct: 179 ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGM-----PQFLSPEAQSLLRALF 233
Query: 297 DPDPKRRLTA 306
+P RL A
Sbjct: 234 KRNPANRLGA 243
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 70/212 (33%), Positives = 101/212 (47%), Gaps = 16/212 (7%)
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH----YTERAAAAVTKTIVEVV 169
H IV D ++ D + L+ME GG+L +I R + E + IV +
Sbjct: 123 DHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLAL 182
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF---SEIVGSPYYMA 226
H +MHRDLK N T +K DFG S + S G+PYY+A
Sbjct: 183 DEVHSRKMMHRDLKSANIFLM---PTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLA 239
Query: 227 PEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP-KV 284
PE+ +R Y + D+WS GVILY LL PF ++ + I++ VL + DP+P V
Sbjct: 240 PELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ----REIMQQVLYGKYDPFPCPV 295
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
S K L+ +L +P R T QQ+L +L+
Sbjct: 296 SSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 2e-21
Identities = 75/291 (25%), Positives = 136/291 (46%), Gaps = 39/291 (13%)
Query: 45 LKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRR 104
L++P G +EL +G G +G Y + G A K + T + E++++
Sbjct: 1 LRDPAGI-----FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV----TGDEEEEIKQ 51
Query: 105 EVDIMRHLPKHQNIVCL------KDTYEDDTAVHLVMELCEGGELFDRIVARGHYT--ER 156
E+++++ H+NI K+ D + LVME C G + D I T E
Sbjct: 52 EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE 111
Query: 157 AAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKF 215
A + + I+ + H+H V+HRD+K +N L E A +K +DFG+S + +
Sbjct: 112 WIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRR 168
Query: 216 SEIVGSPYYMAPEVLKRNYGPEV------DVWSAGVILYILLCGVPPFWAETEQGVAQAI 269
+ +G+PY+MAPEV+ + P+ D+WS G+ + G PP
Sbjct: 169 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL-------CDMHP 221
Query: 270 IRSVLDFRRDPWPKV-----SENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
+R++ R+P P++ S+ + + L + +R T +Q+++HP++
Sbjct: 222 MRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 3e-21
Identities = 85/306 (27%), Positives = 143/306 (46%), Gaps = 47/306 (15%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
E+ ERY +++G G +G D+ G+ A K +S+ ++ + + RE+ +++H
Sbjct: 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRP-FQSEIFAKRAYRELTLLKH 70
Query: 112 LPKHQNIVCLKDTYEDDTAVH------LVMELCEGGELFDRIVARGH-YTERAAAAVTKT 164
+ +H+N++ L D + + LVM + D GH +E +
Sbjct: 71 M-QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ----TDLQKIMGHPLSEDKVQYLVYQ 125
Query: 165 IVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY 224
++ ++ H G++HRDLKP N L N E LK +DFGL+ + + V + +Y
Sbjct: 126 MLCGLKYIHSAGIIHRDLKPGN-LAVN--EDCELKILDFGLAR--HADAEMTGYVVTRWY 180
Query: 225 MAPEVLKR--NYGPEVDVWSAGVILYILLCGV-----------------------PPFWA 259
APEV+ +Y VD+WS G I+ +L G P F
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ 240
Query: 260 ETEQGVAQAIIRSVLDFRRDP----WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
+ E A++ I+S+ + R +PK S A DL+ KML+ D +RLTA + LEHP+
Sbjct: 241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF 300
Query: 316 QNAKKA 321
+ + A
Sbjct: 301 DSFRDA 306
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-21
Identities = 77/280 (27%), Positives = 131/280 (46%), Gaps = 40/280 (14%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDI--------EDVR--RE 105
RY L + LG+G FG YL D+ K++++++L+ +I E V+ +E
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDK--------KAVAEERLKVLKEIPVGELNPNETVQANQE 52
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTER-AAAAVTKT 164
++ L H IV ++ + A ++ E CEG +L ++ H + + V +
Sbjct: 53 AQLLSKL-DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 165 IVEV---VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-EKFSEIVG 220
+++ V H+ ++HRDLK +N N LK DFG+S + + G
Sbjct: 112 FIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL----LKIGDFGVSRLLMGSCDLATTFTG 167
Query: 221 SPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279
+PYYM+PE LK + Y + D+WS G ILY + C F Q + VL
Sbjct: 168 TPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAF-------EGQNFLSVVLRIVEG 220
Query: 280 PWPKV----SENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
P P + S +++ ML+ DP R +A ++L +P++
Sbjct: 221 PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-21
Identities = 83/293 (28%), Positives = 135/293 (46%), Gaps = 44/293 (15%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
++E+ +G G +G+ C +E + A K + V E RE+ ++R L K
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVK-ETTLRELKMLRTL-KQ 59
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
+NIV LK+ + ++LV E E EL + + G E+ + + + +++ + CH
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEM-PNGVPPEKVRSYIYQ-LIKAIHWCH 117
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE--KFSEIVGSPYYMAPE-VL 230
K+ ++HRD+KPEN L ++ LK DFG + G ++E V + +Y +PE +L
Sbjct: 118 KNDIVHRDIKPENLLISHND---VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLL 174
Query: 231 KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI-IRSVLD---------FRRDP 280
YG VD+WS G IL L G P F E+E + Q I+ VL F +P
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDGQPLFPGESE--IDQLFTIQKVLGPLPAEQMKLFYSNP 232
Query: 281 ------WPKVSENAK--------------DLVRKMLDPDPKRRLTAQQVLEHP 313
+P V+ DL++ +L +P R +Q L HP
Sbjct: 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 4e-21
Identities = 77/315 (24%), Positives = 128/315 (40%), Gaps = 55/315 (17%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
+ LG G FG L + +A K++ KK + + V+ E DI+ ++ +V
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAE-ADNEWVVK 65
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
L +++D ++ VM+ GG++ ++ + E A + ++ HK G +HR
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHR 125
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFK--------------------PGEKFSEI-- 218
D+KP+N L +K DFGL F+ P + + ++
Sbjct: 126 DIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 219 --------------------------VGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILL 251
VG+P Y+APEV L++ Y D WS GVIL+ +L
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 252 CGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKR--RLTAQQV 309
G PPF A T +I P K+S A DL+ K+ +R R A +
Sbjct: 243 VGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302
Query: 310 LEHPWLQNAKKAPNV 324
HP+ + ++
Sbjct: 303 KAHPFFSEVDFSSDI 317
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 7e-21
Identities = 76/280 (27%), Positives = 133/280 (47%), Gaps = 23/280 (8%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD-IEDVRREVDIMRHL 112
EE + +G+G FG + D A K I L A D IED+++E+ ++
Sbjct: 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIID---LEEAEDEIEDIQQEITVLSQC 59
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC 172
+ +Y T + ++ME GG D + A G + E A + K I++ +
Sbjct: 60 -DSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYL 117
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVLK 231
H +HRD+K N L + E +K DFG++ + K + VG+P++MAPEV++
Sbjct: 118 HSEKKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQ 174
Query: 232 RN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV----SE 286
++ Y + D+WS G+ L G PP +R + ++ P + S+
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPP-------NSDMHPMRVLFLIPKNNPPTLTGEFSK 227
Query: 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWL-QNAKKAPNVS 325
K+ + L+ DP R TA+++L+H ++ +NAKK ++
Sbjct: 228 PFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKKTSYLT 267
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 8e-21
Identities = 77/273 (28%), Positives = 127/273 (46%), Gaps = 23/273 (8%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
R + YEL + +G G +G Y + G+ A K I KL D +++E+ +++
Sbjct: 5 RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKII---KLEPGDDFSLIQQEIFMVK 61
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ 170
KH NIV +Y + + ME C GG L D G +E A V + ++ +
Sbjct: 62 EC-KHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLA 120
Query: 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-EKFSEIVGSPYYMAPEV 229
H G MHRD+K N L + + +K DFG++ K +G+PY+MAPEV
Sbjct: 121 YLHSKGKMHRDIKGANILLTDNGD---VKLADFGVAAKITATIAKRKSFIGTPYWMAPEV 177
Query: 230 --LKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285
+++N Y D+W+ G+ L PP + + + S +F+ PK+
Sbjct: 178 AAVEKNGGYNQLCDIWAVGITAIELAELQPPMF--DLHPMRALFLMSKSNFQP---PKLK 232
Query: 286 ENAK------DLVRKMLDPDPKRRLTAQQVLEH 312
+ K + V+ L +PK+R TA+++L H
Sbjct: 233 DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 1e-20
Identities = 77/262 (29%), Positives = 124/262 (47%), Gaps = 22/262 (8%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG + G +ACK + KK+L+ + E +I+ + IV L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLA 59
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIV---ARGHYTERA---AAAVTKTIVEVVQMCHKHG 176
+E T + LVM L GG+L I RG ER +A +T I+ + H
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHL----HSMD 115
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN-YG 235
+++RD+KPEN L ++ + D GL+V K G+ ++ G+ YMAPE+LK Y
Sbjct: 116 IVYRDMKPENVLLDDQGNC---RLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYS 172
Query: 236 PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD----FRRDPWPKVSENAKDL 291
VD ++ G +Y ++ G PF E+ + + R L+ F +E +KD+
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQ---NFTEESKDI 229
Query: 292 VRKMLDPDPKRRLTAQQVLEHP 313
R L P+ RL +++ + P
Sbjct: 230 CRLFLAKKPEDRLGSREKNDDP 251
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 2e-20
Identities = 68/245 (27%), Positives = 115/245 (46%), Gaps = 11/245 (4%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG L + + +A K + K + D+E E ++ K + L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
++ ++ VME GG+L I G + E A I + H+ G+++RDL
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDL 127
Query: 183 KPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDV 240
K +N + ++ +K DFG+ G G+P Y+APE++ + YG VD
Sbjct: 128 KLDNVMLDSEGH---IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDW 184
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-VSENAKDLVRKMLDPD 299
W+ GV+LY +L G PPF E E + Q+I+ + + PK +S+ A + + ++
Sbjct: 185 WAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSY-----PKSLSKEAVSICKGLMTKH 239
Query: 300 PKRRL 304
P +RL
Sbjct: 240 PSKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 3e-20
Identities = 71/261 (27%), Positives = 125/261 (47%), Gaps = 20/261 (7%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+ +E+ + +GRG FG + + +A K ++K ++ + R E +++ +
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVN-GD 59
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCH 173
Q I L ++D+ ++LVM+ GG+L + E A +V + H
Sbjct: 60 CQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH 119
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEI-VGSPYYMAPEVLK 231
+ +HRD+KP+N L ++ DFG + + G S + VG+P Y++PE+L+
Sbjct: 120 QLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQ 176
Query: 232 R------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-- 283
YGPE D WS GV +Y +L G PF+AE+ I+ F+ +P
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---FPSHI 233
Query: 284 --VSENAKDLVRKMLDPDPKR 302
VSE AKDL+++++ +R
Sbjct: 234 TDVSEEAKDLIQRLICSRERR 254
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-20
Identities = 80/285 (28%), Positives = 130/285 (45%), Gaps = 40/285 (14%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDI-EDVRREVDIMRHLP 113
+ +E+ +G+G +G + +++NG A K L DI E++ E +I++ L
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKI-----LDPIHDIDEEIEAEYNILKALS 72
Query: 114 KHQNIVCL------KDTYEDDTAVHLVMELCEGGELFDRI---VARG-HYTERAAAAVTK 163
H N+V KD D + LV+ELC GG + D + + RG E A +
Sbjct: 73 DHPNVVKFYGMYYKKDVKNGDQ-LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILH 131
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSP 222
+ +Q H + +HRD+K N L + +K +DFG+S + + VG+P
Sbjct: 132 EALMGLQHLHVNKTIHRDVKGNNILLTTE---GGVKLVDFGVSAQLTSTRLRRNTSVGTP 188
Query: 223 YYMAPEV------LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF 276
++MAPEV L Y DVWS G+ L G PP A+ +R++
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL-ADLHP------MRALFKI 241
Query: 277 RRDPWPKV------SENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
R+P P + S D +RK L D ++R T +L+H ++
Sbjct: 242 PRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 3e-20
Identities = 80/313 (25%), Positives = 125/313 (39%), Gaps = 63/313 (20%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
YE+ +LG G FG Y + G A K I + I +R E+ I++ L K
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKL-K 65
Query: 115 HQNIVCLKD-TYE--DDTA-----VHLVM-----ELCEGGELFDRIVARGHYTERAAAAV 161
H N+V L D E D + V++V +L G L + V TE
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLS--GLLENPSV---KLTESQIKCY 120
Query: 162 TKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-----KPG---- 212
++E + H++ ++HRD+K N L N+ LK DFGL+ + P
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQ---GILKIADFGLARPYDGPPPNPKGGGG 177
Query: 213 ---EKFSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ 267
K++ +V + +Y PE+L +R Y VD+W G + + P +++
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH 237
Query: 268 AIIRSVLDFRRDPWP--------------------------KVSENAKDLVRKMLDPDPK 301
I + + WP K+ DL+ K+L DP
Sbjct: 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPY 297
Query: 302 RRLTAQQVLEHPW 314
+RLTA LEHP+
Sbjct: 298 KRLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 4e-20
Identities = 74/274 (27%), Positives = 133/274 (48%), Gaps = 21/274 (7%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
EE + ++G+G FG + D A K I ++ +IED+++E+ ++
Sbjct: 3 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQC- 59
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
+ +Y DT + ++ME GG D ++ G E A + + I++ + H
Sbjct: 60 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLH 118
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVLKR 232
+HRD+K N L + E +K DFG++ + K + VG+P++MAPEV+K+
Sbjct: 119 SEKKIHRDIKAANVLLSEHGE---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 233 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN---- 287
+ Y + D+WS G+ L G PP +E + + L + +P P + N
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPP---HSELHPMKVLF---LIPKNNP-PTLEGNYSKP 228
Query: 288 AKDLVRKMLDPDPKRRLTAQQVLEHPW-LQNAKK 320
K+ V L+ +P R TA+++L+H + ++ AKK
Sbjct: 229 LKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKK 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 4e-20
Identities = 71/274 (25%), Positives = 126/274 (45%), Gaps = 24/274 (8%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
R +GRG + L ++ +A K I K+ + DI+ V+ E + H +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
L ++ ++ + V+E GG+L + + E A + I + H+ G+++R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 181 DLKPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEV 238
DLK +N L + +K D+G+ +PG+ S G+P Y+APE+L+ +YG V
Sbjct: 121 DLKLDNVLLDAEGH---IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177
Query: 239 DVWSAGVILYILLCGVPPF---------WAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289
D W+ GV+++ ++ G PF TE + Q I+ + R +S A
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAS 233
Query: 290 DLVRKMLDPDPKRRLTAQ------QVLEHPWLQN 317
+++ L+ DPK RL + HP+ +N
Sbjct: 234 SVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 4e-20
Identities = 77/294 (26%), Positives = 135/294 (45%), Gaps = 39/294 (13%)
Query: 42 LCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIED 101
L L++P G +EL +G G +G Y + G A K + T + E+
Sbjct: 8 LSALRDPAGI-----FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV----TEDEEEE 58
Query: 102 VRREVDIMRHLPKHQNIVCL------KDTYEDDTAVHLVMELCEGGELFDRIV-ARGH-Y 153
++ E+++++ H+NI K D + LVME C G + D + +G+
Sbjct: 59 IKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNAL 118
Query: 154 TERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPG 212
E A + + I+ + H H V+HRD+K +N L E A +K +DFG+S +
Sbjct: 119 KEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTV 175
Query: 213 EKFSEIVGSPYYMAPEVLKRNYGPEV------DVWSAGVILYILLCGVPPFWAETEQGVA 266
+ + +G+PY+MAPEV+ + P+ D+WS G+ + G PP
Sbjct: 176 GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL-------CD 228
Query: 267 QAIIRSVLDFRRDPWPKV-----SENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
+R++ R+P PK+ S+ D + L + R + +Q+L+HP++
Sbjct: 229 MHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 6e-20
Identities = 82/287 (28%), Positives = 131/287 (45%), Gaps = 32/287 (11%)
Query: 47 EPTGREIEERYELGRELGRGEFGITYLCTDR-ENGDAFACKSISKKKLRTAVDIEDVRRE 105
E T +E ++Y + R LG G G T LC R +G+ FA K + + + + D + E
Sbjct: 24 EATAKEQAKKYWISRVLGSGATG-TVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAE 81
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTA-------VHLVMELCEGGELFDRIVARGH----YT 154
V + + + C +D + D + LV++ G+L I +R +
Sbjct: 82 VCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFR 141
Query: 155 ERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP--- 211
E A + ++ V H ++HRD+K N L + +K DFG S +
Sbjct: 142 EHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCS---NGLVKLGDFGFSKMYAATVS 198
Query: 212 ---GEKFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ 267
G F G+PYY+APE+ +R Y + D++S GV+LY LL PF E + V
Sbjct: 199 DDVGRTF---CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH 255
Query: 268 AIIRSVLDFRRDPWP-KVSENAKDLVRKMLDPDPKRRLTAQQVLEHP 313
L R DP P +S +++V +L DPKRR ++ ++L P
Sbjct: 256 ----KTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298
|
Length = 496 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 9e-20
Identities = 65/281 (23%), Positives = 113/281 (40%), Gaps = 50/281 (17%)
Query: 61 RELGRGEFGITYLCTDRENGDAF---ACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
++LG G FG Y + A K++ K+ + + +D +E +M+ L H N
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL--KEDASEEERKDFLKEARVMKKL-GHPN 57
Query: 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC----- 172
+V L ++ ++LV+E EGG+L D + + ++ +++
Sbjct: 58 VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTL-SLKDLLSFAIQIAK 116
Query: 173 -----HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY--- 224
+HRDL N L +K DFGLS ++ YY
Sbjct: 117 GMEYLASKKFVHRDLAARNCLVGEDLV---VKISDFGLSR---------DVYDDDYYRKK 164
Query: 225 ---------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGV-AQAIIRS 272
MAPE LK + + DVWS GV+L+ I G P+ G+ + ++
Sbjct: 165 TGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYP-----GLSNEEVLEY 219
Query: 273 VLDFRRDPWPK-VSENAKDLVRKMLDPDPKRRLTAQQVLEH 312
+ R P P+ + +L+ DP+ R T +++E
Sbjct: 220 LRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 1e-19
Identities = 72/282 (25%), Positives = 114/282 (40%), Gaps = 53/282 (18%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR---TAVDIEDVRREVDIMRHLPK 114
ELG++LG G FG Y T + +G+ ++ K L+ + + E+ E IM+ L
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGE-GTETKVAVKTLKEGASEEEREEFLEEASIMKKL-S 59
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC-- 172
H NIV L +++V E GG+L D + G T+ +++QM
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE---------KLTLKDLLQMALQ 110
Query: 173 --------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY 224
+HRDL N L +K DFGLS +I YY
Sbjct: 111 IAKGMEYLESKNFVHRDLAARNCLVTENLV---VKISDFGLS---------RDIYEDDYY 158
Query: 225 ------------MAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAII 270
MAPE LK + + DVWS GV+L+ I G P+ + + V + +
Sbjct: 159 RKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLE 218
Query: 271 RSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312
+R + +L+ + DP+ R T +++E
Sbjct: 219 D---GYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVED 257
|
Length = 258 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 1e-19
Identities = 76/306 (24%), Positives = 140/306 (45%), Gaps = 50/306 (16%)
Query: 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI 108
T E+ +RY +++G G +G DR G A K + + ++ + + RE+ +
Sbjct: 9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRP-FQSELFAKRAYRELRL 67
Query: 109 MRHLPKHQNIVCLKDTYEDDTAV------HLVMELCEGGELFDRIVARGHYTERAAAAVT 162
++H+ KH+N++ L D + D ++ +LVM G +++ +E +
Sbjct: 68 LKHM-KHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLV 124
Query: 163 KTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG-- 220
+++ ++ H G++HRDLKP N E LK +DFGL+ + SE+ G
Sbjct: 125 YQMLKGLKYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLA-----RQTDSEMTGYV 176
Query: 221 -SPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVP---------------------- 255
+ +Y APEV+ +Y VD+WS G I+ +L G P
Sbjct: 177 VTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS 236
Query: 256 -PFWAETEQGVAQAIIRSVLDFRRDPW----PKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
F + + A+ ++ + FR+ + P + A +++ KML D + R+TA + L
Sbjct: 237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296
Query: 311 EHPWLQ 316
HP+ +
Sbjct: 297 AHPYFE 302
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 2e-19
Identities = 85/310 (27%), Positives = 127/310 (40%), Gaps = 51/310 (16%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
RY++ +G+G +G+ D G+ A K I D + RE+ ++R L +H
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-NDVFEHVSDATRILREIKLLRLL-RH 58
Query: 116 QNIVCLKD--------TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE 167
+IV +K ++D +++V EL E +L I A T ++
Sbjct: 59 PDIVEIKHIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLR 114
Query: 168 VVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFK--PGEKF-SEIVGSPY 223
++ H V HRDLKP+N L AN LK DFGL+ V F P F ++ V + +
Sbjct: 115 ALKYIHTANVFHRDLKPKNIL-ANAD--CKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 224 YMAPEV---LKRNYGPEVDVWSAGVILYILLCGVPPF-------------------WAET 261
Y APE+ Y P +D+WS G I +L G P F ET
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET 231
Query: 262 EQGVAQAIIRSVLDFRR--------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHP 313
V R L R +P A L+ ++L DPK R TA++ L P
Sbjct: 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADP 291
Query: 314 WLQNAKKAPN 323
+ + K
Sbjct: 292 YFKGLAKVER 301
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-19
Identities = 68/252 (26%), Positives = 105/252 (41%), Gaps = 55/252 (21%)
Query: 104 REVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
REV ++++L KH NIV L D + + LV E + Y + ++
Sbjct: 52 REVSLLKNL-KHANIVTLHDIIHTERCLTLVFEYLDSD--------LKQYLDNCGNLMSM 102
Query: 164 TIVEV--------VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL----SVFFKP 211
V++ + CHK ++HRDLKP+N L K E LK DFGL SV P
Sbjct: 103 HNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE---LKLADFGLARAKSV---P 156
Query: 212 GEKFSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI 269
+ +S V + +Y P+VL Y +D+W G ILY + G P F T + I
Sbjct: 157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216
Query: 270 IRSVLDFRRDPWPKVSENAK--------------------------DLVRKMLDPDPKRR 303
R + + WP ++ N + DL+ +L + K R
Sbjct: 217 FRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSR 276
Query: 304 LTAQQVLEHPWL 315
++A+ L H +
Sbjct: 277 ISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 2e-19
Identities = 78/300 (26%), Positives = 131/300 (43%), Gaps = 46/300 (15%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
E+ ERY+ +G G +G D + G A K +S+ ++ + + RE+ +++H
Sbjct: 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKH 72
Query: 112 LPKHQNIVCLKDTY------EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
+ KH+N++ L D + E+ V+LV L G + IV T+ + I
Sbjct: 73 M-KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI 129
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
+ ++ H ++HRDLKP N E LK +DFGL+ ++ + V + +Y
Sbjct: 130 LRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYR 184
Query: 226 APEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV---------- 273
APE++ +Y VD+WS G I+ LL G F + I+R V
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 244
Query: 274 ------------------LDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
++F + + + A DL+ KML D +R+TA Q L H +
Sbjct: 245 ISSESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 3e-19
Identities = 69/270 (25%), Positives = 123/270 (45%), Gaps = 27/270 (10%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMRHLP 113
E +G G G Y R G +A K I + VR RE++I+R +
Sbjct: 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH------EDTVRRQICREIEILRDV- 129
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
H N+V D ++ + + +++E +GG L +A E+ A V + I+ + H
Sbjct: 130 NHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIAD----EQFLADVARQILSGIAYLH 185
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLKR 232
+ ++HRD+KP N L + K +K DFG+S + + + + VG+ YM+PE +
Sbjct: 186 RRHIVHRDIKPSNLLINSAKN---VKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINT 242
Query: 233 NY------GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV-LDFRRDPWPKVS 285
+ G D+WS GV + G PF QG +++ ++ + + S
Sbjct: 243 DLNHGAYDGYAGDIWSLGVSILEFYLGRFPF-GVGRQGDWASLMCAICMSQPPEAPATAS 301
Query: 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
+ + L +P +R +A Q+L+HP++
Sbjct: 302 REFRHFISCCLQREPAKRWSAMQLLQHPFI 331
|
Length = 353 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 5e-19
Identities = 77/266 (28%), Positives = 120/266 (45%), Gaps = 18/266 (6%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN---IV 119
+GRG FG Y C + G +A K + KK+++ E + IM L + IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTGDCPFIV 60
Query: 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMH 179
C+ + + +++L GG+L + G ++E I+ ++ H V++
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN--YGPE 237
RDLKP N L E ++ D GL+ F +K VG+ YMAPEVL++ Y
Sbjct: 121 RDLKPANILL---DEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVLQKGVAYDSS 176
Query: 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP-KVSENAKDLVRKML 296
D +S G +L+ LL G PF + I R L + P S + L+ +L
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVE-LPDSFSPELRSLLEGLL 234
Query: 297 DPDPKRRL-----TAQQVLEHPWLQN 317
D RRL AQ+V EHP+ ++
Sbjct: 235 QRDVNRRLGCLGRGAQEVKEHPFFRS 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 7e-19
Identities = 75/274 (27%), Positives = 128/274 (46%), Gaps = 22/274 (8%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD-IEDVRREVDIMRHL 112
EE + +G+G FG Y D + A K I L A D IED+++E+ ++
Sbjct: 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIID---LEEAEDEIEDIQQEITVLSQC 59
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC 172
I +Y T + ++ME GG D ++ G E A + + I++ +
Sbjct: 60 -DSPYITRYYGSYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYL 117
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVLK 231
H +HRD+K N L + E +K DFG++ + K + VG+P++MAPEV+K
Sbjct: 118 HSERKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK 174
Query: 232 RN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV----SE 286
++ Y + D+WS G+ L G PP +R + ++ P + S+
Sbjct: 175 QSAYDFKADIWSLGITAIELAKGEPPN-------SDLHPMRVLFLIPKNSPPTLEGQYSK 227
Query: 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320
K+ V L+ DP+ R TA+++L+H ++ K
Sbjct: 228 PFKEFVEACLNKDPRFRPTAKELLKHKFITRYTK 261
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 8e-19
Identities = 84/296 (28%), Positives = 116/296 (39%), Gaps = 56/296 (18%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLR----TAVDIEDVRREVDIMRHLPKHQ 116
+LG G + Y R NG A K IS K TA+ RE +++ L KH
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI------REASLLKGL-KHA 63
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
NIV L D + V E I G ++ + H
Sbjct: 64 NIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH 123
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIVGSPYYMAPEVL--KRN 233
++HRDLKP+N L + E LK DFGL+ P + +S V + +Y P+VL +
Sbjct: 124 ILHRDLKPQNLLISYLGE---LKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATD 180
Query: 234 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI-----IRSVLDF-RRDPWPKVSE- 286
Y +D+W AG I +L G P F GV+ I +VL D WP VS+
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQPAF-----PGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235
Query: 287 ---------------------------NAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
A+DL +ML PK R++AQ L HP+
Sbjct: 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-18
Identities = 74/299 (24%), Positives = 130/299 (43%), Gaps = 44/299 (14%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
E+ ERY+ +G G +G D A K +S+ ++ + RE+ +++H
Sbjct: 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRP-FQSLIHARRTYRELRLLKH 70
Query: 112 LPKHQNIVCLKDTY------EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
+ KH+N++ L D + E+ V+LV L G + IV ++ + +
Sbjct: 71 M-KHENVIGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQFLIYQL 127
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
+ ++ H G++HRDLKP N E L+ +DFGL+ + ++ + V + +Y
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNVAV---NEDCELRILDFGLAR--QADDEMTGYVATRWYR 182
Query: 226 APEVLKR--NYGPEVDVWSAGVILYILLCG-----------------------VPPFWAE 260
APE++ +Y VD+WS G I+ LL G P +
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242
Query: 261 TEQGVAQAIIRSVLDFRRDPWPKVSENAK----DLVRKMLDPDPKRRLTAQQVLEHPWL 315
A+ I+S+ + K+ A DL+ KML D +R++A + L HP+
Sbjct: 243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-18
Identities = 67/245 (27%), Positives = 114/245 (46%), Gaps = 11/245 (4%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG L + + +A K + K + D+E E ++ K + L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
++ ++ VME GG+L +I G + E A I + H G+++RDL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 183 KPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDV 240
K +N + ++ +K DFG+ G G+P Y+APE++ + YG VD
Sbjct: 128 KLDNVMLDSEGH---IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDW 184
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-VSENAKDLVRKMLDPD 299
W+ GV+LY +L G PF E E + Q+I+ + + PK +S+ A + + ++
Sbjct: 185 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY-----PKSMSKEAVAICKGLMTKH 239
Query: 300 PKRRL 304
P +RL
Sbjct: 240 PGKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 2e-18
Identities = 74/279 (26%), Positives = 119/279 (42%), Gaps = 28/279 (10%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR--REVDIM 109
++ + LG E+G G G Y ++ G A K + RT E+ R ++D++
Sbjct: 13 DLNDLENLG-EIGSGTCGQVYKMRFKKTGHVMAVKQMR----RTGNKEENKRILMDLDVV 67
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVE 167
IV + D+ V + MEL D+++ R G E +T IV+
Sbjct: 68 LKSHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVK 125
Query: 168 VVQ-MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMA 226
+ + KHGV+HRD+KP N L + +K DFG+S + + G YMA
Sbjct: 126 ALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMA 182
Query: 227 PEVL-----KRNYGPEVDVWSAGVILYILLCGVPPF-WAETEQGVAQAIIRS---VLDFR 277
PE + Y DVWS G+ L L G P+ +TE V I++ L
Sbjct: 183 PERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPN 242
Query: 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
S + V L D ++R +++L+HP+++
Sbjct: 243 EG----FSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 3e-18
Identities = 78/297 (26%), Positives = 132/297 (44%), Gaps = 45/297 (15%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMR 110
++YE E+G G +G + D +NG F ++ K++R E + REV ++R
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRF----VALKRVRVQTGEEGMPLSTIREVAVLR 56
Query: 111 HLP--KHQNIV-----CLKDTYEDDTAVHLVMELCEGG--ELFDRIVARGHYTERAAAAV 161
HL +H N+V C + +T + LV E + D++ G TE +
Sbjct: 57 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 116
Query: 162 TKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGS 221
+ ++ + H H V+HRDLKP+N L + + +K DFGL+ + + +V +
Sbjct: 117 FQ-LLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVVVT 172
Query: 222 PYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP 280
+Y APEV L+ +Y VD+WS G I + P F ++ I+ + +
Sbjct: 173 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 232
Query: 281 WPK-----------------------VSENAKDLVRKMLDPDPKRRLTAQQVLEHPW 314
WP+ + E KDL+ K L +P +R++A L HP+
Sbjct: 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 6e-18
Identities = 74/264 (28%), Positives = 118/264 (44%), Gaps = 16/264 (6%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN---IV 119
+GRG FG Y C + G +A K + KK+++ E + IM L + IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTGDCPFIV 60
Query: 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMH 179
C+ + + +++L GG+L + G ++E+ I+ ++ H V++
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN--YGPE 237
RDLKP N L E ++ D GL+ F + + VG+ YMAPEVL++ Y
Sbjct: 121 RDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGTAYDSS 176
Query: 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297
D +S G +L+ LL G PF + I R L + S K L+ +L
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTVNVELPDSFSPELKSLLEGLLQ 235
Query: 298 PDPKRRL-----TAQQVLEHPWLQ 316
D +RL AQ+V EH + +
Sbjct: 236 RDVSKRLGCLGRGAQEVKEHVFFK 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 7e-18
Identities = 65/251 (25%), Positives = 112/251 (44%), Gaps = 49/251 (19%)
Query: 104 REVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
REV +++ L KH NIV L D D ++ LV E D+ + + Y + ++
Sbjct: 53 REVSLLKDL-KHANIVTLHDIVHTDKSLTLVFEY------LDKDLKQ--YMDDCGNIMSM 103
Query: 164 TIVEV--------VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEK 214
V++ + CH+ V+HRDLKP+N L + E LK DFGL+ P +
Sbjct: 104 HNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKT 160
Query: 215 FSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS 272
+S V + +Y P+VL Y ++D+W G I + + G P F T + I R
Sbjct: 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRL 220
Query: 273 VLDFRRDPWPKVSENAK--------------------------DLVRKMLDPDPKRRLTA 306
+ + WP +S N + +L+ K L + K+R++A
Sbjct: 221 LGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISA 280
Query: 307 QQVLEHPWLQN 317
++ ++H + ++
Sbjct: 281 EEAMKHAYFRS 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-17
Identities = 63/250 (25%), Positives = 112/250 (44%), Gaps = 49/250 (19%)
Query: 104 REVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
REV +++ L KH NIV L D + ++ LV E D+ + + Y + ++
Sbjct: 53 REVSLLKDL-KHANIVTLHDIIHTEKSLTLVFEY------LDKDLKQ--YLDDCGNSINM 103
Query: 164 TIVEV--------VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEK 214
V++ + CH+ V+HRDLKP+N L + E LK DFGL+ P +
Sbjct: 104 HNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKT 160
Query: 215 FSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS 272
+S V + +Y P++L +Y ++D+W G I Y + G P F T + I R
Sbjct: 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRI 220
Query: 273 VLDFRRDPWPKVSENAK--------------------------DLVRKMLDPDPKRRLTA 306
+ + WP + N + +L+ K+L + ++R++A
Sbjct: 221 LGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISA 280
Query: 307 QQVLEHPWLQ 316
++ ++HP+
Sbjct: 281 EEAMKHPYFH 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 82/306 (26%), Positives = 129/306 (42%), Gaps = 63/306 (20%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA----VDIEDVRREVDIMRHLP 113
E R +G G FG+ + TD +G K ++ KK+ V + V RE+ ++
Sbjct: 3 EPDRPIGYGAFGVVWSVTDPRDG-----KRVALKKMPNVFQNLVSCKRVFRELKMLCFF- 56
Query: 114 KHQNIVCLKDT--------YEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
KH N++ D +E+ +++V EL + +L IV+ + I
Sbjct: 57 KHDNVLSALDILQPPHIDPFEE---IYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQI 112
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK--FSEIVGSPY 223
+ ++ H G++HRD+KP N L + LK DFGL+ +P E ++ V + Y
Sbjct: 113 LRGLKYLHSAGILHRDIKPGNLLVNS---NCVLKICDFGLARVEEPDESKHMTQEVVTQY 169
Query: 224 YMAPEVL--KRNYGPEVDVWSAGVI---------------------LYILLCGVPPFWAE 260
Y APE+L R+Y VD+WS G I L L G P A
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAM 229
Query: 261 TE--QGVAQAIIRSVLDFRRDPWPKV--------SENAKDLVRKMLDPDPKRRLTAQQVL 310
+G I+R + P V + A L+ +ML DP +R++A L
Sbjct: 230 RSACEGARAHILRGPH---KPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286
Query: 311 EHPWLQ 316
HP+L
Sbjct: 287 AHPYLD 292
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 75/313 (23%), Positives = 124/313 (39%), Gaps = 75/313 (23%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+G+G FG L ++ G +A K++ K ++ + V+ E D++ +V L
Sbjct: 9 IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE-SDSPWVVSLY 67
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
+++D ++L+ME GG+L ++ ++E V ++ HK G +HRD+
Sbjct: 68 YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDI 127
Query: 183 KPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYYM--------APEVLKRN 233
KP+N L +K DFGLS F K + S YY + RN
Sbjct: 128 KPDNILI---DRGGHIKLSDFGLSTGFHKQHD-------SAYYQKLLQGKSNKNRIDNRN 177
Query: 234 -------------------------------------YGPEV----------DVWSAGVI 246
PE+ D WS G I
Sbjct: 178 SVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237
Query: 247 LYILLCGVPPFWAETEQGVAQAII--RSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRL 304
++ L G PPF +E + II R L F D +S A+DL+R+++ + + RL
Sbjct: 238 MFECLIGWPPFCSENSHETYRKIINWRETLYFPDD--IHLSVEAEDLIRRLIT-NAENRL 294
Query: 305 ---TAQQVLEHPW 314
A ++ HP+
Sbjct: 295 GRGGAHEIKSHPF 307
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 3e-17
Identities = 76/314 (24%), Positives = 134/314 (42%), Gaps = 54/314 (17%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCL 121
ELG G G+ R +G A K I +++ A+ + RE+ ++ H IV
Sbjct: 8 ELGAGNGGVVTKVLHRPSGLIMARKLI-HLEIKPAIR-NQIIRELKVL-HECNSPYIVGF 64
Query: 122 KDTYEDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVE-VVQMCHKHGVMH 179
+ D + + ME +GG L D+++ + G E ++ ++ + + KH +MH
Sbjct: 65 YGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMH 123
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI----VGSPYYMAPEVLKRN-Y 234
RD+KP N L ++ E +K DFG+S G+ + VG+ YM+PE L+ Y
Sbjct: 124 RDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTHY 175
Query: 235 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI------------------------- 269
+ D+WS G+ L + G P + +
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR 235
Query: 270 ---IRSVLDF-RRDPWPKV-----SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320
I +LD+ +P PK+ S+ +D V K L +PK R +++ +HP+++ A +
Sbjct: 236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA-E 294
Query: 321 APNVSLGETVKARL 334
V V + +
Sbjct: 295 LEEVDFAGWVCSTM 308
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 41/101 (40%), Positives = 61/101 (60%), Gaps = 10/101 (9%)
Query: 218 IVGSPYYMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF 276
I+G+P Y+APE+L + +GP VD W+ GV L+ L G+PPF ET Q V Q I+
Sbjct: 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILN----- 594
Query: 277 RRDPWP----KVSENAKDLVRKMLDPDPKRRLTAQQVLEHP 313
R PWP K+S NA++ + +L DP +R +++ +HP
Sbjct: 595 RDIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHP 635
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 4e-16
Identities = 85/332 (25%), Positives = 129/332 (38%), Gaps = 100/332 (30%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
+ +RY+ + +G G GI D G A K +S+ + + RE+ +M+ L
Sbjct: 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRP-FQNVTHAKRAYRELVLMK-L 71
Query: 113 PKHQNIVCL------KDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIV 166
H+NI+ L + + E+ V+LVMEL + +
Sbjct: 72 VNHKNIIGLLNVFTPQKSLEEFQDVYLVMEL-----------------------MDANLC 108
Query: 167 EVVQM---------------C-----HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206
+V+QM C H G++HRDLKP N + K LK +DFGL+
Sbjct: 109 QVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA 165
Query: 207 VFFKPGEKF--SEIVGSPYYMAPEV-LKRNYGPEVDVWSAGVIL---------------- 247
G F + V + YY APEV L Y VD+WS G I+
Sbjct: 166 R--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI 223
Query: 248 -----YILLCGVPP--FWAETEQGVA---------QAIIRSVLDFRRDPWPKVSEN---- 287
I G P F + + V L F +P SE+
Sbjct: 224 DQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEEL-FPDVLFPPDSESHNKL 282
Query: 288 ----AKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
A+DL+ KML DP++R++ L+HP++
Sbjct: 283 KASQARDLLSKMLVIDPEKRISVDDALQHPYI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 7e-16
Identities = 85/351 (24%), Positives = 148/351 (42%), Gaps = 63/351 (17%)
Query: 14 GKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITY- 72
GK + N KK + + + + + + + R + Y+LG +G G FG+ Y
Sbjct: 26 GKFEMNDKKLDEEERSHNNNAGEDEDEEKMIDND-INRSPNKSYKLGNIIGNGSFGVVYE 84
Query: 73 -LCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTY------ 125
+C D A KK L+ D + RE+ IM++L H NI+ LKD Y
Sbjct: 85 AICIDTSEKVAI------KKVLQ---DPQYKNRELLIMKNL-NHINIIFLKDYYYTECFK 134
Query: 126 --EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV--QMC------HKH 175
E + +++VME + + + R A+ +V++ Q+C H
Sbjct: 135 KNEKNIFLNVVMEF-----IPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK 189
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVL--KRN 233
+ HRDLKP+N L T LK DFG + G++ + S +Y APE++ N
Sbjct: 190 FICHRDLKPQNLLIDPNTHT--LKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATN 247
Query: 234 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR---------------SVLDFR- 277
Y +D+WS G I+ ++ G P F ++ II+ + D +
Sbjct: 248 YTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKF 307
Query: 278 --------RDPWPK-VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319
+ +PK ++A + + + L +P +RL + L P+ + +
Sbjct: 308 PDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358
|
Length = 440 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 8e-16
Identities = 82/312 (26%), Positives = 127/312 (40%), Gaps = 72/312 (23%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR----TAVDIEDVRREVDIMR 110
+ YE +LG G + Y + NG A K I ++ TA+ RE +++
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI------REASLLK 58
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVME-----LCEGGELFDRIVARGHYTERAAAAVTKTI 165
L KH NIV L D + LV E LC+ Y ++ +
Sbjct: 59 GL-KHANIVLLHDIIHTKETLTLVFEYVHTDLCQ-------------YMDKHPGGLHPEN 104
Query: 166 VEV--------VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFS 216
V++ + H+ ++HRDLKP+N L + +T LK DFGL+ P +S
Sbjct: 105 VKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS---DTGELKLADFGLARAKSVPSHTYS 161
Query: 217 EIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETE-QGVAQAI---- 269
V + +Y P+VL Y +D+W G I ++ GV F + Q + I
Sbjct: 162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVL 221
Query: 270 ----------IRSVLDFR------------RDPWPKVS--ENAKDLVRKMLDPDPKRRLT 305
+ S+ F+ R W K+S +A+DL K+L PK RL+
Sbjct: 222 GTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLS 281
Query: 306 AQQVLEHPWLQN 317
AQ L H + +
Sbjct: 282 AQAALSHEYFSD 293
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 53/157 (33%), Positives = 79/157 (50%), Gaps = 11/157 (7%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
IEE + + + + RG FG YL + N +A K + K + + V+ E D + L
Sbjct: 3 IEE-FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALA-L 60
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV--- 169
K IV L + + V+LVME GG++ + G++ E A K I EV
Sbjct: 61 SKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA---VKYISEVALAL 117
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206
H+HG++HRDLKP+N L +N+ +K DFGLS
Sbjct: 118 DYLHRHGIIHRDLKPDNMLISNEGH---IKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 77/306 (25%), Positives = 133/306 (43%), Gaps = 53/306 (17%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+RY+ + +G G GI D G A K +S+ + + RE+ +++ +
Sbjct: 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP-FQNQTHAKRAYRELVLLKCV-N 78
Query: 115 HQNIVCL------KDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV 168
H+NI+ L + + E+ V+LVMEL + +++ ER + + + + +
Sbjct: 79 HKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYLLYQMLCGI 136
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPE 228
+ H G++HRDLKP N + K LK +DFGL+ + V + YY APE
Sbjct: 137 KHL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPE 192
Query: 229 V-LKRNYGPEVDVWSAGVILYILLCGVPPF--------WAETEQGVA-------QAIIRS 272
V L Y VD+WS G I+ L+ G F W + + + + +
Sbjct: 193 VILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT 252
Query: 273 VLDF--RRDPWPKVS---------------------ENAKDLVRKMLDPDPKRRLTAQQV 309
V ++ R +P +S A+DL+ KML DP +R++ +
Sbjct: 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA 312
Query: 310 LEHPWL 315
L HP++
Sbjct: 313 LRHPYI 318
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 20/223 (8%)
Query: 103 RREVDIMRHLPKHQNIVCLKDTYE-DDTAVHLVMELCEGGELFDRIVARGHYTERAAAAV 161
RRE + L H NIV L D+ E + V E G L + + A G +
Sbjct: 26 RRETALCARL-YHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRL 84
Query: 162 TKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG--------- 212
+++ + H G++HRDLKP+N + + K +DFG+ PG
Sbjct: 85 MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLL-PGVRDADVATL 143
Query: 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR 271
+ +E++G+P Y APE L+ P D+++ G+I L G + VA+ + +
Sbjct: 144 TRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGAS---VAEILYQ 200
Query: 272 --SVLDFRRDPWPKVSENAKDLVRKMLDPDPKRR-LTAQQVLE 311
S +D PW ++RK L+ DP++R +A + E
Sbjct: 201 QLSPVDVSLPPWIA-GHPLGQVLRKALNKDPRQRAASAPALAE 242
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 77/293 (26%), Positives = 117/293 (39%), Gaps = 48/293 (16%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+RY++ R +G+G G YL D A K I + + + RE I L
Sbjct: 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-I 60
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFD--------RIVARGHYTERAAAA---VTK 163
H IV + D V+ M EG L +++ + + A +
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK------------- 210
I ++ H GV+HRDLKP+N L E L D+G ++F K
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVIL---DWGAAIFKKLEEEDLLDIDVDE 177
Query: 211 PGEKFSE------IVGSPYYMAPEVLKRNYGPE-VDVWSAGVILYILLCGVPPFWAETEQ 263
+S IVG+P YMAPE L E D+++ GVILY +L P+ ++
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY--RRKK 235
Query: 264 GVAQAIIRSVLD------FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
G + +L +R P P +S+ + K L DP R ++ Q L
Sbjct: 236 GRKISYRDVILSPIEVAPYREIP-PFLSQ----IAMKALAVDPAERYSSVQEL 283
|
Length = 932 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 4e-15
Identities = 76/306 (24%), Positives = 131/306 (42%), Gaps = 53/306 (17%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+RY+ + +G G GI D A K +S+ + + RE+ +M+ +
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV-N 74
Query: 115 HQNIVCL------KDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV 168
H+NI+ L + + E+ V+LVMEL + +++ ER + + + + +
Sbjct: 75 HKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGI 132
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPE 228
+ H G++HRDLKP N + K LK +DFGL+ + V + YY APE
Sbjct: 133 KHL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 188
Query: 229 V-LKRNYGPEVDVWSAGVIL---------------------YILLCGVP-PFWAETEQGV 265
V L Y VD+WS G I+ I G P P + + Q
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248
Query: 266 AQAIIRSVLDFRRDPWPKV----------------SENAKDLVRKMLDPDPKRRLTAQQV 309
+ + + + +PK+ + A+DL+ KML DP +R++ +
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEA 308
Query: 310 LEHPWL 315
L+HP++
Sbjct: 309 LQHPYI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 5e-15
Identities = 61/216 (28%), Positives = 94/216 (43%), Gaps = 29/216 (13%)
Query: 54 EERY-ELGRELGRGEFGITYLCT-DRENGDAFACKSISKKKLRTA---VDIEDVRREVDI 108
E+R+ + ++LG G FG LC D + ++ K L + D RE++I
Sbjct: 2 EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAV--KSLNHSGEEQHRSDFEREIEI 59
Query: 109 MRHLPKHQNIVCLKDTYEDD--TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIV 166
+R L H+NIV K E ++ L+ME G L R + H R + + ++
Sbjct: 60 LRTL-DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSL--RDYLQRH---RDQINLKRLLL 113
Query: 167 EVVQMC------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF---SE 217
Q+C +HRDL N L ++ +K DFGL+ + + E
Sbjct: 114 FSSQICKGMDYLGSQRYIHRDLAARNILVESEDL---VKISDFGLAKVLPEDKDYYYVKE 170
Query: 218 IVGSP-YYMAPEVLK-RNYGPEVDVWSAGVILYILL 251
SP ++ APE L+ + DVWS GV LY L
Sbjct: 171 PGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 6e-15
Identities = 72/277 (25%), Positives = 104/277 (37%), Gaps = 54/277 (19%)
Query: 63 LGRGEFGITYLCTDR-ENGDAFACKSISKKKLRTAVDIEDVR---REVDIMRHLPKHQNI 118
LG G FG Y T G ++ K LR ++ + +E +M + H NI
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNI 61
Query: 119 VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK----TIVEVVQMC-- 172
V L + +++MEL EGG+L Y A T+ E++ +C
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLL-------SYLRDARVERFGPPLLTLKELLDICLD 114
Query: 173 --------HKHGVMHRDLKPENFLFANKKETAP--LKAIDFGLSVFFKPGEKFSEIVGSP 222
+ +HRDL N L + K A +K DFGL+ +I S
Sbjct: 115 VAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA---------RDIYKSD 165
Query: 223 YY------------MAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQA 268
YY MAPE L + + DVWS GV+++ IL G P+ A Q V Q
Sbjct: 166 YYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH 225
Query: 269 IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLT 305
+ R + L+ DP R T
Sbjct: 226 VTA---GGRLQKPENCPDKIYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 75/306 (24%), Positives = 133/306 (43%), Gaps = 53/306 (17%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+RY+ + +G G GI D A K +S+ + + RE+ +M+ +
Sbjct: 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV-N 81
Query: 115 HQNIVCLKDTY------EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV 168
H+NI+ L + + E+ V++VMEL + +++ ER + + + + +
Sbjct: 82 HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGI 139
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPE 228
+ H G++HRDLKP N + K LK +DFGL+ + V + YY APE
Sbjct: 140 KHL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 229 V-LKRNYGPEVDVWSAGVILYILLCGVPPF--------WAETEQGVA----------QAI 269
V L Y VD+WS G I+ ++ G F W + + + Q
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255
Query: 270 IRSVLDFR--------RDPWPKV------------SENAKDLVRKMLDPDPKRRLTAQQV 309
+R+ ++ R +P V + A+DL+ KML D +R++ +
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 310 LEHPWL 315
L+HP++
Sbjct: 316 LQHPYI 321
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 5e-14
Identities = 62/255 (24%), Positives = 102/255 (40%), Gaps = 47/255 (18%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDI---EDVRREVD 107
ELG G FG Y + + S++ K L+ + ++ R+E +
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKT--- 164
+M L +H NIVCL + ++ E G+L + +V +++ A + +T
Sbjct: 61 LMSDL-QHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119
Query: 165 -------------IVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211
I ++ H +HRDL N L +K DFGLS
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT---VKISDFGLS----- 171
Query: 212 GEKFSEIVGSPYY------------MAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPF 257
+I + YY M PE +L + E D+WS GV+L+ I G+ P+
Sbjct: 172 ----RDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPY 227
Query: 258 WAETEQGVAQAIIRS 272
+ + Q V + +IRS
Sbjct: 228 YGFSNQEVIE-MIRS 241
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-13
Identities = 80/324 (24%), Positives = 137/324 (42%), Gaps = 75/324 (23%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDA--FACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
YE G ++GRG +G Y ++ D +A K I + + RE+ ++R L K
Sbjct: 4 YE-GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA-----CREIALLREL-K 56
Query: 115 HQNIVCLKDTY--EDDTAVHLVMELCEGGELFDRIVARGHYTERA-----------AAAV 161
H N++ L+ + D V L+ + E +L+ + + H +A ++
Sbjct: 57 HPNVISLQKVFLSHADRKVWLLFDYAEH-DLWH--IIKFHRASKANKKPVQLPRGMVKSL 113
Query: 162 TKTIVEVVQMCHKHGVMHRDLKPENFLFANK-KETAPLKAIDFGLSVFF----KPGEKFS 216
I++ + H + V+HRDLKP N L + E +K D G + F KP
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 217 EIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETE------------ 262
+V + +Y APE+L R+Y +D+W+ G I LL P F E
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 233
Query: 263 ----------------QGVAQAIIRSVL--DFRRDPWP-----------KVSENAK--DL 291
+ + + S L DFRR+ + KV ++K L
Sbjct: 234 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHL 293
Query: 292 VRKMLDPDPKRRLTAQQVLEHPWL 315
++K+L DP +R+T++Q ++ P+
Sbjct: 294 LQKLLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 82/321 (25%), Positives = 132/321 (41%), Gaps = 69/321 (21%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDA--FACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
YE G ++GRG +G Y ++ D +A K I + + RE+ ++R L K
Sbjct: 4 YE-GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA-----CREIALLREL-K 56
Query: 115 HQNIVCLKDTY--EDDTAVHLVMELCEGGEL----FDRIVARGHYTERAAAAVTKT---- 164
H N++ L+ + D V L+ + E F R + ++ K+
Sbjct: 57 HPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQ 116
Query: 165 IVEVVQMCHKHGVMHRDLKPENFLFANK-KETAPLKAIDFGLSVFF----KPGEKFSEIV 219
I++ + H + V+HRDLKP N L + E +K D G + F KP +V
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 220 GSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI-------- 269
+ +Y APE+L R+Y +D+W+ G I LL P F E
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR 236
Query: 270 IRSVL----------------------DFRRDPWP-----------KVSENAKD--LVRK 294
I SV+ DFRR + KV ++K L++K
Sbjct: 237 IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQK 296
Query: 295 MLDPDPKRRLTAQQVLEHPWL 315
+L DP +R+T++Q L+ P+
Sbjct: 297 LLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 4e-13
Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 30/208 (14%)
Query: 61 RELGRGEFG-ITYLCTDREN---GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
R LG G FG ++ C D N G+ A K++ K+ + ++E++I++ L H+
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTL--KRECGQQNTSGWKKEINILKTL-YHE 66
Query: 117 NIVCLKDTYED--DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC-- 172
NIV K + + L+ME G L D Y + + + ++ Q+C
Sbjct: 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRD-------YLPKHKLNLAQLLLFAQQICEG 119
Query: 173 ----HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF---SEIVGSP-YY 224
H +HRDL N L N + +K DFGL+ G ++ E SP ++
Sbjct: 120 MAYLHSQHYIHRDLAARNVLLDNDR---LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 176
Query: 225 MAPEVLKRN-YGPEVDVWSAGVILYILL 251
A E LK N + DVWS GV LY LL
Sbjct: 177 YAVECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 7e-13
Identities = 74/314 (23%), Positives = 133/314 (42%), Gaps = 59/314 (18%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
++ +E ELG G G+ + + + +G A K I +++ A+ + RE+ ++ H
Sbjct: 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLI-HLEIKPAIR-NQIIRELQVL-HEC 60
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE-VVQMC 172
IV + D + + ME +GG L + G E+ V+ +++ + +
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 120
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI----VGSPYYMAPE 228
KH +MHRD+KP N L ++ E +K DFG+S G+ + VG+ YM+PE
Sbjct: 121 EKHKIMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPE 172
Query: 229 VLK-RNYGPEVDVWSAGVILYILLCG----VPPFWAETEQGVAQAI-------------- 269
L+ +Y + D+WS G+ L + G PP E E +
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPR 232
Query: 270 ------------------IRSVLDF-RRDPWPKV-----SENAKDLVRKMLDPDPKRRLT 305
I +LD+ +P PK+ +D V K L +P R
Sbjct: 233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERAD 292
Query: 306 AQQVLEHPWLQNAK 319
+Q++ H +++ ++
Sbjct: 293 LKQLMVHAFIKRSE 306
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 8e-13
Identities = 80/330 (24%), Positives = 138/330 (41%), Gaps = 56/330 (16%)
Query: 35 QGNGGHKLCVLKEPTG--REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKK 92
Q + + C + + +Y + L G G ++CT GD K I K
Sbjct: 70 QTDVCQEPCETTSSSDPASVVRMQYNILSSLTPGSEGEVFVCTKH--GDEQRKKVIVK-- 125
Query: 93 LRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH 152
+ RE+DI++ + H+ I+ L Y + V +VM + +LF + G
Sbjct: 126 --AVTGGKTPGREIDILKTI-SHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGP 181
Query: 153 YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212
A + + ++E + H G++HRD+K EN +F ++ E A L DFG + K
Sbjct: 182 LPLEQAITIQRRLLEALAYLHGRGIIHRDVKTEN-IFLDEPENAVLG--DFGAAC--KLD 236
Query: 213 E-----KFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGV 265
+ G+ +PE+L + Y + D+WSAG++L+ + + V F + +
Sbjct: 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSS 296
Query: 266 AQ--AIIRSV----LDF------------------RRDPW--PKV------SENAKDLVR 293
+Q +IIR + L+F R P+ P V + + L+
Sbjct: 297 SQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIA 356
Query: 294 KMLDPDPKRRLTAQQVLEHPWLQNAKKAPN 323
KML D + R +AQ +L P K+ N
Sbjct: 357 KMLTFDQEFRPSAQDILSLPLF--TKEPIN 384
|
Length = 392 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-12
Identities = 53/192 (27%), Positives = 88/192 (45%), Gaps = 15/192 (7%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCL 121
E+G G+FG+ +L A K+I + A+ ED E +M L H +V L
Sbjct: 11 EIGSGQFGLVWLGY-WLEKRKVAIKTIREG----AMSEEDFIEEAQVMMKL-SHPKLVQL 64
Query: 122 KDTYEDDTAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
+ + + LV E E G L D + A RG +++ + + E + V+HR
Sbjct: 65 YGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHR 124
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY---YMAPEVLK-RNYGP 236
DL N L E +K DFG++ F ++++ G+ + + +PEV Y
Sbjct: 125 DLAARNCLVG---ENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSSPEVFSFSKYSS 180
Query: 237 EVDVWSAGVILY 248
+ DVWS GV+++
Sbjct: 181 KSDVWSFGVLMW 192
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 79/287 (27%), Positives = 126/287 (43%), Gaps = 54/287 (18%)
Query: 61 RELGRGEFGITYLCTDRENGD----AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
R+LG G FG LC GD A KS+ K I D+++E++I+R+L H+
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL--KPESGGNHIADLKKEIEILRNL-YHE 66
Query: 117 NIVCLKDTYEDD--TAVHLVMELCEGGELFDRIVARGHYTERAAAAVT-KTIVE-VVQMC 172
NIV K +D + L+ME G L + Y R + K ++ VQ+C
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKE-------YLPRNKNKINLKQQLKYAVQIC 119
Query: 173 H------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI---VGSP- 222
+HRDL N L ++ + +K DFGL+ + +++ + + SP
Sbjct: 120 KGMDYLGSRQYVHRDLAARNVLVESEHQ---VKIGDFGLTKAIETDKEYYTVKDDLDSPV 176
Query: 223 YYMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETE----------------QGV 265
++ APE L + + DVWS GV LY LL + ++E Q
Sbjct: 177 FWYAPECLIQSKFYIASDVWSFGVTLYELLT-----YCDSESSPMTLFLKMIGPTHGQMT 231
Query: 266 AQAIIRSVLDFRRDPWP-KVSENAKDLVRKMLDPDPKRRLTAQQVLE 311
++R + + +R P P E L+RK + P +R T Q ++E
Sbjct: 232 VTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 3e-12
Identities = 56/197 (28%), Positives = 80/197 (40%), Gaps = 17/197 (8%)
Query: 62 ELGRGEFGITYLCT-DRENGDAF--ACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI 118
+LG G FG+ G A K + KL +D D +E IM L H+N+
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMD--DFLKEAAIMHSL-DHENL 58
Query: 119 VCLKDTYEDDTAVHLVMELCEGGELFDRI--VARGHYTERAAAAVTKTIVEVVQMCHKHG 176
+ L + +V EL G L DR+ A GH+ I ++
Sbjct: 59 IRLYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE---KFSEIVGSPY-YMAPEVLK- 231
+HRDL N L A+ + +K DFGL E E + P+ + APE L+
Sbjct: 118 FIHRDLAARNILLASDDK---VKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174
Query: 232 RNYGPEVDVWSAGVILY 248
R + DVW GV L+
Sbjct: 175 RTFSHASDVWMFGVTLW 191
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 8e-12
Identities = 72/270 (26%), Positives = 108/270 (40%), Gaps = 32/270 (11%)
Query: 55 ERYELGRELGRGEFGITYLCT-DRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
E LGR +G G+FG Y + A + K + E +E IMR
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF- 64
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHY--TERAAAAVTKTIVEVVQM 171
H +IV L ++ V +VMEL GEL Y + + + I+ Q+
Sbjct: 65 DHPHIVKLIGVITEN-PVWIVMELAPLGEL-------RSYLQVNKYSLDLASLILYSYQL 116
Query: 172 C------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGS-PY- 223
+HRD+ N L ++ +K DFGLS + + + G P
Sbjct: 117 STALAYLESKRFVHRDIAARNVLVSSPD---CVKLGDFGLSRYLEDESYYKASKGKLPIK 173
Query: 224 YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQA-IIRSVLDFRRDP 280
+MAPE + R + DVW GV ++ IL+ GV PF QGV +I + + R P
Sbjct: 174 WMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPF-----QGVKNNDVIGRIENGERLP 228
Query: 281 WPKVSENA-KDLVRKMLDPDPKRRLTAQQV 309
P L+ K DP +R ++
Sbjct: 229 MPPNCPPTLYSLMTKCWAYDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 9e-12
Identities = 68/278 (24%), Positives = 118/278 (42%), Gaps = 35/278 (12%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRR---EVDIMRHLPKHQN 117
ELGRG +G+ G A K ++R V+ ++ +R ++DI
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVK-----RIRATVNSQEQKRLLMDLDISMRSVDCPY 61
Query: 118 IVCLKDTYEDDTAVHLVMELCEGG--ELFDRIVARG-HYTERAAAAVTKTIVEVVQMCH- 173
V + V + ME+ + + + ++ +G E + +IV+ ++ H
Sbjct: 62 TVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVL--- 230
K V+HRD+KP N L N+ +K DFG+S + + G YMAPE +
Sbjct: 122 KLSVIHRDVKPSNVL-INRN--GQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPE 178
Query: 231 --KRNYGPEVDVWSAGVILYILLCGVPPF--WAETEQGVAQAIIRSVLDFRRDPWPKV-- 284
++ Y + DVWS G+ + L G P+ W Q + Q + +P P++
Sbjct: 179 LNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV--------EEPSPQLPA 230
Query: 285 ---SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319
S +D V K L + K R ++L+HP+ +
Sbjct: 231 EKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 71/328 (21%), Positives = 129/328 (39%), Gaps = 67/328 (20%)
Query: 58 ELGRELGRGEFGIT--YLCTDRENGDAFACKSISKKKLRTAVDIEDVRR---EVDIMRHL 112
EL +G+ + +L + A K I+ L + ED++ E+ R L
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKIN---LDSCSK-EDLKLLQQEIITSRQL 56
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYT----ERAAAAVTKTIVEV 168
+H NI+ ++ D+ +++V L G D + + H+ E A A + K ++
Sbjct: 57 -QHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLNA 113
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV---FFKPGEKFSEIVGSP--- 222
+ H G +HR +K + L + K + GL K G++ + P
Sbjct: 114 LDYIHSKGFIHRSVKASHILL-----SGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSS 168
Query: 223 ----YYMAPEVLKRN---YGPEVDVWSAGVILYILLCGVPPFWAETE---------QGVA 266
+++PEVL++N Y + D++S G+ L G PF + +G
Sbjct: 169 VKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPF-KDMPATQMLLEKVRGTV 227
Query: 267 QAII-RSVL--------------------DFRRDPWPKV-SENAKDLVRKMLDPDPKRRL 304
++ +S D P+ + SE+ V L DP+ R
Sbjct: 228 PCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRP 287
Query: 305 TAQQVLEHPWLQNAKKAPNVSLGETVKA 332
+A Q+L H + + K+ N SL + +K
Sbjct: 288 SASQLLNHSFFKQCKRR-NTSLLDLLKP 314
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-11
Identities = 66/259 (25%), Positives = 107/259 (41%), Gaps = 21/259 (8%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
+LG +G+GEFG L R G A K + K TA E +M L +H N
Sbjct: 9 KLGATIGKGEFGDVMLGDYR--GQKVAVKCL--KDDSTAAQ--AFLAEASVMTTL-RHPN 61
Query: 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKH 175
+V L +++V E G L D + +RG T + E ++ +
Sbjct: 62 LVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK 121
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY-YMAPEVLKRN- 233
+HRDL N L + E K DFGL+ K + + P + APE L+
Sbjct: 122 NFVHRDLAARNVLVS---EDLVAKVSDFGLA---KEASQGQDSGKLPVKWTAPEALREKK 175
Query: 234 YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
+ + DVWS G++L+ I G P+ + V + + +R + ++
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG---YRMEAPEGCPPEVYKVM 232
Query: 293 RKMLDPDPKRRLTAQQVLE 311
+ + DP +R T +Q+ E
Sbjct: 233 KDCWELDPAKRPTFKQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 59/260 (22%), Positives = 104/260 (40%), Gaps = 21/260 (8%)
Query: 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI 118
+ELG G+FG+ +L R A K I + A+ +D E +M L H N+
Sbjct: 8 FLKELGSGQFGVVHLGKWR-GKIDVAIKMIREG----AMSEDDFIEEAKVMMKL-SHPNL 61
Query: 119 VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAA-AVTKTIVEVVQMCHKHGV 177
V L + +V E G L + + R + + E ++ +G
Sbjct: 62 VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGF 121
Query: 178 MHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY---YMAPEVLKRN- 233
+HRDL N L E +K DFGL+ + + S G+ + + PEV +
Sbjct: 122 IHRDLAARNCLVG---EDNVVKVSDFGLARYVLDDQYTSS-QGTKFPVKWAPPEVFDYSR 177
Query: 234 YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV-SENAKDL 291
+ + DVWS GV+++ + G P+ + V +++ R PK+ +
Sbjct: 178 FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY----RLYRPKLAPTEVYTI 233
Query: 292 VRKMLDPDPKRRLTAQQVLE 311
+ P+ R +++L
Sbjct: 234 MYSCWHEKPEDRPAFKKLLS 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 6e-11
Identities = 58/242 (23%), Positives = 99/242 (40%), Gaps = 48/242 (19%)
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCH 173
H +++ +KDT +V+ +L+ + R A + K I+E ++ H
Sbjct: 116 HPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH 174
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN 233
++HRD+K EN +F N + + D G + F F + G+ APEVL R+
Sbjct: 175 AQRIIHRDVKTEN-IFINDVDQVCIG--DLGAAQFPVVAPAFLGLAGTVETNAPEVLARD 231
Query: 234 -YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS----VLD-----------FR 277
Y + D+WSAG++L+ +L P E + ++S +L F
Sbjct: 232 KYNSKADIWSAGIVLFEML-AYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290
Query: 278 RDP---------------------WPKVS-----ENAKDLVRKMLDPDPKRRLTAQQVLE 311
RDP +P + + LV KML D R +A+++L
Sbjct: 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350
Query: 312 HP 313
+P
Sbjct: 351 YP 352
|
Length = 357 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 7e-11
Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
++ +E ELG G G+ + +G A K I +++ A+ + RE+ ++ H
Sbjct: 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLI-HLEIKPAIR-NQIIRELQVL-HEC 60
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE-VVQMC 172
IV + D + + ME +GG L + E V+ ++ + +
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLR 120
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI----VGSPYYMAPE 228
KH +MHRD+KP N L ++ E +K DFG+S G+ + VG+ YM+PE
Sbjct: 121 EKHQIMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPE 172
Query: 229 VLK-RNYGPEVDVWSAGVILYILLCG---VPP 256
L+ +Y + D+WS G+ L L G +PP
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 57/191 (29%), Positives = 94/191 (49%), Gaps = 20/191 (10%)
Query: 68 FGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRR-----EVDIMRHLPKHQNIVCLK 122
F I T G AFAC K V I+ +R E I+R + H +I+ LK
Sbjct: 94 FSILETFTPGAEGFAFAC---IDNKTCEHVVIKAGQRGGTATEAHILRAI-NHPSIIQLK 149
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
T+ + L++ + +L+ + A+ + A+ ++++ +Q H++ ++HRD+
Sbjct: 150 GTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDI 208
Query: 183 KPENFLFANKKETAPLKAIDFGLSVFFKP----GEKFSEIVGSPYYMAPEVLKRN-YGPE 237
K EN +F N L DFG + F P K+ G+ APE+L R+ YGP
Sbjct: 209 KAEN-IFINHPGDVCLG--DFGAACF--PVDINANKYYGWAGTIATNAPELLARDPYGPA 263
Query: 238 VDVWSAGVILY 248
VD+WSAG++L+
Sbjct: 264 VDIWSAGIVLF 274
|
Length = 391 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 65/269 (24%), Positives = 102/269 (37%), Gaps = 23/269 (8%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDI---EDVRREVDIMRH 111
G+ LG G FG T + A ++ K L+ E + E+ IM H
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 112 LPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFD--RIVARGHYTERAAAAVTKTIVEVV 169
L H+NIV L + ++ E C G+L + R T + + + + +
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL-------SVFFKPGEKFSEIVGSP 222
+HRDL N L + K K DFGL S + G +
Sbjct: 155 AFLASKNCIHRDLAARNVLLTHGKIV---KICDFGLARDIMNDSNYVVKGNARLPV---- 207
Query: 223 YYMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP 280
+MAPE + Y E DVWS G++L+ I G P+ +I+ +R
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE--GYRMAQ 265
Query: 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQV 309
D+++ D DP +R T +Q+
Sbjct: 266 PEHAPAEIYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-10
Identities = 57/218 (26%), Positives = 100/218 (45%), Gaps = 18/218 (8%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRT-AVDIEDVRREVDIMRHLPKHQNIV 119
+ELG G+FG+ +L G A ++ K + A+ ED E +M L H +V
Sbjct: 10 KELGSGQFGVVHL------GKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKL-SHPKLV 62
Query: 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVM 178
L +++V E E G L + + R G ++ ++ + + E ++ ++ +
Sbjct: 63 QLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFI 122
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY---YMAPEVLKRN-Y 234
HRDL N L + T +K DFG++ + E S G+ + + PEV + Y
Sbjct: 123 HRDLAARNCLVS---STGVVKVSDFGMTRYVLDDEYTSS-SGAKFPVKWSPPEVFNFSKY 178
Query: 235 GPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 271
+ DVWS GV+++ + G PF ++ V + I R
Sbjct: 179 SSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 69/287 (24%), Positives = 117/287 (40%), Gaps = 53/287 (18%)
Query: 59 LGRELGRGEFGITYL--CTDRENGDAF---ACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
L RELG G FG +L C E + A K++ + A +D RE +++ +
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDAR--KDFEREAELLTNF- 65
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK----TIVEVV 169
+H+NIV + +V E E G+L + + G + + T+ +++
Sbjct: 66 QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 170 Q-----------MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI 218
Q + +H V HRDL N L +K DFG+S ++
Sbjct: 126 QIAVQIASGMVYLASQHFV-HRDLATRNCLVGYD---LVVKIGDFGMS---------RDV 172
Query: 219 VGSPYY------------MAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQG 264
+ YY M PE ++ R + E DVWS GV+L+ I G P++ + +
Sbjct: 173 YTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE 232
Query: 265 VAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311
V + I + L R P D++ DP++R+ + + E
Sbjct: 233 VIECITQGRLLQRPRTCPS---EVYDIMLGCWKRDPQQRINIKDIHE 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 5e-10
Identities = 60/243 (24%), Positives = 99/243 (40%), Gaps = 50/243 (20%)
Query: 62 ELGRGEFGITYL-----CTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
ELG FG Y E A A K++ K K + E+ + E +MR +H
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKAEGPLR-EEFKHEA-MMRSRLQHP 68
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI---VEVVQMCH 173
NIVCL + + ++ C +L + +V R +++ + KT+ +E H
Sbjct: 69 NIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVH 128
Query: 174 -------------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG 220
H V+H+DL N L +K +K D GL F E+
Sbjct: 129 IVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN---VKISDLGL---------FREVYA 176
Query: 221 SPYY------------MAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVA 266
+ YY M+PE ++ + + D+WS GV+L+ + G+ P+ + Q V
Sbjct: 177 ADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI 236
Query: 267 QAI 269
+ I
Sbjct: 237 EMI 239
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 8e-10
Identities = 66/270 (24%), Positives = 118/270 (43%), Gaps = 34/270 (12%)
Query: 63 LGRGEFGITYLC----TDRENGDAF-ACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
LGRGEFG +L + E G+ K++ K K + RRE+D+ R L H+N
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENL--QSEFRRELDMFRKL-SHKN 69
Query: 118 IVCLKDTYEDDTAVHLVMELCEGGEL--FDRIVARGHYTERAAAAVTKTIVEVV-QMCH- 173
+V L + ++++E + G+L F R + TK V + Q+
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 174 -----KHGVMHRDLKPENFLFANKKETAPLKAIDFGLS--VFFKPGEKFSEIVGSPYYMA 226
+HRDL N L ++++E +K LS V+ K + ++A
Sbjct: 130 MDHLSNARFVHRDLAARNCLVSSQRE---VKVSLLSLSKDVYNSEYYKLRNALIPLRWLA 186
Query: 227 PE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284
PE V + ++ + DVWS GV+++ + G PF+ +++ V + L+ P V
Sbjct: 187 PEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLE-----LP-V 240
Query: 285 SENAKDLVRKML----DPDPKRRLTAQQVL 310
E + K++ +PK R + +++
Sbjct: 241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELV 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 54/199 (27%), Positives = 88/199 (44%), Gaps = 30/199 (15%)
Query: 131 VHLVMELCEGGEL--FDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFL 188
+ + E +GG L + +I H R A AV K + + + ++HRD+KP N L
Sbjct: 74 ISICTEFMDGGSLDVYRKIPE--HVLGRIAVAVVKGLTYLWSL----KILHRDVKPSNML 127
Query: 189 FANKKETAPLKAIDFGLSVFFKPGEKFSEI----VGSPYYMAPE-VLKRNYGPEVDVWSA 243
+ + +K DFG+S + + I VG+ YMAPE + YG DVWS
Sbjct: 128 VNTRGQ---VKLCDFGVST-----QLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSL 179
Query: 244 GVILYILLCGVPPF-WAETEQG------VAQAIIRSVLDFRRDPWPKVSENAKDLVRKML 296
G+ L G P+ + QG + Q I+ D P + SE + + +
Sbjct: 180 GISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE--DPPVLPVGQFSEKFVHFITQCM 237
Query: 297 DPDPKRRLTAQQVLEHPWL 315
PK R + +++HP++
Sbjct: 238 RKQPKERPAPENLMDHPFI 256
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 65/214 (30%), Positives = 97/214 (45%), Gaps = 28/214 (13%)
Query: 54 EERY-ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR--TAVDIEDVRREVDIMR 110
EER+ + ++LG+G FG LC D + ++ KKL+ TA + D RE++I++
Sbjct: 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTG-EVVAVKKLQHSTAEHLRDFEREIEILK 60
Query: 111 HLPKHQNIVCLKDT-YE-DDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV 168
L +H NIV K Y + LVME G L D + + K ++
Sbjct: 61 SL-QHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDH-----RKLLLYA 114
Query: 169 VQMCH------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSP 222
Q+C +HRDL N L ++ +K DFGL+ P +K V P
Sbjct: 115 SQICKGMEYLGSKRYVHRDLATRNILVESE---NRVKIGDFGLTKVL-PQDKEYYKVREP 170
Query: 223 -----YYMAPEVLKRN-YGPEVDVWSAGVILYIL 250
++ APE L + + DVWS GV+LY L
Sbjct: 171 GESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 71/265 (26%), Positives = 107/265 (40%), Gaps = 26/265 (9%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLR---TAVDIEDVRREVDIMRHLPKHQN 117
+ +G GEFG + G ++ K L+ + D E IM H N
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKK--EIDVAIKTLKAGSSDKQRLDFLTEASIMGQF-DHPN 66
Query: 118 IVCLKDTYEDDTAVHLVMELCEGGEL--FDRIVARGHYTERAAAAVTKTIVEVVQMCHKH 175
I+ L+ V ++ E E G L F R G +T + + I ++ +
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLR-ENDGKFTVGQLVGMLRGIASGMKYLSEM 125
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG--SPY-YMAPEVLK- 231
+HRDL N L N K DFGLS + E G P + APE +
Sbjct: 126 NYVHRDLAARNIL-VNSNLVC--KVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY 182
Query: 232 RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290
R + DVWS G++++ ++ G P+W + Q V I++V D R P P +A
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV----IKAVEDGYRLPPPMDCPSA-- 236
Query: 291 LVRKMLD---PDPKRRLTAQQVLEH 312
L + MLD D R T Q++
Sbjct: 237 LYQLMLDCWQKDRNERPTFSQIVST 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-09
Identities = 64/262 (24%), Positives = 114/262 (43%), Gaps = 31/262 (11%)
Query: 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI 118
LG +G GEFG + + ++ K ++ V + E +M L H+N+
Sbjct: 10 LGEIIGEGEFGAVL-------QGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKL-HHKNL 61
Query: 119 VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKT------IVEVVQMC 172
V L + +++VMEL G L + + RG RA +V + + E ++
Sbjct: 62 VRLLGVILHN-GLYIVMELMSKGNLVNFLRTRG----RALVSVIQLLQFSLDVAEGMEYL 116
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY-YMAPEVLK 231
++HRDL N L + E K DFGL+ + G + P + APE LK
Sbjct: 117 ESKKLVHRDLAARNILVS---EDGVAKVSDFGLA---RVGSMGVDNSKLPVKWTAPEALK 170
Query: 232 RN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289
+ + DVWS GV+L+ + G P+ + + V + + + +R +P +
Sbjct: 171 HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG---YRMEPPEGCPADVY 227
Query: 290 DLVRKMLDPDPKRRLTAQQVLE 311
L+ + +PK+R + ++ E
Sbjct: 228 VLMTSCWETEPKKRPSFHKLRE 249
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 66/279 (23%), Positives = 113/279 (40%), Gaps = 35/279 (12%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRR---EVDIMRHLPK 114
+LG E+GRG FG + +G A K I R+ VD ++ +R ++D++
Sbjct: 8 DLG-EIGRGAFGTVNKMLHKPSGTIMAVKRI-----RSTVDEKEQKRLLMDLDVVMRSSD 61
Query: 115 HQNIVCLKDTY------EDDTAVHLVMELCEGG-ELFDRIV---ARGHYTERAAAAVTKT 164
IV + E D + MEL + + F + V + E +
Sbjct: 62 CPYIV----KFYGALFREGDCWI--CMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVA 115
Query: 165 IVEVVQ-MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY 223
V+ + + + ++HRD+KP N L +K DFG+S + G
Sbjct: 116 TVKALNYLKEELKIIHRDVKPSNILL---DRNGNIKLCDFGISGQLVDSIAKTRDAGCRP 172
Query: 224 YMAPEVLKRN----YGPEVDVWSAGVILYILLCGVPPF--WAETEQGVAQAIIRSVLDFR 277
YMAPE + + Y DVWS G+ LY + G P+ W + Q +
Sbjct: 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILS 232
Query: 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
+ S + + + L D +R +++LEHP+++
Sbjct: 233 NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIK 271
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 4e-09
Identities = 55/215 (25%), Positives = 78/215 (36%), Gaps = 53/215 (24%)
Query: 61 RELGRGEFGITYLCTDRENGD---AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
+ELG G FG A K++ ++ + ++ RE +M L H
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAA--GKKEFLREASVMAQL-DHPC 57
Query: 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH---- 173
IV L + + + LVMEL G L + R ++ ++ H
Sbjct: 58 IVRLIGVCKGE-PLMLVMELAPLGPLLKYLKKRREIPV----------SDLKELAHQVAM 106
Query: 174 -------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMA 226
KH V HRDL N L N+ + K DFG+S GS YY A
Sbjct: 107 GMAYLESKHFV-HRDLAARNVLLVNRHQA---KISDFGMSRALGA--------GSDYYRA 154
Query: 227 PEVLK---RNYGPEV----------DVWSAGVILY 248
+ + Y PE DVWS GV L+
Sbjct: 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 6e-09
Identities = 70/279 (25%), Positives = 105/279 (37%), Gaps = 37/279 (13%)
Query: 58 ELGRELGRGEFGITYLCTDR-ENGDA--FACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
L R LG G FG Y R +GDA + + + D D E IM
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF-N 67
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIV----EVVQ 170
HQNIV L + +++EL GG+L + ER ++ K ++ +V +
Sbjct: 68 HQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAK 127
Query: 171 MCH---KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY--- 224
C ++ +HRD+ N L K K DFG++ +I + YY
Sbjct: 128 GCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA---------RDIYRASYYRKG 178
Query: 225 ---------MAPEV-LKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSV 273
M PE L + + DVWS GV+L+ I G P+ T Q V + +
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG 238
Query: 274 LDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312
R DP ++ P+ R +LE
Sbjct: 239 ---RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 7e-09
Identities = 63/236 (26%), Positives = 101/236 (42%), Gaps = 43/236 (18%)
Query: 55 ERYELGRELGRGEFGITYLC----TDRENGDAFACKSISKKKLR---TAVDIEDVRREVD 107
+R LG+ LG G FG D+ D +++ K L+ T D+ D+ E++
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTV--TVAVKMLKDNATDKDLADLISEME 69
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE 167
+M+ + KH+NI+ L + +++++E G L + + AR +TK E
Sbjct: 70 LMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEE 129
Query: 168 VVQMCHKHGV------------------MHRDLKPENFLFANKKETAPLKAIDFGLSV-- 207
Q+ K V +HRDL N L E +K DFGL+
Sbjct: 130 --QLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT---EDNVMKIADFGLARGV 184
Query: 208 ----FFKPGEKFSEIVGSPYYMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 257
++K K S +MAPE L R Y + DVWS G++++ I G P+
Sbjct: 185 HDIDYYK---KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 64/238 (26%), Positives = 96/238 (40%), Gaps = 49/238 (20%)
Query: 55 ERYELGRELGRGEFGITYL-----CTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIM 109
+R LG+ LG G FG + A K + K T D+ D+ E+++M
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML--KDDATEKDLSDLVSEMEMM 69
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR---GHYTERAAAAVTK--- 163
+ + KH+NI+ L + +++V+E G L D + AR G Y +
Sbjct: 70 KMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL 129
Query: 164 TIVEVVQMCHK----------HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213
T ++V ++ +HRDL N L E +K DFGL+
Sbjct: 130 TQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT---EDHVMKIADFGLA------- 179
Query: 214 KFSEIVGSPYY------------MAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 257
+I YY MAPE L R Y + DVWS GV+L+ I G P+
Sbjct: 180 --RDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-08
Identities = 58/251 (23%), Positives = 107/251 (42%), Gaps = 23/251 (9%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCL 121
+LG G++G Y ++ A K++ + + +E+ +E +M+ + KH N+V L
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEI-KHPNLVQL 67
Query: 122 KDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAV--TKTIVEVVQMCHKHGVMH 179
+ +++ E G L D + A + I ++ K +H
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 127
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY---YMAPEVLKRN-YG 235
RDL N L E +K DFGLS G+ ++ G+ + + APE L N +
Sbjct: 128 RDLAARNCLVG---ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFS 183
Query: 236 PEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLD--FRRDPWPKVSENAKDLV 292
+ DVW+ GV+L+ I G+ P+ G+ + + +L+ +R + +L+
Sbjct: 184 IKSDVWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKGYRMERPEGCPPKVYELM 238
Query: 293 RKMLDPDPKRR 303
R +P R
Sbjct: 239 RACWQWNPSDR 249
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-08
Identities = 62/251 (24%), Positives = 101/251 (40%), Gaps = 34/251 (13%)
Query: 73 LCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132
L D F K LR + + R + I +P N+VCL + +V
Sbjct: 11 LVMDTRTQQTFILKG-----LRKSSEYSRERLTI-IPHCVP---NMVCLHKYIVSEDSVF 61
Query: 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK 192
LV++ EGG+L+ I + E +V + H+ G++ RDL P N L ++
Sbjct: 62 LVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR 121
Query: 193 KETAPLKAIDFGLSVFFKP---GEKFSEIVGSPYYMAPEVLKRNYGPEV-DVWSAGVILY 248
++ F + GE + Y APEV + E D WS G IL+
Sbjct: 122 GH---IQLTYFSRWSEVEDSCDGEAVENM-----YCAPEVGGISEETEACDWWSLGAILF 173
Query: 249 ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTA-- 306
LL G G+ ++ ++ VSE A+ L++++L +P RL A
Sbjct: 174 ELLTGKTLVECHP-SGINTHTTLNIPEW-------VSEEARSLLQQLLQFNPTERLGAGV 225
Query: 307 ---QQVLEHPW 314
+ + HP+
Sbjct: 226 AGVEDIKSHPF 236
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 65/251 (25%), Positives = 102/251 (40%), Gaps = 21/251 (8%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIED-VRREVDIMRHLPKHQNIVC 120
+GRG FG + R + A KS + D++ +E I++ H NIV
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRET---LPPDLKAKFLQEARILKQY-SHPNIVR 57
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMH 179
L +++VMEL +GG+ + G + + + ++ +H
Sbjct: 58 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIH 117
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE--IVGSPY-YMAPEVLKRNYG- 235
RDL N L K LK DFG+S + G S + P + APE L NYG
Sbjct: 118 RDLAARNCLVTEKNV---LKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEAL--NYGR 172
Query: 236 --PEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
E DVWS G++L+ G P+ + Q +AI + V R + L+
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV---RLPCPELCPDAVYRLM 229
Query: 293 RKMLDPDPKRR 303
+ + DP +R
Sbjct: 230 ERCWEYDPGQR 240
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 56/231 (24%), Positives = 99/231 (42%), Gaps = 33/231 (14%)
Query: 55 ERYELGRELGRGEFGITYLC----TDRENGDAFACKSISKKKLR---TAVDIEDVRREVD 107
++ LG+ LG G FG + D++ +++ K L+ T D+ D+ E++
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAV--TVAVKMLKDDATEKDLSDLVSEME 72
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR----------------G 151
+M+ + KH+NI+ L D +++++E G L + + AR
Sbjct: 73 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDE 132
Query: 152 HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211
T + + T + ++ +HRDL N L E +K DFGL+
Sbjct: 133 QMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDVNN 189
Query: 212 GEKFSEIVGSPY---YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 257
+ + + +MAPE L R Y + DVWS GV+++ I G P+
Sbjct: 190 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 4e-08
Identities = 60/232 (25%), Positives = 96/232 (41%), Gaps = 32/232 (13%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDI----------EDVRRE 105
++ + +G GEFG +C+ R K K+++ A+ D E
Sbjct: 5 CIKIEKVIGAGEFG--EVCSGR-------LKLPGKREIPVAIKTLKAGYTEKQRRDFLSE 55
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTK 163
IM H NI+ L+ V +V E E G L D + + G +T + +
Sbjct: 56 ASIMGQF-DHPNIIHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLR 113
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK--PGEKFSEIVGS 221
I ++ G +HRDL N L K DFGLS + P ++ G
Sbjct: 114 GIASGMKYLSDMGYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 170
Query: 222 -PY-YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 269
P + APE + R + DVWS G++++ ++ G P+W + Q V +AI
Sbjct: 171 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI 222
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 4e-08
Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 159 AAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE- 217
AV + ++ + H G++HRD+K EN + N E L DFG + F + G +
Sbjct: 263 TAVARQLLSAIDYIHGEGIIHRDIKTEN-VLVNGPEDICLG--DFGAACFAR-GSWSTPF 318
Query: 218 ---IVGSPYYMAPEVLKRN-YGPEVDVWSAGVILY 248
I G+ APEVL + Y P VD+WSAG++++
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 5e-08
Identities = 74/279 (26%), Positives = 111/279 (39%), Gaps = 55/279 (19%)
Query: 52 EIEER-YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT-AVDIEDVRREVDIM 109
EI+ +L R+LG G+FG + N ++ K L+ +D +D E IM
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVW--EGLWNNTT----PVAVKTLKPGTMDPKDFLAEAQIM 55
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV 169
+ L +H ++ L + +++V EL + G L + Y + A K + +++
Sbjct: 56 KKL-RHPKLIQLYAVCTLEEPIYIVTELMKYGSLLE-------YLQGGAGRALK-LPQLI 106
Query: 170 QMC----------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-------PG 212
M +HRDL N L E K DFGL+ K G
Sbjct: 107 DMAAQVASGMAYLEAQNYIHRDLAARNVLVG---ENNICKVADFGLARVIKEDIYEAREG 163
Query: 213 EKFSEIVGSPY-YMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 269
KF P + APE N + + DVWS G++L I+ G P+ T V Q +
Sbjct: 164 AKF------PIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV 217
Query: 270 IRSVLDFRRDPWPKVSENAKDLVRKMLD---PDPKRRLT 305
+ R P P K+L MLD DP R T
Sbjct: 218 DQGY----RMPCPPGCP--KELYDIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 5e-08
Identities = 60/240 (25%), Positives = 102/240 (42%), Gaps = 33/240 (13%)
Query: 46 KEPTGREIEERYELGRELGRGEFGITYLCT----DRENGDAFACKSISKKKLR---TAVD 98
++P +R LG+ LG G FG + D+E + ++ K L+ T D
Sbjct: 9 EDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVT--KVAVKMLKSDATEKD 66
Query: 99 IEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG------H 152
+ D+ E+++M+ + KH+NI+ L D +++++E G L + + AR
Sbjct: 67 LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYC 126
Query: 153 YTERAAAAVTKTIVEVVQMCHK----------HGVMHRDLKPENFLFANKKETAPLKAID 202
Y + ++V ++ +HRDL N L E +K D
Sbjct: 127 YNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIAD 183
Query: 203 FGLSVFFKPGEKFSEIVGSPY---YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 257
FGL+ + + + +MAPE L R Y + DVWS GV+L+ I G P+
Sbjct: 184 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 6e-08
Identities = 77/303 (25%), Positives = 122/303 (40%), Gaps = 59/303 (19%)
Query: 59 LGRELGRGEFGITYL------CTDRENGDAFACKSISKKKLRTAVD--IEDVRREVDIMR 110
L RELG G FG +L C +++ ++ K L+ A D +D RE +++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDK------ILVAVKTLKDASDNARKDFHREAELLT 62
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ 170
+L +H++IV + + +V E + G+L + A G A + Q
Sbjct: 63 NL-QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQ 121
Query: 171 MCH-------------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE 217
M H +HRDL N L E +K DFG+S +
Sbjct: 122 MLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENLLVKIGDFGMS---------RD 169
Query: 218 IVGSPYY------------MAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQ 263
+ + YY M PE ++ R + E DVWS GV+L+ I G P++ +
Sbjct: 170 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN 229
Query: 264 GVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPN 323
V + I + + R P + DL+ +P RL +++ H LQN KA
Sbjct: 230 EVIECITQGRVLQRPRTCP---KEVYDLMLGCWQREPHMRLNIKEI--HSLLQNLAKASP 284
Query: 324 VSL 326
V L
Sbjct: 285 VYL 287
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 9e-08
Identities = 56/217 (25%), Positives = 86/217 (39%), Gaps = 41/217 (18%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
++G+G FG Y + N + A K+ + +E +I++ H NIV
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEV-AVKTC--RSTLPPDLKRKFLQEAEILKQY-DHPNIVK 56
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC-------- 172
L +++VMEL GG L + + +T +++QM
Sbjct: 57 LIGVCVQKQPIYIVMELVPGGSLLT-------FLRKKKNRLTVK--KLLQMSLDAAAGME 107
Query: 173 --HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-----VFFKPGEKFSEIVGSPY-Y 224
+HRDL N L E LK DFG+S + + +I P +
Sbjct: 108 YLESKNCIHRDLAARNCLVG---ENNVLKISDFGMSREEEGGIYTVSDGLKQI---PIKW 161
Query: 225 MAPEVLKRNYG---PEVDVWSAGVILY-ILLCGVPPF 257
APE L NYG E DVWS G++L+ G P+
Sbjct: 162 TAPEAL--NYGRYTSESDVWSYGILLWETFSLGDTPY 196
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 37/232 (15%)
Query: 56 RYELGRELGRGEFGITYLC------TDRENGDAFACKSISKKKLR---TAVDIEDVRREV 106
R LG+ LG G FG + D+ N +++ K L+ T D+ D+ E+
Sbjct: 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPV----TVAVKMLKDDATDKDLSDLVSEM 68
Query: 107 DIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR---------------- 150
++M+ + KH+NI+ L D +++++E G L + + AR
Sbjct: 69 EMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPE 128
Query: 151 GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210
T + + + ++ +HRDL N L E +K DFGL+
Sbjct: 129 EQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT---EDNVMKIADFGLARDVH 185
Query: 211 PGEKFSEIVGSPY---YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 257
+ + + +MAPE L R Y + DVWS GV+L+ I G P+
Sbjct: 186 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 58/259 (22%), Positives = 102/259 (39%), Gaps = 51/259 (19%)
Query: 62 ELGRGEFGITY----LCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
ELG FG Y ++ A K++ K + + ++E +M L H N
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTL--KDINNPQQWGEFQQEASLMAEL-HHPN 68
Query: 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAA----------------- 160
IVCL + V ++ E G+L + ++ R +++ ++
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 161 VTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG 220
+ I ++ H +H+DL N L E +K D GLS EI
Sbjct: 129 IAIQIAAGMEYLSSHFFVHKDLAARNILIG---EQLHVKISDLGLS---------REIYS 176
Query: 221 SPYY------------MAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVA 266
+ YY M PE ++ + + D+WS GV+L+ I G+ P++ + Q V
Sbjct: 177 ADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI 236
Query: 267 QAI-IRSVLDFRRDPWPKV 284
+ + R +L D P++
Sbjct: 237 EMVRKRQLLPCSEDCPPRM 255
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 59/238 (24%), Positives = 92/238 (38%), Gaps = 45/238 (18%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDI---------EDVRRE 105
E + L R+LG G FG + + + K ++R A+ I +D ++E
Sbjct: 6 EEFTLERKLGSGYFGEVW-------------EGLWKNRVRVAIKILKSDDLLKQQDFQKE 52
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHY---TERAAAAVT 162
V ++ L +H++++ L V+++ EL E G L + E V
Sbjct: 53 VQALKRL-RHKHLISLFAVCSVGEPVYIITELMEKGSLL-------AFLRSPEGQVLPVA 104
Query: 163 KTIVEVVQ----MCH--KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS 216
I Q M + + +HRDL N L E K DFGL+ K S
Sbjct: 105 SLIDMACQVAEGMAYLEEQNSIHRDLAARNILVG---EDLVCKVADFGLARLIKEDVYLS 161
Query: 217 EIVGSPY-YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 271
PY + APE + + DVWS G++LY + G P+ V I
Sbjct: 162 SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA 219
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 67/255 (26%), Positives = 101/255 (39%), Gaps = 40/255 (15%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDI------EDVRR----EVDIMRHL 112
+G GEFG +C R K K+++ A+ E RR E IM
Sbjct: 12 IGAGEFG--EVCRGR-------LKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 62
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGEL--FDRIVARGHYTERAAAAVTKTIVEVVQ 170
H NI+ L+ V ++ E E G L F R G +T + + I ++
Sbjct: 63 -DHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMK 120
Query: 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPY---Y 224
+ +HRDL N L K DFGLS F + ++ +G +
Sbjct: 121 YLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW 177
Query: 225 MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282
APE + R + DVWS G++++ ++ G P+W + Q V AI + D+R P
Sbjct: 178 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ---DYRLPPPM 234
Query: 283 KVSENAKDLVRKMLD 297
L MLD
Sbjct: 235 DCPTALHQL---MLD 246
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 57/218 (26%), Positives = 91/218 (41%), Gaps = 18/218 (8%)
Query: 63 LGRGEFGITY---LCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIV 119
+G GEFG + L A A K++ K T +D E IM H NI+
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTL--KPGYTEKQRQDFLSEASIMGQF-SHHNII 69
Query: 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGV 177
L+ ++ E E G L D+ + G ++ + + I ++
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNY 128
Query: 178 MHRDLKPENFLFANKKETAPLKAIDFGLSVFFK--PGEKFSEIVGS-PY-YMAPEVLK-R 232
+HRDL N L + E K DFGLS + P ++ G P + APE + R
Sbjct: 129 VHRDLAARNILVNSNLEC---KVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185
Query: 233 NYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 269
+ DVWS G++++ ++ G P+W + V +AI
Sbjct: 186 KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI 223
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 4e-07
Identities = 92/395 (23%), Positives = 152/395 (38%), Gaps = 103/395 (26%)
Query: 6 VTPAAAKQGKKKTNKKKQNPFSIDYGTHHQG-NGGHKLCVLKEPTGREIE---ERYELGR 61
TP + KKK + Y +Q GH VL G +I+ +R+++
Sbjct: 85 TTPTTNVEVAPPPKKKK-----VTYALPNQSREEGHFYVVL----GEDIDVSTQRFKILS 135
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISK--KKLRTA-VDIEDVR--REVDIMRHLPKHQ 116
LG G FG DR+ + A K + K R A ++I+ + R+ D P
Sbjct: 136 LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFP--- 192
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGE-LFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH 175
++ ++ ++++T H+ + + + G L D I+ G ++ R A + + H
Sbjct: 193 -LMKIQRYFQNETG-HMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTE 250
Query: 176 -GVMHRDLKPENFLF---------ANKKETAP----LKAIDFGLSVFFKPGEKFSE--IV 219
+MH DLKPEN L + P ++ D G E+ S IV
Sbjct: 251 LHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCC----DERHSRTAIV 306
Query: 220 GSPYYMAPEV-LKRNYGPEVDVWSAGVILYIL----------------------LCGVPP 256
+ +Y +PEV L + D+WS G I+Y L L +P
Sbjct: 307 STRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPS 366
Query: 257 FWAE---TEQG---------------------VAQAIIRSVLDFRRDPWPKVSENAKDLV 292
WA TE+ +A+A R V + RD DL+
Sbjct: 367 EWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARA--RPVREVIRDDL------LCDLI 418
Query: 293 RKMLDPDPKRRLTAQQVLEHPWLQN----AKKAPN 323
+L D ++RL A+Q+ HP++ ++ PN
Sbjct: 419 YGLLHYDRQKRLNARQMTTHPYVLKYYPECRQHPN 453
|
Length = 467 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 56/226 (24%), Positives = 101/226 (44%), Gaps = 21/226 (9%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E +L ++LG G+FG ++ N A K++ + +E E ++M+ L +
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMSVQAFLE----EANLMKTL-Q 59
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMC 172
H +V L + ++++ E G L D + + G + I E +
Sbjct: 60 HDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 119
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY---YMAPEV 229
+ +HRDL+ N L + E+ K DFGL+ + E ++ G+ + + APE
Sbjct: 120 ERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEA 175
Query: 230 LKRNYGP---EVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 271
+ N+G + DVWS G++LY I+ G P+ + V A+ R
Sbjct: 176 I--NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR 219
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 73/293 (24%), Positives = 123/293 (41%), Gaps = 45/293 (15%)
Query: 55 ERYELGRELGRGEFGITY--LCTDRENGDA---FACKSISKK-KLRTAVDIEDVRREVDI 108
E+ L RELG+G FG+ Y D G+A A K++++ LR ++ + E +
Sbjct: 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN---EASV 62
Query: 109 MRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV 168
M+ H ++V L +VMEL G+L + + E T+ E+
Sbjct: 63 MKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121
Query: 169 VQMC----------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV------FFKPG 212
+QM + +HRDL N + A +K DFG++ +++ G
Sbjct: 122 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 213 EKFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAII 270
K V +MAPE LK + D+WS GV+L+ + + QG++ + ++
Sbjct: 179 GKGLLPV---RWMAPESLKDGVFTTSSDMWSFGVVLW----EITSLAEQPYQGLSNEQVL 231
Query: 271 RSVLDFRRDPWPK-VSENAKDLVRKMLDPDPKRRLTAQQVLE------HPWLQ 316
+ V+D P E DL+R +PK R T +++ HP
Sbjct: 232 KFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 284
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 7e-07
Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 33/218 (15%)
Query: 54 EERYELGRELGRGEFGITY--LCTDRENGDAF---ACKSISKKKLRTAVDIEDVRREVDI 108
E+ L RELG+G FG+ Y L G+ A K++++ + + + E +
Sbjct: 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASV 62
Query: 109 MRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV 168
M+ H ++V L +VMEL G+L + +R E T+ +
Sbjct: 63 MKEFNCH-HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF 121
Query: 169 VQMC-----------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGL------SVFFKP 211
+QM K V HRDL N + A E +K DFG+ + +++
Sbjct: 122 IQMAAEIADGMAYLAAKKFV-HRDLAARNCMVA---EDLTVKIGDFGMTRDIYETDYYRK 177
Query: 212 GEKFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILY 248
G K V +MAPE LK + + DVWS GV+L+
Sbjct: 178 GGKGLLPV---RWMAPESLKDGVFTTKSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 61/269 (22%), Positives = 118/269 (43%), Gaps = 28/269 (10%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E +L ++LG G+FG ++ T ++ A K++ + + E ++M+ L +
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSVEAFLA----EANVMKTL-Q 59
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAV--TKTIVEVVQMC 172
H +V L + ++++ E G L D + + + + + I E +
Sbjct: 60 HDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 118
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY---YMAPEV 229
+ +HRDL+ N L + + K DFGL+ + E ++ G+ + + APE
Sbjct: 119 EQRNYIHRDLRAANILVS---ASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEA 174
Query: 230 LKRNYGP---EVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285
+ N+G + DVWS G++L I+ G P+ + V +A+ R R + P
Sbjct: 175 I--NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCP--- 229
Query: 286 ENAKDLVRKMLDPDPKRRLT---AQQVLE 311
E +++ + P+ R T Q VL+
Sbjct: 230 EELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 83/326 (25%), Positives = 118/326 (36%), Gaps = 95/326 (29%)
Query: 54 EERYELGRELGRGEFGITYLCT-----------DRENGDAFACKSISKKKLRTAVDI--- 99
+ +LG G+FG +LC EN +A A ++ K LR
Sbjct: 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAR 63
Query: 100 EDVRREVDIMRHLPKHQNI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYT 154
ED +EV I+ L NI VC D + +ME E G+L +
Sbjct: 64 EDFLKEVKILSRL-SDPNIARLLGVCTVD---PPLCM--IMEYMENGDL-------NQFL 110
Query: 155 ERAAAAVTKTIVE---------VVQMC----------HKHGVMHRDLKPENFLFANKKET 195
+ A T + ++ M +HRDL N L K T
Sbjct: 111 -QKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL-VGKNYT 168
Query: 196 APLKAIDFGLSVFFKPGEKFSEIVGSPYY------------MAPE-VLKRNYGPEVDVWS 242
+K DFG+S + S YY MA E VL + + DVW+
Sbjct: 169 --IKIADFGMS---------RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWA 217
Query: 243 AGVILY-IL-LCGVPPFWAETEQGVAQAIIRSVLDFRRD------PWPKVSENAKDLVRK 294
GV L+ IL LC P+ T+Q V + FR D P P KD+
Sbjct: 218 FGVTLWEILTLCREQPYEHLTDQQVIENAGHF---FRDDGRQIYLPRPPNC--PKDIYEL 272
Query: 295 MLD---PDPKRRLTAQQVLEHPWLQN 317
ML+ D + R T +++ H +LQ
Sbjct: 273 MLECWRRDEEDRPTFREI--HLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 67/254 (26%), Positives = 107/254 (42%), Gaps = 31/254 (12%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG + T ++ A K+ K+ L + I+ + E I++ H NIV L
Sbjct: 3 LGKGNFGEVFKGTLKDK-TPVAVKT-CKEDLPQELKIKFLS-EARILKQY-DHPNIVKLI 58
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV---VQMCHKHGVMH 179
+++VMEL GG+ + R E + K ++ + +H
Sbjct: 59 GVCTQRQPIYIVMELVPGGDFLSFL--RKKKDELKTKQLVKFALDAAAGMAYLESKNCIH 116
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLS------VFFKPGEKFSEIVGSPYYMAPEVLKRN 233
RDL N L E LK DFG+S ++ G K I + APE L N
Sbjct: 117 RDLAARNCLVG---ENNVLKISDFGMSRQEDDGIYSSSGLKQIPI----KWTAPEAL--N 167
Query: 234 YG---PEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289
YG E DVWS G++L+ GV P+ T Q + + + +R K ++
Sbjct: 168 YGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG---YRMSCPQKCPDDVY 224
Query: 290 DLVRKMLDPDPKRR 303
++++ D P+ R
Sbjct: 225 KVMQRCWDYKPENR 238
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 67/284 (23%), Positives = 114/284 (40%), Gaps = 50/284 (17%)
Query: 59 LGRELGRGEFGITYL--CTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
L RELG G FG +L C + ++ K T +D +RE +++ +L +H+
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-QHE 67
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYT-----------------ERAAA 159
+IV D + +V E + G+L + A G +
Sbjct: 68 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 160 AVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIV 219
++ +V + +H V HRDL N L +K DFG+S ++
Sbjct: 128 IASQIASGMVYLASQHFV-HRDLATRNCLVGA---NLLVKIGDFGMS---------RDVY 174
Query: 220 GSPYY------------MAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGV 265
+ YY M PE ++ R + E DVWS GVIL+ I G P++ + V
Sbjct: 175 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 234
Query: 266 AQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQV 309
+ I + + R PK D++ +P++RL +++
Sbjct: 235 IECITQGRVLERPRVCPK---EVYDIMLGCWQREPQQRLNIKEI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 50/193 (25%), Positives = 82/193 (42%), Gaps = 15/193 (7%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
+ELG G+FG+ R D A K I + + ++ E +M L H+ +V
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSE----DEFIEEAKVMMKL-SHEKLVQ 63
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAA-AVTKTIVEVVQMCHKHGVMH 179
L +++V E G L + + G + + + K + E + +H
Sbjct: 64 LYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIH 123
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY---YMAPEVLKR-NYG 235
RDL N L + +K DFGLS + E S VGS + + PEVL +
Sbjct: 124 RDLAARNCLV---DDQGCVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLLYSKFS 179
Query: 236 PEVDVWSAGVILY 248
+ DVW+ GV+++
Sbjct: 180 SKSDVWAFGVLMW 192
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 51/199 (25%), Positives = 86/199 (43%), Gaps = 19/199 (9%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+ +L + +G+GEFG L R N A C ++ + E +M L +
Sbjct: 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKC-------IKNDATAQAFLAEASVMTQL-R 57
Query: 115 HQNIV-CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAV--TKTIVEVVQM 171
H N+V L E+ +++V E G L D + +RG + + + E ++
Sbjct: 58 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 117
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY-YMAPEVL 230
+ +HRDL N L + E K DFGL+ K + P + APE L
Sbjct: 118 LEANNFVHRDLAARNVLVS---EDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEAL 171
Query: 231 K-RNYGPEVDVWSAGVILY 248
+ + + + DVWS G++L+
Sbjct: 172 REKKFSTKSDVWSFGILLW 190
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 4e-06
Identities = 65/270 (24%), Positives = 113/270 (41%), Gaps = 34/270 (12%)
Query: 57 YELGRELGRGEFGI---TYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
+ LGR LG+GEFG L ++ + A K + K + ++ DIE+ RE M+
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEF- 58
Query: 114 KHQNI-----VCLKDTYEDDTAVHLV-MELCEGGELFDRIVARGHYTERAAAAVTKTIVE 167
H N+ V L+ + + +V + + G+L ++ E + +
Sbjct: 59 DHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF 118
Query: 168 VVQMC------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGS 221
++ + +HRDL N + E + DFGLS G+ + + S
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCMLN---ENMTVCVADFGLSKKIYSGDYYRQGCAS 175
Query: 222 PY---YMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVL-- 274
++A E L N Y DVW+ GV ++ I+ G P+ GV + I + L
Sbjct: 176 KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY-----AGVENSEIYNYLIK 230
Query: 275 -DFRRDPWPKVSENAKDLVRKMLDPDPKRR 303
+ + P P E+ +L+ + P+PK R
Sbjct: 231 GNRLKQP-PDCLEDVYELMCQCWSPEPKCR 259
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 4e-06
Identities = 28/120 (23%), Positives = 47/120 (39%), Gaps = 14/120 (11%)
Query: 91 KKLRTAVDIEDVRREVDIMRHLPKHQNIV-CLKDTYEDDTAVHLVMELCEGGELFDRIVA 149
K + D REV I++ L + V + + E D +L+ME EG L
Sbjct: 27 KINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL------ 80
Query: 150 RGHYTERAAAAVTKTIVEVVQMCHKH---GVMHRDLKPENFLFANKKETAPLKAIDFGLS 206
+E + + + E++ H+ + H DL P N L + K ID+ +
Sbjct: 81 -DEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILG---IIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 8e-06
Identities = 67/279 (24%), Positives = 114/279 (40%), Gaps = 49/279 (17%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRR---------- 104
E+ + RELG+G FG+ Y G A K + K + T V I+ V
Sbjct: 6 EKITMSRELGQGSFGMVY------EGIA---KGVVKDEPETRVAIKTVNEAASMRERIEF 56
Query: 105 --EVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVT 162
E +M+ H ++V L ++MEL G+L + + E
Sbjct: 57 LNEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAP 115
Query: 163 KTIVEVVQMC----------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV----- 207
++ +++QM + + +HRDL N + A E +K DFG++
Sbjct: 116 PSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYET 172
Query: 208 -FFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQG 264
+++ G K V +M+PE LK + DVWS GV+L+ I P+ + +
Sbjct: 173 DYYRKGGKGLLPV---RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ 229
Query: 265 VAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRR 303
V + ++ L + D P + +L+R +PK R
Sbjct: 230 VLRFVMEGGLLDKPDNCPDM---LFELMRMCWQYNPKMR 265
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 56/213 (26%), Positives = 87/213 (40%), Gaps = 28/213 (13%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD---IEDVRREVDIMR 110
E E + LG G FG Y G+ ++ K LR +++ E +M
Sbjct: 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEK-VKIPVAIKVLREETSPKANKEILDEAYVMA 64
Query: 111 HLPKHQNIV-----CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
+ H ++V CL V L+ +L G L D + R H + +
Sbjct: 65 SV-DHPHVVRLLGICLSSQ------VQLITQLMPLGCLLDYV--RNHKDNIGSQYLLNWC 115
Query: 166 VEVVQ-MCH--KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSP 222
V++ + M + + ++HRDL N L K +K DFGL+ EK G
Sbjct: 116 VQIAKGMSYLEEKRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLDVDEKEYHAEGGK 172
Query: 223 Y---YMAPE-VLKRNYGPEVDVWSAGVILYILL 251
+MA E +L R Y + DVWS GV ++ L+
Sbjct: 173 VPIKWMALESILHRIYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 70/269 (26%), Positives = 102/269 (37%), Gaps = 40/269 (14%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+ RG+ G +Y +NG F K I+ + +I D M L +H NIV L
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD-------MGKL-QHPNIVKLI 749
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH---GVMH 179
+ +L+ E EG L + V R ER + I + ++ H V+
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSE--VLRNLSWER-RRKIAIGIAKALRFLHCRCSPAVVV 806
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPE-V 238
+L PE + K E ++ L K S Y+APE + E
Sbjct: 807 GNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKC-------FISSAYVAPETRETKDITEKS 859
Query: 239 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIR----SVLDFRRDPW------PKVSENA 288
D++ G+IL LL G P A+ E GV +I+ D D W VS N
Sbjct: 860 DIYGFGLILIELLTGKSP--ADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ 917
Query: 289 KDLVRKM------LDPDPKRRLTAQQVLE 311
++V M DP R A VL+
Sbjct: 918 NEIVEVMNLALHCTATDPTARPCANDVLK 946
|
Length = 968 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 67/270 (24%), Positives = 106/270 (39%), Gaps = 32/270 (11%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+G G FG +++G K+ + D D E++++ L H NI+ L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 123 DTYEDDTAVHLVMELCEGGELFDRI-VARGHYTERAAAAV--TKTIVEVVQMCH------ 173
E ++L +E G L D + +R T+ A A T + + Q+ H
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 174 -------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLS----VFFKPGEKFSEIVGSP 222
+ +HRDL N L E K DFGLS V+ K +
Sbjct: 135 RGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSRGQEVYVKKTMGRLPV---- 187
Query: 223 YYMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP 280
+MA E L + Y DVWS GV+L+ I+ G P+ T A+ + +R +
Sbjct: 188 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYEKLPQGYRLEK 244
Query: 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
+ DL+R+ P R + Q+L
Sbjct: 245 PLNCDDEVYDLMRQCWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 67/264 (25%), Positives = 109/264 (41%), Gaps = 40/264 (15%)
Query: 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI 118
L R+LG G+FG ++ T A K++ + E +E IM+ L +H +
Sbjct: 10 LERKLGAGQFGEVWMGTWNGTTKV-AVKTLKP----GTMSPEAFLQEAQIMKKL-RHDKL 63
Query: 119 VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC------ 172
V L ++ +++V E G L D + ++ + ++V M
Sbjct: 64 VQLYAVCSEEEPIYIVTEYMSKGSLLDFL--------KSGEGKKLRLPQLVDMAAQIAEG 115
Query: 173 ----HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY---YM 225
+HRDL N L E K DFGL+ + E ++ G+ + +
Sbjct: 116 MAYLESRNYIHRDLAARNILVG---ENLVCKIADFGLARLIEDDE-YTAREGAKFPIKWT 171
Query: 226 APEVLKRNYGP---EVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281
APE NYG + DVWS G++L I+ G P+ T + V + + R +R
Sbjct: 172 APEAA--NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG---YRMPRP 226
Query: 282 PKVSENAKDLVRKMLDPDPKRRLT 305
P E DL+ + D DP+ R T
Sbjct: 227 PNCPEELYDLMLQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 3e-05
Identities = 37/129 (28%), Positives = 53/129 (41%), Gaps = 17/129 (13%)
Query: 195 TAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCG 253
T G SV FK E PY+MAPEV++ +Y + D++S G+ LY L
Sbjct: 45 TWDGLLKLDG-SVAFKTPE--QSRPD-PYFMAPEVIQGQSYTEKADIYSLGITLYEALDY 100
Query: 254 VPPFWAETEQGVAQAIIRSVLDF-------RRDPWPKVSE--NAKDLVRKMLDPDPKRRL 304
P E+ AI+ +L+ R VS + +D +R P+RR
Sbjct: 101 ELP---YNEERELSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRRE 157
Query: 305 TAQQVLEHP 313
A L H
Sbjct: 158 AANHYLAHC 166
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 71/297 (23%), Positives = 114/297 (38%), Gaps = 71/297 (23%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDI-----------EDVRREVDIMR 110
ELG G FG +L C ++ ++ + V + +D +RE +++
Sbjct: 12 ELGEGAFGKVFLAE---------CHNLLPEQDKMLVAVKALKEASESARQDFQREAELLT 62
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGEL--FDR-------------IVARGHYTE 155
L +HQ+IV + + +V E G+L F R VA G T
Sbjct: 63 VL-QHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTL 121
Query: 156 RAAAAVTKTIVE-VVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214
A+ I +V + H V HRDL N L + +K DFG+S
Sbjct: 122 GQMLAIASQIASGMVYLASLHFV-HRDLATRNCLVG---QGLVVKIGDFGMS-------- 169
Query: 215 FSEIVGSPYY------------MAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAE 260
+I + YY M PE +L R + E D+WS GV+L+ I G P W +
Sbjct: 170 -RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP-WYQ 227
Query: 261 TEQGVAQAIIRSVLDFRRDPWPKVSEN-AKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
A I + R P+ +++ +P++R+ + + H LQ
Sbjct: 228 LSNTEAIECITQGRELER---PRTCPPEVYAIMQGCWQREPQQRMVIKDI--HSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 4e-05
Identities = 70/290 (24%), Positives = 119/290 (41%), Gaps = 34/290 (11%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+G G FG +++G K+ + D D E++++ L H NI+ L
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 123 DTYEDDTAVHLVMELCEGGELFD-----RIV------ARGH-----YTERAAAAVTKTIV 166
E+ +++ +E G L D R++ A+ H T + +
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 167 EVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK--FSEIVGS-PY 223
+Q + +HRDL N L E K DFGLS GE+ + +G P
Sbjct: 130 TGMQYLSEKQFIHRDLAARNVLVG---ENLASKIADFGLS----RGEEVYVKKTMGRLPV 182
Query: 224 -YMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP 280
+MA E L + Y + DVWS GV+L+ I+ G P+ T A+ + +R +
Sbjct: 183 RWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT---CAELYEKLPQGYRMEK 239
Query: 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQV-LEHPWLQNAKKA-PNVSLGE 328
+ +L+R+ P R Q+ ++ + A+KA N++L E
Sbjct: 240 PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYVNMALFE 289
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 7e-05
Identities = 67/268 (25%), Positives = 110/268 (41%), Gaps = 43/268 (16%)
Query: 61 RELGRGEFGITY---LCTDRENGDAFACKSISKKKLRTAVDIEDVR---REVDIMRHLPK 114
R +G+G FG Y L A KS+++ D+E+V +E IM+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR-----ITDLEEVEQFLKEGIIMKDF-S 54
Query: 115 HQNIVCLKD-TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
H N++ L + + +V+ + G+L + I +E V I +Q+
Sbjct: 55 HPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFI-----RSETHNPTVKDLIGFGLQVAK 109
Query: 174 ------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLS--VFFKPGEKFSEIVGSPY-- 223
+HRDL N + E+ +K DFGL+ ++ K G+
Sbjct: 110 GMEYLASKKFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV 166
Query: 224 -YMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDP 280
+MA E L+ + + + DVWS GV+L+ L+ G PP+ + I +L RR
Sbjct: 167 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY----PDVDSFDITVYLLQGRRLL 222
Query: 281 WPKVSENAKDLVRKML---DPDPKRRLT 305
P+ + L ML P P+ R T
Sbjct: 223 QPEYCPDP--LYEVMLSCWHPKPEMRPT 248
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 7e-05
Identities = 53/201 (26%), Positives = 90/201 (44%), Gaps = 21/201 (10%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E +L ++LG G+FG ++ A KS+ + + E E ++M+ L +
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGY-YNGHTKVAIKSLKQGSM----SPEAFLAEANLMKQL-Q 59
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRI-VARGH-YTERAAAAVTKTIVEVVQMC 172
H +V L + ++++ E E G L D + G T + I E +
Sbjct: 60 HPRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI 118
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY---YMAPEV 229
+ +HRDL+ N L + ET K DFGL+ + E ++ G+ + + APE
Sbjct: 119 ERKNYIHRDLRAANILVS---ETLCCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEA 174
Query: 230 LKRNYGP---EVDVWSAGVIL 247
+ NYG + DVWS G++L
Sbjct: 175 I--NYGTFTIKSDVWSFGILL 193
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 9e-05
Identities = 32/91 (35%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 160 AVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKFSE- 217
A+ K ++ V+ H ++HRD+K EN +F N L DFG ++ F K E F
Sbjct: 271 AIMKQLLCAVEYIHDKKLIHRDIKLEN-IFLNCDGKIVLG--DFGTAMPFEKEREAFDYG 327
Query: 218 IVGSPYYMAPEVLKRN-YGPEVDVWSAGVIL 247
VG+ +PE+L + Y D+WS G+IL
Sbjct: 328 WVGTVATNSPEILAGDGYCEITDIWSCGLIL 358
|
Length = 501 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 27/89 (30%), Positives = 46/89 (51%), Gaps = 8/89 (8%)
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPE-V 229
+H ++HR+L N L K + ++ DFG++ P +K +SE +MA E +
Sbjct: 127 EHRMVHRNLAARNILL---KSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 230 LKRNYGPEVDVWSAGVILYILLC-GVPPF 257
L Y + DVWS GV ++ ++ G P+
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPY 212
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 65/279 (23%), Positives = 119/279 (42%), Gaps = 43/279 (15%)
Query: 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR---TAVDIEDVRREVDIMRHLPKH 115
LG+ LG GEFG T +++ K L+ ++ ++ D+ E ++++ + H
Sbjct: 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-NH 62
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGEL--FDRIVAR------GHYTERAAAAVTKTIVE 167
+++ L D + L++E + G L F R + G R ++ +
Sbjct: 63 PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122
Query: 168 VV----------QMCH------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLS--VFF 209
+ Q+ + ++HRDL N L A ++ +K DFGLS V+
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRK---MKISDFGLSRDVYE 179
Query: 210 KPGE-KFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVA 266
+ K S+ +MA E L + Y + DVWS GV+L+ I+ G P+ G+A
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY-----PGIA 234
Query: 267 QAIIRSVLD--FRRDPWPKVSENAKDLVRKMLDPDPKRR 303
+ ++L +R + SE +L+ +P +R
Sbjct: 235 PERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKR 273
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 1e-04
Identities = 50/199 (25%), Positives = 85/199 (42%), Gaps = 23/199 (11%)
Query: 62 ELGRGEFGIT---YLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMRHLPK 114
ELG G FG + + K+++ K L+ + ++ RE ++M+ L
Sbjct: 2 ELGSGNFGTVKKGMYKMKK------SEKTVAVKILKNDNNDPALKDELLREANVMQQL-D 54
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
+ IV + E ++ + LVMEL E G L + H TE+ + + ++ +
Sbjct: 55 NPYIVRMIGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEE 113
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGS---PY-YMAPEVL 230
+HRDL N L + K DFGLS E + + P + APE +
Sbjct: 114 TNFVHRDLAARNVLLVTQHYA---KISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM 170
Query: 231 K-RNYGPEVDVWSAGVILY 248
+ + DVWS GV+++
Sbjct: 171 NYYKFSSKSDVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 25/73 (34%), Positives = 39/73 (53%), Gaps = 5/73 (6%)
Query: 160 AVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIV 219
V + ++ ++ H+ G++HRD+KPEN L + +K IDFG +V G F+ +
Sbjct: 313 GVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ---VKIIDFGAAVDMCTGINFNPLY 369
Query: 220 G--SPYYMAPEVL 230
G P Y PE L
Sbjct: 370 GMLDPRYSPPEEL 382
|
Length = 507 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 63/256 (24%), Positives = 101/256 (39%), Gaps = 40/256 (15%)
Query: 55 ERYELGRELGRGEFGITYLCTDR-------ENGDAFACKS--ISKKKLRTAVDI---EDV 102
++ L +LG G+FG +LC E F + ++ K LR V D
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64
Query: 103 RREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAA-- 160
+E+ IM L K+ NI+ L D + ++ E E G+L + R + A
Sbjct: 65 LKEIKIMSRL-KNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNI 123
Query: 161 ----------VTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210
+ I ++ +HRDL N L N +K DFG+S
Sbjct: 124 PSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN---HYTIKIADFGMSRNLY 180
Query: 211 PGEKFSEIVGSPY----YMAPE-VLKRNYGPEVDVWSAGVILY--ILLCGVPPFWAETEQ 263
G+ + I G +MA E +L + DVW+ GV L+ LC P+ +++
Sbjct: 181 SGD-YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239
Query: 264 GVAQAIIRSVLDFRRD 279
V I + +F R+
Sbjct: 240 QV----IENTGEFFRN 251
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 36/114 (31%), Positives = 53/114 (46%), Gaps = 14/114 (12%)
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY---YMAPE-VLKR 232
++HRDL N L + +K DFGL+ EK G +MA E +L R
Sbjct: 130 LVHRDLAARNVLVKTPQH---VKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHR 186
Query: 233 NYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDF-RRDPWPKV 284
Y + DVWS GV ++ L+ G P+ G+ + I S+L+ R P P +
Sbjct: 187 IYTHQSDVWSYGVTVWELMTFGSKPY-----DGIPASEISSILEKGERLPQPPI 235
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 3e-04
Identities = 54/216 (25%), Positives = 85/216 (39%), Gaps = 30/216 (13%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+G G FG +++G K+ + D D E++++ L H NI+ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 123 DTYEDDTAVHLVMELCEGGELFD-----RIV------ARGHYT-----ERAAAAVTKTIV 166
E ++L +E G L D R++ A + T + +
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 167 EVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK--FSEIVGS-PY 223
+ + +HRDL N L E K DFGLS G++ + +G P
Sbjct: 123 RGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS----RGQEVYVKKTMGRLPV 175
Query: 224 -YMAPEVLKRN-YGPEVDVWSAGVILY--ILLCGVP 255
+MA E L + Y DVWS GV+L+ + L G P
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 6e-04
Identities = 30/107 (28%), Positives = 45/107 (42%), Gaps = 14/107 (13%)
Query: 103 RREVDIMRHLPKHQNIVCLKDTYEDDT-AVHLVMELCEGGELFDRIVARGHYTERAAAAV 161
RRE I+ + V + Y+ D +VME EG L D E A +
Sbjct: 47 RREARILAKARE--AGVPVPIVYDVDPDNGLIVMEYIEGELLKD-------ALEEARPDL 97
Query: 162 TKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208
+ + +V HK G++H DL N + + + + IDFGL F
Sbjct: 98 LREVGRLVGKLHKAGIVHGDLTTSNIILSGGR----IYFIDFGLGEF 140
|
Length = 204 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 6e-04
Identities = 41/143 (28%), Positives = 66/143 (46%), Gaps = 16/143 (11%)
Query: 178 MHRDLKPENFLFANKKETAPLKAIDFGLS--VFFKPGEKFSEIVGSPY-YMAPE-VLKRN 233
+HRDL N L + E +K DFGL+ ++ P P +MAPE + R
Sbjct: 201 IHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV 257
Query: 234 YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
Y + DVWS GV+L+ I G P+ + + R + + R P + ++
Sbjct: 258 YTIQSDVWSFGVLLWEIFSLGASPYPGVK---IDEEFCRRLKEGTRMRAPDYT--TPEMY 312
Query: 293 RKMLD---PDPKRRLTAQQVLEH 312
+ MLD +P +R T +++EH
Sbjct: 313 QTMLDCWHGEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 7e-04
Identities = 32/93 (34%), Positives = 45/93 (48%), Gaps = 8/93 (8%)
Query: 178 MHRDLKPENFLFANKKETAPLKAIDFGLS--VFFKPGEKFSEIVGSPY-YMAPE-VLKRN 233
+HRDL N L E +K DFGLS ++ K SE P +M PE +
Sbjct: 152 VHRDLATRNCLVG---ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR 208
Query: 234 YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGV 265
Y E DVW+ GV+L+ I G+ P++ + V
Sbjct: 209 YTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV 241
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 7e-04
Identities = 21/70 (30%), Positives = 36/70 (51%), Gaps = 4/70 (5%)
Query: 161 VTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS--EI 218
+ + I+ + H G++HRD+KP+N +F+ + K ID G + + G + E
Sbjct: 260 IMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGS--FKIIDLGAAADLRVGINYIPKEF 317
Query: 219 VGSPYYMAPE 228
+ P Y APE
Sbjct: 318 LLDPRYAAPE 327
|
Length = 566 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 72/296 (24%), Positives = 123/296 (41%), Gaps = 55/296 (18%)
Query: 62 ELGRGEFGITYLC--------TDRENGDAFACKS---ISKKKLRTAVDI---EDVRREVD 107
+LG G+FG +LC D++ + ++ K LR + D +E+
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE 167
IM L K NI+ L + ++ E E G+L ++ ++R H + AA +
Sbjct: 72 IMSRL-KDPNIIRLLAVCITSDPLCMITEYMENGDL-NQFLSR-HEPQEAAEKADVVTIS 128
Query: 168 VVQMCH---------KH----GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214
+ K+ +HRDL N L K T +K DFG+S G+
Sbjct: 129 YSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL-VGKNYT--IKIADFGMSRNLYSGD- 184
Query: 215 FSEIVGSPY----YMAPE-VLKRNYGPEVDVWSAGVILY--ILLCGVPPFWAETEQGVAQ 267
+ I G +M+ E +L + DVW+ GV L+ + LC P+ +++ V
Sbjct: 185 YYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV-- 242
Query: 268 AIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPN 323
I + +F RD +V L + L PD + +++ W +NAK+ P+
Sbjct: 243 --IENTGEFFRDQGRQVY-----LPKPALCPD-----SLYKLMLSCWRRNAKERPS 286
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 0.002
Identities = 32/121 (26%), Positives = 48/121 (39%), Gaps = 22/121 (18%)
Query: 91 KKLRTAVDIEDVRREVDIMRHLPK---HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRI 147
++ RT RRE IM K + V D +VME EG L D +
Sbjct: 42 RRERT-------RREARIMSRARKAGVNVPAVYFVDPENFI----IVMEYIEGEPLKD-L 89
Query: 148 VARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207
+ +++ I +V H G++H DL N + + K + IDFGL+
Sbjct: 90 INSN---GMEELELSREIGRLVGKLHSAGIIHGDLTTSNMILSGGK----IYLIDFGLAE 142
Query: 208 F 208
F
Sbjct: 143 F 143
|
Length = 211 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 26/90 (28%), Positives = 41/90 (45%), Gaps = 3/90 (3%)
Query: 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAV---DIEDVRREVDIMRHLPKH 115
LGR LG G FG T + + ++ K L++ + + + E+ IM HL H
Sbjct: 41 LGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPH 100
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFD 145
NIV L ++++ E C G+L D
Sbjct: 101 LNIVNLLGACTKGGPIYIITEYCRYGDLVD 130
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.003
Identities = 29/94 (30%), Positives = 40/94 (42%), Gaps = 26/94 (27%)
Query: 178 MHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY------------M 225
+HRDL N L + +K DFGL+ +I P Y M
Sbjct: 195 IHRDLAARNILLSENN---VVKICDFGLA---------RDIYKDPDYVRKGDARLPLKWM 242
Query: 226 APE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPF 257
APE + + Y + DVWS GV+L+ I G P+
Sbjct: 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.003
Identities = 55/209 (26%), Positives = 86/209 (41%), Gaps = 43/209 (20%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDI----------EDVRREVDIMRH 111
ELG G FG C + + KK++ A+ + +++ RE +IM
Sbjct: 2 ELGSGNFG----CVKK------GVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQ 51
Query: 112 LPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV--- 168
L + IV + E + A+ LVME+ GG L + + +VE+
Sbjct: 52 L-DNPYIVRMIGVCEAE-ALMLVMEMASGGPLNKFLSGK------KDEITVSNVVELMHQ 103
Query: 169 VQMCHKH----GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF--SEIVGS- 221
V M K+ +HRDL N L N+ K DFGLS + + + G
Sbjct: 104 VSMGMKYLEGKNFVHRDLAARNVLLVNQHYA---KISDFGLSKALGADDSYYKARSAGKW 160
Query: 222 PY-YMAPE-VLKRNYGPEVDVWSAGVILY 248
P + APE + R + DVWS G+ ++
Sbjct: 161 PLKWYAPECINFRKFSSRSDVWSYGITMW 189
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 352 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.9 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.9 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.87 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.86 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.85 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.84 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.8 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.79 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.79 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.77 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.76 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.72 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.71 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.7 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.6 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.57 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.56 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.55 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.52 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.51 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.48 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.47 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.43 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.42 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.27 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.26 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.19 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.17 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.05 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.04 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.04 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.94 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.77 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.73 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.67 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.65 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.59 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.57 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.52 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.52 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.52 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.48 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.45 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.33 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.26 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.23 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.03 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.96 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.96 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.91 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.76 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.7 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.67 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.62 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.56 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.53 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.45 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.39 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.38 | |
| PLN02236 | 344 | choline kinase | 97.35 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.32 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.3 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.25 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.22 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.22 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.08 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.71 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.63 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.57 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.44 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.07 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.03 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.77 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.72 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.58 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.09 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.06 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 94.69 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-62 Score=432.12 Aligned_cols=271 Identities=36% Similarity=0.671 Sum_probs=244.7
Q ss_pred ccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCCh----hcHHHHHHHHHHHHhCCCCCCeeEeeeEEE
Q 018640 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA----VDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (352)
Q Consensus 51 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~ 126 (352)
..+.+.|.+.+.||+|+||.|-+|..+.+|+.||||++.+...... .......+|+++|++| +|||||+++++|+
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-~HP~IV~~~d~f~ 246 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-SHPNIVRIKDFFE 246 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-CCCCEEEEeeeee
Confidence 3466789999999999999999999999999999999987654332 2344567999999999 9999999999999
Q ss_pred eCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccc
Q 018640 127 DDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (352)
Q Consensus 127 ~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a 206 (352)
..+..||||||++||.|.+.+..++.+.+.....++.|++.|+.|||+.||+||||||+|||+..+.+...+||+|||+|
T Consensus 247 ~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 247 VPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred cCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 99999999999999999999999999999999999999999999999999999999999999998888899999999999
Q ss_pred eecCCCCcccccccccccccchhccc-c---CCCcchHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcccccCCCCC
Q 018640 207 VFFKPGEKFSEIVGSPYYMAPEVLKR-N---YGPEVDVWSAGVILYILLCGVPPFWAETEQG-VAQAIIRSVLDFRRDPW 281 (352)
Q Consensus 207 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~---~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~ 281 (352)
+.......+.+.+||+.|.|||++.. + +..+.|+||+||+||-+++|.+||....... ....+......+.+..|
T Consensus 327 K~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w 406 (475)
T KOG0615|consen 327 KVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW 406 (475)
T ss_pred hccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence 99887777889999999999999862 2 4458999999999999999999998776554 67778888888888889
Q ss_pred cCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccCC
Q 018640 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAP 322 (352)
Q Consensus 282 ~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~ 322 (352)
..++++..+||.+||..||++|||+.|+|+||||+.++...
T Consensus 407 ~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~s 447 (475)
T KOG0615|consen 407 DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCLS 447 (475)
T ss_pred hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccccc
Confidence 99999999999999999999999999999999999776443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-58 Score=403.29 Aligned_cols=266 Identities=27% Similarity=0.431 Sum_probs=231.0
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC-eEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT-AVHL 133 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~-~~~l 133 (352)
.+.+.+++||+|..|+||++.++.+++.+|+|++... .+.....++.+|++++... +|||||.+++.|..+. ...|
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~~isI 155 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGEEISI 155 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCceEEe
Confidence 3678889999999999999999999999999999543 3455677899999999999 9999999999999988 5999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
+||||++|||.+++...+++++..+..|+.+++.||.|||+ .+||||||||+|||++..++ |||||||.+..+.+.
T Consensus 156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGe---VKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGE---VKICDFGVSGILVNS 232 (364)
T ss_pred ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCC---EEeccccccHHhhhh
Confidence 99999999999999988899999999999999999999995 99999999999999987777 999999999877655
Q ss_pred Ccccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhcccccCCCCCcC-CC
Q 018640 213 EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAE-----TEQGVAQAIIRSVLDFRRDPWPK-VS 285 (352)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~~~-~~ 285 (352)
...+++||..|||||.+.+ .|+.++||||||++++|+++|+.||... ...+....+.. ..++..+.. ++
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~---~ppP~lP~~~fS 308 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD---EPPPRLPEGEFS 308 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc---CCCCCCCcccCC
Confidence 5678899999999999886 5999999999999999999999999764 33334444443 233333443 89
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccCCCCCCcHHHH
Q 018640 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVK 331 (352)
Q Consensus 286 ~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~ 331 (352)
+++++||..||++||.+|||+.|+++|||+++.. .++.+++..+.
T Consensus 309 ~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~-~~~vd~~~~~~ 353 (364)
T KOG0581|consen 309 PEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE-DPNVDMASFVR 353 (364)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc-cccccHHHHHH
Confidence 9999999999999999999999999999999864 46666665444
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-57 Score=417.75 Aligned_cols=255 Identities=37% Similarity=0.634 Sum_probs=236.5
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
.+|...+.||+|||+.||.+++..+|+.||+|++.+.........+.+.+|+++.+.| +|||||+++++|++.+.+|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL-KHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc-CCCcEEeeeeEeecCCceEEE
Confidence 5799999999999999999999999999999999998887888889999999999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC-C
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-E 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~-~ 213 (352)
.|+|+.++|..+++.++.+++.+++.+++||+.||.|||+++|+|||||..|++++.+.+ |||+|||+|.....+ +
T Consensus 97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~---VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMN---VKIGDFGLATQLEYDGE 173 (592)
T ss_pred EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCc---EEecccceeeeecCccc
Confidence 999999999999999999999999999999999999999999999999999999975444 999999999988644 7
Q ss_pred cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHH
Q 018640 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (352)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 292 (352)
...+.+|||.|.|||++. .+.+..+||||+||+||.|+.|++||....-.+....+.......+ ..++.++.+||
T Consensus 174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P----~~ls~~A~dLI 249 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMP----SHLSAEAKDLI 249 (592)
T ss_pred ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccc----cccCHHHHHHH
Confidence 778899999999999987 5699999999999999999999999999888888888877655544 36899999999
Q ss_pred HHhcCCCcCCCCCHHHHhcCccccc
Q 018640 293 RKMLDPDPKRRLTAQQVLEHPWLQN 317 (352)
Q Consensus 293 ~~~l~~dP~~Rps~~ell~hp~f~~ 317 (352)
.++|++||.+|||+.+||.|+||+.
T Consensus 250 ~~lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 250 RKLLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred HHHhcCCcccCCCHHHHhcCHhhhC
Confidence 9999999999999999999999953
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-55 Score=383.13 Aligned_cols=258 Identities=34% Similarity=0.635 Sum_probs=233.4
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
.++|+++++||+|+||+||+++.+.+++.+|+|++++..+......+....|..+|.++ +||.||.++..|++.+.+|+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-KHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-CCCcEeeeEEecccCCeEEE
Confidence 35799999999999999999999999999999999998887777788899999999999 99999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec-CCC
Q 018640 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPG 212 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~-~~~ 212 (352)
|+||+.||.|...|.+.+.+++..++.++.+|+.||.|||++|||||||||+|||++.++. ++|+|||+++.. ..+
T Consensus 103 Vld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GH---i~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGH---IKLTDFGLCKEDLKDG 179 (357)
T ss_pred EEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCc---EEEeccccchhcccCC
Confidence 9999999999999999999999999999999999999999999999999999999976665 999999999854 444
Q ss_pred Ccccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHH
Q 018640 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (352)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 291 (352)
....+++||+.|||||++. ..|+..+|.||||+++|||++|.+||...+.......+.+.... ..+..++.+.+++
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~---~~p~~ls~~ardl 256 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLP---LPPGYLSEEARDL 256 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCC---CCCccCCHHHHHH
Confidence 5556789999999999876 56999999999999999999999999999888777777765422 2223489999999
Q ss_pred HHHhcCCCcCCCC----CHHHHhcCcccccc
Q 018640 292 VRKMLDPDPKRRL----TAQQVLEHPWLQNA 318 (352)
Q Consensus 292 i~~~l~~dP~~Rp----s~~ell~hp~f~~~ 318 (352)
+.++|..||++|. ++.+|-+||||...
T Consensus 257 l~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 257 LKKLLKRDPRQRLGGPGDAEEIKRHPFFKGI 287 (357)
T ss_pred HHHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence 9999999999995 79999999999954
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-54 Score=384.85 Aligned_cols=264 Identities=37% Similarity=0.649 Sum_probs=234.8
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
.-.+|.+.+.||+|+||+||+|+.+.++..||||.+.+... .....+.+..|+++|+.+ +|||||.++++++.++..+
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel-~H~nIV~l~d~~~~~~~i~ 85 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKEL-KHPNIVRLLDCIEDDDFIY 85 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhc-CCcceeeEEEEEecCCeEE
Confidence 34579999999999999999999999999999999987754 445577889999999999 8999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCC---CCEEEEecccceec
Q 018640 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKET---APLKAIDFGLSVFF 209 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~---~~vkl~Dfg~a~~~ 209 (352)
||||||.||+|.+++..++.+++..++.++.||+.||++||+++||||||||+|||++..... ..+||+|||+|+..
T Consensus 86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 999999999999999999999999999999999999999999999999999999999875232 67999999999999
Q ss_pred CCCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHH
Q 018640 210 KPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (352)
Q Consensus 210 ~~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (352)
.+.....+.+|++.|||||++. ++|+.|+|+||+|+++|++++|+.||...+..+....+.+.. ...+......+...
T Consensus 166 ~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~-~~~~~~~~~~s~~~ 244 (429)
T KOG0595|consen 166 QPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGN-EIVPVLPAELSNPL 244 (429)
T ss_pred CchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccc-cccCchhhhccCch
Confidence 8888788899999999999985 779999999999999999999999999988887776554432 22233334567777
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 289 ~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
.+++...++.+|.+|.+..+-+.|+++...+
T Consensus 245 ~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 245 RELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred hhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 8999999999999999999999999998654
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-55 Score=396.57 Aligned_cols=264 Identities=33% Similarity=0.553 Sum_probs=232.2
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC-e
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT-A 130 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~-~ 130 (352)
.+.++|.++++||.|.||.||+|+..++|+.||||++++.- ....+.-. .+|+..|+++..||||+++.+++.+.+ .
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf-~s~ee~~n-LREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKF-YSWEECMN-LREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhh-ccHHHHHH-HHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 46689999999999999999999999999999999998753 33333323 469999999955999999999998887 9
Q ss_pred EEEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 131 VHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
+++|||||+. +|++.++.+. .|++..++.|+.||++||+|+|++|+.|||+||+|||+.. ...|||+|||+|+..
T Consensus 85 L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~---~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 85 LYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISG---NDVIKIADFGLAREV 160 (538)
T ss_pred EeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecc---cceeEeccccccccc
Confidence 9999999965 9999998765 4999999999999999999999999999999999999974 344899999999999
Q ss_pred CCCCcccccccccccccchhcc--ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCc-----
Q 018640 210 KPGEKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP----- 282 (352)
Q Consensus 210 ~~~~~~~~~~gt~~y~aPE~~~--~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----- 282 (352)
.+...++..+.|.+|+|||++- +.|+.+.|+||+||+++|+++-++.|.+..+.+++..+..-+.......|+
T Consensus 161 ~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 161 RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 8888889999999999999864 569999999999999999999999999999999888888777664433322
Q ss_pred ---------------------CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccC
Q 018640 283 ---------------------KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKA 321 (352)
Q Consensus 283 ---------------------~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~ 321 (352)
..+.++.++|.+|+.+||++||||.|+|+||||+.....
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~ 300 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS 300 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence 357889999999999999999999999999999976554
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-56 Score=369.31 Aligned_cols=298 Identities=41% Similarity=0.770 Sum_probs=270.7
Q ss_pred ccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe
Q 018640 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (352)
Q Consensus 51 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 130 (352)
..+.+.|++.++||+|.|+.||++.+..+|+.+|+|.+....+... +-+++.+|+++...| +|||||++.+.+.+...
T Consensus 7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~L-qHP~IvrL~~ti~~~~~ 84 (355)
T KOG0033|consen 7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKL-QHPNIVRLHDSIQEESF 84 (355)
T ss_pred cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhc-CCCcEeehhhhhcccce
Confidence 3577889999999999999999999999999999999987766554 678899999999999 99999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
.++|+|++.|+.|..-+-++..+++..+-..++||++||.|+|.+||||||+||+|+++.+......+||+|||+|....
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred eEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 99999999999998877777678999999999999999999999999999999999999988877789999999999988
Q ss_pred CCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHH
Q 018640 211 PGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (352)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (352)
.+.......||++|||||+++ ..|+..+|||+-|++||-|+.|.+|||+.......+.+......++...|+.++++..
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak 244 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAK 244 (355)
T ss_pred CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHH
Confidence 777777889999999999987 4599999999999999999999999999888899999999999999999999999999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcCcccccccc-CCCCCCcHHHHHHHHhhHHHHHHHHHHHhhc
Q 018640 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK-APNVSLGETVKARLKQFSVMNKLKKRALKVM 351 (352)
Q Consensus 290 ~li~~~l~~dP~~Rps~~ell~hp~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (352)
+||++||..||.+|.|+.|+|+|||+.+... .....+.++|. -|+-|-.++|||-..+.-+
T Consensus 245 ~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd-~lrkfNarRKLKgavLtav 306 (355)
T KOG0033|consen 245 SLIRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQDTVD-CLKKFNARRKLKGAILTTV 306 (355)
T ss_pred HHHHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhHHHHH-HHHHhhHHHHHHHHHHHHH
Confidence 9999999999999999999999999997533 23455566665 7889999999998876543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-55 Score=373.22 Aligned_cols=259 Identities=28% Similarity=0.581 Sum_probs=224.0
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
+.|+.+.++|+|+||+||+|+++.+|+.||||++..+. .++.-.+-..+|+++|+++ +|+|+|.++++|.....+++|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqL-kH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQL-KHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhc-ccchHHHHHHHHHhcceeEEE
Confidence 46889999999999999999999999999999987653 2233344567899999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC-CC
Q 018640 135 MELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PG 212 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~-~~ 212 (352)
+||++. ++.+.|.... .++...+.+++.|++.|+.|+|++++|||||||+|||++.++. +||||||+|+.+. ++
T Consensus 80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gv---vKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGV---VKLCDFGFARTLSAPG 155 (396)
T ss_pred eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCc---EEeccchhhHhhcCCc
Confidence 999976 7777776654 4899999999999999999999999999999999999986665 8999999999887 66
Q ss_pred Ccccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCC-----------
Q 018640 213 EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD----------- 279 (352)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 279 (352)
..++..+.|.+|+|||.+.+ +|+...||||.||++.||++|.+.|.+..+.+++..+...+....+.
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 67788899999999998765 59999999999999999999999999998888777776665542211
Q ss_pred ----------------CCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 280 ----------------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 280 ----------------~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
..+.++.-+.||+..||+.||++|++.++++.||||.+..
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~ 291 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFI 291 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHH
Confidence 1234567789999999999999999999999999997553
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-54 Score=392.61 Aligned_cols=258 Identities=33% Similarity=0.624 Sum_probs=234.6
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
-.+|.+.+.||+|+|++|++|++..+++.||||++.+..+......+-+..|-.+|.+|.+||.|++|+..|.++..+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 35799999999999999999999999999999999988766666667788899999999999999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
|+||+++|.|.+++.+.+.|++...+.++.+|+.||+|||++|||||||||+|||++.++. ++|+|||.|..+.+..
T Consensus 152 vLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmh---ikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGH---IKITDFGSAKILSPSQ 228 (604)
T ss_pred EEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCc---EEEeeccccccCChhh
Confidence 9999999999999999999999999999999999999999999999999999999986665 8999999998764321
Q ss_pred c--------------ccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC
Q 018640 214 K--------------FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR 278 (352)
Q Consensus 214 ~--------------~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 278 (352)
. ...++||..|.+||++.. ..+..+|||+|||+||+|+.|.+||.+.++-...+.+......++
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp- 307 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP- 307 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC-
Confidence 1 145899999999999985 478899999999999999999999999999888888887766654
Q ss_pred CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 279 DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 279 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
+.+++.+.+||.++|..||.+|+|+.+|-+||||...
T Consensus 308 ---~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V 344 (604)
T KOG0592|consen 308 ---EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV 344 (604)
T ss_pred ---CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence 5678999999999999999999999999999999965
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-52 Score=388.56 Aligned_cols=298 Identities=58% Similarity=1.012 Sum_probs=271.5
Q ss_pred cccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC
Q 018640 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (352)
Q Consensus 50 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 129 (352)
...+...|++.++||+|.||.||+|..+.+|+.+|+|.+.+.........+.+.+|+.+|+++..|||||.+.++|+...
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence 34567789999999999999999999999999999999988876665567889999999999966999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCC-CCCEEEEeccccee
Q 018640 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE-TAPLKAIDFGLSVF 208 (352)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~-~~~vkl~Dfg~a~~ 208 (352)
..++|||++.||.|.+.+... .+++..+..++.|++.|++|||+.|++||||||+|+|+..... ...+|++|||++..
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred eEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 999999999999999999877 5999999999999999999999999999999999999987654 34799999999998
Q ss_pred cCCCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHH
Q 018640 209 FKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (352)
Q Consensus 209 ~~~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (352)
..........+||+.|+|||++. ..|+..+||||+|+++|.|++|.+||++.........+......+....|+.+++.
T Consensus 189 ~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~ 268 (382)
T KOG0032|consen 189 IKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISES 268 (382)
T ss_pred ccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHH
Confidence 88777778899999999999998 67999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcCccccccccCCCCCCcHHHHHHHHhhHHHHHHHHHHH
Q 018640 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRAL 348 (352)
Q Consensus 288 ~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (352)
+.++|..||..||..|+|+.++|+|||++.....++......+..+.+.+..++++++.+.
T Consensus 269 akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (382)
T KOG0032|consen 269 AKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEATNIPLDISVLSRSKQFLSMSKLKKLAL 329 (382)
T ss_pred HHHHHHHhcccCcccCCCHHHHhcCccccCCcccccccccchhhhhHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999988777777777777667777777777766543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-52 Score=352.05 Aligned_cols=258 Identities=33% Similarity=0.580 Sum_probs=228.8
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|...+.||+|.||.||+|++.++|+.||||++......+..+.. ..+|++.|+.+ +|+||+.++++|...+...||
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~t-alREIK~Lqel-~h~nIi~LiD~F~~~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRT-ALREIKLLQEL-KHPNIIELIDVFPHKSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHH-HHHHHHHHHHc-cCcchhhhhhhccCCCceEEE
Confidence 4789999999999999999999999999999999988666655544 55699999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 135 MELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
+||++. +|...++.+. .++...+..++.+++.||+|||++.|+||||||.|+|+++++. +||+|||+|+...+..
T Consensus 80 fEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~---lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 80 FEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQ---LKIADFGLARFFGSPN 155 (318)
T ss_pred EEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCc---EEeecccchhccCCCC
Confidence 999976 9999997654 5999999999999999999999999999999999999986665 8999999999875443
Q ss_pred -cccccccccccccchhcc--ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcC-------
Q 018640 214 -KFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK------- 283 (352)
Q Consensus 214 -~~~~~~gt~~y~aPE~~~--~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 283 (352)
.....+-|.+|+|||.+- ..|+...|+||.||++.||+.|.+-|.+.++-+++..+.+.+....+..|+.
T Consensus 156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 333347899999999875 4599999999999999999999999999999999999998888766655553
Q ss_pred -----------------CCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 284 -----------------VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 284 -----------------~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
.++++.||+.+||..||.+|+|+.|+|+|+||+..
T Consensus 236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence 46778999999999999999999999999999965
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-52 Score=382.35 Aligned_cols=261 Identities=33% Similarity=0.569 Sum_probs=235.9
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
-.++|.++.+||+|+||.||+|+.+.+|+.+|+|++.++........+.++.|-.+|... +.|+||+|+..|++.+.+|
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecCCCeeE
Confidence 346799999999999999999999999999999999999888888888999999999996 9999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC-
Q 018640 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP- 211 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~- 211 (352)
|||||+|||++..+|...+.|++..++.++.+++.|++.||+.|+|||||||+|+||+..|+ +||+|||++.-...
T Consensus 218 LiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GH---iKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGH---IKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCC---Eeeccccccchhhhh
Confidence 99999999999999999999999999999999999999999999999999999999976555 99999999853311
Q ss_pred ----------------------C-Cc----c--------------------cccccccccccchhcc-ccCCCcchHHHH
Q 018640 212 ----------------------G-EK----F--------------------SEIVGSPYYMAPEVLK-RNYGPEVDVWSA 243 (352)
Q Consensus 212 ----------------------~-~~----~--------------------~~~~gt~~y~aPE~~~-~~~s~~~Di~Sl 243 (352)
. .. . ...+|||.|+|||++. .+|+...|.|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 0 00 0 1257999999999976 459999999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCC---CHHHHhcCcccccc
Q 018640 244 GVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRL---TAQQVLEHPWLQNA 318 (352)
Q Consensus 244 G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp---s~~ell~hp~f~~~ 318 (352)
|||+|||+.|.+||...+..+....+.++...+..+.-..++++++|||.+||. ||++|. .+.||-.||||+..
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v 451 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGV 451 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence 999999999999999999999999999998766666556788999999999999 999997 69999999999964
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-51 Score=381.92 Aligned_cols=260 Identities=41% Similarity=0.720 Sum_probs=227.5
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCCh--hcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA--VDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 129 (352)
...+.|.+.+.||+|+||+|++|.+..+|+.||+|++.+...... ...+.+.+|+.+++++..||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 455689999999999999999999999999999998777532211 234567789999999955999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
..++||||+.||+|++++...+++.+..++.+++|++.|++|||++||+||||||+|||++.+. ..+||+|||++...
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~--~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNE--GNLKLSDFGLSAIS 171 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCC--CCEEEecccccccc
Confidence 9999999999999999999988999999999999999999999999999999999999998662 44999999999987
Q ss_pred -CCCCcccccccccccccchhccc-c-C-CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCC-
Q 018640 210 -KPGEKFSEIVGSPYYMAPEVLKR-N-Y-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV- 284 (352)
Q Consensus 210 -~~~~~~~~~~gt~~y~aPE~~~~-~-~-s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 284 (352)
.......+.+||+.|+|||++.+ . | +.++||||+|++||.|++|+.||...........+.......+ ..+
T Consensus 172 ~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p----~~~~ 247 (370)
T KOG0583|consen 172 PGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIP----SYLL 247 (370)
T ss_pred CCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCC----CCcC
Confidence 45566788899999999999875 3 4 5789999999999999999999998776666666555444433 334
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhcCccccc
Q 018640 285 SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (352)
Q Consensus 285 ~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~ 317 (352)
+.++.+|+.+||..||.+|+|+.+++.||||+.
T Consensus 248 S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 248 SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 999999999999999999999999999999997
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-51 Score=374.48 Aligned_cols=257 Identities=32% Similarity=0.551 Sum_probs=225.2
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC--CeEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--TAVH 132 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~--~~~~ 132 (352)
+.|+.+++||+|.||.||+|++..+|+.||+|++.......... .-..+||.+|++| +||||++|.+...+. ..+|
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~-~t~~REI~ILr~l-~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFP-ITAIREIKILRRL-DHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcch-HHHHHHHHHHHhc-CCCcccceeeEEEecCCceEE
Confidence 46999999999999999999999999999999998765444333 3455799999999 999999999988766 6899
Q ss_pred EEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 133 LVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
||+|||+. +|.-++.... .|++.++..++.||+.||+|||++||+|||||.+||||++++. +||+|||+|+.+..
T Consensus 195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~---LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGV---LKIADFGLARFYTP 270 (560)
T ss_pred EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCC---EEeccccceeeccC
Confidence 99999976 8888886643 6999999999999999999999999999999999999986665 89999999997755
Q ss_pred CC--cccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCc-----
Q 018640 212 GE--KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP----- 282 (352)
Q Consensus 212 ~~--~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----- 282 (352)
.. .++..+-|.+|+|||.+.| .|+...|+||.||||.||++|++.|.+.++.+++..+.+.........|+
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence 43 4566788999999998764 49999999999999999999999999999999999999887765555544
Q ss_pred --------------------CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccc
Q 018640 283 --------------------KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (352)
Q Consensus 283 --------------------~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~ 317 (352)
.++....+|+..+|..||.+|.||.++|+++||..
T Consensus 351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 14777889999999999999999999999999943
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-51 Score=352.01 Aligned_cols=254 Identities=30% Similarity=0.610 Sum_probs=233.7
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++++.||.|+||.|.+++.+.+|..+|+|++++.......+.+...+|..+|+.+ .||.++++.+.|.+.+..+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v-~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAV-SHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhc-cCceeEEEEEeeccCCeEEEE
Confidence 5799999999999999999999999999999999988777777778889999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCc
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (352)
|||++||.|..++++.+++++..++.++.||+.||+|||+++|++||+||+|||+++++. +||+|||+|......
T Consensus 123 meyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~---iKitDFGFAK~v~~r-- 197 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGH---IKITDFGFAKRVSGR-- 197 (355)
T ss_pred EeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCc---EEEEeccceEEecCc--
Confidence 999999999999999999999999999999999999999999999999999999986666 999999999987644
Q ss_pred ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHH
Q 018640 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (352)
Q Consensus 215 ~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 293 (352)
.-+.+||+.|+|||.+. ..++..+|.||||+++|||+.|.+||.........+.+......++ .-++.++.+||.
T Consensus 198 T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP----~~fs~~~kdLl~ 273 (355)
T KOG0616|consen 198 TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFP----SYFSSDAKDLLK 273 (355)
T ss_pred EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCC----cccCHHHHHHHH
Confidence 46779999999999877 6699999999999999999999999999999888888887766654 457899999999
Q ss_pred HhcCCCcCCCC-----CHHHHhcCcccccc
Q 018640 294 KMLDPDPKRRL-----TAQQVLEHPWLQNA 318 (352)
Q Consensus 294 ~~l~~dP~~Rp-----s~~ell~hp~f~~~ 318 (352)
.+|+.|-.+|. -..+|-+||||+..
T Consensus 274 ~LL~vD~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 274 KLLQVDLTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred HHHhhhhHhhhcCcCCCccccccCcccccc
Confidence 99999999993 57799999999943
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-51 Score=364.83 Aligned_cols=262 Identities=29% Similarity=0.500 Sum_probs=225.8
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
.+.|++..+||.|.-++||+|+...+++.||||++..+.+.+ +.+.+++|+..|+.+ +||||+.++..|..+..+|+
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~-~HPNIv~~~~sFvv~~~LWv 101 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN--DLDALRKEVQTMSLI-DHPNIVTYHCSFVVDSELWV 101 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhc-CCCCcceEEEEEEecceeEE
Confidence 457999999999999999999999999999999999876544 378999999999999 99999999999999999999
Q ss_pred EEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC-
Q 018640 134 VMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK- 210 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~- 210 (352)
||.||.+||+.++++..- .+++..+..|+++++.||.|||++|.||||||+.|||++.+|. |||+|||.+..+.
T Consensus 102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~---VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGT---VKLADFGVSASLFD 178 (516)
T ss_pred eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCc---EEEcCceeeeeecc
Confidence 999999999999998653 4999999999999999999999999999999999999987666 9999999876543
Q ss_pred CCCc----ccccccccccccchhcc---ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc------cC
Q 018640 211 PGEK----FSEIVGSPYYMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD------FR 277 (352)
Q Consensus 211 ~~~~----~~~~~gt~~y~aPE~~~---~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~------~~ 277 (352)
.+.. ..+++||+.|||||++. .+|+.|+||||||++..||.+|..||....+-.++..-.+.-.. .+
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~ 258 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLD 258 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCC
Confidence 2221 25669999999999954 45999999999999999999999999988877665555444332 11
Q ss_pred CCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccC
Q 018640 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKA 321 (352)
Q Consensus 278 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~ 321 (352)
.+....++..+..+|..||+.||.+|||+.++|.|+||++.+..
T Consensus 259 ~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~ 302 (516)
T KOG0582|consen 259 KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK 302 (516)
T ss_pred hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence 11223578889999999999999999999999999999987543
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-52 Score=354.21 Aligned_cols=263 Identities=37% Similarity=0.698 Sum_probs=239.4
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCC-hh----cHHHHHHHHHHHHhCCCCCCeeEeeeEEEe
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT-AV----DIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~----~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 127 (352)
+-..|.-.++||.|..++|.++..+.+|..+|+|++....... .. -.+.-.+|+.+|+++..||+|+.+.++|+.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 4456888899999999999999999999999999986543221 11 134557799999999999999999999999
Q ss_pred CCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccce
Q 018640 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (352)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~ 207 (352)
+...++|+|.++.|.|.|+|...-.+++...+.|++|+++|++|||.++||||||||+|||++++.+ ++|+|||+|.
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~---i~isDFGFa~ 171 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMN---IKISDFGFAC 171 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccc---eEEeccceee
Confidence 9999999999999999999998888999999999999999999999999999999999999976554 8999999999
Q ss_pred ecCCCCcccccccccccccchhcc-------ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCC
Q 018640 208 FFKPGEKFSEIVGSPYYMAPEVLK-------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP 280 (352)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~~~-------~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 280 (352)
.+..++.....+||++|+|||.+. .+|+...|+||.|++||.|+.|.+|||.......+..+......+..+.
T Consensus 172 ~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~spe 251 (411)
T KOG0599|consen 172 QLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPE 251 (411)
T ss_pred ccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcc
Confidence 999999999999999999999874 2488899999999999999999999999988888889999999999999
Q ss_pred CcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 281 ~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
|..++....|||.+||+.||.+|.|+.|+|.||||.+.
T Consensus 252 Wadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 252 WADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred hhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 99999999999999999999999999999999999654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-51 Score=367.48 Aligned_cols=258 Identities=33% Similarity=0.554 Sum_probs=213.9
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC--eEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT--AVH 132 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~--~~~ 132 (352)
.+|...+.||+|+||+||++.+.++|+..|||.+.... .. ..+.+.+|+.+|.++ +|||||+.+|...... .++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--~~-~~~~l~~Ei~iL~~l-~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED--SP-TSESLEREIRILSRL-NHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeeccc--ch-hHHHHHHHHHHHHhC-CCCCEEeeCCccccccCeeeE
Confidence 45888999999999999999999999999999987652 11 167799999999999 6999999999754444 689
Q ss_pred EEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 133 LVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
+.|||+++|+|.+++...+ .+++..++.+.+||++||+|||++||||+||||+|||++.. .+.+||+|||++.....
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~--~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPS--NGDVKLADFGLAKKLES 170 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCC--CCeEEeccCcccccccc
Confidence 9999999999999999877 79999999999999999999999999999999999999762 23389999999987653
Q ss_pred ----CCcccccccccccccchhcccc--CCCcchHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcccccCCCCCcCC
Q 018640 212 ----GEKFSEIVGSPYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVLDFRRDPWPKV 284 (352)
Q Consensus 212 ----~~~~~~~~gt~~y~aPE~~~~~--~s~~~Di~SlG~~l~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 284 (352)
........||+.|||||++... ...++|||||||+++||+||..||... ........+... ...+..+..+
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~--~~~P~ip~~l 248 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRE--DSLPEIPDSL 248 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhcc--CCCCCCCccc
Confidence 1223457899999999998744 334999999999999999999999774 222222222211 1223455679
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 285 SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 285 ~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
++++++||..|+..||++||||.++|+|||..+...
T Consensus 249 s~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 249 SDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 999999999999999999999999999999987554
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-51 Score=353.14 Aligned_cols=262 Identities=27% Similarity=0.460 Sum_probs=228.4
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe--CCeEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--DTAVH 132 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~--~~~~~ 132 (352)
+.|+.++.|++|+||.||+|+++.+++.||+|+++.+.-.....+.. .+|+.+|.++ +|||||.+-.+... -+.+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPIts-LREIniLl~~-~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITS-LREINILLKA-RHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchh-HHHHHHHHhc-CCCCeeeeEEEEeccccceee
Confidence 56999999999999999999999999999999998765444444444 4699999999 89999999988764 45799
Q ss_pred EEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 133 LVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
|||||++. +|...+..-+ ++...++..++.|++.|++|||++.|+||||||+|+|+...+. +||+|||+|+.+..
T Consensus 154 ~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~---lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGI---LKIADFGLAREYGS 229 (419)
T ss_pred eeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCc---EEecccchhhhhcC
Confidence 99999975 8988887765 7999999999999999999999999999999999999976555 89999999998765
Q ss_pred C-Ccccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcC-----
Q 018640 212 G-EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK----- 283 (352)
Q Consensus 212 ~-~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 283 (352)
. ..++..+-|.+|+|||.+-+ .|++..|+||+|||+.||+++++.|.+....+++..+++.+.......|+.
T Consensus 230 p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 230 PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 4 45677788999999998754 599999999999999999999999999999999999999887766555553
Q ss_pred -----------------------CCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccCC
Q 018640 284 -----------------------VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAP 322 (352)
Q Consensus 284 -----------------------~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~ 322 (352)
+++...+|+..+|..||.+|.|+.+.|.|.||.+.+...
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~ 371 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPI 371 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCC
Confidence 247778999999999999999999999999999864443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-51 Score=379.23 Aligned_cols=256 Identities=32% Similarity=0.540 Sum_probs=224.7
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
..|....+||+|+-|.||.|....+++.||||++..... ...+-+.+|+.+|+.+ +|+|||.+++.|...+.+|+|
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q---~~keLilnEi~Vm~~~-~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ---PKKELLLNEILVMRDL-HHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC---CchhhhHHHHHHHHhc-cchHHHHHHHHhcccceeEEE
Confidence 468889999999999999999999999999999987542 3356789999999999 999999999999988999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC-
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (352)
|||++||+|.|.+... .+++.++..|+++++.||+|||.+||+|||||.+|||++.++. +||+|||++..+....
T Consensus 349 MEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~---vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGS---VKLTDFGFCAQISEEQS 424 (550)
T ss_pred EeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCc---EEEeeeeeeeccccccC
Confidence 9999999999988665 5999999999999999999999999999999999999987666 9999999998876655
Q ss_pred cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHH
Q 018640 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (352)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 292 (352)
...+.+||+.|||||+.. ..|+.+.||||||++++||+-|.+||........+..+ ..........+..++..+++|+
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI-a~ng~P~lk~~~klS~~~kdFL 503 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGTPKLKNPEKLSPELKDFL 503 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH-hhcCCCCcCCccccCHHHHHHH
Confidence 456789999999999987 56999999999999999999999999876554443333 3333444455668999999999
Q ss_pred HHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 293 RKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 293 ~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
.+||+.||++|+++.|||+||||+.+.
T Consensus 504 ~~cL~~dv~~RasA~eLL~HpFl~~a~ 530 (550)
T KOG0578|consen 504 DRCLVVDVEQRASAKELLEHPFLKMAK 530 (550)
T ss_pred HHHhhcchhcCCCHHHHhcChhhhhcC
Confidence 999999999999999999999997553
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-52 Score=355.14 Aligned_cols=246 Identities=29% Similarity=0.541 Sum_probs=211.1
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeee-EEEeC-CeE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKD-TYEDD-TAV 131 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~-~~~~~-~~~ 131 (352)
-.+|+|.++||+|.||+||++....+|..||.|.+.... .+....+.+..|+.+|++| +|||||++++ .+.++ +.+
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL-~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM-MDAKARQDCVKEISLLKQL-NHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh-ccHHHHHHHHHHHHHHHhc-CCchHHHHHHHhhhccchhh
Confidence 346999999999999999999999999999999998543 3444567788899999999 9999999998 44444 448
Q ss_pred EEEEEecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH--cC--CEEecCCCCceEeecCCCCCCEEEEec
Q 018640 132 HLVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHK--HG--VMHRDLKPENFLFANKKETAPLKAIDF 203 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH~--~~--ivH~Dikp~NIll~~~~~~~~vkl~Df 203 (352)
+|||||+.+|+|.+.++. +..+++..+|+++.|++.||..+|+ .. |+||||||.||+++.++ .|||+||
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g---vvKLGDf 172 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG---VVKLGDF 172 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC---ceeeccc
Confidence 999999999999998863 3459999999999999999999999 45 99999999999997554 5999999
Q ss_pred ccceecCCCCcc-cccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCC
Q 018640 204 GLSVFFKPGEKF-SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281 (352)
Q Consensus 204 g~a~~~~~~~~~-~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (352)
|+++........ .+.+|||.||+||.+. ..|+.+|||||+||++|||..-.+||.+.+..+....+.+. ++++-+.
T Consensus 173 GL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg--d~~~~p~ 250 (375)
T KOG0591|consen 173 GLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG--DYPPLPD 250 (375)
T ss_pred hhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC--CCCCCcH
Confidence 999988765543 5679999999999987 45999999999999999999999999999877777777766 3333232
Q ss_pred cCCCHHHHHHHHHhcCCCcCCCCCH
Q 018640 282 PKVSENAKDLVRKMLDPDPKRRLTA 306 (352)
Q Consensus 282 ~~~~~~~~~li~~~l~~dP~~Rps~ 306 (352)
.-+|.++..+|..|+..||+.||+.
T Consensus 251 ~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 251 EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHhhhHHHHHHHHHccCCcccCCCc
Confidence 4689999999999999999999985
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-50 Score=368.83 Aligned_cols=249 Identities=28% Similarity=0.419 Sum_probs=214.6
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcE-EEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC-eEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDA-FACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT-AVH 132 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~-~~~ 132 (352)
....+.+.||.|+||+||+|.+. |.. ||+|++......... .+.|.+|+.+|.++ +|||||+++|++.+.. ..+
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l-~HpNIV~f~G~~~~~~~~~~ 116 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRL-RHPNIVQFYGACTSPPGSLC 116 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCceE
Confidence 34566677999999999999987 666 999999876554444 77999999999999 9999999999999887 799
Q ss_pred EEEEecCCcchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcC-CEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 133 LVMELCEGGELFDRIVA--RGHYTERAAAAVTKTIVEVVQMCHKHG-VMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~qi~~aL~~lH~~~-ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
+||||+++|+|.+++.. ...+++..+..++.+|+.||+|||+.+ ||||||||+|||++.++ .++||+|||+++..
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~--~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG--KTLKIADFGLSREK 194 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC--CEEEECCCccceee
Confidence 99999999999999987 567999999999999999999999999 99999999999997655 35999999999876
Q ss_pred CCC-Ccccccccccccccchhcccc---CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCC
Q 018640 210 KPG-EKFSEIVGSPYYMAPEVLKRN---YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (352)
Q Consensus 210 ~~~-~~~~~~~gt~~y~aPE~~~~~---~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (352)
... ...+...||..|||||++.+. ++.|+||||||+++|||+||+.||......+....+.... .++..+...+
T Consensus 195 ~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~--~Rp~~p~~~~ 272 (362)
T KOG0192|consen 195 VISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGG--LRPPIPKECP 272 (362)
T ss_pred ccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcC--CCCCCCccCC
Confidence 544 334447899999999999843 9999999999999999999999999888766666555432 3333344589
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 286 ENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 286 ~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
+.+..++..||+.||..||++.+++.
T Consensus 273 ~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 273 PHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 99999999999999999999999854
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-50 Score=363.37 Aligned_cols=259 Identities=30% Similarity=0.503 Sum_probs=219.0
Q ss_pred ceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEE
Q 018640 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (352)
Q Consensus 57 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e 136 (352)
|++.+.||+|+||+||+|.+..+|+.||+|.+.............+.+|+.+++++ +|++|+.+++++...+..++|||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-CCCcEEEEEEEEccCCeEEEEEE
Confidence 78899999999999999999999999999998765444333445678899999999 89999999999999999999999
Q ss_pred ecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCc
Q 018640 137 LCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (352)
Q Consensus 137 ~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (352)
|+++|+|.+.+... ..+++..+..++.|++.||+|||+.+|+||||||+|||++.++. ++|+|||++........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~---~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGH---IRISDLGLAVQIPEGET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC---EEEeeCCCcEEcCCCCe
Confidence 99999998887543 35899999999999999999999999999999999999975544 89999999987654444
Q ss_pred ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHH
Q 018640 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (352)
Q Consensus 215 ~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 293 (352)
.....||..|+|||++. ..++.++||||||+++|+|++|+.||...........+..............++..+.+||.
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 237 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICR 237 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHH
Confidence 45567999999999986 45899999999999999999999999876543333333333333333445568999999999
Q ss_pred HhcCCCcCCCCC-----HHHHhcCccccccc
Q 018640 294 KMLDPDPKRRLT-----AQQVLEHPWLQNAK 319 (352)
Q Consensus 294 ~~l~~dP~~Rps-----~~ell~hp~f~~~~ 319 (352)
+||+.||++||+ +.++++||||.+..
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 238 MLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred HHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 999999999997 89999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-51 Score=379.24 Aligned_cols=259 Identities=37% Similarity=0.665 Sum_probs=237.9
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
-|++.+.||.|+-|.|-+|++..+|+.+|||++.+...........+.+|+-+|+.+ .|||++++++++++..++|+|.
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi-~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLI-EHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHh-cCCCeeeeeeeeccCceEEEEE
Confidence 489999999999999999999999999999999887444555567899999999999 9999999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCcc
Q 018640 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF 215 (352)
Q Consensus 136 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~ 215 (352)
||++||.|++++..++++++.++.++++||+.|+.|+|..+|+|||+||+|+|++...+ +||+|||+|..-..+.-.
T Consensus 92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n---IKIADFGMAsLe~~gklL 168 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN---IKIADFGMASLEVPGKLL 168 (786)
T ss_pred EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC---EeeeccceeecccCCccc
Confidence 99999999999999999999999999999999999999999999999999999975554 999999999988777777
Q ss_pred cccccccccccchhcccc--CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHH
Q 018640 216 SEIVGSPYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (352)
Q Consensus 216 ~~~~gt~~y~aPE~~~~~--~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 293 (352)
.+.+|+++|.+||++.|. .+.++||||-|+|||.|+||+.||++.+....+..+.++....+ ..++.++++||.
T Consensus 169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP----s~Is~eaQdLLr 244 (786)
T KOG0588|consen 169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP----SNISSEAQDLLR 244 (786)
T ss_pred cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC----CcCCHHHHHHHH
Confidence 888999999999998764 57899999999999999999999999998888888888776655 568999999999
Q ss_pred HhcCCCcCCCCCHHHHhcCccccccccCC
Q 018640 294 KMLDPDPKRRLTAQQVLEHPWLQNAKKAP 322 (352)
Q Consensus 294 ~~l~~dP~~Rps~~ell~hp~f~~~~~~~ 322 (352)
+||..||..|.|++||+.|||+......+
T Consensus 245 ~ml~VDp~~RiT~~eI~kHP~l~g~~~~~ 273 (786)
T KOG0588|consen 245 RMLDVDPSTRITTEEILKHPFLSGYTSLP 273 (786)
T ss_pred HHhccCccccccHHHHhhCchhhcCCCCC
Confidence 99999999999999999999999875543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-51 Score=376.74 Aligned_cols=256 Identities=31% Similarity=0.574 Sum_probs=227.1
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|.+.+.||+|.||.||+|+.+.+.+.||+|.+.+... ...+...+++|+++++.+ +|||||.++++|+...+.|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~l-kHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSL-KHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhc-CCcchhhHHHhhcccceEEEE
Confidence 479999999999999999999999999999999988643 334567799999999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCc
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (352)
.||+.| +|..++...+.++++.++.|+.+++.||.|||+++|+|||+||.|||++ .++.+|+||||+|+....+..
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~---~~~~~KlcdFg~Ar~m~~~t~ 155 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLE---KGGTLKLCDFGLARAMSTNTS 155 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeec---CCCceeechhhhhhhcccCce
Confidence 999977 9999999999999999999999999999999999999999999999996 444589999999998765543
Q ss_pred -ccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHH
Q 018640 215 -FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (352)
Q Consensus 215 -~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 292 (352)
.+.+.||+.|||||...+ .|+..+|+||+||++||+++|++||......+....+... +..++..++..+.+|+
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d----~v~~p~~~S~~f~nfl 231 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD----PVKPPSTASSSFVNFL 231 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC----CCCCcccccHHHHHHH
Confidence 367789999999999875 5999999999999999999999999877666555555544 3334457899999999
Q ss_pred HHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 293 RKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 293 ~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
..+|++||.+|.|..+++.|||++....
T Consensus 232 ~gLL~kdP~~RltW~~Ll~HpF~k~~~~ 259 (808)
T KOG0597|consen 232 QGLLIKDPAQRLTWTDLLGHPFWKGKIN 259 (808)
T ss_pred HHHhhcChhhcccHHHHhcChHHhhhhh
Confidence 9999999999999999999999986533
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-50 Score=362.36 Aligned_cols=254 Identities=29% Similarity=0.514 Sum_probs=220.5
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++++.||+|+||+||+|.+..+|+.||+|++...........+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SHPFIIRLFWTEHDQRFLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC-CCCcHhhhHhhhccCCeEEEE
Confidence 3689999999999999999999999999999998765433333456788999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCc
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (352)
|||+++++|.+++.....+++..+..++.|++.||+|||++|++||||||+||+++.++. +||+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~---~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGH---IKLTDFGFAKKLRDR-- 154 (291)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC---EEEEecCcchhccCC--
Confidence 999999999999988888999999999999999999999999999999999999975544 899999999765432
Q ss_pred ccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHH
Q 018640 215 FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (352)
Q Consensus 215 ~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 293 (352)
.....||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+...... ....++..+.++|.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~~~li~ 230 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLE----FPRHLDLYAKDLIK 230 (291)
T ss_pred cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcC----CCccCCHHHHHHHH
Confidence 234578999999998864 4889999999999999999999999888776666665544322 23456889999999
Q ss_pred HhcCCCcCCCCC-----HHHHhcCcccccc
Q 018640 294 KMLDPDPKRRLT-----AQQVLEHPWLQNA 318 (352)
Q Consensus 294 ~~l~~dP~~Rps-----~~ell~hp~f~~~ 318 (352)
+||+.||.+||+ +.++++||||+..
T Consensus 231 ~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 231 KLLVVDRTRRLGNMKNGADDVKNHRWFKSV 260 (291)
T ss_pred HHcCCCHHHccCCccCCHHHHhcCccccCC
Confidence 999999999995 9999999999854
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=366.96 Aligned_cols=254 Identities=31% Similarity=0.582 Sum_probs=221.3
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++++ +||||+++++++..++..++|
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEcCCEEEEE
Confidence 5799999999999999999999999999999999765444444566788999999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCc
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (352)
|||+++++|.+++.....+++..+..++.|++.||+|||++||+||||||+|||++.++. +||+|||++.......
T Consensus 97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~---~kl~Dfg~~~~~~~~~- 172 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGH---VKVTDFGFAKKVPDRT- 172 (329)
T ss_pred EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCC---EEEeeccCceEcCCCc-
Confidence 999999999999998888999999999999999999999999999999999999976554 8999999998764332
Q ss_pred ccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHH
Q 018640 215 FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (352)
Q Consensus 215 ~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 293 (352)
....||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+..... ..+..++..+.+||.
T Consensus 173 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~----~~p~~~~~~~~~li~ 247 (329)
T PTZ00263 173 -FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRL----KFPNWFDGRARDLVK 247 (329)
T ss_pred -ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCc----CCCCCCCHHHHHHHH
Confidence 34579999999999874 488999999999999999999999988776655555544322 223457899999999
Q ss_pred HhcCCCcCCCCC-----HHHHhcCcccccc
Q 018640 294 KMLDPDPKRRLT-----AQQVLEHPWLQNA 318 (352)
Q Consensus 294 ~~l~~dP~~Rps-----~~ell~hp~f~~~ 318 (352)
+||+.||.+||+ +.++++||||++.
T Consensus 248 ~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 248 GLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 999999999996 7999999999863
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-50 Score=352.89 Aligned_cols=271 Identities=32% Similarity=0.514 Sum_probs=229.8
Q ss_pred CcccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe-
Q 018640 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED- 127 (352)
Q Consensus 49 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~- 127 (352)
+...+..+|..++.||+|+||.|..+.+..+|+.||||++... +......++..+|+++|+++ +|+||+.+.+.+..
T Consensus 16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~-~HeNIi~l~di~~p~ 93 (359)
T KOG0660|consen 16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHL-RHENIIGLLDIFRPP 93 (359)
T ss_pred eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHh-cCCCcceEEeecccc
Confidence 3445667788899999999999999999999999999998754 45666778889999999999 79999999998854
Q ss_pred ----CCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEec
Q 018640 128 ----DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDF 203 (352)
Q Consensus 128 ----~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Df 203 (352)
-+..|+|+|+| +.+|.+.++.+..++...+.-++.|++.||+|+|+.+++|||+||.|++++.+-. +||+||
T Consensus 94 ~~~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~---lKI~DF 169 (359)
T KOG0660|consen 94 SRDKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCD---LKICDF 169 (359)
T ss_pred cccccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCC---EEeccc
Confidence 35789999999 4599999998888999999999999999999999999999999999999975544 899999
Q ss_pred ccceecCC---CCcccccccccccccchhcc--ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC
Q 018640 204 GLSVFFKP---GEKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR 278 (352)
Q Consensus 204 g~a~~~~~---~~~~~~~~gt~~y~aPE~~~--~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 278 (352)
|+|+.... ...++..+.|.+|+|||.+. ..|+...||||.||++.||++|++.|.+.....++..+.........
T Consensus 170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~ 249 (359)
T KOG0660|consen 170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE 249 (359)
T ss_pred cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence 99998754 34456778899999999864 56999999999999999999999999888777666655554443211
Q ss_pred C---------------------------CCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccCCCCC
Q 018640 279 D---------------------------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVS 325 (352)
Q Consensus 279 ~---------------------------~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~ 325 (352)
. .++..++.+.+|+.+||..||.+|+|++|+|+||||...-.....+
T Consensus 250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 1 1345789999999999999999999999999999999765444433
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=366.84 Aligned_cols=258 Identities=31% Similarity=0.537 Sum_probs=222.3
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++++.||+|+||.||+|.+..+++.||+|++.............+.+|+.++..+ +||||+++++++...+..++|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT-KSEWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhC-CCCCCccEEEEEEcCCEEEEE
Confidence 3699999999999999999999999999999999766443344456788999999999 799999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCc
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (352)
|||++|++|.+++.....+++..++.++.|++.||.|||+.||+||||||+||+++.++. +||+|||++..... .
T Consensus 80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~---~kL~Dfg~a~~~~~--~ 154 (333)
T cd05600 80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGH---IKLTDFGLSKGIVT--Y 154 (333)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC---EEEEeCcCCccccc--c
Confidence 999999999999988888999999999999999999999999999999999999976554 89999999976543 2
Q ss_pred ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCC----cCCCHHHH
Q 018640 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW----PKVSENAK 289 (352)
Q Consensus 215 ~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 289 (352)
.....||+.|+|||++. ..++.++|||||||++|||++|..||......+....+............ ..+++++.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 34557999999999886 45899999999999999999999999888776665555443322221111 25689999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 290 ~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
++|.+||..+|++||++.++++||||.+.
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 99999999999999999999999999964
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=365.79 Aligned_cols=250 Identities=30% Similarity=0.543 Sum_probs=216.0
Q ss_pred eeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEecCC
Q 018640 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~~ 140 (352)
+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-RHPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999999999999999765444444456778899999999 899999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC-CCCcccccc
Q 018640 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIV 219 (352)
Q Consensus 141 ~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~ 219 (352)
++|.+++.....+++..+..++.||+.||+|||+.||+||||||+||+++.++. +||+|||++.... .........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~---~kl~DfG~a~~~~~~~~~~~~~~ 156 (323)
T cd05571 80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH---IKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC---EEEeeCCCCcccccCCCccccee
Confidence 999999988888999999999999999999999999999999999999976554 8999999987532 223334567
Q ss_pred cccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCC
Q 018640 220 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298 (352)
Q Consensus 220 gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 298 (352)
||+.|+|||++. ..++.++|||||||++|||++|..||...........+.... ...+..+++++.+||.+||+.
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~----~~~p~~~~~~~~~li~~~L~~ 232 (323)
T cd05571 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE----IRFPRTLSPEAKSLLAGLLKK 232 (323)
T ss_pred cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC----CCCCCCCCHHHHHHHHHHccC
Confidence 999999999986 458999999999999999999999998877665555544332 223356899999999999999
Q ss_pred CcCCCC-----CHHHHhcCcccccc
Q 018640 299 DPKRRL-----TAQQVLEHPWLQNA 318 (352)
Q Consensus 299 dP~~Rp-----s~~ell~hp~f~~~ 318 (352)
||++|| ++.++++||||...
T Consensus 233 dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 233 DPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred CHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999999 89999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-49 Score=368.53 Aligned_cols=259 Identities=29% Similarity=0.486 Sum_probs=217.4
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++++.||+|+||+||+|.+..+++.||+|++.............+.+|+.++..+ +|+||+++++.+.+....++|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~~~~~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSFQDKLNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCeEEEE
Confidence 3699999999999999999999999999999999765443444456788899999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC-
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (352)
|||++||+|.+++.....+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~---~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKG---HVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC---CEEEeeccCccccccccc
Confidence 99999999999998888899999999999999999999999999999999999997654 48999999987542210
Q ss_pred -----------------------------------cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCC
Q 018640 214 -----------------------------------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPF 257 (352)
Q Consensus 214 -----------------------------------~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~ 257 (352)
......||+.|+|||++. ..++.++|||||||++|||++|..||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 012357999999999986 45899999999999999999999999
Q ss_pred CCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcC---CCCCHHHHhcCcccccc
Q 018640 258 WAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPK---RRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~---~Rps~~ell~hp~f~~~ 318 (352)
......+....+..............+++++.++|.+++. +|. .||++.||++||||+..
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 237 CSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred CCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence 8887776666665533222222223578999999999765 344 46899999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-49 Score=368.96 Aligned_cols=259 Identities=30% Similarity=0.544 Sum_probs=220.1
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++++.||+|+||+||+|.+..+|+.||+|++.............+.+|+.++..+ +||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-DNPWVVKLYYSFQDENYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCeEEEE
Confidence 3699999999999999999999999999999999765433334456688899999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC-
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (352)
|||+++|+|.+++.....+++..++.++.|++.||+|||+.||+||||||+|||++.++. ++|+|||++.......
T Consensus 80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~---~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGH---IKLSDFGLCTGLKKSHR 156 (364)
T ss_pred ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC---EEEeecccceecccccc
Confidence 999999999999988888999999999999999999999999999999999999976554 8999999987542211
Q ss_pred --------------------------------------cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCC
Q 018640 214 --------------------------------------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGV 254 (352)
Q Consensus 214 --------------------------------------~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~ 254 (352)
......||+.|+|||++. ..++.++|||||||++|||++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 001246999999999876 45899999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCC---HHHHhcCcccccc
Q 018640 255 PPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLT---AQQVLEHPWLQNA 318 (352)
Q Consensus 255 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps---~~ell~hp~f~~~ 318 (352)
.||...........+..............+++.+.+||.+|+. +|.+|++ +.+++.||||+..
T Consensus 237 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 237 PPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 9998887766665555443332222233578999999999997 8999997 9999999999864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-50 Score=355.58 Aligned_cols=255 Identities=37% Similarity=0.693 Sum_probs=236.5
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
+.-+|++.+.||+|.||.|-+|.....|+.||||.+.+..+.+..+.-.+++|+++|..| +||||++++.+|+..+.++
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhhcCCceEE
Confidence 445799999999999999999999999999999999999999988888999999999999 9999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
|||||..+|.|+|++.+++.|++.+++.+++||+.|+.|+|+++++|||||.+|||++.+.+ +||+|||++..+...
T Consensus 130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~N---iKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNN---IKIADFGLSNLYADK 206 (668)
T ss_pred EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCC---eeeeccchhhhhccc
Confidence 99999999999999999999999999999999999999999999999999999999987666 899999999988888
Q ss_pred Ccccccccccccccchhcccc--CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHH
Q 018640 213 EKFSEIVGSPYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (352)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~~--~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (352)
.-..+++|++-|.+||+.++. -++..|-||||++||.|+.|..||++........++.+.-..- +.-+.+..-
T Consensus 207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE-----P~~PSdA~g 281 (668)
T KOG0611|consen 207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE-----PETPSDASG 281 (668)
T ss_pred cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC-----CCCCchHHH
Confidence 888899999999999999875 4788999999999999999999999999887777777654332 345778899
Q ss_pred HHHHhcCCCcCCCCCHHHHhcCcccc
Q 018640 291 LVRKMLDPDPKRRLTAQQVLEHPWLQ 316 (352)
Q Consensus 291 li~~~l~~dP~~Rps~~ell~hp~f~ 316 (352)
||.+||-.||++|.|+.+|..|.|++
T Consensus 282 LIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 282 LIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred HHHHHHhcCcccchhHHHHhhhheee
Confidence 99999999999999999999999987
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=368.61 Aligned_cols=259 Identities=29% Similarity=0.480 Sum_probs=217.5
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
.|++++.||+|+||+||+|.+..+++.||+|++.............+.+|+.+++.+ +|+||+++++++.+.+..++||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-DNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-CCCCeeeeEEEEecCCEEEEEE
Confidence 589999999999999999999999999999999765544444566789999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC--
Q 018640 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-- 213 (352)
Q Consensus 136 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-- 213 (352)
||++||+|.+++.....+++..++.++.||+.||+|||+.||+||||||+|||++.++ .+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~---~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG---HIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCC---CEEEeeCcCCccccccccc
Confidence 9999999999998888899999999999999999999999999999999999997544 48999999875321000
Q ss_pred ----------------------------------------------cccccccccccccchhcc-ccCCCcchHHHHHHH
Q 018640 214 ----------------------------------------------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVI 246 (352)
Q Consensus 214 ----------------------------------------------~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~ 246 (352)
......||+.|+|||++. ..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 012347999999999876 458999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhc--CCCcCCCCCHHHHhcCcccccc
Q 018640 247 LYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKML--DPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 247 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l--~~dP~~Rps~~ell~hp~f~~~ 318 (352)
+|||++|..||...........+..............++.++.+||.+|+ ..+|..||++.++++||||++.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 99999999999887766655555543333333333468999999999955 5556669999999999999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-49 Score=367.67 Aligned_cols=259 Identities=35% Similarity=0.620 Sum_probs=224.3
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++.+.||+|+||+||+|.+..+|+.||+|++.............+.+|+.++..+ +|+||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-DSPWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-CCCCccchhhheecCCeEEEE
Confidence 3699999999999999999999999999999999866444444566788999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC-
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (352)
|||+++++|.+++.....+++..++.++.|++.||+|||+.||+||||||+||+++.++. +||+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~---~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGH---IKLADFGLCKKMNKAKD 156 (350)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC---EEeecCCCCccCcccCc
Confidence 999999999999988888999999999999999999999999999999999999976554 8999999997654332
Q ss_pred -----------------------------cccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 018640 214 -----------------------------KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQ 263 (352)
Q Consensus 214 -----------------------------~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~ 263 (352)
......||+.|+|||++.+ .++.++|||||||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 2234578999999999874 5899999999999999999999999888877
Q ss_pred HHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCC-HHHHhcCcccccc
Q 018640 264 GVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLT-AQQVLEHPWLQNA 318 (352)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps-~~ell~hp~f~~~ 318 (352)
.....+..............+++.+.++|..||. ||.+||+ +.++++||||++.
T Consensus 237 ~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 6666666533333333334579999999999998 9999999 9999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-49 Score=364.01 Aligned_cols=255 Identities=30% Similarity=0.523 Sum_probs=220.6
Q ss_pred cccceeceeeeccCceEEEEEEECCCC-cEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENG-DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
.++|++.+.||+|+||.||+|.+..++ ..||+|++...........+.+.+|+.+++.+ +||||+++++++...+..+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCCcceEEEEEeCCEEE
Confidence 357999999999999999999876554 68999998765444444566788999999999 8999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
+||||+++|+|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||++.++. +||+|||++......
T Consensus 108 lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~---ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGF---IKMTDFGFAKVVDTR 184 (340)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC---EEEecCCCCeecCCC
Confidence 99999999999999998888999999999999999999999999999999999999975544 899999999865432
Q ss_pred Ccccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHH
Q 018640 213 EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (352)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 291 (352)
.....||+.|+|||++.+ .++.++|||||||++|||++|..||...........+...... .+..+++.+.++
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~----~p~~~~~~~~~l 258 (340)
T PTZ00426 185 --TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIY----FPKFLDNNCKHL 258 (340)
T ss_pred --cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC----CCCCCCHHHHHH
Confidence 245579999999999864 4899999999999999999999999988776666666554332 234578999999
Q ss_pred HHHhcCCCcCCCC-----CHHHHhcCcccccc
Q 018640 292 VRKMLDPDPKRRL-----TAQQVLEHPWLQNA 318 (352)
Q Consensus 292 i~~~l~~dP~~Rp-----s~~ell~hp~f~~~ 318 (352)
|.+||+.||++|+ ++.++++||||.+.
T Consensus 259 i~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred HHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 9999999999995 89999999999864
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-49 Score=368.61 Aligned_cols=259 Identities=28% Similarity=0.514 Sum_probs=216.0
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++++.||+|+||+||+|.+..+|+.||+|++...........+.+.+|+.+++.+ +||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSFQDAQYLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCeeEEE
Confidence 3699999999999999999999999999999998765433344456788999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC-
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (352)
|||++||+|.+++.....+++..++.++.|++.||+|||+.||+||||||+|||++.++. +||+|||+++......
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~---~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGH---IKLSDFGLSTGFHKQHD 156 (377)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC---EEEeecccccccccccc
Confidence 999999999999988888999999999999999999999999999999999999975544 8999999986321100
Q ss_pred -----------------------------------------------cccccccccccccchhcc-ccCCCcchHHHHHH
Q 018640 214 -----------------------------------------------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGV 245 (352)
Q Consensus 214 -----------------------------------------------~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~ 245 (352)
......||+.|+|||++. ..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 001246999999999876 45899999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCC---CCHHHHhcCcccccc
Q 018640 246 ILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRR---LTAQQVLEHPWLQNA 318 (352)
Q Consensus 246 ~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R---ps~~ell~hp~f~~~ 318 (352)
++|||++|..||......+....+..............++.++.+||.+||. +|.+| +++.+++.||||+..
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 9999999999998877666555555432222222223578999999999998 67765 599999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=343.13 Aligned_cols=261 Identities=29% Similarity=0.499 Sum_probs=224.5
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCC-eeEeeeEEEeCC---
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN-IVCLKDTYEDDT--- 129 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~-iv~l~~~~~~~~--- 129 (352)
...|..+++||+|+||+||+|+.+.+|+.||+|++..+..... .-....+|+.+|+.+ +|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG-~P~taiREisllk~L-~~~~~iv~L~dv~~~~~~~~ 87 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEG-VPSTAIREISLLKRL-SHANHIVRLHDVIHTSNNHR 87 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccC-CCchhhHHHHHHHHh-CCCcceEEEEeeeeeccccc
Confidence 4468888999999999999999999999999999987643222 223456799999999 8999 999999998766
Q ss_pred ---eEEEEEEecCCcchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEe
Q 018640 130 ---AVHLVMELCEGGELFDRIVARG----HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAID 202 (352)
Q Consensus 130 ---~~~lv~e~~~~~sL~~~l~~~~----~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~D 202 (352)
..++|+||++. +|.+++.... .++...++.+++||+.||+|||+++|+||||||+|||+++++. +||+|
T Consensus 88 ~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~---lKlaD 163 (323)
T KOG0594|consen 88 GIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGV---LKLAD 163 (323)
T ss_pred ccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCc---Eeeec
Confidence 88999999965 9999998755 4778899999999999999999999999999999999986544 89999
Q ss_pred cccceecC-CCCcccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCC
Q 018640 203 FGLSVFFK-PGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279 (352)
Q Consensus 203 fg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 279 (352)
||+|+... +....+..++|.+|+|||++-+ .|+...||||+||++.||+++++.|.+..+.+++..+.+........
T Consensus 164 FGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 164 FGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK 243 (323)
T ss_pred cchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence 99999765 3344677799999999998764 49999999999999999999999999999999999998887765544
Q ss_pred CCcC--------------------------CCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 280 PWPK--------------------------VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 280 ~~~~--------------------------~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
.|+. .+.+..+++.+||+.+|.+|.|+..+++||||.+...
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 4442 2357889999999999999999999999999998744
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=358.16 Aligned_cols=248 Identities=31% Similarity=0.544 Sum_probs=214.8
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEecCCcc
Q 018640 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGE 142 (352)
Q Consensus 63 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~~~s 142 (352)
||+|+||+||+|.+..+++.||+|++.............+.+|+.++.++ +||||+++++++...+..++||||+++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 79999999999999999999999998765444445567788899999999 89999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC-Ccccccccc
Q 018640 143 LFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-EKFSEIVGS 221 (352)
Q Consensus 143 L~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt 221 (352)
|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++. ++|+|||++...... .......||
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~gt 156 (312)
T cd05585 80 LFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGH---IALCDFGLCKLNMKDDDKTNTFCGT 156 (312)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCc---EEEEECcccccCccCCCccccccCC
Confidence 9999988888999999999999999999999999999999999999976554 899999998754322 223455799
Q ss_pred cccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCc
Q 018640 222 PYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300 (352)
Q Consensus 222 ~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP 300 (352)
+.|+|||++.+ .++.++||||||+++|+|++|..||...........+... ....+..+++.+.++|.+||+.||
T Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~L~~dp 232 (312)
T cd05585 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE----PLRFPDGFDRDAKDLLIGLLSRDP 232 (312)
T ss_pred cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC----CCCCCCcCCHHHHHHHHHHcCCCH
Confidence 99999998864 5899999999999999999999999887766655555443 233345688999999999999999
Q ss_pred CCCC---CHHHHhcCcccccc
Q 018640 301 KRRL---TAQQVLEHPWLQNA 318 (352)
Q Consensus 301 ~~Rp---s~~ell~hp~f~~~ 318 (352)
.+|| ++.+++.||||.+.
T Consensus 233 ~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 233 TRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred HHcCCCCCHHHHHcCCCcCCC
Confidence 9997 58999999999974
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-49 Score=369.31 Aligned_cols=259 Identities=29% Similarity=0.514 Sum_probs=234.1
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
.--++|.++++||+|+||+|+++..+.+++.+|||++++...-..++.+....|.+|+....+||.++.++.+|+.++++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 33468999999999999999999999999999999999998888889999999999999998899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC-
Q 018640 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK- 210 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~- 210 (352)
|+||||+.||++..+ ...+.+++..++.++..++.||.|||++|||+||||.+|||++.+|. +||+|||+++..-
T Consensus 445 ~fvmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh---~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGH---VKIADFGLCKEGMG 520 (694)
T ss_pred EEEEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCc---EEecccccccccCC
Confidence 999999999995443 34457999999999999999999999999999999999999987666 8999999998653
Q ss_pred CCCcccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHH
Q 018640 211 PGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (352)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (352)
.+...++++||+.|+|||++.+ .|+...|.||||++||||+.|..||.+.++++....+...-..+ +..++.+..
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~y----P~~ls~ea~ 596 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRY----PRFLSKEAI 596 (694)
T ss_pred CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC----CCcccHHHH
Confidence 5566789999999999999875 59999999999999999999999999999999888888764443 346899999
Q ss_pred HHHHHhcCCCcCCCCC-----HHHHhcCcccccc
Q 018640 290 DLVRKMLDPDPKRRLT-----AQQVLEHPWLQNA 318 (352)
Q Consensus 290 ~li~~~l~~dP~~Rps-----~~ell~hp~f~~~ 318 (352)
+++.++|..+|++|.- +.+|..||||+.+
T Consensus 597 ~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 597 AIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred HHHHHHhccCcccccCCCCCCchhhhhCCccccC
Confidence 9999999999999983 7899999999954
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-48 Score=358.48 Aligned_cols=250 Identities=30% Similarity=0.554 Sum_probs=215.3
Q ss_pred eeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEecCC
Q 018640 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~~ 140 (352)
+.||+|+||.||++.+..+|..||+|++.............+.+|+.+++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCEEEEEEeCCCC
Confidence 4699999999999999999999999999765443444456778899999999 999999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC-CCcccccc
Q 018640 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEIV 219 (352)
Q Consensus 141 ~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~ 219 (352)
++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++..... ........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~---~kL~Dfg~~~~~~~~~~~~~~~~ 156 (323)
T cd05595 80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH---IKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCC---EEecccHHhccccCCCCcccccc
Confidence 999999988888999999999999999999999999999999999999976554 89999999875322 22334567
Q ss_pred cccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCC
Q 018640 220 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298 (352)
Q Consensus 220 gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 298 (352)
||+.|+|||++. +.++.++||||||+++|||++|+.||...........+..... ..+..+++.+.++|.+||+.
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~----~~p~~~~~~~~~li~~~L~~ 232 (323)
T cd05595 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI----RFPRTLSPEAKSLLAGLLKK 232 (323)
T ss_pred CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC----CCCCCCCHHHHHHHHHHccC
Confidence 999999999986 4589999999999999999999999988776655555543322 23346789999999999999
Q ss_pred CcCCCC-----CHHHHhcCcccccc
Q 018640 299 DPKRRL-----TAQQVLEHPWLQNA 318 (352)
Q Consensus 299 dP~~Rp-----s~~ell~hp~f~~~ 318 (352)
||++|| ++.++++||||.+.
T Consensus 233 dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 233 DPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred CHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 999998 89999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-49 Score=354.91 Aligned_cols=269 Identities=35% Similarity=0.660 Sum_probs=227.2
Q ss_pred CCCcccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCC-----------hhcHHHHHHHHHHHHhCCCC
Q 018640 47 EPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT-----------AVDIEDVRREVDIMRHLPKH 115 (352)
Q Consensus 47 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~~h 115 (352)
..++...-++|++++.||+|.||.|-+|.+..+++.||||++.+..... ....+..++|+.+|+++ .|
T Consensus 89 ~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl-~H 167 (576)
T KOG0585|consen 89 DDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL-HH 167 (576)
T ss_pred CcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc-CC
Confidence 3445555678999999999999999999999999999999997764322 12357899999999999 89
Q ss_pred CCeeEeeeEEEe--CCeEEEEEEecCCcchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecC
Q 018640 116 QNIVCLKDTYED--DTAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK 192 (352)
Q Consensus 116 ~~iv~l~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~-l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~ 192 (352)
||||+|+.+..+ .+.+|||+|||..|.+... ...+. +++.++++++++++.||+|||.+|||||||||+|+|++.+
T Consensus 168 ~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~-p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 168 PNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWC-PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSD 246 (576)
T ss_pred cCeeEEEEeecCcccCceEEEEEeccCCccccC-CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCC
Confidence 999999999864 4689999999998877443 23334 9999999999999999999999999999999999999765
Q ss_pred CCCCCEEEEecccceecCCC------Ccccccccccccccchhccc-c----CCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 018640 193 KETAPLKAIDFGLSVFFKPG------EKFSEIVGSPYYMAPEVLKR-N----YGPEVDVWSAGVILYILLCGVPPFWAET 261 (352)
Q Consensus 193 ~~~~~vkl~Dfg~a~~~~~~------~~~~~~~gt~~y~aPE~~~~-~----~s~~~Di~SlG~~l~el~tg~~p~~~~~ 261 (352)
+ +|||+|||.+.....+ ......+||+.|+|||...+ . .+.+.||||+|++||.|+.|..||.+..
T Consensus 247 g---~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~ 323 (576)
T KOG0585|consen 247 G---TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF 323 (576)
T ss_pred C---cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence 4 4999999998765322 22345799999999998754 1 4668999999999999999999999999
Q ss_pred HHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccCC
Q 018640 262 EQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAP 322 (352)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~ 322 (352)
..+....+++.-..++.. +.+.+.+.+||.+||++||++|.++.+|..|||...-...+
T Consensus 324 ~~~l~~KIvn~pL~fP~~--pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~ 382 (576)
T KOG0585|consen 324 ELELFDKIVNDPLEFPEN--PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP 382 (576)
T ss_pred HHHHHHHHhcCcccCCCc--ccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence 999999998887766554 36789999999999999999999999999999998764444
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=366.90 Aligned_cols=258 Identities=31% Similarity=0.523 Sum_probs=219.1
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
+|++++.||+|+||+||+|.+..+++.||+|++.............+.+|+.+++.+ +|+||+++++.+.+.+..++||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEEEeCCEEEEEE
Confidence 589999999999999999999999999999998765433344456788999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC---
Q 018640 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG--- 212 (352)
Q Consensus 136 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~--- 212 (352)
||+++|+|.+++.....+++..++.++.||+.||+|||+.||+||||||+|||++.++. +||+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~---~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH---IKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC---EEEeECCCCccccccccc
Confidence 99999999999988778999999999999999999999999999999999999976554 899999997532100
Q ss_pred ---------------------------------------------Ccccccccccccccchhcc-ccCCCcchHHHHHHH
Q 018640 213 ---------------------------------------------EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVI 246 (352)
Q Consensus 213 ---------------------------------------------~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~ 246 (352)
.......||+.|+|||++. ..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 0012347899999999876 458999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCC---HHHHhcCcccccc
Q 018640 247 LYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLT---AQQVLEHPWLQNA 318 (352)
Q Consensus 247 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps---~~ell~hp~f~~~ 318 (352)
+|||++|+.||......+....+..............+++++.++|.+|+ .+|.+|++ +.++++||||+..
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 99999999999888776666666554434333444568999999999986 59999997 9999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=358.96 Aligned_cols=250 Identities=28% Similarity=0.529 Sum_probs=215.0
Q ss_pred eeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEecCC
Q 018640 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~~ 140 (352)
+.||+|+||.||++.+..+|+.||+|++.............+.+|+.+++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-RHPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999999999999999765444444556788899999999 899999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC-CCcccccc
Q 018640 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEIV 219 (352)
Q Consensus 141 ~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~ 219 (352)
++|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||++..... ........
T Consensus 80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~---~kL~DfG~~~~~~~~~~~~~~~~ 156 (328)
T cd05593 80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH---IKITDFGLCKEGITDAATMKTFC 156 (328)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCc---EEEecCcCCccCCCccccccccc
Confidence 999999988888999999999999999999999999999999999999976554 89999999875422 22334567
Q ss_pred cccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCC
Q 018640 220 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298 (352)
Q Consensus 220 gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 298 (352)
||+.|+|||++. ..++.++||||||+++|+|++|..||...........+.... ...+..++.++.++|.+||+.
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~----~~~p~~~~~~~~~li~~~L~~ 232 (328)
T cd05593 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED----IKFPRTLSADAKSLLSGLLIK 232 (328)
T ss_pred CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC----ccCCCCCCHHHHHHHHHHcCC
Confidence 999999999986 458999999999999999999999998777665544443322 223356889999999999999
Q ss_pred CcCCCC-----CHHHHhcCcccccc
Q 018640 299 DPKRRL-----TAQQVLEHPWLQNA 318 (352)
Q Consensus 299 dP~~Rp-----s~~ell~hp~f~~~ 318 (352)
||++|| ++.++++||||...
T Consensus 233 dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 233 DPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred CHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 999997 89999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-50 Score=361.80 Aligned_cols=274 Identities=27% Similarity=0.444 Sum_probs=231.6
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
..|+..+.||+|.||.||+|.+..+++.||+|++..... ...++.+.+|+.+|..+ +++||.++++.+..+..++++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~--~deIediqqei~~Ls~~-~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA--EDEIEDIQQEISVLSQC-DSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhc--chhhHHHHHHHHHHHhc-CcchHHhhhhheeecccHHHH
Confidence 458888999999999999999999999999999988753 44578899999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCc
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (352)
|||+.||++.+.+.....+.+..+..|+++++.||.|||..+.+|||||+.|||+..++. |||+|||.+........
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~---vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGD---VKLADFGVAGQLTNTVK 166 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCc---EEEEecceeeeeechhh
Confidence 999999999999988877899999999999999999999999999999999999986644 89999999987765543
Q ss_pred c-cccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHH
Q 018640 215 F-SEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (352)
Q Consensus 215 ~-~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 292 (352)
. .+++||+.|||||++.+ .|+.++||||||++.+||++|.+|+....+..++..+.+ ..++.....+++.+++|+
T Consensus 167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk---~~PP~L~~~~S~~~kEFV 243 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK---SAPPRLDGDFSPPFKEFV 243 (467)
T ss_pred ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC---CCCCccccccCHHHHHHH
Confidence 3 78899999999999885 699999999999999999999999977665322222211 112222235788999999
Q ss_pred HHhcCCCcCCCCCHHHHhcCccccccccCCCCCCcHHHHHHHHhhHHH
Q 018640 293 RKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVM 340 (352)
Q Consensus 293 ~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (352)
..||+.||+.||||.++|.|+|++.+ .+.+.-.++-.|.+.++.+
T Consensus 244 ~~CL~k~P~~RpsA~~LLKh~FIk~a---~k~s~L~~~i~r~~~~~~~ 288 (467)
T KOG0201|consen 244 EACLDKNPEFRPSAKELLKHKFIKRA---KKTSELKELIDRYKRWRVK 288 (467)
T ss_pred HHHhhcCcccCcCHHHHhhhHHHHhc---CCchHHHHHHHHHHHHhhc
Confidence 99999999999999999999999973 3333344444566666554
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-48 Score=350.70 Aligned_cols=254 Identities=28% Similarity=0.450 Sum_probs=210.6
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++.+.||+|+||+||+|.+..++..||+|++..... ......+.+|+.+++.+ +||||+++++++..++..++|
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNL-KHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhC-CCCCEeeEEEEEcCCCeEEEE
Confidence 369999999999999999999999999999999865432 22235677899999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 135 MELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
|||+++ +|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++. +||+|||++.......
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~---~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE---LKLADFGLARAKSVPT 157 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC---EEECcCcceeeccCCC
Confidence 999975 8998887654 4789999999999999999999999999999999999976554 8999999997653322
Q ss_pred -cccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCC-----------
Q 018640 214 -KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD----------- 279 (352)
Q Consensus 214 -~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 279 (352)
......+++.|+|||.+.+ .++.++||||+|+++|+|++|+.||......+....+..........
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 2344578999999998753 48899999999999999999999998877665555444322211100
Q ss_pred ---------------CCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 280 ---------------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 280 ---------------~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
..+..++++.+||.+||++||.+|||+.|+++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 012467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=367.35 Aligned_cols=258 Identities=29% Similarity=0.499 Sum_probs=218.0
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
+|++++.||+|+||+||+|.+..+++.||+|++.............+.+|+.++..+ +|+||+++++.+.+++..++||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-DNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCEEEEEE
Confidence 699999999999999999999999999999998765433333456788999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC---
Q 018640 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG--- 212 (352)
Q Consensus 136 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~--- 212 (352)
||+++|+|.+++.....+++..++.++.||+.||+|||+.||+||||||+|||++.++. +||+|||++......
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~---ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH---IKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCC---EEEEeCCCCccccccccc
Confidence 99999999999988888999999999999999999999999999999999999975544 899999997422100
Q ss_pred -----------------------------------------Ccccccccccccccchhccc-cCCCcchHHHHHHHHHHH
Q 018640 213 -----------------------------------------EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYIL 250 (352)
Q Consensus 213 -----------------------------------------~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el 250 (352)
.......||+.|+|||++.+ .++.++|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 00113479999999999864 589999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCC---CHHHHhcCcccccc
Q 018640 251 LCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRL---TAQQVLEHPWLQNA 318 (352)
Q Consensus 251 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp---s~~ell~hp~f~~~ 318 (352)
++|+.||......+....+..............++..+.++|.+|+ .+|.+|+ ++.++++||||+..
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence 9999999888776665555543333333334468899999999977 5999999 99999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=330.74 Aligned_cols=255 Identities=33% Similarity=0.615 Sum_probs=230.3
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|.+.+.||+|-||.||+|+.++++-.||+|++-++..........+++|+++-..| +||||++++++|-+....||+
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L-~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHL-RHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeeccc-CCccHHhhhhheeccceeEEE
Confidence 5699999999999999999999999999999999888766655667899999999999 999999999999999999999
Q ss_pred EEecCCcchHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 135 MELCEGGELFDRIV--ARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 135 ~e~~~~~sL~~~l~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
+||.+.|+|+..|. ...++++.....++.|++.||.|+|.+++|||||||+|+|++..+. +||+|||.+.... .
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~---lkiAdfGwsV~~p-~ 176 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHAP-S 176 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCC---eeccCCCceeecC-C
Confidence 99999999999998 5567999999999999999999999999999999999999987666 8999999998765 4
Q ss_pred Ccccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHH
Q 018640 213 EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (352)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 291 (352)
....+.+||..|.+||...+ ..+...|+|++|++.||++.|.+||......+...++......++ ..++..+.|+
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p----~~is~~a~dl 252 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP----STISGGAADL 252 (281)
T ss_pred CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC----cccChhHHHH
Confidence 44567899999999999875 489999999999999999999999998887777777766544443 6789999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 292 VRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 292 i~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
|.+||..+|.+|.+..|++.|||+...
T Consensus 253 I~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 253 ISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred HHHHhccCccccccHHHHhhhHHHHhc
Confidence 999999999999999999999998753
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-49 Score=347.69 Aligned_cols=276 Identities=31% Similarity=0.485 Sum_probs=227.6
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC--
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT-- 129 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~-- 129 (352)
...-.|.-.+++|.|+||.||+|...++++.||||++-.... .-.+|+.+|+.+ +|||||+++.+|....
T Consensus 21 ~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l-~HpNIV~L~~~f~~~~~~ 92 (364)
T KOG0658|consen 21 KVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKL-DHPNIVRLLYFFSSSTES 92 (364)
T ss_pred ceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhc-CCcCeeeEEEEEEecCCC
Confidence 344568889999999999999999999999999998754321 123599999998 9999999999885322
Q ss_pred ---eEEEEEEecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEe
Q 018640 130 ---AVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAID 202 (352)
Q Consensus 130 ---~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~D 202 (352)
...+||||+|. +|.+.++. +..++.-.++-+.+||+.||.|||+.||+||||||+|+|++. .++.+||||
T Consensus 93 d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~--~tg~LKicD 169 (364)
T KOG0658|consen 93 DEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDP--DTGVLKICD 169 (364)
T ss_pred chhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcC--CCCeEEecc
Confidence 45689999976 99998874 456899999999999999999999999999999999999974 556699999
Q ss_pred cccceecCCCCcccccccccccccchhcc--ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCC-
Q 018640 203 FGLSVFFKPGEKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD- 279 (352)
Q Consensus 203 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~- 279 (352)
||.|+....++.......|..|+|||.+- ..|+.+.||||.||++.||+-|++.|.+....+++..+.+.+.....+
T Consensus 170 FGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~ 249 (364)
T KOG0658|consen 170 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRED 249 (364)
T ss_pred CCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHH
Confidence 99999988877777778899999999865 459999999999999999999999999988888888877766542211
Q ss_pred ------------------------CCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccCCCCCCc-HHHHHHH
Q 018640 280 ------------------------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLG-ETVKARL 334 (352)
Q Consensus 280 ------------------------~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~-~~~~~~~ 334 (352)
.....++++.+|+.++|+.+|++|.++.|++.||||..+... +..++ +.-.+.|
T Consensus 250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~-~~~l~~g~~lp~l 328 (364)
T KOG0658|consen 250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP-NTKLPNGRPLPPL 328 (364)
T ss_pred HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc-CccCcCCCcCCCc
Confidence 112368999999999999999999999999999999987554 44443 2233445
Q ss_pred HhhHH
Q 018640 335 KQFSV 339 (352)
Q Consensus 335 ~~~~~ 339 (352)
++|.+
T Consensus 329 f~f~~ 333 (364)
T KOG0658|consen 329 FNFKR 333 (364)
T ss_pred cCchH
Confidence 55544
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-48 Score=349.35 Aligned_cols=259 Identities=31% Similarity=0.509 Sum_probs=219.3
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
.|++.+.||+|+||+||++.+..+++.||+|++.............+.+|+.+++.+ +|+||+++++.+..++..++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-CCCCEeeeeeeecCCCeEEEEE
Confidence 488999999999999999999989999999998765443333345677899999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 136 ELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 136 e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++ .++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~---~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG---HIRISDLGLAVEIPEGE 156 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCC---CEEEeeCCCceecCCCC
Confidence 999999999888653 3589999999999999999999999999999999999997544 48999999998765444
Q ss_pred cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHH
Q 018640 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (352)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 292 (352)
......|+..|+|||++. ..++.++||||||+++|||++|..||...........+...........+..++..+.+||
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236 (285)
T ss_pred ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence 444557899999999876 4588999999999999999999999987665444444444333333444456899999999
Q ss_pred HHhcCCCcCCCC-----CHHHHhcCcccccc
Q 018640 293 RKMLDPDPKRRL-----TAQQVLEHPWLQNA 318 (352)
Q Consensus 293 ~~~l~~dP~~Rp-----s~~ell~hp~f~~~ 318 (352)
..||+.||++|| ++.++++||||.+.
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred HHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 999999999999 89999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-48 Score=355.68 Aligned_cols=256 Identities=27% Similarity=0.460 Sum_probs=219.5
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
+|++++.||+|+||.||+|.+..+++.||+|++...........+.+..|+.++..+.+|++|+.+++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 48899999999999999999999999999999976544344456678889999999955567889999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC-CCCc
Q 018640 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEK 214 (352)
Q Consensus 136 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~-~~~~ 214 (352)
||+++++|.+++.....+++..+..++.||+.||+|||+.||+||||||+|||++.++. +||+|||++.... ....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~---~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH---IKIADFGMCKENIFGGKT 157 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCC---EEEeecCcceecCCCCCc
Confidence 99999999999988888999999999999999999999999999999999999976544 8999999987532 2223
Q ss_pred ccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHH
Q 018640 215 FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (352)
Q Consensus 215 ~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 293 (352)
.....||+.|+|||++.+ .++.++||||||+++|+|++|+.||...........+.... ...+..+++.+.+++.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~----~~~~~~~~~~~~~li~ 233 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN----VSYPKSLSKEAVSICK 233 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC----CCCCCCCCHHHHHHHH
Confidence 345579999999999874 58999999999999999999999998887766666655432 2334568899999999
Q ss_pred HhcCCCcCCCCCH-----HHHhcCcccccc
Q 018640 294 KMLDPDPKRRLTA-----QQVLEHPWLQNA 318 (352)
Q Consensus 294 ~~l~~dP~~Rps~-----~ell~hp~f~~~ 318 (352)
+||+.||.+|++. .++++||||...
T Consensus 234 ~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 234 GLLTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 9999999999976 899999999864
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-49 Score=360.08 Aligned_cols=243 Identities=26% Similarity=0.388 Sum_probs=211.2
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
.+++++.||+|.||.||+|.+.. ...||+|.+.... ...+.|.+|+++|++| +|++||+++++|..+..++|||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~----m~~~~f~~Ea~iMk~L-~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGS----MSPEAFLREAQIMKKL-RHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccc----cChhHHHHHHHHHHhC-cccCeEEEEEEEecCCceEEEE
Confidence 47788999999999999999863 4479999987643 2346788999999999 9999999999999988999999
Q ss_pred EecCCcchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 136 ELCEGGELFDRIVA--RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 136 e~~~~~sL~~~l~~--~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
||++.|+|.++|.. ...+...+.+.++.||++||+||+++++|||||.++||||+.+. .+||+|||+|+...++.
T Consensus 281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~---~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDL---VVKISDFGLARLIGDDE 357 (468)
T ss_pred EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCc---eEEEcccccccccCCCc
Confidence 99999999999987 44699999999999999999999999999999999999996544 59999999999655554
Q ss_pred cccccc--cccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHH
Q 018640 214 KFSEIV--GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (352)
Q Consensus 214 ~~~~~~--gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (352)
...... -...|+|||.+. +.++.+|||||||++|||++| |+.||.+....+++..+.+. .+.+.++.+|+.+.
T Consensus 358 Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~G---yRlp~P~~CP~~vY 434 (468)
T KOG0197|consen 358 YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERG---YRLPRPEGCPDEVY 434 (468)
T ss_pred eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhcc---CcCCCCCCCCHHHH
Confidence 433222 256799999987 679999999999999999999 99999999999888888764 45556678999999
Q ss_pred HHHHHhcCCCcCCCCCHHHHh
Q 018640 290 DLVRKMLDPDPKRRLTAQQVL 310 (352)
Q Consensus 290 ~li~~~l~~dP~~Rps~~ell 310 (352)
+++..||+.+|++|||+..+.
T Consensus 435 ~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 435 ELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHHHHhhCCcccCCCHHHHH
Confidence 999999999999999999664
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-48 Score=356.63 Aligned_cols=251 Identities=31% Similarity=0.536 Sum_probs=215.9
Q ss_pred eeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEecCC
Q 018640 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~~ 140 (352)
++||+|+||+||+|.+..+++.||+|++...........+.+..|..++..+.+||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999987654333444567778999998876899999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC-CCCcccccc
Q 018640 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIV 219 (352)
Q Consensus 141 ~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~ 219 (352)
++|.+++.....+++..+..++.|++.||+|||+.+++||||||+|||++.++. +||+|||++.... .........
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~---~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGH---CKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc---EEEeeCCCCeecCcCCCcccccc
Confidence 999999988888999999999999999999999999999999999999976554 8999999987542 222334567
Q ss_pred cccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCC
Q 018640 220 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298 (352)
Q Consensus 220 gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 298 (352)
||+.|+|||++. ..++.++||||||+++|+|++|+.||...........+..... .....++.++.++|.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~----~~~~~~~~~~~~li~~~L~~ 233 (320)
T cd05590 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV----VYPTWLSQDAVDILKAFMTK 233 (320)
T ss_pred cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC----CCCCCCCHHHHHHHHHHccc
Confidence 999999999987 4588999999999999999999999988877766666554322 22345789999999999999
Q ss_pred CcCCCCCH------HHHhcCcccccc
Q 018640 299 DPKRRLTA------QQVLEHPWLQNA 318 (352)
Q Consensus 299 dP~~Rps~------~ell~hp~f~~~ 318 (352)
||++||++ .++++||||+..
T Consensus 234 dP~~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 234 NPTMRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred CHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence 99999998 999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-48 Score=362.66 Aligned_cols=260 Identities=32% Similarity=0.518 Sum_probs=220.4
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
-.++|++.+.||+|+||+||+|.+..+++.||+|++.............+.+|+.+++.+ +||||+++++++..++..+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCEEE
Confidence 346799999999999999999999999999999998765433334455678899999999 9999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
+||||++||+|.+++... .+++..+..++.|++.||+|||+.||+||||||+|||++.++. +||+|||++......
T Consensus 120 lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~---~kL~DfG~~~~~~~~ 195 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH---LKLADFGTCMKMDAN 195 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCC---EEEEeccceeeccCC
Confidence 999999999999988654 5899999999999999999999999999999999999976554 899999999865433
Q ss_pred C--cccccccccccccchhccc-----cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCC
Q 018640 213 E--KFSEIVGSPYYMAPEVLKR-----NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (352)
Q Consensus 213 ~--~~~~~~gt~~y~aPE~~~~-----~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (352)
. ......||+.|+|||.+.. .++.++|||||||++|||++|..||...........+..............++
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 275 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEIS 275 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCC
Confidence 2 2235579999999998752 37889999999999999999999999887766666665433222222233579
Q ss_pred HHHHHHHHHhcCCCcCC--CCCHHHHhcCccccc
Q 018640 286 ENAKDLVRKMLDPDPKR--RLTAQQVLEHPWLQN 317 (352)
Q Consensus 286 ~~~~~li~~~l~~dP~~--Rps~~ell~hp~f~~ 317 (352)
.++.+||.+||+.+|++ |+|+.++++||||++
T Consensus 276 ~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 276 KQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred HHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 99999999999999988 999999999999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-48 Score=349.35 Aligned_cols=256 Identities=29% Similarity=0.469 Sum_probs=210.2
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++.+.||+|+||+||+|.+..+++.||+|++..... .....+.+.+|+.+++.+ +||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTL-KQENIVELKEAFRRRGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhC-CCccccchhhhEecCCEEEEE
Confidence 369999999999999999999999999999999876432 223356788899999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC-
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (352)
|||++++.+..+......+++..++.++.|++.||.|||+.+++||||||+||+++.++. +||+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDV---LKLCDFGFARNLSEGSN 155 (287)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc---EEEeeccCccccccccc
Confidence 999998777655555557999999999999999999999999999999999999975554 8999999998754322
Q ss_pred -cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC--------------
Q 018640 214 -KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR-------------- 277 (352)
Q Consensus 214 -~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------------- 277 (352)
......||+.|+|||++. ..++.++||||||+++|||++|+.||......+....+.......+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 223457899999999876 4589999999999999999999999987665444333222111100
Q ss_pred -----C---------CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 278 -----R---------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 278 -----~---------~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
. .....++.++.+||.+||+.||++|||+.++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0 0012367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=359.92 Aligned_cols=259 Identities=30% Similarity=0.476 Sum_probs=220.2
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|.+.+.||+|+||+||+|.+..+|+.||+|++.............+.+|+.+++.+ +|+||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~~~~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQDKDNLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCeEEEE
Confidence 3699999999999999999999999999999999876443444556788999999998 899999999999999999999
Q ss_pred EEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
|||+++++|.+++... ..+++..+..++.|++.||+|||+.+|+||||||+||+++.++. +||+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~---~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGH---IKLADFGSAARLTANK 156 (330)
T ss_pred ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCC---EEeccCCCCeECCCCC
Confidence 9999999999999876 57999999999999999999999999999999999999976554 8999999998764433
Q ss_pred cc--cccccccccccchhcc-------ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCC
Q 018640 214 KF--SEIVGSPYYMAPEVLK-------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (352)
Q Consensus 214 ~~--~~~~gt~~y~aPE~~~-------~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (352)
.. ....||+.|+|||++. ..++.++||||||+++|||++|..||...........+............+.+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV 236 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCC
Confidence 22 2347899999999874 23778999999999999999999999887776666555543222222223467
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 285 SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 285 ~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
++.+.+||..||+ +|.+|||+.++++||||...
T Consensus 237 ~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 237 SSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred CHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 8999999999998 99999999999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-48 Score=357.83 Aligned_cols=260 Identities=30% Similarity=0.569 Sum_probs=214.4
Q ss_pred cceeceeeeccCceEEEEEEEC---CCCcEEEEEEccccccC-ChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 56 RYELGRELGRGEFGITYLCTDR---ENGDAFACKSISKKKLR-TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
+|++++.||+|+||+||++.+. .+++.||+|++.+.... .....+.+..|+.++..+.+|++|+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4889999999999999998864 47899999998754322 2233456788999999997799999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
++||||+++|+|.+++..+..+++..+..++.||+.||.|||+.||+||||||+|||++.++. +||+|||++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~---~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGH---VVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCC---EEEeeCcCCccccc
Confidence 999999999999999988888999999999999999999999999999999999999976554 89999999976433
Q ss_pred CC--cccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHH
Q 018640 212 GE--KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (352)
Q Consensus 212 ~~--~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (352)
.. ......||+.|+|||++.+ .++.++||||||+++|||++|..||...........+...........+..++..
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPE 237 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHH
Confidence 22 2234579999999999864 3788999999999999999999999643322222222222223333444568999
Q ss_pred HHHHHHHhcCCCcCCCC-----CHHHHhcCcccccc
Q 018640 288 AKDLVRKMLDPDPKRRL-----TAQQVLEHPWLQNA 318 (352)
Q Consensus 288 ~~~li~~~l~~dP~~Rp-----s~~ell~hp~f~~~ 318 (352)
+.+++.+||+.||++|| ++.++++||||++.
T Consensus 238 ~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 238 AQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 99999999999999999 88899999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-48 Score=354.28 Aligned_cols=256 Identities=26% Similarity=0.448 Sum_probs=220.5
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
+|++++.||+|+||.||+|.+..+++.||+|++.+.........+.+..|..++..+.+|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 48899999999999999999999999999999886544344445567778889888877999999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC-CCc
Q 018640 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEK 214 (352)
Q Consensus 136 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~-~~~ 214 (352)
||+++|+|.+.+.....+++..+..++.|++.||+|||+.||+||||||+|||++.++. +||+|||++..... ...
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~---~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH---IKIADFGMCKENMWDGVT 157 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCc---EEEccCCCceecCCCCCc
Confidence 99999999999988888999999999999999999999999999999999999976554 89999999975432 223
Q ss_pred ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHH
Q 018640 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (352)
Q Consensus 215 ~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 293 (352)
.....||+.|+|||++. ..++.++|||||||++|||++|+.||...........+..... ..+..+++++.+++.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~----~~p~~~s~~~~~li~ 233 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV----AYPKSMSKEAVAICK 233 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC----CCCCcCCHHHHHHHH
Confidence 34567999999999887 4589999999999999999999999998877766666654432 233468899999999
Q ss_pred HhcCCCcCCCCC-----HHHHhcCcccccc
Q 018640 294 KMLDPDPKRRLT-----AQQVLEHPWLQNA 318 (352)
Q Consensus 294 ~~l~~dP~~Rps-----~~ell~hp~f~~~ 318 (352)
+||+.||++|++ ..++++||||+..
T Consensus 234 ~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 234 GLMTKHPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred HHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 999999999997 4899999999854
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=350.15 Aligned_cols=260 Identities=27% Similarity=0.402 Sum_probs=208.2
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
.++|++.+.||+|+||+||+|.+..+++.||+|++..... ......+.+|+.+++.+ +||||+++++++......++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 80 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGL-KHANIVLLHDIIHTKETLTL 80 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhC-CCCCcCeEEEEEecCCeEEE
Confidence 3579999999999999999999999999999999875432 12234577899999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 134 VMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
||||++ ++|.+++... ..+++..+..++.|++.||+|||+.+|+||||||+||+++.++. +||+|||++......
T Consensus 81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 81 VFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGE---LKLADFGLARAKSVP 156 (303)
T ss_pred EEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC---EEECCCCcceeccCC
Confidence 999996 5787777654 46899999999999999999999999999999999999975544 899999998754322
Q ss_pred -Ccccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcccccC-----------
Q 018640 213 -EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVLDFR----------- 277 (352)
Q Consensus 213 -~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~----------- 277 (352)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..||...... .....+........
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence 22344578999999998753 4788999999999999999999999765332 22222222111100
Q ss_pred ---CCC--------------CcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 278 ---RDP--------------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 278 ---~~~--------------~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
+.. ....++.+.+|+.+||+.||.+|||+.|+++||||++.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~ 296 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP 296 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence 000 0124567889999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-48 Score=356.66 Aligned_cols=255 Identities=26% Similarity=0.500 Sum_probs=210.6
Q ss_pred eeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEecCC
Q 018640 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~~ 140 (352)
++||+|+||.||+|.+..+++.||+|++...........+.+..|..++..+.+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999999999999999998765444445667888999999987899999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec-CCCCcccccc
Q 018640 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKFSEIV 219 (352)
Q Consensus 141 ~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~-~~~~~~~~~~ 219 (352)
++|.+++.....+++..+..++.|++.||.|||++|++||||||+||+++.++. +||+|||++... ..........
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~---~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGH---IKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC---EEECcCccccccccCCCcccccc
Confidence 999999988888999999999999999999999999999999999999976544 899999998753 2233334568
Q ss_pred cccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhcccccCCCCCcCCCHHHHHHHH
Q 018640 220 GSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQ-----GVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (352)
Q Consensus 220 gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 293 (352)
||+.|+|||++.+ .++.++|+||||+++|+|++|+.||...... .......+.........+..++..+.++|.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~ 237 (329)
T cd05588 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237 (329)
T ss_pred CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999874 5889999999999999999999999532110 000111111112222233467899999999
Q ss_pred HhcCCCcCCCCC------HHHHhcCcccccc
Q 018640 294 KMLDPDPKRRLT------AQQVLEHPWLQNA 318 (352)
Q Consensus 294 ~~l~~dP~~Rps------~~ell~hp~f~~~ 318 (352)
+||+.||.+||+ +.++++||||.+.
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 238 GFLNKDPKERLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred HHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 999999999987 7899999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-48 Score=360.75 Aligned_cols=261 Identities=31% Similarity=0.502 Sum_probs=219.5
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
..++|++.+.||+|+||.||++.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++..++..+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEE
Confidence 446899999999999999999999999999999998764433334455688899999999 9999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
+||||+++|+|.+++... .+++..+..++.||+.||+|||+++|+||||||+|||++.++. +||+|||++......
T Consensus 120 lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~---~kL~DFG~a~~~~~~ 195 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH---LKLADFGTCMKMDET 195 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC---EEEEecccceecccC
Confidence 999999999999998654 5899999999999999999999999999999999999975544 899999999876432
Q ss_pred C--cccccccccccccchhccc-----cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCC
Q 018640 213 E--KFSEIVGSPYYMAPEVLKR-----NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (352)
Q Consensus 213 ~--~~~~~~gt~~y~aPE~~~~-----~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (352)
. ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+..............++
T Consensus 196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s 275 (370)
T cd05621 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEIS 275 (370)
T ss_pred CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCC
Confidence 2 2245679999999998753 27889999999999999999999998887776666665543333222233578
Q ss_pred HHHHHHHHHhcCCCcCC--CCCHHHHhcCcccccc
Q 018640 286 ENAKDLVRKMLDPDPKR--RLTAQQVLEHPWLQNA 318 (352)
Q Consensus 286 ~~~~~li~~~l~~dP~~--Rps~~ell~hp~f~~~ 318 (352)
..+.+++..||..+|.+ |+++.++++||||+..
T Consensus 276 ~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 276 KHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 99999999999866544 8999999999999863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-48 Score=360.94 Aligned_cols=259 Identities=29% Similarity=0.526 Sum_probs=217.9
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++++.||+|+||+||+|.+..+++.||+|++.............+.+|+.++..+ +|++|+++++.+...+..++|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSFQDKRNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEE
Confidence 3689999999999999999999999999999999765443444566788999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC-
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (352)
|||++||+|.+++.....+++..++.++.|++.||+|||+.||+||||||+|||++.++. ++|+|||++.......
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~---vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGH---VKLSDFGLCTGLKKAHR 156 (360)
T ss_pred EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC---EEEeeccCCcccccccc
Confidence 999999999999988888999999999999999999999999999999999999975544 8999999986442110
Q ss_pred -----------------------------------cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCC
Q 018640 214 -----------------------------------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPF 257 (352)
Q Consensus 214 -----------------------------------~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~ 257 (352)
......||+.|+|||++. ..++.++|||||||++|||++|..||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 011347999999999976 45899999999999999999999999
Q ss_pred CCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCC---CHHHHhcCcccccc
Q 018640 258 WAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRL---TAQQVLEHPWLQNA 318 (352)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp---s~~ell~hp~f~~~ 318 (352)
...........+..............+++++.++|.+|+. ||.+|+ ++.++++||||++.
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 237 CSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence 8887776666655432222212223478999999999874 999998 58999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=353.85 Aligned_cols=250 Identities=27% Similarity=0.514 Sum_probs=216.1
Q ss_pred eeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEecCC
Q 018640 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~~ 140 (352)
++||+|+||.||+|.+..+++.||+|++...........+.+..|..++..+.+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999997654444445567788999998876899999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC-CCcccccc
Q 018640 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEIV 219 (352)
Q Consensus 141 ~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~ 219 (352)
++|.+.+.....+++..+..++.|++.||.|||+.||+||||||+||+++.++. +||+|||++..... ........
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~---~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGH---CKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC---EEEeecccceecccCCccccccc
Confidence 999999988888999999999999999999999999999999999999976554 89999999875432 22334557
Q ss_pred cccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCC
Q 018640 220 GSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298 (352)
Q Consensus 220 gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 298 (352)
||+.|+|||++.+ .++.++||||||+++|+|++|+.||...........+...... .+..++.++.++|.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~----~p~~~~~~~~~ll~~~L~~ 233 (321)
T cd05591 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVL----YPVWLSKEAVSILKAFMTK 233 (321)
T ss_pred cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC----CCCCCCHHHHHHHHHHhcc
Confidence 9999999998874 5899999999999999999999999988877776666554322 2235789999999999999
Q ss_pred CcCCCC-------CHHHHhcCccccc
Q 018640 299 DPKRRL-------TAQQVLEHPWLQN 317 (352)
Q Consensus 299 dP~~Rp-------s~~ell~hp~f~~ 317 (352)
||++|| ++.++++||||..
T Consensus 234 dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 234 NPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred CHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 999999 9999999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=346.28 Aligned_cols=252 Identities=31% Similarity=0.512 Sum_probs=209.4
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEecCCcc
Q 018640 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGE 142 (352)
Q Consensus 63 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~~~s 142 (352)
||+|+||+||++.+..+|+.||+|++...........+.+..|+.+++.+ +|+||+++.+++..+...++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 79999999999999999999999998765444444456778899999999 99999999999999999999999999999
Q ss_pred hHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCc-ccc
Q 018640 143 LFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK-FSE 217 (352)
Q Consensus 143 L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~-~~~ 217 (352)
|.+.+.. ...+++..+..++.|++.||.|||+.+|+||||||+||+++.++ .++|+|||++........ ...
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~---~~~l~dfg~~~~~~~~~~~~~~ 156 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG---NVRISDLGLAVELKDGQSKTKG 156 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC---CEEEeeCccceecCCCCccccc
Confidence 9887743 34589999999999999999999999999999999999997544 389999999976544322 234
Q ss_pred cccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhc
Q 018640 218 IVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKML 296 (352)
Q Consensus 218 ~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 296 (352)
..||+.|+|||++. ..++.++||||||+++|+|++|+.||..........................++..+.+++.+||
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 236 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL 236 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHh
Confidence 57899999999886 45889999999999999999999999765433222233333323233334568999999999999
Q ss_pred CCCcCCCC-----CHHHHhcCcccccc
Q 018640 297 DPDPKRRL-----TAQQVLEHPWLQNA 318 (352)
Q Consensus 297 ~~dP~~Rp-----s~~ell~hp~f~~~ 318 (352)
+.||++|| +++++++||||+..
T Consensus 237 ~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 237 AKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred cCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 99999999 88999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=354.74 Aligned_cols=255 Identities=26% Similarity=0.501 Sum_probs=210.2
Q ss_pred eeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEecCC
Q 018640 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~~ 140 (352)
+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.++.++.+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999998765444445567888999998877899999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC-CCCcccccc
Q 018640 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIV 219 (352)
Q Consensus 141 ~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~ 219 (352)
++|..++.....+++..++.++.|++.||.|||+++|+||||||+||+++.++. +||+|||++.... .........
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~---~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCC---EEEeeCCccccccCCCCcccccc
Confidence 999999988888999999999999999999999999999999999999976554 8999999987532 222334567
Q ss_pred cccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhcccccCCCCCcCCCHHHHHHHH
Q 018640 220 GSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAET-----EQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (352)
Q Consensus 220 gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 293 (352)
||..|+|||++.+ .++.++||||||+++|+|++|..||.... .......+.+.........+..++..+.++|.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~ 237 (329)
T cd05618 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237 (329)
T ss_pred CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 9999999999864 58899999999999999999999995211 11111111111122222334567899999999
Q ss_pred HhcCCCcCCCCC------HHHHhcCcccccc
Q 018640 294 KMLDPDPKRRLT------AQQVLEHPWLQNA 318 (352)
Q Consensus 294 ~~l~~dP~~Rps------~~ell~hp~f~~~ 318 (352)
+||+.||++||+ +.++++||||++.
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 238 SFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 999999999998 5799999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=351.49 Aligned_cols=251 Identities=32% Similarity=0.522 Sum_probs=213.0
Q ss_pred eeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEecCC
Q 018640 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~~ 140 (352)
++||+|+||+||+|.+..+++.||+|++...........+.+..|..++..+.+||||+++++++...+..++||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999997654333344556667888887766899999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC-Ccccccc
Q 018640 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-EKFSEIV 219 (352)
Q Consensus 141 ~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~ 219 (352)
++|.+++.....+++..+..++.|++.||.|||+.+|+||||||+||+++.++. +||+|||++...... .......
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~---~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH---IKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCC---EEEccCcCCeECCCCCCcccccc
Confidence 999999988888999999999999999999999999999999999999976554 899999999764322 2334567
Q ss_pred cccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCC
Q 018640 220 GSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298 (352)
Q Consensus 220 gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 298 (352)
||+.|+|||++.+ .++.++|||||||++|||++|..||......+....+... ....+..++.++.++|.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~----~~~~~~~~~~~~~~ll~~~l~~ 233 (316)
T cd05592 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND----RPHFPRWISKEAKDCLSKLFER 233 (316)
T ss_pred CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC----CCCCCCCCCHHHHHHHHHHccC
Confidence 9999999999864 5899999999999999999999999887776665555432 2233345789999999999999
Q ss_pred CcCCCCCH-HHHhcCcccccc
Q 018640 299 DPKRRLTA-QQVLEHPWLQNA 318 (352)
Q Consensus 299 dP~~Rps~-~ell~hp~f~~~ 318 (352)
||++||++ .++++||||...
T Consensus 234 ~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 234 DPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred CHHHcCCChHHHHcCcccCCC
Confidence 99999986 589999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=353.50 Aligned_cols=260 Identities=28% Similarity=0.471 Sum_probs=209.8
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC-----Ce
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD-----TA 130 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~-----~~ 130 (352)
+|++.+.||+|+||.||+|.+..+|..||+|++.... ........+.+|+.+++.+ +||||+++++++... ..
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~ 78 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKD 78 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhC-CCCCEeeecceEeccCCCCCce
Confidence 5899999999999999999999999999999886432 2223345688999999999 899999999987543 35
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
.++||||++ ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++....
T Consensus 79 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~---~kL~Dfg~~~~~~ 154 (338)
T cd07859 79 IYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCK---LKICDFGLARVAF 154 (338)
T ss_pred EEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc---EEEccCccccccc
Confidence 799999995 689999988888999999999999999999999999999999999999976554 8999999997543
Q ss_pred CCC----cccccccccccccchhcc---ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc----------
Q 018640 211 PGE----KFSEIVGSPYYMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV---------- 273 (352)
Q Consensus 211 ~~~----~~~~~~gt~~y~aPE~~~---~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~---------- 273 (352)
... ......||..|+|||++. ..++.++|||||||++|||++|+.||...........+....
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 221 123457899999999875 358899999999999999999999997665433222211110
Q ss_pred -------------cccCC----CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccC
Q 018640 274 -------------LDFRR----DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKA 321 (352)
Q Consensus 274 -------------~~~~~----~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~ 321 (352)
..... ...+..++.+.++|.+||+.||++|||+.++++||||+.....
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~ 299 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKV 299 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCcc
Confidence 00000 1123567889999999999999999999999999999876553
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=351.07 Aligned_cols=251 Identities=29% Similarity=0.483 Sum_probs=212.8
Q ss_pred eeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEecCC
Q 018640 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~~ 140 (352)
++||+|+||.||+|.+..+|+.||+|++.............+..|..++....+||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999999999999999997654322334556777888888766899999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC-CCcccccc
Q 018640 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEIV 219 (352)
Q Consensus 141 ~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~ 219 (352)
++|.+++.....+++..+..++.|++.||+|||++||+||||||+||+++.++. ++|+|||++..... ........
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH---IKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC---EEeCccCCCeecccCCCceeccC
Confidence 999999988888999999999999999999999999999999999999976554 89999999875322 22334567
Q ss_pred cccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCC
Q 018640 220 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298 (352)
Q Consensus 220 gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 298 (352)
||+.|+|||++. ..++.++||||||+++|||++|..||...........+.... ......++.++.++|.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~ 233 (316)
T cd05620 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT----PHYPRWITKESKDILEKLFER 233 (316)
T ss_pred CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----CCCCCCCCHHHHHHHHHHccC
Confidence 999999999987 458999999999999999999999998877765555544332 222335789999999999999
Q ss_pred CcCCCCCH-HHHhcCcccccc
Q 018640 299 DPKRRLTA-QQVLEHPWLQNA 318 (352)
Q Consensus 299 dP~~Rps~-~ell~hp~f~~~ 318 (352)
||++||++ .++++||||+..
T Consensus 234 dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 234 DPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred CHHHcCCChHHHHcCCCcCCC
Confidence 99999997 589999999875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-48 Score=355.34 Aligned_cols=250 Identities=29% Similarity=0.550 Sum_probs=214.4
Q ss_pred eeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEecCC
Q 018640 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~~ 140 (352)
+.||+|+||+||++.+..+|+.||+|++.............+.+|++++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876444444556778899999999 899999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEecCCCCceEeecCCCCCCEEEEecccceecC-CCCccccc
Q 018640 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEI 218 (352)
Q Consensus 141 ~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~ 218 (352)
++|.+++.....+++..+..++.||+.||.|||+ .||+||||||+|||++.++. +||+|||++.... ........
T Consensus 80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~---~kL~Dfg~~~~~~~~~~~~~~~ 156 (325)
T cd05594 80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH---IKITDFGLCKEGIKDGATMKTF 156 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCC---EEEecCCCCeecCCCCcccccc
Confidence 9999999888889999999999999999999997 79999999999999976554 8999999987543 22233455
Q ss_pred ccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcC
Q 018640 219 VGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297 (352)
Q Consensus 219 ~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 297 (352)
.||+.|+|||++. ..++.++||||||+++|+|++|..||...........+..... ..+..+++++.++|.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~----~~p~~~~~~~~~li~~~L~ 232 (325)
T cd05594 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI----RFPRTLSPEAKSLLSGLLK 232 (325)
T ss_pred cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCC----CCCCCCCHHHHHHHHHHhh
Confidence 7999999999986 4589999999999999999999999988776655554443322 2334678999999999999
Q ss_pred CCcCCCC-----CHHHHhcCcccccc
Q 018640 298 PDPKRRL-----TAQQVLEHPWLQNA 318 (352)
Q Consensus 298 ~dP~~Rp-----s~~ell~hp~f~~~ 318 (352)
.||++|+ ++.++++||||.+.
T Consensus 233 ~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 233 KDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred cCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 9999997 99999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-48 Score=360.89 Aligned_cols=262 Identities=31% Similarity=0.456 Sum_probs=219.5
Q ss_pred CcccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCC-----CCeeEeee
Q 018640 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH-----QNIVCLKD 123 (352)
Q Consensus 49 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-----~~iv~l~~ 123 (352)
..+.+..+|.++++||+|+||.|.+|++.++++.||||++++.. .-......|+.+|..|.+| -|+|++++
T Consensus 180 ~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d 255 (586)
T KOG0667|consen 180 VNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLD 255 (586)
T ss_pred ecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeee
Confidence 34566678999999999999999999999999999999998643 2334556799999999534 48999999
Q ss_pred EEEeCCeEEEEEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEE
Q 018640 124 TYEDDTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAI 201 (352)
Q Consensus 124 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~ 201 (352)
+|...++.|||+|.+. .+|+++++.+. .++...++.++.||+.||.+||+.+|||+||||+||||.+-... .|||+
T Consensus 256 ~F~fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~-~vKVI 333 (586)
T KOG0667|consen 256 YFYFRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRS-RIKVI 333 (586)
T ss_pred ccccccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcC-ceeEE
Confidence 9999999999999994 59999999875 48999999999999999999999999999999999999764443 69999
Q ss_pred ecccceecCCCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCC-
Q 018640 202 DFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD- 279 (352)
Q Consensus 202 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~- 279 (352)
|||.|......- .+...+..|+|||++- ..|+.+.||||||||+.||++|.+.|.+..+.+++..+.+.....+..
T Consensus 334 DFGSSc~~~q~v--ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~m 411 (586)
T KOG0667|consen 334 DFGSSCFESQRV--YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKM 411 (586)
T ss_pred ecccccccCCcc--eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999998765433 2668899999999875 569999999999999999999999998888887777666554421100
Q ss_pred ----------------C------------------------------Cc------------CCCHHHHHHHHHhcCCCcC
Q 018640 280 ----------------P------------------------------WP------------KVSENAKDLVRKMLDPDPK 301 (352)
Q Consensus 280 ----------------~------------------------------~~------------~~~~~~~~li~~~l~~dP~ 301 (352)
. .+ .-...+.+||.+||++||.
T Consensus 412 L~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~ 491 (586)
T KOG0667|consen 412 LDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPA 491 (586)
T ss_pred HHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCch
Confidence 0 00 1134568999999999999
Q ss_pred CCCCHHHHhcCcccccc
Q 018640 302 RRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 302 ~Rps~~ell~hp~f~~~ 318 (352)
+|+|+.++|+||||...
T Consensus 492 ~R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 492 ERITPAQALNHPFLTGT 508 (586)
T ss_pred hcCCHHHHhcCcccccc
Confidence 99999999999999943
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-47 Score=350.09 Aligned_cols=259 Identities=23% Similarity=0.384 Sum_probs=214.9
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
.++|++++.||+|+||.||++.+..+|..||+|.+.... .....+.+.+|+++++.+ +||||+++++++..++..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEE
Confidence 468999999999999999999999999999999987542 233456789999999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
||||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++. ++|+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDS 157 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCc---EEEccCccccccccc
Confidence 999999999999998888899999999999999999999986 6999999999999976554 899999998765332
Q ss_pred Ccccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------------------
Q 018640 213 EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS------------------- 272 (352)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~------------------- 272 (352)
......||..|+|||++.+ .++.++||||||+++|||++|+.||......+....+...
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 2244578999999999874 5899999999999999999999999765543322111110
Q ss_pred -----------------------cccc--CCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 273 -----------------------VLDF--RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 273 -----------------------~~~~--~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
.... +......+++++.+||.+||+.||++|||+.++++||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 0000 0011124678999999999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=351.45 Aligned_cols=253 Identities=30% Similarity=0.508 Sum_probs=214.9
Q ss_pred ceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHH---hCCCCCCeeEeeeEEEeCCeEEE
Q 018640 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR---HLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 57 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~---~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
|++++.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.++. .+ +||||+++++++...+..++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSE-RHPFLVNLFACFQTEDHVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcccc-CCCChhceeeEEEcCCEEEE
Confidence 678999999999999999999999999999997654333444566777777664 45 79999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC-C
Q 018640 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-G 212 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~-~ 212 (352)
||||+++++|...+.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++. +||+|||++..... .
T Consensus 80 v~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~---~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 80 VMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF---VKIADFGLCKEGMGFG 155 (324)
T ss_pred EEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCc---EEeCcccCCccCCCCC
Confidence 9999999999888754 46999999999999999999999999999999999999976554 89999999875332 2
Q ss_pred Ccccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHH
Q 018640 213 EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (352)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 291 (352)
.......||+.|+|||.+.+ .++.++||||||+++|+|++|..||...........+..... ..+..+++.+.++
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~----~~p~~~~~~~~~l 231 (324)
T cd05589 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV----RYPRFLSREAISI 231 (324)
T ss_pred CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC----CCCCCCCHHHHHH
Confidence 23345679999999998864 588999999999999999999999988877766666555432 2334678999999
Q ss_pred HHHhcCCCcCCCC-----CHHHHhcCcccccc
Q 018640 292 VRKMLDPDPKRRL-----TAQQVLEHPWLQNA 318 (352)
Q Consensus 292 i~~~l~~dP~~Rp-----s~~ell~hp~f~~~ 318 (352)
|.+||+.||.+|| ++.++++||||++.
T Consensus 232 i~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 232 MRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred HHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 9999999999999 79999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=350.76 Aligned_cols=251 Identities=30% Similarity=0.530 Sum_probs=215.7
Q ss_pred eeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEecCC
Q 018640 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~~ 140 (352)
+.||+|+||+||+|.+..++..||+|++.+.........+.+.+|..++..+.+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999998764444445667788999999887899999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC-CCCcccccc
Q 018640 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIV 219 (352)
Q Consensus 141 ~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~ 219 (352)
++|.+++.....+++..+..++.|++.||.|||+.+++||||||+||+++.++. ++|+|||++.... .........
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGH---IKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCc---EEecccCCCeecCcCCCccccee
Confidence 999999988888999999999999999999999999999999999999976554 8999999987532 222234457
Q ss_pred cccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCC
Q 018640 220 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298 (352)
Q Consensus 220 gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 298 (352)
||+.|+|||++. ..++.++|||||||++|+|++|..||...........+..... ..+..+++.+.++|.+||+.
T Consensus 158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~----~~~~~~~~~~~~li~~~l~~ 233 (318)
T cd05570 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV----RYPRWLSKEAKSILKSFLTK 233 (318)
T ss_pred cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC----CCCCcCCHHHHHHHHHHccC
Confidence 899999999986 4589999999999999999999999987776665555544322 23346789999999999999
Q ss_pred CcCCCCCH-----HHHhcCcccccc
Q 018640 299 DPKRRLTA-----QQVLEHPWLQNA 318 (352)
Q Consensus 299 dP~~Rps~-----~ell~hp~f~~~ 318 (352)
||++|||+ .++++||||+..
T Consensus 234 dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 234 NPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred CHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 99999999 999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-47 Score=343.75 Aligned_cols=256 Identities=28% Similarity=0.438 Sum_probs=207.3
Q ss_pred ccceeceeeeccCceEEEEEEECC-CCcEEEEEEccccccCChhcHHHHHHHHHHHHhCC--CCCCeeEeeeEEE-----
Q 018640 55 ERYELGRELGRGEFGITYLCTDRE-NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP--KHQNIVCLKDTYE----- 126 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~~iv~l~~~~~----- 126 (352)
++|++++.||+|+||+||+|.+.. ++..||+|++....... .....+.+|+.+++.+. +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 369999999999999999999854 46889999887543222 22345566777777663 6999999999885
Q ss_pred eCCeEEEEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecc
Q 018640 127 DDTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (352)
Q Consensus 127 ~~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg 204 (352)
.....++||||++ ++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+|||++.++. +||+|||
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~---~kl~Dfg 155 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFG 155 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCC---EEEcccc
Confidence 3456899999996 5899888654 34899999999999999999999999999999999999976554 8999999
Q ss_pred cceecCCCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCC----
Q 018640 205 LSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD---- 279 (352)
Q Consensus 205 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 279 (352)
++.............||+.|+|||.+. ..++.++||||||+++|||++|.+||......+....+........+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (290)
T cd07862 156 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 235 (290)
T ss_pred ceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence 998765444445567899999999876 458999999999999999999999999887776666665433211110
Q ss_pred -------------------CCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 280 -------------------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 280 -------------------~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
..+.+++.+.+++.+||+.||++|||+.++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 113467888999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=363.32 Aligned_cols=256 Identities=25% Similarity=0.425 Sum_probs=207.8
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC----
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD---- 128 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~---- 128 (352)
..++|++++.||+|+||+||+|.+..+++.||||++.... ....+|+.+++.+ +|+||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l-~h~niv~l~~~~~~~~~~~ 135 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNL-NHINIIFLKDYYYTECFKK 135 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhc-CCCCCcceeeeEeeccccc
Confidence 4567999999999999999999999999999999875421 2345799999999 899999999876432
Q ss_pred ----CeEEEEEEecCCcchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEE
Q 018640 129 ----TAVHLVMELCEGGELFDRIV----ARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKA 200 (352)
Q Consensus 129 ----~~~~lv~e~~~~~sL~~~l~----~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl 200 (352)
...++||||+++ +|.+++. ....+++..++.++.||+.||.|||+.+|+||||||+|||++.++ ..+||
T Consensus 136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~--~~vkL 212 (440)
T PTZ00036 136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNT--HTLKL 212 (440)
T ss_pred CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCC--Cceee
Confidence 246789999975 7777664 345699999999999999999999999999999999999997443 24899
Q ss_pred EecccceecCCCCcccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc--
Q 018640 201 IDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF-- 276 (352)
Q Consensus 201 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-- 276 (352)
+|||+++............||+.|+|||++.+ .++.++|||||||++|||++|.+||.+....+....+.+.....
T Consensus 213 ~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 213 CDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred eccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 99999987655544455678999999998753 58999999999999999999999998876665555544322111
Q ss_pred ---------------CC--------CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 277 ---------------RR--------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 277 ---------------~~--------~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
+. ..+...++++.+||.+||+.||.+|||+.|+++||||.+..
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 00 01123678999999999999999999999999999998753
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-47 Score=348.87 Aligned_cols=256 Identities=26% Similarity=0.467 Sum_probs=219.2
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
+|.+.+.||+|+||+||+|.+..+|+.||+|++...........+.+..|..++..+.+|++|+++.+++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 37788999999999999999999999999999876543334445677889999998866788999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC-Cc
Q 018640 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-EK 214 (352)
Q Consensus 136 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~-~~ 214 (352)
||+++|+|.+++.....+++..+..++.|++.||.|||++|++||||||+|||++.++. ++|+|||++...... ..
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~---ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH---IKIADFGMCKEHMVDGVT 157 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC---EEEeccccccccCCCCcc
Confidence 99999999999988888999999999999999999999999999999999999976554 899999998754322 22
Q ss_pred ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHH
Q 018640 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (352)
Q Consensus 215 ~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 293 (352)
.....||+.|+|||++. ..++.++||||||+++|+|++|..||...........+..... ..+..++..+.+++.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~----~~p~~~~~~~~~li~ 233 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV----SYPKSLSKEAVSICK 233 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC----CCCccCCHHHHHHHH
Confidence 34457999999999886 4589999999999999999999999988877766666654332 233467899999999
Q ss_pred HhcCCCcCCCCC-----HHHHhcCcccccc
Q 018640 294 KMLDPDPKRRLT-----AQQVLEHPWLQNA 318 (352)
Q Consensus 294 ~~l~~dP~~Rps-----~~ell~hp~f~~~ 318 (352)
+||+.+|.+|++ ..++++||||...
T Consensus 234 ~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 234 GLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred HHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 999999999997 5799999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-47 Score=355.63 Aligned_cols=261 Identities=31% Similarity=0.489 Sum_probs=219.5
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
..++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.+ +||||+++++++...+..+
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEE
Confidence 347899999999999999999999999999999998764433334455678899999998 9999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
+||||+++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||++......
T Consensus 120 lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~---ikL~DfG~a~~~~~~ 195 (371)
T cd05622 120 MVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH---LKLADFGTCMKMNKE 195 (371)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCC---EEEEeCCceeEcCcC
Confidence 999999999999988654 5899999999999999999999999999999999999976544 899999999876433
Q ss_pred C--cccccccccccccchhccc-----cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCC
Q 018640 213 E--KFSEIVGSPYYMAPEVLKR-----NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (352)
Q Consensus 213 ~--~~~~~~gt~~y~aPE~~~~-----~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (352)
. ......||+.|+|||++.. .++.++|||||||++|||++|..||...........+..............++
T Consensus 196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 275 (371)
T cd05622 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 275 (371)
T ss_pred CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCC
Confidence 2 2235679999999998753 27889999999999999999999999888776666665543333333334689
Q ss_pred HHHHHHHHHhcCCCcCC--CCCHHHHhcCcccccc
Q 018640 286 ENAKDLVRKMLDPDPKR--RLTAQQVLEHPWLQNA 318 (352)
Q Consensus 286 ~~~~~li~~~l~~dP~~--Rps~~ell~hp~f~~~ 318 (352)
..+.++|..||..++.+ |+++.++++||||++.
T Consensus 276 ~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 276 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 99999999999854443 7899999999999863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-47 Score=347.64 Aligned_cols=251 Identities=29% Similarity=0.460 Sum_probs=212.2
Q ss_pred eeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEecCC
Q 018640 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~~ 140 (352)
+.||+|+||+||+|.+..+++.||+|++.............+..|..++..+.+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999987654322334456677888888766899999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC-CCcccccc
Q 018640 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEIV 219 (352)
Q Consensus 141 ~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~ 219 (352)
|+|.+++.....+++..+..++.|++.||.|||+.+++||||||+||+++.++. +||+|||++..... ........
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGH---IKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC---EEEccCCcceECCCCCCceeeec
Confidence 999999988778999999999999999999999999999999999999976554 89999999875322 22234557
Q ss_pred cccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCC
Q 018640 220 GSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298 (352)
Q Consensus 220 gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 298 (352)
||..|+|||++.+ .++.++|||||||++|||++|..||......+....+.... ......++.++.++|.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~----~~~~~~~~~~~~~li~~~l~~ 233 (316)
T cd05619 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN----PCYPRWLTREAKDILVKLFVR 233 (316)
T ss_pred CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----CCCCccCCHHHHHHHHHHhcc
Confidence 8999999999864 58999999999999999999999998877665555543322 222335789999999999999
Q ss_pred CcCCCCCHH-HHhcCcccccc
Q 018640 299 DPKRRLTAQ-QVLEHPWLQNA 318 (352)
Q Consensus 299 dP~~Rps~~-ell~hp~f~~~ 318 (352)
||++||++. ++++||||+..
T Consensus 234 ~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 234 EPERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred CHhhcCCChHHHHcCcccCCC
Confidence 999999996 99999999875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-47 Score=342.08 Aligned_cols=258 Identities=31% Similarity=0.524 Sum_probs=213.9
Q ss_pred ceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEE
Q 018640 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (352)
Q Consensus 57 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e 136 (352)
|++.+.||+|+||+||++.+..+++.||+|.+.............+.+|+.+++++ +|++++.+++.+...+..++|||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-CCCCeeeeeEEEecCCEEEEEEE
Confidence 77889999999999999999999999999998765444433445677899999999 89999999999999999999999
Q ss_pred ecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCc
Q 018640 137 LCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (352)
Q Consensus 137 ~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (352)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+++||||||+||+++.++. ++|+|||++........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~---~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGH---IRISDLGLAVHVPEGQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC---EEEeeccceeecCCCcc
Confidence 999999999886433 5899999999999999999999999999999999999975544 89999999976554444
Q ss_pred ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHH
Q 018640 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (352)
Q Consensus 215 ~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 293 (352)
.....|+..|+|||++. ..++.++||||||+++|+|++|..||..........................++.++.+|+.
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCK 237 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHH
Confidence 34457899999999986 45899999999999999999999999765432111111111111222334567899999999
Q ss_pred HhcCCCcCCCCC-----HHHHhcCcccccc
Q 018640 294 KMLDPDPKRRLT-----AQQVLEHPWLQNA 318 (352)
Q Consensus 294 ~~l~~dP~~Rps-----~~ell~hp~f~~~ 318 (352)
+||+.||++||| +.|+++||||+..
T Consensus 238 ~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 238 MLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred HHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 999999999999 9999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-47 Score=356.27 Aligned_cols=253 Identities=23% Similarity=0.399 Sum_probs=206.0
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
.+|++++.||+|+||.||+|.+..+++.||+|.... ..+.+|+.+++++ +||||+++++++......++|
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv 161 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAI-NHPSIIQLKGTFTYNKFTCLI 161 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhC-CCCCCCCEeEEEEECCeeEEE
Confidence 579999999999999999999999999999997532 3467899999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC--
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-- 212 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~-- 212 (352)
+|++. ++|..++.....+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||++......
T Consensus 162 ~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~---vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 162 LPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGD---VCLGDFGAACFPVDINA 237 (391)
T ss_pred EecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCC---EEEEeCCcccccccccc
Confidence 99995 689999988778999999999999999999999999999999999999976554 899999999653221
Q ss_pred Ccccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhcccccC-------
Q 018640 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET-------EQGVAQAIIRSVLDFR------- 277 (352)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~-------~~~~~~~~~~~~~~~~------- 277 (352)
.......||+.|+|||++. ..++.++||||||+++|||++|..||.... .......+.......+
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 2223457999999999986 458999999999999999999998875432 1111111111110000
Q ss_pred ---------------------CCC---CcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccC
Q 018640 278 ---------------------RDP---WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKA 321 (352)
Q Consensus 278 ---------------------~~~---~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~ 321 (352)
... ...++.++.+||.+||+.||.+|||+.|+|+||||+.....
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 385 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP 385 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence 000 01346788999999999999999999999999999986544
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-47 Score=349.56 Aligned_cols=251 Identities=27% Similarity=0.476 Sum_probs=210.9
Q ss_pred eeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEecCC
Q 018640 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~~ 140 (352)
+.||+|+||+||+|.+..+++.||+|++...........+.+.+|+.++.++.+||+|+.+++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999998765444445667889999999987899999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC-CCCcccccc
Q 018640 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIV 219 (352)
Q Consensus 141 ~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~ 219 (352)
++|.+++.....+++..+..++.||+.||+|||++|++||||||+||+++.++. +||+|||++.... .........
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGH---IKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCC---EEEeccccceeccCCCCceeccc
Confidence 999999988788999999999999999999999999999999999999976554 8999999987532 223334568
Q ss_pred cccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCC------H-HHHHHHHHhcccccCCCCCcCCCHHHHHH
Q 018640 220 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET------E-QGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (352)
Q Consensus 220 gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~------~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 291 (352)
||+.|+|||++. ..++.++||||||+++|+|++|..||.... . ......+. ..+...+..++..+.++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~p~~~~~~~~~l 233 (327)
T cd05617 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL----EKPIRIPRFLSVKASHV 233 (327)
T ss_pred CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH----hCCCCCCCCCCHHHHHH
Confidence 999999999876 458999999999999999999999995321 1 11222222 22223344678999999
Q ss_pred HHHhcCCCcCCCCC------HHHHhcCcccccc
Q 018640 292 VRKMLDPDPKRRLT------AQQVLEHPWLQNA 318 (352)
Q Consensus 292 i~~~l~~dP~~Rps------~~ell~hp~f~~~ 318 (352)
|.+||+.||.+|++ +.++++||||+..
T Consensus 234 i~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 234 LKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred HHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 99999999999997 5799999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-47 Score=348.21 Aligned_cols=251 Identities=32% Similarity=0.559 Sum_probs=212.9
Q ss_pred ceeeeccCceEEEEEEEC---CCCcEEEEEEccccccC-ChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 60 GRELGRGEFGITYLCTDR---ENGDAFACKSISKKKLR-TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 60 ~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
++.||+|+||.||++.+. .+++.||+|++...... .......+.+|+.+++.+ +||||+++++++..++..++||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv~ 79 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHPFIVDLIYAFQTGGKLYLIL 79 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-CCCchhceeeEEecCCeEEEEE
Confidence 367999999999999863 46889999998764321 222345678899999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC-CCc
Q 018640 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEK 214 (352)
Q Consensus 136 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~-~~~ 214 (352)
||+++++|.+++.....+++..+..++.|++.||+|||++||+||||||+|||++.++. +||+|||++..... ...
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~~~~~~~~~~~ 156 (323)
T cd05584 80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGH---VKLTDFGLCKESIHEGTV 156 (323)
T ss_pred eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC---EEEeeCcCCeecccCCCc
Confidence 99999999999988888999999999999999999999999999999999999976554 89999999875432 222
Q ss_pred ccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHH
Q 018640 215 FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (352)
Q Consensus 215 ~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 293 (352)
.....||+.|+|||++.+ .++.++||||||+++|||++|+.||...........+..... ..++.+++.+.++|.
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~ 232 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL----NLPPYLTPEARDLLK 232 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC----CCCCCCCHHHHHHHH
Confidence 344579999999999864 588999999999999999999999988877666666554332 334567899999999
Q ss_pred HhcCCCcCCCC-----CHHHHhcCcccccc
Q 018640 294 KMLDPDPKRRL-----TAQQVLEHPWLQNA 318 (352)
Q Consensus 294 ~~l~~dP~~Rp-----s~~ell~hp~f~~~ 318 (352)
+||+.||++|| ++.++++||||...
T Consensus 233 ~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 233 KLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred HHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 99999999999 89999999999753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=350.25 Aligned_cols=257 Identities=26% Similarity=0.437 Sum_probs=209.5
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
-++|++++.||+|+||+||+|.+..+|+.||+|++.... .......+.+|+.+++.+ +|+||+++++++...+..++
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDV-NHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhC-CCCCcceeeeEeccCCeEEE
Confidence 356899999999999999999999999999999986432 223356788999999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
||||+++++|.+. ...++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++.......
T Consensus 150 v~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~---~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 150 LLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN---VKIADFGVSRILAQTM 222 (353)
T ss_pred EEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC---EEEcccccceeccccc
Confidence 9999999998653 24677888999999999999999999999999999999976544 8999999998654322
Q ss_pred -cccccccccccccchhccc------cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCH
Q 018640 214 -KFSEIVGSPYYMAPEVLKR------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (352)
Q Consensus 214 -~~~~~~gt~~y~aPE~~~~------~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (352)
......||..|+|||.+.. ..+.++|||||||++|||++|+.||..........................++.
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASR 302 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCH
Confidence 2344579999999998742 245689999999999999999999974433222222222222223333456889
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 287 ~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
++.+||.+||+.||++|||+.|+++||||.....
T Consensus 303 ~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~ 336 (353)
T PLN00034 303 EFRHFISCCLQREPAKRWSAMQLLQHPFILRAQP 336 (353)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCcccccCCc
Confidence 9999999999999999999999999999998743
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=338.85 Aligned_cols=258 Identities=32% Similarity=0.521 Sum_probs=219.5
Q ss_pred ceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEE
Q 018640 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (352)
Q Consensus 57 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e 136 (352)
|+..+.||+|+||+||+|.+..+++.||+|.+.............+.+|+.+++.+ +|+|++.+.+.+..++..+++||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCcCceeEEEEEecCCEEEEEEE
Confidence 77889999999999999999999999999998765444444445678899999999 99999999999999999999999
Q ss_pred ecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCc
Q 018640 137 LCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (352)
Q Consensus 137 ~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (352)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+||+++.++ .++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~---~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG---HIRISDLGLAVKIPEGES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCC---CEEEecCCcceecCCCCc
Confidence 99999999888653 3599999999999999999999999999999999999997554 489999999976554444
Q ss_pred ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHH
Q 018640 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (352)
Q Consensus 215 ~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 293 (352)
.....|+..|+|||.+. ..++.++|+||||+++|+|++|..||...........+..............++..+.+|+.
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICK 237 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHH
Confidence 44557899999999876 45899999999999999999999999877655444444444433334445678899999999
Q ss_pred HhcCCCcCCCCC-----HHHHhcCcccccc
Q 018640 294 KMLDPDPKRRLT-----AQQVLEHPWLQNA 318 (352)
Q Consensus 294 ~~l~~dP~~Rps-----~~ell~hp~f~~~ 318 (352)
.||+.||++||+ +.+++.||||...
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 238 MLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 999999999999 8899999999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-47 Score=348.90 Aligned_cols=250 Identities=28% Similarity=0.535 Sum_probs=210.3
Q ss_pred eeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHH-HHHhCCCCCCeeEeeeEEEeCCeEEEEEEecC
Q 018640 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVD-IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCE 139 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~ 139 (352)
+.||+|+||+||+|.+..+|+.||+|++.............+..|.. +++.+ +||||+++++++...+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-CCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence 46999999999999999999999999987654333333445555555 45667 89999999999999999999999999
Q ss_pred CcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC-CCccccc
Q 018640 140 GGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEI 218 (352)
Q Consensus 140 ~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~ 218 (352)
+++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++..... .......
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~---~kl~Dfg~~~~~~~~~~~~~~~ 156 (323)
T cd05575 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGH---VVLTDFGLCKEGIEHSKTTSTF 156 (323)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc---EEEeccCCCcccccCCCccccc
Confidence 9999999988888999999999999999999999999999999999999976554 89999999875422 2233455
Q ss_pred ccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcC
Q 018640 219 VGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297 (352)
Q Consensus 219 ~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 297 (352)
.||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+..... ...+.++..+.++|.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~----~~~~~~~~~~~~li~~~l~ 232 (323)
T cd05575 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL----RLKPNISVSARHLLEGLLQ 232 (323)
T ss_pred cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC----CCCCCCCHHHHHHHHHHhh
Confidence 79999999998764 588999999999999999999999988777666555554322 2335679999999999999
Q ss_pred CCcCCCCCH----HHHhcCcccccc
Q 018640 298 PDPKRRLTA----QQVLEHPWLQNA 318 (352)
Q Consensus 298 ~dP~~Rps~----~ell~hp~f~~~ 318 (352)
.||.+||++ .++++||||...
T Consensus 233 ~~p~~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 233 KDRTKRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred cCHHhCCCCCCCHHHHHcCCCcCCC
Confidence 999999987 699999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=346.75 Aligned_cols=260 Identities=29% Similarity=0.522 Sum_probs=214.8
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++++.||+|+||+||++.+..+++.||+|++.+.........+.+.+|+.++..+ +|+||+++++++..++..++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEecCCeEEEE
Confidence 4699999999999999999999999999999998764433344456788999999998 999999999999999999999
Q ss_pred EEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 135 MELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
|||+++++|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++. +||+|||++.......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGH---IRLADFGSCLRLLADG 156 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCC---EEEEECCceeecCCCC
Confidence 999999999999976 456999999999999999999999999999999999999975554 8999999987654332
Q ss_pred c--ccccccccccccchhcc------ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC-CCCCcCC
Q 018640 214 K--FSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR-RDPWPKV 284 (352)
Q Consensus 214 ~--~~~~~gt~~y~aPE~~~------~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 284 (352)
. .....||+.|+|||++. +.++.++|||||||++|+|++|+.||......+....+........ +.....+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 236 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDV 236 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCC
Confidence 2 12346899999999875 2367899999999999999999999987766655555543322111 1122357
Q ss_pred CHHHHHHHHHhcCCCcCC--CCCHHHHhcCcccccc
Q 018640 285 SENAKDLVRKMLDPDPKR--RLTAQQVLEHPWLQNA 318 (352)
Q Consensus 285 ~~~~~~li~~~l~~dP~~--Rps~~ell~hp~f~~~ 318 (352)
++.+.++|.+||..++++ |+++.++++||||...
T Consensus 237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred CHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 999999999988764443 7899999999999764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-47 Score=336.80 Aligned_cols=258 Identities=32% Similarity=0.566 Sum_probs=229.1
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
+.|++++.||.|.-|+||+|....++..+|+|++.+..........+...|..||+.+ +||.++.|+..|+.+...++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhheeeccceeEEE
Confidence 5699999999999999999999999999999999998777666677888899999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC-
Q 018640 135 MELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP- 211 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~- 211 (352)
||||+||+|...+.++. .+++..++.++.+++.||+|||-.|||.|||||+||||..+++ |.|+||.++....-
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGH---IMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGH---IMLSDFDLSLRCPVS 232 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCc---EEeeeccccccCCCC
Confidence 99999999999887654 5999999999999999999999999999999999999976555 99999997653210
Q ss_pred --------------------------------C-C-----------------------cccccccccccccchhccc-cC
Q 018640 212 --------------------------------G-E-----------------------KFSEIVGSPYYMAPEVLKR-NY 234 (352)
Q Consensus 212 --------------------------------~-~-----------------------~~~~~~gt~~y~aPE~~~~-~~ 234 (352)
. . ....++||-.|.|||++.+ +.
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 0123579999999999985 48
Q ss_pred CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCC----HHHHh
Q 018640 235 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLT----AQQVL 310 (352)
Q Consensus 235 s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps----~~ell 310 (352)
+.++|.|+||+++|||+.|..||.+.+..+.+.++...-..++... ..+..++|||+++|.+||.+|.- +.||-
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence 9999999999999999999999999999999999887766665543 67899999999999999999997 99999
Q ss_pred cCcccccc
Q 018640 311 EHPWLQNA 318 (352)
Q Consensus 311 ~hp~f~~~ 318 (352)
+||||+..
T Consensus 391 ~HpFF~gV 398 (459)
T KOG0610|consen 391 RHPFFEGV 398 (459)
T ss_pred cCccccCC
Confidence 99999965
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=336.14 Aligned_cols=252 Identities=28% Similarity=0.466 Sum_probs=206.2
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEecCCcc
Q 018640 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGE 142 (352)
Q Consensus 63 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~~~s 142 (352)
||+|+||+||++.+..+|+.||+|++.............+..|+++++.+ +||||+++++++..+...++||||++|++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 79999999999999999999999998765443333344566799999999 99999999999999999999999999999
Q ss_pred hHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCccccccc
Q 018640 143 LFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG 220 (352)
Q Consensus 143 L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g 220 (352)
|.+++.... .+++..+..++.|++.||+|||+.|++||||||+||+++.++. ++|+|||++.............|
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~---~~l~Dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGN---CRLSDLGLAVELKDGKTITQRAG 156 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCC---EEEeeceeeeecCCCceeeccCC
Confidence 998886543 4889999999999999999999999999999999999976544 89999999987655444445578
Q ss_pred ccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc-cCCCCCcCCCHHHHHHHHHhcCC
Q 018640 221 SPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD-FRRDPWPKVSENAKDLVRKMLDP 298 (352)
Q Consensus 221 t~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~ 298 (352)
+..|+|||++. ..++.++||||||+++|||++|..||...........+...... ........+++++.++|..||+.
T Consensus 157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence 99999999876 45899999999999999999999999754332211222222111 11112246789999999999999
Q ss_pred CcCCCCCH----HHHhcCcccccc
Q 018640 299 DPKRRLTA----QQVLEHPWLQNA 318 (352)
Q Consensus 299 dP~~Rps~----~ell~hp~f~~~ 318 (352)
||++||++ .+++.||||+..
T Consensus 237 ~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 237 KPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred CHhhCCCCccchhhhhcChhhcCC
Confidence 99999999 678899999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=328.38 Aligned_cols=269 Identities=39% Similarity=0.715 Sum_probs=239.4
Q ss_pred cccccceec-eeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEE----
Q 018640 52 EIEERYELG-RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE---- 126 (352)
Q Consensus 52 ~~~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~---- 126 (352)
.+.++|++- ++||-|-.|.|..|..+.+|+.+|+|++.. ....++|+++.-....|||||+++++|+
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D--------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD--------SPKARREVELHWMASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc--------CHHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence 466778874 579999999999999999999999998853 2567789888888889999999999885
Q ss_pred eCCeEEEEEEecCCcchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecc
Q 018640 127 DDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (352)
Q Consensus 127 ~~~~~~lv~e~~~~~sL~~~l~~~~~--l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg 204 (352)
....+.+|||.++||.|+..+..++. +++.++..|++||..|+.|||+.+|.||||||+|+|+.....+..+||+|||
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence 45678999999999999999988775 9999999999999999999999999999999999999988888889999999
Q ss_pred cceecCCCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhcccccCCC
Q 018640 205 LSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAE----TEQGVAQAIIRSVLDFRRD 279 (352)
Q Consensus 205 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~----~~~~~~~~~~~~~~~~~~~ 279 (352)
+|+.........+-+-|+.|.|||++. ..|+..-|+||+|+++|-|++|.+||+.. ...+...++......++.+
T Consensus 210 FAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~p 289 (400)
T KOG0604|consen 210 FAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEP 289 (400)
T ss_pred cccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCCh
Confidence 999876656666678899999999998 56999999999999999999999999754 3445667778888889999
Q ss_pred CCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccCCCCCCcH
Q 018640 280 PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGE 328 (352)
Q Consensus 280 ~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~ 328 (352)
.|..+|+...++|+.+|..+|.+|.|+.++++|||++....-|.+.+.+
T Consensus 290 EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~t 338 (400)
T KOG0604|consen 290 EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLST 338 (400)
T ss_pred hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCchh
Confidence 9999999999999999999999999999999999999887777777753
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=347.00 Aligned_cols=250 Identities=28% Similarity=0.539 Sum_probs=210.5
Q ss_pred eeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHH-HHhCCCCCCeeEeeeEEEeCCeEEEEEEecC
Q 018640 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI-MRHLPKHQNIVCLKDTYEDDTAVHLVMELCE 139 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~ 139 (352)
+.||+|+||+||+|.+..+|+.||+|++.............+..|..+ ++.+ +||||+++++++...+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC-CCCCCccEEEEEecCCEEEEEEcCCC
Confidence 469999999999999999999999999876543333344556666654 5566 99999999999999999999999999
Q ss_pred CcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC-CCccccc
Q 018640 140 GGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEI 218 (352)
Q Consensus 140 ~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~ 218 (352)
+++|...+.....+++..+..++.||+.||+|||+.||+||||||+|||++.++. +||+|||++..... .......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~---~kL~DfG~~~~~~~~~~~~~~~ 156 (325)
T cd05604 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGH---VVLTDFGLCKEGIAQSDTTTTF 156 (325)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC---EEEeecCCcccCCCCCCCcccc
Confidence 9999999988888999999999999999999999999999999999999976554 89999999875322 2233456
Q ss_pred ccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcC
Q 018640 219 VGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297 (352)
Q Consensus 219 ~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 297 (352)
.||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+..... ...+..+..+.++|..||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~ll~~ll~ 232 (325)
T cd05604 157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL----VLRPGASLTAWSILEELLE 232 (325)
T ss_pred cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc----cCCCCCCHHHHHHHHHHhc
Confidence 79999999999874 588999999999999999999999988777666555554322 2334678999999999999
Q ss_pred CCcCCCCCH----HHHhcCcccccc
Q 018640 298 PDPKRRLTA----QQVLEHPWLQNA 318 (352)
Q Consensus 298 ~dP~~Rps~----~ell~hp~f~~~ 318 (352)
.+|.+||++ .+++.||||+..
T Consensus 233 ~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 233 KDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred cCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 999999976 599999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=337.05 Aligned_cols=255 Identities=28% Similarity=0.457 Sum_probs=205.9
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCC--CCCCeeEeeeEEEe-----C
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP--KHQNIVCLKDTYED-----D 128 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~~iv~l~~~~~~-----~ 128 (352)
+|++++.||+|+||+||+|.+..+|+.||+|.+........ ....+.+|+.+++.+. +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG-LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC-CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 58999999999999999999999999999998875432221 1234556777777653 69999999998764 3
Q ss_pred CeEEEEEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccc
Q 018640 129 TAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a 206 (352)
...++++||+++ +|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++.++. +||+|||++
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~---~kl~dfg~~ 155 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ---VKLADFGLA 155 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC---EEECccCcc
Confidence 457999999975 8888887643 4899999999999999999999999999999999999976554 899999999
Q ss_pred eecCCCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC--------
Q 018640 207 VFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR-------- 277 (352)
Q Consensus 207 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------- 277 (352)
.............||..|+|||++. ..++.++||||||+++|+|++|.+||...........+........
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 156 RIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred ccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence 8765444445567899999999876 4589999999999999999999999987766655555443221100
Q ss_pred ---------------CCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 278 ---------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 278 ---------------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
....+.+++.+.++|.+||+.||++|||+.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 01123567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=348.54 Aligned_cols=258 Identities=27% Similarity=0.436 Sum_probs=207.8
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC--
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT-- 129 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~-- 129 (352)
.+.++|++.+.||+|+||.||+|.+..+|..||+|++.... ........+.+|+.+++.+ +||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 95 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCV-NHKNIISLLNVFTPQKSL 95 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCCc
Confidence 45678999999999999999999999999999999986542 2333456788899999999 8999999999986443
Q ss_pred ----eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccc
Q 018640 130 ----AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (352)
Q Consensus 130 ----~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~ 205 (352)
..++||||+++ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~---~kl~Dfg~ 169 (359)
T cd07876 96 EEFQDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGL 169 (359)
T ss_pred cccceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC---EEEecCCC
Confidence 57999999975 67666643 4889999999999999999999999999999999999976554 89999999
Q ss_pred ceecCCCCcccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc---------
Q 018640 206 SVFFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD--------- 275 (352)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--------- 275 (352)
+.............||+.|+|||.+.+ .++.++||||||+++|+|++|+.||...........+......
T Consensus 170 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 170 ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred ccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 976544444455678999999998864 5899999999999999999999999876544333222211110
Q ss_pred -------------cCC----------------CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccc
Q 018640 276 -------------FRR----------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (352)
Q Consensus 276 -------------~~~----------------~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~ 317 (352)
.+. ......++.+.+||.+||+.||++|||+.|+++||||..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 000 001123577899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-46 Score=343.53 Aligned_cols=258 Identities=24% Similarity=0.407 Sum_probs=212.2
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
.++|++.+.||+|+||.||++.+..++..+|+|.+.... .....+.+.+|+++++.+ +|+||+++++++...+..++
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHC-CCCcccceeEEEEECCEEEE
Confidence 468999999999999999999999999999999886542 223356788999999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
||||+++++|.+++.....+++..+..++.|++.||.|||+. +++|+||||+||+++.++. +||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~---~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDS 157 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCC---EEEeeCCcchhhhhh
Confidence 999999999999998888899999999999999999999985 7999999999999976554 899999998754322
Q ss_pred Ccccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----------------------
Q 018640 213 EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI---------------------- 269 (352)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~---------------------- 269 (352)
......||..|+|||++.+ .++.++|+|||||++|+|++|+.||...........+
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR 236 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccc
Confidence 2234578999999999874 5889999999999999999999999755433221110
Q ss_pred ------------------HhcccccCCC--CCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 270 ------------------IRSVLDFRRD--PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 270 ------------------~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
.......... ....++.++.+||.+||+.||++|||+.|++.||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred hhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 0000000000 011357889999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-46 Score=357.45 Aligned_cols=260 Identities=22% Similarity=0.336 Sum_probs=204.9
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCC-----CCCCeeEeeeEEEe
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP-----KHQNIVCLKDTYED 127 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~l~~~~~~ 127 (352)
..++|+++++||+|+||+||+|.+..+++.||||++.... .....+..|+.+++.+. +|.+++.+++++..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3578999999999999999999999999999999986421 12234566777777661 34568899998875
Q ss_pred C-CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEecCCCCceEeecCCC-----------
Q 018640 128 D-TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKE----------- 194 (352)
Q Consensus 128 ~-~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dikp~NIll~~~~~----------- 194 (352)
. ...++|||++ |++|.+++.....+++..+..|+.||+.||+|||+ .|||||||||+|||++.++.
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 4 5788999988 77999999888889999999999999999999998 59999999999999976542
Q ss_pred --CCCEEEEecccceecCCCCcccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 018640 195 --TAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR 271 (352)
Q Consensus 195 --~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~ 271 (352)
...+||+|||.+.... .......||+.|+|||++.+ .++.++|||||||++|||++|+.||......+....+..
T Consensus 282 ~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 359 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK 359 (467)
T ss_pred CCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 2348999999876432 22345689999999998764 589999999999999999999999987766554444333
Q ss_pred cccccCC-----------------------CCC---------------cCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCc
Q 018640 272 SVLDFRR-----------------------DPW---------------PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHP 313 (352)
Q Consensus 272 ~~~~~~~-----------------------~~~---------------~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp 313 (352)
.....+. ... ...++.+.+||.+||++||++|||+.|+|+||
T Consensus 360 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp 439 (467)
T PTZ00284 360 TLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHP 439 (467)
T ss_pred HcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCc
Confidence 2211110 000 01245678999999999999999999999999
Q ss_pred cccccc
Q 018640 314 WLQNAK 319 (352)
Q Consensus 314 ~f~~~~ 319 (352)
||.+..
T Consensus 440 ~~~~~~ 445 (467)
T PTZ00284 440 YVLKYY 445 (467)
T ss_pred cccccC
Confidence 999753
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-47 Score=349.03 Aligned_cols=250 Identities=30% Similarity=0.540 Sum_probs=209.1
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCC--CCCCeeEeeeEEEeCCeEEEEEEecCC
Q 018640 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP--KHQNIVCLKDTYEDDTAVHLVMELCEG 140 (352)
Q Consensus 63 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~~iv~l~~~~~~~~~~~lv~e~~~~ 140 (352)
||+|+||+||+|.+..+|+.||+|++................|..++..+. +||||+.+++++...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999999999999999987654333333344556777776654 799999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC-CCcccccc
Q 018640 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEIV 219 (352)
Q Consensus 141 ~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~ 219 (352)
++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|+|||++..... ........
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~---~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGH---IALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC---EEEecCCcCcCCCCCCCCccCcc
Confidence 999999988888999999999999999999999999999999999999976554 89999999875422 22334567
Q ss_pred cccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcC
Q 018640 220 GSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297 (352)
Q Consensus 220 gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 297 (352)
||..|+|||++.+ .++.++||||||+++|+|++|..||......+....+.......+ ...+++++.++|.+||+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~~~~~~~li~~~L~ 234 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFP---KNVLSDEGRQFVKGLLN 234 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCC---CccCCHHHHHHHHHHcC
Confidence 9999999998753 478999999999999999999999988776665555543322222 23478999999999999
Q ss_pred CCcCCCC----CHHHHhcCcccccc
Q 018640 298 PDPKRRL----TAQQVLEHPWLQNA 318 (352)
Q Consensus 298 ~dP~~Rp----s~~ell~hp~f~~~ 318 (352)
.||++|| ++.++++||||.+.
T Consensus 235 ~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 235 RNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred CCHHHCCCCCCCHHHHhcCccccCC
Confidence 9999998 79999999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=334.32 Aligned_cols=254 Identities=38% Similarity=0.692 Sum_probs=211.2
Q ss_pred ceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEE
Q 018640 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (352)
Q Consensus 57 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e 136 (352)
|++++.||+|+||+||++.+..+++.||+|++........ ......+|+.+++++ +||||+++++++......++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEE-EREENIREIKILRRL-RHPNIVQILDVFQDDNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHH-HHHHHHHHHHHHHHH-TBTTBCHEEEEEEESSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccc-ccchhhhhhhccccc-ccccccccccccccccccccccc
Confidence 7899999999999999999999999999999987643222 222345599999999 99999999999999999999999
Q ss_pred ecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec-CCCCcc
Q 018640 137 LCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKF 215 (352)
Q Consensus 137 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~-~~~~~~ 215 (352)
|+++++|.+++.....+++..+..++.|++.||.+||+.+++|+||||+||+++.++. ++|+|||.+... ......
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~---~~l~Dfg~~~~~~~~~~~~ 155 (260)
T PF00069_consen 79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGE---VKLIDFGSSVKLSENNENF 155 (260)
T ss_dssp EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSE---EEESSGTTTEESTSTTSEB
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccc
Confidence 9999999999997778999999999999999999999999999999999999975555 799999999763 333444
Q ss_pred cccccccccccchhcc--ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc---ccCCCCCcCCCHHHHH
Q 018640 216 SEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL---DFRRDPWPKVSENAKD 290 (352)
Q Consensus 216 ~~~~gt~~y~aPE~~~--~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 290 (352)
....++..|+|||.+. ...+.++||||+|+++++|++|..||...........+..... ..........++.+.+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRD 235 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHH
Confidence 5668899999999986 4589999999999999999999999987733333322222221 1111111123489999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 291 LVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 291 li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
+|..||+.||++|||+.++++||||
T Consensus 236 li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 236 LIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHccCChhHCcCHHHHhcCCCC
Confidence 9999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-46 Score=343.71 Aligned_cols=260 Identities=29% Similarity=0.502 Sum_probs=215.7
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++.+.||+|+||+||++.+..+++.||+|++.+...........+.+|+.++..+ +|++|+++++++...+..++|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQDENNLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCEEEEE
Confidence 3699999999999999999999999999999998754333333445688899999998 999999999999999999999
Q ss_pred EEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 135 MELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
|||+++|+|.+++.. ...+++..++.++.|++.||+|||+.+|+||||||+|||++.++. +||+|||++.......
T Consensus 80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~---~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH---IRLADFGSCLKLMEDG 156 (332)
T ss_pred EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC---EEEeecchheecccCC
Confidence 999999999999976 456899999999999999999999999999999999999975544 8999999987543322
Q ss_pred c--ccccccccccccchhcc------ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC-CCCCcCC
Q 018640 214 K--FSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR-RDPWPKV 284 (352)
Q Consensus 214 ~--~~~~~gt~~y~aPE~~~------~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 284 (352)
. .....||+.|+|||++. +.++.++||||||+++|||++|+.||...........+........ +.....+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDV 236 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccC
Confidence 2 23457999999999874 3478899999999999999999999988777666666554332221 1223457
Q ss_pred CHHHHHHHHHhcCCCcCC--CCCHHHHhcCcccccc
Q 018640 285 SENAKDLVRKMLDPDPKR--RLTAQQVLEHPWLQNA 318 (352)
Q Consensus 285 ~~~~~~li~~~l~~dP~~--Rps~~ell~hp~f~~~ 318 (352)
++.+.+||.+||..+|++ |+++.++++||||.+.
T Consensus 237 s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 237 SEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred CHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 999999999999765544 6899999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=340.71 Aligned_cols=259 Identities=27% Similarity=0.453 Sum_probs=212.4
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++.+.||+|+||+||+|.+..+++.||+|++..... ......+.+|+.+++++ +|+||+++++++..++..++|
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDL-KHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhC-CCCCcceEEEEEeeCCeEEEE
Confidence 469999999999999999999999999999999875432 22234577899999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 135 MELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
|||+++ +|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||++.......
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSVPT 158 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC---EEECccccceecCCCc
Confidence 999975 8888876544 4899999999999999999999999999999999999976554 8999999997643322
Q ss_pred -cccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc--------------
Q 018640 214 -KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF-------------- 276 (352)
Q Consensus 214 -~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------------- 276 (352)
......+|..|+|||.+.+ .++.++||||||+++++|++|+.||......+....+.......
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 2234467899999998753 47899999999999999999999998776655444443321110
Q ss_pred -----CC-------CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 277 -----RR-------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 277 -----~~-------~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
+. ...+.+++++.++|.+||+.||.+|||+.|+++||||+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 294 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT 294 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence 00 011346888999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-46 Score=343.82 Aligned_cols=260 Identities=27% Similarity=0.484 Sum_probs=215.8
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++.+.||+|+||+||++.+..+++.||+|++.+...........+.+|..++..+ +|++|+++++++...+..++|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEE
Confidence 4799999999999999999999999999999998764333333455688899999998 899999999999999999999
Q ss_pred EEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 135 MELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
|||++||+|.+++.. ...+++..+..++.|++.||+|||+++|+||||||+|||++.++. +||+|||++.......
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~---~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGH---IRLADFGSCLKMNQDG 156 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCC---EEEEeccceeeccCCC
Confidence 999999999999987 457899999999999999999999999999999999999975554 8999999997654332
Q ss_pred cc--cccccccccccchhccc------cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC-CCCCcCC
Q 018640 214 KF--SEIVGSPYYMAPEVLKR------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR-RDPWPKV 284 (352)
Q Consensus 214 ~~--~~~~gt~~y~aPE~~~~------~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 284 (352)
.. ....||+.|+|||++.+ .++.++||||||+++|+|++|+.||......+....+........ +.....+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDV 236 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccC
Confidence 21 33579999999998753 478899999999999999999999988776665555544322221 1223457
Q ss_pred CHHHHHHHHHhcCCCcCC--CCCHHHHhcCcccccc
Q 018640 285 SENAKDLVRKMLDPDPKR--RLTAQQVLEHPWLQNA 318 (352)
Q Consensus 285 ~~~~~~li~~~l~~dP~~--Rps~~ell~hp~f~~~ 318 (352)
++.+.++|.+||..++++ |++++++++||||...
T Consensus 237 ~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 237 SEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred CHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence 899999999999876654 5699999999999863
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-46 Score=348.95 Aligned_cols=257 Identities=29% Similarity=0.452 Sum_probs=211.7
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC-----e
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT-----A 130 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~-----~ 130 (352)
+|++.+.||+|+||+||+|.+..+|+.||+|++.... ........+.+|+.+++.+ +|+||+++++++...+ .
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 78 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFF-KHDNVLSALDILQPPHIDPFEE 78 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhC-CCCCcCCHhheecCCCccccce
Confidence 4788999999999999999999999999999886432 2333456788999999999 8999999999998766 7
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
.++|+||+. ++|.+.+.....+++..+..++.||+.||.|||+.|++||||||+|||++.++. +||+|||++....
T Consensus 79 ~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~---~kL~Dfg~a~~~~ 154 (372)
T cd07853 79 IYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV---LKICDFGLARVEE 154 (372)
T ss_pred EEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCC---EEeccccceeecc
Confidence 899999996 588888887778999999999999999999999999999999999999976544 8999999998654
Q ss_pred CCC--cccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc----------
Q 018640 211 PGE--KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF---------- 276 (352)
Q Consensus 211 ~~~--~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~---------- 276 (352)
... ......+|+.|+|||.+.+ .++.++|||||||+++||++|+.||...........+.+.....
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 322 2234467899999998764 37899999999999999999999998776655544443321100
Q ss_pred ------------CC------CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 277 ------------RR------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 277 ------------~~------~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
++ ......++++.+||.+||+.||++|||+.|+++||||...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 00 1123457889999999999999999999999999999873
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=345.65 Aligned_cols=249 Identities=29% Similarity=0.513 Sum_probs=212.3
Q ss_pred eeeeccCceEEEEEEE---CCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEe
Q 018640 61 RELGRGEFGITYLCTD---RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMEL 137 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~ 137 (352)
+.||+|+||.||++.+ ..+|+.||+|++...... ......+.+|+.+++++ +||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEV-NHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCEEEEEEcC
Confidence 6799999999999886 357899999999765332 22345677899999999 899999999999999999999999
Q ss_pred cCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC-Cccc
Q 018640 138 CEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-EKFS 216 (352)
Q Consensus 138 ~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~-~~~~ 216 (352)
+++++|.+++.....+++..++.++.||+.||.|||+.||+||||||+||+++.++. +||+|||++...... ....
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---~kL~Dfg~~~~~~~~~~~~~ 156 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH---IKLTDFGLSKESIDHEKKAY 156 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCc---EEEeeccCCcccCCCCCcee
Confidence 999999999988878999999999999999999999999999999999999976554 899999998765433 2334
Q ss_pred ccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHh
Q 018640 217 EIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKM 295 (352)
Q Consensus 217 ~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 295 (352)
...||+.|+|||.+.+ .++.++||||||+++|||++|+.||...........+..... ..+..+++.+.++|.+|
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~----~~p~~~~~~~~~li~~~ 232 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL----GMPQFLSPEAQSLLRAL 232 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC----CCCCCCCHHHHHHHHHH
Confidence 5679999999999864 588999999999999999999999988777666655554332 23346789999999999
Q ss_pred cCCCcCCCCC-----HHHHhcCcccccc
Q 018640 296 LDPDPKRRLT-----AQQVLEHPWLQNA 318 (352)
Q Consensus 296 l~~dP~~Rps-----~~ell~hp~f~~~ 318 (352)
|+.||++||+ +.+++.||||...
T Consensus 233 l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 233 FKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred hhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 9999999999 7789999999754
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=351.64 Aligned_cols=274 Identities=28% Similarity=0.459 Sum_probs=232.3
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
.++.|.-++.||.|+||.||.|++..+.+.||||++..+.-.+...+..+..|+..|.++ .|||.+.+-++|..+...|
T Consensus 24 PEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l-~HPntieYkgCyLre~TaW 102 (948)
T KOG0577|consen 24 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQL-RHPNTIEYKGCYLREHTAW 102 (948)
T ss_pred HHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhc-cCCCcccccceeeccchHH
Confidence 345688899999999999999999999999999999887666666678899999999999 9999999999999999999
Q ss_pred EEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 133 LVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
||||||- ||-.|++.- .+++.+-.+..|..+.+.||.|||+.+.||||||+.|||++ +++.|||+|||.|....+
T Consensus 103 LVMEYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs---e~g~VKLaDFGSAsi~~P 178 (948)
T KOG0577|consen 103 LVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS---EPGLVKLADFGSASIMAP 178 (948)
T ss_pred HHHHHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec---CCCeeeeccccchhhcCc
Confidence 9999995 488888764 45799999999999999999999999999999999999996 455599999999987643
Q ss_pred CCcccccccccccccchhcc----ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHH
Q 018640 212 GEKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (352)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~----~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (352)
..+++||+.|||||++- |.|+-++||||||++..||...++|+...+....+..+.+.-. +--..+.+++.
T Consensus 179 ---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNes--PtLqs~eWS~~ 253 (948)
T KOG0577|consen 179 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--PTLQSNEWSDY 253 (948)
T ss_pred ---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCC--CCCCCchhHHH
Confidence 36679999999999752 6799999999999999999999999998887776666655421 11123467899
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcCccccccccCCCCCCcHHHHHHHHhhHH
Q 018640 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSV 339 (352)
Q Consensus 288 ~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 339 (352)
+++|+..||+.-|.+|||..++|.|+|+.- ..|..-+ -++-.|.|+-++
T Consensus 254 F~~Fvd~CLqKipqeRptse~ll~H~fv~R--~Rp~tvi-~dLIqRTKdaVr 302 (948)
T KOG0577|consen 254 FRNFVDSCLQKIPQERPTSEELLKHRFVLR--ERPPTVI-MDLIQRTKDAVR 302 (948)
T ss_pred HHHHHHHHHhhCcccCCcHHHHhhcchhcc--CCCchHH-HHHHHHHHHHHH
Confidence 999999999999999999999999999984 3343333 344558887544
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=342.61 Aligned_cols=250 Identities=28% Similarity=0.503 Sum_probs=208.6
Q ss_pred eeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHH-HHHhCCCCCCeeEeeeEEEeCCeEEEEEEecC
Q 018640 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVD-IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCE 139 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~ 139 (352)
++||+|+||+||+|.+..+|+.||+|++.+...........+..|.. +++.+ +||||+++++++...+..++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCEEEEEEcCCC
Confidence 46999999999999999999999999987654333333445555654 56777 89999999999999999999999999
Q ss_pred CcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC-CCccccc
Q 018640 140 GGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEI 218 (352)
Q Consensus 140 ~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~ 218 (352)
+++|...+.....+++..+..++.||+.||.|||+.+|+||||||+||+++.++. +||+|||++..... .......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~~~~~~~~~~~~~~~ 156 (321)
T cd05603 80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGH---VVLTDFGLCKEGVEPEETTSTF 156 (321)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC---EEEccCCCCccCCCCCCccccc
Confidence 9999999988778999999999999999999999999999999999999976554 89999999875322 2223455
Q ss_pred ccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcC
Q 018640 219 VGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297 (352)
Q Consensus 219 ~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 297 (352)
.||+.|+|||.+.+ .++.++|||||||++|||++|..||...........+... +...++..+..+.++|.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~----~~~~~~~~~~~~~~li~~~l~ 232 (321)
T cd05603 157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK----PLQLPGGKTVAACDLLVGLLH 232 (321)
T ss_pred cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC----CCCCCCCCCHHHHHHHHHHcc
Confidence 78999999999864 5899999999999999999999999887766555555433 223334678899999999999
Q ss_pred CCcCCCCCH----HHHhcCcccccc
Q 018640 298 PDPKRRLTA----QQVLEHPWLQNA 318 (352)
Q Consensus 298 ~dP~~Rps~----~ell~hp~f~~~ 318 (352)
.||.+||++ .++++||||...
T Consensus 233 ~~p~~R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 233 KDQRRRLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred CCHhhcCCCCCCHHHHhCCCCcCCC
Confidence 999999875 599999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=342.73 Aligned_cols=250 Identities=27% Similarity=0.513 Sum_probs=208.7
Q ss_pred eeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHH-HHHhCCCCCCeeEeeeEEEeCCeEEEEEEecC
Q 018640 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVD-IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCE 139 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~ 139 (352)
+.||+|+||+||+|.+..+++.||+|++.............+..|.. +++.+ +|+||+++++++...+..++||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEEcCCeEEEEEeCCC
Confidence 46999999999999999999999999987653322223334444544 45667 89999999999999999999999999
Q ss_pred CcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC-CCccccc
Q 018640 140 GGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEI 218 (352)
Q Consensus 140 ~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~ 218 (352)
+++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++. +||+|||++..... .......
T Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~---~kl~DfG~a~~~~~~~~~~~~~ 156 (325)
T cd05602 80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH---IVLTDFGLCKENIEHNGTTSTF 156 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC---EEEccCCCCcccccCCCCcccc
Confidence 9999999988888999999999999999999999999999999999999976554 89999999875422 2233456
Q ss_pred ccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcC
Q 018640 219 VGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297 (352)
Q Consensus 219 ~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 297 (352)
.||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+.... ....+.++..+.++|.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~----~~~~~~~~~~~~~li~~~l~ 232 (325)
T cd05602 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP----LQLKPNITNSARHLLEGLLQ 232 (325)
T ss_pred cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC----cCCCCCCCHHHHHHHHHHcc
Confidence 79999999998864 58899999999999999999999999877766655554432 22335689999999999999
Q ss_pred CCcCCCCCHH----HHhcCcccccc
Q 018640 298 PDPKRRLTAQ----QVLEHPWLQNA 318 (352)
Q Consensus 298 ~dP~~Rps~~----ell~hp~f~~~ 318 (352)
.||.+||++. ++++|+||...
T Consensus 233 ~~p~~R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 233 KDRTKRLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred cCHHHCCCCCCCHHHHhcCcccCCC
Confidence 9999999865 89999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=343.55 Aligned_cols=258 Identities=26% Similarity=0.403 Sum_probs=210.0
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC---
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--- 128 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~--- 128 (352)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.+ +||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~~~~~ 98 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSL 98 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhc-CCCCccccceeecccccc
Confidence 35678999999999999999999999999999999987542 2233456778899999999 899999999987543
Q ss_pred ---CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccc
Q 018640 129 ---TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (352)
Q Consensus 129 ---~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~ 205 (352)
...++||||+++ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||+
T Consensus 99 ~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~---~kL~DfG~ 172 (364)
T cd07875 99 EEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGL 172 (364)
T ss_pred cccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCc---EEEEeCCC
Confidence 357999999965 77777753 4889999999999999999999999999999999999976554 89999999
Q ss_pred ceecCCCCcccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC-------
Q 018640 206 SVFFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR------- 277 (352)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------- 277 (352)
++............||..|+|||++.+ .++.++|||||||++|+|++|+.||......+....+........
T Consensus 173 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 173 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred ccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 987654444455678999999998864 589999999999999999999999987776555544433211100
Q ss_pred -------------------------------CCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccc
Q 018640 278 -------------------------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (352)
Q Consensus 278 -------------------------------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~ 317 (352)
.......+..+.+||.+||+.||.+|||+.++|+||||..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 0001113567899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=344.24 Aligned_cols=259 Identities=26% Similarity=0.401 Sum_probs=208.9
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC---
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--- 128 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~--- 128 (352)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKSL 91 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHh-CCCchhceeeeeeccccc
Confidence 45678999999999999999999999999999999987543 2233456778899999999 899999999988643
Q ss_pred ---CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccc
Q 018640 129 ---TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (352)
Q Consensus 129 ---~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~ 205 (352)
...++||||+++ +|.+.+.. .+++..+..++.|++.||.|||+.||+||||||+||+++.++. +||+|||+
T Consensus 92 ~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~---~kl~Dfg~ 165 (355)
T cd07874 92 EEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGL 165 (355)
T ss_pred cccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCC---EEEeeCcc
Confidence 357999999965 77776643 4889999999999999999999999999999999999976544 89999999
Q ss_pred ceecCCCCcccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc--------
Q 018640 206 SVFFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF-------- 276 (352)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------- 276 (352)
++............||..|+|||++.+ .++.++||||||+++|+|++|+.||.+.................
T Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred cccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 987654444455688999999998764 58999999999999999999999998766544333322211100
Q ss_pred ------------------------------CCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 277 ------------------------------RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 277 ------------------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
........+..+.+||.+||+.||++|||+.|+++||||...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 000111235678999999999999999999999999999744
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=325.75 Aligned_cols=255 Identities=28% Similarity=0.495 Sum_probs=214.1
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCC--hhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT--AVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
+.|.+.+.||+|++|.||.|.+..+++.||+|.+....... ......+.+|+.+++++ +||||+++++++..+...+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQYYGCLRDDETLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEccCCeEE
Confidence 46899999999999999999999999999999886543221 22345788999999999 9999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
+|+||+++++|.+.+.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 81 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~---~~l~dfg~~~~~~~~ 157 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGN---VKLGDFGASKRLQTI 157 (263)
T ss_pred EEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC---EEEeecccceecccc
Confidence 99999999999999988888999999999999999999999999999999999999976554 899999998765332
Q ss_pred Ccc----cccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHH
Q 018640 213 EKF----SEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (352)
Q Consensus 213 ~~~----~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (352)
... ....|+..|+|||.+.+ .++.++||||||+++|++++|+.||............... .........+++.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 235 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ--PTNPQLPSHVSPD 235 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhcc--CCCCCCCccCCHH
Confidence 111 23467889999999874 4889999999999999999999999766554443333222 1222334568899
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 288 ~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
+.++|.+||+.+|++|||+.++++||||
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 236 ARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 9999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=331.15 Aligned_cols=255 Identities=32% Similarity=0.597 Sum_probs=220.6
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++.+.||+|++|.||++.+..+++.||+|++...........+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHPFLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCeEEEE
Confidence 3699999999999999999999999999999998765444444567789999999999 799999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCc
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (352)
|||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. +||+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~---~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGY---IKITDFGFAKRVKGR-- 154 (290)
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC---EEEeeCCCccccCCC--
Confidence 999999999999988888999999999999999999999999999999999999976554 899999999876443
Q ss_pred ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHH
Q 018640 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (352)
Q Consensus 215 ~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 293 (352)
.....|++.|+|||.+. ...+.++||||||+++++|++|..||...........+.... ...+..++..+.++|.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~ 230 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK----VRFPSFFSPDAKDLIR 230 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC----ccCCccCCHHHHHHHH
Confidence 34457899999999876 457889999999999999999999998776554444444322 2233457899999999
Q ss_pred HhcCCCcCCCC-----CHHHHhcCccccccc
Q 018640 294 KMLDPDPKRRL-----TAQQVLEHPWLQNAK 319 (352)
Q Consensus 294 ~~l~~dP~~Rp-----s~~ell~hp~f~~~~ 319 (352)
+||+.||.+|+ +++++++||||....
T Consensus 231 ~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 231 NLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred HHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 99999999999 999999999998654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=333.73 Aligned_cols=259 Identities=26% Similarity=0.452 Sum_probs=211.7
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.+ +|+||+++++++..++..++|
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDL-KHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhc-CCCCcceEEEEEecCCeEEEE
Confidence 469999999999999999999999999999998865432 22234577899999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
|||++ ++|.+++... ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++. ++|+|||++.......
T Consensus 83 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~---~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 83 FEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPT 158 (301)
T ss_pred Eeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCc---EEECcCcchhccCCCC
Confidence 99997 4898888754 45899999999999999999999999999999999999976554 8999999987543222
Q ss_pred -cccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC------------
Q 018640 214 -KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR------------ 278 (352)
Q Consensus 214 -~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------------ 278 (352)
......+++.|+|||.+.+ .++.++||||||+++|+|++|+.||......+....+.........
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 2234467899999998753 4788999999999999999999999877665544433322111000
Q ss_pred --------------CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 279 --------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 279 --------------~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
...+.+++.+.+||.+||+.||.+|||+.|+++||||+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~ 294 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE 294 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 011246888999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=353.24 Aligned_cols=254 Identities=28% Similarity=0.425 Sum_probs=214.8
Q ss_pred ccceeceeeeccCceEEEEEEECCC-CcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDREN-GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
..|.+.+.||+|++|.||+|.+..+ +..||+|.+... .......+.+|+.+++.+ +||||+++++++...+..++
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAAC-DHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEECCEEEE
Confidence 3599999999999999999998877 788999976433 233345678899999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 134 VMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+|+||||||+|||++.++. +||+|||++...
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~---~kL~DFgla~~~ 219 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI---IKLGDFGFSKQY 219 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCc---EEEEeCcCceec
Confidence 9999999999987754 345899999999999999999999999999999999999976554 899999999876
Q ss_pred CCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCC
Q 018640 210 KPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (352)
Q Consensus 210 ~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (352)
..... .....||+.|+|||++. ..++.++|||||||++|+|++|+.||......+....+...... ..+..++
T Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~---~~~~~~s 296 (478)
T PTZ00267 220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD---PFPCPVS 296 (478)
T ss_pred CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---CCCccCC
Confidence 43321 24457999999999986 45899999999999999999999999887776665555443221 2234678
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 286 ~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
..+.++|..||+.||++||++.+++.|||++..
T Consensus 297 ~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 297 SGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 999999999999999999999999999999753
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=354.11 Aligned_cols=260 Identities=27% Similarity=0.467 Sum_probs=217.2
Q ss_pred ccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC-
Q 018640 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT- 129 (352)
Q Consensus 51 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~- 129 (352)
....++|++.+.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+..+..+ +|+|++++.+.+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~-~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNC-DFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcC-CCCcEEEeecceecccc
Confidence 3455789999999999999999999999999999999876533 334456788899999999 8999999988765332
Q ss_pred -------eEEEEEEecCCcchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCE
Q 018640 130 -------AVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPL 198 (352)
Q Consensus 130 -------~~~lv~e~~~~~sL~~~l~~~----~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~v 198 (352)
..++||||+++|+|.+++..+ ..+++..+..++.|++.||+|||+.+|+||||||+|||++.++. +
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~---v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL---V 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCC---E
Confidence 368999999999999988653 35899999999999999999999999999999999999976554 8
Q ss_pred EEEecccceecCCC---Ccccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Q 018640 199 KAIDFGLSVFFKPG---EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL 274 (352)
Q Consensus 199 kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 274 (352)
||+|||+++..... .......||+.|+|||++.+ .++.++||||||+++|||++|+.||.................
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~ 262 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY 262 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence 99999999765322 12245679999999999874 589999999999999999999999988777665555543322
Q ss_pred ccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 275 DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 275 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
...++.+++++.+++..||+.||.+||++.++++|||++..
T Consensus 263 ---~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 263 ---DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred ---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 22345688999999999999999999999999999998753
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=342.72 Aligned_cols=255 Identities=33% Similarity=0.566 Sum_probs=229.2
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe-EEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA-VHL 133 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~-~~l 133 (352)
++|..++++|+|+||.+++++.+.++..+++|.+........ ..+...+|+.+++++ .|||||.+.+.|++++. .+|
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~-~r~~A~~E~~lis~~-~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP-ERRSAIQEMDLLSKL-LHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch-hhHHHHHHHHHHHhc-cCCCeeeeccchhcCCceEEE
Confidence 569999999999999999999999999999999987765444 344678899999999 99999999999998888 999
Q ss_pred EEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 134 VMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
||+|++||+|.+.+...+ .++++.+..++.|++.|+.|||+++|+|||||+.||+++.+.. |+|+|||+|+...+
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~---VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKK---VKLGDFGLAKILNP 158 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCc---eeecchhhhhhcCC
Confidence 999999999999997654 5899999999999999999999999999999999999986665 89999999998877
Q ss_pred CC-cccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHH
Q 018640 212 GE-KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (352)
Q Consensus 212 ~~-~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (352)
.. ...+.+||+.|++||.+.+ .|+.|+|||||||++|||++-+.+|...+..+....+.+.... +.+..++.++.
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~---Plp~~ys~el~ 235 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYS---PLPSMYSSELR 235 (426)
T ss_pred chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCC---CCCccccHHHH
Confidence 65 5578899999999999985 5999999999999999999999999999988888888877632 23346899999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcCccccc
Q 018640 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (352)
Q Consensus 290 ~li~~~l~~dP~~Rps~~ell~hp~f~~ 317 (352)
.+|..||+.+|..||++.++|.+|....
T Consensus 236 ~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 236 SLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred HHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 9999999999999999999999998873
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=327.57 Aligned_cols=270 Identities=28% Similarity=0.491 Sum_probs=224.1
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++.+.||.|++|.||+|.+..+++.||+|.+.... .......+.+|+.+++.+ +|+|++++++++.++...++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQC-RSPYITKYYGSFLKGSKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHc-CCCCeeeeeEEEEECCeEEEE
Confidence 36899999999999999999999999999999987542 233456788999999999 799999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC-C
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-E 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~-~ 213 (352)
+||+++++|.+++... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++...... .
T Consensus 78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~---~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 78 MEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD---VKLADFGVSGQLTSTMS 153 (274)
T ss_pred EEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC---EEEcccccceeeccccc
Confidence 9999999999998765 7899999999999999999999999999999999999976554 899999999876543 2
Q ss_pred cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcC-CCHHHHHH
Q 018640 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-VSENAKDL 291 (352)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l 291 (352)
......++..|+|||.+. ..++.++||||||+++|+|++|..||...........+.... .+..... ++..+.++
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 230 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN---PPSLEGNKFSKPFKDF 230 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC---CCCCcccccCHHHHHH
Confidence 234457888999999876 458999999999999999999999997665444433333321 1222222 78899999
Q ss_pred HHHhcCCCcCCCCCHHHHhcCccccccccCCCCCCcHHHHHHHHhh
Q 018640 292 VRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQF 337 (352)
Q Consensus 292 i~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~ 337 (352)
+.+||..+|++|||+.++++||||.+.... +....++.+.|.|
T Consensus 231 l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~---~~~~~~~~~~~~~ 273 (274)
T cd06609 231 VSLCLNKDPKERPSAKELLKHKFIKKAKKT---SYLTLLIERIKKW 273 (274)
T ss_pred HHHHhhCChhhCcCHHHHhhChhhcCCCcc---cHHHHHHHHHHhc
Confidence 999999999999999999999999986543 5555555555543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=344.41 Aligned_cols=262 Identities=24% Similarity=0.329 Sum_probs=207.3
Q ss_pred cccccCCCcccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEe
Q 018640 42 LCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCL 121 (352)
Q Consensus 42 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l 121 (352)
...+...+...++++|.-.+.||+|+||.||+|... +|..||||++....... ..+|.+|+.++.++ +|||+|+|
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l-~H~Nlv~L 136 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG---EREFLNEVEILSRL-RHPNLVKL 136 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc---hhHHHHHHHHHhcC-CCcCcccE
Confidence 444556667778899999999999999999999975 46999999876543221 35599999999999 79999999
Q ss_pred eeEEEeCC-eEEEEEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC---CEEecCCCCceEeecCCCC
Q 018640 122 KDTYEDDT-AVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHG---VMHRDLKPENFLFANKKET 195 (352)
Q Consensus 122 ~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dikp~NIll~~~~~~ 195 (352)
+|||.+.+ ..+||+||+++|+|.++|.... .++|..+.+|+.+++.||+|||... ||||||||+|||+|.++.
T Consensus 137 lGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~- 215 (361)
T KOG1187|consen 137 LGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN- 215 (361)
T ss_pred EEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC-
Confidence 99999988 5999999999999999998765 7999999999999999999999854 999999999999987776
Q ss_pred CCEEEEecccceecCC-CCccccc-ccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCC---H---HHHH
Q 018640 196 APLKAIDFGLSVFFKP-GEKFSEI-VGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET---E---QGVA 266 (352)
Q Consensus 196 ~~vkl~Dfg~a~~~~~-~~~~~~~-~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~---~---~~~~ 266 (352)
.||+|||+|+.... ....... .||.+|+|||++. +..+.++||||||++|+|++||+.+..... . ....
T Consensus 216 --aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~ 293 (361)
T KOG1187|consen 216 --AKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWA 293 (361)
T ss_pred --EEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHH
Confidence 59999999976554 3333333 8999999999986 679999999999999999999998876432 1 1111
Q ss_pred HHHHhc--ccccCCCCC--cCCC-----HHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 267 QAIIRS--VLDFRRDPW--PKVS-----ENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 267 ~~~~~~--~~~~~~~~~--~~~~-----~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
...... ......+.+ ...+ ..+..+...|++.+|..||+|.||+.
T Consensus 294 ~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 294 KPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred HHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 111111 111111111 1222 23667889999999999999999754
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=366.01 Aligned_cols=267 Identities=29% Similarity=0.507 Sum_probs=218.6
Q ss_pred CcccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe-
Q 018640 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED- 127 (352)
Q Consensus 49 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~- 127 (352)
.+....++|++++.||+|+||+||+|.+..++..||+|++..... .......+..|+.+++.+ +|||||+++++|..
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L-~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMREL-KHKNIVRYIDRFLNK 84 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEec
Confidence 344566789999999999999999999999999999999876533 233456788999999999 89999999998854
Q ss_pred -CCeEEEEEEecCCcchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHc-------CCEEecCCCCceEeecCC--
Q 018640 128 -DTAVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTKTIVEVVQMCHKH-------GVMHRDLKPENFLFANKK-- 193 (352)
Q Consensus 128 -~~~~~lv~e~~~~~sL~~~l~~~----~~l~~~~~~~i~~qi~~aL~~lH~~-------~ivH~Dikp~NIll~~~~-- 193 (352)
...++|||||+++++|.++|... ..+++..++.|+.||+.||.|||+. +||||||||+|||++.+.
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 45789999999999999988652 4699999999999999999999985 499999999999996432
Q ss_pred ------------CCCCEEEEecccceecCCCCcccccccccccccchhcc---ccCCCcchHHHHHHHHHHHHhCCCCCC
Q 018640 194 ------------ETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFW 258 (352)
Q Consensus 194 ------------~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~s~~~Di~SlG~~l~el~tg~~p~~ 258 (352)
....+||+|||++.............||+.|+|||++. ..++.++|||||||+||+|++|..||.
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 23348999999998765444445568999999999874 247899999999999999999999997
Q ss_pred CCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 259 AETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
.............. .+.......+.++.+||..||+.+|.+||++.++|.||||+....
T Consensus 245 ~~~~~~qli~~lk~---~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 245 KANNFSQLISELKR---GPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP 303 (1021)
T ss_pred cCCcHHHHHHHHhc---CCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence 66544333333222 222233457899999999999999999999999999999986543
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-46 Score=337.96 Aligned_cols=268 Identities=37% Similarity=0.646 Sum_probs=238.7
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
.|.+-|.+.+.||+|.|++|-+|++.-+|+.||||++++...... .-..+.+|++-|+.+ +|||||+|+++......+
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~-st~hlfqEVRCMKLV-QHpNiVRLYEViDTQTKl 92 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLV-QHPNIVRLYEVIDTQTKL 92 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh-hhhHHHHHHHHHHHh-cCcCeeeeeehhcccceE
Confidence 466779999999999999999999999999999999998765443 345677899999999 999999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 132 HLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
|||+|.=++|+|++++.++. .+.+..+.+++.||+.|+.|+|+..+|||||||+|+.+.. .-+.|||+|||++..+.
T Consensus 93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFE--KlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFE--KLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEee--ecCceEeeeccccccCC
Confidence 99999999999999997664 5999999999999999999999999999999999998863 34459999999999999
Q ss_pred CCCcccccccccccccchhcccc-C-CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHH
Q 018640 211 PGEKFSEIVGSPYYMAPEVLKRN-Y-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (352)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~~~-~-s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (352)
+++...+.+|+..|.|||++-+. | .+..||||||++||.|++|++||...+..+.+-.+...... .+..++.++
T Consensus 171 PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYt----vPshvS~eC 246 (864)
T KOG4717|consen 171 PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYT----VPSHVSKEC 246 (864)
T ss_pred CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccccc----CchhhhHHH
Confidence 99999999999999999987654 5 45799999999999999999999998888887777766444 345789999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcCccccccccCCCCCCc
Q 018640 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLG 327 (352)
Q Consensus 289 ~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~ 327 (352)
++||..||..||.+|.|.+||..++|++.....+.+.++
T Consensus 247 rdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT~iP 285 (864)
T KOG4717|consen 247 RDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLSTAIP 285 (864)
T ss_pred HHHHHHHHhcCchhhccHHHHhccccccCCCCCccccCc
Confidence 999999999999999999999999999988877776665
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=339.90 Aligned_cols=260 Identities=27% Similarity=0.461 Sum_probs=209.6
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC---
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--- 128 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~--- 128 (352)
.+.++|++++.||+|+||+||+|.+..++..||+|++.... ........+.+|+.+++.+ +|+||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF-QSLIHARRTYRELRLLKHM-KHENVIGLLDVFTPATSI 89 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh-hhhHHHHHHHHHHHHHHhc-CCCchhhhhhhhcccccc
Confidence 45678999999999999999999999999999999987542 2223345677899999999 899999999987533
Q ss_pred ---CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccc
Q 018640 129 ---TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (352)
Q Consensus 129 ---~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~ 205 (352)
...+++++++ +++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+||+++.++. +||+|||+
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~---~kl~Dfg~ 164 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE---LRILDFGL 164 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCC---EEEcCCcc
Confidence 3578999998 6789887753 46999999999999999999999999999999999999976554 89999999
Q ss_pred ceecCCCCcccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc-------
Q 018640 206 SVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF------- 276 (352)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~------- 276 (352)
+...... .....||..|+|||++.+ .++.++||||||+++|+|++|..||...........+.......
T Consensus 165 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07878 165 ARQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242 (343)
T ss_pred ceecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 9865432 244578999999998764 48899999999999999999999997765544433332211110
Q ss_pred ----------------CCC----CCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 277 ----------------RRD----PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 277 ----------------~~~----~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
+.. .....++.+.+||.+||+.||++|||+.|+++||||.....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~ 306 (343)
T cd07878 243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD 306 (343)
T ss_pred cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence 000 01235667899999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=327.52 Aligned_cols=256 Identities=30% Similarity=0.589 Sum_probs=211.6
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++.+.||+|++|.||+|.+..+|+.||+|++..... .....+.+.+|+.+++.+ +|+|++++++++......++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQL-KHPNLVNLIEVFRRKRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhC-CCCCEeeeeeEEeeCCEEEEE
Confidence 469999999999999999999998999999998865432 222345678899999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC-
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (352)
|||+++++|..++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~---~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQ---IKLCDFGFARILTGPGD 155 (286)
T ss_pred EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCc---EEECccccceecCCCcc
Confidence 999999888887776667999999999999999999999999999999999999976554 8999999998764433
Q ss_pred cccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc---------------
Q 018640 214 KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF--------------- 276 (352)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~--------------- 276 (352)
......++..|+|||.+.+ .++.++|+||||+++++|++|..||......+....+.......
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 2334467889999998753 47889999999999999999999998766554443332211110
Q ss_pred ----CC--------CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 277 ----RR--------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 277 ----~~--------~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
+. ...+.++..+.+|+.+||+.+|++||++.|++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 00 0123467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-45 Score=328.08 Aligned_cols=258 Identities=22% Similarity=0.363 Sum_probs=209.1
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++++.||+|+||.||+|.+..++..||+|++.... .......+.+|+.+++++ +||||+++++++...+..++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 77 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKC-DSPYIIGFYGAFFVENRISIC 77 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEECCEEEEE
Confidence 36889999999999999999999999999999886542 233346788999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCc
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (352)
|||+++++|..+ ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++...... .
T Consensus 78 ~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~---~~l~dfg~~~~~~~~-~ 149 (279)
T cd06619 78 TEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ---VKLCDFGVSTQLVNS-I 149 (279)
T ss_pred EecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCC---EEEeeCCcceecccc-c
Confidence 999999998654 25789999999999999999999999999999999999976554 899999999765432 2
Q ss_pred ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhcccc--cCCCCCcCCCHHH
Q 018640 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQG---VAQAIIRSVLD--FRRDPWPKVSENA 288 (352)
Q Consensus 215 ~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~---~~~~~~~~~~~--~~~~~~~~~~~~~ 288 (352)
.....||..|+|||.+. ..++.++|+||||+++|+|++|..||....... ........... .........++++
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKF 229 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHH
Confidence 23457899999999876 458999999999999999999999996532111 00111111111 1111223578899
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcCccccccccCCC
Q 018640 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPN 323 (352)
Q Consensus 289 ~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~ 323 (352)
.++|.+||+.+|++||++.++++||||......+.
T Consensus 230 ~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~~~ 264 (279)
T cd06619 230 VHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNA 264 (279)
T ss_pred HHHHHHHhhCChhhCCCHHHHhcCcccccccCccH
Confidence 99999999999999999999999999997754443
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-45 Score=328.48 Aligned_cols=274 Identities=29% Similarity=0.424 Sum_probs=223.2
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++++.||+|+||.||+|.+..+|..||+|.+.... .......+.+|+.+++++ +|+||+++++.+...+..++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKA-VSPYIVDFYGAFFIEGAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhc-CCCcHHhhhhheecCCeEEEE
Confidence 36899999999999999999999899999999886431 233456788999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH-cCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 135 MELCEGGELFDRIVAR---GHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~---~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
|||+++++|..++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++. ++|+|||++....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~---~~l~dfg~~~~~~ 154 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQ---VKLCDFGVSGNLV 154 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCC---EEEeecCCccccc
Confidence 9999999999888763 368999999999999999999997 59999999999999976444 8999999987653
Q ss_pred CCCcccccccccccccchhccc-------cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcC
Q 018640 211 PGEKFSEIVGSPYYMAPEVLKR-------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (352)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~~-------~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (352)
.. ......++..|+|||.+.+ .++.++|+||||+++|+|++|..||...........+...........++.
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd06622 155 AS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG 233 (286)
T ss_pred CC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcc
Confidence 22 2233467889999998742 247899999999999999999999976554443333322222223334456
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccCCCCCCcHHHHHHHHh
Q 018640 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQ 336 (352)
Q Consensus 284 ~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~ 336 (352)
++.++.++|.+||+.+|++||++.++++||||..... +..++.+.+..++++
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~ 285 (286)
T cd06622 234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN-ADVDMAEWVTGALKR 285 (286)
T ss_pred cCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC-CccchHHHHHHHHhc
Confidence 8999999999999999999999999999999997654 466666666656553
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=337.72 Aligned_cols=251 Identities=23% Similarity=0.355 Sum_probs=199.5
Q ss_pred cccceeceeeeccCceEEEEEEE-----CCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC
Q 018640 54 EERYELGRELGRGEFGITYLCTD-----RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 128 (352)
.++|++.+.||+|+||.||+|.+ ..++..||+|++.... .......+.+|+.++..+.+||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 35799999999999999999975 2346789999986432 2233467889999999998899999999988754
Q ss_pred -CeEEEEEEecCCcchHHHHHhc---------------------------------------------------------
Q 018640 129 -TAVHLVMELCEGGELFDRIVAR--------------------------------------------------------- 150 (352)
Q Consensus 129 -~~~~lv~e~~~~~sL~~~l~~~--------------------------------------------------------- 150 (352)
...++||||+++|+|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4688999999999999998653
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCc---cccccccc
Q 018640 151 -----GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSP 222 (352)
Q Consensus 151 -----~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~ 222 (352)
..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+++....... .....++.
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~---~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNV---VKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCc---EEEeecccccccccCcchhcccCCCCCc
Confidence 23677888999999999999999999999999999999975544 89999999976533221 12335678
Q ss_pred ccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCc
Q 018640 223 YYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300 (352)
Q Consensus 223 ~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP 300 (352)
.|+|||++. ..++.++||||||+++|||++ |..||................. ........++.+.+++.+||+.||
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp 318 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT--RMRAPENATPEIYRIMLACWQGDP 318 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCC--CCCCCCCCCHHHHHHHHHHccCCh
Confidence 899999876 558999999999999999997 9999976543332222222211 122234678999999999999999
Q ss_pred CCCCCHHHHhc
Q 018640 301 KRRLTAQQVLE 311 (352)
Q Consensus 301 ~~Rps~~ell~ 311 (352)
++|||+.++++
T Consensus 319 ~~RPs~~el~~ 329 (338)
T cd05102 319 KERPTFSALVE 329 (338)
T ss_pred hhCcCHHHHHH
Confidence 99999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=325.26 Aligned_cols=255 Identities=29% Similarity=0.495 Sum_probs=217.9
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
+|++.+.||.|+||.||+|.+..+++.||+|++...........+.+.+|+++++++ +||||+++++.+.+....++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-CCCChHHHHHhhcCCCeEEEEE
Confidence 488999999999999999999989999999999876544444567899999999999 9999999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCcc
Q 018640 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF 215 (352)
Q Consensus 136 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~ 215 (352)
||+++++|.+++.....+++..+..++.|++.||.|||+++++|+||+|+||+++.++. ++|+|||++.........
T Consensus 80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~---~~l~d~~~~~~~~~~~~~ 156 (258)
T cd05578 80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGH---VHITDFNIATKVTPDTLT 156 (258)
T ss_pred eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCC---EEEeecccccccCCCccc
Confidence 99999999999988778999999999999999999999999999999999999976554 899999998876544344
Q ss_pred cccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHH
Q 018640 216 SEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK 294 (352)
Q Consensus 216 ~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 294 (352)
....|+..|+|||.+.. .++.++|+||||+++|+|++|..||...... ....+...........+...+..+.++|.+
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 235 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIRAKQETADVLYPATWSTEAIDAINK 235 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHHHHhccccccCcccCcHHHHHHHHH
Confidence 55678899999998764 4799999999999999999999999876631 111112222213333445678999999999
Q ss_pred hcCCCcCCCCCH--HHHhcCccc
Q 018640 295 MLDPDPKRRLTA--QQVLEHPWL 315 (352)
Q Consensus 295 ~l~~dP~~Rps~--~ell~hp~f 315 (352)
||+.||.+||++ .++++||||
T Consensus 236 ~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 236 LLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HccCChhHcCCccHHHHhcCCCC
Confidence 999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=340.48 Aligned_cols=250 Identities=23% Similarity=0.355 Sum_probs=198.9
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
.+|++++.||+|+||.||+|.+..++..||+|+.... ....|+.+++++ +|+||+++++++......++|
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNV-NHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhC-CCCCCcChhheEEeCCeeEEE
Confidence 4699999999999999999999999999999975432 234689999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
+|++. ++|.+++... ..+++..+..|+.||+.||.|||+.||+||||||+|||++.++. ++|+|||++.......
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~---~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQ---VCIGDLGAAQFPVVAP 211 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC---EEEecCccccccccCc
Confidence 99995 5888888653 46999999999999999999999999999999999999976554 8999999997544333
Q ss_pred cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHH----------HHHHHHHhcccccCCCC--
Q 018640 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ----------GVAQAIIRSVLDFRRDP-- 280 (352)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~----------~~~~~~~~~~~~~~~~~-- 280 (352)
......||..|+|||++. ..++.++|||||||++|||+++..|+...... ..+..+.......+...
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 344567999999999876 45899999999999999999865554322110 11111111111000000
Q ss_pred ----------------------------CcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 281 ----------------------------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 281 ----------------------------~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
...++.++.+||.+||+.||.+|||+.|+|+||||++.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence 01346677889999999999999999999999999863
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=335.24 Aligned_cols=263 Identities=19% Similarity=0.294 Sum_probs=206.5
Q ss_pred eceeeecc--CceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEE
Q 018640 59 LGRELGRG--EFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (352)
Q Consensus 59 ~~~~lG~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e 136 (352)
++++||+| +|++||++.+..+|+.||+|++...... ....+.+.+|+.+++.+ +||||+++++++..++..++|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCEEEEEEe
Confidence 56889999 7899999999999999999998765322 22345677899999999 99999999999999999999999
Q ss_pred ecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC-C
Q 018640 137 LCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-E 213 (352)
Q Consensus 137 ~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~-~ 213 (352)
|+++++|.+++... ..+++..++.++.|++.||+|||+.+|+||||||+||+++.++. ++++||+.+...... .
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~---~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK---VYLSGLRSNLSMINHGQ 156 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCc---EEEcccchhhccccccc
Confidence 99999999998653 35899999999999999999999999999999999999976554 899999865432111 1
Q ss_pred c-------ccccccccccccchhccc---cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC------
Q 018640 214 K-------FSEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR------ 277 (352)
Q Consensus 214 ~-------~~~~~gt~~y~aPE~~~~---~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------ 277 (352)
. .....++..|+|||++.+ .++.++|||||||+++||++|..||....................
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence 0 112356778999999863 488999999999999999999999976554333222221111000
Q ss_pred ------------------------------------CCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccC
Q 018640 278 ------------------------------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKA 321 (352)
Q Consensus 278 ------------------------------------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~ 321 (352)
......+++.+.+||.+||+.||++|||+.++++||||++....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~~~ 316 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRR 316 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcchh
Confidence 00011346789999999999999999999999999999986654
Q ss_pred CCCCC
Q 018640 322 PNVSL 326 (352)
Q Consensus 322 ~~~~~ 326 (352)
+...+
T Consensus 317 ~~~~~ 321 (327)
T cd08227 317 ASEAL 321 (327)
T ss_pred hhhhh
Confidence 44333
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=323.62 Aligned_cols=255 Identities=26% Similarity=0.472 Sum_probs=210.3
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC---
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--- 128 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~--- 128 (352)
..++.|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.++.++.+|+|++++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 35667999999999999999999999999999999986432 23467889999999987799999999998643
Q ss_pred ---CeEEEEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEec
Q 018640 129 ---TAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDF 203 (352)
Q Consensus 129 ---~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Df 203 (352)
...+++|||+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+||
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~---~~l~Df 155 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE---VKLVDF 155 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCC---EEEccC
Confidence 4689999999999999998864 35899999999999999999999999999999999999976554 899999
Q ss_pred ccceecCCC-Ccccccccccccccchhcc------ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc
Q 018640 204 GLSVFFKPG-EKFSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF 276 (352)
Q Consensus 204 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 276 (352)
|++...... .......|+..|+|||++. ..++.++|+||||+++|||++|..||............... ..
T Consensus 156 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~--~~ 233 (272)
T cd06637 156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN--PA 233 (272)
T ss_pred CCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC--CC
Confidence 999765432 2234457899999999874 24788999999999999999999999766544333332221 11
Q ss_pred CCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 277 RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 277 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
.......++..+.+|+.+||+.+|.+|||+.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 234 PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 222234578999999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=329.94 Aligned_cols=257 Identities=26% Similarity=0.415 Sum_probs=211.2
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++.+.||+|+||.||++.+..++..+|+|.+.... .......+.+|++++.++ +||||+++++++..++..++|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHEC-NSPYIVGFYGAFYSDGEISIC 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCEEEEE
Confidence 36999999999999999999999999999999886432 223345688899999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
|||+++++|.+++.....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++. ++|+|||++......
T Consensus 78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~---~~l~dfg~~~~~~~~- 153 (308)
T cd06615 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDS- 153 (308)
T ss_pred eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCc---EEEccCCCccccccc-
Confidence 9999999999999888889999999999999999999997 59999999999999976554 899999998755332
Q ss_pred cccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc----------------
Q 018640 214 KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF---------------- 276 (352)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~---------------- 276 (352)
......|+..|+|||.+.+ .++.++|+||||+++++|++|+.||...........+.......
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 2244578999999998764 48899999999999999999999986554332221111110000
Q ss_pred ------------------CCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 277 ------------------RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 277 ------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
+..+...++.++.+++.+||+.+|++|||+.++++||||.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 000111367889999999999999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=321.98 Aligned_cols=253 Identities=28% Similarity=0.500 Sum_probs=212.3
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCCh------hcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA------VDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 129 (352)
+|.+...||+|++|.||+|.+..++..||+|.+........ ...+.+.+|+.+++++ +||||+++++++...+
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHENIVQYLGSSLDAD 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCC
Confidence 47788999999999999999988899999998865432221 1235688899999999 8999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
..++++||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~---~~l~dfg~~~~~ 156 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG---IKISDFGISKKL 156 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCC---EEecccCCCccc
Confidence 99999999999999999988888999999999999999999999999999999999999975544 899999998765
Q ss_pred CCCC-------cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCC
Q 018640 210 KPGE-------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281 (352)
Q Consensus 210 ~~~~-------~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (352)
.... ......|+..|+|||.+. ..++.++|+||||+++|+|++|..||...........+.. ...+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~ 233 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE---NASPEIP 233 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc---cCCCcCC
Confidence 4211 112345788999999876 4588899999999999999999999987655444333322 2223334
Q ss_pred cCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 282 ~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
...+..+.++|.+||+.||++||++.++++||||
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 234 SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred cccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 4678999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=331.10 Aligned_cols=258 Identities=31% Similarity=0.550 Sum_probs=217.5
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++.+.||+|++|+||+|.+..+++.||+|.+.............+.+|+.++..+ +|+||+++++.+......++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPTLYASFQTETYLCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhC-CCCCchhheeeeecCCEEEEE
Confidence 3689999999999999999999989999999999876444334556788999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 135 MELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
|||+.+++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~---~~l~dfg~~~~~~~~ 156 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGH---IMLSDFDLSKQSDVE 156 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCC---EEEeecchhhccccc
Confidence 9999999999998754 46899999999999999999999999999999999999976544 899999988654321
Q ss_pred C------------------------------cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 018640 213 E------------------------------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET 261 (352)
Q Consensus 213 ~------------------------------~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~ 261 (352)
. ......||..|+|||.+. ..++.++||||||+++|+|++|..||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 1 112346788999999876 448889999999999999999999998777
Q ss_pred HHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCC----HHHHhcCcccccc
Q 018640 262 EQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLT----AQQVLEHPWLQNA 318 (352)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps----~~ell~hp~f~~~ 318 (352)
.......+......++ ....+++.+.++|.+||+.||++||| +.++++||||++.
T Consensus 237 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 237 RDETFSNILKKEVTFP--GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred hHHHHHHHhcCCccCC--CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence 6655555443322222 12237899999999999999999999 9999999999975
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=318.83 Aligned_cols=252 Identities=25% Similarity=0.457 Sum_probs=214.7
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
+|.+.+.||+|++|.||+|.+..+++.|++|.+...... ....+.+.+|+.+++.+ +|||++++++++...+..++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKL-DSSYIIRYYESFLDKGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhc-CCCCeehheeeeccCCEEEEEE
Confidence 478899999999999999999999999999998754332 34567788999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 136 ELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 136 e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~---~~l~df~~~~~~~~~~ 155 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN---VKIGDLGVAKLLSDNT 155 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCC---EEEcccccceeccCcc
Confidence 999999999999764 46899999999999999999999999999999999999986554 8999999988664432
Q ss_pred c-ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHH
Q 018640 214 K-FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (352)
Q Consensus 214 ~-~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 291 (352)
. .....|+..|+|||++. ..++.++|+||||+++++|++|+.||...........+.... .......++..+.++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 232 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV---FPPVSQMYSQQLAQL 232 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC---CCCCccccCHHHHHH
Confidence 2 23446889999999876 458899999999999999999999998777655544444322 122223678999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcCccc
Q 018640 292 VRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 292 i~~~l~~dP~~Rps~~ell~hp~f 315 (352)
+.+||+.+|++||++.++++|||+
T Consensus 233 i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 233 IDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHccCCcccCcCHHHHhhCCCC
Confidence 999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=328.03 Aligned_cols=258 Identities=29% Similarity=0.509 Sum_probs=217.3
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
+|++++.||+|+||.||++.+..+++.||+|.+...........+.+.+|+.+++.+ +||||+++++.+..++..++||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-ENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEecCCEEEEEE
Confidence 689999999999999999999999999999998765433334456788999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC--
Q 018640 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-- 213 (352)
Q Consensus 136 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-- 213 (352)
||++|++|.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~---~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH---IKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCC---EEEeeCCCccccCcCccc
Confidence 99999999999988888999999999999999999999999999999999999975544 8999999886421100
Q ss_pred --------------cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC
Q 018640 214 --------------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR 278 (352)
Q Consensus 214 --------------~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 278 (352)
......++..|+|||.+. ..++.++|+||||+++||+++|..||.+....+............+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence 001235788999999875 45899999999999999999999999887776666655544333222
Q ss_pred CCCcCCCHHHHHHHHHhcCCCcCCCCC---HHHHhcCcccccc
Q 018640 279 DPWPKVSENAKDLVRKMLDPDPKRRLT---AQQVLEHPWLQNA 318 (352)
Q Consensus 279 ~~~~~~~~~~~~li~~~l~~dP~~Rps---~~ell~hp~f~~~ 318 (352)
.. ..++..+.++|.+||+.||++||+ +.++++||||...
T Consensus 238 ~~-~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 238 GD-EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred cc-ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 22 257899999999999999999997 7999999999753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-46 Score=319.10 Aligned_cols=265 Identities=38% Similarity=0.653 Sum_probs=228.2
Q ss_pred cccccee-ceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 53 IEERYEL-GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 53 ~~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
+.+-|++ .+.||+|+|+.|--|....+|..+|||++.+. ......++.+|++++.+...|+||++|+++|+++...
T Consensus 75 F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F 151 (463)
T KOG0607|consen 75 FEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF 151 (463)
T ss_pred HHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE
Confidence 4555665 46799999999999999999999999999876 3344678899999999999999999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
|||||-+.||+|...+.++..+++.++.++..+|+.||.+||.+||.|||+||+|||......-..||||||.+......
T Consensus 152 YLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~ 231 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKL 231 (463)
T ss_pred EEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccccc
Confidence 99999999999999999999999999999999999999999999999999999999998766666799999988764422
Q ss_pred CC--------cccccccccccccchhcc---c---cCCCcchHHHHHHHHHHHHhCCCCCCCCC---------------H
Q 018640 212 GE--------KFSEIVGSPYYMAPEVLK---R---NYGPEVDVWSAGVILYILLCGVPPFWAET---------------E 262 (352)
Q Consensus 212 ~~--------~~~~~~gt~~y~aPE~~~---~---~~s~~~Di~SlG~~l~el~tg~~p~~~~~---------------~ 262 (352)
.. ...+-+|+..|||||+.. + .|+.+-|.||||+++|-|+.|.+||.+.. .
T Consensus 232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ 311 (463)
T KOG0607|consen 232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ 311 (463)
T ss_pred CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHH
Confidence 11 123457888999999642 3 38889999999999999999999995432 2
Q ss_pred HHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 263 QGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
......+......++...|..++.+..++|+.+|..|+.+|.++.++++|||++....
T Consensus 312 ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ 369 (463)
T KOG0607|consen 312 NKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP 369 (463)
T ss_pred HHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence 2345556666677888888899999999999999999999999999999999997644
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=324.83 Aligned_cols=254 Identities=30% Similarity=0.495 Sum_probs=207.2
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
+|++++.||+|++|.||+|.+..++..||+|++..... .......+.+|+.+++.+ +||||+++++++..++..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKEL-QHPNIVCLQDVLMQESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhc-CCCCEeeeEEEEeeCCeEEEEE
Confidence 48899999999999999999998999999999865432 222346788899999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 136 ELCEGGELFDRIVAR---GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 136 e~~~~~sL~~~l~~~---~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
||++ ++|.+++... ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++......
T Consensus 79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~---~~l~dfg~~~~~~~~ 154 (285)
T cd07861 79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV---IKLADFGLARAFGIP 154 (285)
T ss_pred ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCc---EEECcccceeecCCC
Confidence 9997 5888887543 45899999999999999999999999999999999999976554 899999998754332
Q ss_pred C-cccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC------------
Q 018640 213 E-KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR------------ 277 (352)
Q Consensus 213 ~-~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------------ 277 (352)
. ......+++.|+|||.+.+ .++.++||||||+++++|++|+.||....................
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 2 2233467889999998753 368899999999999999999999987665443333322211100
Q ss_pred -------------CCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 278 -------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 278 -------------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
......+++++.++|.+||+.||.+|||+.+|++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 01123478899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=323.90 Aligned_cols=258 Identities=31% Similarity=0.505 Sum_probs=214.9
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
+.|++.+.||+|+||.||+|.+..++..+++|.+... .....+.+.+|+.+++.+ +|+|++++++++...+..++|
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~~~~v 80 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASC-DHPNIVKLLDAFYYENNLWIL 80 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHC-CCCCeeeEEEEEeeCCEEEEE
Confidence 4478999999999999999999999999999988643 233456788899999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC-
Q 018640 135 MELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~- 212 (352)
+||+++++|..++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~---~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGD---IKLADFGVSAKNTRTI 157 (282)
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCC---EEEccccccccccccc
Confidence 999999999888765 456899999999999999999999999999999999999976554 899999998754322
Q ss_pred Ccccccccccccccchhcc------ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCH
Q 018640 213 EKFSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (352)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~------~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (352)
.......++..|+|||++. ..++.++|+||||+++|+|++|..||...........+...... .......++.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 236 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP-TLAQPSRWSS 236 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCC-CCCCccccCH
Confidence 2224457899999999873 23678999999999999999999999877665554444433211 1122345789
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 287 ~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
++.++|.+||+.||++||++.++++||||.....
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 270 (282)
T cd06643 237 EFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSN 270 (282)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCCCEeccCC
Confidence 9999999999999999999999999999997543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=339.52 Aligned_cols=254 Identities=24% Similarity=0.401 Sum_probs=205.1
Q ss_pred cccccceeceeeeccCceEEEEEEEC--CCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDR--ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 129 (352)
.+..+|.+++.||+|+||.||+|... .++..||+|.+... ....+|+.+++.+ +||||+++++++....
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l-~h~~iv~~~~~~~~~~ 159 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTI-SHRAIINLIHAYRWKS 159 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhc-CCCCccceeeeEeeCC
Confidence 45567999999999999999999754 35678999987543 2345799999999 8999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
..+++||++. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|+|||++...
T Consensus 160 ~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~---~~l~DfG~a~~~ 235 (392)
T PHA03207 160 TVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPEN---AVLGDFGAACKL 235 (392)
T ss_pred EEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC---EEEccCcccccc
Confidence 9999999995 589999877778999999999999999999999999999999999999976554 899999999765
Q ss_pred CCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhccccc------
Q 018640 210 KPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ---GVAQAIIRSVLDF------ 276 (352)
Q Consensus 210 ~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~---~~~~~~~~~~~~~------ 276 (352)
..... .....||+.|+|||++. ..++.++|||||||++|||++|+.||.+.... .....+.......
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 43321 23457999999999987 45899999999999999999999999765321 1222222111100
Q ss_pred -----------------CCCC-C------cCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 277 -----------------RRDP-W------PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 277 -----------------~~~~-~------~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
+... . ..++.++.++|.+||..||++|||+.|+|.||||...
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 0000 0 1346788999999999999999999999999999864
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=321.01 Aligned_cols=253 Identities=31% Similarity=0.505 Sum_probs=210.7
Q ss_pred eeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEecCC
Q 018640 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~~ 140 (352)
+.||+|+||.||+|.+..+|+.||+|++.............+..|..++....+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999999899999999987543322223334555666655555899999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCccccccc
Q 018640 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG 220 (352)
Q Consensus 141 ~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g 220 (352)
++|.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++..... .....+
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~---~~l~dfg~~~~~~~---~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGH---LKLTDFGLSRNGLE---NKKFVG 155 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc---EEEeecccceeccc---cccCCC
Confidence 999999988788999999999999999999999999999999999999976544 89999999875432 234468
Q ss_pred ccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCC
Q 018640 221 SPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPD 299 (352)
Q Consensus 221 t~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 299 (352)
+..|+|||.+.+ .++.++||||||+++++|++|..||...........+......++......+++.+.++|.+||+.+
T Consensus 156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 235 (260)
T cd05611 156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235 (260)
T ss_pred CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCC
Confidence 889999998764 4789999999999999999999999887776665555544444444444468999999999999999
Q ss_pred cCCCC---CHHHHhcCccccccc
Q 018640 300 PKRRL---TAQQVLEHPWLQNAK 319 (352)
Q Consensus 300 P~~Rp---s~~ell~hp~f~~~~ 319 (352)
|++|| ++.|++.||||++.+
T Consensus 236 p~~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 236 PAKRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred HHHccCCCcHHHHHcChHhhcCC
Confidence 99999 457999999998754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=326.03 Aligned_cols=259 Identities=31% Similarity=0.507 Sum_probs=215.2
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
...+|++.+.||+|++|.||+|.+..++..||+|.+..... ...+.+.+|+.+++.+ +|+|++++++.+......+
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~-~h~~v~~~~~~~~~~~~~~ 93 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMREN-KNPNIVNYLDSYLVGDELW 93 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhC-CCCCEeeEEEEEEeCCEEE
Confidence 44689999999999999999999999999999998875432 2346788999999999 9999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
+||||+++++|.+++.. ..+++.++..++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++......
T Consensus 94 lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~---~kl~dfg~~~~~~~~ 169 (296)
T cd06654 94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQITPE 169 (296)
T ss_pred EeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC---EEECccccchhcccc
Confidence 99999999999998864 36899999999999999999999999999999999999975544 899999998765333
Q ss_pred Cc-ccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHH
Q 018640 213 EK-FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (352)
Q Consensus 213 ~~-~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (352)
.. .....|++.|+|||.+.+ .++.++||||||+++|+|++|..||............... ..........++..+.+
T Consensus 170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~ 248 (296)
T cd06654 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQNPEKLSAIFRD 248 (296)
T ss_pred ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCCCCCCccccCHHHHH
Confidence 22 234478899999998764 4889999999999999999999999876654333222211 11111223457889999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 291 LVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 291 li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
++.+||+.+|++||++.++++||||.....
T Consensus 249 li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 278 (296)
T cd06654 249 FLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278 (296)
T ss_pred HHHHHCcCCcccCcCHHHHhhChhhhccCC
Confidence 999999999999999999999999987533
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=322.78 Aligned_cols=254 Identities=30% Similarity=0.493 Sum_probs=210.5
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.+ +||||+++++++...+..++
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l-~h~~ii~~~~~~~~~~~~~l 83 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDC-KHSNIVAYFGSYLRRDKLWI 83 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEE
Confidence 457999999999999999999999999999999986542 22345678899999999 99999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
|+||+++++|.+++...+.+++..+..++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++.......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~---~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGH---VKLADFGVSAQITATI 160 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC---EEECcceeeeEccCcc
Confidence 9999999999999988888999999999999999999999999999999999999975554 8999999987653322
Q ss_pred -cccccccccccccchhcc----ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC-CCCcCCCHH
Q 018640 214 -KFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR-DPWPKVSEN 287 (352)
Q Consensus 214 -~~~~~~gt~~y~aPE~~~----~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 287 (352)
......|+..|+|||.+. +.++.++|+||||+++|+|++|..||...................+. .....++..
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNS 240 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHH
Confidence 223457899999999863 34788999999999999999999998765443332222222111111 111246788
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcCcc
Q 018640 288 AKDLVRKMLDPDPKRRLTAQQVLEHPW 314 (352)
Q Consensus 288 ~~~li~~~l~~dP~~Rps~~ell~hp~ 314 (352)
+.++|.+||+.+|++||++.++++|||
T Consensus 241 ~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 241 FHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=325.41 Aligned_cols=252 Identities=33% Similarity=0.554 Sum_probs=210.9
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEecCCcc
Q 018640 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGE 142 (352)
Q Consensus 63 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~~~s 142 (352)
||+|+||+||+|.+..+|+.||+|.+.............+.+|+.+++.+ +||||+++++++...+..++||||+++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhC-CCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 69999999999999999999999998765443344455677899999999 89999999999999999999999999999
Q ss_pred hHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCccccccc
Q 018640 143 LFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG 220 (352)
Q Consensus 143 L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g 220 (352)
|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++.............+
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~---~~l~dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN---VRISDLGLAVELKGGKKIKGRAG 156 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC---EEEccCcchhhhccCCccccccC
Confidence 999997765 6899999999999999999999999999999999999976554 89999999876544333344567
Q ss_pred ccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCC
Q 018640 221 SPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPD 299 (352)
Q Consensus 221 t~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 299 (352)
+..|+|||.+. +.++.++||||||+++++|++|+.||...........+...........+..+++.+.++|.+||+.|
T Consensus 157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence 88999999876 44888999999999999999999999765542222333333333333444567999999999999999
Q ss_pred cCCCC-----CHHHHhcCcccccc
Q 018640 300 PKRRL-----TAQQVLEHPWLQNA 318 (352)
Q Consensus 300 P~~Rp-----s~~ell~hp~f~~~ 318 (352)
|++|| ++.+++.||||...
T Consensus 237 p~~R~~~~~~~~~~ll~h~~~~~~ 260 (277)
T cd05577 237 PEKRLGCRGGSADEVREHPLFKDL 260 (277)
T ss_pred hhHccCCCcccHHHHHhChhhhcC
Confidence 99999 88889999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=317.02 Aligned_cols=252 Identities=26% Similarity=0.513 Sum_probs=211.1
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe-CCeEEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED-DTAVHLV 134 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~-~~~~~lv 134 (352)
+|++.+.||+|++|.||++.+..+++.||+|++..... .....+.+.+|+.+++++ +|+|++++++.+.. +...+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~lv 78 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQL-KHPNIVAYRESWEGEDGLLYIV 78 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhC-CCCCeeeeeeeecCCCCEEEEE
Confidence 48999999999999999999999999999999865432 223456788999999999 89999999998764 4468999
Q ss_pred EEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 135 MELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
|||+++++|.+++... ..+++.++..++.+++.||.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~---~~l~df~~~~~~~~~ 155 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNI---IKVGDLGIARVLENQ 155 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCc---EEEecccceEEeccc
Confidence 9999999999998763 35899999999999999999999999999999999999975544 899999999765432
Q ss_pred C-cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHH
Q 018640 213 E-KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (352)
Q Consensus 213 ~-~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (352)
. ......+++.|+|||++. ..++.++|+||||++++++++|+.||...........+..... .......++.+.+
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 232 (257)
T cd08223 156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL---PPMPKDYSPELGE 232 (257)
T ss_pred CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC---CCCccccCHHHHH
Confidence 2 223456889999999876 4588899999999999999999999987766555444433221 2233467899999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 291 LVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 291 li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
++.+||+.+|++|||+.++++||||
T Consensus 233 li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 233 LIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHhccCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=320.44 Aligned_cols=250 Identities=32% Similarity=0.576 Sum_probs=213.1
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEecCCcc
Q 018640 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGE 142 (352)
Q Consensus 63 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~~~s 142 (352)
||.|++|.||+|.+..++..||+|++...........+.+.+|+.+++.+ +||||+++++.+.++...++++||+++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 79999999999999989999999999766544444557899999999999 89999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCccccccccc
Q 018640 143 LFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSP 222 (352)
Q Consensus 143 L~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~ 222 (352)
|.+++.....+++..+..++.|++.||+|||+++++|+||+|+||+++.++. ++|+|||++.............++.
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~---~~l~df~~~~~~~~~~~~~~~~~~~ 156 (262)
T cd05572 80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY---VKLVDFGFAKKLKSGQKTWTFCGTP 156 (262)
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCC---EEEeeCCcccccCcccccccccCCc
Confidence 9999988778999999999999999999999999999999999999976554 8999999998765543334457889
Q ss_pred ccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCC
Q 018640 223 YYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET--EQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPD 299 (352)
Q Consensus 223 ~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 299 (352)
.|++||.+. ..++.++|+||||+++|+|++|..||.... .......+... ......+...++.+.++|.+||+.+
T Consensus 157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~ 234 (262)
T cd05572 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKG--NGKLEFPNYIDKAAKDLIKQLLRRN 234 (262)
T ss_pred CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhcc--CCCCCCCcccCHHHHHHHHHHccCC
Confidence 999999876 458899999999999999999999998766 43333333321 1122233445899999999999999
Q ss_pred cCCCCC-----HHHHhcCcccccc
Q 018640 300 PKRRLT-----AQQVLEHPWLQNA 318 (352)
Q Consensus 300 P~~Rps-----~~ell~hp~f~~~ 318 (352)
|++||+ +.|+++||||++.
T Consensus 235 p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 235 PEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred hhhCcCCcccCHHHHhcChhhhCC
Confidence 999999 9999999999864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=322.18 Aligned_cols=254 Identities=28% Similarity=0.454 Sum_probs=208.9
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.+ +||||+++++++..++..++
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~-~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKEC-KHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhc-CCCCeeeeeEEEEeCCEEEE
Confidence 457999999999999999999999999999999986432 22345688899999999 99999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
||||+++++|.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++.......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~---~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD---VKLADFGVAAKITATI 160 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC---EEECcCccceeecccc
Confidence 9999999999999988778999999999999999999999999999999999999975554 8999999998654322
Q ss_pred -cccccccccccccchhcc----ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC-CCCCcCCCHH
Q 018640 214 -KFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR-RDPWPKVSEN 287 (352)
Q Consensus 214 -~~~~~~gt~~y~aPE~~~----~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 287 (352)
......|+..|+|||.+. ..++.++|+||||++++||++|..||...........+........ ......++..
T Consensus 161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06646 161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSST 240 (267)
T ss_pred cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHH
Confidence 223456889999999873 3377899999999999999999999865543322221111111111 1111246889
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcCcc
Q 018640 288 AKDLVRKMLDPDPKRRLTAQQVLEHPW 314 (352)
Q Consensus 288 ~~~li~~~l~~dP~~Rps~~ell~hp~ 314 (352)
+.++|.+||+.+|++|||+.++++|+|
T Consensus 241 ~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 241 FHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=324.15 Aligned_cols=241 Identities=18% Similarity=0.209 Sum_probs=202.9
Q ss_pred eeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe----CCeEEEEEE
Q 018640 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED----DTAVHLVME 136 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~----~~~~~lv~e 136 (352)
..||+|++|.||+|.+ +|+.||+|++...........+.+.+|+.+|+++ +||||+++++++.+ ....++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-DSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhc-CCCCEEEEeeeEEecccCCCceEEEEE
Confidence 5799999999999997 5899999998765433333356788999999999 89999999999876 347899999
Q ss_pred ecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCcc
Q 018640 137 LCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF 215 (352)
Q Consensus 137 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~ 215 (352)
|+++|+|.+++.....+++.....++.+++.||.|||+ .+++||||||+||+++.++. +||+|||++.......
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~---~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYK---LKIICHGLEKILSSPP-- 177 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCc---EEEcccchHhhhcccc--
Confidence 99999999999888889999999999999999999998 49999999999999976544 8999999987654322
Q ss_pred cccccccccccchhccc---cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHH
Q 018640 216 SEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (352)
Q Consensus 216 ~~~~gt~~y~aPE~~~~---~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 292 (352)
....|+..|+|||.+.+ .++.++||||||+++|||++|..||......+....+....... ......++.+.+++
T Consensus 178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~~l~~li 255 (283)
T PHA02988 178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL--KLPLDCPLEIKCIV 255 (283)
T ss_pred ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC--CCCCcCcHHHHHHH
Confidence 23468899999999863 58999999999999999999999999887766655554433222 22236789999999
Q ss_pred HHhcCCCcCCCCCHHHHhc
Q 018640 293 RKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 293 ~~~l~~dP~~Rps~~ell~ 311 (352)
.+||+.||++|||+.++++
T Consensus 256 ~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 256 EACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHhcCCcccCcCHHHHHH
Confidence 9999999999999999985
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=319.89 Aligned_cols=255 Identities=28% Similarity=0.483 Sum_probs=213.0
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++.+.||.|++|+||+|.+..++..+|+|++....... ....+.+|+..++.+ +|+|++++++.+...+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQC-NHPNVVKYYTSFVVGDELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhc-CCCCEEEEEEEEeeCCEEEEE
Confidence 46999999999999999999998899999999986543222 557889999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 135 MELCEGGELFDRIVAR---GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~---~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
+|++++++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~---~~l~df~~~~~~~~ 154 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS---VKIADFGVSASLAD 154 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC---EEEcccchHHHhcc
Confidence 9999999999999764 35899999999999999999999999999999999999976544 89999999876543
Q ss_pred CCc-----ccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCC--Cc
Q 018640 212 GEK-----FSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP--WP 282 (352)
Q Consensus 212 ~~~-----~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~ 282 (352)
... .....|+..|+|||++.. .++.++|+||||+++++|++|..||....................... +.
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK 234 (267)
T ss_pred CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccc
Confidence 321 134468899999998763 588999999999999999999999987665544444433321111111 13
Q ss_pred CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 283 ~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
.+++.+.+++.+||+.||++|||+.+++.||||
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 235 KYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred cccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 578899999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=326.27 Aligned_cols=264 Identities=30% Similarity=0.509 Sum_probs=217.4
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
...++|++++.||+|++|.||+|.+..++..||+|.+.... ....+.+.+|+.+++.+ +|+||+++++++...+..
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~ 91 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ---QPKKELIINEILVMREN-KNPNIVNYLDSYLVGDEL 91 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc---cchHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCEE
Confidence 34578999999999999999999999999999999986542 22346788899999999 999999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++. ++|+|||++.....
T Consensus 92 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~---~~l~Dfg~~~~~~~ 167 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQITP 167 (297)
T ss_pred EEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC---EEECcCccceEccC
Confidence 999999999999998865 35899999999999999999999999999999999999975544 89999999876543
Q ss_pred CCc-ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHH
Q 018640 212 GEK-FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (352)
Q Consensus 212 ~~~-~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (352)
... .....+++.|+|||.+. ..++.++|+||||+++|++++|..||............... ..........++..+.
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 246 (297)
T cd06656 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPELQNPERLSAVFR 246 (297)
T ss_pred CccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccC-CCCCCCCccccCHHHH
Confidence 322 23446889999999876 45889999999999999999999999765543322211111 1111122345788899
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcCccccccccCCCC
Q 018640 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNV 324 (352)
Q Consensus 290 ~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~ 324 (352)
+++.+||+.+|++||++.++++||||..+...++.
T Consensus 247 ~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~ 281 (297)
T cd06656 247 DFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSSL 281 (297)
T ss_pred HHHHHHccCChhhCcCHHHHhcCchhccccccccc
Confidence 99999999999999999999999999977655443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=325.27 Aligned_cols=256 Identities=27% Similarity=0.503 Sum_probs=210.8
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++.+.||+|+||.||+|.+..+++.||+|++....... ...+.+.+|+.+++.+ +||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQL-RHENLVNLIEVFRRKKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhc-CCcchhhHHHhcccCCeEEEE
Confidence 36899999999999999999998889999999987643322 3345688899999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC-
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (352)
+||+++++|.++......+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~---~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGV---VKLCDFGFARTLAAPGE 155 (286)
T ss_pred EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCc---EEEEeeeeeeeccCCcc
Confidence 999999888887766667999999999999999999999999999999999999976554 8999999987654332
Q ss_pred cccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC--------------
Q 018640 214 KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR-------------- 277 (352)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------------- 277 (352)
......++..|+|||.+.+ .++.++||||||++++||++|..||......+....+........
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence 2234567899999998753 378899999999999999999999976554433333222111100
Q ss_pred -------------CCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 278 -------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 278 -------------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
...++.++..+.+++.+||+.+|++||++.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 00124578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=346.19 Aligned_cols=259 Identities=29% Similarity=0.483 Sum_probs=221.0
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
.+-|.|+..||.|+||.||+|..++++-..|.|++... +....+.+.-|+.||..+ +||+||+|++.|..++.+||
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~C-dHP~ivkLl~ayy~enkLwi 106 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAEC-DHPVIVKLLSAYYFENKLWI 106 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcC-CChHHHHHHHHHhccCceEE
Confidence 34689999999999999999999988888899988643 455677888899999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC-C
Q 018640 134 VMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-P 211 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~-~ 211 (352)
+.|||.||....++..-+ .|++.++.-+++|++.||.|||+++|||||||+.|||++.+|. |+|+|||.+.... .
T Consensus 107 liEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd---irLADFGVSAKn~~t 183 (1187)
T KOG0579|consen 107 LIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD---IRLADFGVSAKNKST 183 (1187)
T ss_pred EEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc---EeeecccccccchhH
Confidence 999999999988876644 5999999999999999999999999999999999999998887 8999999886533 2
Q ss_pred CCcccccccccccccchhcc------ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCC
Q 018640 212 GEKFSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (352)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~------~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (352)
......+.||++|||||+.. ..|+.++||||||++|.||..+.+|-...+...++..+...-.. ....+..++
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePP-TLlqPS~Ws 262 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP-TLLQPSHWS 262 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCC-cccCcchhh
Confidence 23446789999999999753 34899999999999999999999998777766666555443211 111234578
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 286 ~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
..+.||+..||..||..||++.++|.||||.++..
T Consensus 263 ~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~S 297 (1187)
T KOG0579|consen 263 RSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPS 297 (1187)
T ss_pred hHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCc
Confidence 89999999999999999999999999999997744
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=330.67 Aligned_cols=249 Identities=27% Similarity=0.477 Sum_probs=192.0
Q ss_pred ceeeeccCceEEEEEEEC--CCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe--CCeEEEEE
Q 018640 60 GRELGRGEFGITYLCTDR--ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--DTAVHLVM 135 (352)
Q Consensus 60 ~~~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~--~~~~~lv~ 135 (352)
..+||+|+||+||+|.+. .+++.||+|.+.... ....+.+|+.+++++ +||||+++++++.. ....++++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-----ISMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-----CcHHHHHHHHHHHhc-CCCCCcceeeeEecCCCcEEEEEE
Confidence 357999999999999965 467899999886432 124567899999999 99999999998854 45688999
Q ss_pred EecCCcchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecC-CCCCCEEEEeccc
Q 018640 136 ELCEGGELFDRIVAR---------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK-KETAPLKAIDFGL 205 (352)
Q Consensus 136 e~~~~~sL~~~l~~~---------~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~-~~~~~vkl~Dfg~ 205 (352)
||+++ +|.+++... ..+++..++.++.||+.||+|||+.||+||||||+|||+..+ .....+||+|||+
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 80 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 99954 888877532 248899999999999999999999999999999999999643 2345699999999
Q ss_pred ceecCCCC----cccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHH
Q 018640 206 SVFFKPGE----KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQ---------GVAQAII 270 (352)
Q Consensus 206 a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~---------~~~~~~~ 270 (352)
++...... ......||+.|+|||++.+ .++.++||||+||++++|++|+.||...... .....+.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence 98654321 2245678999999998753 4889999999999999999999999643321 1111111
Q ss_pred hcccccC---------------------C-------------CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 271 RSVLDFR---------------------R-------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 271 ~~~~~~~---------------------~-------------~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
....... . ......+..+.+||.+||+.||++|||++|+|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 1110000 0 0001235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=316.69 Aligned_cols=253 Identities=28% Similarity=0.470 Sum_probs=215.6
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
+|++.+.||+|++|.||+|.+..++..+|+|.+...... ......+.+|+.+++.+ +|||++++++.+...+..++|+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLL-SHPNIIEYYENFLEDKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhC-CCCchhheeeeEecCCEEEEEE
Confidence 588999999999999999999999999999998765432 23457789999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 136 ELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 136 e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
||+++++|.+++... ..+++..+..++.+++.||.|||++|++|+||+|+||+++.++ ..++|+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~--~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHK--MVVKIGDFGISKILSSKS 156 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEEccCCCceecCCCc
Confidence 999999999999764 3489999999999999999999999999999999999997443 347999999998765544
Q ss_pred cccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHH
Q 018640 214 KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (352)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 292 (352)
......|+..|+|||.+.+ .++.++||||||+++++|++|..||...........+.... .......++..+.+++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li 233 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGT---FAPISDRYSPDLRQLI 233 (256)
T ss_pred cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcC---CCCCCCCcCHHHHHHH
Confidence 4445578899999998864 47889999999999999999999998776655544443322 2223345789999999
Q ss_pred HHhcCCCcCCCCCHHHHhcCccc
Q 018640 293 RKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 293 ~~~l~~dP~~Rps~~ell~hp~f 315 (352)
.+||+.+|++|||+.++++||||
T Consensus 234 ~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 234 LSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHccCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=325.42 Aligned_cols=260 Identities=32% Similarity=0.517 Sum_probs=212.3
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCC--hhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT--AVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
+|++.+.||+|++|.||+|.+..+|+.||+|.+....... ......+.+|+.+++.+ +|+||+++++++.+.+..++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-KHPNIIGLLDVFGHKSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhc-CCCCChhhhheeecCCEEEE
Confidence 4888999999999999999999899999999987654331 11234567899999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 134 VMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
||||+ +++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~---~~l~dfg~~~~~~~~ 155 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGV---LKLADFGLARSFGSP 155 (298)
T ss_pred EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCC---EEEccceeeeeccCC
Confidence 99999 889999998766 7999999999999999999999999999999999999986554 899999999876443
Q ss_pred C-cccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC-----------
Q 018640 213 E-KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR----------- 278 (352)
Q Consensus 213 ~-~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----------- 278 (352)
. ......++..|+|||.+.+ .++.++|+||||+++++|++|.+||...........+.........
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence 2 2233466888999998753 4788999999999999999998888766554444333322111000
Q ss_pred -------------CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 279 -------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 279 -------------~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
......+..+.++|.+||+++|++|||+.+++.||||.+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~ 290 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA 290 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence 011235788999999999999999999999999999998543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=323.72 Aligned_cols=258 Identities=31% Similarity=0.527 Sum_probs=216.3
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
..+|++.+.||.|++|+||+|.+..+|+.||+|.+.... ....+.+.+|+.+++.+ +|+|++++++++......++
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 93 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKEL-KNPNIVNFLDSFLVGDELFV 93 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhc-CCCceeeeeeeEecCceEEE
Confidence 357999999999999999999999999999999886542 22356788999999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
|+||+++++|.+++... .+++.++..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 94 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~---~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 94 VMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS---VKLTDFGFCAQITPEQ 169 (296)
T ss_pred EEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC---EEEccCccchhccccc
Confidence 99999999999988654 6899999999999999999999999999999999999975544 8999999987654332
Q ss_pred c-ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHH
Q 018640 214 K-FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (352)
Q Consensus 214 ~-~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 291 (352)
. .....++..|+|||.+. ..++.++|+||||+++|++++|..||...........+.... ......+..++..+.++
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l 248 (296)
T cd06655 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSPIFRDF 248 (296)
T ss_pred ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CcccCCcccCCHHHHHH
Confidence 2 23447889999999876 458899999999999999999999998776654433332211 11122334678999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 292 VRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 292 i~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
|.+||..||++||++.+++.||||+.+..
T Consensus 249 i~~~l~~dp~~Rpt~~~il~~~~~~~~~~ 277 (296)
T cd06655 249 LNRCLEMDVEKRGSAKELLQHPFLKLAKP 277 (296)
T ss_pred HHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence 99999999999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=322.62 Aligned_cols=260 Identities=30% Similarity=0.478 Sum_probs=214.5
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
..+.|++++.||+|+||.||+|.+..++..|++|.+... .....+.+.+|+.+++.+ +|+|++++++.+..++..+
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 85 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATC-NHPYIVKLLGAFYWDGKLW 85 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhC-CCCcEeeeEEEEEeCCeEE
Confidence 456799999999999999999999999999999998653 334456788899999999 8999999999999999999
Q ss_pred EEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 133 LVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
+||||+++++|..++.. ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++.....
T Consensus 86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~---~kl~dfg~~~~~~~ 162 (292)
T cd06644 86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGD---IKLADFGVSAKNVK 162 (292)
T ss_pred EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCC---EEEccCccceeccc
Confidence 99999999999887754 346899999999999999999999999999999999999975544 89999998875432
Q ss_pred C-Ccccccccccccccchhcc------ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCC
Q 018640 212 G-EKFSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (352)
Q Consensus 212 ~-~~~~~~~gt~~y~aPE~~~------~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (352)
. .......++..|+|||++. ..++.++|+||||+++|+|++|..||...........+..... ........+
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 241 (292)
T cd06644 163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP-PTLSQPSKW 241 (292)
T ss_pred cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCC-ccCCCCccc
Confidence 2 2223456888999999873 2367789999999999999999999977665444444332211 111123457
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 285 SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 285 ~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
+.++.++|.+||+.+|++||++.++++||||.....
T Consensus 242 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 277 (292)
T cd06644 242 SMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTS 277 (292)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 889999999999999999999999999999986544
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=325.64 Aligned_cols=254 Identities=29% Similarity=0.517 Sum_probs=204.5
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
+|++.+.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+++++ +|+||+++++++.+....++|+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKEL-KHKNIVRLYDVLHSDKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhc-CCCCeeeHHHHhccCCceEEEE
Confidence 48899999999999999999999999999999875432 222235677899999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC-
Q 018640 136 ELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (352)
Q Consensus 136 e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (352)
||+++ +|.+++.. ...+++..++.++.||+.||.|||+.+++|+||||+||+++.++. ++|+|||++.......
T Consensus 79 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~---~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 79 EYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGE---LKLADFGLARAFGIPVR 154 (284)
T ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCc---EEECccchhhccCCCCC
Confidence 99975 78887764 456999999999999999999999999999999999999976554 8999999987654322
Q ss_pred cccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcccc--------------c
Q 018640 214 KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVLD--------------F 276 (352)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~-~~~~~~~~~~~~~~~--------------~ 276 (352)
......++..|+|||.+.+ .++.++||||||+++|+|++|..|+... ........+...... .
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 2234467889999998754 3688999999999999999998886443 333332222211100 0
Q ss_pred ------C-----CCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 277 ------R-----RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 277 ------~-----~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
. ....+.+++++.++|.+||+.||.+|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 01123468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=321.92 Aligned_cols=272 Identities=26% Similarity=0.441 Sum_probs=223.7
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
...|+.++.||.|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.+ +|+||+++++.+......++
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKGTKLWI 79 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCEEEE
Confidence 356889999999999999999998899999999886542 223456788999999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
||||+++++|.+++.. ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++. ++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~---~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 80 IMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCC---EEEcccccceeccCCc
Confidence 9999999999998865 46899999999999999999999999999999999999976554 8999999997654332
Q ss_pred c-ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHH
Q 018640 214 K-FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (352)
Q Consensus 214 ~-~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 291 (352)
. .....++..|+|||++. ..++.++|+||||+++|||++|..||...........+.. ...+.....++..+.++
T Consensus 156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l 232 (277)
T cd06640 156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK---NNPPTLTGEFSKPFKEF 232 (277)
T ss_pred cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc---CCCCCCchhhhHHHHHH
Confidence 2 23346788999999876 4588999999999999999999999987665544333221 11222333578889999
Q ss_pred HHHhcCCCcCCCCCHHHHhcCccccccccCCCCCCcHHHHHHHHhh
Q 018640 292 VRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQF 337 (352)
Q Consensus 292 i~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~ 337 (352)
+.+||+.+|++||++.+++.||||.+... +.+...++..|++.|
T Consensus 233 i~~~l~~~p~~Rp~~~~il~~~~~~~~~~--~~~~~~~~~~~~~~~ 276 (277)
T cd06640 233 IDACLNKDPSFRPTAKELLKHKFIVKNAK--KTSYLTELIDRFKRW 276 (277)
T ss_pred HHHHcccCcccCcCHHHHHhChHhhhcch--hhhHHHHHHHHHHhc
Confidence 99999999999999999999999986543 455566666666654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=322.69 Aligned_cols=256 Identities=33% Similarity=0.522 Sum_probs=214.5
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++.+.||.|+||+||+|.+..++..||+|++... .....+.+.+|+.+++++ +|+||+++++.+..+...++|
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSEC-KHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhC-CCCceeEEEEEEecCCeEEEE
Confidence 5699999999999999999999889999999998643 334456788999999999 799999999999999999999
Q ss_pred EEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC-
Q 018640 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~- 212 (352)
|||+++++|.+++... ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~---~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD---VKLADFGVSAKNKSTL 157 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCC---EEEccCccchhhcccc
Confidence 9999999999998764 46999999999999999999999999999999999999976544 899999988654322
Q ss_pred Ccccccccccccccchhcc------ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCH
Q 018640 213 EKFSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (352)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~------~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (352)
.......++..|+|||.+. ..++.++|+||||+++|+|++|..||...........+..... ........++.
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 236 (280)
T cd06611 158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEP-PTLDQPSKWSS 236 (280)
T ss_pred cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCC-CCcCCcccCCH
Confidence 2223456899999999863 2367799999999999999999999987765544444432211 11122345789
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 287 ~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
++.++|..||+.+|.+||++.++++||||.+.
T Consensus 237 ~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 237 SFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 99999999999999999999999999999976
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=318.18 Aligned_cols=254 Identities=28% Similarity=0.505 Sum_probs=208.3
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCC--hhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe--CCeE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT--AVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--DTAV 131 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~--~~~~ 131 (352)
+|++.+.||+|+||.||+|.+..++..||+|++....... ......+.+|+.+++.+ +||||+++++++.. ....
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc-CCCCeeeEEEEEEcCCCCEE
Confidence 5889999999999999999999999999999886543221 22345788999999999 89999999998865 3578
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
++++||+++++|.+++.....+++...+.++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~---~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGN---VKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC---EEEccCCCcccccc
Confidence 899999999999999988778999999999999999999999999999999999999975544 89999999875432
Q ss_pred C----Ccccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCH
Q 018640 212 G----EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (352)
Q Consensus 212 ~----~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (352)
. .......++..|+|||.+.+ .++.++|+||||+++|||++|+.||............... ...+.....+++
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 236 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQ--PTNPQLPSHISE 236 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcC--CCCCCCchhcCH
Confidence 1 11223468899999998864 4889999999999999999999999776544443333221 112223345688
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcCcccc
Q 018640 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316 (352)
Q Consensus 287 ~~~~li~~~l~~dP~~Rps~~ell~hp~f~ 316 (352)
.+.+++ .||..+|++||++.||++||||+
T Consensus 237 ~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 237 HARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 888998 67778999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=322.27 Aligned_cols=253 Identities=28% Similarity=0.460 Sum_probs=202.5
Q ss_pred eeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhC--CCCCCeeEeeeEEEeCCeEEEEEEecC
Q 018640 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL--PKHQNIVCLKDTYEDDTAVHLVMELCE 139 (352)
Q Consensus 62 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~~h~~iv~l~~~~~~~~~~~lv~e~~~ 139 (352)
.||+|+||.||++.+..+++.+|+|.+.............+.+|..++..+ .+|++++.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999999999999998765433322223344454443332 279999999999999999999999999
Q ss_pred CcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCcccccc
Q 018640 140 GGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIV 219 (352)
Q Consensus 140 ~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 219 (352)
+++|.+++.....+++..+..++.|++.||.|||+.+++|+||||+||+++.++. ++|+|||++....... .....
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~---~~l~dfg~~~~~~~~~-~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGH---VRISDLGLACDFSKKK-PHASV 156 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCC---EEEccCCcceeccccC-ccCcC
Confidence 9999999988888999999999999999999999999999999999999975544 8999999987554322 23347
Q ss_pred cccccccchhcc-c-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcC
Q 018640 220 GSPYYMAPEVLK-R-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297 (352)
Q Consensus 220 gt~~y~aPE~~~-~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 297 (352)
||..|+|||.+. + .++.++||||||+++++|++|..||........ ..+...........++.++.++.++|.+||+
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 235 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTVNVELPDSFSPELKSLLEGLLQ 235 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHHHhhcCCcCCccccCHHHHHHHHHHhc
Confidence 899999999875 3 478999999999999999999999975432211 1111122222333445688999999999999
Q ss_pred CCcCCCC-----CHHHHhcCccccccc
Q 018640 298 PDPKRRL-----TAQQVLEHPWLQNAK 319 (352)
Q Consensus 298 ~dP~~Rp-----s~~ell~hp~f~~~~ 319 (352)
.||.+|| |+.++++||||+...
T Consensus 236 ~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 236 RDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred CCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 9999999 699999999999854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=319.60 Aligned_cols=258 Identities=24% Similarity=0.461 Sum_probs=212.0
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCC---hhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT---AVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
+|+..+.||+|++|.||++.+..+++.||+|++....... ....+.+.+|+.+++++ +|+|++++++++.+.+..+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPHIIRMLGATCEDSHFN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc-CCCceehhhceeccCCeEE
Confidence 4788899999999999999999999999999986543211 12346788999999999 9999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
+|+||+++++|.+++.....+++..+..++.|++.||.|||++|++|+||+|+||+++.++. .++|+|||++......
T Consensus 80 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~--~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ--RLRIADFGAAARLAAK 157 (268)
T ss_pred EEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEEcccccccccccc
Confidence 99999999999999988788999999999999999999999999999999999999975433 3899999998765432
Q ss_pred Cc-----ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-cccCCCCCcCCC
Q 018640 213 EK-----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV-LDFRRDPWPKVS 285 (352)
Q Consensus 213 ~~-----~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 285 (352)
.. .....|+..|+|||.+. ..++.++|+||+|++++++++|..||...........+.... ........+.++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 11 12346788999999876 458899999999999999999999996544322222222211 112233334678
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcCcccc
Q 018640 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316 (352)
Q Consensus 286 ~~~~~li~~~l~~dP~~Rps~~ell~hp~f~ 316 (352)
+++.+++.+||+.+|++||++.++++||||.
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 9999999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=321.91 Aligned_cols=274 Identities=26% Similarity=0.434 Sum_probs=221.4
Q ss_pred ccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe
Q 018640 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (352)
Q Consensus 51 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 130 (352)
....++|++.+.||+|+||+||+|.+..+|+.||+|++.............+.+|+.+++.+ +|||++++.+++...+.
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~ 89 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-RHPNTIEYKGCYLREHT 89 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEEeCCe
Confidence 34556799999999999999999999889999999998654433444456788999999999 89999999999999999
Q ss_pred EEEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 131 VHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
.++|+||++| +|.+.+.. ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++...
T Consensus 90 ~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~---~kL~dfg~~~~~ 165 (307)
T cd06607 90 AWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT---VKLADFGSASLV 165 (307)
T ss_pred EEEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCC---EEEeecCcceec
Confidence 9999999974 77777654 456899999999999999999999999999999999999976554 899999998765
Q ss_pred CCCCcccccccccccccchhcc----ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCC
Q 018640 210 KPGEKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (352)
Q Consensus 210 ~~~~~~~~~~gt~~y~aPE~~~----~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (352)
... ....++..|+|||.+. +.++.++||||||+++|||++|..||...........+.... .+......++
T Consensus 166 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 240 (307)
T cd06607 166 SPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND--SPTLSSNDWS 240 (307)
T ss_pred CCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCC--CCCCCchhhC
Confidence 432 3446788999999863 348889999999999999999999998776554443333221 1111123467
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccCCCCCCcHHHHHHHHhh
Q 018640 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQF 337 (352)
Q Consensus 286 ~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~ 337 (352)
+.+.++|.+||+.+|++||++.+++.||||.... .+....++..++++.
T Consensus 241 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~---~~~~~~~~~~~~~~~ 289 (307)
T cd06607 241 DYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER---PPTVIIDLIQRTKDA 289 (307)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC---CcHHHHHHHHHHHHH
Confidence 8999999999999999999999999999999643 233335555666663
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=320.05 Aligned_cols=259 Identities=25% Similarity=0.435 Sum_probs=210.9
Q ss_pred cccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC-
Q 018640 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD- 128 (352)
Q Consensus 50 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~- 128 (352)
...+.++|.+.+.||+|+||.||+|.+..+++.+|+|++.... ...+.+.+|+.++.++.+|||++++++++...
T Consensus 17 ~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 17 LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred CCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 3345778999999999999999999999999999999986431 12356788999999987899999999998643
Q ss_pred ----CeEEEEEEecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEE
Q 018640 129 ----TAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKA 200 (352)
Q Consensus 129 ----~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl 200 (352)
...++|+||+++++|.+++.. ...+++..++.++.|++.||+|||+.+++|+||||+||+++.++. ++|
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~---~kl 169 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG---VKL 169 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC---EEE
Confidence 368999999999999998753 346899999999999999999999999999999999999976554 899
Q ss_pred EecccceecCCCC-cccccccccccccchhccc------cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 018640 201 IDFGLSVFFKPGE-KFSEIVGSPYYMAPEVLKR------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV 273 (352)
Q Consensus 201 ~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~ 273 (352)
+|||++....... ......|+..|+|||.+.. .++.++||||||+++|+|++|+.||...........+....
T Consensus 170 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~ 249 (291)
T cd06639 170 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP 249 (291)
T ss_pred eecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC
Confidence 9999987654322 2234468899999998742 26789999999999999999999998766554444443321
Q ss_pred cccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccc
Q 018640 274 LDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316 (352)
Q Consensus 274 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~ 316 (352)
.. ........+..+.++|.+||+.+|++||++.++++||||+
T Consensus 250 ~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 250 PP-TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CC-CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 11 1111235678899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=320.95 Aligned_cols=255 Identities=31% Similarity=0.549 Sum_probs=211.1
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
+|++.+.||+|++|.||+|.+..+|..||+|++...... ......+.+|+.+++++ +|+|++++++++......++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQAC-QHPYVVKLLDVFPHGSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhC-CCCCCcceeeEEecCCeeEEEe
Confidence 589999999999999999999989999999998765322 22346788999999999 7999999999999999999999
Q ss_pred EecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC-
Q 018640 136 ELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (352)
Q Consensus 136 e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (352)
||+ +++|.+++... ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++.......
T Consensus 79 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~---~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 79 EYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGV---LKIADFGLARLFSEEEP 154 (286)
T ss_pred ccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCc---EEEeeeeecccccCCCC
Confidence 999 99999998653 46899999999999999999999999999999999999976444 8999999988664432
Q ss_pred -cccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC------------
Q 018640 214 -KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR------------ 278 (352)
Q Consensus 214 -~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------------ 278 (352)
......|+..|+|||.+.+ .++.++||||+|+++++|++|.+||...........+.........
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 2344578999999998753 3688999999999999999998888766655444443332211100
Q ss_pred --------------CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccc
Q 018640 279 --------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316 (352)
Q Consensus 279 --------------~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~ 316 (352)
...+..+..+.++|.+||+.+|++|||+.++++||||.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 01134678899999999999999999999999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=314.56 Aligned_cols=252 Identities=27% Similarity=0.554 Sum_probs=214.4
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
+|++.+.||+|+||.||++.+..+|+.||+|.+...... ......+.+|+.+++.+ +|+||+++++++...+..++|+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNM-KHPNIVQYQESFEENGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhC-CCCCeeeeEeeecCCCeEEEEE
Confidence 589999999999999999999999999999998754332 23456789999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 136 ELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 136 e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
||+++++|.+.+.... .+++..+..++.|++.||.|||+++++|+||+|+||+++.++. ++|+|||++.......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~---~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT---IKLGDFGIARVLNSTV 155 (256)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC---EEEeeccceeecCcch
Confidence 9999999999887643 4789999999999999999999999999999999999976554 8999999997654332
Q ss_pred c-ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHH
Q 018640 214 K-FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (352)
Q Consensus 214 ~-~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 291 (352)
. .....|+..|+|||++. +.++.++|+||||++++++++|..||......+....+.... .......++.++.++
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l 232 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS---YPPVSSHYSYDLRNL 232 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC---CCCCcccCCHHHHHH
Confidence 2 23346888999999876 458889999999999999999999998777666555554332 222334678999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcCccc
Q 018640 292 VRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 292 i~~~l~~dP~~Rps~~ell~hp~f 315 (352)
|.+||+.+|++||++.++++||||
T Consensus 233 i~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 233 VSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHhhCChhhCcCHHHHhhCcCC
Confidence 999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=321.34 Aligned_cols=258 Identities=29% Similarity=0.457 Sum_probs=207.2
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe----
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA---- 130 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~---- 130 (352)
++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.+.+|+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 369999999999999999999999999999998765422 222345678899999999778999999999876665
Q ss_pred -EEEEEEecCCcchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecc
Q 018640 131 -VHLVMELCEGGELFDRIVAR-----GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (352)
Q Consensus 131 -~~lv~e~~~~~sL~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg 204 (352)
.++||||+++ +|.+++... ..+++..++.++.||+.||.|||+.+++||||+|+||+++.+ ...++|+|||
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~--~~~~kl~dfg 156 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQ--KGLLKIADLG 156 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecC--CCeEEEeecc
Confidence 8999999986 888887542 347999999999999999999999999999999999999752 2348999999
Q ss_pred cceecCCC-Ccccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC---
Q 018640 205 LSVFFKPG-EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR--- 278 (352)
Q Consensus 205 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--- 278 (352)
++...... .......+++.|+|||.+.+ .++.++|+||||+++|+|++|..||...........+.........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 98765322 22233356889999998753 4789999999999999999999999877665554444332211000
Q ss_pred ---------------------CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccc
Q 018640 279 ---------------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316 (352)
Q Consensus 279 ---------------------~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~ 316 (352)
...+.+++.+.++|.+||++||.+||++.+++.||||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 01134788899999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=342.25 Aligned_cols=261 Identities=28% Similarity=0.465 Sum_probs=219.8
Q ss_pred eeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEecCCc
Q 018640 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGG 141 (352)
Q Consensus 62 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~~~ 141 (352)
+||+|.||+||.|+|..+...+|||.+.... .....-+..|+.+.++| +|.|||+++|.+.+++..-|.||-+|||
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~L-rHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTL-RHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHH-hhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 6999999999999999999999999886542 22234577899999999 9999999999999999999999999999
Q ss_pred chHHHHHhcC-CC--CHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCc-ccc
Q 018640 142 ELFDRIVARG-HY--TERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK-FSE 217 (352)
Q Consensus 142 sL~~~l~~~~-~l--~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~-~~~ 217 (352)
||.+.|.... ++ ++.+...+..||++||.|||++.|||||||-+|+|++ .-.+.+||+|||.++.+..-.. ..+
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAginP~TET 735 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGINPCTET 735 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe--eccceEEecccccchhhccCCccccc
Confidence 9999998763 55 7888999999999999999999999999999999996 3455699999999876543333 356
Q ss_pred cccccccccchhcc---ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHH
Q 018640 218 IVGSPYYMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK 294 (352)
Q Consensus 218 ~~gt~~y~aPE~~~---~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 294 (352)
+-||..|||||++. .+|+..+|||||||++.||.||++||......... -..-.+....++.+..++.+..+||.+
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA-MFkVGmyKvHP~iPeelsaeak~Filr 814 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA-MFKVGMYKVHPPIPEELSAEAKNFILR 814 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh-hhhhcceecCCCCcHHHHHHHHHHHHH
Confidence 78999999999986 34999999999999999999999999755443222 222334455566667788999999999
Q ss_pred hcCCCcCCCCCHHHHhcCccccccccCCCCCCcHH
Q 018640 295 MLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGET 329 (352)
Q Consensus 295 ~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~ 329 (352)
|+.+||.+||++.++|..||++..++++.+.++.+
T Consensus 815 cFepd~~~R~sA~~LL~DpFlq~~~kk~r~~ls~~ 849 (1226)
T KOG4279|consen 815 CFEPDPCDRPSAKDLLQDPFLQHNNKKPRPKLSLN 849 (1226)
T ss_pred HcCCCcccCccHHHhccCcccccCCCCCCCCCCcc
Confidence 99999999999999999999998877777776643
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=340.67 Aligned_cols=250 Identities=25% Similarity=0.399 Sum_probs=200.4
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
...|.+.+.||+|+||.||+|.+..++..||+|.... ..+.+|+++++++ +|+|||++++++...+..++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L-~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRL-SHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHC-CCCCCCcEEEEEEECCEEEE
Confidence 4479999999999999999999999999999996421 2356799999999 99999999999999999999
Q ss_pred EEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 134 VMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
|||++. ++|.+++... ..+++..++.|+.|++.||.|||++||+||||||+|||++.++. ++|+|||+++.....
T Consensus 238 v~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~---vkL~DFGla~~~~~~ 313 (461)
T PHA03211 238 VLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED---ICLGDFGAACFARGS 313 (461)
T ss_pred EEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCC---EEEcccCCceecccc
Confidence 999995 6888888664 46999999999999999999999999999999999999975544 899999999765432
Q ss_pred Cc---ccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhcccc----cC
Q 018640 213 EK---FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAET-------EQGVAQAIIRSVLD----FR 277 (352)
Q Consensus 213 ~~---~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~-------~~~~~~~~~~~~~~----~~ 277 (352)
.. .....||..|+|||++.+ .++.++|||||||++|||++|..|+.... ....+..+++.... +.
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~ 393 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP 393 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence 21 124579999999999864 58999999999999999999876653321 11122222221110 00
Q ss_pred ------------------------CCCCc---CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccc
Q 018640 278 ------------------------RDPWP---KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (352)
Q Consensus 278 ------------------------~~~~~---~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~ 317 (352)
...|. .++..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 00111 34568899999999999999999999999999974
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=316.51 Aligned_cols=254 Identities=29% Similarity=0.466 Sum_probs=210.0
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccC---ChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR---TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
+|++.+.||+|+||+||+|.+ .+|+.+|+|.+...... .......+.+|+.+++++ +|+||+++++++.+.+..+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHVNIVQYLGTCLDDNTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc-CCCCEeeEeeEeecCCeEE
Confidence 488899999999999999986 47889999988654221 122345688999999999 8999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
+++||+++++|.+++.....+++..+..++.|++.||+|||+.+++|+||+|+||+++.++. ++|+|||++......
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~---~~l~dfg~~~~~~~~ 155 (265)
T cd06631 79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGI---IKLIDFGCARRLAWV 155 (265)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCe---EEeccchhhHhhhhc
Confidence 99999999999999988778999999999999999999999999999999999999975544 899999988754211
Q ss_pred -------Ccccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCC
Q 018640 213 -------EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (352)
Q Consensus 213 -------~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (352)
.......|+..|+|||.+.+ .++.++|+||||+++++|++|..||...........+... ....+.....+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 234 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAH-RGLMPRLPDSF 234 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhc-cCCCCCCCCCC
Confidence 11234568899999999864 4889999999999999999999999776554433332221 11222334568
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 285 SENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 285 ~~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
+..+.++|.+||+.+|++||++.+++.||||
T Consensus 235 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 8999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=328.96 Aligned_cols=260 Identities=32% Similarity=0.529 Sum_probs=232.3
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
+.|+.-++||+|+||.||-|..+.+|+.+|+|.+.+.............+|-.+|.++ +.+.||.+-..|+..+.+++|
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV-~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKV-SSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh-ccCcEEEEeeeecCCCceEEE
Confidence 4588889999999999999999999999999999888777666677788999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 135 MELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
+..|.||+|.-+|...+ .+++..++.++.+|+.||++||..+||.||+||+|||+|+.++ |+|+|+|+|..+..+
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~Gh---vRISDLGLAvei~~g 340 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGH---VRISDLGLAVEIPEG 340 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCC---eEeeccceEEecCCC
Confidence 99999999988887655 5999999999999999999999999999999999999976555 999999999999888
Q ss_pred Ccccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHH
Q 018640 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (352)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 291 (352)
+.....+||.+|||||++. +.|+...|.|||||+||||+.|+.||..........++-+...+........+++++.++
T Consensus 341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eaksl 420 (591)
T KOG0986|consen 341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSL 420 (591)
T ss_pred CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHH
Confidence 8877779999999999987 459999999999999999999999998776555544555555555566667899999999
Q ss_pred HHHhcCCCcCCCC-----CHHHHhcCcccccc
Q 018640 292 VRKMLDPDPKRRL-----TAQQVLEHPWLQNA 318 (352)
Q Consensus 292 i~~~l~~dP~~Rp-----s~~ell~hp~f~~~ 318 (352)
...+|..||.+|. .++++-+||||++.
T Consensus 421 c~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l 452 (591)
T KOG0986|consen 421 CEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL 452 (591)
T ss_pred HHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence 9999999999997 67799999999964
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=331.24 Aligned_cols=262 Identities=27% Similarity=0.474 Sum_probs=207.4
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
..|++++.||+||.+.||++.. .+...+|+|++.... .+....+.+.+|+..|.+|.+|.+|++|++|-..++.+|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred chhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 4699999999999999999985 456677877765543 34556788999999999999999999999999999999999
Q ss_pred EEecCCcchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 135 MELCEGGELFDRIVARGH-YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~-l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
|||=+ .+|..+|.+... .+.-.++.+..||+.|+.++|..||||-||||.|+|+.. +.+||+|||+|..+..+.
T Consensus 439 mE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk----G~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 439 MECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK----GRLKLIDFGIANAIQPDT 513 (677)
T ss_pred eeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe----eeEEeeeechhcccCccc
Confidence 99974 599999988765 444588999999999999999999999999999999864 337999999998876554
Q ss_pred c---ccccccccccccchhccc------------cCCCcchHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcccccC
Q 018640 214 K---FSEIVGSPYYMAPEVLKR------------NYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVLDFR 277 (352)
Q Consensus 214 ~---~~~~~gt~~y~aPE~~~~------------~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~ 277 (352)
. ....+||+.||+||.+.. ..++++||||+||+||+|+.|+.||...... ..+..+..-....
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~I- 592 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEI- 592 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccc-
Confidence 3 245699999999998731 1567899999999999999999999654422 1222222211111
Q ss_pred CCCCcCC--CHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccCCCCCCc
Q 018640 278 RDPWPKV--SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLG 327 (352)
Q Consensus 278 ~~~~~~~--~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~ 327 (352)
..+.+ ..++.++++.||++||++|||+.++|+|||++.. .-+..++.
T Consensus 593 --efp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~-~i~~~~m~ 641 (677)
T KOG0596|consen 593 --EFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ-PIPVEQMA 641 (677)
T ss_pred --cccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc-cccchHHH
Confidence 11222 2338999999999999999999999999999963 33444443
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=312.56 Aligned_cols=252 Identities=31% Similarity=0.504 Sum_probs=215.4
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
+|+++++||.|+||.||.+.+..+++.+++|.+...... ......+.+|+.+++++ +|+||+++++++.+.+..+++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLL-QHPNIIAYYNHFMDDNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhC-CCCCeeEEEeEEecCCeEEEEE
Confidence 589999999999999999999999999999998765432 33456788999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 136 ELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 136 e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. +||+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~---~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL---IKLGDFGISKILGSEY 155 (256)
T ss_pred EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCC---EEECcCcceEEccccc
Confidence 999999999999765 35899999999999999999999999999999999999976554 8999999998654333
Q ss_pred -cccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHH
Q 018640 214 -KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (352)
Q Consensus 214 -~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 291 (352)
......|++.|+|||.+.+ .++.++|+||||+++++|++|..||......+....+..... ......++..+.++
T Consensus 156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 232 (256)
T cd08221 156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNY---TPVVSVYSSELISL 232 (256)
T ss_pred ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC---CCCccccCHHHHHH
Confidence 2344578999999998764 478899999999999999999999987766655555543221 12225678999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcCccc
Q 018640 292 VRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 292 i~~~l~~dP~~Rps~~ell~hp~f 315 (352)
+.+||+.+|++||++.++++|||+
T Consensus 233 i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 233 VHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHcccCcccCCCHHHHhhCcCC
Confidence 999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=317.75 Aligned_cols=250 Identities=27% Similarity=0.460 Sum_probs=203.4
Q ss_pred cccceeceee--eccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 54 EERYELGREL--GRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 54 ~~~y~~~~~l--G~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
.++|.+.+.+ |+|+||.||++.+..++..+|+|.+....... .|+.....+.+|+|++++++.+...+..
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3567777776 99999999999999999999999986543211 1233333344799999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
++||||+++++|.+++..+..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. .++|+|||++.....
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKD--RIYLCDYGLCKIIGT 162 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCC--eEEEecCccceecCC
Confidence 999999999999999988778999999999999999999999999999999999999986552 389999999876543
Q ss_pred CCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcccccCCCCCcCCCHHHH
Q 018640 212 GEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAIIRSVLDFRRDPWPKVSENAK 289 (352)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 289 (352)
. ....++..|+|||++. ..++.++|+||||+++++|++|..||......... ..+.... ......++..++.+.
T Consensus 163 ~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 238 (267)
T PHA03390 163 P---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNAN 238 (267)
T ss_pred C---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHHHH
Confidence 2 2346889999999986 45889999999999999999999999755433221 2222222 223334456899999
Q ss_pred HHHHHhcCCCcCCCCC-HHHHhcCccccc
Q 018640 290 DLVRKMLDPDPKRRLT-AQQVLEHPWLQN 317 (352)
Q Consensus 290 ~li~~~l~~dP~~Rps-~~ell~hp~f~~ 317 (352)
++|.+||+.+|.+||+ ++++++||||++
T Consensus 239 ~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 239 DFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 9999999999999996 699999999974
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=333.85 Aligned_cols=252 Identities=22% Similarity=0.349 Sum_probs=202.9
Q ss_pred cccceeceeeeccCceEEEEEEE-----CCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC
Q 018640 54 EERYELGRELGRGEFGITYLCTD-----RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 128 (352)
.++|++.+.||+|+||+||+|.+ ..++..||+|++.... .....+.+.+|+.++..+.+||||+++++++...
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 34799999999999999999974 3457789999986542 2233467889999999997899999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhcC---------------------------------------------------------
Q 018640 129 TAVHLVMELCEGGELFDRIVARG--------------------------------------------------------- 151 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~--------------------------------------------------------- 151 (352)
+..++||||+++|+|.+++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 99999999999999999886421
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 152 ------------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 152 ------------------~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
.+++..+..++.||+.||.|||+.+++||||||+|||++.+. .+||+|||++.......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~---~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR---ITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC---cEEEecCccceeccCcc
Confidence 367888999999999999999999999999999999997544 48999999998654332
Q ss_pred cc---cccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHH
Q 018640 214 KF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (352)
Q Consensus 214 ~~---~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (352)
.. ....++..|+|||.+. ..++.++||||||+++|||++ |..||................. ....+...+.++
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l 346 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY--RMLSPECAPSEM 346 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCc--cCCCCCCCCHHH
Confidence 21 1234466799999876 458999999999999999998 8999977654443333333221 222233467899
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 289 KDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 289 ~~li~~~l~~dP~~Rps~~ell~h 312 (352)
.++|..||+.||++|||+.+|++.
T Consensus 347 ~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 347 YDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHHHccCChhHCcCHHHHHHH
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=313.38 Aligned_cols=254 Identities=30% Similarity=0.484 Sum_probs=214.2
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccC--ChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR--TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
+|+..+.||+|++|+||+|.+..++..|++|.+...... .....+.+.+|+.+++.+ +|+||+++++++......++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNIVQYLGTEREEDNLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-CCCCchheeeeEecCCeEEE
Confidence 477889999999999999999889999999988654321 123456788999999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
++||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. +||+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~---~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 80 FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGV---VKLADFGMAKQVVEFS 156 (258)
T ss_pred EEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC---EEEccCccceeccccc
Confidence 9999999999999988777999999999999999999999999999999999999976544 8999999988654443
Q ss_pred cccccccccccccchhcc-cc-CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHH
Q 018640 214 KFSEIVGSPYYMAPEVLK-RN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (352)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~-~~-~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 291 (352)
......|+..|++||.+. .. ++.++|+||||+++|++++|..||............... ......++.+++.+.++
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l 234 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS--KELPPIPDHLSDEAKDF 234 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhc--ccCCCcCCCcCHHHHHH
Confidence 334567889999999875 34 789999999999999999999999776644433333221 11223345678999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcCccc
Q 018640 292 VRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 292 i~~~l~~dP~~Rps~~ell~hp~f 315 (352)
+.+||+.+|++||++.+++.|||+
T Consensus 235 i~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 235 ILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=314.90 Aligned_cols=252 Identities=28% Similarity=0.491 Sum_probs=211.2
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
.++|++.+.||+|+||.||+|.+..++..+++|.+.... ..+.+.+|+.+++++ +|+||+++++++......++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l 75 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQC-DSPYIVKYYGSYFKNTDLWI 75 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhC-CCCcEeeeeeeeecCCcEEE
Confidence 357999999999999999999998889999999986532 157899999999999 99999999999999999999
Q ss_pred EEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 134 VMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
++||+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++......
T Consensus 76 ~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~---~~l~dfg~~~~~~~~ 152 (256)
T cd06612 76 VMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQ---AKLADFGVSGQLTDT 152 (256)
T ss_pred EEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCc---EEEcccccchhcccC
Confidence 99999999999998753 46899999999999999999999999999999999999976554 899999998866443
Q ss_pred C-cccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHH
Q 018640 213 E-KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (352)
Q Consensus 213 ~-~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (352)
. ......++..|+|||++.+ .++.++||||||+++++|++|+.||...........+.... .........++..+.+
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 231 (256)
T cd06612 153 MAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKP-PPTLSDPEKWSPEFND 231 (256)
T ss_pred ccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCC-CCCCCchhhcCHHHHH
Confidence 3 2334468899999998764 58899999999999999999999997655443332222111 1111122346789999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 291 LVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 291 li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
+|.+||+.||++|||+.+++.||||
T Consensus 232 ~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 232 FVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHhcChhhCcCHHHHhcCCCC
Confidence 9999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=316.92 Aligned_cols=256 Identities=25% Similarity=0.439 Sum_probs=209.8
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCC-------hhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT-------AVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 128 (352)
+|.+.+.||+|++|.||+|.+..+|+.||+|.+....... ....+.+.+|+.+++.+ +|+|++++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DHLNIVQYLGFETTE 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc-CCCCcceEEEEeccC
Confidence 4888999999999999999998899999999875432111 11235688899999999 899999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccccee
Q 018640 129 TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~ 208 (352)
+..++||||+++++|.+++.....+++..+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||++..
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~---~~l~d~~~~~~ 157 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGI---CKISDFGISKK 157 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCe---EEEeecccccc
Confidence 999999999999999999988888999999999999999999999999999999999999975544 89999999875
Q ss_pred cCCCC---cccccccccccccchhccc---cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--cccCCCC
Q 018640 209 FKPGE---KFSEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV--LDFRRDP 280 (352)
Q Consensus 209 ~~~~~---~~~~~~gt~~y~aPE~~~~---~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~ 280 (352)
..... ......|+..|+|||.+.. .++.++|+||||++++++++|..||................ .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV 237 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccc
Confidence 43221 1234468899999998753 37889999999999999999999996555443333322211 1122223
Q ss_pred CcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 281 ~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
.+.++..+.++|.+||+.+|++|||+.++++||||
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 238 SMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 34578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=319.85 Aligned_cols=262 Identities=25% Similarity=0.353 Sum_probs=214.1
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++++.||+|+||+||++.+..+|..||+|++.... .......+.+|+++++.+ +||||+++++++......++|
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHEC-RSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHc-CCCCcceEeeeEecCCEEEEE
Confidence 57999999999999999999999999999999876542 233456788999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
|||+++++|.+++...+.+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++ .++|+|||++......
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~---~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG---QIKLCDFGVSGELINS- 157 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC---cEEEccCCcccchhhh-
Confidence 9999999999999887789999999999999999999997 5899999999999997554 4899999998654322
Q ss_pred cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhccc-ccCCCC-CcC
Q 018640 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-------GVAQAIIRSVL-DFRRDP-WPK 283 (352)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~-------~~~~~~~~~~~-~~~~~~-~~~ 283 (352)
......|+..|+|||++. +.++.++|+||||++++++++|..||...... ........... ...... ...
T Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd06620 158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSD 237 (284)
T ss_pred ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchh
Confidence 123457899999999875 56889999999999999999999999754432 00111111111 111111 123
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccCCC
Q 018640 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPN 323 (352)
Q Consensus 284 ~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~ 323 (352)
++..+.+|+.+||+.||++|||+.|+++||||.+......
T Consensus 238 ~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~~~ 277 (284)
T cd06620 238 FPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASN 277 (284)
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccccc
Confidence 7789999999999999999999999999999987654443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=318.64 Aligned_cols=252 Identities=29% Similarity=0.512 Sum_probs=205.2
Q ss_pred ceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC--CeEEEE
Q 018640 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--TAVHLV 134 (352)
Q Consensus 57 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~--~~~~lv 134 (352)
|++++.||+|+||.||+|.+..++..||+|++.... ..... ....+|+..+.++.+|+|++++++++.+. +..++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~-~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF-KSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhcc-CCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 678899999999999999999999999999886542 22222 23456888999986799999999999877 889999
Q ss_pred EEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
+||+++ +|.+.+... ..+++..+..++.|++.||+|||+.+++|+||+|+||+++. ..+||+|||++.......
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~----~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD----DILKLADFGSCRGIYSKP 153 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC----CCeEEEecccccccccCC
Confidence 999975 888887654 46899999999999999999999999999999999999976 458999999998765444
Q ss_pred cccccccccccccchhcc--ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC-------------
Q 018640 214 KFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR------------- 278 (352)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~--~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------------- 278 (352)
......++..|+|||.+. +.++.++||||||+++|||++|..||......+....+.........
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 444556889999999764 34788999999999999999999999876655444333322111000
Q ss_pred ------------CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 279 ------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 279 ------------~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
...+.++..+.++|.+||+++|++||++.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0012467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=314.45 Aligned_cols=255 Identities=28% Similarity=0.514 Sum_probs=208.8
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEcccccc--CChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC--Ce
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL--RTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--TA 130 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~--~~ 130 (352)
.+|++.+.||+|+||.||.|.+..+|..||+|.+..... ......+.+.+|+.+++++ +|+||+++++++.+. ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-LHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-CCCCeeeEEeEeccCCCce
Confidence 368999999999999999999999999999998764321 1223356788999999999 899999999988653 46
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
.+++|||+++++|.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++....
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~---~~l~Dfg~~~~~~ 157 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN---VKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCC---EEECcCccccccc
Confidence 7899999999999999988777899999999999999999999999999999999999975554 8999999987543
Q ss_pred CC----Ccccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCC
Q 018640 211 PG----EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (352)
Q Consensus 211 ~~----~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (352)
.. .......|+..|+|||.+. ..++.++||||||+++|+|++|+.||............... ...+..+..++
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ--PTNPVLPPHVS 235 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcC--CCCCCCchhhC
Confidence 21 1223446889999999876 45889999999999999999999999766544443333221 11222334577
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcCcccc
Q 018640 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316 (352)
Q Consensus 286 ~~~~~li~~~l~~dP~~Rps~~ell~hp~f~ 316 (352)
..+.++|.+|+. +|++||++.++++|||+.
T Consensus 236 ~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 236 DHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 889999999995 899999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=322.05 Aligned_cols=252 Identities=22% Similarity=0.284 Sum_probs=201.5
Q ss_pred cccceeceeeeccCceEEEEEEECC----------------CCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCC
Q 018640 54 EERYELGRELGRGEFGITYLCTDRE----------------NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~ 117 (352)
.++|++.++||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.++.++ +|||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~n 80 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRL-KDPN 80 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhc-CCCC
Confidence 4579999999999999999998532 34479999887542 233456789999999999 8999
Q ss_pred eeEeeeEEEeCCeEEEEEEecCCcchHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCCE
Q 018640 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG-------------------HYTERAAAAVTKTIVEVVQMCHKHGVM 178 (352)
Q Consensus 118 iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------------------~l~~~~~~~i~~qi~~aL~~lH~~~iv 178 (352)
|+++++++...+..++||||+++++|.+++.... .+++..+..++.||+.||.|||+.||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999999999999999999999886431 367788999999999999999999999
Q ss_pred EecCCCCceEeecCCCCCCEEEEecccceecCCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh--
Q 018640 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-- 252 (352)
Q Consensus 179 H~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-- 252 (352)
||||||+|||++.++. +||+|||+++....... .....++..|+|||.+. +.++.++||||||+++|||++
T Consensus 161 H~dlkp~Nill~~~~~---~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 161 HRDLATRNCLVGENLT---IKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred ccCcchhheEEcCCcc---EEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 9999999999976544 89999999986543321 12335578899999875 568999999999999999986
Q ss_pred CCCCCCCCCHHHHHHHHHhccc----ccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 253 GVPPFWAETEQGVAQAIIRSVL----DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 253 g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
+..||................. .......+.+++.+.+++.+||+.||++|||+.+|.+
T Consensus 238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 5678876665554443322211 1112223467899999999999999999999999943
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=319.68 Aligned_cols=268 Identities=24% Similarity=0.335 Sum_probs=209.8
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++++.||+|+||.||+|.+..+|+.||+|++...... .....+..|+.++.+..+|||++++++++..++..+++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS--QEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc--HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 3689999999999999999999999999999988754321 22345566777644444899999999999999999999
Q ss_pred EEecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc-CCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 135 MELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
|||++ ++|.+++.. ...+++..++.++.|++.||.|||++ +++||||||+||+++.++. +||+|||++...
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~---~kl~dfg~~~~~ 154 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ---VKLCDFGISGYL 154 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC---EEEeeccccccc
Confidence 99996 588777754 23589999999999999999999997 9999999999999976544 899999999865
Q ss_pred CCCCcccccccccccccchhccc-----cCCCcchHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcccccCCCCCcC
Q 018640 210 KPGEKFSEIVGSPYYMAPEVLKR-----NYGPEVDVWSAGVILYILLCGVPPFWAET-EQGVAQAIIRSVLDFRRDPWPK 283 (352)
Q Consensus 210 ~~~~~~~~~~gt~~y~aPE~~~~-----~~s~~~Di~SlG~~l~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 283 (352)
..........|+..|+|||.+.+ .++.++|+||||+++|+|++|+.||.... ..+......... ........
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~ 232 (283)
T cd06617 155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP--SPQLPAEK 232 (283)
T ss_pred ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC--CCCCCccc
Confidence 44333344578899999998743 36889999999999999999999996432 222222222211 11111235
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccCCCCCCcHHHH
Q 018640 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVK 331 (352)
Q Consensus 284 ~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~ 331 (352)
+++++.++|.+||..+|++||++.++++||||.+.. ..+..+.+.++
T Consensus 233 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~-~~~~~~~~~~~ 279 (283)
T cd06617 233 FSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL-SKNTDVASFVS 279 (283)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc-cccHHHHHHHH
Confidence 789999999999999999999999999999999864 34444444443
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=316.26 Aligned_cols=249 Identities=17% Similarity=0.256 Sum_probs=206.1
Q ss_pred cccceeceeeeccCceEEEEEEEC---CCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe
Q 018640 54 EERYELGRELGRGEFGITYLCTDR---ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 130 (352)
.++|++.+.||+|+||.||+|.+. ..+..||+|.+.... .......+.+|+.++.++ +||||+++++++...+.
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQF-DHSNIVRLEGVITRGNT 80 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEecCCC
Confidence 357999999999999999999864 456789999987542 223346788999999999 89999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 131 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
.++||||+++++|.+++... ..+++..++.++.|++.||+|||+++++||||||+||+++.++. ++++|||.+...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~---~~l~dfg~~~~~ 157 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLV---CKISGFRRLQED 157 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCc---EEECCCcccccc
Confidence 99999999999999999764 46899999999999999999999999999999999999976544 899999987654
Q ss_pred CCCCcc--cccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCC
Q 018640 210 KPGEKF--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (352)
Q Consensus 210 ~~~~~~--~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (352)
...... ....++..|+|||.+. +.++.++||||||+++||+++ |..||+.....+....+.+.. ....+..++
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~ 234 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF---RLPAPRNCP 234 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC---CCCCCCCCC
Confidence 322211 1234567899999876 568999999999999999775 999999887776666554332 223345688
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 286 ENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 286 ~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
..+.+++.+||+.+|++||++.+|++
T Consensus 235 ~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 235 NLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 99999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=317.22 Aligned_cols=269 Identities=29% Similarity=0.508 Sum_probs=216.6
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCC--CCCCeeEeeeEEEeCCeEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP--KHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~~iv~l~~~~~~~~~~~l 133 (352)
.|++.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.+. .|||++++++++......++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 4888999999999999999999999999999986542 2334567888999999994 39999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
||||+++++|.+++... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~---~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG---NVKLCDFGVAALLNQNS 155 (277)
T ss_pred EEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC---CEEEccCCceeecCCCc
Confidence 99999999999988654 789999999999999999999999999999999999997644 48999999997664332
Q ss_pred -cccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHH
Q 018640 214 -KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (352)
Q Consensus 214 -~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (352)
......|+..|+|||.+.. .++.++|+||||+++|+|++|..||...........+... ..+......++.++.+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 233 (277)
T cd06917 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPPRLEDNGYSKLLRE 233 (277)
T ss_pred cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--CCCCCCcccCCHHHHH
Confidence 2334578899999998753 3688999999999999999999999776554333222111 1111111237889999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcCccccccccCCCCCCcHHHHHH
Q 018640 291 LVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKAR 333 (352)
Q Consensus 291 li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~ 333 (352)
++..||+.||++||++.+++.||||++.. ..+.....++..+
T Consensus 234 ~i~~~l~~~p~~R~~~~~il~~~~~~~~~-~~~~~~~~~~~~~ 275 (277)
T cd06917 234 FVAACLDEEPKERLSAEELLKSKWIKAHS-KTPVSILKELISR 275 (277)
T ss_pred HHHHHcCCCcccCcCHHHHhhChHhhccc-cCchhhHHHHHHh
Confidence 99999999999999999999999998754 3334444444433
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=319.38 Aligned_cols=258 Identities=27% Similarity=0.434 Sum_probs=207.9
Q ss_pred cccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEE---
Q 018640 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE--- 126 (352)
Q Consensus 50 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~--- 126 (352)
.....++|++.+.||+|+||.||+|.+..+++.+|+|++.... ...+.+.+|+.+++.+.+|+||+++++++.
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3456778999999999999999999999999999999875421 123567889999999867999999999874
Q ss_pred --eCCeEEEEEEecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEE
Q 018640 127 --DDTAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKA 200 (352)
Q Consensus 127 --~~~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl 200 (352)
.....++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+++||||||+||+++.++. ++|
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~---~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG---VKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCC---EEE
Confidence 34578999999999999988753 245889999999999999999999999999999999999976554 899
Q ss_pred EecccceecCCCC-cccccccccccccchhcc------ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 018640 201 IDFGLSVFFKPGE-KFSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV 273 (352)
Q Consensus 201 ~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~ 273 (352)
+|||++....... ......|+..|+|||++. ..++.++||||||+++|+|++|..||................
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~ 245 (286)
T cd06638 166 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP 245 (286)
T ss_pred ccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC
Confidence 9999987654322 223447899999999874 237889999999999999999999997765443332221111
Q ss_pred cccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 274 LDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 274 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
.........++..+.++|.+||+.||++|||+.++++|+||
T Consensus 246 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 246 -PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred -CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 11111122357889999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=348.84 Aligned_cols=246 Identities=26% Similarity=0.430 Sum_probs=212.9
Q ss_pred ccceeceeeeccCceEEEEEEEC-----CCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC
Q 018640 55 ERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 129 (352)
.+.+..++||+|+||.||+|... ++...||||.++... +.....+|++|++++..+ +|||||+|+|+|.+++
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l-~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAEL-QHPNIVRLLGVCREGD 562 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhc-cCCCeEEEEEEEccCC
Confidence 34667799999999999999864 334579999987642 444578899999999999 9999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCC
Q 018640 130 AVHLVMELCEGGELFDRIVARG--------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKET 195 (352)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~--------------~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~ 195 (352)
..++|+|||..|+|.++|..+. +|+..+.+.|+.||+.||+||-++.+|||||-.+|+||+ +.
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg---e~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG---EN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec---cc
Confidence 9999999999999999996431 278889999999999999999999999999999999995 55
Q ss_pred CCEEEEecccceecCCCCccc---ccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 018640 196 APLKAIDFGLSVFFKPGEKFS---EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAII 270 (352)
Q Consensus 196 ~~vkl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~ 270 (352)
..|||+|||+++.......+. ...-..+|||||.+. +.+|++|||||||++|||+++ |+.||.+..+++++..+.
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~ 719 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR 719 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH
Confidence 669999999998765443322 234467899999865 789999999999999999998 999999999999998888
Q ss_pred hcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHH
Q 018640 271 RSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQV 309 (352)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~el 309 (352)
+... .+.+...|.++.+|+..||+.+|.+||++.||
T Consensus 720 ~g~l---L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 720 AGQL---LSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred cCCc---ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 7654 44556899999999999999999999999998
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=314.25 Aligned_cols=255 Identities=27% Similarity=0.447 Sum_probs=215.8
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
+|++.+.||+|++|.||+|.+..+++.|++|++...... .....+.+|+..+.++ +|+|++++++++......++|+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSC-ESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhc-CCCCeeeEEEEEccCCeEEEEE
Confidence 688999999999999999999999999999998765321 3457799999999999 7999999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCc
Q 018640 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (352)
Q Consensus 136 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (352)
||+++++|.+++.....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++. ++|+|||++........
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~---~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE---VKIADFGISKVLENTLD 155 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCC---EEEccCccceecccCCC
Confidence 999999999999887889999999999999999999999 99999999999999976554 89999999987644333
Q ss_pred c-cccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcccccCCCCCcC-CCHHH
Q 018640 215 F-SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET---EQGVAQAIIRSVLDFRRDPWPK-VSENA 288 (352)
Q Consensus 215 ~-~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 288 (352)
. ....++..|+|||.+. ..++.++|+||||+++|+|++|..||.... ..+....+.. ......... ++..+
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l 232 (264)
T cd06623 156 QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---GPPPSLPAEEFSPEF 232 (264)
T ss_pred cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---CCCCCCCcccCCHHH
Confidence 2 2456889999999876 458889999999999999999999997663 2223323222 111222233 78999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 289 ~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
.++|.+||..+|++||++.++++||||+.+.
T Consensus 233 ~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~ 263 (264)
T cd06623 233 RDFISACLQKDPKKRPSAAELLQHPFIKKAD 263 (264)
T ss_pred HHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence 9999999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=319.58 Aligned_cols=256 Identities=31% Similarity=0.527 Sum_probs=210.4
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++.+.||+|++|.||+|.+..+++.||+|++..... .....+.+.+|+++++++ +|+||+++++++...+..+++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv 78 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQL-RHENIVNLKEAFRRKGRLYLV 78 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhc-CCCCeeehhheEEECCEEEEE
Confidence 369999999999999999999999999999998875432 233456789999999999 799999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC-
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (352)
+||++++.+..+......+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~---~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGV---LKLCDFGFARALRARPA 155 (288)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC---EEEEeeecccccCCCcc
Confidence 999998777666666667999999999999999999999999999999999999976444 8999999988765433
Q ss_pred -cccccccccccccchhcc-c-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC------------
Q 018640 214 -KFSEIVGSPYYMAPEVLK-R-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR------------ 278 (352)
Q Consensus 214 -~~~~~~gt~~y~aPE~~~-~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------------ 278 (352)
......++..|+|||.+. . .++.++||||||+++|+|++|..||......+....+........+
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 334457789999999875 4 5788999999999999999999999766554433332221111000
Q ss_pred ----------------CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 279 ----------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 279 ----------------~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
.....++..+.+||.+||+.+|++|||+.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0111248889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=319.22 Aligned_cols=253 Identities=28% Similarity=0.480 Sum_probs=216.5
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
++-|.++++||+|+||.||+|.++++|..+|||.+... .+..++..|+.++.++ +.|++|++++.|-....+|+
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC-~S~yVVKYYGSYFK~sDLWI 105 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQC-KSKYVVKYYGSYFKHSDLWI 105 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHc-CCchhhhhhhhhccCCceEe
Confidence 45699999999999999999999999999999998643 4578899999999999 99999999999999999999
Q ss_pred EEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 134 VMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
|||||..|+..+.++.+ +++++.++..+++..+.||+|||...=||||||..|||++.++. .||+|||.|..+.+.
T Consensus 106 VMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~---AKLADFGVAGQLTDT 182 (502)
T KOG0574|consen 106 VMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGI---AKLADFGVAGQLTDT 182 (502)
T ss_pred ehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccch---hhhhhccccchhhhh
Confidence 99999999999999754 57999999999999999999999999999999999999987776 599999999876433
Q ss_pred -Ccccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCC---CcCCCHH
Q 018640 213 -EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP---WPKVSEN 287 (352)
Q Consensus 213 -~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 287 (352)
...+++.||+.|||||++.. +|+.++||||||++..||..|++||..-.+... + -.+...+++. +...+.+
T Consensus 183 MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA---I-FMIPT~PPPTF~KPE~WS~~ 258 (502)
T KOG0574|consen 183 MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA---I-FMIPTKPPPTFKKPEEWSSE 258 (502)
T ss_pred HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce---e-EeccCCCCCCCCChHhhhhH
Confidence 34477899999999999874 699999999999999999999999965433211 1 1111111111 2346889
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 288 ~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
+.||+++||-.+|++|-|+.++++|||+++++
T Consensus 259 F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 259 FNDFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred HHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 99999999999999999999999999999763
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=317.89 Aligned_cols=254 Identities=26% Similarity=0.455 Sum_probs=207.6
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEE------
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE------ 126 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~------ 126 (352)
..+.|++.+.||.|+||.||+|.+..+++.+|+|++... ......+..|+.+++++.+|+|++++++++.
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 446799999999999999999999999999999987543 2234568889999999878999999999884
Q ss_pred eCCeEEEEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecc
Q 018640 127 DDTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (352)
Q Consensus 127 ~~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg 204 (352)
.....+++|||+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~---~~l~dfg 166 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE---VKLVDFG 166 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC---EEEeeCc
Confidence 245789999999999999988753 34888899999999999999999999999999999999975544 8999999
Q ss_pred cceecCCC-Ccccccccccccccchhcc------ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC
Q 018640 205 LSVFFKPG-EKFSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR 277 (352)
Q Consensus 205 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 277 (352)
++...... .......|+..|+|||.+. ..++.++|+||||+++|||++|..||...........+.... ..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~--~~ 244 (282)
T cd06636 167 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--PP 244 (282)
T ss_pred chhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCC--CC
Confidence 98754322 2223457899999999864 247889999999999999999999997665443333322211 11
Q ss_pred CCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 278 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
......++..+.++|.+||+.||.+|||+.|+++||||
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 245 KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 11223578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=318.95 Aligned_cols=261 Identities=30% Similarity=0.492 Sum_probs=211.4
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++.+.||+|++|+||+|.+..+|+.||+|.+...... ....+.+.+|+.+++++ +|+||+++++++......++|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhc-cCCCEeeEEEEEecCCeEEEE
Confidence 4699999999999999999999999999999998664322 22345688899999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 135 MELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~--l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
|||++ ++|.+++..... +++..+..++.||+.||+|||+++++|+||+|+||+++.++. .+||+|||++......
T Consensus 80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~--~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLARAFGIP 156 (294)
T ss_pred Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCC--EEEEcccccccccCCC
Confidence 99996 488888765443 578889999999999999999999999999999999975433 3899999999764332
Q ss_pred C-cccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCC----------
Q 018640 213 E-KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD---------- 279 (352)
Q Consensus 213 ~-~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 279 (352)
. ......+++.|+|||.+.+ .++.++||||||+++|+|+||..||......+....+..........
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 2 2233467889999998753 47889999999999999999999998766655544443321111000
Q ss_pred ---------------CCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 280 ---------------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 280 ---------------~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
..+.+++.+.+++.+||+.+|++||++.++++||||.+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~ 292 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence 12356888999999999999999999999999999997643
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=312.98 Aligned_cols=255 Identities=28% Similarity=0.489 Sum_probs=210.9
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
+|++.+.||+|+||.||+|.+..++..|++|.+...... ....+.+.+|+.+++.+ +|+||+++++.+...+..++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELL-KHPNLVKYYGVEVHREKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhC-CCCChhheeeeEecCCEEEEEE
Confidence 588999999999999999999889999999998765432 34567899999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCc-
Q 018640 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK- 214 (352)
Q Consensus 136 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~- 214 (352)
||+++++|.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~---~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGV---IKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC---EEEcccccccccCCCCCc
Confidence 99999999999988777899999999999999999999999999999999999976444 89999999876543322
Q ss_pred ----ccccccccccccchhccc-c---CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCH
Q 018640 215 ----FSEIVGSPYYMAPEVLKR-N---YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (352)
Q Consensus 215 ----~~~~~gt~~y~aPE~~~~-~---~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (352)
.....++..|+|||++.+ . ++.++||||||++++++++|..||.....................+....+++
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSP 235 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCH
Confidence 123467889999998763 2 68899999999999999999999975533222222222111111112224588
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 287 ~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
.+.++|.+||+.+|++|||+.+++.|||+
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 236 EGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 99999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=332.33 Aligned_cols=251 Identities=20% Similarity=0.319 Sum_probs=202.2
Q ss_pred cccceeceeeeccCceEEEEEEECCC-----CcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC
Q 018640 54 EERYELGRELGRGEFGITYLCTDREN-----GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 128 (352)
.++|++.+.||+|+||.||+|.+... +..||+|++.... .....+.+.+|+.+++.+.+|+||+++++++...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 35799999999999999999986443 4579999987543 2233567889999999997899999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhc----------------------------------------------------------
Q 018640 129 TAVHLVMELCEGGELFDRIVAR---------------------------------------------------------- 150 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~---------------------------------------------------------- 150 (352)
...++||||+++|+|.+++...
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 9999999999999999988542
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCcc---
Q 018640 151 ------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF--- 215 (352)
Q Consensus 151 ------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~--- 215 (352)
..+++..++.++.||+.||.|||++|++||||||+||+++.++ .++|+|||+++........
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~---~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR---VAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC---eEEEeeceeeeeccCCcceeec
Confidence 1367888999999999999999999999999999999997544 4899999999765433221
Q ss_pred cccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHH
Q 018640 216 SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (352)
Q Consensus 216 ~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 293 (352)
....++..|+|||++. ..++.++||||||+++|||++ |+.||................ .........++++.+++.
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~ 349 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRG--YQMSRPDFAPPEIYSIMK 349 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcc--cCccCCCCCCHHHHHHHH
Confidence 2234567899999875 568999999999999999997 999997665443333333322 122223356899999999
Q ss_pred HhcCCCcCCCCCHHHHhc
Q 018640 294 KMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 294 ~~l~~dP~~Rps~~ell~ 311 (352)
+||+.||++|||+.++++
T Consensus 350 ~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 350 MCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHcCCChhhCcCHHHHHH
Confidence 999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=318.96 Aligned_cols=254 Identities=28% Similarity=0.478 Sum_probs=208.0
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
+|++++.||.|++|.||+|.+..+|..||+|++..... .......+.+|+++++++ +||||+++++++.+.+..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhc-CCCCCcchhhhcccCCcEEEEe
Confidence 48899999999999999999999999999998865432 222345788999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 136 ELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 136 e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
||++ ++|.+++... ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++. ++|+|||++.......
T Consensus 79 e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~---~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 79 EFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPV 154 (284)
T ss_pred eccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC---EEEeeccchhhcccCc
Confidence 9996 5888888653 45899999999999999999999999999999999999976554 8999999987553322
Q ss_pred -cccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC------------
Q 018640 214 -KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR------------ 278 (352)
Q Consensus 214 -~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------------ 278 (352)
......++..|+|||.+.+ .++.++||||||+++|+|+||+.||...........+.........
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 2233457889999998754 2688999999999999999999999776655444443332211100
Q ss_pred -------------CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 279 -------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 279 -------------~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
...+.++..+.++|.+||+.||.+|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0123467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=312.95 Aligned_cols=253 Identities=31% Similarity=0.512 Sum_probs=212.3
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++.+.||+|+||.||+|.+..+++.+++|++.... ....+.+.+|+.+++++ +||||+++++++......+++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKEC-RHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhC-CCCChhceEEEEEeCCEEEEE
Confidence 57999999999999999999998889999999987542 22457889999999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~---~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGD---VKLADFGVSAQLTATI 155 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCC---EEECccccchhhhhhh
Confidence 9999999999998776 67999999999999999999999999999999999999986554 8999999987654322
Q ss_pred -cccccccccccccchhcc-c---cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc-CCCCCcCCCHH
Q 018640 214 -KFSEIVGSPYYMAPEVLK-R---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF-RRDPWPKVSEN 287 (352)
Q Consensus 214 -~~~~~~gt~~y~aPE~~~-~---~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 287 (352)
......++..|+|||.+. . .++.++|+||||+++++|++|..||................... ........+.+
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (262)
T cd06613 156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPV 235 (262)
T ss_pred hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHH
Confidence 223457888999999875 3 57889999999999999999999998776554444333321111 11112345788
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcCcc
Q 018640 288 AKDLVRKMLDPDPKRRLTAQQVLEHPW 314 (352)
Q Consensus 288 ~~~li~~~l~~dP~~Rps~~ell~hp~ 314 (352)
+.+++.+||..+|.+|||+.+++.|||
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 236 FHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=317.97 Aligned_cols=254 Identities=27% Similarity=0.434 Sum_probs=210.8
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++.+.||+|++|.||+|.+..+++.||+|.+..... ......+.+|+.+++++ +||||+++++.+......+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv 77 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKC-NSPYIVGFYGAFYNNGDISIC 77 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHC-CCCchhhhheeeecCCEEEEE
Confidence 368889999999999999999999999999999876532 23456788999999999 799999999999999999999
Q ss_pred EEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
+||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++. ++|+|||.+......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~---~~l~d~g~~~~~~~~ 154 (265)
T cd06605 78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ---IKLCDFGVSGQLVNS 154 (265)
T ss_pred EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCC---EEEeecccchhhHHH
Confidence 9999999999999876 679999999999999999999999 99999999999999976544 899999998755322
Q ss_pred Ccccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhcccccCCCCCcC-CC
Q 018640 213 EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAET-----EQGVAQAIIRSVLDFRRDPWPK-VS 285 (352)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~-~~ 285 (352)
... ...++..|+|||.+.+ .++.++||||||+++++|++|..||.... .......+.. ...+..... ++
T Consensus 155 ~~~-~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 230 (265)
T cd06605 155 LAK-TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN---EPPPRLPSGKFS 230 (265)
T ss_pred Hhh-cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc---CCCCCCChhhcC
Confidence 221 2678899999998764 58899999999999999999999996542 1122222221 111222222 78
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 286 ~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
..+.++|.+||..||++|||+.+++.||||+..
T Consensus 231 ~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 231 PDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 899999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=320.86 Aligned_cols=255 Identities=28% Similarity=0.495 Sum_probs=208.7
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC--CeEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--TAVH 132 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~--~~~~ 132 (352)
++|++.+.||+|+||.||+|.+..+++.+|+|.+...... ......+.+|+.+++++ +||||+++++++... ...+
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKL-QHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhc-CCCCEEEEEEEEEecCCCcEE
Confidence 4699999999999999999999989999999998755332 22234567899999999 799999999998877 8999
Q ss_pred EEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 133 LVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
+|+||+++ +|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++.....
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~---~~l~d~g~~~~~~~ 158 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI---LKICDFGLAREYGS 158 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCc---EEEeecCceeeccC
Confidence 99999975 9998887644 4899999999999999999999999999999999999976544 89999999986654
Q ss_pred C-Ccccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC-----------
Q 018640 212 G-EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR----------- 277 (352)
Q Consensus 212 ~-~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----------- 277 (352)
. .......++..|+|||.+.+ .++.++|+||||+++++|++|..||...........+........
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 3 23344567889999998764 368899999999999999999999987766555444433211000
Q ss_pred ---------------CCCCcC--CCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 278 ---------------RDPWPK--VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 278 ---------------~~~~~~--~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
....+. +++.+.++|.+||+.+|++|||+.|++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 001112 48889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=321.99 Aligned_cols=259 Identities=29% Similarity=0.445 Sum_probs=210.1
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC--CeE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--TAV 131 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~--~~~ 131 (352)
.++|++.+.||+|+||.||+|.+..+|+.||+|++....... .....+.+|+.+++++ +|+|++++++++.+. +..
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNL-RHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhC-CCCCCcceEEEEecCCCCeE
Confidence 356999999999999999999999999999999986543222 1123456799999999 899999999998755 568
Q ss_pred EEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 132 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
++||||+++ +|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~---~kL~dfg~~~~~~ 159 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGC---LKIADFGLARTYG 159 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC---EEECccceeeecC
Confidence 999999965 888887653 56899999999999999999999999999999999999975544 8999999998764
Q ss_pred CC-Ccccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCC-------
Q 018640 211 PG-EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP------- 280 (352)
Q Consensus 211 ~~-~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 280 (352)
.. .......++..|+|||.+.+ .++.++||||||+++|+|++|..||......+....+...........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 160 LPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred CccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence 33 22233356788999998753 478999999999999999999999988877766665554322111000
Q ss_pred -------------------CcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 281 -------------------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 281 -------------------~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
....++.+.++|.+||++||++|||+.+++.||||...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 11257888999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=327.71 Aligned_cols=263 Identities=29% Similarity=0.480 Sum_probs=212.3
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC----
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD---- 128 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~---- 128 (352)
+.++|++.+.||+|+||+||+|.+..+++.||+|.+.... ........+.+|+.+++.+ +|+||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~ 80 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF-DNRIDAKRTLREIKLLRHL-DHENVIAIKDIMPPPHREA 80 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc-cccchhHHHHHHHHHHHhc-CCCCccchHHheecccccc
Confidence 5678999999999999999999999999999999987542 2223345677899999999 899999999987643
Q ss_pred -CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccce
Q 018640 129 -TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (352)
Q Consensus 129 -~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~ 207 (352)
...++|+||+. ++|.+++.....+++..+..++.|++.||.|||+.+++|+||||+||+++.++. +||+|||++.
T Consensus 81 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~---~kL~Dfg~~~ 156 (337)
T cd07858 81 FNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLAR 156 (337)
T ss_pred cCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC---EEECcCcccc
Confidence 35799999995 689999988888999999999999999999999999999999999999976554 8999999998
Q ss_pred ecCCC-Ccccccccccccccchhcc--ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc---------
Q 018640 208 FFKPG-EKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD--------- 275 (352)
Q Consensus 208 ~~~~~-~~~~~~~gt~~y~aPE~~~--~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--------- 275 (352)
..... .......++..|+|||.+. ..++.++||||||+++|+|++|+.||...........+......
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 65433 2223456788999999875 34889999999999999999999999765433322222111100
Q ss_pred --------------cC----CCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccC
Q 018640 276 --------------FR----RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKA 321 (352)
Q Consensus 276 --------------~~----~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~ 321 (352)
.. ....+.+++.+.++|.+||+.+|++|||+.++++||||......
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~ 300 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300 (337)
T ss_pred CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence 00 01124578899999999999999999999999999999876443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=313.99 Aligned_cols=252 Identities=28% Similarity=0.508 Sum_probs=207.0
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++.+.||+|+||.||+|++..+++.||+|.+.............+.+|+.+++.+ +||||+++++++...+..+++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCcceeeeeeeEEECCeEEEE
Confidence 4699999999999999999999999999999988664444444456788999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 135 MELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
+||+++++|.+++.. ...+++..+..++.|++.||.|||+++++|+||+|+||+++.++. ++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~---~~l~d~g~~~~~~ 157 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV---VKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCC---EEECccccceecc
Confidence 999999999988753 234899999999999999999999999999999999999976554 8999999988654
Q ss_pred CCCc-ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhcccccCCCCCcCCCH
Q 018640 211 PGEK-FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE--QGVAQAIIRSVLDFRRDPWPKVSE 286 (352)
Q Consensus 211 ~~~~-~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 286 (352)
.... .....|+..|+|||.+. ..++.++|+||||+++|||++|..||..... ......+.. ...++......+.
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 235 (267)
T cd08228 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ--CDYPPLPTEHYSE 235 (267)
T ss_pred chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhc--CCCCCCChhhcCH
Confidence 3322 23456888999999876 4588899999999999999999999865432 222222211 1122222335778
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 287 NAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 287 ~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
.+.+++.+||+.+|++||++.++++.
T Consensus 236 ~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 236 KLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 99999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=317.62 Aligned_cols=254 Identities=28% Similarity=0.481 Sum_probs=202.9
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++.+.||+|++|.||+|.+..+++.||+|.+...... .....+.+|+.+++.+ +|+||+++++++...+..++|
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDL-KHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhC-CCcceeeEEEEEecCCeEEEE
Confidence 5799999999999999999999989999999998754321 1224467899999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
|||+++ +|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||+++......
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~---~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE---LKLADFGLARAKSVPS 157 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCC---EEECccccccccCCCC
Confidence 999975 899988764 35899999999999999999999999999999999999976554 8999999987543221
Q ss_pred -cccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcccccCC-----------
Q 018640 214 -KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAET-EQGVAQAIIRSVLDFRR----------- 278 (352)
Q Consensus 214 -~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~----------- 278 (352)
......++..|+|||.+.+ .++.++||||||+++|+|++|..||.... .......+.+.......
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 1223356888999998753 47889999999999999999999997654 22222222111110000
Q ss_pred ---------------CCCcCCC--HHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 279 ---------------DPWPKVS--ENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 279 ---------------~~~~~~~--~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
...+.++ ..+.+++.+||+++|++|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0011233 788899999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=326.15 Aligned_cols=263 Identities=29% Similarity=0.497 Sum_probs=208.8
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC----
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD---- 128 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~---- 128 (352)
+.++|++.+.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.+++++ +|+||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 79 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRF-KHENIIGILDIIRPPSFES 79 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhC-CCCCcCchhheeecccccc
Confidence 4578999999999999999999999999999999986421 222345678899999999 899999999987543
Q ss_pred -CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccce
Q 018640 129 -TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (352)
Q Consensus 129 -~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~ 207 (352)
...++++||+++ +|.+.+.. ..+++..+..++.|++.||.+||+.|++||||||+||+++.++. ++|+|||++.
T Consensus 80 ~~~~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~---~kl~dfg~~~ 154 (336)
T cd07849 80 FNDVYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD---LKICDFGLAR 154 (336)
T ss_pred cceEEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC---EEECccccee
Confidence 357999999965 88877744 46999999999999999999999999999999999999976544 8999999987
Q ss_pred ecCCCCc----ccccccccccccchhcc--ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc-----
Q 018640 208 FFKPGEK----FSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF----- 276 (352)
Q Consensus 208 ~~~~~~~----~~~~~gt~~y~aPE~~~--~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~----- 276 (352)
....... .....||..|+|||.+. ..++.++||||||+++++|++|+.||...........+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL 234 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 6543221 12346889999999864 348899999999999999999999997665443332222111100
Q ss_pred ------------------CC----CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccCCC
Q 018640 277 ------------------RR----DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPN 323 (352)
Q Consensus 277 ------------------~~----~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~ 323 (352)
.. ...+..++.+.++|.+||+.+|++|||+.++++||||+......+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~ 303 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSD 303 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCC
Confidence 00 011346788999999999999999999999999999998765433
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=328.30 Aligned_cols=258 Identities=28% Similarity=0.430 Sum_probs=208.3
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC---
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--- 128 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~--- 128 (352)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|.+.... ........+.+|+.+++++ +|+||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 90 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLV-NHKNIIGLLNVFTPQKSL 90 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhc-CCCCCcceeeeeccCCCc
Confidence 35678999999999999999999999999999999986542 2233445677899999999 999999999988643
Q ss_pred ---CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccc
Q 018640 129 ---TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (352)
Q Consensus 129 ---~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~ 205 (352)
...++||||+++ +|.+.+... ++...+..++.|++.||+|||+.|++||||||+||+++.++. ++|+|||+
T Consensus 91 ~~~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~---~kL~Dfg~ 164 (353)
T cd07850 91 EEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGL 164 (353)
T ss_pred cccCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC---EEEccCcc
Confidence 357999999964 888887654 899999999999999999999999999999999999976554 89999999
Q ss_pred ceecCCCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC-------
Q 018640 206 SVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR------- 277 (352)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------- 277 (352)
+.............++..|+|||.+. ..++.++||||||+++++|++|+.||...........+........
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 165 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred ceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 98765444444557889999999876 4589999999999999999999999976655443333322111100
Q ss_pred ---------------CC-----------------CCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccc
Q 018640 278 ---------------RD-----------------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (352)
Q Consensus 278 ---------------~~-----------------~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~ 317 (352)
.. .....++.+.++|.+||+.||++|||+.|+|.||||+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 00 01124567899999999999999999999999998863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=322.09 Aligned_cols=248 Identities=27% Similarity=0.463 Sum_probs=190.5
Q ss_pred eeeeccCceEEEEEEECC--CCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEE--eCCeEEEEEE
Q 018640 61 RELGRGEFGITYLCTDRE--NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE--DDTAVHLVME 136 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~--~~~~~~lv~e 136 (352)
.+||+|+||+||+|.+.. ++..||+|.+.... ....+.+|+.+++.+ +||||+++++++. .+...++|+|
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLREL-KHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhC-CCCCeeeEEEEEeccCCCeEEEEEe
Confidence 579999999999999653 56889999886432 124577899999999 8999999999885 3567899999
Q ss_pred ecCCcchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecC-CCCCCEEEEecccc
Q 018640 137 LCEGGELFDRIVAR---------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK-KETAPLKAIDFGLS 206 (352)
Q Consensus 137 ~~~~~sL~~~l~~~---------~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~-~~~~~vkl~Dfg~a 206 (352)
|+++ +|.+++... ..+++..++.++.|++.||.|||+.+++||||||+||++..+ .....+||+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 9965 787776421 247899999999999999999999999999999999999643 23456999999999
Q ss_pred eecCCCC----cccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHh
Q 018640 207 VFFKPGE----KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQ---------GVAQAIIR 271 (352)
Q Consensus 207 ~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~---------~~~~~~~~ 271 (352)
+...... ......||+.|+|||.+.+ .++.++||||||+++|||+||..||...... .....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 8654322 2234578999999998753 4789999999999999999999999643321 11111111
Q ss_pred cccccC----------------------------------CCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 272 SVLDFR----------------------------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 272 ~~~~~~----------------------------------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
...... .......+..+.+|+.+||+.||.+|||+.|+|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 100000 00011235668899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=334.60 Aligned_cols=235 Identities=27% Similarity=0.419 Sum_probs=203.5
Q ss_pred ceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEecC
Q 018640 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCE 139 (352)
Q Consensus 60 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~ 139 (352)
++-||.|+.|.||+|+.. ++.||||++.. .=..+|+-|++| +|+||+.+.|+|.....++||||||+
T Consensus 129 LeWlGSGaQGAVF~Grl~--netVAVKKV~e----------lkETdIKHLRkL-kH~NII~FkGVCtqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH--NETVAVKKVRE----------LKETDIKHLRKL-KHPNIITFKGVCTQSPCYCIIMEFCA 195 (904)
T ss_pred hhhhccCcccceeeeecc--CceehhHHHhh----------hhhhhHHHHHhc-cCcceeeEeeeecCCceeEEeeeccc
Confidence 445999999999999875 89999998752 123478899999 99999999999999999999999999
Q ss_pred CcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCcccccc
Q 018640 140 GGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIV 219 (352)
Q Consensus 140 ~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 219 (352)
.|.|...|+....++......+..+|+.|+.|||.+.|||||||.-||||..++. |||+|||.++..........++
T Consensus 196 ~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~---VKIsDFGTS~e~~~~STkMSFa 272 (904)
T KOG4721|consen 196 QGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDV---VKISDFGTSKELSDKSTKMSFA 272 (904)
T ss_pred cccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccce---EEeccccchHhhhhhhhhhhhh
Confidence 9999999999999999999999999999999999999999999999999986665 8999999998876666667789
Q ss_pred cccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc--cCCCCCcCCCHHHHHHHHHhc
Q 018640 220 GSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD--FRRDPWPKVSENAKDLVRKML 296 (352)
Q Consensus 220 gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l 296 (352)
||..|||||+++. ..+.|.||||||+|||||+||..||...... .++-.+.. .....+..+++.+.=||++||
T Consensus 273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----AIIwGVGsNsL~LpvPstcP~GfklL~Kqcw 348 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----AIIWGVGSNSLHLPVPSTCPDGFKLLLKQCW 348 (904)
T ss_pred hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----eeEEeccCCcccccCcccCchHHHHHHHHHH
Confidence 9999999999985 4899999999999999999999999654433 22222222 223344578999999999999
Q ss_pred CCCcCCCCCHHHHhcCcc
Q 018640 297 DPDPKRRLTAQQVLEHPW 314 (352)
Q Consensus 297 ~~dP~~Rps~~ell~hp~ 314 (352)
+-.|.+|||++++|.|--
T Consensus 349 ~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 349 NSKPRNRPSFRQILLHLD 366 (904)
T ss_pred hcCCCCCccHHHHHHHHh
Confidence 999999999999999943
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=319.50 Aligned_cols=258 Identities=22% Similarity=0.318 Sum_probs=205.5
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|...+.||+|+||.||++.+..+++.||+|.+...... .....+.+|+.++.++.+|+||+++++++..+...+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 3577788999999999999999999999999998754322 34567889999999996699999999999988899999
Q ss_pred EEecCCcchHHHH---H--hcCCCCHHHHHHHHHHHHHHHHHHHHc-CCEEecCCCCceEeecCCCCCCEEEEeccccee
Q 018640 135 MELCEGGELFDRI---V--ARGHYTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (352)
Q Consensus 135 ~e~~~~~sL~~~l---~--~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~ 208 (352)
|||++. ++.++. . ....+++..+..++.|++.||+|||+. +++||||||+||+++.++. ++|+|||++..
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~---~kl~dfg~~~~ 157 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGN---IKLCDFGISGQ 157 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCc---EEEeecchhHH
Confidence 999864 554433 2 235699999999999999999999975 9999999999999976544 89999999976
Q ss_pred cCCCCcccccccccccccchhccc----cCCCcchHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcc-cccCCCCCc
Q 018640 209 FKPGEKFSEIVGSPYYMAPEVLKR----NYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSV-LDFRRDPWP 282 (352)
Q Consensus 209 ~~~~~~~~~~~gt~~y~aPE~~~~----~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~-~~~~~~~~~ 282 (352)
...........|+..|+|||++.+ .++.++||||||+++|+|++|+.||...... +......... .........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd06616 158 LVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER 237 (288)
T ss_pred hccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCC
Confidence 544333344578899999998763 4788999999999999999999999654421 1111111111 111112223
Q ss_pred CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 283 ~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
.++..+.+||.+||+.+|++|||+.+++.||||...
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 578999999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=320.79 Aligned_cols=256 Identities=27% Similarity=0.452 Sum_probs=212.7
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
.+.|++.+.||+|+||.||+|.+..++..||+|.+..... ....+.+.+|+.+++++ +|+||+++++++...+..++
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQC-DSPYITRYYGSYLKGTKLWI 79 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcC-CCCccHhhhcccccCCceEE
Confidence 4568899999999999999999988899999998865421 22356789999999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
|+||+++++|.+++.. ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++. ++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~---~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 80 IMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCC---EEEccccccccccCcc
Confidence 9999999999998864 46899999999999999999999999999999999999976544 8999999987654332
Q ss_pred -cccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHH
Q 018640 214 -KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (352)
Q Consensus 214 -~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 291 (352)
......|+..|+|||++.+ .++.++|+||||++++||++|..||...........+... .........+..+.++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l 232 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN---SPPTLEGQYSKPFKEF 232 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC---CCCCCCcccCHHHHHH
Confidence 1233467889999999864 5888999999999999999999999765544333322221 1122223568889999
Q ss_pred HHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 292 VRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 292 i~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
|.+||+.+|++||++.++++||||....
T Consensus 233 i~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 233 VEACLNKDPRFRPTAKELLKHKFITRYT 260 (277)
T ss_pred HHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence 9999999999999999999999998643
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=314.95 Aligned_cols=257 Identities=32% Similarity=0.543 Sum_probs=214.1
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
..|...+.||+|++|.||++.+..+++.+++|++... .....+.+.+|+.+++.+ +|+||+++++++...+..+++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~-~h~~vv~~~~~~~~~~~~~~v 94 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDY-QHPNIVEMYSSYLVGDELWVV 94 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHc-CCCChheEEEEEEcCCeEEEE
Confidence 3566678999999999999999889999999987543 223345688999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC-
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (352)
+||+++++|.+++.. ..+++..+..++.|++.||++||++|++||||+|+||+++.++. ++|+|||++.......
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 95 MEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGR---VKLSDFGFCAQVSKEVP 170 (285)
T ss_pred EeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCc---EEEcccccchhhccCCc
Confidence 999999999999877 57899999999999999999999999999999999999976544 8999999886543322
Q ss_pred cccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHH
Q 018640 214 KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (352)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 292 (352)
......|+..|+|||.+.+ .++.++||||||+++++|++|..||...........+..... ........++..+.+++
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li 249 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLP-PKLKNLHKVSPRLRSFL 249 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCC-CCCcccccCCHHHHHHH
Confidence 2233468999999998764 488999999999999999999999987666555554443321 11112234788999999
Q ss_pred HHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 293 RKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 293 ~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
.+||+.+|++||++.++++||||+++..
T Consensus 250 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 250 DRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred HHHcccChhhCcCHHHHccCcccccCCC
Confidence 9999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=320.18 Aligned_cols=260 Identities=31% Similarity=0.528 Sum_probs=215.2
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
...+.|.....||+|+||.||++.+..++..||||.+... .....+.+.+|+.+++.+ +|+|++++++.+...+..
T Consensus 19 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~~ 94 (292)
T cd06658 19 DPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---KQQRRELLFNEVVIMRDY-HHENVVDMYNSYLVGDEL 94 (292)
T ss_pred chHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc---hHHHHHHHHHHHHHHHhC-CCCcHHHHHHheecCCeE
Confidence 3455677778899999999999999889999999988643 223456788999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
++||||+++++|.+++.. ..+++..+..++.||+.||.|||+.+++||||+|+||+++.++. ++|+|||++.....
T Consensus 95 ~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~---~kL~dfg~~~~~~~ 170 (292)
T cd06658 95 WVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR---IKLSDFGFCAQVSK 170 (292)
T ss_pred EEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC---EEEccCcchhhccc
Confidence 999999999999988754 46899999999999999999999999999999999999976544 89999999875432
Q ss_pred CC-cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHH
Q 018640 212 GE-KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (352)
Q Consensus 212 ~~-~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (352)
.. ......|+..|+|||.+. ..++.++|+||||++++||++|..||...........+..... ........++..+.
T Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 249 (292)
T cd06658 171 EVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLP-PRVKDSHKVSSVLR 249 (292)
T ss_pred ccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CccccccccCHHHH
Confidence 22 223446889999999876 4588999999999999999999999987766555444433221 11122235788999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 290 ~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
+++..||..||.+|||+.++++||||.....
T Consensus 250 ~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~ 280 (292)
T cd06658 250 GFLDLMLVREPSQRATAQELLQHPFLKLAGP 280 (292)
T ss_pred HHHHHHccCChhHCcCHHHHhhChhhhccCC
Confidence 9999999999999999999999999996544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=310.48 Aligned_cols=252 Identities=31% Similarity=0.553 Sum_probs=212.0
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe--CCeEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--DTAVHL 133 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~--~~~~~l 133 (352)
+|++.+.||.|+||.||+|.+..+|..||+|++..... .....+.+.+|+.+++.+ +|+|++++++++.. ....++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~ 78 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILREL-KHPNIVRYYDRIIDRSNQTLYI 78 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhc-CCCccceeeeeeecCCCCEEEE
Confidence 48899999999999999999999999999999876533 334456788999999999 89999999998753 456899
Q ss_pred EEEecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----HcCCEEecCCCCceEeecCCCCCCEEEEecc
Q 018640 134 VMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCH-----KHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH-----~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg 204 (352)
+|||+++++|.+++.. ...+++..++.++.|++.||.||| +.+++|+||+|+||+++.++. ++|+|||
T Consensus 79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~---~kl~d~g 155 (265)
T cd08217 79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNN---VKLGDFG 155 (265)
T ss_pred EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCC---EEEeccc
Confidence 9999999999999865 356899999999999999999999 899999999999999976544 8999999
Q ss_pred cceecCCCCc-ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCc
Q 018640 205 LSVFFKPGEK-FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282 (352)
Q Consensus 205 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (352)
++........ .....++..|+|||.+. ..++.++|+||||+++++|++|..||...........+.... .+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~ 232 (265)
T cd08217 156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK---FRRIPY 232 (265)
T ss_pred ccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCC---CCCCcc
Confidence 9987654433 34457899999999876 458889999999999999999999998777554444443322 122334
Q ss_pred CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 283 ~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
.++..+.+++.+||+.+|++||++.+|++|||+
T Consensus 233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 678999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=316.26 Aligned_cols=249 Identities=23% Similarity=0.357 Sum_probs=207.3
Q ss_pred ccceeceeeeccCceEEEEEEECCCC-----cEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENG-----DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 129 (352)
++|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.++..+ +||||+++++++....
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDL-QHPNIVCLLGVCTKEQ 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhc-CCcccceEEEEEcCCC
Confidence 46999999999999999999976554 679999886432 233456789999999999 8999999999999989
Q ss_pred eEEEEEEecCCcchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCC
Q 018640 130 AVHLVMELCEGGELFDRIVAR----------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK 193 (352)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~ 193 (352)
..+++|||+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 999999999999999999754 3478889999999999999999999999999999999997654
Q ss_pred CCCCEEEEecccceecCCCC---cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 018640 194 ETAPLKAIDFGLSVFFKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQA 268 (352)
Q Consensus 194 ~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~ 268 (352)
. ++|+|||++....... ......+++.|+|||.+. +.++.++||||||+++|||++ |..||.+....+....
T Consensus 162 ~---~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05048 162 T---VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM 238 (283)
T ss_pred c---EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 4 8999999997653322 123345678899999875 568999999999999999998 9999988777665555
Q ss_pred HHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 269 IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
+.... .......+++++.+++.+||+.||.+||++.+|+++
T Consensus 239 i~~~~---~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 239 IRSRQ---LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHcCC---cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 44322 222335689999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=318.35 Aligned_cols=266 Identities=30% Similarity=0.474 Sum_probs=215.6
Q ss_pred CCCcccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCC-----CeeEe
Q 018640 47 EPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ-----NIVCL 121 (352)
Q Consensus 47 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-----~iv~l 121 (352)
...++.+..+|.++..+|+|.||.|-.+++.+++..||+|+++.- ....+...-|+++|.++..+. .+|++
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m 156 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQM 156 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEee
Confidence 345677789999999999999999999999999999999998643 223455667999999994333 47899
Q ss_pred eeEEEeCCeEEEEEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCC------
Q 018640 122 KDTYEDDTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK------ 193 (352)
Q Consensus 122 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~------ 193 (352)
.+||...++.+||+|.+ |.|+.+++..+. +++...++.++.|++.++++||+.+++|.||||+|||+.+..
T Consensus 157 ~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~ 235 (415)
T KOG0671|consen 157 RDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYN 235 (415)
T ss_pred ehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEec
Confidence 99999999999999999 779999998865 589999999999999999999999999999999999996432
Q ss_pred -----------CCCCEEEEecccceecCCCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 018640 194 -----------ETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET 261 (352)
Q Consensus 194 -----------~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~ 261 (352)
....|+|+|||.|+... +..+.++.|..|+|||++. -+++.+.||||+||||+|++||...|+...
T Consensus 236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~--e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 236 PKKKVCFIRPLKSTAIKVIDFGSATFDH--EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred cCCccceeccCCCcceEEEecCCcceec--cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence 12358999999998754 3447789999999999876 579999999999999999999999998777
Q ss_pred HHHHHHHHHhcccccCC-----C-----------CCc--------------------------CCCHHHHHHHHHhcCCC
Q 018640 262 EQGVAQAIIRSVLDFRR-----D-----------PWP--------------------------KVSENAKDLVRKMLDPD 299 (352)
Q Consensus 262 ~~~~~~~~~~~~~~~~~-----~-----------~~~--------------------------~~~~~~~~li~~~l~~d 299 (352)
+.+.+.-+..-....+. . .|+ .....+.|||..||..|
T Consensus 314 n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD 393 (415)
T KOG0671|consen 314 NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD 393 (415)
T ss_pred cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence 55543222211111110 0 000 12345789999999999
Q ss_pred cCCCCCHHHHhcCccccccc
Q 018640 300 PKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 300 P~~Rps~~ell~hp~f~~~~ 319 (352)
|.+|+|+.|+|.||||+...
T Consensus 394 P~~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 394 PARRITLREALSHPFFARLT 413 (415)
T ss_pred ccccccHHHHhcCHHhhcCC
Confidence 99999999999999999754
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=313.28 Aligned_cols=255 Identities=27% Similarity=0.471 Sum_probs=208.7
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC---
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT--- 129 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~--- 129 (352)
..++|++.+.||+|++|.||+|.+..+++.+++|++.... ...+.+.+|+.+++++.+|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 4578999999999999999999998889999999886542 234678899999999977999999999997544
Q ss_pred ---eEEEEEEecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEe
Q 018640 130 ---AVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAID 202 (352)
Q Consensus 130 ---~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~D 202 (352)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~---~~l~d 156 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAE---VKLVD 156 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCe---EEECC
Confidence 48999999999999998864 346899999999999999999999999999999999999976544 89999
Q ss_pred cccceecCCCC-cccccccccccccchhccc------cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc
Q 018640 203 FGLSVFFKPGE-KFSEIVGSPYYMAPEVLKR------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD 275 (352)
Q Consensus 203 fg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 275 (352)
||++....... ......|+..|+|||++.. .++.++||||||+++++|++|..||...........+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 236 (275)
T cd06608 157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPP 236 (275)
T ss_pred CccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCC
Confidence 99987654322 2234568899999998642 3677899999999999999999999765544444443332111
Q ss_pred cCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 276 FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 276 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
.......+++.+.++|.+||..||++|||+.+++.|||+
T Consensus 237 -~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 237 -TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred -CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 111112367899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=311.02 Aligned_cols=252 Identities=28% Similarity=0.463 Sum_probs=203.6
Q ss_pred ceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEE
Q 018640 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (352)
Q Consensus 57 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e 136 (352)
......||+|+||.||+|.+..++..||+|.+... .....+.+.+|+.+++.+ +|+||+++++++..++..++|+|
T Consensus 10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYL-KHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred CCceEEEecCCceEEEEeEecCCCcEEEEEEecCC---CHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeccCCEEEEEEe
Confidence 33446899999999999999989999999987653 233456788999999999 89999999999999999999999
Q ss_pred ecCCcchHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 137 LCEGGELFDRIVAR-GHY--TERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 137 ~~~~~sL~~~l~~~-~~l--~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
|+++++|.+++... ..+ ++..+..++.|++.||.|||+.+|+|+||||+||+++.+. ..++|+|||++.......
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~--~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYS--GVVKISDFGTSKRLAGIN 163 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC--CeEEEecchhheecccCC
Confidence 99999999998764 345 8888999999999999999999999999999999996422 348999999987653322
Q ss_pred -cccccccccccccchhccc---cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHH
Q 018640 214 -KFSEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (352)
Q Consensus 214 -~~~~~~gt~~y~aPE~~~~---~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (352)
......|+..|+|||.+.. .++.++|+||||+++|+|++|..||............ .......+..+..+++++.
T Consensus 164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 242 (268)
T cd06624 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK-VGMFKIHPEIPESLSAEAK 242 (268)
T ss_pred CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh-hhhhccCCCCCcccCHHHH
Confidence 2233467899999998753 3788999999999999999999999654322111111 1111122223346788999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 290 DLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 290 ~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
+++.+||+.+|++|||+.+++.||||
T Consensus 243 ~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 243 NFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 99999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=325.58 Aligned_cols=265 Identities=29% Similarity=0.460 Sum_probs=213.1
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe----C
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED----D 128 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~----~ 128 (352)
+.++|++.+.||+|++|.||+|.+..+|..||+|++..... .......+.+|+.+++.+ +||||+++++++.. .
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 80 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHF-KHDNIIAIRDILRPPGADF 80 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhc-CCCCccCHHHhccccCCCC
Confidence 45789999999999999999999999999999999875422 223456778899999999 89999999998753 3
Q ss_pred CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccccee
Q 018640 129 TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~ 208 (352)
...++|+||+. ++|.+++.....+++..+..++.|++.||.|||+.+++||||||+||+++.++. +||+|||++..
T Consensus 81 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~---~kl~dfg~~~~ 156 (334)
T cd07855 81 KDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE---LRIGDFGMARG 156 (334)
T ss_pred ceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc---EEeccccccee
Confidence 57899999995 589999987777999999999999999999999999999999999999976554 89999999976
Q ss_pred cCCCCc-----ccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-------
Q 018640 209 FKPGEK-----FSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL------- 274 (352)
Q Consensus 209 ~~~~~~-----~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~------- 274 (352)
...... .....|+..|+|||.+.. .++.++||||||+++|+|++|+.||...........+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 533221 124478899999998753 488999999999999999999999976544332222211111
Q ss_pred ----------------ccCCC----CCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccCCC
Q 018640 275 ----------------DFRRD----PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPN 323 (352)
Q Consensus 275 ----------------~~~~~----~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~ 323 (352)
..... ..+..++.+.++|.+||+.+|++|||+.+++.||||.+......
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~ 305 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDD 305 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcc
Confidence 00011 11346899999999999999999999999999999987755544
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=319.94 Aligned_cols=250 Identities=23% Similarity=0.312 Sum_probs=202.4
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcE--EEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDA--FACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
++|++.+.||+|+||+||+|.+..++.. +|+|.+... ........+.+|+.++.++.+|+||+++++++..++..+
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 3689999999999999999998877765 466665432 233445678899999999978999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCC
Q 018640 133 LVMELCEGGELFDRIVARG----------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETA 196 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~ 196 (352)
+||||+++++|.+++.... .+++..++.++.|++.||+|||++|++||||||+|||++.++.
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~-- 162 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV-- 162 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc--
Confidence 9999999999999996542 4789999999999999999999999999999999999976544
Q ss_pred CEEEEecccceecCCCCcccccccccccccchhccc-cCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc
Q 018640 197 PLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVL 274 (352)
Q Consensus 197 ~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~ 274 (352)
++|+|||++.............++..|+|||.+.+ .++.++||||||++++||+| |..||......+....+...
T Consensus 163 -~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-- 239 (303)
T cd05088 163 -AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-- 239 (303)
T ss_pred -EEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC--
Confidence 89999999864322111122234667999998764 47899999999999999998 99999877665554444322
Q ss_pred ccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 275 DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 275 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
.....+...++.+.+++.+||+.+|++||++.+++.+
T Consensus 240 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 240 -YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred -CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1222234578899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=314.48 Aligned_cols=253 Identities=30% Similarity=0.536 Sum_probs=207.3
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
+|++.+.||.|++|.||+|.+..+|..||+|++..... ....+.+.+|+.+++++ +|+||+++++++...+..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKEL-KHENIVRLHDVIHTENKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhh-cCCCEeeeeeeEeeCCcEEEEE
Confidence 48899999999999999999999999999999876432 22345677899999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 136 ELCEGGELFDRIVARG---HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 136 e~~~~~sL~~~l~~~~---~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
||+++ +|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||++++++. ++|+|||++......
T Consensus 78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~---~~l~d~g~~~~~~~~ 153 (284)
T cd07836 78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE---LKLADFGLARAFGIP 153 (284)
T ss_pred ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCc---EEEeecchhhhhcCC
Confidence 99985 8888886543 5899999999999999999999999999999999999976554 899999999754332
Q ss_pred C-cccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc-------------
Q 018640 213 E-KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF------------- 276 (352)
Q Consensus 213 ~-~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~------------- 276 (352)
. ......++..|++||.+.+ .++.++|+||||+++|+|++|..||......+....+.+.....
T Consensus 154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 2 2233467889999998754 36889999999999999999999998776555444433221100
Q ss_pred -CCC-----------CCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 277 -RRD-----------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 277 -~~~-----------~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
... ..+..+..+.+++..||+.||.+||++.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 000 012457888999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=311.84 Aligned_cols=256 Identities=30% Similarity=0.593 Sum_probs=229.5
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
-++|..+++||+|.||.|.+|+.+.+|+.+|+|+++++..-.......-..|-++|+.. +||.+..+-..|+..+.+++
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~-~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNC-RHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhc-cCcHHHHhhhhhccCceEEE
Confidence 36799999999999999999999999999999999988766666666677899999999 99999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccccee-cCCC
Q 018640 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF-FKPG 212 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~-~~~~ 212 (352)
||||+.||.|.-.|.....+++...+.+..+|+.||.|||+++||.||+|.+|.|++.++. +||+|||+++. +..+
T Consensus 246 VMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGH---IKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGH---IKITDFGLCKEEIKYG 322 (516)
T ss_pred EEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCc---eEeeecccchhccccc
Confidence 9999999999999988888999999999999999999999999999999999999987666 99999999975 3555
Q ss_pred Ccccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHH
Q 018640 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (352)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 291 (352)
....+++||+.|+|||++. ..|+...|.|.+|+++|||++|+.||+.........-+.-.-..++ ..++++...|
T Consensus 323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFP----r~ls~eAktL 398 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFP----RTLSPEAKTL 398 (516)
T ss_pred ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCC----ccCCHHHHHH
Confidence 6678899999999999998 4599999999999999999999999998887766555554444443 4689999999
Q ss_pred HHHhcCCCcCCCC-----CHHHHhcCccccc
Q 018640 292 VRKMLDPDPKRRL-----TAQQVLEHPWLQN 317 (352)
Q Consensus 292 i~~~l~~dP~~Rp-----s~~ell~hp~f~~ 317 (352)
+..+|..||.+|. .+.||.+|+||..
T Consensus 399 LsGLL~kdP~kRLGgGpdDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 399 LSGLLKKDPKKRLGGGPDDAKEIMRHRFFAS 429 (516)
T ss_pred HHHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence 9999999999996 6999999999984
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=312.27 Aligned_cols=250 Identities=34% Similarity=0.593 Sum_probs=212.0
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEecCCcc
Q 018640 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGE 142 (352)
Q Consensus 63 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~~~s 142 (352)
||.|+||.||++.+..+|+.+++|++...........+.+.+|+.+++++ +|+||+++++.+......++++||+++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhC-CCcchhHHHHheecCcEEEEEEecCCCCc
Confidence 68999999999999988999999998765444445567889999999999 79999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC---------
Q 018640 143 LFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE--------- 213 (352)
Q Consensus 143 L~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~--------- 213 (352)
|.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++.......
T Consensus 80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~---~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGH---LKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCC---EEEEecccchhcccCcccccccccc
Confidence 9999988778999999999999999999999999999999999999986554 8999999987543221
Q ss_pred cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHH
Q 018640 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (352)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 292 (352)
......++..|++||.+. ...+.++|+||||++++++++|..||...........+......++ .....+..+.+++
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i 234 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWP--EDVEVSDEAIDLI 234 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCC--ccccCCHHHHHHH
Confidence 223446788999999876 4488899999999999999999999988777666555544222221 1112489999999
Q ss_pred HHhcCCCcCCCCCH---HHHhcCcccccc
Q 018640 293 RKMLDPDPKRRLTA---QQVLEHPWLQNA 318 (352)
Q Consensus 293 ~~~l~~dP~~Rps~---~ell~hp~f~~~ 318 (352)
.+||+.+|++|||+ .++++||||++.
T Consensus 235 ~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 235 SKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred HHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 99999999999999 999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=317.81 Aligned_cols=255 Identities=27% Similarity=0.449 Sum_probs=200.9
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC-----
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT----- 129 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~----- 129 (352)
++|++.+.||+|+||.||+|.+..+++.||+|.+....... .....+.+|+.+++++ +||||+++++++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLL-KHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhC-CCCCccceEEEEecccccccC
Confidence 46999999999999999999999999999999886543221 2223456799999999 8999999999886543
Q ss_pred ---eEEEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccc
Q 018640 130 ---AVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (352)
Q Consensus 130 ---~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~ 205 (352)
..++||||+.+ +|.+.+.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. +||+|||+
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~---~kl~dfg~ 165 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI---LKLADFGL 165 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCc---EEECcCCC
Confidence 45999999964 8888776543 6899999999999999999999999999999999999975544 89999999
Q ss_pred ceecCCCCc-----ccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC
Q 018640 206 SVFFKPGEK-----FSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR 278 (352)
Q Consensus 206 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 278 (352)
+........ .....++..|+|||.+.+ .++.++||||||+++|+|++|..||...........+.......+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 976533221 123467888999998754 3688999999999999999999999776654433332221111111
Q ss_pred CC----------------------------CcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 279 DP----------------------------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 279 ~~----------------------------~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
.. ....+..+.++|.+||+.||.+|||+.++++||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 10 00135677899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=329.64 Aligned_cols=262 Identities=32% Similarity=0.615 Sum_probs=231.0
Q ss_pred cccccee--ceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe
Q 018640 53 IEERYEL--GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (352)
Q Consensus 53 ~~~~y~~--~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 130 (352)
+..-|+| .++||+|.||+||-|+.+++|+.||||++++..+... ..+.+++|+.+|..+ .||.||.+---|+..+.
T Consensus 560 ~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l-~HPGiV~le~M~ET~er 637 (888)
T KOG4236|consen 560 ISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNL-HHPGIVNLECMFETPER 637 (888)
T ss_pred HHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCc-hHHHHHHHHHHHHhc-CCCCeeEEEEeecCCce
Confidence 3444665 5789999999999999999999999999999876554 347899999999999 99999999999999999
Q ss_pred EEEEEEecCCcchHHH-HH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccccee
Q 018640 131 VHLVMELCEGGELFDR-IV-ARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~-l~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~ 208 (352)
.|+|||-+.| +..+. |. +.+++++.....++.||+.||+|||.++|+|.||||+|||+.+...-..+||||||+|+.
T Consensus 638 vFVVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARi 716 (888)
T KOG4236|consen 638 VFVVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARI 716 (888)
T ss_pred EEEEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceee
Confidence 9999999966 55554 43 346799999999999999999999999999999999999998877777899999999999
Q ss_pred cCCCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHH
Q 018640 209 FKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (352)
Q Consensus 209 ~~~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (352)
+....-...++||+.|+|||++. .+|+..-|+||.|+++|.-+.|..||.... ++..++.+...-+++.+|.+++..
T Consensus 717 IgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis~~ 794 (888)
T KOG4236|consen 717 IGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEISPE 794 (888)
T ss_pred cchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcCHH
Confidence 87666667889999999999987 569999999999999999999999996543 345566666667888999999999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 288 ~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
..|||..+|+..=.+|.|.++.|.|||+++..
T Consensus 795 AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 795 AIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred HHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence 99999999999999999999999999999754
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=315.99 Aligned_cols=261 Identities=31% Similarity=0.567 Sum_probs=213.6
Q ss_pred cceeceeeeccCceEEEEEEEC---CCCcEEEEEEccccccCC-hhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 56 RYELGRELGRGEFGITYLCTDR---ENGDAFACKSISKKKLRT-AVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
.|++.+.||+|+||.||.|.+. .+|..||+|++....... ....+.+.+|+.++.++.+|+||+.+++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999874 478999999987543222 223467888999999997799999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
++|+||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+||+++.++ .++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~---~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG---HVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCC---CEEEeeCccceeccc
Confidence 99999999999999998888899999999999999999999999999999999999997654 489999999976543
Q ss_pred CC--cccccccccccccchhccc---cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCH
Q 018640 212 GE--KFSEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (352)
Q Consensus 212 ~~--~~~~~~gt~~y~aPE~~~~---~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (352)
.. ......|+..|+|||.+.. .++.++||||||+++|+|++|..||...........+..............++.
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 237 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCH
Confidence 22 2234568899999998753 367899999999999999999999964332222223333222222333446789
Q ss_pred HHHHHHHHhcCCCcCCCC-----CHHHHhcCccccccc
Q 018640 287 NAKDLVRKMLDPDPKRRL-----TAQQVLEHPWLQNAK 319 (352)
Q Consensus 287 ~~~~li~~~l~~dP~~Rp-----s~~ell~hp~f~~~~ 319 (352)
.+.+++.+||+.||++|| ++.+++.||||+...
T Consensus 238 ~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 238 LAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred HHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 999999999999999997 899999999999764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=338.83 Aligned_cols=266 Identities=21% Similarity=0.294 Sum_probs=196.0
Q ss_pred CcccccccceeceeeeccCceEEEEEEECCCC-cEEEEEE--------------ccccccCChhcHHHHHHHHHHHHhCC
Q 018640 49 TGREIEERYELGRELGRGEFGITYLCTDRENG-DAFACKS--------------ISKKKLRTAVDIEDVRREVDIMRHLP 113 (352)
Q Consensus 49 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK~--------------~~~~~~~~~~~~~~~~~E~~~l~~l~ 113 (352)
.+..+.++|++++.||+|+||+||+|..+... ..++.|. +.+...........+.+|+.+++++
T Consensus 142 ~~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l- 220 (501)
T PHA03210 142 HDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL- 220 (501)
T ss_pred cchhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC-
Confidence 34556788999999999999999998764322 2222221 1111111122345688999999999
Q ss_pred CCCCeeEeeeEEEeCCeEEEEEEecCCcchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceE
Q 018640 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR-----GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFL 188 (352)
Q Consensus 114 ~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIl 188 (352)
+|+||+++++++...+..++|++++. ++|.+++... .......++.|+.||+.||+|||++||+||||||+|||
T Consensus 221 ~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NIL 299 (501)
T PHA03210 221 NHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIF 299 (501)
T ss_pred CCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 99999999999999999999999995 4777776542 12346678889999999999999999999999999999
Q ss_pred eecCCCCCCEEEEecccceecCCCCc--ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCC---CH
Q 018640 189 FANKKETAPLKAIDFGLSVFFKPGEK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAE---TE 262 (352)
Q Consensus 189 l~~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~---~~ 262 (352)
++.++. +||+|||++........ .....||..|+|||++. ..++.++|||||||++|||++|..+++.. ..
T Consensus 300 l~~~~~---vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~ 376 (501)
T PHA03210 300 LNCDGK---IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP 376 (501)
T ss_pred ECCCCC---EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH
Confidence 976554 89999999987643322 23457999999999986 45899999999999999999987654322 12
Q ss_pred HHHHHHHHhcccccCCC----------------------C------CcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcc
Q 018640 263 QGVAQAIIRSVLDFRRD----------------------P------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPW 314 (352)
Q Consensus 263 ~~~~~~~~~~~~~~~~~----------------------~------~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~ 314 (352)
......+.......... . ...++.++.++|.+||+.||.+|||+.|+|.|||
T Consensus 377 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~ 456 (501)
T PHA03210 377 GKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL 456 (501)
T ss_pred HHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence 22222222211100000 0 0124667788999999999999999999999999
Q ss_pred ccccc
Q 018640 315 LQNAK 319 (352)
Q Consensus 315 f~~~~ 319 (352)
|....
T Consensus 457 f~~~~ 461 (501)
T PHA03210 457 FSAEE 461 (501)
T ss_pred hhcCC
Confidence 98653
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=311.22 Aligned_cols=268 Identities=26% Similarity=0.432 Sum_probs=218.8
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
+-|++.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.++.++ +||||+++++++..+...++|
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 80 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTKLWII 80 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhc-CCCCEeEEEEEEEeCCeEEEE
Confidence 458889999999999999999988999999998765422 23346788999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC-
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (352)
|||+++++|.+++.. ..+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~---~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 81 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE---VKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCC---EEEeecccceecccchh
Confidence 999999999988864 46899999999999999999999999999999999999976544 8999999987654322
Q ss_pred cccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHH
Q 018640 214 KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (352)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 292 (352)
......++..|+|||.+.. .++.++|+||||+++++|++|..||...........+... ..+.....++.++.+++
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~i 233 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN---NPPTLEGNYSKPLKEFV 233 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC---CCCCCCcccCHHHHHHH
Confidence 2234468889999998764 4788999999999999999999999766654444333221 12223345789999999
Q ss_pred HHhcCCCcCCCCCHHHHhcCccccccccCCCCCCcHHHHHHH
Q 018640 293 RKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARL 334 (352)
Q Consensus 293 ~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~ 334 (352)
..||+.+|++||++.++++||||.+.. .......++..|-
T Consensus 234 ~~~l~~~p~~Rp~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ 273 (277)
T cd06641 234 EACLNKEPSFRPTAKELLKHKFIVRFA--KKTSYLTELIDRY 273 (277)
T ss_pred HHHccCChhhCcCHHHHHhCHHHhhhh--hccchHHHHHHHh
Confidence 999999999999999999999999853 3344444444443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=312.74 Aligned_cols=253 Identities=24% Similarity=0.313 Sum_probs=209.0
Q ss_pred cccceeceeeeccCceEEEEEEECC-----CCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC
Q 018640 54 EERYELGRELGRGEFGITYLCTDRE-----NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 128 (352)
.++|++.+.||+|++|.||+|.+.. ++..||+|.+.... .......+.+|+.+++.+ +|+||+++++++.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 81 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKF-NHQNIVRLIGVSFER 81 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccC
Confidence 4579999999999999999999876 67889999875432 233345688899999999 899999999999988
Q ss_pred CeEEEEEEecCCcchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEE
Q 018640 129 TAVHLVMELCEGGELFDRIVARG-------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAI 201 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~-------~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~ 201 (352)
...++||||+++++|.+++.... .+++..+..++.||+.||+|||+++++|+||||+||+++.++....+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 89999999999999999987643 48899999999999999999999999999999999999876655668999
Q ss_pred ecccceecCCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccc
Q 018640 202 DFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDF 276 (352)
Q Consensus 202 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 276 (352)
|||+++....... ......+..|+|||++. ..++.++||||||+++|||++ |..||...........+... .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~---~ 238 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG---G 238 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC---C
Confidence 9999986532221 11223356899999876 559999999999999999997 99999877766554443322 1
Q ss_pred CCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 277 RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 277 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
....+..++..+.+++.+||+.+|++|||+.++++|
T Consensus 239 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 239 RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 223345678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=309.45 Aligned_cols=253 Identities=27% Similarity=0.530 Sum_probs=213.0
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
+|++.+.||+|+||.||+|.+..+|..||+|.+..... .....+.+.+|+.+++.+ +|+|++++++.+......++|+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKM-KHPNIVTFFASFQENGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhC-CCCChhhhhheeccCCeEEEEE
Confidence 48899999999999999999999999999999876532 223456788999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 136 ELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 136 e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. .++|+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~--~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM--VAKLGDFGIARQLNDSM 156 (257)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC--eEEecccccchhccCCc
Confidence 9999999999987643 4799999999999999999999999999999999999975433 36999999987654332
Q ss_pred c-ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHH
Q 018640 214 K-FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (352)
Q Consensus 214 ~-~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 291 (352)
. .....|+..|+|||.+. ..++.++|+||||++++++++|..||................ .....+.++..+.++
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 233 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY---FAPISPNFSRDLRSL 233 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc---CCCCCCCCCHHHHHH
Confidence 2 22346889999999876 458899999999999999999999998766555444443322 222334678999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcCccc
Q 018640 292 VRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 292 i~~~l~~dP~~Rps~~ell~hp~f 315 (352)
|.+||+.+|++|||+.+++.||||
T Consensus 234 i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 234 ISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=313.67 Aligned_cols=252 Identities=28% Similarity=0.466 Sum_probs=201.6
Q ss_pred eeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHH---HHhCCCCCCeeEeeeEEEeCCeEEEEEEec
Q 018640 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI---MRHLPKHQNIVCLKDTYEDDTAVHLVMELC 138 (352)
Q Consensus 62 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~---l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~ 138 (352)
.||+|+||.||+|.+..+++.||+|.+.............+..|..+ +... .||+|+.+++++...+..++||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhC-CCCcEeeeeeeeecCCEEEEEEecC
Confidence 48999999999999988999999999876543322222233444433 3334 7999999999999999999999999
Q ss_pred CCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCccccc
Q 018640 139 EGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI 218 (352)
Q Consensus 139 ~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 218 (352)
+|++|.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++....... ....
T Consensus 80 ~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~---~kl~dfg~~~~~~~~~-~~~~ 155 (278)
T cd05606 80 NGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH---VRISDLGLACDFSKKK-PHAS 155 (278)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCC---EEEccCcCccccCccC-CcCc
Confidence 99999999988778999999999999999999999999999999999999975544 8999999987553322 2344
Q ss_pred ccccccccchhcc-c-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhc
Q 018640 219 VGSPYYMAPEVLK-R-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKML 296 (352)
Q Consensus 219 ~gt~~y~aPE~~~-~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 296 (352)
.|+..|+|||.+. + .++.++||||+|+++|+|++|+.||......... .............+...+..+.+++.+||
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~~li~~~l 234 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSPELRSLLEGLL 234 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH-HHHHHhhccCCCCCCcCCHHHHHHHHHHh
Confidence 7899999999976 3 4889999999999999999999999765321111 11111112223333457899999999999
Q ss_pred CCCcCCCC-----CHHHHhcCccccccc
Q 018640 297 DPDPKRRL-----TAQQVLEHPWLQNAK 319 (352)
Q Consensus 297 ~~dP~~Rp-----s~~ell~hp~f~~~~ 319 (352)
..+|.+|| ++.++++||||+...
T Consensus 235 ~~~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 235 QRDVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred hcCHHhccCCCCCCHHHHHhCccccCCC
Confidence 99999999 999999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=314.50 Aligned_cols=261 Identities=28% Similarity=0.465 Sum_probs=215.8
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
.....|...+.||+|+||.||++.+..++..||+|++.............+.+|+.+++.+ +|+|++++++++..+...
T Consensus 22 ~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 100 (317)
T cd06635 22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSIEYKGCYLREHTA 100 (317)
T ss_pred CchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeCCeE
Confidence 3445689999999999999999999989999999998765333334456788999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 132 HLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
++||||++| +|.+.+.. ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++....
T Consensus 101 ~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~---~kl~dfg~~~~~~ 176 (317)
T cd06635 101 WLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ---VKLADFGSASIAS 176 (317)
T ss_pred EEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCC---EEEecCCCccccC
Confidence 999999975 77777754 456899999999999999999999999999999999999976544 8999999887543
Q ss_pred CCCcccccccccccccchhcc----ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCH
Q 018640 211 PGEKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (352)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~----~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (352)
.. ....|+..|+|||.+. +.++.++||||||+++++|++|..||...........+..... ........++
T Consensus 177 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 251 (317)
T cd06635 177 PA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--PTLQSNEWSD 251 (317)
T ss_pred Cc---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccC--CCCCCccccH
Confidence 22 3446889999999863 4588899999999999999999999987765555554444322 1222335788
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcCccccccccCC
Q 018640 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAP 322 (352)
Q Consensus 287 ~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~ 322 (352)
.+.++|.+||+.+|.+||++.++++|+|+......+
T Consensus 252 ~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~ 287 (317)
T cd06635 252 YFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPET 287 (317)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHhChhhhccCccc
Confidence 999999999999999999999999999998654443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=314.60 Aligned_cols=254 Identities=30% Similarity=0.595 Sum_probs=217.0
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|.+.+.||+|++|.||+|.+..+|..||+|++.............+.+|+.++.++.+|+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36999999999999999999999999999999987754444444567889999999994499999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC-
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (352)
|||+++++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~---~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMH---IKITDFGTAKVLDPNSS 157 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC---EEecCCccccccCCccc
Confidence 999999999999988888999999999999999999999999999999999999976554 8999999987653321
Q ss_pred --------------------cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 018640 214 --------------------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS 272 (352)
Q Consensus 214 --------------------~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~ 272 (352)
......++..|+|||.+. ..++.++|+||||++++++++|..||...........+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL 237 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence 112346788999999876 45888999999999999999999999877655544444432
Q ss_pred ccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCH----HHHhcCccc
Q 018640 273 VLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTA----QQVLEHPWL 315 (352)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~----~ell~hp~f 315 (352)
.......+++.+.++|..||+.+|++|||+ .++++||||
T Consensus 238 ----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 238 ----EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred ----CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 223335678999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=312.43 Aligned_cols=260 Identities=29% Similarity=0.473 Sum_probs=207.2
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe--CCeEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--DTAVH 132 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~--~~~~~ 132 (352)
++|...+.||.|++|.||+|.+..+++.+|+|.+..... ......+.+|+++++++ +||||+++++++.. .+..+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSC-KSPYIVKYYGAFLDESSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEccCCCeEE
Confidence 368899999999999999999998999999998875422 23456789999999999 89999999998854 34789
Q ss_pred EEEEecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccccee
Q 018640 133 LVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~ 208 (352)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++..
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~---~~l~dfg~~~~ 154 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ---VKLCDFGVSGE 154 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCe---EEEeecccccc
Confidence 99999999999887653 235899999999999999999999999999999999999976544 89999999875
Q ss_pred cCCCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhcccc-cCCCCC
Q 018640 209 FKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET-----EQGVAQAIIRSVLD-FRRDPW 281 (352)
Q Consensus 209 ~~~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~-----~~~~~~~~~~~~~~-~~~~~~ 281 (352)
..... .....++..|+|||.+. ..++.++||||||+++|+|++|..||.... ..+....+...... ......
T Consensus 155 ~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 155 LVNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred ccccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 43222 12346788999999876 458999999999999999999999997652 12222222211110 000111
Q ss_pred --cCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccC
Q 018640 282 --PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKA 321 (352)
Q Consensus 282 --~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~ 321 (352)
..+++.+.++|.+||+.+|.+|||+.|++.||||++...+
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~ 275 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK 275 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccc
Confidence 1346789999999999999999999999999999876554
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=301.76 Aligned_cols=252 Identities=27% Similarity=0.413 Sum_probs=204.1
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC---
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--- 128 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~--- 128 (352)
.-+++|+|.+.||+|||+.||++....+++.+|+|++... ...+.+...+|++..+++ +|||+++++++...+
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---~~~~~e~~~rEid~~rkf-~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---SQEDIEEALREIDNHRKF-NSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc---chHHHHHHHHHHHHHHhh-CCcchHHHHHHHHHhhcc
Confidence 3456899999999999999999999999999999998754 345678899999999999 899999999987433
Q ss_pred --CeEEEEEEecCCcchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcC--CEEecCCCCceEeecCCCCCCEEE
Q 018640 129 --TAVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTKTIVEVVQMCHKHG--VMHRDLKPENFLFANKKETAPLKA 200 (352)
Q Consensus 129 --~~~~lv~e~~~~~sL~~~l~~~----~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dikp~NIll~~~~~~~~vkl 200 (352)
...||+++|...|||.+.+... ..+++.+++.|+.+++.||++||+.. +.||||||.|||+.+.+. .+|
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~---~vl 170 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL---PVL 170 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc---eEE
Confidence 3589999999999999988643 35899999999999999999999998 999999999999976555 699
Q ss_pred EecccceecCCC----------Ccccccccccccccchhcc----ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH--
Q 018640 201 IDFGLSVFFKPG----------EKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQG-- 264 (352)
Q Consensus 201 ~Dfg~a~~~~~~----------~~~~~~~gt~~y~aPE~~~----~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~-- 264 (352)
.|||.++...-. +.+.....|..|+|||.+. ...+.++|||||||+||+|+.|..||..-...+
T Consensus 171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS 250 (302)
T KOG2345|consen 171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS 250 (302)
T ss_pred EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe
Confidence 999998764311 1123346789999999886 237889999999999999999999995332211
Q ss_pred HHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 265 VAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
....+.+....++.. ..+++.+.++|+.||+.||.+||++.+++.+
T Consensus 251 laLAv~n~q~s~P~~--~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 251 LALAVQNAQISIPNS--SRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred EEEeeeccccccCCC--CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 111111212223322 3489999999999999999999999999875
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=312.75 Aligned_cols=253 Identities=31% Similarity=0.516 Sum_probs=208.2
Q ss_pred ceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC--CeEEEE
Q 018640 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--TAVHLV 134 (352)
Q Consensus 57 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~--~~~~lv 134 (352)
|++.+.||+|++|.||+|.+..+|+.+|+|++.... ........+.+|+.+++.+ +|+|++++++++... +..++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv 78 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKL-RHPNIVRLKEIVTSKGKGSIYMV 78 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhc-cCCCeeeheeeEecCCCCcEEEE
Confidence 678899999999999999999899999999998653 2223345688899999999 899999999999887 899999
Q ss_pred EEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
+||+++ +|.+++... ..+++..++.++.|++.||++||+.+++|+||+|+||+++.++. ++|+|||++.......
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~---~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 79 FEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV---LKLADFGLARPYTKRN 154 (287)
T ss_pred eccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCC---EEEccccceeeccCCC
Confidence 999975 898888765 46999999999999999999999999999999999999976554 8999999998664432
Q ss_pred --cccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCC---------
Q 018640 214 --KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP--------- 280 (352)
Q Consensus 214 --~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 280 (352)
......++..|+|||.+.+ .++.++||||||++++||++|..||...........+...........
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 2334467888999997653 478999999999999999999999987766554444433221111100
Q ss_pred -----------------CcC-CCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 281 -----------------WPK-VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 281 -----------------~~~-~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
... ++..+.+++.+||+.+|++||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 011 37889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=311.80 Aligned_cols=251 Identities=27% Similarity=0.519 Sum_probs=206.1
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++.+.||+|++|.||+|.+..+++.+|+|.+.............+.+|+.+++.+ +|+||+++++++..++..+++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-cCCchhhhhheeEeCCeEEEE
Confidence 3688999999999999999999889999999988765444444556788999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 135 MELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
|||+++++|.+++.. ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~---~~l~dfg~~~~~~ 157 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV---VKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC---EEECcchhhhccc
Confidence 999999999998863 345899999999999999999999999999999999999976544 8999999987654
Q ss_pred CCCc-ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcccccCCCCCcCCCH
Q 018640 211 PGEK-FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ--GVAQAIIRSVLDFRRDPWPKVSE 286 (352)
Q Consensus 211 ~~~~-~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 286 (352)
.... .....|+..|+|||.+. ..++.++|+||||+++|+|++|..||...... .....+.. ...++......++
T Consensus 158 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 235 (267)
T cd08229 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ--CDYPPLPSDHYSE 235 (267)
T ss_pred cCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhc--CCCCCCCcccccH
Confidence 3322 23446889999999886 45888999999999999999999999754332 11111111 1122222345788
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 287 NAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 287 ~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
.+.+++.+||+.||++|||+.+|++
T Consensus 236 ~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 236 ELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHHH
Confidence 9999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=313.84 Aligned_cols=253 Identities=29% Similarity=0.497 Sum_probs=207.3
Q ss_pred ceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEE
Q 018640 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (352)
Q Consensus 57 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e 136 (352)
|++.+.||.|++|.||+|.+..+|..||+|++...... ......+.+|+.+++.+ +|+|++++++++...+..++++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l-~~~~iv~~~~~~~~~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKEL-NHPNIVRLLDVVHSENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhc-CCCCccCHhheeccCCeEEEEEe
Confidence 67889999999999999999999999999998765322 22335678899999999 89999999999999999999999
Q ss_pred ecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC-
Q 018640 137 LCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (352)
Q Consensus 137 ~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (352)
|++ ++|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++.......
T Consensus 79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~---~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 79 FLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGA---LKLADFGLARAFGVPVR 154 (283)
T ss_pred ccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCc---EEEeecccccccCCCcc
Confidence 995 58999987765 6899999999999999999999999999999999999976444 8999999987543222
Q ss_pred cccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc----------------
Q 018640 214 KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD---------------- 275 (352)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~---------------- 275 (352)
......++..|+|||++.+ .++.++|+||||+++|+|++|..||...........+.+....
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 2233356889999998753 3688999999999999999999999776654443333322110
Q ss_pred -----c----CCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 276 -----F----RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 276 -----~----~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
. .....+.+++.+.++|.+||+.+|.+|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0 011124567899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=306.46 Aligned_cols=272 Identities=29% Similarity=0.511 Sum_probs=216.0
Q ss_pred ccceeceeeeccCceEEEEEEECCCCc----EEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe-CC
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGD----AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED-DT 129 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~-~~ 129 (352)
..|+++..||+|.||.||+|....++- .+|+|.+..+...+.... ...+|+.+++.+ +|||++.+..+|.. +.
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~-SAcREiaL~REl-~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISM-SACREIALLREL-KHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCH-HHHHHHHHHHHh-cCCcchhHHHHHhccCc
Confidence 469999999999999999997554433 689999877654444433 355699999999 99999999999876 78
Q ss_pred eEEEEEEecCCcchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCC-CCCCEEEEec
Q 018640 130 AVHLVMELCEGGELFDRIVAR-----GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK-ETAPLKAIDF 203 (352)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~-~~~~vkl~Df 203 (352)
..++++||.+. +|++.++.+ ..++...+..|++||+.|+.|||++.|+||||||.|||+..++ +.+.|||+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999999976 999988643 3589999999999999999999999999999999999997653 3567999999
Q ss_pred ccceecCCC----Ccccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCC---------HHHHHHH
Q 018640 204 GLSVFFKPG----EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAET---------EQGVAQA 268 (352)
Q Consensus 204 g~a~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~---------~~~~~~~ 268 (352)
|+++.+.+. .....++-|.+|+|||.+-+ .|+.+.||||.||++.||+|-.+.|.+.. ..++..+
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 999987543 23356678999999998753 49999999999999999999988875432 2245566
Q ss_pred HHhcccccCCCCCcC---------------------------------CCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 269 IIRSVLDFRRDPWPK---------------------------------VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 269 ~~~~~~~~~~~~~~~---------------------------------~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
+.+.+.......|+. -++...+|+.+||+.||.+|.|+.++++|+||
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF 340 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF 340 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence 666555444444432 13446789999999999999999999999999
Q ss_pred cccccCCCCCCcHHH
Q 018640 316 QNAKKAPNVSLGETV 330 (352)
Q Consensus 316 ~~~~~~~~~~~~~~~ 330 (352)
..- +.|+.++++++
T Consensus 341 ~~d-~lpp~pt~~~v 354 (438)
T KOG0666|consen 341 TED-PLPPLPTSDNV 354 (438)
T ss_pred ccC-CCCCCccccee
Confidence 964 33444444444
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=330.05 Aligned_cols=249 Identities=22% Similarity=0.398 Sum_probs=204.6
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
.+...+...||+|.||+||+|.|.. .||||++..... +....+.|++|+.++++- +|.||+-+.|++..... .|
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkT-RH~NIlLFMG~~~~p~~-AI 464 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDP-TPEQLQAFKNEVAVLKKT-RHENILLFMGACMNPPL-AI 464 (678)
T ss_pred HHHhhccceeccccccceeeccccc---ceEEEEEecCCC-CHHHHHHHHHHHHHHhhc-chhhheeeehhhcCCce-ee
Confidence 3457788899999999999999864 499999987754 344788999999999999 99999999999998877 99
Q ss_pred EEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC--
Q 018640 134 VMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-- 210 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~-- 210 (352)
|+.+|+|-+|+.+++... .|.....+.|++||++|+.|||.++|||||||..||++.++ .+|||+|||++....
T Consensus 465 iTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~---~kVkIgDFGLatvk~~w 541 (678)
T KOG0193|consen 465 ITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHED---LKVKIGDFGLATVKTRW 541 (678)
T ss_pred eehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccC---CcEEEecccceeeeeee
Confidence 999999999999997543 58999999999999999999999999999999999999644 559999999997532
Q ss_pred -CCCcccccccccccccchhccc----cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC-CCCcCC
Q 018640 211 -PGEKFSEIVGSPYYMAPEVLKR----NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR-DPWPKV 284 (352)
Q Consensus 211 -~~~~~~~~~gt~~y~aPE~~~~----~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 284 (352)
.......-.|...|||||+++. .|+..+||||||+++|||++|..||.....+.++-.+-+....... ......
T Consensus 542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~ 621 (678)
T KOG0193|consen 542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNC 621 (678)
T ss_pred ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccC
Confidence 2223334467788999998862 3899999999999999999999999865555443333332211111 112357
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 285 SENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 285 ~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
++++.+|+..||..++++||.+.+||.
T Consensus 622 pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 622 PKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 889999999999999999999999987
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=312.71 Aligned_cols=255 Identities=29% Similarity=0.450 Sum_probs=201.4
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
.++|++++.||+|+||.||+|.+..+|..||+|++...... .....+.+|+.+++.+ +|+||+++.+++..+...++
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~l 80 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGL-KHANIVLLHDIIHTKETLTF 80 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhc-CCCCEeEEEEEEecCCeEEE
Confidence 35799999999999999999999999999999998654321 2234567899999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 134 VMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
|+||++ ++|.+.+... ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++. ++|+|||++......
T Consensus 81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~---~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 81 VFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE---LKLADFGLARAKSIP 156 (291)
T ss_pred EEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCc---EEEeccccccccCCC
Confidence 999996 5777766543 45788999999999999999999999999999999999976554 899999998754322
Q ss_pred -Ccccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccc--------------
Q 018640 213 -EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVL-------------- 274 (352)
Q Consensus 213 -~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~-------------- 274 (352)
.......++..|+|||.+.+ .++.++||||||+++++|++|..||...... +..........
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 157 SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 22234467899999998753 4788999999999999999999999755432 11111111000
Q ss_pred ccCCC------------CCc--CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 275 DFRRD------------PWP--KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 275 ~~~~~------------~~~--~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
.+... .+. ..+..+.+++.+|++.||.+|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00000 000 125678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=304.81 Aligned_cols=253 Identities=32% Similarity=0.549 Sum_probs=213.8
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC--CeEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--TAVHL 133 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~--~~~~l 133 (352)
+|++.+.||+|++|.||+|.+..++..|++|++...... ....+.+.+|+.+++++ +|+||+++++.+... ...++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~l 78 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSL-QHPNIVRYYGSERDEEKNTLNI 78 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHc-CCCCEeeEEEEEecCCCCeEEE
Confidence 478889999999999999999989999999998765322 34567899999999999 899999999999988 89999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
++||+++++|.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~---~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 79 FLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGV---VKLADFGCAKRLGDIE 155 (260)
T ss_pred EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC---EEEcccccEEeccccc
Confidence 9999999999999988778999999999999999999999999999999999999986444 8999999998765544
Q ss_pred c---ccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcccccCCCCCcCCCHHH
Q 018640 214 K---FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVLDFRRDPWPKVSENA 288 (352)
Q Consensus 214 ~---~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (352)
. .....++..|+|||.+.+ ..+.++||||||+++++|++|..||...... .....+.. .......+..++..+
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l 233 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS--SGEPPEIPEHLSEEA 233 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc--cCCCcCCCcccCHHH
Confidence 2 344578899999998774 4899999999999999999999999776521 11111111 112223334568999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 289 KDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 289 ~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
.++|.+||+.+|++||++.+++.||||
T Consensus 234 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 234 KDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=329.42 Aligned_cols=251 Identities=25% Similarity=0.369 Sum_probs=212.4
Q ss_pred ccceeceeeeccCceEEEEEEECCCCc---E-EEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGD---A-FACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~-vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 130 (352)
++-.+.++||+|+||.||+|.....+. . ||+|....+.......+.++.+|+++|+.+ +|||||+++|+...+..
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-NHPNVVRFYGVAVLEEP 235 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEcCCCc
Confidence 445566899999999999999765422 3 899988765555677788999999999999 99999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 131 VHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~-l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
+++|||+|+||+|.++|...+. ++..+...++.+.+.||+|||++++|||||-.+|+|++.++. +||+|||+++..
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~---vKISDFGLs~~~ 312 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGV---VKISDFGLSRAG 312 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCe---EEeCccccccCC
Confidence 9999999999999999998874 999999999999999999999999999999999999975443 799999999865
Q ss_pred CCCCccc-ccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCH
Q 018640 210 KPGEKFS-EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (352)
Q Consensus 210 ~~~~~~~-~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (352)
....... ...-...|+|||.+. +.++.++||||||+++||+++ |..||.+....+....+.... ++...++..+.
T Consensus 313 ~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~--~r~~~~~~~p~ 390 (474)
T KOG0194|consen 313 SQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNG--YRMPIPSKTPK 390 (474)
T ss_pred cceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcC--ccCCCCCCCHH
Confidence 4222111 112457899999987 569999999999999999998 888999999887777774432 33334457789
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 287 NAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 287 ~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
.+..++.+|+..+|++||++.++.+
T Consensus 391 ~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 391 ELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHHHhccCChhhccCHHHHHH
Confidence 9999999999999999999999865
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=316.14 Aligned_cols=257 Identities=30% Similarity=0.534 Sum_probs=213.5
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
.|.....||+|+||.||+|.+..++..||+|++.... ....+.+.+|+.++..+ +|||++++++.+..++..++|+
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDY-QHQNVVEMYKSYLVGEELWVLM 97 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc---cchHHHHHHHHHHHHhC-CCCchhhhhhheeeCCeEEEEE
Confidence 4556678999999999999998899999999986542 22346788999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC-c
Q 018640 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-K 214 (352)
Q Consensus 136 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-~ 214 (352)
||+++++|.+++.. ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++....... .
T Consensus 98 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~---~kL~dfg~~~~~~~~~~~ 173 (297)
T cd06659 98 EFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR---VKLSDFGFCAQISKDVPK 173 (297)
T ss_pred ecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCc---EEEeechhHhhccccccc
Confidence 99999999887754 46899999999999999999999999999999999999976554 8999999987543322 2
Q ss_pred ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHH
Q 018640 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (352)
Q Consensus 215 ~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 293 (352)
.....|+..|+|||++. ..++.++||||||++++||++|..||......+....+.... .........++..+.++|.
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~i~ 252 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-PPKLKNAHKISPVLRDFLE 252 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC-CCCccccCCCCHHHHHHHH
Confidence 23457899999999886 458899999999999999999999998766555444433221 1112223467889999999
Q ss_pred HhcCCCcCCCCCHHHHhcCccccccccC
Q 018640 294 KMLDPDPKRRLTAQQVLEHPWLQNAKKA 321 (352)
Q Consensus 294 ~~l~~dP~~Rps~~ell~hp~f~~~~~~ 321 (352)
+||+.+|++||++.++++||||.++.-.
T Consensus 253 ~~l~~~P~~Rps~~~ll~~~~~~~~~~~ 280 (297)
T cd06659 253 RMLTREPQERATAQELLDHPFLLQTGLP 280 (297)
T ss_pred HHhcCCcccCcCHHHHhhChhhccCCCc
Confidence 9999999999999999999999987553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=315.49 Aligned_cols=257 Identities=32% Similarity=0.531 Sum_probs=211.7
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
.++|++.+.||+|+||.||++.+..++..||+|.+... .....+.+.+|+.+++.+ +|||++++++.+...+..++
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~l 93 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ---QQPKKELIINEILVMREN-KHPNIVNYLDSYLVGDELWV 93 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc---cchHHHHHHHHHHHHhhc-CCCCeeehhheeeeCCcEEE
Confidence 36799999999999999999999888999999998643 223346788999999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
|+||+++++|.+++... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 94 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~---~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 94 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG---SVKLTDFGFCAQITPEQ 169 (293)
T ss_pred EEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCC---CEEEccCcceecccccc
Confidence 99999999999988654 588999999999999999999999999999999999997554 48999999887554332
Q ss_pred -cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHH
Q 018640 214 -KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (352)
Q Consensus 214 -~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 291 (352)
......|++.|+|||.+. +.++.++|+||||+++|++++|..||...........+... ..........++..+.++
T Consensus 170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l 248 (293)
T cd06647 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPELQNPEKLSAIFRDF 248 (293)
T ss_pred cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcC-CCCCCCCccccCHHHHHH
Confidence 223346888999999876 45889999999999999999999999765543222211111 111111223467889999
Q ss_pred HHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 292 VRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 292 i~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
|.+||+.+|++||++.+++.||||+...
T Consensus 249 i~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 249 LNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 9999999999999999999999999765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=306.09 Aligned_cols=248 Identities=29% Similarity=0.524 Sum_probs=209.0
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
+|++.+.||+|+||.||++.+..++..+|+|.+.... .....+.+.+|+.+++.+ +|+|++++++.+...+..+++|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKM-KHPNIVAFKESFEADGHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhC-CCCCcceEEEEEEECCEEEEEE
Confidence 4889999999999999999999999999999886432 223456788899999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 136 ELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 136 e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
||+++++|.+++... ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~---~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGK---VKLGDFGSARLLTSPG 154 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCc---EEEcccCcceeecccc
Confidence 999999999988653 34899999999999999999999999999999999999976544 8999999997654332
Q ss_pred -cccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHH
Q 018640 214 -KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (352)
Q Consensus 214 -~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 291 (352)
......|+..|+|||++.+ .++.++|+||||+++|+|++|..||...........+.... .......++..+.++
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l 231 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGS---YKPLPSHYSYELRSL 231 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCC---CCCCCcccCHHHHHH
Confidence 2234578899999999864 58899999999999999999999998776655544443322 122234578899999
Q ss_pred HHHhcCCCcCCCCCHHHHhcC
Q 018640 292 VRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 292 i~~~l~~dP~~Rps~~ell~h 312 (352)
|.+||+.||++|||+.++++-
T Consensus 232 i~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 232 IKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHhCCcccCCCHHHHhhc
Confidence 999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=321.61 Aligned_cols=266 Identities=33% Similarity=0.512 Sum_probs=219.9
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC-----e
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT-----A 130 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~-----~ 130 (352)
+|++.+.||+|++|.||+|.+..+|+.||+|++.... ........+.+|+.+++.+ +|+||+++.+++.... .
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~ 78 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHL-RHENIIGLLDILRPPSPEDFND 78 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhc-CCcchhhhhhhhcccCcccccc
Confidence 5899999999999999999999889999999887542 2233456788999999999 8999999999987765 7
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
.+++|||++ ++|.+++.....+++..+..++.|++.||++||+.|++|+||||+||+++.++ .++|+|||++....
T Consensus 79 ~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~---~~~L~dfg~~~~~~ 154 (330)
T cd07834 79 VYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNC---DLKICDFGLARGVD 154 (330)
T ss_pred eEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC---CEEEcccCceEeec
Confidence 899999997 48999998777899999999999999999999999999999999999997654 48999999998765
Q ss_pred CCC----cccccccccccccchhcc-c-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCC-----
Q 018640 211 PGE----KFSEIVGSPYYMAPEVLK-R-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD----- 279 (352)
Q Consensus 211 ~~~----~~~~~~gt~~y~aPE~~~-~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----- 279 (352)
... ......++..|+|||.+. . .++.++|+||||+++++|++|..||......+....+..........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 443 234456789999999876 3 58899999999999999999999998777665554444432211110
Q ss_pred ----------------------CCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccCCCCCCc
Q 018640 280 ----------------------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLG 327 (352)
Q Consensus 280 ----------------------~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~ 327 (352)
..+.++..+.++|.+||+.+|++||++.+++.||||+.....+.....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~ 304 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVA 304 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCC
Confidence 113467889999999999999999999999999999987665554443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=314.87 Aligned_cols=250 Identities=23% Similarity=0.298 Sum_probs=203.8
Q ss_pred ccceeceeeeccCceEEEEEEECCCCc--EEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGD--AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
++|++.++||+|+||.||+|.+..++. .+++|.+... ......+.+.+|+.++.++.+||||+++++++...+..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 469999999999999999999877765 4688877532 223345678899999999977999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCC
Q 018640 133 LVMELCEGGELFDRIVARG----------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETA 196 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~ 196 (352)
+++||+++++|.+++.... .+++..++.++.|++.||+|||++|++||||||+||+++.++.
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~-- 157 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA-- 157 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe--
Confidence 9999999999999996532 4788999999999999999999999999999999999976544
Q ss_pred CEEEEecccceecCCCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc
Q 018640 197 PLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVL 274 (352)
Q Consensus 197 ~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~ 274 (352)
+||+|||++..............+..|+|||++. ..++.++||||||+++|||++ |..||......+....+....
T Consensus 158 -~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~- 235 (297)
T cd05089 158 -SKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY- 235 (297)
T ss_pred -EEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-
Confidence 8999999986432221112223356799999876 458999999999999999997 999998877766655554332
Q ss_pred ccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 275 DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 275 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
.......++..+.+++.+||+.+|.+|||+.++++.
T Consensus 236 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 --RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred --CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 222334578999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=302.55 Aligned_cols=250 Identities=32% Similarity=0.551 Sum_probs=211.1
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
+|.+.+.||+|++|.||++.+..++..+++|++..... .....+.+|+.+++.+ +|+|++++++++......++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l~~ 76 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKC-KHPNIVKYYGSYLKKDELWIVM 76 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCeEEEEE
Confidence 47888999999999999999988999999999876432 3457889999999999 7999999999999999999999
Q ss_pred EecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCc
Q 018640 136 ELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (352)
Q Consensus 136 e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (352)
||+++++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~---~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGE---VKLIDFGLSAQLSDTKA 153 (253)
T ss_pred ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCe---EEEeecccccccccccc
Confidence 999999999999776 57999999999999999999999999999999999999976544 89999999987654432
Q ss_pred ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCC-CcCCCHHHHHHH
Q 018640 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP-WPKVSENAKDLV 292 (352)
Q Consensus 215 ~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li 292 (352)
.....++..|+|||.+. ..++.++|+||||+++++|++|..||............... ...... ...++..+.++|
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~i 231 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN--GPPGLRNPEKWSDEFKDFL 231 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc--CCCCcCcccccCHHHHHHH
Confidence 34557889999999876 44788999999999999999999999776444433333321 111111 123488999999
Q ss_pred HHhcCCCcCCCCCHHHHhcCcc
Q 018640 293 RKMLDPDPKRRLTAQQVLEHPW 314 (352)
Q Consensus 293 ~~~l~~dP~~Rps~~ell~hp~ 314 (352)
.+||+.||++|||+.+++.|||
T Consensus 232 ~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 232 KKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHccCChhhCCCHHHHhcCCC
Confidence 9999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=310.20 Aligned_cols=251 Identities=21% Similarity=0.330 Sum_probs=203.5
Q ss_pred ccccceeceeeeccCceEEEEEEEC-----CCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe
Q 018640 53 IEERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 127 (352)
..++|++.+.||+|+||+||+|.+. .++..||+|++.... .......+.+|+.+++.+ +|+||+++++++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~ 80 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQ 80 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcC
Confidence 4678999999999999999999864 245679999875432 223345688999999999 89999999999999
Q ss_pred CCeEEEEEEecCCcchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCC
Q 018640 128 DTAVHLVMELCEGGELFDRIVARG----------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAP 197 (352)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~----------~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~ 197 (352)
....++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+++|+||||+||+++.++.
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~--- 157 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--- 157 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC---
Confidence 999999999999999999986532 2577889999999999999999999999999999999975444
Q ss_pred EEEEecccceecCCCCcc---cccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 018640 198 LKAIDFGLSVFFKPGEKF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRS 272 (352)
Q Consensus 198 vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~ 272 (352)
++|+|||++......... ....++..|+|||++. +.++.++||||||+++|||++ |..||...........+...
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 237 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG 237 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 899999998754332211 2234577899999876 458999999999999999999 78898877666555444332
Q ss_pred ccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 273 VLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
. ........+..+.+++.+||+.||++|||+.|++++
T Consensus 238 ~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 238 G---LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred C---cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2 122334678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=307.29 Aligned_cols=247 Identities=21% Similarity=0.353 Sum_probs=207.2
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
.+|.+.+.||+|+||.||+|.+..+++.||+|.+... ......+.+|+.+++.+ +|+||+++++++..++..+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhC-CCCChhheEEEEcCCCCcEEE
Confidence 4688999999999999999999999999999988643 22356788999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 135 MELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
|||+++++|.+++.... .+++..+..++.|++.||.|||+++++|+||||+||+++.++. +||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~---~kl~df~~~~~~~~~ 157 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL---VKVADFGLSRLMTGD 157 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCc---EEeCCCccccccccc
Confidence 99999999999987543 5899999999999999999999999999999999999975544 899999999765433
Q ss_pred Ccc--cccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHH
Q 018640 213 EKF--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (352)
Q Consensus 213 ~~~--~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (352)
... ....++..|+|||.+. ..++.++||||||+++|||++ |..||......+....+... .........+..+
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 234 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG---YRMERPEGCPPKV 234 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC---CCCCCCCCCCHHH
Confidence 221 1223466899999876 458899999999999999998 99999877666555444432 2233445688999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 289 KDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 289 ~~li~~~l~~dP~~Rps~~ell~h 312 (352)
.++|.+||+.+|++|||+.++++.
T Consensus 235 ~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 235 YELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred HHHHHHHccCCcccCCCHHHHHHH
Confidence 999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=305.77 Aligned_cols=254 Identities=29% Similarity=0.503 Sum_probs=210.0
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEcccccc--CChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC--Ce
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL--RTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--TA 130 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~--~~ 130 (352)
.+|++.+.||+|+||.||+|.+..++..||+|.+..... ........+.+|+.+++++ +|+||+++++++... ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHc-CCCCcceEEEEEEcCCCCE
Confidence 369999999999999999999999999999998754311 1233456788999999999 899999999998654 46
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
.++++||+++++|.+.+.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++....
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~---~~l~dfg~~~~~~ 157 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGN---VKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC---EEECccccccccc
Confidence 8899999999999999988778999999999999999999999999999999999999976544 8999999997653
Q ss_pred CC----Ccccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCC
Q 018640 211 PG----EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (352)
Q Consensus 211 ~~----~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (352)
.. .......++..|+|||.+.+ .++.++|+||||++++++++|+.||...........+.. ....+..+..++
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~p~~~~ 235 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT--QPTKPMLPDGVS 235 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc--CCCCCCCCcccC
Confidence 21 11234568899999998864 488999999999999999999999987655544433321 122334456788
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 286 ~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
+.+.+++.+||+. |..||++.+++.|||.
T Consensus 236 ~~~~~~i~~~l~~-~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 236 DACRDFLKQIFVE-EKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHHHHHhcC-cccCccHHHHhcCCCC
Confidence 9999999999994 7999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=318.52 Aligned_cols=264 Identities=31% Similarity=0.463 Sum_probs=212.5
Q ss_pred ccccccee-ceeeeccCceEEEEEEECCCCcEEEEEEccccccCChh-----------cHHHHHHHHHHHHhCCCCCCee
Q 018640 52 EIEERYEL-GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAV-----------DIEDVRREVDIMRHLPKHQNIV 119 (352)
Q Consensus 52 ~~~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~~h~~iv 119 (352)
.+.++|.. .+.||.|+||+||+|.+..+++.||+|++......... ....+.+|+.+++.+ +|+||+
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv 83 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI-KHENIM 83 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC-CCccee
Confidence 35567765 57799999999999999999999999998654322100 012477899999999 899999
Q ss_pred EeeeEEEeCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEE
Q 018640 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLK 199 (352)
Q Consensus 120 ~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vk 199 (352)
++++++...+..++||||++ ++|.+++.....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~---~k 159 (335)
T PTZ00024 84 GLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI---CK 159 (335)
T ss_pred eeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCC---EE
Confidence 99999999999999999997 599999988778999999999999999999999999999999999999976544 89
Q ss_pred EEecccceecCCC---------------Ccccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q 018640 200 AIDFGLSVFFKPG---------------EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETE 262 (352)
Q Consensus 200 l~Dfg~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~ 262 (352)
|+|||++...... .......++..|+|||.+.+ .++.++|+||||+++++|++|..||.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999998765411 11123356888999998764 368899999999999999999999987776
Q ss_pred HHHHHHHHhcccccCCC------------------------CCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 263 QGVAQAIIRSVLDFRRD------------------------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 263 ~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
.+....+.......... ..+..++.+.++|..||+.+|++|||+.+++.||||+..
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 65554443322211110 012357889999999999999999999999999999976
Q ss_pred cc
Q 018640 319 KK 320 (352)
Q Consensus 319 ~~ 320 (352)
..
T Consensus 320 ~~ 321 (335)
T PTZ00024 320 PL 321 (335)
T ss_pred CC
Confidence 43
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=303.92 Aligned_cols=252 Identities=28% Similarity=0.553 Sum_probs=214.9
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
+|++.+.||.|++|.||++.+..++..||+|++..... .......+.+|+++++.+ +|+|++++.+.+......++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKL-NHPNIIKYYESFEEKGKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhc-CCCChhheEEEEecCCEEEEEE
Confidence 58899999999999999999998999999999876532 234556788999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 136 ELCEGGELFDRIVAR----GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 136 e~~~~~sL~~~l~~~----~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
||+++++|.+.+... ..+++..+..++.+++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~---~~l~d~~~~~~~~~ 155 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL---VKLGDFGISKVLSS 155 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCc---EEECCccceeeccc
Confidence 999999999998764 56999999999999999999999999999999999999976444 89999999976544
Q ss_pred CC-cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHH
Q 018640 212 GE-KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (352)
Q Consensus 212 ~~-~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (352)
.. ......|++.|+|||.+. ..++.++|+||+|+++++|++|..||................ .......++..+.
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 232 (258)
T cd08215 156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ---YPPIPSQYSSELR 232 (258)
T ss_pred CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC---CCCCCCCCCHHHH
Confidence 33 223457889999999876 458899999999999999999999998776555555444332 2222336789999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 290 DLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 290 ~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
+++.+||+.+|++|||+.++++||||
T Consensus 233 ~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 233 NLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=309.89 Aligned_cols=245 Identities=28% Similarity=0.456 Sum_probs=199.5
Q ss_pred eeceeeeccCceEEEEEEEC----CCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 58 ELGRELGRGEFGITYLCTDR----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 58 ~~~~~lG~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
.+.+.||.|.||.||+|.+. ..+..|+||.+... ......+.+.+|++.++++ +||||+++++++...+..++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~~~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIENEPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEESSSSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccc-cccccccccccccccccccc
Confidence 35688999999999999987 45678999998542 2344468899999999999 99999999999998888999
Q ss_pred EEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 134 VMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
|+||+++|+|.+++... ..+++..+..|+.|++.||.|||+++++|+||+++||+++.++. +||+|||++.....
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~---~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQ---VKLSDFGLSRPISE 155 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTE---EEEESTTTGEETTT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccc
Confidence 99999999999999887 57999999999999999999999999999999999999986554 89999999987632
Q ss_pred CCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCH
Q 018640 212 GEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (352)
Q Consensus 212 ~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (352)
... .....+...|+|||.+. ..++.++||||||+++||+++ |..||......+....+.+... ......++.
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 232 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR---LPIPDNCPK 232 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE---TTSBTTSBH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ceeccchhH
Confidence 221 13345678899999986 448999999999999999999 7899988877766666644322 223346799
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 287 NAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 287 ~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
.+.++|..||+.||++|||+.+|++
T Consensus 233 ~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 233 DIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHh
Confidence 9999999999999999999999974
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=312.01 Aligned_cols=257 Identities=28% Similarity=0.449 Sum_probs=213.0
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
...+.|...+.||+|+||+||+|.+..+|..|++|++.............+.+|+.+++.+ +|+|++++++++.+....
T Consensus 18 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 96 (313)
T cd06633 18 DPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTIEYKGCYLKEHTA 96 (313)
T ss_pred CHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEeCCEE
Confidence 3445588889999999999999999999999999998765444444456788899999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 132 HLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
++||||+++ +|.+.+.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 97 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~---~kL~dfg~~~~~~ 172 (313)
T cd06633 97 WLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ---VKLADFGSASKSS 172 (313)
T ss_pred EEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCC---EEEeecCCCcccC
Confidence 999999964 77777765 346899999999999999999999999999999999999975544 8999999886432
Q ss_pred CCCcccccccccccccchhcc----ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCH
Q 018640 211 PGEKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (352)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~----~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (352)
......|+..|+|||.+. +.++.++||||||+++|+|++|..||...........+.... .+......++.
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 247 (313)
T cd06633 173 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND--SPTLQSNEWTD 247 (313)
T ss_pred ---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CCCCCccccCH
Confidence 223457889999999873 447889999999999999999999998776554444443321 12222335678
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 287 ~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
.+.+|+.+||+.+|++||++.+++.||||...
T Consensus 248 ~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 248 SFRGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 89999999999999999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=317.00 Aligned_cols=248 Identities=21% Similarity=0.275 Sum_probs=202.0
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcE----EEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDA----FACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 130 (352)
.+|++.+.||+|+||+||+|.+..+++. ||+|++... ......+++.+|+.+++.+ +||||+++++++... .
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l-~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEcCC-C
Confidence 4699999999999999999998766664 899988643 2233456788999999999 999999999998765 5
Q ss_pred EEEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 131 VHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
.++++||+++|+|.+++.... .+++..+..++.|++.||+|||+.+++||||||+||+++.++. +||+|||+++..
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~---~kl~DfG~a~~~ 159 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH---VKITDFGLAKLL 159 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCc---EEEccccccccc
Confidence 679999999999999998754 5889999999999999999999999999999999999975544 899999999876
Q ss_pred CCCCcc---cccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCC
Q 018640 210 KPGEKF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (352)
Q Consensus 210 ~~~~~~---~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (352)
...... ....++..|+|||.+. ..++.++||||||+++|||++ |..||......+... +...... ....+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~--~~~~~~~ 236 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGER--LPQPPIC 236 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHhCCCC--CCCCCCC
Confidence 543322 1223467899999876 558999999999999999997 999998766554433 3322222 2223457
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 285 SENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 285 ~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
+.++.+++..||+.+|++||++.+++.+
T Consensus 237 ~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 237 TIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 8899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=317.34 Aligned_cols=258 Identities=30% Similarity=0.527 Sum_probs=202.0
Q ss_pred cceeceeeeccCceEEEEEEECC--CCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC--CeE
Q 018640 56 RYELGRELGRGEFGITYLCTDRE--NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--TAV 131 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~--~~~ 131 (352)
+|++.+.||+|++|.||+|.+.. ++..||+|.+...........+.+.+|+.+++.+ +||||+++++++... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-KHENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhc-CCCCccceEEEEeCCCCceE
Confidence 48899999999999999999988 8999999998764322223345678899999999 899999999999887 789
Q ss_pred EEEEEecCCcchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCC-CCCCEEEEeccc
Q 018640 132 HLVMELCEGGELFDRIVAR-----GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK-ETAPLKAIDFGL 205 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~-~~~~vkl~Dfg~ 205 (352)
++||||+++ +|.+.+... ..+++..++.++.|++.||.|||+.+++||||||+||+++.++ ....+||+|||+
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~ 158 (316)
T cd07842 80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL 158 (316)
T ss_pred EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence 999999975 677766432 2589999999999999999999999999999999999998622 245589999999
Q ss_pred ceecCCCCc----ccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHHH
Q 018640 206 SVFFKPGEK----FSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQG---------VAQAII 270 (352)
Q Consensus 206 a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~---------~~~~~~ 270 (352)
+........ .....++..|+|||.+.+ .++.++||||||+++++|++|+.||....... ....+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence 886533221 234467889999998653 47889999999999999999999997544321 111111
Q ss_pred hccc---------------------ccCCCCCc------------CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 271 RSVL---------------------DFRRDPWP------------KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 271 ~~~~---------------------~~~~~~~~------------~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
.... .......+ ..+..+.+++.+||++||++|||+.|++.||||
T Consensus 239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 1100 00000011 456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=310.40 Aligned_cols=248 Identities=24% Similarity=0.381 Sum_probs=206.3
Q ss_pred ccceeceeeeccCceEEEEEEECC-----CCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC
Q 018640 55 ERYELGRELGRGEFGITYLCTDRE-----NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 129 (352)
++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .....+.+.+|+++++.+ +|+||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNF-QHENIVKFYGVCTEGD 81 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhc-CCCCchheeeEEecCC
Confidence 468999999999999999998743 36789999986542 222456899999999999 8999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCC
Q 018640 130 AVHLVMELCEGGELFDRIVARG--------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKET 195 (352)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~--------------~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~ 195 (352)
..++||||+++++|.+++...+ .+++..+..++.|++.||.+||++|++|+||||+||+++.++.
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~- 160 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV- 160 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe-
Confidence 9999999999999999997542 3788899999999999999999999999999999999976544
Q ss_pred CCEEEEecccceecCCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 018640 196 APLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAII 270 (352)
Q Consensus 196 ~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~ 270 (352)
++|+|||++........ .....+++.|+|||++. +.++.++||||||+++|||++ |..||...........+.
T Consensus 161 --~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05049 161 --VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT 238 (280)
T ss_pred --EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 89999999976432221 12334578899999876 558999999999999999998 999998877766655555
Q ss_pred hcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 271 RSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
.... .......+..+.+++.+||+.||++||++.|+++
T Consensus 239 ~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 239 QGRL---LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred cCCc---CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 3322 2223467899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=343.83 Aligned_cols=252 Identities=28% Similarity=0.417 Sum_probs=202.2
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|+++++||+|+||.||+|.+..+|+.||+|++...........+++.+|+.+++.+ +||||+++++++.+.+..++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L-~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-IHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhC-CCcCcCeEEEEEeeCCEEEEE
Confidence 4799999999999999999999999999999998765333334456789999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEec
Q 018640 135 MELCEGGELFDRIVAR-----------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDF 203 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~-----------~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Df 203 (352)
|||++|++|.+++... ..++...+..++.||+.||+|||+.||+||||||+||+++.++. ++|+||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~---vKLiDF 157 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE---VVILDW 157 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCC---EEEEec
Confidence 9999999999988641 23556778899999999999999999999999999999976554 899999
Q ss_pred ccceecCCCC-------------------cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 018640 204 GLSVFFKPGE-------------------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ 263 (352)
Q Consensus 204 g~a~~~~~~~-------------------~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~ 263 (352)
|++....... ......||+.|+|||++. ..++.++|||||||++|||+||..||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 9997652110 012346999999999876 45899999999999999999999999765433
Q ss_pred HHHHHHHhcccc-cCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 264 GVAQAIIRSVLD-FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 264 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
..... ..... ........+++.+.+++.+||+.||++||+..+.+.+
T Consensus 238 ki~~~--~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 238 KISYR--DVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhh--hhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 22211 11111 1111234678999999999999999999876554433
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=305.50 Aligned_cols=251 Identities=27% Similarity=0.536 Sum_probs=206.7
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++.+.||+|++|.||+|.+..+|+.||+|.+...........+.+.+|+.+++++ +|+|++++++++...+..++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCeeeeeeeeecCCeEEEE
Confidence 4799999999999999999999989999999988765444444567899999999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 135 MELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
|||+++++|.+++.. ...+++..+..++.+++.||.|||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~---~~l~d~~~~~~~~ 157 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGV---VKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCc---EEEeccceeeecc
Confidence 999999999998864 234899999999999999999999999999999999999976554 8999999987654
Q ss_pred CCC-cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhcccccCCCCCcCCCH
Q 018640 211 PGE-KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE--QGVAQAIIRSVLDFRRDPWPKVSE 286 (352)
Q Consensus 211 ~~~-~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 286 (352)
... ......++..|+|||.+. ..++.++|+||||+++|+|++|..||..... ......+... ...+.....++.
T Consensus 158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 235 (267)
T cd08224 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC--DYPPLPADHYSE 235 (267)
T ss_pred CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC--CCCCCChhhcCH
Confidence 322 223346888999999876 4588999999999999999999999865432 1222222221 112222236788
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 287 NAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 287 ~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
.+.++|.+||+.+|++|||+.+|++
T Consensus 236 ~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 236 ELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=304.31 Aligned_cols=245 Identities=24% Similarity=0.375 Sum_probs=203.9
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++.+.||+|+||.||++.+. ++..+|+|.+.... ...+.+.+|+.+++++ +||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA----MSEEDFIEEAKVMMKL-SHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC----ccHHHHHHHHHHHHHC-CCCCceeEEEEEccCCCEEEE
Confidence 46889999999999999999875 46689999876432 2346788999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
|||+++++|.+++... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.++......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~---~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGV---VKVSDFGMTRYVLDDE 154 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCe---EEECCCCCccccCCCc
Confidence 9999999999998753 46899999999999999999999999999999999999975544 8999999987653322
Q ss_pred cc--cccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHH
Q 018640 214 KF--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (352)
Q Consensus 214 ~~--~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (352)
.. ....++..|+|||.+. ..++.++|+||||+++|+|++ |+.||......+....+.+... .......+..+.
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~ 231 (256)
T cd05114 155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR---LYRPKLASMTVY 231 (256)
T ss_pred eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC---CCCCCCCCHHHH
Confidence 21 2224566899999876 458899999999999999999 8999988777666666554321 222334678899
Q ss_pred HHHHHhcCCCcCCCCCHHHHhc
Q 018640 290 DLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 290 ~li~~~l~~dP~~Rps~~ell~ 311 (352)
+++.+||+.+|++|||+.++++
T Consensus 232 ~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 232 EVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHHccCCcccCcCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=324.14 Aligned_cols=251 Identities=24% Similarity=0.332 Sum_probs=201.7
Q ss_pred cccceeceeeeccCceEEEEEEECCC-----CcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC
Q 018640 54 EERYELGRELGRGEFGITYLCTDREN-----GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 128 (352)
.++|++.+.||+|+||.||+|.+... +..||+|++.... .....+.+.+|+.+++++..||||+++++++...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 45799999999999999999987432 3469999986542 2233567899999999995599999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhc----------------------------------------------------------
Q 018640 129 TAVHLVMELCEGGELFDRIVAR---------------------------------------------------------- 150 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~---------------------------------------------------------- 150 (352)
+..++||||+++|+|.+++..+
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 9999999999999999988542
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecC
Q 018640 151 --------------------------------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK 192 (352)
Q Consensus 151 --------------------------------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~ 192 (352)
..+++..+..++.|++.||.|||+.+++|+||||+||+++.+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~ 273 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG 273 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCC
Confidence 136778889999999999999999999999999999999765
Q ss_pred CCCCCEEEEecccceecCCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 018640 193 KETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQ 267 (352)
Q Consensus 193 ~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~ 267 (352)
+. +||+|||++........ .....++..|+|||.+. ..++.++||||||+++|||++ |..||..........
T Consensus 274 ~~---~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~ 350 (400)
T cd05105 274 KI---VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY 350 (400)
T ss_pred CE---EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence 44 89999999986543221 22345678899999876 458999999999999999997 999987654433333
Q ss_pred HHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 268 AIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
...... ........++..+.+++.+||+.||++|||+.+|.+
T Consensus 351 ~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 351 NKIKSG--YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHhcC--CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 322221 122233467899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=301.62 Aligned_cols=252 Identities=32% Similarity=0.573 Sum_probs=215.1
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
+|++.+.||+|++|.||++.+..+++.|++|.+...... ....+.+.+|++++.++ +|+|++++++++...+..++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNL-KHPNIVKYIGSIETSDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEEEEEE
Confidence 488999999999999999999989999999998765432 23457899999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCc-
Q 018640 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK- 214 (352)
Q Consensus 136 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~- 214 (352)
||+++++|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~---~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG---VVKLADFGVATKLNDVSKD 155 (254)
T ss_pred ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCC---CEEEeccccceecCCCccc
Confidence 9999999999998888899999999999999999999999999999999999997644 489999999987654332
Q ss_pred ccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHH
Q 018640 215 FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (352)
Q Consensus 215 ~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 293 (352)
.....++..|+|||...+ .++.++|+||+|+++++|++|..||+............. .........+++.+.+++.
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~i~ 232 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ---DDHPPLPEGISPELKDFLM 232 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc---cCCCCCCCCCCHHHHHHHH
Confidence 234568899999998763 478899999999999999999999987654433333321 2223334567899999999
Q ss_pred HhcCCCcCCCCCHHHHhcCccc
Q 018640 294 KMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 294 ~~l~~dP~~Rps~~ell~hp~f 315 (352)
+||+.+|++|||+.+++.||||
T Consensus 233 ~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 233 QCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHhCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=309.26 Aligned_cols=257 Identities=24% Similarity=0.339 Sum_probs=206.0
Q ss_pred ccccceeceeeeccCceEEEEEEEC-----CCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe
Q 018640 53 IEERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 127 (352)
..++|++.+.||+|+||.||+|... ..+..||+|.+.... .......+.+|+.+++.+ +|+||+++++++..
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 80 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGF-TCHHVVRLLGVVSK 80 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcC
Confidence 3468999999999999999999754 235589999876432 222345678899999999 89999999999999
Q ss_pred CCeEEEEEEecCCcchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCC
Q 018640 128 DTAVHLVMELCEGGELFDRIVAR----------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAP 197 (352)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~----------~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~ 197 (352)
.+..++||||+++|+|.+++... ..++...+..++.|++.||.|||+++++||||||+||+++.++.
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~--- 157 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--- 157 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCc---
Confidence 99999999999999999999652 22466788999999999999999999999999999999976544
Q ss_pred EEEEecccceecCCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 018640 198 LKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRS 272 (352)
Q Consensus 198 vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~ 272 (352)
++|+|||+++....... .....++..|+|||.+. +.++.++|+||||+++|||++ |..||......+....+...
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 237 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG 237 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 89999999875433221 12224567899999876 458999999999999999998 78899876665544443322
Q ss_pred ccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc------Ccccccc
Q 018640 273 VLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE------HPWLQNA 318 (352)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~------hp~f~~~ 318 (352)
. ........++.+.+++.+||+.||++|||+.++++ ||||...
T Consensus 238 ~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 238 G---YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred C---CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 1 11122356789999999999999999999999987 8888764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=319.61 Aligned_cols=258 Identities=31% Similarity=0.474 Sum_probs=207.0
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC----
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD---- 128 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~---- 128 (352)
+..+|++.+.||.|+||.||+|.+..+|..||+|++..... ...+.+.+|+.+++.+ +||||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRL-DHDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhc-CCCcchhhHhhhccccccc
Confidence 45789999999999999999999999999999998865432 3456788899999999 999999999876543
Q ss_pred ----------CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCE
Q 018640 129 ----------TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPL 198 (352)
Q Consensus 129 ----------~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~v 198 (352)
...++|+||++ ++|.+++.. ..+++..++.++.||+.||.|||+.|++||||||+||+++.++ ..+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~--~~~ 154 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTED--LVL 154 (342)
T ss_pred ccccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC--ceE
Confidence 35789999997 488888754 4689999999999999999999999999999999999997433 347
Q ss_pred EEEecccceecCCCCc----ccccccccccccchhcc--ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 018640 199 KAIDFGLSVFFKPGEK----FSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS 272 (352)
Q Consensus 199 kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~--~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~ 272 (352)
+|+|||++........ .....++..|+|||.+. ..++.++|||||||++|+|++|+.||...............
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999999976532211 12336788999999764 34788999999999999999999999876655444433322
Q ss_pred cccc---------------------CC-----CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 273 VLDF---------------------RR-----DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 273 ~~~~---------------------~~-----~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
.... .. ...+.++.++.+||.+||+.||++|||+.+++.||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 1100 00 0123577889999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=329.94 Aligned_cols=255 Identities=23% Similarity=0.440 Sum_probs=216.3
Q ss_pred ceeceeeeccCceEEEEEEECCCCcEEEEEEcccccc-CChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC--eEEE
Q 018640 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL-RTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT--AVHL 133 (352)
Q Consensus 57 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~--~~~l 133 (352)
.+...+||+|+|-+||+|.|..+|..||.-.++.... ..+...++|..|+.+|+.| +||||+++++++.+.. ...+
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL-~H~NIirfy~SW~d~~n~~in~ 120 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSL-KHPNIIRFYDSWVDTDNKTINF 120 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccC-CCCceeeeeeheecCCCceeee
Confidence 3456889999999999999999999999766655433 3445568999999999999 9999999999997655 4889
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG--VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
|+|.+.+|+|..++++.+..+...+..|++||+.||.|||++. |||||||=+||+|+ +..+.|||+|+|+|+....
T Consensus 121 iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 121 ITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred eeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceeecchhHHHHhhc
Confidence 9999999999999999999999999999999999999999874 99999999999996 6777799999999998654
Q ss_pred CCcccccccccccccchhccccCCCcchHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcccccCCCCCcCCCHHHHH
Q 018640 212 GEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVLDFRRDPWPKVSENAKD 290 (352)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (352)
... ..+.|||.|||||.+...|+...||||||++++||+|+..||...... ++..++..++..- ....--.+++++
T Consensus 199 s~a-ksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~--sl~kV~dPevr~ 275 (632)
T KOG0584|consen 199 SHA-KSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPA--ALSKVKDPEVRE 275 (632)
T ss_pred ccc-ceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHH--HhhccCCHHHHH
Confidence 433 337999999999999999999999999999999999999999766544 3444444433221 111234788999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 291 LVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 291 li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
||.+||.. ...|||+.|+|.||||..-
T Consensus 276 fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 276 FIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHHhcC-chhccCHHHHhhChhhccc
Confidence 99999999 8999999999999999964
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=319.62 Aligned_cols=252 Identities=22% Similarity=0.343 Sum_probs=200.2
Q ss_pred cccceeceeeeccCceEEEEEEECC-----CCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe-
Q 018640 54 EERYELGRELGRGEFGITYLCTDRE-----NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED- 127 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~- 127 (352)
.++|++.+.||+|+||.||+|.+.. +++.||+|++.... .....+.+.+|+.++.++.+|+||+++++++..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 3579999999999999999997533 45789999886432 222345678899999999789999999998864
Q ss_pred CCeEEEEEEecCCcchHHHHHhc---------------------------------------------------------
Q 018640 128 DTAVHLVMELCEGGELFDRIVAR--------------------------------------------------------- 150 (352)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~--------------------------------------------------------- 150 (352)
+...++++||+++++|.+++...
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 45788999999999999988542
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCc---ccccccccc
Q 018640 151 ----GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPY 223 (352)
Q Consensus 151 ----~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~ 223 (352)
..+++..+..++.||+.||.|||+++|+||||||+||+++.++ .++|+|||++........ .....++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~---~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN---VVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC---cEEEeccccchhcccCcchhhccCCCCCcc
Confidence 2578899999999999999999999999999999999998544 389999999986533221 123355778
Q ss_pred cccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcC
Q 018640 224 YMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPK 301 (352)
Q Consensus 224 y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~ 301 (352)
|+|||++. ..++.++|||||||+++||++ |..||......+.......... ........++++.+++.+||+.+|+
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~~cl~~~p~ 318 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT--RMRAPEYATPEIYSIMLDCWHNNPE 318 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccC--CCCCCccCCHHHHHHHHHHccCChh
Confidence 99999875 559999999999999999998 9999976544333322222211 1122345788999999999999999
Q ss_pred CCCCHHHHhcC
Q 018640 302 RRLTAQQVLEH 312 (352)
Q Consensus 302 ~Rps~~ell~h 312 (352)
+||++.++++|
T Consensus 319 ~RPs~~ell~~ 329 (337)
T cd05054 319 DRPTFSELVEI 329 (337)
T ss_pred hCcCHHHHHHH
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=303.55 Aligned_cols=245 Identities=34% Similarity=0.628 Sum_probs=211.8
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEecCCcc
Q 018640 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGE 142 (352)
Q Consensus 63 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~~~s 142 (352)
||+|+||.||++.+..+++.+|+|++...........+.+..|+.+++.+ +|+|++++++.+..+...++||||+++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHc-CCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 69999999999999888999999998876555555677899999999999 89999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC-Ccccccccc
Q 018640 143 LFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-EKFSEIVGS 221 (352)
Q Consensus 143 L~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt 221 (352)
|.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++...... .......++
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05123 80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGH---IKLTDFGLAKELSSEGSRTNTFCGT 156 (250)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCc---EEEeecCcceecccCCCcccCCcCC
Confidence 9999988878999999999999999999999999999999999999976554 899999999765443 223455788
Q ss_pred cccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCc
Q 018640 222 PYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300 (352)
Q Consensus 222 ~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP 300 (352)
..|++||...+ ..+.++|+||||+++|++++|..||...........+.. .........+..+.+++.+||..||
T Consensus 157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~~i~~~l~~~p 232 (250)
T cd05123 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK----DPLRFPEFLSPEARDLISGLLQKDP 232 (250)
T ss_pred ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc----CCCCCCCCCCHHHHHHHHHHhcCCH
Confidence 99999998764 478899999999999999999999977665444444433 2233444568999999999999999
Q ss_pred CCCCCH---HHHhcCccc
Q 018640 301 KRRLTA---QQVLEHPWL 315 (352)
Q Consensus 301 ~~Rps~---~ell~hp~f 315 (352)
++||++ .++++||||
T Consensus 233 ~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 233 TKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred hhCCCcccHHHHHhCCCC
Confidence 999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=309.55 Aligned_cols=258 Identities=33% Similarity=0.549 Sum_probs=217.0
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
...+.|++...||+|++|.||+|.+..++..|++|++..... ..+.+.+|+.+++.+ +|+|++++++.+......
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 90 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDC-KHPNIVDYYDSYLVGDEL 90 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHC-CCCCeeEEEEEEEECCEE
Confidence 456679999999999999999999988899999999875422 456788999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 132 HLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
++++||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~---~~l~d~~~~~~~~ 167 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS---VKLADFGFAAQLT 167 (286)
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCC---EEECccchhhhhc
Confidence 99999999999999998876 7999999999999999999999999999999999999976554 8999999886554
Q ss_pred CCC-cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHH
Q 018640 211 PGE-KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (352)
Q Consensus 211 ~~~-~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (352)
... ......++..|+|||.+. ..++.++|+||||+++|+|++|..||...........+...... .......++..+
T Consensus 168 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 246 (286)
T cd06614 168 KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP-PLKNPEKWSPEF 246 (286)
T ss_pred cchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCcchhhCCHHH
Confidence 322 223346788999999876 44889999999999999999999999876655444333322111 111223478999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 289 ~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
.++|.+||+.+|.+|||+.+++.||||++.
T Consensus 247 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 247 KDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred HHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 999999999999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=311.57 Aligned_cols=260 Identities=25% Similarity=0.360 Sum_probs=207.2
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
-++|++.+.||+|++|.||+|.+..++..||+|.+..... ......+..|+.++.+..+|+||+++++++......++
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 3569999999999999999999988899999999875422 22334566688777777579999999999999999999
Q ss_pred EEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 134 VMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
+|||+++ +|.+.+.. ...+++..+..++.|++.||.|||+ .+++||||+|+||+++.++ .++|+|||++.....
T Consensus 92 v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~---~~kL~dfg~~~~~~~ 167 (296)
T cd06618 92 CMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG---NVKLCDFGISGRLVD 167 (296)
T ss_pred EeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC---CEEECccccchhccC
Confidence 9999854 77776655 3468999999999999999999997 5999999999999997554 489999999876544
Q ss_pred CCcccccccccccccchhccc-----cCCCcchHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcccccCCCCCcCCC
Q 018640 212 GEKFSEIVGSPYYMAPEVLKR-----NYGPEVDVWSAGVILYILLCGVPPFWAETE-QGVAQAIIRSVLDFRRDPWPKVS 285 (352)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~~-----~~s~~~Di~SlG~~l~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 285 (352)
........++..|+|||.+.+ .++.++||||||+++|+|++|+.||..... .+....+...... .......++
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 246 (296)
T cd06618 168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP-SLPPNEGFS 246 (296)
T ss_pred CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCC-CCCCCCCCC
Confidence 433344467889999998753 278899999999999999999999975432 2233333222111 111112478
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 286 ~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
+++.+|+.+||+.||++||++.+++.||||.....
T Consensus 247 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 281 (296)
T cd06618 247 PDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET 281 (296)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence 89999999999999999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=326.26 Aligned_cols=259 Identities=36% Similarity=0.607 Sum_probs=230.2
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
...|.+...||+|.|++|.+|++.-++..||+|.+++..... .....+.+|+++|+.+ +|||||+++.+.+.+..+++
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~-~~~~k~~rev~imk~l-~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP-SKRQKLGREVDIMKSL-NHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh-HHHHHHHHHHHHHHhc-CCcceeeeeeeeeecceeEE
Confidence 346999999999999999999999999999999998875443 3445588999999999 99999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
||||+.+|.+++++.++++..+..++.++.|++.|++|||+++|||||||++|||++.+.+ +||+|||++..+..+.
T Consensus 133 V~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mn---ikIaDfgfS~~~~~~~ 209 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMN---IKIADFGFSTFFDYGL 209 (596)
T ss_pred EEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccc---eeeeccccceeecccc
Confidence 9999999999999999999999999999999999999999999999999999999975554 8999999999988888
Q ss_pred cccccccccccccchhcccc--CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHH
Q 018640 214 KFSEIVGSPYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (352)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~~~--~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 291 (352)
...+.+|++.|.|||++.+. .++..|+||+|+++|.|+.|..||.+.+..+.....+...... +.-++.+..++
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rI----p~~ms~dce~l 285 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRI----PFYMSCDCEDL 285 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecc----cceeechhHHH
Confidence 88889999999999998754 6789999999999999999999999887766655555443332 23468899999
Q ss_pred HHHhcCCCcCCCCCHHHHhcCccccccccC
Q 018640 292 VRKMLDPDPKRRLTAQQVLEHPWLQNAKKA 321 (352)
Q Consensus 292 i~~~l~~dP~~Rps~~ell~hp~f~~~~~~ 321 (352)
|+++|..+|.+|++++++..|.|.+.....
T Consensus 286 Lrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 286 LRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred HHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 999999999999999999999999865443
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=315.33 Aligned_cols=260 Identities=32% Similarity=0.488 Sum_probs=207.3
Q ss_pred cceeceeeeccCceEEEEEEECCC--CcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe----CC
Q 018640 56 RYELGRELGRGEFGITYLCTDREN--GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED----DT 129 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~----~~ 129 (352)
+|++.+.||+|+||.||++.+..+ +..||+|++.... ........+.+|+.+++++.+|+||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 488999999999999999999887 8899999886432 2222345677899999999679999999987543 24
Q ss_pred eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
..+++++|+. ++|.+.+.....+++..+..++.|++.||+|||+.|++||||||+||+++.++. ++|+|||++...
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~---~kl~Dfg~a~~~ 155 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE---LKICDFGLARGF 155 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCC---EEeCcCCCceec
Confidence 5788999985 589999987778999999999999999999999999999999999999976554 899999999765
Q ss_pred CCCC-----cccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc--------
Q 018640 210 KPGE-----KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL-------- 274 (352)
Q Consensus 210 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~-------- 274 (352)
.... ......||..|+|||.+.+ .++.++||||||++++++++|..||...........+.....
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 4322 1234578999999998653 478999999999999999999999977654433333222111
Q ss_pred ---------------ccC----CCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 275 ---------------DFR----RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 275 ---------------~~~----~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
..+ ....+..+..+.+++.+||+.||++|||+.+++.||||.....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~ 300 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHD 300 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcC
Confidence 000 0112346788999999999999999999999999999985543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=308.63 Aligned_cols=249 Identities=20% Similarity=0.360 Sum_probs=203.6
Q ss_pred ccceeceeeeccCceEEEEEEE----CCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe
Q 018640 55 ERYELGRELGRGEFGITYLCTD----RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 130 (352)
++|++.+.||+|+||+||+|.+ ..++..||+|.+.... .......+.+|+.+++.+ +||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAEL-HHPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCc
Confidence 4688999999999999999985 3456789999886432 233446788999999999 89999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCC
Q 018640 131 VHLVMELCEGGELFDRIVAR-----------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK 193 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~-----------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~ 193 (352)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||+++++|+||||+||+++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 99999999999999998532 2378889999999999999999999999999999999997654
Q ss_pred CCCCEEEEecccceecCCCC---cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 018640 194 ETAPLKAIDFGLSVFFKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQA 268 (352)
Q Consensus 194 ~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~ 268 (352)
. +||+|||+++...... ......++..|+|||++. +.++.++||||||++++||++ |..||...........
T Consensus 162 ~---~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05090 162 H---VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238 (283)
T ss_pred c---EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 4 8999999997653322 123345577899999876 558999999999999999998 9999987765544444
Q ss_pred HHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 269 IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
+.... ....+..+++.+.+++.+||+.||.+||++.+|+++
T Consensus 239 ~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 239 VRKRQ---LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHcCC---cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 43321 122334678999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=307.15 Aligned_cols=254 Identities=28% Similarity=0.465 Sum_probs=206.5
Q ss_pred ceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCC--CCCCeeEeeeEEEeCCe----
Q 018640 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP--KHQNIVCLKDTYEDDTA---- 130 (352)
Q Consensus 57 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~~iv~l~~~~~~~~~---- 130 (352)
|++.+.||+|+||.||+|.+..++..||+|++....... .....+.+|+.+++++. +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 678899999999999999998889999999987543222 22345667888877763 59999999999987766
Q ss_pred -EEEEEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccce
Q 018640 131 -VHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (352)
Q Consensus 131 -~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~ 207 (352)
.+++|||+++ +|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .++|+|||++.
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~---~~~l~dfg~~~ 155 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG---QVKIADFGLAR 155 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCC---CEEEeccCcce
Confidence 9999999975 8988887643 489999999999999999999999999999999999998664 48999999998
Q ss_pred ecCCCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC---------
Q 018640 208 FFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR--------- 277 (352)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--------- 277 (352)
............++..|+|||.+. ..++.++|+||||+++++|++|.+||......+....+........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence 765544444556788999999876 4588999999999999999999999987776665555544321100
Q ss_pred --------------CCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 278 --------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 278 --------------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
....+..+..+.++|.+||+.||++||++.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00012346778899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=308.80 Aligned_cols=252 Identities=24% Similarity=0.386 Sum_probs=206.5
Q ss_pred ccceeceeeeccCceEEEEEEE-----CCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC
Q 018640 55 ERYELGRELGRGEFGITYLCTD-----RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 129 (352)
.+|.+.+.||+|+||+||++.+ ..++..+|+|.+... .......+.+|+.+++++ +|+||+++++++...+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNL-QHEHIVKFYGVCVEGD 80 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecCC
Confidence 4699999999999999999985 334667999988643 233456789999999999 8999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCC
Q 018640 130 AVHLVMELCEGGELFDRIVARG-------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETA 196 (352)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~-------------~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~ 196 (352)
..++||||+++++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~-- 158 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL-- 158 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc--
Confidence 9999999999999999987543 3899999999999999999999999999999999999976554
Q ss_pred CEEEEecccceecCCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 018640 197 PLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIR 271 (352)
Q Consensus 197 ~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~ 271 (352)
++|+|||++........ .....++..|+|||++. ..++.++||||||+++++|++ |..||...........+..
T Consensus 159 -~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~ 237 (288)
T cd05093 159 -VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 237 (288)
T ss_pred -EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 89999999976533221 12334577899999887 458999999999999999998 9999987776665555544
Q ss_pred cccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 272 SVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
... .......+..+.+++.+||+.||.+|||+.+++. .+++.
T Consensus 238 ~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~--~l~~~ 279 (288)
T cd05093 238 GRV---LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS--LLQNL 279 (288)
T ss_pred CCc---CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH--HHHHH
Confidence 321 1222357889999999999999999999999955 34444
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=309.94 Aligned_cols=256 Identities=29% Similarity=0.465 Sum_probs=211.7
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
..+.|...+.||+|+||+||+|.+..++..||+|.+.............+.+|+.+++.+ +|+|++++.+++......+
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 91 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAW 91 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCeeE
Confidence 445688899999999999999999999999999988654333333456788899999999 8999999999999999999
Q ss_pred EEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 133 LVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
+|+||+. ++|.+.+.. ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .++|+|||++.....
T Consensus 92 lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~---~~kl~dfg~~~~~~~ 167 (308)
T cd06634 92 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG---LVKLGDFGSASIMAP 167 (308)
T ss_pred EEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCC---cEEECCcccceeecC
Confidence 9999996 588777754 44589999999999999999999999999999999999997554 489999999876543
Q ss_pred CCcccccccccccccchhcc----ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHH
Q 018640 212 GEKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (352)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~----~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (352)
. ....++..|+|||.+. +.++.++||||||+++|+|++|..||...........+..... +......++..
T Consensus 168 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 242 (308)
T cd06634 168 A---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--PALQSGHWSEY 242 (308)
T ss_pred c---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC--CCcCcccccHH
Confidence 2 3346888999999863 3478899999999999999999999977665544444433221 11122357889
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 288 ~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
+.++|.+||+.+|++||++.+++.|||+...
T Consensus 243 ~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 9999999999999999999999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=311.71 Aligned_cols=259 Identities=32% Similarity=0.552 Sum_probs=208.4
Q ss_pred ccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC-
Q 018640 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT- 129 (352)
Q Consensus 51 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~- 129 (352)
....++|++.+.||+|+||+||+|.+..+|+.||+|++...... ......+.+|+.+++++ +|||++++++++....
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~ 80 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQL-NHRNIVNLKEIVTDKQD 80 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhC-CCCCeeeeeheecCcch
Confidence 34567899999999999999999999999999999998754322 22335677899999999 8999999999886544
Q ss_pred ---------eEEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEE
Q 018640 130 ---------AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLK 199 (352)
Q Consensus 130 ---------~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vk 199 (352)
..++|+||+++ ++.+.+... ..+++..+..++.|++.||.|||+.+|+|+||+|+||+++.++. +|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~---~k 156 (302)
T cd07864 81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ---IK 156 (302)
T ss_pred hhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCc---EE
Confidence 78999999976 777777654 36899999999999999999999999999999999999976544 89
Q ss_pred EEecccceecCCCC--cccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc
Q 018640 200 AIDFGLSVFFKPGE--KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD 275 (352)
Q Consensus 200 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 275 (352)
|+|||++....... ......++..|+|||.+.+ .++.++||||||+++++|++|+.||...........+......
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS 236 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 99999997654332 2223356788999998753 3788999999999999999999999876655544444332211
Q ss_pred cCC--------------------------CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 276 FRR--------------------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 276 ~~~--------------------------~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
... ..+..++..+.+++..||+.||++||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 110 0122468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=296.51 Aligned_cols=258 Identities=25% Similarity=0.381 Sum_probs=217.5
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
+.+++..||.|.-|+|+++..+.+|...|||.+.+.. +..+..++...+.++....+.|+||+.+|+|..+...++.|
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 4667888999999999999999999999999998753 44456778888888887767899999999999999999999
Q ss_pred EecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 136 ELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 136 e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
|.|. ..+..++.. ..++++..+-++..-++.||.||-. ++|+|||+||+|||++..++ +||||||++..+.+..
T Consensus 171 elMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~Gn---iKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 171 ELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGN---IKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCC---EEeecccccceeeccc
Confidence 9994 466666654 3469999999999999999999985 58999999999999976655 9999999998877777
Q ss_pred cccccccccccccchhcc----ccCCCcchHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcccccCCCCCcCCCHHH
Q 018640 214 KFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (352)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~----~~~s~~~Di~SlG~~l~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (352)
..+...|-+.|||||.+. ..|+.++||||||++++||.||..||.+. ++.+++..+.+.... ....-..+++++
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP-~L~~~~gFSp~F 325 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPP-LLPGHMGFSPDF 325 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCC-CCCcccCcCHHH
Confidence 677779999999999885 24888999999999999999999999764 566677666664321 111222489999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 289 ~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
++|+..||..|+.+||...++|+|||+....+
T Consensus 326 ~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~ 357 (391)
T KOG0983|consen 326 QSFVKDCLTKDHRKRPKYNKLLEHPFIKRYET 357 (391)
T ss_pred HHHHHHHhhcCcccCcchHHHhcCcceeecch
Confidence 99999999999999999999999999997644
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=309.86 Aligned_cols=252 Identities=22% Similarity=0.282 Sum_probs=205.1
Q ss_pred cccceeceeeeccCceEEEEEEECCCC----------------cEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCC
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENG----------------DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~----------------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~ 117 (352)
.++|++++.||+|+||.||+|.+...+ ..||+|.+.... .....+.+.+|+++++++ +|||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~ 80 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRL-SDPN 80 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhc-CCCC
Confidence 357999999999999999999876544 457999887542 224467889999999999 8999
Q ss_pred eeEeeeEEEeCCeEEEEEEecCCcchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCc
Q 018640 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG-----------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPEN 186 (352)
Q Consensus 118 iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~N 186 (352)
|+++++++..++..++++||+++++|.+++.... .+++..++.++.|++.||.|||+.+++|+||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999997655 68999999999999999999999999999999999
Q ss_pred eEeecCCCCCCEEEEecccceecCCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh--CCCCCCCC
Q 018640 187 FLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC--GVPPFWAE 260 (352)
Q Consensus 187 Ill~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t--g~~p~~~~ 260 (352)
|+++.++ .++|+|||++........ .....++..|+|||.+. +.++.++||||||+++|||++ +..||...
T Consensus 161 ili~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 161 CLVGKNY---TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred eeecCCC---ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 9997654 489999999876533221 12335677899999876 468999999999999999998 77888776
Q ss_pred CHHHHHHHHHhcccc----cCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 261 TEQGVAQAIIRSVLD----FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 261 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
............... .........+.++.+++.+||+.||++|||+.+|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 238 TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred ChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 665554444432111 111223356789999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=317.85 Aligned_cols=263 Identities=32% Similarity=0.516 Sum_probs=211.6
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC--C
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--T 129 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~--~ 129 (352)
.+.++|++.+.||+|+||.||+|.+..+|+.+|+|++... .........+.+|+.++.++.+|+||+++++++... .
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~-~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDA-FRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccc-cCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 4677899999999999999999999888999999988643 222333456778999999997899999999988643 3
Q ss_pred eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
..++||||+++ +|.+++... .+++..+..++.|++.||.|||+.||+|+||+|+||+++.++. ++|+|||++...
T Consensus 83 ~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~---~kl~d~g~~~~~ 157 (337)
T cd07852 83 DIYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR---VKLADFGLARSL 157 (337)
T ss_pred eEEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc---EEEeeccchhcc
Confidence 68999999974 998888765 7889999999999999999999999999999999999976554 899999999765
Q ss_pred CCCC------cccccccccccccchhcc--ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc------
Q 018640 210 KPGE------KFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD------ 275 (352)
Q Consensus 210 ~~~~------~~~~~~gt~~y~aPE~~~--~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~------ 275 (352)
.... ......||..|+|||.+. ..++.++||||||+++|+|++|+.||...........+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 3322 223446889999999864 34788999999999999999999999766544433332221110
Q ss_pred -----------------c----CCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 276 -----------------F----RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 276 -----------------~----~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
. .....+.++.++.++|..||+.||++|||+.++++||||++...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~ 303 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN 303 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence 0 01112346889999999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=304.22 Aligned_cols=245 Identities=22% Similarity=0.380 Sum_probs=205.0
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|+++++||+|++|.||+|.+. ++..||+|.+.... ...+.+.+|+.+++.+ +|+||+++++.+...+..+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTL-QHDKLVRLYAVVTKEEPIYII 79 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCcEEE
Confidence 57999999999999999999964 56789999876432 2356789999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 135 MELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
|||+++++|.+++... ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++. ++|+|||++......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~---~~l~dfg~~~~~~~~ 156 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLM---CKIADFGLARVIEDN 156 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCc---EEECCCccceecCCC
Confidence 9999999999998653 45889999999999999999999999999999999999976544 899999999875433
Q ss_pred Ccc--cccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHH
Q 018640 213 EKF--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (352)
Q Consensus 213 ~~~--~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (352)
... ....++..|+|||++. +.++.++||||||+++|+|++ |..||...........+... ...+....++..+
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 233 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG---YRMPRMENCPDEL 233 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCHHH
Confidence 211 2234567899999876 458889999999999999998 99999877766655555433 2223345678999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhc
Q 018640 289 KDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 289 ~~li~~~l~~dP~~Rps~~ell~ 311 (352)
.+++.+||+.+|++||+++++.+
T Consensus 234 ~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 234 YDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHHccCCcccCcCHHHHHH
Confidence 99999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=319.94 Aligned_cols=266 Identities=28% Similarity=0.496 Sum_probs=216.0
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe-
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA- 130 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~- 130 (352)
.+.++|++...||+|++|.||+|.+..++..||+|++.... ........+.+|+.+++.+ +|+|++++.+++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHM-DHENVIGLLDVFTPASSL 89 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhc-cCCCHHHHHHHhhccccc
Confidence 46678999999999999999999999999999999886542 2223345677899999999 99999999998765554
Q ss_pred -----EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccc
Q 018640 131 -----VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (352)
Q Consensus 131 -----~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~ 205 (352)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||+
T Consensus 90 ~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~---~kL~dfg~ 164 (343)
T cd07851 90 EDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE---LKILDFGL 164 (343)
T ss_pred cccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC---EEEccccc
Confidence 89999999 6699888865 46999999999999999999999999999999999999976554 89999999
Q ss_pred ceecCCCCcccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC------
Q 018640 206 SVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR------ 277 (352)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------ 277 (352)
+...... .....++..|+|||.+.+ .++.++||||||++++++++|+.||...........+........
T Consensus 165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (343)
T cd07851 165 ARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK 242 (343)
T ss_pred ccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Confidence 9865432 234467889999998753 478899999999999999999999987766554444433221100
Q ss_pred -----------------C----CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccCCCCCC
Q 018640 278 -----------------R----DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSL 326 (352)
Q Consensus 278 -----------------~----~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~ 326 (352)
. .....+++.+.++|.+||+.+|++|||+.+|++||||.+.......++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~ 312 (343)
T cd07851 243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPV 312 (343)
T ss_pred ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCccccc
Confidence 0 001246889999999999999999999999999999998766655544
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=304.55 Aligned_cols=249 Identities=23% Similarity=0.351 Sum_probs=206.1
Q ss_pred ccceeceeeeccCceEEEEEEECCC---CcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 55 ERYELGRELGRGEFGITYLCTDREN---GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
++|++.+.||+|+||+||+|.+..+ ...||+|.+.... .......+.+|+.+++.+ +||||+++++++...+..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQF-DHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhC-CCCCcceEeEEEecCCce
Confidence 4699999999999999999998644 4579999886542 233456788899999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 132 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
+++|||+++++|.+++... ..+++..+..++.|++.||.|||+++|+|+||+|+||+++.++. ++|+|||++....
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~---~~l~dfg~~~~~~ 157 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLV---CKVSDFGLSRRLE 157 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCC---EEECccchhhccc
Confidence 9999999999999998764 46899999999999999999999999999999999999976544 8999999998764
Q ss_pred CCC-cc--cccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCC
Q 018640 211 PGE-KF--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (352)
Q Consensus 211 ~~~-~~--~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (352)
... .. ....++..|+|||.+. ..++.++||||||+++|+|++ |..||...........+.... ........+
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~ 234 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY---RLPPPMDCP 234 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCC
Confidence 211 11 1223467899999876 458999999999999999998 999998777666555554321 222334678
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 286 ENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 286 ~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
+.+.+++.+||+.+|++||++.+++++
T Consensus 235 ~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 235 SALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=302.75 Aligned_cols=242 Identities=25% Similarity=0.363 Sum_probs=198.6
Q ss_pred eeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEecCC
Q 018640 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~~ 140 (352)
+.||+|+||+||+|.+..+++.||+|.+.... .......+.+|+.+++.+ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcCCCCeEEEEeeccC
Confidence 36999999999999999899999999876431 233456789999999999 899999999999999999999999999
Q ss_pred cchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCcc---c
Q 018640 141 GELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF---S 216 (352)
Q Consensus 141 ~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~---~ 216 (352)
++|.+++.... .+++..++.++.|++.||.|||+.+++|+||+|+||+++.++. +||+|||++......... .
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~---~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNV---LKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCc---EEECccccCcccccccccccCC
Confidence 99999987644 5899999999999999999999999999999999999975544 899999998754332111 1
Q ss_pred ccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHH
Q 018640 217 EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK 294 (352)
Q Consensus 217 ~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 294 (352)
...++..|+|||.+. +.++.++||||||+++|||++ |..||...........+... .+.......+..+.+++.+
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~ 231 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG---VRLPCPELCPDAVYRLMER 231 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC---CCCCCcccCCHHHHHHHHH
Confidence 112345699999876 458999999999999999997 88998776655444433332 2223344678999999999
Q ss_pred hcCCCcCCCCCHHHHhc
Q 018640 295 MLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 295 ~l~~dP~~Rps~~ell~ 311 (352)
||+.+|++|||+.++++
T Consensus 232 ~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 232 CWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HcCCChhhCcCHHHHHH
Confidence 99999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=337.50 Aligned_cols=248 Identities=33% Similarity=0.535 Sum_probs=204.7
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeE-EEe---C--
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDT-YED---D-- 128 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~-~~~---~-- 128 (352)
-+++|.+.|.+|||+.||+|.+...|..||+|++... +....+.+.+|+.+|++|.+|+|||.+++. ... .
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 3688999999999999999999887799999988653 556678899999999999889999999993 321 1
Q ss_pred -CeEEEEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcC--CEEecCCCCceEeecCCCCCCEEEEec
Q 018640 129 -TAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHG--VMHRDLKPENFLFANKKETAPLKAIDF 203 (352)
Q Consensus 129 -~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dikp~NIll~~~~~~~~vkl~Df 203 (352)
-.++|.||||.||+|-|++..+ ..|++.++++|+.++++|+.+||... |||||||-+||||..++. +|||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~---~KLCDF 190 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN---YKLCDF 190 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC---EEeCcc
Confidence 2578999999999999999854 35999999999999999999999987 999999999999976654 899999
Q ss_pred ccceecCCCC-cc---------cccccccccccchhcc---c-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 018640 204 GLSVFFKPGE-KF---------SEIVGSPYYMAPEVLK---R-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI 269 (352)
Q Consensus 204 g~a~~~~~~~-~~---------~~~~gt~~y~aPE~~~---~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~ 269 (352)
|.++...... .. -...-|+.|+|||.+. + ..+.|+|||+|||+||-|+....||...-.. +|
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----aI 266 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----AI 266 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----eE
Confidence 9987432221 11 1124589999999864 2 4899999999999999999999999766332 34
Q ss_pred HhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcc
Q 018640 270 IRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPW 314 (352)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~ 314 (352)
.+....++ ..+.+++.+.+||..||+.||++||++.+++.+-+
T Consensus 267 lng~Y~~P--~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 267 LNGNYSFP--PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred EeccccCC--CCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 44434443 33689999999999999999999999999988633
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=308.37 Aligned_cols=253 Identities=33% Similarity=0.553 Sum_probs=207.3
Q ss_pred ceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEE
Q 018640 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (352)
Q Consensus 57 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e 136 (352)
|++.+.||+|++|+||+|.+..+++.|++|++...... .......+|+..++++.+|+|++++++++...+..++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 67889999999999999999888999999998654321 2233455799999999449999999999999999999999
Q ss_pred ecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCc
Q 018640 137 LCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (352)
Q Consensus 137 ~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (352)
|+ +++|.+.+.... .+++..+..++.|++.||.|||+++++|+||+|+||+++.++. ++|+|||++........
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~---~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV---VKIADFGLAREIRSRPP 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCC---EEEeecccceeccCCCC
Confidence 99 779999887765 6899999999999999999999999999999999999976554 89999999987655444
Q ss_pred ccccccccccccchhcc--ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC--------------
Q 018640 215 FSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR-------------- 278 (352)
Q Consensus 215 ~~~~~gt~~y~aPE~~~--~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-------------- 278 (352)
.....++..|+|||.+. ..++.++|+||||+++++|++|..||...........+.........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 45567889999999874 34789999999999999999999999766554444333322111100
Q ss_pred ------------CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 279 ------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 279 ------------~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
...+..+..+.++|.+||+.+|++|||+.|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0012236889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=344.19 Aligned_cols=248 Identities=26% Similarity=0.407 Sum_probs=213.5
Q ss_pred ccceeceeeeccCceEEEEEEECCCCc-----EEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGD-----AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 129 (352)
...++...||+|+||.||.|....... .||+|.+.+. .+.....+|.+|+.+|+.+ +|||||+++|++....
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKF-DHPNIVSLIGVCLDSG 768 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcC-CCcceeeEEEeecCCC
Confidence 457788999999999999999754333 3888888754 4566778999999999999 9999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEe
Q 018640 130 AVHLVMELCEGGELFDRIVAR-------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAID 202 (352)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~D 202 (352)
..+|++|||.||+|..+|++. ..++...+..++.+|+.|++||+++++|||||..+|+|++.. ..|||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~---r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDER---RVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeeccc---CcEEEcc
Confidence 999999999999999999875 248999999999999999999999999999999999999754 5599999
Q ss_pred cccceecCCCCccc---ccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccC
Q 018640 203 FGLSVFFKPGEKFS---EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFR 277 (352)
Q Consensus 203 fg~a~~~~~~~~~~---~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 277 (352)
||+|+.+....... ...-...|||||.+. +.++.++||||||++|||++| |..||......++........ +
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg---R 922 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG---R 922 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC---c
Confidence 99999554333221 113346899999987 679999999999999999999 999999998888877666654 5
Q ss_pred CCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 278 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
...+..+++.+.+++.+||+.+|++||++..|++
T Consensus 923 L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 923 LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred cCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 5666789999999999999999999999999987
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=303.00 Aligned_cols=243 Identities=25% Similarity=0.393 Sum_probs=207.2
Q ss_pred eeeeccCceEEEEEEECCC---CcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEe
Q 018640 61 RELGRGEFGITYLCTDREN---GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMEL 137 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~ 137 (352)
+.||+|+||.||+|.+... +..|++|.+....... ..+.+.+|+..+..+ +|+|++++++++......++||||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKL-GHPNVVRLLGVCTEEEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhc-CCCChheeeeeecCCCceEEEEEe
Confidence 4699999999999999866 8899999987653222 467899999999999 699999999999999999999999
Q ss_pred cCCcchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccccee
Q 018640 138 CEGGELFDRIVAR---------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (352)
Q Consensus 138 ~~~~sL~~~l~~~---------~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~ 208 (352)
+++++|.+++... ..+++..++.++.|++.||.+||+++++|+||+|+||+++.++. ++|+|||.+..
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~---~~l~dfg~~~~ 154 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLV---VKISDFGLSRD 154 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCc---EEEcccccccc
Confidence 9999999999875 67999999999999999999999999999999999999976644 89999999987
Q ss_pred cCCCC---cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcC
Q 018640 209 FKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (352)
Q Consensus 209 ~~~~~---~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (352)
..... ......++..|+|||.+. ..++.++||||||+++++|++ |..||...........+... ........
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~ 231 (262)
T cd00192 155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG---YRLPKPEY 231 (262)
T ss_pred cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---CCCCCCcc
Confidence 65432 223446788999999876 468999999999999999999 69999888776666555542 22333456
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 284 ~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
++.++.+++.+||+.+|++|||+.+++++
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 232 CPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 78999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=316.04 Aligned_cols=261 Identities=28% Similarity=0.498 Sum_probs=210.6
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC--
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT-- 129 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~-- 129 (352)
.+.++|++++.||+|+||.||+|.+..+|..||+|++.... ........+.+|+.+++.+ +|+||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHM-KHENVIGLLDVFTPDLSL 89 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhc-CCCCccceeeeecCCccc
Confidence 36678999999999999999999999999999999886532 2222345688899999999 9999999999987543
Q ss_pred ----eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccc
Q 018640 130 ----AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (352)
Q Consensus 130 ----~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~ 205 (352)
..++||||+ +++|.+++.. ..+++..++.++.|++.||.|||+.||+||||+|+||+++.++. ++|+|||+
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~---~kl~dfg~ 164 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE---LKILDFGL 164 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC---EEEeeccc
Confidence 458999999 6788887754 46999999999999999999999999999999999999976554 89999999
Q ss_pred ceecCCCCcccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc--------
Q 018640 206 SVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD-------- 275 (352)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-------- 275 (352)
+...... .....+++.|+|||.+.+ .++.++|+||||++++++++|..||...........+......
T Consensus 165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07880 165 ARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK 242 (343)
T ss_pred ccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 9765432 233467889999998763 4788999999999999999999999876654443333221111
Q ss_pred ---------------cCC----CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccC
Q 018640 276 ---------------FRR----DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKA 321 (352)
Q Consensus 276 ---------------~~~----~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~ 321 (352)
... ..++.++..+.++|.+||+.||++|||+.+++.||||+.....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~ 307 (343)
T cd07880 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307 (343)
T ss_pred hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence 000 1123567889999999999999999999999999999976443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=302.53 Aligned_cols=246 Identities=22% Similarity=0.309 Sum_probs=204.4
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++.+.||+|+||+||.|.+.. +..+|+|.+.... ...+.+.+|+.+++.+ +||||+++++++......+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS----MSEDEFIEEAKVMMKL-SHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc----ccHHHHHHHHHHHhcC-CCCCeeeEEEEEccCCCcEEE
Confidence 468999999999999999998753 5569999886432 2346789999999999 899999999999988899999
Q ss_pred EEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. +||+|||.+.......
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~---~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGC---VKVSDFGLSRYVLDDE 154 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCC---EEECCCccceecCCCc
Confidence 9999999999998764 36899999999999999999999999999999999999975544 8999999987654332
Q ss_pred cc--cccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHH
Q 018640 214 KF--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (352)
Q Consensus 214 ~~--~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (352)
.. ....++..|+|||.+. ..++.++||||||+++|+|++ |..||...........+.+.... ......++.+.
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 231 (256)
T cd05113 155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL---YRPHLASEKVY 231 (256)
T ss_pred eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC---CCCCCCCHHHH
Confidence 21 1224567899999986 458899999999999999998 99999877766555555443222 22335689999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcC
Q 018640 290 DLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 290 ~li~~~l~~dP~~Rps~~ell~h 312 (352)
+++.+||+.+|++||++.+++.+
T Consensus 232 ~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 232 AIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHcCCCcccCCCHHHHHHh
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=309.66 Aligned_cols=260 Identities=33% Similarity=0.565 Sum_probs=209.6
Q ss_pred cceeceeeeccCceEEEEEEEC---CCCcEEEEEEccccccCC-hhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 56 RYELGRELGRGEFGITYLCTDR---ENGDAFACKSISKKKLRT-AVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
+|++.+.||+|++|.||++.+. .+++.||+|++....... ....+.+.+|+.++.++.+||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999864 467899999987543221 223456888999999997799999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
++||||+++++|.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~---~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGH---VVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC---EEEEECcccccccc
Confidence 999999999999999987778999999999999999999999999999999999999976544 89999999876543
Q ss_pred CCc--ccccccccccccchhcccc---CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCH
Q 018640 212 GEK--FSEIVGSPYYMAPEVLKRN---YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (352)
Q Consensus 212 ~~~--~~~~~gt~~y~aPE~~~~~---~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (352)
... .....|+..|+|||.+.+. .+.++|+||||+++++|++|..||...........+.+............++.
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSA 237 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCH
Confidence 322 1234688999999987532 68899999999999999999999954322211222222222222333456789
Q ss_pred HHHHHHHHhcCCCcCCCCC---HHHHhcCcccccc
Q 018640 287 NAKDLVRKMLDPDPKRRLT---AQQVLEHPWLQNA 318 (352)
Q Consensus 287 ~~~~li~~~l~~dP~~Rps---~~ell~hp~f~~~ 318 (352)
.+.+++.+||+.||++||| +.++++||||+..
T Consensus 238 ~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 238 EARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred HHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 9999999999999999998 5677999999875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=308.96 Aligned_cols=256 Identities=31% Similarity=0.539 Sum_probs=212.2
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
.|.....||+|+||.||++....+|+.||+|++... .....+.+.+|+.+++.+ +|+|++++++.+...+..++||
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 96 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVVM 96 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhc-CCcchhheeeEEEeCCEEEEEE
Confidence 344557899999999999999999999999987543 223456788999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC-c
Q 018640 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-K 214 (352)
Q Consensus 136 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-~ 214 (352)
||+++++|.+++.. ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++....... .
T Consensus 97 e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~---~~l~dfg~~~~~~~~~~~ 172 (292)
T cd06657 97 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR---VKLSDFGFCAQVSKEVPR 172 (292)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC---EEEcccccceeccccccc
Confidence 99999999987754 46899999999999999999999999999999999999976544 8999999887654322 2
Q ss_pred ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHH
Q 018640 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (352)
Q Consensus 215 ~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 293 (352)
.....|+..|+|||.+. ..++.++|+||||+++|+|++|..||...........+..... ........++..+.+++.
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~ 251 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PKLKNLHKVSPSLKGFLD 251 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC-cccCCcccCCHHHHHHHH
Confidence 23356889999999876 4578999999999999999999999987665544444433221 112223457899999999
Q ss_pred HhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 294 KMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 294 ~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
+||+.+|.+||++.+++.||||.....
T Consensus 252 ~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 252 RLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred HHHhCCcccCcCHHHHhcChHHhccCC
Confidence 999999999999999999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=302.23 Aligned_cols=241 Identities=24% Similarity=0.321 Sum_probs=197.6
Q ss_pred eeeccCceEEEEEEE--CCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEecC
Q 018640 62 ELGRGEFGITYLCTD--RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCE 139 (352)
Q Consensus 62 ~lG~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~ 139 (352)
+||+|+||.||+|.+ ..++..+|+|++.... ......+.+.+|+.+++.+ +|+||+++++++.. +..++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQL-DNPYIVRMIGICEA-ESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcC-CCcEEEEecCC
Confidence 689999999999965 4568899999886543 2333456789999999999 89999999998764 46789999999
Q ss_pred CcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCc----c
Q 018640 140 GGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK----F 215 (352)
Q Consensus 140 ~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~----~ 215 (352)
+++|.+++.....+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++........ .
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~---~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH---YAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCC---eEEECCCccccccCCCCCeeeec
Confidence 999999998877899999999999999999999999999999999999997654 489999999976543322 1
Q ss_pred cccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHH
Q 018640 216 SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (352)
Q Consensus 216 ~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 293 (352)
....++..|+|||.+. ..++.++|+||||+++|||++ |..||...........+.+.. ....+..+++++.++|.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~---~~~~~~~~~~~l~~li~ 232 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE---RMECPQRCPPEMYDLMK 232 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC---CCCCCCCCCHHHHHHHH
Confidence 2223457899999876 458889999999999999998 999998776655544443321 22334568999999999
Q ss_pred HhcCCCcCCCCCHHHHhc
Q 018640 294 KMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 294 ~~l~~dP~~Rps~~ell~ 311 (352)
+||+.||++||++.+|..
T Consensus 233 ~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 233 LCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHhccCchhCcCHHHHHH
Confidence 999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=345.47 Aligned_cols=258 Identities=32% Similarity=0.519 Sum_probs=225.0
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
.++|.|+++||+|+||.|.+++.+.+++.||.|++.+.......+-.-|..|-.+|..- +.+-|+++...|+++.++|+
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHhcCccceEE
Confidence 46799999999999999999999999999999999886554444556788899999876 89999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
||||++||+|..++....++++..++.++..|+.||..||+.|+|||||||+|||++..|+ +||+|||.+-.+..+.
T Consensus 153 VMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GH---ikLADFGsClkm~~dG 229 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGH---IKLADFGSCLKMDADG 229 (1317)
T ss_pred EEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCc---EeeccchhHHhcCCCC
Confidence 9999999999999999889999999999999999999999999999999999999976555 9999999887665333
Q ss_pred --cccccccccccccchhcc------ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--ccccCCCCCcC
Q 018640 214 --KFSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS--VLDFRRDPWPK 283 (352)
Q Consensus 214 --~~~~~~gt~~y~aPE~~~------~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 283 (352)
.....+|||.|.+||++. +.|+...|.||+|+++|||+.|..||+...-.+..-.+.+- ...++ ....
T Consensus 230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP--~~~~ 307 (1317)
T KOG0612|consen 230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP--DETD 307 (1317)
T ss_pred cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC--cccc
Confidence 235669999999999874 34899999999999999999999999988877777776655 34444 2345
Q ss_pred CCHHHHHHHHHhcCCCcCCCCC---HHHHhcCcccccc
Q 018640 284 VSENAKDLVRKMLDPDPKRRLT---AQQVLEHPWLQNA 318 (352)
Q Consensus 284 ~~~~~~~li~~~l~~dP~~Rps---~~ell~hp~f~~~ 318 (352)
+|+++.+||.+++.. |+.|.. +.++-+||||.+.
T Consensus 308 VSeeakdLI~~ll~~-~e~RLgrngiedik~HpFF~g~ 344 (1317)
T KOG0612|consen 308 VSEEAKDLIEALLCD-REVRLGRNGIEDIKNHPFFEGI 344 (1317)
T ss_pred cCHHHHHHHHHHhcC-hhhhcccccHHHHHhCccccCC
Confidence 999999999999875 688887 9999999999864
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=317.44 Aligned_cols=257 Identities=17% Similarity=0.275 Sum_probs=202.1
Q ss_pred eeeecc--CceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEec
Q 018640 61 RELGRG--EFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELC 138 (352)
Q Consensus 61 ~~lG~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~ 138 (352)
..||+| +||+||++.+..+|+.||+|++..... .....+.+.+|+.+++.+ +||||+++++++..++..++|+||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFF-RHPNIMTSWTVFTTGSWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhC-CCCCcceEeeeEecCCceEEEEecc
Confidence 457777 999999999999999999999875432 223457788999999999 8999999999999999999999999
Q ss_pred CCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCc--
Q 018640 139 EGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK-- 214 (352)
Q Consensus 139 ~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~-- 214 (352)
++++|.+++.... .+++..+..++.|++.||+|||+.+++||||||+||+++.++. ++++||+.+........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~---~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGL---VSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCc---EEEechHHHhhhhccCccc
Confidence 9999999887643 4899999999999999999999999999999999999976544 89999985533211110
Q ss_pred ------ccccccccccccchhccc---cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc----------
Q 018640 215 ------FSEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD---------- 275 (352)
Q Consensus 215 ------~~~~~gt~~y~aPE~~~~---~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~---------- 275 (352)
.....++..|+|||++.+ .++.++||||||+++++|++|..||..................
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 011234667999999764 3688999999999999999999999776544333222221100
Q ss_pred ---------------------------------cCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccCC
Q 018640 276 ---------------------------------FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAP 322 (352)
Q Consensus 276 ---------------------------------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~ 322 (352)
........+++.+.+|+.+||+.||++|||+.++++||||.+..+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~~ 318 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQT 318 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHhc
Confidence 00001123567889999999999999999999999999999876653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=307.40 Aligned_cols=253 Identities=32% Similarity=0.548 Sum_probs=209.1
Q ss_pred ceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEE
Q 018640 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (352)
Q Consensus 57 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e 136 (352)
|++.+.||+|++|.||+|.+..+|+.+++|.+...... ......+.+|+.+++++ +|+||+++++++...+..++|+|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKEL-NHPNIIKLLDVFRHKGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHh-cCCCcchHHHhhccCCCEEEEEe
Confidence 67789999999999999999889999999998765332 23456788899999999 79999999999999999999999
Q ss_pred ecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC-c
Q 018640 137 LCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-K 214 (352)
Q Consensus 137 ~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-~ 214 (352)
|+++ +|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||.+....... .
T Consensus 79 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~---~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 79 FMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGV---LKLADFGLARSFGSPVRP 154 (283)
T ss_pred ccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCc---EEEeeeeeeEecCCCccc
Confidence 9975 888888664 57899999999999999999999999999999999999975544 8999999997665433 2
Q ss_pred ccccccccccccchhcc-c-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC--------------
Q 018640 215 FSEIVGSPYYMAPEVLK-R-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR-------------- 278 (352)
Q Consensus 215 ~~~~~gt~~y~aPE~~~-~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-------------- 278 (352)
.....++..|+|||.+. . .++.++|+||||+++|+|++|+.||......+....+.........
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 33446788999999875 3 5888999999999999999999999777665544444332211100
Q ss_pred ------------CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 279 ------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 279 ------------~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
...+.++..+.++|.+||++||.+||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0112467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=307.69 Aligned_cols=249 Identities=22% Similarity=0.348 Sum_probs=204.1
Q ss_pred ccceeceeeeccCceEEEEEEECC-----CCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC
Q 018640 55 ERYELGRELGRGEFGITYLCTDRE-----NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 129 (352)
.+|++.+.||+|+||.||+|.+.. .+..||+|++.... .....+.+.+|+.++..+ +||||+++++++...+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRL-QHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcCCC
Confidence 358899999999999999998754 35789999987542 222346788999999999 8999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCC
Q 018640 130 AVHLVMELCEGGELFDRIVAR----------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK 193 (352)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~ 193 (352)
..++++||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 999999999999999998532 2478888999999999999999999999999999999997544
Q ss_pred CCCCEEEEecccceecCCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 018640 194 ETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQA 268 (352)
Q Consensus 194 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~ 268 (352)
. +||+|||+++....... .....+++.|+|||.+. +.++.++||||||+++|||++ |..||......+....
T Consensus 162 ~---~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05091 162 N---VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238 (283)
T ss_pred c---eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 4 89999999876533221 12335678899999875 568999999999999999998 8889887776655555
Q ss_pred HHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 269 IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
+.+... ......+++.+.+++.+||+.+|++||++.+|+..
T Consensus 239 i~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 239 IRNRQV---LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHcCCc---CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 544322 22234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=301.26 Aligned_cols=251 Identities=28% Similarity=0.473 Sum_probs=212.3
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
+|++.+.||+|+||.||++.+..+++.+|+|.+...... ......+.+|+.+++.+ +|+||+++.+++......++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASV-NHPNIISYKEAFLDGNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhC-CCCCchhhhhhhccCCEEEEEe
Confidence 488999999999999999999999999999998765432 23456778899999999 7999999999999999999999
Q ss_pred EecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 136 ELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 136 e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~---~kl~d~g~~~~~~~ 155 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDL---VKIGDLGISKVLKK 155 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCc---EEEeeccchhhhcc
Confidence 99999999998866 346899999999999999999999999999999999999986444 89999999977654
Q ss_pred CCcccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHH
Q 018640 212 GEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (352)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (352)
. ......++..|+|||.+.+ .++.++|+||||+++++|++|+.||...........+.... .......++.++.+
T Consensus 156 ~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 231 (256)
T cd08530 156 N-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK---YPPIPPIYSQDLQN 231 (256)
T ss_pred C-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---CCCCchhhCHHHHH
Confidence 4 2233468889999998764 47889999999999999999999998777654444433221 12222367899999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 291 LVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 291 li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
++.+||+.+|++||++.++++||++
T Consensus 232 li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 232 FIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=304.69 Aligned_cols=249 Identities=24% Similarity=0.332 Sum_probs=204.9
Q ss_pred cccceeceeeeccCceEEEEEEECCC-----CcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC
Q 018640 54 EERYELGRELGRGEFGITYLCTDREN-----GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 128 (352)
.++|++.+.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+++.+ +|+||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~ 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEF-NCHHVVRLLGVVSTG 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhC-CCCceeEEEEEEcCC
Confidence 46799999999999999999997643 4789999976432 223345788899999999 899999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCE
Q 018640 129 TAVHLVMELCEGGELFDRIVARG----------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPL 198 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~----------~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~v 198 (352)
...++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+++|+||||+||+++.++. +
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~---~ 158 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT---V 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCC---E
Confidence 99999999999999999986432 3678899999999999999999999999999999999976554 8
Q ss_pred EEEecccceecCCCC---cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 018640 199 KAIDFGLSVFFKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSV 273 (352)
Q Consensus 199 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 273 (352)
||+|||+++...... ......++..|+|||.+. +.++.++||||||+++||+++ |..||...........+...
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~- 237 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG- 237 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC-
Confidence 999999987653322 112335678899999876 558999999999999999998 99999877766655544422
Q ss_pred cccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 274 LDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 274 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
.....+...+..+.+++.+||+.+|++|||+.++++
T Consensus 238 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 238 --GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 122233457899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=276.11 Aligned_cols=258 Identities=30% Similarity=0.554 Sum_probs=219.4
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
.|.-.++||+|.||+||+|++.++++.||+|.++........ .....+|+-+++.+ +|.|||+++++.-.+...-+|+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegv-pssalreicllkel-khknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGV-PSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCC-cHHHHHHHHHHHHh-hhcceeehhhhhccCceeEEeH
Confidence 467778999999999999999999999999999876543332 34567799999999 9999999999999999999999
Q ss_pred EecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCc
Q 018640 136 ELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (352)
Q Consensus 136 e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (352)
|||.. +|..+... ++.+..+.++.++.|++.||.++|+.+++|||+||.|.|++.+++ +|++|||+++...-.-.
T Consensus 81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~nge---lkladfglarafgipvr 156 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGE---LKLADFGLARAFGIPVR 156 (292)
T ss_pred HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCc---EEecccchhhhcCCceE
Confidence 99954 78777765 456899999999999999999999999999999999999987766 89999999997654433
Q ss_pred c-cccccccccccchhccc--cCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcC-------
Q 018640 215 F-SEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPK------- 283 (352)
Q Consensus 215 ~-~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 283 (352)
+ +..+-|.+|++|.++-+ -|++..|+||.||++.|+.. |++.|.+..-.+++.++.........+.|+.
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence 2 44567999999998754 39999999999999999987 8888988888888888888776655444442
Q ss_pred ------------------CCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 284 ------------------VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 284 ------------------~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
+...-++++..+|.-+|.+|.+++++++||||.+..
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s 290 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS 290 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence 234457999999999999999999999999999753
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=307.52 Aligned_cols=247 Identities=24% Similarity=0.379 Sum_probs=203.5
Q ss_pred ccceeceeeeccCceEEEEEEEC-----CCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC
Q 018640 55 ERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 129 (352)
.+|.+.+.||+|+||.||+|.+. .++..+++|.+... .....+.+.+|+.+++++ +|+||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNL-QHEHIVKFYGVCGDGD 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCC
Confidence 46899999999999999999853 34567899987643 223346788999999999 8999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCC
Q 018640 130 AVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK 193 (352)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~ 193 (352)
..++||||+++++|.+++.... .+++..++.++.||+.||.|||+++++||||||+||+++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 9999999999999999997532 378999999999999999999999999999999999997654
Q ss_pred CCCCEEEEecccceecCCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 018640 194 ETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQA 268 (352)
Q Consensus 194 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~ 268 (352)
.++|+|||++........ .....++..|+|||++. ..++.++||||||+++|||++ |..||...........
T Consensus 161 ---~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 237 (291)
T cd05094 161 ---LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237 (291)
T ss_pred ---cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 489999999976533221 23345678899999876 458899999999999999999 9999987776655554
Q ss_pred HHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 269 IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
+..... .......+..+.+++.+||+.+|++|||+.++++
T Consensus 238 ~~~~~~---~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 238 ITQGRV---LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HhCCCC---CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 433221 1223457889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=308.32 Aligned_cols=253 Identities=25% Similarity=0.373 Sum_probs=206.6
Q ss_pred cccccceeceeeeccCceEEEEEEECCC-----CcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDREN-----GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~ 126 (352)
...++|++.+.||+|+||.||++.+... ...+|+|.+.... .......+.+|+.+++++.+|+||+++++++.
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 3456799999999999999999987643 3689999887532 22334568899999999977999999999999
Q ss_pred eCCeEEEEEEecCCcchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEee
Q 018640 127 DDTAVHLVMELCEGGELFDRIVAR----------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFA 190 (352)
Q Consensus 127 ~~~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~ 190 (352)
..+..+++|||+++++|.+++... ..+++..+..++.|++.||+|||+.+|+|+||||+||+++
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT 166 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence 999999999999999999998642 3588999999999999999999999999999999999997
Q ss_pred cCCCCCCEEEEecccceecCCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 018640 191 NKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGV 265 (352)
Q Consensus 191 ~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~ 265 (352)
.++ .++|+|||+++....... .....++..|+|||.+. ..++.++||||||+++||+++ |..||......+.
T Consensus 167 ~~~---~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 243 (293)
T cd05053 167 EDH---VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 243 (293)
T ss_pred CCC---eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence 554 489999999986543321 12223467899999875 558999999999999999997 9999987776655
Q ss_pred HHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 266 AQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
...+.... ........+..+.+|+.+||+.||++|||+.+++++
T Consensus 244 ~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 244 FKLLKEGY---RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHcCC---cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 54443322 222334678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=303.42 Aligned_cols=247 Identities=22% Similarity=0.351 Sum_probs=207.8
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
..+|++.+.||.|+||.||+|.+.. +..+|+|++.... ......+.+|+.+++.+ +|+||+++++++......++
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRL-RHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcC-CCcchhheeeeEecCCCeEE
Confidence 4579999999999999999999876 8999999987542 22356788999999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 134 VMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
||||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~---~kl~d~g~~~~~~~ 156 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLV---CKVADFGLARLIKE 156 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCce---EEEccccchhhcCC
Confidence 99999999999999753 35899999999999999999999999999999999999976554 89999999976543
Q ss_pred CCc-ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHH
Q 018640 212 GEK-FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (352)
Q Consensus 212 ~~~-~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (352)
... .....++..|+|||.+. +.++.++||||||+++++|++ |+.||......+....+... ........+++.+
T Consensus 157 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 233 (261)
T cd05148 157 DVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG---YRMPCPAKCPQEI 233 (261)
T ss_pred ccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhC---CcCCCCCCCCHHH
Confidence 221 12334567899999876 458899999999999999998 89999877766665555432 2233345788999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhc
Q 018640 289 KDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 289 ~~li~~~l~~dP~~Rps~~ell~ 311 (352)
.++|.+||+.||++|||+.++++
T Consensus 234 ~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 234 YKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=304.41 Aligned_cols=248 Identities=21% Similarity=0.271 Sum_probs=201.3
Q ss_pred cccceeceeeeccCceEEEEEEECCCCc----EEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGD----AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 129 (352)
.++|++++.||+|+||+||+|.+..+|. .||+|++.... .......+.+|+.+++.+ +|+||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~- 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGV-GSPYVCRLLGICLTS- 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhc-CCCCCceEEEEEcCC-
Confidence 3579999999999999999999877776 47999886432 233456788999999999 899999999998754
Q ss_pred eEEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccccee
Q 018640 130 AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (352)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~ 208 (352)
..++++||+++|+|.+++... ..+++..+..++.|++.||.|||+++++||||||+||++++++. +||+|||+++.
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~---~kL~dfG~~~~ 158 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH---VKITDFGLARL 158 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc---EEECCCCceee
Confidence 567899999999999999764 46899999999999999999999999999999999999975444 89999999987
Q ss_pred cCCCCcc---cccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcC
Q 018640 209 FKPGEKF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (352)
Q Consensus 209 ~~~~~~~---~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (352)
....... ....++..|+|||.+. ..++.++||||||+++|||++ |..||...........+ .... .......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~--~~~~~~~ 235 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL-EKGE--RLPQPPI 235 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCC--cCCCCcc
Confidence 6433221 1223467899999876 558999999999999999998 89998766655443333 2221 2223346
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 284 VSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 284 ~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
.+.++.+++.+||+.||++||++.+++.
T Consensus 236 ~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 236 CTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 7899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=308.73 Aligned_cols=252 Identities=24% Similarity=0.369 Sum_probs=204.6
Q ss_pred ccccceeceeeeccCceEEEEEEECC-------CCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRE-------NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTY 125 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~ 125 (352)
..++|.+.+.||+|+||.||+|.+.. ++..+|+|.+.... .......+.+|+.+++.+.+|+||+++++++
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 34679999999999999999998643 23579999887542 2334567888999999997899999999999
Q ss_pred EeCCeEEEEEEecCCcchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEe
Q 018640 126 EDDTAVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLF 189 (352)
Q Consensus 126 ~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll 189 (352)
...+..++||||+++++|.+++.... .+++..+..++.|++.||+|||+.|++||||||+||++
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 173 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 173 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE
Confidence 99999999999999999999997542 37889999999999999999999999999999999999
Q ss_pred ecCCCCCCEEEEecccceecCCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 018640 190 ANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQG 264 (352)
Q Consensus 190 ~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~ 264 (352)
+.++ .++|+|||++........ .....++..|+|||++. ..++.++||||||+++|||++ |..||......+
T Consensus 174 ~~~~---~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~ 250 (307)
T cd05098 174 TEDN---VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250 (307)
T ss_pred cCCC---cEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 7554 489999999876532211 11223456899999876 458999999999999999998 889998776655
Q ss_pred HHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 265 VAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
....+... .....+...+.++.+++.+||+.+|++|||+.+++++
T Consensus 251 ~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 251 LFKLLKEG---HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHcC---CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 44444332 1223345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=301.60 Aligned_cols=246 Identities=22% Similarity=0.364 Sum_probs=203.1
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
.+|++.+.||+|+||.||+|.+. ++..+|+|.+.... ...+.+.+|+.+++.+ +|+||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA----MSEDDFIEEAKVMMKL-SHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC----CCHHHHHHHHHHHHhC-CCCCEEEEEEEEcCCCceEEE
Confidence 35889999999999999999875 46789999876432 2345688899999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++. +||+|||+++......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~---~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNV---VKVSDFGLARYVLDDQ 154 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCc---EEECCcccceeccccc
Confidence 9999999999999764 46899999999999999999999999999999999999976554 8999999997654322
Q ss_pred cc--cccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHH
Q 018640 214 KF--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (352)
Q Consensus 214 ~~--~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (352)
.. ....++..|+|||.+. ..++.++|+||||+++|++++ |..||......+....+... .........+..+.
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 231 (256)
T cd05059 155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG---YRLYRPKLAPTEVY 231 (256)
T ss_pred ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC---CcCCCCCCCCHHHH
Confidence 21 1122345799999876 558999999999999999999 89999776665555444332 22233345799999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcC
Q 018640 290 DLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 290 ~li~~~l~~dP~~Rps~~ell~h 312 (352)
+++.+||+.+|++|||+.++++.
T Consensus 232 ~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 232 TIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHHH
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=300.24 Aligned_cols=246 Identities=23% Similarity=0.316 Sum_probs=204.4
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
.++|++.+.||+|++|.||+|.+. +++.||+|.+.... ...+.+.+|+.+++++ +|+||+++++++...+..++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT----MDPKDFLAEAQIMKKL-RHPKLIQLYAVCTLEEPIYI 78 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc----ccHHHHHHHHHHHHHC-CCCCccceeEEEecCCCeee
Confidence 357999999999999999999975 46789999986542 2346788999999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 134 VMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
+|||+++++|.+++.... .+++..+..++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++.....
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~~l~dfg~~~~~~~ 155 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNI---CKVADFGLARVIKE 155 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCC---EEECCcceEEEccC
Confidence 999999999999997654 6899999999999999999999999999999999999976554 89999999987643
Q ss_pred CCcc--cccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHH
Q 018640 212 GEKF--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (352)
Q Consensus 212 ~~~~--~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (352)
.... .....+..|+|||.+. ..++.++||||||++++||++ |+.||...........+... .........++.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 232 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG---YRMPCPPGCPKE 232 (261)
T ss_pred CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---CCCCCCCcCCHH
Confidence 2211 1112345799999876 458999999999999999999 99999877666555544332 122333467899
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 288 AKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 288 ~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
+.+++.+||+.+|++||++.+++.
T Consensus 233 ~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 233 LYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHHHhhcCcccCCCHHHHHH
Confidence 999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=303.59 Aligned_cols=243 Identities=23% Similarity=0.320 Sum_probs=196.5
Q ss_pred eeeeccCceEEEEEEECCCCcE--EEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEec
Q 018640 61 RELGRGEFGITYLCTDRENGDA--FACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELC 138 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~ 138 (352)
++||+|+||.||+|.+.+++.. +++|.+... ......+.+.+|+.++.++.+||||+++++++...+..+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 3689999999999999887764 588877532 223345678899999999988999999999999999999999999
Q ss_pred CCcchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEe
Q 018640 139 EGGELFDRIVARG----------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAID 202 (352)
Q Consensus 139 ~~~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~D 202 (352)
++++|.+++.... .+++..+..++.|++.||+|||+.|++|+||||+||+++.++. +||+|
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~---~kl~d 155 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV---AKIAD 155 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCe---EEECC
Confidence 9999999987532 3789999999999999999999999999999999999975544 89999
Q ss_pred cccceecCCCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCC
Q 018640 203 FGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDP 280 (352)
Q Consensus 203 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 280 (352)
||++..............+..|+|||++. ..++.++||||||++++||++ |..||...........+... .....
T Consensus 156 fgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~---~~~~~ 232 (270)
T cd05047 156 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YRLEK 232 (270)
T ss_pred CCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC---CCCCC
Confidence 99986432211112223456799999876 458899999999999999997 99999877665555444332 12223
Q ss_pred CcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 281 ~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
....+.++.+++.+||+.+|.+|||+.+++.
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 233 PLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 3457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=307.42 Aligned_cols=253 Identities=24% Similarity=0.354 Sum_probs=205.3
Q ss_pred cccccceeceeeeccCceEEEEEEE-----CCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTD-----RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~ 126 (352)
...++|.+.+.||+|+||.||++.+ ..++..||+|.+.... .....+.+.+|+.+++++.+|+||+++++++.
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 109 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACT 109 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence 4456899999999999999999975 2345689999886542 22335678999999999977999999999999
Q ss_pred eCCeEEEEEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecc
Q 018640 127 DDTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (352)
Q Consensus 127 ~~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg 204 (352)
..+..+++|||+++++|.+++.... .+++.++..++.|++.||.|||+++++|+||||+||+++.+. .++|+|||
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~---~~~l~dfg 186 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK---IVKICDFG 186 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC---eEEECCCc
Confidence 9999999999999999999997543 389999999999999999999999999999999999997544 48999999
Q ss_pred cceecCCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCC
Q 018640 205 LSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRD 279 (352)
Q Consensus 205 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 279 (352)
++........ .....++..|+|||.+. +.++.++||||||+++|+|++ |..||................ ....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~--~~~~ 264 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG--YRMA 264 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcC--CcCC
Confidence 9976533221 12234577899999876 458999999999999999998 999997766544443433322 1222
Q ss_pred CCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 280 PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 280 ~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
.....++.+.+++.+||+++|++|||+.+++.
T Consensus 265 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 265 QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 23456899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=310.43 Aligned_cols=256 Identities=27% Similarity=0.436 Sum_probs=203.3
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC-----
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD----- 128 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~----- 128 (352)
.++|++.+.||+|+||.||+|.+..+++.||+|++........ ....+.+|+++++.+ +|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKL-KHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhc-CCCCccchhhheeccccccc
Confidence 4689999999999999999999999999999998865432222 223567899999999 899999999987543
Q ss_pred ---CeEEEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecc
Q 018640 129 ---TAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (352)
Q Consensus 129 ---~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg 204 (352)
...++|+||+.+ +|...+.. ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~---~~l~dfg 160 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI---LKIADFG 160 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC---EEECcCc
Confidence 346999999965 67776654 346999999999999999999999999999999999999976554 8999999
Q ss_pred cceecCCCCc------------ccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 018640 205 LSVFFKPGEK------------FSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII 270 (352)
Q Consensus 205 ~a~~~~~~~~------------~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~ 270 (352)
++........ .....+++.|+|||.+.+ .++.++||||||++++||++|+.||...........+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9975532211 123356888999998753 47889999999999999999999998776655444433
Q ss_pred hcccccCCC--------------------------CCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 271 RSVLDFRRD--------------------------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 271 ~~~~~~~~~--------------------------~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
.......+. ....+++.+.++|.+||+.||.+|||+.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 321111000 012345788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=307.37 Aligned_cols=251 Identities=23% Similarity=0.310 Sum_probs=200.7
Q ss_pred ccceeceeeeccCceEEEEEEECCCC--------------cEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENG--------------DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~--------------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~ 120 (352)
++|++.+.||+|+||.||+|.+..++ ..||+|.+.... .....+.+.+|+++++++ +|+|+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l-~h~~i~~ 81 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRL-KNPNIIR 81 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhC-CCCCcCe
Confidence 57999999999999999999875432 358999886532 233456789999999999 8999999
Q ss_pred eeeEEEeCCeEEEEEEecCCcchHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceE
Q 018640 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARG------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFL 188 (352)
Q Consensus 121 l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIl 188 (352)
+++++...+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+++|+||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999999986532 3678899999999999999999999999999999999
Q ss_pred eecCCCCCCEEEEecccceecCCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh--CCCCCCCCCH
Q 018640 189 FANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC--GVPPFWAETE 262 (352)
Q Consensus 189 l~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t--g~~p~~~~~~ 262 (352)
++.++. +||+|||++........ .....++..|+|||.+. +.++.++||||||+++++|++ +..||.....
T Consensus 162 l~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~ 238 (295)
T cd05097 162 VGNHYT---IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238 (295)
T ss_pred EcCCCc---EEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence 975544 89999999976533221 12234567899999875 568999999999999999988 6778876665
Q ss_pred HHHHHHHHhccc----ccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 263 QGVAQAIIRSVL----DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 263 ~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
............ .......+..++.+.+|+.+||+.||++|||+.+|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 239 EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 554443322111 1112223457899999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=303.10 Aligned_cols=248 Identities=21% Similarity=0.310 Sum_probs=200.6
Q ss_pred ceeceeeeccCceEEEEEEECCC---CcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe---
Q 018640 57 YELGRELGRGEFGITYLCTDREN---GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA--- 130 (352)
Q Consensus 57 y~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~--- 130 (352)
|++.+.||+|+||.||.|.+..+ +..||+|.+.... ......+.+.+|+..++.+ +|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI-HTYSEIEEFLSEAACMKDF-DHPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc-CCHHHHHHHHHHHHHHHhC-CCCCeeeEEeeeccCCcccc
Confidence 57889999999999999997653 4789999987542 2334456789999999999 89999999998865443
Q ss_pred ---EEEEEEecCCcchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEE
Q 018640 131 ---VHLVMELCEGGELFDRIVAR------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAI 201 (352)
Q Consensus 131 ---~~lv~e~~~~~sL~~~l~~~------~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~ 201 (352)
.++++||+++++|..++... ..+++..+..++.|++.||.|||+.+++||||||+||+++.++. +||+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~---~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMT---VCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCe---EEEC
Confidence 79999999999999888432 25899999999999999999999999999999999999975543 8999
Q ss_pred ecccceecCCCCcc---cccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccc
Q 018640 202 DFGLSVFFKPGEKF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDF 276 (352)
Q Consensus 202 Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 276 (352)
|||+++........ ....++..|+|||.+. ..++.++||||||+++|||++ |..||...........+....
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--- 232 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN--- 232 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---
Confidence 99999865433211 1223467899999876 458999999999999999999 889997776665554444322
Q ss_pred CCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 277 RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 277 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
........+..+.+++.+||+.||++|||+.+++.+
T Consensus 233 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 233 RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 222334678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=314.31 Aligned_cols=261 Identities=29% Similarity=0.486 Sum_probs=208.1
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC---
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--- 128 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~--- 128 (352)
.+.++|.+.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+.+|+.++.++ +|+||+++.+++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l-~h~~iv~~~~~~~~~~~~ 91 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSL 91 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHHHHHHc-CCCcccceeeeeeecccc
Confidence 45678999999999999999999999999999999987542 1222345678899999999 899999999987543
Q ss_pred ---CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccc
Q 018640 129 ---TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (352)
Q Consensus 129 ---~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~ 205 (352)
...+++++++ +++|.+++... .+++..+..++.|++.||.|||+.+++||||||+||+++.++. ++|+|||+
T Consensus 92 ~~~~~~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~---~kl~dfg~ 166 (345)
T cd07877 92 EEFNDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGL 166 (345)
T ss_pred cccccEEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCC---EEEecccc
Confidence 3467888887 77998877543 6999999999999999999999999999999999999976554 89999999
Q ss_pred ceecCCCCcccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc---------
Q 018640 206 SVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL--------- 274 (352)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~--------- 274 (352)
+..... ......++..|+|||.+.+ .++.++||||||+++++|++|+.||...........+.....
T Consensus 167 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T cd07877 167 ARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 244 (345)
T ss_pred cccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 876432 2234578899999998754 478899999999999999999999976654443332222111
Q ss_pred --------------ccCC----CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccC
Q 018640 275 --------------DFRR----DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKA 321 (352)
Q Consensus 275 --------------~~~~----~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~ 321 (352)
..+. ......+..+.++|.+||+.||++||++.++++||||.+....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~ 309 (345)
T cd07877 245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 309 (345)
T ss_pred cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCC
Confidence 0000 0012357889999999999999999999999999999976443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=314.82 Aligned_cols=259 Identities=29% Similarity=0.514 Sum_probs=206.9
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC----
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD---- 128 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~---- 128 (352)
+.++|.+.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.+ +|+||+++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 90 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHM-QHENVIGLLDVFTSAVSGD 90 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhc-CCCCccchhheecccccCC
Confidence 45689999999999999999999998999999999865422 222335678899999999 899999999998654
Q ss_pred --CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccc
Q 018640 129 --TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (352)
Q Consensus 129 --~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a 206 (352)
...++|+||+.. +|..++. ..+++..+..++.|++.||.|||+.+++||||+|+||+++.++. ++|+|||++
T Consensus 91 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~---~kL~dfg~~ 164 (342)
T cd07879 91 EFQDFYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCE---LKILDFGLA 164 (342)
T ss_pred CCceEEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC---EEEeeCCCC
Confidence 246899999964 7766652 36899999999999999999999999999999999999976554 899999998
Q ss_pred eecCCCCcccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc----------
Q 018640 207 VFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL---------- 274 (352)
Q Consensus 207 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~---------- 274 (352)
..... ......++..|+|||.+.+ .++.++||||||++++||++|+.||...........+.....
T Consensus 165 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07879 165 RHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL 242 (342)
T ss_pred cCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 76432 2234467889999998754 478899999999999999999999987665444333322110
Q ss_pred -------------ccCCC----CCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccC
Q 018640 275 -------------DFRRD----PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKA 321 (352)
Q Consensus 275 -------------~~~~~----~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~ 321 (352)
..... .++..+..+.++|.+||+.||++||++.+++.||||......
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 00000 123467889999999999999999999999999999977543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=310.68 Aligned_cols=267 Identities=31% Similarity=0.505 Sum_probs=212.7
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe-CCe
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED-DTA 130 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~-~~~ 130 (352)
.+.++|++++.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.++..+ +||||+++.+++.. ...
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF-STPVLAKRTYRELKLLKHL-RHENIISLSDIFISPLED 84 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc-cccchhHHHHHHHHHHHhc-CCCCeeeEeeeEecCCCc
Confidence 46788999999999999999999999999999999886542 2223346678899999999 89999999999865 567
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
.++++||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .++|+|||++....
T Consensus 85 ~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~---~~~l~dfg~~~~~~ 159 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENC---DLKICDFGLARIQD 159 (328)
T ss_pred EEEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCC---CEEeCccccccccC
Confidence 89999999 5688887764 3688899999999999999999999999999999999997544 48999999987543
Q ss_pred CCCcccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc-------------
Q 018640 211 PGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD------------- 275 (352)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~------------- 275 (352)
. ......++..|+|||.+.+ .++.++||||||+++++|++|..||...........+.+....
T Consensus 160 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd07856 160 P--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN 237 (328)
T ss_pred C--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchh
Confidence 2 2234467889999998753 4889999999999999999999999766543322221111100
Q ss_pred -------c---CC----CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccCCCCCCc
Q 018640 276 -------F---RR----DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLG 327 (352)
Q Consensus 276 -------~---~~----~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~ 327 (352)
. .. ...+.+++.+.++|.+||+.+|++||++.+++.||||......+....+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~~~ 303 (328)
T cd07856 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPVA 303 (328)
T ss_pred hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccccCc
Confidence 0 00 1123567899999999999999999999999999999877665444444
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=304.06 Aligned_cols=248 Identities=21% Similarity=0.355 Sum_probs=203.6
Q ss_pred cccceeceeeeccCceEEEEEEEC-----CCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC
Q 018640 54 EERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 128 (352)
.++|++.++||+|+||.||++... .++..+|+|.+... .....+.+.+|+++++.+ +|+||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 79 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVL-QHQHIVRFYGVCTEG 79 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcC-CCCCCceEEEEEecC
Confidence 357889999999999999999742 35678999987643 234456799999999999 899999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCC
Q 018640 129 TAVHLVMELCEGGELFDRIVARG---------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK 193 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~---------------~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~ 193 (352)
...++++||+++++|.+++.... .+++..+..++.|++.||+|||+.|++|+||||+||+++.++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 99999999999999999987542 478999999999999999999999999999999999997544
Q ss_pred CCCCEEEEecccceecCCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 018640 194 ETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQA 268 (352)
Q Consensus 194 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~ 268 (352)
.++|+|||++........ .....+++.|+|||.+. ..++.++||||||+++|||++ |..||...........
T Consensus 160 ---~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05092 160 ---VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC 236 (280)
T ss_pred ---CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 489999999875533221 12234567899999876 458999999999999999998 9999977666555544
Q ss_pred HHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 269 IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
+.... .......+++.+.+++.+||+.||++||++.+|+.
T Consensus 237 ~~~~~---~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 237 ITQGR---ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHcCc---cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 43322 22233467899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=298.91 Aligned_cols=241 Identities=22% Similarity=0.332 Sum_probs=197.9
Q ss_pred eeeeccCceEEEEEEECCCC---cEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEe
Q 018640 61 RELGRGEFGITYLCTDRENG---DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMEL 137 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~ 137 (352)
++||+|+||.||+|.+...+ ..+|+|.+...... ...+.+.+|+.+++.+ +|+||+++++++.. ...++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQL-DHPCIVRLIGVCKG-EPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhc-CCCCeeeEEEEEcC-CceEEEEEe
Confidence 46999999999999876554 78999998765432 3456788999999999 89999999998764 467999999
Q ss_pred cCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCcc--
Q 018640 138 CEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF-- 215 (352)
Q Consensus 138 ~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~-- 215 (352)
+++++|.+++.....+++..+..++.|++.||.|||..+++|+||||+||+++.++. +||+|||++.........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~---~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ---AKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCc---EEeccccccceeecCCcccc
Confidence 999999999988778999999999999999999999999999999999999976554 899999999865433221
Q ss_pred --cccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHH
Q 018640 216 --SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (352)
Q Consensus 216 --~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 291 (352)
....++..|+|||.+. ..++.++||||||+++|++++ |..||...........+... ........++..+.++
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~l 230 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG---ERLPRPEECPQEIYSI 230 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC---CcCCCCCCCCHHHHHH
Confidence 1112356799999876 458999999999999999998 99999776655444443322 1223445678999999
Q ss_pred HHHhcCCCcCCCCCHHHHhc
Q 018640 292 VRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 292 i~~~l~~dP~~Rps~~ell~ 311 (352)
|.+||+.+|++||++.++++
T Consensus 231 i~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 231 MLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHhcCChhhCcCHHHHHH
Confidence 99999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=302.34 Aligned_cols=248 Identities=21% Similarity=0.292 Sum_probs=198.1
Q ss_pred ceeceeeeccCceEEEEEEECCCCc--EEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC------
Q 018640 57 YELGRELGRGEFGITYLCTDRENGD--AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD------ 128 (352)
Q Consensus 57 y~~~~~lG~G~~g~Vy~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~------ 128 (352)
|.+.+.||+|+||.||+|.+..++. .||+|.+.... ......+.+.+|+.+++.+ +|+||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 78 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEF-DHPNVMRLIGVCLQTVESEGY 78 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEccCCcccCC
Confidence 3567899999999999999877665 58999886542 2334467788999999999 899999999976422
Q ss_pred CeEEEEEEecCCcchHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEe
Q 018640 129 TAVHLVMELCEGGELFDRIVA------RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAID 202 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~D 202 (352)
...++++||+++++|.+++.. ...+++..+..++.|++.||.|||+++|+||||||+||+++.++. ++|+|
T Consensus 79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---~kl~D 155 (272)
T cd05075 79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMN---VCVAD 155 (272)
T ss_pred CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCC---EEECC
Confidence 256899999999999988742 124789999999999999999999999999999999999975544 89999
Q ss_pred cccceecCCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccC
Q 018640 203 FGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFR 277 (352)
Q Consensus 203 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 277 (352)
||++........ .....++..|++||.+. ..++.++||||||+++|||++ |..||...........+.+.. .
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~---~ 232 (272)
T cd05075 156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN---R 232 (272)
T ss_pred CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC---C
Confidence 999986543321 12224567899999876 458999999999999999999 899997766655444443321 1
Q ss_pred CCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 278 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
....+.++..+.++|.+||+.||++|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 233 LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 22334678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=307.74 Aligned_cols=250 Identities=24% Similarity=0.369 Sum_probs=203.3
Q ss_pred cccceeceeeeccCceEEEEEEEC-------CCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDR-------ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~ 126 (352)
.++|.+.+.||+|+||.||+|.+. .....+|+|.+.... .......+.+|+.+++.+.+||||+++++++.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 357999999999999999999753 235579999876432 23345678899999999967999999999999
Q ss_pred eCCeEEEEEEecCCcchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEee
Q 018640 127 DDTAVHLVMELCEGGELFDRIVAR----------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFA 190 (352)
Q Consensus 127 ~~~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~ 190 (352)
..+..+++|||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+++
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT 168 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence 999999999999999999999653 2478899999999999999999999999999999999997
Q ss_pred cCCCCCCEEEEecccceecCCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 018640 191 NKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGV 265 (352)
Q Consensus 191 ~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~ 265 (352)
.++. +||+|||+++....... .....++..|+|||.+. +.++.++||||||+++|+|++ |..||......+.
T Consensus 169 ~~~~---~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~ 245 (314)
T cd05099 169 EDNV---MKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL 245 (314)
T ss_pred CCCc---EEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 6544 89999999976543211 11223456799999876 458999999999999999999 8999987776655
Q ss_pred HHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 266 AQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
...+... ........++.++.+++.+||+.+|++|||+.++++
T Consensus 246 ~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 246 FKLLREG---HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHcC---CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 5544332 122233467889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=336.56 Aligned_cols=149 Identities=31% Similarity=0.501 Sum_probs=135.4
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++++.||+|+||+||+|.+..+++.||+|++.............+.+|+.++..+ +|+||+++++++......++|
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS-KSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc-CCCCcCeEEEEEEECCEEEEE
Confidence 4699999999999999999999999999999999765444444456788999999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccce
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~ 207 (352)
|||++|++|.+++.....+++..++.++.||+.||+|||+.+|+||||||+|||++.++ .+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g---~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEG---HIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCC---CEEEEeCCCCc
Confidence 99999999999998877899999999999999999999999999999999999997554 48999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=304.56 Aligned_cols=247 Identities=23% Similarity=0.336 Sum_probs=201.0
Q ss_pred cceeceeeeccCceEEEEEEECC-----CCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe
Q 018640 56 RYELGRELGRGEFGITYLCTDRE-----NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 130 (352)
+|++.+.||+|+||.||+|.+.. ....+++|.+.... .....+.+.+|+.+++.+ +||||+++++.+...+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQV-NHPHVIKLYGACSQDGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCC
Confidence 47889999999999999998743 23568888876542 223356788999999999 89999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCc
Q 018640 131 VHLVMELCEGGELFDRIVAR------------------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPEN 186 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~------------------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~N 186 (352)
.++++||+++++|.+++... ..+++..++.++.|++.||.|||+.+++||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 99999999999999988642 247888999999999999999999999999999999
Q ss_pred eEeecCCCCCCEEEEecccceecCCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 018640 187 FLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAET 261 (352)
Q Consensus 187 Ill~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~ 261 (352)
|++++++ .++|+|||+++....... .....++..|+|||.+. ..++.++||||||++++||++ |..||....
T Consensus 158 ill~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 158 VLVAEGR---KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred EEEcCCC---cEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 9997554 489999999976432221 12234567899999865 458999999999999999998 999998777
Q ss_pred HHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 262 EQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
........... ........++.++.+++..||+.+|++||++.+++.
T Consensus 235 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 235 PERLFNLLKTG---YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHHHhCC---CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 66554443322 122334567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=304.74 Aligned_cols=253 Identities=30% Similarity=0.544 Sum_probs=208.3
Q ss_pred ceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEE
Q 018640 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (352)
Q Consensus 57 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e 136 (352)
|++.+.||+|++|.||+|.+..+++.||+|++.... ......+.+.+|+.+++.+ +|+|++++++++...+..++|+|
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKEL-KHPNIVKLLDVIHTERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhc-CCCCHHHHHhhhhcCCceEEEec
Confidence 667789999999999999999999999999987654 2223345677899999999 89999999999999999999999
Q ss_pred ecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC-c
Q 018640 137 LCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-K 214 (352)
Q Consensus 137 ~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-~ 214 (352)
|++ ++|.+++... ..+++..+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||++....... .
T Consensus 79 ~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~---~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 79 YCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGV---LKLADFGLARAFGIPLRT 154 (282)
T ss_pred CcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCC---EEEecCCcccccCCCccc
Confidence 997 4999999876 57999999999999999999999999999999999999976444 8999999987654332 2
Q ss_pred ccccccccccccchhcc-c-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC---------------
Q 018640 215 FSEIVGSPYYMAPEVLK-R-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR--------------- 277 (352)
Q Consensus 215 ~~~~~gt~~y~aPE~~~-~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--------------- 277 (352)
.....++..|+|||.+. . .++.++|+||||++++|+++|..||...........+........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 23345678899999875 3 588999999999999999999999977765554444332211000
Q ss_pred ----------CCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 278 ----------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 278 ----------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
....+.++..+.++|.+||+.||++||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 01123457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=299.40 Aligned_cols=248 Identities=23% Similarity=0.362 Sum_probs=204.4
Q ss_pred ccceeceeeeccCceEEEEEEECCCCc---EEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGD---AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
++|+..+.||+|+||.||+|.+..++. .+|+|.+.... .....+.+.+|+.+++.+ +|+|++++.+++...+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQF-SHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEccCCCc
Confidence 468889999999999999999876555 79999886532 223356788999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 132 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++ .++|+|||++....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~---~~kl~dfg~~~~~~ 158 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNL---ECKVSDFGLSRVLE 158 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCC---cEEECCCccceecc
Confidence 9999999999999998764 4689999999999999999999999999999999999997544 38999999987654
Q ss_pred CCCcc--c--ccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCC
Q 018640 211 PGEKF--S--EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (352)
Q Consensus 211 ~~~~~--~--~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (352)
..... . ....+..|+|||++. ..++.++||||||+++||+++ |..||+..........+... ...+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~---~~~~~~~~~ 235 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG---FRLPAPMDC 235 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcC---CCCCCCCCC
Confidence 32211 1 112345799999876 458999999999999999997 99999887776655555432 122233457
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 285 SENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 285 ~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
+..+.+++.+||+.+|++||++.++++
T Consensus 236 ~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 236 PSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=305.42 Aligned_cols=253 Identities=24% Similarity=0.368 Sum_probs=206.2
Q ss_pred cccccceeceeeeccCceEEEEEEEC-------CCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDR-------ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDT 124 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~ 124 (352)
...++|.+.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.+.+||||++++++
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 34568999999999999999999752 235579999886432 233456788999999999789999999999
Q ss_pred EEeCCeEEEEEEecCCcchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceE
Q 018640 125 YEDDTAVHLVMELCEGGELFDRIVAR----------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFL 188 (352)
Q Consensus 125 ~~~~~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIl 188 (352)
+......++||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 169 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL 169 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEE
Confidence 99999999999999999999999753 23678889999999999999999999999999999999
Q ss_pred eecCCCCCCEEEEecccceecCCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q 018640 189 FANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQ 263 (352)
Q Consensus 189 l~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~ 263 (352)
++.++ .+||+|||++........ .....++..|+|||++. ..++.++||||||+++|++++ |..||......
T Consensus 170 i~~~~---~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 246 (304)
T cd05101 170 VTENN---VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246 (304)
T ss_pred EcCCC---cEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 97554 489999999986543221 12234567899999876 458999999999999999998 88899877766
Q ss_pred HHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 264 GVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
+....+.... ........+..+.+++.+||+.+|++|||+.++++.
T Consensus 247 ~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 247 ELFKLLKEGH---RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHcCC---cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 6555543322 222334678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=297.54 Aligned_cols=242 Identities=25% Similarity=0.399 Sum_probs=204.9
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++.+.||.|+||.||+|... |+.||+|.+..... ..+.+.+|+.+++.+ +|+||+++++++...+..++|
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTL-RHPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhc-CCcceeeeEEEEcCCCCeEEE
Confidence 46899999999999999999864 88999999865421 457789999999999 899999999999989999999
Q ss_pred EEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 135 MELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
|||+++++|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||.+......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~---~~l~d~g~~~~~~~~ 155 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLV---AKVSDFGLAKEASQG 155 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCC---EEEcccccccccccc
Confidence 99999999999998765 6899999999999999999999999999999999999975554 899999999866332
Q ss_pred Ccccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHH
Q 018640 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (352)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (352)
.. ....+..|+|||++. +.++.++||||||++++++++ |..||...........+... .........++.+.+
T Consensus 156 ~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 230 (256)
T cd05039 156 QD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG---YRMEAPEGCPPEVYK 230 (256)
T ss_pred cc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC---CCCCCccCCCHHHHH
Confidence 22 234567799999876 558889999999999999997 99999877766554444332 222333467899999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 018640 291 LVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 291 li~~~l~~dP~~Rps~~ell~ 311 (352)
+|.+||+.+|++|||+.+++.
T Consensus 231 li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 231 VMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHhccChhhCcCHHHHHH
Confidence 999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=300.28 Aligned_cols=248 Identities=24% Similarity=0.367 Sum_probs=204.3
Q ss_pred ccceeceeeeccCceEEEEEEECCCCc---EEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGD---AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
.+|++.+.||+|+||.||+|.+..++. .+|+|.+.... .....+.+.+|+.+++++ +||||+++++++..++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcc
Confidence 479999999999999999999764443 79999886532 223356789999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 132 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
++||||+++++|.+++... ..+++..+..++.|++.||.+||+.+++|+||||+||+++.++. ++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~---~~l~dfg~~~~~~ 157 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLV---CKVSDFGLSRVLE 157 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCe---EEeCCCCcccccc
Confidence 9999999999999999765 45899999999999999999999999999999999999975544 8999999998654
Q ss_pred CCCcc----cccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCC
Q 018640 211 PGEKF----SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (352)
Q Consensus 211 ~~~~~----~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (352)
..... ....++..|+|||.+. +.++.++|+||||++++|+++ |..||......+....+.+.. .......+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~ 234 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY---RLPAPMDC 234 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC---cCCCCCCC
Confidence 33211 1122356799999887 468999999999999999886 999998777665555554432 22233467
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 285 SENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 285 ~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
++.+.+++.+||+.+|++||++.++++
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 235 PAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=300.51 Aligned_cols=248 Identities=24% Similarity=0.385 Sum_probs=204.2
Q ss_pred ccceeceeeeccCceEEEEEEECCCCc---EEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGD---AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
.+|++.+.||+|+||.||+|.+..+++ .||+|.+.... .......+..|+.+++.+ +||||+++.+++..+...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhC-CCcCcceEEEEECCCCce
Confidence 358899999999999999999877665 59999986532 333456799999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 132 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
++||||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~---~~kl~dfg~~~~~~ 157 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL---VCKVSDFGLSRFLE 157 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCC---cEEECCCccccccc
Confidence 9999999999999998764 4589999999999999999999999999999999999997544 48999999987653
Q ss_pred CCCcc---c-ccc--cccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCc
Q 018640 211 PGEKF---S-EIV--GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282 (352)
Q Consensus 211 ~~~~~---~-~~~--gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (352)
..... . ... .+..|+|||.+. ..++.++||||||+++||+++ |..||+..........+... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~---~~~~~~~ 234 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD---YRLPPPM 234 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC---CcCCCcc
Confidence 32211 1 111 245799999876 458999999999999999886 99999887766555554322 2223335
Q ss_pred CCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 283 ~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
.++..+.+++.+||+.+|++||++.+++.
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 235 DCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 67889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=298.87 Aligned_cols=245 Identities=23% Similarity=0.345 Sum_probs=200.4
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
.++|++.+.||+|+||+||+|.+..+ ..||+|.+..... ..+.+.+|+.+++.+ +|+||+++++.+.. ...++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~-~~~~l 77 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPIYI 77 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhC-CCCCcceEEEEECC-CCcEE
Confidence 35799999999999999999998655 4699999875322 346788999999999 89999999998754 56789
Q ss_pred EEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 134 VMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
||||+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~---~~L~dfg~~~~~~~ 154 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV---CKVADFGLARLIED 154 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCc---EEeccCCceeeccc
Confidence 99999999999999753 34789999999999999999999999999999999999976544 89999999976543
Q ss_pred CCcc--cccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHH
Q 018640 212 GEKF--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (352)
Q Consensus 212 ~~~~--~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (352)
.... ....++..|+|||+.. +.++.++||||||+++|+|++ |..||...........+... ........++..
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 231 (262)
T cd05071 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPES 231 (262)
T ss_pred cccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcC---CCCCCccccCHH
Confidence 3221 2234567899999875 568999999999999999999 88899777666554444322 122233468899
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 288 AKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 288 ~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
+.+++.+|++.+|++||++.++++
T Consensus 232 l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 232 LHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHHHHccCCcccCCCHHHHHH
Confidence 999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=301.21 Aligned_cols=248 Identities=21% Similarity=0.292 Sum_probs=198.0
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcE----EEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDA----FACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 130 (352)
++|++.+.||+|+||+||+|.+..++.. +++|.+... .......++..|+..++++ +||||+++++++.. ..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l-~h~~iv~~~~~~~~-~~ 82 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSL-DHAYIVRLLGICPG-AS 82 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcC-CCCCcceEEEEECC-Cc
Confidence 4789999999999999999998777764 667766432 1222345677888899999 89999999998754 45
Q ss_pred EEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 131 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
.++++||+++|+|.+++... ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++ .+||+|||+++..
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~---~~kl~Dfg~~~~~ 159 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDS---IVQIADFGVADLL 159 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC---cEEEcCCccceec
Confidence 77899999999999999764 4689999999999999999999999999999999999997544 4899999999865
Q ss_pred CCCC---cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCC
Q 018640 210 KPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (352)
Q Consensus 210 ~~~~---~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (352)
.... ......++..|+|||.+. +.++.++||||||+++||+++ |..||...........+ .... ........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~--~~~~~~~~ 236 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-EKGE--RLAQPQIC 236 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCC--cCCCCCCC
Confidence 3322 123345678899999876 568999999999999999998 99999776654433333 2211 11222346
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 285 SENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 285 ~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
+.++.+++..||..||++|||+.|+++.
T Consensus 237 ~~~~~~li~~c~~~~p~~Rps~~el~~~ 264 (279)
T cd05111 237 TIDVYMVMVKCWMIDENVRPTFKELANE 264 (279)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 7889999999999999999999999773
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=302.61 Aligned_cols=248 Identities=25% Similarity=0.372 Sum_probs=195.3
Q ss_pred ccc-eeceeeeccCceEEEEEE----ECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC-
Q 018640 55 ERY-ELGRELGRGEFGITYLCT----DRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD- 128 (352)
Q Consensus 55 ~~y-~~~~~lG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~- 128 (352)
++| ++++.||+|+||+||++. ...++..||+|.+.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 79 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTL-YHENIVKYKGCCSEQG 79 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCC
Confidence 455 999999999999998765 34578899999886542 223456788999999999 899999999987653
Q ss_pred -CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccce
Q 018640 129 -TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (352)
Q Consensus 129 -~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~ 207 (352)
...++||||+++++|.+++... .+++..++.++.|++.||+|||+++++|+||||+||+++.++. ++|+|||++.
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~---~~l~dfg~~~ 155 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRL---VKIGDFGLAK 155 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCc---EEEeeccccc
Confidence 4688999999999999998764 5999999999999999999999999999999999999976543 8999999998
Q ss_pred ecCCCCcc----cccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH--------------HHHH
Q 018640 208 FFKPGEKF----SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQG--------------VAQA 268 (352)
Q Consensus 208 ~~~~~~~~----~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~--------------~~~~ 268 (352)
........ ....++..|+|||.+. ..++.++||||||++++||++|..||......- ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence 65433221 2224566799999876 458999999999999999999999985433210 0000
Q ss_pred HHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 269 IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
.... ..........+..+.+++.+||+.+|++|||+.++++
T Consensus 236 ~~~~--~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 236 LLER--GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhc--CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000 0111223457899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=312.05 Aligned_cols=252 Identities=22% Similarity=0.344 Sum_probs=197.7
Q ss_pred cccceeceeeeccCceEEEEEEE-----CCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC
Q 018640 54 EERYELGRELGRGEFGITYLCTD-----RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 128 (352)
.++|++.+.||+|+||+||+|.+ ..+++.||+|++.... .......+.+|+.++.++.+|+||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 35799999999999999999984 3467899999986542 2223456888999999997789999999987654
Q ss_pred -CeEEEEEEecCCcchHHHHHhc---------------------------------------------------------
Q 018640 129 -TAVHLVMELCEGGELFDRIVAR--------------------------------------------------------- 150 (352)
Q Consensus 129 -~~~~lv~e~~~~~sL~~~l~~~--------------------------------------------------------- 150 (352)
...+++|||+++|+|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 5678999999999999988642
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCc---ccc
Q 018640 151 ----------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK---FSE 217 (352)
Q Consensus 151 ----------~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~ 217 (352)
..+++..+..++.|++.||.|||+.+|+||||||+||+++.++ .+||+|||++........ ...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN---VVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC---cEEEEecccccccccCcchhhcCC
Confidence 1367788899999999999999999999999999999997554 489999999876532211 122
Q ss_pred cccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHh
Q 018640 218 IVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKM 295 (352)
Q Consensus 218 ~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 295 (352)
..++..|+|||.+. ..++.++||||||+++|+|++ |..||................. ....+...++.+.+++..|
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~c 318 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT--RMRAPDYTTPEMYQTMLDC 318 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccC--CCCCCCCCCHHHHHHHHHH
Confidence 34567799999875 558999999999999999997 9999876543322222222111 1122234678899999999
Q ss_pred cCCCcCCCCCHHHHhcC
Q 018640 296 LDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 296 l~~dP~~Rps~~ell~h 312 (352)
|+.||++|||+.+|++|
T Consensus 319 l~~~p~~Rps~~eil~~ 335 (343)
T cd05103 319 WHGEPSQRPTFSELVEH 335 (343)
T ss_pred ccCChhhCcCHHHHHHH
Confidence 99999999999999886
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=297.06 Aligned_cols=246 Identities=22% Similarity=0.334 Sum_probs=201.8
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
..++|++.+.||+|+||.||+|.+. ++..+|+|.+..... ..+.+.+|+.+++++ +|+|++++++++. ....+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l-~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKL-RHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhc-CCCceEEEEeEEC-CCCcE
Confidence 3467999999999999999999875 567799998875432 346789999999999 8999999999875 45678
Q ss_pred EEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 133 LVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
++|||+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .++|+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~---~~~l~dfg~~~~~~ 153 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGL---VCKIADFGLARLIE 153 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCc---eEEeCCceeeeecc
Confidence 999999999999998754 3489999999999999999999999999999999999997654 38999999997654
Q ss_pred CCCcc--cccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCH
Q 018640 211 PGEKF--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (352)
Q Consensus 211 ~~~~~--~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (352)
..... ....++..|+|||.+. ..++.++||||||+++|+|++ |..||......+....+... .........+.
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 230 (260)
T cd05070 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG---YRMPCPQDCPI 230 (260)
T ss_pred CcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---CCCCCCCcCCH
Confidence 33211 1224566899999876 458899999999999999999 89999877666555554432 22233346789
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 287 NAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 287 ~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
.+.+++.+||+.+|++|||+.++.+
T Consensus 231 ~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 231 SLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHH
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=296.73 Aligned_cols=241 Identities=24% Similarity=0.376 Sum_probs=200.2
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEE-eCCeEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE-DDTAVHL 133 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~-~~~~~~l 133 (352)
++|++.+.||+|+||.||++... |..||+|.+... ...+.+.+|+.+++++ +|+|++++++++. ..+..++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-----chHHHHHHHHHHHHhC-CCCCeeeEEEEEEcCCCceEE
Confidence 46999999999999999999764 888999987543 2346788999999999 8999999999764 5567899
Q ss_pred EEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 134 VMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
++||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++. +||+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~---~kl~dfg~~~~~~~ 154 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNV---AKVSDFGLTKEASS 154 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCc---EEecCCccceeccc
Confidence 999999999999997654 3789999999999999999999999999999999999976554 89999999876543
Q ss_pred CCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHH
Q 018640 212 GEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (352)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (352)
.. ....++..|+|||++. ..++.++||||||+++|+|++ |+.||......+....+... ......+.++..+.
T Consensus 155 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 229 (256)
T cd05082 155 TQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---YKMDAPDGCPPVVY 229 (256)
T ss_pred cC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC---CCCCCCCCCCHHHH
Confidence 32 2234567899999876 458899999999999999997 99999876665555444332 22333456889999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhc
Q 018640 290 DLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 290 ~li~~~l~~dP~~Rps~~ell~ 311 (352)
+++.+||+.+|++|||+.++++
T Consensus 230 ~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 230 DVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=296.65 Aligned_cols=240 Identities=24% Similarity=0.331 Sum_probs=194.6
Q ss_pred eeeccCceEEEEEEEC--CCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEecC
Q 018640 62 ELGRGEFGITYLCTDR--ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCE 139 (352)
Q Consensus 62 ~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~ 139 (352)
.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++++ +|+||+++++++.. ...++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~-~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQL-DNPYIVRMIGVCEA-EALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhc-CCCCeEEEEEEEcC-CCeEEEEEeCC
Confidence 4899999999999765 446679999886542 233456789999999999 99999999998864 57899999999
Q ss_pred CcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCcc---
Q 018640 140 GGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF--- 215 (352)
Q Consensus 140 ~~sL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~--- 215 (352)
+++|.+++.. ...+++..++.++.|++.||.|||++|++|+||||+||+++.++. +||+|||++.........
T Consensus 78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~---~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHY---AKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCc---EEeccCCccccccCCccceec
Confidence 9999999875 346899999999999999999999999999999999999975543 899999999755333211
Q ss_pred -cccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHH
Q 018640 216 -SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (352)
Q Consensus 216 -~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 292 (352)
....++..|+|||.+. ..++.++||||||+++|++++ |..||...........+.... +....+..++++.++|
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li 231 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK---RLDCPAECPPEMYALM 231 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC---CCCCCCCCCHHHHHHH
Confidence 1122357899999876 458899999999999999996 999998777665554443322 2233456789999999
Q ss_pred HHhcCCCcCCCCCHHHHhc
Q 018640 293 RKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 293 ~~~l~~dP~~Rps~~ell~ 311 (352)
.+||+.+|++||++.+|++
T Consensus 232 ~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 232 KDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHcCCChhhCcCHHHHHH
Confidence 9999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=308.64 Aligned_cols=254 Identities=22% Similarity=0.317 Sum_probs=197.4
Q ss_pred eceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEec
Q 018640 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELC 138 (352)
Q Consensus 59 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~ 138 (352)
+.+.+|.| |.||.+....+++.||+|++.... ......+.+.+|+.+++.+ +|+||+++++++...+..+++|||+
T Consensus 6 i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (314)
T cd08216 6 IGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQL-QHPNILPYVTSFIVDSELYVVSPLM 81 (314)
T ss_pred hhHhhcCC--ceEEEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhc-CCcchhhhhheeecCCeEEEEEecc
Confidence 33444444 555566666689999999987642 2334567899999999999 8999999999999999999999999
Q ss_pred CCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCc--
Q 018640 139 EGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK-- 214 (352)
Q Consensus 139 ~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~-- 214 (352)
++++|.+++... ..+++..+..++.|++.||.|||+.+|+|+||||+||+++.++. ++|+|||.+........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~---~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 82 AYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK---VVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCc---eEEecCccceeeccccccc
Confidence 999999998764 35899999999999999999999999999999999999986554 89999998865432111
Q ss_pred ------ccccccccccccchhccc---cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc---------
Q 018640 215 ------FSEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF--------- 276 (352)
Q Consensus 215 ------~~~~~gt~~y~aPE~~~~---~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~--------- 276 (352)
.....++..|+|||.+.. .++.++|+||||++++||++|..||...................
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhh
Confidence 123456788999998753 47889999999999999999999997655433322211111000
Q ss_pred ---------------------CCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 277 ---------------------RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 277 ---------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
.......++.++.+|+..||+.||++|||+.++++||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 0000012346788999999999999999999999999999765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=315.34 Aligned_cols=253 Identities=23% Similarity=0.321 Sum_probs=202.8
Q ss_pred ccccceeceeeeccCceEEEEEEEC-----CCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe
Q 018640 53 IEERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 127 (352)
-.++|.+.+.||+|+||.||+|.+. .+++.||+|++..... ....+.+.+|+.++.++..||||+++++++..
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 3457899999999999999999864 3456899999975422 22245688999999999559999999999999
Q ss_pred CCeEEEEEEecCCcchHHHHHhcC--------------------------------------------------------
Q 018640 128 DTAVHLVMELCEGGELFDRIVARG-------------------------------------------------------- 151 (352)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~-------------------------------------------------------- 151 (352)
.+..++||||+++|+|.+++....
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 999999999999999999986431
Q ss_pred ------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEe
Q 018640 152 ------------------------------------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLF 189 (352)
Q Consensus 152 ------------------------------------------~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll 189 (352)
.+++..+..++.|++.||.|||+.+++||||||+|||+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl 272 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI 272 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE
Confidence 25667788999999999999999999999999999999
Q ss_pred ecCCCCCCEEEEecccceecCCCC---cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 018640 190 ANKKETAPLKAIDFGLSVFFKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQG 264 (352)
Q Consensus 190 ~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~ 264 (352)
+.++ .++|+|||+++...... ......++..|+|||.+. ..++.++||||||++++||++ |..||......+
T Consensus 273 ~~~~---~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 273 CEGK---LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred eCCC---EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 7544 48999999997643221 122345678899999876 458899999999999999998 899987665544
Q ss_pred HHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 265 VAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
......... .+...+..++.++.+++.+||+.+|++||++.+|++.
T Consensus 350 ~~~~~~~~~--~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 350 QFYNAIKRG--YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHHHcC--CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 433333221 2223344678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=308.43 Aligned_cols=252 Identities=25% Similarity=0.364 Sum_probs=204.7
Q ss_pred ccccceeceeeeccCceEEEEEEECCC-------CcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDREN-------GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTY 125 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~ 125 (352)
...+|++.+.||+|+||.||+|.+... +..||+|.+... ......+.+.+|+.+++++.+|+||+++++++
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 445799999999999999999986432 236899987643 12234567889999999997799999999999
Q ss_pred EeCCeEEEEEEecCCcchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEe
Q 018640 126 EDDTAVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLF 189 (352)
Q Consensus 126 ~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll 189 (352)
...+..++++||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||++
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill 167 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV 167 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE
Confidence 99999999999999999999987532 37788899999999999999999999999999999999
Q ss_pred ecCCCCCCEEEEecccceecCCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 018640 190 ANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQG 264 (352)
Q Consensus 190 ~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~ 264 (352)
+.++. +||+|||+++....... .....++..|+|||++. ..++.++||||||+++|||++ |..||.......
T Consensus 168 ~~~~~---~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 168 TEDNV---MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred cCCCc---EEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 75544 89999999976543221 12223456799999876 458999999999999999998 889998777666
Q ss_pred HHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 265 VAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
....+... .........+..+.+++.+||+.+|++|||+.+++++
T Consensus 245 ~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 245 LFKLLKEG---HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHcC---CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 55544432 2223334678899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=296.52 Aligned_cols=242 Identities=24% Similarity=0.367 Sum_probs=200.3
Q ss_pred eeeeccCceEEEEEEECC-CCc--EEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEe
Q 018640 61 RELGRGEFGITYLCTDRE-NGD--AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMEL 137 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~ 137 (352)
++||+|++|+||+|.+.. .+. .||+|.+...... ...+.+.+|+.+++++ +|+||+++++.+.. ...++|+||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSL-DHENLIRLYGVVLT-HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhc-CCCCccceeEEEcC-CeEEEEEEe
Confidence 468999999999999865 333 5899998765432 4567899999999999 89999999999988 889999999
Q ss_pred cCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCc-
Q 018640 138 CEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK- 214 (352)
Q Consensus 138 ~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~- 214 (352)
+++++|.+++.... .+++..++.++.|++.||.|||+++++|+||+|+||+++.++ .+||+|||++........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~---~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD---KVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC---EEEeccccccccccccccc
Confidence 99999999997764 589999999999999999999999999999999999998664 489999999986643221
Q ss_pred ---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHH
Q 018640 215 ---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (352)
Q Consensus 215 ---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (352)
.....++..|+|||.+. ..++.++||||||+++++|++ |..||......+....+..... ........+..+.
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 231 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGE--RLERPEACPQDIY 231 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC--cCCCCccCCHHHH
Confidence 12345678899999886 458999999999999999998 9999987766655555443221 1222345789999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhc
Q 018640 290 DLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 290 ~li~~~l~~dP~~Rps~~ell~ 311 (352)
+++.+||+.+|++|||+.++++
T Consensus 232 ~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 232 NVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHCCCCcccCCCHHHHHH
Confidence 9999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=296.38 Aligned_cols=246 Identities=24% Similarity=0.352 Sum_probs=203.0
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
..++|+++++||+|+||.||+|... +++.||+|.+.... ...+.+.+|+.+++++ +|+|++++++++. .+..+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS----MSPEAFLAEANLMKQL-QHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC----CcHHHHHHHHHHHHhc-CCcCeeeEEEEEc-cCCcE
Confidence 4568999999999999999999864 57889999886543 2346788999999999 8999999999874 45689
Q ss_pred EEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 133 LVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
++|||+++++|.+++... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~---~~l~dfg~~~~~~ 153 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLC---CKIADFGLARLIE 153 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCC---EEEccCcceeecC
Confidence 999999999999988653 35899999999999999999999999999999999999976544 8999999997654
Q ss_pred CCCcc--cccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCH
Q 018640 211 PGEKF--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (352)
Q Consensus 211 ~~~~~--~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (352)
..... ....++..|+|||++. ..++.++||||||++++|+++ |+.||...........+... .........+.
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 230 (260)
T cd05067 154 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG---YRMPRPDNCPE 230 (260)
T ss_pred CCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC---CCCCCCCCCCH
Confidence 22211 2234567899999886 458899999999999999999 99999877766555544332 22233345788
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 287 NAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 287 ~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
++.+++.+||+.+|++||+++++++
T Consensus 231 ~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 231 ELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHHHHHccCChhhCCCHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=295.84 Aligned_cols=244 Identities=23% Similarity=0.339 Sum_probs=200.1
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|.+...||+|++|.||+|.+..+ ..+|+|.+.... ...+.+.+|+.+++.+ +|+|++++++++. .+..+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~----~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT----MMPEAFLQEAQIMKKL-RHDKLVPLYAVVS-EEPIYIV 78 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC----ccHHHHHHHHHHHHhC-CCCCeeeEEEEEc-CCCcEEE
Confidence 5699999999999999999997654 569999876432 2346788999999999 8999999999875 4567899
Q ss_pred EEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 135 MELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
|||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~---~~l~dfg~~~~~~~~ 155 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLV---CKIADFGLARLIEDN 155 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCe---EEECCCccceEccCC
Confidence 99999999999997643 4789999999999999999999999999999999999976554 899999999765432
Q ss_pred Cc--ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHH
Q 018640 213 EK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (352)
Q Consensus 213 ~~--~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (352)
.. .....++..|+|||... +.++.++||||||+++|+|++ |..||......+....+... .....+...+..+
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 232 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG---YRMPCPQGCPESL 232 (260)
T ss_pred cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---CCCCCCcccCHHH
Confidence 21 12234567899999876 458899999999999999999 99999887766555544332 2223344678999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhc
Q 018640 289 KDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 289 ~~li~~~l~~dP~~Rps~~ell~ 311 (352)
.+++.+||+.||++||+++++++
T Consensus 233 ~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 233 HELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHHHccCCcccCcCHHHHHH
Confidence 99999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=298.73 Aligned_cols=252 Identities=27% Similarity=0.488 Sum_probs=205.5
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccC--ChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR--TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
+|.+.+.||+|+||+||++.+...+..+++|++...... .......+.+|+.+++.+ +||||+++++++......++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-DHPAIVKFHASFLERDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC-CCCcHHHHHHHHhcCCceEE
Confidence 588999999999999999998877777777766543221 122334567799999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 134 VMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
|+||+++++|.+.+.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ .++|+|||++...
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~----~~~l~d~g~~~~~ 155 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN----LLKIGDFGVSRLL 155 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecC----CEeecccCceeec
Confidence 9999999999988853 3468999999999999999999999999999999999999642 3899999998765
Q ss_pred CCCC-cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHH
Q 018640 210 KPGE-KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (352)
Q Consensus 210 ~~~~-~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (352)
.... ......|+..|+|||.+. ..++.++|+||||+++++|++|..||...........+.. ...+.....++.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 232 (260)
T cd08222 156 MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE---GPTPSLPETYSRQ 232 (260)
T ss_pred CCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc---CCCCCCcchhcHH
Confidence 4332 223456888999999876 4578899999999999999999999976655444443332 2222233467889
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 288 ~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
+.++|.+||+.+|++||++.++++||||
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 233 LNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=299.56 Aligned_cols=249 Identities=20% Similarity=0.268 Sum_probs=203.2
Q ss_pred cccceeceeeeccCceEEEEEEECC----CCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe-C
Q 018640 54 EERYELGRELGRGEFGITYLCTDRE----NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED-D 128 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~-~ 128 (352)
.++|++.+.||+|+||.||+|.+.. ++..|++|.+... ......+.+.+|+.+++.+ +|+||+++++++.. .
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGL-SHQNILPILHVCIEDG 81 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCC
Confidence 4579999999999999999999875 3678999987643 2334467788999999999 99999999998765 5
Q ss_pred CeEEEEEEecCCcchHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEE
Q 018640 129 TAVHLVMELCEGGELFDRIVAR--------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKA 200 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~--------~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl 200 (352)
...+++++|+++++|.+++... ..+++..+..++.|++.||+|||+.+++|+||||+||+++.++ .+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~---~~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL---QVKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCC---cEEE
Confidence 6789999999999999998653 3488999999999999999999999999999999999997554 4899
Q ss_pred EecccceecCCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccc
Q 018640 201 IDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLD 275 (352)
Q Consensus 201 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 275 (352)
+|||+++....... .....++..|+|||++. ..++.++||||||+++||+++ |+.||......+....+...
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--- 235 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG--- 235 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC---
Confidence 99999976533221 12335677899999876 458999999999999999999 99999877665544433332
Q ss_pred cCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 276 FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 276 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
........+++.+.+++.+||..||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 236 YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 222223457899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=302.01 Aligned_cols=252 Identities=21% Similarity=0.287 Sum_probs=199.5
Q ss_pred cccceeceeeeccCceEEEEEEECC----------------CCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCC
Q 018640 54 EERYELGRELGRGEFGITYLCTDRE----------------NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~ 117 (352)
.++|++.+.||+|+||+||++.+.. ++..||+|++.... .......+.+|+.+++.+ +|+|
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l-~~~~ 80 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRL-KDPN 80 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhC-CCCC
Confidence 4579999999999999999986432 34579999886542 233456789999999999 8999
Q ss_pred eeEeeeEEEeCCeEEEEEEecCCcchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCc
Q 018640 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG-----------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPEN 186 (352)
Q Consensus 118 iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~N 186 (352)
|+++++++...+..++||||+++++|.+++.... .+++..+..++.|++.||+|||+.|++|+||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 9999999999999999999999999999987542 36678899999999999999999999999999999
Q ss_pred eEeecCCCCCCEEEEecccceecCCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh--CCCCCCCC
Q 018640 187 FLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC--GVPPFWAE 260 (352)
Q Consensus 187 Ill~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t--g~~p~~~~ 260 (352)
|+++.++ .++|+|||++........ .....++..|++||... +.++.++|+||||+++|||++ |..||...
T Consensus 161 ili~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 161 CLVGKNY---TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EEEcCCC---CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 9997544 389999999976533221 12234467899999754 568999999999999999998 77888766
Q ss_pred CHHHHHHHHHhcc----cccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 261 TEQGVAQAIIRSV----LDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 261 ~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
............. ..........+++.+.+++.+||+.||++||++.+|.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 6554443322111 01111223457799999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=301.12 Aligned_cols=249 Identities=22% Similarity=0.319 Sum_probs=203.4
Q ss_pred cccceeceeeeccCceEEEEEEEC-----CCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC
Q 018640 54 EERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 128 (352)
.++|++++.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l-~h~~iv~~~~~~~~~ 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEF-DHPNIVKLLGVCAVG 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhc-CCCchheEEEEEcCC
Confidence 457999999999999999999874 367889999886532 233356788999999999 899999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCc
Q 018640 129 TAVHLVMELCEGGELFDRIVARG----------------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPEN 186 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~----------------------~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~N 186 (352)
...++++||+++++|.+++.... .+++..+..++.|++.||.|||+++++||||+|+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999986432 36788899999999999999999999999999999
Q ss_pred eEeecCCCCCCEEEEecccceecCCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 018640 187 FLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAET 261 (352)
Q Consensus 187 Ill~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~ 261 (352)
|+++.++. ++|+|||++........ ......+..|+|||.+. ..++.++||||||+++|||++ |..||....
T Consensus 161 il~~~~~~---~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 161 CLVGENMV---VKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred eEecCCCc---eEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99975544 89999999876433221 12224467799999876 568999999999999999997 888998777
Q ss_pred HHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 262 EQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
..+....+..... ......++..+.++|.+||+.+|++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 238 HEEVIYYVRDGNV---LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHHHhcCCC---CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 6665554443221 1223457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=294.54 Aligned_cols=246 Identities=28% Similarity=0.414 Sum_probs=206.1
Q ss_pred ceeceeeeccCceEEEEEEECCCC----cEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 57 YELGRELGRGEFGITYLCTDRENG----DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 57 y~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
+++.+.||.|+||.||+|.+...+ ..||+|.+.... .......+.+|+..+..+ +|+||+++++++...+..+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKL-DHPNIVKLLGVCTEEEPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCeeE
Confidence 357789999999999999998766 899999986542 222457889999999999 9999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 133 LVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~--l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
++|||+++++|.+++..... +++..+..++.|++.||.+||+.+++|+||+|+||+++.++ .++|+|||++....
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~---~~~l~dfg~~~~~~ 154 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL---VVKISDFGLSRDLY 154 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCC---eEEEcccCCceecc
Confidence 99999999999999976544 99999999999999999999999999999999999997655 48999999998765
Q ss_pred CCCccc--ccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCH
Q 018640 211 PGEKFS--EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (352)
Q Consensus 211 ~~~~~~--~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (352)
...... ...++..|+|||.+. ..++.++|+||||+++++|++ |..||...........+.... ........+.
T Consensus 155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 231 (258)
T smart00219 155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY---RLPKPENCPP 231 (258)
T ss_pred cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC---CCCCCCcCCH
Confidence 442222 123678899999875 458999999999999999998 888988766665555554432 2223345789
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 287 NAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 287 ~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
.+.+++.+||..||++|||+.++++
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 232 EIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHHHCcCChhhCcCHHHHHh
Confidence 9999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=294.55 Aligned_cols=247 Identities=25% Similarity=0.367 Sum_probs=205.9
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
..++|++.+.||+|+||+||+|.+. ++..||+|.+.... ...+.+.+|+.+++++ +|+|++++++++......+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT----MSPEAFLQEAQIMKKL-RHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc----cCHHHHHHHHHHHhhC-CCCCEeeeeeeeecCCceE
Confidence 3468999999999999999999975 56789999886532 2346789999999999 8999999999999889999
Q ss_pred EEEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 133 LVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
+||||+++++|.+++.... .+++..+..++.|++.||.|||+++++|+||+|+||+++.++. ++|+|||++....
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~---~~l~d~g~~~~~~ 154 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLV---CKIADFGLARLIE 154 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCC---EEECccccceecc
Confidence 9999999999999997653 5899999999999999999999999999999999999976544 8999999987654
Q ss_pred CCCc--ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCH
Q 018640 211 PGEK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (352)
Q Consensus 211 ~~~~--~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (352)
.... .....++..|+|||.+. ..++.++|+||||++++++++ |+.||...........+.... ........+.
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 231 (261)
T cd05034 155 DDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY---RMPRPPNCPE 231 (261)
T ss_pred chhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCCH
Confidence 3211 11223456899999876 458899999999999999998 999998777666665554432 2233345689
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 287 NAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 287 ~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
.+.+++.+||+.+|++||++.++.+
T Consensus 232 ~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 232 ELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHHHHHcccCcccCCCHHHHHH
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=297.48 Aligned_cols=248 Identities=23% Similarity=0.302 Sum_probs=203.9
Q ss_pred cccceeceeeeccCceEEEEEEECCCCc----EEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGD----AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 129 (352)
..+|++.+.||+|+||+||+|.+..+|+ .+|+|.+.... .......+.+|+.+++++ +|+|++++++++.. .
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASV-DHPHVVRLLGICLS-S 81 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec-C
Confidence 3579999999999999999999876665 58999876543 233456788999999999 89999999999887 7
Q ss_pred eEEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccccee
Q 018640 130 AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (352)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~ 208 (352)
..++|+||+++++|.+++... ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++. +||+|||++..
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~---~kL~dfg~~~~ 158 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQH---VKITDFGLAKL 158 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCe---EEECCCccccc
Confidence 889999999999999999764 45899999999999999999999999999999999999975544 89999999986
Q ss_pred cCCCCccc---ccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcC
Q 018640 209 FKPGEKFS---EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (352)
Q Consensus 209 ~~~~~~~~---~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (352)
........ ...++..|+|||.+. ..++.++|+||||++++|+++ |..||......+....+.... ....+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~ 235 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE---RLPQPPI 235 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC---CCCCCCC
Confidence 65332221 122356799999876 568899999999999999998 999998877665554444321 1222345
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 284 VSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 284 ~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
.+..+.+++.+||..+|++||++.++++
T Consensus 236 ~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 236 CTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 7789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=297.49 Aligned_cols=250 Identities=23% Similarity=0.373 Sum_probs=205.4
Q ss_pred ccceeceeeeccCceEEEEEEECC-----CCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC
Q 018640 55 ERYELGRELGRGEFGITYLCTDRE-----NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 129 (352)
++|+++..||+|+||+||+|.... +...|++|.+.... .....+.+.+|+.+++++ +|+||+++++++.+.+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKL-SHKNVVRLLGLCREAE 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhc-CCcceeeeEEEECCCC
Confidence 579999999999999999999653 34679999876432 222356789999999999 8999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEE
Q 018640 130 AVHLVMELCEGGELFDRIVARG---------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKA 200 (352)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl 200 (352)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+++|+||||+||+++.++. +++
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~---~~l 158 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE---VKV 158 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCc---EEE
Confidence 9999999999999999997655 6899999999999999999999999999999999999976554 799
Q ss_pred EecccceecCCCC--cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccc
Q 018640 201 IDFGLSVFFKPGE--KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDF 276 (352)
Q Consensus 201 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 276 (352)
+|||++....... ......++..|+|||.+. +.++.++||||||++++++++ |..||..................+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd05046 159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL 238 (275)
T ss_pred cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence 9999986543221 223345678899999875 457889999999999999998 888997666655555444332222
Q ss_pred CCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 277 RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 277 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
.....++..+.+++.+||+.+|++|||+.+++.+
T Consensus 239 --~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 239 --PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 2234678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=300.22 Aligned_cols=249 Identities=27% Similarity=0.406 Sum_probs=197.5
Q ss_pred cceeceeeeccCceEEEEEEE----CCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC--C
Q 018640 56 RYELGRELGRGEFGITYLCTD----RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--T 129 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~--~ 129 (352)
-|++++.||+|+||.||+|.. ..++..||+|.+.... .......+.+|+.+++.+ +|||++++.+++... .
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCC
Confidence 479999999999999999974 4568899999986542 233456789999999999 999999999998765 5
Q ss_pred eEEEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccccee
Q 018640 130 AVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (352)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~ 208 (352)
..++||||++|++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++. ++|+|||++..
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~---~~l~dfg~~~~ 158 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ---VKIGDFGLTKA 158 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCC---EEECCCccccc
Confidence 7899999999999999987653 5899999999999999999999999999999999999976544 89999999986
Q ss_pred cCCCCc----ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCH--------------HHHHHHH
Q 018640 209 FKPGEK----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE--------------QGVAQAI 269 (352)
Q Consensus 209 ~~~~~~----~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~--------------~~~~~~~ 269 (352)
...... .....++..|+|||.+. ..++.++||||||+++++|+++..|+..... .......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 543321 12345677899999875 4588999999999999999998766532111 0011111
Q ss_pred HhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 270 IRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
... ....+.+..++..+.+|+.+||+.+|++|||+.+++++
T Consensus 239 ~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 239 LEE--GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHc--CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 111 11222345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=296.13 Aligned_cols=252 Identities=29% Similarity=0.516 Sum_probs=206.4
Q ss_pred cceeceeeeccCceEEEEEEECC-CCcEEEEEEcccccc-------CChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe
Q 018640 56 RYELGRELGRGEFGITYLCTDRE-NGDAFACKSISKKKL-------RTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 127 (352)
.|++.+.||+|+||.||+|.+.. .++.+|+|.+..... .......++.+|+.++.+..+|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999877 688999998764321 1222345577788888764489999999999999
Q ss_pred CCeEEEEEEecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEecCCCCceEeecCCCCCCEEEEe
Q 018640 128 DTAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAID 202 (352)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dikp~NIll~~~~~~~~vkl~D 202 (352)
.+..+++|||+++++|.+++.. ...+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++. ++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~---~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK---VTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCc---EEEec
Confidence 9999999999999999988743 3458999999999999999999996 78999999999999976554 89999
Q ss_pred cccceecCCCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCC
Q 018640 203 FGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281 (352)
Q Consensus 203 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (352)
||++.............|+..|+|||.+. +.++.++|+||||+++|+|++|..||...........+...... +...
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~ 235 (269)
T cd08528 158 FGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE--PLPE 235 (269)
T ss_pred ccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCC--cCCc
Confidence 99998765544445567899999999876 44889999999999999999999999877666555554443222 1122
Q ss_pred cCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 282 ~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
..++..+.++|.+||+.||++||++.|+..+
T Consensus 236 ~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 236 GMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred ccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 3578999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=291.31 Aligned_cols=242 Identities=23% Similarity=0.348 Sum_probs=198.3
Q ss_pred eeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEecCC
Q 018640 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~~ 140 (352)
++||+|+||.||+|... ++..+|+|.+.... .......+.+|+.+++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQY-DHPNIVKLIGVCTQRQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEecCCccEEEEECCCC
Confidence 36999999999999864 68899999886542 222345688999999999 899999999999999999999999999
Q ss_pred cchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCcc--cc
Q 018640 141 GELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF--SE 217 (352)
Q Consensus 141 ~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~--~~ 217 (352)
++|.+++... ..+++..+..++.|++.||.|+|++|++|+||+|+||+++.++. ++|+|||++......... ..
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~---~~l~d~g~~~~~~~~~~~~~~~ 153 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNV---LKISDFGMSRQEDDGIYSSSGL 153 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCe---EEECCCccceeccccccccCCC
Confidence 9999988754 35899999999999999999999999999999999999975544 899999998754332211 12
Q ss_pred cccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHh
Q 018640 218 IVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKM 295 (352)
Q Consensus 218 ~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 295 (352)
..++..|+|||++. +.++.++||||||+++|++++ |..||...........+... ........++..+.+++.+|
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~ 230 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG---YRMSCPQKCPDDVYKVMQRC 230 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCHHHHHHHHHH
Confidence 23456799999876 458899999999999999998 99999877665554444332 22233456889999999999
Q ss_pred cCCCcCCCCCHHHHhcC
Q 018640 296 LDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 296 l~~dP~~Rps~~ell~h 312 (352)
|+.+|++||++.++++.
T Consensus 231 l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 231 WDYKPENRPKFSELQKE 247 (250)
T ss_pred cccCcccCCCHHHHHHH
Confidence 99999999999999753
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=315.39 Aligned_cols=261 Identities=34% Similarity=0.501 Sum_probs=215.5
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
.+.+.|.+...+|.|+|+.|-.+.+..++...++|++.+... .-.+|+.++....+|||++++.+.+.+..+.
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~ 391 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEI 391 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCcee
Confidence 356679999999999999999999999999999999987622 1224777788788999999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
++|||.+.|+-+.+.+.....+. ..+..|+.+|+.|+.|||++|+|||||||+|||++ +.+..++|+|||.+.....
T Consensus 392 ~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWSELER 468 (612)
T ss_pred eeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhhhCch
Confidence 99999999999888887665555 78888999999999999999999999999999996 3455599999999987655
Q ss_pred CCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHH
Q 018640 212 GEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (352)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (352)
. +.+-+-|..|.|||++. ..|+...|+||||++||+|++|+.||...+....+...+ .... ....+|+.+++
T Consensus 469 ~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i---~~~~--~s~~vS~~AKd 541 (612)
T KOG0603|consen 469 S--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI---QMPK--FSECVSDEAKD 541 (612)
T ss_pred h--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh---cCCc--cccccCHHHHH
Confidence 4 33446688999999987 459999999999999999999999998877763322222 2221 12578999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcCccccccccCCCCCCcHH
Q 018640 291 LVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGET 329 (352)
Q Consensus 291 li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~ 329 (352)
||.+||+.||.+||++.+++.||||......|.-.+.++
T Consensus 542 Ll~~LL~~dP~~Rl~~~~i~~h~w~~~~~t~p~~q~~~s 580 (612)
T KOG0603|consen 542 LLQQLLQVDPALRLGADEIGAHPWFLSHPTFPPDQLPWS 580 (612)
T ss_pred HHHHhccCChhhCcChhhhccCcchhcCCCCCcccCCcc
Confidence 999999999999999999999999944444444334333
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=313.43 Aligned_cols=265 Identities=22% Similarity=0.349 Sum_probs=221.0
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
+..+..+||.|.||.||.|.|+.-...||||.++.. ....++|..|+.+|+.+ +|||+|+|+++|..+..+|||+
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED----tMeveEFLkEAAvMKei-kHpNLVqLLGVCT~EpPFYIiT 342 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTHEPPFYIIT 342 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhc----chhHHHHHHHHHHHHhh-cCccHHHHhhhhccCCCeEEEE
Confidence 456678999999999999999999999999998753 45678999999999999 9999999999999999999999
Q ss_pred EecCCcchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 136 ELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 136 e~~~~~sL~~~l~~~~~--l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
|||..|+|.++|.+..+ ++.-.++.++.||..|++||..+++|||||-.+|+|++ ++..|||+|||+++.+..+.
T Consensus 343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVg---EnhiVKvADFGLsRlMtgDT 419 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHIVKVADFGLSRLMTGDT 419 (1157)
T ss_pred ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccc---ccceEEeeccchhhhhcCCc
Confidence 99999999999987654 67777888999999999999999999999999999995 55569999999999887554
Q ss_pred ccc--ccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHH
Q 018640 214 KFS--EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (352)
Q Consensus 214 ~~~--~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (352)
... ..--...|.|||.+. ..++.|+|||+||++|||+.| |-.||.+-...++..-+.+ .++...+..+++...
T Consensus 420 YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEk---gyRM~~PeGCPpkVY 496 (1157)
T KOG4278|consen 420 YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEK---GYRMDGPEGCPPKVY 496 (1157)
T ss_pred eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhc---cccccCCCCCCHHHH
Confidence 321 112256799999887 669999999999999999998 8889988776655544443 345555678999999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcCccccccccCCCCCCcHHHHHHHH
Q 018640 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLK 335 (352)
Q Consensus 290 ~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~ 335 (352)
.|+.+||+++|.+||++.|+ |.-|.... ...++++.|..-|+
T Consensus 497 eLMraCW~WsPsDRPsFaei--HqafEtmf--~~sSisdEV~keLg 538 (1157)
T KOG4278|consen 497 ELMRACWNWSPSDRPSFAEI--HQAFETMF--SSSSISDEVQKELG 538 (1157)
T ss_pred HHHHHHhcCCcccCccHHHH--HHHHHHHh--ccccccHHHHHHHh
Confidence 99999999999999999999 54555443 34556666655443
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=292.43 Aligned_cols=246 Identities=24% Similarity=0.389 Sum_probs=203.7
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
.+|++.+.||+|+||.||+|.+. ++..+|+|.+.... ...+.+.+|+.+++++ +|||++++++++......++|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGA----MSEEDFIEEAQVMMKL-SHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCC----CCHHHHHHHHHHHHhC-CCCCeeeEEEEEccCCceEEE
Confidence 36889999999999999999875 47789999886432 2345788999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
+||+++++|.+++... ..+++..+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~---~~l~d~g~~~~~~~~~ 154 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQV---VKVSDFGMTRFVLDDQ 154 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCe---EEECCCcceeecccCc
Confidence 9999999999998764 45899999999999999999999999999999999999975544 8999999987653322
Q ss_pred c--ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHH
Q 018640 214 K--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (352)
Q Consensus 214 ~--~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (352)
. .....++.+|+|||.+. +.++.++||||||+++|||++ |..||...........+..... .......++.+.
T Consensus 155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 231 (256)
T cd05112 155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFR---LYKPRLASQSVY 231 (256)
T ss_pred ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCC---CCCCCCCCHHHH
Confidence 1 12224567899999876 558899999999999999998 9999987776665555543321 122234689999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcC
Q 018640 290 DLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 290 ~li~~~l~~dP~~Rps~~ell~h 312 (352)
+++.+||+.+|++|||+.+++++
T Consensus 232 ~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 232 ELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHHcccChhhCCCHHHHHHh
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=298.70 Aligned_cols=240 Identities=20% Similarity=0.270 Sum_probs=192.2
Q ss_pred eeeeccCceEEEEEEECCCCcE-------EEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 61 RELGRGEFGITYLCTDRENGDA-------FACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~~~~-------vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
+.||+|+||+||+|.+...+.. ||+|.+.... ....+.+.+|+.+++.+ +|||++++++++...+..++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~~~~~l 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQL-SHKHLVLNYGVCVCGDESIM 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhC-CCCChhheeeEEEeCCCcEE
Confidence 3699999999999998655443 8888775432 23346788899999999 89999999999999899999
Q ss_pred EEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCC-----CCCEEEEecccce
Q 018640 134 VMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE-----TAPLKAIDFGLSV 207 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~-----~~~vkl~Dfg~a~ 207 (352)
||||+++|+|.+++..+. .+++..+..++.||+.||+|||+.+|+||||||+||+++.++. ...++++|||++.
T Consensus 77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999999997654 5899999999999999999999999999999999999986543 2347999999886
Q ss_pred ecCCCCcccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHHhcccccCCCCCcCC
Q 018640 208 FFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGV-PPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (352)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (352)
..... ....++..|+|||.+.+ .++.++||||||+++|+|++|. .||......... ..... ....+...
T Consensus 157 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~----~~~~~~~~ 228 (258)
T cd05078 157 TVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFYED----RHQLPAPK 228 (258)
T ss_pred ccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HHHHc----cccCCCCC
Confidence 54322 33467889999998864 4789999999999999999985 565544443322 22222 12223346
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 285 SENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 285 ~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
+.++.+++.+||+.||++|||++++++.
T Consensus 229 ~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 229 WTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 6889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=290.97 Aligned_cols=241 Identities=24% Similarity=0.336 Sum_probs=198.6
Q ss_pred eeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEecCC
Q 018640 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~~ 140 (352)
++||+|+||.||+|.+.. ++.||+|.+...... .....+.+|+.+++++ +|+||+++++++......++|+||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQY-DHPNIVKLIGVCVQKQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCCeEEEEEcCCC
Confidence 469999999999999877 999999988764322 3456789999999999 899999999999999999999999999
Q ss_pred cchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCcc---c
Q 018640 141 GELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF---S 216 (352)
Q Consensus 141 ~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~---~ 216 (352)
++|.+++... ..+++..+..++.+++.||.|||+++++||||+|+||+++.++. ++|+|||++......... .
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~---~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNV---LKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCc---EEEeeccccccccCCcceeccc
Confidence 9999998654 45899999999999999999999999999999999999975544 899999998765422111 1
Q ss_pred ccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHH
Q 018640 217 EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK 294 (352)
Q Consensus 217 ~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 294 (352)
...++..|+|||.+. +.++.++|+||||+++++|++ |..||...........+... .........+..+.+++.+
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~ 230 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG---YRMPAPQLCPEEIYRLMLQ 230 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC---CCCCCCccCCHHHHHHHHH
Confidence 123356799999876 458999999999999999999 88898776655444443322 1222334678999999999
Q ss_pred hcCCCcCCCCCHHHHhc
Q 018640 295 MLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 295 ~l~~dP~~Rps~~ell~ 311 (352)
||+.+|++|||+.|+++
T Consensus 231 ~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 231 CWAYDPENRPSFSEIYN 247 (251)
T ss_pred HhccChhhCcCHHHHHH
Confidence 99999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=293.72 Aligned_cols=249 Identities=26% Similarity=0.349 Sum_probs=202.5
Q ss_pred cccceeceeeeccCceEEEEEEECCC---CcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe
Q 018640 54 EERYELGRELGRGEFGITYLCTDREN---GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 130 (352)
.++|.+.+.||+|+||.||+|.+... ...||+|...... .....+.+.+|+.+++.+ +|+||+++++++... .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~-~ 80 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQF-DHPHIVKLIGVITEN-P 80 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhC-CCCchhceeEEEcCC-C
Confidence 34689999999999999999987543 3468999876542 233456789999999999 899999999988754 5
Q ss_pred EEEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 131 VHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
.++||||+++++|.+++.... .+++..+..++.|++.||+|||+.+++|+||||+||+++.++. ++|+|||++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~---~~l~d~g~~~~~ 157 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDC---VKLGDFGLSRYL 157 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCC---eEEccCceeeec
Confidence 679999999999999997654 5899999999999999999999999999999999999976544 899999998765
Q ss_pred CCCCcc--cccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCC
Q 018640 210 KPGEKF--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (352)
Q Consensus 210 ~~~~~~--~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (352)
...... ....++..|+|||.+. ..++.++||||||++++|+++ |..||......+....+.+. .....+..++
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~ 234 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENG---ERLPMPPNCP 234 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC---CcCCCCCCCC
Confidence 433221 2223456799999876 458999999999999999986 99999877766555444332 1223345788
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 286 ENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 286 ~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
..+.++|.+|+..+|++|||+.+++..
T Consensus 235 ~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 235 PTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=297.23 Aligned_cols=248 Identities=24% Similarity=0.395 Sum_probs=194.9
Q ss_pred ccceeceeeeccCceEEEEEE----ECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe--C
Q 018640 55 ERYELGRELGRGEFGITYLCT----DRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--D 128 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~--~ 128 (352)
.+|++++.||+|+||+||+|. +..++..||+|.+... .....+.+.+|+.+++.+ +||||+++.+++.. .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGR 79 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEccCCC
Confidence 479999999999999999997 3457889999998643 233456789999999999 89999999998743 3
Q ss_pred CeEEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccce
Q 018640 129 TAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~ 207 (352)
...++|+||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++. ++|+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~---~~l~dfg~~~ 156 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR---VKIGDFGLTK 156 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCe---EEECCCcccc
Confidence 4689999999999999999764 45899999999999999999999999999999999999976544 8999999998
Q ss_pred ecCCCCcc----cccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH---------------HHH
Q 018640 208 FFKPGEKF----SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQG---------------VAQ 267 (352)
Q Consensus 208 ~~~~~~~~----~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~---------------~~~ 267 (352)
........ ....++..|+|||.+. ..++.++||||||++++||++|..|+......- ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 65433221 1123345699999876 458899999999999999999877653322110 000
Q ss_pred HHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 268 AIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
...... ........++..+.+++.+||+.+|++|||+.+++.
T Consensus 237 ~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 237 ELLKNN--GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHhcC--CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 111111 111223457889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=296.59 Aligned_cols=239 Identities=17% Similarity=0.190 Sum_probs=189.7
Q ss_pred eeeccCceEEEEEEECCC------------------------CcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCC
Q 018640 62 ELGRGEFGITYLCTDREN------------------------GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117 (352)
Q Consensus 62 ~lG~G~~g~Vy~~~~~~~------------------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~ 117 (352)
.||+|+||.||+|....+ ...|++|++.... ......+.+|+.+++.+ +|||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l-~h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQV-SHIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcC-CCCC
Confidence 599999999999985322 2358888876432 22345688899999999 8999
Q ss_pred eeEeeeEEEeCCeEEEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCC--
Q 018640 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE-- 194 (352)
Q Consensus 118 iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~-- 194 (352)
|+++++++......++||||+++++|..++.. .+.+++..+..++.|++.||+|||+++++||||||+||+++..+.
T Consensus 78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999999998865 456899999999999999999999999999999999999975432
Q ss_pred --CCCEEEEecccceecCCCCcccccccccccccchhccc--cCCCcchHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHH
Q 018640 195 --TAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILL-CGVPPFWAETEQGVAQAI 269 (352)
Q Consensus 195 --~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~-tg~~p~~~~~~~~~~~~~ 269 (352)
...++++|||++...... ....++..|+|||.+.+ .++.++||||||+++||++ +|..||.......... .
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~ 233 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-F 233 (274)
T ss_pred CccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-H
Confidence 234799999987643221 22357788999998753 4789999999999999984 6999997765543322 2
Q ss_pred HhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 270 IRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
..... ......+..+.++|.+||+.+|++|||+.+++++
T Consensus 234 ~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 234 YEKKH----RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHhcc----CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 22111 1122356789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=293.12 Aligned_cols=240 Identities=20% Similarity=0.213 Sum_probs=190.1
Q ss_pred eeeeccCceEEEEEEECC------------CCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC
Q 018640 61 RELGRGEFGITYLCTDRE------------NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~------------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 128 (352)
+.||+|+||.||+|.... ....|++|++.... ......+.+|+.++..+ +||||+++++++..+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l-~hp~iv~~~~~~~~~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQV-SHKHIVLLYGVCVRD 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC
Confidence 368999999999998532 23358889876532 22345688899999999 999999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCC----CCCEEEEec
Q 018640 129 TAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE----TAPLKAIDF 203 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~----~~~vkl~Df 203 (352)
...++||||+++++|..++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++. ...++++||
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999999998888754 46899999999999999999999999999999999999975442 123899999
Q ss_pred ccceecCCCCcccccccccccccchhcc--ccCCCcchHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHhcccccCCCC
Q 018640 204 GLSVFFKPGEKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILL-CGVPPFWAETEQGVAQAIIRSVLDFRRDP 280 (352)
Q Consensus 204 g~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~s~~~Di~SlG~~l~el~-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 280 (352)
|++...... ....++..|+|||.+. ..++.++||||||+++|||+ +|..||......+.. ...... ...
T Consensus 157 g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~----~~~ 228 (262)
T cd05077 157 GIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQ----CML 228 (262)
T ss_pred CCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcC----ccC
Confidence 988654322 2346788999999875 44889999999999999997 588888665443322 221211 111
Q ss_pred CcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 281 ~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
....++++.++|.+||+.||++||++.+|+++
T Consensus 229 ~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 229 VTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 23356889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=292.74 Aligned_cols=244 Identities=22% Similarity=0.289 Sum_probs=189.9
Q ss_pred eeeeccCceEEEEEEEC--CCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEec
Q 018640 61 RELGRGEFGITYLCTDR--ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELC 138 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~ 138 (352)
+.||+|+||.||+|.+. .++..+|+|.+.... .......+.+|+.+++++ +||||+++++++.+....++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSL-QHSNLLQCLGQCTEVTPYLLVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcCCCCcEEEEECC
Confidence 36999999999999864 345679999876543 222345688899999999 8999999999999989999999999
Q ss_pred CCcchHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 139 EGGELFDRIVARG-----HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 139 ~~~sL~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
++++|.+++.... .+++..+..++.|++.||+|||+.+++|+||||+||+++.++ .++|+|||++.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~---~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL---TVKIGDYGLSHNKYKED 154 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC---cEEECCccccccccCcc
Confidence 9999999986532 356778889999999999999999999999999999997544 48999999987543222
Q ss_pred c---ccccccccccccchhccc--------cCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc-cccCCCC
Q 018640 214 K---FSEIVGSPYYMAPEVLKR--------NYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSV-LDFRRDP 280 (352)
Q Consensus 214 ~---~~~~~gt~~y~aPE~~~~--------~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~ 280 (352)
. .....++..|+|||++.+ .++.++|+||||+++|||++ |..||......+......... .......
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05087 155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR 234 (269)
T ss_pred eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCc
Confidence 1 123457788999998752 25789999999999999996 999997766554433322221 1111111
Q ss_pred -CcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 281 -WPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 281 -~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
....++.+.+++..|+ .+|++|||+.+|+.
T Consensus 235 ~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 235 LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred cCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 1246788999999999 58999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=291.20 Aligned_cols=228 Identities=25% Similarity=0.363 Sum_probs=188.3
Q ss_pred cCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEecCCcchHH
Q 018640 66 GEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFD 145 (352)
Q Consensus 66 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL~~ 145 (352)
|.+|.||++.+..+++.||+|++.... .+.+|...+... .|||++++++++...+..++||||+++++|.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPH-CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhc-CCCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence 899999999999999999999987542 223344555555 69999999999999999999999999999999
Q ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCcccccccccccc
Q 018640 146 RIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225 (352)
Q Consensus 146 ~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~ 225 (352)
++.....+++..+..++.|++.||.|||+.+++||||||+||+++.++. ++++|||.+...... .....++..|+
T Consensus 75 ~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---~~l~df~~~~~~~~~--~~~~~~~~~y~ 149 (237)
T cd05576 75 HISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGH---IQLTYFSRWSEVEDS--CDGEAVENMYC 149 (237)
T ss_pred HHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC---EEEecccchhccccc--cccCCcCcccc
Confidence 9988778999999999999999999999999999999999999976554 899999987654332 22345677899
Q ss_pred cchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCC
Q 018640 226 APEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRL 304 (352)
Q Consensus 226 aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp 304 (352)
|||.+. ..++.++|+||+|+++|||++|..|+....... .. .........+++.+.++|.+||+.||++||
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~ 221 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------NT--HTTLNIPEWVSEEARSLLQQLLQFNPTERL 221 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------cc--ccccCCcccCCHHHHHHHHHHccCCHHHhc
Confidence 999886 458899999999999999999998876433210 00 011122345789999999999999999999
Q ss_pred CH-----HHHhcCccc
Q 018640 305 TA-----QQVLEHPWL 315 (352)
Q Consensus 305 s~-----~ell~hp~f 315 (352)
++ .++++||||
T Consensus 222 ~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 222 GAGVAGVEDIKSHPFF 237 (237)
T ss_pred CCCccchHHHHcCCCC
Confidence 86 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=292.96 Aligned_cols=237 Identities=18% Similarity=0.206 Sum_probs=190.1
Q ss_pred eeeeccCceEEEEEEECCCC----------cEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe
Q 018640 61 RELGRGEFGITYLCTDRENG----------DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 130 (352)
+.||+|+||.||+|.+..++ ..+++|.+.... .....+.+|+.+++.+ +|+||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQL-SHKHLVKLYGVCVR-DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcC-CCcchhheeeEEec-CC
Confidence 46999999999999998766 357888765432 1157788999999999 89999999999887 77
Q ss_pred EEEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCC----CCCCEEEEeccc
Q 018640 131 VHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK----ETAPLKAIDFGL 205 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~----~~~~vkl~Dfg~ 205 (352)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||+++++|+||||+||+++.++ ....++|+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 899999999999999998765 689999999999999999999999999999999999998655 223589999999
Q ss_pred ceecCCCCcccccccccccccchhccc---cCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCC
Q 018640 206 SVFFKPGEKFSEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPW 281 (352)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (352)
+..... .....++..|+|||++.+ .++.++||||||+++|+|++ |..||............. . . ....
T Consensus 155 a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~--~--~~~~ 226 (259)
T cd05037 155 PITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-D--Q--HRLP 226 (259)
T ss_pred cccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-c--C--CCCC
Confidence 986543 223356778999999763 48889999999999999999 577776654332222221 1 1 1111
Q ss_pred cCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 282 ~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
......+.++|.+||+.+|++|||+.++++
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 227 MPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 122478999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=292.98 Aligned_cols=245 Identities=20% Similarity=0.290 Sum_probs=190.8
Q ss_pred eeeeccCceEEEEEEECC--CCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEec
Q 018640 61 RELGRGEFGITYLCTDRE--NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELC 138 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~ 138 (352)
++||+|+||.||+|.... ....+|+|.+.... .......+.+|+.+++.+ +|+||+++++.+......++||||+
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l-~h~nii~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYREL-NHPNVLQCLGQCIESIPYLLVLEFC 77 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhC-CCCCcceEEEEECCCCceEEEEEeC
Confidence 369999999999996432 34568888765432 233345688899999999 8999999999999999999999999
Q ss_pred CCcchHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 139 EGGELFDRIVARG-----HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 139 ~~~sL~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
++++|.+++.... ..++..+..++.||+.||+|||+++|+||||||+||+++.++. +||+|||++.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~---~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS---VKIGDYGLALEQYPED 154 (269)
T ss_pred CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCc---EEEeccccccccccch
Confidence 9999999997643 2467888999999999999999999999999999999976544 8999999986543221
Q ss_pred c---ccccccccccccchhcc--------ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc-ccCC-C
Q 018640 214 K---FSEIVGSPYYMAPEVLK--------RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVL-DFRR-D 279 (352)
Q Consensus 214 ~---~~~~~gt~~y~aPE~~~--------~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~-~~~~-~ 279 (352)
. .....++..|+|||++. ..++.++||||||+++|||++ |..||......+.......... ..+. .
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05042 155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ 234 (269)
T ss_pred heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCc
Confidence 1 12334567899999863 236789999999999999999 7888877766555544443322 1111 1
Q ss_pred CCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 280 PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 280 ~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
....+++.+.+++..|+ .||++|||+.+|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~ 266 (269)
T cd05042 235 LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHEL 266 (269)
T ss_pred ccccCCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence 23357888899999998 599999999999763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=293.91 Aligned_cols=245 Identities=26% Similarity=0.340 Sum_probs=197.9
Q ss_pred eeeeccCceEEEEEEECCCC------cEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 61 RELGRGEFGITYLCTDRENG------DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
+.||+|+||.||+|.+.... ..+|+|.+.... .......+.+|+.+++.+ +||||+++++++......++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNF-NHPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhc-CCCCeeeEeeeecCCCCeEEE
Confidence 36999999999999976433 679999876432 123456788999999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCC--CCCCEEEEeccc
Q 018640 135 MELCEGGELFDRIVAR-------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK--ETAPLKAIDFGL 205 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~--~~~~vkl~Dfg~ 205 (352)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ ....++|+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999998642 2378899999999999999999999999999999999998755 333589999999
Q ss_pred ceecCCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCC
Q 018640 206 SVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDP 280 (352)
Q Consensus 206 a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 280 (352)
+........ .....++..|+|||.+. +.++.++||||||+++|+|++ |..||......+....+... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~---~~~~~ 234 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG---GRLQK 234 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC---CccCC
Confidence 875533221 12234567899999876 558999999999999999998 99999876665544443321 12223
Q ss_pred CcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 281 ~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
...++..+.++|.+||+.+|++||++.++++
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 3467899999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=290.24 Aligned_cols=240 Identities=26% Similarity=0.421 Sum_probs=199.1
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++.+.||+|+||.||++.. +++.||+|.+... ...+.+.+|+.+++++ +|||++++++++..+ ..+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~-----~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~-~~~~v 76 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD-----VTAQAFLEETAVMTKL-HHKNLVRLLGVILHN-GLYIV 76 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCc-----chHHHHHHHHHHHHhC-CCCCcCeEEEEEcCC-CcEEE
Confidence 4699999999999999999864 6888999988543 1246788999999999 899999999998755 47899
Q ss_pred EEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 135 MELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
|||+++++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~---~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGV---AKVSDFGLARVGSMG 153 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCc---EEECCCccceecccc
Confidence 99999999999997653 4789999999999999999999999999999999999976554 899999998764322
Q ss_pred Ccccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHH
Q 018640 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (352)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (352)
. .....+..|+|||.+. +.++.++|+||||+++++|++ |+.||......+....+... ........++..+.+
T Consensus 154 ~--~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 228 (254)
T cd05083 154 V--DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG---YRMEPPEGCPADVYV 228 (254)
T ss_pred C--CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC---CCCCCCCcCCHHHHH
Confidence 1 2234467899999876 558899999999999999997 99999877766554444332 223334568899999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 018640 291 LVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 291 li~~~l~~dP~~Rps~~ell~ 311 (352)
++.+||+.+|++||++.+++.
T Consensus 229 li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 229 LMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=288.43 Aligned_cols=276 Identities=28% Similarity=0.533 Sum_probs=227.5
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe------
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED------ 127 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~------ 127 (352)
.+.|.-..+||+|.||.||+|+.+.+|+.||+|++--+.......+.+ .+|+.+|..+ +|+|++.+++.|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpita-lreikiL~~l-kHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITA-LREIKILQLL-KHENVVNLIEICRTKATPTN 93 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHH-HHHHHHHHHh-cchhHHHHHHHHhhccCCcc
Confidence 345888899999999999999999999999998775543334444444 4699999999 99999999987742
Q ss_pred --CCeEEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecc
Q 018640 128 --DTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (352)
Q Consensus 128 --~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg 204 (352)
...+++|+.+|+. +|.-+|... -+++...+.+++.++.+||.|+|+..|+|||+||+|+|++.++. +||+|||
T Consensus 94 r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgi---lklADFG 169 (376)
T KOG0669|consen 94 RDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGI---LKLADFG 169 (376)
T ss_pred cccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCce---EEeeccc
Confidence 3458999999975 888888766 46999999999999999999999999999999999999975544 8999999
Q ss_pred cceecCCCC-----cccccccccccccchhcc--ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC
Q 018640 205 LSVFFKPGE-----KFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR 277 (352)
Q Consensus 205 ~a~~~~~~~-----~~~~~~gt~~y~aPE~~~--~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 277 (352)
+++...... .++..+-|.+|++||.+- ..++++.|||..||++.||+|+.+-+.+..+...+..+.....+..
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 997654322 234446699999999865 4599999999999999999999999999998888888887777766
Q ss_pred CCCCcCC-------------------------------CHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccCCCCCC
Q 018640 278 RDPWPKV-------------------------------SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSL 326 (352)
Q Consensus 278 ~~~~~~~-------------------------------~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~ 326 (352)
++.||.+ +++..+|+.++|..||.+|+++.++++|.||.. ...|-..+
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k-dp~pqanl 328 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK-DPMPQANL 328 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc-CCcchhhH
Confidence 6666542 356789999999999999999999999999995 34455666
Q ss_pred cHHHHHHHHh
Q 018640 327 GETVKARLKQ 336 (352)
Q Consensus 327 ~~~~~~~~~~ 336 (352)
++-++.+|.+
T Consensus 329 ~~ml~t~~~s 338 (376)
T KOG0669|consen 329 QDMLSTHLQS 338 (376)
T ss_pred HHHHHHhHHH
Confidence 7777777766
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=289.68 Aligned_cols=246 Identities=22% Similarity=0.369 Sum_probs=201.2
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
..++|++.+.||+|+||.||++.+. .+..+|+|.+... ....+.+.+|+.+++.+ +|+||+++.+.+.. ...+
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG----SMSVEAFLAEANVMKTL-QHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC----hhHHHHHHHHHHHHHhc-CCCCcceEEEEEcC-CCeE
Confidence 3567999999999999999999864 4667999987643 22346788999999999 89999999999877 7789
Q ss_pred EEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 133 LVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
++|||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||.+....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~---~~~l~d~~~~~~~~ 153 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL---VCKIADFGLARVIE 153 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC---cEEECCCcceeecc
Confidence 999999999999999764 3478889999999999999999999999999999999997554 48999999987654
Q ss_pred CCCcc--cccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCH
Q 018640 211 PGEKF--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (352)
Q Consensus 211 ~~~~~--~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (352)
..... ....++..|+|||++. +.++.++|+||||++++++++ |..||...........+... .........+.
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 230 (260)
T cd05073 154 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG---YRMPRPENCPE 230 (260)
T ss_pred CCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC---CCCCCcccCCH
Confidence 32211 2224567799999886 458889999999999999998 99999877665555444332 22233456889
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 287 NAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 287 ~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
.+.+++.+||+.+|++||++.+++.
T Consensus 231 ~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 231 ELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHH
Confidence 9999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=322.93 Aligned_cols=248 Identities=24% Similarity=0.388 Sum_probs=215.8
Q ss_pred cceeceeeeccCceEEEEEEECCCC---cEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENG---DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
..+|.++||.|.||.|++|..+..| ..||||.++.. .....+.+|..|+.||.++ +||||++|.|+.......+
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G--ytekqrrdFL~EAsIMGQF-dHPNIIrLEGVVTks~PvM 706 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG--YTEKQRRDFLSEASIMGQF-DHPNIIRLEGVVTKSKPVM 706 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccC--ccHHHHhhhhhhhhhcccC-CCCcEEEEEEEEecCceeE
Confidence 4678899999999999999987655 46999998754 3445567899999999999 9999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 133 LVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
||.|||++|+|+.+|+.+. .|+..++..+++.|+.|++||-+.|+|||||.++|||++++ ..+|++|||+++.+.+
T Consensus 707 IiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsn---LvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSN---LVCKVSDFGLSRVLED 783 (996)
T ss_pred EEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccc---eEEEeccccceeeccc
Confidence 9999999999999998764 69999999999999999999999999999999999999654 4489999999998754
Q ss_pred CC--ccccccc--ccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCC
Q 018640 212 GE--KFSEIVG--SPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (352)
Q Consensus 212 ~~--~~~~~~g--t~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (352)
+. ..++..| ...|.|||.+. ..++.+|||||||++|||.++ |..|||...+++++..+.+.. +.+++..+|
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gy---RLPpPmDCP 860 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGY---RLPPPMDCP 860 (996)
T ss_pred CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhcc---CCCCCCCCc
Confidence 43 2233333 46799999987 779999999999999998665 999999999999998887754 555556899
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 286 ENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 286 ~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
..+.+|+..||++|-.+||.+.+|+.+
T Consensus 861 ~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 861 AALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 999999999999999999999998764
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=328.17 Aligned_cols=257 Identities=27% Similarity=0.467 Sum_probs=201.7
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe----
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED---- 127 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~---- 127 (352)
....+|+.++.||+||||.||+++++-+|..||||++.... +......+.+|+..|.+| +|||||+++..+.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~~~ 552 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARL-NHPNVVRYYSAWVESTAE 552 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccCCc
Confidence 46677999999999999999999999999999999997654 333456788999999999 99999998765421
Q ss_pred --------------------------------------------------------------------------------
Q 018640 128 -------------------------------------------------------------------------------- 127 (352)
Q Consensus 128 -------------------------------------------------------------------------------- 127 (352)
T Consensus 553 ~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~ 632 (1351)
T KOG1035|consen 553 LTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSN 632 (1351)
T ss_pred cccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccc
Confidence
Q ss_pred ---------------------------C--------CeEEEEEEecCCcchHHHHHhcCCC-CHHHHHHHHHHHHHHHHH
Q 018640 128 ---------------------------D--------TAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTKTIVEVVQM 171 (352)
Q Consensus 128 ---------------------------~--------~~~~lv~e~~~~~sL~~~l~~~~~l-~~~~~~~i~~qi~~aL~~ 171 (352)
+ ..+||-||||+..+|.+++..+... .....++++++|++||.|
T Consensus 633 tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 633 TSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHH
Confidence 0 1357889999886676766665443 477899999999999999
Q ss_pred HHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC-------------------CCCcccccccccccccchhccc
Q 018640 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-------------------PGEKFSEIVGSPYYMAPEVLKR 232 (352)
Q Consensus 172 lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~ 232 (352)
+|+.|||||||||.||+++.+.. |||+|||+|+... +....+..+||.-|+|||++.+
T Consensus 713 IH~~giIHRDLKP~NIFLd~~~~---VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQGIIHRDLKPRNIFLDSRNS---VKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhCceeeccCCcceeEEcCCCC---eeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 99999999999999999985544 9999999998721 0113356689999999999862
Q ss_pred ----cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHH
Q 018640 233 ----NYGPEVDVWSAGVILYILLCGVPPFWAETEQG-VAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQ 307 (352)
Q Consensus 233 ----~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ 307 (352)
.|+.|+|+||||++|+||+. ||...++.. .+..+.....+.+...+..--+.-..+|.+|++.||.+||||.
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~ 866 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTAT 866 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHH
Confidence 48999999999999999985 576655543 3333333322222222333334456799999999999999999
Q ss_pred HHhcCccccc
Q 018640 308 QVLEHPWLQN 317 (352)
Q Consensus 308 ell~hp~f~~ 317 (352)
|+|++.||-.
T Consensus 867 eLL~s~llpp 876 (1351)
T KOG1035|consen 867 ELLNSELLPP 876 (1351)
T ss_pred HHhhccCCCc
Confidence 9999999984
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=297.27 Aligned_cols=249 Identities=21% Similarity=0.284 Sum_probs=199.6
Q ss_pred cccceeceeeeccCceEEEEEEECCCCc----EEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGD----AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 129 (352)
.++|++.+.||+|+||.||+|.+..+|+ .||+|.+.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASM-DHPHLVRLLGVCLSP- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhC-CCCCcccEEEEEcCC-
Confidence 3578999999999999999999877776 46888776432 222344688899999999 899999999998754
Q ss_pred eEEEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccccee
Q 018640 130 AVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (352)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~ 208 (352)
..++++||+++|+|.+++.... .+++..+..++.|++.||.|||+++++|+||||+||+++.++. +||+|||+++.
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~---~kL~Dfg~~~~ 158 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH---VKITDFGLARL 158 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCc---eEEcccccccc
Confidence 4678999999999999987654 5899999999999999999999999999999999999975443 89999999986
Q ss_pred cCCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcC
Q 018640 209 FKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (352)
Q Consensus 209 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (352)
...... .....++..|+|||.+. ..++.++||||||+++||+++ |..||.......... +...... ....+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~--~~~~~~ 235 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD-LLEKGER--LPQPPI 235 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHCCCC--CCCCCC
Confidence 543322 12234567899999876 458999999999999999997 899997665444333 3332221 222345
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 284 ~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
.+..+.+++..||..+|++||++.+++..
T Consensus 236 ~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 236 CTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 78899999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=289.60 Aligned_cols=243 Identities=22% Similarity=0.326 Sum_probs=190.4
Q ss_pred eeeeccCceEEEEEEECC---CCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEE-eCCeEEEEEE
Q 018640 61 RELGRGEFGITYLCTDRE---NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE-DDTAVHLVME 136 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~-~~~~~~lv~e 136 (352)
+.||+|+||+||+|.+.. ++..||+|.+... ......+.+.+|+.+++.+ +|||++++++++. .++..++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~lv~e 77 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDF-SHPNVLSLLGICLPSEGSPLVVLP 77 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccC-CCCCcceEEEEeecCCCCcEEEEe
Confidence 468999999999998653 3457999987532 2233456788899999999 9999999999765 4556889999
Q ss_pred ecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC--
Q 018640 137 LCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-- 213 (352)
Q Consensus 137 ~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-- 213 (352)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+++||||||+||+++.++. +||+|||+++......
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~---~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 78 YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT---VKVADFGLARDIYDKEYY 154 (262)
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc---EEECCccccccccCCcce
Confidence 999999999997643 4678888999999999999999999999999999999975544 8999999987543221
Q ss_pred ---cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHH
Q 018640 214 ---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (352)
Q Consensus 214 ---~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (352)
......++..|+|||.+. ..++.++||||||+++|||++ |.+||...........+... .........++.+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 231 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG---RRLLQPEYCPDPL 231 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC---CCCCCCCcCCHHH
Confidence 112334577899999875 558899999999999999999 46666655554443333221 1122223468899
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 289 KDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 289 ~~li~~~l~~dP~~Rps~~ell~h 312 (352)
.+++.+||+.+|++||++.+++..
T Consensus 232 ~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 232 YEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=341.13 Aligned_cols=259 Identities=28% Similarity=0.472 Sum_probs=220.2
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
+.-+++-...||.|.||.||-|.+..+|+..|+|.+...... ......+.+|..++..+ +|||+|+++++-.+++..+
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~l-nHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGL-NHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhc-cCccccccCceeecHHHHH
Confidence 445677788999999999999999999999999988765433 34456788999999999 9999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
|.||||++|+|.+.+....-.++...+.+..|++.|+.|||+.|||||||||+||+++.++ .+|++|||.|..+...
T Consensus 1311 IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g---~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNG---LIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCC---cEEeecccceeEecCc
Confidence 9999999999999998877788888999999999999999999999999999999998655 4999999999877544
Q ss_pred C-----cccccccccccccchhccc----cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcC
Q 018640 213 E-----KFSEIVGSPYYMAPEVLKR----NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (352)
Q Consensus 213 ~-----~~~~~~gt~~y~aPE~~~~----~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (352)
. ......||+.|||||++.+ +...++||||+|||++||+||+.||.....+-.+.-.+. ....+..+..
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~--~gh~Pq~P~~ 1465 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVA--AGHKPQIPER 1465 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHh--ccCCCCCchh
Confidence 2 2245689999999999864 356789999999999999999999977665433333322 2333445556
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 284 ~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
++++..+||.+||+.||+.|-++.|+++|.|-+..
T Consensus 1466 ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1466 LSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred hhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 89999999999999999999999999999988754
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=298.78 Aligned_cols=267 Identities=27% Similarity=0.494 Sum_probs=206.6
Q ss_pred CCccccc-ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCC-------CCee
Q 018640 48 PTGREIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH-------QNIV 119 (352)
Q Consensus 48 ~~~~~~~-~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-------~~iv 119 (352)
..|+.+. .+|.++++||+|.|+|||+|+|.++.+.||+|+.+.... ..+....||++|++++.+ ..||
T Consensus 70 ~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh----YtEaAlDEIklL~~v~~~Dp~~~~~~~VV 145 (590)
T KOG1290|consen 70 RIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH----YTEAALDEIKLLQQVREGDPNDPGKKCVV 145 (590)
T ss_pred eccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH----HHHHHHHHHHHHHHHHhcCCCCCCCceee
Confidence 3467777 899999999999999999999999999999999875432 335567799999988543 3799
Q ss_pred EeeeEEE----eCCeEEEEEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH-cCCEEecCCCCceEeecC
Q 018640 120 CLKDTYE----DDTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANK 192 (352)
Q Consensus 120 ~l~~~~~----~~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dikp~NIll~~~ 192 (352)
+|++.|. ...+++||+|++ |.+|..++.... .++...+.+|++|++.||.|||. .||||.||||+|||+..+
T Consensus 146 ~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 146 QLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCST 224 (590)
T ss_pred eeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeecc
Confidence 9999996 456899999999 789999997654 49999999999999999999996 599999999999999543
Q ss_pred C-------------------------------------------------------------------------------
Q 018640 193 K------------------------------------------------------------------------------- 193 (352)
Q Consensus 193 ~------------------------------------------------------------------------------- 193 (352)
.
T Consensus 225 e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n 304 (590)
T KOG1290|consen 225 EIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYN 304 (590)
T ss_pred ccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccc
Confidence 1
Q ss_pred ---------------------------------C----------------------------------------------
Q 018640 194 ---------------------------------E---------------------------------------------- 194 (352)
Q Consensus 194 ---------------------------------~---------------------------------------------- 194 (352)
.
T Consensus 305 ~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~ 384 (590)
T KOG1290|consen 305 NEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDI 384 (590)
T ss_pred cccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCC
Confidence 0
Q ss_pred -----CCCEEEEecccceecCCCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCC------CH
Q 018640 195 -----TAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAE------TE 262 (352)
Q Consensus 195 -----~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~------~~ 262 (352)
...|||+|||.|.... ..++.-..|..|+|||++- ..|+..+||||++|++|||+||...|... ..
T Consensus 385 ~~~~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rD 462 (590)
T KOG1290|consen 385 PLPECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRD 462 (590)
T ss_pred CCCccceeEEEeeccchhhhh--hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCcc
Confidence 0126677777766543 2234446788999999865 56999999999999999999999888422 12
Q ss_pred HHHHHHHHhcccccCC-------------------------CCCc-------------CCCHHHHHHHHHhcCCCcCCCC
Q 018640 263 QGVAQAIIRSVLDFRR-------------------------DPWP-------------KVSENAKDLVRKMLDPDPKRRL 304 (352)
Q Consensus 263 ~~~~~~~~~~~~~~~~-------------------------~~~~-------------~~~~~~~~li~~~l~~dP~~Rp 304 (352)
+..+..++..+...+. .+|+ ....++.+|+.-||+.+|++||
T Consensus 463 EDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~ 542 (590)
T KOG1290|consen 463 EDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRP 542 (590)
T ss_pred HHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccc
Confidence 2333333333322111 1111 1135578999999999999999
Q ss_pred CHHHHhcCccccccccC
Q 018640 305 TAQQVLEHPWLQNAKKA 321 (352)
Q Consensus 305 s~~ell~hp~f~~~~~~ 321 (352)
||.++|+|||++.....
T Consensus 543 tA~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 543 TAAQCLKHPWLNPVAGP 559 (590)
T ss_pred cHHHHhcCccccCCCCC
Confidence 99999999999976543
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=294.08 Aligned_cols=249 Identities=24% Similarity=0.404 Sum_probs=199.5
Q ss_pred ccceeceeeeccCceEEEEEEEC----CCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe--C
Q 018640 55 ERYELGRELGRGEFGITYLCTDR----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--D 128 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~--~ 128 (352)
++|++.+.||+|+||.||+|... .+++.||+|++...... ...+.+.+|+.+++.+ +|+||+++++++.. .
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l-~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTL-DHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhC-CCCChheEEeeeecCCC
Confidence 46888999999999999999864 34889999998754322 2457899999999999 89999999999877 5
Q ss_pred CeEEEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccce
Q 018640 129 TAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~ 207 (352)
...+++|||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++.
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~---~~~l~dfg~~~ 157 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED---LVKISDFGLAK 157 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC---CEEEccccccc
Confidence 68899999999999999997654 589999999999999999999999999999999999997654 48999999998
Q ss_pred ecCCCCcc----cccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH--------------HHHH
Q 018640 208 FFKPGEKF----SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQG--------------VAQA 268 (352)
Q Consensus 208 ~~~~~~~~----~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~--------------~~~~ 268 (352)
........ ....++..|++||.+. ..++.++||||||++++||++|..|+....... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 76532211 1224456799999876 458899999999999999999999986543221 1111
Q ss_pred HHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 269 IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
..... ........++..+.+++.+||+.+|++|||+.+|++
T Consensus 238 ~~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 238 LLKEG--ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHcC--CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11111 112223456789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=295.72 Aligned_cols=256 Identities=13% Similarity=0.151 Sum_probs=188.0
Q ss_pred cccccccceeceeeeccCceEEEEEEECCC---CcEEEEEEccccccCChhc--------HHHHHHHHHHHHhCCCCCCe
Q 018640 50 GREIEERYELGRELGRGEFGITYLCTDREN---GDAFACKSISKKKLRTAVD--------IEDVRREVDIMRHLPKHQNI 118 (352)
Q Consensus 50 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~--------~~~~~~E~~~l~~l~~h~~i 118 (352)
.+...++|++.+.||+|+||+||+|.+..+ +..+|+|+........... ......+...+..+ .|+++
T Consensus 7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i 85 (294)
T PHA02882 7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGI 85 (294)
T ss_pred eccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCC
Confidence 345567899999999999999999998877 6677777643322111000 01112233445556 79999
Q ss_pred eEeeeEEEeCC----eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCC
Q 018640 119 VCLKDTYEDDT----AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE 194 (352)
Q Consensus 119 v~l~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~ 194 (352)
+.+++++.... ..+++++++. .++.+.+......++..+..++.|++.||.|||+.+++||||||+|||++.++.
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 86 PKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR 164 (294)
T ss_pred CcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc
Confidence 99998765443 4477888874 477777766555788999999999999999999999999999999999975444
Q ss_pred CCCEEEEecccceecCCCC--------cccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHH-H
Q 018640 195 TAPLKAIDFGLSVFFKPGE--------KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQ-G 264 (352)
Q Consensus 195 ~~~vkl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~-~ 264 (352)
++|+|||+|+...... ......||+.|+|||++.+ .++.++||||||++++||++|..||...... .
T Consensus 165 ---~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 165 ---GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred ---EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 8999999997653211 1123469999999998764 4899999999999999999999999766322 2
Q ss_pred HHHH----HHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 265 VAQA----IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 265 ~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
.... ....... .....+..++.+.+++..|+..+|++||++.++++
T Consensus 242 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 242 LIHAAKCDFIKRLHE-GKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHhHHHHHHHhhh-hhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 1111 1111111 11123456899999999999999999999999875
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=308.20 Aligned_cols=245 Identities=26% Similarity=0.380 Sum_probs=206.9
Q ss_pred cceeceeeeccCceEEEEEEECC--CCc--EEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 56 RYELGRELGRGEFGITYLCTDRE--NGD--AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
...+.+.||+|.||.||+|.... .|+ .||||.++... ..++.+.|.+|+.+|+.+ +||||++++|+|.+. ..
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnf-dHphIikLIGv~~e~-P~ 465 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNF-DHPHIIKLIGVCVEQ-PM 465 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhC-CCcchhheeeeeecc-ce
Confidence 34556789999999999999642 233 58899887653 445578999999999999 999999999999866 57
Q ss_pred EEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 132 HLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
|||||.++-|.|..+|..++ .++...+..++.||+.||.|||+..+|||||..+|||+.+. ..|||+|||+++...
T Consensus 466 WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp---~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSP---QCVKLADFGLSRYLE 542 (974)
T ss_pred eEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCc---ceeeecccchhhhcc
Confidence 89999999999999998765 59999999999999999999999999999999999999643 449999999999887
Q ss_pred CCCcccc--cccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCH
Q 018640 211 PGEKFSE--IVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (352)
Q Consensus 211 ~~~~~~~--~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (352)
....+.. ..-...|||||.++ ..++.+||||-||+++||+++ |..||.+..+.+++-.+.+. .+.+.++.+|+
T Consensus 543 d~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnG---eRlP~P~nCPp 619 (974)
T KOG4257|consen 543 DDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENG---ERLPCPPNCPP 619 (974)
T ss_pred ccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCC---CCCCCCCCCCh
Confidence 6654432 23356799999998 679999999999999999887 99999888777665555443 34556678999
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHh
Q 018640 287 NAKDLVRKMLDPDPKRRLTAQQVL 310 (352)
Q Consensus 287 ~~~~li~~~l~~dP~~Rps~~ell 310 (352)
.+..|+.+||.++|.+||.+.++.
T Consensus 620 ~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 620 ALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred HHHHHHHHHhccCcccCCcHHHHH
Confidence 999999999999999999988774
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=295.43 Aligned_cols=258 Identities=28% Similarity=0.494 Sum_probs=231.2
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
..+|.++.+||+|+||.|.+|..+.+.+.+|||++++...-..++.+.-..|-++|....+-|.++++..+|+.-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 35789999999999999999999999999999999988766666666666788889888788899999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec-CCC
Q 018640 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPG 212 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~-~~~ 212 (352)
||||+.||+|-..+.+-+.+.+..+..++.+|+.||=+||++|||.||||.+||+++.++. +||+|||++... ..+
T Consensus 428 VMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGH---iKi~DFGmcKEni~~~ 504 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH---IKIADFGMCKENIFDG 504 (683)
T ss_pred EEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCc---eEeeecccccccccCC
Confidence 9999999999999999899999999999999999999999999999999999999987666 999999999753 344
Q ss_pred Ccccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHH
Q 018640 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (352)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 291 (352)
....+++||+.|+|||++. ..|+..+|.||||++||||+.|.+||.+..+.+..+.+......++ ..++.++.++
T Consensus 505 ~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyP----KslSkEAv~i 580 (683)
T KOG0696|consen 505 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYP----KSLSKEAVAI 580 (683)
T ss_pred cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCc----ccccHHHHHH
Confidence 5667889999999999876 6799999999999999999999999999999998888887655544 5689999999
Q ss_pred HHHhcCCCcCCCCC-----HHHHhcCcccccc
Q 018640 292 VRKMLDPDPKRRLT-----AQQVLEHPWLQNA 318 (352)
Q Consensus 292 i~~~l~~dP~~Rps-----~~ell~hp~f~~~ 318 (352)
....|...|.+|.- -++|-.||||...
T Consensus 581 ckg~ltK~P~kRLGcg~~ge~di~~H~FFR~i 612 (683)
T KOG0696|consen 581 CKGLLTKHPGKRLGCGPEGERDIREHPFFRRI 612 (683)
T ss_pred HHHHhhcCCccccCCCCccccchhhCcchhhc
Confidence 99999999999963 4689999999843
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=315.36 Aligned_cols=200 Identities=32% Similarity=0.538 Sum_probs=178.9
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC------
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT------ 129 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~------ 129 (352)
.+...+.||+|+||.||+++++.+|+.||||.+.... .....+.+-+|+++|+++ +|+|||++.++-++..
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKL-nh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKL-NHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHc-CchhhhhhcccCCccccCcccc
Confidence 4667788999999999999999999999999998764 445678899999999999 7999999999865443
Q ss_pred eEEEEEEecCCcchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCC-CCCCEEEEeccc
Q 018640 130 AVHLVMELCEGGELFDRIVARG---HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK-ETAPLKAIDFGL 205 (352)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~---~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~-~~~~vkl~Dfg~ 205 (352)
..++|||||+||||+..|.... .|++.+.+.+...+..||.|||++||+||||||.||++.... .....||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 6789999999999999997543 499999999999999999999999999999999999986543 344579999999
Q ss_pred ceecCCCCcccccccccccccchhcc--ccCCCcchHHHHHHHHHHHHhCCCCCC
Q 018640 206 SVFFKPGEKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFW 258 (352)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~s~~~Di~SlG~~l~el~tg~~p~~ 258 (352)
|+..+++..+..++||..|.+||.+. +.|+...|.|||||++|+++||..||-
T Consensus 171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~ 225 (732)
T KOG4250|consen 171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFI 225 (732)
T ss_pred cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCC
Confidence 99999999999999999999999987 458999999999999999999999984
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=289.81 Aligned_cols=248 Identities=22% Similarity=0.345 Sum_probs=196.7
Q ss_pred ceeceeeeccCceEEEEEEEC---CCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC----
Q 018640 57 YELGRELGRGEFGITYLCTDR---ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT---- 129 (352)
Q Consensus 57 y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~---- 129 (352)
|++.+.||+|+||.||+|.+. .++..||+|++.... ......+.+.+|+.+++.+ +||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEF-DHPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCCCCc
Confidence 677889999999999999864 357889999986543 2334467788999999999 8999999999886432
Q ss_pred --eEEEEEEecCCcchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEE
Q 018640 130 --AVHLVMELCEGGELFDRIVAR------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAI 201 (352)
Q Consensus 130 --~~~lv~e~~~~~sL~~~l~~~------~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~ 201 (352)
..+++++|+++++|.+++... ..+++..+..++.|++.||+|||+.+++|+||||+||+++.++. +||+
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~---~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMT---VCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCC---EEEC
Confidence 347889999999998887432 14788999999999999999999999999999999999975444 8999
Q ss_pred ecccceecCCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccc
Q 018640 202 DFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDF 276 (352)
Q Consensus 202 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 276 (352)
|||+++....... .....++..|++||.+. ..++.++||||||+++|+|++ |..||......+....+....
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--- 232 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN--- 232 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC---
Confidence 9999886543221 12234567899999876 458889999999999999999 889987766654444433321
Q ss_pred CCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 277 RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 277 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
.....+..++.+.+++.+||+.+|++|||+.+++..
T Consensus 233 ~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 233 RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 112224578999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=286.42 Aligned_cols=244 Identities=22% Similarity=0.302 Sum_probs=188.8
Q ss_pred eeeeccCceEEEEEEECCC--CcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEec
Q 018640 61 RELGRGEFGITYLCTDREN--GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELC 138 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~ 138 (352)
++||+|+||+||+|....+ ...+++|.+.... .....+.+.+|+.+++.+ +||||+++++.+......++||||+
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 77 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRIL-QHPNILQCLGQCVEAIPYLLVFEYC 77 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhcc-CCcchhheEEEecCCCccEEEEecC
Confidence 3699999999999975432 2345667655432 223456789999999999 9999999999999999999999999
Q ss_pred CCcchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC--
Q 018640 139 EGGELFDRIVAR----GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-- 212 (352)
Q Consensus 139 ~~~sL~~~l~~~----~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~-- 212 (352)
++++|.+++... ..++...+..++.|++.||+|||+.+++|+||||+|||++.++. ++|+|||++......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~---~~l~Dfg~~~~~~~~~~ 154 (268)
T cd05086 78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLT---VKVGDYGIGPSRYKEDY 154 (268)
T ss_pred CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCcc---EEecccccccccCcchh
Confidence 999999999754 23567788899999999999999999999999999999975544 899999988643211
Q ss_pred -Ccccccccccccccchhccc--------cCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc-c-cCCCC
Q 018640 213 -EKFSEIVGSPYYMAPEVLKR--------NYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVL-D-FRRDP 280 (352)
Q Consensus 213 -~~~~~~~gt~~y~aPE~~~~--------~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~-~-~~~~~ 280 (352)
.......++..|+|||++.. .++.++||||||+++|||++ |..||......+....+..... . ..+..
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQL 234 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCcc
Confidence 11234467889999998642 25678999999999999997 5778876666555554433321 1 12222
Q ss_pred CcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 281 ~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
...+++.+.+++..|| .+|++||++.+|++
T Consensus 235 ~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 235 ELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred CCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 3457889999999999 67999999999965
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=285.86 Aligned_cols=258 Identities=21% Similarity=0.294 Sum_probs=209.7
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++.+-+..||.|+||+|++-..+.+|+..|||+++.... .-...++..|.....+-.+.||||+++|.+-.++..|++
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiC 141 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWIC 141 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeee
Confidence 356667889999999999999999999999999986543 334567888998888887999999999999888889999
Q ss_pred EEecCCcchHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEecCCCCceEeecCCCCCCEEEEeccccee
Q 018640 135 MELCEGGELFDRIV-----ARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (352)
Q Consensus 135 ~e~~~~~sL~~~l~-----~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~ 208 (352)
||.|+ .||..+.+ +...+++..+-.|...++.||.||-. ..|||||+||+|||++..+. |||||||++..
T Consensus 142 MELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~---vKLCDFGIcGq 217 (361)
T KOG1006|consen 142 MELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGD---VKLCDFGICGQ 217 (361)
T ss_pred HHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCC---EeeecccchHh
Confidence 99995 47765543 34569999999999999999999985 58999999999999976555 99999999987
Q ss_pred cCCCCcccccccccccccchhcc---ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCC-----
Q 018640 209 FKPGEKFSEIVGSPYYMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP----- 280 (352)
Q Consensus 209 ~~~~~~~~~~~gt~~y~aPE~~~---~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 280 (352)
+...-..+.-.|-..|||||.+. .+|+.+||+||||++|+|+.||+.||..-.. +..++..-...-++..
T Consensus 218 Lv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l~~~~~ 295 (361)
T KOG1006|consen 218 LVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPILLFDKE 295 (361)
T ss_pred HHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCeecCccc
Confidence 65544445568889999999875 3489999999999999999999999965543 2333332222212111
Q ss_pred CcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 281 ~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
.-.++..++.+|.-||.+|-..||+..+++.+||+..-..
T Consensus 296 ~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~ 335 (361)
T KOG1006|consen 296 CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV 335 (361)
T ss_pred ccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence 1247899999999999999999999999999999986533
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=304.69 Aligned_cols=258 Identities=30% Similarity=0.531 Sum_probs=234.7
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
.+++++..||-|+||.|-++........+|+|.+++....+....+.+..|-++|... +.|.||+++..|.+....|++
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~-~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMEC-RSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhc-CchHHHHHHHHhccchhhhhh
Confidence 4577888999999999999987766667999999998888888888999999999999 799999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCc
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (352)
||-|-||.|+..|..++.|.....+.++..+++|++|||++|||.|||||+|.+++.++- +||.|||+|+.+..+..
T Consensus 499 mEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy---~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGY---LKLVDFGFAKKIGSGRK 575 (732)
T ss_pred HHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCc---eEEeehhhHHHhccCCc
Confidence 999999999999999999999999999999999999999999999999999999975554 89999999999998888
Q ss_pred ccccccccccccchhc-cccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHH
Q 018640 215 FSEIVGSPYYMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (352)
Q Consensus 215 ~~~~~gt~~y~aPE~~-~~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 293 (352)
..+++||+.|.|||++ +.+.+..+|.||||++++||++|.+||.+..+......+...+..+.. +..++....+||+
T Consensus 576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~--Pr~I~k~a~~Lik 653 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEF--PRRITKTATDLIK 653 (732)
T ss_pred eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhc--ccccchhHHHHHH
Confidence 8899999999999975 577999999999999999999999999999888888888777654432 2568899999999
Q ss_pred HhcCCCcCCCCC-----HHHHhcCcccccc
Q 018640 294 KMLDPDPKRRLT-----AQQVLEHPWLQNA 318 (352)
Q Consensus 294 ~~l~~dP~~Rps-----~~ell~hp~f~~~ 318 (352)
++-..+|.+|.- +.+|-.|.||...
T Consensus 654 ~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gf 683 (732)
T KOG0614|consen 654 KLCRDNPTERLGYQKGGINDIKKHRWFEGF 683 (732)
T ss_pred HHHhcCcHhhhccccCChHHHHhhhhhhcC
Confidence 999999999984 8999999999854
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=300.36 Aligned_cols=254 Identities=24% Similarity=0.355 Sum_probs=211.5
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
.+...++++||+|-||.|.+|.. ..+..||+|.++.... .....+|.+|+++|.+| +||||+.++++|..++.+++
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~--~~~r~~F~kEIkiLsqL-khPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDAT--KNARNDFLKEIKILSRL-KHPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred hhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccc--hhHHHHHHHHHHHHhcc-CCCCeeEEEeeeecCCchHH
Confidence 34688899999999999999985 4479999999987643 33457899999999999 99999999999999999999
Q ss_pred EEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 134 VMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
|+||+++|+|.+++.++. .+.-.....|+.||+.||+||.+.++|||||.+.|+|++.++. +||+|||+++.+..
T Consensus 613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~---iKiadfgmsR~lys 689 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFT---IKIADFGMSRNLYS 689 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCccc---EEecCccccccccc
Confidence 999999999999998773 2355667779999999999999999999999999999975554 89999999997655
Q ss_pred CCcc---cccccccccccchhc-cccCCCcchHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHhcccccCC----CCC
Q 018640 212 GEKF---SEIVGSPYYMAPEVL-KRNYGPEVDVWSAGVILYILLC--GVPPFWAETEQGVAQAIIRSVLDFRR----DPW 281 (352)
Q Consensus 212 ~~~~---~~~~gt~~y~aPE~~-~~~~s~~~Di~SlG~~l~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~ 281 (352)
+..+ ...+-...|||||.+ .+.++.++|+|+||+++||+++ ...||.....+++..+.-........ ..+
T Consensus 690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P 769 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRP 769 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCC
Confidence 5443 234557899999975 5889999999999999999765 78899888887776665544433222 224
Q ss_pred cCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccc
Q 018640 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316 (352)
Q Consensus 282 ~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~ 316 (352)
+-++..+.+++..||..+-.+|||++++ |-+|+
T Consensus 770 ~~cp~~lyelml~Cw~~es~~RPsFe~l--h~~lq 802 (807)
T KOG1094|consen 770 PACPQGLYELMLRCWRRESEQRPSFEQL--HLFLQ 802 (807)
T ss_pred CcCcHHHHHHHHHHhchhhhcCCCHHHH--HHHHH
Confidence 5689999999999999999999999999 44444
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=282.03 Aligned_cols=260 Identities=25% Similarity=0.485 Sum_probs=223.4
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
.+|.++.+||+|+|+.|.++..+++.+.+|+|+++++-..+..+++=...|-.+..+..+||.+|-+..+|+.+..+++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 47999999999999999999999999999999999988777777777788989999988999999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec-CCCC
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGE 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~-~~~~ 213 (352)
.||++||+|--.+.++..++++.++.+..+|..||.|||++|||.||||.+|+|++.++. +||+|+|+++.. .++.
T Consensus 330 ieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaegh---ikltdygmcke~l~~gd 406 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGH---IKLTDYGMCKEGLGPGD 406 (593)
T ss_pred EEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCc---eeecccchhhcCCCCCc
Confidence 999999999888888888999999999999999999999999999999999999986665 899999999754 4555
Q ss_pred cccccccccccccchhcccc-CCCcchHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhcccccCCCCCcCCCHHH
Q 018640 214 KFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAE----TEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (352)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~~~-~s~~~Di~SlG~~l~el~tg~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (352)
..++++||+.|.|||++++. |+...|.|+||++++||+.|+.||.-. ...+.-..+.+-+.......+..++...
T Consensus 407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsvka 486 (593)
T KOG0695|consen 407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKA 486 (593)
T ss_pred ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeehhh
Confidence 66889999999999999864 999999999999999999999999421 1122222222222222223334678888
Q ss_pred HHHHHHhcCCCcCCCC------CHHHHhcCccccc
Q 018640 289 KDLVRKMLDPDPKRRL------TAQQVLEHPWLQN 317 (352)
Q Consensus 289 ~~li~~~l~~dP~~Rp------s~~ell~hp~f~~ 317 (352)
..+++..|++||.+|. -+.++-.||||..
T Consensus 487 s~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 487 SHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred HHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 8999999999999996 4789999999984
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=276.28 Aligned_cols=243 Identities=44% Similarity=0.733 Sum_probs=203.0
Q ss_pred CceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEecCCcchHHH
Q 018640 67 EFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDR 146 (352)
Q Consensus 67 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~ 146 (352)
+||.||+|.+..+|+.+|+|++........ .+.+.+|+..++++ +|+|++++++.+......++++||+++++|.++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKL-KHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhC-CCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence 589999999998899999999876533221 57899999999999 999999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCccccccccccccc
Q 018640 147 IVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMA 226 (352)
Q Consensus 147 l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~a 226 (352)
+.....+++..+..++.+++.++.+||+.+++|+||+|.||+++.++ .++|+|||.+.............++..|++
T Consensus 78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 154 (244)
T smart00220 78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDG---HVKLADFGLARQLDPGGLLTTFVGTPEYMA 154 (244)
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC---cEEEccccceeeeccccccccccCCcCCCC
Confidence 98776689999999999999999999999999999999999998654 489999999987765444455678899999
Q ss_pred chhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCC
Q 018640 227 PEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLT 305 (352)
Q Consensus 227 PE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps 305 (352)
||.+. ..++.++||||||++++++++|..||..........................++..+.+++.+||..+|++||+
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 234 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT 234 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence 99876 55888999999999999999999999773333333333222111111111127899999999999999999999
Q ss_pred HHHHhcCccc
Q 018640 306 AQQVLEHPWL 315 (352)
Q Consensus 306 ~~ell~hp~f 315 (352)
+.++++||||
T Consensus 235 ~~~~~~~~~~ 244 (244)
T smart00220 235 AEEALQHPFF 244 (244)
T ss_pred HHHHhhCCCC
Confidence 9999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=304.57 Aligned_cols=255 Identities=25% Similarity=0.349 Sum_probs=212.1
Q ss_pred cccceeceeeeccCceEEEEEEECCC-C--cEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe
Q 018640 54 EERYELGRELGRGEFGITYLCTDREN-G--DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 130 (352)
+++.++.++||+|+||+|++|.|..- | ..||||.+....... ..+.|.+|+.+|.+| +|+|+++|+|+..+ ..
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L-~H~hliRLyGvVl~-qp 184 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKL-QHPHLIRLYGVVLD-QP 184 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhc-cCcceeEEeeeecc-ch
Confidence 34677889999999999999998643 3 358999987654332 568899999999999 99999999999887 67
Q ss_pred EEEEEEecCCcchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccccee
Q 018640 131 VHLVMELCEGGELFDRIVA--RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~ 208 (352)
..+|+|++++|||.+.|.+ +..|....+..++.||+.||.||.++++|||||-.+|+|+.. ...|||+|||+.+.
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllas---prtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLAS---PRTVKICDFGLMRA 261 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecc---cceeeeecccceec
Confidence 8899999999999999987 345888999999999999999999999999999999999964 45599999999998
Q ss_pred cCCCCccccc----ccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCc
Q 018640 209 FKPGEKFSEI----VGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282 (352)
Q Consensus 209 ~~~~~~~~~~----~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (352)
+..++.+..+ .-...|+|||.++ ..++.++|||+||++||||+| |..||-+.....+++.+-. .-+...+.
T Consensus 262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~---~erLpRPk 338 (1039)
T KOG0199|consen 262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDA---GERLPRPK 338 (1039)
T ss_pred cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccc---cccCCCCC
Confidence 8766554322 2245699999998 679999999999999999998 8899988887766655542 23344456
Q ss_pred CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 283 ~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
.+++++.+++..||..+|.+|||+..|.+.-+...+
T Consensus 339 ~csedIY~imk~cWah~paDRptFsair~~~~l~ea 374 (1039)
T KOG0199|consen 339 YCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEA 374 (1039)
T ss_pred CChHHHHHHHHHhccCCccccccHHHHHHhHHHHhc
Confidence 789999999999999999999999999765444433
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=293.60 Aligned_cols=264 Identities=31% Similarity=0.446 Sum_probs=217.2
Q ss_pred ccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCCh----hcHHHHHHHHHHHHhCCCCCCeeEeeeEEE
Q 018640 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA----VDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (352)
Q Consensus 51 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~ 126 (352)
..++++|-++.+||+|||+.||+|.|....++||||+-........ ......-+|.++.+.| +||.||+++++|.
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlYDyfs 537 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLYDYFS 537 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Ccceeeeeeeeee
Confidence 4567889999999999999999999999999999997654322111 1123456799999999 9999999999996
Q ss_pred -eCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--CCEEecCCCCceEeecCCCCCCEEEEec
Q 018640 127 -DDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH--GVMHRDLKPENFLFANKKETAPLKAIDF 203 (352)
Q Consensus 127 -~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~--~ivH~Dikp~NIll~~~~~~~~vkl~Df 203 (352)
+.+.++-|+|||+|.+|.-+|+.+..+++.+++.|+.||+.||.||... .|||-||||.|||+.+....+.+||+||
T Consensus 538 lDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 538 LDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred eccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence 5567888999999999999999999999999999999999999999975 5999999999999988777778999999
Q ss_pred ccceecCCCC--------cccccccccccccchhcc-c----cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHH
Q 018640 204 GLSVFFKPGE--------KFSEIVGSPYYMAPEVLK-R----NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAI 269 (352)
Q Consensus 204 g~a~~~~~~~--------~~~~~~gt~~y~aPE~~~-~----~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~-~~~ 269 (352)
|++..+..+. ..+...||-+|++||.+. + ..+.+.||||.|+++|.++.|+.||........+ +..
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN 697 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN 697 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence 9999875432 225668999999999764 2 3788999999999999999999999766443222 111
Q ss_pred --H-hcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccc
Q 018640 270 --I-RSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (352)
Q Consensus 270 --~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~ 317 (352)
+ ..-..++ .-+.++.+..+||++||++.-++|....++..||||..
T Consensus 698 TIlkAtEVqFP--~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 698 TILKATEVQFP--PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred chhcceeccCC--CCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 1 1111222 23578999999999999999999999999999999985
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=313.20 Aligned_cols=256 Identities=20% Similarity=0.309 Sum_probs=176.1
Q ss_pred ccccceeceeeeccCceEEEEEEECCC----CcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeE----
Q 018640 53 IEERYELGRELGRGEFGITYLCTDREN----GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDT---- 124 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~---- 124 (352)
..++|.+.+.||+|+||.||+|.+..+ +..||+|++.... ..+.+..| .+... .+.++..++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-----~~e~~~~e--~l~~~-~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-----AVEIWMNE--RVRRA-CPNSCADFVYGFLEP 201 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-----hhHHHHHH--HHHhh-chhhHHHHHHhhhcc
Confidence 346899999999999999999999888 8999999875321 11112211 11222 22223222221
Q ss_pred --EEeCCeEEEEEEecCCcchHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHHcCCEEecC
Q 018640 125 --YEDDTAVHLVMELCEGGELFDRIVARGH--------------------YTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182 (352)
Q Consensus 125 --~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------------------l~~~~~~~i~~qi~~aL~~lH~~~ivH~Di 182 (352)
.......++|+||+++++|.+++..... .....+..++.|++.||+|||+.+|+||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 2455688999999999999998865421 123446789999999999999999999999
Q ss_pred CCCceEeecCCCCCCEEEEecccceecCCCC--cccccccccccccchhcc-c----------------------cCCCc
Q 018640 183 KPENFLFANKKETAPLKAIDFGLSVFFKPGE--KFSEIVGSPYYMAPEVLK-R----------------------NYGPE 237 (352)
Q Consensus 183 kp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~----------------------~~s~~ 237 (352)
||+|||++.+. ..+||+|||+|+...... ......+|+.|+|||.+. . .++.+
T Consensus 282 KP~NILl~~~~--~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 282 KPQNIIFSEGS--GSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred CHHHEEEeCCC--CcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 99999997432 348999999997653322 224568899999999653 1 12345
Q ss_pred chHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-c---cc----CC----------CCCcCCCHHHHHHHHHhcCCC
Q 018640 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV-L---DF----RR----------DPWPKVSENAKDLVRKMLDPD 299 (352)
Q Consensus 238 ~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~-~---~~----~~----------~~~~~~~~~~~~li~~~l~~d 299 (352)
+|||||||+||||+++..++.... .......... . .+ .. ..........++||.+||+.|
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~~--~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSNL--IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchHH--HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 699999999999999776653221 1111111100 0 00 00 001112344568999999999
Q ss_pred cCCCCCHHHHhcCcccccccc
Q 018640 300 PKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 300 P~~Rps~~ell~hp~f~~~~~ 320 (352)
|++|||+.++|+||||+....
T Consensus 438 P~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 438 GRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred cccCCCHHHHhCCcCcCCCCc
Confidence 999999999999999997544
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=267.55 Aligned_cols=256 Identities=28% Similarity=0.547 Sum_probs=210.0
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC--CeE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--TAV 131 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~--~~~ 131 (352)
.++|++++.+|+|-|+.||.|....+++.++||+++. .....+.+|+.+|..|..+|||+.+++...+. ..+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 3579999999999999999999999999999999864 34578999999999998899999999998654 477
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
.||+||+.+.+..... ..++...++..+.+++.||.|+|+.||+|||+||.|++++.... .++|+|+|+|..+.+
T Consensus 111 aLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~r--kLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHP 185 (338)
T ss_pred hhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhc--eeeeeecchHhhcCC
Confidence 8999999876654443 24888899999999999999999999999999999999985443 489999999999888
Q ss_pred CCcccccccccccccchhcc--ccCCCcchHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcccc-------------
Q 018640 212 GEKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVLD------------- 275 (352)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~--~~~s~~~Di~SlG~~l~el~tg~~p~~~~-~~~~~~~~~~~~~~~------------- 275 (352)
+...+-.+.+..|-.||.+. ..|+..-|+|||||++..|+..+.||... .+.+++-.+..-+..
T Consensus 186 ~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~ 265 (338)
T KOG0668|consen 186 GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID 265 (338)
T ss_pred CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence 87777778888999999886 45899999999999999999999998544 333333333222211
Q ss_pred -----------cCCCCCc---------CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 276 -----------FRRDPWP---------KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 276 -----------~~~~~~~---------~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
.....|. -.++++.||+..+|..|-++|||+.|++.||||....+
T Consensus 266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~ 330 (338)
T KOG0668|consen 266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVRE 330 (338)
T ss_pred CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHH
Confidence 0011111 14688999999999999999999999999999986543
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=299.25 Aligned_cols=258 Identities=30% Similarity=0.515 Sum_probs=223.1
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
-|..++.||-|+||.|.++...++...+|.|.+.+............+.|-.||..- +++-||+|+..|.+.+.+|+||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEEEeccCCceEEEE
Confidence 478889999999999999999899999999999887766666677788899999998 8999999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC-----
Q 018640 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK----- 210 (352)
Q Consensus 136 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~----- 210 (352)
+|++||++-.+|.+-+-|++..++.++.++..|+++.|+.|+|||||||+||||+.++. |||+|||+++-+.
T Consensus 709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGH---IKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH---IKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCc---eeeeeccccccceecccc
Confidence 99999999999999889999999999999999999999999999999999999987666 9999999986431
Q ss_pred ----CCC-----------------c-----------------ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHH
Q 018640 211 ----PGE-----------------K-----------------FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILL 251 (352)
Q Consensus 211 ----~~~-----------------~-----------------~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~ 251 (352)
.+. . ....+||..|+|||++. .+++...|.||.|+|||||+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 000 0 01247999999999976 56999999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCC---CHHHHhcCcccccc
Q 018640 252 CGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRL---TAQQVLEHPWLQNA 318 (352)
Q Consensus 252 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp---s~~ell~hp~f~~~ 318 (352)
.|+.||......+....++++-........-.++.++.++|.++.. +++.|. -+++|-.||||+.+
T Consensus 866 ~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgI 934 (1034)
T KOG0608|consen 866 VGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGI 934 (1034)
T ss_pred hCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCcccccc
Confidence 9999999888887777777766555555556799999999987654 467776 57789999999965
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=303.39 Aligned_cols=256 Identities=25% Similarity=0.462 Sum_probs=215.9
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEE-----e
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE-----D 127 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~-----~ 127 (352)
-.+.|.|.++||.|.+|.||+++...++..+|+|+..... +..++++.|.++|+.+..|||++.++++|. .
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 3456999999999999999999999999999999886542 334778899999999999999999999985 4
Q ss_pred CCeEEEEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccc
Q 018640 128 DTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (352)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~ 205 (352)
++.+|||||||.|||..|+++.- .++.|..+.-|++.++.||.+||.+.++|||||=.|||++.++. |||+|||.
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~---VKLvDFGv 169 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAE---VKLVDFGV 169 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCc---EEEeeeee
Confidence 56899999999999999998753 46899999999999999999999999999999999999987666 99999999
Q ss_pred ceecCCC-Ccccccccccccccchhccc------cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC
Q 018640 206 SVFFKPG-EKFSEIVGSPYYMAPEVLKR------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR 278 (352)
Q Consensus 206 a~~~~~~-~~~~~~~gt~~y~aPE~~~~------~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 278 (352)
+...+.. ....+..||+.|||||++.. .|+..+|+||||++..||.-|.+|+....+...+..+.+ ..++
T Consensus 170 SaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR---NPPP 246 (953)
T KOG0587|consen 170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPPP 246 (953)
T ss_pred eeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC---CCCc
Confidence 9877544 33467799999999998752 367789999999999999999999977665433322221 1111
Q ss_pred --CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 279 --DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 279 --~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
..+...++++.+||..||..|-++||+..++|.|||++..
T Consensus 247 kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 247 KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred cccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 1234578999999999999999999999999999999943
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=294.09 Aligned_cols=260 Identities=22% Similarity=0.292 Sum_probs=184.8
Q ss_pred cccceeceeeeccCceEEEEEEEC----------------CCCcEEEEEEccccccCCh-----------hcHHHHHHHH
Q 018640 54 EERYELGRELGRGEFGITYLCTDR----------------ENGDAFACKSISKKKLRTA-----------VDIEDVRREV 106 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~~~~~-----------~~~~~~~~E~ 106 (352)
.++|++.++||+|+||+||+|.+. ..++.||||++........ ...+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 568999999999999999999752 3456799999864321100 0112234477
Q ss_pred HHHHhCCCCCC-----eeEeeeEEEe--------CCeEEEEEEecCCcchHHHHHhc-----------------------
Q 018640 107 DIMRHLPKHQN-----IVCLKDTYED--------DTAVHLVMELCEGGELFDRIVAR----------------------- 150 (352)
Q Consensus 107 ~~l~~l~~h~~-----iv~l~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~----------------------- 150 (352)
..+.++ +|.+ +++++++|.. .+..++||||+++++|.+++...
T Consensus 224 ~~l~~l-~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 224 YMCAKI-KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHh-hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777 4443 3667777643 35689999999999999988632
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCcccc--cccccccccc
Q 018640 151 -GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE--IVGSPYYMAP 227 (352)
Q Consensus 151 -~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~--~~gt~~y~aP 227 (352)
..+++..++.++.|++.||.|||+.+|+||||||+||+++.++. +||+|||++........... ..+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~---~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ---VKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCc---EEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12356778899999999999999999999999999999976543 89999999976543332222 2347899999
Q ss_pred hhcccc---------------------C--CCcchHHHHHHHHHHHHhCCC-CCCCCCHHHHH--------HHHHh-ccc
Q 018640 228 EVLKRN---------------------Y--GPEVDVWSAGVILYILLCGVP-PFWAETEQGVA--------QAIIR-SVL 274 (352)
Q Consensus 228 E~~~~~---------------------~--s~~~Di~SlG~~l~el~tg~~-p~~~~~~~~~~--------~~~~~-~~~ 274 (352)
|.+... + ..+.|+||+||++++|++|.. |+......... ..... ...
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 986421 1 124799999999999999875 66432211110 00000 001
Q ss_pred ccCCCCCcCCCHHHHHHHHHhcCCCc---CCCCCHHHHhcCccccc
Q 018640 275 DFRRDPWPKVSENAKDLVRKMLDPDP---KRRLTAQQVLEHPWLQN 317 (352)
Q Consensus 275 ~~~~~~~~~~~~~~~~li~~~l~~dP---~~Rps~~ell~hp~f~~ 317 (352)
......++..++..++|+.+||..+| .+|+|+.|+|+||||.+
T Consensus 460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 12223455678999999999999766 68999999999999974
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=303.94 Aligned_cols=251 Identities=28% Similarity=0.449 Sum_probs=197.7
Q ss_pred ceeceeeeccCceE-EEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 57 YELGRELGRGEFGI-TYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 57 y~~~~~lG~G~~g~-Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
|.-.+++|.|+.|+ ||+|... |+.||||++-.+. .+-..+|+..|..-..|||||++++.-.+++..||+.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 45567899999986 8999874 8899999885432 3456789999999999999999999999999999999
Q ss_pred EecCCcchHHHHHhcC-C---CCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecC--CCCCCEEEEecccceec
Q 018640 136 ELCEGGELFDRIVARG-H---YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK--KETAPLKAIDFGLSVFF 209 (352)
Q Consensus 136 e~~~~~sL~~~l~~~~-~---l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~--~~~~~vkl~Dfg~a~~~ 209 (352)
|.|.. +|.+++.... . ......+.++.|++.||++||+.+||||||||.||||+.. .....++|+|||+++.+
T Consensus 583 ELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 583 ELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 99965 9999998741 1 1224568889999999999999999999999999999863 22356899999999987
Q ss_pred CCCCc----ccccccccccccchhcccc-CCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcC
Q 018640 210 KPGEK----FSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (352)
Q Consensus 210 ~~~~~----~~~~~gt~~y~aPE~~~~~-~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (352)
..+.. .....||-+|+|||++... -+.++|||||||++|+.++ |..||......+. .+.........-. +.
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~~L~-~~ 738 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLVHLE-PL 738 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccceeeec-cC
Confidence 65542 3566899999999998744 6778999999999998887 5999976554422 2222221111000 11
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 284 ~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
...++.+||.+|++++|..||+|.+||.||||.+-.
T Consensus 739 ~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~e 774 (903)
T KOG1027|consen 739 PDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSE 774 (903)
T ss_pred chHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChH
Confidence 122789999999999999999999999999999643
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=291.15 Aligned_cols=262 Identities=26% Similarity=0.438 Sum_probs=215.3
Q ss_pred CCcccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCC-----CCCeeEee
Q 018640 48 PTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK-----HQNIVCLK 122 (352)
Q Consensus 48 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~-----h~~iv~l~ 122 (352)
..|..+..+|.+....|+|-|++|..|.+..-|..||||++.+..... ..-..|+++|++|.. -.++++++
T Consensus 425 ~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~----KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 425 RIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH----KTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred ehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh----hhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 346678889999999999999999999999999999999998764433 334569999999942 34899999
Q ss_pred eEEEeCCeEEEEEEecCCcchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEE
Q 018640 123 DTYEDDTAVHLVMELCEGGELFDRIVARGH---YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLK 199 (352)
Q Consensus 123 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vk 199 (352)
..|...+++|||+|-+. .+|.+.|+..+. |....++.++.|++.||..|-..||+|.||||+|||++.. ..++|
T Consensus 501 r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~--k~iLK 577 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNES--KNILK 577 (752)
T ss_pred HHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccC--cceee
Confidence 99999999999999994 599999987653 8899999999999999999999999999999999999743 34589
Q ss_pred EEecccceecCCCCcccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC
Q 018640 200 AIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR 278 (352)
Q Consensus 200 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 278 (352)
|||||.|......+. +...-+..|.|||++-| .|+...|+||.||+||||+||+..|.+.++...+.-.......++.
T Consensus 578 LCDfGSA~~~~enei-tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~ 656 (752)
T KOG0670|consen 578 LCDFGSASFASENEI-TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN 656 (752)
T ss_pred eccCccccccccccc-cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence 999999987655443 33345677999998764 6999999999999999999999999988877766555544443321
Q ss_pred CCC-------------------------------------------------cCC-------CHHHHHHHHHhcCCCcCC
Q 018640 279 DPW-------------------------------------------------PKV-------SENAKDLVRKMLDPDPKR 302 (352)
Q Consensus 279 ~~~-------------------------------------------------~~~-------~~~~~~li~~~l~~dP~~ 302 (352)
..+ +.+ -..+.+|+.+||..||++
T Consensus 657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K 736 (752)
T KOG0670|consen 657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK 736 (752)
T ss_pred HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence 100 001 245779999999999999
Q ss_pred CCCHHHHhcCccccc
Q 018640 303 RLTAQQVLEHPWLQN 317 (352)
Q Consensus 303 Rps~~ell~hp~f~~ 317 (352)
|.|..++|.||||..
T Consensus 737 Rit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 737 RITVNQALKHPFITE 751 (752)
T ss_pred cCCHHHHhcCCcccC
Confidence 999999999999974
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=270.15 Aligned_cols=257 Identities=28% Similarity=0.457 Sum_probs=212.5
Q ss_pred ccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC--
Q 018640 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD-- 128 (352)
Q Consensus 51 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~-- 128 (352)
..+..+|.-+..+|.|.- .|..|-|.-.+..||+|++... +.......+..+|...+..+ +|+|+++++.+|...
T Consensus 13 ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v-~~~nii~l~n~ftP~~~ 89 (369)
T KOG0665|consen 13 FTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCV-NHKNIISLLNVFTPQKT 89 (369)
T ss_pred eeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhh-cccceeeeeeccCcccc
Confidence 346678999999999999 7888889889999999998877 44455667888899999999 999999999998533
Q ss_pred ----CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecc
Q 018640 129 ----TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (352)
Q Consensus 129 ----~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg 204 (352)
...++|||++. .+|.+.+. -.+....+..|..|++.|++|||+.||+||||||+||++..+ +.+||.|||
T Consensus 90 l~~~~e~y~v~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~---~~lKi~dfg 163 (369)
T KOG0665|consen 90 LEEFQEVYLVMELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSD---CTLKILDFG 163 (369)
T ss_pred HHHHHhHHHHHHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecch---hheeeccch
Confidence 46799999995 58888776 347888999999999999999999999999999999999644 448999999
Q ss_pred cceecCCCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCC----
Q 018640 205 LSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD---- 279 (352)
Q Consensus 205 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 279 (352)
+|+.....-..+..+.|..|.|||++- .++...+||||+||++.||++|...|.+...-++...+.+......+.
T Consensus 164 ~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 164 LARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred hhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 998766555567778899999999864 459999999999999999999999998776666555555544432111
Q ss_pred ---------------------------CCc-------CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccc
Q 018640 280 ---------------------------PWP-------KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316 (352)
Q Consensus 280 ---------------------------~~~-------~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~ 316 (352)
.++ .-...+++++.+||-.||++|.|++++|+||||+
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 111 1134578999999999999999999999999997
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=294.40 Aligned_cols=249 Identities=24% Similarity=0.389 Sum_probs=204.3
Q ss_pred ccceeceeeeccCceEEEEEEEC----C---CCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe
Q 018640 55 ERYELGRELGRGEFGITYLCTDR----E---NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~----~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 127 (352)
++..+.+.||+|+||.|++|... . ....||||.+...... .+.+.+..|+.+|+.+..|+||+.+++++..
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 34567779999999999999743 1 1457999988765432 5678899999999999999999999999999
Q ss_pred CCeEEEEEEecCCcchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeec
Q 018640 128 DTAVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFAN 191 (352)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~ 191 (352)
++..++|+||+..|+|.+++..+. .++...+..++.||+.|++||++..+|||||-.+|||+..
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITK 453 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecC
Confidence 999999999999999999998765 3888999999999999999999999999999999999965
Q ss_pred CCCCCCEEEEecccceecCCCCccc--cccc--ccccccchhccc-cCCCcchHHHHHHHHHHHHh-CCCCCCCCC-HHH
Q 018640 192 KKETAPLKAIDFGLSVFFKPGEKFS--EIVG--SPYYMAPEVLKR-NYGPEVDVWSAGVILYILLC-GVPPFWAET-EQG 264 (352)
Q Consensus 192 ~~~~~~vkl~Dfg~a~~~~~~~~~~--~~~g--t~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~t-g~~p~~~~~-~~~ 264 (352)
+ ..+||+|||+|+......... ...| ...|||||.+.. .++.++||||||++|||+++ |..||.+.. ..+
T Consensus 454 ~---~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~ 530 (609)
T KOG0200|consen 454 N---KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE 530 (609)
T ss_pred C---CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH
Confidence 4 458999999999755443332 1222 345999999875 59999999999999999998 899998754 444
Q ss_pred HHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 265 VAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
... ..+. ..+...+..+++++.+++..||+.+|++||++.++.+
T Consensus 531 l~~-~l~~--G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 531 LLE-FLKE--GNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHH-HHhc--CCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 433 2322 2233444567999999999999999999999999976
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=316.35 Aligned_cols=241 Identities=23% Similarity=0.282 Sum_probs=184.7
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
...|...++||+|+||.||+|.+..++..||+|++..... ....|+..++++ +|||||++++++...+..++
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l-~HpnIv~~~~~~~~~~~~~l 760 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKL-QHPNIVKLIGLCRSEKGAYL 760 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhC-CCCCcceEEEEEEcCCCCEE
Confidence 3457778899999999999999988999999998864321 112468889999 99999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH---KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
||||+++|+|.+++. .+++..+..++.|++.||+||| +.+++||||||+||+++.++. .++. ||......
T Consensus 761 v~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~---~~~~-~~~~~~~~ 833 (968)
T PLN00113 761 IHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE---PHLR-LSLPGLLC 833 (968)
T ss_pred EEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCc---eEEE-eccccccc
Confidence 999999999999995 3899999999999999999999 679999999999999976554 3443 66554322
Q ss_pred CCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccc---------cc---
Q 018640 211 PGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVL---------DF--- 276 (352)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~---------~~--- 276 (352)
.. ....+|..|+|||++. ..++.++||||||+++|||+||+.||...... .......+... ..
T Consensus 834 ~~---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (968)
T PLN00113 834 TD---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIR 910 (968)
T ss_pred cC---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcccc
Confidence 11 2236789999999876 45899999999999999999999998532211 00111111000 00
Q ss_pred -CCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 277 -RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 277 -~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
..........++.+++.+||+.||++|||+.|+++.
T Consensus 911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 000001122356789999999999999999999875
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=270.48 Aligned_cols=248 Identities=26% Similarity=0.403 Sum_probs=190.9
Q ss_pred ccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHh-CCCCCCeeEeeeEEEeC-
Q 018640 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH-LPKHQNIVCLKDTYEDD- 128 (352)
Q Consensus 51 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~~h~~iv~l~~~~~~~- 128 (352)
+.+.++.++.+.||+|.||.||+|.++ |+.||||++... +.+.+.+|.++... +-+|+||+.+++.-..+
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr------dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~ 278 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR------DERSWFRETEIYQTVMLRHENILGFIAADNKDN 278 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc--CCceEEEEeccc------chhhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence 457788999999999999999999997 999999998643 34678888888875 23899999999875432
Q ss_pred ---CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------cCCEEecCCCCceEeecCCCCCC
Q 018640 129 ---TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK--------HGVMHRDLKPENFLFANKKETAP 197 (352)
Q Consensus 129 ---~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~--------~~ivH~Dikp~NIll~~~~~~~~ 197 (352)
..+|||++|.+.|||+|+|.. ..++-....+++..++.||++||- -.|.|||||+.|||+..++.
T Consensus 279 gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~--- 354 (513)
T KOG2052|consen 279 GSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--- 354 (513)
T ss_pred CceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc---
Confidence 278999999999999999987 479999999999999999999994 35999999999999975554
Q ss_pred EEEEecccceecCCCC-----cccccccccccccchhccccCC-------CcchHHHHHHHHHHHHhC----------CC
Q 018640 198 LKAIDFGLSVFFKPGE-----KFSEIVGSPYYMAPEVLKRNYG-------PEVDVWSAGVILYILLCG----------VP 255 (352)
Q Consensus 198 vkl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~s-------~~~Di~SlG~~l~el~tg----------~~ 255 (352)
+.|+|+|+|-...... ..+..+||.+|||||++..... ..+||||||+++||+... .+
T Consensus 355 C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~ 434 (513)
T KOG2052|consen 355 CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQL 434 (513)
T ss_pred EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcC
Confidence 8999999997765442 2356699999999999875422 259999999999998743 56
Q ss_pred CCCCCCHHHHHHHHHhcc---cccCCCC---CcC--CCHHHHHHHHHhcCCCcCCCCCHHHHh
Q 018640 256 PFWAETEQGVAQAIIRSV---LDFRRDP---WPK--VSENAKDLVRKMLDPDPKRRLTAQQVL 310 (352)
Q Consensus 256 p~~~~~~~~~~~~~~~~~---~~~~~~~---~~~--~~~~~~~li~~~l~~dP~~Rps~~ell 310 (352)
||....+.+...+-.+.+ ...++.. |.. .-..+..+++.||..+|.-|.|+-.+-
T Consensus 435 Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 435 PYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred CcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 775443222111111111 1222222 221 234467899999999999999987663
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=265.22 Aligned_cols=256 Identities=28% Similarity=0.466 Sum_probs=209.8
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC-----Ce
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD-----TA 130 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~-----~~ 130 (352)
+.+-.+.||-|+||+||.++|..+|+.||+|++..- +.+...-.++.+|+++|.-+ +|.|++..++..... +.
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfF-kHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSF-RHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhh-ccccHHHHHHhcCCCCchHHHH
Confidence 345567899999999999999999999999988653 34445567788999999999 999999998877543 35
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
+|+++|.+.. +|..++.....++...+.-+..||+.||+|||+.+|+||||||.|.|++ .++.+||||||+++...
T Consensus 132 iYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVN---SNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 132 LYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVN---SNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEec---cCceEEecccccccccc
Confidence 6788899954 8888888878899999999999999999999999999999999999996 45558999999999765
Q ss_pred CCC--cccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCC-------
Q 018640 211 PGE--KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD------- 279 (352)
Q Consensus 211 ~~~--~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------- 279 (352)
... .++..+-|..|+|||.+.+ .|+...||||.||++.|++..+..|......+.++-+.+.+.....+
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 443 3345567899999999874 49999999999999999999999998887777776666655442110
Q ss_pred -----------CCc------------CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccc
Q 018640 280 -----------PWP------------KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (352)
Q Consensus 280 -----------~~~------------~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~ 317 (352)
..+ ....+..+++..+|.+||++|.+..+.+.|+|...
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 000 12345678999999999999999999999998763
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=266.87 Aligned_cols=242 Identities=26% Similarity=0.383 Sum_probs=184.3
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCC-CCCCeeEeeeEEEeCC----e
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP-KHQNIVCLKDTYEDDT----A 130 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-~h~~iv~l~~~~~~~~----~ 130 (352)
..++.++||+|.||.||+|... ++.||||++... +...|.+|-++.+... .|+||+++++.-+... .
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e 282 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME 282 (534)
T ss_pred chhhHHHhhcCccceeehhhcc--CceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence 4677889999999999999865 799999998643 4566777877777532 7999999999876554 8
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---------cCCEEecCCCCceEeecCCCCCCEEEE
Q 018640 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK---------HGVMHRDLKPENFLFANKKETAPLKAI 201 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~---------~~ivH~Dikp~NIll~~~~~~~~vkl~ 201 (352)
++||++|.+.|||.++|..+ ..+|....+|+..++.||+|||+ ..|+|||||..|||+.++.. ..|+
T Consensus 283 ywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT---ccIa 358 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT---CCIA 358 (534)
T ss_pred eeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc---EEee
Confidence 99999999999999999876 69999999999999999999996 36999999999999975554 7999
Q ss_pred ecccceecCCCCc---ccccccccccccchhccccC--C-----CcchHHHHHHHHHHHHhCCC------------CCC-
Q 018640 202 DFGLSVFFKPGEK---FSEIVGSPYYMAPEVLKRNY--G-----PEVDVWSAGVILYILLCGVP------------PFW- 258 (352)
Q Consensus 202 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~--s-----~~~Di~SlG~~l~el~tg~~------------p~~- 258 (352)
|||+|..+..+.. ....+||.+|||||++.+.. . .+.||||+|.+|||+++... ||.
T Consensus 359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA 438 (534)
T ss_pred ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence 9999988765433 23468999999999997542 2 25899999999999997532 221
Q ss_pred ----CCCHHHHHHHHHhcc-cccCCCCCc--CCCHHHHHHHHHhcCCCcCCCCCHHHH
Q 018640 259 ----AETEQGVAQAIIRSV-LDFRRDPWP--KVSENAKDLVRKMLDPDPKRRLTAQQV 309 (352)
Q Consensus 259 ----~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~li~~~l~~dP~~Rps~~el 309 (352)
....++....+.+.. ....++.|. .....+++.+..||+.||+.|.|+.=+
T Consensus 439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 111111222222211 111112222 234567899999999999999998744
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=239.26 Aligned_cols=215 Identities=23% Similarity=0.336 Sum_probs=177.5
Q ss_pred ccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe
Q 018640 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (352)
Q Consensus 51 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 130 (352)
+.-.+...-+..||+|+||.|=+-++..+|...|+|.+...- ......+..+|+.+..+....|.+|.++|.+.....
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 334456777888999999999999999999999999987653 223456778899999988899999999999999999
Q ss_pred EEEEEEecCCcchHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCEEecCCCCceEeecCCCCCCEEEEeccc
Q 018640 131 VHLVMELCEGGELFDRI----VARGHYTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l----~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~ 205 (352)
.++.||.|+. ||..+. ......++..+-+|+..++.||.|||++ .+||||+||+|||++.++. ||+||||+
T Consensus 120 vwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~Gq---VKiCDFGI 195 (282)
T KOG0984|consen 120 VWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQ---VKICDFGI 195 (282)
T ss_pred EEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCc---EEEccccc
Confidence 9999999954 886654 3456799999999999999999999975 8999999999999976665 99999999
Q ss_pred ceecCCCCcccccccccccccchhcc-----ccCCCcchHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHh
Q 018640 206 SVFFKPGEKFSEIVGSPYYMAPEVLK-----RNYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIR 271 (352)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~s~~~Di~SlG~~l~el~tg~~p~~~~-~~~~~~~~~~~ 271 (352)
+..+.+.-..+...|-..|||||.+. .+|+.++||||||++++||.+++.||... ++.+++.++..
T Consensus 196 sG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 196 SGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred ceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 98876554444457888999999875 25889999999999999999999999543 44445555443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=267.17 Aligned_cols=261 Identities=27% Similarity=0.471 Sum_probs=205.7
Q ss_pred cccccccceeceeeeccCceEEEEEEECC---CCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEE
Q 018640 50 GREIEERYELGRELGRGEFGITYLCTDRE---NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (352)
Q Consensus 50 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~ 126 (352)
...+.+.|..+++||+|.|++||++.+.. .++.||+|.+.... ...++.+|++.|..+..+.||+.+.+++.
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~r 105 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFR 105 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhc
Confidence 34567789999999999999999999887 78899999986542 34678999999999999999999999999
Q ss_pred eCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccc
Q 018640 127 DDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (352)
Q Consensus 127 ~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a 206 (352)
.++...+|+||++.....+++.. ++...+..+++.++.||.++|++|||||||||+|+|++..-. .-.|+|||+|
T Consensus 106 nnd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~--rg~LvDFgLA 180 (418)
T KOG1167|consen 106 NNDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQ--RGVLVDFGLA 180 (418)
T ss_pred cCCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccC--CceEEechhH
Confidence 99999999999998888777754 778999999999999999999999999999999999975433 3589999998
Q ss_pred eecC-----------------C--CC--------------------------cccccccccccccchhcc--ccCCCcch
Q 018640 207 VFFK-----------------P--GE--------------------------KFSEIVGSPYYMAPEVLK--RNYGPEVD 239 (352)
Q Consensus 207 ~~~~-----------------~--~~--------------------------~~~~~~gt~~y~aPE~~~--~~~s~~~D 239 (352)
.... . +. ......||++|+|||++. ...+++.|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 7211 0 00 001236999999999875 45788999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH---------------------------------hccccc---------
Q 018640 240 VWSAGVILYILLCGVPPFWAETEQ-GVAQAII---------------------------------RSVLDF--------- 276 (352)
Q Consensus 240 i~SlG~~l~el~tg~~p~~~~~~~-~~~~~~~---------------------------------~~~~~~--------- 276 (352)
|||.|++++-+++++.||...... ..+.++. ......
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 999999999999999998433211 0000000 000000
Q ss_pred -----CCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 277 -----RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 277 -----~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
........+..+.+|+.+||..||.+|.|++++|.||||.....
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~ 389 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADR 389 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhh
Confidence 00011124557899999999999999999999999999996543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=281.75 Aligned_cols=246 Identities=24% Similarity=0.311 Sum_probs=203.5
Q ss_pred cceeceeeeccCceEEEEEEECCCCcE----EEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDA----FACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
..+..++||+|+||+||+|.+--.|+. ||+|++.... ....-.++.+|+-+|.++ +|||++++++++.... .
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masl-dHpnl~RLLgvc~~s~-~ 772 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASL-DHPNLLRLLGVCMLST-L 772 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcC-CCchHHHHhhhcccch-H
Confidence 355678899999999999998766664 7788776543 333356889999999999 9999999999998776 7
Q ss_pred EEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 132 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
.||++|+|+|+|.++++.+ ..+..+..+.|..||++||.|||++.++||||-++|||+. .+..+||.|||+++...
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVk---sP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVK---SPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeec---CCCeEEEEecchhhccC
Confidence 8999999999999999865 4689999999999999999999999999999999999996 44459999999999876
Q ss_pred CCCcc-cccc--cccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCC
Q 018640 211 PGEKF-SEIV--GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (352)
Q Consensus 211 ~~~~~-~~~~--gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (352)
..... .... -.+.|||-|.+. ..++.++||||||+++||++| |..|+.+...+++-.-+... .+.+.++..+
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~g---eRLsqPpiCt 926 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKG---ERLSQPPICT 926 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcc---ccCCCCCCcc
Confidence 55433 2212 246699999876 669999999999999999998 99999888776654444332 2345567789
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 286 ENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 286 ~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
.++.-++.+||..|+..||+++++..
T Consensus 927 iDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 927 IDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHHHHHhccCcccCccHHHHHH
Confidence 99999999999999999999998844
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=282.15 Aligned_cols=259 Identities=29% Similarity=0.503 Sum_probs=224.5
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
-.++|.++..+|.|.||.||++++..+++..|+|+++.. ...+...+.+|+-+++.. +|||||.+++.+...+..+
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe---p~dd~~~iqqei~~~~dc-~h~nivay~gsylr~dklw 88 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE---PGDDFSGIQQEIGMLRDC-RHPNIVAYFGSYLRRDKLW 88 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeecc---CCccccccccceeeeecC-CCcChHHHHhhhhhhcCcE
Confidence 345799999999999999999999999999999999865 344566788899999998 9999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
++|||+.||+|.+.....+++++.++..+++..+.+|+|||+.|=+|||||-.||++++.++ +|++|||.+..+...
T Consensus 89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD---vklaDfgvsaqitat 165 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD---VKLADFGVSAQITAT 165 (829)
T ss_pred EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCc---eeecccCchhhhhhh
Confidence 99999999999999988889999999999999999999999999999999999999987776 899999988765432
Q ss_pred -Ccccccccccccccchhc----cccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC-CCCcCCCH
Q 018640 213 -EKFSEIVGSPYYMAPEVL----KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR-DPWPKVSE 286 (352)
Q Consensus 213 -~~~~~~~gt~~y~aPE~~----~~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 286 (352)
.....+.||+.|||||+. ++.|....|||++|++..|+-.-.+|-..........-+.......+. ......++
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~ 245 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSE 245 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchH
Confidence 234567999999999974 367999999999999999999988887776666666555555443322 22346789
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 287 ~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
.+-+|++.+|..+|++||+++.+|.|||....
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 99999999999999999999999999999865
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=269.07 Aligned_cols=200 Identities=33% Similarity=0.536 Sum_probs=175.4
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhc-----HHHHHHHHHHHHhCC--CCCCeeEeeeEEEeC
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD-----IEDVRREVDIMRHLP--KHQNIVCLKDTYEDD 128 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~-----~~~~~~E~~~l~~l~--~h~~iv~l~~~~~~~ 128 (352)
+|..++.+|+|+||.|++|.++++...|+||.+.++....... .-.+-.|+++|..+. .|+||++++++|+++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 4999999999999999999999999999999998775432111 113456999999993 299999999999999
Q ss_pred CeEEEEEEec-CCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccce
Q 018640 129 TAVHLVMELC-EGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (352)
Q Consensus 129 ~~~~lv~e~~-~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~ 207 (352)
+.+||+||-. +|.+|.+++..+..+++.++..|++|++.|+++||+.||||||||-+|+.++.++- +||+|||.|.
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~---~klidfgsaa 718 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGF---VKLIDFGSAA 718 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCe---EEEeeccchh
Confidence 9999999986 67899999999999999999999999999999999999999999999999986665 8999999987
Q ss_pred ecCCCCcccccccccccccchhcccc--CCCcchHHHHHHHHHHHHhCCCCCCC
Q 018640 208 FFKPGEKFSEIVGSPYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWA 259 (352)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~s~~~Di~SlG~~l~el~tg~~p~~~ 259 (352)
...+ .....+.||..|.|||++++. .+..-|||++|++||.++....||++
T Consensus 719 ~~ks-gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 719 YTKS-GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhcC-CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 6554 456778999999999999865 57889999999999999999999864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=232.20 Aligned_cols=211 Identities=43% Similarity=0.750 Sum_probs=183.6
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEecCCcc
Q 018640 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGE 142 (352)
Q Consensus 63 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~~~s 142 (352)
||+|++|.||++.+..+++.+++|++....... ..+.+.+|+..++.+ .|++++++++++......++++|++++++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKL-NHPNIVKLYGVFEDENHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhc-CCCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence 689999999999998889999999987653221 346799999999999 89999999999999999999999999899
Q ss_pred hHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC-ccccccc
Q 018640 143 LFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVG 220 (352)
Q Consensus 143 L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~g 220 (352)
|.+++... ..++...+..++.+++.++.+||+.|++|+||+|.||+++.. ...++|+|||.+....... ......+
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSD--NGKVKLADFGLSKLLTSDKSLLKTIVG 155 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCC--CCcEEEecCCceEEccCCcchhhcccC
Confidence 99999776 468999999999999999999999999999999999999762 2338999999998664432 1233467
Q ss_pred ccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCC
Q 018640 221 SPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298 (352)
Q Consensus 221 t~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 298 (352)
...|++||.+.. ..+.++|+|++|++++++ ..+.+++..|++.
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~l~~ 200 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKMLQK 200 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHHhhC
Confidence 888999998864 678899999999999998 6778999999999
Q ss_pred CcCCCCCHHHHhcCc
Q 018640 299 DPKRRLTAQQVLEHP 313 (352)
Q Consensus 299 dP~~Rps~~ell~hp 313 (352)
+|++||++.++++++
T Consensus 201 ~p~~R~~~~~l~~~~ 215 (215)
T cd00180 201 DPEKRPSAKEILEHL 215 (215)
T ss_pred CcccCcCHHHHhhCC
Confidence 999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=231.23 Aligned_cols=248 Identities=24% Similarity=0.370 Sum_probs=192.7
Q ss_pred ccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeE-EEeCC
Q 018640 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDT-YEDDT 129 (352)
Q Consensus 51 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~-~~~~~ 129 (352)
-.+.+.|.|.+.||+|.||.+-+|.++.++..+++|-+... .....+|.+|...--.|..|.||+.-+++ |+..+
T Consensus 20 v~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p----~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d 95 (378)
T KOG1345|consen 20 VDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP----QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD 95 (378)
T ss_pred cchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc----hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCc
Confidence 35778899999999999999999999999999999988654 34567899998888888889999987764 67788
Q ss_pred eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
.+++++||+|.|+|..-+... .+.+.....++.|+++||.|+|++++||||||.+|||+...+. ..|||||||.++..
T Consensus 96 ~YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df-~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADF-YRVKLCDFGLTRKV 173 (378)
T ss_pred eEEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCc-cEEEeeeccccccc
Confidence 999999999999999887654 4888999999999999999999999999999999999865332 36999999998764
Q ss_pred CCCCcccccccccccccchhcc----cc--CCCcchHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhcccccCCC
Q 018640 210 KPGEKFSEIVGSPYYMAPEVLK----RN--YGPEVDVWSAGVILYILLCGVPPFWAETEQ----GVAQAIIRSVLDFRRD 279 (352)
Q Consensus 210 ~~~~~~~~~~gt~~y~aPE~~~----~~--~s~~~Di~SlG~~l~el~tg~~p~~~~~~~----~~~~~~~~~~~~~~~~ 279 (352)
...- ...--+..|.+||... +. ..+.+|+|.||++++.++||..||...... ............--+.
T Consensus 174 g~tV--~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~ 251 (378)
T KOG1345|consen 174 GTTV--KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK 251 (378)
T ss_pred Ccee--hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch
Confidence 3221 1122345699999753 22 567899999999999999999999633111 1111122211111122
Q ss_pred CCcCCCHHHHHHHHHhcCCCcCCCCCH
Q 018640 280 PWPKVSENAKDLVRKMLDPDPKRRLTA 306 (352)
Q Consensus 280 ~~~~~~~~~~~li~~~l~~dP~~Rps~ 306 (352)
....+++.+..+.++-|.++|++|--.
T Consensus 252 ~F~~fs~~a~r~Fkk~lt~~~~drcki 278 (378)
T KOG1345|consen 252 KFNPFSEKALRLFKKSLTPRFKDRCKI 278 (378)
T ss_pred hhcccCHHHHHHHHHhcCCcccccchh
Confidence 234578999999999999999999433
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=225.95 Aligned_cols=197 Identities=44% Similarity=0.790 Sum_probs=172.5
Q ss_pred ceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEE
Q 018640 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (352)
Q Consensus 57 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e 136 (352)
|.+.+.||.|++|+||++....+++.+|+|.+...... ...+.+.+|+..+.++ +|+|++++++++......++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKL-KHPNIVKLYGVFEDPEPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhC-CCCChhhheeeeecCCceEEEEe
Confidence 56789999999999999999888999999998765322 2457889999999999 89999999999999999999999
Q ss_pred ecCCcchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC--
Q 018640 137 LCEGGELFDRIVARGH-YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-- 213 (352)
Q Consensus 137 ~~~~~sL~~~l~~~~~-l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-- 213 (352)
|+++++|.+++..... +++..+..++.+++.++.+||+.+++|+||+|.||+++.++ .++|+|||++.......
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~---~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG---LVKLADFGLARFIHRDLAA 154 (225)
T ss_pred ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC---CEEEeeCceeeEecCcccc
Confidence 9999999999987766 89999999999999999999999999999999999997653 48999999998765442
Q ss_pred cccccccccccccchhc-c-ccCCCcchHHHHHHHHHHHHhCCCCCCC
Q 018640 214 KFSEIVGSPYYMAPEVL-K-RNYGPEVDVWSAGVILYILLCGVPPFWA 259 (352)
Q Consensus 214 ~~~~~~gt~~y~aPE~~-~-~~~s~~~Di~SlG~~l~el~tg~~p~~~ 259 (352)
......++..|++||.+ . ..++.++|+||||+++++|++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 33445778889999987 4 3477799999999999999999999966
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=233.28 Aligned_cols=248 Identities=19% Similarity=0.260 Sum_probs=202.7
Q ss_pred ccceeceeeeccCceEEEEEEECCCC-----cEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEE-eC
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENG-----DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE-DD 128 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~-~~ 128 (352)
.+++...++-+|.||.||.|.+.+.. +.|-+|.+... .++.+...+.+|...+..+ .|||+..+.+++. +.
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~-sH~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGA-SHPNLLSVLGVSIEDY 360 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcC-cCCCccceeEEEeecc
Confidence 56888889999999999999876533 33566666543 3556677899999999998 7999999999875 45
Q ss_pred CeEEEEEEecCCcchHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEE
Q 018640 129 TAVHLVMELCEGGELFDRIVAR--------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKA 200 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~--------~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl 200 (352)
...++++.+..-|+|..+|... ..++..++..++.|++.|++|||+.++||.||..+|+++++. ..|||
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~---LqVkl 437 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ---LQVKL 437 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh---eeEEe
Confidence 6789999999889999999732 136777888999999999999999999999999999999644 55999
Q ss_pred EecccceecCCCCcc---cccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccc
Q 018640 201 IDFGLSVFFKPGEKF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLD 275 (352)
Q Consensus 201 ~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 275 (352)
+|=.+++.+.+.... ........||+||.+. ..|+..+|+||||++||||+| |+.|+-.-.+.+....+.+..
T Consensus 438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy-- 515 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY-- 515 (563)
T ss_pred ccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc--
Confidence 999999876544322 2223467799999987 569999999999999999998 999998888887776666543
Q ss_pred cCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 276 FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 276 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
+...+..+|+++..++..||..+|++||++.|+..
T Consensus 516 -RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 516 -RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred -eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 34444579999999999999999999999999853
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=274.14 Aligned_cols=197 Identities=19% Similarity=0.252 Sum_probs=146.2
Q ss_pred CCeeEeeeEE-------EeCCeEEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCce
Q 018640 116 QNIVCLKDTY-------EDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENF 187 (352)
Q Consensus 116 ~~iv~l~~~~-------~~~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NI 187 (352)
+||+.++++| .....+++++|++ +++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 5777788877 2334677888988 55999999753 4599999999999999999999999999999999999
Q ss_pred EeecC----------------CCCCCEEEEecccceecCCC-----------------Ccccccccccccccchhcc-cc
Q 018640 188 LFANK----------------KETAPLKAIDFGLSVFFKPG-----------------EKFSEIVGSPYYMAPEVLK-RN 233 (352)
Q Consensus 188 ll~~~----------------~~~~~vkl~Dfg~a~~~~~~-----------------~~~~~~~gt~~y~aPE~~~-~~ 233 (352)
|++.. +....+|++|||+++..... .......||+.|+|||++. ..
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~ 191 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS 191 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence 99642 12334788888887642110 0011246899999999876 55
Q ss_pred CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCc
Q 018640 234 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHP 313 (352)
Q Consensus 234 ~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp 313 (352)
++.++|||||||+||||++|..|+.... .....+..... ++ ..........+++..||+++|.+||++.|+++||
T Consensus 192 ~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 192 SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL--PP-QILLNWPKEASFCLWLLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc--Ch-hhhhcCHHHHHHHHHhCCCChhhCcChHHHhhch
Confidence 8999999999999999999988875321 12222222111 11 1112245567899999999999999999999999
Q ss_pred ccccc
Q 018640 314 WLQNA 318 (352)
Q Consensus 314 ~f~~~ 318 (352)
||.+.
T Consensus 267 ~~~~~ 271 (793)
T PLN00181 267 FINEP 271 (793)
T ss_pred hhhhh
Confidence 99864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=223.17 Aligned_cols=253 Identities=22% Similarity=0.307 Sum_probs=195.1
Q ss_pred cceeceeeeccCceEEEEEEECCCC-cEEEEEEccccccCChhcHHHHHHHHHHHHhCC---CCCCeeEeeeEE-EeCCe
Q 018640 56 RYELGRELGRGEFGITYLCTDRENG-DAFACKSISKKKLRTAVDIEDVRREVDIMRHLP---KHQNIVCLKDTY-EDDTA 130 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---~h~~iv~l~~~~-~~~~~ 130 (352)
+|++.+.||+|+||.||.|.+..++ ..+|+|.......... ..+..|+.++..+. ...++..+++.+ .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999987764 5788887765422211 25778999999984 236899999999 57888
Q ss_pred EEEEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCC--CCCEEEEecccc
Q 018640 131 VHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE--TAPLKAIDFGLS 206 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~--~~~vkl~Dfg~a 206 (352)
.++||+.+ |.+|.++.... ..++..++..|+.|++.+|++||+.|++||||||+|++++.... ...++|.|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999999 88999988654 46999999999999999999999999999999999999986542 256899999999
Q ss_pred e--ecC-CCC-------c-ccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Q 018640 207 V--FFK-PGE-------K-FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL 274 (352)
Q Consensus 207 ~--~~~-~~~-------~-~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 274 (352)
+ ... ... . .....||..|+++....+ ..+++.|+||++.++.+++.|..||...........+.....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 8 321 110 1 123469999999998764 589999999999999999999999966553322333322222
Q ss_pred ccCCC-CCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 275 DFRRD-PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 275 ~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
..... .....+..+..+...+-..+...+|....+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 22221 223456778888888888899999988877654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=205.22 Aligned_cols=248 Identities=21% Similarity=0.256 Sum_probs=198.1
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
.+.+.|++++.||.|+||.+|+|....+|+.||||+-.... . ...+..|..+...|..-..|+.+..++.+...-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-K----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-C----CcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 45568999999999999999999999999999999875542 2 234667999999997788899999999999999
Q ss_pred EEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 132 HLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
.+||+.+ |.||.+.+.-.. .++..+++-++-|++.-++|+|.+++|||||||+|+|++-+.....+.|+|||+|+.+.
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9999999 889999886543 59999999999999999999999999999999999999877777779999999998764
Q ss_pred CCCc--------ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhcccccCC
Q 018640 211 PGEK--------FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ---AIIRSVLDFRR 278 (352)
Q Consensus 211 ~~~~--------~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~---~~~~~~~~~~~ 278 (352)
+... -....||..|.+-...- -..+.+.|+-|+|.+|..+-.|..||.+.......+ .+.....+.+.
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i 245 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI 245 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence 3321 13457999999987655 347889999999999999999999998765443333 23222222111
Q ss_pred -CCCcCCCHHHHHHHHHhcCCCcCCCCC
Q 018640 279 -DPWPKVSENAKDLVRKMLDPDPKRRLT 305 (352)
Q Consensus 279 -~~~~~~~~~~~~li~~~l~~dP~~Rps 305 (352)
.....+|.++.-.+.-|-..-=++-|.
T Consensus 246 e~LC~G~P~EF~myl~Y~R~L~F~E~Pd 273 (341)
T KOG1163|consen 246 EVLCKGFPAEFAMYLNYCRGLGFEEKPD 273 (341)
T ss_pred HHHhCCCcHHHHHHHHHHhhcCCCCCCc
Confidence 113467888888888886655555565
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=206.22 Aligned_cols=163 Identities=26% Similarity=0.330 Sum_probs=126.6
Q ss_pred cchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCcccccc
Q 018640 141 GELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIV 219 (352)
Q Consensus 141 ~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 219 (352)
|+|.+++..+ ..+++..++.|+.|++.||.|||+.+ ||+||+++.++. +++ ||++....... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~---~~~--fG~~~~~~~~~----~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGL---LKL--DGSVAFKTPEQ----SR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccc---eee--ccceEeecccc----CC
Confidence 6899999874 45999999999999999999999998 999999975554 677 99988654322 26
Q ss_pred cccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcccccCCC---CCcCCCH--HHHHHH
Q 018640 220 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVLDFRRD---PWPKVSE--NAKDLV 292 (352)
Q Consensus 220 gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~--~~~~li 292 (352)
||+.|+|||++. ..++.++||||||+++|||++|+.||...... .....+.......... ....+++ .+.++|
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 889999999986 45899999999999999999999999755432 2233333222221111 1112333 689999
Q ss_pred HHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 293 RKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 293 ~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
..||+.+|++||++.++++|+|+...
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHHHH
Confidence 99999999999999999999998743
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=207.19 Aligned_cols=204 Identities=22% Similarity=0.405 Sum_probs=175.8
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
+.-.|++.++||+|+||..+.|.+.-+++.||||.-... .....++.|.+..+.|...++|+.++.+..+..+-.
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni 100 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI 100 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence 445799999999999999999999999999999965432 234578889999999989999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCC--CCCCEEEEecccceec
Q 018640 133 LVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK--ETAPLKAIDFGLSVFF 209 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~--~~~~vkl~Dfg~a~~~ 209 (352)
||+|.+ |.||.|+..-++ .|+..++..++.|++.-++++|++++|.|||||+|+||+..+ ....|.++|||+|+.+
T Consensus 101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 999999 889999887655 599999999999999999999999999999999999997532 3456899999999987
Q ss_pred CCCCc--------ccccccccccccchhc-cccCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q 018640 210 KPGEK--------FSEIVGSPYYMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETE 262 (352)
Q Consensus 210 ~~~~~--------~~~~~gt~~y~aPE~~-~~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~ 262 (352)
.+... .....||..||+-... ....+.+.|+-|||-++++++.|..||.+...
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 54432 2456899999998864 45689999999999999999999999976543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-25 Score=205.24 Aligned_cols=256 Identities=37% Similarity=0.593 Sum_probs=205.3
Q ss_pred ceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCC-CeeEeeeEEEeCCeEEEEE
Q 018640 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ-NIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 57 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-~iv~l~~~~~~~~~~~lv~ 135 (352)
|.+...||.|+||.||++.+. ..+++|.+.............+.+|+.++..+ .|+ +++.+.+.+......++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASL-NHPPNIVKLYDFFQDEGSLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHc-cCCcceeeEEEEEecCCEEEEEE
Confidence 778899999999999999976 78999998876544433467899999999999 555 8999999998777789999
Q ss_pred EecCCcchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 136 ELCEGGELFDRIVARG---HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 136 e~~~~~sL~~~l~~~~---~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
+++.++++.+++.... .++......++.|++.++.++|+.+++|||+||+||+++.... .++++|||.+......
T Consensus 78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~--~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR--VVKLIDFGLAKLLPDP 155 (384)
T ss_pred ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC--eEEEeccCcceecCCC
Confidence 9999999997777665 6999999999999999999999999999999999999975542 3799999999755433
Q ss_pred C-------cccccccccccccchhccc----cCCCcchHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhcccc-c
Q 018640 213 E-------KFSEIVGSPYYMAPEVLKR----NYGPEVDVWSAGVILYILLCGVPPFWAETE----QGVAQAIIRSVLD-F 276 (352)
Q Consensus 213 ~-------~~~~~~gt~~y~aPE~~~~----~~s~~~Di~SlG~~l~el~tg~~p~~~~~~----~~~~~~~~~~~~~-~ 276 (352)
. ......||..|++||.+.+ ..+...|+||+|++++++++|..||..... ......+...... .
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccc
Confidence 2 2356689999999998764 578899999999999999999999766653 3333333332222 1
Q ss_pred CCCCCcCC----CHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 277 RRDPWPKV----SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 277 ~~~~~~~~----~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
........ ...+.+++..++..+|..|.+..+...+++....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 11111111 2578899999999999999999999888766654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=217.35 Aligned_cols=169 Identities=21% Similarity=0.229 Sum_probs=130.3
Q ss_pred CCcccccccceeceeeeccCceEEEEEEECC-CCcEEEEEEcccccc--CChhcHHHHHHHHHHHHhCCCCCCeeE-eee
Q 018640 48 PTGREIEERYELGRELGRGEFGITYLCTDRE-NGDAFACKSISKKKL--RTAVDIEDVRREVDIMRHLPKHQNIVC-LKD 123 (352)
Q Consensus 48 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~-l~~ 123 (352)
.....+.++|.+.+.||+|+||+||+|.+.. +++.||||++..... ........+.+|+++|+++ +|+|++. +++
T Consensus 11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L-~h~~iv~~l~~ 89 (365)
T PRK09188 11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTV-RGIGVVPQLLA 89 (365)
T ss_pred cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhc-cCCCCCcEEEE
Confidence 3345677889999999999999999998876 678889998653211 1223356799999999999 8999884 544
Q ss_pred EEEeCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecC-CCCceEeecCCCCCCEEEEe
Q 018640 124 TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL-KPENFLFANKKETAPLKAID 202 (352)
Q Consensus 124 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Di-kp~NIll~~~~~~~~vkl~D 202 (352)
+ +..++||||++|++|.. +.. .. ...++.|++.||.|||+.||+|||| ||+|||++.++ .+||+|
T Consensus 90 ~----~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~---~ikLiD 155 (365)
T PRK09188 90 T----GKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDG---EAAVID 155 (365)
T ss_pred c----CCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCC---CEEEEE
Confidence 2 45799999999999963 211 11 2467899999999999999999999 99999996544 489999
Q ss_pred cccceecCCCC---------cccccccccccccchhcc
Q 018640 203 FGLSVFFKPGE---------KFSEIVGSPYYMAPEVLK 231 (352)
Q Consensus 203 fg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~ 231 (352)
||+|+...... ......+++.|+|||.+.
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 99998664322 113457888999999885
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.5e-28 Score=235.44 Aligned_cols=258 Identities=29% Similarity=0.458 Sum_probs=195.9
Q ss_pred eeceeeeccCceEEEEEEECCCCcEEEEEEcccc---ccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKK---KLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 58 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
....++|.|++|.|+.+......+.++.|..... ..........+..|.-+-..+ .|+|++..+..+.+.....-.
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l-~h~~~~e~l~~~~~~~~~~~~ 399 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSL-SHPNIIETLDIVQEIDGILQS 399 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccc-cCCchhhhHHHHhhcccchhh
Confidence 4578899999999999888877777777765421 111111111245566666677 899998888777666655566
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC-
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (352)
|||+++ +|+.++.....++...+..++.|++.|++|+|+.||.|||+|++|+++..++ .+||+|||.+.....+-
T Consensus 400 mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g---~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 400 MEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENG---ILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCC---ceEEeecCcceeeccCcc
Confidence 999999 9999998887899999999999999999999999999999999999998665 48999999987653221
Q ss_pred ----cccccccccccccchhccc-cCCC-cchHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhc----ccccCCCCCc
Q 018640 214 ----KFSEIVGSPYYMAPEVLKR-NYGP-EVDVWSAGVILYILLCGVPPFWAETEQGVAQ-AIIRS----VLDFRRDPWP 282 (352)
Q Consensus 214 ----~~~~~~gt~~y~aPE~~~~-~~s~-~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~-~~~~~----~~~~~~~~~~ 282 (352)
....+.|+..|+|||.+.+ .|.+ ..||||.|+++..|++|+.||.......... ..... ....+...+.
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLS 555 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHH
Confidence 2245689999999999874 4554 6999999999999999999995444332211 00000 0011111234
Q ss_pred CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 283 ~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
.++...+.+|..||+.||.+|.|+++|++.+||+....
T Consensus 556 ~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 556 LLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred hchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 57888899999999999999999999999999997643
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-26 Score=216.60 Aligned_cols=242 Identities=26% Similarity=0.444 Sum_probs=202.7
Q ss_pred eeeccCceEEEEEEE---CCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEec
Q 018640 62 ELGRGEFGITYLCTD---RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELC 138 (352)
Q Consensus 62 ~lG~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~ 138 (352)
++|+|+||.|+++.. ...|..+|.|+..+.+....... ....|..++..+.+||.+|++...++.+...++++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 479999999998653 34577799998887765544333 55668889999977999999999999999999999999
Q ss_pred CCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCccccc
Q 018640 139 EGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI 218 (352)
Q Consensus 139 ~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 218 (352)
.||.|...+.....+.+.........++-|++++|+.+++|||+|++||+++.+|. +++.|||+++..-..+..
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Gh---i~~tdfglske~v~~~~~--- 153 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGH---IKLTDFGLSKEAVKEKIA--- 153 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCc---cccCCchhhhHhHhhhhc---
Confidence 99999999988888999999999999999999999999999999999999987665 799999999865433322
Q ss_pred ccccccccchhccccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCC
Q 018640 219 VGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298 (352)
Q Consensus 219 ~gt~~y~aPE~~~~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 298 (352)
+||..|||||+++ .....+|.||||++++||+||..||.. +....+... ....+..++..+.+++..++..
T Consensus 154 cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~----~~~~p~~l~~~a~~~~~~l~~r 224 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA----ELEMPRELSAEARSLFRQLFKR 224 (612)
T ss_pred ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh----ccCCchhhhHHHHHHHHHHHhh
Confidence 8999999999988 677889999999999999999999977 333344332 3334456788899999999999
Q ss_pred CcCCCCC-----HHHHhcCccccccc
Q 018640 299 DPKRRLT-----AQQVLEHPWLQNAK 319 (352)
Q Consensus 299 dP~~Rps-----~~ell~hp~f~~~~ 319 (352)
+|.+|.- +.|+.+|+||+...
T Consensus 225 ~p~nrLg~~~~~~~eik~h~f~~~i~ 250 (612)
T KOG0603|consen 225 NPENRLGAGPDGVDEIKQHEFFQSID 250 (612)
T ss_pred CHHHHhccCcchhHHHhccchheeee
Confidence 9999974 57999999999653
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=184.13 Aligned_cols=142 Identities=20% Similarity=0.227 Sum_probs=109.6
Q ss_pred ceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhc-----------------------HHHHHHHHHHHHhCCCCC
Q 018640 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD-----------------------IEDVRREVDIMRHLPKHQ 116 (352)
Q Consensus 60 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~-----------------------~~~~~~E~~~l~~l~~h~ 116 (352)
...||+|++|.||+|.+. +|+.||+|++.......... .....+|+.++.++ .++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~ 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL-VTA 79 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH-HHC
Confidence 467999999999999986 89999999997653211110 11234599999999 677
Q ss_pred CeeEeeeEEEeCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCCEEecCCCCceEeecCCCC
Q 018640 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC-HKHGVMHRDLKPENFLFANKKET 195 (352)
Q Consensus 117 ~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~l-H~~~ivH~Dikp~NIll~~~~~~ 195 (352)
++.....+... ..+|||||++|+++.........++...+..++.|++.+|.++ |+.||+||||||+||+++.
T Consensus 80 ~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~---- 153 (190)
T cd05147 80 GIPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD---- 153 (190)
T ss_pred CCCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC----
Confidence 66443332222 2389999999887766544556799999999999999999999 7999999999999999973
Q ss_pred CCEEEEecccceec
Q 018640 196 APLKAIDFGLSVFF 209 (352)
Q Consensus 196 ~~vkl~Dfg~a~~~ 209 (352)
..++|+|||+|...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 23899999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.5e-25 Score=188.00 Aligned_cols=176 Identities=19% Similarity=0.205 Sum_probs=134.7
Q ss_pred ccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHH------HHHHHHHHHhCCCCCCeeEeeeE
Q 018640 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIED------VRREVDIMRHLPKHQNIVCLKDT 124 (352)
Q Consensus 51 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~E~~~l~~l~~h~~iv~l~~~ 124 (352)
+.+.++|+++++||.|+||.||++.+ ++..+|+|++............. +.+|+..+.++ .|++|+.+.++
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL-~~~GI~~~~d~ 103 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRV-RSEGLASLNDF 103 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHH-HHCCCCcceEe
Confidence 45678999999999999999999765 47789999997664433332233 68999999999 99999999988
Q ss_pred EEeC--------CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCC
Q 018640 125 YEDD--------TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETA 196 (352)
Q Consensus 125 ~~~~--------~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~ 196 (352)
+... +..+++|||++|.+|.++. .+++ ....+++.+|..+|+.|++|||++|+||+++.++
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g--- 172 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG--- 172 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC---
Confidence 6533 3588999999999998863 2333 3466999999999999999999999999997543
Q ss_pred CEEEEecccceecCCCCcccccccccccccchhccccCCCcchHHHHHHHHHHHH
Q 018640 197 PLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILL 251 (352)
Q Consensus 197 ~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~s~~~Di~SlG~~l~el~ 251 (352)
++|+|||.+........... =++...+..++|+||||+++..+.
T Consensus 173 -i~liDfg~~~~~~e~~a~d~----------~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAKDR----------IDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhHHH----------HHHHhHhcccccccceeEeehHHH
Confidence 89999998865432221111 012234667999999999987654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=190.69 Aligned_cols=235 Identities=26% Similarity=0.401 Sum_probs=154.9
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCC---------CCCeeEeeeEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK---------HQNIVCLKDTY 125 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~---------h~~iv~l~~~~ 125 (352)
..+...+.||.|+++.||.+++.++|+.+|+|+............+.+++|.-....+.. |-.++..++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 356778999999999999999999999999999877664445567788877755555422 22344333332
Q ss_pred E---------eC---C-----eEEEEEEecCCcchHHHHH---hcCC----CCHHHHHHHHHHHHHHHHHHHHcCCEEec
Q 018640 126 E---------DD---T-----AVHLVMELCEGGELFDRIV---ARGH----YTERAAAAVTKTIVEVVQMCHKHGVMHRD 181 (352)
Q Consensus 126 ~---------~~---~-----~~~lv~e~~~~~sL~~~l~---~~~~----l~~~~~~~i~~qi~~aL~~lH~~~ivH~D 181 (352)
. .. . ..+++|+-+. ++|.+.+. .... +.......+..|++..+++||+.|++|+|
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgd 170 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGD 170 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecc
Confidence 2 11 1 2367788774 58877654 2222 22333455668999999999999999999
Q ss_pred CCCCceEeecCCCCCCEEEEecccceecCCCCcccccccccccccchhccc---------cCCCcchHHHHHHHHHHHHh
Q 018640 182 LKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR---------NYGPEVDVWSAGVILYILLC 252 (352)
Q Consensus 182 ikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~s~~~Di~SlG~~l~el~t 252 (352)
|+|+|++++.++. ++|+||+........... ...+..|.+||.... .++.+.|.|+||+++|.|++
T Consensus 171 i~~~nfll~~~G~---v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 171 IKPENFLLDQDGG---VFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp -SGGGEEE-TTS----EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred cceeeEEEcCCCC---EEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 9999999986655 999999977664332222 244577999996532 26788999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCC
Q 018640 253 GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRR 303 (352)
Q Consensus 253 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 303 (352)
++.||........... .+. .+ ..+|+.+.+||..+|++||.+|
T Consensus 246 ~~lPf~~~~~~~~~~~------~f~-~C-~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW------DFS-RC-RDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG------GGT-TS-S---HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc------cch-hc-CCcCHHHHHHHHHHccCCcccC
Confidence 9999976543311110 122 12 2789999999999999999988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=187.79 Aligned_cols=191 Identities=28% Similarity=0.443 Sum_probs=141.0
Q ss_pred CCCCCCeeEeeeEEEe---------------------------CCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHH
Q 018640 112 LPKHQNIVCLKDTYED---------------------------DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKT 164 (352)
Q Consensus 112 l~~h~~iv~l~~~~~~---------------------------~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~q 164 (352)
|..|||||++..+|.+ ....|+||...+. +|.+++..+ ..+.....-++.|
T Consensus 272 La~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 272 LAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQ 349 (598)
T ss_pred cCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHH
Confidence 3579999999887632 2367899988865 999998765 4677788889999
Q ss_pred HHHHHHHHHHcCCEEecCCCCceEeecCCC-CCCEEEEecccceecCCC-------CcccccccccccccchhccccCC-
Q 018640 165 IVEVVQMCHKHGVMHRDLKPENFLFANKKE-TAPLKAIDFGLSVFFKPG-------EKFSEIVGSPYYMAPEVLKRNYG- 235 (352)
Q Consensus 165 i~~aL~~lH~~~ivH~Dikp~NIll~~~~~-~~~vkl~Dfg~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~s- 235 (352)
+++|..|||++|+.|||+|.+|||+.-+++ ...+.|+|||++-.-+.. .......|.-..||||+...-++
T Consensus 350 lLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp 429 (598)
T KOG4158|consen 350 LLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP 429 (598)
T ss_pred HHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence 999999999999999999999999975544 345789999987543221 11123457778999998753222
Q ss_pred ------CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc-CCCCCcCCCHHHHHHHHHhcCCCcCCCCCHH
Q 018640 236 ------PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF-RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQ 307 (352)
Q Consensus 236 ------~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ 307 (352)
.++|.|+.|.+.||+++...||+..-+...... ...+. -+..+..+++.+++++..+|++||.+|+|.+
T Consensus 430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r---~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR---TYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred ceeeccchhhhhhhhhhHHHHhccCCcccccchheechh---hhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 379999999999999999999987322111000 01111 1222346789999999999999999999854
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-23 Score=174.06 Aligned_cols=189 Identities=21% Similarity=0.272 Sum_probs=140.9
Q ss_pred eeceeeeccCceEEEEEEECCCCcEEEEEEccccccCC-hhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEE
Q 018640 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT-AVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (352)
Q Consensus 58 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e 136 (352)
.+...|++|+||+||.+.. .+..++.+.+....... ......+.+|+++|++|.+++++++++++ +..+++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 3567899999999998765 57778877765443211 11223578999999999777899999986 34689999
Q ss_pred ecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecC-CCCceEeecCCCCCCEEEEecccceecCCCCcc
Q 018640 137 LCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL-KPENFLFANKKETAPLKAIDFGLSVFFKPGEKF 215 (352)
Q Consensus 137 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Di-kp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~ 215 (352)
|+.|.+|.+.+.. ....++.|++.+|+++|++||+|||| ||+|||++.++. ++|+|||++.........
T Consensus 79 yI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~---i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 79 YLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGS---PAVIDFQLAVRGNPRARW 148 (218)
T ss_pred eecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCC---EEEEECCCceecCCcchH
Confidence 9999888654321 12357889999999999999999999 799999975544 899999999865433321
Q ss_pred c--------------ccccccccccchhcc--ccCC-CcchHHHHHHHHHHHHhCCCCCCCCCH
Q 018640 216 S--------------EIVGSPYYMAPEVLK--RNYG-PEVDVWSAGVILYILLCGVPPFWAETE 262 (352)
Q Consensus 216 ~--------------~~~gt~~y~aPE~~~--~~~s-~~~Di~SlG~~l~el~tg~~p~~~~~~ 262 (352)
. ....++.|++|+... ...+ ...+.++.|.-+|.++|+..+.+...+
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 0 112466777777533 2344 568899999999999999999876553
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.9e-23 Score=175.12 Aligned_cols=145 Identities=17% Similarity=0.188 Sum_probs=111.7
Q ss_pred eceeeeccCceEEEEEEECCCCcEEEEEEccccccCChh------------------c-----HHHHHHHHHHHHhCCCC
Q 018640 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAV------------------D-----IEDVRREVDIMRHLPKH 115 (352)
Q Consensus 59 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~------------------~-----~~~~~~E~~~l~~l~~h 115 (352)
+.+.||+|++|+||+|.+. +|+.||||++......... . ...+..|...+.++ .+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~ 78 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRL-YE 78 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHH-Hh
Confidence 3578999999999999987 8999999998765211000 0 12246789999999 78
Q ss_pred CCeeEeeeEEEeCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEecCCCCceEeecCCC
Q 018640 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKE 194 (352)
Q Consensus 116 ~~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dikp~NIll~~~~~ 194 (352)
+++.....+.... .++||||++|+++.........++......++.|++.++.++|+ .||+||||||+||+++ ++
T Consensus 79 ~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~- 154 (190)
T cd05145 79 AGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG- 154 (190)
T ss_pred CCCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC-
Confidence 8875444333322 48999999987665443344568889999999999999999999 9999999999999997 33
Q ss_pred CCCEEEEecccceecCC
Q 018640 195 TAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 195 ~~~vkl~Dfg~a~~~~~ 211 (352)
.++|+|||++.....
T Consensus 155 --~~~liDFG~a~~~~~ 169 (190)
T cd05145 155 --KPYIIDVSQAVELDH 169 (190)
T ss_pred --CEEEEEcccceecCC
Confidence 389999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-24 Score=211.44 Aligned_cols=243 Identities=24% Similarity=0.333 Sum_probs=176.4
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHH---HHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR---REVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~---~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
+|..++.||++.|=.|.+|++.+ |. |+||++-+... ....+.+. .|++ .... ++||++.+.-+-+.+...|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p--~~sL~~~~qrL~~ik-~~l~-~~pn~lPfqk~~~t~kAAy 97 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDP--TISLRPFKQRLEEIK-FALM-KAPNCLPFQKVLVTDKAAY 97 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCC--CCCchHHHHHHHHHH-HHhh-cCCcccchHHHHHhhHHHH
Confidence 57788999999999999998753 55 99999876541 22233333 3444 3333 8999999998887788888
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec--C
Q 018640 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF--K 210 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~--~ 210 (352)
||-+|+.. +|+|.+..++-+..-+...|+.|++.||.-+|..||+|||||.+|||+++=.= +.|+||..-+.. .
T Consensus 98 lvRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW---~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 98 LVRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNW---LYLTDFASFKPTYLP 173 (1431)
T ss_pred HHHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeech---hhhhcccccCCccCC
Confidence 99999954 99999999888999999999999999999999999999999999999975322 589999865432 1
Q ss_pred --CCCcc----cccccccccccchhccc-----------c-CCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 018640 211 --PGEKF----SEIVGSPYYMAPEVLKR-----------N-YGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIR 271 (352)
Q Consensus 211 --~~~~~----~~~~gt~~y~aPE~~~~-----------~-~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~ 271 (352)
+...+ .+...-..|.|||.+.. . .+++.||||+||++.||++ |++||.-. ++.....
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~aYr~ 249 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLLAYRS 249 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHHhHhc
Confidence 11222 12223346999997631 1 4678999999999999988 78888321 1111111
Q ss_pred cccccCCCCCc-CCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 272 SVLDFRRDPWP-KVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 272 ~~~~~~~~~~~-~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
.....+...+. -.+..++++|..|++.||.+|.|+++.|+.
T Consensus 250 ~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 250 GNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred cCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 10000000000 124578999999999999999999999987
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-23 Score=206.46 Aligned_cols=222 Identities=31% Similarity=0.534 Sum_probs=175.7
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
.+.+|..++.|-.|+||.||+++++.+...+|.| +.++.. -+++ ++... .+|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-------ilRn---ilt~a-~npfvv------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-------ILRN---ILTFA-GNPFVV------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-------hhhc---ccccc-CCccee-------------
Confidence 4567999999999999999999999999999994 433211 0111 33322 455444
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
|+=...++.-+.++... +.+++|+|+.||+|||+||+|.+++.-+. +|++|||++......
T Consensus 136 --------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGh---iKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 --------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGH---IKLTDFGLSKKGLMS 196 (1205)
T ss_pred --------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeeccc---ccccchhhhhhhhhh
Confidence 23333444434454433 88999999999999999999999986655 799999988754211
Q ss_pred C----------------cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc
Q 018640 213 E----------------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD 275 (352)
Q Consensus 213 ~----------------~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 275 (352)
. .-..++||+.|.|||++. .+|+..+|.|++|+++||++-|..||.+.+.++.+..++.....
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~ 276 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE 276 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc
Confidence 0 013568999999999865 67999999999999999999999999999999999999999888
Q ss_pred cCCCCCcCCCHHHHHHHHHhcCCCcCCCC---CHHHHhcCccccccc
Q 018640 276 FRRDPWPKVSENAKDLVRKMLDPDPKRRL---TAQQVLEHPWLQNAK 319 (352)
Q Consensus 276 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rp---s~~ell~hp~f~~~~ 319 (352)
|+.. ...++.+++++|.++|+.+|..|. .+-++.+|+||+.+.
T Consensus 277 wpE~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LD 322 (1205)
T KOG0606|consen 277 WPEE-DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLD 322 (1205)
T ss_pred cccc-CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecc
Confidence 8887 457899999999999999999994 788999999999763
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-23 Score=178.85 Aligned_cols=241 Identities=17% Similarity=0.247 Sum_probs=186.8
Q ss_pred ceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEE
Q 018640 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (352)
Q Consensus 57 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e 136 (352)
..++-+|.+...|..|+|+++ |..+++|++......... -..|..|.-.|+.+ .||||+.+++.|.......++..
T Consensus 192 lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~ri-srdfneefp~lrif-shpnilpvlgacnsppnlv~isq 267 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARI-SRDFNEEFPALRIF-SHPNILPVLGACNSPPNLVIISQ 267 (448)
T ss_pred hhhhhhhccCCCccccccccc--Ccchhhhhhhhhhcchhh-cchhhhhCcceeee-cCCchhhhhhhccCCCCceEeee
Confidence 456677999999999999997 555677877665443322 24688899999988 89999999999999999999999
Q ss_pred ecCCcchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcC--CEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 137 LCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHG--VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 137 ~~~~~sL~~~l~~~~~--l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
|+|.|||+..+..... ....++.+++.+++.|+.|||+.. |.--.|....++++.+-.+ .+-.+|--++...
T Consensus 268 ~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedlta-rismad~kfsfqe--- 343 (448)
T KOG0195|consen 268 YMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTA-RISMADTKFSFQE--- 343 (448)
T ss_pred eccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhh-heecccceeeeec---
Confidence 9999999999987654 577889999999999999999874 4455788888999754432 2333444433221
Q ss_pred Ccccccccccccccchhcccc----CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHH
Q 018640 213 EKFSEIVGSPYYMAPEVLKRN----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (352)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~~----~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (352)
....-.+.||+||.+... --...|+|||++++||+.|...||..-.+.+.-..+.-. ..+...++.++..+
T Consensus 344 ---~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkiale--glrv~ippgis~hm 418 (448)
T KOG0195|consen 344 ---VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALE--GLRVHIPPGISRHM 418 (448)
T ss_pred ---cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhc--cccccCCCCccHHH
Confidence 111235789999998643 234699999999999999999999877666555444332 34556678999999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHh
Q 018640 289 KDLVRKMLDPDPKRRLTAQQVL 310 (352)
Q Consensus 289 ~~li~~~l~~dP~~Rps~~ell 310 (352)
..|+.-|.+.||.+||.++.++
T Consensus 419 ~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 419 NKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHHHhcCCCCcCCCcceeh
Confidence 9999999999999999988774
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.7e-22 Score=197.89 Aligned_cols=194 Identities=24% Similarity=0.388 Sum_probs=159.6
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCC---CCCeeEeeeEEEeCCe
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK---HQNIVCLKDTYEDDTA 130 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~---h~~iv~l~~~~~~~~~ 130 (352)
.+.|.|.++||+|+||+||.|.... |+.||+|+-...... +|.--.+++.+| + -+.|+.+...+...+.
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W------EfYI~~q~~~RL-k~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW------EFYICLQVMERL-KPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce------eeeehHHHHHhh-chhhhcchHHHHHHHccCCc
Confidence 3579999999999999999999765 999999987654322 233334556666 3 2445666667777888
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecC----CCCCCEEEEecccc
Q 018640 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK----KETAPLKAIDFGLS 206 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~----~~~~~vkl~Dfg~a 206 (352)
-++|+||.+.|+|.+++...+.+++..+..++.|++..+++||..+|||+||||+|+||... .....++|+|||.+
T Consensus 769 S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s 848 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS 848 (974)
T ss_pred ceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence 89999999999999999988889999999999999999999999999999999999999642 23445899999988
Q ss_pred eec---CCCCcccccccccccccchhcccc-CCCcchHHHHHHHHHHHHhCCC
Q 018640 207 VFF---KPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVP 255 (352)
Q Consensus 207 ~~~---~~~~~~~~~~gt~~y~aPE~~~~~-~s~~~Di~SlG~~l~el~tg~~ 255 (352)
..+ .++......++|-.+-.+|...|. ++...|.|.++.+++.|+.|+.
T Consensus 849 iDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 654 344466777899999999998765 9999999999999999999864
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.9e-21 Score=164.10 Aligned_cols=140 Identities=19% Similarity=0.237 Sum_probs=108.9
Q ss_pred eceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCC----CCCCeeEeeeEEEeCC---e-
Q 018640 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP----KHQNIVCLKDTYEDDT---A- 130 (352)
Q Consensus 59 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~----~h~~iv~l~~~~~~~~---~- 130 (352)
-...||+|+||.||. ++.++.. +||++.... ....+.+.+|+.+++.+. +||||++++++++.+. .
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 347899999999995 6666665 689886542 223467899999999994 4799999999998764 3
Q ss_pred EEEEEEe--cCCcchHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHHcCCEEecCCCCceEeecCC-CCCCEEEEec-cc
Q 018640 131 VHLVMEL--CEGGELFDRIVARGHYTERAAAAVTKTIVEVV-QMCHKHGVMHRDLKPENFLFANKK-ETAPLKAIDF-GL 205 (352)
Q Consensus 131 ~~lv~e~--~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL-~~lH~~~ivH~Dikp~NIll~~~~-~~~~vkl~Df-g~ 205 (352)
..+|+|| +++++|.+++... .+++. ..++.+++.++ +|||+++|+||||||+|||++..+ ....++|+|| |.
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 3378999 5579999999664 46655 35678888777 999999999999999999998644 3346999995 54
Q ss_pred ce
Q 018640 206 SV 207 (352)
Q Consensus 206 a~ 207 (352)
..
T Consensus 157 ~~ 158 (210)
T PRK10345 157 ST 158 (210)
T ss_pred cc
Confidence 33
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.8e-21 Score=166.26 Aligned_cols=146 Identities=20% Similarity=0.131 Sum_probs=112.8
Q ss_pred cceeceeeeccCceEEEEEE-ECCCCcEEEEEEccccccCCh-----------------h----cHHHHHHHHHHHHhCC
Q 018640 56 RYELGRELGRGEFGITYLCT-DRENGDAFACKSISKKKLRTA-----------------V----DIEDVRREVDIMRHLP 113 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~-~~~~~~~vavK~~~~~~~~~~-----------------~----~~~~~~~E~~~l~~l~ 113 (352)
-|++.+.||+|++|.||+|. +..+|+.||+|++........ . ....+.+|+.++.++
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L- 107 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL- 107 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH-
Confidence 48899999999999999998 667899999999875421100 0 112357899999999
Q ss_pred CCC--CeeEeeeEEEeCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC-CEEecCCCCceEee
Q 018640 114 KHQ--NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG-VMHRDLKPENFLFA 190 (352)
Q Consensus 114 ~h~--~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~-ivH~Dikp~NIll~ 190 (352)
.+. .+++++++ ...++||||++|.+|.........+....+..++.|++.++.+||+.| ++|+||||+||+++
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH 183 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence 443 23444442 235899999999888776544455677778899999999999999999 99999999999997
Q ss_pred cCCCCCCEEEEecccceecC
Q 018640 191 NKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 191 ~~~~~~~vkl~Dfg~a~~~~ 210 (352)
++ .++|+|||.+....
T Consensus 184 -~~---~i~LiDFg~a~~~~ 199 (237)
T smart00090 184 -DG---KVVIIDVSQSVELD 199 (237)
T ss_pred -CC---CEEEEEChhhhccC
Confidence 33 48999999987543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-21 Score=180.59 Aligned_cols=245 Identities=24% Similarity=0.368 Sum_probs=165.9
Q ss_pred cceeceeeeccCceEEEEEEECCC---CcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEee--e----EEE
Q 018640 56 RYELGRELGRGEFGITYLCTDREN---GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK--D----TYE 126 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~--~----~~~ 126 (352)
.+.+.+..+..+++.+.......+ .+.++.+....... .......+++-.+.-...|+..+..- . ...
T Consensus 245 s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~---~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~ 321 (516)
T KOG1033|consen 245 SSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSL---CACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSK 321 (516)
T ss_pred cccccccccccccCCchhhhhcccchhhhhccchhhhccch---hhhhhhhhhhhheeccccCCcccccCCCCchhhhcc
Confidence 355666777777777776554332 33444444333210 11222333444444443444433222 0 111
Q ss_pred -----eCCeEEEEEEecCCcchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCE
Q 018640 127 -----DDTAVHLVMELCEGGELFDRIVARG---HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPL 198 (352)
Q Consensus 127 -----~~~~~~lv~e~~~~~sL~~~l~~~~---~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~v 198 (352)
...+.+|.|+++.-.+|.+++..+. ..++.....++.|++.|++| ++.+|+|+||.||++..+.. +
T Consensus 322 ~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q---~ 395 (516)
T KOG1033|consen 322 RNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQ---L 395 (516)
T ss_pred ccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchh---h
Confidence 1236789999999999999997554 36788899999999999999 99999999999999976554 7
Q ss_pred EEEecccceecCCCC-------cccccccccccccchhccc-cCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 018640 199 KAIDFGLSVFFKPGE-------KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAI 269 (352)
Q Consensus 199 kl~Dfg~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~ 269 (352)
||.|||+........ .++...||..||+||++.+ .|+.++||||||++|+|++. -...+. .......+
T Consensus 396 kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d~ 472 (516)
T KOG1033|consen 396 KIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---RIATLTDI 472 (516)
T ss_pred hhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH---HHHhhhhh
Confidence 999999998765544 5577799999999999985 59999999999999999997 222221 11111111
Q ss_pred HhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 270 IRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
.+. .+++..+...+.+ ..|+.+++.+.|.+||++.+..-|+|.
T Consensus 473 r~g--~ip~~~~~d~p~e-~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 473 RDG--IIPPEFLQDYPEE-YTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hcC--CCChHHhhcCcHH-HHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 111 2222333334443 579999999999999998888888775
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.4e-20 Score=173.54 Aligned_cols=199 Identities=22% Similarity=0.323 Sum_probs=155.3
Q ss_pred HhCCCCCCeeEeeeEEEeCCeEEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCC-EEecCCCCce
Q 018640 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGV-MHRDLKPENF 187 (352)
Q Consensus 110 ~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~i-vH~Dikp~NI 187 (352)
+.+ .|.|+.++++.+.+....++|.+|+..|+|.|.+... -.+++.....++++++.||.|+|...| .|+.+++.|+
T Consensus 2 ~~l-~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 2 RQL-DHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred ccc-chhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 456 8999999999999999999999999999999999874 358888999999999999999998766 9999999999
Q ss_pred EeecCCCCCCEEEEecccceecCCC---Ccccccccccccccchhcccc--------CCCcchHHHHHHHHHHHHhCCCC
Q 018640 188 LFANKKETAPLKAIDFGLSVFFKPG---EKFSEIVGSPYYMAPEVLKRN--------YGPEVDVWSAGVILYILLCGVPP 256 (352)
Q Consensus 188 ll~~~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~--------~s~~~Di~SlG~~l~el~tg~~p 256 (352)
+++.... +||+|||+....... .......-...|.|||.++.. .+.+.||||||++++|+++...|
T Consensus 81 lvd~~w~---lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 81 LVDSRWV---LKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred eeeeeEE---EEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9975544 999999998765321 111222345669999988642 46789999999999999999999
Q ss_pred CCCCCH----HHHHHHHHh-cccccCCCCCc--CCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 257 FWAETE----QGVAQAIIR-SVLDFRRDPWP--KVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 257 ~~~~~~----~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
|..... .+....+.+ ....+++..+. ..++.+..++..||..+|..||+++++-..
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~ 220 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSK 220 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhh
Confidence 975322 234444443 22223333221 456678999999999999999999998553
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-19 Score=155.98 Aligned_cols=137 Identities=28% Similarity=0.374 Sum_probs=112.6
Q ss_pred eeeeccCceEEEEEEECCCCcEEEEEEccccccCCh-----hcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA-----VDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
+.||+|++|.||+|.+ +|..|++|+......... .....+.+|+.++..+ .|++++....++...+..+++|
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRA-RKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHH-HHCCCCCCeEEEEeCCCCEEEE
Confidence 5799999999999986 577899997654322221 1234578899999999 7888887777777777889999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccccee
Q 018640 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (352)
Q Consensus 136 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~ 208 (352)
||++|++|.+.+..... ....++.+++.+|.++|+.+++|+|++|.||+++ + ..++|+|||.+..
T Consensus 79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~---~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-G---GKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-C---CCEEEEECCcccC
Confidence 99999999998865422 8889999999999999999999999999999997 2 3389999998875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.5e-19 Score=150.86 Aligned_cols=133 Identities=26% Similarity=0.330 Sum_probs=104.9
Q ss_pred eeeccCceEEEEEEECCCCcEEEEEEccccccCCh-----hcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEE
Q 018640 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA-----VDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (352)
Q Consensus 62 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e 136 (352)
.||+|++|.||+|.+ +|..|++|+......... ...+++.+|+.++..+ .++++....-++......++|||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRA-RKAGVNTPVVYDVDPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHH-HHCCCCCCEEEEEECCCCEEEEE
Confidence 489999999999984 578899998654322211 1235678899999999 67766555555556666789999
Q ss_pred ecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccccee
Q 018640 137 LCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (352)
Q Consensus 137 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~ 208 (352)
|++|++|.+.+..... .++.+++.+|.+||+.|++|+|++|.||+++ + ..++++|||++..
T Consensus 78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~---~~~~liDfg~a~~ 138 (199)
T TIGR03724 78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-D---DKLYLIDFGLGKY 138 (199)
T ss_pred EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-C---CcEEEEECCCCcC
Confidence 9999999988754321 8899999999999999999999999999997 3 3389999998875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.4e-19 Score=172.00 Aligned_cols=143 Identities=23% Similarity=0.292 Sum_probs=112.3
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccC-----ChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR-----TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~ 126 (352)
.....|...+.||+|+||+||++.+... .+++|+....... .....+++.+|+.++..+ +|++++....++.
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~ 406 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEA-RRAGVPTPVIYDV 406 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhh-cccCCCeeEEEEE
Confidence 3344567789999999999999987543 3444433221111 112245688999999999 8999988877777
Q ss_pred eCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccc
Q 018640 127 DDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (352)
Q Consensus 127 ~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a 206 (352)
.....++||||++|++|.+++. ....++.+++.+|.+||+.+++||||||+||+++ ++ .++|+|||++
T Consensus 407 ~~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~---~~~liDFGla 474 (535)
T PRK09605 407 DPEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD---RLYLIDFGLG 474 (535)
T ss_pred eCCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC---cEEEEeCccc
Confidence 7777899999999999999875 4577899999999999999999999999999993 33 3799999999
Q ss_pred eec
Q 018640 207 VFF 209 (352)
Q Consensus 207 ~~~ 209 (352)
+..
T Consensus 475 ~~~ 477 (535)
T PRK09605 475 KYS 477 (535)
T ss_pred ccC
Confidence 764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.8e-19 Score=150.01 Aligned_cols=139 Identities=24% Similarity=0.306 Sum_probs=105.9
Q ss_pred ceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCCh-------------------hcHHHHHHHHHHHHhCCCCC-
Q 018640 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA-------------------VDIEDVRREVDIMRHLPKHQ- 116 (352)
Q Consensus 57 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-------------------~~~~~~~~E~~~l~~l~~h~- 116 (352)
|.+.+.||+|+||.||++.+. +|+.||||++........ ........|..++..+ .++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~ 94 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL-YEEG 94 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH-HHcC
Confidence 788899999999999999874 799999998764321000 0112356788889888 666
Q ss_pred -CeeEeeeEEEeCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCC
Q 018640 117 -NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKET 195 (352)
Q Consensus 117 -~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~ 195 (352)
.++..++. ...++||||++|++|.+... ......++.+++.++.++|+.|++|+||+|+||+++.++
T Consensus 95 i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~-- 162 (198)
T cd05144 95 FPVPKPIDW----NRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE-- 162 (198)
T ss_pred CCCCceeec----CCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC--
Confidence 34444432 34589999999998876532 134567889999999999999999999999999997544
Q ss_pred CCEEEEecccceecC
Q 018640 196 APLKAIDFGLSVFFK 210 (352)
Q Consensus 196 ~~vkl~Dfg~a~~~~ 210 (352)
.++|+|||++....
T Consensus 163 -~~~liDfg~~~~~~ 176 (198)
T cd05144 163 -KIYIIDWPQMVSTD 176 (198)
T ss_pred -cEEEEECCccccCC
Confidence 48999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.9e-20 Score=183.51 Aligned_cols=261 Identities=30% Similarity=0.526 Sum_probs=206.2
Q ss_pred cccceeceeeeccCceEEEEEEECCC-CcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDREN-GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
...|.+.+.||+|+|+.|-.+....+ ...+|.|.+.... ......+.+..|..+-+.+.+|.|++.+++.....+..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 34688888899999999999887543 4456666655443 233344556668888888856999999999999999999
Q ss_pred EEEEecCCcchHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-HcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 133 LVMELCEGGELFDRI-VARG-HYTERAAAAVTKTIVEVVQMCH-KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 133 lv~e~~~~~sL~~~l-~~~~-~l~~~~~~~i~~qi~~aL~~lH-~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
++++|..|+++.+.+ .... ..+.........|+..++.|+| ..++.|+||||+|.+++..+. .++++|||+|...
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~--~l~~~df~~At~~ 175 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS--ALKIADFGLATAY 175 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC--cccCCCchhhccc
Confidence 999999999999988 5444 5778888999999999999999 999999999999999986663 4799999999876
Q ss_pred CC-CC---ccccccc-ccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcccccCCCCC
Q 018640 210 KP-GE---KFSEIVG-SPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAIIRSVLDFRRDPW 281 (352)
Q Consensus 210 ~~-~~---~~~~~~g-t~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~ 281 (352)
.. .. .....+| ++.|+|||...+ ......|+||.|+++.-+++|..|+......... .........+....|
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPW 255 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcc
Confidence 54 22 2244577 999999998765 4678899999999999999999998655443211 111111112234456
Q ss_pred cCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccc
Q 018640 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (352)
Q Consensus 282 ~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~ 317 (352)
..++....+++.+++..+|..|.+.+++-.+||+..
T Consensus 256 ~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 256 NSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ccCChhhhhcccccccCCchhccccccccccccccc
Confidence 778899999999999999999999999999999998
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.8e-18 Score=143.45 Aligned_cols=139 Identities=21% Similarity=0.254 Sum_probs=97.3
Q ss_pred ceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHH---------------------HHHHHHHHHHhCCCCC--
Q 018640 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIE---------------------DVRREVDIMRHLPKHQ-- 116 (352)
Q Consensus 60 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~---------------------~~~~E~~~l~~l~~h~-- 116 (352)
.+.||+|+||+||+|.+. +|+.||||++............ ....|...+.++ .+.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~~ 79 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRL-YEAGV 79 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHH-HHcCC
Confidence 467999999999999976 7999999998754321111111 113566666666 232
Q ss_pred CeeEeeeEEEeCCeEEEEEEecCCcchHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEecCCCCceEeecCCC
Q 018640 117 NIVCLKDTYEDDTAVHLVMELCEGGELFD-RIVARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKE 194 (352)
Q Consensus 117 ~iv~l~~~~~~~~~~~lv~e~~~~~sL~~-~l~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dikp~NIll~~~~~ 194 (352)
.+++.++. ...++||||++++++.. .+... .. ...+..++.+++.++.++|. .+|+|+||||+||+++ ++
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~- 151 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG- 151 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC-
Confidence 23444433 23589999999854322 12111 11 16788999999999999999 9999999999999997 33
Q ss_pred CCCEEEEecccceecC
Q 018640 195 TAPLKAIDFGLSVFFK 210 (352)
Q Consensus 195 ~~~vkl~Dfg~a~~~~ 210 (352)
.++|+|||.+....
T Consensus 152 --~~~liDfg~a~~~~ 165 (187)
T cd05119 152 --KVYIIDVPQAVEID 165 (187)
T ss_pred --cEEEEECccccccc
Confidence 37999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.1e-16 Score=140.60 Aligned_cols=138 Identities=19% Similarity=0.258 Sum_probs=104.1
Q ss_pred eeee-ccCceEEEEEEECCCCcEEEEEEcccccc----------CChhcHHHHHHHHHHHHhCCCCCCe--eEeeeEEEe
Q 018640 61 RELG-RGEFGITYLCTDRENGDAFACKSISKKKL----------RTAVDIEDVRREVDIMRHLPKHQNI--VCLKDTYED 127 (352)
Q Consensus 61 ~~lG-~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~~h~~i--v~l~~~~~~ 127 (352)
..|| .|+.|+||.+... +..+++|.+..... .+......+.+|+.++.++ .|+++ +..+++...
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L-~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQL-YEAGLPVPRPIAARVV 113 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHH-HhCCCCCceeEeeeee
Confidence 4687 8899999998764 78899998754211 1122345688899999999 77774 677776543
Q ss_pred CC----eEEEEEEecCC-cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEe
Q 018640 128 DT----AVHLVMELCEG-GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAID 202 (352)
Q Consensus 128 ~~----~~~lv~e~~~~-~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~D 202 (352)
+. ..++|+|+++| .+|.+++.. ..++... +.+++.+|.+||+.||+|+||||.|||++.++ .++|+|
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~---~v~LID 185 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDG---KFWLID 185 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC---CEEEEE
Confidence 32 23599999997 688888754 3455443 56899999999999999999999999997654 489999
Q ss_pred cccceec
Q 018640 203 FGLSVFF 209 (352)
Q Consensus 203 fg~a~~~ 209 (352)
||.+...
T Consensus 186 fg~~~~~ 192 (239)
T PRK01723 186 FDRGELR 192 (239)
T ss_pred CCCcccC
Confidence 9988763
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.1e-17 Score=157.59 Aligned_cols=258 Identities=21% Similarity=0.262 Sum_probs=198.6
Q ss_pred ccccceeceeeec--cCceEEEEEEE--CCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC
Q 018640 53 IEERYELGRELGR--GEFGITYLCTD--RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (352)
Q Consensus 53 ~~~~y~~~~~lG~--G~~g~Vy~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 128 (352)
....+.+...+|. |.+|.||.+.. ..++..+|+|.-... ...+.....=.+|+.-.+.+..|+|.++....+++.
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p-~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIP-FSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCC-CCCccccccccchhhcccccCccccccccCcccccC
Confidence 3456778889999 99999999998 889999999974332 122222223345777777888899999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEec
Q 018640 129 TAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIVE----VVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDF 203 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~~-l~~~~~~~i~~qi~~----aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Df 203 (352)
+..++-+|++ +.+|..+...... ++...++....+... ||.++|+.+++|-|+||+||+...+. ..++++||
T Consensus 191 ~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~--~s~~~~df 267 (524)
T KOG0601|consen 191 GILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDW--TSCKLTDF 267 (524)
T ss_pred Ccceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccccc--ceeecCCc
Confidence 9999999999 5688888876655 888999999999999 99999999999999999999997663 34799999
Q ss_pred ccceecCCCCcc------cccccccccccchhccccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC
Q 018640 204 GLSVFFKPGEKF------SEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR 277 (352)
Q Consensus 204 g~a~~~~~~~~~------~~~~gt~~y~aPE~~~~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 277 (352)
|+...+...... ....|...|++||..++-++..+|+||+|.++.+..++-.+....... ....+.+.. .+
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-~W~~~r~~~--ip 344 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNS-SWSQLRQGY--IP 344 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCC-Ccccccccc--Cc
Confidence 999877654321 122577889999999999999999999999999988775554332111 011111111 22
Q ss_pred CCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccc
Q 018640 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (352)
Q Consensus 278 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~ 317 (352)
.+.....+..+...+.+|++.+|-.|++++.+.+|+++..
T Consensus 345 ~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 345 LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 2333345667777999999999999999999999998873
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.7e-16 Score=128.83 Aligned_cols=133 Identities=23% Similarity=0.295 Sum_probs=110.2
Q ss_pred eceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCC-CCeeEeeeEEEeCCeEEEEEEe
Q 018640 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH-QNIVCLKDTYEDDTAVHLVMEL 137 (352)
Q Consensus 59 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~~iv~l~~~~~~~~~~~lv~e~ 137 (352)
+++.||+|.++.||++... +..+++|....... ...+.+|+.++..+.++ .++++++.++...+..++++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 4678999999999999975 47899998765421 45788899999999433 5889999988888889999999
Q ss_pred cCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCEEecCCCCceEeecCCCCCCEEEEeccccee
Q 018640 138 CEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH---GVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (352)
Q Consensus 138 ~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~ 208 (352)
++|+++... +......++.+++.+|..+|.. +++|+|++|.||+++.. ..++++|||.+..
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~---~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG---KILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC---cEEEEEecccccC
Confidence 998777543 5567788899999999999985 69999999999999753 3389999998875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.3e-16 Score=138.22 Aligned_cols=238 Identities=18% Similarity=0.211 Sum_probs=154.9
Q ss_pred EEEEEEECCCCcEEEEEEccccccCChhcH-HHHHHHHHHHHhCCCCCCeeEeeeEEEeC-----CeEEEEEEecCCcch
Q 018640 70 ITYLCTDRENGDAFACKSISKKKLRTAVDI-EDVRREVDIMRHLPKHQNIVCLKDTYEDD-----TAVHLVMELCEGGEL 143 (352)
Q Consensus 70 ~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~-~~~~~E~~~l~~l~~h~~iv~l~~~~~~~-----~~~~lv~e~~~~~sL 143 (352)
.||++-+.+.|..|+.-.++.....+.... +..+.=...|-.+ -|.|+|++..++.+. ....++.||+..|++
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllql-vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~ 159 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQL-VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSL 159 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHH-HHHHHHHHHHhhcccccccccceEEEEecccchhH
Confidence 466666666676666544433322222211 1222223344455 699999999887543 457889999999999
Q ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHc--CCEEecCCCCceEeecCCCCCCEEEEecccceecCCC-----
Q 018640 144 FDRIVAR----GHYTERAAAAVTKTIVEVVQMCHKH--GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG----- 212 (352)
Q Consensus 144 ~~~l~~~----~~l~~~~~~~i~~qi~~aL~~lH~~--~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~----- 212 (352)
..+|++. ..+......+++.||+.||.|||+. -|+|+++.-+.|++..++- +|+.--.........
T Consensus 160 ~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngL---Ikig~~ap~s~h~s~~~~~~ 236 (458)
T KOG1266|consen 160 KQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGL---IKIGSVAPDSTHPSVNSTRE 236 (458)
T ss_pred HHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCce---EEecccCccccchhhhhhhH
Confidence 9999753 3488999999999999999999987 4999999999999964332 554321111111000
Q ss_pred Ccccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcccccCCCCCcCCCHHHHH
Q 018640 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVLDFRRDPWPKVSENAKD 290 (352)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (352)
.......+-++|.+||.-. .+.+..+|||+||...++|.-+..--...... ..-..+.+-..... ...-++
T Consensus 237 ~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~le-------n~lqr~ 309 (458)
T KOG1266|consen 237 AEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLE-------NGLQRG 309 (458)
T ss_pred hhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeecc-------CccccC
Confidence 1112224568899999854 45777999999999999998776542222111 11111111111111 122247
Q ss_pred HHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 291 LVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 291 li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
++..|++..|+.||++++++.||..-+.
T Consensus 310 ~i~kcl~~eP~~rp~ar~llfHpllfeV 337 (458)
T KOG1266|consen 310 SITKCLEGEPNGRPDARLLLFHPLLFEV 337 (458)
T ss_pred cCcccccCCCCCCcchhhhhcCceeeec
Confidence 8999999999999999999999987754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.57 E-value=8.1e-16 Score=152.41 Aligned_cols=260 Identities=27% Similarity=0.433 Sum_probs=202.8
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
-+.+.+.+-+-+|.++.++.+.-..+|...++|+......-...+.+.++.+-.++-.. .+|-++.....+.-.....|
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITP-RSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccC-CCCceecccCCCCCCCCcch
Confidence 35677888999999999999988888877777766544322333344455554444433 56666666655666778899
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC---
Q 018640 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK--- 210 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~--- 210 (352)
+++|+.+++|...+...+..+.+..+..+..+..++++||...+.|+|++|.|++...++. .+++|||......
T Consensus 882 ~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh---~~l~~~~t~~~vg~~~ 958 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGH---RPLTDFGTLSKVGLIP 958 (1205)
T ss_pred hhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCC---cccCcccccccccccc
Confidence 9999999999999988877888888899999999999999999999999999999976555 6899987332210
Q ss_pred ---CC--------------------------Ccccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 018640 211 ---PG--------------------------EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAE 260 (352)
Q Consensus 211 ---~~--------------------------~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~ 260 (352)
.. .......||+.|.+||.+. ......+|.|++|++++|.++|.+||...
T Consensus 959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 00 0012347899999999865 55888999999999999999999999999
Q ss_pred CHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHH---HHhcCcccccc
Q 018640 261 TEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQ---QVLEHPWLQNA 318 (352)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~---ell~hp~f~~~ 318 (352)
..+.+...+.+....++... ...+....+++...+..+|.+|..+. ++-.||||+..
T Consensus 1039 tpq~~f~ni~~~~~~~p~g~-~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1039 TPQQIFENILNRDIPWPEGP-EEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred chhhhhhccccCCCCCCCCc-cccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence 98888877777665554432 35788899999999999999999887 99999999965
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.8e-15 Score=140.59 Aligned_cols=255 Identities=22% Similarity=0.231 Sum_probs=190.1
Q ss_pred cccccceeceeeeccCceEEEEEEEC-CCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDR-ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 130 (352)
....+|..+..||.|.|+.|+.+... .++..|++|.+.+.......++. -..|+.+...+..|.+++.....+.....
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~-sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIF-SLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhc-chhhhhHhhHhhcccccCCCCCCcccccc
Confidence 34457889999999999999998866 77889999988776554443333 34577788888789999998888877777
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
.++-.||+.++++.....-...+.+...+.+..|++.++.++|+..++|+|++|+||++.+++ ...++.|||..+.+.
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~--~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG--FFSKLGDFGCWTRLA 418 (524)
T ss_pred ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch--hhhhccccccccccc
Confidence 789999999988877665444588889999999999999999999999999999999998754 336899999886421
Q ss_pred CCCcccccccccccc-cchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHH
Q 018640 211 PGEKFSEIVGSPYYM-APEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (352)
Q Consensus 211 ~~~~~~~~~gt~~y~-aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (352)
.......++.+++ ..|.+.. .+..+.|++|||..+.+.+++...-+..... ..+... .-...+.....
T Consensus 419 --~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~~i~~~----~~p~~~~~~~~ 489 (524)
T KOG0601|consen 419 --FSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---LTIRSG----DTPNLPGLKLQ 489 (524)
T ss_pred --eecccccccccccccchhhccccccccccccccccccccccccCcccCcccccc---eeeecc----cccCCCchHHh
Confidence 1112223344555 3555543 3778999999999999999987654332221 111111 11122344577
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 288 ~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
+..+..-+..+++..||++.++..|+-|...
T Consensus 490 ~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~ 520 (524)
T KOG0601|consen 490 LQVLLKVMINPDRKRRPSAVELSLHSEFYRD 520 (524)
T ss_pred hhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence 8889999999999999999999999877643
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.55 E-value=6.2e-14 Score=133.58 Aligned_cols=144 Identities=19% Similarity=0.254 Sum_probs=98.1
Q ss_pred eeeeccCceEEEEEEECCCCcEEEEEEccccccCCh-----------------------hc--------------HHHHH
Q 018640 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA-----------------------VD--------------IEDVR 103 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-----------------------~~--------------~~~~~ 103 (352)
+.||.|++|.||+|+.. +|+.||||+........- .+ .-.+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 46999999999999964 799999999865421000 00 01245
Q ss_pred HHHHHHHhCC----CCCCeeEeeeEEEeCCeEEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHHcCC
Q 018640 104 REVDIMRHLP----KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVE-VVQMCHKHGV 177 (352)
Q Consensus 104 ~E~~~l~~l~----~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~-aL~~lH~~~i 177 (352)
+|+..+.++. +++++.-..-+....+..+|||||++|++|.+..... ... ....++..++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCc
Confidence 5666666552 2344332222223344579999999999998876432 112 23456666665 5788999999
Q ss_pred EEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 178 MHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 178 vH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
+|+|++|.||++..++ .++++|||++...+.
T Consensus 279 ~H~D~hPgNilv~~~g---~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 279 FHADLHPGNIFVLKDG---KIIALDFGIVGRLSE 309 (437)
T ss_pred eeCCCCcccEEECCCC---cEEEEeCCCeeECCH
Confidence 9999999999997554 389999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.1e-13 Score=110.91 Aligned_cols=148 Identities=20% Similarity=0.248 Sum_probs=113.4
Q ss_pred eceeeeccCceEEEEEEECCCCcEEEEEEccccccCC-----hhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT-----AVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 59 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
.+..|-+|+-+.|+++.+. |+.++||.=....... .....+..+|+++|.++ .--.|....=++.+...-.|
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~-~~~GI~~P~l~~~D~~~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKC-RALGIPAPRLIFIDTYGGQI 87 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHH-HHhCCCCceEEEEecCCCeE
Confidence 5678999999999999875 8888887433333333 23455678899999988 44455555555666666779
Q ss_pred EEEecCC-cchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 134 VMELCEG-GELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 134 v~e~~~~-~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
+|||++| .++.+++.... .........+++.|-+.+.-||+++|||+||..+||++.+++....+.++|||++...
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 9999987 46777775532 2334444789999999999999999999999999999999888877899999998754
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.6e-13 Score=114.45 Aligned_cols=143 Identities=13% Similarity=0.112 Sum_probs=101.9
Q ss_pred ceeeeccCceEEEEEEECC------CCcEEEEEEcccccc--CC-----------------hhcHHHHH----HHHHHHH
Q 018640 60 GRELGRGEFGITYLCTDRE------NGDAFACKSISKKKL--RT-----------------AVDIEDVR----REVDIMR 110 (352)
Q Consensus 60 ~~~lG~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~--~~-----------------~~~~~~~~----~E~~~l~ 110 (352)
...||.|--+.||.|.... .+..+|+|+...+.. .. ......+. +|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999998643 357899998864321 10 01122333 7999999
Q ss_pred hCCCC-CCeeEeeeEEEeCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCCEEecCCCCceE
Q 018640 111 HLPKH-QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC-HKHGVMHRDLKPENFL 188 (352)
Q Consensus 111 ~l~~h-~~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~l-H~~~ivH~Dikp~NIl 188 (352)
++... -+++.++++ ...+|||||+.+..+....-....++......+..+++.+|..+ |+.|+||+||++.||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 98432 456677765 45689999997644432222223456667788899999999998 8999999999999999
Q ss_pred eecCCCCCCEEEEecccceecC
Q 018640 189 FANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 189 l~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
+.. + .++|+|||.+....
T Consensus 158 ~~~-~---~v~iIDF~qav~~~ 175 (197)
T cd05146 158 WHD-G---KVWFIDVSQSVEPT 175 (197)
T ss_pred EEC-C---cEEEEECCCceeCC
Confidence 963 2 37999999887543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.9e-13 Score=113.75 Aligned_cols=129 Identities=18% Similarity=0.168 Sum_probs=94.8
Q ss_pred ceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEecC
Q 018640 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCE 139 (352)
Q Consensus 60 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~ 139 (352)
++.|+.|..+.||++... +..|++|....... ....+..|+.+++.+.+...+++++.+.. +..++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 366899999999999864 78899998754321 12245779999998843333455655543 34579999999
Q ss_pred CcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCC-----EEecCCCCceEeecCCCCCCEEEEeccccee
Q 018640 140 GGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGV-----MHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (352)
Q Consensus 140 ~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~i-----vH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~ 208 (352)
|.++.+. ......++.+++.+|..||+.++ +|+|++|.||+++ ++ .++++|||.+..
T Consensus 75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~---~~~liDf~~a~~ 136 (170)
T cd05151 75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG---RLWLIDWEYAGM 136 (170)
T ss_pred CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC---eEEEEecccccC
Confidence 9887543 11123456799999999999885 9999999999997 22 379999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.47 E-value=6.2e-14 Score=135.33 Aligned_cols=148 Identities=20% Similarity=0.316 Sum_probs=95.8
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccC--------------------------Ch-----hcHH----
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR--------------------------TA-----VDIE---- 100 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------------------------~~-----~~~~---- 100 (352)
.|.. +.||.|++|+||+|+.+.+|+.||||+..+.... .. .-.+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4665 6899999999999999877999999999754210 00 0011
Q ss_pred --HHHHHHHHHHhCC---CCCCeeEeeeEEE-eCCeEEEEEEecCCcchHHH--HHhcC----CCCHHHHHHHHHHHHHH
Q 018640 101 --DVRREVDIMRHLP---KHQNIVCLKDTYE-DDTAVHLVMELCEGGELFDR--IVARG----HYTERAAAAVTKTIVEV 168 (352)
Q Consensus 101 --~~~~E~~~l~~l~---~h~~iv~l~~~~~-~~~~~~lv~e~~~~~sL~~~--l~~~~----~l~~~~~~~i~~qi~~a 168 (352)
.+.+|+..+.++. .+.+.+.+-.++. -....+|||||++|+++.+. +...+ .+....+..++.|+
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--- 276 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--- 276 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH---
Confidence 2444555555542 1333333333332 24567899999999999774 33322 13333333334443
Q ss_pred HHHHHHcCCEEecCCCCceEeecCC-CCCCEEEEecccceecCC
Q 018640 169 VQMCHKHGVMHRDLKPENFLFANKK-ETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 169 L~~lH~~~ivH~Dikp~NIll~~~~-~~~~vkl~Dfg~a~~~~~ 211 (352)
...|++|+|+||.||+++.++ ....++++|||++...+.
T Consensus 277 ----f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ----FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 468999999999999998654 223589999999987654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.1e-12 Score=105.58 Aligned_cols=136 Identities=26% Similarity=0.322 Sum_probs=100.4
Q ss_pred eeeeccCceEEEEEEECCCCcEEEEEEccccccCChh-----cHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAV-----DIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
..|++|+-+.+|.+.+. |..+++|.=.+.....+. ..++-.+|+.++.++ ..-.|...+=+..+.....|+|
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a-~~~GV~~P~v~dvD~~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKA-REAGVPVPIVYDVDPDNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHH-HHcCCCCCeEEEEcCCCCEEEE
Confidence 45789999999999764 555677643333333322 234566799999988 5555555555556666778999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 136 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
||++|..|.+.+... ...++..+-.-+.-||+.||+|+||.++||++..+. +.++|||++....
T Consensus 79 e~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~----i~~IDfGLg~~s~ 142 (204)
T COG3642 79 EYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR----IYFIDFGLGEFSD 142 (204)
T ss_pred EEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc----EEEEECCcccccc
Confidence 999998888888665 255667777778889999999999999999997443 7999999997543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.42 E-value=5.6e-12 Score=120.65 Aligned_cols=182 Identities=17% Similarity=0.203 Sum_probs=133.7
Q ss_pred ceeceeeeccCceEEE-EEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 57 YELGRELGRGEFGITY-LCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 57 y~~~~~lG~G~~g~Vy-~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
|.+ ....-++.+ +| .|..+.++..|.|.+.+.+.. ...+...+-++.|+.+ +||||+++++.++.++..|||+
T Consensus 15 Y~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtl-RHP~Il~yL~t~e~~~~~ylvT 88 (690)
T KOG1243|consen 15 YDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTL-RHPNILSYLDTTEEEGTLYLVT 88 (690)
T ss_pred ccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhc-cCchhhhhhhhhcccCceEEEe
Confidence 444 333344444 34 466678899999998876532 2345677888999999 9999999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCc
Q 018640 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH-KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (352)
Q Consensus 136 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH-~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (352)
|-+. .|..++++. ....+.-.+.||+.||.+|| +.+++|++|.-+.|+++..++ .||++|.++........
T Consensus 89 ErV~--Pl~~~lk~l---~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~Ge---WkLggle~v~~~~~~~~ 160 (690)
T KOG1243|consen 89 ERVR--PLETVLKEL---GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGE---WKLGGLELVSKASGFNA 160 (690)
T ss_pred eccc--cHHHHHHHh---HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCc---EEEeeeEEEeccccCCc
Confidence 9984 666677653 37778888999999999997 678999999999999986666 89999998865433221
Q ss_pred -ccccccccccccchhccccCCCcchHHHHHHHHHHHHhC
Q 018640 215 -FSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCG 253 (352)
Q Consensus 215 -~~~~~gt~~y~aPE~~~~~~s~~~Di~SlG~~l~el~tg 253 (352)
.....--..|..|+.+... .-..|.|-||+++++++.|
T Consensus 161 ~~~~~~~~~s~~~P~~~~~s-~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 161 PAKSLYLIESFDDPEEIDPS-EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccccchhhhcccChhhcCcc-ccchhhhhHHHHHHHHhCc
Confidence 1111112235555543211 1346999999999999998
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.6e-10 Score=106.31 Aligned_cols=218 Identities=17% Similarity=0.231 Sum_probs=158.8
Q ss_pred CceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEE----eCCeEEEEEEecCC-c
Q 018640 67 EFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE----DDTAVHLVMELCEG-G 141 (352)
Q Consensus 67 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~----~~~~~~lv~e~~~~-~ 141 (352)
--.+.|++....+|..|++|++........ ...-.-+++++++ .|.|+|++.++|. .+..+++|++|.|+ +
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl-~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~ 363 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKL-CHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP 363 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHh-ccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence 446899999999999999999944322222 1122356788999 9999999999886 45578999999986 6
Q ss_pred chHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccc
Q 018640 142 ELFDRIVAR---------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (352)
Q Consensus 142 sL~~~l~~~---------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a 206 (352)
+|.+..-.. ...++..+|.++.|+..||.++|+.|+..+-|.|.+|+++.+. .++|+..|+.
T Consensus 364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~---RIriS~C~i~ 440 (655)
T KOG3741|consen 364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM---RIRISGCGIM 440 (655)
T ss_pred hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc---eEEEecccce
Confidence 777765321 2367899999999999999999999999999999999997443 3788887877
Q ss_pred eecCCCCcccccccccccccchhccccCCCcchHHHHHHHHHHHHhCCCCCCCCCHH-HH-HHHHHhcccccCCCCCcCC
Q 018640 207 VFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GV-AQAIIRSVLDFRRDPWPKV 284 (352)
Q Consensus 207 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~ 284 (352)
.....+.. +| + +--.+.|.-.||.+++.|.||..--+..... .. +..+ -..+
T Consensus 441 Dvl~~d~~-----------~~--l--e~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I-----------~~~y 494 (655)
T KOG3741|consen 441 DVLQEDPT-----------EP--L--ESQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI-----------TTTY 494 (655)
T ss_pred eeecCCCC-----------cc--h--hHHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh-----------hhhh
Confidence 66544330 11 0 0123578899999999999996543333221 11 1111 1357
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhcC---cccccc
Q 018640 285 SENAKDLVRKMLDPDPKRRLTAQQVLEH---PWLQNA 318 (352)
Q Consensus 285 ~~~~~~li~~~l~~dP~~Rps~~ell~h---p~f~~~ 318 (352)
+.+++++|.-+...++++ -++.+++.+ -||...
T Consensus 495 S~D~rn~v~yl~s~~~~~-ksI~~llp~~~~~ff~vm 530 (655)
T KOG3741|consen 495 STDLRNVVEYLESLNFRE-KSIQDLLPMIGSRFFTVM 530 (655)
T ss_pred hHHHHHHHHHHHhcCccc-ccHHHHHHHHHHHHHHHH
Confidence 899999999999999887 788888776 455543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.26 E-value=5.1e-11 Score=103.38 Aligned_cols=143 Identities=24% Similarity=0.382 Sum_probs=103.0
Q ss_pred eeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCC-CCeeEeeeEEEeC---CeEEEEEE
Q 018640 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH-QNIVCLKDTYEDD---TAVHLVME 136 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~~iv~l~~~~~~~---~~~~lv~e 136 (352)
+.||.|..+.||++... +|+.+++|........ .....+.+|+.+++.+..+ .++++++.+.... +..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 56899999999999864 3688999987654221 1345688899999999432 3467777776654 36689999
Q ss_pred ecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 018640 137 LCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK------------------------------------------ 174 (352)
Q Consensus 137 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~------------------------------------------ 174 (352)
|++|.++.+.+.. ..++......++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999888765432 245666666677777777777663
Q ss_pred --------------cCCEEecCCCCceEeecCCCCCCEEEEeccccee
Q 018640 175 --------------HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (352)
Q Consensus 175 --------------~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~ 208 (352)
..++|+|++|.||+++.+ ....+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEEEEEecccccc
Confidence 246999999999999753 123368999998865
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.8e-10 Score=95.71 Aligned_cols=130 Identities=22% Similarity=0.223 Sum_probs=82.4
Q ss_pred EEEEEEECCCCcEEEEEEccccccCCh-----------------------hcHHHHHHHHHHHHhCCCC-CCeeEeeeEE
Q 018640 70 ITYLCTDRENGDAFACKSISKKKLRTA-----------------------VDIEDVRREVDIMRHLPKH-QNIVCLKDTY 125 (352)
Q Consensus 70 ~Vy~~~~~~~~~~vavK~~~~~~~~~~-----------------------~~~~~~~~E~~~l~~l~~h-~~iv~l~~~~ 125 (352)
.||.|... +|..+|+|........-. .......+|.+.|.++... -++++++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 48999864 588999998765321100 1133467899999999433 2567777553
Q ss_pred EeCCeEEEEEEecC--CcchHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHcCCEEecCCCCceEeecCCCCCCEEEEe
Q 018640 126 EDDTAVHLVMELCE--GGELFDRIVARGHYTERAAAAVTKTIVEVVQM-CHKHGVMHRDLKPENFLFANKKETAPLKAID 202 (352)
Q Consensus 126 ~~~~~~~lv~e~~~--~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~-lH~~~ivH~Dikp~NIll~~~~~~~~vkl~D 202 (352)
..+|||||++ |..+..+.... ++......++.+++..+.. +|+.|++|+|+++.||+++.+ .+.|+|
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~----~~~iID 149 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG----KVYIID 149 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT----CEEE--
T ss_pred ----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc----eEEEEe
Confidence 3469999998 65554433221 2245667778888885554 689999999999999999754 389999
Q ss_pred cccceecC
Q 018640 203 FGLSVFFK 210 (352)
Q Consensus 203 fg~a~~~~ 210 (352)
||.+....
T Consensus 150 f~qav~~~ 157 (188)
T PF01163_consen 150 FGQAVDSS 157 (188)
T ss_dssp GTTEEETT
T ss_pred cCcceecC
Confidence 99887643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.17 E-value=9.6e-10 Score=97.85 Aligned_cols=136 Identities=18% Similarity=0.140 Sum_probs=94.3
Q ss_pred EEEEEEECCCCcEEEEEEccccccC----C----hhcHHHHHHHHHHHHhCCCCCCe--eEeeeEEEe-----CCeEEEE
Q 018640 70 ITYLCTDRENGDAFACKSISKKKLR----T----AVDIEDVRREVDIMRHLPKHQNI--VCLKDTYED-----DTAVHLV 134 (352)
Q Consensus 70 ~Vy~~~~~~~~~~vavK~~~~~~~~----~----~~~~~~~~~E~~~l~~l~~h~~i--v~l~~~~~~-----~~~~~lv 134 (352)
.|+++.. .|+.|.||........ . ......+.+|...+.++ ..-+| +.++++++. ....++|
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L-~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRL-HEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHH-HHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 3556543 4678888866432211 0 01112467888888777 33333 344555543 2357899
Q ss_pred EEecCCc-chHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecC----CCCCCEEEEecccce
Q 018640 135 MELCEGG-ELFDRIVA--RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK----KETAPLKAIDFGLSV 207 (352)
Q Consensus 135 ~e~~~~~-sL~~~l~~--~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~----~~~~~vkl~Dfg~a~ 207 (352)
+|++++. +|.+++.. ....+......++.+++..+.-||..||+|+|+++.|||++.+ .....+.|+||+.+.
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9999875 78888754 2345677888999999999999999999999999999999752 234568999999875
Q ss_pred e
Q 018640 208 F 208 (352)
Q Consensus 208 ~ 208 (352)
.
T Consensus 194 ~ 194 (268)
T PRK15123 194 I 194 (268)
T ss_pred c
Confidence 3
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=7.1e-09 Score=94.74 Aligned_cols=237 Identities=17% Similarity=0.191 Sum_probs=152.0
Q ss_pred eceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEE------EeCC-eE
Q 018640 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTY------EDDT-AV 131 (352)
Q Consensus 59 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~------~~~~-~~ 131 (352)
....||+|+.+.+|-.-.. +.. +.|++..... .. -.+-+..|.....||-+-.-+.|- .+++ ..
T Consensus 15 ~gr~LgqGgea~ly~l~e~--~d~-VAKIYh~Ppp---a~---~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV--RDQ-VAKIYHAPPP---AA---QAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCccccCCccceeeecchh--hch-hheeecCCCc---hH---HHHHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 4567999999999965422 223 4477754321 11 112334455555676443312221 1222 25
Q ss_pred EEEEEecCCcc-hHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecc
Q 018640 132 HLVMELCEGGE-LFDRIVA------RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (352)
Q Consensus 132 ~lv~e~~~~~s-L~~~l~~------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg 204 (352)
-+.|..++|.. ...++.. .....|..+..+++.++.+...||..|.+-+|+.++|+|++++.. |.|.|-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~---V~LVdsD 162 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSK---VVLVDSD 162 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCce---EEEEccc
Confidence 67788876632 2333321 124789999999999999999999999999999999999975554 7888766
Q ss_pred cceecCCCCcccccccccccccchhcc-c-----cCCCcchHHHHHHHHHHHHhC-CCCCCCCCHH----HHHH-HHHhc
Q 018640 205 LSVFFKPGEKFSEIVGSPYYMAPEVLK-R-----NYGPEVDVWSAGVILYILLCG-VPPFWAETEQ----GVAQ-AIIRS 272 (352)
Q Consensus 205 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~-----~~s~~~Di~SlG~~l~el~tg-~~p~~~~~~~----~~~~-~~~~~ 272 (352)
......++..+.--+|...|.+||... + .-+...|.|.||+++++++.| +.||.+-... .... .+...
T Consensus 163 sfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 163 SFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred ceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 544444455555557889999999654 2 356789999999999998875 9998543211 0000 11111
Q ss_pred cc------------ccCCCCCcCCCHHHHHHHHHhcCC--CcCCCCCHH
Q 018640 273 VL------------DFRRDPWPKVSENAKDLVRKMLDP--DPKRRLTAQ 307 (352)
Q Consensus 273 ~~------------~~~~~~~~~~~~~~~~li~~~l~~--dP~~Rps~~ 307 (352)
.. .....++.-+++++..+..+|+.. ++.-|||++
T Consensus 243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 11 011122445789999999999865 367899876
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=9e-11 Score=112.91 Aligned_cols=151 Identities=20% Similarity=0.342 Sum_probs=107.7
Q ss_pred HHHHHHHHHHH-cCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCcc----------cccccccccccchhccc
Q 018640 164 TIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF----------SEIVGSPYYMAPEVLKR 232 (352)
Q Consensus 164 qi~~aL~~lH~-~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~----------~~~~gt~~y~aPE~~~~ 232 (352)
+.+.||.++|. .++||++|.|++|.++..+. .||+.|+++........+ .-......|.|||++..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~---wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGD---WKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcc---eeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 44489999995 58999999999999975554 899999987655432111 11134567999999875
Q ss_pred c-CCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccC-CCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHH
Q 018640 233 N-YGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFR-RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQV 309 (352)
Q Consensus 233 ~-~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rps~~el 309 (352)
. .+.++|+||+|+++|.++. |+.-+..... ...........+.. ......+++++.+=+.+++..++.-||++.++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~-~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l 262 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGG-LLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLL 262 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCC-cchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhh
Confidence 4 7889999999999999995 4444432211 11111111111111 11225789999999999999999999999999
Q ss_pred hcCcccccc
Q 018640 310 LEHPWLQNA 318 (352)
Q Consensus 310 l~hp~f~~~ 318 (352)
+..|||.+.
T Consensus 263 ~~~~ff~D~ 271 (700)
T KOG2137|consen 263 LSIPFFSDP 271 (700)
T ss_pred hcccccCCc
Confidence 999999975
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.9e-09 Score=91.58 Aligned_cols=111 Identities=18% Similarity=0.223 Sum_probs=86.8
Q ss_pred cHHHHHHHHHHHHhCCCCCC--eeEeeeEEEeCC----eEEEEEEecCC-cchHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 018640 98 DIEDVRREVDIMRHLPKHQN--IVCLKDTYEDDT----AVHLVMELCEG-GELFDRIVARGHYTERAAAAVTKTIVEVVQ 170 (352)
Q Consensus 98 ~~~~~~~E~~~l~~l~~h~~--iv~l~~~~~~~~----~~~lv~e~~~~-~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~ 170 (352)
...+..+|...+..| ..-. ++..+++.+... ..++|+|++++ .+|.+++.....++......++.+++..+.
T Consensus 54 ~~~ra~~E~~~~~~L-~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 54 RRSRAKREWRNLQRL-REAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIA 132 (206)
T ss_pred cchHHHHHHHHHHHH-HHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHH
Confidence 345677787777766 2222 455666665432 45899999987 478998877555778888999999999999
Q ss_pred HHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 171 ~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
-||..||+|+|+++.|||+..++....+.++||+-+...
T Consensus 133 ~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999999999999999988775566899999987753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=5.6e-09 Score=90.70 Aligned_cols=139 Identities=22% Similarity=0.282 Sum_probs=100.6
Q ss_pred ceeceeeeccCceEEEEEEECCCCcEEEEEEcccc--cc---------------CC--hhcHHHHHHHHHHHHhCCCC-C
Q 018640 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKK--KL---------------RT--AVDIEDVRREVDIMRHLPKH-Q 116 (352)
Q Consensus 57 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~---------------~~--~~~~~~~~~E~~~l~~l~~h-~ 116 (352)
+.+...||.|--+.||.|.+. .|..+|+|.=+.. .+ .+ -.......+|.++|.+|... -
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 557789999999999999976 6899999943221 11 01 01234567899999999333 3
Q ss_pred CeeEeeeEEEeCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCC
Q 018640 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETA 196 (352)
Q Consensus 117 ~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~ 196 (352)
.+++.+++- ...+||||++|-.|...- +..+....|+..|+.-+..+-..|+||+|+++-||+++.++.
T Consensus 172 ~VP~P~~~n----RHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~-- 240 (304)
T COG0478 172 KVPKPIAWN----RHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD-- 240 (304)
T ss_pred CCCCccccc----cceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC--
Confidence 677777653 467999999986665432 235556666667777666666899999999999999987666
Q ss_pred CEEEEeccccee
Q 018640 197 PLKAIDFGLSVF 208 (352)
Q Consensus 197 ~vkl~Dfg~a~~ 208 (352)
+.++||--+..
T Consensus 241 -~~vIDwPQ~v~ 251 (304)
T COG0478 241 -IVVIDWPQAVP 251 (304)
T ss_pred -EEEEeCccccc
Confidence 79999986643
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.5e-08 Score=84.60 Aligned_cols=141 Identities=14% Similarity=0.108 Sum_probs=102.9
Q ss_pred eccCceEEEEEEECCCCcEEEEEEccccccCC---hhcHHHHHHHHHHHHhCC--CCCCeeEeeeEEEeC----CeEEEE
Q 018640 64 GRGEFGITYLCTDRENGDAFACKSISKKKLRT---AVDIEDVRREVDIMRHLP--KHQNIVCLKDTYEDD----TAVHLV 134 (352)
Q Consensus 64 G~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~--~h~~iv~l~~~~~~~----~~~~lv 134 (352)
|+||-+-|+..... |..+-+|........+ +.....|.+|...+.+|. +-| +++++...... -.-+||
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvP-VP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVI-VPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCC-CCccceeeeeccCCceEEEEE
Confidence 45788888887643 5578888775332222 557788999999999883 223 45555222221 246899
Q ss_pred EEecCC-cchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccccee
Q 018640 135 MELCEG-GELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (352)
Q Consensus 135 ~e~~~~-~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~ 208 (352)
+|-++| .+|.+++... .+.+......++.+++.+++-||+.|+.|+|+.+.||+++.++ ...|.++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g-~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG-KAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC-CeeEEEEEhhccch
Confidence 998754 6788888653 3467788899999999999999999999999999999997544 33489999997764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.77 E-value=4.8e-10 Score=107.00 Aligned_cols=257 Identities=16% Similarity=0.161 Sum_probs=176.5
Q ss_pred CCcccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCC-eeEeeeEEE
Q 018640 48 PTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN-IVCLKDTYE 126 (352)
Q Consensus 48 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~-iv~l~~~~~ 126 (352)
+..+.-.+.|...+..++|+++.+++.+...+...+ .+.+... ....-++++|.++ +||| .+..++-++
T Consensus 235 p~lkDk~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~-n~P~~~v~~~~d~~ 304 (829)
T KOG0576|consen 235 PTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKV-NNPNPVVRYLEDYD 304 (829)
T ss_pred CcccCCccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHc-cCCCCcccccccCC
Confidence 334444556778888999999999998876555444 5554322 3455688999999 9999 777777788
Q ss_pred eCCeEEEEEEecCCc-chHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecc
Q 018640 127 DDTAVHLVMELCEGG-ELFDRI-VARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (352)
Q Consensus 127 ~~~~~~lv~e~~~~~-sL~~~l-~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg 204 (352)
.+...++.++++.++ +-.... .....+...+...+.+.-+.+++++|+.-=+|+| ||+..++. ++..||+
T Consensus 305 ~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~~----~~~~~~~ 376 (829)
T KOG0576|consen 305 GEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEEE----VKLLDFA 376 (829)
T ss_pred cccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccccc----ccccccc
Confidence 888999999999876 222211 1112355556667778888999999998778888 88875432 5899999
Q ss_pred cceecCCCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC---CC
Q 018640 205 LSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR---DP 280 (352)
Q Consensus 205 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 280 (352)
....+...-...+..+|+.++|||+.. +.+....|.|++|.--.++.-|.+|-...... ...+-.....+.. ..
T Consensus 377 v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~--~~~~g~~p~s~~L~~~~a 454 (829)
T KOG0576|consen 377 VPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPAV--LPMIGNGPNSPMLTDKSA 454 (829)
T ss_pred CCcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCccc--cCCCCCCCCccccchhhh
Confidence 888776554556778999999999765 55888999999998777777776664321110 0000000000000 00
Q ss_pred CcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccCCCCCC
Q 018640 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSL 326 (352)
Q Consensus 281 ~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~ 326 (352)
|. +..-.++...|+...|..|+....++-|.+|+.++...+-.-
T Consensus 455 w~--~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl~i~~aa 498 (829)
T KOG0576|consen 455 WS--PVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPLRIHCAA 498 (829)
T ss_pred cC--cccccCCcccccCCCCCCCcchhhHHHHHHhccCcccceecc
Confidence 11 111125788899999999999999999999999877755433
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.73 E-value=2.4e-07 Score=78.90 Aligned_cols=143 Identities=22% Similarity=0.271 Sum_probs=92.3
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhc------HHHHHHHHHHHHhCC--CCCCeeEeee
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD------IEDVRREVDIMRHLP--KHQNIVCLKD 123 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~------~~~~~~E~~~l~~l~--~h~~iv~l~~ 123 (352)
.+.++|.+.+++-......|.+..- +|+.+++|...........- -+...+++..+.++. +-.....++-
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 4567899999998888777777653 58899999876643211100 011233444444431 1222222222
Q ss_pred E-----EEeCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCE
Q 018640 124 T-----YEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPL 198 (352)
Q Consensus 124 ~-----~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~v 198 (352)
+ +......+++|||++|..|.+... +++ .+...+.+++.-+|+.|++|+|.+|.|+++..++ +
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~----i 173 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG----I 173 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc----E
Confidence 2 222345678999999988866532 222 3556778889999999999999999999997433 7
Q ss_pred EEEeccccee
Q 018640 199 KAIDFGLSVF 208 (352)
Q Consensus 199 kl~Dfg~a~~ 208 (352)
+++||+..+.
T Consensus 174 ~iID~~~k~~ 183 (229)
T PF06176_consen 174 RIIDTQGKRM 183 (229)
T ss_pred EEEECccccc
Confidence 9999986654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=2.6e-07 Score=89.20 Aligned_cols=145 Identities=19% Similarity=0.231 Sum_probs=93.0
Q ss_pred eeeeccCceEEEEEEECCCCcEEEEEEccccccCCh-hc------------------------------------HHHHH
Q 018640 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA-VD------------------------------------IEDVR 103 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~------------------------------------~~~~~ 103 (352)
.-|+.++-|.||+|+.. +|+.||||+.+..-...- .+ .-.+.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 46899999999999976 599999999866421100 00 01234
Q ss_pred HHHHHHHhCC----CCCCeeEeeeEEEeCCeEEEEEEecCCcchHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 018640 104 REVDIMRHLP----KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRI--VARGHYTERAAAAVTKTIVEVVQMCHKHGV 177 (352)
Q Consensus 104 ~E~~~l~~l~----~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l--~~~~~l~~~~~~~i~~qi~~aL~~lH~~~i 177 (352)
+|+..+.++. +.+++.-.-=+++..+..+|+|||++|..+.+.. .. ...+...+.....++ -+..+=..|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHHhcCc
Confidence 4555555442 3344333333334456778999999999998874 33 234433333322222 1233334799
Q ss_pred EEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 178 MHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 178 vH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
+|.|.+|.||++..++. +.+.|||+....+..
T Consensus 287 fHaDpHpGNi~v~~~g~---i~~lDfGi~g~l~~~ 318 (517)
T COG0661 287 FHADPHPGNILVRSDGR---IVLLDFGIVGRLDPK 318 (517)
T ss_pred cccCCCccceEEecCCc---EEEEcCcceecCCHH
Confidence 99999999999986644 789999999876543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.7e-07 Score=94.06 Aligned_cols=203 Identities=20% Similarity=0.194 Sum_probs=141.3
Q ss_pred HHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE----EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 018640 101 DVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH----LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176 (352)
Q Consensus 101 ~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~----lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ 176 (352)
...-|..-+.+. .|+|++.++.|..++...- +..+++..-++...+..-...+...++.+..+++.||.++|+..
T Consensus 228 ~~E~e~~~l~k~-~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 228 TTEIELESLSKI-AHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHHhh-ccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 344566677777 8999999998876554332 34578888888888888888999999999999999999999997
Q ss_pred CEEecCCCCceEeecCCCCCCEEEE--ecccceecCCCCcccccccccccccchhcccc---CCCcchHHHHHHHHHHHH
Q 018640 177 VMHRDLKPENFLFANKKETAPLKAI--DFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN---YGPEVDVWSAGVILYILL 251 (352)
Q Consensus 177 ivH~Dikp~NIll~~~~~~~~vkl~--Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~---~s~~~Di~SlG~~l~el~ 251 (352)
+.|.-+..+-..-........+.++ ||+.+..............+..+-++|....+ .+...|+|.+|..+..+.
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~ 386 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLS 386 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhh
Confidence 7766666552222222223334555 88877766554443333445667788876643 333479999999999988
Q ss_pred hCCCCCCCCCHHHHHHHHHhcccccCCCCCcCC-CHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 252 CGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV-SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 252 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
.|..+-.... . .....+.. .....++..+|+..++++|+++.+++.|||.+..
T Consensus 387 ~~~~i~~~~~---~-----------~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 387 QGEDISEKSA---V-----------PVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred hcCccccccc---c-----------hhhhhccccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 8765431110 0 00111111 1267789999999999999999999999998854
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.1e-06 Score=76.65 Aligned_cols=73 Identities=25% Similarity=0.277 Sum_probs=53.5
Q ss_pred eeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCC-CeeEeeeEEEeCCeEEEEEEecC
Q 018640 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ-NIVCLKDTYEDDTAVHLVMELCE 139 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-~iv~l~~~~~~~~~~~lv~e~~~ 139 (352)
..||+|..+.||+.. |..+++|..... .......+|.+++..+.... .+++.+++....+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~~----~~~~VlR~~~~~-----~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTHK----TGKWMLKLYNPG-----FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEec----CCCEEEEeCCCC-----CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 568999999999842 446778876532 12355788999999884322 25778888877777889999999
Q ss_pred Ccc
Q 018640 140 GGE 142 (352)
Q Consensus 140 ~~s 142 (352)
|.+
T Consensus 78 G~~ 80 (226)
T TIGR02172 78 GKR 80 (226)
T ss_pred Ccc
Confidence 863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.57 E-value=4.2e-07 Score=74.23 Aligned_cols=131 Identities=21% Similarity=0.261 Sum_probs=92.1
Q ss_pred ceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEE
Q 018640 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (352)
Q Consensus 57 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e 136 (352)
.+..+.||+|++|.||+|.+. |..+|+|+-... +....+..|+++|..+...---++++.+..+ ++.||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~d-----s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me 92 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRD-----SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRME 92 (201)
T ss_pred hhhhhhhhcccccEEEEeecc--CceEEEEEecCC-----cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhh
Confidence 456788999999999999976 778999986433 3457788999999998444444566666543 35599
Q ss_pred ecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCC-C-ceEeecCCCCCCEEEEecccceec
Q 018640 137 LCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKP-E-NFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 137 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp-~-NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
|+.|.+|.+.-... . ++-...++++-.-|-..||-|+.|.- . ||++. +.+ +.|+||..|+..
T Consensus 93 ~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~-~~~---~~iIDFd~At~k 156 (201)
T COG2112 93 YIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVN-DRD---VYIIDFDSATFK 156 (201)
T ss_pred hhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEec-CCc---EEEEEccchhhc
Confidence 99998886654321 2 22334455555566778999999875 3 56653 223 799999998853
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.9e-06 Score=74.99 Aligned_cols=79 Identities=24% Similarity=0.223 Sum_probs=56.0
Q ss_pred ceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCC-CCeeEeeeEEE---eCCeEEEEE
Q 018640 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH-QNIVCLKDTYE---DDTAVHLVM 135 (352)
Q Consensus 60 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~~iv~l~~~~~---~~~~~~lv~ 135 (352)
++.|+.|..+.||++.... ..+++|..... .....+.+|..++..+..+ ..+++++.... .....+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 4679999999999998653 58999986432 3456788898888888433 23566776443 334578999
Q ss_pred EecCCcchHH
Q 018640 136 ELCEGGELFD 145 (352)
Q Consensus 136 e~~~~~sL~~ 145 (352)
++++|.++..
T Consensus 75 ~~i~g~~~~~ 84 (239)
T PF01636_consen 75 EYIPGRPLDD 84 (239)
T ss_dssp EEESSEEHHH
T ss_pred EEeccccccc
Confidence 9999987776
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.52 E-value=2.1e-06 Score=72.31 Aligned_cols=129 Identities=19% Similarity=0.243 Sum_probs=91.7
Q ss_pred ccceeceeeeccCc-eEEEEEEECCCCcEEEEEEccccccCCh------------------hcHHHHHHHHHHHHhCCC-
Q 018640 55 ERYELGRELGRGEF-GITYLCTDRENGDAFACKSISKKKLRTA------------------VDIEDVRREVDIMRHLPK- 114 (352)
Q Consensus 55 ~~y~~~~~lG~G~~-g~Vy~~~~~~~~~~vavK~~~~~~~~~~------------------~~~~~~~~E~~~l~~l~~- 114 (352)
.+++.++.||.|.. |.||++... |+.+|+|++..-..... ...+-|..|.+...+|..
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 67999999999999 999999864 88999999322111110 123357889998888843
Q ss_pred -CCCe--eEeeeEEEeC------------------CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 018640 115 -HQNI--VCLKDTYEDD------------------TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173 (352)
Q Consensus 115 -h~~i--v~l~~~~~~~------------------~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH 173 (352)
+.++ |+.+||..-. ..+.||-||++... .++. .-+.+|..-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHHH
Confidence 3344 8888886311 13467888886543 1222 23457777888999
Q ss_pred HcCCEEecCCCCceEeecCCCCCCEEEEecccc
Q 018640 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (352)
Q Consensus 174 ~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a 206 (352)
+.||+-+|+++.|.. +. +|+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~----~G----~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR----GG----KLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc----CC----EEEecccC
Confidence 999999999999987 22 89999964
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.2e-06 Score=77.34 Aligned_cols=75 Identities=16% Similarity=0.163 Sum_probs=54.3
Q ss_pred eeccCc-eEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEecCCc
Q 018640 63 LGRGEF-GITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGG 141 (352)
Q Consensus 63 lG~G~~-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~~~ 141 (352)
|-.|.. +.||+.... +..+.+|...... ...+.+|+.+++.+..+--+++++++....+..++|||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 344555 789998743 4678888765432 2356789999998865655678888887777789999999997
Q ss_pred chHH
Q 018640 142 ELFD 145 (352)
Q Consensus 142 sL~~ 145 (352)
+|..
T Consensus 78 ~l~~ 81 (244)
T cd05150 78 PAAA 81 (244)
T ss_pred cHhH
Confidence 7754
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.8e-06 Score=74.59 Aligned_cols=140 Identities=20% Similarity=0.181 Sum_probs=91.8
Q ss_pred eeeeccCceEEEEEEECCCCcEEEEEEccccccCChh----------------cHHH-----HHHHHHHHHhCCC-CCCe
Q 018640 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAV----------------DIED-----VRREVDIMRHLPK-HQNI 118 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~----------------~~~~-----~~~E~~~l~~l~~-h~~i 118 (352)
..|..|--+.||+|.. .++..+|+|++......... +... ...|...|+++.. +=.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3566777889999985 56899999998765422111 1111 2346777776621 2334
Q ss_pred eEeeeEEEeCCeEEEEEEecCCcch-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEecCCCCceEeecCCCCC
Q 018640 119 VCLKDTYEDDTAVHLVMELCEGGEL-FDRIVARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETA 196 (352)
Q Consensus 119 v~l~~~~~~~~~~~lv~e~~~~~sL-~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dikp~NIll~~~~~~~ 196 (352)
++.+.+. ...|||||+..... .-.|+. -.+.......+..+++..+.-|-. .++||+||+.-|||+. ++.
T Consensus 133 P~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~-- 204 (268)
T COG1718 133 PEPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE-- 204 (268)
T ss_pred CCceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe--
Confidence 5555543 34699999954311 111111 123444688888899999988876 8999999999999997 333
Q ss_pred CEEEEecccceecC
Q 018640 197 PLKAIDFGLSVFFK 210 (352)
Q Consensus 197 ~vkl~Dfg~a~~~~ 210 (352)
+.|+|||-|....
T Consensus 205 -p~iID~~QaV~~~ 217 (268)
T COG1718 205 -PYIIDVSQAVTID 217 (268)
T ss_pred -EEEEECccccccC
Confidence 6999999886543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.45 E-value=8.5e-06 Score=69.17 Aligned_cols=135 Identities=21% Similarity=0.269 Sum_probs=95.5
Q ss_pred ceeeeccCceEEEEEEECCCCcEEEEEEcccccc-------------CChhcHHHHHHHHHHHHhCC-----CCCCeeEe
Q 018640 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKL-------------RTAVDIEDVRREVDIMRHLP-----KHQNIVCL 121 (352)
Q Consensus 60 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~~~E~~~l~~l~-----~h~~iv~l 121 (352)
...||+|+.=.||.- + +.....||+...... .......+..+|+.....+. .+.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 357999999999963 3 355678898876640 01122455666776666662 37789999
Q ss_pred eeEEEeCCeEEEEEEecC------CcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCC
Q 018640 122 KDTYEDDTAVHLVMELCE------GGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKET 195 (352)
Q Consensus 122 ~~~~~~~~~~~lv~e~~~------~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~ 195 (352)
+|+.+.+...-+|+|.+. ..+|.+++... .++. .+...+-.-.++|-+.+|+.+|++|.||++......
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 999999999999999863 24577777443 4554 333444455567888999999999999999876665
Q ss_pred C-CEEEEe
Q 018640 196 A-PLKAID 202 (352)
Q Consensus 196 ~-~vkl~D 202 (352)
. .+.|+|
T Consensus 158 ~~~lvlID 165 (199)
T PF10707_consen 158 EFRLVLID 165 (199)
T ss_pred ceEEEEEe
Confidence 5 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.33 E-value=8.3e-06 Score=84.40 Aligned_cols=81 Identities=22% Similarity=0.324 Sum_probs=56.9
Q ss_pred ceeeeccCceEEEEEEECCCC--cEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCe--eEeeeEEEeC---CeEE
Q 018640 60 GRELGRGEFGITYLCTDRENG--DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI--VCLKDTYEDD---TAVH 132 (352)
Q Consensus 60 ~~~lG~G~~g~Vy~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i--v~l~~~~~~~---~~~~ 132 (352)
+..|+.|.++.+|+......+ ..+++|+...... ......+.+|+.+++.+..|.++ ++++.++.+. +..|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~--~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL--LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc--CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 567899999999998765432 3677776543221 11234688999999999546654 7778877654 4678
Q ss_pred EEEEecCCcc
Q 018640 133 LVMELCEGGE 142 (352)
Q Consensus 133 lv~e~~~~~s 142 (352)
+||||++|..
T Consensus 121 lVME~v~G~~ 130 (822)
T PLN02876 121 YIMEYLEGRI 130 (822)
T ss_pred EEEEecCCcc
Confidence 9999998854
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.26 E-value=9.1e-06 Score=78.45 Aligned_cols=157 Identities=20% Similarity=0.233 Sum_probs=94.4
Q ss_pred ccccccceec--eeeeccCceEEEEEEECCCCcEEEEEEccccccCCh-hc-----------------------------
Q 018640 51 REIEERYELG--RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA-VD----------------------------- 98 (352)
Q Consensus 51 ~~~~~~y~~~--~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~----------------------------- 98 (352)
..+++-|... +.||.-+.|.||+|+.+. |+.||||+-+..-.... .+
T Consensus 155 ~~ie~if~~f~~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~ 233 (538)
T KOG1235|consen 155 APIEDIFSEFDEEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAK 233 (538)
T ss_pred CCHHHHHHhcCcchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHh
Confidence 3344434432 469999999999999764 99999998765421100 00
Q ss_pred ----HHHHHHHHHHHHhCC---CCCC---eeEeeeEE-EeCCeEEEEEEecCCcchHHH--HHhcCCCCHHHHHHHHHHH
Q 018640 99 ----IEDVRREVDIMRHLP---KHQN---IVCLKDTY-EDDTAVHLVMELCEGGELFDR--IVARGHYTERAAAAVTKTI 165 (352)
Q Consensus 99 ----~~~~~~E~~~l~~l~---~h~~---iv~l~~~~-~~~~~~~lv~e~~~~~sL~~~--l~~~~~l~~~~~~~i~~qi 165 (352)
.-.|.+|++...+.. .|-+ -|.+=.++ .-....+|+|||++|..+.|. +.+. .++...+.. .+
T Consensus 234 ~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~---~l 309 (538)
T KOG1235|consen 234 SLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR-GISPHDILN---KL 309 (538)
T ss_pred hhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc-CCCHHHHHH---HH
Confidence 112344544444331 2333 11122222 233467899999999888664 3333 355553333 33
Q ss_pred HHHH-HHHHHcCCEEecCCCCceEeecCC-CCCCEEEEecccceecCCC
Q 018640 166 VEVV-QMCHKHGVMHRDLKPENFLFANKK-ETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 166 ~~aL-~~lH~~~ivH~Dikp~NIll~~~~-~~~~vkl~Dfg~a~~~~~~ 212 (352)
.++. +.|=..|++|.|=+|.||++..+. ....+.+-|||+....+..
T Consensus 310 ~~~~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 310 VEAYLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HHHHHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 3332 233457899999999999998542 3445889999999876543
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.23 E-value=2.8e-05 Score=72.99 Aligned_cols=81 Identities=19% Similarity=0.284 Sum_probs=56.7
Q ss_pred ceeeeccCceEEEEEEECCCCcEEEEEEcccccc---CC-hhcHHHHHHHHHHHHhCCCC--CCeeEeeeEEEeCCeEEE
Q 018640 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKL---RT-AVDIEDVRREVDIMRHLPKH--QNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 60 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~-~~~~~~~~~E~~~l~~l~~h--~~iv~l~~~~~~~~~~~l 133 (352)
.+.||.|.+..||++.+...++.|+||.-..... .. +...++...|.+.|..+..+ .++++++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 3679999999999999864335899998542211 11 23567788899999887443 457777776 3355789
Q ss_pred EEEecCCcc
Q 018640 134 VMELCEGGE 142 (352)
Q Consensus 134 v~e~~~~~s 142 (352)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.03 E-value=3.6e-05 Score=67.49 Aligned_cols=74 Identities=18% Similarity=0.091 Sum_probs=45.9
Q ss_pred eeeeccCce-EEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCC--CeeEeeeEEEeC---CeEEEE
Q 018640 61 RELGRGEFG-ITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ--NIVCLKDTYEDD---TAVHLV 134 (352)
Q Consensus 61 ~~lG~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~--~iv~l~~~~~~~---~~~~lv 134 (352)
+.|+.|+.. .||+.. ..+++|..... .....+.+|+.++..+..+- .++++++..... ...+++
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~-----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSAA-----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCcc-----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 557766666 589752 24677764421 12357888999999884331 344555544332 245889
Q ss_pred EEecCCcchH
Q 018640 135 MELCEGGELF 144 (352)
Q Consensus 135 ~e~~~~~sL~ 144 (352)
|++++|.++.
T Consensus 73 ~~~i~G~~l~ 82 (235)
T cd05155 73 YRWLEGETAT 82 (235)
T ss_pred EEeecCCCCC
Confidence 9999987663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.96 E-value=3.9e-05 Score=64.79 Aligned_cols=99 Identities=17% Similarity=0.173 Sum_probs=78.0
Q ss_pred HHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEecCCcchHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHH---cCC
Q 018640 104 REVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDR---IVARGHYTERAAAAVTKTIVEVVQMCHK---HGV 177 (352)
Q Consensus 104 ~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~---l~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~i 177 (352)
.|.-+++.+...+++++++|+|- .+++.||.+.+++... +..-...+|..+.+|+.+++..+++++. ..+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 47888888866679999999993 4688999987666421 1122246899999999999999999997 357
Q ss_pred EEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 178 MHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 178 vH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
.-.|++|+|+-++.++. +|++|...+...
T Consensus 84 ~lcDv~~~nfgv~~~~~---lk~iDld~v~~~ 112 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGR---LKLIDLDDVFVE 112 (188)
T ss_pred EEeecchHHeEEeCCCc---EEEEechhcchh
Confidence 88899999999986555 899999866543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.96 E-value=9.5e-05 Score=64.72 Aligned_cols=76 Identities=25% Similarity=0.269 Sum_probs=48.8
Q ss_pred ceeeeccCceEEEEEEECC-CCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEec
Q 018640 60 GRELGRGEFGITYLCTDRE-NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELC 138 (352)
Q Consensus 60 ~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~ 138 (352)
++.|..|-...+|++.... .+..|++|+...... .. -...+|+.++..+..+.-.+++++.+. + .++|||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~---~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LI---IDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ce---ecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence 3567788888999987543 357888997654311 11 123468888888844444455655433 1 4799999
Q ss_pred CCcch
Q 018640 139 EGGEL 143 (352)
Q Consensus 139 ~~~sL 143 (352)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 98765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.91 E-value=8.8e-05 Score=65.94 Aligned_cols=135 Identities=19% Similarity=0.155 Sum_probs=77.0
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEecCCcc
Q 018640 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGE 142 (352)
Q Consensus 63 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~~~s 142 (352)
+..|-.+.+|+.. .++..+++|....... .... ...+|..+++.+..+.-.++++.... .++|+||++|.+
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~--~~~~-~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~ 74 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCK--ALGV-DRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEV 74 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccc--cccC-cHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcc
Confidence 4567788899887 3467788887543311 1111 24678889998854433345555432 368999999866
Q ss_pred hHHH----------H-------HhcC----CCCHH-HHHHHHHHH---------HHHHHHHHH--------cCCEEecCC
Q 018640 143 LFDR----------I-------VARG----HYTER-AAAAVTKTI---------VEVVQMCHK--------HGVMHRDLK 183 (352)
Q Consensus 143 L~~~----------l-------~~~~----~l~~~-~~~~i~~qi---------~~aL~~lH~--------~~ivH~Dik 183 (352)
+... + +... +++.. .+.....++ ...++.+-. ..++|+|+.
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 5321 1 1111 11111 111211111 122222222 258999999
Q ss_pred CCceEeecCCCCCCEEEEecccceecC
Q 018640 184 PENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 184 p~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
|.||+++.++ +.|+||..+...+
T Consensus 155 ~~Nil~~~~~----~~lIDwE~a~~gd 177 (256)
T TIGR02721 155 AYNLVVTPQG----LKLIDWEYASDGD 177 (256)
T ss_pred cCcEEEeCCC----CEEEeccccCcCC
Confidence 9999997543 5899999887543
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00046 Score=64.77 Aligned_cols=77 Identities=16% Similarity=0.163 Sum_probs=53.0
Q ss_pred ceeeeccCceEEEEEEECCCCcEEEEEEccccccCCh----hcHHHHHHHHHHHHhCCCC--CCeeEeeeEEEeCCeEEE
Q 018640 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA----VDIEDVRREVDIMRHLPKH--QNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 60 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~E~~~l~~l~~h--~~iv~l~~~~~~~~~~~l 133 (352)
.+.||.|....||+..+. +..++||.-........ ...++-..|+..|+.+.+. ..+++++.++. +..++
T Consensus 37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 577999999999998863 45688997653221111 2345555678888776332 47888888877 34578
Q ss_pred EEEecCC
Q 018640 134 VMELCEG 140 (352)
Q Consensus 134 v~e~~~~ 140 (352)
+||++++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 8999976
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00056 Score=63.13 Aligned_cols=77 Identities=18% Similarity=0.180 Sum_probs=51.3
Q ss_pred eeeccCceEEEEEEECCCCcEEEEEEcccccc----CChhcHHHHHHHHHHHHhCCCC-C-CeeEeeeEEEeCCeEEEEE
Q 018640 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKL----RTAVDIEDVRREVDIMRHLPKH-Q-NIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 62 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~E~~~l~~l~~h-~-~iv~l~~~~~~~~~~~lv~ 135 (352)
+||.|....||++.+...++.|+||.-..... .-+...++..-|...|+..... | .+++++.+ ++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 58999999999999764446899997543221 1144566777788888876432 2 35555443 444556899
Q ss_pred EecCC
Q 018640 136 ELCEG 140 (352)
Q Consensus 136 e~~~~ 140 (352)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99864
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00047 Score=62.57 Aligned_cols=138 Identities=18% Similarity=0.210 Sum_probs=80.9
Q ss_pred ceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCC-CeeEeeeE------EEeCCeEE
Q 018640 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ-NIVCLKDT------YEDDTAVH 132 (352)
Q Consensus 60 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-~iv~l~~~------~~~~~~~~ 132 (352)
++.|..|....+|+... ++..+++|+... ...+.+..|+.++..+..+- .+++++.. ....+..+
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~------~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK------VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCC------CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 45677888889999864 345688898653 12355667888888773221 24454432 23345678
Q ss_pred EEEEecCCcchHH----H---H-------Hh-cCCC----------CHHHH----------HHHHHHHHHHHHHHHH---
Q 018640 133 LVMELCEGGELFD----R---I-------VA-RGHY----------TERAA----------AAVTKTIVEVVQMCHK--- 174 (352)
Q Consensus 133 lv~e~~~~~sL~~----~---l-------~~-~~~l----------~~~~~----------~~i~~qi~~aL~~lH~--- 174 (352)
+|+++++|.++.. . + +. ...+ .+... ......+..++.++.+
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999866421 1 1 00 0000 11100 0011123344445443
Q ss_pred ----cCCEEecCCCCceEeecCCCCCCEEEEeccccee
Q 018640 175 ----HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (352)
Q Consensus 175 ----~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~ 208 (352)
.+++|+|+.|.||+++.+. .+.|+||+.+..
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~---~~~iIDfe~a~~ 205 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDE---LSGVIDFYFACT 205 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCc---eEEEeehhhhcC
Confidence 4699999999999997532 247999998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00047 Score=62.85 Aligned_cols=76 Identities=12% Similarity=0.097 Sum_probs=48.7
Q ss_pred eeeeccCceEEEEEEECC------CCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 61 RELGRGEFGITYLCTDRE------NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
+.|..|--..||++.... .++.+++|+..... .......+|..++..+...--.+++++++.. .+|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v 75 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRI 75 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cch
Confidence 456667777899887533 25789999865432 1123456788888888544434566666542 368
Q ss_pred EEecCCcchH
Q 018640 135 MELCEGGELF 144 (352)
Q Consensus 135 ~e~~~~~sL~ 144 (352)
+||++|.++.
T Consensus 76 ~e~i~G~~l~ 85 (302)
T cd05156 76 EEFIPSRTLT 85 (302)
T ss_pred hheeCCCcCC
Confidence 9999887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.56 E-value=6.4e-05 Score=67.47 Aligned_cols=136 Identities=19% Similarity=0.280 Sum_probs=92.5
Q ss_pred ceeceeeeccCceEEEEEEECCCCcEEEEEEccccc--cC---------------Chhc--HHHHHHHHHHHHhCCCCC-
Q 018640 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKK--LR---------------TAVD--IEDVRREVDIMRHLPKHQ- 116 (352)
Q Consensus 57 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~---------------~~~~--~~~~~~E~~~l~~l~~h~- 116 (352)
+.+.+.||-|--+.||.+.+. .|...++|.=.... +. ++.. .-...+|...|+.|..|.
T Consensus 94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 678899999999999999874 58888887432211 10 0111 112456788888773322
Q ss_pred CeeEeeeEEEeCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCC
Q 018640 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETA 196 (352)
Q Consensus 117 ~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~ 196 (352)
-+++.+++. ..++|||++.|-.|.+.-. ...+..+...+..-+--|...|+||+|+.--||++..++.
T Consensus 173 pVPkpiD~~----RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~-- 240 (465)
T KOG2268|consen 173 PVPKPIDHN----RHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK-- 240 (465)
T ss_pred CCCCccccc----ceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC--
Confidence 245555543 5679999999877755432 2233455566666777888999999999999999975444
Q ss_pred CEEEEecccc
Q 018640 197 PLKAIDFGLS 206 (352)
Q Consensus 197 ~vkl~Dfg~a 206 (352)
++++||--.
T Consensus 241 -i~vIDFPQm 249 (465)
T KOG2268|consen 241 -IVVIDFPQM 249 (465)
T ss_pred -EEEeechHh
Confidence 799999744
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00098 Score=61.04 Aligned_cols=142 Identities=21% Similarity=0.255 Sum_probs=93.5
Q ss_pred eeeeccCceEEEEEEECCCCcEEEEEEccccccCCh-------------------hcHH---H-HHHHHHHHHhCCCCCC
Q 018640 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA-------------------VDIE---D-VRREVDIMRHLPKHQN 117 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-------------------~~~~---~-~~~E~~~l~~l~~h~~ 117 (352)
.-|.-|--+.||.|.. .+|..+|||++..+-..-. .... . ...|++.|+++ +...
T Consensus 150 GCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl-~~aG 227 (520)
T KOG2270|consen 150 GCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRL-NNAG 227 (520)
T ss_pred cccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHH-HhcC
Confidence 4466788889999984 6799999998865421110 0111 1 34688889988 5555
Q ss_pred eeEeeeEEEeCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCCEEecCCCCceEeecCCCCC
Q 018640 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC-HKHGVMHRDLKPENFLFANKKETA 196 (352)
Q Consensus 118 iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~l-H~~~ivH~Dikp~NIll~~~~~~~ 196 (352)
|+..--.... ..+|||+++....-..-.-....++...+..+-.+++.-+.-| |.+++||.||+--|+|+- .+
T Consensus 228 IP~PePIlLk--~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh----dG 301 (520)
T KOG2270|consen 228 IPCPEPILLK--NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH----DG 301 (520)
T ss_pred CCCCCceeee--cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE----CC
Confidence 4432222211 3479999994321111111223577778888888888888776 567999999999999994 34
Q ss_pred CEEEEecccceecC
Q 018640 197 PLKAIDFGLSVFFK 210 (352)
Q Consensus 197 ~vkl~Dfg~a~~~~ 210 (352)
.++|+|.+-+....
T Consensus 302 ~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 302 KLYIIDVSQSVEHD 315 (520)
T ss_pred EEEEEEccccccCC
Confidence 48999998776543
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.00085 Score=62.72 Aligned_cols=79 Identities=15% Similarity=0.152 Sum_probs=53.4
Q ss_pred ceeeeccCceEEEEEEECCCCcEEEEEEccccccC--C-hhcHHHHHHHHHHHHhCCCC-C-CeeEeeeEEEeCCeEEEE
Q 018640 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLR--T-AVDIEDVRREVDIMRHLPKH-Q-NIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 60 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~-~~~~~~~~~E~~~l~~l~~h-~-~iv~l~~~~~~~~~~~lv 134 (352)
...||.|.-..||++.+...++.|+||.-...... + +...++..-|...|+.+.+. | .+++++.+ ++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 57799999999999997544567999965432211 1 44567777888888876432 3 45556543 44455688
Q ss_pred EEecCC
Q 018640 135 MELCEG 140 (352)
Q Consensus 135 ~e~~~~ 140 (352)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999864
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0019 Score=58.73 Aligned_cols=150 Identities=17% Similarity=0.220 Sum_probs=82.9
Q ss_pred eeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCC-CCeeEeeeEEEeCC--eEEEE
Q 018640 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH-QNIVCLKDTYEDDT--AVHLV 134 (352)
Q Consensus 58 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~~iv~l~~~~~~~~--~~~lv 134 (352)
.+++++-.|..-.+|..... ++.+++. ... ............+|..+++.+... --+...++.|.++. ..|.|
T Consensus 28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred ceeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 34455544444555655543 7777777 221 112222345567788889888432 23445566666555 77999
Q ss_pred EEecCCcchHH------------------HHHh-------c-------CCCCHHHHHHHHHHH--------------HHH
Q 018640 135 MELCEGGELFD------------------RIVA-------R-------GHYTERAAAAVTKTI--------------VEV 168 (352)
Q Consensus 135 ~e~~~~~sL~~------------------~l~~-------~-------~~l~~~~~~~i~~qi--------------~~a 168 (352)
|+|+.|..+.+ .|.. . ......++.....+. ...
T Consensus 104 ~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~ 183 (321)
T COG3173 104 MEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL 183 (321)
T ss_pred EEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence 99998733211 1110 0 000111111111111 122
Q ss_pred HHHHHH--------cCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCc
Q 018640 169 VQMCHK--------HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (352)
Q Consensus 169 L~~lH~--------~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (352)
..+++. ..++|+|+.+.||+++.+.. +=|.||+++...++...
T Consensus 184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~---~gVlDwe~~~lGDP~~D 234 (321)
T COG3173 184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRP---TGVLDWELATLGDPLED 234 (321)
T ss_pred HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCe---eEEEeccccccCCcHHH
Confidence 333433 24899999999999986555 67899999987655443
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0061 Score=55.94 Aligned_cols=76 Identities=14% Similarity=0.150 Sum_probs=44.0
Q ss_pred ceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCC-CCeeEeeeE------EEeCCeEE
Q 018640 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH-QNIVCLKDT------YEDDTAVH 132 (352)
Q Consensus 60 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~~iv~l~~~------~~~~~~~~ 132 (352)
++.|+.|....+|..... +| .+++|+... . ..+.+..|+.++..|..+ -.+++++.. ....+..+
T Consensus 27 ~~~l~~G~~n~~y~v~t~-~g-~~vLK~~~~---~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~ 98 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT-QG-EYVLTLFER---L---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA 98 (319)
T ss_pred cchhccccccceEEEEeC-CC-cEEEEEecc---C---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence 355777888899998743 34 688887641 1 123344455666655211 113343321 23355678
Q ss_pred EEEEecCCcch
Q 018640 133 LVMELCEGGEL 143 (352)
Q Consensus 133 lv~e~~~~~sL 143 (352)
++++|++|..+
T Consensus 99 ~l~~~l~G~~~ 109 (319)
T PRK05231 99 AIVTFLEGKWP 109 (319)
T ss_pred EEEEecCCCCC
Confidence 99999998643
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0018 Score=60.16 Aligned_cols=138 Identities=12% Similarity=0.140 Sum_probs=80.1
Q ss_pred eeeeccCceEEEEEEECC----CCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEE
Q 018640 61 RELGRGEFGITYLCTDRE----NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e 136 (352)
..|-.|-...+|++.... .++.|++|+..... ...+++ .+|..+++.+..+.--+++++.+... .|++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~e 113 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEE 113 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEE
Confidence 445457778899987432 24688999876542 122233 56888888885544445677766432 5799
Q ss_pred ecCCcchHHH----------H-------HhcC------CCCHHHHHHHHHH-----------------HHHHHHHHH---
Q 018640 137 LCEGGELFDR----------I-------VARG------HYTERAAAAVTKT-----------------IVEVVQMCH--- 173 (352)
Q Consensus 137 ~~~~~sL~~~----------l-------~~~~------~l~~~~~~~i~~q-----------------i~~aL~~lH--- 173 (352)
|+++.+|... + +... ...+..+..+..+ +...+..|.
T Consensus 114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~ 193 (344)
T PLN02236 114 FIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL 193 (344)
T ss_pred eeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence 9987666321 1 1100 0112222222211 111122221
Q ss_pred -----HcCCEEecCCCCceEeecCCCCCCEEEEeccccee
Q 018640 174 -----KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (352)
Q Consensus 174 -----~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~ 208 (352)
...++|+|+++.||+++.+. ..+.++||..+..
T Consensus 194 ~~~~~~~~~cH~Dl~~~Nil~~~~~--~~~~lID~Eya~~ 231 (344)
T PLN02236 194 SGDDQEIGFCHNDLQYGNIMIDEET--RAITIIDYEYASY 231 (344)
T ss_pred cccCCCceEEeCCCCcCcEEEeCCC--CcEEEEeehhccc
Confidence 23589999999999997432 3489999998864
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0025 Score=57.33 Aligned_cols=32 Identities=22% Similarity=0.270 Sum_probs=25.0
Q ss_pred CCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 176 ~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
.++|+|++|.||+++.++ ...-|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~--~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDA--RVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCC--CEEEEECcHhcccC
Confidence 489999999999997432 22469999988754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0036 Score=57.20 Aligned_cols=139 Identities=19% Similarity=0.235 Sum_probs=78.4
Q ss_pred ceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCC-CCeeEeeeEE------EeCCeEE
Q 018640 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH-QNIVCLKDTY------EDDTAVH 132 (352)
Q Consensus 60 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~~iv~l~~~~------~~~~~~~ 132 (352)
+..++.|....+|++.. .+| .+++|+.... ...+.+..|+.++..|.++ -.+++++... ...+..+
T Consensus 27 i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~-----~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~ 99 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT-DVG-RYILTLYEKR-----VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA 99 (307)
T ss_pred ccccCCccccceEEEEe-CCC-cEEEEEecCC-----CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence 56677888889998864 334 5778876431 1124455677777776321 1244444321 2245678
Q ss_pred EEEEecCCcchH----H-------HH---Hh-cCCC-----------CHHHHH------------HHHHHHHHHHHHHHH
Q 018640 133 LVMELCEGGELF----D-------RI---VA-RGHY-----------TERAAA------------AVTKTIVEVVQMCHK 174 (352)
Q Consensus 133 lv~e~~~~~sL~----~-------~l---~~-~~~l-----------~~~~~~------------~i~~qi~~aL~~lH~ 174 (352)
++++|++|.++. . .+ +. ...+ .|.... .....+...++++..
T Consensus 100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~ 179 (307)
T TIGR00938 100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK 179 (307)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence 999999885431 1 11 10 0001 000000 001123344555542
Q ss_pred -------cCCEEecCCCCceEeecCCCCCCEEEEeccccee
Q 018640 175 -------HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (352)
Q Consensus 175 -------~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~ 208 (352)
.+++|+|+.+.||+++.++ .+.|+||+.+..
T Consensus 180 ~~~~~~~~~l~HgD~~~~Nvl~~~~~---~~~vIDfd~~~~ 217 (307)
T TIGR00938 180 FWPRDLPRGVIHADLFPDNVLFDGDS---VKGVIDFYFACT 217 (307)
T ss_pred hhhhcCCCccCCCCCCcCcEEEECCc---eEEEeecccccC
Confidence 5799999999999997543 257999997753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0028 Score=57.66 Aligned_cols=106 Identities=11% Similarity=0.024 Sum_probs=74.5
Q ss_pred eeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCC--CCeeEeeeEEEe---CCeEE
Q 018640 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH--QNIVCLKDTYED---DTAVH 132 (352)
Q Consensus 58 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h--~~iv~l~~~~~~---~~~~~ 132 (352)
.-.+.||.|..+.||..... ++ .+.+|.... ......+..|+..|+.+... -.++++++++.. .+..+
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~-----~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 17 SRVECISEQPYAALWALYDS-QG-NPMPLMARS-----FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred heeeecCCccceeEEEEEcC-CC-CEEEEEecc-----cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 34567999999999998643 34 466676322 11235788999999998554 357888887754 36689
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc
Q 018640 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH 175 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~ 175 (352)
+|||+++|.++.+. ..+......+..+++.+|.-||+.
T Consensus 90 LVmE~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 90 LLLERLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred EEEeccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 99999999887651 133444566777788888888874
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0017 Score=61.95 Aligned_cols=163 Identities=18% Similarity=0.210 Sum_probs=101.5
Q ss_pred HHHHHHHHHHhCCCCCCeeEeeeEEEeC-CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEE
Q 018640 101 DVRREVDIMRHLPKHQNIVCLKDTYEDD-TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMH 179 (352)
Q Consensus 101 ~~~~E~~~l~~l~~h~~iv~l~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH 179 (352)
.+.--...++.+ .|+|..+.+++-... ....+|+|++ +.||++.+..+. +-..... .|
T Consensus 28 ~ilgr~~~lktl-~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~------------------~~ 86 (725)
T KOG1093|consen 28 QILGRFQYLKSL-QHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL------------------AH 86 (725)
T ss_pred HHhhhhHHHHhh-cCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc------------------cc
Confidence 344456788888 899999999887543 3477899999 569999887654 2111111 12
Q ss_pred ecCCCCceEeecCCCCCCEEEEecccceecCCCCcccccccccccccchhccccCCCcchHHHHHHHHHHHHhCCCCCCC
Q 018640 180 RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWA 259 (352)
Q Consensus 180 ~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~s~~~Di~SlG~~l~el~tg~~p~~~ 259 (352)
+ +-+-||+ +.+| -+++.. ... ..+|+||||+|.++.++.-|...+..
T Consensus 87 ~-~~~~~~~----------~~td-~~~t~~------~~~---------------~~pKsdVwsl~~i~~el~L~~~l~~~ 133 (725)
T KOG1093|consen 87 G-VLHLNII----------YITD-HFLTKY------PSP---------------IGPKSDVWSLGFIILELYLGISLEAE 133 (725)
T ss_pred c-cceehhh----------hccc-cccccC------CCC---------------CCcchhhhhHHHHHHHHHHhhHHHHH
Confidence 1 1122222 3333 111100 000 12499999999999999998776644
Q ss_pred CCHHHHHHHHHhcccccCCCC---------CcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 260 ETEQGVAQAIIRSVLDFRRDP---------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
....+....+..-. ....+. .-.+++..+++...|+-..|..||...++.+++-|.+.
T Consensus 134 ~~~s~~l~~i~k~~-~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 134 LTESEYLEILLKYY-TDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHHHHHHHhc-cCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 44433333222211 111100 01357778899999999999999999999999998865
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.00011 Score=77.66 Aligned_cols=151 Identities=19% Similarity=0.133 Sum_probs=108.4
Q ss_pred HHHHHHHHhCCCCCCeeEeeeEEE--eCCeEEEEEEecCCcchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHc-
Q 018640 103 RREVDIMRHLPKHQNIVCLKDTYE--DDTAVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTKTIVEVVQMCHKH- 175 (352)
Q Consensus 103 ~~E~~~l~~l~~h~~iv~l~~~~~--~~~~~~lv~e~~~~~sL~~~l~~~----~~l~~~~~~~i~~qi~~aL~~lH~~- 175 (352)
..|..-++.. .|+++.....-.. +....+..++|+.+|.+.+.+-+. ..+...-+.....+.+.+..-+|+.
T Consensus 1277 l~e~de~~~~-~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1277 LSERDELREA-KHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhh-hceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3344444445 6888776555443 334668899999999999988653 2344444555555557777777754
Q ss_pred ----CCEEecCCCCceEeecCCCCCCEEEEecccceecCCC-Ccccccccccccccchhccc-cCCCcchHHHHHHHHHH
Q 018640 176 ----GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYI 249 (352)
Q Consensus 176 ----~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~e 249 (352)
--+|+++++.|.++..+.. +|+.++|+.+...+. .......+++.|+.|++.+. .++.++|+|+.|+.+|+
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~---v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYN---VKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred cCCccchhhhhhhhccceecCCc---ccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHH
Confidence 2799999999999976555 799999999843322 23345577888999998764 47778999999999999
Q ss_pred HHhCCCCC
Q 018640 250 LLCGVPPF 257 (352)
Q Consensus 250 l~tg~~p~ 257 (352)
...|..+|
T Consensus 1433 rs~~n~~f 1440 (2724)
T KOG1826|consen 1433 RSDGNAYF 1440 (2724)
T ss_pred HhcccHHH
Confidence 88887776
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0036 Score=57.82 Aligned_cols=75 Identities=11% Similarity=0.145 Sum_probs=45.1
Q ss_pred eeeeccCceEEEEEEECCC---CcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEe
Q 018640 61 RELGRGEFGITYLCTDREN---GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMEL 137 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~ 137 (352)
+.|-.|--..+|++..... +..|++++...... ..++ -.+|..+++.+..+.--+++++++.. . +|.+|
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~Id-R~~E~~il~~l~~~gl~P~~l~~~~~--G--~i~~f 91 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YVID-RERELQAIKYLSAAGFGAKLLGVFGN--G--MIQSF 91 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---eEec-hHHHHHHHHHHHhcCCCCceeEEeCC--c--Eeehh
Confidence 3444477778888865432 33788887754321 1122 24688888888444333566766632 2 58899
Q ss_pred cCCcch
Q 018640 138 CEGGEL 143 (352)
Q Consensus 138 ~~~~sL 143 (352)
++|.+|
T Consensus 92 i~g~~l 97 (330)
T PLN02421 92 INARTL 97 (330)
T ss_pred hcCCCC
Confidence 987665
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.0061 Score=56.70 Aligned_cols=61 Identities=21% Similarity=0.183 Sum_probs=45.8
Q ss_pred eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHcCCEEecCCCCceEeec
Q 018640 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQM-CHKHGVMHRDLKPENFLFAN 191 (352)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~-lH~~~ivH~Dikp~NIll~~ 191 (352)
...++-+|..|.++..+++.. ..++....+++.-.+.||-- +--.+++|.|+.|.||++.-
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred cceeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 345777899999998888654 34556777777776766644 44568999999999999853
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.0065 Score=52.21 Aligned_cols=56 Identities=16% Similarity=0.166 Sum_probs=32.8
Q ss_pred CcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEecCCcch
Q 018640 80 GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGEL 143 (352)
Q Consensus 80 ~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL 143 (352)
++.|++++....+ ...-.-..|..+++.+..+..-+++++++.+. .|++|++|.+|
T Consensus 2 ~~~~~~Ri~g~~t----~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l 57 (211)
T PF01633_consen 2 PEKYLVRIPGEGT----ENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTL 57 (211)
T ss_dssp TSEEEEEEEESCG----CSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE-
T ss_pred CCEEEEEeCCCCc----ccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEeccccc
Confidence 4678888775442 12234456888888885555556777765433 57799977664
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.019 Score=51.86 Aligned_cols=75 Identities=17% Similarity=0.191 Sum_probs=48.8
Q ss_pred eceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCC--CCCCeeEeeeEEEeCCeEEEEEE
Q 018640 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP--KHQNIVCLKDTYEDDTAVHLVME 136 (352)
Q Consensus 59 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~~iv~l~~~~~~~~~~~lv~e 136 (352)
-.+.|+.|....+|+.. .+++.+.+|+-.. .....|..|+.-|+.|. ..-.+++++++....+..+||+|
T Consensus 21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~------~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle 92 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNSE------SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLE 92 (288)
T ss_dssp EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG------GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE
T ss_pred eeEecCCCChhheEEEE--CCCccEEEEecCh------hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEE
Confidence 35668999999999987 5688899997652 22346778888888883 34567899999888778899999
Q ss_pred ecCCc
Q 018640 137 LCEGG 141 (352)
Q Consensus 137 ~~~~~ 141 (352)
|++.+
T Consensus 93 ~l~~~ 97 (288)
T PF03881_consen 93 FLEMG 97 (288)
T ss_dssp -----
T ss_pred eecCC
Confidence 99765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.018 Score=54.30 Aligned_cols=77 Identities=17% Similarity=0.176 Sum_probs=47.8
Q ss_pred ceeeeccCceEEEEEEECCCC-c-----EEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 60 GRELGRGEFGITYLCTDRENG-D-----AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 60 ~~~lG~G~~g~Vy~~~~~~~~-~-----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
++.|..|--..+|++...... . .|.+..... .....++ -.+|+.+++.+..+.--+++++.+.. ++
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~---~~~l~Id-R~~E~~i~~~Ls~~glgP~l~~~f~~----g~ 126 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST---YNSLVID-NDLQYNIAKLLGDNNFGPKIIGRFGD----FT 126 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccC---CCceEec-cHHHHHHHHHHHhCCCCCeEEEecCC----EE
Confidence 345655888899998754321 2 244443221 1111122 24589999999666666788887753 59
Q ss_pred EEEecCCcchH
Q 018640 134 VMELCEGGELF 144 (352)
Q Consensus 134 v~e~~~~~sL~ 144 (352)
++||++|.+|.
T Consensus 127 l~efIeGr~l~ 137 (383)
T PTZ00384 127 IQEWVEGNTMG 137 (383)
T ss_pred EEEEeccccCC
Confidence 99999987663
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.21 Score=46.02 Aligned_cols=72 Identities=14% Similarity=0.086 Sum_probs=43.2
Q ss_pred cCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCC-CeeEee---e--EEEeCCeEEEEEEecC
Q 018640 66 GEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ-NIVCLK---D--TYEDDTAVHLVMELCE 139 (352)
Q Consensus 66 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-~iv~l~---~--~~~~~~~~~lv~e~~~ 139 (352)
+.-..||+... .+|..+++|+..... .....+..|+..+..|..+. .++... + ....++..+.++++++
T Consensus 36 s~eN~vy~v~~-~~~~~~vlKv~r~~~----~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~ 110 (325)
T PRK11768 36 SYENRVYQFGD-EDGRRVVAKFYRPER----WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG 110 (325)
T ss_pred cccceEEEEec-CCCCEEEEEEcCccc----CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence 44567998874 457789999875332 13456777888877763321 122211 1 2233556788999998
Q ss_pred Ccc
Q 018640 140 GGE 142 (352)
Q Consensus 140 ~~s 142 (352)
|..
T Consensus 111 G~~ 113 (325)
T PRK11768 111 GRA 113 (325)
T ss_pred CCC
Confidence 754
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.1 Score=48.00 Aligned_cols=137 Identities=17% Similarity=0.253 Sum_probs=79.5
Q ss_pred eeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCC-----eeEeee----EEEeCCeEE
Q 018640 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN-----IVCLKD----TYEDDTAVH 132 (352)
Q Consensus 62 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~-----iv~l~~----~~~~~~~~~ 132 (352)
.|.+ .-..||+.... +|.. ++|+.... ....++.-|...+..|..+.- +..+-| ........+
T Consensus 33 ~l~s-~eN~~f~~~~~-~g~~-iLki~~~~-----~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a 104 (331)
T COG2334 33 GLNS-EENSNFRVQTE-DGRY-ILKIYRPG-----WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPA 104 (331)
T ss_pred cccc-ccCceEEEEec-CCCe-EEEEecCC-----CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeE
Confidence 3544 55679998753 4554 88887643 234567778888888743321 122222 112223778
Q ss_pred EEEEecCCcchHH-----HH----------Hh--------cC----CCCHHH-------------HHHHHHHHHHHHHHH
Q 018640 133 LVMELCEGGELFD-----RI----------VA--------RG----HYTERA-------------AAAVTKTIVEVVQMC 172 (352)
Q Consensus 133 lv~e~~~~~sL~~-----~l----------~~--------~~----~l~~~~-------------~~~i~~qi~~aL~~l 172 (352)
-+++|++|..+.. .+ +. +. ...|.. -.....++...++.+
T Consensus 105 ~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~ 184 (331)
T COG2334 105 ALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRL 184 (331)
T ss_pred EEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHH
Confidence 8999999877762 11 00 00 112220 111233445555555
Q ss_pred HH--------cC--CEEecCCCCceEeecCCCCCCEEEEeccccee
Q 018640 173 HK--------HG--VMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (352)
Q Consensus 173 H~--------~~--ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~ 208 (352)
.+ .+ +||+|+.|.||+++.+.. .+.++||+-+..
T Consensus 185 ~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~--~~g~iDFdDa~~ 228 (331)
T COG2334 185 LARLPAHLPALGDQIIHGDLHPDNVLFDDDTD--VSGFIDFDDAGY 228 (331)
T ss_pred HhhchhhCCcccceeeecCCCccceeEcCCCC--eeeEEEcccccc
Confidence 53 23 999999999999975543 367999997753
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.77 E-value=0.089 Score=48.55 Aligned_cols=106 Identities=15% Similarity=0.154 Sum_probs=71.0
Q ss_pred CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCEEecCCCCceEeecCCCCCCEEEEecccce
Q 018640 129 TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~ 207 (352)
...|++|++- |+++.- + ..-.++++..++++.+..++-+.++ .+=|||+.-.|||++ +|+ |.|+||-+++
T Consensus 299 ~y~yl~~kdh-gt~is~-i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~Gn---vtLIDfklsR 369 (488)
T COG5072 299 LYLYLHFKDH-GTPISI-I---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGN---VTLIDFKLSR 369 (488)
T ss_pred eEEEEEEecC-Cceeee-e---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCc---eEEEEeeeee
Confidence 3556777775 545532 2 1245788899999999888888865 789999999999997 454 8999999999
Q ss_pred ecCCCCcccccccccccccchhccccCCCcchHHHHHHHH
Q 018640 208 FFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVIL 247 (352)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~~~~~~s~~~Di~SlG~~l 247 (352)
........ .-...-.|-.+.|.-+..-+||-+.-.+
T Consensus 370 l~~~q~~i----sy~rldhp~lF~G~dd~QFeIYrlMr~l 405 (488)
T COG5072 370 LSYSQGII----SYNRLDHPDLFNGVDDYQFEIYRLMRRL 405 (488)
T ss_pred cccCCcee----eccccCchhhhcCccceeeeHHHHHHHH
Confidence 53322211 1122334555555556677777755444
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.31 Score=44.56 Aligned_cols=30 Identities=23% Similarity=0.402 Sum_probs=25.4
Q ss_pred CCEEecCCCCceEeecCCCCCCEEEEeccccee
Q 018640 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (352)
Q Consensus 176 ~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~ 208 (352)
+++|+|+.+.||+++.++. +.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~---~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRG---GYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCC---EEEEEhhhccc
Confidence 7999999999999975544 68999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.58 E-value=0.18 Score=53.68 Aligned_cols=141 Identities=16% Similarity=0.214 Sum_probs=76.7
Q ss_pred eeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCC------CCCeeEee-e----EEEe-C
Q 018640 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK------HQNIVCLK-D----TYED-D 128 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~------h~~iv~l~-~----~~~~-~ 128 (352)
..|+ |..-.+|+... .+|..+++|+..... ....+..|...|..|.. .|.++... + .... +
T Consensus 31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~-----~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~ 103 (1013)
T PRK06148 31 TPLD-GERDLNFRLTT-DDGADYILKIVNPSE-----PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPD 103 (1013)
T ss_pred eecC-CcCCceEEEEe-CCCCeEEEEEcCCcc-----chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCC
Confidence 4564 45677898874 467789999986531 22344456666665532 22333221 1 1111 2
Q ss_pred C--eEEEEEEecCCcchHHH-------H----------Hh------c----CCCCHH-----------------HHHHHH
Q 018640 129 T--AVHLVMELCEGGELFDR-------I----------VA------R----GHYTER-----------------AAAAVT 162 (352)
Q Consensus 129 ~--~~~lv~e~~~~~sL~~~-------l----------~~------~----~~l~~~-----------------~~~~i~ 162 (352)
+ ..+-+++|++|..+.+. + .. . ..+.|. ..+.++
T Consensus 104 G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l 183 (1013)
T PRK06148 104 GEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALV 183 (1013)
T ss_pred CceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHH
Confidence 2 46778999998766541 1 00 0 011111 112223
Q ss_pred HHHHHHHHH-----HH--HcCCEEecCCCCceEeecCCCCCCEEEEeccccee
Q 018640 163 KTIVEVVQM-----CH--KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (352)
Q Consensus 163 ~qi~~aL~~-----lH--~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~ 208 (352)
.+++..+.- +. ..++||+|+.+.||+++.+......-|+|||-+..
T Consensus 184 ~~~~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 184 ERFLARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 333332221 11 14699999999999998654322234999997764
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.09 E-value=0.22 Score=43.16 Aligned_cols=76 Identities=18% Similarity=0.199 Sum_probs=51.4
Q ss_pred eeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCC--CCCeeEeeeEEEeCCeEEEEEEec
Q 018640 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK--HQNIVCLKDTYEDDTAVHLVMELC 138 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~--h~~iv~l~~~~~~~~~~~lv~e~~ 138 (352)
+.+--|.--..|...+. ...+-+|+-.. .....|..|+.-|..+.. .-++++++.+....++.|+|+||+
T Consensus 22 ~~v~gG~inea~~v~dg--~~~~FvK~n~~------~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L 93 (286)
T COG3001 22 EEVSGGDINEAWRLRDG--TDPFFVKCNQR------EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYL 93 (286)
T ss_pred cccCCccccceeEeecC--CcceEEEecch------hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeec
Confidence 44555555555655432 45677786432 234567778777777632 345788999999999999999999
Q ss_pred CCcchH
Q 018640 139 EGGELF 144 (352)
Q Consensus 139 ~~~sL~ 144 (352)
+.+.+.
T Consensus 94 ~~~~~d 99 (286)
T COG3001 94 PTGPLD 99 (286)
T ss_pred cCCCCC
Confidence 876654
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.06 E-value=0.22 Score=47.95 Aligned_cols=77 Identities=13% Similarity=0.070 Sum_probs=45.9
Q ss_pred eceeeeccCceEEEEEEECCC--------CcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe
Q 018640 59 LGRELGRGEFGITYLCTDREN--------GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (352)
Q Consensus 59 ~~~~lG~G~~g~Vy~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 130 (352)
-++.|-.|---.+|++..... ++.|.+++...... .. . .-.+|..+++.+..+.--+++++.+.
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te-~l--I-dR~~E~~v~~~ls~~gi~P~l~~~f~---- 180 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVD-EL--Y-NPISEFEVYKTMSKYRIAPQLLNTFS---- 180 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcc-ce--e-CHHHHHHHHHHHHHCCCCCceEEEeC----
Confidence 345566677778998875421 46788888754321 11 1 23457777777743333345666553
Q ss_pred EEEEEEecCCcch
Q 018640 131 VHLVMELCEGGEL 143 (352)
Q Consensus 131 ~~lv~e~~~~~sL 143 (352)
-+.|.||++|.+|
T Consensus 181 gg~I~efi~g~~l 193 (442)
T PTZ00296 181 GGRIEEWLYGDPL 193 (442)
T ss_pred CCEEEEeeCCccC
Confidence 2467899988644
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=94.69 E-value=0.26 Score=44.59 Aligned_cols=32 Identities=28% Similarity=0.503 Sum_probs=26.0
Q ss_pred CEEecCCCCceEeecCCC--CCCEEEEeccccee
Q 018640 177 VMHRDLKPENFLFANKKE--TAPLKAIDFGLSVF 208 (352)
Q Consensus 177 ivH~Dikp~NIll~~~~~--~~~vkl~Dfg~a~~ 208 (352)
++|||+++.|||+..++. +..+++.||-+++.
T Consensus 217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~ 250 (294)
T PF02958_consen 217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARY 250 (294)
T ss_pred EEcCccCHHhEeEccccccccccceeeccccccC
Confidence 999999999999976433 34588999998864
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 352 | ||||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-58 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-58 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-58 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-58 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-57 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-57 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-57 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-57 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-56 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-56 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-56 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-55 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-55 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-55 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-55 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-55 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-55 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-54 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-54 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-53 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-53 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-53 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-53 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-53 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-53 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-52 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-52 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-52 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-52 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-52 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-51 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-51 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-49 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-49 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-49 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-48 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-48 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-47 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-47 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-47 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-47 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-47 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-46 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-46 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-45 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-45 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-45 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-45 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-45 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-45 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-45 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-45 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-45 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-45 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-45 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-45 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-45 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-45 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-45 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-45 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-44 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-44 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-44 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-44 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-42 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-42 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-42 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-41 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-41 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-41 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-41 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-41 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-41 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-41 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-41 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-41 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-41 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-40 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-40 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-40 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-40 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-40 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-40 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-40 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-39 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-39 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-39 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-39 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-39 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-38 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-37 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-37 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-37 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-37 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-37 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-37 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-37 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-36 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-36 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-36 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-36 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-36 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-36 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-36 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-36 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-35 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-35 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-35 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-35 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-35 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-35 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-35 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-35 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-35 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-35 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-35 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-35 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-35 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-35 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-35 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-35 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-35 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-35 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 8e-35 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 9e-35 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-35 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-35 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-35 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-35 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-35 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-34 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-34 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-34 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-34 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-34 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-34 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-34 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-34 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-34 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-34 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-34 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-34 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-34 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-34 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-34 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-33 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-33 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-33 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-33 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-33 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-33 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-32 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-31 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-31 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-31 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-31 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-31 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-31 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-31 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-31 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-29 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-29 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-28 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-28 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-28 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-28 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-28 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-28 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-27 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-27 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-27 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-27 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-26 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-26 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-26 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-26 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-26 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-26 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-26 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-26 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-26 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-26 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-26 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-26 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-26 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-26 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-26 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-26 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-26 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-26 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-26 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-26 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-26 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-26 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-26 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-26 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-26 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-26 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-25 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-25 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-25 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-25 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-25 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-25 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-25 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-25 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-25 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-25 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-25 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-25 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-25 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-25 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-25 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-25 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-25 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-25 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-25 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-25 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-25 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-25 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-25 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-25 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-25 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-25 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-25 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-25 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-25 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-25 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-25 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-25 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-25 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-25 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-25 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-25 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-25 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-25 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-25 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-25 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-25 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-25 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-25 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-24 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-24 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-24 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-24 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-24 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-24 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-24 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-24 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-24 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-24 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-24 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-24 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-24 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-24 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-24 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-24 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-24 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-24 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-24 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-24 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-24 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-24 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-24 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-24 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-24 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-24 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-24 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-24 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-24 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-24 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-24 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-24 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-24 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-24 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-24 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-24 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-24 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-24 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-24 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-24 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-24 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-24 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-24 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-24 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-24 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-24 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-23 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-23 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-23 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-23 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-23 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-23 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-23 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-23 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-23 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-23 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-23 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-23 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-23 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-23 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-23 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-23 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-23 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-22 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-22 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-22 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-22 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-22 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-22 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-22 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-22 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-22 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-22 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-22 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-22 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-22 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-22 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-22 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-22 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-22 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-22 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-22 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-22 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-22 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-21 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-21 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-21 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-21 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-21 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-21 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-21 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-21 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-21 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-21 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-21 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-20 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-20 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-20 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-20 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-20 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-20 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-20 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-20 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-20 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-20 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-20 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-20 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-20 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-20 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-19 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-19 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-19 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-19 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-19 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-19 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-19 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-19 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-19 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-19 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-19 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-19 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-19 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-19 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-19 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-19 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-19 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-19 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-19 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-19 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-19 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-19 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-19 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-19 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-19 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-19 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-19 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-19 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-19 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-19 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-19 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-19 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-19 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-19 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-19 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-19 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-19 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-19 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-19 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-19 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-19 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-19 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-19 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-19 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-19 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-19 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-19 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-19 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-19 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-19 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-19 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-19 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-19 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-19 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-18 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-18 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-18 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-18 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-18 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-18 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-18 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-18 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-18 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-18 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-18 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-18 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-18 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-18 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-18 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-18 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-17 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-17 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-17 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-17 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-17 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-17 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-17 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-17 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-17 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-17 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-17 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-17 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-17 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-17 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-17 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-17 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-17 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-17 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-17 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-17 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-17 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-17 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-17 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-17 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-17 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-17 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-17 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-17 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-17 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-17 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-17 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-17 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 8e-17 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 8e-17 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 8e-17 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 8e-17 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 9e-17 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-17 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 9e-17 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 9e-17 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-16 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-16 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-16 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 4e-16 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-16 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-16 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-16 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-15 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-15 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-15 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-15 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-15 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-15 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-15 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-15 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-15 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-15 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-15 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-15 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-15 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-15 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-15 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-15 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-15 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-15 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-15 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-15 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-15 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-15 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-15 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-15 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-15 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-15 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-15 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-15 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-15 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-15 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-15 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-15 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-15 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-15 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-15 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-15 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-15 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-15 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-15 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-15 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-15 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-15 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 5e-15 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-15 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-15 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-15 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-15 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-15 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-15 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-15 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-15 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-15 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-15 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-15 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-15 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-15 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-15 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 9e-15 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-14 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-14 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-14 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-14 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-14 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-14 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-14 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-14 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-14 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-14 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-14 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-14 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-14 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-14 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-14 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-14 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-14 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-14 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-14 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-14 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-14 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-14 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-14 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-14 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-14 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-14 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-14 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-14 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-14 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-14 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-14 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-14 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-14 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-14 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-14 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-14 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-14 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-14 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-14 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-14 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-14 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-14 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-14 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-14 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-14 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-14 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-14 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-14 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-14 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-14 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-14 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-13 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-13 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-13 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-13 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-13 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-13 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-13 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-13 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-13 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-13 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-13 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-13 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-13 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-13 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-13 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-13 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-13 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-13 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-13 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-13 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-13 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-13 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-13 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-13 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-13 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-13 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-13 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-13 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-13 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-13 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-12 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-12 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-12 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-12 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-12 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-12 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-12 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-12 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-12 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-12 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-12 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 6e-12 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-12 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-11 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-11 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-11 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-11 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-11 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-11 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-11 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-11 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-11 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-11 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-11 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 5e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-11 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 7e-11 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 7e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-10 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-10 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-10 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-10 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 7e-10 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 8e-10 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-09 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-09 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-09 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-09 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-09 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-09 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-09 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-08 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 4e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-08 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 4e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-08 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 5e-08 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-07 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-07 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-07 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-07 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-07 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-07 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-07 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-07 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-07 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-07 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 9e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-06 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-06 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-06 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-06 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-06 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-06 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-06 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-06 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-06 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-06 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-06 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-06 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-06 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-06 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-06 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-06 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-06 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-06 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-06 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-06 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-06 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-06 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-06 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-06 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 9e-06 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-05 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-05 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-05 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-05 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-05 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-05 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-05 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-05 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 4e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-05 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-05 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 5e-05 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 6e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-04 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-04 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-04 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-04 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-04 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-04 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-04 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-04 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-04 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-04 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-04 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-04 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-04 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-04 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-04 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-04 |
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 527 bits (1359), Expect = 0.0
Identities = 119/322 (36%), Positives = 179/322 (55%), Gaps = 3/322 (0%)
Query: 31 GTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISK 90
+ G + + + Y++ ELG+G F + C + G FA K I+
Sbjct: 5 ASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT 64
Query: 91 KKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR 150
KKL +A D + + RE I R L +H NIV L D+ ++++ +LV +L GGELF+ IVAR
Sbjct: 65 KKL-SARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR 122
Query: 151 GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210
Y+E A+ + I+E + CH +G++HR+LKPEN L A+K + A +K DFGL++
Sbjct: 123 EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182
Query: 211 PGEKFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI 269
E + G+P Y++PEVLK++ Y VD+W+ GVILYILL G PPFW E + + I
Sbjct: 183 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 242
Query: 270 IRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGET 329
D+ W V+ AK L+ ML +PK+R+TA Q L+ PW+ N ++ + +
Sbjct: 243 KAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQD 302
Query: 330 VKARLKQFSVMNKLKKRALKVM 351
LK+F+ KLK L M
Sbjct: 303 TVDCLKKFNARRKLKGAILTTM 324
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 526 bits (1357), Expect = 0.0
Identities = 123/324 (37%), Positives = 179/324 (55%), Gaps = 10/324 (3%)
Query: 33 HHQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKK 92
HH + G + + ERY + LG+G FG C DR +A K I+K
Sbjct: 4 HHHHSSGRENLYFQGT----FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS 59
Query: 93 LRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH 152
+ D + REV++++ L H NI+ L + ED ++ ++V EL GGELFD I+ R
Sbjct: 60 AKNK-DTSTILREVELLKKL-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR 117
Query: 153 YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212
++E AA + K + + HKH ++HRDLKPEN L +K++ +K IDFGLS F+
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177
Query: 213 EKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS 272
K + +G+ YY+APEVL+ Y + DVWSAGVILYILL G PPF+ + E + + +
Sbjct: 178 TKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG 237
Query: 273 VLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN----AKKAPNVSLGE 328
F W +S++AKDL+RKML P R+TA Q LEHPW+Q ++ E
Sbjct: 238 KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLE 297
Query: 329 TVKARLKQFSVMNKLKKRALKVMS 352
+ ++QF KL + AL M+
Sbjct: 298 SAMTNIRQFQAEKKLAQAALLYMA 321
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 524 bits (1351), Expect = 0.0
Identities = 123/305 (40%), Positives = 177/305 (58%), Gaps = 4/305 (1%)
Query: 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI 108
T E Y+L ELG+G F + C G +A I+ KKL +A D + + RE I
Sbjct: 5 TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARI 63
Query: 109 MRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV 168
R L KH NIV L D+ ++ +L+ +L GGELF+ IVAR +Y+E A+ + I+E
Sbjct: 64 CRLL-KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEA 122
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIVGSPYYMAP 227
V CH+ GV+HR+LKPEN L A+K + A +K DFGL++ + + + G+P Y++P
Sbjct: 123 VLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSP 182
Query: 228 EVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286
EVL+++ YG VD+W+ GVILYILL G PPFW E + + Q I DF W V+
Sbjct: 183 EVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP 242
Query: 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKR 346
AKDL+ KML +P +R+TA + L+HPW+ + + + LK+F+ KLK
Sbjct: 243 EAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGA 302
Query: 347 ALKVM 351
L VM
Sbjct: 303 ILTVM 307
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 521 bits (1344), Expect = 0.0
Identities = 121/312 (38%), Positives = 180/312 (57%), Gaps = 5/312 (1%)
Query: 44 VLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR 103
++ T +RY+ R LG+G FG LC D+ G A K ISK++++ D E +
Sbjct: 16 FVQHSTAI-FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 74
Query: 104 REVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
REV +++ L H NI+ L + +ED +LV E+ GGELFD I++R ++E AA + +
Sbjct: 75 REVQLLKQL-DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR 133
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY 223
++ + HK+ ++HRDLKPEN L +K + A ++ IDFGLS F+ +K + +G+ Y
Sbjct: 134 QVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAY 193
Query: 224 YMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283
Y+APEVL Y + DVWS GVILYILL G PPF E + + + + F W K
Sbjct: 194 YIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKK 253
Query: 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK---APNVSLGETVKARLKQFSVM 340
VSE+AKDL+RKML P R++A+ L+H W+Q K + +V + ++QF
Sbjct: 254 VSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGT 313
Query: 341 NKLKKRALKVMS 352
KL + AL M
Sbjct: 314 QKLAQAALLYMG 325
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 515 bits (1328), Expect = 0.0
Identities = 111/350 (31%), Positives = 178/350 (50%), Gaps = 22/350 (6%)
Query: 15 KKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLC 74
+ ++N + QG + +++ G+ I E Y R+LG G +G LC
Sbjct: 4 HHHHSSGRENLY-------FQGIAINPGMYVRKKEGK-IGESYFKVRKLGSGAYGEVLLC 55
Query: 75 TDRENGDAFACKSISKKKLRTAV----------DIEDVRREVDIMRHLPKHQNIVCLKDT 124
++ A K I K + E++ E+ +++ L H NI+ L D
Sbjct: 56 KEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIKLFDV 114
Query: 125 YEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKP 184
+ED +LV E EGGELF++I+ R + E AA + K I+ + HKH ++HRD+KP
Sbjct: 115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKP 174
Query: 185 ENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAG 244
EN L NK +K +DFGLS FF K + +G+ YY+APEVLK+ Y + DVWS G
Sbjct: 175 ENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCG 234
Query: 245 VILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRL 304
VI+YILLCG PPF + +Q + + + + F + W +S+ AK+L++ ML D +R
Sbjct: 235 VIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRC 294
Query: 305 TAQQVLEHPWLQNAKK---APNVSLGETVKARLKQFSVMNKLKKRALKVM 351
TA++ L W++ + + +++F KL + A+ +
Sbjct: 295 TAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILFI 344
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 507 bits (1309), Expect = 0.0
Identities = 113/309 (36%), Positives = 170/309 (55%), Gaps = 10/309 (3%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL--RTAVDIEDVRREVDIM 109
E+ YEL +G+G F + C +RE G FA K + K + ED++RE I
Sbjct: 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC 80
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH----YTERAAAAVTKTI 165
L KH +IV L +TY D +++V E +G +L IV R Y+E A+ + I
Sbjct: 81 HML-KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI 139
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYY 224
+E ++ CH + ++HRD+KP L A+K+ +AP+K FG+++ + G VG+P++
Sbjct: 140 LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF 199
Query: 225 MAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283
MAPEV+KR YG VDVW GVIL+ILL G PF+ T++ + + II+ W
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNPRQWSH 258
Query: 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKL 343
+SE+AKDLVR+ML DP R+T + L HPWL+ + +L++F+ KL
Sbjct: 259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKL 318
Query: 344 KKRALKVMS 352
K L +S
Sbjct: 319 KGAVLAAVS 327
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 511 bits (1318), Expect = 0.0
Identities = 121/344 (35%), Positives = 183/344 (53%), Gaps = 13/344 (3%)
Query: 13 QGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITY 72
+ ++N + G + G + E Y+ ++LG G +G
Sbjct: 2 HHHHHHSSGRENLYFQGDLQATPGM------FITSKKGH-LSEMYQRVKKLGSGAYGEVL 54
Query: 73 LCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132
LC D+ A K I K + T+ + EV +++ L H NI+ L D +ED +
Sbjct: 55 LCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLL-DHPNIMKLYDFFEDKRNYY 112
Query: 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK 192
LVME +GGELFD I+ R + E AA + K ++ V HKH ++HRDLKPEN L +K
Sbjct: 113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESK 172
Query: 193 KETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLC 252
++ A +K +DFGLS F+ +K E +G+ YY+APEVL++ Y + DVWS GVIL+ILL
Sbjct: 173 EKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLA 232
Query: 253 GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312
G PPF +T+Q + + + + F W VSE AKDL+++ML D +RR++AQQ LEH
Sbjct: 233 GYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292
Query: 313 PWLQNAKKAP----NVSLGETVKARLKQFSVMNKLKKRALKVMS 352
PW++ + +++F KL + AL M+
Sbjct: 293 PWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMA 336
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 505 bits (1302), Expect = 0.0
Identities = 129/310 (41%), Positives = 180/310 (58%), Gaps = 11/310 (3%)
Query: 44 VLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR 103
+ + + +E+ ELGRG I Y C + +A K + K D + VR
Sbjct: 43 IDGSNRD-ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVR 96
Query: 104 REVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
E+ ++ L H NI+ LK+ +E T + LV+EL GGELFDRIV +G+Y+ER AA K
Sbjct: 97 TEIGVLLRL-SHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVK 155
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY 223
I+E V H++G++HRDLKPEN L+A APLK DFGLS + + G+P
Sbjct: 156 QILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPG 215
Query: 224 YMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAET-EQGVAQAIIRSVLDFRRDPW 281
Y APE+L+ YGPEVD+WS G+I YILLCG PF+ E +Q + + I+ F W
Sbjct: 216 YCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWW 275
Query: 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMN 341
+VS NAKDLVRK++ DPK+RLT Q L+HPW+ KA N +T + +L++F+
Sbjct: 276 DEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTG--KAANFVHMDTAQKKLQEFNARR 333
Query: 342 KLKKRALKVM 351
KLK V+
Sbjct: 334 KLKAAVKAVV 343
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 499 bits (1286), Expect = e-180
Identities = 113/281 (40%), Positives = 168/281 (59%), Gaps = 4/281 (1%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
+ + Y++ ELG+G F + C + G FA K I+ KKL +A D + + RE I R
Sbjct: 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRK 61
Query: 112 LPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQM 171
L +H NIV L D+ ++++ +LV +L GGELF+ IVAR Y+E A+ + I+E +
Sbjct: 62 L-QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK 231
CH +G++HR+LKPEN L A+K + A +K DFGL++ E + G+P Y++PEVLK
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK 180
Query: 232 RN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290
++ Y VD+W+ GVILYILL G PPFW E + + I D+ W V+ AK
Sbjct: 181 KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 240
Query: 291 LVRKMLDPDPKRRLTAQQVLEHPWLQN-AKKAPNVSLGETV 330
L+ ML +PK+R+TA Q L+ PW+ N + A + +TV
Sbjct: 241 LIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTV 281
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 494 bits (1274), Expect = e-178
Identities = 115/285 (40%), Positives = 164/285 (57%), Gaps = 6/285 (2%)
Query: 33 HHQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKK 92
HH + G + + ERY + LG+G FG C DR +A K I+K
Sbjct: 4 HHHHSSGRENLYFQG----TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS 59
Query: 93 LRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH 152
+ D + REV++++ L H NI+ L + ED ++ ++V EL GGELFD I+ R
Sbjct: 60 AKNK-DTSTILREVELLKKL-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR 117
Query: 153 YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212
++E AA + K + + HKH ++HRDLKPEN L +K++ +K IDFGLS F+
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177
Query: 213 EKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS 272
K + +G+ YY+APEVL+ Y + DVWSAGVILYILL G PPF+ + E + + +
Sbjct: 178 TKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG 237
Query: 273 VLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317
F W +S++AKDL+RKML P R+TA Q LEHPW+Q
Sbjct: 238 KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 494 bits (1275), Expect = e-177
Identities = 106/303 (34%), Positives = 160/303 (52%), Gaps = 13/303 (4%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL---RTAVDIEDVRREVDIM 109
+++ Y+ G ELG G+F + C ++ G +A K I K++ R V ED+ REV I+
Sbjct: 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV 169
+ + +H N++ L + YE+ T V L++EL GGELFD + + TE A K I+ V
Sbjct: 69 KEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 170 QMCHKHGVMHRDLKPENFLFANKK-ETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPE 228
H + H DLKPEN + ++ +K IDFGL+ G +F I G+P ++APE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 229 VLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287
++ G E D+WS GVI YILL G PF +T+Q + +F + + S
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRA 347
AKD +R++L DPK+R+T Q L+HPW++ +S R M K KK A
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALS-------RKASAVNMEKFKKFA 300
Query: 348 LKV 350
+
Sbjct: 301 ARK 303
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 492 bits (1268), Expect = e-177
Identities = 118/278 (42%), Positives = 167/278 (60%), Gaps = 4/278 (1%)
Query: 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI 108
T +I + Y L +GRG +G + + A K I K + D++ ++E++I
Sbjct: 3 TKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEI 59
Query: 109 MRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV 168
M+ L H NI+ L +T+ED+T ++LVMELC GGELF+R+V + + E AA + K ++
Sbjct: 60 MKSL-DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA 118
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPE 228
V CHK V HRDLKPENFLF +PLK IDFGL+ FKPG+ VG+PYY++P+
Sbjct: 119 VAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQ 178
Query: 229 VLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288
VL+ YGPE D WSAGV++Y+LLCG PPF A T+ V I F W VS A
Sbjct: 179 VLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQA 238
Query: 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSL 326
+ L+R++L PK+R+T+ Q LEH W + + +L
Sbjct: 239 ESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRNL 276
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 492 bits (1268), Expect = e-176
Identities = 85/324 (26%), Positives = 153/324 (47%), Gaps = 10/324 (3%)
Query: 33 HHQGNGGHKLCVLKEP----TGREIEERYEL-GRELGRGEFGITYLCTDRENGDAFACKS 87
HH + + + E + Y L +ELGRG+F + C + G +A K
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKF 61
Query: 88 ISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRI 147
+ K++ ++ E+ ++ ++ L + YE+ + + L++E GGE+F
Sbjct: 62 LKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLC 120
Query: 148 VAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205
+ +E + K I+E V H++ ++H DLKP+N L ++ +K +DFG+
Sbjct: 121 LPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM 180
Query: 206 SVFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQG 264
S + EI+G+P Y+APE+L + D+W+ G+I Y+LL PF E Q
Sbjct: 181 SRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE 240
Query: 265 VAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNV 324
I + +D+ + + VS+ A D ++ +L +P++R TA+ L H WLQ
Sbjct: 241 TYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLF 300
Query: 325 SLGET-VKARLKQFSVMNKLKKRA 347
ET ++ + SV + K +
Sbjct: 301 HPEETSSSSQTQDHSVRSSEDKTS 324
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 491 bits (1266), Expect = e-176
Identities = 89/304 (29%), Positives = 160/304 (52%), Gaps = 12/304 (3%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
+E+ E+Y + +LGRGEFGI + C + + + K + K D V++E+ I+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILN 56
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVV 169
+H+NI+ L +++E + ++ E G ++F+RI ER + + E +
Sbjct: 57 IA-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEV 229
Q H H + H D++PEN ++ + ++ +K I+FG + KPG+ F + +P Y APEV
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174
Query: 230 LKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288
+ + D+WS G ++Y+LL G+ PF AET Q + + I+ + F + + ++S A
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRAL 348
D V ++L + K R+TA + L+HPWL+ + + V LK + L K+ L
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTK----VIRTLKHRRYYHTLIKKDL 290
Query: 349 KVMS 352
++
Sbjct: 291 NMVV 294
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 486 bits (1254), Expect = e-174
Identities = 102/322 (31%), Positives = 157/322 (48%), Gaps = 28/322 (8%)
Query: 53 IEERYELG---RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIM 109
+ Y+L + LG G F I C +++ AFA K ISK+ + ++E+ +
Sbjct: 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEITAL 59
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV 169
+ H NIV L + + D LVMEL GGELF+RI + H++E A+ + + +V V
Sbjct: 60 KLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAV 119
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEIVGSPYYMAPE 228
H GV+HRDLKPEN LF ++ + +K IDFG + P + + +Y APE
Sbjct: 120 SHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE 179
Query: 229 VLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQ-------GVAQAIIRSVLDFRRDP 280
+L +N Y D+WS GVILY +L G PF + + + I + F +
Sbjct: 180 LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239
Query: 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSL---------GETVK 331
W VS+ AKDL++ +L DP +RL + + WLQ+ + + L G V
Sbjct: 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVH 299
Query: 332 ARLK-QFSVMNKLKKRALKVMS 352
+K F NK K+ + +
Sbjct: 300 TCVKATFHAFNKYKREGFCLQN 321
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 485 bits (1251), Expect = e-174
Identities = 109/309 (35%), Positives = 167/309 (54%), Gaps = 9/309 (2%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT---AVDIEDVRREVD 107
+++E+ Y++G ELG G+F I C ++ G +A K I K++ R V E++ REV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE 167
I+R + H N++ L D YE+ T V L++EL GGELFD + + +E A + K I++
Sbjct: 68 ILRQV-LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 168 VVQMCHKHGVMHRDLKPENFLFANKKETAP-LKAIDFGLSVFFKPGEKFSEIVGSPYYMA 226
V H + H DLKPEN + +K P +K IDFGL+ + G +F I G+P ++A
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 227 PEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285
PE++ G E D+WS GVI YILL G PF +T+Q I DF + + S
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS 246
Query: 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGE--TVKARLKQFSVMNKL 343
E AKD +RK+L + ++RLT Q+ L HPW+ + E ++ V +
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYVRRRW 306
Query: 344 KKRALKVMS 352
K + ++S
Sbjct: 307 KL-SFSIVS 314
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 484 bits (1248), Expect = e-173
Identities = 104/327 (31%), Positives = 160/327 (48%), Gaps = 19/327 (5%)
Query: 38 GGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAV 97
G H + + + YE+ ++G G + + C + FA K I K K
Sbjct: 5 GVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----- 59
Query: 98 DIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERA 157
D E++I+ +H NI+ LKD Y+D V++V EL +GGEL D+I+ + ++ER
Sbjct: 60 --RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSERE 117
Query: 158 AAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETA-PLKAIDFGLSVFFKPGEK-F 215
A+AV TI + V+ H GV+HRDLKP N L+ ++ ++ DFG + +
Sbjct: 118 ASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177
Query: 216 SEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWA---ETEQGVAQAIIR 271
+ ++APEVL+R Y D+WS GV+LY +L G PF +T + + I
Sbjct: 178 MTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS 237
Query: 272 SVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVK 331
W VS+ AKDLV KML DP +RLTA VL HPW+ + + P L
Sbjct: 238 GKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDA 297
Query: 332 ARLKQ------FSVMNKLKKRALKVMS 352
L + +S +N+ + L+ +
Sbjct: 298 PHLVKGAMAATYSALNRNQSPVLEPVG 324
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 481 bits (1240), Expect = e-173
Identities = 101/290 (34%), Positives = 162/290 (55%), Gaps = 12/290 (4%)
Query: 33 HHQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKK 92
HH + G + + I++ + R+LG G FG +L +R +G K+I+K +
Sbjct: 4 HHHHSSGRENLYFQG----TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR 59
Query: 93 LRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR-- 150
+ V +E + E+++++ L H NI+ + + +ED +++VME CEGGEL +RIV+
Sbjct: 60 SQ--VPMEQIEAEIEVLKSL-DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQA 116
Query: 151 --GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208
+E A + K ++ + H V+H+DLKPEN LF + +P+K IDFGL+
Sbjct: 117 RGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176
Query: 209 FKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQA 268
FK E + G+ YMAPEV KR+ + D+WSAGV++Y LL G PF + + V Q
Sbjct: 177 FKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK 236
Query: 269 IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318
++ + P ++ A DL+++ML DP+RR +A QVL H W + A
Sbjct: 237 ATYKEPNYAVECRP-LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 483 bits (1246), Expect = e-173
Identities = 101/322 (31%), Positives = 157/322 (48%), Gaps = 16/322 (4%)
Query: 7 TPAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRG 66
P+ + + K + Q G E ++Y+ +GRG
Sbjct: 47 DPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAK-EFYQKYDPKDVIGRG 105
Query: 67 EFGITYLCTDRENGDAFACKSISKKKLRTAVD-----IEDVRREVDIMRHLPKHQNIVCL 121
+ C R G FA K + R + + E RRE I+R + H +I+ L
Sbjct: 106 VSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165
Query: 122 KDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRD 181
D+YE + + LV +L GELFD + + +E+ ++ ++++E V H + ++HRD
Sbjct: 166 IDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRD 225
Query: 182 LKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-------RNY 234
LKPEN L + ++ DFG S +PGEK E+ G+P Y+APE+LK Y
Sbjct: 226 LKPENILLDDN---MQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGY 282
Query: 235 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK 294
G EVD+W+ GVIL+ LL G PPFW + + + I+ F W S KDL+ +
Sbjct: 283 GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISR 342
Query: 295 MLDPDPKRRLTAQQVLEHPWLQ 316
+L DP+ RLTA+Q L+HP+ +
Sbjct: 343 LLQVDPEARLTAEQALQHPFFE 364
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 480 bits (1237), Expect = e-172
Identities = 109/275 (39%), Positives = 157/275 (57%), Gaps = 6/275 (2%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL---RTAVDIEDVRREVDIM 109
+E+ YE+G ELG G+F I C + G +A K I K++L R V E++ REV+I+
Sbjct: 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV 169
R + +H NI+ L D +E+ T V L++EL GGELFD + + TE A K I++ V
Sbjct: 63 REI-RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 121
Query: 170 QMCHKHGVMHRDLKPENFLFANKK-ETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPE 228
H + H DLKPEN + +K +K IDFG++ + G +F I G+P ++APE
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181
Query: 229 VLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287
++ G E D+WS GVI YILL G PF ET+Q I DF + + SE
Sbjct: 182 IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241
Query: 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAP 322
AKD +R++L DPKRR+T Q LEH W++ ++
Sbjct: 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 481 bits (1239), Expect = e-171
Identities = 111/307 (36%), Positives = 164/307 (53%), Gaps = 8/307 (2%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT---AVDIEDVRREVDI 108
++E+ Y++G ELG G+F I C ++ G +A K I K++ R V E++ REV I
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68
Query: 109 MRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV 168
+R + H NI+ L D YE+ T V L++EL GGELFD + + +E A + K I++
Sbjct: 69 LRQV-LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAP-LKAIDFGLSVFFKPGEKFSEIVGSPYYMAP 227
V H + H DLKPEN + +K P +K IDFGL+ + G +F I G+P ++AP
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
Query: 228 EVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286
E++ G E D+WS GVI YILL G PF +T+Q I DF + + + SE
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSE 247
Query: 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGE--TVKARLKQFSVMNKLK 344
AKD +RK+L + ++RLT Q+ L HPW+ + E K+ V + K
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQYVRRRWK 307
Query: 345 KRALKVM 351
V
Sbjct: 308 LSFSIVS 314
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 476 bits (1226), Expect = e-169
Identities = 105/357 (29%), Positives = 161/357 (45%), Gaps = 19/357 (5%)
Query: 7 TPAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRG 66
PA A + T P Q H L+ I++ + LG G
Sbjct: 14 FPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLG 73
Query: 67 EFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126
G ++ + FA K + RREV++ + +IV + D YE
Sbjct: 74 INGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYE 125
Query: 127 D----DTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVMHR 180
+ + +VME +GGELF RI RG +TER A+ + K+I E +Q H + HR
Sbjct: 126 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 185
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVD 239
D+KPEN L+ +K+ A LK DFG + + +PYY+APEVL Y D
Sbjct: 186 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 245
Query: 240 VWSAGVILYILLCGVPPFWAE----TEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKM 295
+WS GVI+YILLCG PPF++ G+ I +F W +VSE K L+R +
Sbjct: 246 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 305
Query: 296 LDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVMS 352
L +P +R+T + + HPW+ + K P L + + + + ++ + +
Sbjct: 306 LKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALAT 362
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 471 bits (1215), Expect = e-169
Identities = 101/285 (35%), Positives = 149/285 (52%), Gaps = 16/285 (5%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR--TAVDIEDVR----RE 105
E YE LGRG + C + +A K I +A +++++R +E
Sbjct: 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 73
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
VDI+R + H NI+ LKDTYE +T LV +L + GELFD + + +E+ + + +
Sbjct: 74 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
+EV+ HK ++HRDLKPEN L + +K DFG S PGEK E+ G+P Y+
Sbjct: 134 LEVICALHKLNIVHRDLKPENILLD---DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYL 190
Query: 226 APEVLK-------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR 278
APE+++ YG EVD+WS GVI+Y LL G PPFW + + + I+ F
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 250
Query: 279 DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPN 323
W S+ KDLV + L P++R TA++ L HP+ Q
Sbjct: 251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 467 bits (1203), Expect = e-166
Identities = 112/333 (33%), Positives = 162/333 (48%), Gaps = 22/333 (6%)
Query: 32 THHQGNGGHKLCVLKEPTGREIEERYELGRE-LGRGEFGITYLCTDRENGDAFACKSISK 90
HH +G L EP + + Y+L ++ LG G G C R G A K +
Sbjct: 5 HHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD 64
Query: 91 KKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED----DTAVHLVMELCEGGELFDR 146
R+EVD +IVC+ D YE+ + ++ME EGGELF R
Sbjct: 65 SP--------KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSR 116
Query: 147 IVARGH--YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204
I RG +TER AA + + I +Q H H + HRD+KPEN L+ +K++ A LK DFG
Sbjct: 117 IQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176
Query: 205 LSVFFKPGEKFSEIVGSPYYMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQ 263
+ +PYY+APEVL Y D+WS GVI+YILLCG PPF++ T Q
Sbjct: 177 FAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ 235
Query: 264 GVAQAIIRSVL----DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319
++ + R + F W +VSE+AK L+R +L DP RLT Q + HPW+ +
Sbjct: 236 AISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295
Query: 320 KAPNVSLGETVKARLKQFSVMNKLKKRALKVMS 352
P L + + +++K+ ++
Sbjct: 296 VVPQTPLHTARVLQ-EDKDHWDEVKEEMTSALA 327
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 462 bits (1190), Expect = e-165
Identities = 102/312 (32%), Positives = 157/312 (50%), Gaps = 18/312 (5%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL-----RTAVDIEDVRRE 105
+ + + Y + + LG G G L +R+ A K ISK+K R A +V E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
++I++ L H I+ +K+ ++ + ++V+EL EGGELFD++V E +
Sbjct: 66 IEILKKL-NHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
+ VQ H++G++HRDLKPEN L ++++E +K DFG S + G+P Y+
Sbjct: 124 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 183
Query: 226 APEVL----KRNYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVLDFRRDP 280
APEVL Y VD WS GVIL+I L G PPF T+ + I +F +
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243
Query: 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVM 340
W +VSE A DLV+K+L DPK R T ++ L HPWLQ+ + L + +
Sbjct: 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRK------FQDLLSEENES 297
Query: 341 NKLKKRALKVMS 352
L + + +
Sbjct: 298 TALPQVLAQPST 309
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 467 bits (1204), Expect = e-163
Identities = 98/342 (28%), Positives = 156/342 (45%), Gaps = 9/342 (2%)
Query: 8 PAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRGE 67
++ + + S +Y + E + + Y++ ELG G
Sbjct: 110 RRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGA 169
Query: 68 FGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127
FG+ + T+R G+ FA K + D E VR+E+ M L +H +V L D +ED
Sbjct: 170 FGVVHRVTERATGNNFAAKFVMTPHES---DKETVRKEIQTMSVL-RHPTLVNLHDAFED 225
Query: 128 DTAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPEN 186
D + ++ E GGELF+++ +E A + + + + H++ +H DLKPEN
Sbjct: 226 DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPEN 285
Query: 187 FLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGV 245
+F K+ LK IDFGL+ P + G+ + APEV + + G D+WS GV
Sbjct: 286 IMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGV 344
Query: 246 ILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLT 305
+ YILL G+ PF E + + + + + +SE+ KD +RK+L DP R+T
Sbjct: 345 LSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT 404
Query: 306 AQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRA 347
Q LEHPWL S + +R + K K A
Sbjct: 405 IHQALEHPWLTPGNAPGRDS--QIPSSRYTKIRDSIKTKYDA 444
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 457 bits (1179), Expect = e-163
Identities = 98/304 (32%), Positives = 142/304 (46%), Gaps = 35/304 (11%)
Query: 53 IEERYELGRE-LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
E+ Y+L + LG G C + +A K I K+ V REV+++
Sbjct: 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH---IRSRVFREVEMLYQ 66
Query: 112 LPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQM 171
H+N++ L + +E++ +LV E GG + I R H+ E A+ V + + +
Sbjct: 67 CQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDF 126
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI--------VGSPY 223
H G+ HRDLKPEN L + + +P+K DF L K S I GS
Sbjct: 127 LHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE 186
Query: 224 YMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAE---------------TE 262
YMAPEV++ Y D+WS GVILYILL G PPF +
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246
Query: 263 QGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAP 322
+ ++I +F W +S AKDL+ K+L D K+RL+A QVL+HPW+Q AP
Sbjct: 247 NMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG--CAP 304
Query: 323 NVSL 326
+L
Sbjct: 305 ENTL 308
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 460 bits (1186), Expect = e-163
Identities = 99/359 (27%), Positives = 162/359 (45%), Gaps = 28/359 (7%)
Query: 16 KKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCT 75
K K P DY ++ + E + + Y++ ELG G FG+ + C
Sbjct: 12 SKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCV 71
Query: 76 DRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135
++ G F K I+ +D V+ E+ IM L H ++ L D +ED + L++
Sbjct: 72 EKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMVLIL 127
Query: 136 ELCEGGELFDRIVARGH-YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE 194
E GGELFDRI A + +E + E ++ H+H ++H D+KPEN + K +
Sbjct: 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK-K 186
Query: 195 TAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCG 253
+ +K IDFGL+ P E + + APE++ R G D+W+ GV+ Y+LL G
Sbjct: 187 ASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
Query: 254 VPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHP 313
+ PF E + Q + R +F D + VS AKD ++ +L +P++RLT LEHP
Sbjct: 247 LSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 306
Query: 314 WLQNAKKAPNVSLGETVK---------------------ARLKQFSVMNKLKKRALKVM 351
WL+ + + R+ FS + K + + ++
Sbjct: 307 WLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQEYQIY 365
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 447 bits (1152), Expect = e-158
Identities = 96/300 (32%), Positives = 152/300 (50%), Gaps = 15/300 (5%)
Query: 52 EIEERYELGR--ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIM 109
+ Y + + LG G FG + C + G A K I + ++ D E+V+ E+ +M
Sbjct: 84 AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK---DKEEVKNEISVM 140
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIVEV 168
L H N++ L D +E + LVME +GGELFDRI+ + TE K I E
Sbjct: 141 NQL-DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEG 199
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPE 228
++ H+ ++H DLKPEN L N+ + +K IDFGL+ +KP EK G+P ++APE
Sbjct: 200 IRHMHQMYILHLDLKPENILCVNR-DAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPE 258
Query: 229 VLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287
V+ + D+WS GVI Y+LL G+ PF + + I+ D + + +SE
Sbjct: 259 VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEE 318
Query: 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRA 347
AK+ + K+L + R++A + L+HPWL + K +S A+ K+ +
Sbjct: 319 AKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLS------AQKKKNRGSDAQDFVT 372
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 438 bits (1129), Expect = e-155
Identities = 97/345 (28%), Positives = 161/345 (46%), Gaps = 53/345 (15%)
Query: 32 THHQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKK 91
HH + G + + + E++++Y L +G+G +G+ + + + A K ++K
Sbjct: 3 HHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKN 62
Query: 92 KLR--TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVA 149
K+R D+E ++ EV +M+ L H NI L + YED+ + LVMELC GG L D++
Sbjct: 63 KIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNV 121
Query: 150 RGH----------------------------------------YTERAAAAVTKTIVEVV 169
E+ + + + I +
Sbjct: 122 FIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-----GEKFSEIVGSPYY 224
H G+ HRD+KPENFLF+ ++ +K +DFGLS F + G+PY+
Sbjct: 182 HYLHNQGICHRDIKPENFLFSTN-KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF 240
Query: 225 MAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281
+APEVL +YGP+ D WSAGV+L++LL G PF + ++ L F +
Sbjct: 241 VAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNY 300
Query: 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL-QNAKKAPNVS 325
+S A+DL+ +L+ + R A + L+HPW+ Q + K +S
Sbjct: 301 NVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYKMS 345
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 440 bits (1133), Expect = e-154
Identities = 99/277 (35%), Positives = 149/277 (53%), Gaps = 12/277 (4%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL-----RTAVDIEDVRRE 105
+ + + Y + + LG G G L +R+ A + ISK+K R A +V E
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
++I++ L H I+ +K+ ++ + ++V+EL EGGELFD++V E +
Sbjct: 191 IEILKKL-NHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 248
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
+ VQ H++G++HRDLKPEN L ++++E +K DFG S + G+P Y+
Sbjct: 249 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 308
Query: 226 APEVL----KRNYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVLDFRRDP 280
APEVL Y VD WS GVIL+I L G PPF T+ + I +F +
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368
Query: 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317
W +VSE A DLV+K+L DPK R T ++ L HPWLQ+
Sbjct: 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 434 bits (1117), Expect = e-154
Identities = 95/325 (29%), Positives = 145/325 (44%), Gaps = 39/325 (12%)
Query: 38 GGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAV 97
G H L+ I++ + LG G G ++ + FA K +
Sbjct: 1 GPHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------ 54
Query: 98 DIEDVRREVDIMRHLPKHQNIVCLKDTYED----DTAVHLVMELCEGGELFDRIVARGH- 152
RREV++ + +IV + D YE+ + +VME +GGELF RI RG
Sbjct: 55 --PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ 112
Query: 153 -YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211
+TER A+ + K+I E +Q H + HRD+KPEN L+ +K+ A LK DFG
Sbjct: 113 AFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF------ 166
Query: 212 GEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAE----TEQGVAQ 267
A E Y D+WS GVI+YILLCG PPF++ G+
Sbjct: 167 --------------AKETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 212
Query: 268 AIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLG 327
I +F W +VSE K L+R +L +P +R+T + + HPW+ + K P L
Sbjct: 213 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLH 272
Query: 328 ETVKARLKQFSVMNKLKKRALKVMS 352
+ + + +K+ ++
Sbjct: 273 TSRVLKEDKER-WEDVKEEMTSALA 296
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 335 bits (861), Expect = e-113
Identities = 74/314 (23%), Positives = 137/314 (43%), Gaps = 27/314 (8%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
+ + LG G G T + + A K I + REV ++R
Sbjct: 23 KISFCPKDVLGHGAEG-TIVYRGMFDNRDVAVKRILPECF------SFADREVQLLRESD 75
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIVEVVQMC 172
+H N++ T +D ++ +ELC L + + + + + + +
Sbjct: 76 EHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL 134
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAI--DFGLSVFFKPGE----KFSEIVGSPYYMA 226
H ++HRDLKP N L + +KA+ DFGL G + S + G+ ++A
Sbjct: 135 HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 227 PEVL----KRNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPW 281
PE+L K N VD++SAG + Y ++ G PF ++ + LD P
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC-LHPE 253
Query: 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFS--- 338
A++L+ KM+ DP++R +A+ VL+HP+ + +K + + V R+++ S
Sbjct: 254 KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK--QLQFFQDVSDRIEKESLDG 311
Query: 339 -VMNKLKKRALKVM 351
++ +L++ V+
Sbjct: 312 PIVKQLERGGRAVV 325
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 330 bits (849), Expect = e-111
Identities = 72/339 (21%), Positives = 126/339 (37%), Gaps = 48/339 (14%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
+ ++ + LG G G G A K + + E+ ++
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFC------DIALMEIKLLT 63
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHY-------TERAAAAVTK 163
H N++ + D +++ +ELC L D + ++ E ++ +
Sbjct: 64 ESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLR 122
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKK----------ETAPLKAIDFGLSVFFKPGE 213
I V H ++HRDLKP+N L + E + DFGL G+
Sbjct: 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 214 -----KFSEIVGSPYYMAPEVL--------KRNYGPEVDVWSAGVILYILLC-GVPPFWA 259
+ G+ + APE+L KR +D++S G + Y +L G PF
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242
Query: 260 ETEQGVAQAIIRSVLDF---RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
+ + IIR + + + A DL+ +M+D DP +R TA +VL HP
Sbjct: 243 KYSR--ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW 300
Query: 317 NAKKAPN----VSLGETVKARLKQFSVMNKLKKRALKVM 351
K VS ++ R +++ K + V+
Sbjct: 301 PKSKKLEFLLKVSDRLEIENRDPPSALLMKFDAGSDFVI 339
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 300 bits (771), Expect = e-101
Identities = 62/312 (19%), Positives = 116/312 (37%), Gaps = 43/312 (13%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
+ L LG+G + ++ GD FA K + ++ RE ++++ L
Sbjct: 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKL 64
Query: 113 PKHQNIVCLKDTYEDDTAVH--LVMELCEGGELFDRIVARGH---YTERAAAAVTKTIVE 167
H+NIV L E+ T H L+ME C G L+ + + E V + +V
Sbjct: 65 -NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 168 VVQMCHKHGVMHRDLKPENFL-FANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMA 226
+ ++G++HR++KP N + + + K DFG + + E+F + G+ Y+
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLH 183
Query: 227 PEVLKR---------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL--- 274
P++ +R YG VD+WS GV Y G PF + ++ ++
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243
Query: 275 ------------------DFRRDPWPKVSENAKDLV----RKMLDPDPKRRLTAQQVLEH 312
+S + L+ +L+ D ++ Q
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
Query: 313 PWLQNAKKAPNV 324
+ +
Sbjct: 304 TSDILHRGNSHH 315
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 291 bits (747), Expect = 8e-97
Identities = 63/312 (20%), Positives = 117/312 (37%), Gaps = 43/312 (13%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
+ L LG+G + ++ GD FA K + ++ RE ++++ L
Sbjct: 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKL 64
Query: 113 PKHQNIVCLKDTYEDDTAVH--LVMELCEGGELFDRIVARGH---YTERAAAAVTKTIVE 167
H+NIV L E+ T H L+ME C G L+ + + E V + +V
Sbjct: 65 -NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 168 VVQMCHKHGVMHRDLKPENFL-FANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMA 226
+ ++G++HR++KP N + + + K DFG + + E+F + G+ Y+
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLH 183
Query: 227 PEVLKRN---------YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL--- 274
P++ +R YG VD+WS GV Y G PF + ++ ++
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243
Query: 275 ------------------DFRRDPWPKVSENAKDLV----RKMLDPDPKRRLTAQQVLEH 312
+S + L+ +L+ D ++ Q
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
Query: 313 PWLQNAKKAPNV 324
+ +V
Sbjct: 304 TSDILHRMVIHV 315
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 285 bits (731), Expect = 1e-95
Identities = 87/265 (32%), Positives = 129/265 (48%), Gaps = 10/265 (3%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
RY GR LG+G F + +D + + FA K + K L E + E+ I R L
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-A 73
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
HQ++V +ED+ V +V+ELC L + R TE A + IV Q H+
Sbjct: 74 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 133
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIVGSPYYMAPEVLKRN 233
+ V+HRDLK N E +K DFGL+ + GE+ + G+P Y+APEVL +
Sbjct: 134 NRVIHRDLKLGNLFLNEDLE---VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK 190
Query: 234 -YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
+ EVDVWS G I+Y LL G PPF + I ++ ++ ++ A L+
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKH--INPVAASLI 246
Query: 293 RKMLDPDPKRRLTAQQVLEHPWLQN 317
+KML DP R T ++L + +
Sbjct: 247 QKMLQTDPTARPTINELLNDEFFTS 271
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 284 bits (730), Expect = 3e-95
Identities = 77/321 (23%), Positives = 135/321 (42%), Gaps = 32/321 (9%)
Query: 33 HHQGNGGHKLCVLKEPTGREIE----ERYELGRELGRGEFGITYLCTDRENGDAFACKSI 88
HH + + + E + Y + +++G G + + E +A K +
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYV 60
Query: 89 SKKKLRTAVDIEDVRREVDIMRHLPKHQN--IVCLKDTYEDDTAVHLVMELCEGGELFDR 146
+ ++ ++ R E+ + L + + I+ L D D +++VME C +L
Sbjct: 61 NLEEADNQ-TLDSYRNEIAYLNKL-QQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSW 117
Query: 147 IVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206
+ + + K ++E V H+HG++H DLKP NFL + LK IDFG++
Sbjct: 118 LKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIA 173
Query: 207 VFFKPGEKFSE---IVGSPYYMAPEVLKRN------------YGPEVDVWSAGVILYILL 251
+P VG+ YM PE +K P+ DVWS G ILY +
Sbjct: 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 233
Query: 252 CGVPPFWAETEQGVA-QAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
G PF Q AII + + ++ +D+++ L DPK+R++ ++L
Sbjct: 234 YGKTPFQQIINQISKLHAIIDP--NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291
Query: 311 EHPWLQNAKKAPNVSLGETVK 331
HP++Q N T +
Sbjct: 292 AHPYVQIQTHPVNQMAKGTTE 312
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 284 bits (730), Expect = 7e-95
Identities = 87/264 (32%), Positives = 128/264 (48%), Gaps = 10/264 (3%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
RY GR LG+G F + +D + + FA K + K L E + E+ I R L
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-A 99
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
HQ++V +ED+ V +V+ELC L + R TE A + IV Q H+
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 159
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIVGSPYYMAPEVLKRN 233
+ V+HRDLK N E +K DFGL+ + GE+ + G+P Y+APEVL +
Sbjct: 160 NRVIHRDLKLGNLFLNEDLE---VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK 216
Query: 234 -YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
+ EVDVWS G I+Y LL G PPF + I ++ ++ ++ A L+
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKH--INPVAASLI 272
Query: 293 RKMLDPDPKRRLTAQQVLEHPWLQ 316
+KML DP R T ++L +
Sbjct: 273 QKMLQTDPTARPTINELLNDEFFT 296
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 284 bits (729), Expect = 1e-94
Identities = 79/322 (24%), Positives = 136/322 (42%), Gaps = 34/322 (10%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
Y + +++G G + + E +A K ++ ++ ++ R E+ + L +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKL-Q 65
Query: 115 HQN--IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC 172
+ I+ L D D +++VME C +L + + + K ++E V
Sbjct: 66 QHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 124
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE---IVGSPYYMAPEV 229
H+HG++H DLKP NFL + LK IDFG++ +P VG+ YM PE
Sbjct: 125 HQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 230 LKR------------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAIIRSVLDF 276
+K P+ DVWS G ILY + G PF Q AII +
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP--NH 238
Query: 277 RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGET------V 330
+ ++ +D+++ L DPK+R++ ++L HP++Q N T V
Sbjct: 239 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYV 298
Query: 331 KARLKQFSVMNKLKKRALKVMS 352
+L + N + K A +
Sbjct: 299 LGQLVGLNSPNSILKAAKTLYE 320
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 280 bits (718), Expect = 7e-94
Identities = 90/276 (32%), Positives = 139/276 (50%), Gaps = 11/276 (3%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E +++G LG+G F Y G A K I KK + A ++ V+ EV I L K
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-K 69
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCH 173
H +I+ L + +ED V+LV+E+C GE+ + R ++E A I+ + H
Sbjct: 70 HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIVGSPYYMAPEVLKR 232
HG++HRDL N L +K DFGL+ K P EK + G+P Y++PE+ R
Sbjct: 130 SHGILHRDLTLSNLLLTRNMN---IKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATR 186
Query: 233 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291
+ +G E DVWS G + Y LL G PPF +T + ++ + + P +S AKDL
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM---P-SFLSIEAKDL 242
Query: 292 VRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLG 327
+ ++L +P RL+ VL+HP++ + G
Sbjct: 243 IHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDEG 278
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 279 bits (717), Expect = 2e-93
Identities = 64/299 (21%), Positives = 120/299 (40%), Gaps = 41/299 (13%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
+E LG+G FG + + +A K I + + + EV ++ L
Sbjct: 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASL 59
Query: 113 PKHQNIVCLKDTYEDD-------------TAVHLVMELCEGGELFDRIVARGHYTERAAA 159
HQ +V + + + + + ME CE G L+D I + +R
Sbjct: 60 -NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY 118
Query: 160 A-VTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-------- 210
+ + I+E + H G++HRDLKP N + +K DFGL+
Sbjct: 119 WRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN---VKIGDFGLAKNVHRSLDILKL 175
Query: 211 -------PGEKFSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAET 261
+ + +G+ Y+A EVL +Y ++D++S G+I + ++ P
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGME 233
Query: 262 EQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320
+ + + ++F D + K ++R ++D DP +R A+ +L WL +
Sbjct: 234 RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQ 292
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 280 bits (717), Expect = 2e-92
Identities = 79/322 (24%), Positives = 136/322 (42%), Gaps = 34/322 (10%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
Y + +++G G + + E +A K ++ ++ ++ R E+ + L +
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKL-Q 112
Query: 115 HQN--IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC 172
+ I+ L D D +++VME C +L + + + K ++E V
Sbjct: 113 QHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 171
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE---IVGSPYYMAPEV 229
H+HG++H DLKP NFL + LK IDFG++ +P VG+ YM PE
Sbjct: 172 HQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227
Query: 230 LKR------------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAIIRSVLDF 276
+K P+ DVWS G ILY + G PF Q AII +
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP--NH 285
Query: 277 RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGET------V 330
+ ++ +D+++ L DPK+R++ ++L HP++Q N T V
Sbjct: 286 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYV 345
Query: 331 KARLKQFSVMNKLKKRALKVMS 352
+L + N + K A +
Sbjct: 346 LGQLVGLNSPNSILKAAKTLYE 367
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 279 bits (715), Expect = 3e-92
Identities = 52/310 (16%), Positives = 92/310 (29%), Gaps = 44/310 (14%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL--- 112
+ +L L G+ + +L D E + FA K + + ++E + L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 113 --------------------PKHQNIVCLKDTYEDDTAVH--LVMELCEG------GELF 144
L +D + L+M L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 145 DRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204
V RG A +T ++ + G++H P+N L D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI---MPDGRLMLGDVS 239
Query: 205 LSVFFKPGEKFSEIVGSPYYMAPEVLKRN---YGPEVDVWSAGVILYILLCGVPPFWAET 261
K G + Y E L + + ++ W G+ +Y + C PF T
Sbjct: 240 ALW--KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 262 EQGVAQAIIRSVLDFRRDPW-----PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
S+ D + + K L+ + L+ D +RRL + +E P
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357
Query: 317 NAKKAPNVSL 326
+ + SL
Sbjct: 358 QLQNEISSSL 367
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 274 bits (704), Expect = 1e-91
Identities = 95/278 (34%), Positives = 151/278 (54%), Gaps = 11/278 (3%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E +E+GR LG+G+FG YL ++++ A K + K +L A +RREV+I HL +
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-R 67
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H NI+ L + D T V+L++E G ++ + + E+ A + + CH
Sbjct: 68 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN- 233
V+HRD+KPEN L + E LK DFG SV P + +++ G+ Y+ PE+++
Sbjct: 128 KRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRM 183
Query: 234 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293
+ +VD+WS GV+ Y L G PPF A T Q + I R +F + V+E A+DL+
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFTFPDF--VTEGARDLIS 239
Query: 294 KMLDPDPKRRLTAQQVLEHPWLQ-NAKKAPNVSLGETV 330
++L +P +R ++VLEHPW+ N+ K N E+
Sbjct: 240 RLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 277
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 272 bits (698), Expect = 4e-90
Identities = 93/292 (31%), Positives = 149/292 (51%), Gaps = 11/292 (3%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
Y L + +G+G F L G A K I K +L ++ + REV IM+ L H
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKIL-NH 73
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH 175
NIV L + E + ++L+ME GGE+FD +VA G E+ A + + IV VQ CH+
Sbjct: 74 PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK 133
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNY 234
++HRDLK EN L +K DFG S F G K G+P Y APE+ + + Y
Sbjct: 134 RIVHRDLKAENLLLDADMN---IKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKY 190
Query: 235 -GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293
GPEVDVWS GVILY L+ G PF + + + + ++R +R + +S + ++L++
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG--KYRIPFY--MSTDCENLLK 246
Query: 294 KMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKK 345
+ L +P +R T +Q+++ W+ + + + + ++ +
Sbjct: 247 RFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIMVG 298
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 268 bits (687), Expect = 4e-89
Identities = 86/280 (30%), Positives = 156/280 (55%), Gaps = 10/280 (3%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+ +++GR LG+G+FG YL +++N A K + K +L +RRE++I HL +
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-R 72
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H NI+ + + + D ++L++E GEL+ + G + E+ +A + + + + CH+
Sbjct: 73 HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 132
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVL-KRN 233
V+HRD+KPEN L K E LK DFG SV P + + G+ Y+ PE++ +
Sbjct: 133 RKVIHRDIKPENLLMGYKGE---LKIADFGWSV-HAPSLRRRTMCGTLDYLPPEMIEGKT 188
Query: 234 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293
+ +VD+W AGV+ Y L G+PPF + + + I+ D + P+ +S+ +KDL+
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV--DLKFPPF--LSDGSKDLIS 244
Query: 294 KMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKAR 333
K+L P +RL + V+EHPW++ + + ++ +++
Sbjct: 245 KLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQSTQSK 284
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 266 bits (683), Expect = 1e-88
Identities = 96/269 (35%), Positives = 133/269 (49%), Gaps = 10/269 (3%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
Y LG LG G FG + + G A K ++++K+R+ + ++RE+ ++ +H
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RH 70
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH 175
+I+ L T +VME GGELFD I G E A + + I+ V CH+H
Sbjct: 71 PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVL-KRNY 234
V+HRDLKPEN L K DFGLS GE GSP Y APEV+ R Y
Sbjct: 131 MVVHRDLKPENVLLDAHMN---AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 187
Query: 235 -GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293
GPEVD+WS GVILY LLCG PF E + + I F + ++ + L+
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG--VFYIPEY--LNRSVATLLM 243
Query: 294 KMLDPDPKRRLTAQQVLEHPWLQNAKKAP 322
ML DP +R T + + EH W + +
Sbjct: 244 HMLQVDPLKRATIKDIREHEWFKQDLPSY 272
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 268 bits (685), Expect = 1e-87
Identities = 52/335 (15%), Positives = 104/335 (31%), Gaps = 66/335 (19%)
Query: 47 EPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREV 106
E E G LG+ + TD+E G++F + + I+ ++ EV
Sbjct: 65 ESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEV 124
Query: 107 DIMRHL------------------------PKHQNIVCLKDTYEDDTA--VHLVMELCE- 139
+R L P+ + ++ ++ D + +
Sbjct: 125 LRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQS 184
Query: 140 -----GGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE 194
G L A +T ++ ++ H +G++H L+P + + +
Sbjct: 185 NLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQ 241
Query: 195 TAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN------------YGPEVDVWS 242
+ F V S + PE+ R D W+
Sbjct: 242 RGGVFLTGFEHLV---RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298
Query: 243 AGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKR 302
G+++Y + C P + G ++ I RS + + + + L+ L +
Sbjct: 299 LGLVIYWIWCADLPITKDAALGGSEWIFRSCKN--------IPQPVRALLEGFLRYPKED 350
Query: 303 RLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQF 337
RL Q +E P + L + A L +
Sbjct: 351 RLLPLQAMETPEYEQ--------LRTELSAALPLY 377
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 267 bits (684), Expect = 1e-87
Identities = 85/275 (30%), Positives = 132/275 (48%), Gaps = 11/275 (4%)
Query: 46 KEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRRE 105
P + + RY+ +++G G FG+ L D+ + A K I + E+V+RE
Sbjct: 12 DMPIMHDSD-RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQRE 66
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
+ R L +H NIV K+ T + ++ME GGEL++RI G ++E A + +
Sbjct: 67 IINHRSL-RHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL 125
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
+ V CH + HRDLK EN L + LK DFG S + VG+P Y+
Sbjct: 126 LSGVSYCHSMQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 184
Query: 226 APEVL-KRNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL--DFRRDPW 281
APEVL ++ Y G DVWS GV LY++L G PF E + I+ +L +
Sbjct: 185 APEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDD 244
Query: 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
++S L+ ++ DP R++ ++ H W
Sbjct: 245 IRISPECCHLISRIFVADPATRISIPEIKTHSWFL 279
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 1e-87
Identities = 77/268 (28%), Positives = 124/268 (46%), Gaps = 14/268 (5%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E ++L + LG G +G L +R +A A K + K+ E++++E+ I + L
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKML-N 63
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H+N+V + +L +E C GGELFDRI E A ++ V H
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI---VGSPYYMAPEVL- 230
G+ HRD+KPEN L + LK DFGL+ F+ + + G+ Y+APE+L
Sbjct: 124 IGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 231 KRNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAIIRSVLDFRRDPWPKVSENA 288
+R + VDVWS G++L +L G P+ ++ +PW K+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--KTYLNPWKKIDSAP 238
Query: 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
L+ K+L +P R+T + + W
Sbjct: 239 LALLHKILVENPSARITIPDIKKDRWYN 266
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 264 bits (678), Expect = 3e-87
Identities = 77/268 (28%), Positives = 124/268 (46%), Gaps = 14/268 (5%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E ++L + LG G +G L +R +A A K + K+ E++++E+ I + L
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKML-N 63
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H+N+V + +L +E C GGELFDRI E A ++ V H
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI---VGSPYYMAPEVL- 230
G+ HRD+KPEN L + LK DFGL+ F+ + + G+ Y+APE+L
Sbjct: 124 IGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 231 KRNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAIIRSVLDFRRDPWPKVSENA 288
+R + VDVWS G++L +L G P+ ++ +PW K+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--KTYLNPWKKIDSAP 238
Query: 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
L+ K+L +P R+T + + W
Sbjct: 239 LALLHKILVENPSARITIPDIKKDRWYN 266
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 265 bits (678), Expect = 4e-87
Identities = 86/295 (29%), Positives = 131/295 (44%), Gaps = 26/295 (8%)
Query: 47 EPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIED----- 101
E ++Y LG G FG + D+E K I K+K+ IED
Sbjct: 16 AACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGK 75
Query: 102 VRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMEL-CEGGELFDRIVARGHYTERAAAA 160
V E+ I+ + +H NI+ + D +E+ LVME G +LF I E A+
Sbjct: 76 VTLEIAILSRV-EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY 134
Query: 161 VTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG 220
+ + +V V ++HRD+K EN + A +K IDFG + + + G+ F G
Sbjct: 135 IFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFT---IKLIDFGSAAYLERGKLFYTFCG 191
Query: 221 SPYYMAPEVLKRN-Y-GPEVDVWSAGVILYILLCGVPPF--WAETEQGVAQAIIRSVLDF 276
+ Y APEVL N Y GPE+++WS GV LY L+ PF ET +
Sbjct: 192 TIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEA----------AI 241
Query: 277 RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVK 331
VS+ LV +L P P+RR T ++++ PW+ + + E +
Sbjct: 242 HPPYL--VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFR 294
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 275 bits (703), Expect = 4e-87
Identities = 67/301 (22%), Positives = 118/301 (39%), Gaps = 33/301 (10%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
+E+ LG G FG ++ G+ A K ++ + + E E+ IM+ L H
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKL-NH 71
Query: 116 QNIVCLKDTYEDDTAVH------LVMELCEGGELFDRIVARGH---YTERAAAAVTKTIV 166
N+V ++ + + L ME CEGG+L + + E + I
Sbjct: 72 PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 167 EVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMA 226
++ H++ ++HRDLKPEN + + K ID G + GE +E VG+ Y+A
Sbjct: 132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 191
Query: 227 PEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285
PE+L+ + Y VD WS G + + + G PF + +R + + ++
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT 251
Query: 286 EN--------------------AKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVS 325
+ ++ ML ++R T Q Q ++
Sbjct: 252 GAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311
Query: 326 L 326
L
Sbjct: 312 L 312
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 261 bits (669), Expect = 5e-86
Identities = 79/294 (26%), Positives = 124/294 (42%), Gaps = 22/294 (7%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIED---VRREVD 107
E Y LG LG+G FG + + A K I + ++ + D EV
Sbjct: 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVA 86
Query: 108 IMRHL---PKHQNIVCLKDTYEDDTAVHLVMEL-CEGGELFDRIVARGHYTERAAAAVTK 163
++ + H ++ L D +E LV+E +LFD I +G E +
Sbjct: 87 LLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFG 146
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY 223
+V +Q CH GV+HRD+K EN L K IDFG +++ G+
Sbjct: 147 QVVAAIQHCHSRGVVHRDIKDENILI--DLRRGCAKLIDFGSGALLHDE-PYTDFDGTRV 203
Query: 224 YMAPEVLK-RNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281
Y PE + Y VWS G++LY ++CG PF + E I+ + L F
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAELHFP---- 253
Query: 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLK 335
VS + L+R+ L P P R + +++L PW+Q + ++ + A L
Sbjct: 254 AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGPAPLA 307
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 266 bits (681), Expect = 9e-86
Identities = 94/269 (34%), Positives = 135/269 (50%), Gaps = 10/269 (3%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
Y LG LG G FG + G A K ++++K+R+ + +RRE+ ++ +H
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RH 75
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH 175
+I+ L + + +VME GGELFD I G E+ + + + I+ V CH+H
Sbjct: 76 PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH 135
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVL-KRNY 234
V+HRDLKPEN L K DFGLS GE GSP Y APEV+ R Y
Sbjct: 136 MVVHRDLKPENVLLDAHMN---AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 192
Query: 235 -GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293
GPEVD+WS+GVILY LLCG PF + + + I F + ++ + L++
Sbjct: 193 AGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG--IFYTPQY--LNPSVISLLK 248
Query: 294 KMLDPDPKRRLTAQQVLEHPWLQNAKKAP 322
ML DP +R T + + EH W +
Sbjct: 249 HMLQVDPMKRATIKDIREHEWFKQDLPKY 277
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 260 bits (666), Expect = 3e-85
Identities = 91/263 (34%), Positives = 136/263 (51%), Gaps = 11/263 (4%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
Y + LG G FG L T + A K IS++ L+ + V RE+ ++ L +H
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RH 68
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH 175
+I+ L D T + +V+E GGELFD IV + TE + I+ ++ CH+H
Sbjct: 69 PHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH 127
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNY 234
++HRDLKPEN L + +K DFGLS G GSP Y APEV+ + Y
Sbjct: 128 KIVHRDLKPENLLLDDNLN---VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLY 184
Query: 235 -GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293
GPEVDVWS G++LY++L G PF E + + + + + +S A+ L+R
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC--VYVMPDF--LSPGAQSLIR 240
Query: 294 KMLDPDPKRRLTAQQVLEHPWLQ 316
+M+ DP +R+T Q++ PW
Sbjct: 241 RMIVADPMQRITIQEIRRDPWFN 263
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 258 bits (660), Expect = 1e-84
Identities = 85/292 (29%), Positives = 134/292 (45%), Gaps = 22/292 (7%)
Query: 34 HQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL 93
N H + +E +Y++G LG G FG Y + A K + K ++
Sbjct: 22 APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI 81
Query: 94 RTAVDIED---VRREVDIMRHLPKHQ--NIVCLKDTYEDDTAVHLVMELCEG-GELFDRI 147
++ + V EV +++ + ++ L D +E + L++E E +LFD I
Sbjct: 82 SDWGELPNGTRVPMEVVLLKKV-SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI 140
Query: 148 VARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207
RG E A + ++E V+ CH GV+HRD+K EN L LK IDFG
Sbjct: 141 TERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGA 198
Query: 208 FFKPGEKFSEIVGSPYYMAPEVLK-RNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGV 265
K +++ G+ Y PE ++ Y G VWS G++LY ++CG PF + E
Sbjct: 199 LLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--- 254
Query: 266 AQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317
IIR + FR +VS + L+R L P R T +++ HPW+Q+
Sbjct: 255 ---IIRGQVFFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 299
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 256 bits (656), Expect = 3e-84
Identities = 85/291 (29%), Positives = 138/291 (47%), Gaps = 37/291 (12%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD----------------- 98
+Y L E+G+G +G+ L + + +A K +SKKKL
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 99 ------IEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL--VMELCEGGELFDRIVAR 150
IE V +E+ I++ L H N+V L + +D HL V EL G + + +
Sbjct: 74 IQPRGPIEQVYQEIAILKKL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTL 131
Query: 151 GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210
+E A + +++ ++ H ++HRD+KP N L +K DFG+S FK
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGH---IKIADFGVSNEFK 188
Query: 211 PGEKF-SEIVGSPYYMAPEVL---KRNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGV 265
+ S VG+P +MAPE L ++ + G +DVW+ GV LY + G PF E +
Sbjct: 189 GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248
Query: 266 AQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
I L+F P ++E+ KDL+ +MLD +P+ R+ ++ HPW+
Sbjct: 249 HSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 9e-84
Identities = 71/265 (26%), Positives = 112/265 (42%), Gaps = 13/265 (4%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
++ ++ LG G +G + +E+G +A K S R D EV +
Sbjct: 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVK-RSMSPFRGPKDRARKLAEVGSHEKVG 114
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTKTIVEVVQMC 172
+H V L+ +E+ ++L ELC G L A G E + + +
Sbjct: 115 QHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHL 173
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR 232
H G++H D+KP N + K DFGL V G P YMAPE+L+
Sbjct: 174 HSQGLVHLDVKPANIFLGPRGR---CKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG 230
Query: 233 NYGPEVDVWSAGVILYILLCGVP-PFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291
+YG DV+S G+ + + C + P E Q + Q + +S + +
Sbjct: 231 SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF------TAGLSSELRSV 284
Query: 292 VRKMLDPDPKRRLTAQQVLEHPWLQ 316
+ ML+PDPK R TA+ +L P L+
Sbjct: 285 LVMMLEPDPKLRATAEALLALPVLR 309
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 2e-82
Identities = 60/334 (17%), Positives = 113/334 (33%), Gaps = 49/334 (14%)
Query: 46 KEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDI------ 99
+ Y + R L +G+F LC ++ +A K K L D
Sbjct: 22 YVKEKDKYINDYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNND 79
Query: 100 --------EDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG 151
+D + E+ I+ + K++ + + + V+++ E E +
Sbjct: 80 KISIKSKYDDFKNELQIITDI-KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFF 138
Query: 152 H--------YTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKKETAPLKAID 202
+ + K+++ H + HRD+KP N L +K D
Sbjct: 139 VLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR---VKLSD 195
Query: 203 FGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN---YGPEVDVWSAGVILYILLCGVPPFWA 259
FG S + +K G+ +M PE G +VD+WS G+ LY++ V PF
Sbjct: 196 FGESEYM-VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254
Query: 260 ETEQ----------------GVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRR 303
+ + +S D ++ L +P R
Sbjct: 255 KISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAER 314
Query: 304 LTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQF 337
+T++ L+H WL + + + + K+
Sbjct: 315 ITSEDALKHEWLADTNIEDLREFSKELYKKRKKL 348
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 246 bits (629), Expect = 2e-80
Identities = 82/278 (29%), Positives = 136/278 (48%), Gaps = 25/278 (8%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E YE+ +G G +G + +G K + + T + + + EV+++R L K
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLREL-K 63
Query: 115 HQNIVCLKDTYED--DTAVHLVMELCEGGELFDRIV----ARGHYTERAAAAVTKTIVEV 168
H NIV D D +T +++VME CEGG+L I R + E V +
Sbjct: 64 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 169 VQMCHK-----HGVMHRDLKPEN-FLFANKKETAPLKAIDFGLSVFFKPGEKFSE-IVGS 221
++ CH+ H V+HRDLKP N FL + +K DFGL+ F++ VG+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQN----VKLGDFGLARILNHDTSFAKTFVGT 179
Query: 222 PYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP 280
PYYM+PE + +Y + D+WS G +LY L +PPF A +++ +A I +
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG----KFRR 235
Query: 281 WPKV-SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317
P S+ +++ +ML+ R + +++LE+P +
Sbjct: 236 IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 2e-78
Identities = 71/272 (26%), Positives = 139/272 (51%), Gaps = 16/272 (5%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E+Y +++G G FG L E+G + K I+ ++ ++ + E+ RREV ++ ++ K
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANM-K 81
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMC 172
H NIV ++++E++ ++++VM+ CEGG+LF RI A+ + E I ++
Sbjct: 82 HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 173 HKHGVMHRDLKPEN-FLFANKKETAPLKAIDFGLSVFFKPGEKFSE-IVGSPYYMAPEVL 230
H ++HRD+K +N FL + ++ DFG++ + + +G+PYY++PE+
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGT----VQLGDFGIARVLNSTVELARACIGTPYYLSPEIC 197
Query: 231 KRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP-KVSENA 288
+ Y + D+W+ G +LY L F A + + + II P S +
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG----SFPPVSLHYSYDL 253
Query: 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320
+ LV ++ +P+ R + +LE ++ +
Sbjct: 254 RSLVSQLFKRNPRDRPSVNSILEKGFIAKRIE 285
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 5e-78
Identities = 73/272 (26%), Positives = 128/272 (47%), Gaps = 20/272 (7%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIED-VRREVDIMRHLPK 114
+Y +G LG G +G D E A K + KKKLR + E V++E+ ++R L +
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-R 64
Query: 115 HQNIVCLKD--TYEDDTAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTKTIVEVVQ 170
H+N++ L D E+ +++VME C G E+ D + + A +++ ++
Sbjct: 65 HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP-EKRFPVCQAHGYFCQLIDGLE 123
Query: 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF---FKPGEKFSEIVGSPYYMAP 227
H G++H+D+KP N L LK G++ F + GSP + P
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTGGT---LKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180
Query: 228 EVL--KRNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284
E+ + G +VD+WSAGV LY + G+ PF + + + I + +
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--SYAIPGD--C 236
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
DL++ ML+ +P +R + +Q+ +H W +
Sbjct: 237 GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFR 268
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 1e-75
Identities = 69/312 (22%), Positives = 113/312 (36%), Gaps = 38/312 (12%)
Query: 33 HHQGNGGHKLCVLKEPTGREIE---ERYELGRELGRGEFGITYLCTDRENGDAFACKSIS 89
HH +G L G + + Y ++LG G F L +G +A K I
Sbjct: 8 HHHSSGRENL----YFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL 63
Query: 90 KKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA----VHLVMELCEGGELFD 145
+ + D E+ +RE D+ R H NI+ L + L++ + G L++
Sbjct: 64 CHEQQ---DREEAQREADMHRLF-NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWN 119
Query: 146 RIVAR----GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAI 201
I TE + I ++ H G HRDLKP N L ++ + +
Sbjct: 120 EIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ---PVLM 176
Query: 202 DFGLSVFFKPG----------EKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVIL 247
D G + ++ + Y APE+ DVWS G +L
Sbjct: 177 DLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVL 236
Query: 248 YILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQ 307
Y ++ G P+ ++G + A+ P+ S L+ M+ DP +R
Sbjct: 237 YAMMFGEGPYDMVFQKGDSVALAVQN-QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIP 295
Query: 308 QVLEHPW-LQNA 318
+L LQ
Sbjct: 296 LLLSQLEALQPP 307
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 2e-73
Identities = 63/293 (21%), Positives = 108/293 (36%), Gaps = 38/293 (12%)
Query: 47 EPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREV 106
+ ++ +G G FG + R +G + K + E REV
Sbjct: 3 HTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREV 55
Query: 107 DIMRHLPKHQNIVCLKDTYEDDTA----------------VHLVMELCEGGELFDRIVAR 150
+ L H NIV ++ + + ME C+ G L I R
Sbjct: 56 KALAKL-DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 114
Query: 151 --GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208
+ A + + I + V H +++RDLKP N + K+ +K DFGL
Sbjct: 115 RGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ---VKIGDFGLVTS 171
Query: 209 FKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ 267
K K + G+ YM+PE + ++YG EVD+++ G+IL LL
Sbjct: 172 LKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA--FETSKFFT 229
Query: 268 AIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320
+ ++ + K L++K+L P+ R ++L +
Sbjct: 230 DLRDGIIS------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 4e-73
Identities = 75/289 (25%), Positives = 129/289 (44%), Gaps = 16/289 (5%)
Query: 45 LKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRR 104
L+ G + + +++GRG+F Y +G A K + L A D +
Sbjct: 22 LRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIK 81
Query: 105 EVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG----HYTERAAAA 160
E+D+++ L H N++ ++ +D +++V+EL + G+L I ER
Sbjct: 82 EIDLLKQL-NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWK 140
Query: 161 VTKTIVEVVQMCHKHGVMHRDLKPEN-FLFANKKETAPLKAIDFGLS-VFFKPGEKFSEI 218
+ ++ H VMHRD+KP N F+ A +K D GL F +
Sbjct: 141 YFVQLCSALEHMHSRRVMHRDIKPANVFITATGV----VKLGDLGLGRFFSSKTTAAHSL 196
Query: 219 VGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETE--QGVAQAIIRSVLD 275
VG+PYYM+PE + N Y + D+WS G +LY + PF+ + + + I + D
Sbjct: 197 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--D 254
Query: 276 FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNV 324
+ P SE + LV ++PDP++R V + +A A ++
Sbjct: 255 YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 4e-70
Identities = 78/306 (25%), Positives = 126/306 (41%), Gaps = 41/306 (13%)
Query: 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIM 109
GR + + +E + LGRG FG+ + ++ + +A K I + E V REV +
Sbjct: 1 GRYLTD-FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKAL 57
Query: 110 RHLPKHQNIVCLKDTYEDDTA------------VHLVMELCEGGELFDRIVARGHYTERA 157
L +H IV + + + +++ M+LC L D + R ER
Sbjct: 58 AKL-EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116
Query: 158 AAAVTKT---IVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-------- 206
+ I E V+ H G+MHRDLKP N F +K DFGL
Sbjct: 117 RSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV---VKVGDFGLVTAMDQDEE 173
Query: 207 -----VFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAE 260
+ + VG+ YM+PE + +Y +VD++S G+IL+ LL PF +
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ 230
Query: 261 TEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320
E+ +R+ L F + +V+ ML P P R A ++E+ ++
Sbjct: 231 MERVRTLTDVRN-LKFPPLF-TQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288
Query: 321 APNVSL 326
L
Sbjct: 289 PGKTVL 294
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 1e-68
Identities = 72/301 (23%), Positives = 111/301 (36%), Gaps = 41/301 (13%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
E R + R L G F Y D +G +A K + + + +EV M+ L
Sbjct: 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEE---KNRAIIQEVCFMKKLS 83
Query: 114 KHQNIVCLKDTYEDDTA--------VHLVMELCEGG--ELFDRIVARGHYTERAAAAVTK 163
H NIV L+ ELC+G E ++ +RG + +
Sbjct: 84 GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFY 143
Query: 164 TIVEVVQMCHKHG--VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS----- 216
VQ H+ ++HRDLK EN L +N+ +K DFG + +S
Sbjct: 144 QTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT---IKLCDFGSATTISHYPDYSWSAQR 200
Query: 217 --------EIVGSPYYMAPEVL----KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQG 264
+P Y PE++ G + D+W+ G ILY+L PF E G
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF----EDG 256
Query: 265 VAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNV 324
I+ + P L+R ML +P+ RL+ +V+ A + N
Sbjct: 257 AKLRIVNG--KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNP 314
Query: 325 S 325
Sbjct: 315 K 315
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 218 bits (556), Expect = 5e-68
Identities = 49/312 (15%), Positives = 99/312 (31%), Gaps = 58/312 (18%)
Query: 51 REIEERYEL---GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVD 107
E+ ER G LG+ + TD+E G++F + + I+ ++ EV
Sbjct: 71 SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVL 130
Query: 108 IMRHL------------------------PKHQNIVCLKDTYEDDTAVH--LVMELCEG- 140
+R L P+ + ++ ++ D + + +
Sbjct: 131 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 190
Query: 141 -----GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKET 195
L A +T ++ ++ H +G++H L+P + + +
Sbjct: 191 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD---QR 247
Query: 196 APLKAIDFGLSVFFKPGEKF----SEIVGSPYYMAPEVL------KRNYGPEVDVWSAGV 245
+ F V + G P A +L D W+ G+
Sbjct: 248 GGVFLTGFEHLV--RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305
Query: 246 ILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLT 305
+Y + C P + G ++ I RS + + + L+ L + RL
Sbjct: 306 AIYWIWCADLPNTDDAALGGSEWIFRSC--------KNIPQPVRALLEGFLRYPKEDRLL 357
Query: 306 AQQVLEHPWLQN 317
Q +E P +
Sbjct: 358 PLQAMETPEYEQ 369
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 7e-67
Identities = 64/294 (21%), Positives = 115/294 (39%), Gaps = 40/294 (13%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
+ ++G GEFG + C R +G +A K SKK L +VD ++ REV L
Sbjct: 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK-RSKKPLAGSVDEQNALREVYAHAVL 67
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTKTIVEV 168
+H ++V + +D + + E C GG L D I ++ E + +
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAI----------------DFGLSVFFKPG 212
++ H ++H D+KP N + D G
Sbjct: 128 LRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV---TRI 184
Query: 213 EKFSEIVGSPYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII 270
G ++A EVL+ N + P+ D+++ + + P G I
Sbjct: 185 SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP----RNGDQWHEI 240
Query: 271 RSVLDFRRDPWPKV----SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320
R+ P++ S+ +L++ M+ PDP+RR +A +++H L +A +
Sbjct: 241 ------RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 288
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 9e-64
Identities = 54/319 (16%), Positives = 101/319 (31%), Gaps = 38/319 (11%)
Query: 53 IEERYELGRELGRGEFGITYLCT-----DRENGDAFACKSISKKKLRTAVDIEDVRREVD 107
+ + LG G F Y T D +N F K + + ++
Sbjct: 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIGTQLME 119
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERA-----AAAVT 162
++ + + LV EL G L + I + E+ +
Sbjct: 120 RLKPS-MQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 163 KTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAP--------LKAIDFGLSV---FFKP 211
++ +++ H ++H D+KP+NF+ N L ID G S+ F
Sbjct: 179 MRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK 238
Query: 212 GEKFSEIVGSPYYMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII 270
G F+ + + E+L + + ++D + +Y +L G +
Sbjct: 239 GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGL 298
Query: 271 RSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETV 330
L D W + ML+ L + +L KK +
Sbjct: 299 FRRL-PHLDMW-------NEFFHVMLNIPDCHHLPSLDLLRQKL----KKVFQQHYTNKI 346
Query: 331 KARLKQFSVMNKLKKRALK 349
+A + V+ KR+ K
Sbjct: 347 RALRNRLIVLLLECKRSRK 365
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 2e-58
Identities = 80/268 (29%), Positives = 122/268 (45%), Gaps = 18/268 (6%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
++ G+ LG G F L + +A K + K+ + + V RE D+M L H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 90
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
V L T++DD ++ + + GEL I G + E T IV ++ H G
Sbjct: 91 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLS---VFFKPGEKFSEIVGSPYYMAPEVLKRN 233
++HRDLKPEN L ++ DFG + + + VG+ Y++PE+L
Sbjct: 151 IIHRDLKPENILLNEDMH---IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 207
Query: 234 -YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
D+W+ G I+Y L+ G+PPF A E + Q II+ DF P K A+DLV
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF---P-EKFFPKARDLV 263
Query: 293 RKMLDPDPKRRLT------AQQVLEHPW 314
K+L D +RL + HP+
Sbjct: 264 EKLLVLDATKRLGCEEMEGYGPLKAHPF 291
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-55
Identities = 67/282 (23%), Positives = 118/282 (41%), Gaps = 18/282 (6%)
Query: 43 CVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDV 102
V GR + E+GRG F Y D E A + +KL T + +
Sbjct: 18 AVGMSNDGR----FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRF 72
Query: 103 RREVDIMRHLPKHQNIV----CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAA 158
+ E ++++ L +H NIV + T + + LV EL G L + +
Sbjct: 73 KEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVL 131
Query: 159 AAVTKTIVEVVQMCHKHG--VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS 216
+ + I++ +Q H ++HRDLK +N T +K D GL+ K
Sbjct: 132 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP--TGSVKIGDLGLATL-KRASFAK 188
Query: 217 EIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF 276
++G+P +MAPE+ + Y VDV++ G+ + + P ++E Q AQ R
Sbjct: 189 AVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYP-YSE-CQNAAQIYRRVTSGV 246
Query: 277 RRDPWPKV-SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317
+ + KV K+++ + + R + + +L H + Q
Sbjct: 247 KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 7e-55
Identities = 63/279 (22%), Positives = 103/279 (36%), Gaps = 19/279 (6%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
RE +GRG FG + D++ G A K + + R E+
Sbjct: 54 REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACA 105
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ 170
L IV L + V++ MEL EGG L I G E A +E ++
Sbjct: 106 GL-SSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLE 164
Query: 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS------VFFKPGEKFSEIVGSPYY 224
H ++H D+K +N L ++ A DFG + K I G+ +
Sbjct: 165 YLHTRRILHGDVKADNVLLSSDGSRA--ALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 222
Query: 225 MAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283
MAPEV+ +VD+WS+ ++ +L G P+ + I R P P
Sbjct: 223 MAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIP-PS 281
Query: 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAP 322
+ +++ L +P R +A ++ +
Sbjct: 282 CAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG 320
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 1e-54
Identities = 77/287 (26%), Positives = 127/287 (44%), Gaps = 21/287 (7%)
Query: 47 EPTGREIEERYELGRE-----LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIED 101
+ +E YE LG+G +GI Y D N A K I R + +
Sbjct: 9 DCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI---PERDSRYSQP 65
Query: 102 VRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG---HYTERAA 158
+ E+ + +HL KH+NIV ++ ++ + + ME GG L + ++ E+
Sbjct: 66 LHEEIALHKHL-KHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI 124
Query: 159 AAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSE 217
TK I+E ++ H + ++HRD+K +N L LK DFG S
Sbjct: 125 GFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGV--LKISDFGTSKRLAGINPCTET 182
Query: 218 IVGSPYYMAPEVLKRN---YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL 274
G+ YMAPE++ + YG D+WS G + + G PP + E + A A+ + +
Sbjct: 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP-FYELGEPQA-AMFKVGM 240
Query: 275 DFRRDPWPK-VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320
P+ +S AK + K +PDP +R A +L +L+ + K
Sbjct: 241 FKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK 287
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 1e-54
Identities = 78/314 (24%), Positives = 146/314 (46%), Gaps = 26/314 (8%)
Query: 7 TPAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRG 66
AA K ++++ K+ D+ + + + ++++ + LG G
Sbjct: 3 AAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQL----------DQFDRIKTLGTG 52
Query: 67 EFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126
FG L +E+G+ +A K + K+K+ IE E I++ + +V L+ +++
Sbjct: 53 SFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFK 111
Query: 127 DDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPEN 186
D++ +++VME GGE+F + G ++E A IV + H +++RDLKPEN
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 187 FLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGV 245
L + ++ DFG + + + + G+P +APE++ Y VD W+ GV
Sbjct: 172 LLIDQQGY---IQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGV 226
Query: 246 ILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRL- 304
++Y + G PPF+A+ + + I+ + F P S + KDL+R +L D +R
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRF---P-SHFSSDLKDLLRNLLQVDLTKRFG 282
Query: 305 ----TAQQVLEHPW 314
+ H W
Sbjct: 283 NLKNGVNDIKNHKW 296
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 6e-54
Identities = 80/268 (29%), Positives = 124/268 (46%), Gaps = 16/268 (5%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
YE+ + +GRG FG L + +A K +SK ++ D E DIM
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSP 129
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
+V L ++DD +++VME GG+L +++ E+ A T +V + H G
Sbjct: 130 WVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIHSMG 188
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF--SEIVGSPYYMAPEVLKR-- 232
+HRD+KP+N L ++ LK DFG + VG+P Y++PEVLK
Sbjct: 189 FIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 245
Query: 233 ---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289
YG E D WS GV LY +L G PF+A++ G I+ +S+ AK
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAK 305
Query: 290 DLVRKMLDPDPKRRLT---AQQVLEHPW 314
+L+ L D + RL +++ H +
Sbjct: 306 NLICAFLT-DREVRLGRNGVEEIKRHLF 332
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 2e-53
Identities = 65/268 (24%), Positives = 125/268 (46%), Gaps = 16/268 (5%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
E+ R +G+G FG + + +A K ++K+K ++ +V +E+ IM+ L +H
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPF 76
Query: 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGV 177
+V L +++D+ + +V++L GG+L + H+ E +V + +
Sbjct: 77 LVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRI 136
Query: 178 MHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN---- 233
+HRD+KP+N L E + DF ++ + + + G+ YMAPE+
Sbjct: 137 IHRDMKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAG 193
Query: 234 YGPEVDVWSAGVILYILLCGVPPFW---AETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290
Y VD WS GV Y LL G P+ + + + + +V+ + S+
Sbjct: 194 YSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP----SAWSQEMVS 249
Query: 291 LVRKMLDPDPKRRL-TAQQVLEHPWLQN 317
L++K+L+P+P +R V P++ +
Sbjct: 250 LLKKLLEPNPDQRFSQLSDVQNFPYMND 277
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 1e-52
Identities = 72/335 (21%), Positives = 116/335 (34%), Gaps = 79/335 (23%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSI-------SKKKLRTAVDIEDVRREV 106
+E + +GRG FG+ + ++ + +A K I +++K+ V
Sbjct: 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 64
Query: 107 DIMRHLP-----------------------------------------------KHQNIV 119
I+R+ +N V
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124
Query: 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK---TIVEVVQMCHKHG 176
+++ M+LC L D + R +R I E V+ H G
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLS-------------VFFKPGEKFSEIVGSPY 223
+MHRDLKP N F +K DFGL + VG+
Sbjct: 185 LMHRDLKPSNIFFTMDDV---VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 224 YMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282
YM+PE + NY +VD++S G+IL+ LL F + E+ +R+ L F
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDVRN-LKFPLLFTQ 297
Query: 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317
K +V+ ML P P R A ++E+ +N
Sbjct: 298 K-YPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 1e-52
Identities = 87/309 (28%), Positives = 144/309 (46%), Gaps = 51/309 (16%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMR 110
E+YE ++G G +G+ + C +R+ G A K K + D ++ RE+ +++
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK-----KFLESEDDPVIKKIALREIRMLK 57
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTKTIVEV 168
L KH N+V L + + +HLV E C+ DR + E ++T ++
Sbjct: 58 QL-KHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQA 114
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAP 227
V CHKH +HRD+KPEN L +K DFG + + P + + + V + +Y +P
Sbjct: 115 VNFCHKHNCIHRDVKPENILITKHSV---IKLCDFGFARLLTGPSDYYDDEVATRWYRSP 171
Query: 228 EVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ-AIIRSVL---------- 274
E+L YGP VDVW+ G + LL GVP + +++ V Q +IR L
Sbjct: 172 ELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD--VDQLYLIRKTLGDLIPRHQQV 229
Query: 275 -----DFR-------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
F +P +S A L++ L DP RLT +Q+L HP+ +
Sbjct: 230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE 289
Query: 317 NAKKAPNVS 325
N ++ +++
Sbjct: 290 NIREIEDLA 298
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 5e-52
Identities = 75/267 (28%), Positives = 128/267 (47%), Gaps = 22/267 (8%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+++ R LG G FG +L R NG +A K + K+ + +E E ++ + H
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THP 66
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAA---AAVTKTIVEVVQMCH 173
I+ + T++D + ++M+ EGGELF + + A AA + ++ H
Sbjct: 67 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA---EVCLALEYLH 123
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN 233
+++RDLKPEN L + +K DFG + + + G+P Y+APEV+
Sbjct: 124 SKDIIYRDLKPENILLD---KNGHIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVSTK 178
Query: 234 -YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
Y +D WS G+++Y +L G PF+ + I+ + L F P P +E+ KDL+
Sbjct: 179 PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF---P-PFFNEDVKDLL 234
Query: 293 RKMLDPDPKRRL-----TAQQVLEHPW 314
+++ D +RL + V HPW
Sbjct: 235 SRLITRDLSQRLGNLQNGTEDVKNHPW 261
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 6e-52
Identities = 87/291 (29%), Positives = 143/291 (49%), Gaps = 25/291 (8%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
+ ++G G GI L ++ +G A K + LR E + EV IMR
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDY- 99
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
+H N+V + +Y + ++ME +GG L D IV++ E A V + +++ + H
Sbjct: 100 QHFNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLH 158
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYYMAPEVLKR 232
GV+HRD+K ++ L +K DFG K K +VG+PY+MAPEV+ R
Sbjct: 159 AQGVIHRDIKSDSILLT---LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR 215
Query: 233 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP------KVS 285
+ Y EVD+WS G+++ ++ G PP+++++ + + R P P KVS
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL-------RDSPPPKLKNSHKVS 268
Query: 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQ 336
+D + +ML DP+ R TAQ++L+HP+L L ++ KQ
Sbjct: 269 PVLRDFLERMLVRDPQERATAQELLDHPFLLQTG--LPECLVPLIQLYRKQ 317
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 2e-51
Identities = 78/266 (29%), Positives = 125/266 (46%), Gaps = 12/266 (4%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+ R LG+G FG C R G +ACK + KK+++ E I+ + +
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSR 244
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRI--VARGHYTERAAAAVTKTIVEVVQMCHK 174
+V L YE A+ LV+ L GG+L I + + + E A I ++ H+
Sbjct: 245 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR 304
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN- 233
+++RDLKPEN L + ++ D GL+V G+ VG+ YMAPEV+K
Sbjct: 305 ERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER 361
Query: 234 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293
Y D W+ G +LY ++ G PF ++ + + R V + + + S A+ L
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCS 421
Query: 294 KMLDPDPKRRL-----TAQQVLEHPW 314
++L DP RL +A++V EHP
Sbjct: 422 QLLCKDPAERLGCRGGSAREVKEHPL 447
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 3e-51
Identities = 85/287 (29%), Positives = 139/287 (48%), Gaps = 25/287 (8%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
+++Y ++G+G G Y D G A + + L+ E + E+ +MR
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMREN- 74
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
K+ NIV D+Y + +VME GG L D +V E AAV + ++ ++ H
Sbjct: 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYYMAPEVLKR 232
+ V+HRD+K +N L +K DFG K S +VG+PY+MAPEV+ R
Sbjct: 134 SNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190
Query: 233 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP------KVS 285
YGP+VD+WS G++ ++ G PP+ E I + P K+S
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-------ATNGTPELQNPEKLS 243
Query: 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKA 332
+D + + L+ D ++R +A+++L+H +L+ AK P SL + A
Sbjct: 244 AIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK--PLSSLTPLIAA 288
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 4e-51
Identities = 76/270 (28%), Positives = 125/270 (46%), Gaps = 16/270 (5%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+E+ + +GRG FG + + FA K ++K ++ + R E D++ + +
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSK 134
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIV-ARGHYTERAAAAVTKTIVEVVQMCHKH 175
I L ++DD ++LVM+ GG+L + E A +V + H+
Sbjct: 135 WITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL 194
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF--SEIVGSPYYMAPEVL--- 230
+HRD+KP+N L ++ DFG + S VG+P Y++PE+L
Sbjct: 195 HYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 251
Query: 231 ---KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW-PKVSE 286
K YGPE D WS GV +Y +L G PF+AE+ I+ F+ VSE
Sbjct: 252 EGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSE 311
Query: 287 NAKDLVRKMLDPDPKR--RLTAQQVLEHPW 314
NAKDL+R+++ R + + +HP+
Sbjct: 312 NAKDLIRRLICSREHRLGQNGIEDFKKHPF 341
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 7e-51
Identities = 81/325 (24%), Positives = 135/325 (41%), Gaps = 53/325 (16%)
Query: 31 GTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISK 90
HH + G L E + E+YE +G G +G+ C +++ G A K
Sbjct: 3 HHHHHHSSGVDLGT--ENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK---- 56
Query: 91 KKLRTAVDIEDVR----REVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG--GELF 144
K + D + V+ RE+ +++ L +H+N+V L + + +LV E + +
Sbjct: 57 -KFLESDDDKMVKKIAMREIKLLKQL-RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDL 114
Query: 145 DRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204
+ + I+ + CH H ++HRD+KPEN L + +K DFG
Sbjct: 115 ELF--PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGV---VKLCDFG 169
Query: 205 LS-VFFKPGEKFSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAET 261
+ PGE + + V + +Y APE+L YG VDVW+ G ++ + G P F ++
Sbjct: 170 FARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS 229
Query: 262 EQGVAQ-AIIRSVL---------------DFR-------------RDPWPKVSENAKDLV 292
+ + Q I L F +PK+SE DL
Sbjct: 230 D--IDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLA 287
Query: 293 RKMLDPDPKRRLTAQQVLEHPWLQN 317
+K L DP +R ++L H + Q
Sbjct: 288 KKCLHIDPDKRPFCAELLHHDFFQM 312
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 3e-50
Identities = 69/269 (25%), Positives = 115/269 (42%), Gaps = 20/269 (7%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR--HLPKH 115
+ R +GRG FG Y C + G +A K + KK+++ E ++
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 251
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH 175
IVC+ + + +++L GG+L + G ++E I+ ++ H
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 311
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN-- 233
V++RDLKP N L E ++ D GL+ F + + VG+ YMAPEVL++
Sbjct: 312 FVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMAPEVLQKGVA 367
Query: 234 YGPEVDVWSAGVILYILLCGVPPFWAETE---QGVAQAIIRSVLDFRRDPWPKVSENAKD 290
Y D +S G +L+ LL G PF + + + ++ S +
Sbjct: 368 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPELRS 423
Query: 291 LVRKMLDPDPKRRL-----TAQQVLEHPW 314
L+ +L D RRL AQ+V E P+
Sbjct: 424 LLEGLLQRDVNRRLGCLGRGAQEVKESPF 452
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 4e-50
Identities = 70/273 (25%), Positives = 123/273 (45%), Gaps = 20/273 (7%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+E+ + +GRG F + ++ G +A K ++K + ++ R E D++ + +
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRR 121
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKH 175
I L ++D+ ++LVME GG+L + G A IV + H+
Sbjct: 122 WITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL 181
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF--SEIVGSPYYMAPEVLKR- 232
G +HRD+KP+N L ++ DFG + + VG+P Y++PE+L+
Sbjct: 182 GYVHRDIKPDNILL---DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAV 238
Query: 233 -------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-V 284
+YGPE D W+ GV Y + G PF+A++ I+ + V
Sbjct: 239 GGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGV 298
Query: 285 SENAKDLVRKMLDPDPKRRLT---AQQVLEHPW 314
E A+D ++++L P+ RL A HP+
Sbjct: 299 PEEARDFIQRLLC-PPETRLGRGGAGDFRTHPF 330
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 8e-50
Identities = 87/359 (24%), Positives = 136/359 (37%), Gaps = 61/359 (16%)
Query: 1 MGNCCVTPAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEP---TGREIEERY 57
M T + A+ K + +G V+ P R E Y
Sbjct: 1 MSGRPRTTSFAESCKPVQQPSAFGSMKVS----RDKDGSKVTTVVATPGQGPDRPQEVSY 56
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
+ +G G FG+ Y ++G+ A K + + K RE+ IMR L H N
Sbjct: 57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHCN 108
Query: 118 IVCLKDTY------EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQM 171
IV L+ + +D+ ++LV++ ++ + K + Q+
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM--YQL 165
Query: 172 ------CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
H G+ HRD+KP+N L + +TA LK DFG + GE + S YY
Sbjct: 166 FRSLAYIHSFGICHRDIKPQNLL-LD-PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 223
Query: 226 APEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL--------- 274
APE++ +Y +DVWSAG +L LL G P F ++ II+ VL
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK-VLGTPTREQIR 282
Query: 275 ------------DFRRDPW-----PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
+ PW P+ A L ++L+ P RLT + H +
Sbjct: 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 341
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 9e-50
Identities = 76/263 (28%), Positives = 119/263 (45%), Gaps = 15/263 (5%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG L +E GD +A K + K + D+E E I+ H + L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
++ + VME GG+L I + E A I+ + H G+++RDL
Sbjct: 91 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDL 150
Query: 183 KPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDV 240
K +N L K DFG+ G + G+P Y+APE+L+ YGP VD
Sbjct: 151 KLDNVLL---DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDW 207
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
W+ GV+LY +LCG PF AE E + +AI+ + + + E+A +++ + +P
Sbjct: 208 WAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTW----LHEDATGILKSFMTKNP 263
Query: 301 KRRL------TAQQVLEHPWLQN 317
RL +L HP+ +
Sbjct: 264 TMRLGSLTQGGEHAILRHPFFKE 286
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 3e-49
Identities = 84/323 (26%), Positives = 134/323 (41%), Gaps = 55/323 (17%)
Query: 34 HQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL 93
N K+ TG + E Y + +G G FG+ + E+ + A K + + K
Sbjct: 19 DDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR 77
Query: 94 RTAVDIEDVRREVDIMRHLPKHQNIVCLKDTY------EDDTAVHLVMELCEGGELFDRI 147
RE+ IMR + KH N+V LK + +D+ ++LV+E ++
Sbjct: 78 FKN-------RELQIMRIV-KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRAS 128
Query: 148 VARGHYTERAAAAVTKTIVEVVQM------CHKHGVMHRDLKPENFLFANKKETAPLKAI 201
+ + K + Q+ H G+ HRD+KP+N L + + LK I
Sbjct: 129 RHYAKLKQTMPMLLIKLYM--YQLLRSLAYIHSIGICHRDIKPQNLL-LD-PPSGVLKLI 184
Query: 202 DFGLSVFFKPGEKFSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWA 259
DFG + GE + S YY APE++ NY +D+WS G ++ L+ G P F
Sbjct: 185 DFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPG 244
Query: 260 ETEQGVAQAIIRSVL---------------------DFRRDPW-----PKVSENAKDLVR 293
E+ II+ VL R P+ P+ +A DL+
Sbjct: 245 ESGIDQLVEIIK-VLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLIS 303
Query: 294 KMLDPDPKRRLTAQQVLEHPWLQ 316
++L+ P RLTA + L HP+
Sbjct: 304 RLLEYTPSARLTAIEALCHPFFD 326
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-49
Identities = 71/258 (27%), Positives = 120/258 (46%), Gaps = 10/258 (3%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG +L ++ FA K++ K + D+E E ++ +H + +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
T++ + VME GG+L I + + A I+ +Q H G+++RDL
Sbjct: 85 CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDL 144
Query: 183 KPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDV 240
K +N L + +K DFG+ K + G+P Y+APE+L Y VD
Sbjct: 145 KLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDW 201
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
WS GV+LY +L G PF + E+ + +I + R + + AKDL+ K+ +P
Sbjct: 202 WSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW----LEKEAKDLLVKLFVREP 257
Query: 301 KRRLTA-QQVLEHPWLQN 317
++RL + +HP +
Sbjct: 258 EKRLGVRGDIRQHPLFRE 275
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 4e-49
Identities = 66/262 (25%), Positives = 114/262 (43%), Gaps = 14/262 (5%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG L + + +A K + K + D+E E ++ K + L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
++ ++ VME GG+L I G + E A I + G+++RDL
Sbjct: 88 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 147
Query: 183 KPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDV 240
K +N + +K DFG+ G G+P Y+APE++ YG VD
Sbjct: 148 KLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDW 204
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
W+ GV+LY +L G PF E E + Q+I+ + + + +S+ A + + ++ P
Sbjct: 205 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS----MSKEAVAICKGLMTKHP 260
Query: 301 KRRL-----TAQQVLEHPWLQN 317
+RL + + EH + +
Sbjct: 261 GKRLGCGPEGERDIKEHAFFRY 282
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 1e-48
Identities = 80/304 (26%), Positives = 134/304 (44%), Gaps = 23/304 (7%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
E+ + RE+G G FG Y D N + A K +S ++ +D+ +EV ++ L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL- 111
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
+H N + + Y + LVME C G V + E AAVT ++ + H
Sbjct: 112 RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVL--- 230
H ++HRD+K N L + E +K DFG + P F VG+PY+MAPEV+
Sbjct: 172 SHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPANSF---VGTPYWMAPEVILAM 225
Query: 231 -KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP----WPKVS 285
+ Y +VDVWS G+ L PP + I ++ + S
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN------ESPALQSGHWS 279
Query: 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKK 345
E ++ V L P+ R T++ +L+H ++ + P + + ++ ++ L+
Sbjct: 280 EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER--PPTVIMDLIQRTKDAVRELDNLQY 337
Query: 346 RALK 349
R +K
Sbjct: 338 RKMK 341
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-48
Identities = 76/296 (25%), Positives = 139/296 (46%), Gaps = 15/296 (5%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
EE +++ +LG G +G Y +E G A K + + D++++ +E+ IM+
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQC- 81
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTKTIVEVVQMC 172
++V +Y +T + +VME C G + D I R TE A + ++ ++ ++
Sbjct: 82 DSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYL 141
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYYMAPEVLK 231
H +HRD+K N L K DFG++ K + ++G+P++MAPEV++
Sbjct: 142 HFMRKIHRDIKAGNILLN---TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ 198
Query: 232 RN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290
Y D+WS G+ + G PP+ I + R P S+N D
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKP-ELWSDNFTD 257
Query: 291 LVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKR 346
V++ L P++R TA Q+L+HP++++AK L + + + + ++R
Sbjct: 258 FVKQCLVKSPEQRATATQLLQHPFVRSAK--GVSILRDLINEAMDVKLKRQESQQR 311
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-48
Identities = 78/278 (28%), Positives = 125/278 (44%), Gaps = 22/278 (7%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
E +E+ ELG G FG Y ++E G A K I ++ ++ED E++I+
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEILATC- 73
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTKTIVEVVQMC 172
H IV L Y D + +++E C GG + ++ TE V + ++E +
Sbjct: 74 DHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFL 133
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEIVGSPYYMAPEVL- 230
H ++HRDLK N L ++ DFG+S +K +G+PY+MAPEV+
Sbjct: 134 HSKRIIHRDLKAGNVLMT---LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM 190
Query: 231 -----KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS---VLDFRRDPWP 282
Y + D+WS G+ L + PP V I +S L W
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLL-TPSKW- 248
Query: 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320
S +D ++ LD +P+ R +A Q+LEHP++ +
Sbjct: 249 --SVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS 284
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-48
Identities = 71/276 (25%), Positives = 128/276 (46%), Gaps = 18/276 (6%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
EE + ++G+G FG + D A K I ++ +IED+++E+ ++
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQC- 77
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
+ +Y DT + ++ME GG D ++ G E A + + I++ + H
Sbjct: 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLH 136
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYYMAPEVLKR 232
+HRD+K N L + E +K DFG++ K + VG+P++MAPEV+K+
Sbjct: 137 SEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 193
Query: 233 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS---VLDFRRDPWPKVSENA 288
+ Y + D+WS G+ L G PP V I ++ L+ + S+
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLE---GNY---SKPL 247
Query: 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNV 324
K+ V L+ +P R TA+++L+H ++ K +
Sbjct: 248 KEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSY 283
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 9e-48
Identities = 71/289 (24%), Positives = 126/289 (43%), Gaps = 28/289 (9%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
+ YEL +G G + + A K I+ +K +T ++++ +E+ M
Sbjct: 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQT--SMDELLKEIQAMSQC- 70
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRI--------VARGHYTERAAAAVTKTI 165
H NIV ++ + LVM+L GG + D I G E A + + +
Sbjct: 71 HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS------VFFKPGEKFSEIV 219
+E ++ HK+G +HRD+K N L E ++ DFG+S + V
Sbjct: 131 LEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 220 GSPYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS----- 272
G+P +MAPEV+++ Y + D+WS G+ L G P+ V +++
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 247
Query: 273 -VLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320
++ K ++ + ++ L DP++R TA ++L H + Q AK
Sbjct: 248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-47
Identities = 80/304 (26%), Positives = 128/304 (42%), Gaps = 44/304 (14%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR-----TAVDIEDVRREVDIM 109
+RY +LG G +G Y D + A K I + TA+ REV ++
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAI------REVSLL 87
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV 169
+ L +H+NI+ LK + +HL+ E E +L + + R + ++ V
Sbjct: 88 KEL-QHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGV 145
Query: 170 QMCHKHGVMHRDLKPENFLF--ANKKETAPLKAIDFGLSVFF-KPGEKFSEIVGSPYYMA 226
CH +HRDLKP+N L ++ ET LK DFGL+ F P +F+ + + +Y
Sbjct: 146 NFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRP 205
Query: 227 PEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR------------- 271
PE+L R+Y VD+WS I +L P F ++E I
Sbjct: 206 PEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV 265
Query: 272 -------------SVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318
+R + + DL+ ML+ DP +R++A+ LEHP+ +
Sbjct: 266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325
Query: 319 KKAP 322
P
Sbjct: 326 DFDP 329
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-47
Identities = 78/262 (29%), Positives = 129/262 (49%), Gaps = 15/262 (5%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG L ++ G +A K + K+ + ++ E ++++ +H + LK
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALK 71
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
++ + VME GGELF + +TE A IV ++ H V++RD+
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 183 KPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDV 240
K EN + + +K DFGL G G+P Y+APEVL+ N YG VD
Sbjct: 132 KLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 188
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
W GV++Y ++CG PF+ + + + + I+ + F R +S AK L+ +L DP
Sbjct: 189 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKKDP 244
Query: 301 KRRL-----TAQQVLEHPWLQN 317
K+RL A++V+EH + +
Sbjct: 245 KQRLGGGPSDAKEVMEHRFFLS 266
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 4e-47
Identities = 76/308 (24%), Positives = 123/308 (39%), Gaps = 58/308 (18%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL-------RTAVDIEDVRREVD 107
+++ +LG G + Y ++ G A K + KL TA+ RE+
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV---KLDSEEGTPSTAI------REIS 55
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGG-----ELFDRIVARGHYTERAAAAVT 162
+M+ L KH+NIV L D + + LV E + +
Sbjct: 56 LMKEL-KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQ 114
Query: 163 KTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGS 221
+++ + CH++ ++HRDLKP+N L + + LK DFGL+ F P FS V +
Sbjct: 115 WQLLQGLAFCHENKILHRDLKPQNLLINKRGQ---LKLGDFGLARAFGIPVNTFSSEVVT 171
Query: 222 PYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR-------- 271
+Y AP+VL R Y +D+WS G IL ++ G P F ++ + I
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNES 231
Query: 272 -----SVL-----------------DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQV 309
+ L + + N D + +L +P RL+A+Q
Sbjct: 232 LWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQA 291
Query: 310 LEHPWLQN 317
L HPW
Sbjct: 292 LHHPWFAE 299
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 4e-47
Identities = 80/303 (26%), Positives = 136/303 (44%), Gaps = 56/303 (18%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL--------RTAVDIEDVRREV 106
++YE ++G G +G + +RE + A K + +L +A+ RE+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV---RLDDDDEGVPSSAL------REI 52
Query: 107 DIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTKT 164
+++ L KH+NIV L D D + LV E C+ + FD G +
Sbjct: 53 CLLKEL-KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQ 109
Query: 165 IVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPY 223
+++ + CH V+HRDLKP+N L E LK +FGL+ F P +S V + +
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLLINRNGE---LKLANFGLARAFGIPVRCYSAEVVTLW 166
Query: 224 YMAPEVL--KRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVL------ 274
Y P+VL + Y +D+WSAG I + G P F + I R +L
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR-LLGTPTEE 225
Query: 275 ---------DFRRDP-----------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPW 314
D++ P PK++ +DL++ +L +P +R++A++ L+HP+
Sbjct: 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285
Query: 315 LQN 317
+
Sbjct: 286 FSD 288
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 168 bits (426), Expect = 5e-47
Identities = 66/268 (24%), Positives = 115/268 (42%), Gaps = 14/268 (5%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+ LG+G FG L + + +A K + K + D+E E ++ K
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
+ L ++ ++ VME GG+L I G + E A I + G
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG 462
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLKRN-Y 234
+++RDLK +N + +K DFG+ G G+P Y+APE++ Y
Sbjct: 463 IIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPY 519
Query: 235 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK 294
G VD W+ GV+LY +L G PF E E + Q+I+ + + + +S+ A + +
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS----MSKEAVAICKG 575
Query: 295 MLDPDPKRRL-----TAQQVLEHPWLQN 317
++ P +RL + + EH + +
Sbjct: 576 LMTKHPGKRLGCGPEGERDIKEHAFFRY 603
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 5e-47
Identities = 77/263 (29%), Positives = 122/263 (46%), Gaps = 15/263 (5%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LGRG FG + C + G +ACK ++KK+L+ + E I+ + + IV L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLA 251
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGH----YTERAAAAVTKTIVEVVQMCHKHGVM 178
+E T + LVM + GG++ I + E A T IV ++ H+ ++
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNII 311
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYYMAPEVLKRN-YGP 236
+RDLKPEN L + ++ D GL+V K G+P +MAPE+L Y
Sbjct: 312 YRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDF 368
Query: 237 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKML 296
VD ++ GV LY ++ PF A E+ + + + VL+ K S +KD +L
Sbjct: 369 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALL 428
Query: 297 DPDPKRRL-----TAQQVLEHPW 314
DP++RL + + HP
Sbjct: 429 QKDPEKRLGFRDGSCDGLRTHPL 451
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 159 bits (406), Expect = 5e-47
Identities = 82/297 (27%), Positives = 130/297 (43%), Gaps = 46/297 (15%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDV----RREVDIMR 110
E+Y ++G G +G+ Y + ++ + KK+R + E + RE+ I++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYG------ETFALKKIRLEKEDEGIPSTTIREISILK 55
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTKTIVEV 168
L KH NIV L D + LV E + +L D G A + ++
Sbjct: 56 EL-KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNG 112
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAP 227
+ CH V+HRDLKP+N L + E LK DFGL+ F P K++ + + +Y AP
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEIVTLWYRAP 169
Query: 228 EVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR-------------S 272
+VL + Y +D+WS G I ++ G P F +E I R +
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229
Query: 273 VL-DFR-----------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317
L + + E+ DL+ KML DP +R+TA+Q LEH + +
Sbjct: 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 5e-47
Identities = 79/263 (30%), Positives = 125/263 (47%), Gaps = 19/263 (7%)
Query: 63 LGRGEFGITYLC---TDRENGDAFACKSISKKKL-RTAVDIEDVRREVDIMRHLPKHQNI 118
LG+G +G + T G FA K + K + R A D + E +I+ + KH I
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPFI 83
Query: 119 VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVM 178
V L ++ ++L++E GGELF ++ G + E A I + H+ G++
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGII 143
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLKRN-YGP 236
+RDLKPEN + +K DFGL G G+ YMAPE+L R+ +
Sbjct: 144 YRDLKPENIMLN---HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNR 200
Query: 237 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKML 296
VD WS G ++Y +L G PPF E + I++ L+ +++ A+DL++K+L
Sbjct: 201 AVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPY----LTQEARDLLKKLL 256
Query: 297 DPDPKRRL-----TAQQVLEHPW 314
+ RL A +V HP+
Sbjct: 257 KRNAASRLGAGPGDAGEVQAHPF 279
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 7e-47
Identities = 69/272 (25%), Positives = 123/272 (45%), Gaps = 24/272 (8%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+GRG + L ++ +A K + K+ + DI+ V+ E + H +V L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
++ ++ + V+E GG+L + + E A + I + H+ G+++RDL
Sbjct: 77 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 136
Query: 183 KPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDV 240
K +N L +K D+G+ +PG+ S G+P Y+APE+L+ YG VD
Sbjct: 137 KLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 193
Query: 241 WSAGVILYILLCGVPPFW---------AETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291
W+ GV+++ ++ G PF TE + Q I+ + R +S A +
Sbjct: 194 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS----LSVKAASV 249
Query: 292 VRKMLDPDPKRRL------TAQQVLEHPWLQN 317
++ L+ DPK RL + HP+ +N
Sbjct: 250 LKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 9e-47
Identities = 72/301 (23%), Positives = 122/301 (40%), Gaps = 53/301 (17%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL-------RTAVDIEDVRREVD 107
E Y +LG G + Y + + A K I +L TA+ REV
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI---RLEHEEGAPCTAI------REVS 52
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTKTI 165
+++ L KH NIV L D + ++ LV E + + D +
Sbjct: 53 LLKDL-KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDC--GNIINMHNVKLFLFQL 109
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYY 224
+ + CH+ V+HRDLKP+N L + E LK DFGL+ P + + V + +Y
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTYDNEVVTLWY 166
Query: 225 MAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR----------- 271
P++L +Y ++D+W G I Y + G P F T + I R
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226
Query: 272 --SVL-DFR------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
+F+ P++ + DL+ K+L + + R++A+ ++HP+
Sbjct: 227 GILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286
Query: 317 N 317
+
Sbjct: 287 S 287
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-46
Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 13/261 (4%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+G+G FG L + +A K + KK + + + + E +++ KH +V L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
+++ ++ V++ GGELF + + E A I + H +++RDL
Sbjct: 106 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 165
Query: 183 KPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDV 240
KPEN L + DFGL + S G+P Y+APEVL + Y VD
Sbjct: 166 KPENILLD---SQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDW 222
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
W G +LY +L G+PPF++ + I+ L + + ++ +A+ L+ +L D
Sbjct: 223 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPN----ITNSARHLLEGLLQKDR 278
Query: 301 KRRL----TAQQVLEHPWLQN 317
+RL ++ H +
Sbjct: 279 TKRLGAKDDFMEIKSHVFFSL 299
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 4e-46
Identities = 70/278 (25%), Positives = 127/278 (45%), Gaps = 24/278 (8%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
++L R +GRG + L ++ +A + + K+ + DI+ V+ E + H
Sbjct: 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
+V L ++ ++ + V+E GG+L + + E A + I + H+ G
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 173
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLKRN-Y 234
+++RDLK +N L +K D+G+ +PG+ S G+P Y+APE+L+ Y
Sbjct: 174 IIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 230
Query: 235 GPEVDVWSAGVILYILLCGVPPFW---------AETEQGVAQAIIRSVLDFRRDPWPKVS 285
G VD W+ GV+++ ++ G PF TE + Q I+ + R +S
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS----LS 286
Query: 286 ENAKDLVRKMLDPDPKRRL------TAQQVLEHPWLQN 317
A +++ L+ DPK RL + HP+ +N
Sbjct: 287 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 7e-46
Identities = 74/301 (24%), Positives = 128/301 (42%), Gaps = 47/301 (15%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDV----RREVDIMR 110
E+Y+ ++G G +G+ Y D + + ++ K++R + E + RE+ +++
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQG------RIVALKRIRLDAEDEGIPSTAIREISLLK 74
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTKTIVEV 168
L H NIV L D + + LV E E ++ D + + ++
Sbjct: 75 EL-HHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDEN--KTGLQDSQIKIYLYQLLRG 131
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAP 227
V CH+H ++HRDLKP+N L + LK DFGL+ F P ++ V + +Y AP
Sbjct: 132 VAHCHQHRILHRDLKPQNLLINSDGA---LKLADFGLARAFGIPVRSYTHEVVTLWYRAP 188
Query: 228 EVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR-------------S 272
+VL + Y VD+WS G I ++ G P F T+ I
Sbjct: 189 DVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ 248
Query: 273 VL-DFR------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319
L ++ P + DL+ ML DP +R++A+ + HP+ ++
Sbjct: 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308
Query: 320 K 320
Sbjct: 309 P 309
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 8e-46
Identities = 68/291 (23%), Positives = 128/291 (43%), Gaps = 34/291 (11%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
+EL +G G +G Y + G A K + + + E++++E+++++
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGD-EEEEIKQEINMLKKYS 78
Query: 114 KHQNIVCLKDTY------EDDTAVHLVMELCEGGELFD--RIVARGHYTERAAAAVTKTI 165
H+NI + D + LVME C G + D + E A + + I
Sbjct: 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 138
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYY 224
+ + H+H V+HRD+K +N L E A +K +DFG+S + + + +G+PY+
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYW 195
Query: 225 MAPEVLKRN------YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR 278
MAPEV+ + Y + D+WS G+ + G PP I R+
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN------ 249
Query: 279 DPWPKV-----SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNV 324
P P++ S+ + + L + +R +Q+++HP++++ V
Sbjct: 250 -PAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQV 299
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 9e-46
Identities = 71/262 (27%), Positives = 120/262 (45%), Gaps = 19/262 (7%)
Query: 63 LGRGEFGITYLC---TDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIV 119
LG+G FG +L + + +A K + K L D + E DI+ + H IV
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL-KVRDRVRTKMERDILVEV-NHPFIV 89
Query: 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMH 179
L ++ + ++L+++ GG+LF R+ +TE + + H G+++
Sbjct: 90 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY 149
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPE 237
RDLKPEN L E +K DFGLS +K G+ YMAPEV+ R +
Sbjct: 150 RDLKPENILLD---EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 206
Query: 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297
D WS GV+++ +L G PF + + I+++ L + +S A+ L+R +
Sbjct: 207 ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF----LSPEAQSLLRMLFK 262
Query: 298 PDPKRRL-----TAQQVLEHPW 314
+P RL +++ H +
Sbjct: 263 RNPANRLGAGPDGVEEIKRHSF 284
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-45
Identities = 82/317 (25%), Positives = 144/317 (45%), Gaps = 17/317 (5%)
Query: 7 TPAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIE-ERYELGRELGR 65
A + K+ G+ +G ++ V + +E + LG+
Sbjct: 99 WTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGK 158
Query: 66 GEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTY 125
G FG L ++ G +A K + K+ + ++ E ++++ +H + LK ++
Sbjct: 159 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSF 217
Query: 126 EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH-KHGVMHRDLKP 184
+ + VME GGELF + ++E A IV + H + V++RDLK
Sbjct: 218 QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKL 277
Query: 185 ENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDVWS 242
EN + + +K DFGL K G G+P Y+APEVL+ N YG VD W
Sbjct: 278 ENLMLD---KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWG 334
Query: 243 AGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKR 302
GV++Y ++CG PF+ + + + + I+ + F R + AK L+ +L DPK+
Sbjct: 335 LGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT----LGPEAKSLLSGLLKKDPKQ 390
Query: 303 RL-----TAQQVLEHPW 314
RL A+++++H +
Sbjct: 391 RLGGGSEDAKEIMQHRF 407
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-45
Identities = 73/303 (24%), Positives = 127/303 (41%), Gaps = 49/303 (16%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
++ Y+L R+LGRG++ + + N + K + V + ++RE+ I+ +
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP------VKKKKIKREIKILEN 86
Query: 112 LPKHQNIVCLKDTYEDDTAVH--LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV 169
L NI+ L D +D + LV E + T+ I++ +
Sbjct: 87 LRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKAL 143
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEV 229
CH G+MHRD+KP N + E L+ ID+GL+ F+ PG++++ V S Y+ PE+
Sbjct: 144 DYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 201
Query: 230 L--KRNYGPEVDVWSAGVILYILLCGVPPF------------------------WAETEQ 263
L + Y +D+WS G +L ++ PF + +
Sbjct: 202 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261
Query: 264 -GVAQAIIRSVLDFRRDPW---------PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHP 313
+ + R W VS A D + K+L D + RLTA++ +EHP
Sbjct: 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 321
Query: 314 WLQ 316
+
Sbjct: 322 YFY 324
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 156 bits (398), Expect = 3e-45
Identities = 77/297 (25%), Positives = 120/297 (40%), Gaps = 43/297 (14%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIED-----VRREVDIM 109
+RYE LG G+F Y D+ A K I KL + +D RE+ ++
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI---KLGHRSEAKDGINRTALREIKLL 66
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTKTIVE 167
+ L H NI+ L D + + + LV + E + T A ++
Sbjct: 67 QEL-SHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQ 123
Query: 168 VVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMA 226
++ H+H ++HRDLKP N L LK DFGL+ F P ++ V + +Y A
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGV---LKLADFGLAKSFGSPNRAYTHQVVTRWYRA 180
Query: 227 PEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR------------- 271
PE+L R YG VD+W+ G IL LL VP +++ I
Sbjct: 181 PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240
Query: 272 -------SVLDFRRDPW----PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317
+ F P ++ DL++ + +P R+TA Q L+ + N
Sbjct: 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-44
Identities = 83/272 (30%), Positives = 137/272 (50%), Gaps = 19/272 (6%)
Query: 58 ELGRELGRGEFGITYLC---TDRENGDAFACKSISKKKL-RTAVDIEDVRREVDIMRHLP 113
EL + LG G +G +L + + G +A K + K + + A E R E ++ H+
Sbjct: 57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 116
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
+ +V L ++ +T +HL+++ GGELF + R +TE IV ++ H
Sbjct: 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH 176
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLS--VFFKPGEKFSEIVGSPYYMAPEVLK 231
K G+++RD+K EN L + DFGLS E+ + G+ YMAP++++
Sbjct: 177 KLGIIYRDIKLENILLD---SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 233
Query: 232 RN---YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-VSEN 287
+ VD WS GV++Y LL G PF + E+ I R +L P+P+ +S
Sbjct: 234 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL-KSEPPYPQEMSAL 292
Query: 288 AKDLVRKMLDPDPKRRL-----TAQQVLEHPW 314
AKDL++++L DPK+RL A ++ EH +
Sbjct: 293 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-44
Identities = 77/315 (24%), Positives = 122/315 (38%), Gaps = 49/315 (15%)
Query: 48 PTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR---- 103
P G RYE E+G G +G Y D +G A K +R
Sbjct: 2 PLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALK-----SVRVPNGGGGGGGLPI 56
Query: 104 ---REVDIMRHL--PKHQNIVCLKD-----TYEDDTAVHLVMELCEG--GELFDRIVARG 151
REV ++R L +H N+V L D + + V LV E + D+ G
Sbjct: 57 STVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG 116
Query: 152 HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211
+ + + + H + ++HRDLKPEN L + +K DFGL+ +
Sbjct: 117 -LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT---VKLADFGLARIYSY 172
Query: 212 GEKFSEIVGSPYYMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII 270
+ +V + +Y APEVL + Y VD+WS G I + P F +E I
Sbjct: 173 QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF 232
Query: 271 R-------------------SVLDFRRDPW----PKVSENAKDLVRKMLDPDPKRRLTAQ 307
+ P P++ E+ L+ +ML +P +R++A
Sbjct: 233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAF 292
Query: 308 QVLEHPWLQNAKKAP 322
+ L+H +L + P
Sbjct: 293 RALQHSYLHKDEGNP 307
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 8e-43
Identities = 59/358 (16%), Positives = 118/358 (32%), Gaps = 62/358 (17%)
Query: 33 HHQGNGGHKLCVLKEPTGREIEERYELGRELGRGE--FGITYLCTDRENGDAFACKSISK 90
HH + L + YEL +G+G L + G+ + I+
Sbjct: 3 HHHHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINL 62
Query: 91 KKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFD--RIV 148
+ + ++ E+ + + H NIV + T+ D + +V G D
Sbjct: 63 EACSNE-MVTFLQGELHVSKLF-NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTH 120
Query: 149 ARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV- 207
E A A + + +++ + H G +HR +K + L + + ++
Sbjct: 121 FMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKV---YLSGLRSNLS 177
Query: 208 FFKPGEK-------FSEIVGSPYYMAPEVLKRN---YGPEVDVWSAGVILYILLCGVPPF 257
G++ V +++PEVL++N Y + D++S G+ L G PF
Sbjct: 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237
Query: 258 -----------------------------------------WAETEQGVAQAIIRSVLDF 276
++ S D
Sbjct: 238 KDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDS 297
Query: 277 RRDPWPKV-SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKAR 333
P+ + S + V + L +P R +A +L H + + K+ + +L E ++
Sbjct: 298 PSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPV 355
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 5e-42
Identities = 73/310 (23%), Positives = 128/310 (41%), Gaps = 55/310 (17%)
Query: 55 ERYELGRELGRGEFGITYLCTD-RENGDAFACKSISKKKLR--------TAVDIEDVRRE 105
++YE E+G G +G + D + G A K + +++ + + RE
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEEGMPLSTI------RE 61
Query: 106 VDIMRHL--PKHQNIVCLKD-----TYEDDTAVHLVMELCEG--GELFDRIVARGHYTER 156
V ++RHL +H N+V L D + +T + LV E + D++
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTE 120
Query: 157 AAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS 216
+ ++ + H H V+HRDLKP+N L + + +K DFGL+ + +
Sbjct: 121 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALT 177
Query: 217 EIVGSPYYMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR---- 271
+V + +Y APEVL + +Y VD+WS G I + P F ++ I+
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 237
Query: 272 ---------------SVLDFRRDPW----PKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312
+ P + E KDL+ K L +P +R++A L H
Sbjct: 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297
Query: 313 PWLQNAKKAP 322
P+ Q+ ++
Sbjct: 298 PYFQDLERCK 307
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-41
Identities = 70/301 (23%), Positives = 121/301 (40%), Gaps = 37/301 (12%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E E+G G G + R+ G A K + + + + + ++D++
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG--NKEENKRILMDLDVVLKSHD 82
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH- 173
IV T+ +T V + MEL + +G ER +T IV+ +
Sbjct: 83 CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE 142
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI-----VGSPYYMAPE 228
KHGV+HRD+KP N L + + +K DFG+S G + G YMAPE
Sbjct: 143 KHGVIHRDVKPSNILLDERGQ---IKLCDFGIS-----GRLVDDKAKDRSAGCAAYMAPE 194
Query: 229 VLKRN------YGPEVDVWSAGVILYILLCGVPPFWA-ETEQGVAQAIIRSVLDFRRDPW 281
+ Y DVWS G+ L L G P+ +T+ V +++ +
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ-------EEP 247
Query: 282 PKV------SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLK 335
P + S + + V+ L D ++R ++LEH +++ + V + K +
Sbjct: 248 PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYET-LEVDVASWFKDVMA 306
Query: 336 Q 336
+
Sbjct: 307 K 307
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 8e-41
Identities = 77/312 (24%), Positives = 122/312 (39%), Gaps = 59/312 (18%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
R+ +R+++ R G+G FG L ++ G + A K + + R RE+ IM+
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFR------NRELQIMQ 71
Query: 111 HLP--KHQNIVCLKDTY-------EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAV 161
L H NIV L+ + D +++VME L +
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPIL 130
Query: 162 TKTIVEVVQM------CHK--HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213
K + Q+ H V HRD+KP N L N+ LK DFG + P E
Sbjct: 131 IKVFL--FQLIRSIGCLHLPSVNVCHRDIKPHNVL-VNE-ADGTLKLCDFGSAKKLSPSE 186
Query: 214 KFSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR 271
+ S YY APE++ ++Y VD+WS G I ++ G P F + G I+R
Sbjct: 187 PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR 246
Query: 272 --------------------SVLDFRRDPWPKV--------SENAKDLVRKMLDPDPKRR 303
+ + + PW V ++ A DL+ +L P+ R
Sbjct: 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEER 306
Query: 304 LTAQQVLEHPWL 315
+ + L HP+
Sbjct: 307 MKPYEALCHPYF 318
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 66/272 (24%), Positives = 108/272 (39%), Gaps = 35/272 (12%)
Query: 50 GREIEERYELGRELGRGEFGITYLCTDRE-NGDAFACKSISKKKLRTAVDIEDV---RRE 105
G + +YE+ + G G YL DR NG K L + D E E
Sbjct: 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKG-----LVHSGDAEAQAMAMAE 129
Query: 106 VDIMRHLPKHQNIVCLKDTYED-----DTAVHLVMELCEGGELFDRIVARGHYTERAAAA 160
+ + H +IV + + E D ++VME G L A A
Sbjct: 130 RQFLAEV-VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIA 186
Query: 161 VTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG 220
I+ + H G+++ DLKPEN + ++ LK ID G F + G
Sbjct: 187 YLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ----LKLIDLGAV---SRINSFGYLYG 239
Query: 221 SPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP 280
+P + APE+++ D+++ G L L +P G+ + DP
Sbjct: 240 TPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPE----------DDP 289
Query: 281 WPKVSENAKDLVRKMLDPDPKRR-LTAQQVLE 311
K ++ L+R+ +DPDP++R TA+++
Sbjct: 290 VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSA 321
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-40
Identities = 64/301 (21%), Positives = 109/301 (36%), Gaps = 32/301 (10%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E + E+GRG +G + +G A K I + + + ++D++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSD 79
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR------GHYTERAAAAVTKTIVEV 168
IV + + MEL FD+ E +T V+
Sbjct: 80 CPYIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKA 137
Query: 169 VQMCH-KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI-----VGSP 222
+ ++HRD+KP N L +K DFG+S G+ I G
Sbjct: 138 LNHLKENLKIIHRDIKPSNILLDRSGN---IKLCDFGIS-----GQLVDSIAKTRDAGCR 189
Query: 223 YYMAPEVLK-----RNYGPEVDVWSAGVILYILLCGVPPFWA-ETEQGVAQAIIRS-VLD 275
YMAPE + + Y DVWS G+ LY L G P+ + +++
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQ 249
Query: 276 FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLK 335
+ S + + V L D +R +++L+HP++ ++ V + V L
Sbjct: 250 LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERA-VEVACYVCKILD 308
Query: 336 Q 336
Q
Sbjct: 309 Q 309
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-40
Identities = 77/338 (22%), Positives = 125/338 (36%), Gaps = 92/338 (27%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
++Y LG+ LG G FGI D E+G FA K + + RE+DIM+ L
Sbjct: 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK-------NRELDIMKVL 57
Query: 113 PKHQNIVCLKD--------------------------------------TYEDDTAVHLV 134
H NI+ L D + ++++
Sbjct: 58 -DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVE--VVQM------CHKHGVMHRDLKPEN 186
ME L + R+ ++ ++ + Q+ H G+ HRD+KP+N
Sbjct: 117 MEYVPD-TLHKVL----KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQN 171
Query: 187 FLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVL--KRNYGPEVDVWSAG 244
L N + LK DFG + P E + S +Y APE++ Y P +D+WS G
Sbjct: 172 LL-VN-SKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIG 229
Query: 245 VILYILLCGVPPFWAETEQGVAQ-AIIRSVL---------------------DFRRDPWP 282
+ L+ G P F ET + Q I ++ + W
Sbjct: 230 CVFGELILGKPLFSGET--SIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWR 287
Query: 283 KV-----SENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
K+ A DL+ ++L +P R+ + + HP+
Sbjct: 288 KILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF 325
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-40
Identities = 77/302 (25%), Positives = 137/302 (45%), Gaps = 49/302 (16%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
E+ + Y +G G +G D+ +G+ A K +S+ ++ + + RE+ +++H
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-FQSEIFAKRAYRELLLLKH 79
Query: 112 LPKHQNIVCLKD------TYEDDTAVHLVMELCEGGELFD--RIVARGHYTERAAAAVTK 163
+ +H+N++ L D + + +LVM + D +I+ ++E +
Sbjct: 80 M-QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT----DLQKIM-GLKFSEEKIQYLVY 133
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY 223
+++ ++ H GV+HRDLKP N E LK +DFGL+ + + V + +
Sbjct: 134 QMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLARHADA--EMTGYVVTRW 188
Query: 224 YMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF-----------------------W 258
Y APEV+ +Y VD+WS G I+ +L G F
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 248
Query: 259 AETEQGVAQAIIRSVLDFRRDPW----PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPW 314
+ A++ I+S+ R + P+ S A DL+ KML+ D +RLTA Q L HP+
Sbjct: 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 308
Query: 315 LQ 316
+
Sbjct: 309 FE 310
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 8e-40
Identities = 79/302 (26%), Positives = 131/302 (43%), Gaps = 48/302 (15%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
E+ ERY+ +G G +G D + G A K +S+ ++ + + RE+ +++H
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKH 84
Query: 112 LPKHQNIVCLKD------TYEDDTAVHLVMELCEGGELFD--RIVARGHYTERAAAAVTK 163
+ KH+N++ L D + E+ V+LV L D IV T+ +
Sbjct: 85 M-KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIY 139
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY 223
I+ ++ H ++HRDLKP N E LK +DFGL+ + + V + +
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTAD--EMTGYVATRW 194
Query: 224 YMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF-------------------WAETE 262
Y APE++ +Y VD+WS G I+ LL G F AE
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254
Query: 263 QGV----AQAIIRSVLDFRRDPW----PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPW 314
+ + A+ I+S+ + + + A DL+ KML D +R+TA Q L H +
Sbjct: 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314
Query: 315 LQ 316
Sbjct: 315 FA 316
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-39
Identities = 69/337 (20%), Positives = 125/337 (37%), Gaps = 58/337 (17%)
Query: 46 KEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRRE 105
K+ G ++ +E ELG G G+ + + + +G A K I + + RE
Sbjct: 24 KQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRE 81
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
+ ++ IV + D + + ME +GG L + G E+ V+ +
Sbjct: 82 LQVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 140
Query: 166 VEVVQMCH-KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI----VG 220
++ + KH +MHRD+KP N L ++ E +K DFG+S G+ + VG
Sbjct: 141 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVG 192
Query: 221 SPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279
+ YM+PE L+ Y + D+WS G+ L + G P + + V +
Sbjct: 193 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 252
Query: 280 PWPKV----------------------------------------SENAKDLVRKMLDPD 299
P+ S +D V K L +
Sbjct: 253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 312
Query: 300 PKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQ 336
P R +Q++ H +++ + V + + +
Sbjct: 313 PAERADLKQLMVHAFIKRSDA-EEVDFAGWLCSTIGL 348
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-39
Identities = 83/316 (26%), Positives = 125/316 (39%), Gaps = 72/316 (22%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
++ RY +G G +G+ D N A K IS + RE+ I+
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQRTLREIKILLR 81
Query: 112 LPKHQNIVCLKD-----TYEDDTAVHLVMELCEGGELFD--RIVARGHYTE--------- 155
+H+NI+ + D T E V++V +L E D +++ H +
Sbjct: 82 F-RHENIIGINDIIRAPTIEQMKDVYIVQDLMET----DLYKLLKTQHLSNDHICYFLYQ 136
Query: 156 --RAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213
R K I H V+HRDLKP N L N T LK DFGL+ P
Sbjct: 137 ILRG----LKYI-------HSANVLHRDLKPSN-LLLN--TTCDLKICDFGLARVADPDH 182
Query: 214 KFS----EIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF---------- 257
+ E V + +Y APE++ + Y +D+WS G IL +L P F
Sbjct: 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242
Query: 258 ---------WAETEQGV----AQAIIRSVLDFRRDPW----PKVSENAKDLVRKMLDPDP 300
E + A+ + S+ + PW P A DL+ KML +P
Sbjct: 243 HILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNP 302
Query: 301 KRRLTAQQVLEHPWLQ 316
+R+ +Q L HP+L+
Sbjct: 303 HKRIEVEQALAHPYLE 318
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-39
Identities = 81/316 (25%), Positives = 127/316 (40%), Gaps = 58/316 (18%)
Query: 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI 108
G ++ RY + LG G G+ + D + A K I L ++ RE+ I
Sbjct: 5 HGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---LTDPQSVKHALREIKI 61
Query: 109 MRHLPKHQNIVCLKD--------------TYEDDTAVHLVMELCEGGELFD--RIVARGH 152
+R L H NIV + + + + +V++V E E D ++ +G
Sbjct: 62 IRRL-DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET----DLANVLEQGP 116
Query: 153 YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212
E A ++ ++ H V+HRDLKP N LF N E LK DFGL+ P
Sbjct: 117 LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPAN-LFINT-EDLVLKIGDFGLARIMDPH 174
Query: 213 EKFS----EIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF--------- 257
E + + +Y +P +L NY +D+W+AG I +L G F
Sbjct: 175 YSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM 234
Query: 258 ----------WAETEQGV---AQAIIRSVLDFRRDPW----PKVSENAKDLVRKMLDPDP 300
E Q + IR+ + P P +S A D + ++L P
Sbjct: 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSP 294
Query: 301 KRRLTAQQVLEHPWLQ 316
RLTA++ L HP++
Sbjct: 295 MDRLTAEEALSHPYMS 310
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 2e-39
Identities = 72/315 (22%), Positives = 121/315 (38%), Gaps = 66/315 (20%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMR 110
+YE ++G+G FG + R+ G A K K+ + E RE+ I++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREIKILQ 71
Query: 111 HLPKHQNIVCLKD--------TYEDDTAVHLVMELCEG--GELFDRIVARGHYTERAAAA 160
L KH+N+V L + +++LV + CE L + +T
Sbjct: 72 LL-KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKR 128
Query: 161 VTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG 220
V + ++ + H++ ++HRD+K N L LK DFGL+ F +
Sbjct: 129 VMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV---LKLADFGLARAFSLAKNSQP--- 182
Query: 221 SPY--------YMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII 270
+ Y Y PE+L +R+YGP +D+W AG I+ + P TEQ I
Sbjct: 183 NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 242
Query: 271 R-------------------SVLDFRRD---------PWPKVSENAKDLVRKMLDPDPKR 302
+ L+ + A DL+ K+L DP +
Sbjct: 243 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ 302
Query: 303 RLTAQQVLEHPWLQN 317
R+ + L H + +
Sbjct: 303 RIDSDDALNHDFFWS 317
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 6e-39
Identities = 63/292 (21%), Positives = 115/292 (39%), Gaps = 28/292 (9%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+ E ELGRG +G+ +G A K I + + + + ++DI
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV--NSQEQKRLLMDLDISMRTVD 64
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGG--ELFDRIVAR-GHYTERAAAAVTKTIVEVVQM 171
V + V + MEL + + + +++ + E + +IV+ ++
Sbjct: 65 CPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 172 CH-KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI-----VGSPYYM 225
H K V+HRD+KP N L + +K DFG+S G ++ G YM
Sbjct: 125 LHSKLSVIHRDVKPSNVLINALGQ---VKMCDFGIS-----GYLVDDVAKDIDAGCKPYM 176
Query: 226 APEVLK-----RNYGPEVDVWSAGVILYILLCGVPPFWA-ETEQGVAQAIIRSVLDFRRD 279
APE + + Y + D+WS G+ + L P+ + T + ++ +
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE--PSPQL 234
Query: 280 PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVK 331
P K S D + L + K R T ++++HP+ + + VK
Sbjct: 235 PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHES-KGTDVASFVK 285
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 8e-39
Identities = 73/311 (23%), Positives = 128/311 (41%), Gaps = 55/311 (17%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
+ +RY+ + +G G GI D A K +S+ + + RE+ +M+
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKC 117
Query: 112 LPKHQNIVCLKD------TYEDDTAVHLVMELCEGGELFD-RIVARGHYTERAAAAVTKT 164
+ H+NI+ L + T E+ V+LVMEL + + V + + +
Sbjct: 118 V-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA----NLCQVIQMELDHERMSYLLYQ 172
Query: 165 IVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY 224
++ ++ H G++HRDLKP N + K LK +DFGL+ + V + YY
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 229
Query: 225 MAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPF-------------------WAETEQG 264
APEV L Y VD+WS G I+ ++ F E +
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289
Query: 265 V---AQAIIRSVLDFRRDPWPKV----------------SENAKDLVRKMLDPDPKRRLT 305
+ + + + + +PK+ + A+DL+ KML DP +R++
Sbjct: 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 349
Query: 306 AQQVLEHPWLQ 316
L+HP++
Sbjct: 350 VDDALQHPYIN 360
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 9e-39
Identities = 79/271 (29%), Positives = 128/271 (47%), Gaps = 15/271 (5%)
Query: 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDV---RRE 105
G+ I ERY++ +LG G YL D A K+I + E + RE
Sbjct: 5 IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAI---FIPPREKEETLKRFERE 61
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
V L HQNIV + D E+D +LVME EG L + I + G + A T I
Sbjct: 62 VHNSSQL-SHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQI 120
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE--KFSEIVGSPY 223
++ ++ H ++HRD+KP+N L + K LK DFG++ + + ++G+
Sbjct: 121 LDGIKHAHDMRIVHRDIKPQNILIDSNKT---LKIFDFGIAKALSETSLTQTNHVLGTVQ 177
Query: 224 YMAPEVLKRNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAIIRSVLDFRRDPW 281
Y +PE K D++S G++LY +L G PPF ET +A + I SV + D
Sbjct: 178 YFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVR 237
Query: 282 PKVSENAKDLVRKMLDPDPKRR-LTAQQVLE 311
+ ++ +++ + + D R T Q++ +
Sbjct: 238 KDIPQSLSNVILRATEKDKANRYKTIQEMKD 268
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-38
Identities = 83/327 (25%), Positives = 132/327 (40%), Gaps = 86/327 (26%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR---REVDI 108
I ++L LG G +G+ T + G+ A I KK+ RE+ I
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVA---I--KKIEPFDKPLFALRTLREIKI 62
Query: 109 MRHLPKHQNIVCLKD-----TYEDDTAVHLVMELCEGGELFD--RIVARGHYTE------ 155
++H KH+NI+ + + ++E+ V+++ EL + D R+++ ++
Sbjct: 63 LKHF-KHENIITIFNIQRPDSFENFNEVYIIQELMQT----DLHRVISTQMLSDDHIQYF 117
Query: 156 -----RAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210
RA K + H V+HRDLKP N L N LK DFGL+
Sbjct: 118 IYQTLRA----VKVL-------HGSNVIHRDLKPSN-LLIN--SNCDLKVCDFGLARIID 163
Query: 211 PGEKFSEIVGSP-----------YYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVP-- 255
+ +Y APEV+ Y +DVWS G IL L P
Sbjct: 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223
Query: 256 ------------------PFWAETEQGV----AQAIIRSVLDFRRDPW----PKVSENAK 289
P + + A+ I+S+ + P P+V+
Sbjct: 224 PGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGI 283
Query: 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
DL+++ML DP +R+TA++ LEHP+LQ
Sbjct: 284 DLLQRMLVFDPAKRITAKEALEHPYLQ 310
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-38
Identities = 69/275 (25%), Positives = 121/275 (44%), Gaps = 35/275 (12%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
I+ + E+ +GRG FG+ R K ++ K++ + + + E+ +
Sbjct: 4 MIDYKEIEVEEVVGRGAFGVVCKAKWRA-------KDVAIKQIESESERKAFIVELRQLS 56
Query: 111 HLPKHQNIV-----CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
+ H NIV CL LVME EGG L++ + AA
Sbjct: 57 RV-NHPNIVKLYGACLNPVC-------LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWC 108
Query: 166 VEVVQ-MCHKH-----GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIV 219
++ Q + + H ++HRDLKP N L LK DFG + + +
Sbjct: 109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTV--LKICDFGTACDIQ--THMTNNK 164
Query: 220 GSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR 278
GS +MAPEV + + Y + DV+S G+IL+ ++ PF + G A I+ +V + R
Sbjct: 165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF--DEIGGPAFRIMWAVHNGTR 222
Query: 279 DPWPK-VSENAKDLVRKMLDPDPKRRLTAQQVLEH 312
P K + + + L+ + DP +R + +++++
Sbjct: 223 PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-38
Identities = 72/302 (23%), Positives = 131/302 (43%), Gaps = 48/302 (15%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
E+ Y + +G G +G D G A K + + ++ + + RE+ +++H
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKH 80
Query: 112 LPKHQNIVCLKD------TYEDDTAVHLVMELCEGGELFD--RIVARGHYTERAAAAVTK 163
+ +H+N++ L D T +D T +LVM D +++ E +
Sbjct: 81 M-RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT----DLGKLMKHEKLGEDRIQFLVY 135
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY 223
+++ ++ H G++HRDLKP N E LK +DFGL+ + + V + +
Sbjct: 136 QMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQADS--EMTGYVVTRW 190
Query: 224 YMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF-------------------WAETE 262
Y APEV+ Y VD+WS G I+ ++ G F AE
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250
Query: 263 QGV----AQAIIRSVLDFRRDPW----PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPW 314
Q + A+ ++ + + + + S A +L+ KML D ++R+TA + L HP+
Sbjct: 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 310
Query: 315 LQ 316
+
Sbjct: 311 FE 312
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-38
Identities = 74/366 (20%), Positives = 127/366 (34%), Gaps = 86/366 (23%)
Query: 29 DY--GTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACK 86
DY G +H G + RY L R+LG G F +L D N A K
Sbjct: 1 DYRPGGYHPAFKGEPY----------KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMK 50
Query: 87 SI-SKKKLRTAVDIEDVRREVDIMRHL----------PKHQNIVCLKD--TYEDDTAVH- 132
+ K A + E + +++ + +I+ L D ++ VH
Sbjct: 51 IVRGDKVYTEAAEDE-----IKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHV 105
Query: 133 -LVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFL 188
+V E+ G L I H ++K ++ + H+ G++H D+KPEN L
Sbjct: 106 VMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL 164
Query: 189 FANKK---ETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEV-LKRNYGPEVDVWSAG 244
+K D G + + E ++ + + Y +PEV L +G D+WS
Sbjct: 165 MEIVDSPENLIQIKIADLGNACW--YDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTA 222
Query: 245 VILYILLCGVPPFWAETEQGVAQ-----AIIRSVLD----------------FRRDPWPK 283
+++ L+ G F + + A I +L F +
Sbjct: 223 CLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLR 282
Query: 284 VSENAK-----------------------DLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320
K D + ML DP++R A ++ HPWL++
Sbjct: 283 NISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLG 342
Query: 321 APNVSL 326
+ +
Sbjct: 343 MEEIRV 348
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 8e-38
Identities = 66/318 (20%), Positives = 116/318 (36%), Gaps = 68/318 (21%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAV-----DIEDVR--- 103
++ Y + R + G +G D E G A K + D +
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVL 77
Query: 104 REVDIMRHLPKHQNIVCLKD-----TYEDDTAVHLVMELCEGGELFD--RIVARGHYTER 156
RE+ ++ H H NI+ L+D ++LV EL D +++
Sbjct: 78 REIRLLNHF-HHPNILGLRDIFVHFEEPAMHKLYLVTELMR----TDLAQVIHDQRIV-- 130
Query: 157 AAAAVTKTIVE--VVQMC------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208
++ ++ + + H+ GV+HRDL P N L + + DF L+
Sbjct: 131 ----ISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADNNDITICDFNLARE 183
Query: 209 FKPGEKFSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF--------- 257
+ V +Y APE++ + + VD+WSAG ++ + F
Sbjct: 184 DTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243
Query: 258 --------------WAETEQGVAQAIIRSVLDFR-RDPW----PKVSENAKDLVRKMLDP 298
A+ +R+ L W P A DL+ KML+
Sbjct: 244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEF 303
Query: 299 DPKRRLTAQQVLEHPWLQ 316
+P+RR++ +Q L HP+ +
Sbjct: 304 NPQRRISTEQALRHPYFE 321
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-37
Identities = 75/337 (22%), Positives = 130/337 (38%), Gaps = 67/337 (19%)
Query: 46 KEPTGREIEERYE-LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRR 104
+E+ +E G ++GRG +G Y ++ D K + K++ R
Sbjct: 11 LSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDD---KDYALKQIEGTGISMSACR 67
Query: 105 EVDIMRHLPKHQNIVCLKD--TYEDDTAVHLVMELCEG--GELFDRIVARGHYTERAA-- 158
E+ ++R L KH N++ L+ D V L+ + E + A +
Sbjct: 68 EIALLREL-KHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLP 126
Query: 159 AAVTKT----IVEVVQMCHKHGVMHRDLKPENFLFANKK-ETAPLKAIDFGLS-VFFKPG 212
+ K+ I++ + H + V+HRDLKP N L + E +K D G + +F P
Sbjct: 127 RGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 186
Query: 213 EKFS----EIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA 266
+ + +V + +Y APE+L R+Y +D+W+ G I LL P F E
Sbjct: 187 KPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT 245
Query: 267 QA---------IIR---------------------SVLDFRRDPW-------------PK 283
I + DFRR+ + K
Sbjct: 246 SNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVK 305
Query: 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320
A L++K+L DP +R+T++Q ++ P+
Sbjct: 306 PDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPL 342
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-37
Identities = 63/275 (22%), Positives = 117/275 (42%), Gaps = 33/275 (12%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR----TAVDIEDVRREVDIMRHLP 113
E +++G+G FG+ + ++ A KS+ ++ +REV IM +L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL- 80
Query: 114 KHQNIV-----CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV 168
H NIV +VME G+L+ R++ + H + + ++++
Sbjct: 81 NHPNIVKLYGLMHN-------PPRMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDI 131
Query: 169 VQ-MCHKHG----VMHRDLKPENFLFANKKETAP--LKAIDFGLSVFFKPGEKFSEIVGS 221
+ + ++HRDL+ N + E AP K DFGLS S ++G+
Sbjct: 132 ALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV--HSVSGLLGN 189
Query: 222 PYYMAPEVL---KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR 278
+MAPE + + +Y + D +S +ILY +L G P + E G + I + R
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP-FDEYSYGKIKFINMIREEGLR 248
Query: 279 DPWPK-VSENAKDLVRKMLDPDPKRRLTAQQVLEH 312
P+ ++++ DPK+R +++
Sbjct: 249 PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-37
Identities = 69/311 (22%), Positives = 126/311 (40%), Gaps = 55/311 (17%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
+ +RY+ + +G G GI D A K +S+ + + RE+ +M+
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKC 80
Query: 112 LPKHQNIVCLKD------TYEDDTAVHLVMELCEGGELFD-RIVARGHYTERAAAAVTKT 164
+ H+NI+ L + + E+ V++VMEL + + V + + +
Sbjct: 81 V-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQMELDHERMSYLLYQ 135
Query: 165 IVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY 224
++ ++ H G++HRDLKP N + K LK +DFGL+ + V + YY
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 192
Query: 225 MAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPF-------------------WAETEQG 264
APEV L Y VD+WS G I+ ++ G F E +
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252
Query: 265 V---AQAIIRSVLDFRRDPW----------------PKVSENAKDLVRKMLDPDPKRRLT 305
+ + + + + + + A+DL+ KML D +R++
Sbjct: 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 312
Query: 306 AQQVLEHPWLQ 316
+ L+HP++
Sbjct: 313 VDEALQHPYIN 323
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-36
Identities = 73/267 (27%), Positives = 117/267 (43%), Gaps = 19/267 (7%)
Query: 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDV---RRE 105
T + +RYELG LG G +L D + A K + + A D RRE
Sbjct: 6 TPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVL---RADLARDPSFYLRFRRE 62
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVH----LVMELCEGGELFDRIVARGHYTERAAAAV 161
L H IV + DT E +T +VME +G L D + G T + A V
Sbjct: 63 AQNAAAL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV 121
Query: 162 TKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF----SE 217
+ + H++G++HRD+KP N + + T +K +DFG++ +
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTAA 178
Query: 218 IVGSPYYMAPEVLKRNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF 276
++G+ Y++PE + + DV+S G +LY +L G PPF ++ VA +R
Sbjct: 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 238
Query: 277 RRDPWPKVSENAKDLVRKMLDPDPKRR 303
+S + +V K L +P+ R
Sbjct: 239 PSARHEGLSADLDAVVLKALAKNPENR 265
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-35
Identities = 74/334 (22%), Positives = 122/334 (36%), Gaps = 73/334 (21%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSI-SKKKLRTAVDIEDVRREVDIMRH 111
+ RYE+ + +G+G FG D + A K + ++K+ E + I+ H
Sbjct: 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE-----IRILEH 149
Query: 112 LPKHQ-----NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKT 164
L K N++ + + + + + EL L++ I ++ +
Sbjct: 150 LRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHS 208
Query: 165 IVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY 224
I++ + HK+ ++H DLKPEN L + + +K IDFG S + ++ + S +Y
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSG-IKVIDFGSSCY--EHQRVYTYIQSRFY 265
Query: 225 MAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII------------- 270
APEV L YG +D+WS G IL LL G P E E +I
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA 325
Query: 271 --------------RSVLDFRRDPWPKVSENAKDL------------------------- 291
R V +
Sbjct: 326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLF 385
Query: 292 ---VRKMLDPDPKRRLTAQQVLEHPWLQNAKKAP 322
+++ L+ DP R+T Q L HPWL+ P
Sbjct: 386 LDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKP 419
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-34
Identities = 37/265 (13%), Positives = 67/265 (25%), Gaps = 34/265 (12%)
Query: 48 PTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVD 107
P R RY L G + D A + + + +++
Sbjct: 24 PGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTL 83
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE 167
+ + + + D +V E GG L + VA + A +++
Sbjct: 84 RLSRI-DKPGVARVLDVVHTRAGGLVVAEWIRGGSLQE--VADTSPSPVGAIRAMQSLAA 140
Query: 168 VVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAP 227
H+ GV P + G V + P M
Sbjct: 141 AADAAHRAGVALSIDHPSRVRVS-----------IDGDVV-----------LAYPATMPD 178
Query: 228 EVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW---PKV 284
P+ D+ G LY LL P + R +P +
Sbjct: 179 A------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDI 232
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQV 309
+ + + D R + +
Sbjct: 233 PFQISAVAARSVQGDGGIRSASTLL 257
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-34
Identities = 70/339 (20%), Positives = 120/339 (35%), Gaps = 80/339 (23%)
Query: 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSI-SKKKLRTAVDIEDVRREVDI 108
G + + + R++G G FG LC +N +A K + + KK + IE DI
Sbjct: 30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE-----ADI 84
Query: 109 MRHL----PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVT 162
++ + + NIV + + L+ E G L++ I + +
Sbjct: 85 LKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYC 143
Query: 163 KTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAP----------------------LKA 200
I++ + K + H DLKPEN L + +K
Sbjct: 144 IEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 201 IDFGLSVFFKPGEKFSEIVGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWA 259
IDFG + F + I+ + Y APEV L + D+WS G +L L G F
Sbjct: 204 IDFGCATF--KSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT 261
Query: 260 ETEQ-------GVAQAIIRSVLD----------FRRDP----WPKVSENAK--------- 289
+ Q I +++L +D WP+ + +
Sbjct: 262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCL 321
Query: 290 ------------DLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
D + +L DP R + ++L+H +L+
Sbjct: 322 PLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 58/280 (20%), Positives = 116/280 (41%), Gaps = 44/280 (15%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
E+G +G+G FG Y +G+ A + I ++ ++ +REV R +H+N
Sbjct: 36 EIGELIGKGRFGQVYHGR--WHGEV-AIRLIDIERD-NEDQLKAFKREVMAYRQT-RHEN 90
Query: 118 IV-----CLKDTYEDDTAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTKTIVEVVQM 171
+V C+ + + ++ LC+G L+ + A+ + + IV+ +
Sbjct: 91 VVLFMGACMSPPH-----LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGY 145
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP------GEKFSEIVGSPYYM 225
H G++H+DLK +N + N K + DFGL +K G ++
Sbjct: 146 LHAKGILHKDLKSKNVFYDNGK----VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHL 201
Query: 226 APEVLKRN----------YGPEVDVWSAGVILYILLCGVPPFWAETEQGV-AQAIIRSVL 274
APE++++ + DV++ G I Y L PF + A+AII +
Sbjct: 202 APEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF-----KTQPAEAIIWQMG 256
Query: 275 DFRRDPWPKVS--ENAKDLVRKMLDPDPKRRLTAQQVLEH 312
+ ++ + D++ + + R T ++++
Sbjct: 257 TGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-33
Identities = 62/265 (23%), Positives = 107/265 (40%), Gaps = 22/265 (8%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
+ ++G G FG + G A K + ++ A + + REV IM+ L +H N
Sbjct: 40 NIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDF-HAERVNEFLREVAIMKRL-RHPN 95
Query: 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ-MCHKHG 176
IV + +V E G L+ + G + +V + M + H
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 177 ----VMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLK 231
++HR+LK N L K +K DFGLS + G+P +MAPEVL+
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYT---VKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR 212
Query: 232 RN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGV--AQAIIRSVLDFRRDPWPK-VSEN 287
+ DV+S GVIL+ L P+ + AQ + +R P+ ++
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPW-----GNLNPAQVVAAVGFKCKRLEIPRNLNPQ 267
Query: 288 AKDLVRKMLDPDPKRRLTAQQVLEH 312
++ +P +R + +++
Sbjct: 268 VAAIIEGCWTNEPWKRPSFATIMDL 292
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-33
Identities = 74/331 (22%), Positives = 125/331 (37%), Gaps = 74/331 (22%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAF-ACKSI-SKKKLRTAVDIEDVRREVDIMR 110
++ERYE+ LG G FG C D G + A K I + K R A R E+++++
Sbjct: 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA-----RLEINVLK 71
Query: 111 HLPKH-----QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTK 163
+ + V + D + + + EL G F+ + Y +
Sbjct: 72 KIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAY 130
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAP----------------LKAIDFGLSV 207
+ ++ H++ + H DLKPEN LF N + ++ DFG +
Sbjct: 131 QLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190
Query: 208 FFKPGEKFSEIVGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA 266
F E + IV + +Y PEV L+ + DVWS G IL+ G F +
Sbjct: 191 F--DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248
Query: 267 QAIIR-------SVLD-------FRRD--PWPKVSENAK--------------------- 289
+ + ++ F + W + S + +
Sbjct: 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHV 308
Query: 290 ---DLVRKMLDPDPKRRLTAQQVLEHPWLQN 317
DL+R+ML+ DP +R+T + L HP+
Sbjct: 309 QLFDLMRRMLEFDPAQRITLAEALLHPFFAG 339
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-33
Identities = 62/251 (24%), Positives = 104/251 (41%), Gaps = 8/251 (3%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
Y L R +GRG G Y D A K +S+ V ++RE L +
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QE 93
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH 175
++V + D E D +++ M L G +L + +G A A+ + I + H
Sbjct: 94 PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA 153
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE--KFSEIVGSPYYMAPEVLKRN 233
G HRD+KPEN L + +DFG++ + + VG+ YYMAPE +
Sbjct: 154 GATHRDVKPENILVS---ADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSES 210
Query: 234 Y-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
+ D+++ +LY L G PP+ + V A I + P + ++
Sbjct: 211 HATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAIPRPSTVRPGIPVAFDAVI 269
Query: 293 RKMLDPDPKRR 303
+ + +P+ R
Sbjct: 270 ARGMAKNPEDR 280
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 8e-33
Identities = 79/335 (23%), Positives = 122/335 (36%), Gaps = 74/335 (22%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAF-ACKSI-SKKKLRTAVDIEDVRREVDIMR 110
+ RYE+ LG G FG C D + G A K + + + A E + ++
Sbjct: 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE-----IQVLE 66
Query: 111 HLPKH-----QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTK 163
HL V + + +E + +V EL G +D I G + +
Sbjct: 67 HLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAY 125
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAP----------------LKAIDFGLSV 207
I + V H + + H DLKPEN LF T +K +DFG +
Sbjct: 126 QICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSAT 185
Query: 208 FFKPGEKFSEIVGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQG-- 264
+ E S +V + +Y APEV L + DVWS G IL G F +
Sbjct: 186 Y--DDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243
Query: 265 --------------VAQAIIRSVLDFRRDPWPKVSENAK--------------------- 289
+ + R R W + S +
Sbjct: 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHE 303
Query: 290 ---DLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKA 321
DL++KML+ DP +R+T ++ L+HP+ KK+
Sbjct: 304 RLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-32
Identities = 82/348 (23%), Positives = 133/348 (38%), Gaps = 103/348 (29%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
+ +YEL ++LG+G +GI + DR G+ A K I + + D + RE+ I+
Sbjct: 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILTE 64
Query: 112 LPKHQNIVCLKD--TYEDDTAVHLVMELCE--------GGELFDRIVARGHYTERAAAAV 161
L H+NIV L + ++D V+LV + E L H
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPV-----HK-------- 111
Query: 162 TKTIVEVVQMC------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF 215
+ + V Q+ H G++HRD+KP N + N +K DFGLS F +
Sbjct: 112 -QYV--VYQLIKVIKYLHSGGLLHRDMKPSN-ILLN--AECHVKVADFGLSRSFVNIRRV 165
Query: 216 SEIVGSP----------------------YYMAPEVL--KRNYGPEVDVWSAGVILYILL 251
+ + +Y APE+L Y +D+WS G IL +L
Sbjct: 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL 225
Query: 252 CGVPPF-------------------WAETEQGV----AQAIIRSVLDFRRDPW------- 281
CG P F E + + A+ +I S+ +
Sbjct: 226 CGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIF 285
Query: 282 -------------PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
+E A DL+ K+L +P +R++A L+HP++
Sbjct: 286 TKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVS 333
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-32
Identities = 76/271 (28%), Positives = 113/271 (41%), Gaps = 29/271 (10%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR-TAVDIEDVRREVDIMRHLPKHQ 116
L +G G FG Y GD A K+ + IE+VR+E + L KH
Sbjct: 10 TLEEIIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHP 66
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ-MCHKH 175
NI+ L+ + + LVME GG L + + V++ + M + H
Sbjct: 67 NIIALRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLH 122
Query: 176 G-----VMHRDLKPENFLFANKKETAP-----LKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
++HRDLK N L K E LK DFGL+ + K S G+ +M
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGAYAWM 181
Query: 226 APEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGV--AQAIIRSVLDFRRDPWP 282
APEV++ + + DVWS GV+L+ LL G PF +G+ ++ P P
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEVPF-----RGIDGLAVAYGVAMNKLALPIP 236
Query: 283 K-VSENAKDLVRKMLDPDPKRRLTAQQVLEH 312
E L+ +PDP R + +L+
Sbjct: 237 STCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-32
Identities = 73/357 (20%), Positives = 129/357 (36%), Gaps = 103/357 (28%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
+ + Y + +GRG +G YL D+ A K ++ + +D + + RE+ I+
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-RMFEDLIDCKRILREITILNR 81
Query: 112 LPKHQNIVCLKD-----TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIV 166
L K I+ L D +++V+E+ + +L TE KTI
Sbjct: 82 L-KSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTE----EHIKTI- 134
Query: 167 EVVQMC------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG 220
+ + H+ G++HRDLKP N L N + +K DFGL+ + + +
Sbjct: 135 -LYNLLLGENFIHESGIIHRDLKPANCL-LN--QDCSVKVCDFGLARTINSEKDTNIVND 190
Query: 221 SP-----------------------YYMAPEVL--KRNYGPEVDVWSAGVILYILLC--- 252
+Y APE++ + NY +D+WS G I LL
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250
Query: 253 --------------GVPPFWAETEQGVAQAIIRSVLD----------------------- 275
G F ++ + +S D
Sbjct: 251 SHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKP 310
Query: 276 -----------FRRDPW----PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317
+ P +S++ +L+ ML +P +R+T Q L+HP+L++
Sbjct: 311 EVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-31
Identities = 65/324 (20%), Positives = 113/324 (34%), Gaps = 48/324 (14%)
Query: 51 REIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIM 109
R G LG+G FG T RE G+ K + + +EV +M
Sbjct: 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVM 61
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV 169
R L +H N++ D ++ + E +GG L I + + V
Sbjct: 62 RCL-EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQY---------PWSQRV 111
Query: 170 QMC----------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS------------- 206
H ++HRDL N L + + DFGL+
Sbjct: 112 SFAKDIASGMAYLHSMNIIHRDLNSHNCLV-RENKNV--VVADFGLARLMVDEKTQPEGL 168
Query: 207 --VFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ 263
+ +K +VG+PY+MAPE++ R+Y +VDV+S G++L ++ V
Sbjct: 169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD--PDYL 226
Query: 264 GVAQAIIRSVLDFRRDPWPK-VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAP 322
+V F P + + + D DP++R + ++ WL+ +
Sbjct: 227 PRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLRMHL 284
Query: 323 NVSLGETVKARLKQFSVMNKLKKR 346
L + ++
Sbjct: 285 AGHLPLGPQLEQLDRGFWETYRRG 308
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-31
Identities = 73/338 (21%), Positives = 121/338 (35%), Gaps = 80/338 (23%)
Query: 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSI-SKKKLRTAVDIEDVRREVDI 108
G + +RYE+ +G+G FG DR + A K I +KK + EV +
Sbjct: 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA-----QIEVRL 103
Query: 109 MRHLPKH-----QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAV 161
+ + KH IV LK + + LV E+ L+D + +
Sbjct: 104 LELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKF 162
Query: 162 TKTIVEVVQMCH--KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIV 219
+ + + + ++H DLKPEN L N K +A +K +DFG S G++ + +
Sbjct: 163 AQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSA-IKIVDFGSSCQL--GQRIYQYI 219
Query: 220 GSPYYMAPEV-LKRNYGPEVDVWSA---------GVILY------------ILLCGVPPF 257
S +Y +PEV L Y +D+WS G L+ + + G+PP
Sbjct: 220 QSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPA 279
Query: 258 W----------------------------AETEQGVAQAIIRSVLDFRRDPWPKVSENA- 288
+ + ++L
Sbjct: 280 HILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGES 339
Query: 289 ----------KDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
KDL+ +MLD DPK R+ L+H + +
Sbjct: 340 GHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFK 377
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-30
Identities = 41/270 (15%), Positives = 93/270 (34%), Gaps = 33/270 (12%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
+L G + + G+ K + + + D E +R H N
Sbjct: 13 NFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIF-SHPN 68
Query: 118 IV-----CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ-M 171
++ C L+ G L++ + ++ + AV K +++ + M
Sbjct: 69 VLPVLGACQS---PPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAV-KFALDMARGM 124
Query: 172 CHKHG----VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAP 227
H + L + + + + F+ + + +P ++AP
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDM---TARISMADVKFSFQSPGR----MYAPAWVAP 177
Query: 228 EVLKR----NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283
E L++ D+WS V+L+ L+ PF + + ++ L+ R P
Sbjct: 178 EALQKKPEDTNRRSADMWSFAVLLWELVTREVPF---ADLSNMEIGMKVALEGLRPTIPP 234
Query: 284 -VSENAKDLVRKMLDPDPKRRLTAQQVLEH 312
+S + L++ ++ DP +R ++
Sbjct: 235 GISPHVSKLMKICMNEDPAKRPKFDMIVPI 264
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-30
Identities = 65/284 (22%), Positives = 111/284 (39%), Gaps = 57/284 (20%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
+G+ +G G FG Y +GD A K ++ T ++ + EV ++R +H N
Sbjct: 27 TVGQRIGSGSFGTVYKGK--WHGDV-AVKMLNVTAP-TPQQLQAFKNEVGVLRKT-RHVN 81
Query: 118 IV-----CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC 172
I+ +V + CEG L+ + A E + +++ +
Sbjct: 82 ILLFMGYSTAPQL------AIVTQWCEGSSLYHHLHASETKFE---------MKKLIDIA 126
Query: 173 ----------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI---V 219
H ++HRDLK N +F ++ T +K DFGL+ +
Sbjct: 127 RQTARGMDYLHAKSIIHRDLKSNN-IFLHEDNT--VKIGDFGLATEKSRWSGSHQFEQLS 183
Query: 220 GSPYYMAPEVLKRN----YGPEVDVWSAGVILYILLCGVPPFWAETEQGV--AQAIIRSV 273
GS +MAPEV++ Y + DV++ G++LY L+ G P+ + II V
Sbjct: 184 GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY-----SNINNRDQIIEMV 238
Query: 274 L-DFRRDPWPKVSENA----KDLVRKMLDPDPKRRLTAQQVLEH 312
KV N K L+ + L R + ++L
Sbjct: 239 GRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE 282
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 76/379 (20%), Positives = 128/379 (33%), Gaps = 101/379 (26%)
Query: 32 THHQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKK 91
HH + + +I +RYE+ +G G +G D+ A K I +
Sbjct: 32 QHHSSKPTASMPRPH--SDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-R 88
Query: 92 KLRTAVDIEDVRREVDIMRHLPKHQNIVCLKD-----TYEDDTAVHLVMELCEGGELFDR 146
+D + + RE+ I+ L H ++V + D E +++V+E+ + +
Sbjct: 89 VFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKL 146
Query: 147 IVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206
+ TE + ++ V+ H G++HRDLKP N L N + +K DFGL+
Sbjct: 147 FRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCL-VN--QDCSVKVCDFGLA 203
Query: 207 -VFFKPGEKFSEIVGSP---------------------------YYMAPEVL--KRNYGP 236
P S++ SP +Y APE++ + NY
Sbjct: 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTE 263
Query: 237 EVDVWSAGVILYILLCGVPPFWAETEQG-------------VAQAIIRSVLDFRRDP--- 280
+DVWS G I LL + A Q R
Sbjct: 264 AIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQ 323
Query: 281 ---------------WPKV-SENAKDLVR--------------------------KMLDP 298
+ E+AK +R +ML
Sbjct: 324 LNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVF 383
Query: 299 DPKRRLTAQQVLEHPWLQN 317
+P +R+T + L HP+ +
Sbjct: 384 NPNKRITINECLAHPFFKE 402
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 63/305 (20%), Positives = 115/305 (37%), Gaps = 57/305 (18%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI-- 108
R + L +G+G +G + + + G+ A K S + D + RE ++
Sbjct: 4 RTVARDITLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSR------DEKSWFRETELYN 55
Query: 109 MRHLPKHQNIVCL----KDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKT 164
L +H+NI+ + T + L+ E G L+D + + + +
Sbjct: 56 TVML-RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYD-YLQLTTLDTVSCLRIVLS 113
Query: 165 IV--------EVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS 216
I E+ K + HRDLK +N L + D GL+V
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ---CCIADLGLAVMHSQSTNQL 170
Query: 217 EI-----VGSPYYMAPEVLK-------RNYGPEVDVWSAGVILYILLCGV---------- 254
++ VG+ YMAPEVL + VD+W+ G++L+ + +
Sbjct: 171 DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230
Query: 255 PPFWAETEQGVAQAIIRS--VLDFRRDPWPKVSENA------KDLVRKMLDPDPKRRLTA 306
PPF+ + +R +D +R P + L+++ +P RLTA
Sbjct: 231 PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTA 290
Query: 307 QQVLE 311
++ +
Sbjct: 291 LRIKK 295
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 5e-28
Identities = 66/305 (21%), Positives = 111/305 (36%), Gaps = 57/305 (18%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI-- 108
R I L +G+G FG + R G+ A K S + + RE +I
Sbjct: 38 RTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR------EERSWFREAEIYQ 89
Query: 109 MRHLPKHQNIVCLK--DTYEDDTAVH--LVMELCEGGELFDRIVARGHYTERAAAAVTKT 164
L +H+NI+ D ++ T LV + E G LFD + R T + +
Sbjct: 90 TVML-RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFD-YLNRYTVTVEGMIKLALS 147
Query: 165 IV--------EVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS 216
E+V K + HRDLK +N L K+ D GL+V
Sbjct: 148 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTI 204
Query: 217 EI-----VGSPYYMAPEVLKRNYGPE-------VDVWSAGVILYILLCGV---------- 254
+I VG+ YMAPEVL + + D+++ G++ + +
Sbjct: 205 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264
Query: 255 PPFWAETEQGVAQAIIRS--VLDFRRDPWPKVSENA------KDLVRKMLDPDPKRRLTA 306
P++ + +R R P ++ ++R+ + RLTA
Sbjct: 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 324
Query: 307 QQVLE 311
++ +
Sbjct: 325 LRIKK 329
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-27
Identities = 63/325 (19%), Positives = 113/325 (34%), Gaps = 83/325 (25%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI--MRHLPKH 115
++ +++G+G +G ++ R G+ A K + RE +I + +H
Sbjct: 40 QMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT------EEASWFRETEIYQTVLM-RH 90
Query: 116 QNIVCL----KDTYEDDTAVHLVMELCEGGELFDRI----------------VARG---- 151
+NI+ T ++L+ + E G L+D + G
Sbjct: 91 ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHL 150
Query: 152 HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211
H E+ K + HRDLK +N L K+ D GL+V F
Sbjct: 151 H-------------TEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFIS 194
Query: 212 GEKFSEI-----VGSPYYMAPEVLKRNYGPE-------VDVWSAGVILYILLCGV----- 254
+I VG+ YM PEVL + D++S G+IL+ +
Sbjct: 195 DTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGI 254
Query: 255 -----PPFWAETEQGVAQAIIRS--VLDFRRDPWPKVSENA------KDLVRKMLDPDPK 301
P+ + +R + R +P + L+ + +P
Sbjct: 255 VEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPA 314
Query: 302 RRLTAQQVLEHPWLQNAKKAPNVSL 326
RLTA +V + L ++ ++ L
Sbjct: 315 SRLTALRVKKT--LAKMSESQDIKL 337
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-27
Identities = 71/374 (18%), Positives = 120/374 (32%), Gaps = 114/374 (30%)
Query: 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIM 109
G RY + R+LG G F +L D + A K + K E E+ ++
Sbjct: 32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVK---SAEHYTETALDEIRLL 87
Query: 110 RHL-------PKHQNIVCLKDTYEDD--TAVH--LVMELCEGGELFDRIVARGH--YTER 156
+ + P + +V L D ++ H +V E+ G L I+ +
Sbjct: 88 KSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLP 146
Query: 157 AAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFA------------------------- 190
+ + +++ + H ++H D+KPEN L +
Sbjct: 147 CVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206
Query: 191 ---------------------NKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEV 229
E +K D G + + + F+E + + Y + EV
Sbjct: 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW--VHKHFTEDIQTRQYRSLEV 264
Query: 230 -LKRNYGPEVDVWSAGVILYILLCGVPPF-------WAETEQGVAQAII----------- 270
+ Y D+WS + + L G F + E +A II
Sbjct: 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIAL-IIELLGKVPRKLI 323
Query: 271 ----RSVLDFRRD----------PWPKVS----------ENAK---DLVRKMLDPDPKRR 303
S F + PW E A D + ML+ P++R
Sbjct: 324 VAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKR 383
Query: 304 LTAQQVLEHPWLQN 317
TA + L HPWL +
Sbjct: 384 ATAAECLRHPWLNS 397
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-26
Identities = 69/307 (22%), Positives = 114/307 (37%), Gaps = 75/307 (24%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
+L RG FG + + A K EV + + KH+N
Sbjct: 27 QLLEVKARGRFGCVWKAQLL--NEYVAVKIFPI----QDKQSWQNEYEVYSLPGM-KHEN 79
Query: 118 IV-----CLKDTYEDDTAVHLVMELCEGGELFD-------------RI---VARG----H 152
I+ + T D + L+ E G L D I +ARG H
Sbjct: 80 ILQFIGAEKRGT-SVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLH 138
Query: 153 YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212
+ ++ HK + HRD+K +N L N DFGL++ F+ G
Sbjct: 139 -----------EDIPGLKDGHKPAISHRDIKSKNVLLKNNLT---ACIADFGLALKFEAG 184
Query: 213 EKFSEI---VGSPYYMAPEVL------KRNYGPEVDVWSAGVILYILLCG---------- 253
+ + VG+ YMAPEVL +R+ +D+++ G++L+ L
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244
Query: 254 -VPPFWAET-EQGVAQAIIRSVLDFRRDP-----WPKVSENAK--DLVRKMLDPDPKRRL 304
+ PF E + + + V+ ++ P W K + A + + + D D + RL
Sbjct: 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304
Query: 305 TAQQVLE 311
+A V E
Sbjct: 305 SAGCVGE 311
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 67/322 (20%), Positives = 106/322 (32%), Gaps = 61/322 (18%)
Query: 33 HHQGNGGHKLCVLKEPTGREIE--------ERYELGRELGRGEFGITYLCTDRENGDAFA 84
H R + E LG ++GRG FG + R + A
Sbjct: 84 HLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVA 143
Query: 85 CKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELF 144
KS ++ +E I++ H NIV L +++VMEL +GG+
Sbjct: 144 VKSC--RETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 200
Query: 145 DRIVARGHYTERAAAAVTKTIVEVVQMC----------HKHGVMHRDLKPENFLFANKKE 194
+ G + ++QM +HRDL N L K
Sbjct: 201 TFLRTEGARL---------RVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV 251
Query: 195 TAPLKAIDFGLSVFFKPGEKFSEIVGSPYY------------MAPEVLKRN-YGPEVDVW 241
LK DFG+S E Y APE L Y E DVW
Sbjct: 252 ---LKISDFGMS---------REEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVW 299
Query: 242 SAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
S G++L+ G P+ + Q + + + R + L+ + +P
Sbjct: 300 SFGILLWETFSLGASPYPNLSNQQTREFVEK---GGRLPCPELCPDAVFRLMEQCWAYEP 356
Query: 301 KRRLTAQQVLEHPWLQNAKKAP 322
+R + + + LQ+ +K
Sbjct: 357 GQRPSFSTIYQ--ELQSIRKRH 376
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 4e-22
Identities = 62/309 (20%), Positives = 103/309 (33%), Gaps = 68/309 (22%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK--H 115
+L +GRG +G Y + A K S + ++ E +I R +P H
Sbjct: 16 KLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFA------NRQNFINEKNIYR-VPLMEH 66
Query: 116 QNIV-----CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIV---- 166
NI + T + LVME G L ++ ++ + ++
Sbjct: 67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXK-YLSLHTSDWVSSCRLAHSVTRGLA 125
Query: 167 -----EVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE---- 217
+K + HRDL N L K DFGLS+
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 218 -----IVGSPYYMAPEVLK--------RNYGPEVDVWSAGVILYILLCGV---------- 254
VG+ YMAPEVL+ + +VD+++ G+I + +
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242
Query: 255 ---PPFWAETEQGVAQAIIRSVLDFRR------DPWPKVSENAKDLVRKML---DPDPKR 302
F E ++ ++ + + W + S + L + D D +
Sbjct: 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEA 302
Query: 303 RLTAQQVLE 311
RLTAQ E
Sbjct: 303 RLTAQXAEE 311
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 63/302 (20%), Positives = 112/302 (37%), Gaps = 50/302 (16%)
Query: 33 HHQGNGGHKLCVLKEPTGR----------------EIE-ERYELGRELGRGEFGITYLCT 75
HH + L P + E+E + +LG G++G Y
Sbjct: 181 HHSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGV 240
Query: 76 DRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135
++ A K++ + +++E+ +E +M+ + KH N+V L + +++
Sbjct: 241 WKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIIT 295
Query: 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC----------HKHGVMHRDLKPE 185
E G L D + R + V ++ M K +HR+L
Sbjct: 296 EFMTYGNLLDYL--------RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAAR 347
Query: 186 NFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGS-PY-YMAPEVLK-RNYGPEVDVWS 242
N L E +K DFGLS + P + APE L + + DVW+
Sbjct: 348 NCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 404
Query: 243 AGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPK 301
GV+L+ I G+ P+ V + + + D+R + E +L+R +P
Sbjct: 405 FGVLLWEIATYGMSPYPGIDLSQVYELLEK---DYRMERPEGCPEKVYELMRACWQWNPS 461
Query: 302 RR 303
R
Sbjct: 462 DR 463
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 61/299 (20%), Positives = 102/299 (34%), Gaps = 63/299 (21%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAF---ACKSISKKKLRTAVDIEDVRREVD 107
I +++ LGR LG+GEFG ++ +F A K + K + + DIE+ RE
Sbjct: 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAA 77
Query: 108 IMRHLPKHQNIVCL------KDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAV 161
M+ H ++ L +++ + G+L ++A
Sbjct: 78 CMKEF-DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL-- 134
Query: 162 TKTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211
+ +V+ +HRDL N + A E + DFGLS
Sbjct: 135 --PLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA---EDMTVCVADFGLS----- 184
Query: 212 GEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPF 257
+I YY +A E L Y DVW+ GV ++ I+ G P+
Sbjct: 185 ----RKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY 240
Query: 258 WAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQQVLEH 312
+ ++ R P + V M DPK+R + +
Sbjct: 241 AGIENAEI----YNYLIGGNRLKQP---PECMEEVYDLMYQCWSADPKQRPSFTCLRME 292
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-19
Identities = 62/322 (19%), Positives = 109/322 (33%), Gaps = 67/322 (20%)
Query: 33 HHQGNGGHKLCVLKEPTGREIE------ERYELGRELGRGEFGITYLCTDRENGDAF--- 83
HH + + E ++E LG+ LG GEFG ++
Sbjct: 6 HHHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKV 65
Query: 84 ACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI-----VCLKDTYEDDTAVHLVMELC 138
A K++ K + +IE+ E M+ H N+ VC++ + + +++
Sbjct: 66 AVKTM-KLDNSSQREIEEFLSEAACMKDF-SHPNVIRLLGVCIEMSSQGIPKPMVILPFM 123
Query: 139 EGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH----------KHGVMHRDLKPENFL 188
+ G+L ++ T + +++ +HRDL N +
Sbjct: 124 KYGDLHTYLLYSRLETGPKHI----PLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCM 179
Query: 189 FANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY------------MAPEVLK-RNYG 235
+ + DFGLS +I YY +A E L R Y
Sbjct: 180 LR---DDMTVCVADFGLS---------KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT 227
Query: 236 PEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK 294
+ DVW+ GV ++ I G+ P+ + +L R P E+ D + +
Sbjct: 228 SKSDVWAFGVTMWEIATRGMTPYPGVQNHEM----YDYLLHGHRLKQP---EDCLDELYE 280
Query: 295 -MLD---PDPKRRLTAQQVLEH 312
M DP R T +
Sbjct: 281 IMYSCWRTDPLDRPTFSVLRLQ 302
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 5e-19
Identities = 67/244 (27%), Positives = 95/244 (38%), Gaps = 49/244 (20%)
Query: 33 HHQGNGGHKLCVLKEPTG--REIEERY-ELGRELGRGEFGITYLCTDRENGDAF----AC 85
HH + L VL + G +RY + R+LG G FG L D A
Sbjct: 6 HHHHHHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAV 65
Query: 86 KSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKD--TYEDDTAVHLVMELCEGGEL 143
K++ K ++E+DI+R L H++I+ K ++ LVME G L
Sbjct: 66 KAL--KADAGPQHRSGWKQEIDILRTL-YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSL 122
Query: 144 FDRIVARGHYTERAAAAVTKTIVEVVQMC------HKHGVMHRDLKPENFLFANKKETAP 197
D Y R + + + ++ Q+C H +HRDL N L N +
Sbjct: 123 RD-------YLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL--- 172
Query: 198 LKAIDFGLSVFFKPGEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAG 244
+K DFGL+ G + YY APE LK + DVWS G
Sbjct: 173 VKIGDFGLAKAVPEGHE--------YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFG 224
Query: 245 VILY 248
V LY
Sbjct: 225 VTLY 228
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-18
Identities = 61/296 (20%), Positives = 112/296 (37%), Gaps = 58/296 (19%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCT--DRENGDAF---ACKSISKKKLRTAVDIEDVRRE 105
E+ E+ + RELG+G FG+ Y + A K++ + + + + E
Sbjct: 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNE 78
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
+M+ ++V L ++MEL G+L + + ++
Sbjct: 79 ASVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 166 VEVVQMCH-----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214
+++QM V HRDL N + A +K DFG++
Sbjct: 138 SKMIQMAGEIADGMAYLNANKFV-HRDLAARNCMVAEDFT---VKIGDFGMT-------- 185
Query: 215 FSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAE 260
+I + YY M+PE LK + DVWS GV+L+ I P+
Sbjct: 186 -RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244
Query: 261 TEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQQVLEH 312
+ + V +R V++ P +N D++ + M +PK R + +++
Sbjct: 245 SNEQV----LRFVMEGGLLDKP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-18
Identities = 69/312 (22%), Positives = 110/312 (35%), Gaps = 58/312 (18%)
Query: 51 REIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIE--DVRREVD 107
I+ L ELG G FG +L ++ K L+ A + D +RE +
Sbjct: 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAE 95
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFD-----RIVARGHYTERAAAAVT 162
++ L +HQ+IV + + +V E G+L A+ A
Sbjct: 96 LLTML-QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 154
Query: 163 KTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212
+ +++ + +HRDL N L +K DFG+S
Sbjct: 155 LGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV---VKIGDFGMS------ 205
Query: 213 EKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFW 258
+I + YY M PE + R + E DVWS GV+L+ I G P++
Sbjct: 206 ---RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY 262
Query: 259 AETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQQVLEHPW 314
+ I + R P V M +P++R + + V
Sbjct: 263 QLSNTEA----IDCITQGRELERP---RACPPEVYAIMRGCWQREPQQRHSIKDVHAR-- 313
Query: 315 LQNAKKAPNVSL 326
LQ +AP V L
Sbjct: 314 LQALAQAPPVYL 325
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-18
Identities = 49/248 (19%), Positives = 86/248 (34%), Gaps = 61/248 (24%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAF----ACKSISKKKLRTAVDIEDVRREVDIM 109
E ++ + LG G FG Y G+ A K + ++ + +++ E +M
Sbjct: 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVM 71
Query: 110 RHLPKHQNI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKT 164
+ + ++ +CL T V L+ +L G L D +
Sbjct: 72 ASV-DNPHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKD---------NIG 115
Query: 165 IVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214
++ C ++HRDL N L + +K DFGL+ EK
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEK 172
Query: 215 FSEIVGSPYY-----------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAET 261
Y MA E + R Y + DVWS GV ++ ++ G P+
Sbjct: 173 --------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224
Query: 262 EQGVAQAI 269
++ +
Sbjct: 225 ASEISSIL 232
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-18
Identities = 66/308 (21%), Positives = 112/308 (36%), Gaps = 60/308 (19%)
Query: 52 EIE-ERYELGRELGRGEFGITY--LCTDRENGDAF---ACKSISKKKLRTAVDIEDVRRE 105
E+ + L R LG G FG Y + N + A K++ ++ + D D E
Sbjct: 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLME 83
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
I+ HQNIV ++MEL GG+L + + + + +
Sbjct: 84 ALIISKF-NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPS---SLAM 139
Query: 166 VEVVQMCH-----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214
++++ + H + HRD+ N L K DFG++
Sbjct: 140 LDLLHVARDIACGCQYLEENHFI-HRDIAARNCLLTCPGPGRVAKIGDFGMA-------- 190
Query: 215 FSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAE 260
+I + YY M PE + + D WS GV+L+ I G P+ ++
Sbjct: 191 -RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249
Query: 261 TEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQQVLEHPWLQ 316
+ Q V + V R P +N V + M P+ R +LE ++
Sbjct: 250 SNQEV----LEFVTSGGRMDPP---KNCPGPVYRIMTQCWQHQPEDRPNFAIILER--IE 300
Query: 317 NAKKAPNV 324
+ P+V
Sbjct: 301 YCTQDPDV 308
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 5e-18
Identities = 65/308 (21%), Positives = 112/308 (36%), Gaps = 60/308 (19%)
Query: 52 EIE-ERYELGRELGRGEFGITY--LCTDRENGDAF---ACKSISKKKLRTAVDIEDVRRE 105
E+ + L R LG G FG Y + N + A K++ ++ + D D E
Sbjct: 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLME 124
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
I+ HQNIV +++EL GG+L + + ++ +
Sbjct: 125 ALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL---AM 180
Query: 166 VEVVQMCH-----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214
++++ + H + HRD+ N L K DFG++
Sbjct: 181 LDLLHVARDIACGCQYLEENHFI-HRDIAARNCLLTCPGPGRVAKIGDFGMA-------- 231
Query: 215 FSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAE 260
+I + YY M PE + + D WS GV+L+ I G P+ ++
Sbjct: 232 -RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 290
Query: 261 TEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQQVLEHPWLQ 316
+ Q V + V R P +N V + M P+ R +LE ++
Sbjct: 291 SNQEV----LEFVTSGGRMDPP---KNCPGPVYRIMTQCWQHQPEDRPNFAIILER--IE 341
Query: 317 NAKKAPNV 324
+ P+V
Sbjct: 342 YCTQDPDV 349
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 83.9 bits (207), Expect = 5e-18
Identities = 40/161 (24%), Positives = 70/161 (43%), Gaps = 11/161 (6%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
+ ++ LGR++G G FG YL T+ + + A K + K + E I R L
Sbjct: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKIYRIL 59
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEG---GELFDRIVARGHYTERAAAAVTKTIVEVV 169
I ++ + LVM+L G +LF+ + + + ++ V
Sbjct: 60 QGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRV 116
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210
+ H +HRD+KP+NFL + + IDFGL+ ++
Sbjct: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 8e-18
Identities = 57/228 (25%), Positives = 91/228 (39%), Gaps = 53/228 (23%)
Query: 51 REIEERY-ELGRELGRGEFGITYLCTDRENGDAF----ACKSISKKKLRTAVDIEDVRRE 105
E+R+ + R+LG G FG LC GD A KS+ K I D+++E
Sbjct: 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL--KPESGGNHIADLKKE 73
Query: 106 VDIMRHLPKHQNIVCLKD--TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
++I+R+L H+NIV K T + + L+ME G L + + +
Sbjct: 74 IEILRNL-YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN---------KI 123
Query: 164 TIVEVVQMC----------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213
+ + ++ +HRDL N L ++ + +K DFGL+ + +
Sbjct: 124 NLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ---VKIGDFGLTKAIETDK 180
Query: 214 KFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY 248
+ YY APE L + DVWS GV L+
Sbjct: 181 E--------YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLH 220
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 8e-18
Identities = 44/249 (17%), Positives = 77/249 (30%), Gaps = 48/249 (19%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSIS--KKKLR--TAVDIEDVRREV 106
+I E LG+G F + RE GD K L E
Sbjct: 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAA 63
Query: 107 DIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIV 166
+M L H+++V LV E + G L + + I+
Sbjct: 64 SMMSKL-SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN---------CINIL 113
Query: 167 EVVQMCH----------KHGVMHRDLKPENFLFANKKETAPL-----KAIDFGLSVFFKP 211
+++ ++ ++H ++ +N L +++ K D G+S+
Sbjct: 114 WKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT--- 170
Query: 212 GEKFSEIVGSPYY------MAPEVLK--RNYGPEVDVWSAGVILY-ILLCGVPPFWAETE 262
++ + PE ++ +N D WS G L+ I G P A
Sbjct: 171 ------VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS 224
Query: 263 QGVAQAIIR 271
Q Q
Sbjct: 225 QRKLQFYED 233
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 9e-18
Identities = 45/182 (24%), Positives = 73/182 (40%), Gaps = 15/182 (8%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
+ RY LGR++G G FG YL TD G+ A K K + E I + +
Sbjct: 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMM 61
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFD-RIVARGHYTERAAAAVTKTIVEVVQM 171
I ++ + +VMEL G L D ++ + + ++ ++
Sbjct: 62 QGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 120
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI--------VGSPY 223
H +HRD+KP+NFL K+ + IDFGL+ ++ I G+
Sbjct: 121 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 180
Query: 224 YM 225
Y
Sbjct: 181 YA 182
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 70/297 (23%), Positives = 106/297 (35%), Gaps = 54/297 (18%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR---TAVDIEDVRREVD 107
E + G+ LG G FG T G A ++ K L+ A + E + E+
Sbjct: 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFD----RIVARGHYTERAAAAVTK 163
IM HL +H+NIV L V ++ E C G+L + + A A T
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161
Query: 164 TIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213
+ +++ +HRD+ N L N K DFGL+
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV---AKIGDFGLA------- 211
Query: 214 KFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWA 259
+I+ Y MAPE + Y + DVWS G++L+ I G+ P+
Sbjct: 212 --RDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 269
Query: 260 ETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQQVLEH 312
V + V D + P A + M +P R T QQ+
Sbjct: 270 IL---VNSKFYKLVKDGYQMAQP---AFAPKNIYSIMQACWALEPTHRPTFQQICSF 320
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 65/306 (21%), Positives = 114/306 (37%), Gaps = 56/306 (18%)
Query: 28 IDYGTHHQGNGGHKL---CVLKEPT-------GREIE-ERYELGRELGRGEFGITYLCTD 76
+ Y + H H+L C +P EI E L +LG+G FG ++ T
Sbjct: 146 VAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTW 205
Query: 77 RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI-----VCLKDTYEDDTAV 131
A K++ + E +E +M+ L +H+ + V ++ +
Sbjct: 206 NGTTRV-AIKTLKP----GTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSEE------PI 253
Query: 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC----------HKHGVMHRD 181
++V E G L D + + + ++V M + +HRD
Sbjct: 254 YIVTEYMSKGSLLDFL--------KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 182 LKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGS-PY-YMAPEVLK-RNYGPEV 238
L+ N L E K DFGL+ + E + P + APE + +
Sbjct: 306 LRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 239 DVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297
DVWS G++L + G P+ + V + R +R P+ E+ DL+ +
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMPCPPECPESLHDLMCQCWR 419
Query: 298 PDPKRR 303
+P+ R
Sbjct: 420 KEPEER 425
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-17
Identities = 61/297 (20%), Positives = 107/297 (36%), Gaps = 73/297 (24%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAF---ACKSISKKKLRTAVDIEDVRREVDIMR 110
+GRG FG Y T +N A KS+ ++ ++ E IM+
Sbjct: 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMK 81
Query: 111 HLPKHQNI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
H N+ +CL+ + + +V+ + G+L + I H T+
Sbjct: 82 DF-SHPNVLSLLGICLR----SEGSPLVVLPYMKHGDLRNFIRNETH---------NPTV 127
Query: 166 VEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF 215
+++ +HRDL N + E +K DFGL+
Sbjct: 128 KDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD---EKFTVKVADFGLA--------- 175
Query: 216 SEIVGSPYY--------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWA 259
++ YY MA E L+ + + + DVWS GV+L+ ++ G PP+
Sbjct: 176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 235
Query: 260 ETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQQVLEH 312
+ +L RR P E D + + ML P + R + +++
Sbjct: 236 VNTFDI----TVYLLQGRRLLQP---EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 285
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 65/306 (21%), Positives = 114/306 (37%), Gaps = 56/306 (18%)
Query: 28 IDYGTHHQGNGGHKL---CVLKEPT-------GREIE-ERYELGRELGRGEFGITYLCTD 76
+ Y + H H+L C +P EI E L +LG+G FG ++ T
Sbjct: 229 VAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTW 288
Query: 77 RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI-----VCLKDTYEDDTAV 131
A K++ + E +E +M+ L +H+ + V ++ +
Sbjct: 289 NGTTRV-AIKTLKP----GTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSEE------PI 336
Query: 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC----------HKHGVMHRD 181
++V E G L D + + + ++V M + +HRD
Sbjct: 337 YIVTEYMSKGSLLDFL--------KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 388
Query: 182 LKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGS-PY-YMAPEVLK-RNYGPEV 238
L+ N L E K DFGL+ + E + P + APE + +
Sbjct: 389 LRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 239 DVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297
DVWS G++L + G P+ + V + R +R P+ E+ DL+ +
Sbjct: 446 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMPCPPECPESLHDLMCQCWR 502
Query: 298 PDPKRR 303
+P+ R
Sbjct: 503 KEPEER 508
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-17
Identities = 55/255 (21%), Positives = 82/255 (32%), Gaps = 60/255 (23%)
Query: 51 REI-EERYELGRELGRGEFGITY---LCTDRENGDAFACKSISKKKLRTAVDIEDVRREV 106
I E+ L +LG G FG+ + A K + L ++D REV
Sbjct: 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREV 72
Query: 107 DIMRHLPKHQNI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAV 161
+ M L H+N+ V L + +V EL G L DR+
Sbjct: 73 NAMHSL-DHRNLIRLYGVVLTPP------MKMVTELAPLGSLLDRLRKHQG--------- 116
Query: 162 TKTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211
+ + + +HRDL N L A + +K DFGL
Sbjct: 117 HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL---VKIGDFGLMRALPQ 173
Query: 212 GEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPF 257
+ +Y APE LK R + D W GV L+ + G P+
Sbjct: 174 NDD--------HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 225
Query: 258 WAETEQGVAQAIIRS 272
+ I +
Sbjct: 226 IGLNGSQILHKIDKE 240
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-17
Identities = 51/245 (20%), Positives = 93/245 (37%), Gaps = 51/245 (20%)
Query: 51 REIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIM 109
E++ E L +ELG G+FG+ L + D A K I + ++ ++ +E M
Sbjct: 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKE----GSMSEDEFFQEAQTM 57
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV 169
L H +V + +++V E G L + + + G +++
Sbjct: 58 MKL-SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGL---------EPSQLL 107
Query: 170 QMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIV 219
+MC+ H +HRDL N L +K DFG++ + ++
Sbjct: 108 EMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLC---VKVSDFGMTRY---------VL 155
Query: 220 GSPYY-----------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVA 266
Y APEV Y + DVW+ G++++ + G P+ T V
Sbjct: 156 DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV 215
Query: 267 QAIIR 271
+ +
Sbjct: 216 LKVSQ 220
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 5e-17
Identities = 55/241 (22%), Positives = 94/241 (39%), Gaps = 45/241 (18%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
EI+ + +ELG G+FG+ R D A K I + ++ ++ E +M
Sbjct: 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKE----GSMSEDEFIEEAKVMM 74
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ 170
+L H+ +V L + ++ E G L + + H ++++
Sbjct: 75 NL-SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH---------RFQTQQLLE 124
Query: 171 MCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-------KPGE 213
MC +HRDL N L ++ +K DFGLS + G
Sbjct: 125 MCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV---VKVSDFGLSRYVLDDEYTSSVGS 181
Query: 214 KFSEIVGSPY-YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAII 270
KF P + PEVL + + D+W+ GV+++ I G P+ T A+ I
Sbjct: 182 KF------PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 235
Query: 271 R 271
+
Sbjct: 236 Q 236
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 5e-17
Identities = 56/241 (23%), Positives = 96/241 (39%), Gaps = 43/241 (17%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
E+E + +LG G++G Y ++ A K++ + +++E+ +E +M+
Sbjct: 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMK 64
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ 170
+ KH N+V L + +++ E G L D + R + V ++
Sbjct: 65 EI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--------RECNRQEVSAVVLLY 115
Query: 171 MCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-------PGE 213
M K +HRDL N L E +K DFGLS G
Sbjct: 116 MATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGA 172
Query: 214 KFSEIVGSPY-YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAII 270
KF P + APE L + + DVW+ GV+L+ I G+ P+ V + +
Sbjct: 173 KF------PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 226
Query: 271 R 271
+
Sbjct: 227 K 227
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 7e-17
Identities = 61/307 (19%), Positives = 106/307 (34%), Gaps = 67/307 (21%)
Query: 33 HHQGNGGHKLCVLKEPTGR---------------EIE-ERYELGRELGRGEFGITYLCTD 76
H+ + L +P + + +L + +G+GEFG L
Sbjct: 155 HYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY 214
Query: 77 RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTY----EDDTAVH 132
R N A K ++ + E +M L +H N+V L E+ ++
Sbjct: 215 RGNKVAV-------KCIKNDATAQAFLAEASVMTQL-RHSNLVQL---LGVIVEEKGGLY 263
Query: 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH----------KHGVMHRDL 182
+V E G L D + +RG +++ + +HRDL
Sbjct: 264 IVTEYMAKGSLVDYLRSRGRS--------VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDL 315
Query: 183 KPENFLFANKKETAPLKAIDFGLS---VFFKPGEKFSEIVGSPY-YMAPEVLKRN-YGPE 237
N L + E K DFGL+ + K P + APE L+ + +
Sbjct: 316 AARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL------PVKWTAPEALREKKFSTK 366
Query: 238 VDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKML 296
DVWS G++L+ I G P+ + V + + ++ D D+++
Sbjct: 367 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---GYKMDAPDGCPPAVYDVMKNCW 423
Query: 297 DPDPKRR 303
D R
Sbjct: 424 HLDAATR 430
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 8e-17
Identities = 60/263 (22%), Positives = 89/263 (33%), Gaps = 59/263 (22%)
Query: 31 GTHHQGNGGHKLCVLKEPTGREIEERY-ELGRELGRGEFGITYLCTDRENGDAF----AC 85
G HH + C ++PT EER+ + +LG+G FG LC GD A
Sbjct: 2 GHHHHHHAQLYAC--QDPT--IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAV 57
Query: 86 KSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKD--TYEDDTAVHLVMELCEGGEL 143
K + + D +RE+ I++ L IV + ++ LVME G L
Sbjct: 58 KQL---QHSGPDQQRDFQREIQILKAL-HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCL 113
Query: 144 FDRIVARGHYTERAAAAVTKTIVEVVQMC----------HKHGVMHRDLKPENFLFANKK 193
D + ++ +HRDL N L ++
Sbjct: 114 RDFLQRHRA---------RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA 164
Query: 194 ETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDV 240
+K DFGL+ + YY APE L + + DV
Sbjct: 165 H---VKIADFGLAKLLPLDKD--------YYVVREPGQSPIFWYAPESLSDNIFSRQSDV 213
Query: 241 WSAGVILY-ILLCGVPPFWAETE 262
WS GV+LY + E
Sbjct: 214 WSFGVVLYELFTYCDKSCSPSAE 236
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 8e-17
Identities = 40/161 (24%), Positives = 73/161 (45%), Gaps = 9/161 (5%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
+ Y++GR +G G FG+ + T+ N A K ++ D +R E + L
Sbjct: 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLL 62
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFD-RIVARGHYTERAAAAVTKTIVEVVQM 171
I + ++ LV++L G L D + ++ + A K ++ VQ
Sbjct: 63 AGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 121
Query: 172 CHKHGVMHRDLKPENFLF--ANKKETAPLKAIDFGLSVFFK 210
H+ +++RD+KP+NFL N K + +DFG+ F++
Sbjct: 122 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 8e-17
Identities = 54/253 (21%), Positives = 90/253 (35%), Gaps = 50/253 (19%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAF--ACKSISKKKLRTAVDIEDVRREVDI 108
++ + +G G FG +++G A K + K+ + D D E+++
Sbjct: 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGELEV 78
Query: 109 MRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFD------RIVARGHYTERAAAAVT 162
+ L H NI+ L E ++L +E G L D + + + A T
Sbjct: 79 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138
Query: 163 KTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212
+ +++ + +HRDL N L K DFGLS
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV---AKIADFGLS------ 189
Query: 213 EKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFW 258
+ E Y MA E L Y DVWS GV+L+ I+ G P+
Sbjct: 190 -RGQE-----VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 243
Query: 259 AETEQGVAQAIIR 271
T + + + +
Sbjct: 244 GMTCAELYEKLPQ 256
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 9e-17
Identities = 46/244 (18%), Positives = 83/244 (34%), Gaps = 46/244 (18%)
Query: 51 REI-EERYELGRELGRGEFGITYLCTDRENGDAF----ACKSISKKKLRTAVDIEDVRRE 105
R E + LG G FG + G++ K I + + V
Sbjct: 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI--EDKSGRQSFQAVTDH 65
Query: 106 VDIMRHLPKHQNI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAA 160
+ + L H +I +C + + LV + G L D +
Sbjct: 66 MLAIGSL-DHAHIVRLLGLCPGSS------LQLVTQYLPLGSLLDHVRQHRG-------- 110
Query: 161 VTKTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210
++ +HG++HR+L N L + + ++ DFG++
Sbjct: 111 -ALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQ---VQVADFGVADLLP 166
Query: 211 PGEKFSEIVGS--PY-YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGV 265
P +K + P +MA E + Y + DVWS GV ++ ++ G P+ V
Sbjct: 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV 226
Query: 266 AQAI 269
+
Sbjct: 227 PDLL 230
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 9e-17
Identities = 63/303 (20%), Positives = 106/303 (34%), Gaps = 62/303 (20%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR---TAVDIEDVRREVD 107
E R G+ LG G FG T + A +++ K L+ + E + E+
Sbjct: 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFD--------RIVARGHYTERAAA 159
++ +L H NIV L ++ E C G+L + I ++
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 160 AVTKTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209
+ + +++ + +HRDL N L K DFGL+
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT---HGRITKICDFGLA--- 192
Query: 210 KPGEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVP 255
+I Y MAPE + Y E DVWS G+ L+ + G
Sbjct: 193 ------RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 246
Query: 256 PFWAETEQGVA--QAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQQV 309
P+ G+ + + + R P E+A + M DP +R T +Q+
Sbjct: 247 PY-----PGMPVDSKFYKMIKEGFRMLSP---EHAPAEMYDIMKTCWDADPLKRPTFKQI 298
Query: 310 LEH 312
++
Sbjct: 299 VQL 301
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-16
Identities = 58/239 (24%), Positives = 92/239 (38%), Gaps = 45/239 (18%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
I+ +E+G G+FG+ +L A K+I + A+ ED E ++M
Sbjct: 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIRE----GAMSEEDFIEEAEVMM 58
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ 170
L H +V L + + LV E E G L D + + ++
Sbjct: 59 KL-SHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRG---------LFAAETLLG 108
Query: 171 MCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-------KPGE 213
MC + V+HRDL N L + +K DFG++ F G
Sbjct: 109 MCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV---IKVSDFGMTRFVLDDQYTSSTGT 165
Query: 214 KFSEIVGSPY-YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 269
KF P + +PEV Y + DVWS GV+++ + G P+ + V + I
Sbjct: 166 KF------PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 56/279 (20%), Positives = 112/279 (40%), Gaps = 64/279 (22%)
Query: 28 IDYGTHHQGNGGHKL---CVLKEPTGREIEERYE-------LGRELGRGEFGITYLCTDR 77
+D+ KL C+ +P ++ +E L ++LG G+FG ++ T
Sbjct: 151 VDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYN 210
Query: 78 ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI-----VCLKDTYEDDTAVH 132
++ A K++ ++ +E E ++M+ L +H + V K+ ++
Sbjct: 211 KHTKV-AVKTMKP----GSMSVEAFLAEANVMKTL-QHDKLVKLHAVVTKE------PIY 258
Query: 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH----------KHGVMHRDL 182
++ E G L D + ++ + + +++ + +HRDL
Sbjct: 259 IITEFMAKGSLLDFL--------KSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 310
Query: 183 KPENFLFANKKETAPLKAIDFGLSVFF-------KPGEKFSEIVGSPY-YMAPEVLK-RN 233
+ N L + + K DFGL+ + G KF P + APE + +
Sbjct: 311 RAANILVS---ASLVCKIADFGLARVIEDNEYTAREGAKF------PIKWTAPEAINFGS 361
Query: 234 YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 271
+ + DVWS G++L I+ G P+ + V +A+ R
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 400
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-16
Identities = 70/305 (22%), Positives = 114/305 (37%), Gaps = 67/305 (21%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR---TAVDIEDVRREVD 107
E +R +LG+ LGRG FG C++++ K L+ T + + E+
Sbjct: 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 82
Query: 108 IMRHLPKHQNIVCLKDTY----EDDTAVHLVMELCEGGELFD------RIVARGHYTERA 157
I+ H+ H N+V L + + +++E C+ G L
Sbjct: 83 ILIHIGHHLNVVNL---LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 158 AAAVTKTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207
T+ ++ +HRDL N L + K +K DFGL+
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV---VKICDFGLA- 195
Query: 208 FFKPGEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCG 253
+I P Y MAPE + R Y + DVWS GV+L+ I G
Sbjct: 196 --------RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 247
Query: 254 VPPFWAETEQGVA--QAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQ 307
P+ GV + R + + R P + + + MLD +P +R T
Sbjct: 248 ASPY-----PGVKIDEEFCRRLKEGTRMRAP---DYTTPEMYQTMLDCWHGEPSQRPTFS 299
Query: 308 QVLEH 312
+++EH
Sbjct: 300 ELVEH 304
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-16
Identities = 56/228 (24%), Positives = 86/228 (37%), Gaps = 54/228 (23%)
Query: 51 REIEERY-ELGRELGRGEFGITYLCTDRENGDAF----ACKSISKKKLRTAVDIEDVRRE 105
+ EER+ + ++LG+G FG +C D A K + + T + D RE
Sbjct: 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFERE 92
Query: 106 VDIMRHLPKHQNIVCLKD--TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
++I++ L +H NIV K + L+ME G L D +
Sbjct: 93 IEILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE---------RI 142
Query: 164 TIVEVVQMC----------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213
++++Q +HRDL N L N+ +K DFGL+ +
Sbjct: 143 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDK 199
Query: 214 KFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY 248
+ YY APE L + DVWS GV+LY
Sbjct: 200 E--------YYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 239
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 54/228 (23%), Positives = 86/228 (37%), Gaps = 54/228 (23%)
Query: 51 REIEERY-ELGRELGRGEFGITYLCTDRENGDAF----ACKSISKKKLRTAVDIEDVRRE 105
+ EER+ + ++LG+G FG +C D A K + + T + D RE
Sbjct: 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFERE 61
Query: 106 VDIMRHLPKHQNIVCLKD--TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
++I++ L +H NIV K + L+ME G L D +
Sbjct: 62 IEILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE---------RI 111
Query: 164 TIVEVVQMC----------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213
++++Q +HRDL N L N+ +K DFGL+ +
Sbjct: 112 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDK 168
Query: 214 KFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY 248
+ ++ APE L + DVWS GV+LY
Sbjct: 169 E--------FFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 208
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-16
Identities = 49/248 (19%), Positives = 86/248 (34%), Gaps = 61/248 (24%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAF----ACKSISKKKLRTAVDIEDVRREVDIM 109
E ++ + LG G FG Y G+ A K + ++ + +++ E +M
Sbjct: 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVM 71
Query: 110 RHLPKHQNI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKT 164
+ + ++ +CL T V L+ +L G L D +
Sbjct: 72 ASV-DNPHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKD---------NIG 115
Query: 165 IVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214
++ C ++HRDL N L + +K DFGL+ EK
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEK 172
Query: 215 FSEIVGSPYY-----------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAET 261
Y MA E + R Y + DVWS GV ++ ++ G P+
Sbjct: 173 --------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224
Query: 262 EQGVAQAI 269
++ +
Sbjct: 225 ASEISSIL 232
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-16
Identities = 57/246 (23%), Positives = 102/246 (41%), Gaps = 55/246 (22%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
E+ E +L LG G+FG ++ + A KS+ + ++ + E ++M+
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQ----GSMSPDAFLAEANLMK 63
Query: 111 HLPKHQNI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
L +HQ + V ++ ++++ E E G L D + + + + TI
Sbjct: 64 QL-QHQRLVRLYAVVTQE------PIYIITEYMENGSLVDFL--------KTPSGIKLTI 108
Query: 166 VEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF------ 209
+++ M + +HRDL+ N L + +T K DFGL+
Sbjct: 109 NKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEYT 165
Query: 210 -KPGEKFSEIVGSPY-YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGV 265
+ G KF P + APE + + + DVWS G++L I+ G P+ T V
Sbjct: 166 AREGAKF------PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 219
Query: 266 AQAIIR 271
Q + R
Sbjct: 220 IQNLER 225
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-16
Identities = 70/317 (22%), Positives = 115/317 (36%), Gaps = 77/317 (24%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAV-----------DI 99
I+ L RELG G FG +L C ++S K + V
Sbjct: 11 HIKRRDIVLKRELGEGAFGKVFLAE---------CYNLSPTKDKMLVAVKALKDPTLAAR 61
Query: 100 EDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAA 159
+D +RE +++ +L +H++IV D + +V E + G+L + A G
Sbjct: 62 KDFQREAELLTNL-QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVD 120
Query: 160 AVTK------TIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDF 203
+ + +++ + +HRDL N L +K DF
Sbjct: 121 GQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG---ANLLVKIGDF 177
Query: 204 GLSVFFKPGEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-I 249
G+S ++ + YY M PE + R + E DVWS GVIL+ I
Sbjct: 178 GMS---------RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEI 228
Query: 250 LLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLT 305
G P++ + V I + R P V ML +P++RL
Sbjct: 229 FTYGKQPWFQLSNTEV----IECITQGRVLERP---RVCPKEVYDVMLGCWQREPQQRLN 281
Query: 306 AQQVLEHPWLQNAKKAP 322
+++ + L KA
Sbjct: 282 IKEIYKI--LHALGKAT 296
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A Length = 191 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-16
Identities = 7/43 (16%), Positives = 19/43 (44%)
Query: 310 LEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVMS 352
+ H ++ + G V K + ++ K +K A+ +++
Sbjct: 1 MHHHHHHSSGRENLYFQGIHVLENFKNYGLLLKFQKLAMTIIA 43
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 3e-16
Identities = 63/295 (21%), Positives = 107/295 (36%), Gaps = 69/295 (23%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAF---ACKSISKKKLRTAVDIEDVRREVDIMR 110
+GRG FG Y T +N A KS+ ++ ++ E IM+
Sbjct: 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMK 145
Query: 111 HLPKHQNI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
H N+ +CL+ + + +V+ + G+L + I H T+
Sbjct: 146 DF-SHPNVLSLLGICLR----SEGSPLVVLPYMKHGDLRNFIRNETH---------NPTV 191
Query: 166 VEVVQMCH-----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214
+++ K V HRDL N + E +K DFGL+ E
Sbjct: 192 KDLIGFGLQVAKGMKFLASKKFV-HRDLAARNCMLD---EKFTVKVADFGLARDMYDKEF 247
Query: 215 FSEIVGSPYY-----------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAET 261
S + MA E L+ + + + DVWS GV+L+ ++ G PP+
Sbjct: 248 DS------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 301
Query: 262 EQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQQVLEH 312
+ +L RR P E D + + ML P + R + +++
Sbjct: 302 TFDI----TVYLLQGRRLLQP---EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-16
Identities = 51/248 (20%), Positives = 90/248 (36%), Gaps = 62/248 (25%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAF---ACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
R +G+G FG+ Y + A KS+ ++ +E RE +MR L
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL--SRITEMQQVEAFLREGLLMRGL-N 80
Query: 115 HQNI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV 169
H N+ + L + H+++ G+L I + T+ +++
Sbjct: 81 HPNVLALIGIMLP----PEGLPHVLLPYMCHGDLLQFIRSPQR---------NPTVKDLI 127
Query: 170 QMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIV 219
+ +HRDL N + E+ +K DFGL+ +I+
Sbjct: 128 SFGLQVARGMEYLAEQKFVHRDLAARNCMLD---ESFTVKVADFGLA---------RDIL 175
Query: 220 GSPYY--------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQ 263
YY A E L+ + + DVWS GV+L+ +L G PP+
Sbjct: 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF 235
Query: 264 GVAQAIIR 271
+ + +
Sbjct: 236 DLTHFLAQ 243
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-16
Identities = 62/300 (20%), Positives = 111/300 (37%), Gaps = 58/300 (19%)
Query: 51 REIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR---TAVDIEDVRREV 106
+EI ELG FG Y ++++ K L+ E+ R E
Sbjct: 4 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEA 63
Query: 107 DIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK--- 163
+ L +H N+VCL D + ++ C G+L + +V R +++ + +
Sbjct: 64 MLRARL-QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 164 ---TIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210
+ V + H V+H+DL N L +K +K D GL
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN---VKISDLGLF---- 175
Query: 211 PGEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPP 256
E+ + YY MAPE + + + D+WS GV+L+ + G+ P
Sbjct: 176 -----REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
Query: 257 FWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQQVLEH 312
+ + Q V + + + + P P ++ V M++ P RR + +
Sbjct: 231 YCGYSNQDV----VEMIRNRQVLPCP---DDCPAWVYALMIECWNEFPSRRPRFKDIHSR 283
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 4e-16
Identities = 34/164 (20%), Positives = 64/164 (39%), Gaps = 15/164 (9%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
+ + +G+++G G FG L + + A K + K R + E + L
Sbjct: 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQ----LHLEYRFYKQL 61
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGG----ELFDRIVARGHYTERAAAAVTKTIVEV 168
I + +V+EL G +LFD ++ + + ++
Sbjct: 62 GSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDL--CDRTFSLKTVLMIAIQLISR 117
Query: 169 VQMCHKHGVMHRDLKPENFLF--ANKKETAPLKAIDFGLSVFFK 210
++ H +++RD+KPENFL K + IDF L+ +
Sbjct: 118 MEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 73/303 (24%), Positives = 107/303 (35%), Gaps = 67/303 (22%)
Query: 43 CVLKEPTGREIE---ERYELGRELGRGEFGITY---LCTDRENGDAFACKSISKKKLRTA 96
P+ R+ E ER ELGR +G G+FG + + A A K+ K +
Sbjct: 375 DTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC--KNCTSD 432
Query: 97 VDIEDVRREVDIMRHLPKHQNI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARG 151
E +E MR H +I V ++ V ++MELC GEL + R
Sbjct: 433 SVREKFLQEALTMRQF-DHPHIVKLIGVITENP------VWIIMELCTLGELRSFLQVRK 485
Query: 152 HYTERAAAAVTKTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAI 201
+ + ++ + +HRD+ N L ++ +K
Sbjct: 486 F---------SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC---VKLG 533
Query: 202 DFGLSVFFKPGEKFSEIVGSPYY-----------MAPEVLK-RNYGPEVDVWSAGVILY- 248
DFGLS + S YY MAPE + R + DVW GV ++
Sbjct: 534 DFGLS---------RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWE 584
Query: 249 ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQ 308
IL+ GV PF V I R P L+ K DP RR +
Sbjct: 585 ILMHGVKPFQGVKNNDVIGRIEN---GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTE 641
Query: 309 VLE 311
+
Sbjct: 642 LKA 644
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 4e-16
Identities = 65/289 (22%), Positives = 94/289 (32%), Gaps = 69/289 (23%)
Query: 28 IDYGTHHQGNGGHKLCVLKEPT--------------------GREIE-ERYELGRELGRG 66
+ + HH + K P REIE R + + +G G
Sbjct: 1 MHHHHHHSSGRENLYFQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSG 60
Query: 67 EFGITYLCTDRENGDAF---ACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKD 123
+ G R G A K++ K T D E IM H NI+ L+
Sbjct: 61 DSGEVCYGRLRVPGQRDVPVAIKAL--KAGYTERQRRDFLSEASIMGQF-DHPNIIRLEG 117
Query: 124 TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH---------- 173
+V E E G L + TI+++V M
Sbjct: 118 VVTRGRLAMIVTEYMENGSLDTFLRTHDG---------QFTIMQLVGMLRGVGAGMRYLS 168
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY--------- 224
G +HRDL N L + K DFGLS + Y
Sbjct: 169 DLGYVHRDLAARNVLVDSNLV---CKVSDFGLSRVLEDDP-------DAAYTTTGGKIPI 218
Query: 225 --MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 269
APE + R + DVWS GV+++ +L G P+W T + V ++
Sbjct: 219 RWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 6e-16
Identities = 53/241 (21%), Positives = 91/241 (37%), Gaps = 49/241 (20%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
+ + +L + +G+GEFG L R N A K ++ + E +M
Sbjct: 17 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAV-------KCIKNDATAQAFLAEASVMT 69
Query: 111 HLPKHQNIVCLKDTY----EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIV 166
L +H N+V L E+ +++V E G L D + R+
Sbjct: 70 QL-RHSNLVQL---LGVIVEEKGGLYIVTEYMAKGSLVDYL--------RSRGRSVLGGD 117
Query: 167 EVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLS---VFFKPGE 213
+++ + +HRDL N L + E K DFGL+ +
Sbjct: 118 CLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTG 174
Query: 214 KFSEIVGSPY-YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAII 270
K P + APE L+ + + + DVWS G++L+ I G P+ + V +
Sbjct: 175 KL------PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228
Query: 271 R 271
+
Sbjct: 229 K 229
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 8e-16
Identities = 64/253 (25%), Positives = 95/253 (37%), Gaps = 62/253 (24%)
Query: 51 REIE-ERYELGRELGRGEFGITY---LCTDRENGDAFACKSISKKKLRTAVDIEDVRREV 106
EI+ ER ELGR +G G+FG + + A A K+ K + E +E
Sbjct: 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQEA 67
Query: 107 DIMRHLPKHQNI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAV 161
MR H +I V ++ V ++MELC GEL + R +
Sbjct: 68 LTMRQF-DHPHIVKLIGVITENP------VWIIMELCTLGELRSFLQVRKY--------- 111
Query: 162 TKTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211
+ + ++ + +HRD+ N L ++ +K DFGLS
Sbjct: 112 SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC---VKLGDFGLS----- 163
Query: 212 GEKFSEIVGSPYY-----------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFW 258
+ S YY MAPE + R + DVW GV ++ IL+ GV PF
Sbjct: 164 ----RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 219
Query: 259 AETEQGVAQAIIR 271
V I
Sbjct: 220 GVKNNDVIGRIEN 232
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-15
Identities = 58/252 (23%), Positives = 89/252 (35%), Gaps = 62/252 (24%)
Query: 52 EI-EERYELGRELGRGEFGITY---LCTDRENGDAFACKSISKKKLRTAVDIEDVRREVD 107
I E L R LG G FG Y + A K+ KK T + E E
Sbjct: 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC--KKDCTLDNKEKFMSEAV 65
Query: 108 IMRHLPKHQNI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVT 162
IM++L H +I + ++ ++MEL GEL + + +
Sbjct: 66 IMKNL-DHPHIVKLIGIIEEEP------TWIIMELYPYGELGHYLERNKN---------S 109
Query: 163 KTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212
++ +V +HRD+ N L A+ + +K DFGLS
Sbjct: 110 LKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPEC---VKLGDFGLS------ 160
Query: 213 EKFSEIVGSPYY-----------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWA 259
I YY M+PE + R + DVW V ++ IL G PF+
Sbjct: 161 ---RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 217
Query: 260 ETEQGVAQAIIR 271
+ V + +
Sbjct: 218 LENKDVIGVLEK 229
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-15
Identities = 64/278 (23%), Positives = 98/278 (35%), Gaps = 64/278 (23%)
Query: 34 HQGNGGHKLCVLKEPT---------------GREIE-ERYELGRELGRGEFGITY---LC 74
H GNG KL L+ +E++ + + +G GEFG L
Sbjct: 8 HFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLK 67
Query: 75 TDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134
+ + A K++ K T D E IM H NI+ L+ V +V
Sbjct: 68 LPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMIV 124
Query: 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH----------KHGVMHRDLKP 184
E E G L + T++++V M G +HRDL
Sbjct: 125 TEYMENGSLDSFLRKHDA---------QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAA 175
Query: 185 ENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY-----------MAPEVLK-R 232
N L + K DFGL + E Y +PE + R
Sbjct: 176 RNILINSNLV---CKVSDFGLG-------RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 233 NYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 269
+ DVWS G++L+ ++ G P+W + Q V +A+
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-15
Identities = 70/303 (23%), Positives = 119/303 (39%), Gaps = 63/303 (20%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCT----DRENGDAF---ACKSISKKKLRTAVDIEDVR 103
E ++ LG+ LG G FG + D++ A K + K T D+ D+
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML--KDDATEKDLSDLV 88
Query: 104 REVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
E+++M+ + KH+NI+ L D +++++E G L + + AR + + +
Sbjct: 89 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 164 ------TIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207
T ++V + +HRDL N L +K DFGL+
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV---MKIADFGLA- 204
Query: 208 FFKPGEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCG 253
+I YY MAPE L R Y + DVWS GV+++ I G
Sbjct: 205 --------RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 256
Query: 254 VPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQQV 309
P+ + + + + + R P N + + M D P +R T +Q+
Sbjct: 257 GSPYPGIPVEEL----FKLLKEGHRMDKP---ANCTNELYMMMRDCWHAVPSQRPTFKQL 309
Query: 310 LEH 312
+E
Sbjct: 310 VED 312
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-15
Identities = 34/193 (17%), Positives = 71/193 (36%), Gaps = 28/193 (14%)
Query: 48 PTGREIE----ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR 103
P G+ ++ ++ LG+++G G FG+ YL + A + + +
Sbjct: 26 PEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGP----LF 81
Query: 104 REVDIMRHLPKHQNIVCLKDTYEDDTA----VH--------------LVMELCEGGELFD 145
E+ + + K I + + D + +VME G +L
Sbjct: 82 SELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQK 140
Query: 146 RIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205
G + + + +++V++ H++ +H D+K N L K + D+GL
Sbjct: 141 ISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQ-VYLADYGL 199
Query: 206 SVFFKPGEKFSEI 218
S + P +
Sbjct: 200 SYRYCPNGNHKQY 212
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-15
Identities = 72/303 (23%), Positives = 120/303 (39%), Gaps = 63/303 (20%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCT----DRENGDAF---ACKSISKKKLRTAVDIEDVR 103
E+ +R LG+ LG G FG L D++ + A K + K T D+ D+
Sbjct: 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML--KSDATEKDLSDLI 122
Query: 104 REVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
E+++M+ + KH+NI+ L D +++++E G L + + AR + +
Sbjct: 123 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 182
Query: 164 ------TIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207
+ ++V + +HRDL N L +K DFGL+
Sbjct: 183 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV---MKIADFGLA- 238
Query: 208 FFKPGEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCG 253
+I YY MAPE L R Y + DVWS GV+L+ I G
Sbjct: 239 --------RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 290
Query: 254 VPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQQV 309
P+ + + + + + R P N + + M D P +R T +Q+
Sbjct: 291 GSPYPGVPVEEL----FKLLKEGHRMDKP---SNCTNELYMMMRDCWHAVPSQRPTFKQL 343
Query: 310 LEH 312
+E
Sbjct: 344 VED 346
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} Length = 197 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-15
Identities = 14/46 (30%), Positives = 20/46 (43%), Gaps = 1/46 (2%)
Query: 307 QQVLEHPWL-QNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVM 351
H +N +V L T+ LK F N+LKK AL ++
Sbjct: 2 HHHHHHSSGRENLYFQGHVELSSTLLKNLKNFKKENELKKIALTII 47
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-15
Identities = 54/249 (21%), Positives = 86/249 (34%), Gaps = 50/249 (20%)
Query: 51 REIE-ERYELGRELGRGEFGI----TYLCTDRENGDAFACKSISKKKLRTAVDIEDVRRE 105
EI + +G GEFG + + A K++ K T D E
Sbjct: 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGE 96
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
IM H NI+ L+ + ++ E E G L + + ++
Sbjct: 97 AGIMGQF-SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG---------EFSV 146
Query: 166 VEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF 215
+++V M +HRDL N L + K DFGLS +
Sbjct: 147 LQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV---CKVSDFGLS-------RV 196
Query: 216 SEIVGSPYY-----------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETE 262
E Y APE + R + DVWS G++++ ++ G P+W +
Sbjct: 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN 256
Query: 263 QGVAQAIIR 271
V +AI
Sbjct: 257 HEVMKAIND 265
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-15
Identities = 61/255 (23%), Positives = 87/255 (34%), Gaps = 68/255 (26%)
Query: 54 EERYELGRE--------LGRGEFGITYLCTDRENGDAF--ACKSISKKKLRTAVDIEDVR 103
+++ L R+ LG G FG R A K + K+ D E++
Sbjct: 1 DKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMM 58
Query: 104 REVDIMRHLPKHQNI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAA 158
RE IM L + I VC + + LVME+ GG L +V +
Sbjct: 59 REAQIMHQL-DNPYIVRLIGVCQAEA------LMLVMEMAGGGPLHKFLVGKREEI---- 107
Query: 159 AAVTKTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208
+ V ++ H + +HRDL N L N+ K DFGLS
Sbjct: 108 -----PVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY---AKISDFGLSKA 159
Query: 209 FKPGEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGV 254
+ YY APE + R + DVWS GV ++ L G
Sbjct: 160 LGADD--------SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 211
Query: 255 PPFWAETEQGVAQAI 269
P+ V I
Sbjct: 212 KPYKKMKGPEVMAFI 226
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 4e-15
Identities = 53/237 (22%), Positives = 81/237 (34%), Gaps = 52/237 (21%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR---TAVDIEDVRREVD 107
E E E G+ LG G FG T ++ K L+ + + E + E+
Sbjct: 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFD-------------RIVARGHYT 154
+M L H+NIV L ++L+ E C G+L +
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160
Query: 155 ERAAAAVTKTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFG 204
E T +++ + +HRDL N L +K DFG
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFG 217
Query: 205 LSVFFKPGEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY 248
L+ +I+ Y MAPE L Y + DVWS G++L+
Sbjct: 218 LA---------RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLW 265
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 59/247 (23%), Positives = 87/247 (35%), Gaps = 53/247 (21%)
Query: 51 REIEERYELGR-ELGRGEFGITY---LCTDRENGDAFACKSISKKKLRTAVDIEDVRREV 106
+ + ELG G FG ++ D A K + K+ D E++ RE
Sbjct: 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDV-AIKVL--KQGTEKADTEEMMREA 387
Query: 107 DIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIV 166
IM L + IV L + + + LVME+ GG L +V + +
Sbjct: 388 QIMHQL-DNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEI---------PVS 436
Query: 167 EVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS 216
V ++ H + +HR+L N L N+ K DFGLS +
Sbjct: 437 NVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHY---AKISDFGLSKALGADD--- 490
Query: 217 EIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETE 262
YY APE + R + DVWS GV ++ L G P+
Sbjct: 491 -----SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 545
Query: 263 QGVAQAI 269
V I
Sbjct: 546 PEVMAFI 552
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 7e-15
Identities = 69/303 (22%), Positives = 117/303 (38%), Gaps = 63/303 (20%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCT----DRENGDAF---ACKSISKKKLRTAVDIEDVR 103
E ++ LG+ LG G FG + D++ A K + K T D+ D+
Sbjct: 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML--KDDATEKDLSDLV 134
Query: 104 REVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFD-----RIVARGHYTERAA 158
E+++M+ + KH+NI+ L D +++++E G L + R + +
Sbjct: 135 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 194
Query: 159 AAVTK-TIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207
+ T ++V + +HRDL N L +K DFGL+
Sbjct: 195 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV---MKIADFGLA- 250
Query: 208 FFKPGEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCG 253
+I YY MAPE L R Y + DVWS GV+++ I G
Sbjct: 251 --------RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 302
Query: 254 VPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQQV 309
P+ + + + + + R P N + + M D P +R T +Q+
Sbjct: 303 GSPYPGIPVEEL----FKLLKEGHRMDKP---ANCTNELYMMMRDCWHAVPSQRPTFKQL 355
Query: 310 LEH 312
+E
Sbjct: 356 VED 358
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-14
Identities = 66/320 (20%), Positives = 101/320 (31%), Gaps = 71/320 (22%)
Query: 55 ERYELGRELGRGEFGITYLCT--DRENGDAF---ACKSISKKKLRTAVDIEDVRREVDIM 109
E R++G G FG + + F A K + K+ +A D +RE +M
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML--KEEASADMQADFQREAALM 104
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGEL--------------FDRIVARGHYTE 155
+ NIV L + L+ E G+L
Sbjct: 105 AEF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 156 RAAAAVTKTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205
+ + E + + + +HRDL N L +K DFGL
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV---VKIADFGL 220
Query: 206 SVFFKPGEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILL 251
S I + YY M PE + Y E DVW+ GV+L+ I
Sbjct: 221 S---------RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
Query: 252 CGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQ 307
G+ P++ + V I V D P EN + M P R +
Sbjct: 272 YGLQPYYGMAHEEV----IYYVRDGNILACP---ENCPLELYNLMRLCWSKLPADRPSFC 324
Query: 308 QVLEHPWLQNAKKAPNVSLG 327
+ LQ + ++G
Sbjct: 325 SIHRI--LQRMCERAEGTVG 342
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-14
Identities = 50/242 (20%), Positives = 82/242 (33%), Gaps = 60/242 (24%)
Query: 59 LGRELGRGEFGITYLCTDRENGDAF--ACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+ELG G FG + A K + K + +++ E ++M+ L +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQL-DNP 78
Query: 117 NI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQM 171
I +C ++ LVME+ E G L + H ++++
Sbjct: 79 YIVRMIGICEAES------WMLVMEMAELGPLNKYLQQNRHV----------KDKNIIEL 122
Query: 172 CH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGS 221
H + +HRDL N L + K DFGLS + E
Sbjct: 123 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRADEN------- 172
Query: 222 PYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQ 267
YY APE + + + DVWS GV+++ G P+ V
Sbjct: 173 -YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA 231
Query: 268 AI 269
+
Sbjct: 232 ML 233
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 5e-13
Identities = 60/308 (19%), Positives = 113/308 (36%), Gaps = 68/308 (22%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR---TAVDIEDVRREVD 107
E + LG+ LG GEFG T +++ K L+ + ++ D+ E +
Sbjct: 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGEL--------------FDRIVARGHY 153
+++ + H +++ L D + L++E + G L +R
Sbjct: 79 VLKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137
Query: 154 TERAAAAVTKTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDF 203
+ T+ +++ + ++HRDL N L A ++ +K DF
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK---MKISDF 194
Query: 204 GLSVFFKPGEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-I 249
GLS ++ Y MA E L Y + DVWS GV+L+ I
Sbjct: 195 GLS---------RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 250 LLCGVPPFWAETEQGVA-QAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRL 304
+ G P+ G+ + + + R P +N + + + ML +P +R
Sbjct: 246 VTLGGNPY-----PGIPPERLFNLLKTGHRMERP---DNCSEEMYRLMLQCWKQEPDKRP 297
Query: 305 TAQQVLEH 312
+ +
Sbjct: 298 VFADISKD 305
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 24/181 (13%), Positives = 60/181 (33%), Gaps = 27/181 (14%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIE----DVRREVDIMR 110
+++L R GI Y + +K + ++ ++ + E + +
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDS----GPQKQKFSLKLDAKDGRLFNEQNFFQ 97
Query: 111 HLPKHQNIVCLKDTYEDDTA----VH-----------LVMELCEGGELFD--RIVARGHY 153
K + K Y LV+ G L + +
Sbjct: 98 RAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVL 156
Query: 154 TERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213
+ER+ V +++ ++ H++ +H ++ EN + ++ + +G + + P
Sbjct: 157 SERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQ-VTLAGYGFAFRYCPSG 215
Query: 214 K 214
K
Sbjct: 216 K 216
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-11
Identities = 35/230 (15%), Positives = 80/230 (34%), Gaps = 38/230 (16%)
Query: 8 PAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRGE 67
A Q ++++ K+ G ++ + +++G +G+G
Sbjct: 3 RVKAAQAGRQSSAKRHLAEQFAVGE-----------IITDMAAA----AWKVGLPIGQGG 47
Query: 68 FGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127
FG YL D + ++ + K+ D + E+ + K + I T +
Sbjct: 48 FGCIYLA-DMNSSESVGSDAPCVVKV-EPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKL 105
Query: 128 DTA----VH--------------LVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEV 168
++M+ G +L A ++ + ++ I+++
Sbjct: 106 KYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDI 164
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI 218
++ H+H +H D+K N L K + +D+GL+ + P
Sbjct: 165 LEYIHEHEYVHGDIKASNLLLNYKNPDQ-VYLVDYGLAYRYCPEGVHKAY 213
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 7e-09
Identities = 25/99 (25%), Positives = 45/99 (45%), Gaps = 5/99 (5%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR---TAVDIEDVRREVD 107
E +R +LG+ LGRG FG C++++ K L+ T + + E+
Sbjct: 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 77
Query: 108 IMRHLPKHQNIVCLK-DTYEDDTAVHLVMELCEGGELFD 145
I+ H+ H N+V L + + +++E C+ G L
Sbjct: 78 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 116
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 40.7 bits (95), Expect = 5e-04
Identities = 43/157 (27%), Positives = 64/157 (40%), Gaps = 40/157 (25%)
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY----------- 224
+HRDL N L + K +K DFGL+ +I P Y
Sbjct: 213 KCIHRDLAARNILLSEKNV---VKICDFGLA---------RDIYKDPDYVRKGDARLPLK 260
Query: 225 -MAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVA--QAIIRSVLDFRRD 279
MAPE + Y + DVWS GV+L+ I G P+ GV + R + + R
Sbjct: 261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFCRRLKEGTRM 315
Query: 280 PWPKVSENAKDLVRK-MLD---PDPKRRLTAQQVLEH 312
P + + + MLD +P +R T +++EH
Sbjct: 316 RAP---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 52.6 bits (125), Expect = 6e-08
Identities = 28/202 (13%), Positives = 57/202 (28%), Gaps = 48/202 (23%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA-----VDIEDVRREVDI 108
E+ + ++G G FG + + A K I+ + E++ E+ I
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 109 MRHL--------PKHQNIVCLKDTY------------------------------EDDTA 130
+ L + + + L + D
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFA 190
+ +V+E GG +++ + A + + + + HRDL N L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL- 195
Query: 191 NKKETAPLKAIDFGLSVFFKPG 212
K+T+ K
Sbjct: 196 --KKTSLKKLHYTLNGKSSTIP 215
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 6e-07
Identities = 36/134 (26%), Positives = 60/134 (44%), Gaps = 28/134 (20%)
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF---SEIVGSPYYMAPEV 229
H++ +HRD+K N L ++ TA K DFGL+ + + S IVG+ YMAPE
Sbjct: 150 HENHHIHRDIKSANILL-DEAFTA--KISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA 206
Query: 230 LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP-----WPKV 284
L+ P+ D++S GV+L ++ G +D R+P +
Sbjct: 207 LRGEITPKSDIYSFGVVLLEIITG-----------------LPAVDEHREPQLLLDIKEE 249
Query: 285 SENAKDLVRKMLDP 298
E+ + + +D
Sbjct: 250 IEDEEKTIEDYIDK 263
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 1e-06
Identities = 25/88 (28%), Positives = 42/88 (47%), Gaps = 7/88 (7%)
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF---SEIVGSPYYMAPEV 229
H ++HRD+K N L ++ K DFG+S ++ + + G+ Y+ PE
Sbjct: 156 HTRAIIHRDVKSINILL-DENFVP--KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEY 212
Query: 230 LKRNYGPE-VDVWSAGVILYILLCGVPP 256
+ E DV+S GV+L+ +LC
Sbjct: 213 FIKGRLTEKSDVYSFGVVLFEVLCARSA 240
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} Length = 180 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 2e-05
Identities = 3/27 (11%), Positives = 12/27 (44%)
Query: 326 LGETVKARLKQFSVMNKLKKRALKVMS 352
+ V +K + + ++ + +M+
Sbjct: 2 ISPNVLNNMKSYMKHSNIRNIIINIMA 28
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} Length = 191 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 4e-05
Identities = 6/25 (24%), Positives = 10/25 (40%)
Query: 328 ETVKARLKQFSVMNKLKKRALKVMS 352
+K+F KL + A+ M
Sbjct: 6 TGALGNMKKFQSSQKLAQAAMLFMG 30
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 8e-05
Identities = 45/301 (14%), Positives = 76/301 (25%), Gaps = 114/301 (37%)
Query: 73 LCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN--IVCLKDTYEDDTA 130
L + S KLR I ++ E+ + ++N +V L +
Sbjct: 205 LLYQIDPNWTSRSDHSSNIKLR----IHSIQAELRRLLKSKPYENCLLV-LLNVQNAKAW 259
Query: 131 VHLVMELCEGGELFD---RIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENF 187
F+ +I+ +T T R + +F
Sbjct: 260 -----------NAFNLSCKIL------------LT-T---------------RFKQVTDF 280
Query: 188 LFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAP-EVLKRNYGPEVDVWSA 243
L A L L+ P E + + P EVL N P
Sbjct: 281 LSAATTTHISLDHHSMTLT----PDEVKSLLLKYLDCRPQDLPREVLTTN--P------- 327
Query: 244 GVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKM----LDPD 299
+ G+A D W V+ + + + L+P
Sbjct: 328 ------RRLSI--IAESIRDGLA----------TWDNWKHVNCDKLTTIIESSLNVLEPA 369
Query: 300 PKRRLTAQ------------QVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRA 347
R++ + +L W K V+NKL K +
Sbjct: 370 EYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDV--------------MVVVNKLHKYS 415
Query: 348 L 348
L
Sbjct: 416 L 416
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.0 bits (95), Expect = 6e-04
Identities = 47/353 (13%), Positives = 108/353 (30%), Gaps = 89/353 (25%)
Query: 49 TGREIEERYELGRELGRGEFGITYLCTDREN------GDA------FACKSISKKKLRTA 96
+ EI+ + L + +E + F I ++ + +
Sbjct: 47 SKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPS 106
Query: 97 VDIEDVRREVDIM---------RHLPKHQNIVCLKDT-YEDDTA----VH---------L 133
+ + D + ++ + Q + L+ E A + +
Sbjct: 107 MMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWV 166
Query: 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ-MCHKHGVMHRDLKPENFLFANK 192
+++C ++ ++ + + +T++E++Q + ++ + + + +N
Sbjct: 167 ALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQ---IDPNWTSRSDHSSNI 223
Query: 193 KETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILY---- 248
K + +I L K PY VL +V +A
Sbjct: 224 KL--RIHSIQAELRRLLK---------SKPYENCLLVLL-------NVQNAKAWNAFNLS 265
Query: 249 --ILL----CGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKR 302
ILL V T+ A LD + K L+ K LD P+
Sbjct: 266 CKILLTTRFKQV------TDFLSAATTTHISLDHHSMTLTP--DEVKSLLLKYLDCRPQ- 316
Query: 303 RLTAQQVLEHPWLQNAKKAPNVSL-GETVK---ARLKQFSVMNKLK-KRALKV 350
L + + +P +S+ E+++ A + +N K ++
Sbjct: 317 DLPREVLTTNPRR--------LSIIAESIRDGLATWDNWKHVNCDKLTTIIES 361
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 352 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.87 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.78 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.5 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.32 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.24 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.2 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.91 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.84 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.8 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.56 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.5 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.43 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.37 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.15 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.13 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.96 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.73 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.72 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.65 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.63 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.6 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.53 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.49 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.4 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.19 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.13 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.03 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.79 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.5 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.04 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 84.64 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-65 Score=459.10 Aligned_cols=256 Identities=31% Similarity=0.546 Sum_probs=230.4
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|+++++||+|+||+||+|.+..+|+.||+|++.+.........+.+.+|+++|+++ +|||||++++++++++..|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEE
Confidence 5799999999999999999999999999999999876554455677899999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC--
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-- 212 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~-- 212 (352)
|||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+.....
T Consensus 111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~---vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSPESK 187 (311)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC---EEECCCTTCEECCTTTT
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCC---EEEEEcCCceecCCCCC
Confidence 999999999999999889999999999999999999999999999999999999976554 999999999876433
Q ss_pred -Ccccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHH
Q 018640 213 -EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (352)
Q Consensus 213 -~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (352)
....+.+||+.|||||++.+ .++.++||||+||++|||++|+.||.+.+..+....+.+.... .+..+++++.+
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~----~p~~~s~~~~d 263 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYD----FPEKFFPKARD 263 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC----CCTTCCHHHHH
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC----CCcccCHHHHH
Confidence 23456799999999999874 5899999999999999999999999998888887777765443 33568999999
Q ss_pred HHHHhcCCCcCCCCCHHH------HhcCcccccc
Q 018640 291 LVRKMLDPDPKRRLTAQQ------VLEHPWLQNA 318 (352)
Q Consensus 291 li~~~l~~dP~~Rps~~e------ll~hp~f~~~ 318 (352)
||.+||+.||++|||+.| |++||||++.
T Consensus 264 li~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i 297 (311)
T 4aw0_A 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297 (311)
T ss_dssp HHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred HHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence 999999999999999988 5899999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-64 Score=450.40 Aligned_cols=258 Identities=36% Similarity=0.640 Sum_probs=210.5
Q ss_pred cccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC
Q 018640 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (352)
Q Consensus 50 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 129 (352)
|..+ ++|++++.||+|+||+||+|.+..+|+.||+|++.+.........+.+.+|+.+++++ +|||||++++++.+++
T Consensus 9 G~~i-g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~ 86 (275)
T 3hyh_A 9 GAHI-GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-RHPHIIKLYDVIKSKD 86 (275)
T ss_dssp ------CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-CCTTBCCEEEEEECSS
T ss_pred CCEe-eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECC
Confidence 4445 4799999999999999999999999999999999876655555677899999999999 8999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
..++||||+ +|+|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+..
T Consensus 87 ~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~---vkl~DFGla~~~ 162 (275)
T 3hyh_A 87 EIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLN---VKIADFGLSNIM 162 (275)
T ss_dssp EEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCC---EEECCSSCC---
T ss_pred EEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCC---EEEeecCCCeec
Confidence 999999999 6799999999889999999999999999999999999999999999999976554 999999999877
Q ss_pred CCCCcccccccccccccchhcccc-C-CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHH
Q 018640 210 KPGEKFSEIVGSPYYMAPEVLKRN-Y-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (352)
Q Consensus 210 ~~~~~~~~~~gt~~y~aPE~~~~~-~-s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (352)
.......+.+||+.|||||++.+. + +.++||||+||++|+|+||+.||...........+.+.... .+..++++
T Consensus 163 ~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~----~p~~~s~~ 238 (275)
T 3hyh_A 163 TDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYT----LPKFLSPG 238 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC----CCTTSCHH
T ss_pred CCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC----CCCCCCHH
Confidence 665556677999999999998754 4 67999999999999999999999988877777766655433 33568999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcCccccc
Q 018640 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (352)
Q Consensus 288 ~~~li~~~l~~dP~~Rps~~ell~hp~f~~ 317 (352)
+.+||.+||+.||++|||+.|+++||||+.
T Consensus 239 ~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 239 AAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred HHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 999999999999999999999999999974
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-63 Score=457.74 Aligned_cols=257 Identities=32% Similarity=0.551 Sum_probs=227.3
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
.+.|++++.||+|+||+||+|.+..+|+.||||++..... ...+.+.+|+.+|+.+ +|||||+++++|.+++..||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~i 148 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWV 148 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC---SSGGGGHHHHHHHHHC-CCTTBCCEEEEEEETTEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch---hHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEE
Confidence 4679999999999999999999999999999999976532 2345688999999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC-
Q 018640 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~- 212 (352)
||||++||+|.+++.. ..+++..++.++.||+.||+|||++|||||||||+|||++.++. +||+|||+|+.....
T Consensus 149 vmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~---vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 149 VMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR---VKLSDFGFCAQVSKEV 224 (346)
T ss_dssp EECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC---EEECCCTTCEECCSSS
T ss_pred EEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCC---EEEecCcCceecCCCC
Confidence 9999999999998875 47999999999999999999999999999999999999976554 999999999876543
Q ss_pred Ccccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHH
Q 018640 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (352)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 291 (352)
....+.+||+.|||||++. ..|+.++|||||||++|||++|+.||.+....+....+.... ......+..+++++.+|
T Consensus 225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-~~~~~~~~~~s~~~~dl 303 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-PPRLKNLHKVSPSLKGF 303 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS-CCCCSCGGGSCHHHHHH
T ss_pred CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-CCCCCccccCCHHHHHH
Confidence 3456779999999999987 459999999999999999999999999988877776665543 22333456789999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 292 VRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 292 i~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
|.+||+.||++|||+.|+|+||||++..
T Consensus 304 i~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 304 LDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 9999999999999999999999999753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-63 Score=446.30 Aligned_cols=255 Identities=23% Similarity=0.381 Sum_probs=216.4
Q ss_pred ceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe----CCeEE
Q 018640 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED----DTAVH 132 (352)
Q Consensus 57 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~----~~~~~ 132 (352)
|++.++||+|+||+||+|.+..++..||+|++..... .....+.+.+|+.+|+++ +|||||+++++|.. ++.++
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~~ 105 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEEETTEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEeeccCCCcEEE
Confidence 4788899999999999999999999999999976543 344567899999999999 89999999999865 35689
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG--VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
|||||++||+|.+++.....+++..++.++.||+.||+|||+++ ||||||||+|||++.. .+.+||+|||+|+...
T Consensus 106 lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~--~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP--TGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESST--TSCEEECCTTGGGGCC
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECC--CCCEEEEeCcCCEeCC
Confidence 99999999999999998889999999999999999999999998 9999999999999642 2349999999998643
Q ss_pred CCCcccccccccccccchhccccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHH
Q 018640 211 PGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (352)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (352)
. ....+.+||+.|||||++.+.++.++|||||||++|||+||+.||................. .+...+...++++.+
T Consensus 184 ~-~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~ 261 (290)
T 3fpq_A 184 A-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV-KPASFDKVAIPEVKE 261 (290)
T ss_dssp T-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC-CCGGGGGCCCHHHHH
T ss_pred C-CccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCC-CCCCCCccCCHHHHH
Confidence 3 33456789999999999988899999999999999999999999976554433333322211 122233457889999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcCccccc
Q 018640 291 LVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (352)
Q Consensus 291 li~~~l~~dP~~Rps~~ell~hp~f~~ 317 (352)
||.+||+.||++|||+.|+++||||++
T Consensus 262 li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 262 IIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHccCChhHCcCHHHHhcCccccC
Confidence 999999999999999999999999985
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-63 Score=458.77 Aligned_cols=256 Identities=27% Similarity=0.537 Sum_probs=220.9
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++++.||+|+||+||+|.+..+|+.||||++..... .....+.+.+|+.+|+++ +|||||++++++++++..|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANM-KHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHC-CCCCCCcEEEEEEECCEEEEE
Confidence 579999999999999999999999999999999977643 334567899999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 135 MELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
|||++||+|.+++..++ .+++..++.++.||+.||+|||++|||||||||+|||++.++. +||+|||+|+.....
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~---vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT---VQLGDFGIARVLNST 178 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCC---EEECSTTEESCCCHH
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCC---EEEcccccceeecCC
Confidence 99999999999997653 4789999999999999999999999999999999999976554 999999999876543
Q ss_pred C-cccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHH
Q 018640 213 E-KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (352)
Q Consensus 213 ~-~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (352)
. .....+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+....+....+.+... +..+..+++++.+
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~---~~~~~~~s~~~~~ 255 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF---PPVSLHYSYDLRS 255 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC---CCCCTTSCHHHHH
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC---CCCCccCCHHHHH
Confidence 2 2345689999999999875 599999999999999999999999999888888777766532 2334578999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 291 LVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 291 li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
||.+||+.||++|||+.|+|+||||++.
T Consensus 256 li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 256 LVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 9999999999999999999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-62 Score=458.53 Aligned_cols=257 Identities=32% Similarity=0.552 Sum_probs=227.4
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
.+.|+++++||+|+||+||+|.+..+|+.||||++.... ....+.+.+|+.+|+.+ +|||||+++++|..++.+||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~i 225 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWV 225 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT---CSSGGGHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHhC-CCCCCCceEEEEEECCEEEE
Confidence 457999999999999999999999999999999997653 23346788999999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC-
Q 018640 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~- 212 (352)
||||++||+|.+++.. ..+++..++.++.||+.||+|||++|||||||||+|||++.++. +||+|||+|+.....
T Consensus 226 VmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~---vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 226 VMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR---VKLSDFGFCAQVSKEV 301 (423)
T ss_dssp EEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCC---EEECCCTTCEECCSSC
T ss_pred EEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC---EEEecCccceECCCCC
Confidence 9999999999999865 46999999999999999999999999999999999999976554 999999999876543
Q ss_pred Ccccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHH
Q 018640 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (352)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 291 (352)
....+.+||+.|||||++. ..|+.++|||||||++|||++|+.||.+....+....+.... ......+..+++++.+|
T Consensus 302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-~~~~~~~~~~s~~~~dl 380 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-PPRLKNLHKVSPSLKGF 380 (423)
T ss_dssp CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CCCCSCTTSSCHHHHHH
T ss_pred ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-CCCCcccccCCHHHHHH
Confidence 3456779999999999987 459999999999999999999999999988877776665543 22334456789999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 292 VRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 292 i~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
|.+||+.||++|||+.|+|+||||++..
T Consensus 381 i~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 381 LDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 9999999999999999999999999753
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-62 Score=444.92 Aligned_cols=255 Identities=28% Similarity=0.492 Sum_probs=218.3
Q ss_pred ccceeceeeeccCceEEEEEEEC---CCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 55 ERYELGRELGRGEFGITYLCTDR---ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
++|++++.||+|+||+||+|++. .+++.||+|++.+..... .+...+.+|+.+|+++ +|||||++++++++++..
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV-RDRVRTKMERDILVEV-NHPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE-EECC------CCCCCC-CCTTEECEEEEEEETTEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh-HHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEE
Confidence 57999999999999999999874 468899999997654332 2334688899999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
+|||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+....
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~---vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH---IKLTDFGLSKESID 178 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSC---EEEESSEEEEC---
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCC---EEecccccceeccC
Confidence 999999999999999999889999999999999999999999999999999999999976554 99999999986543
Q ss_pred -CCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHH
Q 018640 212 -GEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (352)
Q Consensus 212 -~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (352)
.....+.+||+.|||||++. ..++.++|||||||++|||+||+.||.+.+..+....+.+.... .+..+++++.
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~----~p~~~s~~~~ 254 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG----MPQFLSPEAQ 254 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----CCTTSCHHHH
T ss_pred CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCC----CCCcCCHHHH
Confidence 33445679999999999987 45999999999999999999999999998888877777665433 3456899999
Q ss_pred HHHHHhcCCCcCCCCC-----HHHHhcCcccccc
Q 018640 290 DLVRKMLDPDPKRRLT-----AQQVLEHPWLQNA 318 (352)
Q Consensus 290 ~li~~~l~~dP~~Rps-----~~ell~hp~f~~~ 318 (352)
+||.+||+.||++||| ++|+++||||++.
T Consensus 255 ~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 255 SLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp HHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 9999999999999998 5799999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-61 Score=442.13 Aligned_cols=254 Identities=24% Similarity=0.346 Sum_probs=219.2
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
+.|++.+.||+|+||+||+|.+..+|+.||||++..... ..+|+.+++.+ +|||||++++++.+++..|||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l-~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGL-SSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTC-CCTTBCCEEEEEEETTEEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEE
Confidence 468999999999999999999999999999999976432 23699999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCc
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (352)
|||++||+|.+++...+.+++..++.++.||+.||+|||++|||||||||+|||++.++. .+||+|||+|+.......
T Consensus 129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS--RAALCDFGHALCLQPDGL 206 (336)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSC--CEEECCCTTCEEC-----
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCC--EEEEeeCCCCeEccCCCc
Confidence 999999999999998889999999999999999999999999999999999999976543 389999999987654321
Q ss_pred ------ccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHH
Q 018640 215 ------FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (352)
Q Consensus 215 ------~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (352)
....+||+.|||||++.+ .++.++|||||||++|||+||+.||.+.........+....... ...++.+++.
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~s~~ 285 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPI-REIPPSCAPL 285 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGG-GGSCTTSCHH
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCc-hhcCccCCHH
Confidence 234589999999999874 59999999999999999999999998877666666666543322 2345678999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHH-------------hcCcccccccc
Q 018640 288 AKDLVRKMLDPDPKRRLTAQQV-------------LEHPWLQNAKK 320 (352)
Q Consensus 288 ~~~li~~~l~~dP~~Rps~~el-------------l~hp~f~~~~~ 320 (352)
+.+||.+||+.||++|||+.|+ ++|||+.+...
T Consensus 286 ~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~ 331 (336)
T 4g3f_A 286 TAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE 331 (336)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred HHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence 9999999999999999999997 68999987643
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-59 Score=437.79 Aligned_cols=261 Identities=27% Similarity=0.437 Sum_probs=223.3
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe----
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED---- 127 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~---- 127 (352)
.+.++|++++.||+|+||+||+|.+..+|+.||||++.... ......+.+.+|+.+|+.+ +|||||++++++..
T Consensus 51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 128 (398)
T 4b99_A 51 DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF-DVVTNAKRTLRELKILKHF-KHDNIIAIKDILRPTVPY 128 (398)
T ss_dssp CCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT-SSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSSCT
T ss_pred CCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc-cchHHHHHHHHHHHHHHhc-CCCCcceEeeeeeccccc
Confidence 35678999999999999999999999999999999997653 2334456788999999999 89999999998753
Q ss_pred --CCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccc
Q 018640 128 --DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (352)
Q Consensus 128 --~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~ 205 (352)
.+..||||||++ |+|.+++.....+++..++.++.||+.||+|||++|||||||||+|||++.++. +||+|||+
T Consensus 129 ~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~---~Ki~DFGl 204 (398)
T 4b99_A 129 GEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCE---LKIGDFGM 204 (398)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC---EEECCCTT
T ss_pred ccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCC---EEEeecce
Confidence 367899999995 689999998889999999999999999999999999999999999999976554 89999999
Q ss_pred ceecCCC-----Ccccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC
Q 018640 206 SVFFKPG-----EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR 278 (352)
Q Consensus 206 a~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 278 (352)
|+..... ....+.+||+.|+|||++.+ .++.++||||+||++|||++|++||.+.+..+....+.........
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9865332 23356799999999998764 4799999999999999999999999999888887777665443221
Q ss_pred CC---------------------------CcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 279 DP---------------------------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 279 ~~---------------------------~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
.. ++.+++++.+||.+||+.||++|||+.|+|+||||++.
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 11 23468999999999999999999999999999999975
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-59 Score=424.72 Aligned_cols=254 Identities=24% Similarity=0.365 Sum_probs=216.4
Q ss_pred ccceeceeeeccCceEEEEEEEC-----CCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC
Q 018640 55 ERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 129 (352)
++|.+.+.||+|+||+||+|.+. .++..||||++... .....++|.+|+++|+++ +|||||+++++|.+++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNL-QHEHIVKFYGVCVEGD 88 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeCC
Confidence 57999999999999999999864 35889999998753 344567899999999999 8999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCC
Q 018640 130 AVHLVMELCEGGELFDRIVAR-------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETA 196 (352)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~-------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~ 196 (352)
..+|||||+++|+|.++|... ..+++..+..|+.||+.||.|||+++||||||||+|||++.++.
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~-- 166 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL-- 166 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc--
Confidence 999999999999999999754 35999999999999999999999999999999999999976655
Q ss_pred CEEEEecccceecCCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 018640 197 PLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIR 271 (352)
Q Consensus 197 ~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~ 271 (352)
+||+|||+|+....... .....||+.|||||++. +.++.++|||||||++|||+| |+.||.+....+....+.+
T Consensus 167 -~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~ 245 (299)
T 4asz_A 167 -VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 245 (299)
T ss_dssp -EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH
T ss_pred -EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 89999999986543322 23347899999999987 569999999999999999998 8999999888877777765
Q ss_pred cccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 272 SVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
.. ....+..+++++.+||.+||+.||++|||+.+| ++|+++..+
T Consensus 246 ~~---~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~~ 289 (299)
T 4asz_A 246 GR---VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLAK 289 (299)
T ss_dssp TC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHHH
T ss_pred CC---CCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHHh
Confidence 43 233445789999999999999999999999999 568876544
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-59 Score=421.82 Aligned_cols=254 Identities=28% Similarity=0.457 Sum_probs=198.0
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC-----
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT----- 129 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~----- 129 (352)
++|++++.||+|+||+||+|.+..+|+.||||++.... .....+.+.+|+.+|+++ +|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKL-EHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEEC-----
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEecCccccc
Confidence 46999999999999999999999999999999987542 344557899999999999 8999999999987544
Q ss_pred -------eEEEEEEecCCcchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEE
Q 018640 130 -------AVHLVMELCEGGELFDRIVARGH---YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLK 199 (352)
Q Consensus 130 -------~~~lv~e~~~~~sL~~~l~~~~~---l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vk 199 (352)
..|+||||++||+|.+++..+.. .++..++.++.||+.||+|||++||+||||||+|||++.++. +|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~---vK 158 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV---VK 158 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC---EE
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCc---EE
Confidence 37899999999999999987654 455678999999999999999999999999999999976554 99
Q ss_pred EEecccceecCCCCc-------------ccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 018640 200 AIDFGLSVFFKPGEK-------------FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGV 265 (352)
Q Consensus 200 l~Dfg~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~ 265 (352)
|+|||+|+....... ....+||+.|||||++.+ .++.++|||||||++|||++ ||......
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~-- 233 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER-- 233 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH--
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH--
Confidence 999999987643321 234579999999999874 59999999999999999996 77543322
Q ss_pred HHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 266 AQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
...+........+..+...++.+.+||.+||+.||++|||+.|+++||||++..
T Consensus 234 ~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 234 VRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred HHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 222211111111112234566788999999999999999999999999999763
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-58 Score=424.53 Aligned_cols=257 Identities=25% Similarity=0.478 Sum_probs=210.9
Q ss_pred cccccceeceeeeccCceEEEEEEEC---CCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDR---ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 128 (352)
.+.++|++++.||+|+||+||+|+++ .+++.||+|++... ....++.+|+++|+.+.+|||||++++++...
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~-----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT-----SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT-----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc-----cCHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 57789999999999999999999874 46789999988653 23456888999999997899999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccccee
Q 018640 129 TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~ 208 (352)
+..++||||++||+|.+++. .+++..++.++.||+.||+|||++||+||||||+|||++.+. ..+||+|||+|+.
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~--~~~kl~DFGla~~ 167 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRL--KKYALVDFGLAQG 167 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT--TEEEECCCTTCEE
T ss_pred CEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCC--CeEEECcCCCCcc
Confidence 99999999999999999983 599999999999999999999999999999999999997542 3489999999976
Q ss_pred cCCCC-----------------------------cccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCC
Q 018640 209 FKPGE-----------------------------KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPF 257 (352)
Q Consensus 209 ~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~ 257 (352)
..... .....+||++|+|||++.+ .++.++||||+||++|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 53221 1234579999999998764 4899999999999999999999999
Q ss_pred CCCC-HHHHHHHHHhcccc--------------------------------------------------cCCCCCcCCCH
Q 018640 258 WAET-EQGVAQAIIRSVLD--------------------------------------------------FRRDPWPKVSE 286 (352)
Q Consensus 258 ~~~~-~~~~~~~~~~~~~~--------------------------------------------------~~~~~~~~~~~ 286 (352)
.... ..+.+..+...... .....+..+++
T Consensus 248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~ 327 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD 327 (361)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence 6554 33333332221000 01122456789
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 287 ~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
++.|||.+||+.||++|||+.|+|+||||++.
T Consensus 328 ~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 328 EAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 99999999999999999999999999999975
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-58 Score=419.97 Aligned_cols=254 Identities=22% Similarity=0.343 Sum_probs=210.1
Q ss_pred ccceeceeeeccCceEEEEEEEC-----CCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC
Q 018640 55 ERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 129 (352)
++|.+.++||+|+||+||+|.+. .++..||||++... +....++|.+|+.+|+++ +|||||+++++|.+.+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTML-QHQHIVRFFGVCTEGR 116 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECC
Confidence 57899999999999999999864 36889999998753 344567899999999999 9999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCC
Q 018640 130 AVHLVMELCEGGELFDRIVAR---------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE 194 (352)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~---------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~ 194 (352)
..+|||||+++|+|.+++... .++++..+..|+.|++.||.|||+++||||||||+|||++.++.
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc
Confidence 999999999999999999753 35899999999999999999999999999999999999986554
Q ss_pred CCCEEEEecccceecCCCC---cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 018640 195 TAPLKAIDFGLSVFFKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAI 269 (352)
Q Consensus 195 ~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~ 269 (352)
+||+|||+|+...... ......||+.|||||++. ..++.++|||||||++|||+| |+.||......+....+
T Consensus 197 ---~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 273 (329)
T 4aoj_A 197 ---VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI 273 (329)
T ss_dssp ---EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred ---EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 8999999998654332 224568999999999987 459999999999999999999 89999988887777766
Q ss_pred HhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 270 IRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
.+.. +...+..+++++.+|+.+||+.||++|||+.||+++ ++....
T Consensus 274 ~~g~---~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~--L~~l~~ 319 (329)
T 4aoj_A 274 TQGR---ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR--LQALAQ 319 (329)
T ss_dssp HHTC---CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH--HHHHHH
T ss_pred HcCC---CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH--HHHHhh
Confidence 6542 334456789999999999999999999999999764 444433
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-58 Score=416.93 Aligned_cols=249 Identities=23% Similarity=0.357 Sum_probs=213.0
Q ss_pred ccceeceeeeccCceEEEEEEEC-----CCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC
Q 018640 55 ERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 129 (352)
.++++.++||+|+||+||+|.+. .+++.||||++.... .....++|.+|+.+++++ +|||||+++++|..++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~~~ 102 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARL-QHPNVVCLLGVVTKDQ 102 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHC-CCTTBCCEEEEECSSS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhC-CCCCCCCcceEEEECC
Confidence 46888999999999999999863 467899999997542 334567899999999999 9999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCC
Q 018640 130 AVHLVMELCEGGELFDRIVAR----------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK 193 (352)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~ 193 (352)
..+|||||+++|+|.++|..+ ..+++..+..|+.||+.||+|||+++||||||||+|||++.++
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCC
Confidence 999999999999999999643 3489999999999999999999999999999999999998665
Q ss_pred CCCCEEEEecccceecCCCC---cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 018640 194 ETAPLKAIDFGLSVFFKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQA 268 (352)
Q Consensus 194 ~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~ 268 (352)
. +||+|||+|+...... ......||+.|||||++. +.++.++|||||||+||||+| |..||.+....+....
T Consensus 183 ~---~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~ 259 (308)
T 4gt4_A 183 N---VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 259 (308)
T ss_dssp C---EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred C---EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 5 8999999998654322 234568999999999886 569999999999999999998 8999999888777766
Q ss_pred HHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 269 IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
+.+.. ..+.++.+++.+.+|+.+||+.||++|||+.||+++
T Consensus 260 i~~~~---~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 260 IRNRQ---VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHTTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHcCC---CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 65432 233456789999999999999999999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-58 Score=414.27 Aligned_cols=249 Identities=22% Similarity=0.371 Sum_probs=203.3
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
+++++.++||+|+||+||+|.+. ..||||+++... .+....+.|.+|+.+++++ +|||||++++++.+ +..+||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVD-PTPEQFQAFRNEVAVLRKT-RHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSS-CCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS-SSCEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecC-CCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEC-CeEEEE
Confidence 46889999999999999999864 359999987543 3344567899999999999 99999999998765 568999
Q ss_pred EEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC-
Q 018640 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~- 212 (352)
|||++||+|.+++... ..+++..+..|+.||+.||+|||+++||||||||+|||++.++. +||+|||+|+.....
T Consensus 110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~---~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLT---VKIGDFGLATVKSRWS 186 (307)
T ss_dssp EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEE---EEECCCSSCBC-----
T ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCc---EEEeeccCceecccCC
Confidence 9999999999999764 46999999999999999999999999999999999999986554 899999999865432
Q ss_pred --Ccccccccccccccchhccc----cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC--CCCCcCC
Q 018640 213 --EKFSEIVGSPYYMAPEVLKR----NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR--RDPWPKV 284 (352)
Q Consensus 213 --~~~~~~~gt~~y~aPE~~~~----~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 284 (352)
.......||+.|||||++.+ .++.++|||||||+||||+||+.||.+.................+ ...++.+
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 266 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNC 266 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTS
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccc
Confidence 23345689999999999852 388899999999999999999999987665554444443322211 2334578
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 285 SENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 285 ~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
++.+.+||.+||+.||++|||+.||+++
T Consensus 267 ~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 267 PKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp CHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999999988654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-57 Score=445.33 Aligned_cols=263 Identities=34% Similarity=0.654 Sum_probs=236.5
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
.+-++|++++.||+|+||+||+|.++.+|+.||+|++... ...+.+.+.+|+.+|+.+ +|||||+++++|.+++..
T Consensus 154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~---~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 229 (573)
T 3uto_A 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDDNEM 229 (573)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEECSSEE
T ss_pred cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc---chhhHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEE
Confidence 3457899999999999999999999999999999998754 334467789999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 132 HLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
+|||||++||+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+. ...+||+|||+|+...
T Consensus 230 ~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~-~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 230 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKR-SNELKLIDFGLTAHLD 308 (573)
T ss_dssp EEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS-CCCEEECCCSSCEECC
T ss_pred EEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCC-CCCEEEeeccceeEcc
Confidence 999999999999999964 45799999999999999999999999999999999999997542 3459999999999887
Q ss_pred CCCcccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHH
Q 018640 211 PGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (352)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (352)
........+||+.|||||++.+ .++.++|||||||++|||++|..||.+....+....+......++...+..+++++.
T Consensus 309 ~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 388 (573)
T 3uto_A 309 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 388 (573)
T ss_dssp TTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHH
T ss_pred CCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 7766677799999999999874 589999999999999999999999999998888888877766666666678999999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 290 ~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
+||.+||+.||.+|||+.|+|+||||+...
T Consensus 389 dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~ 418 (573)
T 3uto_A 389 DFIRKLLLADPNTRMTIHQALEHPWLTPGN 418 (573)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSTTTSCCC
T ss_pred HHHHHHccCChhHCcCHHHHhcCcCcCCCC
Confidence 999999999999999999999999999653
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-57 Score=444.37 Aligned_cols=258 Identities=28% Similarity=0.474 Sum_probs=217.9
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHH---HHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRRE---VDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E---~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
++|+++++||+|+||+||+|.+..+|+.||+|++.+...........+.+| +.+++.+ +|||||+++++|++.+.+
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~-~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC-CCCCEeEEEEEEEECCEE
Confidence 579999999999999999999999999999999987654333333444444 5666666 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
||||||++||+|.+++...+.+++..++.++.||+.||+|||++|||||||||+|||++.++. +||+|||+|+....
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~---vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH---VRISDLGLACDFSK 344 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSC---EEECCCTTCEECSS
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCC---EEecccceeeecCC
Confidence 999999999999999999889999999999999999999999999999999999999976554 99999999987654
Q ss_pred CCcccccccccccccchhcc-c-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHH
Q 018640 212 GEKFSEIVGSPYYMAPEVLK-R-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (352)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~-~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (352)
.. ..+.+||+.|||||++. + .|+.++|+|||||++|||++|..||.+...... ..+...........+..+++++.
T Consensus 345 ~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~-~~i~~~i~~~~~~~p~~~S~~a~ 422 (689)
T 3v5w_A 345 KK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVELPDSFSPELR 422 (689)
T ss_dssp CC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH-HHHHHHHHHCCCCCCTTSCHHHH
T ss_pred CC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhhcCCCCCCCccCCHHHH
Confidence 43 35569999999999985 3 589999999999999999999999976432211 12222222334445567899999
Q ss_pred HHHHHhcCCCcCCCCC-----HHHHhcCcccccc
Q 018640 290 DLVRKMLDPDPKRRLT-----AQQVLEHPWLQNA 318 (352)
Q Consensus 290 ~li~~~l~~dP~~Rps-----~~ell~hp~f~~~ 318 (352)
+||.+||+.||.+|++ +.||++||||++.
T Consensus 423 dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 423 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp HHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred HHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence 9999999999999998 7999999999864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-56 Score=413.81 Aligned_cols=301 Identities=39% Similarity=0.722 Sum_probs=261.9
Q ss_pred CCcccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe
Q 018640 48 PTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (352)
Q Consensus 48 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 127 (352)
.....+.++|++.+.||+|+||+||+|.+..+|+.||+|++..... .....+.+.+|+.+++.+ +||||+++++++.+
T Consensus 22 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~ 99 (362)
T 2bdw_A 22 NASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKL-QHPNIVRLHDSIQE 99 (362)
T ss_dssp --CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEC
T ss_pred cCCCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEe
Confidence 3445678899999999999999999999999999999999976533 334567789999999999 89999999999999
Q ss_pred CCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccce
Q 018640 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (352)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~ 207 (352)
.+..++||||++|++|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++.++....+||+|||++.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 100 ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp SSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred CCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 99999999999999999999888889999999999999999999999999999999999999877666679999999998
Q ss_pred ecCCCCcccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCH
Q 018640 208 FFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (352)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (352)
............||+.|+|||++.+ .++.++||||||+++|+|++|..||+..........+......++...+..+++
T Consensus 180 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 259 (362)
T 2bdw_A 180 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP 259 (362)
T ss_dssp CCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCH
T ss_pred EecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 7765555566789999999999875 589999999999999999999999999888877777777766666666678899
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcCccccccccCCCCCCcHHHHHHHHhhHHHHHHHHHHHhh
Q 018640 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKV 350 (352)
Q Consensus 287 ~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (352)
.+.+||.+||+.||++|||+.++++||||.+............+...++.|...++++.-+...
T Consensus 260 ~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 323 (362)
T 2bdw_A 260 EAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTT 323 (362)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTHHHHSCCCCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCcccCCCcccccccchhhHHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999987544333334456677899998888888765543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-56 Score=423.79 Aligned_cols=300 Identities=41% Similarity=0.713 Sum_probs=261.7
Q ss_pred cccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC
Q 018640 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (352)
Q Consensus 50 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 129 (352)
...+.++|++.+.||+|+||+||+|.+..+|+.||+|++..... .....+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus 6 ~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 83 (444)
T 3soa_A 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLL-KHPNIVRLHDSISEEG 83 (444)
T ss_dssp -CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHC-CBTTBCCEEEEEECSS
T ss_pred cccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhC-CCcCCCeEEEEEEECC
Confidence 44678899999999999999999999999999999999876543 233456789999999999 8999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
..++||||++||+|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++.+.....+||+|||++...
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 99999999999999999999889999999999999999999999999999999999999987656667999999999776
Q ss_pred CCCC-cccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHH
Q 018640 210 KPGE-KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (352)
Q Consensus 210 ~~~~-~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (352)
.... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||+..........+......++...++.+++.
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 243 (444)
T 3soa_A 164 EGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPE 243 (444)
T ss_dssp CTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred cCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHH
Confidence 5433 3355689999999999875 5899999999999999999999999999988888888888777777777889999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcCccccccccCCCCCCcHHHHHHHHhhHHHHHHHHHHHhhc
Q 018640 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVM 351 (352)
Q Consensus 288 ~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (352)
+.+||.+||+.||++|||+.|+|+||||++...............+++.|..++++|..+..+|
T Consensus 244 ~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~klk~~~~~~~ 307 (444)
T 3soa_A 244 AKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAILTVM 307 (444)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHHSCTTHHHHHHSCCCCCHHHHHHHHHHHHHHHHHTTCSCEE
T ss_pred HHHHHHHHcCCChhHCCCHHHHhcCccccCCccccccchhhHHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999976544444444566679999999999987665544
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-56 Score=412.88 Aligned_cols=252 Identities=23% Similarity=0.337 Sum_probs=210.1
Q ss_pred cccceeceeeeccCceEEEEEEECCC-----CcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC
Q 018640 54 EERYELGRELGRGEFGITYLCTDREN-----GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 128 (352)
.++|++.+.||+|+||+||+|.+... ++.||||.+.... .....+.+.+|+.+|.++.+|||||+++++|...
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 36899999999999999999997643 3679999987542 3344567999999999996669999999998664
Q ss_pred -CeEEEEEEecCCcchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeec
Q 018640 129 -TAVHLVMELCEGGELFDRIVAR----------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFAN 191 (352)
Q Consensus 129 -~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~ 191 (352)
+..+|||||+++|+|.++|... ..+++..+..++.||+.||+|||+++||||||||+|||++.
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 220 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence 5789999999999999999753 24899999999999999999999999999999999999986
Q ss_pred CCCCCCEEEEecccceecCCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 018640 192 KKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVA 266 (352)
Q Consensus 192 ~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~ 266 (352)
++. +||+|||+|+....... .....||+.|||||++. +.++.++|||||||++|||+| |..||.+....+..
T Consensus 221 ~~~---vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~ 297 (353)
T 4ase_A 221 KNV---VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 297 (353)
T ss_dssp GGC---EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred CCC---EEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 654 89999999987644332 24567899999999986 569999999999999999998 99999876544433
Q ss_pred HHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 267 QAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
....... .+...++.+++++.++|..||+.||++|||+.||++|
T Consensus 298 ~~~i~~g--~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 298 CRRLKEG--TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcC--CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 3333322 2333445789999999999999999999999999987
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-55 Score=424.80 Aligned_cols=302 Identities=40% Similarity=0.697 Sum_probs=266.5
Q ss_pred CcccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC
Q 018640 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (352)
Q Consensus 49 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 128 (352)
....+.++|++.+.||+|+||+||+|.+..+|+.||+|++...........+.+.+|+.+++++ +||||+++++++...
T Consensus 20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~ 98 (484)
T 3nyv_A 20 STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFEDK 98 (484)
T ss_dssp CCCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-CCTTBCCEEEEEECS
T ss_pred CCCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeC
Confidence 3456788999999999999999999999999999999999776555555678899999999999 899999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccccee
Q 018640 129 TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~ 208 (352)
+..++||||+++++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.......+||+|||++..
T Consensus 99 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 99 GYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 99999999999999999999888999999999999999999999999999999999999997655666799999999987
Q ss_pred cCCCCcccccccccccccchhccccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHH
Q 018640 209 FKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (352)
Q Consensus 209 ~~~~~~~~~~~gt~~y~aPE~~~~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (352)
...........||+.|+|||++.+.++.++||||||+++|+|++|..||......+....+......+..+.+..+++.+
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 258 (484)
T 3nyv_A 179 FEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA 258 (484)
T ss_dssp BCCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHH
T ss_pred cccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHH
Confidence 76655556668999999999998889999999999999999999999999999888888888776666666667899999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcCccccccccC---CCCCCcHHHHHHHHhhHHHHHHHHHHHhhc
Q 018640 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKA---PNVSLGETVKARLKQFSVMNKLKKRALKVM 351 (352)
Q Consensus 289 ~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (352)
.+||.+||+.||.+|||+.|+++||||+..... ...+...+...+++.|...++++..+..+|
T Consensus 259 ~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~qa~l~~i 324 (484)
T 3nyv_A 259 KDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYM 324 (484)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-----CCCBCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHCCCChhHCcCHHHHhhChhhcccccccccccccchHHHHHHHHHHhhhhHHHHHHHHHH
Confidence 999999999999999999999999999976432 233444666678888888888888776654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-55 Score=422.63 Aligned_cols=303 Identities=39% Similarity=0.664 Sum_probs=258.3
Q ss_pred CCCcccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEE
Q 018640 47 EPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (352)
Q Consensus 47 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~ 126 (352)
......+.++|++++.||+|+||+||+|.+..++..||+|++...... ......+.+|+.+++.+ +||||+++++++.
T Consensus 29 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 106 (494)
T 3lij_A 29 TSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLL-DHPNIMKLYDFFE 106 (494)
T ss_dssp CCCBCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTC-CCTTBCCEEEEEE
T ss_pred ecCCCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHhC-CCCCCCeEEEEEE
Confidence 344456788999999999999999999999999999999998765432 22356789999999999 8999999999999
Q ss_pred eCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccc
Q 018640 127 DDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (352)
Q Consensus 127 ~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a 206 (352)
.....++||||+++|+|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++..+....+||+|||++
T Consensus 107 ~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 107 DKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 99999999999999999999988888999999999999999999999999999999999999987666677999999999
Q ss_pred eecCCCCcccccccccccccchhccccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCH
Q 018640 207 VFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (352)
Q Consensus 207 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (352)
.............||+.|+|||++.+.++.++||||||+++|+|++|..||......+....+......+....+..+++
T Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 266 (494)
T 3lij_A 187 AVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSE 266 (494)
T ss_dssp EECBTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCH
T ss_pred eECCCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCH
Confidence 88766666666789999999999988899999999999999999999999999998888888888777666666778999
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcCccccccccC----CCCCCcHHHHHHHHhhHHHHHHHHHHHhhc
Q 018640 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKA----PNVSLGETVKARLKQFSVMNKLKKRALKVM 351 (352)
Q Consensus 287 ~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (352)
.+.+||.+||+.||.+|||+.++|+||||++.... ...+...++..+++.|...++++.-++.++
T Consensus 267 ~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~qa~l~~i 335 (494)
T 3lij_A 267 GAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYM 335 (494)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCCSSHHHHHHTTTTCCHHHHHHHHHH
T ss_pred HHHHHHHHHCCCChhhCccHHHHhcCcccccCcccccccccccccHHHHHHHHHHHHhHHHHHHHHHHH
Confidence 99999999999999999999999999999875322 333444566668888877777776655443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-55 Score=404.74 Aligned_cols=299 Identities=38% Similarity=0.680 Sum_probs=240.8
Q ss_pred cccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccC--ChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe
Q 018640 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR--TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (352)
Q Consensus 50 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 127 (352)
...+.++|++.+.||+|+||+||+|.+..+|+.||+|++...... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus 19 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 97 (351)
T 3c0i_A 19 DVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-KHPHIVELLETYSS 97 (351)
T ss_dssp -CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-CCTTBCCEEEEEEE
T ss_pred CCccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-CCCCCCcEEEEEEe
Confidence 345778999999999999999999999999999999998654322 122467899999999999 89999999999999
Q ss_pred CCeEEEEEEecCCcchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEec
Q 018640 128 DTAVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDF 203 (352)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~----~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Df 203 (352)
.+..++||||++|++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+||
T Consensus 98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecC
Confidence 99999999999999998887543 24899999999999999999999999999999999999987777677999999
Q ss_pred ccceecCCCCc-ccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCC
Q 018640 204 GLSVFFKPGEK-FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281 (352)
Q Consensus 204 g~a~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (352)
|++........ .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.... ......+...........+
T Consensus 178 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~ 256 (351)
T 3c0i_A 178 GVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQW 256 (351)
T ss_dssp TTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHH
T ss_pred cceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcccc
Confidence 99987654432 345689999999999874 58999999999999999999999998753 3444455444333333334
Q ss_pred cCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc-CCCCCCcHHHHHHHHhhHHHHHHHHHHHhhc
Q 018640 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK-APNVSLGETVKARLKQFSVMNKLKKRALKVM 351 (352)
Q Consensus 282 ~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (352)
..+++.+.+||.+||+.||++|||+.++++||||++... .....+.. ...+++.+...++++....+.+
T Consensus 257 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~~~~~~~~~~-~~~~l~~~~~~~~~~~~~~~~~ 326 (351)
T 3c0i_A 257 SHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPE-TVEQLRKFNARRKLKGAVLAAV 326 (351)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHHHHSCCSCCHH-HHHHHHHHHHHHC---------
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCccccccccchH-HHHHHHHHHHHHHHHHHHHHHH
Confidence 578999999999999999999999999999999997643 23333444 4457888888888877666544
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-54 Score=402.29 Aligned_cols=267 Identities=39% Similarity=0.711 Sum_probs=237.1
Q ss_pred ccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCC---hhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe
Q 018640 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT---AVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (352)
Q Consensus 51 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 127 (352)
..+.++|++.+.||+|+||+||+|.+..+|+.||+|++....... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~ 86 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHPNIITLHDVYEN 86 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC-CCcCCCcEEEEEEe
Confidence 357788999999999999999999999999999999997654322 12457899999999999 89999999999999
Q ss_pred CCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCC-CCCEEEEecccc
Q 018640 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE-TAPLKAIDFGLS 206 (352)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~-~~~vkl~Dfg~a 206 (352)
.+..++||||++|++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++. ...+||+|||++
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 9999999999999999999988888999999999999999999999999999999999999976542 225999999999
Q ss_pred eecCCCCcccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCC
Q 018640 207 VFFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (352)
Q Consensus 207 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (352)
.............||+.|+|||++.+ .++.++||||||+++|+|++|..||.+....+....+......+....+..++
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 246 (361)
T 2yab_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTS 246 (361)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred eEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCC
Confidence 88766655667789999999999874 58999999999999999999999999988888877777765555555556789
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 286 ~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
+.+.+||.+||..||.+|||+.|+++||||+..
T Consensus 247 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 999999999999999999999999999999854
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-54 Score=420.53 Aligned_cols=302 Identities=36% Similarity=0.639 Sum_probs=255.2
Q ss_pred CCcccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCCh----------hcHHHHHHHHHHHHhCCCCCC
Q 018640 48 PTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA----------VDIEDVRREVDIMRHLPKHQN 117 (352)
Q Consensus 48 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~~h~~ 117 (352)
.....+.++|++++.||+|+||+||+|.+..++..||+|++........ ...+.+.+|+.+++++ +|||
T Consensus 29 ~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpn 107 (504)
T 3q5i_A 29 KKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPN 107 (504)
T ss_dssp EECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC-CCTT
T ss_pred ccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-CCCC
Confidence 3345678899999999999999999999999999999999876543221 3356789999999999 8999
Q ss_pred eeEeeeEEEeCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCC
Q 018640 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAP 197 (352)
Q Consensus 118 iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~ 197 (352)
|+++++++......++||||++||+|.+.+.....+++..++.++.||+.||.|||+.||+||||||+|||++.++....
T Consensus 108 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 108 IIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSS
T ss_pred CCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999999999999988888999999999999999999999999999999999999987766567
Q ss_pred EEEEecccceecCCCCcccccccccccccchhccccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC
Q 018640 198 LKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR 277 (352)
Q Consensus 198 vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 277 (352)
+||+|||++.............||+.|+|||++.+.++.++||||||+++|+|++|..||......+....+......+.
T Consensus 188 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 267 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD 267 (504)
T ss_dssp EEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred EEEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 99999999988766666667789999999999988899999999999999999999999999998888888877665555
Q ss_pred CCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccCCCCCC---cHHHHHHHHhhHHHHHHHHHHHhh
Q 018640 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSL---GETVKARLKQFSVMNKLKKRALKV 350 (352)
Q Consensus 278 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 350 (352)
...+..+++.+.+||.+||+.||.+|||+.|+|+||||++.......+- ......+++.|...++++.-+..+
T Consensus 268 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~~a~l~~ 343 (504)
T 3q5i_A 268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILF 343 (504)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCCGGGHHHHHHHHHHHHHCCCCSHHHHHHHHH
T ss_pred ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcccccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 4455678999999999999999999999999999999997655433222 233444666666667776655544
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=420.63 Aligned_cols=298 Identities=40% Similarity=0.715 Sum_probs=257.3
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
.+.++|++++.||+|+||+||+|.+..+|+.||+|++...... ......+.+|+.+++++ +||||+++++++......
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 96 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKL-DHPNIMKLFEILEDSSSF 96 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHHHhC-CCCCcCeEEEEEEcCCEE
Confidence 4778999999999999999999999999999999998764322 23457889999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
++||||+++++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++..+....+||+|||++.....
T Consensus 97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 99999999999999998888899999999999999999999999999999999999998766667799999999987766
Q ss_pred CCcccccccccccccchhccccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHH
Q 018640 212 GEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (352)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 291 (352)
........||+.|+|||++.+.++.++||||||+++|+|++|..||......+....+......+....+..+++.+.+|
T Consensus 177 ~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 256 (486)
T 3mwu_A 177 NTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256 (486)
T ss_dssp C----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHH
T ss_pred CCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHH
Confidence 55556678999999999998889999999999999999999999999999888888887776666666667899999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcCccccccccCCCC----CCcHHHHHHHHhhHHHHHHHHHHHhhc
Q 018640 292 VRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNV----SLGETVKARLKQFSVMNKLKKRALKVM 351 (352)
Q Consensus 292 i~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (352)
|.+||+.||.+|||+.++|+||||+........ ........++++|...++++..++.+|
T Consensus 257 i~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i 320 (486)
T 3mwu_A 257 IRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAALLYM 320 (486)
T ss_dssp HHHHTCSSTTTSCCHHHHHHCHHHHHTCCCCCCGGGHHHHHHHHHHHHHHHHSCHHHHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHhcCHhhccCcccCccccccccHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999976543321 112445567777877777777665543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-54 Score=397.38 Aligned_cols=295 Identities=43% Similarity=0.740 Sum_probs=235.8
Q ss_pred CcccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC
Q 018640 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (352)
Q Consensus 49 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 128 (352)
....+.++|++.+.||+|+||+||+|.+..+++.||+|++.... ..+.+.+|+.+++++ +||||+++++++...
T Consensus 47 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 120 (349)
T 2w4o_A 47 NRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRL-SHPNIIKLKEIFETP 120 (349)
T ss_dssp BCSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHC-CCTTBCCEEEEEECS
T ss_pred ccccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhC-CCCCCcceeeeEecC
Confidence 34567788999999999999999999999999999999987542 345688899999999 899999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccccee
Q 018640 129 TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~ 208 (352)
+..++||||+++++|.+++.....+++..++.++.|++.||.|||+.||+||||||+||+++.......+||+|||++..
T Consensus 121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 121 TEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp SEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred CeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 99999999999999999998888899999999999999999999999999999999999998644556699999999987
Q ss_pred cCCCCcccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcccccCCCCCcCCCH
Q 018640 209 FKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQG-VAQAIIRSVLDFRRDPWPKVSE 286 (352)
Q Consensus 209 ~~~~~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 286 (352)
...........||+.|+|||++.+ .++.++||||||+++|||++|..||....... ....+...........++.++.
T Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 280 (349)
T 2w4o_A 201 VEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL 280 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred cCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence 655444456689999999999874 58999999999999999999999997765443 4445555444444445567899
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcCccccccccCCCCCCcHHHHHHHHhhHHHHHHHHHHHhhc
Q 018640 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVM 351 (352)
Q Consensus 287 ~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (352)
.+.+||.+||+.||++|||+.++++||||+.... +.........+++.|...++++.....++
T Consensus 281 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (349)
T 2w4o_A 281 NAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAA--NFVHMDTAQKKLQEFNARRKLKAAVKAVV 343 (349)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTC--CCSCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCcccCCCcc--chhhhcchHHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999997533 23334677779999999999998877654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-53 Score=390.65 Aligned_cols=257 Identities=36% Similarity=0.628 Sum_probs=228.8
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
.-++|++++.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++.+ +||||+++++++...+..+
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKIL-NHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCEEE
Confidence 45679999999999999999999999999999999976543 344567788999999999 8999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
+||||+++++|.+++.....+++..++.++.|++.||+|||++||+||||||+||+++.++. +||+|||++......
T Consensus 91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~---~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN---IKIADFGFSNEFTVG 167 (328)
T ss_dssp EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC---EEECSTTCCGGGSSS
T ss_pred EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCC---EEEeeccCceecCCC
Confidence 99999999999999988889999999999999999999999999999999999999976554 899999999877666
Q ss_pred Ccccccccccccccchhcccc-C-CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHH
Q 018640 213 EKFSEIVGSPYYMAPEVLKRN-Y-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (352)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~~-~-s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (352)
.......||+.|+|||++.+. + +.++||||||+++|+|++|+.||...........+....... +..+++++.+
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~~ 243 (328)
T 3fe3_A 168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI----PFYMSTDCEN 243 (328)
T ss_dssp CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC----CTTSCHHHHH
T ss_pred CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC----CCCCCHHHHH
Confidence 666777899999999998644 4 478999999999999999999999988877777776654332 3457899999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 291 LVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 291 li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
||.+||+.||.+|||+.|+++||||+..
T Consensus 244 li~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 244 LLKRFLVLNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp HHHHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred HHHHHCCCChhHCcCHHHHhcCHhhcCC
Confidence 9999999999999999999999999864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-53 Score=380.70 Aligned_cols=268 Identities=41% Similarity=0.784 Sum_probs=241.9
Q ss_pred ccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe
Q 018640 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (352)
Q Consensus 51 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 130 (352)
..+.++|++.+.||+|+||+||+|.+..+|+.||+|++..... .....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 79 (284)
T 3kk8_A 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKL-QHPNIVRLHDSIQEESF 79 (284)
T ss_dssp CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSE
T ss_pred chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEcCCE
Confidence 3567899999999999999999999999999999999876543 334457788999999999 89999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
.++||||+++++|.+.+.....+++..+..++.|++.||.|||+.|++||||||+||+++.++....+||+|||++....
T Consensus 80 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 99999999999999999888889999999999999999999999999999999999999877777779999999998776
Q ss_pred CCCcccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHH
Q 018640 211 PGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (352)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (352)
.........||+.|+|||.+.+ .++.++||||||+++|+|++|..||+..........+.......+...+..+++.+.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T 3kk8_A 160 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 239 (284)
T ss_dssp SSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred cCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHH
Confidence 6665566789999999999874 489999999999999999999999999988888888877776666666678899999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 290 ~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
++|.+||+.||++|||+.|+++||||++...
T Consensus 240 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 240 SLIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred HHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 9999999999999999999999999997644
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-54 Score=394.27 Aligned_cols=285 Identities=31% Similarity=0.618 Sum_probs=244.0
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
.+.++|++.+.||+|+||+||+|.+..+++.||+|.+... ....+.+.+|+.+++.+ +||||+++++++.+.+..
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 76 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIA-RHRNILHLHESFESMEEL 76 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhC-CCCCCCeEeEEEecCCEE
Confidence 4667899999999999999999999999999999998643 23456788999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 132 HLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
++||||++|++|.+++.... .+++..++.++.|++.||.|||+.||+||||||+|||++.+. ...+||+|||++....
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~-~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRR-SSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS-CCCEEECCCTTCEECC
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCC-CCCEEEEECCCCeECC
Confidence 99999999999999997654 699999999999999999999999999999999999997532 3459999999998876
Q ss_pred CCCcccccccccccccchhcccc-CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHH
Q 018640 211 PGEKFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (352)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~~~-~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (352)
.........||+.|+|||++.+. ++.++||||||+++|+|++|..||...........+......+....++.+++++.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T 1tki_A 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred CCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHH
Confidence 66655667899999999998754 78999999999999999999999999988888888877666555545567899999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcCccccccccCCCCCCcHHHHHHHHhhHHHHHHHHH
Q 018640 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKR 346 (352)
Q Consensus 290 ~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (352)
+||.+||+.||.+|||+.|+++||||++.......... .+++.++.++++.++
T Consensus 236 ~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~ 288 (321)
T 1tki_A 236 DFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVI----RTLKHRRYYHTLIKK 288 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHHHHSCGGGSCCCCC----CCHHHHHHHHHHHCC
T ss_pred HHHHHHcCCChhHCcCHHHHhcChhhccCcccccHHHH----HHHHHHHHHHHHHHH
Confidence 99999999999999999999999999976554433332 334455555555543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-53 Score=391.64 Aligned_cols=267 Identities=37% Similarity=0.707 Sum_probs=234.6
Q ss_pred ccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCC---hhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe
Q 018640 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT---AVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (352)
Q Consensus 51 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 127 (352)
..+.++|++.+.||+|+||+||+|.+..+|+.||+|++....... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~ 85 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYEN 85 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEe
Confidence 357788999999999999999999999999999999987654322 22467899999999999 89999999999999
Q ss_pred CCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCC-CCCCEEEEecccc
Q 018640 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK-ETAPLKAIDFGLS 206 (352)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~-~~~~vkl~Dfg~a 206 (352)
.+..++||||+++++|.+++.....+++..++.++.|++.||.|||+.||+||||||+||+++.++ ....+||+|||++
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 999999999999999999998888899999999999999999999999999999999999997655 2335999999999
Q ss_pred eecCCCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCC
Q 018640 207 VFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (352)
Q Consensus 207 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (352)
.............||+.|+|||++. ..++.++||||||+++|+|++|..||......+....+......+....+...+
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (326)
T 2y0a_A 166 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245 (326)
T ss_dssp EECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred eECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCC
Confidence 8876555556678999999999987 458999999999999999999999999888877777766654444443445789
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 286 ~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
+.+.+||.+||+.||++|||+.++++||||+..
T Consensus 246 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 999999999999999999999999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=382.06 Aligned_cols=269 Identities=43% Similarity=0.807 Sum_probs=238.7
Q ss_pred ccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe
Q 018640 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (352)
Q Consensus 51 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 130 (352)
..+.++|++.+.||+|+||+||+|.+..++..||+|++..... ...+.+.+|+.+++++ +||||+++++++...+.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~ 80 (277)
T 3f3z_A 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSL-DHPNIIRLYETFEDNTD 80 (277)
T ss_dssp -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSE
T ss_pred hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCe
Confidence 3577899999999999999999999999999999999876532 3457899999999999 89999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
.++||||+++++|.+++.....+++..++.++.|++.||.|||++|++|+||||+||++..++....++|+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 81 IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999999999999888889999999999999999999999999999999999999655555669999999998876
Q ss_pred CCCcccccccccccccchhccccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHH
Q 018640 211 PGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (352)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (352)
.........||+.|+|||.+.+.++.++||||||+++++|++|..||......+....+.......+...+..+++.+.+
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (277)
T 3f3z_A 161 PGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAES 240 (277)
T ss_dssp TTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHH
T ss_pred CccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHH
Confidence 66666667899999999999888999999999999999999999999988888777777766554444334468999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcCccccccccCCC
Q 018640 291 LVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPN 323 (352)
Q Consensus 291 li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~ 323 (352)
+|.+||+.||++|||+.++++||||++....+.
T Consensus 241 li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~~ 273 (277)
T 3f3z_A 241 LIRRLLTKSPKQRITSLQALEHEWFEKQLSSSP 273 (277)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTSHHHHHHHCCSG
T ss_pred HHHHHccCChhhCcCHHHHhcCHHHhccccccc
Confidence 999999999999999999999999997655443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-53 Score=394.88 Aligned_cols=258 Identities=30% Similarity=0.543 Sum_probs=224.1
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
-++|++++.||+|+||+||+|.+..+|+.||+|++.+.........+.+.+|..++..+.+||||+++++++...+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 35799999999999999999999999999999999875444445567788999999998789999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC-CC
Q 018640 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PG 212 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~-~~ 212 (352)
||||++||+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.... ..
T Consensus 102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~---ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGH---CKLADFGMCKEGICNG 178 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC---EEECCCTTCBCSCC--
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCC---EEEccccceeecccCC
Confidence 9999999999999998888999999999999999999999999999999999999976554 8999999998643 22
Q ss_pred Ccccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHH
Q 018640 213 EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (352)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 291 (352)
......+||+.|+|||++.+ .++.++||||||+++|||++|..||......+....+......+ +..+++.+.+|
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~----p~~~~~~~~~l 254 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY----PTWLHEDATGI 254 (353)
T ss_dssp -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC----CTTSCHHHHHH
T ss_pred ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC----CCCCCHHHHHH
Confidence 33456689999999999874 59999999999999999999999999988888877777654433 34588999999
Q ss_pred HHHhcCCCcCCCCCH------HHHhcCcccccc
Q 018640 292 VRKMLDPDPKRRLTA------QQVLEHPWLQNA 318 (352)
Q Consensus 292 i~~~l~~dP~~Rps~------~ell~hp~f~~~ 318 (352)
|.+||+.||.+||++ .++++||||++.
T Consensus 255 i~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 255 LKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp HHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred HHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 999999999999998 899999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-53 Score=388.41 Aligned_cols=256 Identities=29% Similarity=0.545 Sum_probs=226.2
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++++.||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+++.+ +||||+++++++...+..++|
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-CCCcCcceEEEEEeCCEEEEE
Confidence 5799999999999999999999999999999999765433344567788999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC-CCC
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGE 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~-~~~ 213 (352)
|||++||+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.... ...
T Consensus 84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~---vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH---IKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC---EEECCCTTCBCSCCTTC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCC---EEEeeccchhhcccCCC
Confidence 999999999999998888999999999999999999999999999999999999976554 8999999998643 333
Q ss_pred cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHH
Q 018640 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (352)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 292 (352)
.....+||+.|+|||++. ..++.++|+||||+++|||++|..||...........+...... .+..+++++.+||
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~----~p~~~s~~~~~li 236 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR----FPRTLSPEAKSLL 236 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----CCTTSCHHHHHHH
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC----CCCCCCHHHHHHH
Confidence 445678999999999987 45899999999999999999999999988877776666654332 3346899999999
Q ss_pred HHhcCCCcCCCC-----CHHHHhcCcccccc
Q 018640 293 RKMLDPDPKRRL-----TAQQVLEHPWLQNA 318 (352)
Q Consensus 293 ~~~l~~dP~~Rp-----s~~ell~hp~f~~~ 318 (352)
.+||+.||++|| ++.++++||||+..
T Consensus 237 ~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 999999999999 99999999999754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=378.79 Aligned_cols=263 Identities=37% Similarity=0.672 Sum_probs=223.0
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
.+.++|++.+.||+|+||+||+|.+..++..||+|++.... .....+.+.+|+.+++++ +||||+++++++...+..
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 95 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSL-DHPNIIKIFEVFEDYHNM 95 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc--cchhHHHHHHHHHHHHhC-CCchHHhHHHheecCCeE
Confidence 47788999999999999999999999999999999987653 233467899999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccce
Q 018640 132 HLVMELCEGGELFDRIVAR----GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~----~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~ 207 (352)
++||||+++++|.+.+... ..+++..++.++.|++.||+|||+.||+||||||+||+++.+.....+||+|||++.
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 9999999999999988543 579999999999999999999999999999999999999765556679999999998
Q ss_pred ecCCCCcccccccccccccchhccccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHH
Q 018640 208 FFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (352)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~~~~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (352)
............||+.|+|||.+.+.++.++||||||+++|+|++|..||..................... ....+++.
T Consensus 176 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 254 (285)
T 3is5_A 176 LFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAV-ECRPLTPQ 254 (285)
T ss_dssp C----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CCCCHH
T ss_pred ecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccc-ccCcCCHH
Confidence 76655555666899999999999888999999999999999999999999988877666555544333222 22347899
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 288 ~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
+.+||.+||+.||++|||+.|+++||||+++
T Consensus 255 ~~~li~~~L~~dP~~Rps~~e~l~hp~f~~a 285 (285)
T 3is5_A 255 AVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285 (285)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHHTSGGGGC-
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHHhhcC
Confidence 9999999999999999999999999999864
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-52 Score=377.52 Aligned_cols=260 Identities=30% Similarity=0.508 Sum_probs=224.4
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
...++|++++.||+|+||+||+|.+..+|+.||+|++..... ...+.+.+|+.+++.+ +||||+++++++...+..
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 92 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMREN-KNPNIVNYLDSYLVGDEL 92 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEE
T ss_pred ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc---cHHHHHHHHHHHHhcC-CCCCCCeEeEEEEECCEE
Confidence 355789999999999999999999999999999999875432 3356788999999999 999999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
++||||+++++|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||++.....
T Consensus 93 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~---~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQITP 168 (297)
T ss_dssp EEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC---EEECCCTTCEECCS
T ss_pred EEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCC---EEEeeCCCceecCC
Confidence 9999999999999999765 6999999999999999999999999999999999999976554 89999999987654
Q ss_pred CC-cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHH
Q 018640 212 GE-KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (352)
Q Consensus 212 ~~-~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (352)
.. ......||+.|+|||++. ..++.++||||||+++|+|++|..||...........+..... .....+..+++.+.
T Consensus 169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 247 (297)
T 3fxz_A 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSAIFR 247 (297)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-CCCSCGGGSCHHHH
T ss_pred cccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCccccCHHHH
Confidence 33 334568999999999876 4589999999999999999999999988877665555443322 12223457899999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 290 ~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
+||.+||+.||++|||+.|+++||||+....
T Consensus 248 ~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 278 (297)
T 3fxz_A 248 DFLNRCLEMDVEKRGSAKELLQHQFLKIAKP 278 (297)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HHHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence 9999999999999999999999999997643
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-53 Score=386.27 Aligned_cols=247 Identities=21% Similarity=0.278 Sum_probs=189.1
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC---
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT--- 129 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~--- 129 (352)
+.++|.+.+.||+|+||+||+|.+ +|+.||||++.... ......+.|+..+.++ +|||||++++++..++
T Consensus 1 Iar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l-~HpNIv~l~g~~~~~~~~~ 73 (303)
T 3hmm_A 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVML-RHENILGFIAADNKDNGTW 73 (303)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSS
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcC-CCCCCCcEEEEEEecCCCc
Confidence 356799999999999999999987 48999999986432 1112234466666778 8999999999997654
Q ss_pred -eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CCEEecCCCCceEeecCCCCCCEEE
Q 018640 130 -AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH--------GVMHRDLKPENFLFANKKETAPLKA 200 (352)
Q Consensus 130 -~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~--------~ivH~Dikp~NIll~~~~~~~~vkl 200 (352)
..+|||||+++|+|.+++... .+++..+..++.|++.||+|||++ +||||||||+|||++.++. +||
T Consensus 74 ~~~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~---~Ki 149 (303)
T 3hmm_A 74 TQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT---CCI 149 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC---EEE
T ss_pred eEEEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC---EEE
Confidence 579999999999999999765 699999999999999999999987 9999999999999976654 899
Q ss_pred EecccceecCCCCc-----ccccccccccccchhccc-------cCCCcchHHHHHHHHHHHHhCCCCCCCCC-------
Q 018640 201 IDFGLSVFFKPGEK-----FSEIVGSPYYMAPEVLKR-------NYGPEVDVWSAGVILYILLCGVPPFWAET------- 261 (352)
Q Consensus 201 ~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~s~~~Di~SlG~~l~el~tg~~p~~~~~------- 261 (352)
+|||+|+....... ....+||+.|||||++.+ .++.++|||||||+||||+||..||....
T Consensus 150 ~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~ 229 (303)
T 3hmm_A 150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 229 (303)
T ss_dssp CCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred EeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccch
Confidence 99999987654332 134579999999999864 25678999999999999999977653211
Q ss_pred --------HHHHHHHHHhcccccCCCCCc-----CCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 262 --------EQGVAQAIIRSVLDFRRDPWP-----KVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 262 --------~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
.......+.... .++..+. ..++.+.+|+.+||+.||++|||+.||++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~--~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 230 DLVPSDPSVEEMRKVVCEQK--LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp TTSCSSCCHHHHHHHHTTSC--CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred hcccccchHHHHHHHHhccc--CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 111222222111 1111111 133578899999999999999999999863
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-53 Score=396.31 Aligned_cols=258 Identities=26% Similarity=0.507 Sum_probs=220.0
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
-++|+++++||+|+||+||+|.+..+++.||+|++.+.........+.+.+|..++.++.+||||+++++++...+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 35799999999999999999999999999999999876555555556788899999988789999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec-CCC
Q 018640 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPG 212 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~-~~~ 212 (352)
||||++||+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.. ...
T Consensus 131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~---ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH---IKLTDYGMCKEGLRPG 207 (396)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC---EEECCCTTCBCCCCTT
T ss_pred EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCC---EEEeecceeeecccCC
Confidence 9999999999999998888999999999999999999999999999999999999976554 899999999863 333
Q ss_pred Ccccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCC---------HHHHHHHHHhcccccCCCCCc
Q 018640 213 EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAET---------EQGVAQAIIRSVLDFRRDPWP 282 (352)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~---------~~~~~~~~~~~~~~~~~~~~~ 282 (352)
......+||+.|+|||++.+ .++.++||||||+++|||++|+.||.... .......+... ....+.
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~----~~~~p~ 283 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK----QIRIPR 283 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC----CCCCCT
T ss_pred CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc----ccCCCC
Confidence 44566789999999999874 58999999999999999999999996331 12222333332 333445
Q ss_pred CCCHHHHHHHHHhcCCCcCCCCCH------HHHhcCcccccc
Q 018640 283 KVSENAKDLVRKMLDPDPKRRLTA------QQVLEHPWLQNA 318 (352)
Q Consensus 283 ~~~~~~~~li~~~l~~dP~~Rps~------~ell~hp~f~~~ 318 (352)
.+++++.+||.+||+.||.+||++ .|+++||||++.
T Consensus 284 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 284 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 689999999999999999999985 799999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=385.05 Aligned_cols=290 Identities=34% Similarity=0.638 Sum_probs=217.3
Q ss_pred ccccceec---eeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC
Q 018640 53 IEERYELG---RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (352)
Q Consensus 53 ~~~~y~~~---~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 129 (352)
+.++|.+. +.||+|+||+||+|.+..+|+.||+|++... ....+.+|+.+++.+.+||||+++++++.+..
T Consensus 6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~ 79 (325)
T 3kn6_A 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQL 79 (325)
T ss_dssp HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence 34567765 7899999999999999999999999998643 24567889999999966999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
..++||||+++++|.+++.....+++..++.++.|++.||+|||++||+||||||+||+++.++....+||+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 80 HTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 99999999999999999999888999999999999999999999999999999999999987665556999999999865
Q ss_pred CCC-Ccccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhcccccCCCC
Q 018640 210 KPG-EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE-------QGVAQAIIRSVLDFRRDP 280 (352)
Q Consensus 210 ~~~-~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~-------~~~~~~~~~~~~~~~~~~ 280 (352)
... .......||+.|+|||++. ..++.++||||||+++|+|++|..||..... .+....+......+....
T Consensus 160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (325)
T 3kn6_A 160 PPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239 (325)
T ss_dssp CC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHH
T ss_pred CCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCccc
Confidence 433 2334567899999999987 4589999999999999999999999976432 334444444333333333
Q ss_pred CcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccCCCCCCc---------HHHHHHHH-hhHHHHHHHHHHH
Q 018640 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLG---------ETVKARLK-QFSVMNKLKKRAL 348 (352)
Q Consensus 281 ~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~---------~~~~~~~~-~~~~~~~~~~~~~ 348 (352)
+..+++++.+||.+||+.||++|||+.++++||||++....+..++. ..+...++ .|+-++++++...
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVKATFHAFNKYKREGF 317 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCCCSCCSHHHHHHHHHHHHHHHHHHHHHHHHHHHHHC-
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCCCCCCCCCcccccchHHHHHHHHHHHHHHHhhhccce
Confidence 45689999999999999999999999999999999987555544442 22333343 3566666665543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-52 Score=391.00 Aligned_cols=270 Identities=33% Similarity=0.648 Sum_probs=235.6
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
.+.++|++++.||+|+||+||+|.+..+|+.||+|++... .......+.+|+.+++.+ +||||+++++++......
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~ 123 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP---YPLDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEM 123 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc---chhhHHHHHHHHHHHHhC-CCcCCCeEEEEEEeCCEE
Confidence 3557899999999999999999999999999999998653 233456789999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 132 HLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
++||||+++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+. ...+||+|||++....
T Consensus 124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~-~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKK-ASSVKIIDFGLATKLN 202 (387)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTT-CCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCC-CCceEEEecccceecC
Confidence 99999999999999997654 699999999999999999999999999999999999997432 3459999999998876
Q ss_pred CCCcccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHH
Q 018640 211 PGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (352)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (352)
.........||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+......+....+..+++.+.
T Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 282 (387)
T 1kob_A 203 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 282 (387)
T ss_dssp TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred CCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence 5555555689999999999874 588999999999999999999999999888777777777666666666678999999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcCccccccccCCCCCC
Q 018640 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSL 326 (352)
Q Consensus 290 ~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~ 326 (352)
+||.+||+.||++|||+.++++||||+.........+
T Consensus 283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~ 319 (387)
T 1kob_A 283 DFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRI 319 (387)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTTCCCCB
T ss_pred HHHHHHcCCChhHCcCHHHHhhCccccCCcccccccC
Confidence 9999999999999999999999999997654443333
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-52 Score=382.90 Aligned_cols=276 Identities=28% Similarity=0.526 Sum_probs=237.7
Q ss_pred cccCCCcccccccceec-eeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEee
Q 018640 44 VLKEPTGREIEERYELG-RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122 (352)
Q Consensus 44 ~~~~~~~~~~~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~ 122 (352)
.+.......+.++|.+. +.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.++..+.+||||++++
T Consensus 17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~ 95 (327)
T 3lm5_A 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLH 95 (327)
T ss_dssp CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 34556677889999998 899999999999999999999999999876532 3334678899999999997789999999
Q ss_pred eEEEeCCeEEEEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEE
Q 018640 123 DTYEDDTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKA 200 (352)
Q Consensus 123 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl 200 (352)
+++...+..++||||+++++|.+++... ..+++..++.++.|++.||+|||+.||+||||||+||+++.......+||
T Consensus 96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL 175 (327)
T 3lm5_A 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKI 175 (327)
T ss_dssp EEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEE
T ss_pred EEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEE
Confidence 9999999999999999999999998653 56999999999999999999999999999999999999986444556999
Q ss_pred EecccceecCCCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCC
Q 018640 201 IDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279 (352)
Q Consensus 201 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 279 (352)
+|||++.............||+.|+|||++. ..++.++||||||+++|+|++|..||...........+..........
T Consensus 176 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 255 (327)
T 3lm5_A 176 VDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEE 255 (327)
T ss_dssp CCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred eeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCch
Confidence 9999998876555556678999999999987 458999999999999999999999999988888877777776666666
Q ss_pred CCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 280 PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 280 ~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
.+..+++.+.++|.+||+.||++|||+.++++||||++...
T Consensus 256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 256 TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF 296 (327)
T ss_dssp TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence 67789999999999999999999999999999999987643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=386.56 Aligned_cols=258 Identities=28% Similarity=0.446 Sum_probs=226.7
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
.++|++.+.||+|+||+||+|.+..+|+.||+|++.+.........+.+..|..++..+.+||||+++++++...+..++
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l 95 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 95 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence 46799999999999999999999999999999999775433334566788899999987689999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC-C
Q 018640 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-G 212 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~-~ 212 (352)
||||++||+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++..... .
T Consensus 96 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~---vkL~DFG~a~~~~~~~ 172 (345)
T 1xjd_A 96 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH---IKIADFGMCKENMLGD 172 (345)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC---EEECCCTTCBCCCCTT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCC---EEEeEChhhhhcccCC
Confidence 9999999999999998888999999999999999999999999999999999999976554 89999999986432 2
Q ss_pred Ccccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHH
Q 018640 213 EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (352)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 291 (352)
......+||+.|+|||++.+ .++.++|+||||+++|||++|..||...........+...... .+..+++++.+|
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~----~p~~~s~~~~~l 248 (345)
T 1xjd_A 173 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF----YPRWLEKEAKDL 248 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----CCTTSCHHHHHH
T ss_pred CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCC----CCcccCHHHHHH
Confidence 33456789999999999864 5899999999999999999999999988887777766654332 334689999999
Q ss_pred HHHhcCCCcCCCCCHH-HHhcCcccccc
Q 018640 292 VRKMLDPDPKRRLTAQ-QVLEHPWLQNA 318 (352)
Q Consensus 292 i~~~l~~dP~~Rps~~-ell~hp~f~~~ 318 (352)
|.+||+.||++||++. ++++||||+..
T Consensus 249 i~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 249 LVKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHHhcCCHhHcCCChHHHHcCccccCC
Confidence 9999999999999998 99999999865
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=390.72 Aligned_cols=259 Identities=24% Similarity=0.488 Sum_probs=225.6
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
..-++|++++.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.+ +||||+++++++...+..
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~ 90 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSFQDEEDM 90 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEE
Confidence 3446899999999999999999999999999999999776544445667889999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
++||||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.....
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~---vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGH---VHITDFNIAAMLPR 167 (384)
T ss_dssp EEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCTTCEECCT
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCC---EEEeccceeeeccC
Confidence 999999999999999998888999999999999999999999999999999999999976554 89999999998766
Q ss_pred CCcccccccccccccchhcc----ccCCCcchHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcccccCCCCCcCC
Q 018640 212 GEKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAET---EQGVAQAIIRSVLDFRRDPWPKV 284 (352)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~----~~~s~~~Di~SlG~~l~el~tg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 284 (352)
........||+.|+|||++. ..++.++|||||||++|||++|..||.... .......+... ....+..+
T Consensus 168 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~----~~~~p~~~ 243 (384)
T 4fr4_A 168 ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT----VVTYPSAW 243 (384)
T ss_dssp TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC----CCCCCTTS
T ss_pred CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc----ccCCCCcC
Confidence 66667789999999999875 248899999999999999999999997433 22333333322 23334568
Q ss_pred CHHHHHHHHHhcCCCcCCCCC-HHHHhcCcccccc
Q 018640 285 SENAKDLVRKMLDPDPKRRLT-AQQVLEHPWLQNA 318 (352)
Q Consensus 285 ~~~~~~li~~~l~~dP~~Rps-~~ell~hp~f~~~ 318 (352)
++.+.+||.+||+.||.+||+ +.++++||||++.
T Consensus 244 s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 244 SQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred CHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence 999999999999999999998 9999999999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-52 Score=380.47 Aligned_cols=254 Identities=28% Similarity=0.554 Sum_probs=225.8
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++++.||+|+||+||+|.+..+|+.||+|++.+.........+.+.+|+.+++.+ +||||+++++++.+.+..++|
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceEeEEEEeCCEEEEE
Confidence 5799999999999999999999999999999999765433334567788999999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCc
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (352)
|||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++......
T Consensus 85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~---~kL~Dfg~a~~~~~~-- 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH---IKITDFGFAKYVPDV-- 159 (318)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC---EEECCCSSCEECSSC--
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCC---EEEeecCcceecCCc--
Confidence 999999999999998888999999999999999999999999999999999999976554 899999999875432
Q ss_pred ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHH
Q 018640 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (352)
Q Consensus 215 ~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 293 (352)
.....||+.|+|||++. ..++.++|+||||+++|||++|..||...........+...... .++.+++++.++|.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----~p~~~~~~~~~li~ 235 (318)
T 1fot_A 160 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR----FPPFFNEDVKDLLS 235 (318)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC----CCTTSCHHHHHHHH
T ss_pred cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----CCCCCCHHHHHHHH
Confidence 34568999999999887 45899999999999999999999999988887777777665433 23468999999999
Q ss_pred HhcCCCcCCCC-----CHHHHhcCcccccc
Q 018640 294 KMLDPDPKRRL-----TAQQVLEHPWLQNA 318 (352)
Q Consensus 294 ~~l~~dP~~Rp-----s~~ell~hp~f~~~ 318 (352)
+||+.||.+|| ++.++++||||++.
T Consensus 236 ~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 236 RLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 99999999999 99999999999854
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-52 Score=384.62 Aligned_cols=257 Identities=27% Similarity=0.511 Sum_probs=221.9
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++++.||+|+||.||+|.+..+|+.||+|++.+.........+.+.+|..++.++.+||||+++++++...+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57999999999999999999999999999999998776555566677889999999887899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC-CCC
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGE 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~-~~~ 213 (352)
|||++||+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++... ...
T Consensus 89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~---~kL~DFG~a~~~~~~~~ 165 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGD 165 (345)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC---EEECCGGGCBCSCCTTC
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC---EEEEeccccccccCCCC
Confidence 999999999999988888999999999999999999999999999999999999976554 8999999998643 333
Q ss_pred cccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHHhcccccCCCCCcC
Q 018640 214 KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAE---------TEQGVAQAIIRSVLDFRRDPWPK 283 (352)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~---------~~~~~~~~~~~~~~~~~~~~~~~ 283 (352)
.....+||+.|+|||++.+ .++.++|||||||++|||++|+.||... ........+... ....+..
T Consensus 166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~----~~~~p~~ 241 (345)
T 3a8x_A 166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK----QIRIPRS 241 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC----CCCCCTT
T ss_pred cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC----CCCCCCC
Confidence 4456789999999999874 5899999999999999999999999652 222233333332 2233456
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCH------HHHhcCcccccc
Q 018640 284 VSENAKDLVRKMLDPDPKRRLTA------QQVLEHPWLQNA 318 (352)
Q Consensus 284 ~~~~~~~li~~~l~~dP~~Rps~------~ell~hp~f~~~ 318 (352)
++..+.+||.+||+.||.+||++ .++++||||++.
T Consensus 242 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 89999999999999999999995 899999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-52 Score=381.81 Aligned_cols=268 Identities=39% Similarity=0.717 Sum_probs=233.9
Q ss_pred ccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCC---hhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe
Q 018640 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT---AVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (352)
Q Consensus 51 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 127 (352)
..+.++|++.+.||+|+||.||+|.+..+|+.||+|++....... ....+.+.+|+.+++++ +||||+++++++..
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 86 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHHNVITLHDVYEN 86 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC-CCCCcceEEEEEec
Confidence 457789999999999999999999999999999999987654322 12467899999999999 89999999999999
Q ss_pred CCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCC-CCEEEEecccc
Q 018640 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKET-APLKAIDFGLS 206 (352)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~-~~vkl~Dfg~a 206 (352)
.+..++||||+++++|.+++.....+++..++.++.|++.||.|||+.|++||||||+||+++.++.. ..+||+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 99999999999999999999888889999999999999999999999999999999999999765521 25899999999
Q ss_pred eecCCCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCC
Q 018640 207 VFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (352)
Q Consensus 207 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (352)
.............||+.|+|||.+. ..++.++||||||+++|+|++|..||......+....+.......+...+..++
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (321)
T 2a2a_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS 246 (321)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred eecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccC
Confidence 8876655556668999999999887 458999999999999999999999999888877777666554444333345688
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 286 ~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
+.+.+||.+||+.||++|||+.++++||||+...
T Consensus 247 ~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp HHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 9999999999999999999999999999998653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=386.32 Aligned_cols=271 Identities=36% Similarity=0.646 Sum_probs=229.7
Q ss_pred CcccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC
Q 018640 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (352)
Q Consensus 49 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 128 (352)
....+.++|++.+.||+|+||+||+|.+..+|+.||+|++..... ...+|+.++.++.+||||+++++++.+.
T Consensus 16 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~ 88 (342)
T 2qr7_A 16 NSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDG 88 (342)
T ss_dssp ---CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred cccCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcC
Confidence 344678899999999999999999999999999999999876432 2346888888887899999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecC-CCCCCEEEEecccce
Q 018640 129 TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK-KETAPLKAIDFGLSV 207 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~-~~~~~vkl~Dfg~a~ 207 (352)
+..++||||++||+|.+.+.....+++..+..++.||+.||+|||++||+||||||+|||+..+ +....+||+|||++.
T Consensus 89 ~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 89 KYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 9999999999999999999988889999999999999999999999999999999999998543 334459999999998
Q ss_pred ecCCC-Ccccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhcccccCCCCCc
Q 018640 208 FFKPG-EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAE---TEQGVAQAIIRSVLDFRRDPWP 282 (352)
Q Consensus 208 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~ 282 (352)
..... .......||+.|+|||++.+ .++.++||||||+++|+|++|..||... ...+....+...........++
T Consensus 169 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 248 (342)
T 2qr7_A 169 QLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWN 248 (342)
T ss_dssp ECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTT
T ss_pred cCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccc
Confidence 76443 23355689999999999874 4889999999999999999999999863 4555666666665555555667
Q ss_pred CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccCCCCCC
Q 018640 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSL 326 (352)
Q Consensus 283 ~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~ 326 (352)
.+++.+.+||.+||+.||++|||+.++++||||.+....+...+
T Consensus 249 ~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~~~~~~~ 292 (342)
T 2qr7_A 249 SVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQL 292 (342)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGGSCCSCC
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCccccccccC
Confidence 89999999999999999999999999999999987554444333
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=387.49 Aligned_cols=257 Identities=35% Similarity=0.590 Sum_probs=220.8
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
.-++|++.+.||+|+||+||+|.+..+|+.||+|++.............+.+|+.+++.+ +||||+++++++...+..+
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~ 85 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHPHIIKLYDVITTPTDIV 85 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEE
Confidence 446799999999999999999999999999999998765433333456789999999999 8999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
+||||+ +|+|.+++.....+++..++.++.|++.||.|||+.||+||||||+|||++.++. +||+|||++......
T Consensus 86 lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~---~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN---VKIADFGLSNIMTDG 161 (336)
T ss_dssp EEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCC---EEECCSSCTBTTTTS
T ss_pred EEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCC---EEEEEeccceeccCC
Confidence 999999 6799999988889999999999999999999999999999999999999976554 899999999877666
Q ss_pred Ccccccccccccccchhcccc--CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHH
Q 018640 213 EKFSEIVGSPYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (352)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~~--~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (352)
.......||+.|+|||++.+. .+.++||||||+++|+|++|..||......... ..........+..+++.+.+
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----~~i~~~~~~~p~~~s~~~~~ 237 (336)
T 3h4j_B 162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----KKVNSCVYVMPDFLSPGAQS 237 (336)
T ss_dssp BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----CCCCSSCCCCCTTSCHHHHH
T ss_pred cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----HHHHcCCCCCcccCCHHHHH
Confidence 656677899999999998754 378999999999999999999999765433211 11112222334468999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 291 LVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 291 li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
||.+||+.||.+|||+.|+++||||+..
T Consensus 238 li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 238 LIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp HHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred HHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 9999999999999999999999999864
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-52 Score=385.46 Aligned_cols=258 Identities=26% Similarity=0.439 Sum_probs=227.0
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
-++|++++.||+|+||+||+|.+..+|+.||+|++.+.........+.+..|..++..+.+||+|+++++++...+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 35799999999999999999999999999999999876443344567788999999988789999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC-CC
Q 018640 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PG 212 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~-~~ 212 (352)
||||++||+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.... ..
T Consensus 99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~---vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH---IKIADFGMCKENIWDG 175 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC---EEECCCTTCBCCCCTT
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCc---EEEEeCCcccccccCC
Confidence 9999999999999998888999999999999999999999999999999999999976554 8999999998643 23
Q ss_pred Ccccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHH
Q 018640 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (352)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 291 (352)
......+||+.|+|||++. ..++.++|+||||+++|||++|..||......+....+...... .+..+++++.+|
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~----~p~~~s~~~~~l 251 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA----YPKSMSKEAVAI 251 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----CCTTSCHHHHHH
T ss_pred cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC----CCCCCCHHHHHH
Confidence 3445678999999999986 45899999999999999999999999988887777777665433 334689999999
Q ss_pred HHHhcCCCcCCCCC-----HHHHhcCcccccc
Q 018640 292 VRKMLDPDPKRRLT-----AQQVLEHPWLQNA 318 (352)
Q Consensus 292 i~~~l~~dP~~Rps-----~~ell~hp~f~~~ 318 (352)
|.+||+.||.+||+ +.++++||||+..
T Consensus 252 i~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 252 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp HHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence 99999999999994 6999999999853
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-52 Score=394.41 Aligned_cols=261 Identities=31% Similarity=0.486 Sum_probs=226.5
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
..++|++++.||+|+||+||+|.+..+++.||+|++.+.........+.+.+|+.+++.+ +||||+++++++.+.+..+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~ 145 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLY 145 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCEEEEEECSSEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEE
Confidence 346899999999999999999999999999999998764333333345688899999999 9999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
+||||++||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++......
T Consensus 146 lV~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~---ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH---LKLADFGTCMKMNKE 221 (410)
T ss_dssp EEECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCTTCEECCTT
T ss_pred EEEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCC---EEEeccceeEeeccC
Confidence 999999999999998754 6999999999999999999999999999999999999976554 899999999876544
Q ss_pred Cc--ccccccccccccchhcccc-----CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCC
Q 018640 213 EK--FSEIVGSPYYMAPEVLKRN-----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (352)
Q Consensus 213 ~~--~~~~~gt~~y~aPE~~~~~-----~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (352)
.. ....+||+.|+|||++.+. ++.++||||||+++|||++|..||...........+.........+....++
T Consensus 222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s 301 (410)
T 3v8s_A 222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 301 (410)
T ss_dssp SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCC
T ss_pred CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCccccc
Confidence 32 3466899999999987532 7789999999999999999999999988888877777654333434445789
Q ss_pred HHHHHHHHHhcCCCcCC--CCCHHHHhcCcccccc
Q 018640 286 ENAKDLVRKMLDPDPKR--RLTAQQVLEHPWLQNA 318 (352)
Q Consensus 286 ~~~~~li~~~l~~dP~~--Rps~~ell~hp~f~~~ 318 (352)
+++.+||.+||+.+|.+ ||++.||++||||++.
T Consensus 302 ~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 302 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp HHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred HHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 99999999999999998 9999999999999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-52 Score=377.09 Aligned_cols=268 Identities=28% Similarity=0.448 Sum_probs=217.1
Q ss_pred CcccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCC--hhcHHHHHHHHHHHHhCC--CCCCeeEeeeE
Q 018640 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT--AVDIEDVRREVDIMRHLP--KHQNIVCLKDT 124 (352)
Q Consensus 49 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~--~h~~iv~l~~~ 124 (352)
.+..+.++|++++.||+|+||+||+|.+..+|+.||+|++....... ......+.+|+.+++.+. +||||++++++
T Consensus 3 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~ 82 (308)
T 3g33_A 3 LGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDV 82 (308)
T ss_dssp -------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred CCcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence 45667889999999999999999999999999999999987543211 112345667888877763 49999999999
Q ss_pred EEeCC-----eEEEEEEecCCcchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCC
Q 018640 125 YEDDT-----AVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAP 197 (352)
Q Consensus 125 ~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~--l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~ 197 (352)
+.... ..++||||++ ++|.+++..... +++..++.++.|++.||+|||+.||+||||||+||+++.++.
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~--- 158 (308)
T 3g33_A 83 CATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT--- 158 (308)
T ss_dssp EEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSC---
T ss_pred eeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC---
Confidence 97655 5899999997 599999987654 999999999999999999999999999999999999976554
Q ss_pred EEEEecccceecCCCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc
Q 018640 198 LKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF 276 (352)
Q Consensus 198 vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 276 (352)
+||+|||++.............||+.|+|||++. ..++.++||||||+++|+|++|+.||...........+.......
T Consensus 159 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (308)
T 3g33_A 159 VKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238 (308)
T ss_dssp EEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred EEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 8999999998766555556678999999999875 568999999999999999999999999988887777776654332
Q ss_pred CCCCC-----------------------cCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 277 RRDPW-----------------------PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 277 ~~~~~-----------------------~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
....+ +.+++.+.+||.+||+.||++|||+.|+|+||||++...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~ 305 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG 305 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-----
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCC
Confidence 22211 357899999999999999999999999999999997644
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=376.53 Aligned_cols=265 Identities=28% Similarity=0.472 Sum_probs=219.4
Q ss_pred CcccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC
Q 018640 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (352)
Q Consensus 49 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 128 (352)
.+..+.++|++++.||+|+||+||+|.+. +|+.||+|++..... .......+.+|+.+++++ +||||+++++++..+
T Consensus 15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~ 91 (311)
T 3niz_A 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKEL-HHPNIVSLIDVIHSE 91 (311)
T ss_dssp CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHC-CCTTBCCEEEEECCS
T ss_pred eecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHc-CCCCEeeeeeEEccC
Confidence 45567889999999999999999999985 599999999875432 222346788999999999 899999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccce
Q 018640 129 TAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~ 207 (352)
+..++||||+++ +|.+.+.... .+++..++.++.|++.||.|||+.||+||||||+|||++.++. +||+|||++.
T Consensus 92 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~---~kl~Dfg~a~ 167 (311)
T 3niz_A 92 RCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA---LKLADFGLAR 167 (311)
T ss_dssp SCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---EEECCCTTCE
T ss_pred CEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCC---EEEccCcCce
Confidence 999999999975 8888887654 5999999999999999999999999999999999999976554 8999999998
Q ss_pred ecCCC-Ccccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCC----
Q 018640 208 FFKPG-EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP---- 280 (352)
Q Consensus 208 ~~~~~-~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 280 (352)
..... .......||+.|+|||++.+ .++.++||||||+++|+|++|+.||......+....+........+..
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 168 AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247 (311)
T ss_dssp ETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGG
T ss_pred ecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhh
Confidence 76433 23345578999999998753 489999999999999999999999988777766666655433322211
Q ss_pred ----------------------CcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 281 ----------------------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 281 ----------------------~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
.+.+++++.+||.+||+.||++|||+.|+++||||++...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 309 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP 309 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence 1246789999999999999999999999999999998653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=382.97 Aligned_cols=255 Identities=28% Similarity=0.534 Sum_probs=227.0
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
-++|++++.||+|+||.||+|.+..+|+.||+|++.+.........+.+.+|+.+++.+ +||||+++++++...+..++
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEEE
Confidence 46799999999999999999999999999999999766444444567889999999999 99999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
||||++|++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++......
T Consensus 119 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~---~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCTTCEECSSC-
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCC---EEEcccccceeccCC-
Confidence 9999999999999998888999999999999999999999999999999999999976554 899999999876433
Q ss_pred cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHH
Q 018640 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (352)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 292 (352)
.....||+.|+|||++. ..++.++||||||+++|||++|..||...........+...... .+..+++.+.++|
T Consensus 195 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~----~p~~~~~~~~~li 269 (350)
T 1rdq_E 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR----FPSHFSSDLKDLL 269 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----CCTTCCHHHHHHH
T ss_pred -cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCC----CCCCCCHHHHHHH
Confidence 34568999999999876 45899999999999999999999999988887777777665333 3346899999999
Q ss_pred HHhcCCCcCCCCC-----HHHHhcCcccccc
Q 018640 293 RKMLDPDPKRRLT-----AQQVLEHPWLQNA 318 (352)
Q Consensus 293 ~~~l~~dP~~Rps-----~~ell~hp~f~~~ 318 (352)
.+||+.||.+||+ +.++++||||+..
T Consensus 270 ~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 9999999999998 9999999999863
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=370.58 Aligned_cols=258 Identities=28% Similarity=0.502 Sum_probs=214.8
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++++.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.+++++ +||||+++++++..++..++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcC-CCCCEeeEEeEEEeCCEEEEE
Confidence 479999999999999999999999999999999976542 333456788999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC-
Q 018640 135 MELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~- 212 (352)
|||+++ +|.+.+.. ...+++..++.++.|++.||+|||++||+||||||+||+++.++. +||+|||++......
T Consensus 80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~---~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE---LKLANFGLARAFGIPV 155 (292)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCTTCEECCSCC
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC---EEEeecccceecCCcc
Confidence 999976 56555544 567999999999999999999999999999999999999976554 899999999876433
Q ss_pred Ccccccccccccccchhccc-c-CCCcchHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhcccccCCC----------
Q 018640 213 EKFSEIVGSPYYMAPEVLKR-N-YGPEVDVWSAGVILYILLCGVPPF-WAETEQGVAQAIIRSVLDFRRD---------- 279 (352)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~-~-~s~~~Di~SlG~~l~el~tg~~p~-~~~~~~~~~~~~~~~~~~~~~~---------- 279 (352)
.......||+.|+|||++.+ . ++.++||||||+++|+|++|..|| ...........+.+........
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence 23345688999999998763 3 799999999999999999887775 4555555555555433222111
Q ss_pred ---------------CCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 280 ---------------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 280 ---------------~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
..+.+++.+.+||.+||+.||++|||+.|+++||||++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 123478899999999999999999999999999999975
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-52 Score=378.90 Aligned_cols=266 Identities=35% Similarity=0.602 Sum_probs=217.2
Q ss_pred cccccceec-eeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe
Q 018640 52 EIEERYELG-RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (352)
Q Consensus 52 ~~~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 130 (352)
.+.++|++. +.||+|+||+||+|.+..+++.||+|++.... ....+.+.+|+.++.++.+||||+++++++...+.
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~ 85 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDR 85 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 466789995 78999999999999999999999999987542 23457889999999997689999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
.++||||+++++|.+++.....+++..++.++.|++.||.|||++||+||||||+||+++.++....+||+|||++....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 99999999999999999988889999999999999999999999999999999999999877666669999999987653
Q ss_pred CCC--------cccccccccccccchhcc------ccCCCcchHHHHHHHHHHHHhCCCCCCCCCH--------------
Q 018640 211 PGE--------KFSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETE-------------- 262 (352)
Q Consensus 211 ~~~--------~~~~~~gt~~y~aPE~~~------~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~-------------- 262 (352)
... ......||+.|+|||++. ..++.++||||||+++|+|++|..||.....
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 211 122346999999999875 3488999999999999999999999976532
Q ss_pred -HHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 263 -QGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 263 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
......+......++...+..+++.+.+||.+||+.||++|||+.|+++||||++...
T Consensus 246 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 304 (316)
T 2ac3_A 246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP 304 (316)
T ss_dssp HHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred HHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence 2233334333333322223467899999999999999999999999999999997643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=389.25 Aligned_cols=264 Identities=36% Similarity=0.675 Sum_probs=214.9
Q ss_pred ccccceec-eeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe----
Q 018640 53 IEERYELG-RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED---- 127 (352)
Q Consensus 53 ~~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~---- 127 (352)
+.++|.+. ++||+|+||+||+|.+..+|+.||||++... ..+.+|+.++.++.+||||+++++++..
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence 44567776 7899999999999999999999999998532 4577899988766699999999999875
Q ss_pred CCeEEEEEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccc
Q 018640 128 DTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (352)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~ 205 (352)
....++||||++||+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.+.....+||+|||+
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 567899999999999999998754 599999999999999999999999999999999999998755566799999999
Q ss_pred ceecCCCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhcccccCCCC
Q 018640 206 SVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQG----VAQAIIRSVLDFRRDP 280 (352)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~----~~~~~~~~~~~~~~~~ 280 (352)
+.............||+.|+|||++. ..++.++|||||||++|||++|..||....... ....+......++...
T Consensus 211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~ 290 (400)
T 1nxk_A 211 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 290 (400)
T ss_dssp CEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTT
T ss_pred ccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcc
Confidence 98766555556678999999999986 458999999999999999999999997654321 3344444444445555
Q ss_pred CcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccCCCC
Q 018640 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNV 324 (352)
Q Consensus 281 ~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~ 324 (352)
+..+++++.+||.+||+.||++|||+.++++||||.+....+..
T Consensus 291 ~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~ 334 (400)
T 1nxk_A 291 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 334 (400)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTTSCCC
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCCCCCC
Confidence 66789999999999999999999999999999999976554443
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=379.58 Aligned_cols=267 Identities=28% Similarity=0.476 Sum_probs=215.8
Q ss_pred ccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe
Q 018640 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (352)
Q Consensus 51 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 130 (352)
...-++|++++.||+|+||+||+|.+..+|+.||+|++..... .....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKEL-QHRNIIELKSVIHHNHR 107 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGC-CCTTBCCEEEEEEETTE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHc-CCCCcceEEEEEecCCE
Confidence 3455689999999999999999999999999999999976532 222345677899999999 89999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCC--CCCCEEEEeccccee
Q 018640 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK--ETAPLKAIDFGLSVF 208 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~--~~~~vkl~Dfg~a~~ 208 (352)
.++||||+++ +|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ ....+||+|||++..
T Consensus 108 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 108 LHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9999999974 9999999888899999999999999999999999999999999999996543 334589999999976
Q ss_pred cCCC-Ccccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCc---
Q 018640 209 FKPG-EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP--- 282 (352)
Q Consensus 209 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 282 (352)
.... .......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+...........++
T Consensus 187 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (329)
T 3gbz_A 187 FGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVT 266 (329)
T ss_dssp HC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred cCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhh
Confidence 5432 23345578999999998764 48999999999999999999999999888877777766543322221111
Q ss_pred -----------------------CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 283 -----------------------KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 283 -----------------------~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
.+++++.+||.+||+.||++|||+.|+++||||++..-
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp GSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred hhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 16789999999999999999999999999999998654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-52 Score=394.25 Aligned_cols=263 Identities=29% Similarity=0.492 Sum_probs=225.5
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
...++|+++++||+|+||+||+|.+..+++.||+|++.+...........+.+|+.++..+ +||||+++++++.+.+..
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAFQDDNNL 149 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeCCEE
Confidence 3457899999999999999999999999999999999764332233334588899999999 999999999999999999
Q ss_pred EEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 132 HLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
++||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++...
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~---vkL~DFGla~~~~ 226 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH---IRLADFGSCLKLM 226 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCC---EEEcchhhhhhcc
Confidence 999999999999999987 467999999999999999999999999999999999999976554 8999999998764
Q ss_pred CCCc--ccccccccccccchhcc------ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC-CCCC
Q 018640 211 PGEK--FSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR-RDPW 281 (352)
Q Consensus 211 ~~~~--~~~~~gt~~y~aPE~~~------~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~ 281 (352)
.... ....+||+.|+|||++. +.++.++||||||+++|||++|+.||......+....+........ +..+
T Consensus 227 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 306 (437)
T 4aw2_A 227 EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQV 306 (437)
T ss_dssp TTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSC
T ss_pred cCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCccc
Confidence 4332 23468999999999874 3489999999999999999999999999888877777765432222 2223
Q ss_pred cCCCHHHHHHHHHhcCCCcCC--CCCHHHHhcCcccccc
Q 018640 282 PKVSENAKDLVRKMLDPDPKR--RLTAQQVLEHPWLQNA 318 (352)
Q Consensus 282 ~~~~~~~~~li~~~l~~dP~~--Rps~~ell~hp~f~~~ 318 (352)
..+++++.+||.+||..+|++ ||++.|+++||||++.
T Consensus 307 ~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 307 TDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred ccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 468999999999999999988 9999999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=371.81 Aligned_cols=267 Identities=42% Similarity=0.759 Sum_probs=236.5
Q ss_pred ccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe
Q 018640 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (352)
Q Consensus 51 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 130 (352)
..+.++|++++.||+|+||+||+|.+..+++.||+|++..... .....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 95 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKL-DHPNIMKLFEILEDSSS 95 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB-SSSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhc-cCCCccEEEEEEeCCCe
Confidence 3567889999999999999999999998999999999876543 234567899999999999 89999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
.++|+||+++++|.+.+.....+++..++.++.|++.||.|||+.|++|+||||+||+++.++....+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 99999999999999999888889999999999999999999999999999999999999876666679999999998765
Q ss_pred CCCcccccccccccccchhccccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHH
Q 018640 211 PGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (352)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (352)
.........||+.|+|||.+.+.++.++||||||+++|+|++|..||...........+...........+..+++.+.+
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (287)
T 2wei_A 176 QNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255 (287)
T ss_dssp CCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHH
T ss_pred CCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHH
Confidence 55544555789999999999888999999999999999999999999988887777776665544444444578999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 291 LVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 291 li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
+|.+||+.||++|||+.++++||||++..
T Consensus 256 li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 256 LIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred HHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 99999999999999999999999998754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-51 Score=371.44 Aligned_cols=265 Identities=41% Similarity=0.755 Sum_probs=230.7
Q ss_pred ccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe
Q 018640 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (352)
Q Consensus 51 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 130 (352)
..+.++|++.+.||+|+||+||+|.+..+|+.||+|++.... ....+.+.+|+.+++.+ +||||+++++++...+.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 80 (304)
T 2jam_A 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP---AFRDSSLENEIAVLKKI-KHENIVTLEDIYESTTH 80 (304)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHC-CCTTBCCEEEEEECSSE
T ss_pred cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc---ccchHHHHHHHHHHHhC-CCCCeeehhhhcccCCE
Confidence 457789999999999999999999999999999999987542 22345788999999999 89999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
.++||||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||||+||++..++....++|+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred EEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 99999999999999999888889999999999999999999999999999999999999654455669999999997643
Q ss_pred CCCcccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHH
Q 018640 211 PGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (352)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (352)
.. ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||...........+......+....+..+++.+.
T Consensus 161 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (304)
T 2jam_A 161 NG-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAK 239 (304)
T ss_dssp CB-TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHH
T ss_pred CC-ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHH
Confidence 32 2334578999999999874 588999999999999999999999998888877777777666666566678899999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 290 ~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
++|.+||+.||++|||+.++++||||+....
T Consensus 240 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (304)
T 2jam_A 240 DFICHLLEKDPNERYTCEKALSHPWIDGNTA 270 (304)
T ss_dssp HHHHHHHCSSTTTSCCHHHHHTSHHHHSSCS
T ss_pred HHHHHHcCCChhHCcCHHHHhcCccccCCCc
Confidence 9999999999999999999999999997543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=368.11 Aligned_cols=263 Identities=34% Similarity=0.597 Sum_probs=225.2
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
..++|++.+.||+|+||+||+|.+..++..||+|++.............+.+|+.+++++ +||||+++++++...+..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 85 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVY 85 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC-CCCCCcchhheEecCCEEE
Confidence 346799999999999999999999999999999998765443444467789999999999 8999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
+||||+++++|.+++.....+++..++.++.|++.||.|||+.||+|+||||+||+++.++. ++|+|||++......
T Consensus 86 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~---~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSS 162 (279)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSC---EEECSCCEESCC---
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCC---EEEEeccccccCCcc
Confidence 99999999999999988888999999999999999999999999999999999999976554 899999998654332
Q ss_pred Ccccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHH
Q 018640 213 EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (352)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 291 (352)
. .....||+.|+|||.+.+ .++.++||||||+++|+|++|..||...........+...... .+..+++.+.+|
T Consensus 163 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l 237 (279)
T 3fdn_A 163 R-RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT----FPDFVTEGARDL 237 (279)
T ss_dssp ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC----CCTTSCHHHHHH
T ss_pred c-ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCC----CCCcCCHHHHHH
Confidence 2 244578999999998874 4788999999999999999999999988877766666554322 334678999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcCccccccccCCCC
Q 018640 292 VRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNV 324 (352)
Q Consensus 292 i~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~ 324 (352)
|.+||+.||.+|||+.|+++||||++....+..
T Consensus 238 i~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~~~ 270 (279)
T 3fdn_A 238 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 270 (279)
T ss_dssp HHHHCCSSGGGSCCHHHHHHCHHHHHHCSSCCC
T ss_pred HHHHhccChhhCCCHHHHhhCccccCCccCccc
Confidence 999999999999999999999999987655543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-52 Score=383.32 Aligned_cols=270 Identities=34% Similarity=0.655 Sum_probs=227.7
Q ss_pred cccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccC--ChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe
Q 018640 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR--TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (352)
Q Consensus 50 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 127 (352)
...+.++|++++.||+|+||+||+|.+..+++.||+|++...... .....+.+.+|+.+++++ +||||+++++++.+
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~ 99 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVYED 99 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-CCTTBCCEEEEEEC
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-CCCCcceeehhhcc
Confidence 346778999999999999999999999999999999998765321 234467899999999999 89999999999999
Q ss_pred CCeEEEEEEecCCcchHHHHHhc----------------------------------------CCCCHHHHHHHHHHHHH
Q 018640 128 DTAVHLVMELCEGGELFDRIVAR----------------------------------------GHYTERAAAAVTKTIVE 167 (352)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~----------------------------------------~~l~~~~~~~i~~qi~~ 167 (352)
.+..++||||+++++|.+++... ..+++..++.++.|++.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999988420 11367788999999999
Q ss_pred HHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC-----cccccccccccccchhcc---ccCCCcch
Q 018640 168 VVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-----KFSEIVGSPYYMAPEVLK---RNYGPEVD 239 (352)
Q Consensus 168 aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~---~~~s~~~D 239 (352)
||.|||+.||+||||||+||+++.++ ...+||+|||++....... ......||+.|+|||.+. ..++.++|
T Consensus 180 ~l~~LH~~~ivH~Dlkp~NIll~~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 180 ALHYLHNQGICHRDIKPENFLFSTNK-SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHHHTTEECCCCCGGGEEESCSS-SCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHHHCCccccCCChhhEEEecCC-CceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 99999999999999999999997543 2358999999998653211 124557999999999875 45889999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 240 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 240 i~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
|||||+++|||++|..||......+....+...........+..+++.+.+||.+||+.||.+|||+.++++||||++..
T Consensus 259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 99999999999999999999888888888877766555555556899999999999999999999999999999999875
Q ss_pred cC
Q 018640 320 KA 321 (352)
Q Consensus 320 ~~ 321 (352)
..
T Consensus 339 ~~ 340 (345)
T 3hko_A 339 DK 340 (345)
T ss_dssp SC
T ss_pred Hh
Confidence 54
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=394.67 Aligned_cols=260 Identities=28% Similarity=0.534 Sum_probs=217.4
Q ss_pred ccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe
Q 018640 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (352)
Q Consensus 51 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 130 (352)
....++|++++.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.+ +||||+++++++...+.
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~ 222 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDR 222 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCC-SCTTSCCEEEEEEETTE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-CCCeEeeEEEEEeeCCE
Confidence 33457899999999999999999999999999999999876444444556788899999999 89999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
.++||||+++++|.+++.....+++..+..++.||+.||+|||+ .||+||||||+|||++.++. +||+|||++...
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~---~kl~DFG~a~~~ 299 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH---IKITDFGLCKEG 299 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSC---EEECCCCCCCTT
T ss_pred EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCC---EEEccCCCceec
Confidence 99999999999999999888889999999999999999999998 99999999999999976554 899999999764
Q ss_pred C-CCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHH
Q 018640 210 K-PGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (352)
Q Consensus 210 ~-~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (352)
. .........||+.|+|||++. ..++.++||||||+++|||++|+.||...........+...... .+..+++.
T Consensus 300 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~----~p~~~~~~ 375 (446)
T 4ejn_A 300 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR----FPRTLGPE 375 (446)
T ss_dssp CC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----CCTTSCHH
T ss_pred cCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC----CCccCCHH
Confidence 3 233445678999999999986 55999999999999999999999999988887777666654333 33468899
Q ss_pred HHHHHHHhcCCCcCCCC-----CHHHHhcCcccccc
Q 018640 288 AKDLVRKMLDPDPKRRL-----TAQQVLEHPWLQNA 318 (352)
Q Consensus 288 ~~~li~~~l~~dP~~Rp-----s~~ell~hp~f~~~ 318 (352)
+.+||.+||+.||.+|| ++.|+++||||++.
T Consensus 376 ~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 376 AKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp HHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 99999999999999999 99999999999965
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=375.25 Aligned_cols=259 Identities=25% Similarity=0.382 Sum_probs=212.5
Q ss_pred CcccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC
Q 018640 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (352)
Q Consensus 49 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 128 (352)
.+..+.++|+++++||+|+||+||+|.+..+|+.||||++..... ..........|+..+.++.+||||+++++++.+.
T Consensus 51 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~ 129 (311)
T 3p1a_A 51 PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR-GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG 129 (311)
T ss_dssp SSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC-SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc-ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC
Confidence 345677899999999999999999999999999999998765432 2333445556666666666899999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccce
Q 018640 129 TAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~ 207 (352)
+..++||||+ +++|.+++.... .+++..++.++.|++.||+|||+.+|+||||||+|||++.++. +||+|||++.
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~---~kl~DFG~a~ 205 (311)
T 3p1a_A 130 GILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR---CKLGDFGLLV 205 (311)
T ss_dssp TEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGC---EEECCCTTCE
T ss_pred CEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC---EEEccceeee
Confidence 9999999999 669988887654 5999999999999999999999999999999999999976655 8999999998
Q ss_pred ecCCCCcccccccccccccchhccccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHH
Q 018640 208 FFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (352)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~~~~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (352)
............||+.|+|||++.+.++.++||||||+++|||++|..|++.... ...+.... .+......+++.
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~--~~~~~~~~~~~~ 280 (311)
T 3p1a_A 206 ELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGY--LPPEFTAGLSSE 280 (311)
T ss_dssp ECC------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTC--CCHHHHTTSCHH
T ss_pred ecccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccC--CCcccccCCCHH
Confidence 7765555556679999999999988899999999999999999999777755322 22222221 111223467899
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcCccccc
Q 018640 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (352)
Q Consensus 288 ~~~li~~~l~~dP~~Rps~~ell~hp~f~~ 317 (352)
+.++|.+||+.||++|||+.|+++||||++
T Consensus 281 l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 281 LRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 999999999999999999999999999986
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=396.26 Aligned_cols=262 Identities=35% Similarity=0.629 Sum_probs=230.5
Q ss_pred CcccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC
Q 018640 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (352)
Q Consensus 49 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 128 (352)
.+....++|.+.+.||+|+||+||+|.+..+|+.||+|++...........+.+.+|+.+++.+ +||||+++++++...
T Consensus 10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~ 88 (476)
T 2y94_A 10 DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHPHIIKLYQVISTP 88 (476)
T ss_dssp CSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-CCTTBCCEEEEEECS
T ss_pred CCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC
Confidence 3445567899999999999999999999999999999999765443334467899999999999 899999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccccee
Q 018640 129 TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~ 208 (352)
+..++||||++|++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+|||++..
T Consensus 89 ~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~---vkL~DFG~a~~ 165 (476)
T 2y94_A 89 SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN---AKIADFGLSNM 165 (476)
T ss_dssp SEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCC---EEECCCSSCEE
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCC---eEEEeccchhh
Confidence 999999999999999999988888999999999999999999999999999999999999976554 89999999988
Q ss_pred cCCCCcccccccccccccchhcccc--CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCH
Q 018640 209 FKPGEKFSEIVGSPYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (352)
Q Consensus 209 ~~~~~~~~~~~gt~~y~aPE~~~~~--~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (352)
..........+||+.|+|||++.+. .+.++||||||+++|+|++|..||...........+...... .+..+++
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~----~p~~~s~ 241 (476)
T 2y94_A 166 MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFY----TPQYLNP 241 (476)
T ss_dssp CCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCC----CCTTCCH
T ss_pred ccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcC----CCccCCH
Confidence 7665555667899999999998754 467999999999999999999999888777666666554332 2345789
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 287 ~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
.+.+||.+||+.||.+|||+.++++||||++.
T Consensus 242 ~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 242 SVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 99999999999999999999999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=369.05 Aligned_cols=267 Identities=40% Similarity=0.750 Sum_probs=227.5
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCC---hhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT---AVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 129 (352)
+.++|++.+.||+|+||+||+|.+..+|+.||+|++....... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 81 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHPNIITLHDIFENKT 81 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSS
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC-CCCCeeehhheecCCC
Confidence 5678999999999999999999999999999999987654322 22467899999999999 8999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCC-CCCCEEEEeccccee
Q 018640 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK-ETAPLKAIDFGLSVF 208 (352)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~-~~~~vkl~Dfg~a~~ 208 (352)
..++||||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||||+||+++.++ ....+||+|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 9999999999999999998888899999999999999999999999999999999999997654 233589999999987
Q ss_pred cCCCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHH
Q 018640 209 FKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (352)
Q Consensus 209 ~~~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (352)
...........||+.|+|||.+. ..++.++||||||+++++|++|..||...........+...........+...++.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T 3bhy_A 162 IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241 (283)
T ss_dssp CC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred ccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHH
Confidence 76555555667999999999887 45899999999999999999999999988877766666554433333333568899
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 288 ~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
+.++|.+||+.||++|||+.++++||||+....
T Consensus 242 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred HHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 999999999999999999999999999997643
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-51 Score=382.39 Aligned_cols=258 Identities=26% Similarity=0.496 Sum_probs=216.5
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHH-HhCCCCCCeeEeeeEEEeCCeE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIM-RHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
..++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|..++ +.+ +||||+++++++...+..
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~-~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCC-CCTTBCCEEEEEECSSEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEeCCEE
Confidence 346799999999999999999999999999999999877654444556677777774 556 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC-
Q 018640 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK- 210 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~- 210 (352)
++||||++||+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++...
T Consensus 115 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~---ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH---IVLTDFGLCKENIE 191 (373)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC---EEECCCCBCGGGBC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC---EEEeeCcccccccc
Confidence 999999999999999998888999999999999999999999999999999999999976554 8999999997643
Q ss_pred CCCcccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHH
Q 018640 211 PGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (352)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (352)
........+||+.|+|||++.+ .++.++|+||||+++|||++|..||......+....+...... ..+.++..+.
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~~ 267 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ----LKPNITNSAR 267 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCC----CCSSSCHHHH
T ss_pred CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccC----CCCCCCHHHH
Confidence 3334456789999999999874 5899999999999999999999999988887777777665333 3356899999
Q ss_pred HHHHHhcCCCcCCCCCH----HHHhcCcccccc
Q 018640 290 DLVRKMLDPDPKRRLTA----QQVLEHPWLQNA 318 (352)
Q Consensus 290 ~li~~~l~~dP~~Rps~----~ell~hp~f~~~ 318 (352)
+||.+||+.||.+||++ .++++||||+..
T Consensus 268 ~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 268 HLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp HHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred HHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 99999999999999986 699999999854
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-51 Score=373.12 Aligned_cols=261 Identities=27% Similarity=0.471 Sum_probs=207.1
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
.++|++++.||+|+||+||+|.+..+|+.||+|++.... .....+.+.+|+.+++++ +||||+++++++..++..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~l 80 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKEL-KHENIVRLYDVIHTENKLTL 80 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTC-CBTTBCCEEEEECCTTEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhc-CCCCcceEEEEEEECCeEEE
Confidence 357999999999999999999999999999999987543 223346788999999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccce
Q 018640 134 VMELCEGGELFDRIVAR------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~------~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~ 207 (352)
||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++. +||+|||++.
T Consensus 81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~---~kl~Dfg~~~ 156 (317)
T 2pmi_A 81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ---LKLGDFGLAR 156 (317)
T ss_dssp EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---EEECCCSSCE
T ss_pred EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCC---EEECcCccce
Confidence 999998 4999988754 35899999999999999999999999999999999999976554 8999999998
Q ss_pred ecCCC-Ccccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCC-----
Q 018640 208 FFKPG-EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD----- 279 (352)
Q Consensus 208 ~~~~~-~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----- 279 (352)
..... .......||+.|+|||++.+ .++.++||||||+++|+|++|+.||......+....+.+........
T Consensus 157 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 157 AFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV 236 (317)
T ss_dssp ETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred ecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence 76433 23345588999999998764 48999999999999999999999999888877776665533221111
Q ss_pred -------------------------CCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccC
Q 018640 280 -------------------------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKA 321 (352)
Q Consensus 280 -------------------------~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~ 321 (352)
....+++.+.+||.+||+.||++|||+.|+++||||++....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH 303 (317)
T ss_dssp GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence 112468899999999999999999999999999999986543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=383.21 Aligned_cols=260 Identities=32% Similarity=0.548 Sum_probs=206.4
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
..++|++++.||+|+||+||+|.+..+++.||+|++.... ...+.+.+|+.+++.+ +||||+++++++...+..+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA----AIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST----TSCHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc----cccHHHHHHHHHHHhC-CCCCCCcEEEEEeeCCEEE
Confidence 4568999999999999999999999999999999987542 2235688999999999 8999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
+||||+++++|.+++.....+++..++.++.|++.||.|||++||+||||||+||+++.++. ..+||+|||+++.....
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~-~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLH 171 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSS-CCEEECCCCCC------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC-ceEEEeecCcccccccc
Confidence 99999999999999988888999999999999999999999999999999999999975432 34899999999855444
Q ss_pred Ccccccccccccccchhccc-cCCCc-chHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc--CCCCCcCCCHHH
Q 018640 213 EKFSEIVGSPYYMAPEVLKR-NYGPE-VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF--RRDPWPKVSENA 288 (352)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~-~~s~~-~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 288 (352)
.......||+.|+|||++.+ .++.+ +||||||+++|+|++|+.||................... .......+++.+
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 251 (361)
T 3uc3_A 172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPEC 251 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHH
T ss_pred CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHH
Confidence 44455689999999998764 45444 899999999999999999997654432222222222221 122233679999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 289 ~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
.+||.+||+.||++|||+.|+++||||...
T Consensus 252 ~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 252 CHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp HHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred HHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 999999999999999999999999999754
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-51 Score=384.61 Aligned_cols=263 Identities=32% Similarity=0.539 Sum_probs=211.0
Q ss_pred cccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC
Q 018640 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (352)
Q Consensus 50 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 129 (352)
+..+.++|++++.||+|+||+||+|.+..+|+.||+|++... .........+.+|+.++..+.+||||+++++++...+
T Consensus 4 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 82 (388)
T 3oz6_A 4 DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN 82 (388)
T ss_dssp CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred cCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc-ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence 345677899999999999999999999999999999998654 2344556778899999999966999999999997544
Q ss_pred --eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccce
Q 018640 130 --AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (352)
Q Consensus 130 --~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~ 207 (352)
..++||||++ ++|.+++.. ..+++..+..++.||+.||+|||+.||+||||||+|||++.++. +||+|||+++
T Consensus 83 ~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~---~kl~DFG~a~ 157 (388)
T 3oz6_A 83 DRDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECH---VKVADFGLSR 157 (388)
T ss_dssp SSCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---EEECCCTTCE
T ss_pred CCEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCC---EEecCCcccc
Confidence 7899999997 589998876 47999999999999999999999999999999999999976554 8999999998
Q ss_pred ecCCC----------------------Ccccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 018640 208 FFKPG----------------------EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQ 263 (352)
Q Consensus 208 ~~~~~----------------------~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~ 263 (352)
..... .......||++|+|||++.+ .++.++|||||||++|||++|+.||.+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 65321 12234589999999998754 5899999999999999999999999988887
Q ss_pred HHHHHHHhcccccCC-------------------------------------------CCCcCCCHHHHHHHHHhcCCCc
Q 018640 264 GVAQAIIRSVLDFRR-------------------------------------------DPWPKVSENAKDLVRKMLDPDP 300 (352)
Q Consensus 264 ~~~~~~~~~~~~~~~-------------------------------------------~~~~~~~~~~~~li~~~l~~dP 300 (352)
.....+......... .....+++++.+||.+||+.||
T Consensus 238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP 317 (388)
T 3oz6_A 238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP 317 (388)
T ss_dssp HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence 777666543321110 0112568899999999999999
Q ss_pred CCCCCHHHHhcCcccccc
Q 018640 301 KRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 301 ~~Rps~~ell~hp~f~~~ 318 (352)
++|||+.|+++||||+..
T Consensus 318 ~~R~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 318 NKRISANDALKHPFVSIF 335 (388)
T ss_dssp GGSCCHHHHTTSTTTTTT
T ss_pred ccCCCHHHHhCCHHHHHh
Confidence 999999999999998764
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=383.12 Aligned_cols=263 Identities=37% Similarity=0.722 Sum_probs=228.1
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCC-----hhcHHHHHHHHHHHHhCCCCCCeeEeeeEEE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT-----AVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~ 126 (352)
.+.++|++.+.||+|+||.||+|.+..+|+.||||++....... ....+.+.+|+.+++++.+||||+++++++.
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 170 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 45578999999999999999999999899999999987543111 1124567889999999977999999999999
Q ss_pred eCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccc
Q 018640 127 DDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (352)
Q Consensus 127 ~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a 206 (352)
..+..++||||++|++|.+++.....+++..+..++.||+.||.|||+.|++|+||||+||+++.++. ++|+|||++
T Consensus 171 ~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~---ikl~DfG~~ 247 (365)
T 2y7j_A 171 SSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQ---IRLSDFGFS 247 (365)
T ss_dssp BSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC---EEECCCTTC
T ss_pred eCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC---EEEEecCcc
Confidence 99999999999999999999988888999999999999999999999999999999999999976554 899999999
Q ss_pred eecCCCCcccccccccccccchhccc-------cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCC
Q 018640 207 VFFKPGEKFSEIVGSPYYMAPEVLKR-------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279 (352)
Q Consensus 207 ~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 279 (352)
.............||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+..........
T Consensus 248 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 327 (365)
T 2y7j_A 248 CHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSP 327 (365)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHH
T ss_pred cccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 88766665667789999999998752 37889999999999999999999999888777666666554444333
Q ss_pred CCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccc
Q 018640 280 PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (352)
Q Consensus 280 ~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~ 317 (352)
.+...+..+.++|.+||+.||++|||+.++++||||+.
T Consensus 328 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 328 EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 34578899999999999999999999999999999973
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-51 Score=368.12 Aligned_cols=257 Identities=32% Similarity=0.511 Sum_probs=212.9
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++++.||+|+||+||+|.+ .+|+.||+|++..... .....+.+.+|+.+++++ +||||+++++++...+..++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSCEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhc-CCCCEeeeeeEEccCCeEEEE
Confidence 4799999999999999999998 6799999999865432 222346788999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC-
Q 018640 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~- 212 (352)
|||+++ +|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||++......
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPV 154 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC---EEECCTTHHHHHCC--
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC---EEEeECccccccCccc
Confidence 999975 999988764 56999999999999999999999999999999999999976554 899999999765432
Q ss_pred Ccccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC------------
Q 018640 213 EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR------------ 278 (352)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------------ 278 (352)
.......||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+.........
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence 22344578999999998753 4899999999999999999999999988877666666543222111
Q ss_pred -------------CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 279 -------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 279 -------------~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
.....+++.+.+||.+||+.||++|||+.|+++||||++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 0123578999999999999999999999999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=367.28 Aligned_cols=265 Identities=38% Similarity=0.681 Sum_probs=231.8
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCC------hhcHHHHHHHHHHHHhCCCCCCeeEeeeEE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT------AVDIEDVRREVDIMRHLPKHQNIVCLKDTY 125 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~ 125 (352)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|++....... ....+.+.+|+.+++++.+||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 45678999999999999999999999999999999987543111 122456789999999996699999999999
Q ss_pred EeCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccc
Q 018640 126 EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (352)
Q Consensus 126 ~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~ 205 (352)
...+..++||||+++++|.+++.....+++..++.++.|++.||.|||+.|++|+||||+||+++.++. +||+|||+
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~kl~dfg~ 170 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN---IKLTDFGF 170 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC---EEECCCTT
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCc---EEEecccc
Confidence 999999999999999999999998888999999999999999999999999999999999999976554 89999999
Q ss_pred ceecCCCCcccccccccccccchhcc-------ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC
Q 018640 206 SVFFKPGEKFSEIVGSPYYMAPEVLK-------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR 278 (352)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 278 (352)
+.............||+.|+|||.+. ..++.++||||||+++++|++|..||...........+.........
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T 1phk_A 171 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 250 (298)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred hhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc
Confidence 98776655556678999999999874 24788999999999999999999999988887777777766555555
Q ss_pred CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 279 DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 279 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
..+..+++.+.++|.+||+.||++|||+.++++||||++..
T Consensus 251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 55567899999999999999999999999999999999764
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=400.73 Aligned_cols=263 Identities=30% Similarity=0.511 Sum_probs=224.3
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
...++|++++.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+|+.+ +||||+++++++...+..
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l 259 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDAL 259 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-CCCCEeeEEEEEeeCCEE
Confidence 3456799999999999999999999999999999999775444444567788999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 132 HLVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~--l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
++||||++||+|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++...
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~---vKL~DFGla~~~ 336 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGH---IRISDLGLAVHV 336 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC---EEECCCTTCEEC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCC---eEEEecccceec
Confidence 999999999999999986543 999999999999999999999999999999999999976554 899999999887
Q ss_pred CCCCcccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHH
Q 018640 210 KPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (352)
Q Consensus 210 ~~~~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (352)
..........||+.|+|||++.+ .++.++||||||+++|||++|..||...........+.......+...+..+++++
T Consensus 337 ~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~ 416 (576)
T 2acx_A 337 PEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQA 416 (576)
T ss_dssp CTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred ccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHH
Confidence 66555566789999999999874 58999999999999999999999998754221111222222223334446789999
Q ss_pred HHHHHHhcCCCcCCCC-----CHHHHhcCcccccc
Q 018640 289 KDLVRKMLDPDPKRRL-----TAQQVLEHPWLQNA 318 (352)
Q Consensus 289 ~~li~~~l~~dP~~Rp-----s~~ell~hp~f~~~ 318 (352)
.+||.+||+.||.+|| ++.|+++||||++.
T Consensus 417 ~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 417 RSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp HHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred HHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 9999999999999999 89999999999963
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=376.67 Aligned_cols=260 Identities=30% Similarity=0.528 Sum_probs=216.7
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
+.++|++++.||+|+||+||+|.+..+++.||+|++..... ....+.+.+|+.+++.+ +||||+++++++...+..+
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~ 81 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKML-NHENVVKFYGHRREGNIQY 81 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHC-CCTTBCCEEEEEECSSEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCeEE
Confidence 45689999999999999999999999999999999865432 22335688999999999 8999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
+||||+++++|.+++.....+++..++.++.|++.||.|||+.||+||||||+|||++.++. +||+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~---~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 158 (323)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC---EEECCCTTCEECEET
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCC---EEEEEeeccceeccC
Confidence 99999999999999988778999999999999999999999999999999999999976554 899999999765322
Q ss_pred ---Ccccccccccccccchhcccc--CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHH
Q 018640 213 ---EKFSEIVGSPYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (352)
Q Consensus 213 ---~~~~~~~gt~~y~aPE~~~~~--~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (352)
.......||+.|+|||++.+. ++.++||||||+++|+|++|..||................ ......+..+++.
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 237 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-KTYLNPWKKIDSA 237 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTT-CTTSTTGGGSCHH
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcc-cccCCccccCCHH
Confidence 223456899999999998643 4778999999999999999999997665432222222211 1222334678999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 288 ~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
+.+||.+||+.||++|||+.|+++||||++..
T Consensus 238 ~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 238 PLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 99999999999999999999999999998753
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=387.59 Aligned_cols=262 Identities=26% Similarity=0.469 Sum_probs=222.9
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
...++|++++.||+|+||+||+|.+..+|+.||+|++.+.........+.+.+|..++..+ +||||+++++++.+.+..
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFAFQDENYL 136 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeCCEE
Confidence 3457899999999999999999999999999999999764333333445688899999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 132 HLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
++||||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++....
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~---vkL~DFGla~~~~ 213 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGH---IRLADFGSCLKLR 213 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCTTCEECC
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCC---EEEeechhheecc
Confidence 99999999999999998754 7999999999999999999999999999999999999976554 8999999998765
Q ss_pred CCCc--ccccccccccccchhcc--------ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCC-
Q 018640 211 PGEK--FSEIVGSPYYMAPEVLK--------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD- 279 (352)
Q Consensus 211 ~~~~--~~~~~gt~~y~aPE~~~--------~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~- 279 (352)
.... ....+||+.|+|||++. +.++.++|||||||++|||++|+.||......+....+..........
T Consensus 214 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 293 (412)
T 2vd5_A 214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPL 293 (412)
T ss_dssp TTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC-
T ss_pred CCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCc
Confidence 4432 23468999999999875 348999999999999999999999999988877777766533222211
Q ss_pred CCcCCCHHHHHHHHHhcCCCcCCC---CCHHHHhcCcccccc
Q 018640 280 PWPKVSENAKDLVRKMLDPDPKRR---LTAQQVLEHPWLQNA 318 (352)
Q Consensus 280 ~~~~~~~~~~~li~~~l~~dP~~R---ps~~ell~hp~f~~~ 318 (352)
....+++++.+||.+||. +|.+| |++.|+++||||+..
T Consensus 294 ~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 294 VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp ---CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 234689999999999999 99998 599999999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=383.23 Aligned_cols=262 Identities=35% Similarity=0.645 Sum_probs=223.6
Q ss_pred cccccee--ceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe
Q 018640 53 IEERYEL--GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (352)
Q Consensus 53 ~~~~y~~--~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 130 (352)
+...|.+ .+.||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~ 160 (373)
T 2x4f_A 85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQL-DHANLIQLYDAFESKND 160 (373)
T ss_dssp GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSE
T ss_pred cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCE
Confidence 4445555 678999999999999999999999999987542 24457899999999999 89999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 131 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
.++||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+..+. ...+||+|||++...
T Consensus 161 ~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 161 IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRD-AKQIKIIDFGLARRY 239 (373)
T ss_dssp EEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETT-TTEEEECCCSSCEEC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCC-CCcEEEEeCCCceec
Confidence 99999999999999988654 3699999999999999999999999999999999999995432 234899999999987
Q ss_pred CCCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHH
Q 018640 210 KPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (352)
Q Consensus 210 ~~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (352)
..........||+.|+|||++. ..++.++||||||+++|||++|..||......+....+...........++.+++.+
T Consensus 240 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 319 (373)
T 2x4f_A 240 KPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA 319 (373)
T ss_dssp CTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHH
T ss_pred CCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHH
Confidence 6665556668999999999887 458899999999999999999999999988888887777765555555556789999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 289 ~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
.+||.+||+.||.+|||+.|+++||||++..
T Consensus 320 ~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~ 350 (373)
T 2x4f_A 320 KEFISKLLIKEKSWRISASEALKHPWLSDHK 350 (373)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence 9999999999999999999999999999753
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=372.32 Aligned_cols=258 Identities=31% Similarity=0.523 Sum_probs=213.8
Q ss_pred ccccceeceeeeccCceEEEEEEEC---CCCcEEEEEEccccccC-ChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC
Q 018640 53 IEERYELGRELGRGEFGITYLCTDR---ENGDAFACKSISKKKLR-TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 128 (352)
..++|++++.||+|+||+||+|.+. .+|+.||+|++...... .......+.+|+.+++.+ +||||+++++++...
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPFIVDLIYAFQTG 93 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHC-CCTTBCCEEEEEECS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-CCCCccceeEEEEcC
Confidence 4568999999999999999999985 68999999999765322 223345678899999999 899999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccccee
Q 018640 129 TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~ 208 (352)
+..++||||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++..
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~---~kl~Dfg~~~~ 170 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGH---VKLTDFGLCKE 170 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSC---EEECCCSCC--
T ss_pred CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCc---EEEEeCCcccc
Confidence 999999999999999999998888999999999999999999999999999999999999976554 89999999975
Q ss_pred cCCC-Ccccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCH
Q 018640 209 FKPG-EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (352)
Q Consensus 209 ~~~~-~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (352)
.... .......||+.|+|||++. ..++.++||||||+++|+|++|..||...........+...... .++.+++
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~----~p~~~~~ 246 (327)
T 3a62_A 171 SIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN----LPPYLTQ 246 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC----CCTTSCH
T ss_pred cccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC----CCCCCCH
Confidence 4322 2334568999999999876 45899999999999999999999999988887777776665333 3346899
Q ss_pred HHHHHHHHhcCCCcCCCC-----CHHHHhcCcccccc
Q 018640 287 NAKDLVRKMLDPDPKRRL-----TAQQVLEHPWLQNA 318 (352)
Q Consensus 287 ~~~~li~~~l~~dP~~Rp-----s~~ell~hp~f~~~ 318 (352)
.+.++|.+||+.||.+|| ++.++++||||+..
T Consensus 247 ~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 247 EARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp HHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred HHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 999999999999999999 88999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-51 Score=369.52 Aligned_cols=256 Identities=32% Similarity=0.599 Sum_probs=212.4
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCC-----------------------hhcHHHHHHHHHHHH
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT-----------------------AVDIEDVRREVDIMR 110 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~~~E~~~l~ 110 (352)
-++|++.+.||+|+||+||+|.+..+|+.||+|++....... ....+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 467999999999999999999999999999999987653211 112356889999999
Q ss_pred hCCCCCCeeEeeeEEEe--CCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceE
Q 018640 111 HLPKHQNIVCLKDTYED--DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFL 188 (352)
Q Consensus 111 ~l~~h~~iv~l~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIl 188 (352)
++ +||||+++++++.. .+..++||||+++++|.+++. ...+++..++.++.|++.||.|||++||+||||||+||+
T Consensus 92 ~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 92 KL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL 169 (298)
T ss_dssp TC-CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred hC-CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 99 89999999999986 568999999999999987653 347999999999999999999999999999999999999
Q ss_pred eecCCCCCCEEEEecccceecCCCC-cccccccccccccchhcccc----CCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 018640 189 FANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVLKRN----YGPEVDVWSAGVILYILLCGVPPFWAETEQ 263 (352)
Q Consensus 189 l~~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~s~~~Di~SlG~~l~el~tg~~p~~~~~~~ 263 (352)
++.++. +||+|||++....... ......||+.|+|||.+.+. ++.++||||||+++|+|++|..||......
T Consensus 170 ~~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 246 (298)
T 2zv2_A 170 VGEDGH---IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246 (298)
T ss_dssp ECTTSC---EEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ECCCCC---EEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence 976554 8999999998765432 33456899999999998643 367899999999999999999999887766
Q ss_pred HHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccc
Q 018640 264 GVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316 (352)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~ 316 (352)
.....+....... ...+.+++.+.++|.+||+.||++|||+.|+++||||+
T Consensus 247 ~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 247 CLHSKIKSQALEF--PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHHHCCCCC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHHHhcccCCC--CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 6655555443332 22356899999999999999999999999999999996
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=370.32 Aligned_cols=262 Identities=31% Similarity=0.584 Sum_probs=216.4
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
-++|++++.||+|+||+||+|.+..+|+.||+|++.... ......+.+.+|+.+++++ +||||+++++++...+..++
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~l 79 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQL-KHPNLVNLLEVFRRKRRLHL 79 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhC-CCCCccchhheeecCCeEEE
Confidence 357999999999999999999999999999999886543 2333456788999999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC-
Q 018640 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~- 212 (352)
||||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||||+||+++.++ .+||+|||++......
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHS---VIKLCDFGFARLLTGPS 156 (311)
T ss_dssp EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS---CEEECCCTTCEECC---
T ss_pred EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCC---CEEEeeCCCchhccCcc
Confidence 999999999999988888899999999999999999999999999999999999997555 4899999999876533
Q ss_pred Ccccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC-------------
Q 018640 213 EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR------------- 277 (352)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------------- 277 (352)
.......||..|+|||.+.+ .++.++||||||+++|+|++|..||......+....+........
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 23345588999999998753 479999999999999999999999988877766555544322110
Q ss_pred ----CC----------CCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 278 ----RD----------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 278 ----~~----------~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
.. ..+.+++.+.+||.+||+.||++|||+.|+++||||++...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 293 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence 00 01357889999999999999999999999999999998754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=392.27 Aligned_cols=266 Identities=37% Similarity=0.660 Sum_probs=215.3
Q ss_pred ccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCC-----hhcHHHHHHHHHHHHhCCCCCCeeEeeeEE
Q 018640 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT-----AVDIEDVRREVDIMRHLPKHQNIVCLKDTY 125 (352)
Q Consensus 51 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~ 125 (352)
..+.++|++.+.||+|+||+||+|.+..+++.||+|++....... ......+.+|+.+++++ +||||+++++++
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~ 209 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFF 209 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCCCEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeEEEEE
Confidence 345678999999999999999999999999999999987654321 11223578999999999 999999999998
Q ss_pred EeCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccc
Q 018640 126 EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (352)
Q Consensus 126 ~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~ 205 (352)
.. +..++||||+++++|.+++.....+++..++.++.|++.||+|||++||+||||||+|||++.++....+||+|||+
T Consensus 210 ~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 210 DA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp ES-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred ec-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccc
Confidence 64 45789999999999999998888899999999999999999999999999999999999998777667799999999
Q ss_pred ceecCCCCcccccccccccccchhcc----ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcccccCCCC
Q 018640 206 SVFFKPGEKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVLDFRRDP 280 (352)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~ 280 (352)
+.............||+.|+|||++. ..++.++||||||+++|+|++|..||...... .....+........+..
T Consensus 289 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~ 368 (419)
T 3i6u_A 289 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368 (419)
T ss_dssp TTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHH
T ss_pred ceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchh
Confidence 98776555556678999999999874 34788999999999999999999999765433 22333333333333333
Q ss_pred CcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 281 ~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
+..+++.+.+||.+||+.||++|||+.|+++||||++.
T Consensus 369 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred hcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 45689999999999999999999999999999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=381.12 Aligned_cols=263 Identities=19% Similarity=0.288 Sum_probs=214.7
Q ss_pred cccceeceeeecc--CceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 54 EERYELGRELGRG--EFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 54 ~~~y~~~~~lG~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
.++|++++.||+| +||+||+|.+..+|+.||+|++..... .....+.+.+|+.+++.+ +||||+++++++...+..
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNEL 101 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhC-CCCCCCcEeEEEEECCEE
Confidence 4579999999999 999999999999999999999976543 334567788999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 132 HLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
++||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||.+...
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~---~~kl~dfg~~~~~ 178 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG---KVYLSGLRSNLSM 178 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC---CEEECCGGGCEEC
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC---CEEEcccccceee
Confidence 9999999999999999875 5699999999999999999999999999999999999997555 4899999988654
Q ss_pred CCCC--------cccccccccccccchhccc---cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc---
Q 018640 210 KPGE--------KFSEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD--- 275 (352)
Q Consensus 210 ~~~~--------~~~~~~gt~~y~aPE~~~~---~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--- 275 (352)
.... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||..................
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence 2211 1123478999999998764 4899999999999999999999999776544433332221110
Q ss_pred ---------------------------------------cCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccc
Q 018640 276 ---------------------------------------FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316 (352)
Q Consensus 276 ---------------------------------------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~ 316 (352)
.....+..+++.+.+||.+||+.||++|||+.|+++||||+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~ 338 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 338 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGG
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHH
Confidence 00012345788999999999999999999999999999999
Q ss_pred ccccC
Q 018640 317 NAKKA 321 (352)
Q Consensus 317 ~~~~~ 321 (352)
+....
T Consensus 339 ~~~~~ 343 (389)
T 3gni_B 339 QIKRR 343 (389)
T ss_dssp GC---
T ss_pred HHhhc
Confidence 86543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=375.65 Aligned_cols=266 Identities=37% Similarity=0.665 Sum_probs=219.8
Q ss_pred ccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccC-----ChhcHHHHHHHHHHHHhCCCCCCeeEeeeEE
Q 018640 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR-----TAVDIEDVRREVDIMRHLPKHQNIVCLKDTY 125 (352)
Q Consensus 51 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~ 125 (352)
..+.++|++.+.||+|+||.||+|.+..+++.||+|++...... .......+.+|+.+++++ +||||+++++++
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~ 84 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFF 84 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCceEeeEE
Confidence 45778999999999999999999999999999999998764321 122234588999999999 899999999998
Q ss_pred EeCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccc
Q 018640 126 EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (352)
Q Consensus 126 ~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~ 205 (352)
..+. .++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++....+||+|||+
T Consensus 85 ~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 85 DAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp ESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred cCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 7665 899999999999999998888899999999999999999999999999999999999998777666799999999
Q ss_pred ceecCCCCcccccccccccccchhcc----ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcccccCCCC
Q 018640 206 SVFFKPGEKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVLDFRRDP 280 (352)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~ 280 (352)
+.............||+.|+|||++. ..++.++||||||+++|+|++|..||...... .....+........+..
T Consensus 164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (322)
T 2ycf_A 164 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243 (322)
T ss_dssp CEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHH
T ss_pred ceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchh
Confidence 98765544444567999999999863 45889999999999999999999999765433 22233333322222222
Q ss_pred CcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 281 ~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
+..+++.+.++|.+||+.||++|||+.++++||||++.
T Consensus 244 ~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 34679999999999999999999999999999999853
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=376.71 Aligned_cols=270 Identities=23% Similarity=0.385 Sum_probs=225.5
Q ss_pred CccccccCCCcccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCC----CC
Q 018640 40 HKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP----KH 115 (352)
Q Consensus 40 ~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~----~h 115 (352)
.....+....+..+.++|++++.||+|+||+||+|.+..+++.||+|++... ......+..|+.+++.+. +|
T Consensus 20 ~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h 95 (360)
T 3llt_A 20 DEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINN 95 (360)
T ss_dssp CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTG
T ss_pred ccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCC
Confidence 3455667788889999999999999999999999999999999999998642 234466788999999994 39
Q ss_pred CCeeEeeeEEEeCCeEEEEEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCC
Q 018640 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK 193 (352)
Q Consensus 116 ~~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~ 193 (352)
|||+++++++...+..++||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++...
T Consensus 96 ~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~ 174 (360)
T 3llt_A 96 NNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPY 174 (360)
T ss_dssp GGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTT
T ss_pred CCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccc
Confidence 99999999999999999999999 889999998764 499999999999999999999999999999999999997421
Q ss_pred ----------------------CCCCEEEEecccceecCCCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHH
Q 018640 194 ----------------------ETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYIL 250 (352)
Q Consensus 194 ----------------------~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el 250 (352)
....+||+|||++...... .....||+.|+|||++. ..++.++||||||+++|+|
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred ccccccchhcccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 2455999999999865432 34568999999999876 4599999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhcccccCCCC---------------------C---------------------cCCCHHH
Q 018640 251 LCGVPPFWAETEQGVAQAIIRSVLDFRRDP---------------------W---------------------PKVSENA 288 (352)
Q Consensus 251 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------~---------------------~~~~~~~ 288 (352)
++|+.||......+....+.......+... + ...++.+
T Consensus 253 l~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 332 (360)
T 3llt_A 253 YTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF 332 (360)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred HHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence 999999988877766655544332211000 0 0124778
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcCcccc
Q 018640 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316 (352)
Q Consensus 289 ~~li~~~l~~dP~~Rps~~ell~hp~f~ 316 (352)
.+||.+||+.||.+|||+.|+|+||||+
T Consensus 333 ~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 333 CDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 8999999999999999999999999996
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=363.05 Aligned_cols=266 Identities=32% Similarity=0.610 Sum_probs=229.0
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
...++|++.+.||+|+||+||+|.+..++..||+|++...........+.+.+|+.+++.+ +||||+++++++...+..
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRMYNYFHDRKRI 89 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-CCCCEeeEEEEEEcCCEE
Confidence 3446899999999999999999999999999999998765433333456789999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
++||||+++++|.+++.....+++..++.++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++.....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGE---LKIADFGWSVHAPS 166 (284)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCC---EEECCCTTCEECSS
T ss_pred EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCC---EEEecccccccCcc
Confidence 999999999999999998888999999999999999999999999999999999999976554 89999999976543
Q ss_pred CCcccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHH
Q 018640 212 GEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (352)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (352)
. ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||...........+..... ...+.++..+.+
T Consensus 167 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 241 (284)
T 2vgo_A 167 L-RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL----KFPPFLSDGSKD 241 (284)
T ss_dssp S-CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC----CCCTTSCHHHHH
T ss_pred c-ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc----CCCCcCCHHHHH
Confidence 2 2345579999999998874 589999999999999999999999988877666655554322 233568999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcCccccccccCCCCCC
Q 018640 291 LVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSL 326 (352)
Q Consensus 291 li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~ 326 (352)
+|.+||+.||.+|||+.++++||||+.......++.
T Consensus 242 li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~~p~~ 277 (284)
T 2vgo_A 242 LISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPV 277 (284)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCCCCCC
T ss_pred HHHHHhhcCHhhCCCHHHHhhCHHHHhhccccCCCc
Confidence 999999999999999999999999998765544443
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-50 Score=361.86 Aligned_cols=261 Identities=33% Similarity=0.501 Sum_probs=228.2
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
...++|++.+.||+|+||+||+|.+..+++.||+|++...........+.+.+|+.+++.+ +||||+++++++...+..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 90 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFV 90 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCEE
Confidence 3557899999999999999999999999999999999876555556677899999999999 999999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
++||||+++++|.+++.....+++..++.++.|++.||.|||+.|++|+||||+||+++.++. +||+|||++.....
T Consensus 91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE---VKIGDFGLATKVEY 167 (294)
T ss_dssp EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---EEECCCTTCEECCS
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCC---EEEEeccCceeccc
Confidence 999999999999999988888999999999999999999999999999999999999976554 89999999987643
Q ss_pred C-Ccccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHH
Q 018640 212 G-EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (352)
Q Consensus 212 ~-~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (352)
. .......||+.|+|||.+.+ .++.++||||||+++++|++|..||......+....+..... .....+++.+.
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~ 243 (294)
T 2rku_A 168 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY----SIPKHINPVAA 243 (294)
T ss_dssp TTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC----CCCTTSCHHHH
T ss_pred CccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccC----CCccccCHHHH
Confidence 2 23345678999999999864 488999999999999999999999988877666555544322 23346789999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 290 ~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
++|.+||+.||++|||+.++++||||.....
T Consensus 244 ~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 274 (294)
T 2rku_A 244 SLIQKMLQTDPTARPTINELLNDEFFTSGYI 274 (294)
T ss_dssp HHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred HHHHHHcccChhhCcCHHHHhhChheecCCc
Confidence 9999999999999999999999999986543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=362.66 Aligned_cols=262 Identities=37% Similarity=0.614 Sum_probs=218.2
Q ss_pred cccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC
Q 018640 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (352)
Q Consensus 50 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 129 (352)
+....++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.+ +||||+++++++...+
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 84 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHPHIIKLYQVISTPT 84 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSS
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcC-CCCCEeEEEEEEecCC
Confidence 445567899999999999999999999989999999998765433344567899999999999 8999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
..++||||+++++|.+++.....+++..+..++.|++.||.|||++|++|+||||+||+++.++. ++|+|||++...
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~~l~dfg~~~~~ 161 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN---AKIADFGLSNMM 161 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSC---EEECCCCGGGCC
T ss_pred eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCC---EEEeeccccccc
Confidence 99999999999999999988888999999999999999999999999999999999999976554 899999999876
Q ss_pred CCCCcccccccccccccchhcccc--CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHH
Q 018640 210 KPGEKFSEIVGSPYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (352)
Q Consensus 210 ~~~~~~~~~~gt~~y~aPE~~~~~--~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (352)
..........||+.|+|||.+.+. .+.++||||||+++++|++|..||...........+...... ....++..
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 237 (276)
T 2h6d_A 162 SDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFY----IPEYLNRS 237 (276)
T ss_dssp CC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----CCTTSCHH
T ss_pred CCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc----CchhcCHH
Confidence 555444556789999999998754 367999999999999999999999887776666555544322 23457899
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 288 ~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
+.++|.+||+.||++|||+.++++||||++..
T Consensus 238 l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 238 VATLLMHMLQVDPLKRATIKDIREHEWFKQDL 269 (276)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred HHHHHHHHccCChhhCCCHHHHHhChhhccCc
Confidence 99999999999999999999999999998653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-51 Score=375.03 Aligned_cols=260 Identities=27% Similarity=0.478 Sum_probs=213.1
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++++.||+|+||+||+|.+..+++.||+|++...... .....+.+|+.+++.+ +||||+++++++...+..++|
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDL-KHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCC-CCTTBCCEEEEEECSSCEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhc-CCCCCCeeeeEEeeCCEEEEE
Confidence 4799999999999999999999999999999998654311 1112345699999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC-
Q 018640 135 MELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~- 212 (352)
|||++ ++|.+++.... .+++..++.++.|++.||.|||+.||+||||||+||+++.++. +||+|||++......
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~---~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 79 FEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPT 154 (324)
T ss_dssp EECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCC---EEECSSSEEECC----
T ss_pred ecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCC---EEEccCcccccccCCc
Confidence 99997 59999887654 5999999999999999999999999999999999999976554 899999999765432
Q ss_pred Ccccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCC---------
Q 018640 213 EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW--------- 281 (352)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------- 281 (352)
.......||+.|+|||++.+ .++.++||||||+++|+|++|+.||......+....+...........+
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence 23345578999999998754 4899999999999999999999999998888777777665443332222
Q ss_pred -----------------cCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccC
Q 018640 282 -----------------PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKA 321 (352)
Q Consensus 282 -----------------~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~ 321 (352)
+.+++++.+||.+||+.||++|||+.|+++||||.+....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 2468889999999999999999999999999999987554
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=375.22 Aligned_cols=265 Identities=26% Similarity=0.414 Sum_probs=220.9
Q ss_pred cccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC
Q 018640 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (352)
Q Consensus 50 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 129 (352)
...+.++|++.+.||+|+||+||+|.+..+++.||+|++.............+.+|+.+++++ +||||+++++++....
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~ 85 (311)
T 3ork_A 7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAET 85 (311)
T ss_dssp CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-CCTTBCCEEEEEEEEE
T ss_pred cceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-CCCCcceEEEeeeccC
Confidence 346788999999999999999999999999999999999876555555567889999999999 8999999999987654
Q ss_pred ----eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccc
Q 018640 130 ----AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (352)
Q Consensus 130 ----~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~ 205 (352)
..++||||++|++|.+++.....+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+
T Consensus 86 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~ 162 (311)
T 3ork_A 86 PAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA---VKVMDFGI 162 (311)
T ss_dssp TTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSC---EEECCCSC
T ss_pred CCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCC---EEEeeccC
Confidence 34999999999999999998888999999999999999999999999999999999999986654 89999999
Q ss_pred ceecCCCC----cccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCC
Q 018640 206 SVFFKPGE----KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP 280 (352)
Q Consensus 206 a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 280 (352)
+....... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.......................
T Consensus 163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (311)
T 3ork_A 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 242 (311)
T ss_dssp C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHH
T ss_pred cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccc
Confidence 97654322 2234578999999998864 588999999999999999999999998887766666555433322223
Q ss_pred CcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 281 ~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
...+++++.++|.+||+.||++||++.+++.|+|++..
T Consensus 243 ~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 34689999999999999999999999999999999854
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=365.85 Aligned_cols=254 Identities=30% Similarity=0.528 Sum_probs=219.1
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
.|...+.||+|+||+||+|.+..+|+.||||++.... ....+.+.+|+.+++++ +||||+++++++...+..++||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 121 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDY-QHFNVVEMYKSYLVGEELWVLM 121 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhC-CCCCcceEEEEEEECCEEEEEE
Confidence 4888889999999999999999899999999986542 33457788999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC-c
Q 018640 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-K 214 (352)
Q Consensus 136 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-~ 214 (352)
||+++++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++. +||+|||++....... .
T Consensus 122 e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~~~~~~~~~~~ 197 (321)
T 2c30_A 122 EFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR---VKLSDFGFCAQISKDVPK 197 (321)
T ss_dssp CCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC---EEECCCTTCEECCSSSCC
T ss_pred ecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCc---EEEeeeeeeeecccCccc
Confidence 99999999998864 46999999999999999999999999999999999999976554 8999999998765432 3
Q ss_pred ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHH
Q 018640 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (352)
Q Consensus 215 ~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 293 (352)
.....||+.|+|||++. ..++.++||||||+++|+|++|+.||...........+...... .......+++.+.++|.
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~ 276 (321)
T 2c30_A 198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP-KLKNSHKVSPVLRDFLE 276 (321)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC-CCTTGGGSCHHHHHHHH
T ss_pred cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-CcCccccCCHHHHHHHH
Confidence 34568999999999986 45899999999999999999999999888776666555443221 11223467899999999
Q ss_pred HhcCCCcCCCCCHHHHhcCcccccc
Q 018640 294 KMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 294 ~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
+||+.||++|||+.++++||||.+.
T Consensus 277 ~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 277 RMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp HHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred HHccCChhhCcCHHHHhcChhhccC
Confidence 9999999999999999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=388.73 Aligned_cols=262 Identities=27% Similarity=0.437 Sum_probs=200.5
Q ss_pred ccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe---
Q 018640 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--- 127 (352)
Q Consensus 51 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~--- 127 (352)
..+.++|++++.||+|+||+||+|.+..+|+.||||++... .......+.+.+|+.+|+++ +||||+++++++..
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 126 (458)
T 3rp9_A 49 WQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDV 126 (458)
T ss_dssp CCSCTTEEECCC-------CEEEEEECC--CEEEEEEECST-TSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCT
T ss_pred CccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhC-CCCCCCceEEEEecCCc
Confidence 45678999999999999999999999999999999998654 33445567899999999999 89999999999843
Q ss_pred --CCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccc
Q 018640 128 --DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (352)
Q Consensus 128 --~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~ 205 (352)
....++||||+ +++|.+++.....+++..++.++.||+.||+|||+.||+||||||+|||++.++. +||+|||+
T Consensus 127 ~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~---~kl~DFGl 202 (458)
T 3rp9_A 127 EKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS---VKVCDFGL 202 (458)
T ss_dssp TTCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC---EEECCCTT
T ss_pred ccCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCC---Eeeccccc
Confidence 35789999998 5699999988888999999999999999999999999999999999999976554 99999999
Q ss_pred ceecCCCC----------------------------cccccccccccccchhc-c-ccCCCcchHHHHHHHHHHHHh---
Q 018640 206 SVFFKPGE----------------------------KFSEIVGSPYYMAPEVL-K-RNYGPEVDVWSAGVILYILLC--- 252 (352)
Q Consensus 206 a~~~~~~~----------------------------~~~~~~gt~~y~aPE~~-~-~~~s~~~Di~SlG~~l~el~t--- 252 (352)
++...... .....+||++|+|||++ . ..++.++|||||||++|||++
T Consensus 203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~ 282 (458)
T 3rp9_A 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282 (458)
T ss_dssp CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence 98654221 22345789999999975 3 459999999999999999998
Q ss_pred --------CCCCCCCCCH--------------------HHHHHHHHhcccccC---------------------------
Q 018640 253 --------GVPPFWAETE--------------------QGVAQAIIRSVLDFR--------------------------- 277 (352)
Q Consensus 253 --------g~~p~~~~~~--------------------~~~~~~~~~~~~~~~--------------------------- 277 (352)
|+++|.+... ......+.+......
T Consensus 283 ~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (458)
T 3rp9_A 283 ENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDL 362 (458)
T ss_dssp TTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCG
T ss_pred ccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCH
Confidence 6666654331 122222221111100
Q ss_pred CCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 278 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
...++..++++.+||.+||+.||++|||+.|+|+||||++.
T Consensus 363 ~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 363 AERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp GGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 11134568999999999999999999999999999999976
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-51 Score=390.76 Aligned_cols=258 Identities=27% Similarity=0.422 Sum_probs=210.9
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC---
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--- 128 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~--- 128 (352)
.+.++|++++.||+|+||+||+|.+..+|+.||||++... .........+.+|+.+++.+ +||||+++++++...
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 136 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTL 136 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESG-GGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCST
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcc-ccChHHHHHHHHHHHHHHhC-CCCCCCcEEEEEccCCcc
Confidence 4568899999999999999999999999999999999765 23444567888999999999 999999999999654
Q ss_pred ---CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccc
Q 018640 129 ---TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (352)
Q Consensus 129 ---~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~ 205 (352)
...++||||+++ +|.+.+.. .+++..++.++.||+.||+|||+.||+||||||+|||++.++. +||+|||+
T Consensus 137 ~~~~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~---~kl~DFG~ 210 (464)
T 3ttj_A 137 EEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGL 210 (464)
T ss_dssp TTCCEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC---EEECCCCC
T ss_pred ccCCeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCC---EEEEEEEe
Confidence 467999999975 67776643 4999999999999999999999999999999999999976554 89999999
Q ss_pred ceecCCCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCC---
Q 018640 206 SVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW--- 281 (352)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 281 (352)
++............||+.|+|||++. ..++.++|||||||++|||++|+.||.+....+....+.+......+..+
T Consensus 211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 211 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp C-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred eeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 98776555556678999999999876 45999999999999999999999999988877777666554332110000
Q ss_pred -----------------------cC------------CCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccc
Q 018640 282 -----------------------PK------------VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (352)
Q Consensus 282 -----------------------~~------------~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~ 317 (352)
+. .++++.+||.+||+.||++|||+.|+|+||||+.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 00 1467899999999999999999999999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-50 Score=381.70 Aligned_cols=264 Identities=26% Similarity=0.497 Sum_probs=211.4
Q ss_pred cccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC-
Q 018640 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD- 128 (352)
Q Consensus 50 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~- 128 (352)
...+.++|++++.||+|+||+||+|.+..+|+.||||++... .........+.+|+.+|+++ +||||+++++++...
T Consensus 21 ~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 98 (432)
T 3n9x_A 21 NVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILNRL-KSDYIIRLYDLIIPDD 98 (432)
T ss_dssp GCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST-TTSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSC
T ss_pred cceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch-hcChHHHHHHHHHHHHHHHc-CCCCcceEEEEEecCC
Confidence 345778999999999999999999999999999999998754 33445567899999999999 899999999999766
Q ss_pred ----CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecc
Q 018640 129 ----TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (352)
Q Consensus 129 ----~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg 204 (352)
...++||||++ ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+|||
T Consensus 99 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~---~kL~DFG 174 (432)
T 3n9x_A 99 LLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCS---VKVCDFG 174 (432)
T ss_dssp TTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---EEECCCT
T ss_pred CCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCC---EEEccCC
Confidence 57899999996 599999988888999999999999999999999999999999999999976544 8999999
Q ss_pred cceecCCCC-----------------------cccccccccccccchhc-c-ccCCCcchHHHHHHHHHHHHhCCCC---
Q 018640 205 LSVFFKPGE-----------------------KFSEIVGSPYYMAPEVL-K-RNYGPEVDVWSAGVILYILLCGVPP--- 256 (352)
Q Consensus 205 ~a~~~~~~~-----------------------~~~~~~gt~~y~aPE~~-~-~~~s~~~Di~SlG~~l~el~tg~~p--- 256 (352)
+++...... .....+||++|+|||++ . ..++.++|||||||++|||++|..|
T Consensus 175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 254 (432)
T 3n9x_A 175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254 (432)
T ss_dssp TCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccc
Confidence 998764322 12556899999999985 3 4599999999999999999985433
Q ss_pred --------CCCCC-----------------HHHHHHHHHhccccc--------------------CCC-------CCcCC
Q 018640 257 --------FWAET-----------------EQGVAQAIIRSVLDF--------------------RRD-------PWPKV 284 (352)
Q Consensus 257 --------~~~~~-----------------~~~~~~~~~~~~~~~--------------------~~~-------~~~~~ 284 (352)
|.+.. ....+..+.+..... +.. .++.+
T Consensus 255 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (432)
T 3n9x_A 255 DPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSI 334 (432)
T ss_dssp SGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTS
T ss_pred ccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCC
Confidence 33322 112222222211110 000 12457
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 285 SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 285 ~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
++.+.+||.+||+.||++|||+.|+|+||||++..
T Consensus 335 s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 335 SDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence 99999999999999999999999999999999763
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-50 Score=368.32 Aligned_cols=260 Identities=33% Similarity=0.505 Sum_probs=228.2
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
...++|.+.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.+ +|+||+++++++.+.+..
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 116 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFV 116 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCeE
Confidence 3456899999999999999999999999999999999876555556677899999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
++||||+++++|.+++.....+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||++.....
T Consensus 117 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~---~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 117 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE---VKIGDFGLATKVEY 193 (335)
T ss_dssp EEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC---EEECCCTTCEECCS
T ss_pred EEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCC---EEEeeccCceeccc
Confidence 999999999999999988888999999999999999999999999999999999999976544 89999999987643
Q ss_pred C-Ccccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHH
Q 018640 212 G-EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (352)
Q Consensus 212 ~-~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (352)
. .......||..|+|||++.+ .++.++||||||+++|+|++|..||......+....+...... ....+++.+.
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 269 (335)
T 2owb_A 194 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS----IPKHINPVAA 269 (335)
T ss_dssp TTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC----CCTTSCHHHH
T ss_pred CcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCC----CCccCCHHHH
Confidence 2 23345679999999998864 4889999999999999999999999888776666555544322 2346789999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 290 ~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
+||.+||+.||++|||+.++++||||....
T Consensus 270 ~li~~~l~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 270 SLIQKMLQTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp HHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred HHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence 999999999999999999999999998653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-50 Score=370.27 Aligned_cols=272 Identities=28% Similarity=0.445 Sum_probs=226.3
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
...++|++++.||+|+||+||+|.+..+|+.||||++...........+.+.+|+.+++++ +||||+++++++...+..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 129 (348)
T 1u5q_A 51 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTA 129 (348)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEE
T ss_pred chhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCeE
Confidence 3456799999999999999999999999999999998765433444456789999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 132 HLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
++||||++ |+|.+.+.. ...+++..+..++.|++.||.|||+.||+||||||+|||++.++. +||+|||++....
T Consensus 130 ~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~---~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 130 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL---VKLGDFGSASIMA 205 (348)
T ss_dssp EEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE---EEECCCTTCBSSS
T ss_pred EEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC---EEEeeccCceecC
Confidence 99999997 588887754 457999999999999999999999999999999999999986554 8999999997654
Q ss_pred CCCcccccccccccccchhcc----ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCH
Q 018640 211 PGEKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (352)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~----~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (352)
.. ....||+.|+|||++. +.++.++||||||+++|||++|..||...........+..... +......+++
T Consensus 206 ~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 280 (348)
T 1u5q_A 206 PA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--PALQSGHWSE 280 (348)
T ss_dssp SB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC--CCCCCTTSCH
T ss_pred CC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CCCCCCCCCH
Confidence 32 3457999999999873 4589999999999999999999999988877666655554322 2222346789
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcCccccccccCCCCCCcHHHHHHHHh
Q 018640 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQ 336 (352)
Q Consensus 287 ~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~ 336 (352)
.+.+||.+||+.||++|||+.++++||||..... .....+...|.++
T Consensus 281 ~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~---~~~~~~~~~~~~~ 327 (348)
T 1u5q_A 281 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP---PTVIMDLIQRTKD 327 (348)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC---TTHHHHHHHHHHH
T ss_pred HHHHHHHHHcccChhhCcCHHHHhhChhhhccCC---cchhhHHHHHHHH
Confidence 9999999999999999999999999999986422 2333344445554
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-51 Score=374.87 Aligned_cols=254 Identities=32% Similarity=0.557 Sum_probs=218.5
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCCh-----hcHHHHHHHHHHHHhCCCCCCeeEeeeEEE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA-----VDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~ 126 (352)
.+.++|++++.||+|+||+||+|.+..+|+.||+|++........ ...+.+.+|+.+++++ +||||+++++++.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~ 99 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-EHANIIKVLDIFE 99 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-CCTTBCCEEEEEE
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEe
Confidence 467889999999999999999999999999999999976543221 1234577899999999 8999999999999
Q ss_pred eCCeEEEEEEecCCc-chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccc
Q 018640 127 DDTAVHLVMELCEGG-ELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (352)
Q Consensus 127 ~~~~~~lv~e~~~~~-sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~ 205 (352)
..+..++||||+.+| +|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+|||+
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~---~kL~Dfg~ 176 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFT---IKLIDFGS 176 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC---EEECCCTT
T ss_pred eCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCc---EEEeeccc
Confidence 999999999998766 99999998888999999999999999999999999999999999999976544 89999999
Q ss_pred ceecCCCCcccccccccccccchhcccc-C-CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcC
Q 018640 206 SVFFKPGEKFSEIVGSPYYMAPEVLKRN-Y-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (352)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~-s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (352)
+.............||+.|+|||++.+. + +.++||||||+++|+|++|..||..... ...........
T Consensus 177 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------~~~~~~~~~~~ 246 (335)
T 3dls_A 177 AAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------TVEAAIHPPYL 246 (335)
T ss_dssp CEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----------GTTTCCCCSSC
T ss_pred ceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH----------HHhhccCCCcc
Confidence 9887666555667899999999988643 3 7889999999999999999999965322 11122223345
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 284 ~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
+++.+.+||.+||+.||++|||+.++++||||++..
T Consensus 247 ~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 247 VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence 899999999999999999999999999999998753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-50 Score=360.18 Aligned_cols=258 Identities=23% Similarity=0.351 Sum_probs=213.7
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
.+.++|++++.||+|+||+||+|.+..+++.||+|++...... ......+.+|+..+..+.+||||+++++++...+..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~ 86 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG-SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM 86 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT-SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 4678899999999999999999999999999999998765332 334567888999999988899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCC--------------
Q 018640 132 HLVMELCEGGELFDRIVAR----GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK-------------- 193 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~----~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~-------------- 193 (352)
++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999999999999999764 5699999999999999999999999999999999999998654
Q ss_pred --CCCCEEEEecccceecCCCCcccccccccccccchhcccc--CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 018640 194 --ETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI 269 (352)
Q Consensus 194 --~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~ 269 (352)
....+||+|||++....... ...||+.|+|||.+.+. ++.++||||||+++++|++|..|+..... ...+
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~ 240 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEI 240 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHHH
T ss_pred cCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHHH
Confidence 44568999999998765432 33689999999998754 55799999999999999999987754432 2223
Q ss_pred HhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 270 IRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
.... .+.....+++.+.++|.+||+.||++|||+.++++||||++..
T Consensus 241 ~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 241 RQGR---LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287 (289)
T ss_dssp HTTC---CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred HcCC---CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence 2221 2233457899999999999999999999999999999999764
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=360.40 Aligned_cols=258 Identities=34% Similarity=0.569 Sum_probs=197.1
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++.+.||+|+||+||+|.+..+|+.||+|++...........+.+.+|+.+++++ +||||+++++++...+..++|
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-CCTTBCCEEEEEECSSEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-CCCCeEeEEEEEccCCeEEEE
Confidence 4699999999999999999999999999999998765433333457889999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC-
Q 018640 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~- 212 (352)
|||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++. +||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~---~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN---IKIADFGLATQLKMPH 166 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCC---EEECCCTTCEECC---
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC---EEEEeecceeeccCCC
Confidence 9999999999999875 56999999999999999999999999999999999999976554 899999999876432
Q ss_pred Ccccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHH
Q 018640 213 EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (352)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 291 (352)
.......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||...........+. ......+..++..+.++
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l 242 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV----LADYEMPSFLSIEAKDL 242 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC----SSCCCCCTTSCHHHHHH
T ss_pred CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh----hcccCCccccCHHHHHH
Confidence 22334578999999998864 58899999999999999999999997665443332221 11222334678999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 292 VRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 292 i~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
|.+||+.||++|||+.++++||||.+...
T Consensus 243 i~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 271 (278)
T 3cok_A 243 IHQLLRRNPADRLSLSSVLDHPFMSRNSS 271 (278)
T ss_dssp HHHHSCSSGGGSCCHHHHTTSTTTC----
T ss_pred HHHHcccCHhhCCCHHHHhcCccccCCCC
Confidence 99999999999999999999999997643
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=403.12 Aligned_cols=257 Identities=26% Similarity=0.445 Sum_probs=228.6
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|+++++||+|+||+||+|.+..+++.||+|++.+.........+.+..|..++..+.+||+|+++++++...+..++|
T Consensus 341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV 420 (674)
T 3pfq_A 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 420 (674)
T ss_dssp TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence 57999999999999999999999999999999998654434445677888999999987899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC-CCC
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGE 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~-~~~ 213 (352)
|||++||+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++... ...
T Consensus 421 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~---ikL~DFGla~~~~~~~~ 497 (674)
T 3pfq_A 421 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH---IKIADFGMCKENIWDGV 497 (674)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSC---EEECCCTTCEECCCTTC
T ss_pred EeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCc---EEEeecceeeccccCCc
Confidence 999999999999998888999999999999999999999999999999999999976654 8999999998643 333
Q ss_pred cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHH
Q 018640 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (352)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 292 (352)
......||+.|+|||++. ..++.++||||||+++|||++|..||......+....+...... .+..+++++.+||
T Consensus 498 ~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~----~p~~~s~~~~~li 573 (674)
T 3pfq_A 498 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA----YPKSMSKEAVAIC 573 (674)
T ss_dssp CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCC----CCTTSCHHHHHHH
T ss_pred ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC----CCccCCHHHHHHH
Confidence 446678999999999987 55999999999999999999999999998888777777665433 3356899999999
Q ss_pred HHhcCCCcCCCCCH-----HHHhcCcccccc
Q 018640 293 RKMLDPDPKRRLTA-----QQVLEHPWLQNA 318 (352)
Q Consensus 293 ~~~l~~dP~~Rps~-----~ell~hp~f~~~ 318 (352)
.+||+.||++||++ .+|++||||+..
T Consensus 574 ~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 574 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp HHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred HHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 99999999999997 999999999864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-50 Score=370.25 Aligned_cols=259 Identities=27% Similarity=0.475 Sum_probs=218.4
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe------
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED------ 127 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~------ 127 (352)
-++|++++.||+|+||+||+|.+..+|+.||+|++...... ......+.+|+.+++.+ +||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLL-KHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS-SSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEEC-----
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc-ccchHHHHHHHHHHHhc-cCCCcccHhheeeccccccc
Confidence 35799999999999999999999999999999998765432 22345678899999999 89999999999876
Q ss_pred --CCeEEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecc
Q 018640 128 --DTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (352)
Q Consensus 128 --~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg 204 (352)
.+..++||||+++ +|.+.+... ..+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~---~kl~Dfg 169 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV---LKLADFG 169 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCT
T ss_pred cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCC---EEEccch
Confidence 4468999999975 777777654 56999999999999999999999999999999999999976554 8999999
Q ss_pred cceecCCC-----Ccccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC
Q 018640 205 LSVFFKPG-----EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR 277 (352)
Q Consensus 205 ~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 277 (352)
++...... .......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+........
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 99865422 22345578999999998753 479999999999999999999999999888877777766655544
Q ss_pred CCCCcC----------------------------CCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 278 RDPWPK----------------------------VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 278 ~~~~~~----------------------------~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
...++. .++.+.+||.+||+.||++|||+.|+++||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence 443332 26779999999999999999999999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=372.29 Aligned_cols=262 Identities=26% Similarity=0.435 Sum_probs=215.2
Q ss_pred cccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC
Q 018640 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (352)
Q Consensus 50 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 129 (352)
...+.++|++++.||+|+||+||+|.+..+|+.||||++.... ......+.+.+|+.+++.+ +||||+++++++....
T Consensus 20 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~ 97 (367)
T 1cm8_A 20 AWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDE 97 (367)
T ss_dssp EECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCS
T ss_pred eeeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhC-CCcCCCCceeeEecCC
Confidence 3456788999999999999999999999999999999986542 3344467788999999999 8999999999997653
Q ss_pred ------eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEec
Q 018640 130 ------AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDF 203 (352)
Q Consensus 130 ------~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Df 203 (352)
..++||||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++. +||+||
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~---~kl~Df 172 (367)
T 1cm8_A 98 TLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE---LKILDF 172 (367)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---EEECCC
T ss_pred ccccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCC---EEEEee
Confidence 469999999 7899999876 47999999999999999999999999999999999999976544 899999
Q ss_pred ccceecCCCCcccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC----
Q 018640 204 GLSVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR---- 277 (352)
Q Consensus 204 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---- 277 (352)
|+++.... ......||+.|+|||++.+ .++.++|||||||+++||++|+.||.+....+....+.......+
T Consensus 173 g~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 173 GLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp TTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred eccccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 99987543 2345688999999998754 589999999999999999999999998887766666554322111
Q ss_pred -----------------------CCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 278 -----------------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 278 -----------------------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
...++..++.+.+||.+||+.||++|||+.++++||||+....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 0123457899999999999999999999999999999997643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=391.97 Aligned_cols=257 Identities=30% Similarity=0.514 Sum_probs=221.0
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
.++|++.++||+|+||.||+|.+..+|+.||+|++.+.........+.+.+|+.+++++ +||||+++++++...+..++
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-CCCCEeeEEEEEeeCCEEEE
Confidence 46799999999999999999999999999999999776544444567889999999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 134 VMELCEGGELFDRIVAR----GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~----~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++...
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~---vkL~DFGla~~~ 339 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN---VRISDLGLAVEL 339 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC---EEECCCTTCEEC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCC---EEEeecceeeec
Confidence 99999999999999764 35999999999999999999999999999999999999976554 899999999876
Q ss_pred CCCCc-ccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcccccCCCCCcC
Q 018640 210 KPGEK-FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAET----EQGVAQAIIRSVLDFRRDPWPK 283 (352)
Q Consensus 210 ~~~~~-~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 283 (352)
..... ....+||+.|+|||++.+ .++.++|||||||++|||++|..||.... .......+... ....+..
T Consensus 340 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~----~~~~p~~ 415 (543)
T 3c4z_A 340 KAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ----AVTYPDK 415 (543)
T ss_dssp CTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC----CCCCCTT
T ss_pred cCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc----ccCCCcc
Confidence 54433 344589999999999874 58999999999999999999999997653 23333444333 2333457
Q ss_pred CCHHHHHHHHHhcCCCcCCCCC-----HHHHhcCcccccc
Q 018640 284 VSENAKDLVRKMLDPDPKRRLT-----AQQVLEHPWLQNA 318 (352)
Q Consensus 284 ~~~~~~~li~~~l~~dP~~Rps-----~~ell~hp~f~~~ 318 (352)
+++.+.+||.+||+.||++||+ +.++++||||++.
T Consensus 416 ~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 416 FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred cCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 8999999999999999999996 5899999999963
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=369.29 Aligned_cols=256 Identities=27% Similarity=0.435 Sum_probs=206.1
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC--
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT-- 129 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~-- 129 (352)
.+.++|++++.||+|+||+||+|.+..+|+.||||++.... .....+.+.+|+.+++++ +||||+++++++.+..
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 79 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKL-EHPGIVRYFNAWLETPPE 79 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSC-CCTTBCCEEEEEEECCSC
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEeccc
Confidence 35678999999999999999999999999999999987543 333457899999999999 8999999999986543
Q ss_pred -------------------------------------------------------eEEEEEEecCCcchHHHHHhcCC--
Q 018640 130 -------------------------------------------------------AVHLVMELCEGGELFDRIVARGH-- 152 (352)
Q Consensus 130 -------------------------------------------------------~~~lv~e~~~~~sL~~~l~~~~~-- 152 (352)
..++||||+++++|.+++.....
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~ 159 (332)
T 3qd2_B 80 KWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE 159 (332)
T ss_dssp HHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGG
T ss_pred hhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCcc
Confidence 37999999999999999987653
Q ss_pred -CCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC-------------ccccc
Q 018640 153 -YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-------------KFSEI 218 (352)
Q Consensus 153 -l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-------------~~~~~ 218 (352)
.++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||++....... .....
T Consensus 160 ~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~---~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T 3qd2_B 160 DREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD---VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ 236 (332)
T ss_dssp GSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC---CEEECCCTTCEECSCC--------------CCCSC
T ss_pred chhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCC---CEEEeecCcccccccchhhcccccccccccccccc
Confidence 56667999999999999999999999999999999997655 48999999998765432 22345
Q ss_pred ccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcC
Q 018640 219 VGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297 (352)
Q Consensus 219 ~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 297 (352)
.||+.|+|||++. ..++.++||||||+++|||++|..|+... ......... ...+..+...++.+.++|.+||+
T Consensus 237 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~ 311 (332)
T 3qd2_B 237 VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVRN---LKFPLLFTQKYPQEHMMVQDMLS 311 (332)
T ss_dssp C-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHT---TCCCHHHHHHCHHHHHHHHHHHC
T ss_pred CCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhc---cCCCcccccCChhHHHHHHHHcc
Confidence 7999999999886 45899999999999999999987765211 111111111 11111123457788999999999
Q ss_pred CCcCCCCCHHHHhcCcccccc
Q 018640 298 PDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 298 ~dP~~Rps~~ell~hp~f~~~ 318 (352)
.||++|||+.|+++||||++.
T Consensus 312 ~~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 312 PSPTERPEATDIIENAIFENL 332 (332)
T ss_dssp SSGGGSCCHHHHHHSTTCCCC
T ss_pred CCCCcCCCHHHHhhchhhhcC
Confidence 999999999999999999863
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=358.09 Aligned_cols=258 Identities=22% Similarity=0.372 Sum_probs=216.2
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe----CC
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED----DT 129 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~----~~ 129 (352)
.+.|++.+.||+|+||+||+|.+..++..||+|++..... .....+.+.+|+.+++.+ +||||+++++++.. ..
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhC-CCCCeeeeeeeeccccCCCc
Confidence 3468999999999999999999999999999999876543 344567899999999999 89999999999865 45
Q ss_pred eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CEEecCCCCceEeecCCCCCCEEEEecccce
Q 018640 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG--VMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (352)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~ 207 (352)
..++||||+++++|.+++.....+++..++.++.|++.||.|||+.+ ++|+||||+||+++. ....+||+|||++.
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~--~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS--TTSCEEECCTTGGG
T ss_pred eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEEC--CCCCEEEeeCCCcc
Confidence 68999999999999999998888999999999999999999999999 999999999999962 22348999999997
Q ss_pred ecCCCCcccccccccccccchhccccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHH
Q 018640 208 FFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (352)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~~~~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (352)
..... ......||+.|+|||.+.+.++.++||||||+++|+|++|..||................. .+.......++.
T Consensus 181 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 258 (290)
T 1t4h_A 181 LKRAS-FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV-KPASFDKVAIPE 258 (290)
T ss_dssp GCCTT-SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC-CCGGGGGCCCHH
T ss_pred ccccc-ccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccC-CccccCCCCCHH
Confidence 54433 2344579999999999988899999999999999999999999987554433333222211 111223456789
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcCccccc
Q 018640 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (352)
Q Consensus 288 ~~~li~~~l~~dP~~Rps~~ell~hp~f~~ 317 (352)
+.++|.+||+.||++|||+.++++||||++
T Consensus 259 l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 259 VKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 999999999999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=370.98 Aligned_cols=272 Identities=39% Similarity=0.721 Sum_probs=198.1
Q ss_pred cCCCcccccccceece-eeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeE
Q 018640 46 KEPTGREIEERYELGR-ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDT 124 (352)
Q Consensus 46 ~~~~~~~~~~~y~~~~-~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~ 124 (352)
..+....+.++|.+++ +||+|+||+||+|.+..+|+.||+|++... ....+|+..+.+..+||||++++++
T Consensus 19 p~~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~ 90 (336)
T 3fhr_A 19 PEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--------PKARQEVDHHWQASGGPHIVCILDV 90 (336)
T ss_dssp -CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--------HHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred CCCCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--------HHHHHHHHHHHHhcCCCChHHHHHH
Confidence 3445557888999965 699999999999999999999999998542 2233344443333499999999999
Q ss_pred EEe----CCeEEEEEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCE
Q 018640 125 YED----DTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPL 198 (352)
Q Consensus 125 ~~~----~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~v 198 (352)
+.. ....++||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++....+
T Consensus 91 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~ 170 (336)
T 3fhr_A 91 YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVL 170 (336)
T ss_dssp EEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCE
T ss_pred HhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceE
Confidence 876 456899999999999999998764 59999999999999999999999999999999999999876666779
Q ss_pred EEEecccceecCCCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhcc
Q 018640 199 KAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA----QAIIRSV 273 (352)
Q Consensus 199 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~----~~~~~~~ 273 (352)
||+|||++...... ......||+.|+|||++. ..++.++||||||+++|+|++|..||......... ..+....
T Consensus 171 kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 249 (336)
T 3fhr_A 171 KLTDFGFAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ 249 (336)
T ss_dssp EECCCTTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------
T ss_pred EEeccccceecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccc
Confidence 99999999865433 234457899999999986 45888999999999999999999999766544332 2222222
Q ss_pred cccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccCCCCCC
Q 018640 274 LDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSL 326 (352)
Q Consensus 274 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~ 326 (352)
...+...+..+++.+.+||.+||+.||++|||+.|+++||||++....+..++
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~ 302 (336)
T 3fhr_A 250 YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPL 302 (336)
T ss_dssp -CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSCCCBC
T ss_pred cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCCCCcc
Confidence 23334445678999999999999999999999999999999998766555544
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=360.66 Aligned_cols=265 Identities=28% Similarity=0.445 Sum_probs=219.3
Q ss_pred CcccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC
Q 018640 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (352)
Q Consensus 49 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 128 (352)
.+..+.++|++++.||+|+||+||+|.+..++..||+|++...........+.+.+|+.+++++ +||||+++++++...
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~ 83 (294)
T 4eqm_A 5 IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNIVSMIDVDEED 83 (294)
T ss_dssp CSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CBTTBCCEEEEEECS
T ss_pred hhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-CCCCCceEEEeeeeC
Confidence 4567889999999999999999999999999999999998765544555567899999999999 899999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccccee
Q 018640 129 TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~ 208 (352)
+..++||||++|++|.+++.....+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||++..
T Consensus 84 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~---~kl~Dfg~~~~ 160 (294)
T 4eqm_A 84 DCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT---LKIFDFGIAKA 160 (294)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC---EEECCCSSSTT
T ss_pred CeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC---EEEEeCCCccc
Confidence 999999999999999999998888999999999999999999999999999999999999976554 89999999976
Q ss_pred cCCCC--cccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc-cCCCCCcCC
Q 018640 209 FKPGE--KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD-FRRDPWPKV 284 (352)
Q Consensus 209 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 284 (352)
..... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.................. ......+.+
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (294)
T 4eqm_A 161 LSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDI 240 (294)
T ss_dssp C-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTS
T ss_pred cccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCC
Confidence 54332 2234579999999998764 5889999999999999999999999888776655444433221 112234568
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhcCccccc
Q 018640 285 SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (352)
Q Consensus 285 ~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~ 317 (352)
++.+.++|.+||+.||.+||+..+.+.+.|..-
T Consensus 241 ~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 241 PQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp CHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred CHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 999999999999999999996555555656553
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=373.17 Aligned_cols=258 Identities=27% Similarity=0.453 Sum_probs=212.0
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCC-CCCeeEeeeEEEeCCeE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK-HQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~-h~~iv~l~~~~~~~~~~ 131 (352)
..++|++++.||+|+||+||+|.+.. ++.||||++..... .....+.+.+|+.++.++.+ ||||+++++++...+..
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~ 131 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 131 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence 34579999999999999999999764 99999999876532 34456789999999999953 69999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
++|||+ .+++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||+++ ..+||+|||++.....
T Consensus 132 ~lv~E~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~----~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 132 YMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLIDFGIANQMQP 206 (390)
T ss_dssp EEEEEC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS----SCEEECCCSSSCCC--
T ss_pred EEEEec-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC----CeEEEEecCccccccC
Confidence 999994 57899999998888999999999999999999999999999999999999952 3489999999987643
Q ss_pred CC---cccccccccccccchhccc------------cCCCcchHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcccc
Q 018640 212 GE---KFSEIVGSPYYMAPEVLKR------------NYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVLD 275 (352)
Q Consensus 212 ~~---~~~~~~gt~~y~aPE~~~~------------~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~ 275 (352)
.. ......||+.|+|||++.+ .++.++|||||||++|||++|..||...... .....+.....
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~- 285 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH- 285 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTS-
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccc-
Confidence 32 2245689999999998753 4788999999999999999999999765432 33333333221
Q ss_pred cCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 276 FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 276 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
........++.+.+||.+||+.||++|||+.|+++||||+...
T Consensus 286 -~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 286 -EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp -CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred -cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 1222334578999999999999999999999999999998643
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=367.81 Aligned_cols=262 Identities=28% Similarity=0.424 Sum_probs=213.7
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCCh--hcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA--VDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 130 (352)
..++|++++.||+|+||+||+|.+..+|+.||+|++........ .....+.+|+.+++.+ +||||+++++++...+.
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTTC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-CCCCCCeEEEEEeeCCc
Confidence 45689999999999999999999999999999999875432211 1124678899999999 89999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 131 VHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
.++||||+++ +|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||+++.++. +||+|||++...
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~---~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV---LKLADFGLAKSF 162 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC---EEECCCGGGSTT
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCC---EEEEecccceec
Confidence 9999999976 8988887654 5899999999999999999999999999999999999976554 899999999866
Q ss_pred CCC-Ccccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCC------
Q 018640 210 KPG-EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP------ 280 (352)
Q Consensus 210 ~~~-~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 280 (352)
... .......||+.|+|||++.+ .++.++||||||+++|+|++|.+||...........+...........
T Consensus 163 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 242 (346)
T 1ua2_A 163 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 242 (346)
T ss_dssp TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred cCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence 432 23345688999999998753 378899999999999999999999998888777777665433222111
Q ss_pred ------------------CcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 281 ------------------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 281 ------------------~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
+..+++.+.+||.+||+.||++|||+.|+++||||++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 134578999999999999999999999999999999753
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=373.80 Aligned_cols=261 Identities=32% Similarity=0.562 Sum_probs=216.7
Q ss_pred ccceeceeeeccCceEEEEEEEC---CCCcEEEEEEccccccC-ChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe
Q 018640 55 ERYELGRELGRGEFGITYLCTDR---ENGDAFACKSISKKKLR-TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 130 (352)
++|++++.||+|+||+||+|.+. .+|+.||+|++...... .....+.+.+|+.+++++.+||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 68999999999999999999984 57999999998764321 122345577899999999679999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
.++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~---~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH---VVLTDFGLSKEFV 210 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC---EEESCSSEEEECC
T ss_pred EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCc---EEEeeCCCCeecc
Confidence 9999999999999999998888999999999999999999999999999999999999976554 8999999998654
Q ss_pred CCC--cccccccccccccchhccc---cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCC
Q 018640 211 PGE--KFSEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (352)
Q Consensus 211 ~~~--~~~~~~gt~~y~aPE~~~~---~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (352)
... ......||+.|+|||++.+ .++.++||||||+++|||++|..||...........+...........+..++
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 290 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcccC
Confidence 322 2234579999999999863 37889999999999999999999997543222222222322233344456789
Q ss_pred HHHHHHHHHhcCCCcCCCC-----CHHHHhcCcccccc
Q 018640 286 ENAKDLVRKMLDPDPKRRL-----TAQQVLEHPWLQNA 318 (352)
Q Consensus 286 ~~~~~li~~~l~~dP~~Rp-----s~~ell~hp~f~~~ 318 (352)
..+.+||.+||+.||++|| |+.++++||||++.
T Consensus 291 ~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 291 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 9999999999999999999 99999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=355.08 Aligned_cols=261 Identities=30% Similarity=0.526 Sum_probs=219.5
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
+.++|++++.||+|+||.||+|.+..+++.||+|++..... ....+.+.+|+.+++.+ +||||+++++++...+..+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 81 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKML-NHENVVKFYGHRREGNIQY 81 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhc-CCCCceeeeeEEEcCCEEE
Confidence 45689999999999999999999999999999999875432 23457889999999999 8999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
+||||+++++|.+++.....+++..++.++.|++.||.|||+.|++|+||||+||+++.++. +||+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 158 (276)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC---EEECCCTTCEECEET
T ss_pred EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCC---EEEeeCCCccccCCC
Confidence 99999999999999987778999999999999999999999999999999999999976554 899999999765322
Q ss_pred C---cccccccccccccchhcccc--CCCcchHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcccccCCCCCcCCCH
Q 018640 213 E---KFSEIVGSPYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQG-VAQAIIRSVLDFRRDPWPKVSE 286 (352)
Q Consensus 213 ~---~~~~~~gt~~y~aPE~~~~~--~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 286 (352)
. ......||+.|+|||.+.+. .+.++||||||+++++|++|..||....... ......... .....+..+++
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 236 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--TYLNPWKKIDS 236 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC--TTSTTGGGSCH
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc--cccCchhhcCH
Confidence 2 23455789999999998643 4678999999999999999999997765432 222222211 11223456899
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcCccccccccC
Q 018640 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKA 321 (352)
Q Consensus 287 ~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~ 321 (352)
.+.++|.+||+.||++|||+.++++||||++....
T Consensus 237 ~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 271 (276)
T 2yex_A 237 APLALLHKILVENPSARITIPDIKKDRWYNKPLKK 271 (276)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC-
T ss_pred HHHHHHHHHCCCCchhCCCHHHHhcCccccChhhc
Confidence 99999999999999999999999999999976543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-50 Score=367.53 Aligned_cols=261 Identities=27% Similarity=0.473 Sum_probs=216.2
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
.-++|++++.||+|+||+||+|.+..+|+.||+|++.... ......+.+.+|+.+++++ +||||+++++++...+..+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 100 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQL-RHENLVNLLEVCKKKKRWY 100 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhC-CCCCEeeEEEEeecCCEEE
Confidence 3467999999999999999999999999999999986543 2333456688999999999 8999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
+||||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||||+||+++.++ .+||+|||++......
T Consensus 101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG---VVKLCDFGFARTLAAP 177 (331)
T ss_dssp EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS---CEEECCCTTC------
T ss_pred EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCC---cEEEEeCCCceeecCC
Confidence 9999999999988887777899999999999999999999999999999999999997655 4899999999765432
Q ss_pred -Ccccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC------------
Q 018640 213 -EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR------------ 277 (352)
Q Consensus 213 -~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------------ 277 (352)
.......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||...........+........
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 23345578999999998864 488999999999999999999999988877666555543221110
Q ss_pred -----C----------CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 278 -----R----------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 278 -----~----------~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
. ...+.+++.+.+||.+||+.||++|||+.|+++||||+..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 0 0123578999999999999999999999999999999863
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=359.64 Aligned_cols=257 Identities=28% Similarity=0.508 Sum_probs=213.5
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe--CCe
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--DTA 130 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~--~~~ 130 (352)
..++|++++.||+|+||+||+|.+..+++.||+|++... ..+.+.+|+.+++++.+||||+++++++.. ...
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 357899999999999999999999999999999998642 346789999999999669999999999987 668
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
.++||||+++++|.+++. .+++..++.++.|++.||.|||++||+||||||+|||++.++. .+||+|||++....
T Consensus 108 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYH 182 (330)
T ss_dssp EEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT--EEEECCCTTCEECC
T ss_pred eEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCC--EEEEEeCCCceEcC
Confidence 899999999999998874 3899999999999999999999999999999999999975542 38999999998776
Q ss_pred CCCcccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcccc------------
Q 018640 211 PGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAET-EQGVAQAIIRSVLD------------ 275 (352)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~-~~~~~~~~~~~~~~------------ 275 (352)
.........||..|+|||.+.+ .++.++||||||+++|+|++|..||.... .......+......
T Consensus 183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred CCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 6655566789999999998763 48999999999999999999999995443 22222222111100
Q ss_pred ---------------------cCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 276 ---------------------FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 276 ---------------------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
........+++.+.+||.+||+.||++|||+.|+++||||++..+
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 328 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 328 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence 001111237899999999999999999999999999999997643
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=377.64 Aligned_cols=269 Identities=26% Similarity=0.425 Sum_probs=216.7
Q ss_pred CcccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCC-----CCCCeeEeee
Q 018640 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP-----KHQNIVCLKD 123 (352)
Q Consensus 49 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~l~~ 123 (352)
....+..+|++++.||+|+||+||+|.+..+++.||||++... ......+.+|+.+++.+. +|+||+++++
T Consensus 91 ~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~ 166 (429)
T 3kvw_A 91 PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLE 166 (429)
T ss_dssp TTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEE
T ss_pred CCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEe
Confidence 3456778999999999999999999999999999999998643 233456777888888762 5779999999
Q ss_pred EEEeCCeEEEEEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEE
Q 018640 124 TYEDDTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAI 201 (352)
Q Consensus 124 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~ 201 (352)
++...+..++||||++ ++|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++.++. ..+||+
T Consensus 167 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~-~~vkL~ 244 (429)
T 3kvw_A 167 NFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGR-SGIKVI 244 (429)
T ss_dssp EEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTS-CCEEEC
T ss_pred ecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCC-cceEEe
Confidence 9999999999999996 59999987764 4999999999999999999999999999999999999976543 238999
Q ss_pred ecccceecCCCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCC-
Q 018640 202 DFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD- 279 (352)
Q Consensus 202 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~- 279 (352)
|||++..... ......||+.|+|||++. ..++.++|||||||++|||++|..||......+....+..........
T Consensus 245 DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~ 322 (429)
T 3kvw_A 245 DFGSSCYEHQ--RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKL 322 (429)
T ss_dssp CCTTCEETTC--CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ecccceecCC--cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 9999976543 234568999999999876 459999999999999999999999999888777666555432111000
Q ss_pred ------------------------------------------------------CCcCCCHHHHHHHHHhcCCCcCCCCC
Q 018640 280 ------------------------------------------------------PWPKVSENAKDLVRKMLDPDPKRRLT 305 (352)
Q Consensus 280 ------------------------------------------------------~~~~~~~~~~~li~~~l~~dP~~Rps 305 (352)
.....++.+.+||.+||++||++|||
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt 402 (429)
T 3kvw_A 323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT 402 (429)
T ss_dssp HHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC
Confidence 00123678999999999999999999
Q ss_pred HHHHhcCccccccccCCCCC
Q 018640 306 AQQVLEHPWLQNAKKAPNVS 325 (352)
Q Consensus 306 ~~ell~hp~f~~~~~~~~~~ 325 (352)
+.|+|+||||++....+...
T Consensus 403 a~e~L~Hpw~~~~~~~~~~~ 422 (429)
T 3kvw_A 403 PGQALRHPWLRRRLPKPPTG 422 (429)
T ss_dssp HHHHHTSTTTC---------
T ss_pred HHHHhCChhhccCCCCCCcc
Confidence 99999999999876554443
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=367.78 Aligned_cols=260 Identities=28% Similarity=0.479 Sum_probs=217.6
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC---
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--- 128 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~--- 128 (352)
.+.++|++++.||+|+||+||+|.+..+++.||+|++... ......+.+.+|+.+++++ +||||+++++++...
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 100 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIE 100 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT--TCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTT
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc--cCcHHHHHHHHHHHHHHhc-CCCCCccceeEEecCCcc
Confidence 3557899999999999999999999999999999998743 2334457788999999999 899999999998654
Q ss_pred --CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccc
Q 018640 129 --TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (352)
Q Consensus 129 --~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a 206 (352)
...++||||++ ++|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||++
T Consensus 101 ~~~~~~iv~e~~~-~~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~---~kl~Dfg~a 175 (364)
T 3qyz_A 101 QMKDVYIVQDLME-TDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLA 175 (364)
T ss_dssp TCCCEEEEEECCS-EEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---EEECCCTTC
T ss_pred ccceEEEEEcccC-cCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCC---EEEEeCcce
Confidence 46899999996 5999988664 6999999999999999999999999999999999999976554 899999999
Q ss_pred eecCCCCc----ccccccccccccchhcc--ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC--
Q 018640 207 VFFKPGEK----FSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR-- 278 (352)
Q Consensus 207 ~~~~~~~~----~~~~~gt~~y~aPE~~~--~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-- 278 (352)
........ .....||+.|+|||++. ..++.++||||||+++|+|++|+.||......+....+.........
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 87643321 24458999999999864 34899999999999999999999999888777666665543222110
Q ss_pred -------------------------CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 279 -------------------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 279 -------------------------~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
...+.+++.+.+||.+||+.||++|||+.|+++||||++..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence 01235789999999999999999999999999999999763
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=370.95 Aligned_cols=261 Identities=29% Similarity=0.456 Sum_probs=202.4
Q ss_pred cccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC-
Q 018640 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD- 128 (352)
Q Consensus 50 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~- 128 (352)
...+.++|++++.||+|+||+||+|.+..+|+.||||++.... ........+.+|+.+++.+ +||||+++++++...
T Consensus 24 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~ 101 (367)
T 2fst_X 24 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPAR 101 (367)
T ss_dssp EEEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCS
T ss_pred ccCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCC
Confidence 3456789999999999999999999999999999999986542 3344567788999999999 899999999998654
Q ss_pred -----CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEec
Q 018640 129 -----TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDF 203 (352)
Q Consensus 129 -----~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Df 203 (352)
...++|+|++ +++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++. +||+||
T Consensus 102 ~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~---~kL~DF 176 (367)
T 2fst_X 102 SLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE---LKILDF 176 (367)
T ss_dssp SGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC---EEECC-
T ss_pred ccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCC---EEEeec
Confidence 5679999999 6899998865 57999999999999999999999999999999999999976544 899999
Q ss_pred ccceecCCCCcccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC----
Q 018640 204 GLSVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR---- 277 (352)
Q Consensus 204 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---- 277 (352)
|+++..... .....||+.|+|||++.+ .++.++|||||||+++||++|+.||.+.........+.+......
T Consensus 177 G~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 177 GLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred ccccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 999865432 345589999999998764 589999999999999999999999998887766666554322210
Q ss_pred -------------------CC----CCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 278 -------------------RD----PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 278 -------------------~~----~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
.. ..+..++.+.+||.+||+.||++|||+.++|+||||++..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 00 1234688899999999999999999999999999999753
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-50 Score=365.86 Aligned_cols=262 Identities=23% Similarity=0.383 Sum_probs=213.5
Q ss_pred cccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC
Q 018640 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (352)
Q Consensus 50 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 129 (352)
+....++|++.+.||+|+||+||+|.+..+|+.||+|++..... ....+.+.+|+.+++++ +||||+++++++....
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 80 (319)
T 4euu_A 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETT 80 (319)
T ss_dssp EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTT
T ss_pred ccCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhc-CCCCcceEEEEeecCC
Confidence 34567889999999999999999999999999999999876432 23357788999999999 8999999999998665
Q ss_pred --eEEEEEEecCCcchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeec-CCCCCCEEEEec
Q 018640 130 --AVHLVMELCEGGELFDRIVARGH---YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFAN-KKETAPLKAIDF 203 (352)
Q Consensus 130 --~~~lv~e~~~~~sL~~~l~~~~~---l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~-~~~~~~vkl~Df 203 (352)
..++||||+++++|.+++..... +++..++.++.|++.||.|||+.||+||||||+||++.. +.....+||+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Df 160 (319)
T 4euu_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (319)
T ss_dssp TCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCC
T ss_pred CceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccC
Confidence 78999999999999999986543 999999999999999999999999999999999999832 223345899999
Q ss_pred ccceecCCCCcccccccccccccchhcc---------ccCCCcchHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHH
Q 018640 204 GLSVFFKPGEKFSEIVGSPYYMAPEVLK---------RNYGPEVDVWSAGVILYILLCGVPPFWAETE----QGVAQAII 270 (352)
Q Consensus 204 g~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~----~~~~~~~~ 270 (352)
|++.............||+.|+|||++. ..++.++||||||+++|||++|..||..... .+....+.
T Consensus 161 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 161 GAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp TTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred CCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 9998876666666678999999999874 4588999999999999999999999964332 23333333
Q ss_pred hccccc-------------------C--CCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcc
Q 018640 271 RSVLDF-------------------R--RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPW 314 (352)
Q Consensus 271 ~~~~~~-------------------~--~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~ 314 (352)
...... + ......+++.+.++|.+||+.||++|||+.|+++||-
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 322100 0 0111234567889999999999999999999999973
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=370.85 Aligned_cols=256 Identities=29% Similarity=0.469 Sum_probs=212.4
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe-----
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED----- 127 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~----- 127 (352)
..++|++++.||+|+||+||+|.+..+|+.||+|++..... ...+|+.+++.+ +||||+++++++..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVL-DHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTC-CCTTBCCEEEEEEEC----
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHc-CCCCccchhheeeecCccc
Confidence 45689999999999999999999999999999998864421 123699999999 89999999999843
Q ss_pred ---------------------------------CCeEEEEEEecCCcchHHHHH----hcCCCCHHHHHHHHHHHHHHHH
Q 018640 128 ---------------------------------DTAVHLVMELCEGGELFDRIV----ARGHYTERAAAAVTKTIVEVVQ 170 (352)
Q Consensus 128 ---------------------------------~~~~~lv~e~~~~~sL~~~l~----~~~~l~~~~~~~i~~qi~~aL~ 170 (352)
....++||||+++ +|.+.+. ....+++..++.++.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 3348899999974 7776664 3467999999999999999999
Q ss_pred HHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCcccccccccccccchhccc--cCCCcchHHHHHHHHH
Q 018640 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILY 248 (352)
Q Consensus 171 ~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~ 248 (352)
|||+.||+||||||+||+++.+ ...+||+|||++.............||+.|+|||.+.+ .++.++|||||||++|
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSK--DNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETT--TTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred HHHHCcCccCccCHHHEEEcCC--CCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence 9999999999999999999732 23489999999987766665666788999999998753 4899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhcccccC-------------------------CCCCcCCCHHHHHHHHHhcCCCcCCC
Q 018640 249 ILLCGVPPFWAETEQGVAQAIIRSVLDFR-------------------------RDPWPKVSENAKDLVRKMLDPDPKRR 303 (352)
Q Consensus 249 el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~dP~~R 303 (352)
||++|+.||.+....+....+........ .......++.+.+||.+||+.||++|
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence 99999999998888777776655322110 00123478899999999999999999
Q ss_pred CCHHHHhcCccccccc
Q 018640 304 LTAQQVLEHPWLQNAK 319 (352)
Q Consensus 304 ps~~ell~hp~f~~~~ 319 (352)
||+.|+++||||++..
T Consensus 314 ~t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 314 INPYEAMAHPFFDHLR 329 (383)
T ss_dssp CCHHHHHTSGGGHHHH
T ss_pred CCHHHHhcCHHHHHHH
Confidence 9999999999998653
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=352.41 Aligned_cols=274 Identities=27% Similarity=0.444 Sum_probs=229.8
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
...+.|++++.||+|+||+||+|.+..+++.||+|++..... ....+.+.+|+.+++.+ +||||+++++++......
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 95 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTKL 95 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEE
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCeE
Confidence 456789999999999999999999999999999999876532 23467899999999999 999999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++. +||+|||++.....
T Consensus 96 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE---VKLADFGVAGQLTD 171 (303)
T ss_dssp EEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCTTCEECBT
T ss_pred EEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCC---EEEeecccceecCc
Confidence 999999999999999865 47999999999999999999999999999999999999976554 89999999987654
Q ss_pred CC-cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHH
Q 018640 212 GE-KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (352)
Q Consensus 212 ~~-~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (352)
.. ......||+.|+|||.+. ..++.++||||||+++|+|++|..||...........+.... .......++..+.
T Consensus 172 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~ 248 (303)
T 3a7i_A 172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSKPLK 248 (303)
T ss_dssp TBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC---CCCCCSSCCHHHH
T ss_pred cccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC---CCCCccccCHHHH
Confidence 32 234557899999999986 458899999999999999999999998877666555544322 2233457899999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcCccccccccCCCCCCcHHHHHHHHhh
Q 018640 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQF 337 (352)
Q Consensus 290 ~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~ 337 (352)
++|.+||+.||++|||+.++++||||..... ..+....+..+.+.+
T Consensus 249 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~--~~~~~~~~~~~~~~~ 294 (303)
T 3a7i_A 249 EFVEACLNKEPSFRPTAKELLKHKFILRNAK--KTSYLTELIDRYKRW 294 (303)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTTCHHHHHHCC--CGGGGHHHHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHhhChhhhcCCC--ccHHHHHHHHHHHHh
Confidence 9999999999999999999999999986533 233334444454443
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=355.44 Aligned_cols=261 Identities=23% Similarity=0.293 Sum_probs=199.7
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
...++|++++.||+|+||+||+|.+..+|+.||+|++..... .....+.+.++...++.+ +||||+++++++...+..
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTV-DCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSSE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhC-CCCeEEEEeeeeeccCCE
Confidence 345789999999999999999999999999999999875421 222233344445556666 999999999999999999
Q ss_pred EEEEEecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc-CCEEecCCCCceEeecCCCCCCEEEEecccc
Q 018640 132 HLVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a 206 (352)
++||||+++ +|.+++.. ...+++..++.++.|++.||.|||++ |++||||||+||+++.++ .+||+|||++
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~---~~kl~Dfg~~ 157 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG---QVKMCDFGIS 157 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC---CEEBCCC---
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC---CEEEeecCCc
Confidence 999999974 88777653 45799999999999999999999998 999999999999997655 4899999999
Q ss_pred eecCCCCcccccccccccccchhc----c-ccCCCcchHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcccccCCCC
Q 018640 207 VFFKPGEKFSEIVGSPYYMAPEVL----K-RNYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVLDFRRDP 280 (352)
Q Consensus 207 ~~~~~~~~~~~~~gt~~y~aPE~~----~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~ 280 (352)
.............||+.|+|||.+ . ..++.++||||||+++|+|++|..||... ............. .....
T Consensus 158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~ 235 (290)
T 3fme_A 158 GYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP--SPQLP 235 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC--CCCCC
T ss_pred ccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccC--CCCcc
Confidence 876555444555899999999986 2 34788999999999999999999999753 3333333333322 12222
Q ss_pred CcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 281 ~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
...+++.+.++|.+||+.||++|||+.|+++||||+....
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~ 275 (290)
T 3fme_A 236 ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHES 275 (290)
T ss_dssp TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred cccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCcc
Confidence 3468999999999999999999999999999999997543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=370.45 Aligned_cols=258 Identities=26% Similarity=0.418 Sum_probs=204.9
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC--
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT-- 129 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~-- 129 (352)
.+.++|++++.||+|+||+||+|.+..+|+.||+|++.... ......+.+.+|+.+++.+ +||||+++++++...+
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 99 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSL 99 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSCCST
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhc-CCCCccceEEeecccccc
Confidence 45678999999999999999999999999999999987542 2344556788999999999 8999999999997654
Q ss_pred ----eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccc
Q 018640 130 ----AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (352)
Q Consensus 130 ----~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~ 205 (352)
..++||||+++ +|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 100 ~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~---~kl~Dfg~ 173 (371)
T 2xrw_A 100 EEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGL 173 (371)
T ss_dssp TTCCEEEEEEECCSE-EHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC---EEECCCCC
T ss_pred ccccceEEEEEcCCC-CHHHHHhh--ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC---EEEEEeec
Confidence 78999999975 88888853 5999999999999999999999999999999999999976554 89999999
Q ss_pred ceecCCCCcccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC------
Q 018640 206 SVFFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR------ 278 (352)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------ 278 (352)
+.............||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+........+
T Consensus 174 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 174 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred ccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 987655444456689999999998764 5899999999999999999999999988877666665543221100
Q ss_pred -----------CC--------------Cc-------CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccc
Q 018640 279 -----------DP--------------WP-------KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (352)
Q Consensus 279 -----------~~--------------~~-------~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~ 317 (352)
.. .+ ..++.+.+||.+||+.||++|||+.|+++||||+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 00 00 01467899999999999999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=357.65 Aligned_cols=265 Identities=26% Similarity=0.459 Sum_probs=216.6
Q ss_pred cCCCcccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEE
Q 018640 46 KEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTY 125 (352)
Q Consensus 46 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~ 125 (352)
.........++|++++.||+|+||.||+|.+..+|+.||+|++.... ...+.+.+|+.+++++.+||||+++++++
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 34445567789999999999999999999999999999999986532 23467889999999997899999999999
Q ss_pred Ee------CCeEEEEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCC
Q 018640 126 ED------DTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAP 197 (352)
Q Consensus 126 ~~------~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~ 197 (352)
.. .+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++.
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~--- 167 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--- 167 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC---
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCC---
Confidence 76 46889999999999999999864 46999999999999999999999999999999999999975544
Q ss_pred EEEEecccceecCCC-Ccccccccccccccchhcc------ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 018640 198 LKAIDFGLSVFFKPG-EKFSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII 270 (352)
Q Consensus 198 vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~ 270 (352)
+||+|||++...... .......||+.|+|||++. ..++.++||||||+++|+|++|..||...........+.
T Consensus 168 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 247 (326)
T 2x7f_A 168 VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP 247 (326)
T ss_dssp EEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred EEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh
Confidence 899999999765432 2234457899999999874 348899999999999999999999998877665555444
Q ss_pred hcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 271 RSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
.... +......+++.+.++|.+||+.||.+|||+.++++||||++..
T Consensus 248 ~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 248 RNPA--PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp HSCC--CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred cCcc--ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 3321 2222356799999999999999999999999999999999753
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=360.23 Aligned_cols=266 Identities=29% Similarity=0.463 Sum_probs=219.6
Q ss_pred CCCcccccccceeceeeeccCceEEEEEEE-CCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCC------Cee
Q 018640 47 EPTGREIEERYELGRELGRGEFGITYLCTD-RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ------NIV 119 (352)
Q Consensus 47 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~------~iv 119 (352)
...+..+.++|++++.||+|+||+||+|.+ ..+++.||+|++... ....+.+.+|+.+++.+ +|+ +++
T Consensus 6 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l-~~~~~~~~~~i~ 80 (339)
T 1z57_A 6 CQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHL-NTTDPNSTFRCV 80 (339)
T ss_dssp CSTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHH-HHHCTTCTTCBC
T ss_pred eecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHh-hhcCCCCceeeE
Confidence 355778889999999999999999999998 567899999998643 23456788899999988 554 599
Q ss_pred EeeeEEEeCCeEEEEEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCC---
Q 018640 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE--- 194 (352)
Q Consensus 120 ~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~--- 194 (352)
++++++...+..++||||+ +++|.+++.... .+++..++.++.|++.||+|||++||+||||||+||+++.++.
T Consensus 81 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 159 (339)
T 1z57_A 81 QMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEA 159 (339)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEE
T ss_pred eeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccc
Confidence 9999999999999999999 789999998765 5899999999999999999999999999999999999976331
Q ss_pred -------------CCCEEEEecccceecCCCCcccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 018640 195 -------------TAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAE 260 (352)
Q Consensus 195 -------------~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~ 260 (352)
...+||+|||++...... .....||+.|+|||++.+ .++.++||||||+++|||++|..||...
T Consensus 160 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 160 YNPKIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp EC----CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCCccccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 445899999999875432 345589999999998864 5899999999999999999999999887
Q ss_pred CHHHHHHHHHhcccccCC----------------------------------------CCCcCCCHHHHHHHHHhcCCCc
Q 018640 261 TEQGVAQAIIRSVLDFRR----------------------------------------DPWPKVSENAKDLVRKMLDPDP 300 (352)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~li~~~l~~dP 300 (352)
...+....+.......+. ......++.+.+||.+||+.||
T Consensus 238 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 317 (339)
T 1z57_A 238 DSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP 317 (339)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred ChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence 776655444333221110 0011235678899999999999
Q ss_pred CCCCCHHHHhcCcccccccc
Q 018640 301 KRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 301 ~~Rps~~ell~hp~f~~~~~ 320 (352)
.+|||+.|+++||||+...+
T Consensus 318 ~~Rpt~~ell~hp~f~~~~~ 337 (339)
T 1z57_A 318 AKRITLREALKHPFFDLLKK 337 (339)
T ss_dssp TTSCCHHHHTTSGGGGGGGC
T ss_pred ccccCHHHHhcCHHHHHHhc
Confidence 99999999999999998755
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=376.88 Aligned_cols=251 Identities=18% Similarity=0.243 Sum_probs=202.8
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCC--CCCCeeEee-------eE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP--KHQNIVCLK-------DT 124 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~~iv~l~-------~~ 124 (352)
.++|++.+.||+|+||+||+|.+..+|+.||||++...........+.+.+|+.+++.+. +||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 578999999999999999999998899999999998654445556678999995555443 799999998 66
Q ss_pred EEeCC-----------------eEEEEEEecCCcchHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHHcCCEEe
Q 018640 125 YEDDT-----------------AVHLVMELCEGGELFDRIVARGHYTE-------RAAAAVTKTIVEVVQMCHKHGVMHR 180 (352)
Q Consensus 125 ~~~~~-----------------~~~lv~e~~~~~sL~~~l~~~~~l~~-------~~~~~i~~qi~~aL~~lH~~~ivH~ 180 (352)
+...+ ..++||||+ +|+|.+++.....+++ ..++.|+.||+.||+|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 66553 388999999 6799999987554554 8888999999999999999999999
Q ss_pred cCCCCceEeecCCCCCCEEEEecccceecCCCCcccccccccccccchhcc-c-----------cCCCcchHHHHHHHHH
Q 018640 181 DLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-R-----------NYGPEVDVWSAGVILY 248 (352)
Q Consensus 181 Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~-----------~~s~~~Di~SlG~~l~ 248 (352)
||||+|||++.++ .+||+|||++..... ......| +.|+|||++. . .++.++||||||+++|
T Consensus 231 Dikp~NIll~~~~---~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ 304 (377)
T 3byv_A 231 YLRPVDIVLDQRG---GVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304 (377)
T ss_dssp CCCGGGEEECTTC---CEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCC---CEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence 9999999997655 489999999986432 3345577 9999999876 3 5899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 249 ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 249 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
||++|+.||.......... .....+..+++.+.+||.+||+.||++|||+.++++||||++..
T Consensus 305 elltg~~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 305 WIWCADLPITKDAALGGSE--------WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 367 (377)
T ss_dssp HHHHSSCCC------CCSG--------GGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred HHHHCCCCCcccccccchh--------hhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence 9999999996654322111 11122357899999999999999999999999999999998754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-49 Score=362.76 Aligned_cols=259 Identities=28% Similarity=0.472 Sum_probs=209.6
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCC-CCeeEeeeEEEeCCe
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH-QNIVCLKDTYEDDTA 130 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~~iv~l~~~~~~~~~ 130 (352)
...++|++++.||+|+||+||+|.+ .+++.||+|++.... ......+.+.+|+.++.++.+| +||+++++++...+.
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 3456899999999999999999997 468999999987653 2334457889999999999432 999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
.++|||+ .+++|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||++. ..+||+|||++....
T Consensus 84 ~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~----~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 84 IYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET----TEEEECCCSSSCCC-
T ss_pred EEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC----CcEEEeecccccccC
Confidence 9999995 57899999999888999999999999999999999999999999999999962 238999999998764
Q ss_pred CCCc---ccccccccccccchhcc------------ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccc
Q 018640 211 PGEK---FSEIVGSPYYMAPEVLK------------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVL 274 (352)
Q Consensus 211 ~~~~---~~~~~gt~~y~aPE~~~------------~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~ 274 (352)
.... .....||+.|+|||++. ..++.++||||||+++|+|++|+.||...... .....+...
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-- 236 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP-- 236 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT--
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcC--
Confidence 3322 23557999999999874 34788999999999999999999999765433 222222221
Q ss_pred ccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 275 DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 275 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
......+...++.+.+||..||+.||.+|||+.|+++||||+...
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 237 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 122233345678999999999999999999999999999998543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=367.37 Aligned_cols=264 Identities=24% Similarity=0.393 Sum_probs=218.9
Q ss_pred CcccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC
Q 018640 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (352)
Q Consensus 49 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 128 (352)
.+....++|++++.||+|+||+||+|.+..+|..||+|++.... .....+.+.+|+.+++.+ +||||+++++++...
T Consensus 27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 103 (360)
T 3eqc_A 27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSD 103 (360)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEET
T ss_pred ccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHC-CCCCEEEEeEEEEEC
Confidence 34556788999999999999999999999999999999987542 344457789999999999 899999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCEEecCCCCceEeecCCCCCCEEEEecccce
Q 018640 129 TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~ 207 (352)
+..++||||+++++|.+++.....+++..+..++.|++.||.|||+. ||+||||||+||+++.++. +||+|||++.
T Consensus 104 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~---~kl~Dfg~~~ 180 (360)
T 3eqc_A 104 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSG 180 (360)
T ss_dssp TEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC---EEECCCCCCH
T ss_pred CEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCC---EEEEECCCCc
Confidence 99999999999999999999888899999999999999999999996 9999999999999976554 8999999986
Q ss_pred ecCCCCcccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----------------
Q 018640 208 FFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII---------------- 270 (352)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~---------------- 270 (352)
..... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||...........+.
T Consensus 181 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3eqc_A 181 QLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 259 (360)
T ss_dssp HHHHH-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred ccccc-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence 54221 2234578999999998874 58999999999999999999999998766543321110
Q ss_pred ----------------------hcccc--cCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 271 ----------------------RSVLD--FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 271 ----------------------~~~~~--~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
..... ........++..+.+||.+||+.||++|||+.|+++||||+...
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp --------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred CCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 00000 11111234788999999999999999999999999999999754
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=354.99 Aligned_cols=262 Identities=30% Similarity=0.484 Sum_probs=216.7
Q ss_pred ccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe
Q 018640 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (352)
Q Consensus 51 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 130 (352)
....++|++++.||+|+||+||+|.+..+|+.||+|++... .....+.+.+|+.+++.+ +||||+++++++...+.
T Consensus 15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 90 (302)
T 2j7t_A 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYIVEIEILATC-DHPYIVKLLGAYYHDGK 90 (302)
T ss_dssp SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHC-CCTTBCCEEEEEECC-C
T ss_pred cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC---CHHHHHHHHHHHHHHhcC-CCCCEeeeeeeeeeCCe
Confidence 35677899999999999999999999999999999998654 233467889999999999 89999999999999999
Q ss_pred EEEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 131 VHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
.++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++. +||+|||++...
T Consensus 91 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 91 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD---IRLADFGVSAKN 167 (302)
T ss_dssp EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSC---EEECCCHHHHHH
T ss_pred EEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCC---EEEEECCCCccc
Confidence 9999999999999998876 456999999999999999999999999999999999999975554 899999987542
Q ss_pred CCC-Ccccccccccccccchhcc------ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCc
Q 018640 210 KPG-EKFSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282 (352)
Q Consensus 210 ~~~-~~~~~~~gt~~y~aPE~~~------~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (352)
... .......||+.|+|||.+. ..++.++||||||+++|+|++|..||...........+...... ......
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~ 246 (302)
T 2j7t_A 168 LKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPP-TLLTPS 246 (302)
T ss_dssp HHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-CCSSGG
T ss_pred cccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCc-ccCCcc
Confidence 111 1223457899999999872 44788999999999999999999999888776665555443221 112234
Q ss_pred CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 283 ~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
.++..+.++|.+||+.||++|||+.++++||||+....
T Consensus 247 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 284 (302)
T 2j7t_A 247 KWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS 284 (302)
T ss_dssp GSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred ccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence 67899999999999999999999999999999997643
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=370.40 Aligned_cols=257 Identities=28% Similarity=0.439 Sum_probs=211.5
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC---
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--- 128 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~--- 128 (352)
....+|++.+.||+|+||+||+|.+..+|+.||||++.... ....+|+.+++.+ +||||+++++++...
T Consensus 51 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~ 122 (420)
T 1j1b_A 51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKL-DHCNIVRLRYFFYSSGEK 122 (420)
T ss_dssp CEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-------TSCCHHHHHHHTC-CCTTBCCEEEEEEEEETT
T ss_pred cccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-------hhHHHHHHHHHHc-CCCCccceeeEEeccCCC
Confidence 34567999999999999999999999999999999986432 1233699999999 899999999988532
Q ss_pred ---CeEEEEEEecCCcchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEE
Q 018640 129 ---TAVHLVMELCEGGELFDRIV----ARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAI 201 (352)
Q Consensus 129 ---~~~~lv~e~~~~~sL~~~l~----~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~ 201 (352)
...++||||+++ +|.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ ..+||+
T Consensus 123 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~--~~~kl~ 199 (420)
T 1j1b_A 123 KDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT--AVLKLC 199 (420)
T ss_dssp TTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTT--TEEEEC
T ss_pred CcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCC--CeEEec
Confidence 246799999975 6666554 345799999999999999999999999999999999999997543 237999
Q ss_pred ecccceecCCCCcccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc---
Q 018640 202 DFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF--- 276 (352)
Q Consensus 202 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~--- 276 (352)
|||+++............||+.|+|||++.+ .++.++|||||||++|||++|+.||.+....+....+.+.....
T Consensus 200 DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 200 DFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 279 (420)
T ss_dssp CCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred cchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999987765555556789999999998753 58999999999999999999999999888776666655432110
Q ss_pred ---------CC---C----------CCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 277 ---------RR---D----------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 277 ---------~~---~----------~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
.. . ..+..++++.+||.+||+.||.+|||+.|+++||||++..
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 00 0 1134688999999999999999999999999999998763
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=367.47 Aligned_cols=262 Identities=29% Similarity=0.458 Sum_probs=212.4
Q ss_pred CCCcccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEE
Q 018640 47 EPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (352)
Q Consensus 47 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~ 126 (352)
...+.....+|++++.||+|+||+||+|.+..+++ ||+|++..... ...+|+.+++.+ +||||+++++++.
T Consensus 32 ~~~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-------~~~~E~~il~~l-~h~niv~l~~~~~ 102 (394)
T 4e7w_A 32 GKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-------FKNRELQIMRIV-KHPNVVDLKAFFY 102 (394)
T ss_dssp SSSCCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-------SCCHHHHHHHTC-CCTTBCCEEEEEE
T ss_pred CCCCCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-------hHHHHHHHHHhC-CCCCcceEEEEEE
Confidence 34556677899999999999999999999877665 88887754321 123699999999 8999999999986
Q ss_pred eCC------eEEEEEEecCCcchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCC
Q 018640 127 DDT------AVHLVMELCEGGELFDRIV----ARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETA 196 (352)
Q Consensus 127 ~~~------~~~lv~e~~~~~sL~~~l~----~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~ 196 (352)
..+ ..++||||+++ ++.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||++. ...
T Consensus 103 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~--~~~ 179 (394)
T 4e7w_A 103 SNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDP--PSG 179 (394)
T ss_dssp EESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET--TTT
T ss_pred ecCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcC--CCC
Confidence 443 37899999976 4444332 3457999999999999999999999999999999999999972 223
Q ss_pred CEEEEecccceecCCCCcccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Q 018640 197 PLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL 274 (352)
Q Consensus 197 ~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 274 (352)
.+||+|||+++............||+.|+|||++.+ .++.++|||||||++|||++|+.||.+....+....+.....
T Consensus 180 ~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 259 (394)
T 4e7w_A 180 VLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLG 259 (394)
T ss_dssp EEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred cEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 489999999988766655566789999999998753 489999999999999999999999998887776666655321
Q ss_pred ccC--------------------C-----CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 275 DFR--------------------R-----DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 275 ~~~--------------------~-----~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
... . ...+..++++.+||.+||+.||.+|||+.|+++||||++...
T Consensus 260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 260 TPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp CCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred CCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 110 0 012247899999999999999999999999999999997643
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=356.27 Aligned_cols=264 Identities=27% Similarity=0.434 Sum_probs=217.3
Q ss_pred cccccceeceeeeccCceEEEEEEEC-CCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCC--CCCCeeEeeeEEE--
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDR-ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP--KHQNIVCLKDTYE-- 126 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~~iv~l~~~~~-- 126 (352)
.+.++|++++.||+|+||+||+|.+. .+|+.||+|++....... .....+.+|+.+++.+. +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 46678999999999999999999985 678999999987653222 12234556777766553 7999999999987
Q ss_pred ---eCCeEEEEEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEE
Q 018640 127 ---DDTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAI 201 (352)
Q Consensus 127 ---~~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~ 201 (352)
.....++||||++ ++|.+++.... .+++..++.++.|++.||.|||+.|++|+||||+||+++.++. +||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~---~kl~ 162 (326)
T 1blx_A 87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLA 162 (326)
T ss_dssp ECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC---EEEC
T ss_pred ccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCC---EEEe
Confidence 5567899999997 59999998754 4999999999999999999999999999999999999976554 8999
Q ss_pred ecccceecCCCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC---
Q 018640 202 DFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR--- 277 (352)
Q Consensus 202 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--- 277 (352)
|||++.............||..|+|||++. ..++.++||||||+++|+|++|+.||...........+........
T Consensus 163 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 163 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp SCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred cCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 999998765444445668899999999876 4589999999999999999999999998887776666654322110
Q ss_pred --------------------CCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 278 --------------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 278 --------------------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
......+++.+.+||.+||+.||++|||+.++++||||++...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 0112457899999999999999999999999999999997643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=354.73 Aligned_cols=261 Identities=24% Similarity=0.361 Sum_probs=209.3
Q ss_pred ccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe
Q 018640 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (352)
Q Consensus 51 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 130 (352)
....++|++.+.||+|+||+||+|.+ +|..||+|++..... .....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRL-RHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSTTC
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCc
Confidence 34457899999999999999999986 488999999876532 334456789999999999 89999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcC--CEEecCCCCceEeecCCCCCCEEEEeccc
Q 018640 131 VHLVMELCEGGELFDRIVARGH---YTERAAAAVTKTIVEVVQMCHKHG--VMHRDLKPENFLFANKKETAPLKAIDFGL 205 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~---l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dikp~NIll~~~~~~~~vkl~Dfg~ 205 (352)
.++||||+++++|.+++..... +++..++.++.|++.||+|||+.| |+||||||+||+++.++. +||+|||+
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~---~kL~Dfg~ 185 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT---VKVCDFGL 185 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCC---EEECCCC-
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCc---EEECCCCC
Confidence 9999999999999999987653 999999999999999999999999 999999999999976544 89999999
Q ss_pred ceecCCCC-cccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcC
Q 018640 206 SVFFKPGE-KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (352)
Q Consensus 206 a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (352)
+....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+.... ........
T Consensus 186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~ 263 (309)
T 3p86_A 186 SRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC--KRLEIPRN 263 (309)
T ss_dssp ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSC--CCCCCCTT
T ss_pred CccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--CCCCCCcc
Confidence 97544332 2345579999999999874 48999999999999999999999998887776655554332 22334457
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhc--Ccccccccc
Q 018640 284 VSENAKDLVRKMLDPDPKRRLTAQQVLE--HPWLQNAKK 320 (352)
Q Consensus 284 ~~~~~~~li~~~l~~dP~~Rps~~ell~--hp~f~~~~~ 320 (352)
+++.+.++|.+||+.||.+|||+.++++ .++++....
T Consensus 264 ~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p 302 (309)
T 3p86_A 264 LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302 (309)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence 8999999999999999999999999988 466665433
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=352.11 Aligned_cols=259 Identities=27% Similarity=0.472 Sum_probs=214.1
Q ss_pred ccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe
Q 018640 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (352)
Q Consensus 51 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 130 (352)
....++|++.+.||+|+||.||+|.+..+|+.||+|++... ...+.+.+|+.+++.+ +||||+++++++...+.
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 98 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE-----SDLQEIIKEISIMQQC-DSPHVVKYYGSYFKNTD 98 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT-----SCCHHHHHHHHHHHTC-CCTTBCCEEEEEEETTE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch-----HHHHHHHHHHHHHHhC-CCCCCccEEEEEEeCCE
Confidence 34567899999999999999999999999999999998653 2346788999999999 89999999999999999
Q ss_pred EEEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 131 VHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
.++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++. +||+|||++...
T Consensus 99 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~kl~dfg~~~~~ 175 (314)
T 3com_A 99 LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH---AKLADFGVAGQL 175 (314)
T ss_dssp EEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC---EEECCCTTCEEC
T ss_pred EEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCC---EEEeecccchhh
Confidence 9999999999999999974 457999999999999999999999999999999999999976554 899999999766
Q ss_pred CCCC-cccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHH
Q 018640 210 KPGE-KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (352)
Q Consensus 210 ~~~~-~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (352)
.... ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||...........+.... .........+++.
T Consensus 176 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 254 (314)
T 3com_A 176 TDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP-PPTFRKPELWSDN 254 (314)
T ss_dssp BTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CCCCSSGGGSCHH
T ss_pred hhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC-CcccCCcccCCHH
Confidence 4432 2345578999999999864 58999999999999999999999998777655544433322 1111223457899
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 288 ~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
+.++|.+||+.||.+|||+.++++||||+...
T Consensus 255 l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 255 FTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred HHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 99999999999999999999999999999753
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=370.19 Aligned_cols=263 Identities=26% Similarity=0.483 Sum_probs=198.9
Q ss_pred cccccccceec-eeeeccCceEEEEEEEC--CCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEE
Q 018640 50 GREIEERYELG-RELGRGEFGITYLCTDR--ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (352)
Q Consensus 50 ~~~~~~~y~~~-~~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~ 126 (352)
...+.+.|.+. ++||+|+||+||+|.+. .+++.||+|++.... ....+.+|+.+|+++ +||||+++++++.
T Consensus 15 ~~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 88 (405)
T 3rgf_A 15 RERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-----ISMSACREIALLREL-KHPNVISLQKVFL 88 (405)
T ss_dssp CCCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-----CCHHHHHHHHHHHHC-CCTTBCCCCEEEE
T ss_pred hhhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-----CCHHHHHHHHHHHhc-CCCCeeeEeeEEe
Confidence 34567778884 58999999999999965 578999999986542 224678899999999 8999999999995
Q ss_pred e--CCeEEEEEEecCCcchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecC-CC
Q 018640 127 D--DTAVHLVMELCEGGELFDRIVAR---------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK-KE 194 (352)
Q Consensus 127 ~--~~~~~lv~e~~~~~sL~~~l~~~---------~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~-~~ 194 (352)
. ....++||||++ ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+..+ ..
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~ 167 (405)
T 3rgf_A 89 SHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPE 167 (405)
T ss_dssp ETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTT
T ss_pred cCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCC
Confidence 4 678999999996 5888877532 148999999999999999999999999999999999999543 34
Q ss_pred CCCEEEEecccceecCCC----Ccccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCH------
Q 018640 195 TAPLKAIDFGLSVFFKPG----EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETE------ 262 (352)
Q Consensus 195 ~~~vkl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~------ 262 (352)
...+||+|||+++..... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.....
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 247 (405)
T 3rgf_A 168 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 247 (405)
T ss_dssp TTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------C
T ss_pred CCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccc
Confidence 456999999999866432 22345689999999998764 489999999999999999999999976543
Q ss_pred ---HHHHHHHHhcccccCCCCCc----------------------------------CCCHHHHHHHHHhcCCCcCCCCC
Q 018640 263 ---QGVAQAIIRSVLDFRRDPWP----------------------------------KVSENAKDLVRKMLDPDPKRRLT 305 (352)
Q Consensus 263 ---~~~~~~~~~~~~~~~~~~~~----------------------------------~~~~~~~~li~~~l~~dP~~Rps 305 (352)
.+....+...........|. ..++.+.+||.+||+.||.+|||
T Consensus 248 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t 327 (405)
T 3rgf_A 248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT 327 (405)
T ss_dssp CCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC
T ss_pred cchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCC
Confidence 23444444433322222221 12678899999999999999999
Q ss_pred HHHHhcCccccccc
Q 018640 306 AQQVLEHPWLQNAK 319 (352)
Q Consensus 306 ~~ell~hp~f~~~~ 319 (352)
+.|+|+||||++..
T Consensus 328 a~e~L~hp~f~~~~ 341 (405)
T 3rgf_A 328 SEQAMQDPYFLEDP 341 (405)
T ss_dssp HHHHHTSGGGTSSS
T ss_pred HHHHhcChhhccCC
Confidence 99999999998753
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=366.20 Aligned_cols=264 Identities=23% Similarity=0.450 Sum_probs=220.3
Q ss_pred CcccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcH--------------HHHHHHHHHHHhCCC
Q 018640 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDI--------------EDVRREVDIMRHLPK 114 (352)
Q Consensus 49 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~--------------~~~~~E~~~l~~l~~ 114 (352)
.+....++|++++.||+|+||.||+|.+ +|+.||+|++........... +.+.+|+.+++++ +
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 101 (348)
T 2pml_X 25 EKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-K 101 (348)
T ss_dssp SSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC-C
T ss_pred hcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC-C
Confidence 3445567899999999999999999998 799999999876543322211 7899999999999 8
Q ss_pred CCCeeEeeeEEEeCCeEEEEEEecCCcchHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEecCCCC
Q 018640 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDR------IVA--RGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPE 185 (352)
Q Consensus 115 h~~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~------l~~--~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dikp~ 185 (352)
||||+++++++...+..++||||+++++|.++ +.. ...+++..++.++.|++.||.|||+ .|++|+||||+
T Consensus 102 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~ 181 (348)
T 2pml_X 102 NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPS 181 (348)
T ss_dssp CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGG
T ss_pred CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChH
Confidence 99999999999999999999999999999998 655 4579999999999999999999999 99999999999
Q ss_pred ceEeecCCCCCCEEEEecccceecCCCCcccccccccccccchhcccc--CCC-cchHHHHHHHHHHHHhCCCCCCCCCH
Q 018640 186 NFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN--YGP-EVDVWSAGVILYILLCGVPPFWAETE 262 (352)
Q Consensus 186 NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~s~-~~Di~SlG~~l~el~tg~~p~~~~~~ 262 (352)
||+++.++. +||+|||++...... ......||..|+|||.+.+. ++. ++||||||+++++|++|..||.....
T Consensus 182 Nil~~~~~~---~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 182 NILMDKNGR---VKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp GEEECTTSC---EEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred hEEEcCCCc---EEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 999976554 899999999876443 34556899999999998744 445 89999999999999999999987766
Q ss_pred -HHHHHHHHhcccccCCCC---------------CcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 263 -QGVAQAIIRSVLDFRRDP---------------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 263 -~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
.+....+......++... ...+++.+.+||.+||+.||.+|||+.++++||||++..
T Consensus 258 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 258 LVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp SHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred HHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 445555444333222110 146889999999999999999999999999999999753
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=359.26 Aligned_cols=263 Identities=30% Similarity=0.482 Sum_probs=216.4
Q ss_pred cccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC-
Q 018640 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD- 128 (352)
Q Consensus 50 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~- 128 (352)
...+.++|++.+.||+|+||+||+|.+..+|+.||||++... ........+.+|+.+++++ +||||+++++++...
T Consensus 6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 82 (353)
T 2b9h_A 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHF-KHENIITIFNIQRPDS 82 (353)
T ss_dssp CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSC
T ss_pred ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhC-cCCCcCCeeeeecccc
Confidence 345778999999999999999999999999999999998643 2334456788999999999 899999999987654
Q ss_pred ----CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecc
Q 018640 129 ----TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (352)
Q Consensus 129 ----~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg 204 (352)
...++||||++ ++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||
T Consensus 83 ~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~---~kl~Dfg 157 (353)
T 2b9h_A 83 FENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD---LKVCDFG 157 (353)
T ss_dssp STTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC---EEECCCT
T ss_pred cCccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCc---EEEEecc
Confidence 67899999996 599998876 46999999999999999999999999999999999999976554 8999999
Q ss_pred cceecCCCC-----------cccccccccccccchhcc--ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 018640 205 LSVFFKPGE-----------KFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR 271 (352)
Q Consensus 205 ~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~--~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~ 271 (352)
++....... ......||+.|+|||++. ..++.++||||||+++|+|++|..||...........+..
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 237 (353)
T 2b9h_A 158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237 (353)
T ss_dssp TCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence 998754321 122357899999999864 4588999999999999999999999988876655544433
Q ss_pred cccccC------------------------CC----CCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 272 SVLDFR------------------------RD----PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 272 ~~~~~~------------------------~~----~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
...... .. .++.+++.+.+||.+||+.||++|||+.++++||||+....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 221111 00 12367899999999999999999999999999999997643
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=363.80 Aligned_cols=258 Identities=29% Similarity=0.497 Sum_probs=213.3
Q ss_pred ccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe
Q 018640 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (352)
Q Consensus 51 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 130 (352)
..+.++|++.+.||+|+||+||+|.+..+|+.||+|++.... ........+.+|+.+++.+ +||||+++++++...+.
T Consensus 38 ~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 115 (371)
T 4exu_A 38 WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASS 115 (371)
T ss_dssp EEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSS
T ss_pred ecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhc-CCCCchhhhhheeccCC
Confidence 456789999999999999999999999999999999987643 2334457788999999999 89999999999987765
Q ss_pred E------EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecc
Q 018640 131 V------HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (352)
Q Consensus 131 ~------~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg 204 (352)
. ++||||++ ++|.+.+.. .+++..+..++.|++.||+|||+.||+||||||+||+++.++. +||+|||
T Consensus 116 ~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~---~kL~Dfg 189 (371)
T 4exu_A 116 LRNFYDFYLVMPFMQ-TDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE---LKILDFG 189 (371)
T ss_dssp STTCCCCEEEEECCC-EEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC---EEECSTT
T ss_pred cccceeEEEEEcccc-ccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCC---EEEEecC
Confidence 4 99999997 588887743 4999999999999999999999999999999999999976554 8999999
Q ss_pred cceecCCCCcccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc------
Q 018640 205 LSVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF------ 276 (352)
Q Consensus 205 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~------ 276 (352)
++..... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||......+....+.......
T Consensus 190 ~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 267 (371)
T 4exu_A 190 LARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 267 (371)
T ss_dssp CC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred ccccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence 9986543 2345578999999998764 58999999999999999999999999887766665554422111
Q ss_pred -----------------CCC----CCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 277 -----------------RRD----PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 277 -----------------~~~----~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
... .++.+++.+.+||.+||+.||++|||+.|+++||||+..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 000 123568999999999999999999999999999999865
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=364.38 Aligned_cols=264 Identities=28% Similarity=0.442 Sum_probs=216.7
Q ss_pred CCCcccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCC-----CeeEe
Q 018640 47 EPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ-----NIVCL 121 (352)
Q Consensus 47 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-----~iv~l 121 (352)
...+..+.++|++.+.||+|+||+||+|.+..+++.||||++... ......+..|+.+++.+..|+ +++++
T Consensus 46 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~ 121 (382)
T 2vx3_A 46 VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHL 121 (382)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCE
T ss_pred eecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEe
Confidence 345677888999999999999999999999999999999998643 233466778999998885465 49999
Q ss_pred eeEEEeCCeEEEEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HcCCEEecCCCCceEeecCCCCCC
Q 018640 122 KDTYEDDTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCH--KHGVMHRDLKPENFLFANKKETAP 197 (352)
Q Consensus 122 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH--~~~ivH~Dikp~NIll~~~~~~~~ 197 (352)
++++...+..++||||+++ +|.+++... ..+++..++.++.|++.||.||| +.||+||||||+|||++.+ ....
T Consensus 122 ~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~-~~~~ 199 (382)
T 2vx3_A 122 KRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNP-KRSA 199 (382)
T ss_dssp EEEEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESST-TSCC
T ss_pred eeeeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecC-CCCc
Confidence 9999999999999999965 999999865 35999999999999999999999 5799999999999999642 2334
Q ss_pred EEEEecccceecCCCCcccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc
Q 018640 198 LKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF 276 (352)
Q Consensus 198 vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 276 (352)
+||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|||++|+.||......+....+.......
T Consensus 200 ~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 277 (382)
T 2vx3_A 200 IKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277 (382)
T ss_dssp EEECCCTTCEETTCC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred EEEEeccCceecccc--cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 899999999876432 345689999999998874 58999999999999999999999999888777766665432211
Q ss_pred CC------------------CCC--------------cC----------------------------CCHHHHHHHHHhc
Q 018640 277 RR------------------DPW--------------PK----------------------------VSENAKDLVRKML 296 (352)
Q Consensus 277 ~~------------------~~~--------------~~----------------------------~~~~~~~li~~~l 296 (352)
+. ..+ +. ..+.+.+||.+||
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL 357 (382)
T 2vx3_A 278 PAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRML 357 (382)
T ss_dssp CHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHT
T ss_pred CHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhc
Confidence 10 000 00 0137899999999
Q ss_pred CCCcCCCCCHHHHhcCcccccc
Q 018640 297 DPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 297 ~~dP~~Rps~~ell~hp~f~~~ 318 (352)
+.||++|||+.|+|+||||++.
T Consensus 358 ~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 358 DYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp CSCTTTSCCHHHHTTSGGGCC-
T ss_pred CCChhhCCCHHHHhcCcccccC
Confidence 9999999999999999999875
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=352.51 Aligned_cols=259 Identities=27% Similarity=0.486 Sum_probs=215.3
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccC-ChhcHHHHHHHHHHHHhCCCCCCeeEeeeEE--EeCC
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR-TAVDIEDVRREVDIMRHLPKHQNIVCLKDTY--EDDT 129 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~--~~~~ 129 (352)
+.++|++.+.||+|+||.||+|.+..+++.||+|++...... .....+.+.+|+.+++.+ +||||+++++++ .+..
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECC---
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCC
Confidence 456899999999999999999999999999999998765322 123457899999999999 899999999998 4556
Q ss_pred eEEEEEEecCCcchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccce
Q 018640 130 AVHLVMELCEGGELFDRIVA--RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (352)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~ 207 (352)
..++||||++++ |.+.+.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++. +||+|||++.
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~---~kl~dfg~~~ 157 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT---LKISALGVAE 157 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC---EEECCCTTCE
T ss_pred eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCc---EEeecccccc
Confidence 889999999875 7777765 346999999999999999999999999999999999999976554 8999999998
Q ss_pred ecCCC---Ccccccccccccccchhcccc---CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCC
Q 018640 208 FFKPG---EKFSEIVGSPYYMAPEVLKRN---YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281 (352)
Q Consensus 208 ~~~~~---~~~~~~~gt~~y~aPE~~~~~---~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (352)
..... .......||+.|+|||++.+. ++.++||||||+++|+|++|..||...........+..... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~----~~~ 233 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY----AIP 233 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC----CCC
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC----CCC
Confidence 76432 223455789999999987642 47799999999999999999999998877766666555432 233
Q ss_pred cCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 282 ~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
..+++.+.++|.+||+.||.+|||+.++++||||++...
T Consensus 234 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 234 GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred CccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 468899999999999999999999999999999987644
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-49 Score=355.96 Aligned_cols=263 Identities=27% Similarity=0.478 Sum_probs=196.4
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
..++|++.+.||+|+||+||+|.+..+++.||+|++..... ....+.+.+|+.+++++ +||||+++++++...+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQC-HHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCC-CCTTBCCEEEEEESSSCEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhc-CCCCEeeEEEEEeecCCcE
Confidence 45689999999999999999999988999999999865432 23356788999999999 8999999999999999999
Q ss_pred EEEEecCCcchHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecc
Q 018640 133 LVMELCEGGELFDRIVA--------RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~--------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg 204 (352)
+||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++. +||+|||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~kl~dfg 166 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS---VQIADFG 166 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC---EEECCCH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCC---EEEEecc
Confidence 99999999999999874 345899999999999999999999999999999999999976554 8999999
Q ss_pred cceecCCCC------cccccccccccccchhcc--ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc
Q 018640 205 LSVFFKPGE------KFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF 276 (352)
Q Consensus 205 ~a~~~~~~~------~~~~~~gt~~y~aPE~~~--~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 276 (352)
++....... ......||+.|+|||.+. ..++.++||||||+++|+|++|..||...................
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 246 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCC
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCc
Confidence 987653321 123457899999999886 358999999999999999999999998877665544443332211
Q ss_pred C------CCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccC
Q 018640 277 R------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKA 321 (352)
Q Consensus 277 ~------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~ 321 (352)
. ......+++.+.++|.+||+.||.+|||+.++++||||++....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 297 (303)
T 2vwi_A 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK 297 (303)
T ss_dssp TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence 1 11234678999999999999999999999999999999976543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=357.58 Aligned_cols=266 Identities=29% Similarity=0.446 Sum_probs=212.6
Q ss_pred CcccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEE--
Q 018640 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE-- 126 (352)
Q Consensus 49 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~-- 126 (352)
.+..+.++|++++.||+|+||+||+|.+..+|+.||+|++... .....+.+.+|+.+++++ +||||+++++++.
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 80 (320)
T 2i6l_A 5 HGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRL-DHDNIVKVFEILGPS 80 (320)
T ss_dssp -CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECTT
T ss_pred ccCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhc-CCCCeeEEEEecccc
Confidence 3556788999999999999999999999999999999988643 344567889999999999 8999999999873
Q ss_pred ------------eCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCC
Q 018640 127 ------------DDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE 194 (352)
Q Consensus 127 ------------~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~ 194 (352)
.....++||||++ ++|.+++.. ..+++..++.++.|++.||+|||++||+||||||+||+++.++
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~- 157 (320)
T 2i6l_A 81 GSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED- 157 (320)
T ss_dssp SCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-
T ss_pred ccccccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-
Confidence 4467899999997 599998864 4699999999999999999999999999999999999997433
Q ss_pred CCCEEEEecccceecCCC----Ccccccccccccccchhcc--ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 018640 195 TAPLKAIDFGLSVFFKPG----EKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQA 268 (352)
Q Consensus 195 ~~~vkl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~--~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~ 268 (352)
..+||+|||++...... .......+|..|+|||.+. ..++.++||||||+++|+|++|+.||......+....
T Consensus 158 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 236 (320)
T 2i6l_A 158 -LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQL 236 (320)
T ss_dssp -TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred -CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 34899999999865432 1223446799999999864 4588999999999999999999999998877666555
Q ss_pred HHhccccc----------------------CC----CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccCC
Q 018640 269 IIRSVLDF----------------------RR----DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAP 322 (352)
Q Consensus 269 ~~~~~~~~----------------------~~----~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~ 322 (352)
+....... +. ...+.+++.+.+||.+||+.||++|||+.++++||||+......
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM 316 (320)
T ss_dssp HHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred HHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence 54432110 00 01235799999999999999999999999999999999765443
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=360.27 Aligned_cols=261 Identities=25% Similarity=0.376 Sum_probs=203.6
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe-
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA- 130 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~- 130 (352)
..-++|++.+.||+|+||+||+|.+..+|+.||||++.... .......+|+..+..+ +||||+++++++...+.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP----RFRNRELQIMQDLAVL-HHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT----TCCCHHHHHHHHHHHH-CCTTBCCEEEEEEEECSS
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc----cccHHHHHHHHHHHhc-CCCCcccHHHhhhccccc
Confidence 34468999999999999999999999999999999885432 2234566788888998 89999999999865433
Q ss_pred ------EEEEEEecCCcchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH--HcCCEEecCCCCceEeecCCCCCCE
Q 018640 131 ------VHLVMELCEGGELFDRIV----ARGHYTERAAAAVTKTIVEVVQMCH--KHGVMHRDLKPENFLFANKKETAPL 198 (352)
Q Consensus 131 ------~~lv~e~~~~~sL~~~l~----~~~~l~~~~~~~i~~qi~~aL~~lH--~~~ivH~Dikp~NIll~~~~~~~~v 198 (352)
.++||||+++ +|.+.+. ....+++..+..++.|++.||.||| +.||+||||||+|||++.. ...+
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~--~~~~ 171 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEA--DGTL 171 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETT--TTEE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCC--CCcE
Confidence 7899999986 5544433 4556899999999999999999999 9999999999999999752 2348
Q ss_pred EEEecccceecCCCCcccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc
Q 018640 199 KAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF 276 (352)
Q Consensus 199 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 276 (352)
||+|||++.............||+.|+|||++.+ .++.++||||||+++|+|++|+.||...........+.+.....
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 251 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251 (360)
T ss_dssp EECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred EEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCC
Confidence 9999999987766655566789999999998753 38999999999999999999999999888777776665532211
Q ss_pred C----------------------------CCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 277 R----------------------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 277 ~----------------------------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
. .......++.+.+||.+||+.||.+|||+.|+++||||++...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 1 0111225678999999999999999999999999999997744
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-50 Score=373.65 Aligned_cols=261 Identities=17% Similarity=0.221 Sum_probs=197.8
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCC-CCCCeeEee-------eEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP-KHQNIVCLK-------DTY 125 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-~h~~iv~l~-------~~~ 125 (352)
...|++.+.||+|+||+||+|.+..+|+.||+|++...........+.+.+|+.+++.+. +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345999999999999999999999999999999998765444556677888977666663 499988755 444
Q ss_pred EeC-----------------CeEEEEEEecCCcchHHHHHhcC-CCCHHHH------HHHHHHHHHHHHHHHHcCCEEec
Q 018640 126 EDD-----------------TAVHLVMELCEGGELFDRIVARG-HYTERAA------AAVTKTIVEVVQMCHKHGVMHRD 181 (352)
Q Consensus 126 ~~~-----------------~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~------~~i~~qi~~aL~~lH~~~ivH~D 181 (352)
... ...++||||++ ++|.+++.... .+++..+ ..++.||+.||+|||++||+|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 433 33799999998 79999998642 3555555 67789999999999999999999
Q ss_pred CCCCceEeecCCCCCCEEEEecccceecCCCCcccccccccccccchhccc---cCCCcchHHHHHHHHHHHHhCCCCCC
Q 018640 182 LKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFW 258 (352)
Q Consensus 182 ikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~s~~~Di~SlG~~l~el~tg~~p~~ 258 (352)
|||+|||++.++. +||+|||++...... .....+|+.|+|||++.+ .++.++||||||+++|||++|+.||.
T Consensus 220 ikp~NIll~~~~~---~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 220 FTPDNLFIMPDGR---LMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp CSGGGEEECTTSC---EEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred CCHHHEEECCCCC---EEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence 9999999976554 899999999876432 224567799999999864 48999999999999999999999997
Q ss_pred CCCHHHHH--HH---HHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 259 AETEQGVA--QA---IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 259 ~~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
........ .. ............++.+++.+.+||.+||+.||++|||+.++++||||++...
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 361 (371)
T 3q60_A 295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQN 361 (371)
T ss_dssp BCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHH
T ss_pred CcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHH
Confidence 66332100 00 0000011122223478999999999999999999999999999999997654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=354.92 Aligned_cols=252 Identities=23% Similarity=0.334 Sum_probs=212.5
Q ss_pred ccccccceeceeeeccCceEEEEEEECCCCc---EEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe
Q 018640 51 REIEERYELGRELGRGEFGITYLCTDRENGD---AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (352)
Q Consensus 51 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 127 (352)
....++|++.+.||+|+||+||+|.+..++. .||||++.... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQF-DHPNIIRLEGVVTR 121 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECG
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEe
Confidence 3456789999999999999999999976555 49999987542 334457799999999999 89999999999999
Q ss_pred CCeEEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccc
Q 018640 128 DTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (352)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a 206 (352)
.+..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||++.++. +||+|||++
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~a 198 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLV---CKVSDFGLS 198 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC---EEECCCSSC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCC---EEECCCCcc
Confidence 99999999999999999999755 47999999999999999999999999999999999999975544 899999999
Q ss_pred eecCCCCc----ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCC
Q 018640 207 VFFKPGEK----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDP 280 (352)
Q Consensus 207 ~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 280 (352)
........ .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||...........+.... ....
T Consensus 199 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~---~~~~ 275 (325)
T 3kul_A 199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY---RLPA 275 (325)
T ss_dssp EECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC---CCCC
T ss_pred cccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC---CCCC
Confidence 87644321 12335677899999987 558999999999999999999 999999888877766665542 2333
Q ss_pred CcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 281 ~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
...+++.+.++|..||+.||++|||+.++++
T Consensus 276 ~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 276 PMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 4578999999999999999999999999987
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=367.32 Aligned_cols=263 Identities=24% Similarity=0.415 Sum_probs=210.4
Q ss_pred CCcccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCC-------CCCCeeE
Q 018640 48 PTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP-------KHQNIVC 120 (352)
Q Consensus 48 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-------~h~~iv~ 120 (352)
..+..+.++|++++.||+|+||+||+|.+..+++.||+|++... ....+.+.+|+.+++.+. +|+||++
T Consensus 30 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~ 105 (397)
T 1wak_A 30 KIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQ 105 (397)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred ehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence 44567788999999999999999999999999999999998643 334567889999999983 2788999
Q ss_pred eeeEEE----eCCeEEEEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc-CCEEecCCCCceEeecCC
Q 018640 121 LKDTYE----DDTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKK 193 (352)
Q Consensus 121 l~~~~~----~~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~-~ivH~Dikp~NIll~~~~ 193 (352)
+++++. .....++||||+ +++|.+.+... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~ 184 (397)
T 1wak_A 106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNE 184 (397)
T ss_dssp EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCH
T ss_pred eecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccc
Confidence 999987 556899999999 55777766554 4599999999999999999999998 999999999999997553
Q ss_pred ----------------------------------------------CCCCEEEEecccceecCCCCcccccccccccccc
Q 018640 194 ----------------------------------------------ETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAP 227 (352)
Q Consensus 194 ----------------------------------------------~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aP 227 (352)
....+||+|||++...... .....||+.|+||
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aP 262 (397)
T 1wak_A 185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSL 262 (397)
T ss_dssp HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCH
T ss_pred hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCC
Confidence 1135999999999876432 3455799999999
Q ss_pred hhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhcccccCC----------------------
Q 018640 228 EVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAET------EQGVAQAIIRSVLDFRR---------------------- 278 (352)
Q Consensus 228 E~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~------~~~~~~~~~~~~~~~~~---------------------- 278 (352)
|++.+ .++.++|||||||++|||++|+.||.... .......+.......+.
T Consensus 263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 342 (397)
T 1wak_A 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI 342 (397)
T ss_dssp HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence 98764 58999999999999999999999997544 22223333222111100
Q ss_pred ----------------CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccc
Q 018640 279 ----------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (352)
Q Consensus 279 ----------------~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~ 317 (352)
......+..+.+||.+||+.||++|||+.|+++||||++
T Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 343 TKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred cccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 011223467889999999999999999999999999974
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=362.86 Aligned_cols=259 Identities=22% Similarity=0.262 Sum_probs=218.5
Q ss_pred cccccceeceeeeccCceEEEEEE-----ECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEE
Q 018640 52 EIEERYELGRELGRGEFGITYLCT-----DRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~ 126 (352)
...++|++++.||+|+||+||+|. +..++..||+|++... ........+.+|+.+++++ +||||+++++++.
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~ 144 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKF-NHQNIVRCIGVSL 144 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEC
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhC-CCCCCCeEEEEEe
Confidence 345789999999999999999999 4456789999998643 2344456788999999999 8999999999999
Q ss_pred eCCeEEEEEEecCCcchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEE
Q 018640 127 DDTAVHLVMELCEGGELFDRIVARG-------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLK 199 (352)
Q Consensus 127 ~~~~~~lv~e~~~~~sL~~~l~~~~-------~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vk 199 (352)
.....++||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++....+|
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 9999999999999999999997643 489999999999999999999999999999999999998777767799
Q ss_pred EEecccceecCC---CCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc
Q 018640 200 AIDFGLSVFFKP---GEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVL 274 (352)
Q Consensus 200 l~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~ 274 (352)
|+|||+++.... ........||+.|+|||++. ..++.++||||||+++|||++ |..||...........+....
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~- 303 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG- 303 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-
Confidence 999999975421 12223456799999999876 568999999999999999998 999998888776666655433
Q ss_pred ccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccc
Q 018640 275 DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316 (352)
Q Consensus 275 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~ 316 (352)
.......++..+.+||.+||+.||++|||+.+|+++.++.
T Consensus 304 --~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 304 --RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 2233456899999999999999999999999999997665
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=361.30 Aligned_cols=264 Identities=26% Similarity=0.401 Sum_probs=208.9
Q ss_pred cccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccC--------ChhcHHHHHHHHHHHHhCCCCCCeeEe
Q 018640 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR--------TAVDIEDVRREVDIMRHLPKHQNIVCL 121 (352)
Q Consensus 50 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~~~E~~~l~~l~~h~~iv~l 121 (352)
...+.++|++.+.||+|+||.||+|.+.. |..||+|++...... .....+.+.+|+.+++++ +||||+++
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~ 94 (362)
T 3pg1_A 17 LHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-HHPNILGL 94 (362)
T ss_dssp HHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-CCTTBCCC
T ss_pred HHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-CCcCccce
Confidence 45677899999999999999999999754 999999998654322 122247789999999999 89999999
Q ss_pred eeEEEe-----CCeEEEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCC
Q 018640 122 KDTYED-----DTAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKET 195 (352)
Q Consensus 122 ~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~ 195 (352)
++++.. ....++||||++ ++|.+.+.... .+++..+..++.||+.||.|||+.||+||||||+||+++.++.
T Consensus 95 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~- 172 (362)
T 3pg1_A 95 RDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND- 172 (362)
T ss_dssp SEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC-
T ss_pred eeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC-
Confidence 999853 336899999997 58888887543 6999999999999999999999999999999999999976554
Q ss_pred CCEEEEecccceecCCCCcccccccccccccchhcc--ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 018640 196 APLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV 273 (352)
Q Consensus 196 ~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~ 273 (352)
+||+|||++.............||+.|+|||++. ..++.++||||||+++|+|++|+.||......+....+....
T Consensus 173 --~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 250 (362)
T 3pg1_A 173 --ITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVV 250 (362)
T ss_dssp --EEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred --EEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence 8999999998665555555668999999999876 458999999999999999999999999888777666665432
Q ss_pred cccC------------------------CC----CCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 274 LDFR------------------------RD----PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 274 ~~~~------------------------~~----~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
.... .. ..+..++.+.+||.+||+.||++|||+.|+++||||+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp CCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred CCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 2111 00 1234688899999999999999999999999999999763
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=346.97 Aligned_cols=258 Identities=28% Similarity=0.457 Sum_probs=209.1
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
+|.....||+|+||+||+|.+..++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++...+..++||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 98 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHL-KHKNIVQYLGSFSENGFIKIFM 98 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhC-CCCCEeeEeeEEEeCCcEEEEE
Confidence 3455569999999999999999999999999987542 23456789999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 136 ELCEGGELFDRIVARG---HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 136 e~~~~~sL~~~l~~~~---~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||+++.. ...+||+|||++......
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~--~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTY--SGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT--TCCEEECCTTTCEESCC-
T ss_pred EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECC--CCCEEEeecccccccCCC
Confidence 9999999999997652 46789999999999999999999999999999999999752 234899999999876432
Q ss_pred C-cccccccccccccchhccc---cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHH
Q 018640 213 E-KFSEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (352)
Q Consensus 213 ~-~~~~~~gt~~y~aPE~~~~---~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (352)
. ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||............ ..........+..+++.+
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 255 (295)
T 2clq_A 177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK-VGMFKVHPEIPESMSAEA 255 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH-HHHHCCCCCCCTTSCHHH
T ss_pred CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh-hccccccccccccCCHHH
Confidence 2 2345578999999998763 2788999999999999999999999755433221111 111223334445789999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 289 ~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
.++|.+||+.||++|||+.++++||||+....
T Consensus 256 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 287 (295)
T 2clq_A 256 KAFILKCFEPDPDKRACANDLLVDEFLKVSSK 287 (295)
T ss_dssp HHHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred HHHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence 99999999999999999999999999997644
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=347.68 Aligned_cols=258 Identities=30% Similarity=0.543 Sum_probs=217.3
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEE--eCCeE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE--DDTAV 131 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~--~~~~~ 131 (352)
.++|++++.||+|+||+||+|.+..+|+.||+|++..... .....+.+.+|+.+++++ +||||+++++++. .....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEEGGGTEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhc-CCCCCCeEEEEEecCCCceE
Confidence 4689999999999999999999999999999999876532 334567899999999999 8999999999875 35689
Q ss_pred EEEEEecCCcchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcC-----CEEecCCCCceEeecCCCCCCEEEEe
Q 018640 132 HLVMELCEGGELFDRIVAR----GHYTERAAAAVTKTIVEVVQMCHKHG-----VMHRDLKPENFLFANKKETAPLKAID 202 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~----~~l~~~~~~~i~~qi~~aL~~lH~~~-----ivH~Dikp~NIll~~~~~~~~vkl~D 202 (352)
++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++. +||+|
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~---~kl~d 159 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGD 159 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSC---EEECC
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCC---EEEec
Confidence 9999999999999998753 34999999999999999999999999 999999999999976554 89999
Q ss_pred cccceecCCCCc-ccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCC
Q 018640 203 FGLSVFFKPGEK-FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP 280 (352)
Q Consensus 203 fg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 280 (352)
||++........ .....||..|+|||.+.+ .++.++||||||+++|+|++|..||...........+..... ...
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~---~~~ 236 (279)
T 2w5a_A 160 FGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF---RRI 236 (279)
T ss_dssp CCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC---CCC
T ss_pred CchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc---ccC
Confidence 999976543322 234578999999998764 588999999999999999999999988877666665554432 223
Q ss_pred CcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 281 ~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
...+++.+.++|.+||+.||++|||+.++++|+|+....
T Consensus 237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 346899999999999999999999999999999999753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=354.37 Aligned_cols=272 Identities=23% Similarity=0.345 Sum_probs=197.0
Q ss_pred ccccccceeceeeeccCceEEEEEEECCCCc---EEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe
Q 018640 51 REIEERYELGRELGRGEFGITYLCTDRENGD---AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (352)
Q Consensus 51 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 127 (352)
....++|++.+.||+|+||+||+|.+..++. .||+|++..... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEF-DHPHVAKLVGVSLR 96 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTC-CCTTBCCCCEEEEC
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHC-CCCceehhhceeec
Confidence 3456789999999999999999999877665 899999876532 234467899999999999 99999999999987
Q ss_pred CCeE------EEEEEecCCcchHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCC
Q 018640 128 DTAV------HLVMELCEGGELFDRIVARG------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKET 195 (352)
Q Consensus 128 ~~~~------~lv~e~~~~~sL~~~l~~~~------~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~ 195 (352)
.... ++||||+++++|.+++.... .+++..++.++.|++.||.|||+.||+||||||+||+++.++
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~-- 174 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM-- 174 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS--
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC--
Confidence 6654 99999999999999986532 589999999999999999999999999999999999997654
Q ss_pred CCEEEEecccceecCCCCcc---cccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 018640 196 APLKAIDFGLSVFFKPGEKF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAII 270 (352)
Q Consensus 196 ~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~ 270 (352)
.+||+|||++......... ....+|+.|+|||.+. ..++.++||||||+++|+|++ |..||...........+.
T Consensus 175 -~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~ 253 (323)
T 3qup_A 175 -TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI 253 (323)
T ss_dssp -CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred -CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh
Confidence 4899999999865433221 2345678899999887 458999999999999999999 999998887776666655
Q ss_pred hcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCC-------HHHHhcCccccccccCCCCCCcHHH
Q 018640 271 RSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLT-------AQQVLEHPWLQNAKKAPNVSLGETV 330 (352)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps-------~~ell~hp~f~~~~~~~~~~~~~~~ 330 (352)
... .....+.+++.+.++|.+||+.||++||| ++++++|||+......|-....++.
T Consensus 254 ~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl~~~~~~~ 317 (323)
T 3qup_A 254 GGN---RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLYINIERA 317 (323)
T ss_dssp TTC---CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------------------
T ss_pred cCC---CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCCCCCCCcC
Confidence 432 23334578999999999999999999999 8889999999987666555444443
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=355.20 Aligned_cols=265 Identities=26% Similarity=0.438 Sum_probs=215.9
Q ss_pred CCCcccccccceeceeeeccCceEEEEEEECCCC-cEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCC------ee
Q 018640 47 EPTGREIEERYELGRELGRGEFGITYLCTDRENG-DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN------IV 119 (352)
Q Consensus 47 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~------iv 119 (352)
...+..+.++|++++.||+|+||+||+|.+..++ ..||+|++... ....+.+.+|+.+++.+ +|++ ++
T Consensus 11 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~~~~~~~~~~~~ 85 (355)
T 2eu9_A 11 CRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKI-KEKDKENKFLCV 85 (355)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHH-HHHCTTSCSCBC
T ss_pred cccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHH-hhcCCCCceeEE
Confidence 3456678899999999999999999999998777 68999998642 23456788899999988 5554 89
Q ss_pred EeeeEEEeCCeEEEEEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecC-----
Q 018640 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK----- 192 (352)
Q Consensus 120 ~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~----- 192 (352)
.+++++...+..++||||+ +++|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++..
T Consensus 86 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~ 164 (355)
T 2eu9_A 86 LMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETL 164 (355)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEE
T ss_pred EeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccc
Confidence 9999999999999999999 567777776653 69999999999999999999999999999999999999543
Q ss_pred -----------CCCCCEEEEecccceecCCCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 018640 193 -----------KETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAE 260 (352)
Q Consensus 193 -----------~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~ 260 (352)
.....+||+|||++...... .....||+.|+|||++. ..++.++||||||+++|||++|..||...
T Consensus 165 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 165 YNEHKSCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp ECCC-CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 23455999999999865432 34558999999999876 45899999999999999999999999888
Q ss_pred CHHHHHHHHHhcccccCCC----------------------------------------CCcCCCHHHHHHHHHhcCCCc
Q 018640 261 TEQGVAQAIIRSVLDFRRD----------------------------------------PWPKVSENAKDLVRKMLDPDP 300 (352)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~li~~~l~~dP 300 (352)
...+....+.......+.. .....+..+.+||.+||+.||
T Consensus 243 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 243 ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred CHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 7766555444432221100 001124578899999999999
Q ss_pred CCCCCHHHHhcCccccccc
Q 018640 301 KRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 301 ~~Rps~~ell~hp~f~~~~ 319 (352)
++|||+.|+++||||++..
T Consensus 323 ~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 323 AQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp TTSCCHHHHTTSGGGGGCC
T ss_pred hhCcCHHHHhcChhhcCCC
Confidence 9999999999999999764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=357.76 Aligned_cols=252 Identities=24% Similarity=0.376 Sum_probs=213.3
Q ss_pred ccccceeceeeeccCceEEEEEEEC-------CCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDR-------ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTY 125 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~ 125 (352)
..++|++.+.||+|+||+||+|.+. .++..||+|++.... .....+.+.+|+.+++.+.+||||+++++++
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 4578999999999999999999864 345679999987542 3345678999999999997899999999999
Q ss_pred EeCCeEEEEEEecCCcchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEe
Q 018640 126 EDDTAVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLF 189 (352)
Q Consensus 126 ~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll 189 (352)
...+..++||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 236 (370)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence 99999999999999999999998653 47899999999999999999999999999999999999
Q ss_pred ecCCCCCCEEEEecccceecCCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 018640 190 ANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQG 264 (352)
Q Consensus 190 ~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~ 264 (352)
+.++. +||+|||++........ .....+|+.|+|||++. ..++.++||||||+++|||++ |..||......+
T Consensus 237 ~~~~~---~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~ 313 (370)
T 2psq_A 237 TENNV---MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313 (370)
T ss_dssp CTTCC---EEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred CCCCC---EEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 76554 89999999986644322 23346788999999876 458999999999999999999 999998887766
Q ss_pred HHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 265 VAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
....+.... ....+..+++.+.++|.+||+.||++|||+.|++++
T Consensus 314 ~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 314 LFKLLKEGH---RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHHHTTC---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCC---CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 665554432 233445789999999999999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=348.06 Aligned_cols=256 Identities=25% Similarity=0.480 Sum_probs=206.7
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe----
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED---- 127 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~---- 127 (352)
.+.++|++++.||+|+||+||+|.+..+|+.||+|++... ....+.+.+|+.+++++ +||||+++++++.+
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 77 (303)
T 1zy4_A 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASL-NHQYVVRYYAAWLERRNF 77 (303)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEECCCC
T ss_pred cccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhc-CchHHHHHHHHHHhhcch
Confidence 3567899999999999999999999999999999998643 23457789999999999 89999999998764
Q ss_pred ---------CCeEEEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCC
Q 018640 128 ---------DTAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAP 197 (352)
Q Consensus 128 ---------~~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~ 197 (352)
....++||||+++++|.+++.... .+++..++.++.|++.||.|||++|++|+||||+||+++.++.
T Consensus 78 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~--- 154 (303)
T 1zy4_A 78 VKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN--- 154 (303)
T ss_dssp CC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC---
T ss_pred hhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCC---
Confidence 457899999999999999998654 5788999999999999999999999999999999999976554
Q ss_pred EEEEecccceecCCC---------------Ccccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 018640 198 LKAIDFGLSVFFKPG---------------EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAE 260 (352)
Q Consensus 198 vkl~Dfg~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~ 260 (352)
+||+|||++...... .......||+.|+|||.+.+ .++.++||||||+++|+|++ ||...
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~ 231 (303)
T 1zy4_A 155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG 231 (303)
T ss_dssp EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc
Confidence 899999999765421 12234578999999999863 58999999999999999998 55433
Q ss_pred C-HHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 261 T-EQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 261 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
. .......+......++.......++.+.++|.+||+.||++|||+.++++||||+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 232 MERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred hhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 2 223333333333344444455678889999999999999999999999999999853
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=354.76 Aligned_cols=259 Identities=28% Similarity=0.490 Sum_probs=212.7
Q ss_pred ccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe
Q 018640 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (352)
Q Consensus 51 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 130 (352)
..+.++|.+.+.||+|+||+||+|.+..+|+.||||++.... ......+.+.+|+.+++.+ +||||+++++++.....
T Consensus 20 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 97 (353)
T 3coi_A 20 WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASS 97 (353)
T ss_dssp EEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSS
T ss_pred cccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhc-CCCCcccHhheEecccc
Confidence 346688999999999999999999999999999999987542 2334456788999999999 89999999999987654
Q ss_pred ------EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecc
Q 018640 131 ------VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (352)
Q Consensus 131 ------~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg 204 (352)
.++||||++ ++|.+++.. .+++..+..++.||+.||.|||++||+||||||+||+++.++. +||+|||
T Consensus 98 ~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~---~kl~Dfg 171 (353)
T 3coi_A 98 LRNFYDFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE---LKILDFG 171 (353)
T ss_dssp GGGCCCCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCC---EEECSTT
T ss_pred cccceeEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCc---EEEeecc
Confidence 499999997 588887743 5999999999999999999999999999999999999976554 8999999
Q ss_pred cceecCCCCcccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc-------
Q 018640 205 LSVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD------- 275 (352)
Q Consensus 205 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~------- 275 (352)
++...... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+......
T Consensus 172 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (353)
T 3coi_A 172 LARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 249 (353)
T ss_dssp CTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHT
T ss_pred cccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 99765432 344578999999998764 5899999999999999999999999888766655554432111
Q ss_pred ----------------cC----CCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 276 ----------------FR----RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 276 ----------------~~----~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
.. ...++.+++.+.+||.+||+.||++|||+.++++||||+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 00 112346789999999999999999999999999999998653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-48 Score=351.32 Aligned_cols=251 Identities=25% Similarity=0.416 Sum_probs=209.7
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
.++|++.+.||+|+||+||+|.+..+++.||+|++... .....+.+.+|+.+++++ +||||+++++++..++..++
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~l 84 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCL-EHPNVLKFIGVLYKDKRLNF 84 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhC-CCcCcccEEEEEecCCeeEE
Confidence 46899999999999999999999999999999988542 345567899999999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 134 VMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
||||+++++|.+++.. ...+++..+..++.|++.||+|||+.||+||||||+||+++.++. +||+|||++......
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKN---VVVADFGLARLMVDE 161 (310)
T ss_dssp EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSC---EEECCCTTCEECC--
T ss_pred EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCC---EEEeecccceecccc
Confidence 9999999999999987 456999999999999999999999999999999999999976554 899999999875432
Q ss_pred Ccc---------------cccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHh
Q 018640 213 EKF---------------SEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQG-----VAQAIIR 271 (352)
Q Consensus 213 ~~~---------------~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~-----~~~~~~~ 271 (352)
... ....||+.|+|||++.+ .++.++||||||+++|+|++|..||....... .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence 211 14579999999999874 58999999999999999999999986432211 0111111
Q ss_pred cccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 272 SVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
....+.+++.+.++|.+||+.||++|||+.++++ +++...
T Consensus 242 ------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~ 281 (310)
T 3s95_A 242 ------RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLR 281 (310)
T ss_dssp ------HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHH
T ss_pred ------ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHH
Confidence 1123467889999999999999999999999987 666543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=347.74 Aligned_cols=261 Identities=25% Similarity=0.341 Sum_probs=195.3
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
--++|++++.||+|+||+||+|.+..+|+.||+|++..... .....+.+.++..+++.+ +||||+++++++...+..+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~ 100 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSH-DCPYIVQCFGTFITNTDVF 100 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTT-TCTTBCCEEEEEECSSEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcEE
Confidence 34679999999999999999999999999999999875431 122233344455567776 9999999999999999999
Q ss_pred EEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHc-CCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 133 LVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
+||||+ ++.+..+... ...+++..++.++.|++.||.|||+. |++|+||||+||+++.++. +||+|||++....
T Consensus 101 lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~---~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ---IKLCDFGISGRLV 176 (318)
T ss_dssp EEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSC---EEECCCTTC----
T ss_pred EEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCC---EEEEECCCchhcc
Confidence 999999 5566555543 45799999999999999999999995 9999999999999976554 8999999997765
Q ss_pred CCCcccccccccccccchhcc------ccCCCcchHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcccccCCCCCcC
Q 018640 211 PGEKFSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVLDFRRDPWPK 283 (352)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~------~~~s~~~Di~SlG~~l~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 283 (352)
.........||+.|+|||.+. ..++.++||||||+++|+|++|..||... ........+....... ......
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~ 255 (318)
T 2dyl_A 177 DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL-LPGHMG 255 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCC-CCSSSC
T ss_pred CCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCC-CCccCC
Confidence 544445567999999999873 34788999999999999999999999764 3444444444432211 112235
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 284 ~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
+++.+.++|.+||+.||.+|||+.++++||||++...
T Consensus 256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (318)
T 2dyl_A 256 FSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYET 292 (318)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhccc
Confidence 7999999999999999999999999999999997644
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=354.30 Aligned_cols=259 Identities=31% Similarity=0.519 Sum_probs=214.9
Q ss_pred CCcccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCCh---hcHHHHHHHHHHHHhCC-CCCCeeEeee
Q 018640 48 PTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA---VDIEDVRREVDIMRHLP-KHQNIVCLKD 123 (352)
Q Consensus 48 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~-~h~~iv~l~~ 123 (352)
..+..+.++|++.+.||+|+||+||+|.+..+|+.||+|++........ ...+.+.+|+.+++++. .|+||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 4456678899999999999999999999999999999999976543321 12245677999999995 3699999999
Q ss_pred EEEeCCeEEEEEEecCC-cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEe
Q 018640 124 TYEDDTAVHLVMELCEG-GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAID 202 (352)
Q Consensus 124 ~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~D 202 (352)
++...+..++|+|++.+ ++|.+++.....+++..++.++.|++.||.|||+.||+||||||+||+++.+ ...+||+|
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~--~~~~kL~D 193 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLN--RGELKLID 193 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT--TTEEEECC
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCC--CCCEEEee
Confidence 99999999999999975 8999999988889999999999999999999999999999999999999732 22389999
Q ss_pred cccceecCCCCcccccccccccccchhccc-c-CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCC
Q 018640 203 FGLSVFFKPGEKFSEIVGSPYYMAPEVLKR-N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP 280 (352)
Q Consensus 203 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~-~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 280 (352)
||++...... ......||+.|+|||++.+ . .+.++||||||+++|||++|..||.... ...... ...
T Consensus 194 fg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~----~~~ 262 (320)
T 3a99_A 194 FGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ----VFF 262 (320)
T ss_dssp CTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCC----CCC
T ss_pred Cccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhccc----ccc
Confidence 9999876543 2345579999999998763 3 4678999999999999999999996532 122221 122
Q ss_pred CcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 281 ~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
...+++.+.+||.+||+.||++|||+.++++||||++..
T Consensus 263 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 263 RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 356899999999999999999999999999999999763
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=356.70 Aligned_cols=254 Identities=22% Similarity=0.341 Sum_probs=210.2
Q ss_pred cccccceeceeeeccCceEEEEEE-----ECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEE
Q 018640 52 EIEERYELGRELGRGEFGITYLCT-----DRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~ 126 (352)
...++|++.+.||+|+||.||+|. ...+++.||+|++.... .....+.+.+|+.++.++.+||||+++++++.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 96 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 96 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence 345789999999999999999998 45667899999987542 33345679999999999988999999999998
Q ss_pred eCC-eEEEEEEecCCcchHHHHHhcCC-----------------------------------------------------
Q 018640 127 DDT-AVHLVMELCEGGELFDRIVARGH----------------------------------------------------- 152 (352)
Q Consensus 127 ~~~-~~~lv~e~~~~~sL~~~l~~~~~----------------------------------------------------- 152 (352)
..+ ..++||||+++|+|.+++.....
T Consensus 97 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (359)
T 3vhe_A 97 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176 (359)
T ss_dssp STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence 755 48999999999999999976532
Q ss_pred -------------CCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC---ccc
Q 018640 153 -------------YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE---KFS 216 (352)
Q Consensus 153 -------------l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~---~~~ 216 (352)
+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||++....... ...
T Consensus 177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~---~kl~Dfg~a~~~~~~~~~~~~~ 253 (359)
T 3vhe_A 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV---VKICDFGLARDIYKDPDYVRKG 253 (359)
T ss_dssp -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC---EEECCCGGGSCTTSCTTCEEC-
T ss_pred hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCc---EEEEeccceeeecccccchhcc
Confidence 899999999999999999999999999999999999976554 8999999998654332 224
Q ss_pred ccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHH
Q 018640 217 EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK 294 (352)
Q Consensus 217 ~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 294 (352)
...||+.|+|||++. ..++.++||||||+++|||++ |..||................. ....+..+++.+.++|.+
T Consensus 254 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~ 331 (359)
T 3vhe_A 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT--RMRAPDYTTPEMYQTMLD 331 (359)
T ss_dssp -CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTC--CCCCCTTCCHHHHHHHHH
T ss_pred ccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCC--CCCCCCCCCHHHHHHHHH
Confidence 457889999999876 558999999999999999998 9999987664444433333322 223335688999999999
Q ss_pred hcCCCcCCCCCHHHHhcC
Q 018640 295 MLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 295 ~l~~dP~~Rps~~ell~h 312 (352)
||+.||.+|||+.++++|
T Consensus 332 ~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 332 CWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCChhhCCCHHHHHHH
Confidence 999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=345.18 Aligned_cols=254 Identities=24% Similarity=0.361 Sum_probs=206.2
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
.-++|++.+.||+|+||+||+|.+..+++.||+|++...........+.+.+|+.+++++ +||||+++++++..++..+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEEeeCCeEE
Confidence 346799999999999999999999999999999999776544455567899999999999 8999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
+||||+++++|.+++.....+++..++.++.|++.||.|||+.||+|+||||+||+++.++. +||+|||++......
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~---~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDF---AYLVDFGIASATTDE 187 (309)
T ss_dssp EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC---EEECSCCC-------
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCC---EEEecCccCcccccc
Confidence 99999999999999998888999999999999999999999999999999999999976554 899999999765433
Q ss_pred C--cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHH
Q 018640 213 E--KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (352)
Q Consensus 213 ~--~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (352)
. ......||+.|+|||.+. ..++.++||||||+++|+|++|..||........ ...............+.+++.+.
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~ 266 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM-GAHINQAIPRPSTVRPGIPVAFD 266 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH-HHHHHSCCCCGGGTSTTCCTHHH
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH-HHHhccCCCCccccCCCCCHHHH
Confidence 2 223457899999999886 4589999999999999999999999987655433 33333332223334467899999
Q ss_pred HHHHHhcCCCcCCCC-CHHHHhc
Q 018640 290 DLVRKMLDPDPKRRL-TAQQVLE 311 (352)
Q Consensus 290 ~li~~~l~~dP~~Rp-s~~ell~ 311 (352)
++|.+||+.||++|| |+.++++
T Consensus 267 ~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 267 AVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHhccCCHHHHHHhHHHHHH
Confidence 999999999999999 8888876
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=358.40 Aligned_cols=264 Identities=24% Similarity=0.429 Sum_probs=210.2
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCC----------CCCCeeEee
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP----------KHQNIVCLK 122 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~----------~h~~iv~l~ 122 (352)
..++|++++.||+|+||+||+|.+..+++.||+|++... ....+.+.+|+.+++++. .|+||++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 346899999999999999999999999999999998643 234567888999999883 178999999
Q ss_pred eEEEeCC----eEEEEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc-CCEEecCCCCceEeecCC--
Q 018640 123 DTYEDDT----AVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKK-- 193 (352)
Q Consensus 123 ~~~~~~~----~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~-~ivH~Dikp~NIll~~~~-- 193 (352)
+++...+ ..++||||+ +++|.+++... ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred HHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCC
Confidence 9987654 789999999 88999999864 3599999999999999999999998 999999999999996543
Q ss_pred -CCCCEEEEecccceecCCCCcccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCC------HHHH
Q 018640 194 -ETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAET------EQGV 265 (352)
Q Consensus 194 -~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~------~~~~ 265 (352)
....+||+|||++...... .....||+.|+|||++.+ .++.++||||||+++|||++|..||.... ....
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 2335899999999876432 344579999999999864 58999999999999999999999997543 2223
Q ss_pred HHHHHhcccccC--------------------------------------CCCCcCCCHHHHHHHHHhcCCCcCCCCCHH
Q 018640 266 AQAIIRSVLDFR--------------------------------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQ 307 (352)
Q Consensus 266 ~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ 307 (352)
...+.......+ .......++.+.+||.+||+.||++|||+.
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 333332221111 011123467889999999999999999999
Q ss_pred HHhcCccccccccCCC
Q 018640 308 QVLEHPWLQNAKKAPN 323 (352)
Q Consensus 308 ell~hp~f~~~~~~~~ 323 (352)
|+++||||++......
T Consensus 330 ell~hp~f~~~~~~~~ 345 (373)
T 1q8y_A 330 GLVNHPWLKDTLGMEE 345 (373)
T ss_dssp HHHTCGGGTTCTTCTT
T ss_pred HHhhChhhhcccCccc
Confidence 9999999998754433
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=346.30 Aligned_cols=267 Identities=27% Similarity=0.435 Sum_probs=212.5
Q ss_pred ccCCCcccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCC-CCCeeEeee
Q 018640 45 LKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK-HQNIVCLKD 123 (352)
Q Consensus 45 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~-h~~iv~l~~ 123 (352)
+.........++|++++.||+|+||.||+|.+. +++.||+|++..... .....+.+.+|+.++.++.. |+||+++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEE
Confidence 344555566778999999999999999999975 589999999876432 33456788999999999943 699999999
Q ss_pred EEEeCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEec
Q 018640 124 TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDF 203 (352)
Q Consensus 124 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Df 203 (352)
++...+..++|||+ .+++|.+++.....+++..++.++.|++.||.|||+.|++||||||+||++++ ..+||+||
T Consensus 96 ~~~~~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~----~~~kL~Df 170 (313)
T 3cek_A 96 YEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLIDF 170 (313)
T ss_dssp EEECSSEEEEEECC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET----TEEEECCC
T ss_pred EeecCCEEEEEEec-CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC----CeEEEeec
Confidence 99999999999994 57899999998888999999999999999999999999999999999999963 34899999
Q ss_pred ccceecCCCCc---ccccccccccccchhccc------------cCCCcchHHHHHHHHHHHHhCCCCCCCCCHH-HHHH
Q 018640 204 GLSVFFKPGEK---FSEIVGSPYYMAPEVLKR------------NYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQ 267 (352)
Q Consensus 204 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~------------~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~-~~~~ 267 (352)
|++........ .....||+.|+|||.+.+ .++.++||||||+++|+|++|..||...... ....
T Consensus 171 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 250 (313)
T 3cek_A 171 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 250 (313)
T ss_dssp SSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH
T ss_pred cccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHH
Confidence 99986543321 234578999999998753 4778999999999999999999999765433 2222
Q ss_pred HHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 268 AIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
...... .........++.+.++|.+||+.||++|||+.++++||||+....
T Consensus 251 ~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 301 (313)
T 3cek_A 251 AIIDPN--HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 301 (313)
T ss_dssp HHHCTT--SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC--
T ss_pred HHHhcc--cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCC
Confidence 222221 122233456889999999999999999999999999999997543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=338.06 Aligned_cols=247 Identities=24% Similarity=0.379 Sum_probs=212.1
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
.++|++++.||+|+||+||+|.+. ++..||+|++.... ...+.+.+|+.+++++ +||||+++++++.+.+..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~l 82 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA----MSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICL 82 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccc----cCHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCceEE
Confidence 357999999999999999999986 57789999987542 2346789999999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 134 VMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
||||+++++|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++. +||+|||++......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~---~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 83 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV---IKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC---EEECCTTGGGGBCCH
T ss_pred EEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCC---EEecccccccccccc
Confidence 99999999999999764 45899999999999999999999999999999999999976554 899999999865433
Q ss_pred C--cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHH
Q 018640 213 E--KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (352)
Q Consensus 213 ~--~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (352)
. ......+|+.|+|||.+. ..++.++||||||+++++|++ |..||...........+.... ........++.+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 236 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF---RLYKPRLASTHV 236 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC---CCCCCTTSCHHH
T ss_pred ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCc---cCCCCCcCCHHH
Confidence 2 123346678899999987 568999999999999999999 999999888877766665542 223334679999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 289 KDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 289 ~~li~~~l~~dP~~Rps~~ell~h 312 (352)
.+++..||+.||++|||+.++++|
T Consensus 237 ~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 237 YQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCCcccCcCHHHHHHH
Confidence 999999999999999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=345.64 Aligned_cols=257 Identities=23% Similarity=0.317 Sum_probs=216.2
Q ss_pred CCCcccccccceeceeeeccCceEEEEEEEC-----CCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEe
Q 018640 47 EPTGREIEERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCL 121 (352)
Q Consensus 47 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l 121 (352)
.+......++|++.+.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.+ +||||+++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hp~iv~~ 91 (314)
T 2ivs_A 15 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQV-NHPHVIKL 91 (314)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTC-CCTTBCCE
T ss_pred CcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhC-CCCceeeE
Confidence 3444455678999999999999999999973 456899999987542 344567889999999999 89999999
Q ss_pred eeEEEeCCeEEEEEEecCCcchHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHHcCC
Q 018640 122 KDTYEDDTAVHLVMELCEGGELFDRIVARGH------------------------YTERAAAAVTKTIVEVVQMCHKHGV 177 (352)
Q Consensus 122 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------------------l~~~~~~~i~~qi~~aL~~lH~~~i 177 (352)
++++...+..++||||+++++|.+++..... +++..++.++.|++.||.|||++||
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 171 (314)
T 2ivs_A 92 YGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKL 171 (314)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred EEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCC
Confidence 9999999999999999999999999986543 8899999999999999999999999
Q ss_pred EEecCCCCceEeecCCCCCCEEEEecccceecCCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-
Q 018640 178 MHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC- 252 (352)
Q Consensus 178 vH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t- 252 (352)
+||||||+||+++.++. +||+|||++........ .....+|+.|+|||.+. ..++.++||||||+++|+|++
T Consensus 172 vH~dikp~NIli~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 248 (314)
T 2ivs_A 172 VHRDLAARNILVAEGRK---MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 248 (314)
T ss_dssp ECCCCSGGGEEEETTTE---EEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred cccccchheEEEcCCCC---EEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhC
Confidence 99999999999986554 89999999987644322 23346788999999876 458999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 253 GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 253 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
|..||...........+.... ....+..+++.+.++|.+||+.||++|||+.+++++
T Consensus 249 g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 249 GGNPYPGIPPERLFNLLKTGH---RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp SCCSSTTCCGGGHHHHHHTTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHhhcCC---cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999998887766655554432 233345789999999999999999999999999875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=335.85 Aligned_cols=248 Identities=22% Similarity=0.318 Sum_probs=212.1
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
..++|++++.||+|+||+||+|.+. ++..||+|++.... ...+.+.+|+.+++++ +||||+++++++...+..+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 79 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGS----MSEDEFFQEAQTMMKL-SHPKLVKFYGVCSKEYPIY 79 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTT----BCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCC----CcHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCceE
Confidence 4568999999999999999999875 57789999987543 2346789999999999 8999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 133 LVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
+||||+++++|.+++.... .+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~---~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLC---VKVSDFGMTRYVLD 156 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCC---EEECCTTCEEECCT
T ss_pred EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCC---EEEccCccceecch
Confidence 9999999999999997754 4999999999999999999999999999999999999976554 89999999987654
Q ss_pred CCcc--cccccccccccchhccc-cCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHH
Q 018640 212 GEKF--SEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (352)
Q Consensus 212 ~~~~--~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (352)
.... ....+|+.|+|||.+.+ .++.++||||||+++++|++ |..||...........+..... .......++.
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 233 (268)
T 3sxs_A 157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR---LYRPHLASDT 233 (268)
T ss_dssp TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC---CCCCTTSCHH
T ss_pred hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCC---CCCCCcChHH
Confidence 4322 33456778999999874 58999999999999999999 9999988887766666554432 2223457899
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 288 AKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 288 ~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
+.++|..||+.||++|||+.+++++
T Consensus 234 l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 234 IYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=353.31 Aligned_cols=255 Identities=25% Similarity=0.371 Sum_probs=216.1
Q ss_pred cccccccceeceeeeccCceEEEEEEECC-------CCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEee
Q 018640 50 GREIEERYELGRELGRGEFGITYLCTDRE-------NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122 (352)
Q Consensus 50 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~ 122 (352)
.....++|++.+.||+|+||+||+|.+.. ++..||+|++... ........+.+|+.+++++.+||||++++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 34556789999999999999999999753 3357999998754 23444577899999999998899999999
Q ss_pred eEEEeCCeEEEEEEecCCcchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCc
Q 018640 123 DTYEDDTAVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPEN 186 (352)
Q Consensus 123 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~N 186 (352)
+++...+..++||||+++++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence 99999999999999999999999998753 48999999999999999999999999999999999
Q ss_pred eEeecCCCCCCEEEEecccceecCCCC---cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 018640 187 FLFANKKETAPLKAIDFGLSVFFKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAET 261 (352)
Q Consensus 187 Ill~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~ 261 (352)
||++.++. +||+|||++....... ......+|+.|+|||++. ..++.++||||||+++++|++ |..||....
T Consensus 222 Ill~~~~~---~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 222 VLVTEDNV---MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp EEECTTCC---EEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEEcCCCc---EEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99976554 8999999998664332 223446788999999876 458999999999999999999 999998887
Q ss_pred HHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 262 EQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
..+....+.... .......+++.+.++|.+||+.||++|||+.+++++
T Consensus 299 ~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 299 VEELFKLLKEGH---RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHHHHTTC---CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCC---CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 776665555432 233345789999999999999999999999999886
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=357.68 Aligned_cols=249 Identities=24% Similarity=0.345 Sum_probs=211.0
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
.++|++.+.||+|+||+||+|.+..+++.||+|++... ......+.+.+|+.+++++ +||||+++++++...+..++
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTC-CCTTBCCEEEEECSSSSCEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEecCCCcEE
Confidence 46899999999999999999999989999999998653 2233345688999999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 134 VMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
||||+++|+|.+++.... .+++..+..++.|++.||+|||++|++||||||+|||++.++ .+||+|||+++.....
T Consensus 190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~---~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN---VLKISDFGMSREEADG 266 (377)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC---CEEECCGGGCEECTTS
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCC---cEEECcCCCceecCCC
Confidence 999999999999997654 599999999999999999999999999999999999997554 4899999999865433
Q ss_pred Ccc---cccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHH
Q 018640 213 EKF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (352)
Q Consensus 213 ~~~---~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (352)
... ....++..|+|||.+. +.++.++||||||+++|||++ |..||...........+.... ....+..+++.
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 343 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG---RLPCPELCPDA 343 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC---CCCCCTTCCHH
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCCHH
Confidence 211 1224577899999986 558999999999999999998 999998887766555444322 22334568999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 288 AKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 288 ~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
+.++|.+||+.||++|||+.++++
T Consensus 344 l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 344 VFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCchhCcCHHHHHH
Confidence 999999999999999999999975
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=350.42 Aligned_cols=272 Identities=23% Similarity=0.320 Sum_probs=195.1
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHH-HHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVD-IMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
.++|++++.||+|+||.||+|.+..+|+.||+|++.... .......+..|+. +++.+ +||||+++++++...+..+
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~-~h~niv~~~~~~~~~~~~~ 97 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSS-DCPYIVQFYGALFREGDCW 97 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSC-CCTTBCCEEEEEECSSEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcC-CCCcEeeeeeEEEeCCceE
Confidence 468999999999999999999999999999999987542 2233445666666 55555 9999999999999999999
Q ss_pred EEEEecCCcchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHc-CCEEecCCCCceEeecCCCCCCEEEEecccc
Q 018640 133 LVMELCEGGELFDRIVA-----RGHYTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a 206 (352)
+||||+++ +|.+++.. ...+++..+..++.|++.||.|||+. |++||||||+||+++.++. +||+|||++
T Consensus 98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~---~kl~Dfg~~ 173 (327)
T 3aln_A 98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN---IKLCDFGIS 173 (327)
T ss_dssp EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTE---EEECCCSSS
T ss_pred EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCC---EEEccCCCc
Confidence 99999975 88887763 45799999999999999999999999 9999999999999976554 899999999
Q ss_pred eecCCCCcccccccccccccchhcc-----ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc----cC
Q 018640 207 VFFKPGEKFSEIVGSPYYMAPEVLK-----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD----FR 277 (352)
Q Consensus 207 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~----~~ 277 (352)
.............||+.|+|||++. ..++.++||||||+++|+|++|..||...... ...+...... ..
T Consensus 174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~ 251 (327)
T 3aln_A 174 GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV--FDQLTQVVKGDPPQLS 251 (327)
T ss_dssp CC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCCCCSCCCCCC
T ss_pred eecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH--HHHHHHHhcCCCCCCC
Confidence 8765544444557999999999872 34889999999999999999999999764321 1111111111 11
Q ss_pred CCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccCCCCCCcHHHHHHHH
Q 018640 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLK 335 (352)
Q Consensus 278 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~ 335 (352)
......+++.+.+||..||+.||++|||+.++++||||...... .......+...+.
T Consensus 252 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~-~~~~~~~~~~~~~ 308 (327)
T 3aln_A 252 NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEER-AVEVACYVCKILD 308 (327)
T ss_dssp CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHS-CCCHHHHHHHHHH
T ss_pred CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHhh-HHHHHHHHHHHHh
Confidence 11223589999999999999999999999999999999976443 2334444444443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=339.13 Aligned_cols=253 Identities=24% Similarity=0.371 Sum_probs=208.7
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhc----HHHHHHHHHHHHhCCCCCCeeEeeeEEEe
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD----IEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~----~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 127 (352)
...++|++.+.||+|+||+||+|.+..+++.||+|++.......... .+.+.+|+.+++++ +||||+++++++..
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNIVKLYGLMHN 94 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-CCTTBCCEEEEETT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-CCCCchhhheeecC
Confidence 45578999999999999999999999999999999987653322211 26789999999999 89999999999876
Q ss_pred CCeEEEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcC--CEEecCCCCceEeecCCC--CCCEEEEe
Q 018640 128 DTAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHG--VMHRDLKPENFLFANKKE--TAPLKAID 202 (352)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dikp~NIll~~~~~--~~~vkl~D 202 (352)
.. ++||||+++++|.+.+.... .+++..++.++.|++.||+|||+.| ++||||||+||+++.++. ...+||+|
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 65 69999999999998886554 6999999999999999999999999 999999999999976443 33489999
Q ss_pred cccceecCCCCcccccccccccccchhcc---ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhcccccC
Q 018640 203 FGLSVFFKPGEKFSEIVGSPYYMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGV--AQAIIRSVLDFR 277 (352)
Q Consensus 203 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~ 277 (352)
||++..... ......||+.|+|||++. ..++.++||||||+++|+|++|+.||........ ...+.. ....
T Consensus 173 fg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~ 248 (287)
T 4f0f_A 173 FGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE--EGLR 248 (287)
T ss_dssp CTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH--SCCC
T ss_pred CCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc--cCCC
Confidence 999975433 334568999999999983 3478899999999999999999999976654333 222222 2333
Q ss_pred CCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 278 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
......+++.+.++|.+||+.||++|||+.++++
T Consensus 249 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 249 PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 4445678999999999999999999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=336.24 Aligned_cols=252 Identities=29% Similarity=0.423 Sum_probs=200.7
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCC-hhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT-AVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
.++|++.+.||+|+||+||+|.+. |..||+|++....... ....+.+.+|+.+++.+ +||||+++++++...+..+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHC-CCTTBCCEEEEECCC--CE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-CCCCEeeEEEEEecCCceE
Confidence 357999999999999999999975 8899999987643222 23457789999999999 8999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---CEEecCCCCceEeecCCC-----CCCEEEEecc
Q 018640 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG---VMHRDLKPENFLFANKKE-----TAPLKAIDFG 204 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dikp~NIll~~~~~-----~~~vkl~Dfg 204 (352)
+||||+++++|.+++. ...+++..++.++.|++.||.|||+.| ++||||||+||+++.+.. ...+||+|||
T Consensus 83 lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 9999999999999885 447999999999999999999999999 899999999999975322 4569999999
Q ss_pred cceecCCCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcC
Q 018640 205 LSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (352)
Q Consensus 205 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (352)
++........ ....||+.|+|||.+. ..++.++||||||+++++|++|+.||................ ........
T Consensus 162 ~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~ 238 (271)
T 3dtc_A 162 LAREWHRTTK-MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK--LALPIPST 238 (271)
T ss_dssp C--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSC--CCCCCCTT
T ss_pred cccccccccc-cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCC--CCCCCCcc
Confidence 9986544332 3457899999999886 458999999999999999999999998887766655554432 22334457
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 284 ~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
+++.+.++|.+||+.||++|||+.|++++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 89999999999999999999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-47 Score=341.53 Aligned_cols=257 Identities=19% Similarity=0.279 Sum_probs=212.4
Q ss_pred cccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC
Q 018640 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (352)
Q Consensus 50 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 129 (352)
+..+.++|++.+.||+|+||+||+|.+..+|+.||+|++.... ..+.+.+|+.+++.+.+|+|++++++++....
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 79 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL 79 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCc
Confidence 4567789999999999999999999999999999999886432 22457889999999988999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCC--CCCCEEEEecccc
Q 018640 130 AVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK--ETAPLKAIDFGLS 206 (352)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~--~~~~vkl~Dfg~a 206 (352)
..++||||+ +++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++ ....+||+|||++
T Consensus 80 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 80 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred eeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 999999999 899999998754 599999999999999999999999999999999999997653 2345899999999
Q ss_pred eecCCCCc--------ccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhccc
Q 018640 207 VFFKPGEK--------FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAET---EQGVAQAIIRSVL 274 (352)
Q Consensus 207 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~---~~~~~~~~~~~~~ 274 (352)
........ .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||.... .......+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 87654321 245579999999999874 58999999999999999999999997743 3333333322221
Q ss_pred ccC-CCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 275 DFR-RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 275 ~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
..+ ....+.+++.+.++|..||+.||++|||+.+|++.
T Consensus 239 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 239 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 111 11223678999999999999999999999999763
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-47 Score=348.83 Aligned_cols=252 Identities=21% Similarity=0.287 Sum_probs=213.4
Q ss_pred cccccceeceeeeccCceEEEEEEEC-----CCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~ 126 (352)
...++|++++.||+|+||.||+|.+. .+++.||+|++.... .....+.+.+|+.+++++ +||||+++++++.
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 120 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEF-DNPNIVKLLGVCA 120 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEc
Confidence 44578999999999999999999986 355899999987542 334457799999999999 8999999999999
Q ss_pred eCCeEEEEEEecCCcchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecC
Q 018640 127 DDTAVHLVMELCEGGELFDRIVAR------------------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182 (352)
Q Consensus 127 ~~~~~~lv~e~~~~~sL~~~l~~~------------------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Di 182 (352)
..+..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 999999999999999999999764 46899999999999999999999999999999
Q ss_pred CCCceEeecCCCCCCEEEEecccceecCCCC---cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCC
Q 018640 183 KPENFLFANKKETAPLKAIDFGLSVFFKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPF 257 (352)
Q Consensus 183 kp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~ 257 (352)
||+||+++.++. +||+|||++....... ......+|+.|+|||.+. ..++.++||||||+++|+|++ |..||
T Consensus 201 kp~NIl~~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 201 ATRNCLVGENMV---VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SGGGEEECGGGC---EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CcceEEECCCCe---EEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 999999976554 8999999997653221 223456789999999876 558999999999999999999 99999
Q ss_pred CCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 258 WAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
......+....+..... ......+++.+.++|.+||+.||++|||+.+++++
T Consensus 278 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 278 YGMAHEEVIYYVRDGNI---LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp TTSCHHHHHHHHHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCChHHHHHHHhCCCc---CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 98887766666554322 23345689999999999999999999999999863
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=349.79 Aligned_cols=258 Identities=29% Similarity=0.529 Sum_probs=202.7
Q ss_pred CcccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCCh---hcHHHHHHHHHHHHhCC---CCCCeeEee
Q 018640 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA---VDIEDVRREVDIMRHLP---KHQNIVCLK 122 (352)
Q Consensus 49 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~---~h~~iv~l~ 122 (352)
.+..+.++|++.+.||+|+||.||+|.+..+++.||+|++........ .....+.+|+.++.++. +|+||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 456678899999999999999999999999999999999976533221 12234566888888874 699999999
Q ss_pred eEEEeCCeEEEEEEe-cCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEee-cCCCCCCEEE
Q 018640 123 DTYEDDTAVHLVMEL-CEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFA-NKKETAPLKA 200 (352)
Q Consensus 123 ~~~~~~~~~~lv~e~-~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~-~~~~~~~vkl 200 (352)
+++...+..++|+|| +++++|.+++.....+++..++.++.|++.||.|||+.||+||||||+||+++ .++ .+||
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---~~kl 181 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG---CAKL 181 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTT---EEEE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCC---eEEE
Confidence 999999999999999 78999999999888899999999999999999999999999999999999997 333 3899
Q ss_pred EecccceecCCCCcccccccccccccchhccc-cC-CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC
Q 018640 201 IDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR-NY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR 278 (352)
Q Consensus 201 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 278 (352)
+|||++...... ......||..|+|||++.+ .+ +.++||||||+++|+|++|+.||.... .+... ..
T Consensus 182 ~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~----~~ 250 (312)
T 2iwi_A 182 IDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA----EL 250 (312)
T ss_dssp CCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHT----CC
T ss_pred EEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhh----cc
Confidence 999999876543 3345679999999998764 33 458999999999999999999996532 12222 12
Q ss_pred CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 279 DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 279 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
.....++..+.++|.+||+.||++|||+.|+++||||+....
T Consensus 251 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 251 HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence 233568999999999999999999999999999999997644
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=349.53 Aligned_cols=253 Identities=23% Similarity=0.324 Sum_probs=209.7
Q ss_pred ccccceeceeeeccCceEEEEEEE-----CCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe
Q 018640 53 IEERYELGRELGRGEFGITYLCTD-----RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 127 (352)
..++|++.+.||+|+||+||+|.+ ..++..||+|++.... .....+.+.+|+.+++++.+||||+++++++..
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 456899999999999999999997 3456789999987542 233457899999999999789999999999999
Q ss_pred CCeEEEEEEecCCcchHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCC
Q 018640 128 DTAVHLVMELCEGGELFDRIVARG-----------------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKP 184 (352)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~-----------------------~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp 184 (352)
.+..++||||+++|+|.+++.... .+++..++.++.||+.||.|||+.||+||||||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 200 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 200 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 999999999999999999997653 278999999999999999999999999999999
Q ss_pred CceEeecCCCCCCEEEEecccceecCCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCC
Q 018640 185 ENFLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWA 259 (352)
Q Consensus 185 ~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~ 259 (352)
+||+++.++. +||+|||++........ .....||+.|+|||.+. +.++.++||||||+++|+|+| |..||..
T Consensus 201 ~NIll~~~~~---~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 201 RNVLVTHGKV---VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp GGEEEETTTE---EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred hhEEEcCCCc---EEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 9999986554 89999999986543322 23446788999999876 558999999999999999998 9999987
Q ss_pred CCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 260 ETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
............... .......+++.+.++|.+||+.||.+|||+.+++++
T Consensus 278 ~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 278 IPVDANFYKLIQNGF--KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp CCCSHHHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcHHHHHHHHhcCC--CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 765544444444322 223345689999999999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=347.51 Aligned_cols=260 Identities=22% Similarity=0.269 Sum_probs=215.3
Q ss_pred cccccceeceeeeccCceEEEEEE-----ECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEE
Q 018640 52 EIEERYELGRELGRGEFGITYLCT-----DRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~ 126 (352)
...++|++++.||+|+||+||+|. +..++..||+|++... ........+.+|+.+++++ +||||+++++++.
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKF-NHQNIVRCIGVSL 103 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS--CCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEC
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--cchhhHHHHHHHHHHHhhC-CCCCCCeEEEEEc
Confidence 456789999999999999999999 5567889999998643 2334556788999999999 9999999999999
Q ss_pred eCCeEEEEEEecCCcchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEE
Q 018640 127 DDTAVHLVMELCEGGELFDRIVARG-------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLK 199 (352)
Q Consensus 127 ~~~~~~lv~e~~~~~sL~~~l~~~~-------~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vk 199 (352)
.....++||||+++++|.+++.... .+++..++.++.|++.||.|||+.||+||||||+||+++.++....+|
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999999998653 489999999999999999999999999999999999998766666799
Q ss_pred EEecccceecCCCC---cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc
Q 018640 200 AIDFGLSVFFKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVL 274 (352)
Q Consensus 200 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~ 274 (352)
|+|||++....... ......||+.|+|||.+. ..++.++||||||+++|+|++ |..||...........+....
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~- 262 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG- 262 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC-
Confidence 99999987543222 223446789999999876 558999999999999999998 999998877766655554432
Q ss_pred ccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccc
Q 018640 275 DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (352)
Q Consensus 275 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~ 317 (352)
.......+++.+.++|.+||+.||.+|||+.+++++.|+..
T Consensus 263 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 263 --RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 22334578999999999999999999999999999988753
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=338.43 Aligned_cols=247 Identities=35% Similarity=0.650 Sum_probs=198.8
Q ss_pred ccccceec-eeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe----
Q 018640 53 IEERYELG-RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED---- 127 (352)
Q Consensus 53 ~~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~---- 127 (352)
+.++|.+. +.||+|+||.||+|.+..+++.||+|++... ..+.+|+.++.++.+||||+++++++..
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 44567776 7899999999999999999999999998532 4577899998666599999999999876
Q ss_pred CCeEEEEEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccc
Q 018640 128 DTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (352)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~ 205 (352)
....++||||+++++|.+++.... .+++..++.++.|++.||.|||+.||+||||||+||+++.+.....+||+|||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 678899999999999999998764 599999999999999999999999999999999999998755456799999999
Q ss_pred ceecCCCCcccccccccccccchhccccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCC----C
Q 018640 206 SVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP----W 281 (352)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~----~ 281 (352)
+..... ..++.++||||||+++|+|++|..||....................... +
T Consensus 167 a~~~~~--------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (299)
T 3m2w_A 167 AKETTG--------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 226 (299)
T ss_dssp CEECTT--------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHH
T ss_pred cccccc--------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhc
Confidence 875431 2357789999999999999999999976554322211111111111111 1
Q ss_pred cCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccCCCCCCc
Q 018640 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLG 327 (352)
Q Consensus 282 ~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~ 327 (352)
..+++.+.++|.+||+.||++|||+.|+++||||++....+..+..
T Consensus 227 ~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~~ 272 (299)
T 3m2w_A 227 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLH 272 (299)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCCBCS
T ss_pred ccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCCCCc
Confidence 3578999999999999999999999999999999988766665553
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=341.01 Aligned_cols=255 Identities=27% Similarity=0.505 Sum_probs=200.7
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
...++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.+ +||||+++++++...+..
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNEL 107 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCcE
Confidence 3456799999999999999999999999999999999765545555677899999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccce
Q 018640 132 HLVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~ 207 (352)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++. +||+|||++.
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~---~kl~Dfg~~~ 184 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV---VKLGDLGLGR 184 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC---EEECCC----
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCC---EEEEecccee
Confidence 999999999999998864 456899999999999999999999999999999999999975554 8999999997
Q ss_pred ecCCCC-cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhcccccCCCCCcC
Q 018640 208 FFKPGE-KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE--QGVAQAIIRSVLDFRRDPWPK 283 (352)
Q Consensus 208 ~~~~~~-~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 283 (352)
...... ......||+.|+|||.+. ..++.++||||||+++|+|++|..||..... ......+... ..+......
T Consensus 185 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 262 (310)
T 2wqm_A 185 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPPLPSDH 262 (310)
T ss_dssp --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT--CSCCCCTTT
T ss_pred eecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc--cCCCCcccc
Confidence 654332 223457899999999876 4588999999999999999999999975432 2222222221 222223356
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 284 ~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
+++.+.++|.+||+.||++|||+.+++++
T Consensus 263 ~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 263 YSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 89999999999999999999999999873
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-47 Score=348.17 Aligned_cols=253 Identities=17% Similarity=0.209 Sum_probs=207.2
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
.+.++|++.+.||+|+||+||+|.+..+|+.||+|++..... .+.+.+|+.+++.+.+||||+++++++...+..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 80 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN 80 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence 466789999999999999999999999999999999865421 235788999999998899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCC--CCCEEEEeccccee
Q 018640 132 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE--TAPLKAIDFGLSVF 208 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~--~~~vkl~Dfg~a~~ 208 (352)
++||||+ +++|.+++... ..+++..++.++.|++.||+|||+.||+||||||+|||++.++. ...+||+|||++..
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred EEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 9999999 89999999864 57999999999999999999999999999999999999976543 23389999999987
Q ss_pred cCCCCc--------ccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhccccc
Q 018640 209 FKPGEK--------FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETE---QGVAQAIIRSVLDF 276 (352)
Q Consensus 209 ~~~~~~--------~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~---~~~~~~~~~~~~~~ 276 (352)
...... .....||+.|+|||++.+ .++.++||||||+++|||++|..||..... .+....+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 543321 245689999999999874 589999999999999999999999987433 22333332222211
Q ss_pred CCCC-CcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 277 RRDP-WPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 277 ~~~~-~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
+... ....+ .+.+++..||+.||.+||++.+|++
T Consensus 240 ~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 240 PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 1111 12244 9999999999999999999998866
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=337.18 Aligned_cols=251 Identities=27% Similarity=0.343 Sum_probs=200.9
Q ss_pred cccccceeceeeeccCceEEEEEEECCC---CcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDREN---GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 128 (352)
...++|++.+.||+|+||+||+|.+..+ +..||+|++... ......+.+.+|+.+++++ +||||+++++++. +
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~ 87 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-E 87 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC-S
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhC-CCCccceEEEEEc-c
Confidence 4567899999999999999999998653 457999988653 2344567789999999999 8999999999984 4
Q ss_pred CeEEEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccce
Q 018640 129 TAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~ 207 (352)
+..++||||+++++|.+++.... .+++..++.++.|++.||.|||+.|++||||||+||+++.++. +||+|||++.
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---~kl~Dfg~~~ 164 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC---VKLGDFGLSR 164 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE---EEECC-----
T ss_pred CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCC---EEECcccccc
Confidence 57889999999999999998654 6999999999999999999999999999999999999986654 8999999998
Q ss_pred ecCCCCc--ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcC
Q 018640 208 FFKPGEK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (352)
Q Consensus 208 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (352)
....... .....+|+.|+|||.+. ..++.++||||||+++|||++ |..||......+....+.... .....+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~ 241 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE---RLPMPPN 241 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC---CCCCCTT
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC---CCCCCCC
Confidence 7644322 23345678999999886 558999999999999999996 999998887776666555432 2234457
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 284 ~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
+++.+.++|.+||+.||++|||+.+++++
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 242 CPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 89999999999999999999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=340.95 Aligned_cols=253 Identities=23% Similarity=0.342 Sum_probs=202.8
Q ss_pred cccccceeceeeeccCceEEEEEE----ECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe
Q 018640 52 EIEERYELGRELGRGEFGITYLCT----DRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 127 (352)
...++|++++.||+|+||+||+|. +..+++.||+|++... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSL-QHDNIVKYKGVCYS 82 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECH
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec
Confidence 456789999999999999999998 5678999999998643 344457789999999999 89999999999854
Q ss_pred --CCeEEEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecc
Q 018640 128 --DTAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (352)
Q Consensus 128 --~~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg 204 (352)
....++||||+++++|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||+++.++. +||+|||
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~---~kl~Dfg 159 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFG 159 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE---EEECCCC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCe---EEEccCc
Confidence 456899999999999999998754 4999999999999999999999999999999999999987655 8999999
Q ss_pred cceecCCCCc----ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH------------HHH
Q 018640 205 LSVFFKPGEK----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQG------------VAQ 267 (352)
Q Consensus 205 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~------------~~~ 267 (352)
++........ .....+|..|+|||.+. ..++.++||||||+++|+|++|..|+....... ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence 9987643321 23345778899999886 558999999999999999999999985432210 000
Q ss_pred HHHhcc-cccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 268 AIIRSV-LDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 268 ~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
...... .......+..+++.+.++|.+||+.||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 240 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 111111 12233344578999999999999999999999999976
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=337.08 Aligned_cols=249 Identities=21% Similarity=0.322 Sum_probs=210.0
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
...++|++++.||+|+||+||+|.+. ++..||+|++.... ...+.+.+|+.+++++ +||||+++++++...+..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 94 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS----MSEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPI 94 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC----CCHHHHHHHHHHHhcC-CCCCEeeEEEEEecCCCe
Confidence 34568999999999999999999876 57789999987542 2346789999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 132 HLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++. +||+|||++....
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~---~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV---VKVSDFGLSRYVL 171 (283)
T ss_dssp EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSC---EEECSTTGGGGBC
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCC---EEEcccccccccc
Confidence 999999999999999976 456999999999999999999999999999999999999975554 8999999998654
Q ss_pred CCCc--ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCH
Q 018640 211 PGEK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (352)
Q Consensus 211 ~~~~--~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (352)
.... .....+|+.|+|||.+. ..++.++||||||+++|+|++ |+.||...........+..... .......++
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 248 (283)
T 3gen_A 172 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR---LYRPHLASE 248 (283)
T ss_dssp CHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC---CCCCTTCCH
T ss_pred ccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccC---CCCCCcCCH
Confidence 3321 22345678899999886 568999999999999999998 9999998887777666655432 223346789
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 287 NAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 287 ~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
.+.++|.+||+.||++|||+.++++|
T Consensus 249 ~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 249 KVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHHHH
Confidence 99999999999999999999999876
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=342.37 Aligned_cols=253 Identities=23% Similarity=0.336 Sum_probs=212.9
Q ss_pred ccccceeceeeeccCceEEEEEEE-----CCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe
Q 018640 53 IEERYELGRELGRGEFGITYLCTD-----RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 127 (352)
..++|++.+.||+|+||+||+|.+ ..+++.||+|++.... .....+.+.+|+.+++++.+||||+++++++..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 346899999999999999999985 4568899999987542 334457899999999999889999999999999
Q ss_pred CCeEEEEEEecCCcchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEe
Q 018640 128 DTAVHLVMELCEGGELFDRIVARG------------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLF 189 (352)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~------------------~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll 189 (352)
.+..++||||+++++|.+++.... .+++..++.++.|++.||.|||++|++||||||+||++
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence 999999999999999999997654 38999999999999999999999999999999999999
Q ss_pred ecCCCCCCEEEEecccceecCCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 018640 190 ANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQG 264 (352)
Q Consensus 190 ~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~ 264 (352)
+.++. +||+|||++........ .....+|+.|+|||.+. ..++.++||||||+++|+|++ |..||.......
T Consensus 179 ~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 179 THGRI---TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp ETTTE---EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred cCCCC---EEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 76554 89999999987654432 23446788999999876 558999999999999999999 999998776554
Q ss_pred HHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 265 VAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
.......... .......+++.+.++|.+||+.||.+|||+.+++++
T Consensus 256 ~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 256 KFYKMIKEGF--RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHHHTC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhccCC--CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 4444443322 222345689999999999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=345.21 Aligned_cols=250 Identities=21% Similarity=0.283 Sum_probs=202.5
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEE----EEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAF----ACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~v----avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 128 (352)
..++|++++.||+|+||+||+|.+..+++.+ |+|.+.... .....+.+.+|+.+++++ +||||+++++++...
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASV-DNPHVCRLLGICLTS 89 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHC-CBTTBCCEEEEEESS
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecC
Confidence 3568999999999999999999988777765 777665432 234457899999999999 899999999999876
Q ss_pred CeEEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccce
Q 018640 129 TAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~ 207 (352)
. .++|+||+++|+|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||++.++. +||+|||+++
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~---~kl~Dfg~a~ 165 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH---VKITDFGLAK 165 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE---EEECCTTHHH
T ss_pred C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCC---EEEccCccee
Confidence 5 77899999999999999874 46999999999999999999999999999999999999987665 8999999998
Q ss_pred ecCCCCcc---cccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCc
Q 018640 208 FFKPGEKF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282 (352)
Q Consensus 208 ~~~~~~~~---~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (352)
........ ....+|..|+|||++. ..++.++||||||+++|||++ |..||...........+.... .....+
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~---~~~~~~ 242 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE---RLPQPP 242 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC---CCCCCT
T ss_pred EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC---CCCCCc
Confidence 66443322 2345688999999876 558999999999999999999 999998877766555444332 223345
Q ss_pred CCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 283 ~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
.++..+.+++.+||+.||++|||+.+++++
T Consensus 243 ~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 243 ICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp TBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 688999999999999999999999999875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=346.43 Aligned_cols=250 Identities=23% Similarity=0.317 Sum_probs=208.6
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEE--EEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAF--ACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~v--avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
++|++.+.||+|+||.||+|.+..+|..+ |+|.+... ......+.+.+|+.+++++.+||||+++++++...+..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc--cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 67999999999999999999998888865 89988643 233345678899999999988999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCC
Q 018640 133 LVMELCEGGELFDRIVARG----------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETA 196 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~ 196 (352)
+||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~-- 180 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV-- 180 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCe--
Confidence 9999999999999997654 6999999999999999999999999999999999999976554
Q ss_pred CEEEEecccceecCCCCcccccccccccccchhccc-cCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc
Q 018640 197 PLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVL 274 (352)
Q Consensus 197 ~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~ 274 (352)
+||+|||++.............+++.|+|||.+.+ .++.++||||||+++|+|++ |..||...........+...
T Consensus 181 -~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~-- 257 (327)
T 1fvr_A 181 -AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-- 257 (327)
T ss_dssp -EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT--
T ss_pred -EEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC--
Confidence 89999999975433333334467889999998874 48999999999999999998 99999888776655554433
Q ss_pred ccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 275 DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 275 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
........+++.+.++|.+||+.||++|||+.+++++
T Consensus 258 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 258 -YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp -CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2233345689999999999999999999999999886
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=351.64 Aligned_cols=250 Identities=23% Similarity=0.344 Sum_probs=201.0
Q ss_pred ccccceeceeeeccCceEEEEEEEC---CCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC
Q 018640 53 IEERYELGRELGRGEFGITYLCTDR---ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 129 (352)
..++|++.+.||+|+||+||+|.+. .++..||+|++.... .....+.+.+|+.+++++ +||||+++++++...+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTKSK 119 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSS
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCC
Confidence 3468999999999999999999876 467789999987542 334467899999999999 8999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccccee
Q 018640 130 AVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (352)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~ 208 (352)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++.++. +||+|||+++.
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~a~~ 196 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV---CKVSDFGLGRV 196 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC---EEECCC-----
T ss_pred ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCC---EEECcCccccc
Confidence 9999999999999999998754 6999999999999999999999999999999999999976544 89999999987
Q ss_pred cCCCCc----ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCc
Q 018640 209 FKPGEK----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282 (352)
Q Consensus 209 ~~~~~~----~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (352)
...... .....+|..|+|||++. ..++.++||||||+++|||++ |..||+..........+.... ......
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~---~~~~~~ 273 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY---RLPPPM 273 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE---ECCCCT
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---CCCCCc
Confidence 643321 11224577899999987 558999999999999999998 999999888777666655432 222334
Q ss_pred CCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 283 ~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
.++..+.++|.+||+.||++||++.++++
T Consensus 274 ~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp TCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 68899999999999999999999999876
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=340.43 Aligned_cols=249 Identities=18% Similarity=0.251 Sum_probs=205.9
Q ss_pred ccccceeceeeeccCceEEEEEEECCCC-------cEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENG-------DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTY 125 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~ 125 (352)
..++|++.+.||+|+||+||+|.+..++ ..||+|++... .....+.+.+|+.+++++ +||||+++++++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 81 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---HRNYSESFFEAASMMSKL-SHKHLVLNYGVC 81 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG---GGGGHHHHHHHHHHHHTS-CCTTBCCEEEEE
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc---cHHHHHHHHHHHHHHHhC-CCCCEeEEEEEE
Confidence 4568999999999999999999988777 46999998654 234457899999999999 899999999999
Q ss_pred EeCCeEEEEEEecCCcchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCC-----CCEE
Q 018640 126 EDDTAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKET-----APLK 199 (352)
Q Consensus 126 ~~~~~~~lv~e~~~~~sL~~~l~~~~~-l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~-----~~vk 199 (352)
...+..++||||+++++|.+++..... +++..++.++.|++.||.|||++||+||||||+||+++.++.. ..+|
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999999999987654 9999999999999999999999999999999999999876542 2289
Q ss_pred EEecccceecCCCCcccccccccccccchhcc--ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC
Q 018640 200 AIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR 277 (352)
Q Consensus 200 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 277 (352)
|+|||++...... ....||+.|+|||.+. ..++.++||||||+++|+|++|..|++.............. .
T Consensus 162 l~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~----~ 234 (289)
T 4fvq_A 162 LSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED----R 234 (289)
T ss_dssp ECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT----T
T ss_pred eccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc----c
Confidence 9999998654322 3346889999999876 44899999999999999999965554444333333333332 2
Q ss_pred CCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 278 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
.......++.+.++|.+||+.||++|||+.+++++
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 235 HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 22334567889999999999999999999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=341.42 Aligned_cols=253 Identities=24% Similarity=0.373 Sum_probs=212.8
Q ss_pred cccccceeceeeeccCceEEEEEEEC-------CCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDR-------ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDT 124 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~ 124 (352)
...++|++.+.||+|+||+||+|.+. .++..||+|++.... .....+.+.+|+.+++++.+||||++++++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 109 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 109 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence 34578999999999999999999975 467789999987542 334467789999999999889999999999
Q ss_pred EEeCCeEEEEEEecCCcchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceE
Q 018640 125 YEDDTAVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFL 188 (352)
Q Consensus 125 ~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIl 188 (352)
+...+..++||||+++++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||+
T Consensus 110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 189 (334)
T ss_dssp ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEE
Confidence 999999999999999999999997653 3899999999999999999999999999999999999
Q ss_pred eecCCCCCCEEEEecccceecCCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q 018640 189 FANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQ 263 (352)
Q Consensus 189 l~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~ 263 (352)
++.++. +||+|||++........ .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||......
T Consensus 190 l~~~~~---~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 266 (334)
T 2pvf_A 190 VTENNV---MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266 (334)
T ss_dssp ECTTCC---EEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred EcCCCC---EEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence 975544 89999999987654322 23346788999999876 458999999999999999999 99999888777
Q ss_pred HHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 264 GVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
+....+.... .......++..+.++|.+||+.||.+|||+.+++++
T Consensus 267 ~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 267 ELFKLLKEGH---RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHHTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCC---CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 6665555432 223345689999999999999999999999999875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=359.92 Aligned_cols=260 Identities=23% Similarity=0.393 Sum_probs=209.9
Q ss_pred cccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC
Q 018640 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (352)
Q Consensus 50 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 129 (352)
+....++|++.+.||+|+||+||+|.+..+|+.||+|++..... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 4 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~ 80 (396)
T 4eut_A 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETT 80 (396)
T ss_dssp EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTT
T ss_pred CCCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhc-CCCCCCeEEEeeccCC
Confidence 34567899999999999999999999999999999999876432 23457788999999999 8999999999998765
Q ss_pred --eEEEEEEecCCcchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeec-CCCCCCEEEEec
Q 018640 130 --AVHLVMELCEGGELFDRIVARGH---YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFAN-KKETAPLKAIDF 203 (352)
Q Consensus 130 --~~~lv~e~~~~~sL~~~l~~~~~---l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~-~~~~~~vkl~Df 203 (352)
..++||||+++++|.+++..... +++..++.++.|++.||+|||++||+||||||+|||+.. +.....+||+||
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DF 160 (396)
T 4eut_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (396)
T ss_dssp TCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCG
T ss_pred CCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecC
Confidence 78999999999999999976433 999999999999999999999999999999999999832 223345899999
Q ss_pred ccceecCCCCcccccccccccccchhcc---------ccCCCcchHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHH
Q 018640 204 GLSVFFKPGEKFSEIVGSPYYMAPEVLK---------RNYGPEVDVWSAGVILYILLCGVPPFWAET----EQGVAQAII 270 (352)
Q Consensus 204 g~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~s~~~Di~SlG~~l~el~tg~~p~~~~~----~~~~~~~~~ 270 (352)
|++.............||+.|+|||++. ..++.++||||||+++|||++|+.||.... ..+....+.
T Consensus 161 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 240 (396)
T 4eut_A 161 GAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (396)
T ss_dssp GGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred CCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence 9998876665556678999999999875 347789999999999999999999996422 233333443
Q ss_pred hccccc---------------C------CCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 271 RSVLDF---------------R------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 271 ~~~~~~---------------~------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
...... . ......++..+.++|..||+.||++|||+.+++++
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 322110 0 00012345678899999999999999999998543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=335.28 Aligned_cols=249 Identities=21% Similarity=0.355 Sum_probs=214.6
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
...++|++.+.||+|+||+||+|.+..++..||+|++... ....+.+.+|+.+++++ +||||+++++++...+..
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCCE
Confidence 4567899999999999999999999999999999998643 23457899999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 132 HLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
++||||+++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++...
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~---~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL---VKVADFGLSRLM 161 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGC---EEECCCCGGGTS
T ss_pred EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCC---EEEccCccceec
Confidence 99999999999999998643 4899999999999999999999999999999999999976554 899999999865
Q ss_pred CCCCc--ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCC
Q 018640 210 KPGEK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (352)
Q Consensus 210 ~~~~~--~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (352)
..... .....+|+.|+|||.+. ..++.++||||||+++|+|++ |..||...........+... .....+..++
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~ 238 (288)
T 3kfa_A 162 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD---YRMERPEGCP 238 (288)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT---CCCCCCTTCC
T ss_pred cCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc---CCCCCCCCCC
Confidence 43332 23346688999999886 558999999999999999999 99999887766665555443 2233445789
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 286 ENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 286 ~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
+.+.++|.+||+.||.+|||+.++++
T Consensus 239 ~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 239 EKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 99999999999999999999999976
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=336.71 Aligned_cols=250 Identities=25% Similarity=0.419 Sum_probs=211.6
Q ss_pred cccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe--
Q 018640 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED-- 127 (352)
Q Consensus 50 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~-- 127 (352)
+..+.++|++++.||+|+||.||+|.+..+|+.||+|++.... +.+.+|+.+++++ +||||+++++++..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 77 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKL-DHVNIVHYNGCWDGFD 77 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHC-CCTTBCCEEEEEEEEE
T ss_pred cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhC-CCCCEEEEeeeEeccc
Confidence 4567889999999999999999999999899999999986532 3467899999999 89999999998854
Q ss_pred --------------CCeEEEEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeec
Q 018640 128 --------------DTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFAN 191 (352)
Q Consensus 128 --------------~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~ 191 (352)
....++||||+++++|.+++... ..+++..++.++.|++.||.|||+.||+|+||||+||+++.
T Consensus 78 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 157 (284)
T 2a19_B 78 YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVD 157 (284)
T ss_dssp EC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE
T ss_pred cCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcC
Confidence 44689999999999999999754 56999999999999999999999999999999999999986
Q ss_pred CCCCCCEEEEecccceecCCCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 018640 192 KKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII 270 (352)
Q Consensus 192 ~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~ 270 (352)
++. +||+|||++.............||+.|+|||.+. ..++.++||||||+++|+|++|..|+... ......+.
T Consensus 158 ~~~---~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~ 232 (284)
T 2a19_B 158 TKQ---VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLR 232 (284)
T ss_dssp TTE---EEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHH
T ss_pred CCC---EEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhh
Confidence 654 8999999998876655555668999999999886 45899999999999999999999887432 11222222
Q ss_pred hcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 271 RSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
.. .....++..+.++|.+||+.||.+|||+.+++++.+.-..
T Consensus 233 ~~------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 233 DG------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp TT------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred cc------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 11 1234678999999999999999999999999999876643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=335.55 Aligned_cols=254 Identities=25% Similarity=0.380 Sum_probs=204.1
Q ss_pred cccccceeceeeeccCceEEEEEE----ECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe
Q 018640 52 EIEERYELGRELGRGEFGITYLCT----DRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 127 (352)
...++|++++.||+|+||.||+|. +..+++.||+|++.... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNL-YHENIVKYKGICTE 94 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhC-CCCCeeeeeeEEec
Confidence 345679999999999999999998 56789999999987653 333467899999999999 89999999999987
Q ss_pred C--CeEEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecc
Q 018640 128 D--TAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (352)
Q Consensus 128 ~--~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg 204 (352)
. ...++||||+++++|.+++... ..+++..++.++.|++.||+|||+.||+||||||+||+++.++. +||+|||
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~---~kl~Dfg 171 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ---VKIGDFG 171 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE---EEECCCT
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCC---EEECccc
Confidence 6 6789999999999999999544 56999999999999999999999999999999999999987654 8999999
Q ss_pred cceecCCCCc----ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHH
Q 018640 205 LSVFFKPGEK----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE-----------QGVAQA 268 (352)
Q Consensus 205 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~-----------~~~~~~ 268 (352)
++........ .....||..|+|||.+. ..++.++||||||+++|+|++|..|+..... ......
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence 9987654432 23456888899999876 4588899999999999999999987532211 111111
Q ss_pred HHhcc-cccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 269 IIRSV-LDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 269 ~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
+.... .......++.+++.+.++|.+||+.||.+|||+.++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 252 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 11111 11223344578999999999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=334.14 Aligned_cols=249 Identities=21% Similarity=0.306 Sum_probs=208.1
Q ss_pred cccceece-eeeccCceEEEEEEE--CCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe
Q 018640 54 EERYELGR-ELGRGEFGITYLCTD--RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (352)
Q Consensus 54 ~~~y~~~~-~lG~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 130 (352)
.++|++.+ .||+|+||+||+|.+ ..+++.||+|++.... ......+.+.+|+.+++.+ +||||+++++++ ..+.
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQL-DNPYIVRMIGIC-EAES 91 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTC-CCTTBCCEEEEE-ESSS
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEE-CCCC
Confidence 46799988 999999999999954 5668899999987653 2333467899999999999 899999999999 5667
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
.++||||+++++|.+++.....+++..++.++.|++.||.|||+.|++|+||||+||+++.++. +||+|||++....
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~---~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALR 168 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE---EEECCCTTCEECC
T ss_pred cEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCc---EEEccCCcceeec
Confidence 8999999999999999998888999999999999999999999999999999999999987654 8999999998765
Q ss_pred CCCcc----cccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCC
Q 018640 211 PGEKF----SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (352)
Q Consensus 211 ~~~~~----~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (352)
..... ....+|+.|+|||.+. ..++.++||||||+++|+|++ |..||...........+.... .......+
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~ 245 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE---RMGCPAGC 245 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC---CCCCCTTC
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---CCCCCCCC
Confidence 43321 2235678899999886 458889999999999999999 999998887766655554432 22334578
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 285 SENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 285 ~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
++.+.++|.+||+.||++|||+.++++
T Consensus 246 ~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 246 PREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999999976
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=340.97 Aligned_cols=252 Identities=23% Similarity=0.338 Sum_probs=210.9
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCc-----EEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGD-----AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 127 (352)
..++|++.+.||+|+||+||+|.+..++. .||+|.+.... .....+.+.+|+.+++.+.+||||+++++++..
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 45689999999999999999999876654 79999986542 334467789999999999789999999999999
Q ss_pred CCeEEEEEEecCCcchHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCC
Q 018640 128 DTAVHLVMELCEGGELFDRIVAR--------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK 193 (352)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~--------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~ 193 (352)
.+..++||||+++|+|.+++... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC
Confidence 99999999999999999998653 3579999999999999999999999999999999999998665
Q ss_pred CCCCEEEEecccceecCCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 018640 194 ETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQA 268 (352)
Q Consensus 194 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~ 268 (352)
. +||+|||++........ .....+|+.|+|||.+. ..++.++||||||+++|+|++ |..||...........
T Consensus 202 ~---~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 278 (333)
T 2i1m_A 202 V---AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278 (333)
T ss_dssp E---EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred e---EEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence 4 89999999986533222 23446788999999876 558999999999999999998 9999987665554444
Q ss_pred HHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 269 IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
...... ........++.+.++|..||+.||.+|||+.++++
T Consensus 279 ~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 279 LVKDGY--QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhcCC--CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 444322 22233457899999999999999999999999987
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=339.99 Aligned_cols=253 Identities=23% Similarity=0.343 Sum_probs=208.9
Q ss_pred ccccceeceeeeccCceEEEEEEE-----CCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe
Q 018640 53 IEERYELGRELGRGEFGITYLCTD-----RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 127 (352)
..++|++.+.||+|+||+||+|.+ ..+++.||+|++.... .....+.+.+|+.++.++.+||||+++++++..
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 102 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK 102 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence 457899999999999999999985 3567899999987542 333456789999999999789999999999876
Q ss_pred CC-eEEEEEEecCCcchHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEee
Q 018640 128 DT-AVHLVMELCEGGELFDRIVARGH----------------YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFA 190 (352)
Q Consensus 128 ~~-~~~lv~e~~~~~sL~~~l~~~~~----------------l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~ 190 (352)
.+ ..++||||+++++|.+++..... +++..++.++.|++.||.|||+.||+||||||+||+++
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~ 182 (316)
T 2xir_A 103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 182 (316)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC
Confidence 54 58999999999999999987543 88999999999999999999999999999999999997
Q ss_pred cCCCCCCEEEEecccceecCCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 018640 191 NKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGV 265 (352)
Q Consensus 191 ~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~ 265 (352)
.++. +||+|||++........ .....||+.|+|||++. ..++.++||||||+++|+|++ |..||........
T Consensus 183 ~~~~---~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~ 259 (316)
T 2xir_A 183 EKNV---VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259 (316)
T ss_dssp GGGC---EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred CCCC---EEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence 6554 89999999986543322 23446788999999876 458999999999999999998 9999977654433
Q ss_pred HHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 266 AQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
......... .......+++.+.++|.+||+.||.+|||+.++++|
T Consensus 260 ~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 260 FCRRLKEGT--RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHHTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhccCc--cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 333322221 222334678999999999999999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=345.06 Aligned_cols=249 Identities=22% Similarity=0.310 Sum_probs=204.1
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcE----EEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDA----FACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 129 (352)
.++|++++.||+|+||+||+|.+..+++. ||+|.+.... .......+.+|+.+++++ +||||+++++++. .+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSL-DHAHIVRLLGLCP-GS 87 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTC-CCTTBCCEEEEEC-BS
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEc-CC
Confidence 45799999999999999999999888876 6677664332 122234577899999999 8999999999886 45
Q ss_pred eEEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccccee
Q 018640 130 AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (352)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~ 208 (352)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++. +||+|||++..
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~---~kl~Dfg~a~~ 164 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQ---VQVADFGVADL 164 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSC---EEECSCSGGGG
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCe---EEECCCCcccc
Confidence 688999999999999999764 46999999999999999999999999999999999999976554 89999999987
Q ss_pred cCCCC---cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcC
Q 018640 209 FKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (352)
Q Consensus 209 ~~~~~---~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (352)
..... ......||..|+|||++. +.++.++||||||+++|+|++ |..||...........+.... .......
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~ 241 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE---RLAQPQI 241 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC---BCCCCTT
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC---CCCCCCc
Confidence 64432 224456788999999987 568999999999999999999 999998877665555554332 2223345
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 284 ~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
++..+.++|.+||+.||.+|||+.+++++
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 242 CTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp BCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred CcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 78889999999999999999999999886
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=346.06 Aligned_cols=257 Identities=19% Similarity=0.276 Sum_probs=207.2
Q ss_pred CcccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC
Q 018640 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (352)
Q Consensus 49 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 128 (352)
......++|++.+.||+|+||+||+|.+ .+|+.||+|++... .....+.+.+|+.+++.+ +||||+++++++...
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPE---SSQGIEEFETEIETLSFC-RHPHLVSLIGFCDER 107 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSC---CSSHHHHHHHHHHGGGSC-CCTTBCCEEEECCCT
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEeccc---ChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcCC
Confidence 3445678999999999999999999996 46899999988654 233467899999999999 899999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecc
Q 018640 129 TAVHLVMELCEGGELFDRIVARG----HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~----~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg 204 (352)
+..++||||+++++|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENF---VPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTC---CEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCC---CEEEeecc
Confidence 99999999999999999986543 489999999999999999999999999999999999997554 48999999
Q ss_pred cceecCCCC---cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHH-hc-
Q 018640 205 LSVFFKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA------QAII-RS- 272 (352)
Q Consensus 205 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~------~~~~-~~- 272 (352)
++....... ......||+.|+|||++. +.++.++||||||+++|||++|+.||......... .... ..
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 998653221 223456899999999875 56899999999999999999999999765432111 0000 00
Q ss_pred ccc-----cCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCc
Q 018640 273 VLD-----FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHP 313 (352)
Q Consensus 273 ~~~-----~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp 313 (352)
... ......+..+..+.+++.+||+.||++|||+.+++++.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 000 01111223467789999999999999999999999763
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=360.17 Aligned_cols=247 Identities=21% Similarity=0.359 Sum_probs=213.0
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
.++|++.+.||+|+||.||+|.+..++..||||++.... ...+.+.+|+.+++++ +||||+++++++......++
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS----SCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc----cchHHHHHHHHHHHhc-CCCCEeeEEEEEecCCcEEE
Confidence 467999999999999999999999889999999987542 2467899999999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 134 VMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++. +||+|||+++....
T Consensus 294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~---~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHL---VKVADFGLSRLMTG 370 (495)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC---EEECCTTCEECCTT
T ss_pred EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCc---EEEeecccceeccC
Confidence 99999999999999864 35899999999999999999999999999999999999976554 89999999987644
Q ss_pred CCc--ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHH
Q 018640 212 GEK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (352)
Q Consensus 212 ~~~--~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (352)
... .....++..|+|||++. +.++.++||||||+++|||++ |..||...........+... .+...+..+++.
T Consensus 371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 447 (495)
T 1opk_A 371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD---YRMERPEGCPEK 447 (495)
T ss_dssp CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT---CCCCCCTTCCHH
T ss_pred CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCHH
Confidence 322 12335678899999987 558999999999999999999 99999887776665554432 233344578999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 288 AKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 288 ~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
+.+||.+||+.||++|||+.+|++
T Consensus 448 l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 448 VYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCcChhHCcCHHHHHH
Confidence 999999999999999999999976
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=353.97 Aligned_cols=242 Identities=24% Similarity=0.382 Sum_probs=206.0
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC-eEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT-AVH 132 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~-~~~ 132 (352)
.++|++.+.||+|+||+||+|.+. |+.||||++.... ..+.+.+|+.+++++ +||||+++++++.... ..+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 263 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLY 263 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTC-CCTTBCCEEEEEECTTSCEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhc-cCCCEEEEEEEEEcCCCceE
Confidence 467999999999999999999875 7899999987542 356799999999999 8999999999987665 799
Q ss_pred EEEEecCCcchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 133 LVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~--l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
+||||+++|+|.+++..... +++..+..++.|++.||+|||+++|+||||||+|||++.++ .+||+|||+++...
T Consensus 264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~---~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN---VAKVSDFGLTKEAS 340 (450)
T ss_dssp EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTS---CEEECCCTTCEECC
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCC---CEEEeeCCCccccc
Confidence 99999999999999987654 79999999999999999999999999999999999997554 48999999998654
Q ss_pred CCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHH
Q 018640 211 PGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (352)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (352)
... ....++..|+|||++. ..++.++||||||+++|||++ |..||......+....+... .+...+..+++.+
T Consensus 341 ~~~--~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~---~~~~~p~~~~~~l 415 (450)
T 1k9a_A 341 STQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---YKMDAPDGCPPAV 415 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTT---CCCCCCTTCCHHH
T ss_pred ccc--cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---CCCCCCCcCCHHH
Confidence 322 2336788999999986 558999999999999999998 99999887776666655443 2334456789999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhc
Q 018640 289 KDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 289 ~~li~~~l~~dP~~Rps~~ell~ 311 (352)
.++|.+||+.||++|||+.++++
T Consensus 416 ~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 416 YDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999975
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=338.98 Aligned_cols=254 Identities=21% Similarity=0.318 Sum_probs=213.7
Q ss_pred cccccccceeceeeeccCceEEEEEEEC-----CCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeE
Q 018640 50 GREIEERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDT 124 (352)
Q Consensus 50 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~ 124 (352)
.....++|++.+.||+|+||+||+|.+. .++..||+|++... ........+.+|+.+++.+ +||||++++++
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~ 96 (322)
T 1p4o_A 20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEF-NCHHVVRLLGV 96 (322)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGC-CCTTBCCEEEE
T ss_pred hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc--cCHHHHHHHHHHHHHHHhc-CCCCEeeeEEE
Confidence 3456678999999999999999999876 45788999998753 2333456788999999999 89999999999
Q ss_pred EEeCCeEEEEEEecCCcchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCC
Q 018640 125 YEDDTAVHLVMELCEGGELFDRIVAR----------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE 194 (352)
Q Consensus 125 ~~~~~~~~lv~e~~~~~sL~~~l~~~----------~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~ 194 (352)
+...+..++||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe
Confidence 99999999999999999999998653 35789999999999999999999999999999999999976544
Q ss_pred CCCEEEEecccceecCCCC---cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 018640 195 TAPLKAIDFGLSVFFKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAI 269 (352)
Q Consensus 195 ~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~ 269 (352)
+||+|||++....... ......+|+.|+|||.+. ..++.++||||||+++|+|++ |..||...........+
T Consensus 177 ---~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 253 (322)
T 1p4o_A 177 ---VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253 (322)
T ss_dssp ---EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred ---EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence 8999999997653322 123346788999999986 458999999999999999999 89999888777666555
Q ss_pred HhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 270 IRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
..... ......+++.+.++|.+||+.||++|||+.+++++
T Consensus 254 ~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 254 MEGGL---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HcCCc---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 54322 22345789999999999999999999999999887
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=334.23 Aligned_cols=255 Identities=22% Similarity=0.401 Sum_probs=199.1
Q ss_pred CCcccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe
Q 018640 48 PTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (352)
Q Consensus 48 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 127 (352)
+.++...++|++.+.||+|+||+||+|.+. ..||+|++.... ......+.+.+|+.+++++ +||||+++++++ .
T Consensus 17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~ 90 (289)
T 3og7_A 17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKT-RHVNILLFMGYS-T 90 (289)
T ss_dssp -CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSS-CCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE-C
T ss_pred CCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccC-CCHHHHHHHHHHHHHHHhC-CCCcEEEEEeec-c
Confidence 445667788999999999999999999864 359999987653 2344567899999999999 899999999965 5
Q ss_pred CCeEEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccc
Q 018640 128 DTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (352)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a 206 (352)
....++||||+++++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++. +||+|||++
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~---~kl~Dfg~~ 167 (289)
T 3og7_A 91 APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNT---VKIGDFGLA 167 (289)
T ss_dssp SSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE---EEECCCC--
T ss_pred CCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC---EEEccceec
Confidence 55689999999999999999654 45999999999999999999999999999999999999986654 899999999
Q ss_pred eecCCC---Ccccccccccccccchhcc----ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-cccC-
Q 018640 207 VFFKPG---EKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV-LDFR- 277 (352)
Q Consensus 207 ~~~~~~---~~~~~~~gt~~y~aPE~~~----~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~- 277 (352)
...... .......||+.|+|||.+. ..++.++||||||+++|+|++|..||................ ....
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 247 (289)
T 3og7_A 168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL 247 (289)
T ss_dssp ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCT
T ss_pred cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcch
Confidence 765321 2234457899999999874 347889999999999999999999998766554444443332 2111
Q ss_pred CCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 278 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
......+++.+.++|.+||+.||++|||+.++++
T Consensus 248 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 248 SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1223468899999999999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=328.61 Aligned_cols=246 Identities=24% Similarity=0.378 Sum_probs=210.8
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++.+.||+|+||.||+|.+. ++..||+|++.... ...+.+.+|+.+++++ +||||+++++++...+..++|
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 81 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA----MSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLV 81 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTT----BCHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSCEEE
T ss_pred hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccC----CCHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCCeEEE
Confidence 57999999999999999999986 57889999987543 2346789999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++. +||+|||++.......
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~---~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV---IKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGC---EEECCTTGGGGBCCHH
T ss_pred EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCC---EEEccccccccccccc
Confidence 9999999999999865 45899999999999999999999999999999999999976554 8999999997654321
Q ss_pred --cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHH
Q 018640 214 --KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (352)
Q Consensus 214 --~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (352)
......+|..|+|||.+. ..++.++||||||+++|+|++ |..||...........+.... ........++.+.
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~---~~~~~~~~~~~l~ 235 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF---RLYKPRLASTHVY 235 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC---CCCCCTTSCHHHH
T ss_pred ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC---cCCCCccCcHHHH
Confidence 123346778899999987 558899999999999999999 899998887776666655432 2233346789999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcC
Q 018640 290 DLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 290 ~li~~~l~~dP~~Rps~~ell~h 312 (352)
+++.+||+.||++|||+.+++++
T Consensus 236 ~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 236 QIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999874
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=329.40 Aligned_cols=245 Identities=15% Similarity=0.241 Sum_probs=207.9
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC--CeE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--TAV 131 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~--~~~ 131 (352)
-++|++.+.||+|+||+||+|.+. +..||+|++.... ......+.+.+|+.+++++ +||||+++++++... ...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRD-WSTRKSRDFNEECPRLRIF-SHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTT-CCHHHHHHHHHHGGGGCCC-SCTTEECEEEEECTTTSSSC
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccc-cCHHHHHHHHHHHHHHHhc-CCCchhheEEEEccCCCCCe
Confidence 457999999999999999999975 8899999987653 2334456799999999999 899999999999876 788
Q ss_pred EEEEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC--CEEecCCCCceEeecCCCCCCEEEEecccce
Q 018640 132 HLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHG--VMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~ 207 (352)
++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++. ++|+|||++.
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~---~~l~~~~~~~ 161 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT---ARISMADVKF 161 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSC---EEEEGGGSCC
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcc---eeEEecccee
Confidence 99999999999999998765 4899999999999999999999999 999999999999975544 7999998875
Q ss_pred ecCCCCcccccccccccccchhcccc-C---CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcC
Q 018640 208 FFKPGEKFSEIVGSPYYMAPEVLKRN-Y---GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (352)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~---s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (352)
.... ....||+.|+|||.+.+. + +.++||||||+++|||++|..||................ .....+..
T Consensus 162 ~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~ 235 (271)
T 3kmu_A 162 SFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEG--LRPTIPPG 235 (271)
T ss_dssp TTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSC--CCCCCCTT
T ss_pred eecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcC--CCCCCCCC
Confidence 4322 334789999999987643 3 337999999999999999999998888776666555443 23334457
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 284 VSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 284 ~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
+++.+.++|..||+.||++|||+.++++
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 236 ISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 8999999999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=330.59 Aligned_cols=249 Identities=25% Similarity=0.331 Sum_probs=209.2
Q ss_pred cccceece-eeeccCceEEEEEEEC--CCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe
Q 018640 54 EERYELGR-ELGRGEFGITYLCTDR--ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (352)
Q Consensus 54 ~~~y~~~~-~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 130 (352)
.++|.+.+ .||+|+||+||+|.+. .++..||+|++... ......+.+.+|+.+++.+ +||||+++++++ ..+.
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~-~~~~ 83 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQL-DNPYIVRLIGVC-QAEA 83 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE-ESSS
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc--cchhHHHHHHHHHHHHHhC-CCCCEeEEEEEe-cCCC
Confidence 45677777 9999999999999864 46888999998764 2344567899999999999 899999999999 5567
Q ss_pred EEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 131 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
.++||||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++. +||+|||++...
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~---~kl~Dfg~~~~~ 160 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY---AKISDFGLSKAL 160 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE---EEECCCTTCEEC
T ss_pred cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCC---EEECcccceeee
Confidence 89999999999999999654 45999999999999999999999999999999999999986654 899999999876
Q ss_pred CCCCc----ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcC
Q 018640 210 KPGEK----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (352)
Q Consensus 210 ~~~~~----~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (352)
..... .....+|+.|+|||.+. ..++.++||||||+++|+|++ |..||......+....+.... ....++.
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~---~~~~~~~ 237 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---RMECPPE 237 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC---CCCCCTT
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC---cCCCCCC
Confidence 43322 12335688999999986 458999999999999999998 999998877766655554432 2334457
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 284 ~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
+++.+.++|..||+.||++|||+.+++++
T Consensus 238 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 266 (287)
T 1u59_A 238 CPPELYALMSDCWIYKWEDRPDFLTVEQR 266 (287)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 89999999999999999999999999886
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=347.49 Aligned_cols=256 Identities=14% Similarity=0.184 Sum_probs=194.5
Q ss_pred ccccceeceeeeccCceEEEEEEECCC-----CcEEEEEEccccccCCh--------hcHHHHHHHHHHHHhCCCCCCee
Q 018640 53 IEERYELGRELGRGEFGITYLCTDREN-----GDAFACKSISKKKLRTA--------VDIEDVRREVDIMRHLPKHQNIV 119 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~--------~~~~~~~~E~~~l~~l~~h~~iv 119 (352)
..++|++.+.||+|+||+||+|.+..+ ++.||+|++........ .....+.+|+..+..+ +||||+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~~iv 111 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKL-KYLGVP 111 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTC-SCCCSC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhc-cCCCCC
Confidence 345899999999999999999998764 57899999865421000 0111233455556666 799999
Q ss_pred EeeeEEEeC----CeEEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCC
Q 018640 120 CLKDTYEDD----TAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE 194 (352)
Q Consensus 120 ~l~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~ 194 (352)
++++++... ...++||||+ |++|.+++... ..+++..++.++.||+.||+|||+.||+||||||+|||++.+ .
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~-~ 189 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK-N 189 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESS-C
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecC-C
Confidence 999998764 4689999999 99999999876 579999999999999999999999999999999999999732 2
Q ss_pred CCCEEEEecccceecCCCCc--------ccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 018640 195 TAPLKAIDFGLSVFFKPGEK--------FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGV 265 (352)
Q Consensus 195 ~~~vkl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~ 265 (352)
...+||+|||+++....... .....||+.|+|||++.+ .++.++||||||+++|||++|+.||........
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 34599999999976543211 133459999999999875 489999999999999999999999975432221
Q ss_pred HHHHHh-----cccccCC--CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 266 AQAIIR-----SVLDFRR--DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 266 ~~~~~~-----~~~~~~~--~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
...... ....... .....+++.+.+++..||+.||++||++.+|++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 270 YVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 111111 0000000 011457899999999999999999999999976
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=333.23 Aligned_cols=253 Identities=20% Similarity=0.271 Sum_probs=203.1
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCee-EeeeEEEeCCe
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIV-CLKDTYEDDTA 130 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv-~l~~~~~~~~~ 130 (352)
.+.++|++.+.||+|+||+||+|.+..+|+.||+|++.... ..+.+.+|+.+++.+ +|++++ .+..++...+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l-~~~~~i~~~~~~~~~~~~ 79 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMM-QGGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-----SCCHHHHHHHHHHHH-TTSTTCCCEEEEEEETTE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-----chhHHHHHHHHHHHh-hcCCCCCccccccCCCCc
Confidence 46788999999999999999999999999999999886542 224588999999999 565554 44445577788
Q ss_pred EEEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 131 VHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
.++||||+ +++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++....+||+|||++...
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred eEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 89999999 8899999974 456999999999999999999999999999999999999963334455999999999876
Q ss_pred CCCCc--------ccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcccccC
Q 018640 210 KPGEK--------FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAET---EQGVAQAIIRSVLDFR 277 (352)
Q Consensus 210 ~~~~~--------~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~---~~~~~~~~~~~~~~~~ 277 (352)
..... .....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.... .......+.......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 54322 245579999999999874 58999999999999999999999997632 2222233322222211
Q ss_pred -CCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 278 -RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 278 -~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
......+++.+.++|..||+.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 1112467899999999999999999999999976
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=338.44 Aligned_cols=250 Identities=22% Similarity=0.294 Sum_probs=202.7
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEE----EEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAF----ACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~v----avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 128 (352)
..++|++++.||+|+||+||+|.+..+++.| |+|.+... ......+.+.+|+.+++++ +||||+++++++...
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~--~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS 89 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC--SSCCCHHHHHHHHHHHTTC-CBTTBCCCCEEEESS
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc--cCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEecC
Confidence 3468999999999999999999998888766 55555432 2334567899999999999 899999999999876
Q ss_pred CeEEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccce
Q 018640 129 TAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~ 207 (352)
. .++|++|+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||++.
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~---~kL~DfG~a~ 165 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH---VKITDFGLAK 165 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE---EEECCTTC--
T ss_pred C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCC---EEEccCccee
Confidence 5 78899999999999999864 46999999999999999999999999999999999999986655 8999999998
Q ss_pred ecCCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCc
Q 018640 208 FFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282 (352)
Q Consensus 208 ~~~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (352)
....... .....+|+.|+|||.+. ..++.++||||||+++|+|++ |..||...........+.... .....+
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~ 242 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE---RLPQPP 242 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC---CCCCCT
T ss_pred EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC---CCCCCc
Confidence 6543322 22345678899999876 458999999999999999999 999998877766655554432 223345
Q ss_pred CCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 283 ~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
.++..+.++|..||+.||.+|||+.|+++.
T Consensus 243 ~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 243 ICTIDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp TBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 689999999999999999999999999873
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=341.44 Aligned_cols=251 Identities=22% Similarity=0.271 Sum_probs=197.5
Q ss_pred CCcccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe
Q 018640 48 PTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (352)
Q Consensus 48 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 127 (352)
++...-.++|++.+.||+|+||+||+|.+. ++.||+|++.... .......+|+.+++++ +||||+++++++..
T Consensus 17 ~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~ 89 (322)
T 3soc_A 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGM-KHENILQFIGAEKR 89 (322)
T ss_dssp CCEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEE
T ss_pred cccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcC-CCCCchhhcceecc
Confidence 333444568999999999999999999875 8999999986532 2334566789999999 89999999999986
Q ss_pred CC----eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc----------CCEEecCCCCceEeecCC
Q 018640 128 DT----AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH----------GVMHRDLKPENFLFANKK 193 (352)
Q Consensus 128 ~~----~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~----------~ivH~Dikp~NIll~~~~ 193 (352)
.. ..++||||+++|+|.+++... .+++..++.++.|++.||.|||+. +|+||||||+|||++.++
T Consensus 90 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~ 168 (322)
T 3soc_A 90 GTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL 168 (322)
T ss_dssp ECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC
T ss_pred CCCCCceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC
Confidence 44 479999999999999999765 599999999999999999999999 999999999999997554
Q ss_pred CCCCEEEEecccceecCCCCc---ccccccccccccchhccc------cCCCcchHHHHHHHHHHHHhCCCCCCCCCH--
Q 018640 194 ETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLKR------NYGPEVDVWSAGVILYILLCGVPPFWAETE-- 262 (352)
Q Consensus 194 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~------~~s~~~Di~SlG~~l~el~tg~~p~~~~~~-- 262 (352)
.+||+|||++........ .....||+.|+|||++.+ .++.++||||||+++|||++|+.||.....
T Consensus 169 ---~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 245 (322)
T 3soc_A 169 ---TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245 (322)
T ss_dssp ---CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCC
T ss_pred ---eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchh
Confidence 489999999987644322 234579999999998864 356688999999999999999999965321
Q ss_pred --------------HHHHHHHHhcccccCCCCCc-----CCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 263 --------------QGVAQAIIRSVLDFRRDPWP-----KVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 263 --------------~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
........... ..+.... ..++.+.+||.+||+.||++|||+.++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 246 MLPFEEEIGQHPSLEDMQEVVVHKK--KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSC--CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccchhhhhccCCchhhhhhhhhccc--CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11111111111 1111111 12345999999999999999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=340.06 Aligned_cols=250 Identities=25% Similarity=0.370 Sum_probs=202.0
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEE----eC
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE----DD 128 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~----~~ 128 (352)
..++|++++.||+|+||.||+|.+..+|+.||+|++... .....+.+.+|+.+++.+ +||||+++++++. ..
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLF-NHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEEEETTE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhc-CCCCeeeEEEEEEeccCCC
Confidence 356899999999999999999999999999999988643 344567889999999999 9999999999986 23
Q ss_pred CeEEEEEEecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecc
Q 018640 129 TAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg 204 (352)
...++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.||+||||||+||+++.++. +||+|||
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~---~kl~dfg 179 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ---PVLMDLG 179 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC---EEECCCS
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCC---EEEEecC
Confidence 478999999999999999875 356999999999999999999999999999999999999976554 8999999
Q ss_pred cceecCCCCc----------ccccccccccccchhccc----cCCCcchHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH
Q 018640 205 LSVFFKPGEK----------FSEIVGSPYYMAPEVLKR----NYGPEVDVWSAGVILYILLCGVPPFWAETEQ--GVAQA 268 (352)
Q Consensus 205 ~a~~~~~~~~----------~~~~~gt~~y~aPE~~~~----~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~--~~~~~ 268 (352)
++........ .....||+.|+|||.+.+ .++.++||||||+++|+|++|..||...... .....
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 259 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH
Confidence 9876432110 123457999999998753 2688999999999999999999999532110 11111
Q ss_pred HHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 269 IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
+ .. .......+.+++.+.++|.+||+.||.+|||+.+++++
T Consensus 260 ~-~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 260 V-QN--QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp H-HC--C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred h-hc--cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 1 11 12222335689999999999999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=329.10 Aligned_cols=251 Identities=25% Similarity=0.300 Sum_probs=207.0
Q ss_pred cccccceeceeeeccCceEEEEEEECC---CCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRE---NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 128 (352)
...++|++.+.||+|+||+||+|.+.. ++..||+|.+.... .....+.+.+|+.+++.+ +||||+++++++.++
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 85 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNL-DHPHIVKLIGIIEEE 85 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHH-CCTTBCCEEEEECSS
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhC-CCCCcceEEEEEcCC
Confidence 345689999999999999999998653 34469999987542 334567899999999999 899999999998754
Q ss_pred CeEEEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccce
Q 018640 129 TAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~ 207 (352)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||+++.++. +||+|||++.
T Consensus 86 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---~kl~Dfg~~~ 161 (281)
T 3cc6_A 86 -PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPEC---VKLGDFGLSR 161 (281)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTE---EEECCCCGGG
T ss_pred -CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCc---EEeCccCCCc
Confidence 5689999999999999997654 5999999999999999999999999999999999999987654 8999999998
Q ss_pred ecCCCCc--ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcC
Q 018640 208 FFKPGEK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (352)
Q Consensus 208 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (352)
....... .....+|+.|+|||.+. ..++.++||||||+++|+|++ |+.||...........+.... .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~ 238 (281)
T 3cc6_A 162 YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD---RLPKPDL 238 (281)
T ss_dssp CC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTC---CCCCCTT
T ss_pred ccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCC---CCCCCCC
Confidence 6543321 23446788999999886 558999999999999999998 999998777666655554432 2223356
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 284 ~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
+++.+.++|.+||+.||++|||+.+++++
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 239 CPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 89999999999999999999999999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=353.86 Aligned_cols=247 Identities=22% Similarity=0.353 Sum_probs=209.9
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
...++|++.+.||+|+||+||+|.+. ++..||||++.... ...+.+.+|+.+++++ +||||+++++++. .+..
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTL-QHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHTTC-CCTTBCCEEEEEC-SSSC
T ss_pred echHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC----ccHHHHHHHHHHHhhC-CCCCEeeEEEEEe-CCcc
Confidence 34568999999999999999999985 47789999987542 3467899999999999 8999999999986 5678
Q ss_pred EEEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 132 HLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+++..
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~---~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL---VCKIADFGLARVI 334 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTC---CEEECSTTGGGGB
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCC---cEEEeeCCCceEc
Confidence 9999999999999999754 3689999999999999999999999999999999999997554 4899999999875
Q ss_pred CCCCc--ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCC
Q 018640 210 KPGEK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (352)
Q Consensus 210 ~~~~~--~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (352)
..... .....+|..|+|||++. +.++.++||||||+++|||++ |+.||......+....+.... ....+..++
T Consensus 335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~---~~~~~~~~~ 411 (454)
T 1qcf_A 335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY---RMPRPENCP 411 (454)
T ss_dssp CCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC---CCCCCTTSC
T ss_pred CCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCC
Confidence 43221 12335678899999987 568999999999999999999 999999888777766665532 233345789
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 286 ENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 286 ~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
+.+.++|.+||+.||++|||+.+|++
T Consensus 412 ~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 412 EELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHH
Confidence 99999999999999999999999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=352.82 Aligned_cols=255 Identities=24% Similarity=0.356 Sum_probs=197.7
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
.+|.+.+.||+|+||+||... ..+|+.||||++..... ..+.+|+.+++.+.+||||+++++++.+.+..++|
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~-~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRG-MFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEE-ESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred EEEecCCeeecCcCEEEEEEE-EeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 469999999999999976433 45799999999865422 23557999999997899999999999999999999
Q ss_pred EEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCC--CCCCEEEEecccceecCC
Q 018640 135 MELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK--ETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~--~~~~vkl~Dfg~a~~~~~ 211 (352)
|||++ |+|.+++.... .+.+..+..++.||+.||.|||++||+||||||+|||++.++ ....+||+|||++.....
T Consensus 97 ~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp EECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred EECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 99996 59999997654 356667789999999999999999999999999999996432 234578999999987653
Q ss_pred CC----cccccccccccccchhcc----ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCc
Q 018640 212 GE----KFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282 (352)
Q Consensus 212 ~~----~~~~~~gt~~y~aPE~~~----~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (352)
.. ......||+.|+|||++. ..++.++|||||||++|||++ |..||........ ................
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~ 254 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-NILLGACSLDCLHPEK 254 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-HHHTTCCCCTTSCTTC
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-HHHhccCCccccCccc
Confidence 32 234567999999999885 347789999999999999999 8999865544332 2222111111111112
Q ss_pred CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 283 ~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
..+..+.+||.+||+.||.+|||+.++++||||...
T Consensus 255 ~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 255 HEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp HHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred cccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 345668899999999999999999999999999864
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=351.97 Aligned_cols=257 Identities=25% Similarity=0.396 Sum_probs=199.2
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
.+.+.|.+.+.||+|+||+||.+. ..+|+.||||++... ..+.+.+|+.++.++.+||||+++++++...+..
T Consensus 12 ~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 84 (434)
T 2rio_A 12 SLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFL 84 (434)
T ss_dssp SCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred hhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeE
Confidence 456678888999999999998764 457999999988643 2356788999999876899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCC----------C
Q 018640 132 HLVMELCEGGELFDRIVARGHY-------TERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK----------E 194 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l-------~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~----------~ 194 (352)
++||||++ |+|.+++...... ++..++.++.||+.||+|||++||+||||||+|||++.++ .
T Consensus 85 ~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~ 163 (434)
T 2rio_A 85 YIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAE 163 (434)
T ss_dssp EEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCC
T ss_pred EEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCC
Confidence 99999995 6999999765432 2234578999999999999999999999999999997542 3
Q ss_pred CCCEEEEecccceecCCCCc-----ccccccccccccchhccc--------cCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q 018640 195 TAPLKAIDFGLSVFFKPGEK-----FSEIVGSPYYMAPEVLKR--------NYGPEVDVWSAGVILYILLC-GVPPFWAE 260 (352)
Q Consensus 195 ~~~vkl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~--------~~s~~~Di~SlG~~l~el~t-g~~p~~~~ 260 (352)
...+||+|||++........ .....||+.|+|||++.+ .++.++|||||||++|||++ |..||...
T Consensus 164 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp SCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred ceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 45699999999987654321 234579999999998753 47889999999999999999 99999765
Q ss_pred CHHHHHHHHHhcccccCCCC---CcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 261 TEQGVAQAIIRSVLDFRRDP---WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
.... ..+........... ...+++++.++|.+||+.||.+|||+.++++||||...
T Consensus 244 ~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 244 YSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp TTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred hhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence 4433 23333332222111 12345789999999999999999999999999999753
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=341.38 Aligned_cols=267 Identities=19% Similarity=0.236 Sum_probs=209.2
Q ss_pred cccCCCcccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeee
Q 018640 44 VLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKD 123 (352)
Q Consensus 44 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~ 123 (352)
.+...+.....++|++.+.||+|+||+||+|.+ .+|+.||+|++...... .....+.+|+.+++.+ +||||+++++
T Consensus 19 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~ 94 (326)
T 3uim_A 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ--GGELQFQTEVEMISMA-VHRNLLRLRG 94 (326)
T ss_dssp ECCTHHHHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-------CCCHHHHHHHGGGTC-CCTTBCCCCE
T ss_pred eecHHHHHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCc--hHHHHHHHHHHHHHhc-cCCCccceEE
Confidence 344455566778999999999999999999985 46999999998765322 2233688999999999 8999999999
Q ss_pred EEEeCCeEEEEEEecCCcchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHc---CCEEecCCCCceEeecCCCCC
Q 018640 124 TYEDDTAVHLVMELCEGGELFDRIVARG----HYTERAAAAVTKTIVEVVQMCHKH---GVMHRDLKPENFLFANKKETA 196 (352)
Q Consensus 124 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dikp~NIll~~~~~~~ 196 (352)
++...+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+. ||+||||||+||+++.++.
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~-- 172 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE-- 172 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC--
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC--
Confidence 9999999999999999999999997653 389999999999999999999999 9999999999999975544
Q ss_pred CEEEEecccceecCCCC--cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHH
Q 018640 197 PLKAIDFGLSVFFKPGE--KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET----EQGVAQAI 269 (352)
Q Consensus 197 ~vkl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~----~~~~~~~~ 269 (352)
+||+|||++....... ......||+.|+|||++. ..++.++||||||+++|+|++|..||.... ........
T Consensus 173 -~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 251 (326)
T 3uim_A 173 -AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251 (326)
T ss_dssp -EEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred -EEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence 8999999998764332 234456999999999886 558999999999999999999999995210 00011111
Q ss_pred Hhccccc-----------CCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccc
Q 018640 270 IRSVLDF-----------RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (352)
Q Consensus 270 ~~~~~~~-----------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~ 317 (352)
....... ........++.+.+++..||+.||.+|||+.+|++|-.-..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp HTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred HHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 1111110 00111223477999999999999999999999999855443
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=338.27 Aligned_cols=252 Identities=22% Similarity=0.348 Sum_probs=206.5
Q ss_pred cccceeceeeeccCceEEEEEE----ECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEE--e
Q 018640 54 EERYELGRELGRGEFGITYLCT----DRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE--D 127 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~--~ 127 (352)
.++|++++.||+|+||.||+|. +..+++.||+|++... .....+.+.+|+.+++++ +||||+++++++. .
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKAL-HSDFIVKYRGVSYGPG 97 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCC
Confidence 3689999999999999999998 5678999999998754 334456789999999999 9999999999886 4
Q ss_pred CCeEEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccc
Q 018640 128 DTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (352)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a 206 (352)
....++||||+++++|.+++... ..+++..++.++.|++.||+|||+.||+||||||+||+++.++. +||+|||++
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~---~kl~Dfg~~ 174 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH---VKIADFGLA 174 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE---EEECCGGGC
T ss_pred CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCC---EEEcccccc
Confidence 56789999999999999999763 46999999999999999999999999999999999999987655 899999999
Q ss_pred eecCCCCc----ccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH-----------HHHHH
Q 018640 207 VFFKPGEK----FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGV-----------AQAII 270 (352)
Q Consensus 207 ~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~-----------~~~~~ 270 (352)
........ .....||..|+|||++.+ .++.++||||||+++|+|++|..||........ ...+.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 87654332 233467888999998864 478999999999999999999999854432210 01111
Q ss_pred hcc-cccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 271 RSV-LDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 271 ~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
... ..........+++.+.++|..||+.||++|||+.+++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 111 112233345789999999999999999999999999664
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=337.47 Aligned_cols=251 Identities=22% Similarity=0.329 Sum_probs=204.5
Q ss_pred ccccceeceeeeccCceEEEEEEECCCC----cEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENG----DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 128 (352)
..++|++.+.||+|+||+||+|.+..++ ..||+|++.... .......+.+|+.+++++ +||||+++++++...
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISKY 118 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSS
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecC
Confidence 3467999999999999999999976543 359999986542 334456788999999999 899999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccce
Q 018640 129 TAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~ 207 (352)
+..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++ .+||+|||++.
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~---~~kl~Dfg~~~ 195 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL---VCKVSDFGLSR 195 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC---CEEECCCCC--
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCC---cEEECCCCcch
Confidence 9999999999999999999765 5699999999999999999999999999999999999997554 48999999998
Q ss_pred ecCCCCc----ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCC
Q 018640 208 FFKPGEK----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPW 281 (352)
Q Consensus 208 ~~~~~~~----~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (352)
....... .....+|..|+|||.+. ..++.++||||||+++|||++ |..||......+....+.... .....
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~---~~~~~ 272 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF---RLPTP 272 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC---CCCCC
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCC---cCCCc
Confidence 6543321 12235678899999886 458999999999999999999 999998887776665554432 22334
Q ss_pred cCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 282 ~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
..+++.+.++|.+||+.||++||++.+++++
T Consensus 273 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 273 MDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5688999999999999999999999999875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=332.73 Aligned_cols=253 Identities=23% Similarity=0.337 Sum_probs=201.8
Q ss_pred cccccceeceeeeccCceEEEEEEECC-CCc--EEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRE-NGD--AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 128 (352)
...++|++++.||+|+||+||+|.+.. ++. .||+|++...........+.+.+|+.+++++ +||||+++++++...
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLTP 93 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEccC
Confidence 345689999999999999999998643 333 6899998766544555677899999999999 899999999999876
Q ss_pred CeEEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccce
Q 018640 129 TAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~ 207 (352)
. .++|+||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++. +||+|||++.
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~---~kl~Dfg~~~ 169 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL---VKIGDFGLMR 169 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE---EEECCCTTCE
T ss_pred C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCC---EEEccccccc
Confidence 5 78999999999999999764 46999999999999999999999999999999999999986654 8999999998
Q ss_pred ecCCCCc----ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCC
Q 018640 208 FFKPGEK----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPW 281 (352)
Q Consensus 208 ~~~~~~~----~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (352)
....... .....+|..|+|||.+. ..++.++||||||+++|+|++ |..||...........+...... ....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~ 247 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER--LPRP 247 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC--CCCC
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCC--CCCC
Confidence 7644322 12346788899999886 448889999999999999999 99999888877766666544322 2234
Q ss_pred cCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 282 ~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
..+++.+.++|.+||+.||++|||+.++++
T Consensus 248 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 248 EDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 578999999999999999999999999987
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=337.03 Aligned_cols=254 Identities=26% Similarity=0.349 Sum_probs=204.1
Q ss_pred ccccccc-eeceeeeccCceEEEEEEE----CCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEE
Q 018640 51 REIEERY-ELGRELGRGEFGITYLCTD----RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTY 125 (352)
Q Consensus 51 ~~~~~~y-~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~ 125 (352)
..+.++| ++++.||+|+||+||++.. ..+|+.||+|++... ......+.+.+|+.+++++ +||||+++++++
T Consensus 26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 102 (318)
T 3lxp_A 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTL-YHEHIIKYKGCC 102 (318)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc--cChHHHHHHHHHHHHHHhC-CCcchhhEEEEE
Confidence 3466666 9999999999999988754 457899999998754 2334567799999999999 899999999999
Q ss_pred EeC--CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEec
Q 018640 126 EDD--TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDF 203 (352)
Q Consensus 126 ~~~--~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Df 203 (352)
... ...++||||+++++|.+++... .+++..++.++.|++.||.|||+.||+|+||||+||+++.++. +||+||
T Consensus 103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~---~kl~Df 178 (318)
T 3lxp_A 103 EDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL---VKIGDF 178 (318)
T ss_dssp EETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC---EEECCG
T ss_pred ecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCC---EEECCc
Confidence 874 6789999999999999999765 4999999999999999999999999999999999999976544 899999
Q ss_pred ccceecCCCCc----ccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH-----------HHH
Q 018640 204 GLSVFFKPGEK----FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQG-----------VAQ 267 (352)
Q Consensus 204 g~a~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~-----------~~~ 267 (352)
|++........ .....+|..|+|||++.+ .++.++||||||+++|+|++|..||....... ...
T Consensus 179 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 258 (318)
T 3lxp_A 179 GLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL 258 (318)
T ss_dssp GGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHH
T ss_pred cccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHH
Confidence 99987654432 234467888999999874 58889999999999999999999986543210 111
Q ss_pred HHHhcc-cccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 268 AIIRSV-LDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 268 ~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
.+.... ..........+++.+.+||.+||+.||++|||+.++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 259 RLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 111111 11223334578999999999999999999999999985
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=331.07 Aligned_cols=253 Identities=20% Similarity=0.260 Sum_probs=197.3
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeE-eeeEEEeCCe
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC-LKDTYEDDTA 130 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~-l~~~~~~~~~ 130 (352)
.+.++|++.+.||+|+||+||+|.+..+++.||+|++..... .+.+.+|+.+++.+ +|++++. +..++...+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l-~~~~~i~~~~~~~~~~~~ 79 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMM-QGGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHH-TTSTTCCCEEEEEEETTE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHh-cCCCCCCeeeeecCCCCc
Confidence 467889999999999999999999999999999998654422 23477899999999 5555554 4455577888
Q ss_pred EEEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 131 VHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
.++||||+ +++|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+||+++.+.....+||+|||++...
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred eEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 99999999 8899999975 456999999999999999999999999999999999999953334445999999999876
Q ss_pred CCCCc--------ccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhcccccC
Q 018640 210 KPGEK--------FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQ---GVAQAIIRSVLDFR 277 (352)
Q Consensus 210 ~~~~~--------~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~ 277 (352)
..... .....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||...... .....+.......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 44322 235578999999999874 5889999999999999999999999764321 22222222211111
Q ss_pred -CCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 278 -RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 278 -~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
......+++.+.++|..||+.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 1112457899999999999999999999999987
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=335.39 Aligned_cols=247 Identities=24% Similarity=0.373 Sum_probs=194.9
Q ss_pred ccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHh--CCCCCCeeEeeeEEEe-
Q 018640 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH--LPKHQNIVCLKDTYED- 127 (352)
Q Consensus 51 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~~h~~iv~l~~~~~~- 127 (352)
..+.++|++.+.||+|+||+||+|.+ +|+.||+|++... ....+.+|.+++.. + +||||+++++++..
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l-~h~niv~~~~~~~~~ 74 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR------DEKSWFRETELYNTVML-RHENILGFIASDMTS 74 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHTCC-CCTTBCCEEEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc------cchhhHHHHHHHHHhhc-cCcCeeeEEEeeccc
Confidence 45778999999999999999999987 5899999998643 23556667777776 6 89999999998654
Q ss_pred ---CCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HcCCEEecCCCCceEeecCCCCC
Q 018640 128 ---DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH--------KHGVMHRDLKPENFLFANKKETA 196 (352)
Q Consensus 128 ---~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH--------~~~ivH~Dikp~NIll~~~~~~~ 196 (352)
....++||||+++|+|.+++.. ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.
T Consensus 75 ~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~-- 151 (301)
T 3q4u_A 75 RHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ-- 151 (301)
T ss_dssp ETTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSC--
T ss_pred cCCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCC--
Confidence 3468999999999999999954 47999999999999999999999 999999999999999976554
Q ss_pred CEEEEecccceecCCCCc-----ccccccccccccchhcccc-------CCCcchHHHHHHHHHHHHhC----------C
Q 018640 197 PLKAIDFGLSVFFKPGEK-----FSEIVGSPYYMAPEVLKRN-------YGPEVDVWSAGVILYILLCG----------V 254 (352)
Q Consensus 197 ~vkl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-------~s~~~Di~SlG~~l~el~tg----------~ 254 (352)
+||+|||++........ .....||+.|+|||++.+. ++.++||||||+++|||++| .
T Consensus 152 -~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~ 230 (301)
T 3q4u_A 152 -CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230 (301)
T ss_dssp -EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred -EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence 89999999976543322 1334799999999988643 34689999999999999999 8
Q ss_pred CCCCCCCH----HHHHHHHHhcccccCCCCC-----cCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 255 PPFWAETE----QGVAQAIIRSVLDFRRDPW-----PKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 255 ~p~~~~~~----~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
.||..... ............ ...... ...++.+.++|.+||+.||++|||+.++++
T Consensus 231 ~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 231 PPFYDVVPNDPSFEDMRKVVCVDQ-QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSC-CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ccccccCCCCcchhhhhHHHhccC-CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 88865322 122222221111 111111 124577999999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=333.96 Aligned_cols=253 Identities=19% Similarity=0.280 Sum_probs=200.7
Q ss_pred cccccceeceeeeccCceEEEEEEECC---CCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRE---NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 128 (352)
...++|++.+.||+|+||+||+|.+.. ++..||+|++.... ......+.+.+|+.+++++ +||||+++++++...
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN-SSQREIEEFLSEAACMKDF-SHPNVIRLLGVCIEM 108 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C-CCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEC-
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc-cchhHHHHHHHHHHHHhcC-CCCCeeeeeEEEeec
Confidence 345689999999999999999998765 45589999987543 2334457789999999999 899999999999765
Q ss_pred C-----eEEEEEEecCCcchHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCC
Q 018640 129 T-----AVHLVMELCEGGELFDRIVA------RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAP 197 (352)
Q Consensus 129 ~-----~~~lv~e~~~~~sL~~~l~~------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~ 197 (352)
+ ..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.||+||||||+||+++.++.
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~--- 185 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT--- 185 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC---
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc---
Confidence 4 45999999999999999843 345999999999999999999999999999999999999976544
Q ss_pred EEEEecccceecCCCC---cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 018640 198 LKAIDFGLSVFFKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRS 272 (352)
Q Consensus 198 vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~ 272 (352)
+||+|||++....... ......+++.|+|||.+. ..++.++||||||+++|+|++ |..||...........+...
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 265 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG 265 (313)
T ss_dssp EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC
Confidence 8999999997654332 123346788999999986 458999999999999999999 89999887776666555543
Q ss_pred ccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 273 VLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
. ....+..+++.+.++|.+||+.||.+|||+.+++++
T Consensus 266 ~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 266 H---RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp C---CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred C---CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2 233345788999999999999999999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=345.57 Aligned_cols=256 Identities=18% Similarity=0.228 Sum_probs=197.9
Q ss_pred cccceeceeeeccCceEEEEEEECC---CCcEEEEEEccccccCC--------hhcHHHHHHHHHHHHhCCCCCCeeEee
Q 018640 54 EERYELGRELGRGEFGITYLCTDRE---NGDAFACKSISKKKLRT--------AVDIEDVRREVDIMRHLPKHQNIVCLK 122 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~--------~~~~~~~~~E~~~l~~l~~h~~iv~l~ 122 (352)
.++|++.+.||+|+||+||+|.+.. ++..||+|++....... ......+.+|+..+..+ +||||++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~ni~~~~ 114 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-DYLGIPLFY 114 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-SCCCCCCEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-cccCcceee
Confidence 4689999999999999999999987 78899999987542110 01223466788889999 899999999
Q ss_pred eEEEe----CCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCE
Q 018640 123 DTYED----DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPL 198 (352)
Q Consensus 123 ~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~v 198 (352)
+++.. ....++||||+ +++|.+++.....+++..++.++.||+.||+|||+.||+||||||+|||++.++. ..+
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~-~~~ 192 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNP-DQV 192 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSST-TSE
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCC-CcE
Confidence 99987 77899999999 9999999987778999999999999999999999999999999999999986542 258
Q ss_pred EEEecccceecCCCC--------cccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCH-HHHHHH
Q 018640 199 KAIDFGLSVFFKPGE--------KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETE-QGVAQA 268 (352)
Q Consensus 199 kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~-~~~~~~ 268 (352)
||+|||+++...... ......||+.|+|||++.+ .++.++||||||+++|||++|..||..... ......
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 999999998653221 1244579999999999875 489999999999999999999999965321 111111
Q ss_pred HHhccc-ccCC-----CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 269 IIRSVL-DFRR-----DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 269 ~~~~~~-~~~~-----~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
...... ..+. .....+++.+.++|..||+.||++|||+.+|++.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 273 AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 111111 1110 0112688999999999999999999999999773
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=325.57 Aligned_cols=247 Identities=24% Similarity=0.340 Sum_probs=208.2
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
...++|++++.||+|+||+||+|.+. ++..||+|++.... ...+.+.+|+.+++.+ +||||+++++++.. +..
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-~~~ 82 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQL-QHQRLVRLYAVVTQ-EPI 82 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSC
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc----ccHHHHHHHHHHHHhC-CCcCcceEEEEEcC-CCc
Confidence 34568999999999999999999975 57789999986532 2357899999999999 89999999998864 468
Q ss_pred EEEEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 132 HLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
++||||+++++|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||+++.++ .+||+|||++...
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~---~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL---SCKIADFGLARLI 159 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS---CEEECCCTTCEEC
T ss_pred EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCC---CEEECCCcccccc
Confidence 89999999999999997543 699999999999999999999999999999999999997554 4899999999876
Q ss_pred CCCCc--ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCC
Q 018640 210 KPGEK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (352)
Q Consensus 210 ~~~~~--~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (352)
..... .....++..|+|||.+. +.++.++||||||+++++|++ |..||......+....+.... .......++
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~ 236 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY---RMVRPDNCP 236 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC---CCCCCTTCC
T ss_pred cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhccc---CCCCccccc
Confidence 54332 12345678899999987 558899999999999999999 999998887776665554432 223345789
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 286 ENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 286 ~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
+.+.+++..||+.||++|||+.++++
T Consensus 237 ~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 237 EELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHhccChhhCCCHHHHHH
Confidence 99999999999999999999999976
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=371.14 Aligned_cols=264 Identities=25% Similarity=0.401 Sum_probs=212.8
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe-----
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED----- 127 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~----- 127 (352)
..++|++.+.||+|+||+||+|.+..+|+.||+|++... ......+.+.+|+.+++++ +||||+++++++..
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~v~~~~~~~~ 88 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKL-NHPNVVSAREVPDGLQKLA 88 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHC-CBTTBCCEEECCTTTCCCC
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhC-CCCCCCceeeeeccccccc
Confidence 346899999999999999999999999999999998654 2344567899999999999 89999999998755
Q ss_pred -CCeEEEEEEecCCcchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEec
Q 018640 128 -DTAVHLVMELCEGGELFDRIVARG---HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDF 203 (352)
Q Consensus 128 -~~~~~lv~e~~~~~sL~~~l~~~~---~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Df 203 (352)
.+..++||||++|++|.+++.... .+++..++.++.|++.||.|||+.||+||||||+||+++.++....+||+||
T Consensus 89 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 89 PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp TTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred CCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccc
Confidence 677899999999999999998654 5899999999999999999999999999999999999998777667899999
Q ss_pred ccceecCCCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---------H-H--
Q 018640 204 GLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQA---------I-I-- 270 (352)
Q Consensus 204 g~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~---------~-~-- 270 (352)
|++.............||+.|+|||.+. ..++.++||||||+++|+|++|..||........... . .
T Consensus 169 G~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 248 (676)
T 3qa8_A 169 GYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248 (676)
T ss_dssp CCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred ccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence 9998876665556678999999999987 5589999999999999999999999976533211000 0 0
Q ss_pred --hccccc------CCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 271 --RSVLDF------RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 271 --~~~~~~------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
.....+ +......+++.+.++|..||++||++|||+.++++||||+...
T Consensus 249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~ 305 (676)
T 3qa8_A 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD 305 (676)
T ss_dssp CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHH
T ss_pred hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHH
Confidence 000000 0111223578899999999999999999999999999998653
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=342.88 Aligned_cols=248 Identities=15% Similarity=0.194 Sum_probs=199.9
Q ss_pred cccceeceeeeccCceEEEEEEECC--------CCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeE-----
Q 018640 54 EERYELGRELGRGEFGITYLCTDRE--------NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC----- 120 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~----- 120 (352)
.++|++.+.||+|+||+||+|.+.. +++.||+|++... +.+.+|+.+++++ +||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l-~h~niv~~~~~~ 111 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRA-AKPLQVNKWKKL 111 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHH-CCHHHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHh-cccchhhhhhhh
Confidence 4689999999999999999999987 4889999998643 3577899999999 8999887
Q ss_pred ----------eeeEEEe-CCeEEEEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCce
Q 018640 121 ----------LKDTYED-DTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENF 187 (352)
Q Consensus 121 ----------l~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NI 187 (352)
+++++.. .+..++||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI 190 (352)
T 2jii_A 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI 190 (352)
T ss_dssp TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 5677765 67899999999 99999999876 6799999999999999999999999999999999999
Q ss_pred EeecCCCCCCEEEEecccceecCCCC--------cccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCC
Q 018640 188 LFANKKETAPLKAIDFGLSVFFKPGE--------KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFW 258 (352)
Q Consensus 188 ll~~~~~~~~vkl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~ 258 (352)
+++.++. ..+||+|||++....... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.
T Consensus 191 l~~~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 191 FVDPEDQ-SQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEETTEE-EEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEcCCCC-ceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9986541 148999999997654321 1234479999999999875 58999999999999999999999997
Q ss_pred CCC-HHHHHHHHHhcccccCCC------CCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 259 AET-EQGVAQAIIRSVLDFRRD------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 259 ~~~-~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
... .................. .+..+++.+.++|.+||+.||++|||+.++++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 270 NCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp GGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred cCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 654 222222222221111111 123568999999999999999999999999773
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=335.47 Aligned_cols=250 Identities=24% Similarity=0.342 Sum_probs=202.0
Q ss_pred ceeceeeeccCceEEEEEEECCCCcEEEEEEcccccc-CChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEE
Q 018640 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL-RTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (352)
Q Consensus 57 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 135 (352)
|...+.||+|+||+||+|.+ ++..||+|++..... ......+.+.+|+.+++.+ +||||+++++++...+..++||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 109 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-QHENLVELLGFSSDGDDLCLVY 109 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc-CCCCeEEEEEEEecCCceEEEE
Confidence 44558999999999999986 588999999865432 2233467899999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 136 ELCEGGELFDRIVA---RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 136 e~~~~~sL~~~l~~---~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++ .+||+|||++......
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~---~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAF---TAKISDFGLARASEKF 186 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC---CEEECCCTTCEECCSC
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC---cEEEeecccccccccc
Confidence 99999999999874 34599999999999999999999999999999999999997554 4899999999865432
Q ss_pred Cc---ccccccccccccchhccccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-----------ccCC
Q 018640 213 EK---FSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL-----------DFRR 278 (352)
Q Consensus 213 ~~---~~~~~gt~~y~aPE~~~~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~-----------~~~~ 278 (352)
.. .....||+.|+|||.+.+.++.++||||||+++|+|++|..||...........+..... ....
T Consensus 187 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (307)
T 2nru_A 187 AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMN 266 (307)
T ss_dssp SSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCS
T ss_pred cccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccc
Confidence 21 234578999999999888899999999999999999999999976543222111111110 1111
Q ss_pred CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 279 DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 279 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
......++.+.+++.+||+.||.+|||+.+++++
T Consensus 267 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 267 DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1223345778999999999999999999999864
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=337.15 Aligned_cols=250 Identities=26% Similarity=0.436 Sum_probs=187.8
Q ss_pred ccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEE----
Q 018640 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE---- 126 (352)
Q Consensus 51 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~---- 126 (352)
.....+|++.+.||+|+||+||+|.+..+|+.||+|++... .....+.+.+|+.++.++.+||||+++++++.
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 100 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE 100 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence 34456899999999999999999999999999999988543 33445678899999999966999999999984
Q ss_pred ----eCCeEEEEEEecCCcchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC--CEEecCCCCceEeecCCCCCC
Q 018640 127 ----DDTAVHLVMELCEGGELFDRIVA---RGHYTERAAAAVTKTIVEVVQMCHKHG--VMHRDLKPENFLFANKKETAP 197 (352)
Q Consensus 127 ----~~~~~~lv~e~~~~~sL~~~l~~---~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dikp~NIll~~~~~~~~ 197 (352)
.....++||||++ |+|.+++.. ...+++..++.++.||+.||.|||+.| |+||||||+|||++.++.
T Consensus 101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~--- 176 (337)
T 3ll6_A 101 ESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT--- 176 (337)
T ss_dssp TSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC---
T ss_pred ccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC---
Confidence 3446899999995 699988864 456999999999999999999999999 999999999999976554
Q ss_pred EEEEecccceecCCCCcc-------------cccccccccccchhcc----ccCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 018640 198 LKAIDFGLSVFFKPGEKF-------------SEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAE 260 (352)
Q Consensus 198 vkl~Dfg~a~~~~~~~~~-------------~~~~gt~~y~aPE~~~----~~~s~~~Di~SlG~~l~el~tg~~p~~~~ 260 (352)
+||+|||++......... ....||+.|+|||++. ..++.++||||||+++|+|++|..||...
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 899999999876433221 1446899999999873 34788999999999999999999999765
Q ss_pred CHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCc
Q 018640 261 TEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHP 313 (352)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp 313 (352)
...... ... .........+..+.+||.+||+.||++|||+.|++++-
T Consensus 257 ~~~~~~----~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 257 AKLRIV----NGK--YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp ---------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred hHHHhh----cCc--ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 443221 111 12223345678899999999999999999999999874
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=349.53 Aligned_cols=247 Identities=23% Similarity=0.330 Sum_probs=204.8
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
...++|++.+.||+|+||+||+|.+.. +..||||++.... ...+.+.+|+.+++++ +||||+++++++.. +..
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~-~~~ 253 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT----MSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPI 253 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS----SCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC----CCHHHHHHHHHHHHhC-CCCCEeeEEEEEcC-Cce
Confidence 345679999999999999999999864 5679999987543 2356899999999999 89999999999876 678
Q ss_pred EEEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 132 HLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++. +||+|||+++..
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~---~kl~DfG~a~~~ 330 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV---CKVADFGLARLI 330 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC---EEECCCCTTC--
T ss_pred EEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCC---EEECCCccceec
Confidence 9999999999999999743 46999999999999999999999999999999999999976554 899999999865
Q ss_pred CCCCc--ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCC
Q 018640 210 KPGEK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (352)
Q Consensus 210 ~~~~~--~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (352)
..... .....+|..|+|||.+. +.++.++||||||+++|||++ |..||......+....+... .+...++.++
T Consensus 331 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~---~~~~~~~~~~ 407 (452)
T 1fmk_A 331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECP 407 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT---CCCCCCTTSC
T ss_pred CCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCC
Confidence 43321 12345678999999876 568999999999999999999 99999888877766665543 2233445789
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 286 ENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 286 ~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
+.+.++|.+||+.||++|||+.++++
T Consensus 408 ~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 408 ESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999999999999987
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=327.93 Aligned_cols=248 Identities=21% Similarity=0.308 Sum_probs=202.0
Q ss_pred cceeceeeeccCceEEEEEEECCCCc---EEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE-
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGD---AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV- 131 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~- 131 (352)
.|.+.+.||+|+||+||+|.+..++. .||+|.+... ......+.+.+|+.+++.+ +||||+++++++...+..
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 98 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGL-NHPNVLALIGIMLPPEGLP 98 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSSSCC
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEecCCCCc
Confidence 57788999999999999999765544 7999988653 2344567889999999999 899999999999766654
Q ss_pred EEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 132 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
++||||+.+++|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++ .+||+|||++....
T Consensus 99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~---~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESF---TVKVADFGLARDIL 175 (298)
T ss_dssp EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC---CEEECCTTSSCTTT
T ss_pred EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC---cEEeCcCCCccccc
Confidence 9999999999999999763 4689999999999999999999999999999999999997554 48999999997553
Q ss_pred CCC-----cccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhcccccCCCCCcC
Q 018640 211 PGE-----KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPP-FWAETEQGVAQAIIRSVLDFRRDPWPK 283 (352)
Q Consensus 211 ~~~-----~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (352)
... ......+|..|+|||.+.+ .++.++||||||+++|+|++|..| |...........+.... .......
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 252 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR---RLPQPEY 252 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC---CCCCCTT
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC---CCCCCcc
Confidence 321 2234567899999999874 589999999999999999995555 54444444444443322 2223456
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 284 ~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
+++.+.++|.+||+.||.+|||+.++++.
T Consensus 253 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 253 CPDSLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 88999999999999999999999999773
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=327.19 Aligned_cols=242 Identities=23% Similarity=0.375 Sum_probs=198.6
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC-CeEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD-TAVH 132 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~-~~~~ 132 (352)
.++|++.+.||+|+||+||+|.+. |+.||+|++... ...+.+.+|+.+++++ +||||+++++++... +..+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 91 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLY 91 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-----C--HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CCE
T ss_pred hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch-----hHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCCceE
Confidence 468999999999999999999874 889999998643 2456789999999999 899999999987544 5789
Q ss_pred EEEEecCCcchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 133 LVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~--l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
+||||+++++|.+++..... +++..+..++.|++.||.|||+.|++|+||||+||+++.++ .+||+|||++....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~---~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN---VAKVSDFGLTKEAS 168 (278)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS---CEEECCCCC-----
T ss_pred EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCC---cEEEeecccccccc
Confidence 99999999999999976543 89999999999999999999999999999999999997554 48999999997654
Q ss_pred CCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHH
Q 018640 211 PGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (352)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (352)
... ....+++.|+|||.+. ..++.++||||||+++|+|++ |..||...........+... ........+++.+
T Consensus 169 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l 243 (278)
T 1byg_A 169 STQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---YKMDAPDGCPPAV 243 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT---CCCCCCTTCCHHH
T ss_pred ccc--cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC---CCCCCcccCCHHH
Confidence 322 2336788999999986 458999999999999999998 99999887776665555433 2333445789999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhc
Q 018640 289 KDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 289 ~~li~~~l~~dP~~Rps~~ell~ 311 (352)
.++|..||+.||++|||+.++++
T Consensus 244 ~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 244 YEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCChhhCCCHHHHHH
Confidence 99999999999999999999976
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=327.65 Aligned_cols=251 Identities=21% Similarity=0.291 Sum_probs=202.7
Q ss_pred ccccceeceeeeccCceEEEEEEECCCC---cEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEE-EeC
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENG---DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTY-EDD 128 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~-~~~ 128 (352)
-..+|++.+.||+|+||+||+|.+..++ ..||+|.+... ......+.+.+|+.+++++ +||||+++++++ ..+
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 99 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSE 99 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSS
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhC-CCCCEeeeeeEEEcCC
Confidence 3457999999999999999999975433 35899988653 2344567889999999999 899999999986 456
Q ss_pred CeEEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccce
Q 018640 129 TAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~ 207 (352)
+..++||||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||++.
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~---~~kl~Dfg~a~ 176 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF---TVKVADFGLAR 176 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC---CEEECSCGGGC
T ss_pred CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCC---CEEECcccccc
Confidence 6889999999999999999764 4589999999999999999999999999999999999997554 48999999998
Q ss_pred ecCCCC-----cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCC
Q 018640 208 FFKPGE-----KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDP 280 (352)
Q Consensus 208 ~~~~~~-----~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 280 (352)
...... ......+|+.|+|||.+. ..++.++||||||+++|+|++ |.+||...........+..... ...
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 253 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR---LLQ 253 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC---CCC
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC---CCC
Confidence 654332 123446788999999886 458999999999999999999 6667766665555555544322 223
Q ss_pred CcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 281 ~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
...+++.+.+++.+||+.||++|||+.++++.
T Consensus 254 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 285 (298)
T 3f66_A 254 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 285 (298)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 34678999999999999999999999999873
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=330.27 Aligned_cols=241 Identities=27% Similarity=0.416 Sum_probs=194.1
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++.+.||+|+||+||+|.+. ++.||+|++... ...+.+.+|+.+++++ +||||+++++++.+ ..++|
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~lv 77 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRV-NHPNIVKLYGACLN--PVCLV 77 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHC-CCTTBCCEEEBCTT--TTEEE
T ss_pred hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcC-CCCCcCeEEEEEcC--CcEEE
Confidence 57999999999999999999874 789999998532 3457789999999999 89999999998874 47899
Q ss_pred EEecCCcchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---cCCEEecCCCCceEeecCCCCCCEEEEeccccee
Q 018640 135 MELCEGGELFDRIVARG---HYTERAAAAVTKTIVEVVQMCHK---HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~---~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~ 208 (352)
|||+++++|.+++.... .++...+..++.|++.||.|||+ +||+||||||+||+++.++. .+||+|||++..
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~--~~kl~Dfg~~~~ 155 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT--VLKICDFGTACD 155 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT--EEEECCCCC---
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC--EEEEcccccccc
Confidence 99999999999998665 37899999999999999999999 89999999999999975543 279999999976
Q ss_pred cCCCCcccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcccccCCCCCcCCC
Q 018640 209 FKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQ--GVAQAIIRSVLDFRRDPWPKVS 285 (352)
Q Consensus 209 ~~~~~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 285 (352)
.... .....||+.|+|||++.+ .++.++||||||+++|||++|+.||...... ........ .........++
T Consensus 156 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 230 (307)
T 2eva_A 156 IQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN---GTRPPLIKNLP 230 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT---TCCCCCBTTCC
T ss_pred cccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc---CCCCCcccccC
Confidence 5432 234468999999999874 5899999999999999999999999754322 12222221 22333445789
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 286 ENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 286 ~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
+.+.++|.+||+.||++|||+.+++++
T Consensus 231 ~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 231 KPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 999999999999999999999999873
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=341.34 Aligned_cols=247 Identities=18% Similarity=0.227 Sum_probs=195.9
Q ss_pred cccccceeceeeeccCceEEEEE-----EECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCC--CCCeeEeeeE
Q 018640 52 EIEERYELGRELGRGEFGITYLC-----TDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK--HQNIVCLKDT 124 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~--h~~iv~l~~~ 124 (352)
...++|++.+.||+|+||+||+| .+..+++.||+|++... ....+.+|+.++..+.. |+||+.++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------NPWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------CHHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------ChhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 34568999999999999999999 46678999999998643 34578888999988832 8999999999
Q ss_pred EEeCCeEEEEEEecCCcchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeec--------
Q 018640 125 YEDDTAVHLVMELCEGGELFDRIVA-----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFAN-------- 191 (352)
Q Consensus 125 ~~~~~~~~lv~e~~~~~sL~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~-------- 191 (352)
+...+..++||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC---
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccc
Confidence 9999999999999999999999974 456999999999999999999999999999999999999976
Q ss_pred CCCCCCEEEEecccceecC---CCCcccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 018640 192 KKETAPLKAIDFGLSVFFK---PGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ 267 (352)
Q Consensus 192 ~~~~~~vkl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~ 267 (352)
+.....+||+|||+|.... .........||+.|+|||++.+ .++.++||||||+++|||++|+.||.......
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--- 292 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--- 292 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence 1224559999999997543 2334456689999999999874 48999999999999999999999996443210
Q ss_pred HHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 268 AIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
....... .....++.+.+++..||+.+|.+|++..+.+.+
T Consensus 293 ----~~~~~~~-~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 293 ----CKPEGLF-RRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp ----EEECSCC-TTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred ----eeechhc-cccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 0000000 011246778999999999999999654444443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=358.63 Aligned_cols=242 Identities=22% Similarity=0.306 Sum_probs=203.1
Q ss_pred eeeeccCceEEEEEEE--CCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEec
Q 018640 61 RELGRGEFGITYLCTD--RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELC 138 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~ 138 (352)
+.||+|+||+||+|.+ ..+++.||||++.... ......+.+.+|+.+++++ +|||||++++++.. +..++||||+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~-~~~~lv~E~~ 451 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQL-DNPYIVRMIGICEA-ESWMLVMEMA 451 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHC-CCTTBCCEEEEEES-SSEEEEEECC
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec-CCEEEEEEcc
Confidence 4799999999999954 4567899999987653 3344567899999999999 89999999999965 4588999999
Q ss_pred CCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCc----
Q 018640 139 EGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK---- 214 (352)
Q Consensus 139 ~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~---- 214 (352)
++|+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.......
T Consensus 452 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~---~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 452 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE---EEECCTTHHHHTTC-------
T ss_pred CCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCC---EEEEEcCCccccccCcccccc
Confidence 99999999998888999999999999999999999999999999999999987654 89999999986643322
Q ss_pred ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHH
Q 018640 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (352)
Q Consensus 215 ~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 292 (352)
.....+|+.|+|||++. ..++.++||||||+++|||++ |+.||......+....+.... ....+..+++++.+||
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~---~~~~p~~~~~~l~~li 605 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE---RMGCPAGCPREMYDLM 605 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC---CCCCCTTCCHHHHHHH
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCCHHHHHHH
Confidence 12335678899999987 469999999999999999998 999999888877666665432 2333457899999999
Q ss_pred HHhcCCCcCCCCCHHHHhc
Q 018640 293 RKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 293 ~~~l~~dP~~Rps~~ell~ 311 (352)
..||+.||++|||+.+|++
T Consensus 606 ~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 606 NLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHTCSSTTTSCCHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHH
Confidence 9999999999999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=347.43 Aligned_cols=254 Identities=20% Similarity=0.260 Sum_probs=206.4
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
.+.++|++++.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.+.++++++.+..++...+..
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~ 78 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYN 78 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence 467889999999999999999999999999999998765432 234778999999996667777787788888899
Q ss_pred EEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 132 HLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
++||||+ +++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||++.+.....+||+|||++....
T Consensus 79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9999999 8899999975 4569999999999999999999999999999999999999644445569999999998765
Q ss_pred CCCc--------ccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhccccc-C
Q 018640 211 PGEK--------FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETE---QGVAQAIIRSVLDF-R 277 (352)
Q Consensus 211 ~~~~--------~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~---~~~~~~~~~~~~~~-~ 277 (352)
.... .....||..|+|||++.+ .++.++||||||++||||++|+.||..... ......+....... .
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 4322 125689999999999874 589999999999999999999999976433 22222222221111 1
Q ss_pred CCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 278 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
......+++++.+||..||+.||++||++.+|++
T Consensus 238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1112357899999999999999999999998865
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=339.74 Aligned_cols=249 Identities=21% Similarity=0.303 Sum_probs=196.0
Q ss_pred ccceeceeeeccCceEEEEEEECCCC---cEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEE-eCCe
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENG---DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE-DDTA 130 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~-~~~~ 130 (352)
..|++.+.||+|+||+||+|.+..++ ..||+|.+... ......+.+.+|+.+++++ +||||+++++++. .++.
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~ 165 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGS 165 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTC-CCTTBCCCCEEECCCSSC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCCC
Confidence 45889999999999999999975433 46899988643 2344567899999999999 8999999999865 4567
Q ss_pred EEEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 131 VHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~---~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF---TVKVADFGLARDM 242 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC---CEEECCC------
T ss_pred eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCC---CEEEeeccccccc
Confidence 899999999999999997654 589999999999999999999999999999999999997554 4899999999865
Q ss_pred CCCC-----cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCc
Q 018640 210 KPGE-----KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282 (352)
Q Consensus 210 ~~~~-----~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (352)
.... ......+|+.|+|||.+. ..++.++||||||+++|||++ |.+||......+....+.... ....+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~---~~~~p~ 319 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR---RLLQPE 319 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC---CCCCCT
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC---CCCCCC
Confidence 3322 113346788999999886 558999999999999999999 777887666555554444332 222335
Q ss_pred CCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 283 ~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
.+++.+.++|.+||+.||++|||+.+++++
T Consensus 320 ~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 320 YCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 689999999999999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=354.84 Aligned_cols=252 Identities=25% Similarity=0.333 Sum_probs=205.2
Q ss_pred ccceece-eeeccCceEEEEEEEC--CCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 55 ERYELGR-ELGRGEFGITYLCTDR--ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 55 ~~y~~~~-~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
+++.+.+ .||+|+||+||+|.+. .++..||||++.... .....+.+.+|+.+|+++ +|||||++++++.. +..
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~~~ 410 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA-EAL 410 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTC-CCTTBCCEEEEEES-SSE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhC-CCCCEeeEEEEecc-CCe
Confidence 3455555 8999999999999875 356679999997642 334567899999999999 89999999999976 568
Q ss_pred EEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 132 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++. +||+|||+++...
T Consensus 411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~---vkL~DFGla~~~~ 487 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHY---AKISDFGLSKALG 487 (613)
T ss_dssp EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE---EEECCCSTTTTCC
T ss_pred EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCc---EEEeeccCccccc
Confidence 9999999999999999754 45999999999999999999999999999999999999986654 8999999998654
Q ss_pred CCCcc----cccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCC
Q 018640 211 PGEKF----SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (352)
Q Consensus 211 ~~~~~----~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (352)
..... ....+|+.|+|||++. +.++.++||||||+++|||++ |+.||......+....+.... ....+..+
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~---~~~~p~~~ 564 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---RMECPPEC 564 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC---CCCCCTTC
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC---CCCCCCcC
Confidence 33211 2234568899999986 569999999999999999998 999998887776666555432 23344578
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHh---cCcccc
Q 018640 285 SENAKDLVRKMLDPDPKRRLTAQQVL---EHPWLQ 316 (352)
Q Consensus 285 ~~~~~~li~~~l~~dP~~Rps~~ell---~hp~f~ 316 (352)
++.+.++|..||+.||++|||+.+|+ ++.|+.
T Consensus 565 ~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 565 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp CHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999999999999984 444444
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=329.26 Aligned_cols=253 Identities=23% Similarity=0.345 Sum_probs=204.4
Q ss_pred cccccceeceeeeccCceEEEEEE----ECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe
Q 018640 52 EIEERYELGRELGRGEFGITYLCT----DRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 127 (352)
...++|++++.||+|+||.||+|. +..+|+.||+|++... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 113 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSL-QHDNIVKYKGVCYS 113 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTC-CCTTBCCEEEEECC
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEe
Confidence 445679999999999999999998 4568999999998753 334457899999999999 89999999999865
Q ss_pred CC--eEEEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecc
Q 018640 128 DT--AVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (352)
Q Consensus 128 ~~--~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg 204 (352)
.+ ..++||||+++++|.+++.... .+++..++.++.|++.||.|||+.|++||||||+||+++.++. +||+|||
T Consensus 114 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~---~kL~Dfg 190 (326)
T 2w1i_A 114 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFG 190 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE---EEECCCT
T ss_pred cCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCc---EEEecCc
Confidence 43 7899999999999999998764 5999999999999999999999999999999999999986654 8999999
Q ss_pred cceecCCCCc----ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHH------------HHHH
Q 018640 205 LSVFFKPGEK----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ------------GVAQ 267 (352)
Q Consensus 205 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~------------~~~~ 267 (352)
++........ .....++..|+|||.+. ..++.++||||||+++++|++|..||...... ....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHH
T ss_pred chhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHH
Confidence 9987654332 12345678899999886 45889999999999999999999988543111 0111
Q ss_pred HHHhccc-ccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 268 AIIRSVL-DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 268 ~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
.+..... .........+++.+.++|.+||+.||++|||+.++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 271 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1111111 1122334578999999999999999999999999985
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=350.70 Aligned_cols=248 Identities=23% Similarity=0.321 Sum_probs=209.3
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
...++|++.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+.+|+++ +|+||+++++++.+ +..
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT----MSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS----SCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSC
T ss_pred cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC----CCHHHHHHHHHHHHhC-CCCCEeeEEEEEee-ccc
Confidence 345689999999999999999999864 5679999987543 2357899999999999 89999999999876 678
Q ss_pred EEEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 132 HLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++. +||+|||+++..
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~---~kl~DFG~a~~~ 413 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV---CKVADFGLARLI 413 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC---EEECCTTSTTTC
T ss_pred eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCc---EEEcccccceec
Confidence 9999999999999999743 46999999999999999999999999999999999999976544 899999999865
Q ss_pred CCCCc--ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCC
Q 018640 210 KPGEK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (352)
Q Consensus 210 ~~~~~--~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (352)
..... .....++..|+|||++. +.++.++||||||+++|||++ |+.||......+....+.... .......++
T Consensus 414 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~---~~~~~~~~~ 490 (535)
T 2h8h_A 414 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY---RMPCPPECP 490 (535)
T ss_dssp CCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC---CCCCCTTCC
T ss_pred CCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCC
Confidence 43211 12335678899999876 568999999999999999999 999998888777666665432 233345789
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 286 ENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 286 ~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
+.+.+||.+||+.||++|||+.+|++.
T Consensus 491 ~~l~~li~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 491 ESLHDLMCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 999999999999999999999999873
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=329.87 Aligned_cols=250 Identities=23% Similarity=0.350 Sum_probs=193.5
Q ss_pred cccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhC-CCCCCeeEeeeEEEeC
Q 018640 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL-PKHQNIVCLKDTYEDD 128 (352)
Q Consensus 50 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~~h~~iv~l~~~~~~~ 128 (352)
...+.++|++++.||+|+||.||+|.+. |+.||+|++... ....+.+|.+++..+ .+||||+++++++...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT------EEASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc------ccchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 4467789999999999999999999875 899999998543 223444555555543 2899999999999877
Q ss_pred ----CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CCEEecCCCCceEeecCCCCC
Q 018640 129 ----TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH--------GVMHRDLKPENFLFANKKETA 196 (352)
Q Consensus 129 ----~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~--------~ivH~Dikp~NIll~~~~~~~ 196 (352)
...++||||+++++|.+++... .+++..++.++.|++.||.|||+. ||+||||||+|||++.++.
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~-- 180 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT-- 180 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC--
T ss_pred CCCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC--
Confidence 7899999999999999999665 699999999999999999999998 9999999999999976554
Q ss_pred CEEEEecccceecCCCCcc-----cccccccccccchhcccc-CCCc------chHHHHHHHHHHHHhC----------C
Q 018640 197 PLKAIDFGLSVFFKPGEKF-----SEIVGSPYYMAPEVLKRN-YGPE------VDVWSAGVILYILLCG----------V 254 (352)
Q Consensus 197 ~vkl~Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~-~s~~------~Di~SlG~~l~el~tg----------~ 254 (352)
+||+|||++......... ....||+.|+|||++.+. .+.. +||||||+++|||++| .
T Consensus 181 -~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 181 -CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp -EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred -EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 899999999765433221 245799999999998744 4443 8999999999999999 6
Q ss_pred CCCCCCCH----HHHHHHHHhcccccCCCCC-----cCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 255 PPFWAETE----QGVAQAIIRSVLDFRRDPW-----PKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 255 ~p~~~~~~----~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
.||..... .......... ........ ..+++.+.++|.+||+.||.+|||+.+++++
T Consensus 260 ~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 260 LPYHDLVPSDPSYEDMREIVCI-KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTT-SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ccHhhhcCCCCchhhhHHHHhh-hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 77754321 1122222211 11111111 1356779999999999999999999999885
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=341.99 Aligned_cols=249 Identities=17% Similarity=0.211 Sum_probs=192.8
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCC-CCeeE---------ee--
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH-QNIVC---------LK-- 122 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~~iv~---------l~-- 122 (352)
..|++.+.||+|+||+||+|.+..+|+.||||++...........+.+.+|+.+++.+ .| +|... ..
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l-~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL-RGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGS-TTCCSHHHHHHHTCBCCCCEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhh-ccCCCHHHHHHhcccccchhh
Confidence 4588999999999999999999999999999998755444444567899999999999 54 32211 11
Q ss_pred ----------eEEEe-----CCeEEEEEEecCCcchHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEe
Q 018640 123 ----------DTYED-----DTAVHLVMELCEGGELFDRIVA-------RGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180 (352)
Q Consensus 123 ----------~~~~~-----~~~~~lv~e~~~~~sL~~~l~~-------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~ 180 (352)
.++.. ....+++|+++ +++|.+++.. ...+++..+..++.|++.||+|||++||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 11111 12456777776 6799988841 2237788999999999999999999999999
Q ss_pred cCCCCceEeecCCCCCCEEEEecccceecCCCCcccccccccccccchhc----------cc-cCCCcchHHHHHHHHHH
Q 018640 181 DLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVL----------KR-NYGPEVDVWSAGVILYI 249 (352)
Q Consensus 181 Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~----------~~-~~s~~~Di~SlG~~l~e 249 (352)
||||+|||++.++. +||+|||+++..... .....| +.|+|||++ .. .++.++|||||||++||
T Consensus 236 DiKp~NILl~~~~~---~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 236 YLRPVDIVLDQRGG---VFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp CCCGGGEEECTTCC---EEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred CcccceEEEecCCe---EEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 99999999986655 899999998865432 345577 999999987 32 37789999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 250 LLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 250 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
|++|+.||...........+ ......+++.+.+||.+||+.||++|||+.++++||||++..
T Consensus 310 lltg~~Pf~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 310 IWCADLPNTDDAALGGSEWI--------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 371 (413)
T ss_dssp HHHSSCCCCTTGGGSCSGGG--------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred HHHCCCCCCCcchhhhHHHH--------HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHH
Confidence 99999999765543221111 112346789999999999999999999999999999998753
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=326.97 Aligned_cols=249 Identities=23% Similarity=0.341 Sum_probs=200.2
Q ss_pred cccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhC-CCCCCeeEeeeEEEeC
Q 018640 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL-PKHQNIVCLKDTYEDD 128 (352)
Q Consensus 50 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~~h~~iv~l~~~~~~~ 128 (352)
+..+.++|++.+.||+|+||+||+|.+ +|+.||+|++... ....+.+|++++..+ .+||||+++++++...
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 456778999999999999999999997 4899999998543 245677899999883 2899999999999877
Q ss_pred C----eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HcCCEEecCCCCceEeecCCCCC
Q 018640 129 T----AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH--------KHGVMHRDLKPENFLFANKKETA 196 (352)
Q Consensus 129 ~----~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH--------~~~ivH~Dikp~NIll~~~~~~~ 196 (352)
. ..++||||+++++|.+++... .+++..++.++.|++.||.||| +.+|+||||||+||+++.++.
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~-- 185 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT-- 185 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC--
T ss_pred CCccceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC--
Confidence 5 789999999999999999764 6999999999999999999999 899999999999999976554
Q ss_pred CEEEEecccceecCCCC-----cccccccccccccchhcccc-------CCCcchHHHHHHHHHHHHhC----------C
Q 018640 197 PLKAIDFGLSVFFKPGE-----KFSEIVGSPYYMAPEVLKRN-------YGPEVDVWSAGVILYILLCG----------V 254 (352)
Q Consensus 197 ~vkl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-------~s~~~Di~SlG~~l~el~tg----------~ 254 (352)
+||+|||++....... ......||+.|+|||.+.+. ++.++||||||+++|||++| .
T Consensus 186 -~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 186 -CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp -EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred -EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 8999999998765433 12445799999999998653 23589999999999999999 7
Q ss_pred CCCCCCCH-----HHHHHHHHhcccccCCCCC-----cCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 255 PPFWAETE-----QGVAQAIIRSVLDFRRDPW-----PKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 255 ~p~~~~~~-----~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
.||..... ......+.... ..+... ...++.+.++|.+||+.||++|||+.+++++
T Consensus 265 ~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 265 LPYYDLVPSDPSVEEMRKVVCEQK--LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSC--CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCccccCcCcccHHHHHHHHHHHH--hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 88865421 22222222211 111111 1234678999999999999999999999875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=329.45 Aligned_cols=255 Identities=24% Similarity=0.320 Sum_probs=188.9
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHH--HhCCCCCCeeEeeeEEE-----
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIM--RHLPKHQNIVCLKDTYE----- 126 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l--~~l~~h~~iv~l~~~~~----- 126 (352)
-++|++++.||+|+||+||+|.+ +++.||+|++.... ...+..|..++ ..+ +||||+++++.+.
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~-~h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLM-EHDNIARFIVGDERVTAD 82 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECTT
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhc-cCcchhhheecccccccC
Confidence 35799999999999999999976 58999999986432 23444444444 446 8999999998653
Q ss_pred eCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---------CCEEecCCCCceEeecCCCCCC
Q 018640 127 DDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH---------GVMHRDLKPENFLFANKKETAP 197 (352)
Q Consensus 127 ~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~---------~ivH~Dikp~NIll~~~~~~~~ 197 (352)
.....++||||+++|+|.+++... ..++..++.++.|++.||.|||+. ||+||||||+|||++.++ .
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~---~ 158 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG---T 158 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS---C
T ss_pred CCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC---c
Confidence 233678999999999999999765 458999999999999999999999 999999999999997654 4
Q ss_pred EEEEecccceecCCCC---------cccccccccccccchhccc--------cCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 018640 198 LKAIDFGLSVFFKPGE---------KFSEIVGSPYYMAPEVLKR--------NYGPEVDVWSAGVILYILLCGVPPFWAE 260 (352)
Q Consensus 198 vkl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~--------~~s~~~Di~SlG~~l~el~tg~~p~~~~ 260 (352)
+||+|||++....... ......||+.|+|||++.+ .++.++||||||+++|||++|..||...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 8999999998764321 1234579999999998864 3567899999999999999997776432
Q ss_pred CH-----------------HHHHHHHHhcccccCCCCCc------CCCHHHHHHHHHhcCCCcCCCCCHHHH------hc
Q 018640 261 TE-----------------QGVAQAIIRSVLDFRRDPWP------KVSENAKDLVRKMLDPDPKRRLTAQQV------LE 311 (352)
Q Consensus 261 ~~-----------------~~~~~~~~~~~~~~~~~~~~------~~~~~~~~li~~~l~~dP~~Rps~~el------l~ 311 (352)
.. ........... ...+.... ..++.+.+||.+||+.||++|||+.|+ +-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSRE-KQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTS-CCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhccc-ccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 11 11111111111 11111111 134579999999999999999999999 55
Q ss_pred CccccccccCC
Q 018640 312 HPWLQNAKKAP 322 (352)
Q Consensus 312 hp~f~~~~~~~ 322 (352)
++|-++....+
T Consensus 318 ~~~~~~~~~~~ 328 (336)
T 3g2f_A 318 MIWERNKSVSP 328 (336)
T ss_dssp HCCCC------
T ss_pred HHHHhcccCCC
Confidence 67877765443
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=328.03 Aligned_cols=253 Identities=21% Similarity=0.335 Sum_probs=206.3
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
..++|++.+.||+|+||+||+|.+.. .||+|++..... .....+.+.+|+.+++++ +||||+++++++...+..+
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 105 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQT-RHENVVLFMGACMSPPHLA 105 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTC-CCTTBCCCCEEEECSSCEE
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcC-CCCCEeEEEEEEecCCceE
Confidence 34679999999999999999999753 499999876532 223345677899999999 8999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 133 LVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
+||||+++++|.+++.... .+++..++.++.|++.||.|||+.|++||||||+||++++ + .+||+|||++.....
T Consensus 106 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~~-~---~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDN-G---KVVITDFGLFSISGV 181 (319)
T ss_dssp EECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC------CCEECCCSCCC----
T ss_pred EEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEeC-C---CEEEeecCCcccccc
Confidence 9999999999999997755 6999999999999999999999999999999999999962 2 479999999865421
Q ss_pred C------Ccccccccccccccchhccc----------cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc
Q 018640 212 G------EKFSEIVGSPYYMAPEVLKR----------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD 275 (352)
Q Consensus 212 ~------~~~~~~~gt~~y~aPE~~~~----------~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 275 (352)
. .......||+.|+|||.+.+ .++.++||||||+++|+|++|..||...........+......
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 261 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP 261 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCC
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCC
Confidence 1 12234468999999998753 3678999999999999999999999888877666555443221
Q ss_pred cCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 276 FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 276 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
......+++.+.++|..||+.||++|||+.++++ .++..
T Consensus 262 --~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l 300 (319)
T 2y4i_B 262 --NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKL 300 (319)
T ss_dssp --CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC
T ss_pred --CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHH
Confidence 1222357899999999999999999999999987 44444
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=338.23 Aligned_cols=250 Identities=16% Similarity=0.252 Sum_probs=194.6
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccC-----ChhcHHHHHHHHHHHHhCC--------CCCCeeE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR-----TAVDIEDVRREVDIMRHLP--------KHQNIVC 120 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~--------~h~~iv~ 120 (352)
.++|++++.||+|+||+||+|.+ +|+.||+|++...... .....+.+.+|+.+++.+. .||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46899999999999999999997 6899999999875422 2234578899999999884 3666666
Q ss_pred eeeEE-----------------Ee-------------CCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 018640 121 LKDTY-----------------ED-------------DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ 170 (352)
Q Consensus 121 l~~~~-----------------~~-------------~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~ 170 (352)
+.+.+ .. .+..++||||+++|++.+.+.. ..+++..++.++.||+.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence 66553 32 6789999999999987776644 56899999999999999999
Q ss_pred HHH-HcCCEEecCCCCceEeecCCC-----------------CCCEEEEecccceecCCCCcccccccccccccchhccc
Q 018640 171 MCH-KHGVMHRDLKPENFLFANKKE-----------------TAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR 232 (352)
Q Consensus 171 ~lH-~~~ivH~Dikp~NIll~~~~~-----------------~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~ 232 (352)
||| ++||+||||||+|||++.++. ...+||+|||+|+..... ...||+.|+|||++.+
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g 251 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG 251 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC
Confidence 999 999999999999999987651 225999999999876432 3479999999999987
Q ss_pred cCCCcchHHHHHHH-HHHHHhCCCCCCCCCH-HHHHHHHHhcccccCCCC----CcCCCHHHHHHHHHhcCCCcCCCCCH
Q 018640 233 NYGPEVDVWSAGVI-LYILLCGVPPFWAETE-QGVAQAIIRSVLDFRRDP----WPKVSENAKDLVRKMLDPDPKRRLTA 306 (352)
Q Consensus 233 ~~s~~~Di~SlG~~-l~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~ 306 (352)
..+.++||||++++ .+++++|..||..... ......+.... ...... ++.+++++.+||.+||+.| |+
T Consensus 252 ~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa 325 (336)
T 2vuw_A 252 DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQM-TFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SA 325 (336)
T ss_dssp CSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTC-CCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SH
T ss_pred CCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhh-ccCcccchhhhhhcCHHHHHHHHHHhccC-----CH
Confidence 77889999998877 6678889999843211 11222222211 111111 2246888999999999976 99
Q ss_pred HHHh-cCcccc
Q 018640 307 QQVL-EHPWLQ 316 (352)
Q Consensus 307 ~ell-~hp~f~ 316 (352)
.|+| +||||+
T Consensus 326 ~e~l~~Hp~f~ 336 (336)
T 2vuw_A 326 TDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHCGGGC
T ss_pred HHHHhcCCCcC
Confidence 9999 999995
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=348.73 Aligned_cols=249 Identities=27% Similarity=0.349 Sum_probs=206.9
Q ss_pred ccccceeceeeeccCceEEEEEEECCC---CcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC
Q 018640 53 IEERYELGRELGRGEFGITYLCTDREN---GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 129 (352)
..++|++.+.||+|+||+||+|.+..+ +..||+|++... ......+.+.+|+.+++++ +||||+++++++. ++
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-EN 463 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEC-SS
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEe-cC
Confidence 446899999999999999999998643 457999988653 2334457899999999999 8999999999985 45
Q ss_pred eEEEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccccee
Q 018640 130 AVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (352)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~ 208 (352)
..++||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||++..
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~---vkL~DFG~a~~ 540 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC---VKLGDFGLSRY 540 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE---EEECCCCCCCS
T ss_pred ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCC---EEEEecCCCee
Confidence 6899999999999999998654 6899999999999999999999999999999999999987654 89999999987
Q ss_pred cCCCCc--ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCC
Q 018640 209 FKPGEK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (352)
Q Consensus 209 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (352)
...... .....+|+.|+|||.+. ..++.++||||||+++|||++ |..||......+....+.... ....++.+
T Consensus 541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~ 617 (656)
T 2j0j_A 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE---RLPMPPNC 617 (656)
T ss_dssp CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTC---CCCCCTTC
T ss_pred cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC---CCCCCccc
Confidence 644322 22345678999999886 458999999999999999997 999998888777666665432 22344578
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 285 SENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 285 ~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
++.+.++|.+||+.||++|||+.++++
T Consensus 618 ~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 618 PPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999999999975
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=360.37 Aligned_cols=246 Identities=24% Similarity=0.361 Sum_probs=204.6
Q ss_pred CCcccccccceeceeeeccCceEEEEEEECC-CCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEE
Q 018640 48 PTGREIEERYELGRELGRGEFGITYLCTDRE-NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (352)
Q Consensus 48 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~ 126 (352)
..+..+.++|++++.||+|+||+||+|.+.. +|+.||||++... ........+.+|+.+++++ +||||+++++++.
T Consensus 73 ~~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 149 (681)
T 2pzi_A 73 NPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEV-VHPSIVQIFNFVE 149 (681)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS--CCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEE
T ss_pred CCCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc--CCHHHHHHHHHHHHHHHhc-CCCCcCeEeeeEe
Confidence 4566788999999999999999999999976 7899999988653 2334456788999999999 8999999999998
Q ss_pred eCCe-----EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEE
Q 018640 127 DDTA-----VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAI 201 (352)
Q Consensus 127 ~~~~-----~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~ 201 (352)
..+. .++||||++|++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+
T Consensus 150 ~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~----~~kl~ 223 (681)
T 2pzi_A 150 HTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE----QLKLI 223 (681)
T ss_dssp EECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS----CEEEC
T ss_pred ecCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC----cEEEE
Confidence 7665 7999999999999988755 79999999999999999999999999999999999999753 48999
Q ss_pred ecccceecCCCCcccccccccccccchhccccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC-CC
Q 018640 202 DFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR-DP 280 (352)
Q Consensus 202 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~ 280 (352)
|||++...... ....||+.|+|||++.+.++.++||||||+++++|++|..||...... ..+. ..
T Consensus 224 DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----------~~~~~~~ 289 (681)
T 2pzi_A 224 DLGAVSRINSF---GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVD-----------GLPEDDP 289 (681)
T ss_dssp CCTTCEETTCC---SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECS-----------SCCTTCH
T ss_pred ecccchhcccC---CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCcccccc-----------ccccccc
Confidence 99999876543 455799999999998877789999999999999999999888643211 0000 01
Q ss_pred CcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccc
Q 018640 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316 (352)
Q Consensus 281 ~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~ 316 (352)
....++.+.++|.+||+.||++||+..+.+.|+|+.
T Consensus 290 ~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 290 VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 112467899999999999999999998888888875
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=316.90 Aligned_cols=233 Identities=14% Similarity=0.097 Sum_probs=189.7
Q ss_pred CCcc-cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEE
Q 018640 48 PTGR-EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (352)
Q Consensus 48 ~~~~-~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~ 126 (352)
..|. .+.++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.++.++ +||||+++++++.
T Consensus 23 ~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~ 101 (286)
T 3uqc_A 23 VPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVARVLDVVH 101 (286)
T ss_dssp CTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEE
T ss_pred CCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-CCCCcceeeEEEE
Confidence 3444 6778999999999999999999999999999999999876544455567899999999999 9999999999999
Q ss_pred eCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccc
Q 018640 127 DDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (352)
Q Consensus 127 ~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a 206 (352)
..+..++||||++|++|.+++... .....+..++.|++.||+|||++||+||||||+|||++.++. +||+++|
T Consensus 102 ~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~---~kl~~~~-- 174 (286)
T 3uqc_A 102 TRAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD---VVLAYPA-- 174 (286)
T ss_dssp ETTEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSC---EEECSCC--
T ss_pred ECCcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCC---EEEEecc--
Confidence 999999999999999999999543 466678999999999999999999999999999999986654 7887443
Q ss_pred eecCCCCcccccccccccccchhccccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC---CCCCcC
Q 018640 207 VFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR---RDPWPK 283 (352)
Q Consensus 207 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 283 (352)
|++| ++.++||||||+++|||++|+.||.................... ....+.
T Consensus 175 -----------------~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T 3uqc_A 175 -----------------TMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRD 231 (286)
T ss_dssp -----------------CCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTT
T ss_pred -----------------ccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccC
Confidence 3333 67899999999999999999999976543211100000000000 011246
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 284 ~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
+++.+.++|.+||+.||++| |+.|+++.
T Consensus 232 ~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 232 IPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp SCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred CCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 89999999999999999999 99999874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=288.78 Aligned_cols=188 Identities=18% Similarity=0.159 Sum_probs=136.5
Q ss_pred eeeeccCceEEEEEEECCCCcEEEEEEccccccCC-------hhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRT-------AVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
..++.|+.|.+..++....|+.||+|++.+..... ..+.++|.+|+++|+++..|+||+++++++++++..||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 34677888888877777789999999997653221 23456799999999999889999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC-
Q 018640 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~- 212 (352)
||||++|++|.+.+...++++.. .|+.||+.||+|+|++|||||||||+|||++.++. +||+|||+|+.....
T Consensus 320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~---vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQH---ARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSC---EEECCCTTEESCC---
T ss_pred EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCC---EEEeecccCeeCCCCC
Confidence 99999999999999988888765 58899999999999999999999999999976554 999999999876443
Q ss_pred CcccccccccccccchhccccCCCcchHHHHHHHHHHHHhCC
Q 018640 213 EKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGV 254 (352)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~~~s~~~Di~SlG~~l~el~tg~ 254 (352)
....+.+||++|+|||++.+.+...+|+||+|++++++.++.
T Consensus 394 ~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 394 SWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp CCSHHHHHHHHHHHHHHC-----------------CCCCTTH
T ss_pred ccccCceechhhccHHHhCCCCCCcccccccccchhhhcccc
Confidence 334566899999999999988888999999999987766553
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.6e-30 Score=248.52 Aligned_cols=184 Identities=22% Similarity=0.198 Sum_probs=145.5
Q ss_pred eeceeeeccCceEEEEEEECCCCcEEEEEEccccccCCh-----hcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA-----VDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 58 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
...+.||+|+||+||+|. ..+..+++|+......... ...+++.+|+++++++ +||||+++..++...+..+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~ 415 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV-KDFGIPAPYIFDVDLDNKR 415 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG-GGGTCCCCCEEEEETTTTE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc-CCCCcCceEEEEEeCCccE
Confidence 446789999999999995 3478899998655333222 1245589999999999 9999997777766777889
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
+||||++|++|.+++.. +..++.|++.||+|||++||+||||||+|||++. .+||+|||+++.....
T Consensus 416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~-----~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK-----DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS-----SEEECCCTTCEECCCH
T ss_pred EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC-----eEEEEECccCEECCCc
Confidence 99999999999999865 6689999999999999999999999999999975 5899999999987553
Q ss_pred Cc--------ccccccccccccchhccc---cCCCcchHHHHHHHHHHHHhCCCCC
Q 018640 213 EK--------FSEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPF 257 (352)
Q Consensus 213 ~~--------~~~~~gt~~y~aPE~~~~---~~s~~~Di~SlG~~l~el~tg~~p~ 257 (352)
.. .....||+.|+|||++.. .|+...|+||..+-.++.+.++.+|
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 22 135689999999999863 4788899999999999888877766
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.6e-26 Score=205.24 Aligned_cols=147 Identities=22% Similarity=0.293 Sum_probs=115.5
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCCh---------------hcHHHHHHHHHHHHhCCCCCCeeE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA---------------VDIEDVRREVDIMRHLPKHQNIVC 120 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~~E~~~l~~l~~h~~iv~ 120 (352)
.|.+.+.||+|+||.||+|.+ .+|+.||+|++........ .....+.+|+.+++++ + | ++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l-~--~-~~ 165 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-Q--G-LA 165 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-T--T-SS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc-c--C-CC
Confidence 355669999999999999999 7899999999865321111 1345788999999999 4 4 66
Q ss_pred eeeEEEeCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEE
Q 018640 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKA 200 (352)
Q Consensus 121 l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl 200 (352)
+.+++.. +..++||||++|++|.+ +. ......++.|++.||.|||+.||+||||||+|||++ ++. +||
T Consensus 166 v~~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~---vkl 233 (282)
T 1zar_A 166 VPKVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEG---IWI 233 (282)
T ss_dssp SCCEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTE---EEE
T ss_pred cCeEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCc---EEE
Confidence 6665544 45699999999999988 42 234557999999999999999999999999999998 443 899
Q ss_pred EecccceecCCCCcccccccccccccchhcc
Q 018640 201 IDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK 231 (352)
Q Consensus 201 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 231 (352)
+|||+|+. +..++|||.+.
T Consensus 234 ~DFG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 234 IDFPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp CCCTTCEE------------TTSTTHHHHHH
T ss_pred EECCCCeE------------CCCCCHHHHHH
Confidence 99999974 34478888764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.7e-22 Score=177.73 Aligned_cols=140 Identities=16% Similarity=0.168 Sum_probs=107.2
Q ss_pred ceeceeeeccCceEEEEEEECCCCcE--EEEEEccccccCCh---------------------hcHHHHHHHHHHHHhCC
Q 018640 57 YELGRELGRGEFGITYLCTDRENGDA--FACKSISKKKLRTA---------------------VDIEDVRREVDIMRHLP 113 (352)
Q Consensus 57 y~~~~~lG~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~~~---------------------~~~~~~~~E~~~l~~l~ 113 (352)
|.+.+.||+|+||.||+|.+..+|+. ||||++........ .....+.+|+.++.++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l- 127 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA- 127 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH-
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH-
Confidence 77899999999999999998778999 99998754321100 1123678899999999
Q ss_pred CCCCe--eEeeeEEEeCCeEEEEEEecCC-c----chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HcCCEEecCCCC
Q 018640 114 KHQNI--VCLKDTYEDDTAVHLVMELCEG-G----ELFDRIVARGHYTERAAAAVTKTIVEVVQMCH-KHGVMHRDLKPE 185 (352)
Q Consensus 114 ~h~~i--v~l~~~~~~~~~~~lv~e~~~~-~----sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH-~~~ivH~Dikp~ 185 (352)
.|+++ +.++++ ...++||||+.+ | +|.+.... .++..+..++.|++.||.+|| +.||+||||||+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~ 200 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY 200 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence 67654 334432 356899999932 3 66665432 335578899999999999999 999999999999
Q ss_pred ceEeecCCCCCCEEEEecccceec
Q 018640 186 NFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 186 NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
|||++. .++|+|||+|...
T Consensus 201 NILl~~-----~~~liDFG~a~~~ 219 (258)
T 1zth_A 201 NIMYID-----KVYFIDMGQAVTL 219 (258)
T ss_dssp SEEESS-----SEEECCCTTCEET
T ss_pred HEEEcC-----cEEEEECcccccC
Confidence 999964 4899999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.78 E-value=2.7e-19 Score=165.34 Aligned_cols=143 Identities=17% Similarity=0.252 Sum_probs=100.6
Q ss_pred ceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCC-----------hhcHHH--------HHHHHHHHHhCCCCCC
Q 018640 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT-----------AVDIED--------VRREVDIMRHLPKHQN 117 (352)
Q Consensus 57 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~--------~~~E~~~l~~l~~h~~ 117 (352)
|++.+.||.|++|.||+|.+. +|+.||||+++...... ...... ..+|...|.++ .+.+
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL-~~~g 174 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL-YEEG 174 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH-HHTT
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH-HhcC
Confidence 899999999999999999974 69999999876432110 001111 23466777777 3333
Q ss_pred eeEeeeEEEeCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCC-
Q 018640 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETA- 196 (352)
Q Consensus 118 iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~- 196 (352)
+....-+... ..+|||||++|++|.+.. .......++.|++.+|.+||+.|||||||||.|||++.++...
T Consensus 175 v~vp~p~~~~--~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d 246 (397)
T 4gyi_A 175 FPVPEPIAQS--RHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAED 246 (397)
T ss_dssp CSCCCEEEEE--TTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSC
T ss_pred CCCCeeeecc--CceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccc
Confidence 3221111111 237999999998886542 2234567889999999999999999999999999998765321
Q ss_pred ------CEEEEecccceec
Q 018640 197 ------PLKAIDFGLSVFF 209 (352)
Q Consensus 197 ------~vkl~Dfg~a~~~ 209 (352)
.+.|+||+-+...
T Consensus 247 ~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 247 PSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp TTSEEEEEEECCCTTCEET
T ss_pred ccccccceEEEEeCCcccC
Confidence 2689999977653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=2.4e-13 Score=119.98 Aligned_cols=141 Identities=18% Similarity=0.170 Sum_probs=112.0
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
..|++...+|.|+.+.||++... +..+++|+....... ....+.+|+.+++.+..+..++++++++...+..++|
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~---~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCC---CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 45888999999999999999743 688999988643211 2245889999999996677888999999998999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK---------------------------------------- 174 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~---------------------------------------- 174 (352)
|||++|.+|.+.+ .+......++.+++.+|..||+
T Consensus 89 ~e~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 89 MSEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EEecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 9999999987753 1223345788999999999998
Q ss_pred -------------------cCCEEecCCCCceEeecCCCCCCEEEEeccccee
Q 018640 175 -------------------HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (352)
Q Consensus 175 -------------------~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~ 208 (352)
..++|+|++|.||+++.+ ..+.|+||+.+..
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~---~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG---KVSGFIDLGRSGR 213 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETT---EEEEECCCTTCEE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECC---cEEEEEEchhccc
Confidence 458999999999999642 2256999998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.32 E-value=3.4e-12 Score=112.09 Aligned_cols=135 Identities=14% Similarity=0.149 Sum_probs=97.6
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCC-CeeEeeeEEEeCCeEEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ-NIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-~iv~l~~~~~~~~~~~lv 134 (352)
.|.+..+.+.|..+.||++.. .+|..+++|..... ....+.+|+.+++.+..+. .+++++++....+..++|
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v 93 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 93 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence 456545445666799999964 56788999986542 1245778999999985442 256788888888889999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--------------------------------------
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG-------------------------------------- 176 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~-------------------------------------- 176 (352)
|||++|.+|. .. ... ...++.+++.+|..||+..
T Consensus 94 ~e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 94 LGEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp EECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred EEecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 9999998884 21 122 2356677777777777643
Q ss_pred --------------------CEEecCCCCceEeecCCCCCCEEEEeccccee
Q 018640 177 --------------------VMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (352)
Q Consensus 177 --------------------ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~ 208 (352)
++|+|++|.||+++.+ ..+.|+|||.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~---~~~~liD~~~a~~ 214 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENG---RFSGFIDCGRLGV 214 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETT---EEEEECCCTTCEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECC---cEEEEEcchhccc
Confidence 9999999999999643 2256999998764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.24 E-value=2.4e-11 Score=112.23 Aligned_cols=145 Identities=19% Similarity=0.318 Sum_probs=106.1
Q ss_pred eceeeeccCceEEEEEEECCCCcEEEEEEcc--ccccCChhcHHHHHHHHHHHHhCCC-CCCeeEeeeEEEeC---CeEE
Q 018640 59 LGRELGRGEFGITYLCTDRENGDAFACKSIS--KKKLRTAVDIEDVRREVDIMRHLPK-HQNIVCLKDTYEDD---TAVH 132 (352)
Q Consensus 59 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~E~~~l~~l~~-h~~iv~l~~~~~~~---~~~~ 132 (352)
.++.|+.|.++.||++... +..+++|+.. .... ......+.+|+.+++.+.. +..+++++.++.+. +..+
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 3577999999999998754 4678888765 3211 1123467889999999943 34578888888766 4589
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 018640 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK-------------------------------------- 174 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~-------------------------------------- 174 (352)
+||||++|.++.+.. -..++......++.+++.+|..||+
T Consensus 118 ~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999999998775421 1246788889999999999999997
Q ss_pred --------------------cCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 175 --------------------HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 175 --------------------~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
..++|+|++|.||+++.++. ..+.|+||+.+....
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~-~v~~viDwe~a~~g~ 250 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEP-RVLAVLDWELSTLGH 250 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSS-CEEEECCCTTCEEEC
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCC-cEEEEECccccccCC
Confidence 35899999999999975443 235899999987643
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.20 E-value=4e-11 Score=108.15 Aligned_cols=185 Identities=18% Similarity=0.232 Sum_probs=123.6
Q ss_pred ceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCC--eeEeeeEEEeCC---eEEEE
Q 018640 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN--IVCLKDTYEDDT---AVHLV 134 (352)
Q Consensus 60 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~--iv~l~~~~~~~~---~~~lv 134 (352)
++.++.|....||++. ..+++|+.... .....+.+|+.+++.+..+.. +++++....... ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 4568999999999863 45888875422 335678899999988844433 344555443333 45889
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK---------------------------------------- 174 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~---------------------------------------- 174 (352)
|++++|.+|.+.... .++..+...++.+++..|..||+
T Consensus 95 m~~i~G~~l~~~~~~--~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLLN--NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHHH--TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCccccc--cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 999999998764432 47788888888899888888886
Q ss_pred ------------------cCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCcccccccccccccchhcc---cc
Q 018640 175 ------------------HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK---RN 233 (352)
Q Consensus 175 ------------------~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~ 233 (352)
..++|+|++|.||+++.+. ...+.|+||+.+.................-..|+... ..
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~-~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEK-NTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTT-TEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCC-CCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence 1379999999999998531 2336899999987654332221111100002333211 11
Q ss_pred CCC------------cchHHHHHHHHHHHHhCCCCC
Q 018640 234 YGP------------EVDVWSAGVILYILLCGVPPF 257 (352)
Q Consensus 234 ~s~------------~~Di~SlG~~l~el~tg~~p~ 257 (352)
|.. -.+.|+++.+++.+.+|..+|
T Consensus 252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 211 258999999999999998876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.84 E-value=7.4e-08 Score=86.79 Aligned_cols=140 Identities=19% Similarity=0.245 Sum_probs=95.6
Q ss_pred ceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCC--CeeEeeeEEE-eCCeEEEEEE
Q 018640 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ--NIVCLKDTYE-DDTAVHLVME 136 (352)
Q Consensus 60 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~--~iv~l~~~~~-~~~~~~lv~e 136 (352)
+..++.|....||+. |..+++|+.. .......+.+|+.+|..+..+- .+++++.++. ..+..++|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~-----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK-----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES-----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC-----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 456888999999987 4568888742 2233567899999999995432 3566777664 4556789999
Q ss_pred ecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-----------------------------------------
Q 018640 137 LCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH----------------------------------------- 175 (352)
Q Consensus 137 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~----------------------------------------- 175 (352)
+++|.++.+..-. .++......++.++...|..||+.
T Consensus 94 ~i~G~~l~~~~~~--~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGMA--VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHHT--TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhhh--hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 9999888763211 244555555555555555555532
Q ss_pred -------------------CCEEecCCCCceEeecCCCCCC-EEEEecccceecCC
Q 018640 176 -------------------GVMHRDLKPENFLFANKKETAP-LKAIDFGLSVFFKP 211 (352)
Q Consensus 176 -------------------~ivH~Dikp~NIll~~~~~~~~-vkl~Dfg~a~~~~~ 211 (352)
.++|+|++|.||+++.+..... +.|+||+.+.....
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd~ 227 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISDP 227 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEECG
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCCH
Confidence 3599999999999975222222 47999998876543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.80 E-value=3.9e-08 Score=86.74 Aligned_cols=133 Identities=17% Similarity=0.212 Sum_probs=95.8
Q ss_pred eeccCce-EEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEecCCc
Q 018640 63 LGRGEFG-ITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGG 141 (352)
Q Consensus 63 lG~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~~~ 141 (352)
+..|..| .||+......+..+++|+-... ....+.+|...|+.+..+--+++++.++.+.+..++|||+++|.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 4445544 6999887777788999975432 34568889999999865555788999999999999999999998
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q 018640 142 ELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK----------------------------------------------- 174 (352)
Q Consensus 142 sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~----------------------------------------------- 174 (352)
++.+..... ......+..++...|..||+
T Consensus 106 ~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 106 TAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp EHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 887765331 22233455555555555553
Q ss_pred -----------cCCEEecCCCCceEeecCCCCCCEEEEeccccee
Q 018640 175 -----------HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (352)
Q Consensus 175 -----------~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~ 208 (352)
..++|+|+.+.||+++.+. .+-|+||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~---~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGK---LIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTE---EEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCe---EEEEEECccccc
Confidence 1279999999999997432 246899998865
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=3.9e-07 Score=85.02 Aligned_cols=81 Identities=19% Similarity=0.171 Sum_probs=51.4
Q ss_pred ceeeeccCceEEEEEEECCCCcEEEEEEcccccc----CChhcHHHHHHHHHHHHhCCCC-C-CeeEeeeEEEeCCeEEE
Q 018640 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKL----RTAVDIEDVRREVDIMRHLPKH-Q-NIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 60 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~E~~~l~~l~~h-~-~iv~l~~~~~~~~~~~l 133 (352)
.+.||.|..+.||++....+++.+++|....... ......+++..|+.+++.+... + .+++++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 4679999999999997655678899997653211 0012345677899999887432 3 34455543 3445689
Q ss_pred EEEecCCcc
Q 018640 134 VMELCEGGE 142 (352)
Q Consensus 134 v~e~~~~~s 142 (352)
|||++++..
T Consensus 113 vmE~l~g~~ 121 (397)
T 2olc_A 113 VMEDLSHLK 121 (397)
T ss_dssp EECCCTTSE
T ss_pred EEEeCCCcc
Confidence 999998743
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=3.8e-07 Score=83.78 Aligned_cols=86 Identities=9% Similarity=0.075 Sum_probs=56.1
Q ss_pred eceee-eccCceEEEEEEEC--C----CCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCC--CCeeEeeeEEEeC-
Q 018640 59 LGREL-GRGEFGITYLCTDR--E----NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH--QNIVCLKDTYEDD- 128 (352)
Q Consensus 59 ~~~~l-G~G~~g~Vy~~~~~--~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h--~~iv~l~~~~~~~- 128 (352)
..+.| +.|....+|+.... . ++..+++|...............+.+|+.+++.+..+ -.+++++.++.+.
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 34667 88989999988643 1 2567888976543200000113467788888888544 3467788877655
Q ss_pred --CeEEEEEEecCCcchH
Q 018640 129 --TAVHLVMELCEGGELF 144 (352)
Q Consensus 129 --~~~~lv~e~~~~~sL~ 144 (352)
+..++||||++|.++.
T Consensus 104 ~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTSSCEEEEECCCCBCCC
T ss_pred ccCCceEEEEecCCCChh
Confidence 3578999999986643
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.15 E-value=3.8e-05 Score=69.58 Aligned_cols=75 Identities=12% Similarity=0.123 Sum_probs=42.6
Q ss_pred ceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCC-CCeeEeee------EEEeCCeEE
Q 018640 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH-QNIVCLKD------TYEDDTAVH 132 (352)
Q Consensus 60 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~~iv~l~~------~~~~~~~~~ 132 (352)
+..|+.|..+.||++... +..+++|+.... .+.+..|+.++..|..+ -.+++++. +....+..+
T Consensus 37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~-------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~ 107 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRP-------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF 107 (346)
T ss_dssp EEECC----CEEEEEEET--TEEEEEEEECSC-------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred eeeccccccCcEEEEEeC--CCCEEEEecCCC-------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence 345666778999998753 345889987642 13344555555555211 12344443 123466789
Q ss_pred EEEEecCCcch
Q 018640 133 LVMELCEGGEL 143 (352)
Q Consensus 133 lv~e~~~~~sL 143 (352)
++|+|++|.++
T Consensus 108 ~l~~~i~G~~~ 118 (346)
T 2q83_A 108 VVYDWIEGRPF 118 (346)
T ss_dssp EEEECCCCBCC
T ss_pred EEEEeecCccC
Confidence 99999998654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.13 E-value=1.6e-05 Score=74.74 Aligned_cols=77 Identities=8% Similarity=0.009 Sum_probs=46.0
Q ss_pred ceeeeccCceEEEEEEECCCCcEEEEEEcccccc--CC--h--hcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKL--RT--A--VDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 60 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~--~--~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
++.||.|..+.||++.. ++..+++|....... .. . .....+..|+..+..-.....+++++.+. .+..++
T Consensus 39 i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 46789999999999964 467899994332111 00 0 12233444443332211234566777665 466789
Q ss_pred EEEec-CC
Q 018640 134 VMELC-EG 140 (352)
Q Consensus 134 v~e~~-~~ 140 (352)
||||+ +|
T Consensus 115 v~e~l~~g 122 (420)
T 2pyw_A 115 GMRYLEPP 122 (420)
T ss_dssp EECCCCTT
T ss_pred EEeecCCc
Confidence 99999 76
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.96 E-value=4.7e-05 Score=68.45 Aligned_cols=76 Identities=18% Similarity=0.152 Sum_probs=60.0
Q ss_pred ceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCC--CCeeEeeeEEEeCCeEEEEEEe
Q 018640 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH--QNIVCLKDTYEDDTAVHLVMEL 137 (352)
Q Consensus 60 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h--~~iv~l~~~~~~~~~~~lv~e~ 137 (352)
.+.|+.|....+|+... ++..+++|+.... ....+..|+..|+.|... ..+++++.++...+..++||||
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~ 112 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA 112 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence 46789999999999874 4678888976432 246788899999888433 5688899888888889999999
Q ss_pred cCCcch
Q 018640 138 CEGGEL 143 (352)
Q Consensus 138 ~~~~sL 143 (352)
++|.++
T Consensus 113 l~G~~~ 118 (312)
T 3jr1_A 113 LNKSKN 118 (312)
T ss_dssp CCCCCC
T ss_pred ccCCCC
Confidence 998654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00028 Score=62.47 Aligned_cols=80 Identities=14% Similarity=0.013 Sum_probs=55.7
Q ss_pred cceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCC--CeeEeeeEEEeCCeEEE
Q 018640 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ--NIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 56 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~--~iv~l~~~~~~~~~~~l 133 (352)
...-++.+|.|..+.||+... .+|+.|.+|+..... ......+..|+..|+.|.... -+++++.+. ..++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~---~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~l 87 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDA---PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTL 87 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTC---CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEE
T ss_pred CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCC---cchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceE
Confidence 455678899999999999985 579999999865432 122345788999999885432 244555442 2378
Q ss_pred EEEecCCcch
Q 018640 134 VMELCEGGEL 143 (352)
Q Consensus 134 v~e~~~~~sL 143 (352)
||||++++..
T Consensus 88 v~e~l~~~~~ 97 (288)
T 3f7w_A 88 AMEWVDERPP 97 (288)
T ss_dssp EEECCCCCCC
T ss_pred EEEeecccCC
Confidence 9999986543
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.72 E-value=7.4e-05 Score=66.71 Aligned_cols=72 Identities=10% Similarity=-0.021 Sum_probs=44.5
Q ss_pred ceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEec-
Q 018640 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELC- 138 (352)
Q Consensus 60 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~- 138 (352)
++.|+.|....+|++ ..+++|+...... ... ...+|+.+++.+..+.-.++++++. .+.-++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~-~~~---~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE-EYI---NRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-----CC---CHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCcc-cee---CHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence 677999999999998 4588887754311 111 1245777777664332225565543 33346899999
Q ss_pred CCcch
Q 018640 139 EGGEL 143 (352)
Q Consensus 139 ~~~sL 143 (352)
+|.++
T Consensus 91 ~g~~l 95 (301)
T 3dxq_A 91 GAQTM 95 (301)
T ss_dssp TCEEC
T ss_pred CCccC
Confidence 77655
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00045 Score=57.99 Aligned_cols=136 Identities=14% Similarity=0.041 Sum_probs=87.7
Q ss_pred CcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCcccc
Q 018640 140 GGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE 217 (352)
Q Consensus 140 ~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~ 217 (352)
.-||.++|... .+++++++|.++.|.+.+|.-+-. ..-..+=+.|..|++..+|. |-+.+ +.+.
T Consensus 32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~---V~f~~-~~s~---------- 97 (229)
T 2yle_A 32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGA---VTLAP-AADD---------- 97 (229)
T ss_dssp EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSC---EEECC-C-------------
T ss_pred cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCc---eeccc-cccc----------
Confidence 35799999765 479999999999999999887632 12123444567888865554 43332 1110
Q ss_pred cccccccccchhccccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcC
Q 018640 218 IVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297 (352)
Q Consensus 218 ~~gt~~y~aPE~~~~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 297 (352)
.....+.|||......+.+.-|||||+++|..+--..|- .....+++.+-+||..|..
T Consensus 98 -~~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~e---------------------~eE~eLS~~LE~LL~~Mt~ 155 (229)
T 2yle_A 98 -AGEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLKE---------------------NEERELSPPLEQLIDHMAN 155 (229)
T ss_dssp ----------CCSSSSSCHHHHHHHHHHHHHHHHTTTCCT---------------------TEEECCCHHHHHHHHHHTT
T ss_pred -ccccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCCc---------------------ccchhhCHHHHHHHHHHHh
Confidence 112346688876545567889999999999988533321 1124689999999999986
Q ss_pred C-------------------------CcCCCCCHHHHhc
Q 018640 298 P-------------------------DPKRRLTAQQVLE 311 (352)
Q Consensus 298 ~-------------------------dP~~Rps~~ell~ 311 (352)
. .+..|+++++|++
T Consensus 156 ~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~ 194 (229)
T 2yle_A 156 TVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK 194 (229)
T ss_dssp CCC--------------------CCSCCCCCCSHHHHHH
T ss_pred cccccccccccccccccccccccccccccCcCCHHHHHH
Confidence 6 2457888888865
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00012 Score=67.57 Aligned_cols=141 Identities=12% Similarity=0.114 Sum_probs=83.2
Q ss_pred ceeeeccCceEEEEEEECC-------CCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 60 GRELGRGEFGITYLCTDRE-------NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 60 ~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
++.|..|-...+|++.... ++..+++++.... ........+|..+++.+..+.-.+++++.+.+ .
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI----LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----G 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc----cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence 3557778888999988642 3578999986331 11345566899999888555445677776643 2
Q ss_pred EEEEecCCcchHH--------------HH---HhcC-----CC--CHHHHHHHHHHHHH-------------------HH
Q 018640 133 LVMELCEGGELFD--------------RI---VARG-----HY--TERAAAAVTKTIVE-------------------VV 169 (352)
Q Consensus 133 lv~e~~~~~sL~~--------------~l---~~~~-----~l--~~~~~~~i~~qi~~-------------------aL 169 (352)
+||||++|.+|.. .| +.-. .. -+.++.++..++.. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 8999999866531 11 1111 11 13455555544322 23
Q ss_pred HHHHH--------cCCEEecCCCCceEeecCC-CCCCEEEEeccccee
Q 018640 170 QMCHK--------HGVMHRDLKPENFLFANKK-ETAPLKAIDFGLSVF 208 (352)
Q Consensus 170 ~~lH~--------~~ivH~Dikp~NIll~~~~-~~~~vkl~Dfg~a~~ 208 (352)
..|.+ ..++|+|+.+.||+++.+. ....+.|+||..+..
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 33332 2599999999999997651 223589999998875
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00016 Score=67.96 Aligned_cols=75 Identities=13% Similarity=0.083 Sum_probs=50.8
Q ss_pred ceeeeccCceEEEEEEECC-------CCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 60 GRELGRGEFGITYLCTDRE-------NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 60 ~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
++.|+.|....||++.... ++..+++|+.... ...+.+.+|..+++.+..+.-.+++++.+.+ .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-----~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-----ETESHLVAESVIFTLLSERHLGPKLYGIFSG----G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-----CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence 4668888899999998643 2578999987321 1114455799999888544434667766542 3
Q ss_pred EEEEecCCcch
Q 018640 133 LVMELCEGGEL 143 (352)
Q Consensus 133 lv~e~~~~~sL 143 (352)
+|+||++|.+|
T Consensus 149 ~v~e~l~G~~l 159 (429)
T 1nw1_A 149 RLEEYIPSRPL 159 (429)
T ss_dssp EEECCCCEEEC
T ss_pred EEEEEeCCccc
Confidence 89999987554
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00015 Score=65.13 Aligned_cols=139 Identities=17% Similarity=0.172 Sum_probs=77.0
Q ss_pred ceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCC-CeeEeeeE------EEeCCeEE
Q 018640 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ-NIVCLKDT------YEDDTAVH 132 (352)
Q Consensus 60 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-~iv~l~~~------~~~~~~~~ 132 (352)
++.|+.|....+|++... +| .+++|+.... ...+.+..|+.++..+..+. .+++++.. ....+..+
T Consensus 27 ~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~-----~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~ 99 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTT-KD-PLILTLYEKR-----VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 99 (322)
T ss_dssp EEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred eeccCCCcccceEEEEeC-Cc-cEEEEEeCCC-----CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence 456778888999998753 34 6788987542 11234666788877764321 13444422 12345678
Q ss_pred EEEEecCCcchHH-----------H---HHhc-CCC--------CHHHHHH---------------HHHHHHHHHHHHHH
Q 018640 133 LVMELCEGGELFD-----------R---IVAR-GHY--------TERAAAA---------------VTKTIVEVVQMCHK 174 (352)
Q Consensus 133 lv~e~~~~~sL~~-----------~---l~~~-~~l--------~~~~~~~---------------i~~qi~~aL~~lH~ 174 (352)
++++|++|.++.. . ++.. ..+ ....... +...+...++.++.
T Consensus 100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~ 179 (322)
T 2ppq_A 100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 179 (322)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence 9999999865310 1 1110 011 1110000 01123445555553
Q ss_pred -------cCCEEecCCCCceEeecCCCCCCEEEEeccccee
Q 018640 175 -------HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (352)
Q Consensus 175 -------~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~ 208 (352)
.+++|+|+.+.||+++.+. .+.|+||+.+..
T Consensus 180 ~~~~~~~~~liHgDl~~~Nil~~~~~---~~~lIDf~~a~~ 217 (322)
T 2ppq_A 180 HWPKDLPAGVIHADLFQDNVFFLGDE---LSGLIDFYFACN 217 (322)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETTE---EEEECCCTTCEE
T ss_pred hCcccCCcccCCCCCCccCEEEeCCc---eEEEecchhccC
Confidence 3699999999999997432 247999997764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00051 Score=61.80 Aligned_cols=77 Identities=13% Similarity=0.138 Sum_probs=49.4
Q ss_pred eeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCC-CeeEeeeE-----EEeCCeEEEE
Q 018640 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ-NIVCLKDT-----YEDDTAVHLV 134 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-~iv~l~~~-----~~~~~~~~lv 134 (352)
..|+ |....||++.. .+|+.+++|...... ...+.+..|..++..+..+. .+++++.. ....+..+++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~----~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPER----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCC----CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 4566 88889998764 456679999875321 12456777888888774321 24444443 2234567889
Q ss_pred EEecCCcch
Q 018640 135 MELCEGGEL 143 (352)
Q Consensus 135 ~e~~~~~sL 143 (352)
+++++|.++
T Consensus 106 ~~~i~G~~~ 114 (328)
T 1zyl_A 106 FPSVGGRQF 114 (328)
T ss_dssp EECCCCEEC
T ss_pred EEecCCCCC
Confidence 999988554
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00023 Score=64.38 Aligned_cols=37 Identities=27% Similarity=0.393 Sum_probs=27.8
Q ss_pred cCCEEecCCCCceEeecCCC-CCCEEEEecccceecCC
Q 018640 175 HGVMHRDLKPENFLFANKKE-TAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 175 ~~ivH~Dikp~NIll~~~~~-~~~vkl~Dfg~a~~~~~ 211 (352)
..++|+|+.+.||+++.+.. ...+.|+||+.+.....
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~ 220 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHR 220 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECT
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCC
Confidence 46999999999999975311 13478999998876543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0033 Score=59.47 Aligned_cols=76 Identities=14% Similarity=0.096 Sum_probs=49.2
Q ss_pred ceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEecC
Q 018640 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCE 139 (352)
Q Consensus 60 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~~ 139 (352)
++.|+.|-...+|++.....+..+++|+..... ....+ -.+|..++..|..+.-.+++++.+. + .+|+||++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~id---R~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~ 184 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIIN---REREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD 184 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSC---HHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcC---HHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence 456888888999999875445788899874321 11111 2478999999855444467777763 2 25999999
Q ss_pred Ccch
Q 018640 140 GGEL 143 (352)
Q Consensus 140 ~~sL 143 (352)
|.+|
T Consensus 185 G~~l 188 (458)
T 2qg7_A 185 GYAL 188 (458)
T ss_dssp SEEC
T ss_pred CccC
Confidence 8555
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.13 E-value=0.00071 Score=62.08 Aligned_cols=76 Identities=13% Similarity=0.103 Sum_probs=44.7
Q ss_pred ceeeeccCceEEEEEEECC--------CCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 60 GRELGRGEFGITYLCTDRE--------NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 60 ~~~lG~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
+..|+.|....+|++.... .+..+++|+...... .......|..+++.+..+.-++++++.. . -
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~ 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD----ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--G 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG----GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--T
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc----ceecHHHHHHHHHHHHhcCCCCceEEec--C--C
Confidence 4567888889999998643 136788888654211 1112356888888774443245666544 2 2
Q ss_pred EEEEEecCCcch
Q 018640 132 HLVMELCEGGEL 143 (352)
Q Consensus 132 ~lv~e~~~~~sL 143 (352)
++||||++|.++
T Consensus 110 ~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 GRIEEWLYGDPL 121 (369)
T ss_dssp EEEEECCCSEEC
T ss_pred cEEEEEecCCcC
Confidence 689999998554
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.79 E-value=0.016 Score=52.36 Aligned_cols=69 Identities=13% Similarity=0.075 Sum_probs=42.4
Q ss_pred eccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCC--CCCCeeEeeeE------EEeCCeEEEEE
Q 018640 64 GRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP--KHQNIVCLKDT------YEDDTAVHLVM 135 (352)
Q Consensus 64 G~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~~iv~l~~~------~~~~~~~~lv~ 135 (352)
|.|....||++.. .+| .+++|+...... ..|+.++..|. .-+.+++++.. ....+..+++|
T Consensus 32 G~g~~N~vy~v~~-~~g-~~vLK~~~~~~~---------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~ 100 (339)
T 3i1a_A 32 GADTNAFAYQADS-ESK-SYFIKLKYGYHD---------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAY 100 (339)
T ss_dssp TSCSSCEEEEEEC-SSC-EEEEEEEECSSC---------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEE
T ss_pred cCccccceEEEEe-CCC-CEEEEEecCccc---------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEE
Confidence 3344689999874 345 899998754321 23555555542 22334555432 23456789999
Q ss_pred EecCCcch
Q 018640 136 ELCEGGEL 143 (352)
Q Consensus 136 e~~~~~sL 143 (352)
+|++|..+
T Consensus 101 ~~i~G~~~ 108 (339)
T 3i1a_A 101 PFIHAPNG 108 (339)
T ss_dssp ECCCCCBT
T ss_pred eccCCCcC
Confidence 99998665
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.50 E-value=0.01 Score=55.52 Aligned_cols=76 Identities=13% Similarity=0.141 Sum_probs=48.7
Q ss_pred ceeeeccCceEEEEEEECCC-------CcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 60 GRELGRGEFGITYLCTDREN-------GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 60 ~~~lG~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
++.|..|-...+|++..... +..+++++..... .... .-.+|..+++.+..+.-.+++++.+. -+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~i---dR~~E~~~l~~L~~~gi~P~l~~~~~----~~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFY---DSKVELDVFRYLSNINIAPNIIADFP----EG 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCC---CHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhc---CHHHHHHHHHHHHhcCCCCCEEEEcC----CC
Confidence 45677788899999986521 5789999864432 1111 12468888887744443456665432 26
Q ss_pred EEEEecCCcch
Q 018640 133 LVMELCEGGEL 143 (352)
Q Consensus 133 lv~e~~~~~sL 143 (352)
+|+||++|.+|
T Consensus 147 ~I~efI~G~~l 157 (424)
T 3mes_A 147 RIEEFIDGEPL 157 (424)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEeCCccC
Confidence 89999998664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=96.04 E-value=0.02 Score=53.02 Aligned_cols=33 Identities=30% Similarity=0.413 Sum_probs=26.2
Q ss_pred CEEecCCCCceEeecC---CCCCCEEEEecccceec
Q 018640 177 VMHRDLKPENFLFANK---KETAPLKAIDFGLSVFF 209 (352)
Q Consensus 177 ivH~Dikp~NIll~~~---~~~~~vkl~Dfg~a~~~ 209 (352)
++|+|+.+.||++..+ .....+.++||.+|...
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 6899999999999542 34456899999988753
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=84.64 E-value=0.081 Score=49.96 Aligned_cols=63 Identities=5% Similarity=0.016 Sum_probs=17.6
Q ss_pred eceeeeccCceEEEEEEECCCCcEEEE------EEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEE
Q 018640 59 LGRELGRGEFGITYLCTDRENGDAFAC------KSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (352)
Q Consensus 59 ~~~~lG~G~~g~Vy~~~~~~~~~~vav------K~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~ 126 (352)
+.+.|| ||.||+|.+......||+ |....... .......+.+|..+++.+ +|+|+++.+++-.
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~-~~e~~~~~~rea~l~~~~-~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGV-SEKRLTSLVRRATLKENE-QIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-------------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccc-cccccccccccccccccc-cccccCCCcceEE
Confidence 456676 999999998765567888 65543221 223344677888888888 8999999887653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 352 | ||||
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-95 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-92 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-91 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-90 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-88 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-87 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-87 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-85 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-84 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-83 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-83 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-82 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-80 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-77 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-77 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-76 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-76 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-75 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-74 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-73 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-72 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-69 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-68 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-68 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-68 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-68 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-67 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-67 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-66 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-66 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-65 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-65 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-65 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-64 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-64 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-62 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-62 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-61 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-61 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-60 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-60 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-59 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-58 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-58 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-58 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-58 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-58 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-58 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-57 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-57 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-57 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-56 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-54 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-54 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-54 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-50 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-50 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-48 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-47 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-47 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-46 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-21 | |
| d2pula1 | 392 | d.144.1.6 (A:5-396) Methylthioribose kinase MtnK { | 6e-06 |
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 283 bits (724), Expect = 5e-95
Identities = 111/295 (37%), Positives = 171/295 (57%), Gaps = 5/295 (1%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
+I + Y+ LG G F L D+ A K I+KK L + E+ ++
Sbjct: 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHK 63
Query: 112 LPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQM 171
+ KH NIV L D YE ++L+M+L GGELFDRIV +G YTER A+ + +++ V+
Sbjct: 64 I-KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKY 122
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK 231
H G++HRDLKPEN L+ + E + + DFGLS PG S G+P Y+APEVL
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA 182
Query: 232 -RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290
+ Y VD WS GVI YILLCG PPF+ E + + + I+++ +F W +S++AKD
Sbjct: 183 QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKD 242
Query: 291 LVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKK 345
+R +++ DP++R T +Q L+HPW+ A + ++ ++V ++K+ +K K+
Sbjct: 243 FIRHLMEKDPEKRFTCEQALQHPWIAG-DTALDKNIHQSVSEQIKKNFAKSKWKQ 296
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 276 bits (708), Expect = 2e-92
Identities = 89/304 (29%), Positives = 161/304 (52%), Gaps = 12/304 (3%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
+E+ E+Y + +LGRGEFGI + C + + + K + K D V++E+ I+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILN 56
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVV 169
+H+NI+ L +++E + ++ E G ++F+RI ER + + E +
Sbjct: 57 IA-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEV 229
Q H H + H D++PEN ++ ++ + +K I+FG + KPG+ F + +P Y APEV
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTRRS-STIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174
Query: 230 LKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288
+ + D+WS G ++Y+LL G+ PF AET Q + + I+ + F + + ++S A
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRAL 348
D V ++L + K R+TA + L+HPWL+ + + + T LK + L K+ L
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRT----LKHRRYYHTLIKKDL 290
Query: 349 KVMS 352
++
Sbjct: 291 NMVV 294
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 275 bits (703), Expect = 3e-91
Identities = 91/294 (30%), Positives = 148/294 (50%), Gaps = 7/294 (2%)
Query: 47 EPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREV 106
E + + Y++ ELG G FG+ + C ++ G F K I+ +D V+ E+
Sbjct: 21 EVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEI 77
Query: 107 DIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTI 165
IM L H ++ L D +ED + L++E GGELFDRI A + +E +
Sbjct: 78 SIMNQL-HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQA 136
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
E ++ H+H ++H D+KPEN + K+ + +K IDFGL+ P E + +
Sbjct: 137 CEGLKHMHEHSIVHLDIKPENIMC-ETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFA 195
Query: 226 APEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284
APE++ R G D+W+ GV+ Y+LL G+ PF E + Q + R +F D + V
Sbjct: 196 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV 255
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFS 338
S AKD ++ +L +P++RLT LEHPWL+ + + +++Q
Sbjct: 256 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKI 309
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 271 bits (694), Expect = 6e-90
Identities = 91/272 (33%), Positives = 140/272 (51%), Gaps = 7/272 (2%)
Query: 47 EPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREV 106
E + + Y++ ELG G FG+ + T+R G+ FA K + D E VR+E+
Sbjct: 18 EIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES---DKETVRKEI 74
Query: 107 DIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIV-ARGHYTERAAAAVTKTI 165
M L +H +V L D +EDD + ++ E GGELF+++ +E A + +
Sbjct: 75 QTMSVL-RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQV 133
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
+ + H++ +H DLKPEN +F K+ LK IDFGL+ P + G+ +
Sbjct: 134 CKGLCHMHENNYVHLDLKPENIMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVTTGTAEFA 192
Query: 226 APEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284
APEV + + G D+WS GV+ YILL G+ PF E + + + + + +
Sbjct: 193 APEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI 252
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
SE+ KD +RK+L DP R+T Q LEHPWL
Sbjct: 253 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 284
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 265 bits (677), Expect = 3e-88
Identities = 100/275 (36%), Positives = 142/275 (51%), Gaps = 16/275 (5%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD------IEDVRREVDI 108
E YE LGRG + C + +A K I + E +EVDI
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 109 MRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV 168
+R + H NI+ LKDTYE +T LV +L + GELFD + + +E+ + + ++EV
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPE 228
+ HK ++HRDLKPEN L + +K DFG S PGEK E+ G+P Y+APE
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMN---IKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 179
Query: 229 VL-------KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281
++ YG EVD+WS GVI+Y LL G PPFW + + + I+ F W
Sbjct: 180 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 239
Query: 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
S+ KDLV + L P++R TA++ L HP+ Q
Sbjct: 240 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 262 bits (670), Expect = 4e-87
Identities = 100/270 (37%), Positives = 152/270 (56%), Gaps = 6/270 (2%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL---RTAVDIEDVRREVDIM 109
+++ Y+ G ELG G+F + C ++ G +A K I K++ R V ED+ REV I+
Sbjct: 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV 169
+ + +H N++ L + YE+ T V L++EL GGELFD + + TE A K I+ V
Sbjct: 68 KEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAP-LKAIDFGLSVFFKPGEKFSEIVGSPYYMAPE 228
H + H DLKPEN + ++ P +K IDFGL+ G +F I G+P ++APE
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 229 VLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287
++ G E D+WS GVI YILL G PF +T+Q + +F + + S
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317
AKD +R++L DPK+R+T Q L+HPW++
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 261 bits (667), Expect = 5e-87
Identities = 92/263 (34%), Positives = 143/263 (54%), Gaps = 10/263 (3%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E +E+GR LG+G+FG YL ++++ A K + K +L A +RREV+I HL +
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-R 64
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H NI+ L + D T V+L++E G ++ + + E+ A + + CH
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RN 233
V+HRD+KPEN L + E LK DFG SV P + + + G+ Y+ PE+++ R
Sbjct: 125 KRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRM 180
Query: 234 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293
+ +VD+WS GV+ Y L G PPF A T Q + I R F V+E A+DL+
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF----PDFVTEGARDLIS 236
Query: 294 KMLDPDPKRRLTAQQVLEHPWLQ 316
++L +P +R ++VLEHPW+
Sbjct: 237 RLLKHNPSQRPMLREVLEHPWIT 259
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 259 bits (662), Expect = 1e-85
Identities = 79/302 (26%), Positives = 134/302 (44%), Gaps = 15/302 (4%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
+ E+ + RE+G G FG Y D N + A K +S ++ +D+ +EV ++
Sbjct: 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71
Query: 112 LPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQM 171
L +H N + + Y + LVME C G V + E AAVT ++ +
Sbjct: 72 L-RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVL- 230
H H ++HRD+K N L + +K DFG + P F VG+PY+MAPEV+
Sbjct: 131 LHSHNMIHRDVKAGNILLSEPGL---VKLGDFGSASIMAPANSF---VGTPYWMAPEVIL 184
Query: 231 ---KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287
+ Y +VDVWS G+ L PP + I ++ + SE
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--ESPALQSGHWSEY 242
Query: 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRA 347
++ V L P+ R T++ +L+H ++ + P + + ++ ++ L+ R
Sbjct: 243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER--PPTVIMDLIQRTKDAVRELDNLQYRK 300
Query: 348 LK 349
+K
Sbjct: 301 MK 302
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 254 bits (651), Expect = 4e-84
Identities = 80/276 (28%), Positives = 138/276 (50%), Gaps = 11/276 (3%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
+ +++Y ++G+G G Y D G A + ++ ++ E + E+ +MR
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRE 73
Query: 112 LPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQM 171
K+ NIV D+Y + +VME GG L D +V E AAV + ++ ++
Sbjct: 74 N-KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 131
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIVGSPYYMAPEVL 230
H + V+HRD+K +N L +K DFG K S +VG+PY+MAPEV+
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 231 KRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289
R YGP+VD+WS G++ ++ G PP+ E I + K+S +
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQNPEKLSAIFR 247
Query: 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVS 325
D + + LD D ++R +A+++L+H +L+ AK +++
Sbjct: 248 DFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLT 283
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 252 bits (644), Expect = 2e-83
Identities = 79/271 (29%), Positives = 129/271 (47%), Gaps = 12/271 (4%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E ++L + LG G +G L +R +A A K + K+ E++++E+ I + L
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKML-N 61
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H+N+V + +L +E C GGELFDRI E A ++ V H
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK 231
G+ HRD+KPEN L + LK DFGL+ F+ + +++ G+ Y+APE+LK
Sbjct: 122 IGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 232 RN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289
R + VDVWS G++L +L G P+ ++ + + +PW K+
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-KKTYLNPWKKIDSAPL 237
Query: 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320
L+ K+L +P R+T + + W K
Sbjct: 238 ALLHKILVENPSARITIPDIKKDRWYNKPLK 268
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 251 bits (642), Expect = 7e-83
Identities = 84/288 (29%), Positives = 134/288 (46%), Gaps = 25/288 (8%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E ++ G+ LG G F L + +A K + K+ + + V RE D+M L
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-D 66
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H V L T++DD ++ + + GEL I G + E T IV ++ H
Sbjct: 67 HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 126
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK 231
G++HRDLKPEN L E ++ DFG + P K + VG+ Y++PE+L
Sbjct: 127 KGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 232 -RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290
++ D+W+ G I+Y L+ G+PPF A E + Q II+ DF K A+D
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF----PEKFFPKARD 239
Query: 291 LVRKMLDPDPKRRLTAQQ------VLEHPWLQN-------AKKAPNVS 325
LV K+L D +RL ++ + HP+ ++ + P ++
Sbjct: 240 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 287
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 248 bits (635), Expect = 7e-82
Identities = 82/277 (29%), Positives = 129/277 (46%), Gaps = 16/277 (5%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
E+ +E+ ELG G FG Y ++E A K I K ++ED E+DI+
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE---ELEDYMVEIDILASC- 66
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIVEVVQMC 172
H NIV L D + + + +++E C GG + ++ TE V K ++ +
Sbjct: 67 DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL 126
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKFSEIVGSPYYMAPEVL- 230
H + ++HRDLK N LF + +K DFG+S + ++ +G+PY+MAPEV+
Sbjct: 127 HDNKIIHRDLKAGNILFTLDGD---IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 183
Query: 231 -----KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285
R Y + DVWS G+ L + PP V I +S P + S
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP-SRWS 242
Query: 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAP 322
N KD ++K L+ + R T Q+L+HP++ P
Sbjct: 243 SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKP 279
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 247 bits (631), Expect = 1e-80
Identities = 98/312 (31%), Positives = 153/312 (49%), Gaps = 21/312 (6%)
Query: 53 IEERYE-LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
I + Y+ + LG G G ++ + FA K + RREV++
Sbjct: 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWR 60
Query: 112 LPKHQNIVCLKDTYED----DTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTI 165
+ +IV + D YE+ + +VME +GGELF RI RG +TER A+ + K+I
Sbjct: 61 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 120
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
E +Q H + HRD+KPEN L+ +K+ A LK DFG + + +PYY+
Sbjct: 121 GEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYV 180
Query: 226 APEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL----DFRRDP 280
APEVL Y D+WS GVI+YILLCG PPF++ ++ + + +F
Sbjct: 181 APEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240
Query: 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVM 340
W +VSE K L+R +L +P +R+T + + HPW+ + K P L T + +
Sbjct: 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL-HTSRVLKEDKERW 299
Query: 341 NKLKKRALKVMS 352
+K+ ++
Sbjct: 300 EDVKEEMTSALA 311
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (605), Expect = 2e-77
Identities = 60/274 (21%), Positives = 113/274 (41%), Gaps = 13/274 (4%)
Query: 50 GREIEERY-ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI 108
G + R+ + E+GRG F Y D E A + +KL T + + + E ++
Sbjct: 3 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEM 61
Query: 109 MRHLPKHQNIVCLKDTYED----DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKT 164
++ L +H NIV D++E + LV EL G L + + + +
Sbjct: 62 LKGL-QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQ 120
Query: 165 IVEVVQMCHKHG--VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSP 222
I++ +Q H ++HRDLK +N + +K D GL+ K ++G+P
Sbjct: 121 ILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATL-KRASFAKAVIGTP 177
Query: 223 YYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282
+MAPE+ + Y VDV++ G+ + + P+ + S +
Sbjct: 178 EFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-PASFDK 236
Query: 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
K+++ + + R + + +L H + Q
Sbjct: 237 VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (607), Expect = 3e-77
Identities = 67/324 (20%), Positives = 120/324 (37%), Gaps = 50/324 (15%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
++ +E ELG G G+ + + + +G A K I + + RE+ ++
Sbjct: 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHEC- 61
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
IV + D + + ME +GG L + G E+ V+ +++ +
Sbjct: 62 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 174 -KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK- 231
KH +MHRD+KP N L ++ E +K DFG+S S VG+ YM+PE L+
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMANS-FVGTRSYMSPERLQG 177
Query: 232 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL----------------- 274
+Y + D+WS G+ L + G P + + V
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237
Query: 275 -----------------------DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311
+ P S +D V K L +P R +Q++
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297
Query: 312 HPWLQNAKKAPNVSLGETVKARLK 335
H +++ + V + + +
Sbjct: 298 HAFIKRSDAEE-VDFAGWLCSTIG 320
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (599), Expect = 1e-76
Identities = 82/274 (29%), Positives = 134/274 (48%), Gaps = 21/274 (7%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E YE+ +G G +G + +G K + + T + + + EV+++R L K
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLREL-K 61
Query: 115 HQNIVCLKDTYED--DTAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEV 168
H NIV D D +T +++VME CEGG+L I R + E V +
Sbjct: 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121
Query: 169 VQMCHK-----HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS-EIVGSP 222
++ CH+ H V+HRDLKP N K+ +K DFGL+ F+ VG+P
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARILNHDTSFAKAFVGTP 178
Query: 223 YYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281
YYM+PE + R Y + D+WS G +LY L +PPF A +++ +A I R
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK---FRRIP 235
Query: 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
+ S+ +++ +ML+ R + +++LE+P +
Sbjct: 236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (598), Expect = 6e-76
Identities = 73/266 (27%), Positives = 126/266 (47%), Gaps = 10/266 (3%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E + L + LG+G FG +L ++ FA K++ K + D+E E ++ +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H + + T++ + VME GG+L I + + A I+ +Q H
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVLK-R 232
G+++RDLK +N L + +K DFG+ G+ K + G+P Y+APE+L +
Sbjct: 122 KGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ 178
Query: 233 NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
Y VD WS GV+LY +L G PF + E+ + +I + + + AKDL+
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY----PRWLEKEAKDLL 234
Query: 293 RKMLDPDPKRRLTA-QQVLEHPWLQN 317
K+ +P++RL + +HP +
Sbjct: 235 VKLFVREPEKRLGVRGDIRQHPLFRE 260
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 232 bits (592), Expect = 2e-75
Identities = 67/274 (24%), Positives = 113/274 (41%), Gaps = 7/274 (2%)
Query: 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI 108
T + +RYELG LG G +L D A K + R RRE
Sbjct: 1 TPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQN 60
Query: 109 MRHLPKHQNIVCLKDTYEDDTA----VHLVMELCEGGELFDRIVARGHYTERAAAAVTKT 164
L H IV + DT E +T ++VME +G L D + G T + A V
Sbjct: 61 AAAL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIAD 119
Query: 165 IVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG-LSVFFKPGEKFSEIVGSPY 223
+ + H++G++HRD+KP N + + + ++ + + ++G+
Sbjct: 120 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 224 YMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282
Y++PE + + DV+S G +LY +L G PPF ++ VA +R
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 239
Query: 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
+S + +V K L +P+ R + ++
Sbjct: 240 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 5e-74
Identities = 83/272 (30%), Positives = 132/272 (48%), Gaps = 20/272 (7%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIED---VRREVDIM 109
+E +Y++G LG G FG Y + A K + K ++ ++ + V EV ++
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 110 RHL-PKHQNIVCLKDTYEDDTAVHLVMELCEGG-ELFDRIVARGHYTERAAAAVTKTIVE 167
+ + ++ L D +E + L++E E +LFD I RG E A + ++E
Sbjct: 62 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 168 VVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAP 227
V+ CH GV+HRD+K EN L + LK IDFG K +++ G+ Y P
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKD-TVYTDFDGTRVYSPP 178
Query: 228 EVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285
E + R +G VWS G++LY ++CG PF + E IIR + FR +VS
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFR----QRVS 228
Query: 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317
+ L+R L P R T +++ HPW+Q+
Sbjct: 229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 230 bits (586), Expect = 2e-73
Identities = 73/272 (26%), Positives = 118/272 (43%), Gaps = 14/272 (5%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR--HL 112
+ + R +GRG FG Y C + G +A K + KK+++ E ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC 172
IVC+ + + +++L GG+L + G ++E I+ ++
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR 232
H V++RDLKP N L E ++ D GL+ F K VG+ YMAPEVL++
Sbjct: 124 HNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQK 179
Query: 233 N--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290
Y D +S G +L+ LL G PF + + I R L + S +
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVELPDSFSPELRS 238
Query: 291 LVRKMLDPDPKRRLT-----AQQVLEHPWLQN 317
L+ +L D RRL AQ+V E P+ ++
Sbjct: 239 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 223 bits (570), Expect = 9e-72
Identities = 72/269 (26%), Positives = 129/269 (47%), Gaps = 16/269 (5%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+ +++ R LG G FG +L R NG +A K + K+ + +E E ++ +
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-T 62
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H I+ + T++D + ++M+ EGGELF + + A + ++ H
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RN 233
+++RDLKPEN L + +K DFG + + + + G+P Y+APEV+ +
Sbjct: 123 KDIIYRDLKPENILLD---KNGHIKITDFGFAKYVP--DVTYTLCGTPDYIAPEVVSTKP 177
Query: 234 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293
Y +D WS G+++Y +L G PF+ + I+ + L F P +E+ KDL+
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF----PPFFNEDVKDLLS 233
Query: 294 KMLDPDPKRRL-----TAQQVLEHPWLQN 317
+++ D +RL + V HPW +
Sbjct: 234 RLITRDLSQRLGNLQNGTEDVKNHPWFKE 262
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 5e-69
Identities = 77/270 (28%), Positives = 130/270 (48%), Gaps = 15/270 (5%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
++ + LG+G FG L ++ G +A K + K+ + ++ E ++++ +
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-R 63
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H + LK ++ + VME GGELF + +TE A IV ++ H
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKFSEIVGSPYYMAPEVLKRN 233
V++RD+K EN + +K DFGL G G+P Y+APEVL+ N
Sbjct: 124 RDVVYRDIKLENLMLDKDGH---IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 234 -YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
YG VD W GV++Y ++CG PF+ + + + + I+ + F +S AK L+
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF----PRTLSPEAKSLL 236
Query: 293 RKMLDPDPKRRL-----TAQQVLEHPWLQN 317
+L DPK+RL A++V+EH + +
Sbjct: 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 3e-68
Identities = 74/313 (23%), Positives = 126/313 (40%), Gaps = 49/313 (15%)
Query: 48 PTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVD 107
P E+ +YE ++G+G FG + R+ G A K + + + I RE+
Sbjct: 4 PFCDEVS-KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT-ALREIK 61
Query: 108 IMRHLPKHQNIVCLKDTYEDDTA--------VHLVMELCEGGELFDRIVARGHYTERAAA 159
I++ L KH+N+V L + + ++LV + CE +T
Sbjct: 62 ILQLL-KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 120
Query: 160 AVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK----- 214
V + ++ + H++ ++HRD+K N L LK DFGL+ F +
Sbjct: 121 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV---LKLADFGLARAFSLAKNSQPNR 177
Query: 215 FSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS 272
++ V + +Y PE+L +R+YGP +D+W AG I+ + P TEQ I +
Sbjct: 178 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237
Query: 273 VLDFRRDPWPKV----------------------------SENAKDLVRKMLDPDPKRRL 304
+ WP V A DL+ K+L DP +R+
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297
Query: 305 TAQQVLEHPWLQN 317
+ L H + +
Sbjct: 298 DSDDALNHDFFWS 310
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 215 bits (547), Expect = 4e-68
Identities = 75/304 (24%), Positives = 128/304 (42%), Gaps = 49/304 (16%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+ Y+L R+LGRG++ + + N + K + K + ++RE+ I+ +L
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLRG 88
Query: 115 HQNIVCLKDTYEDDTA--VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC 172
NI+ L D +D + LV E + T+ I++ + C
Sbjct: 89 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 145
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK- 231
H G+MHRD+KP N + + E L+ ID+GL+ F+ PG++++ V S Y+ PE+L
Sbjct: 146 HSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 203
Query: 232 -RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL---------------- 274
+ Y +D+WS G +L ++ PF+ + I VL
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263
Query: 275 ------------------DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
+ VS A D + K+L D + RLTA++ +EHP+
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
Query: 317 NAKK 320
K
Sbjct: 324 TVVK 327
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 7e-68
Identities = 58/272 (21%), Positives = 108/272 (39%), Gaps = 20/272 (7%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
EI + +G+ +G G FG Y + A K ++ T ++ + EV ++R
Sbjct: 4 EIPDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAP-TPQQLQAFKNEVGVLR 59
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTKTIVEVV 169
+H NI+ Y + +V + CEG L+ + + + + + + +
Sbjct: 60 KT-RHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 117
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE---KFSEIVGSPYYMA 226
H ++HRDLK N +K DFGL+ +F ++ GS +MA
Sbjct: 118 DYLHAKSIIHRDLKSNNIFLHEDLT---VKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 227 PEVLKRN----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS--VLDFRRDP 280
PEV++ Y + DV++ G++LY L+ G P+ + ++ +
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234
Query: 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312
+ K L+ + L R Q+L
Sbjct: 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 9e-68
Identities = 80/316 (25%), Positives = 124/316 (39%), Gaps = 47/316 (14%)
Query: 47 EPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREV 106
+ R E Y + +G G FG+ Y ++G+ A K + + K RE+
Sbjct: 12 QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNREL 64
Query: 107 DIMRHLPKHQNIVCLKDTY------EDDTAVHLVMELCEGG---ELFDRIVARGHYTERA 157
IMR L H NIV L+ + +D+ ++LV++ A+
Sbjct: 65 QIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY 123
Query: 158 AAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE 217
+ + H G+ HRD+KP+N L +TA LK DFG + GE
Sbjct: 124 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 218 IVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD 275
+ S YY APE++ +Y +DVWSAG +L LL G P F ++ II+ +
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 276 FRRDPW-------------------------PKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
R+ P+ A L ++L+ P RLT +
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 311 EHPWLQNAKKAPNVSL 326
H + + PNV L
Sbjct: 302 AHSFFDELRD-PNVKL 316
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 1e-67
Identities = 79/337 (23%), Positives = 132/337 (39%), Gaps = 47/337 (13%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
++ RY +G G +G+ D N A K IS + +T + RE+ I+
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQT--YCQRTLREIKILLR 62
Query: 112 LPKHQNIVCLKDTYEDDTAVHL----VMELCEGGELFDRIVARGHYTERAAAAVTKTIVE 167
+H+NI+ + D T + ++ G +L+ + H + I+
Sbjct: 63 F-RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILR 120
Query: 168 VVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE----KFSEIVGSPY 223
++ H V+HRDLKP N L + LK DFGL+ P +E V + +
Sbjct: 121 GLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRW 177
Query: 224 YMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281
Y APE++ + Y +D+WS G IL +L P F + I+ + ++
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237
Query: 282 ---------------------------PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPW 314
P A DL+ KML +P +R+ +Q L HP+
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 297
Query: 315 LQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVM 351
L+ + + E A K ++ L K LK +
Sbjct: 298 LEQYYDPSDEPIAE---APFKFDMELDDLPKEKLKEL 331
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 4e-67
Identities = 74/289 (25%), Positives = 115/289 (39%), Gaps = 33/289 (11%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD--IEDVRREVDIMRHLPKH 115
E LG G+F Y D+ A K I A D RE+ +++ L H
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SH 59
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH 175
NI+ L D + + + LV + E T A ++ ++ H+H
Sbjct: 60 PNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKFSEIVGSPYYMAPEVLK--R 232
++HRDLKP N L LK DFGL+ F P ++ V + +Y APE+L R
Sbjct: 120 WILHRDLKPNNLLLDENGV---LKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGAR 176
Query: 233 NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP---------- 282
YG VD+W+ G IL LL VP +++ I ++ + WP
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 283 --------------KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317
++ DL++ + +P R+TA Q L+ + N
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 3e-66
Identities = 84/277 (30%), Positives = 139/277 (50%), Gaps = 17/277 (6%)
Query: 55 ERYELGRELGRGEFGITYLC---TDRENGDAFACKSISKKKL-RTAVDIEDVRREVDIMR 110
E +EL + LG G +G +L + + G +A K + K + + A E R E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ 170
H+ + +V L ++ +T +HL+++ GGELF + R +TE IV ++
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP--GEKFSEIVGSPYYMAPE 228
HK G+++RD+K EN L + + DFGLS F E+ + G+ YMAP+
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNG---HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 229 VLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285
+++ + VD WS GV++Y LL G PF + E+ I R +L ++S
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260
Query: 286 ENAKDLVRKMLDPDPKRRL-----TAQQVLEHPWLQN 317
AKDL++++L DPK+RL A ++ EH + Q
Sbjct: 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 8e-66
Identities = 74/299 (24%), Positives = 126/299 (42%), Gaps = 35/299 (11%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL- 112
+++YE E+G G +G + D +NG F + + REV ++RHL
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 65
Query: 113 -PKHQNIVCLKD-----TYEDDTAVHLVMELCEGGEL-FDRIVARGHYTERAAAAVTKTI 165
+H N+V L D + +T + LV E + + V + +
Sbjct: 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
+ + H H V+HRDLKP+N L + + K DFGL+ + + +V + +Y
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILVTSSGQI---KLADFGLARIYSFQMALTSVVVTLWYR 182
Query: 226 APEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK- 283
APEVL ++ Y VD+WS G I + P F ++ I+ + + WP+
Sbjct: 183 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242
Query: 284 ----------------------VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320
+ E KDL+ K L +P +R++A L HP+ Q+ ++
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 3e-65
Identities = 74/292 (25%), Positives = 124/292 (42%), Gaps = 34/292 (11%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
++YE ++G G +G + +RE + A K + V RE+ +++ L K
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV-PSSALREICLLKEL-K 59
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H+NIV L D D + LV E C+ G + +++ + CH
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKFSEIVGSPYYMAPEVL--K 231
V+HRDLKP+N L E K +FGL+ F P +S V + +Y P+VL
Sbjct: 120 RNVLHRDLKPQNLLINRNGEL---KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 232 RNYGPEVDVWSAGVILYILLCG-VPPFWAETEQGVAQAIIRSVLDFRRDPW--------- 281
+ Y +D+WSAG I L P F + I R + + W
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 282 ----------------PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317
PK++ +DL++ +L +P +R++A++ L+HP+ +
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 207 bits (527), Expect = 6e-65
Identities = 73/269 (27%), Positives = 132/269 (49%), Gaps = 16/269 (5%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
++++ + LG G FG L +E+G+ +A K + K+K+ IE E I++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
+V L+ +++D++ +++VME GGE+F + G ++E A IV + H
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RN 233
+++RDLKPEN L + ++ DFG + K + + G+P +APE++ +
Sbjct: 160 LDLIYRDLKPENLLIDQQG---YIQVTDFGFAKRVK--GRTWTLCGTPEALAPEIILSKG 214
Query: 234 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293
Y VD W+ GV++Y + G PPF+A+ + + I+ + F S + KDL+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF----PSHFSSDLKDLLR 270
Query: 294 KMLDPDPKRRL-----TAQQVLEHPWLQN 317
+L D +R + H W
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 205 bits (521), Expect = 9e-65
Identities = 84/290 (28%), Positives = 127/290 (43%), Gaps = 34/290 (11%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E+Y ++G G +G+ Y + G+ FA K I +K + RE+ I++ L K
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGI-PSTTIREISILKEL-K 58
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H NIV L D + LV E + V G A + ++ + CH
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKFSEIVGSPYYMAPEVL--K 231
V+HRDLKP+N L + E LK DFGL+ F P K++ + + +Y AP+VL
Sbjct: 119 RRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 232 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP--------- 282
+ Y +D+WS G I ++ G P F +E I R + WP
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 283 ----------------KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
+ E+ DL+ KML DP +R+TA+Q LEH + +
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 7e-64
Identities = 77/302 (25%), Positives = 130/302 (43%), Gaps = 35/302 (11%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E ++ ++G G +G+ Y ++ G+ A K I + T RE+ +++ L
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL-N 59
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCE-GGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
H NIV L D + ++LV E + F A + +++ + CH
Sbjct: 60 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKFSEIVGSPYYMAPEVLKR 232
H V+HRDLKP+N L + +K DFGL+ F P ++ V + +Y APE+L
Sbjct: 120 SHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 233 N--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW--------- 281
Y VD+WS G I ++ F ++E I R++ W
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 282 ----------------PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA-KKAPNV 324
P + E+ + L+ +ML DP +R++A+ L HP+ Q+ K P++
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL 296
Query: 325 SL 326
L
Sbjct: 297 RL 298
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 8e-64
Identities = 69/304 (22%), Positives = 125/304 (41%), Gaps = 44/304 (14%)
Query: 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI 108
T E+ Y + +G G +G D G A K + + ++ + + RE+ +
Sbjct: 12 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-YRPFQSELFAKRAYRELRL 70
Query: 109 MRHLPKHQNIVCLKDTYEDD------TAVHLVMELCEGGELFDRIVARGHYTERAAAAVT 162
++H+ +H+N++ L D + D T +LVM G +++ E +
Sbjct: 71 LKHM-RHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLV 127
Query: 163 KTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSP 222
+++ ++ H G++HRDLKP N E LK +DFGL+ + + V +
Sbjct: 128 YQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQ--ADSEMTGYVVTR 182
Query: 223 YYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP 280
+Y APEV+ Y VD+WS G I+ ++ G F + I++ +
Sbjct: 183 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242
Query: 281 W---------------------------PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHP 313
S A +L+ KML D ++R+TA + L HP
Sbjct: 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 302
Query: 314 WLQN 317
+ ++
Sbjct: 303 YFES 306
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 4e-62
Identities = 61/289 (21%), Positives = 104/289 (35%), Gaps = 36/289 (12%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD---IEDVRREVDIMRH 111
E E G+ LG G FG T ++ K L+ D E + E+ +M
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 112 LPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH------------------- 152
L H+NIV L ++L+ E C G+L + + ++
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 153 ----YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208
T + + ++ +HRDL N L + K +K DFGL+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV---VKICDFGLARD 213
Query: 209 FKPGEKFS---EIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQ 263
+ +MAPE L Y + DVWS G++L+ I GV P+
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 264 GVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312
+I++ F+ D +E +++ D ++R + +
Sbjct: 274 ANFYKLIQN--GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 7e-62
Identities = 61/294 (20%), Positives = 105/294 (35%), Gaps = 26/294 (8%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+ +G G FG +++G K+ + D D E++++ L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRI----------------VARGHYTERAA 158
H NI+ L E ++L +E G L D + + +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 159 AAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI 218
+ + + +HRDL N L K DFGLS + K +
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV---AKIADFGLSRGQEVYVKKTMG 186
Query: 219 VGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILL-CGVPPFWAETEQGVAQAIIRSVLDF 276
+MA E L + Y DVWS GV+L+ ++ G P+ T + + + + +
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ---GY 243
Query: 277 RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH--PWLQNAKKAPNVSLGE 328
R + + DL+R+ P R + Q+L L+ K N +L E
Sbjct: 244 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYE 297
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 2e-61
Identities = 58/269 (21%), Positives = 105/269 (39%), Gaps = 22/269 (8%)
Query: 50 GREIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI 108
G + + +L + +G+GEFG L R G+ A K I + E +
Sbjct: 1 GWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASV 53
Query: 109 MRHLPKHQNIVCLKDT-YEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTI 165
M L +H N+V L E+ +++V E G L D + +RG + +
Sbjct: 54 MTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 112
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
E ++ + +HRDL N L + K DFGL+ + +
Sbjct: 113 CEAMEYLEGNNFVHRDLAARNVLVSEDNV---AKVSDFGLTKEASSTQ--DTGKLPVKWT 167
Query: 226 APEVLK-RNYGPEVDVWSAGVILYILL-CGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283
APE L+ + + + DVWS G++L+ + G P+ + V + + ++ D
Sbjct: 168 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---GYKMDAPDG 224
Query: 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEH 312
++++ D R + Q+ E
Sbjct: 225 CPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (497), Expect = 5e-61
Identities = 51/281 (18%), Positives = 91/281 (32%), Gaps = 21/281 (7%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
+ RY LGR++G G FG YL TD G+ A K K + E I + +
Sbjct: 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMM 59
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC 172
I ++ + +VMEL ++ + + ++ ++
Sbjct: 60 QGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE--------KFSEIVGSPYY 224
H +HRD+KP+NFL K+ + IDFGL+ ++ + + G+ Y
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 225 MAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP--- 280
+ D+ S G +L G P+ Q R P
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 281 -WPKVSENAKDLVRKMLDPDPKRRLTAQ---QVLEHPWLQN 317
+ + Q+ + + +
Sbjct: 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 1e-60
Identities = 71/298 (23%), Positives = 124/298 (41%), Gaps = 40/298 (13%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
E+ ERY+ +G G +G D + G A K + + ++ + + RE+ +++H
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 73
Query: 112 LPKHQNIVCLKDTYEDDTAV----HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE 167
+ KH+N++ L D + ++ + + G + IV T+ + I+
Sbjct: 74 M-KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 132
Query: 168 VVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAP 227
++ H ++HRDLKP N E LK +DFGL+ ++ + V + +Y AP
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 187
Query: 228 EVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR-------- 277
E++ +Y VD+WS G I+ LL G F + I+R V
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 278 -------------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
+ + + A DL+ KML D +R+TA Q L H +
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 5e-60
Identities = 61/276 (22%), Positives = 101/276 (36%), Gaps = 19/276 (6%)
Query: 54 EERYELGRELGRGEFGITYLCTDRE---NGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
E+ L +LG G FG+ + A K + L ++D REV+ M
Sbjct: 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVV 169
L H+N++ L + +V EL G L DR+ GH+ + + E +
Sbjct: 67 SL-DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF----SEIVGSPYYM 225
+HRDL N L A + +K DFGL + +
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDL---VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 226 APEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283
APE LK R + D W GV L+ + G P+ + I + R
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE--GERLPRPED 239
Query: 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319
++ +++ + P+ R T + + +L A+
Sbjct: 240 CPQDIYNVMVQCWAHKPEDRPTFVALRD--FLLEAQ 273
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 190 bits (484), Expect = 5e-59
Identities = 67/284 (23%), Positives = 106/284 (37%), Gaps = 20/284 (7%)
Query: 51 REIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISK-KKLRTAVDIEDVRREVDI 108
+EI+ ++ + +G GEFG + G +I K T D E I
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI 80
Query: 109 MRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVE 167
M H N++ L+ T V ++ E E G L + G +T + + I
Sbjct: 81 MGQF-DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAA 139
Query: 168 VVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE------IVGS 221
++ +HRDL N L + K DFGLS F +
Sbjct: 140 GMKYLADMNYVHRDLAARNILVNSNLV---CKVSDFGLSRFLEDDTSDPTYTSALGGKIP 196
Query: 222 PYYMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279
+ APE ++ R + DVWS G++++ ++ G P+W T Q V AI + D+R
Sbjct: 197 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ---DYRLP 253
Query: 280 PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPN 323
P L+ D R Q++ L + PN
Sbjct: 254 PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT--LDKMIRNPN 295
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 1e-58
Identities = 55/271 (20%), Positives = 98/271 (36%), Gaps = 20/271 (7%)
Query: 61 RELGRGEFGITYLCTDREN--GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI 118
+ELG G FG + A K + K + +++ E ++M+ L + I
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQL-DNPYI 70
Query: 119 VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVM 178
V + E ++ LVME+ E G L + H ++ + + ++ + +
Sbjct: 71 VRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFV 129
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF----SEIVGSPYYMAPEVLKRN- 233
HRDL N L + K DFGLS + E + + + APE +
Sbjct: 130 HRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 234 YGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
+ + DVWS GV+++ G P+ V + + R DL+
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK---GERMGCPAGCPREMYDLM 243
Query: 293 RKMLDPDPKRRLTAQQV---LEHPWLQNAKK 320
D + R V L + + +
Sbjct: 244 NLCWTYDVENRPGFAAVELRLRNYYYDVVNE 274
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 2e-58
Identities = 55/263 (20%), Positives = 100/263 (38%), Gaps = 17/263 (6%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+ +ELG G+FG+ R A K I + + ++ E +M +L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNL-S 57
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTKTIVEVVQMCH 173
H+ +V L + ++ E G L + + R + + + K + E ++
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE--KFSEIVGSPYYMAPEVLK 231
+HRDL N L ++ +K DFGLS + E + PEVL
Sbjct: 118 SKQFLHRDLAARNCLVNDQGV---VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 174
Query: 232 RN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289
+ + + D+W+ GV+++ I G P+ T A+ I + R SE
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ---GLRLYRPHLASEKVY 231
Query: 290 DLVRKMLDPDPKRRLTAQQVLEH 312
++ R T + +L +
Sbjct: 232 TIMYSCWHEKADERPTFKILLSN 254
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 188 bits (478), Expect = 2e-58
Identities = 54/280 (19%), Positives = 109/280 (38%), Gaps = 18/280 (6%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
E+E + +LG G++G Y ++ A K++ + + ++E+ +E +M+
Sbjct: 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMK 68
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHY--TERAAAAVTKTIVEV 168
+ KH N+V L + +++ E G L D + + + I
Sbjct: 69 EI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 127
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE--KFSEIVGSPYYMA 226
++ K +HRDL N L +K DFGLS + + A
Sbjct: 128 MEYLEKKNFIHRDLAARNCLVGENHL---VKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 184
Query: 227 PEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285
PE L N + + DVW+ GV+L+ + + + ++ D+R +
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK--DYRMERPEGCP 242
Query: 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVS 325
E +L+R +P R + ++ + + + ++S
Sbjct: 243 EKVYELMRACWQWNPSDRPSFAEIHQ--AFETMFQESSIS 280
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 3e-58
Identities = 59/263 (22%), Positives = 103/263 (39%), Gaps = 17/263 (6%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+E+G G+FG+ +L N D A K+I + + ED E ++M L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKL-S 58
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIVEVVQMCH 173
H +V L + + LV E E G L D + + + + + E +
Sbjct: 59 HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE--KFSEIVGSPYYMAPEVLK 231
+ V+HRDL N L + +K DFG++ F + + + +PEV
Sbjct: 119 EACVIHRDLAARNCLVGENQV---IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175
Query: 232 RN-YGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289
+ Y + DVWS GV+++ + G P+ + V + I FR S +
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST---GFRLYKPRLASTHVY 232
Query: 290 DLVRKMLDPDPKRRLTAQQVLEH 312
++ P+ R ++L
Sbjct: 233 QIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 4e-58
Identities = 59/275 (21%), Positives = 105/275 (38%), Gaps = 22/275 (8%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
EI E L +LG+G FG ++ T A K++ + E +E +M+
Sbjct: 13 EIPRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM----SPEAFLQEAQVMK 67
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEV 168
L +H+ +V L ++ +++V E G L D + + + I
Sbjct: 68 KL-RHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 125
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE--KFSEIVGSPYYMA 226
+ + +HRDL+ N L K DFGL+ + E + A
Sbjct: 126 MAYVERMNYVHRDLRAANILVGENLV---CKVADFGLARLIEDNEYTARQGAKFPIKWTA 182
Query: 227 PEVLKRN-YGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284
PE + + DVWS G++L L G P+ + V + R +R P+
Sbjct: 183 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMPCPPEC 239
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQVLE--HPWLQN 317
E+ DL+ + +P+ R T + + + +
Sbjct: 240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 4e-58
Identities = 64/279 (22%), Positives = 99/279 (35%), Gaps = 23/279 (8%)
Query: 55 ERYELG-RELGRGEFGITYLCTDRENGD--AFACKSISKKKLRTAVDIEDVRREVDIMRH 111
+ + ELG G FG R A K + + + D E++ RE IM
Sbjct: 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMREAQIMHQ 65
Query: 112 LPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQ 170
L + IV L + + + LVME+ GG L +V R A + + ++
Sbjct: 66 L-DNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMK 123
Query: 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE----IVGSPYYMA 226
+ +HRDL N L N+ K DFGLS + + + A
Sbjct: 124 YLEEKNFVHRDLAARNVLLVNRHY---AKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180
Query: 227 PEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284
PE + R + DVWS GV ++ L G P+ V I + R + P+
Sbjct: 181 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---GKRMECPPEC 237
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQV---LEHPWLQNAKK 320
L+ + R V + + A K
Sbjct: 238 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 2e-57
Identities = 72/270 (26%), Positives = 106/270 (39%), Gaps = 19/270 (7%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGD---AFACKSISKKKLRTAVDIEDVRREVD 107
EI+ ER ELGR +G G+FG + + A A K+ K + E +E
Sbjct: 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQEAL 60
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIV 166
MR H +IV L ++ V ++MELC GEL + R + +
Sbjct: 61 TMRQF-DHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 118
Query: 167 EVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE--KFSEIVGSPYY 224
+ +HRD+ N L ++ +K DFGLS + + K S+ +
Sbjct: 119 TALAYLESKRFVHRDIAARNVLVSSNDC---VKLGDFGLSRYMEDSTYYKASKGKLPIKW 175
Query: 225 MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282
MAPE + R + DVW GV ++ IL+ GV PF V I R P
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN---GERLPMPP 232
Query: 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312
L+ K DP RR ++
Sbjct: 233 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 2e-57
Identities = 66/311 (21%), Positives = 118/311 (37%), Gaps = 53/311 (17%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
+ +RY+ + +G G GI D A K + + + + RE+ +M+
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMKC 72
Query: 112 LPKHQNIVCLKDTY------EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
+ H+NI+ L + + E+ V+LVMEL + + + + +
Sbjct: 73 V-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQM 128
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
+ ++ H G++HRDLKP N + + K +DFGL+ + V + YY
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTL---KILDFGLARTAGTSFMMTPYVVTRYYR 185
Query: 226 APE-VLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR------------- 271
APE +L Y VD+WS G I+ ++ F +I
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 272 -------------------------SVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTA 306
S+ + + A+DL+ KML DP +R++
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305
Query: 307 QQVLEHPWLQN 317
L+HP++
Sbjct: 306 DDALQHPYINV 316
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 3e-57
Identities = 60/267 (22%), Positives = 104/267 (38%), Gaps = 20/267 (7%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
E+ E +L LG G+FG ++ A KS+ + + + E ++M+
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMK 63
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEV 168
L +HQ +V L + ++++ E E G L D + T + I E
Sbjct: 64 QL-QHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE--IVGSPYYMA 226
+ + +HRDL+ N L ++ K DFGL+ + E + + A
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEYTAREGAKFPIKWTA 178
Query: 227 PEVLKRN-YGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284
PE + + + DVWS G++L ++ G P+ T V Q + R +R
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER---GYRMVRPDNC 235
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQVLE 311
E L+R P+ R T +
Sbjct: 236 PEELYQLMRLCWKERPEDRPTFDYLRS 262
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 182 bits (463), Expect = 4e-56
Identities = 49/274 (17%), Positives = 94/274 (34%), Gaps = 20/274 (7%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
+ Y++GR +G G FG+ + T+ N A K ++ D +R E + L
Sbjct: 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLL 57
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC 172
I + ++ LV++L + ++ + A K ++ VQ
Sbjct: 58 AGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 117
Query: 173 HKHGVMHRDLKPENFLFANK--KETAPLKAIDFGLSVFFKPGE--------KFSEIVGSP 222
H+ +++RD+KP+NFL K + +DFG+ F++ + + G+
Sbjct: 118 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 223 YYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP- 280
YM+ R D+ + G + L G P+ Q R + P
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237
Query: 281 ---WPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311
E + + +
Sbjct: 238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 1e-54
Identities = 61/287 (21%), Positives = 104/287 (36%), Gaps = 32/287 (11%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR---TAVDIEDVRREVD 107
E R G+ LG G FG T + A +++ K L+ + E + E+
Sbjct: 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH--------------- 152
++ +L H NIV L ++ E C G+L + + +
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 153 ---YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209
+ + + + + +HRDL N L + + T K DFGL+
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT---KICDFGLARDI 195
Query: 210 KPGEKF---SEIVGSPYYMAPEVLKRNY-GPEVDVWSAGVILYILLC-GVPPFWAETEQG 264
K + +MAPE + E DVWS G+ L+ L G P+
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 265 VAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311
+I+ FR D+++ D DP +R T +Q+++
Sbjct: 256 KFYKMIKE--GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 3e-54
Identities = 51/267 (19%), Positives = 97/267 (36%), Gaps = 16/267 (5%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD---IEDVRREVDIMR 110
E ++ + LG G FG Y G+ ++ K+LR A +++ E +M
Sbjct: 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMA 66
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ 170
+ + ++ L T + + G L + + + I + +
Sbjct: 67 SV-DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAP 227
++HRDL N L + +K DFGL+ EK +MA
Sbjct: 126 YLEDRRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 228 EVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285
E + R Y + DVWS GV ++ L+ G P+ ++ + + R P +
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQPPICT 239
Query: 286 ENAKDLVRKMLDPDPKRRLTAQQVLEH 312
+ ++ K D R ++++
Sbjct: 240 IDVYMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 7e-54
Identities = 56/283 (19%), Positives = 100/283 (35%), Gaps = 30/283 (10%)
Query: 55 ERYELGRELGRGEFGITYLCTDR-------ENGDAFACKSISKKKLRTAVDIEDVRREVD 107
+R LG+ LG G FG L A K + D+ D+ E++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEME 70
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRI----------------VARG 151
+M+ + KH+NI+ L D +++++E G L + +
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 152 HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211
+ + + + ++ +HRDL N L
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 212 GEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 269
+K + +MAPE L R Y + DVWS GV+L+ I G P+ + + + +
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250
Query: 270 IRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312
R D + ++R P +R T +Q++E
Sbjct: 251 KE---GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (427), Expect = 1e-50
Identities = 53/299 (17%), Positives = 95/299 (31%), Gaps = 42/299 (14%)
Query: 48 PTGREIE---ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD---IED 101
P +E E R++G G FG + ++ K L+ D
Sbjct: 3 PKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD 62
Query: 102 VRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHY-------- 153
+RE +M + NIV L + L+ E G+L + + + +
Sbjct: 63 FQREAALMAEF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 121
Query: 154 ----------------TERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAP 197
+ + + + + + +HRDL N L
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV--- 178
Query: 198 LKAIDFGLSVFFKPGEKF---SEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLC- 252
+K DFGLS + + +M PE + N Y E DVW+ GV+L+ +
Sbjct: 179 VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238
Query: 253 GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311
G+ P++ + V + +L+R P R + +
Sbjct: 239 GLQPYYGMAHEEVIYYVRD---GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 3e-50
Identities = 62/284 (21%), Positives = 104/284 (36%), Gaps = 23/284 (8%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGD----AFACKSISKKKLRTAVDIEDVRREV 106
EI + +G GEFG Y + + A K++ K T D E
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGEA 60
Query: 107 DIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTI 165
IM H NI+ L+ + ++ E E G L + + G ++ + + I
Sbjct: 61 GIMGQF-SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGI 119
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK----FSEIVGS 221
++ +HRDL N L + K DFGLS + + S
Sbjct: 120 AAGMKYLANMNYVHRDLAARNILVNSNLV---CKVSDFGLSRVLEDDPEATYTTSGGKIP 176
Query: 222 PYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRD 279
+ APE + R + DVWS G++++ ++ G P+W + V +AI FR
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND---GFRLP 233
Query: 280 PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPN 323
L+ + + RR ++ L +AP+
Sbjct: 234 TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI--LDKLIRAPD 275
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 4e-49
Identities = 57/272 (20%), Positives = 106/272 (38%), Gaps = 23/272 (8%)
Query: 54 EERYELGRELGRGEFGITYLCTDREN---GDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
+GRG FG Y T +N A KS+ ++ ++ E IM+
Sbjct: 26 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMK 83
Query: 111 HLPKHQNIVCLKDT-YEDDTAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIVEV 168
H N++ L + + +V+ + G+L + I H T + + +
Sbjct: 84 DF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG 142
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE-----IVGSPY 223
++ +HRDL N + K +K DFGL+ E S
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMYDKEFDSVHNKTGAKLPVK 199
Query: 224 YMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPW 281
+MA E L+ + + + DVWS GV+L+ L+ G PP+ + +++ RR
Sbjct: 200 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG----RRLLQ 255
Query: 282 PK-VSENAKDLVRKMLDPDPKRRLTAQQVLEH 312
P+ + +++ K P + R + +++
Sbjct: 256 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 8e-48
Identities = 55/282 (19%), Positives = 109/282 (38%), Gaps = 30/282 (10%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRRE 105
E+ E+ + RELG+G FG+ Y + E A K++++ + + E
Sbjct: 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNE 73
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH----------YTE 155
+M+ ++V L ++MEL G+L + + +
Sbjct: 74 ASVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132
Query: 156 RAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-- 213
+ I + + + + +HRDL N + A +K DFG++ +
Sbjct: 133 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMTRDIYETDYY 189
Query: 214 -KFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAII 270
K + + +M+PE LK + DVWS GV+L+ I P+ + + V + ++
Sbjct: 190 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 249
Query: 271 RSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312
D + +L+R +PK R + +++
Sbjct: 250 E---GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (404), Expect = 3e-47
Identities = 60/300 (20%), Positives = 105/300 (35%), Gaps = 51/300 (17%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
I L +G+G FG + R G+ A K S ++ R+ E+ L
Sbjct: 1 IARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERS----WFREAEIYQTVML 54
Query: 113 PKHQNIVCLKDTYEDD----TAVHLVMELCEGGELFDRIVARGHYTERA-------AAAV 161
+H+NI+ D T + LV + E G LFD + E A+ +
Sbjct: 55 -RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGL 113
Query: 162 TKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-----KFS 216
+E+V K + HRDLK +N L D GL+V +
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT---CCIADLGLAVRHDSATDTIDIAPN 170
Query: 217 EIVGSPYYMAPEVLKRN-------YGPEVDVWSAGVILYILLCGVPPFWAETEQG----- 264
VG+ YMAPEVL + D+++ G++ + + +
Sbjct: 171 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230
Query: 265 ------VAQAIIRSVLDFRRDP-------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311
+ + + V + + P + ++R+ + RLTA ++ +
Sbjct: 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 5e-47
Identities = 57/287 (19%), Positives = 108/287 (37%), Gaps = 31/287 (10%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR---REVD 107
E +R +LG+ LGRG FG C++++ K L+ + R E+
Sbjct: 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 68
Query: 108 IMRHLPKHQNIVCLKD-TYEDDTAVHLVMELCEGGELFDRIVARGHY------------- 153
I+ H+ H N+V L + + +++E C+ G L + ++ +
Sbjct: 69 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128
Query: 154 ---TERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210
T + + + ++ +HRDL N L + K +K DFGL+
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV---VKICDFGLARDIY 185
Query: 211 PGEKF---SEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGV-PPFWAETEQGV 265
+ + +MAPE + Y + DVWS GV+L+ + P+
Sbjct: 186 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245
Query: 266 AQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312
++ R + + + +P +R T +++EH
Sbjct: 246 FCRRLKEGTRMRAPDY--TTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 158 bits (399), Expect = 7e-46
Identities = 64/333 (19%), Positives = 113/333 (33%), Gaps = 66/333 (19%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL--- 112
RY L R+LG G F +L D N A K + K+ T E E+ +++ +
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQRVNDA 69
Query: 113 -------PKHQNIVCLKDTYED--DTAVHLVMELCEGG---ELFDRIVARGHYTERAAAA 160
+I+ L D + VH+VM G +
Sbjct: 70 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129
Query: 161 VTKTIVEVVQ-MCHKHGVMHRDLKPENFLFANKKETAPLKAI-DFGLSVFFKPGEKFSEI 218
++K ++ + M + G++H D+KPEN L L I L E ++
Sbjct: 130 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 189
Query: 219 VGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI-------- 269
+ + Y +PEVL +G D+WS +++ L+ G F + +
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249
Query: 270 ------------------------------------IRSVLDFRRDPWPKVSENAKDLVR 293
+ VL + ++ D +
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309
Query: 294 KMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSL 326
ML DP++R A ++ HPWL++ + +
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRV 342
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 86.8 bits (214), Expect = 8e-21
Identities = 43/204 (21%), Positives = 69/204 (33%), Gaps = 25/204 (12%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACK-----SISKKKLRTAVDIEDVR-REVDIMR 110
+G+ +G G+ + C E K S KK++ D D+ + I
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 111 HLPKHQNIVCLKDTYE----DDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIV 166
+ + + L+ ++MEL + E V I+
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKE-------LYRVRVENPDEVLDMIL 113
Query: 167 EVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMA 226
E V + G++H DL N L + + + IDF SV E + EI+
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVSEEG----IWIIDFPQSVEVGE-EGWREILERDVRNI 168
Query: 227 PEVLKRNYGPEVDVWSAGVILYIL 250
R Y E D+ S I IL
Sbjct: 169 ITYFSRTYRTEKDINS--AIDRIL 190
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} Length = 392 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Score = 45.2 bits (106), Expect = 6e-06
Identities = 20/136 (14%), Positives = 44/136 (32%), Gaps = 4/136 (2%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACK----SISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+E+G G + D+E+ A K + I+ R E + +H
Sbjct: 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHV 91
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
+ + Y D VME ++ + + G + + + + + + +
Sbjct: 92 PHLVPRVFYSDTEMAVTVMEDLSHLKIARKGLIEGENYPHLSQHIGEFLGKTLFYSSDYA 151
Query: 177 VMHRDLKPENFLFANK 192
+ + K F N
Sbjct: 152 LEPKVKKQLVKQFTNP 167
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 352 | |||
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.76 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.46 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.15 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.56 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.25 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.98 |
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-64 Score=456.25 Aligned_cols=289 Identities=38% Similarity=0.725 Sum_probs=233.0
Q ss_pred ccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe
Q 018640 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (352)
Q Consensus 51 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 130 (352)
+.+.++|++++.||+|+||+||+|.+..+|+.||||++....... ....+.+|+.+|+++ +|||||++++++.+++.
T Consensus 5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 81 (307)
T d1a06a_ 5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKI-KHPNIVALDDIYESGGH 81 (307)
T ss_dssp SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTC-CCTTBCCEEEEEECSSE
T ss_pred CCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCE
Confidence 457788999999999999999999999999999999997654322 235688999999999 89999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
.++||||++||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||+........+||+|||+|+...
T Consensus 82 ~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred EEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 99999999999999999988899999999999999999999999999999999999999865566679999999998776
Q ss_pred CCCcccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHH
Q 018640 211 PGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (352)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (352)
........+||+.|+|||++.+ .++.++|||||||++|||++|+.||.+....+....+...........++.+++++.
T Consensus 162 ~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 241 (307)
T d1a06a_ 162 PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 241 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred CCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence 6665667789999999999874 589999999999999999999999999888888888877766666666678999999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcCccccccccCCCCCCcHHHHHHHHhhHHHHHH
Q 018640 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKL 343 (352)
Q Consensus 290 ~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (352)
+||.+||+.||++|||+.|+++||||++. ......+...+..+++.....+++
T Consensus 242 ~li~~~L~~dP~~R~s~~eil~hp~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 294 (307)
T d1a06a_ 242 DFIRHLMEKDPEKRFTCEQALQHPWIAGD-TALDKNIHQSVSEQIKKNFAKSKW 294 (307)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHSTTTTSS-CCCCCCCHHHHHHHHHHHSCCCTT
T ss_pred HHHHHHccCCHhHCcCHHHHhcCHhhCCC-CccccccchhHHHHHHHHHHHhhh
Confidence 99999999999999999999999999864 334445566666666654333333
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-63 Score=438.24 Aligned_cols=254 Identities=35% Similarity=0.611 Sum_probs=227.0
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++++.||+|+||+||+|.+..+|+.||+|++.+.........+.+.+|+.+++++ +|||||++++++.+++..++|
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-CCCCCCeEEEEEEECCEEEEE
Confidence 4699999999999999999999999999999999766544445567899999999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCc
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (352)
|||+++|+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|.......
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~---~kl~DFG~a~~~~~~~- 160 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSR- 160 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC---EEECCCCSCSCCCCCC-
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCC---EeecccceeeecCCCc-
Confidence 999999999999998889999999999999999999999999999999999999976554 8999999998765433
Q ss_pred ccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHH
Q 018640 215 FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (352)
Q Consensus 215 ~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 293 (352)
.....||+.|+|||++.+ .++.++|||||||++|||++|+.||......+....+.+... ..++.+++++.+||.
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~----~~p~~~s~~~~~li~ 236 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF----TFPDFVTEGARDLIS 236 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC----CCCTTSCHHHHHHHH
T ss_pred ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC----CCCccCCHHHHHHHH
Confidence 345689999999999875 489999999999999999999999998888777666655432 333568999999999
Q ss_pred HhcCCCcCCCCCHHHHhcCccccc
Q 018640 294 KMLDPDPKRRLTAQQVLEHPWLQN 317 (352)
Q Consensus 294 ~~l~~dP~~Rps~~ell~hp~f~~ 317 (352)
+||+.||++|||+.|+++||||+.
T Consensus 237 ~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 237 RLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHccCCHhHCcCHHHHHcCcCcCC
Confidence 999999999999999999999985
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-62 Score=436.81 Aligned_cols=258 Identities=30% Similarity=0.535 Sum_probs=217.8
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
-++|++++.||+|+||+||+|.+..+|+.||||++..... ....+.+.+|+.+++++ +|||||++++++.+++..++
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l-~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKML-NHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhC-CCCCEeeEeeeeccCceeEE
Confidence 3579999999999999999999999999999999876532 22345789999999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
||||++||+|.+++..+..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+......
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~---~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNN 157 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC---EEECCCTTCEECEETT
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCC---EEEccchhheeeccCC
Confidence 9999999999999988888999999999999999999999999999999999999976554 8999999998764332
Q ss_pred ---cccccccccccccchhccc-c-CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHH
Q 018640 214 ---KFSEIVGSPYYMAPEVLKR-N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (352)
Q Consensus 214 ---~~~~~~gt~~y~aPE~~~~-~-~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (352)
.....+||+.|+|||++.+ . ++.++|||||||++|||++|+.||................ ......+..+++++
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~ 236 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-KTYLNPWKKIDSAP 236 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTT-CTTSTTGGGSCHHH
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-CCCCCccccCCHHH
Confidence 2355689999999999864 3 4678999999999999999999997665443333322222 12233446789999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 289 ~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
.+||.+||+.||++|||+.|+++||||++.
T Consensus 237 ~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 237 LALLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 999999999999999999999999999864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-62 Score=438.93 Aligned_cols=266 Identities=37% Similarity=0.704 Sum_probs=236.8
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCC---hhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT---AVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 129 (352)
++++|++++.||+|+||+||+|.+..+|+.||||++.+..... ....+.+.+|+.+|+++ +|||||++++++.+++
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~ 86 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYENKT 86 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSS
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECC
Confidence 6788999999999999999999999999999999997654322 23467899999999999 8999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCC-CCCEEEEeccccee
Q 018640 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE-TAPLKAIDFGLSVF 208 (352)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~-~~~vkl~Dfg~a~~ 208 (352)
..++||||++||+|.+++...+.+++..++.++.|++.||+|||+.+|+||||||+|||++.++. ...+||+|||+|..
T Consensus 87 ~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 87 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 99999999999999999998889999999999999999999999999999999999999986553 34599999999998
Q ss_pred cCCCCcccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHH
Q 018640 209 FKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (352)
Q Consensus 209 ~~~~~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (352)
...........||+.|+|||++.+ .++.++|||||||++|||++|+.||.+....+....+......++...++.+++.
T Consensus 167 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 246 (293)
T d1jksa_ 167 IDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246 (293)
T ss_dssp CTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHH
T ss_pred cCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHH
Confidence 776666677789999999999874 5899999999999999999999999998888887777766555544445678999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 288 ~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
+.+||.+||+.||++|||+.|+++||||++..
T Consensus 247 ~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 278 (293)
T d1jksa_ 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278 (293)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 99999999999999999999999999998643
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-61 Score=434.43 Aligned_cols=256 Identities=31% Similarity=0.518 Sum_probs=223.9
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
.++|++++.||+|+||+||+|.+..+|+.||||++..... ...+.+.+|+.+++++ +|||||++++++..++..++
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~i 94 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWV 94 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC---hHHHHHHHHHHHHHhC-CCCCEeeEeEEEEECCEEEE
Confidence 4579999999999999999999999999999999876532 3457799999999999 99999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
||||++||+|.+++..+ .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+......
T Consensus 95 vmEy~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~---vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQITPEQ 170 (293)
T ss_dssp EEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC---EEECCCTTCEECCSTT
T ss_pred EEEecCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCc---Eeeccchhheeecccc
Confidence 99999999999987654 6999999999999999999999999999999999999976554 8999999998765433
Q ss_pred -cccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHH
Q 018640 214 -KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (352)
Q Consensus 214 -~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 291 (352)
......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+..... .....++.+++.+.+|
T Consensus 171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~l 249 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSAIFRDF 249 (293)
T ss_dssp CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-CCCSSGGGSCHHHHHH
T ss_pred ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-CCCCCcccCCHHHHHH
Confidence 3456689999999999875 589999999999999999999999998887766665554322 2223345789999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 292 VRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 292 i~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
|.+||+.||++|||+.|+|+||||+..
T Consensus 250 i~~~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 250 LNRCLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp HHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999999999854
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-61 Score=433.55 Aligned_cols=256 Identities=31% Similarity=0.549 Sum_probs=225.0
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++++.||+|+||+||+|.+..+|+.||||++.+.........+.+.+|+++++++ +||||+++++++.+++..++|
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CSTTBCCEEEEEECSSEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-CCCCeeEEEEEEEECCEEEEE
Confidence 5799999999999999999999999999999999876544445567899999999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC-
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (352)
|||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||+|+......
T Consensus 87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~---vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSPESK 163 (288)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC---EEECCCTTCEECC----
T ss_pred EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCce---EEecccccceecccCCc
Confidence 999999999999998889999999999999999999999999999999999999976554 8999999998765332
Q ss_pred --cccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHH
Q 018640 214 --KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (352)
Q Consensus 214 --~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (352)
......||+.|+|||++.+ .++.++|||||||++|||++|..||...+..+....+.+... ..+..+++++.+
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~----~~p~~~s~~~~~ 239 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY----DFPEKFFPKARD 239 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC----CCCTTCCHHHHH
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCC----CCCccCCHHHHH
Confidence 2345689999999999874 589999999999999999999999998888777777665433 334578999999
Q ss_pred HHHHhcCCCcCCCCCHHH------HhcCcccccc
Q 018640 291 LVRKMLDPDPKRRLTAQQ------VLEHPWLQNA 318 (352)
Q Consensus 291 li~~~l~~dP~~Rps~~e------ll~hp~f~~~ 318 (352)
||.+||+.||++|||++| +++||||++.
T Consensus 240 li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 240 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp HHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred HHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence 999999999999999998 5889999865
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-61 Score=426.17 Aligned_cols=256 Identities=23% Similarity=0.404 Sum_probs=216.3
Q ss_pred cccc-eeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe----C
Q 018640 54 EERY-ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED----D 128 (352)
Q Consensus 54 ~~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~----~ 128 (352)
+++| ++.++||+|+||+||+|.+..+++.||+|++..... .....+.+.+|+++|+++ +|||||++++++.. +
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~ 84 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGK 84 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSC
T ss_pred CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeccccC
Confidence 3444 778899999999999999999999999999876543 344567899999999999 89999999999865 3
Q ss_pred CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CEEecCCCCceEeecCCCCCCEEEEecccc
Q 018640 129 TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG--VMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a 206 (352)
...++||||+++|+|.+++.....+++..++.++.||+.||+|||+++ |+||||||+|||++.+ ...+||+|||+|
T Consensus 85 ~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~--~~~~Kl~DFGla 162 (270)
T d1t4ha_ 85 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP--TGSVKIGDLGLA 162 (270)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESST--TSCEEECCTTGG
T ss_pred CEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCC--CCCEEEeecCcc
Confidence 568999999999999999998888999999999999999999999998 9999999999999632 234899999999
Q ss_pred eecCCCCcccccccccccccchhccccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcccccCCCCCcCCC
Q 018640 207 VFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAIIRSVLDFRRDPWPKVS 285 (352)
Q Consensus 207 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 285 (352)
+..... ......||+.|+|||++.+.++.++|||||||++|||++|+.||......... ..+.... .+.......+
T Consensus 163 ~~~~~~-~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~--~~~~~~~~~~ 239 (270)
T d1t4ha_ 163 TLKRAS-FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV--KPASFDKVAI 239 (270)
T ss_dssp GGCCTT-SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC--CCGGGGGCCC
T ss_pred eeccCC-ccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCC--CCcccCccCC
Confidence 864332 33466899999999999888999999999999999999999999766544333 3333221 1122234578
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcCcccc
Q 018640 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316 (352)
Q Consensus 286 ~~~~~li~~~l~~dP~~Rps~~ell~hp~f~ 316 (352)
+++.+||.+||+.||++|||+.|+++||||+
T Consensus 240 ~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 9999999999999999999999999999996
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.9e-61 Score=441.03 Aligned_cols=269 Identities=33% Similarity=0.648 Sum_probs=238.4
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
+.++|++++.||+|+||+||+|.+..+|+.||||++... ...+...+.+|+.+|+++ +|||||++++++.+++..+
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~ 102 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP---YPLDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMV 102 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc---chhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEE
Confidence 456899999999999999999999999999999998754 233456788999999999 8999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 133 LVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
+||||++||+|.+.+.... .+++..++.|+.||+.||+|||++||+||||||+|||++.. ....+||+|||+|.....
T Consensus 103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~-~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK-KASSVKIIDFGLATKLNP 181 (352)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TCCCEEECCCTTCEECCT
T ss_pred EEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccccccccc-CCCeEEEeecccceecCC
Confidence 9999999999999876554 69999999999999999999999999999999999999742 234599999999998877
Q ss_pred CCcccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHH
Q 018640 212 GEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (352)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (352)
........||+.|+|||++.+ .++.++|||||||++|||+||+.||.+....+....+......++...++.+++++.+
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 261 (352)
T d1koba_ 182 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 261 (352)
T ss_dssp TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 666667789999999999874 4899999999999999999999999999988888888887777676677789999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcCccccccccCCCCCC
Q 018640 291 LVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSL 326 (352)
Q Consensus 291 li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~ 326 (352)
||.+||+.||++|||+.|+|+||||+.........+
T Consensus 262 li~~~L~~dp~~R~s~~eil~Hp~~~~~~~~~~~~~ 297 (352)
T d1koba_ 262 FIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRI 297 (352)
T ss_dssp HHHTTSCSSGGGSCCHHHHHTSTTTSSCCTTCCCCB
T ss_pred HHHHHccCChhHCcCHHHHhcCHhhCCCcchhcccC
Confidence 999999999999999999999999987544443333
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.5e-61 Score=441.63 Aligned_cols=262 Identities=34% Similarity=0.656 Sum_probs=234.3
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
+-++|++++.||+|+||+||+|.+..+|+.||||++... .....+.+.+|+.+|+++ +|||||++++++.+++..+
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~---~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~ 99 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDDNEMV 99 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC---SHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEEETTEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc---chhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEE
Confidence 446899999999999999999999999999999998754 334567889999999999 8999999999999999999
Q ss_pred EEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 133 LVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
+||||++||+|.+++.. ...+++..++.++.||+.||.|||++|||||||||+|||++.+. ...+||+|||+|+....
T Consensus 100 ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~-~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKR-SNELKLIDFGLTAHLDP 178 (350)
T ss_dssp EEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTT-SCCEEECCCTTCEECCT
T ss_pred EEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCC-CCeEEEeecchheeccc
Confidence 99999999999999854 45799999999999999999999999999999999999996532 24599999999998776
Q ss_pred CCcccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHH
Q 018640 212 GEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (352)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (352)
........||+.|+|||++.+ .++.++|||||||++|||++|+.||.+....+....+...........++.+++++.+
T Consensus 179 ~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 258 (350)
T d1koaa2 179 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 258 (350)
T ss_dssp TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHH
T ss_pred ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 666667799999999999874 4889999999999999999999999998888888888777666665556679999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 291 LVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 291 li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
||.+||+.||++|||+.|+|+||||++..
T Consensus 259 li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 259 FIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp HHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred HHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 99999999999999999999999998653
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.4e-61 Score=433.79 Aligned_cols=257 Identities=29% Similarity=0.443 Sum_probs=225.7
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
.++.|++++.||+|+||+||+|.+..+|+.||||++...........+.+.+|+.+|+++ +|||||++++++.+++..+
T Consensus 13 p~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~ 91 (309)
T d1u5ra_ 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAW 91 (309)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEE
T ss_pred cHHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEECCEEE
Confidence 355799999999999999999999999999999999876554555567799999999999 8999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
+||||+++|+|..++..+..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|.....
T Consensus 92 iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~---~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL---VKLGDFGSASIMAP- 167 (309)
T ss_dssp EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE---EEECCCTTCBSSSS-
T ss_pred EEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCC---EEEeecccccccCC-
Confidence 99999999999888888888999999999999999999999999999999999999986554 89999999986543
Q ss_pred Ccccccccccccccchhcc----ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHH
Q 018640 213 EKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (352)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~----~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (352)
.....||+.|+|||++. +.++.++|||||||++|||++|..||.+....+....+...... ......+++.+
T Consensus 168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~s~~~ 243 (309)
T d1u5ra_ 168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP--ALQSGHWSEYF 243 (309)
T ss_dssp --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC--CCSCTTSCHHH
T ss_pred --CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC--CCCCCCCCHHH
Confidence 24568999999999874 34889999999999999999999999988877776666654322 22234689999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 289 ~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
.+||.+||+.||++|||+.|+|+||||...
T Consensus 244 ~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 999999999999999999999999999853
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-61 Score=431.33 Aligned_cols=257 Identities=31% Similarity=0.500 Sum_probs=223.1
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
++.|++++.||+|+||+||+|.+..+|+.||+|++... .....+.+.+|+++|+++ +|||||++++++.+++..++
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~l 86 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASC-DHPNIVKLLDAFYYENNLWI 86 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---SSGGGGGTHHHHHHHHHC-CCTTBCCEEEEEEETTEEEE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCeEEE
Confidence 35799999999999999999999999999999998754 233456788999999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 134 VMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|......
T Consensus 87 vmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~---~Kl~DFG~a~~~~~~ 163 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGD---IKLADFGVSAKNTRT 163 (288)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCTTCEECHHH
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCC---EEEEechhhhccCCC
Confidence 99999999999987654 56999999999999999999999999999999999999986654 899999999765322
Q ss_pred -Ccccccccccccccchhcc------ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCC
Q 018640 213 -EKFSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (352)
Q Consensus 213 -~~~~~~~gt~~y~aPE~~~------~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (352)
.......||+.|+|||++. ..++.++|||||||++|||++|+.||......+....+...... ....+..++
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~s 242 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPP-TLAQPSRWS 242 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCC-CCSSGGGSC
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC-CCCccccCC
Confidence 2234568999999999873 34789999999999999999999999988887777776654322 122345789
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 286 ~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
+++.+||.+||+.||++|||+.|+++||||+..
T Consensus 243 ~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 243 SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999999854
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.3e-60 Score=423.59 Aligned_cols=261 Identities=38% Similarity=0.691 Sum_probs=233.2
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCCh------hcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA------VDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 127 (352)
.++|++++.||+|+||+||+|++..+|+.||||++.+...... ...+.+.+|+.+++++..||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 4689999999999999999999999999999999977543321 1234688899999999669999999999999
Q ss_pred CCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccce
Q 018640 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (352)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~ 207 (352)
++..+|||||++||+|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~---~kl~DFG~a~ 158 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN---IKLTDFGFSC 158 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC---EEECCCTTCE
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCC---eEEccchhee
Confidence 9999999999999999999998889999999999999999999999999999999999999975554 8999999999
Q ss_pred ecCCCCcccccccccccccchhccc-------cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCC
Q 018640 208 FFKPGEKFSEIVGSPYYMAPEVLKR-------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP 280 (352)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 280 (352)
............||+.|+|||.+.+ .++.++||||+||++|||++|+.||.+.........+.......+...
T Consensus 159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (277)
T d1phka_ 159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238 (277)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 8776655666789999999998742 367899999999999999999999999998888877877766666666
Q ss_pred CcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccc
Q 018640 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (352)
Q Consensus 281 ~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~ 317 (352)
++.+|+++.+||.+||+.||++|||+.|+++||||++
T Consensus 239 ~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 6789999999999999999999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-60 Score=422.14 Aligned_cols=253 Identities=31% Similarity=0.558 Sum_probs=209.1
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe--CCeEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--DTAVH 132 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~--~~~~~ 132 (352)
++|++++.||+|+||+||+|.++.+|+.||+|++..... .....+.+.+|+++++++ +|||||++++++.+ .+..+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSC-CCTTBCCEEEEEEC----CEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEeCCCCEEE
Confidence 579999999999999999999999999999999977643 344567799999999999 89999999999864 45689
Q ss_pred EEEEecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC-----CEEecCCCCceEeecCCCCCCEEEEec
Q 018640 133 LVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHG-----VMHRDLKPENFLFANKKETAPLKAIDF 203 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~-----ivH~Dikp~NIll~~~~~~~~vkl~Df 203 (352)
+||||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+||
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~---vkl~DF 158 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDF 158 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSC---EEECCH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCc---EEEeec
Confidence 99999999999998864 356999999999999999999999976 999999999999976554 899999
Q ss_pred ccceecCCCC-cccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCC
Q 018640 204 GLSVFFKPGE-KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281 (352)
Q Consensus 204 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (352)
|+|+...... ......||+.|+|||++.+ .++.++|||||||++|||+||+.||......+....+...... ..+
T Consensus 159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~---~~~ 235 (269)
T d2java1 159 GLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR---RIP 235 (269)
T ss_dssp HHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC---CCC
T ss_pred cceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC---CCC
Confidence 9998765433 3355789999999999874 5899999999999999999999999988887777666554322 234
Q ss_pred cCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 018640 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (352)
Q Consensus 282 ~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f 315 (352)
..+++++.+||.+||+.||++|||+.|+++|||+
T Consensus 236 ~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 5789999999999999999999999999999995
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-60 Score=431.40 Aligned_cols=256 Identities=29% Similarity=0.545 Sum_probs=229.6
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++++.||+|+||+||+|.+..+|+.||+|++.+.........+.+.+|+.+|+++ +||||+++++++.+++..++|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-CCCCEEEEEeeeccccccccc
Confidence 4799999999999999999999999999999999876544455677899999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC-CC
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GE 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~-~~ 213 (352)
|||++||+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+.... ..
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~---vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH---IKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC---EEECCCTTCBCSCCTTC
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCC---EEEeecccccccccCCc
Confidence 999999999999999889999999999999999999999999999999999999976654 89999999986543 34
Q ss_pred cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHH
Q 018640 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (352)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 292 (352)
.....+||+.|+|||++. ..++.++|||||||++|||++|+.||.+....+....+..... ..+..+++++.+||
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~----~~p~~~s~~~~dli 236 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI----RFPRTLSPEAKSLL 236 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----CCCTTSCHHHHHHH
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCC----CCCccCCHHHHHHH
Confidence 456679999999999987 4599999999999999999999999999888877777666543 33457899999999
Q ss_pred HHhcCCCcCCCCC-----HHHHhcCcccccc
Q 018640 293 RKMLDPDPKRRLT-----AQQVLEHPWLQNA 318 (352)
Q Consensus 293 ~~~l~~dP~~Rps-----~~ell~hp~f~~~ 318 (352)
.+||+.||.+||+ +.|+++||||++.
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HhhccCCchhhcccccccHHHHHcCcccccC
Confidence 9999999999994 9999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-60 Score=432.31 Aligned_cols=273 Identities=31% Similarity=0.628 Sum_probs=238.9
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
++-++|++++.||+|+||+||+|.+..+|+.||+|++.... .+...+.+|+.+|+.+ +|||||++++++.+++..
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~ 76 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIA-RHRNILHLHESFESMEEL 76 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEE
Confidence 45678999999999999999999999999999999997542 3345688999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 132 HLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
++||||++||+|.+++...+ .+++..++.++.||+.||+|||+.||+||||||+|||++.++ ...+||+|||++....
T Consensus 77 ~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~-~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRR-SSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS-CCCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCC-ceEEEEcccchhhccc
Confidence 99999999999999998765 699999999999999999999999999999999999997543 3458999999998876
Q ss_pred CCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHH
Q 018640 211 PGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (352)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (352)
.........||+.|+|||.+. ..++.++|||||||++|+|++|..||......+....+.+....++...++.+++++.
T Consensus 156 ~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T d1tkia_ 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHH
Confidence 666566678999999999876 4589999999999999999999999999998888888877666555555567899999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcCccccccccCCCCCCcHHH
Q 018640 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETV 330 (352)
Q Consensus 290 ~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~ 330 (352)
+||.+||+.||++|||+.|+++||||++........+..++
T Consensus 236 ~li~~~L~~dp~~R~s~~eil~hp~~~~~~~~~~~~~~~~~ 276 (321)
T d1tkia_ 236 DFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTL 276 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHHHHSCGGGSCCCCCCCH
T ss_pred HHHHHHccCChhHCcCHHHHhcCHhhccCccccChhhcccc
Confidence 99999999999999999999999999876554444444333
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-61 Score=437.60 Aligned_cols=272 Identities=24% Similarity=0.377 Sum_probs=221.4
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
..+++|++++.||+|+||+||+|.+..+|+.||+|++.... .....+.+.+|+.+|+++ +|||||+++++|.+++..
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 79 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEI 79 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGC-CCTTBCCEEEEEECSSEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEE
Confidence 34678999999999999999999999999999999987642 333457889999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
++||||++||+|.+++.+.+.+++..++.++.|++.||.|||+ +||+||||||+|||++.++. +||+|||+|+...
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~---vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI 156 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC---EEECCCCCCHHHH
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCC---EEEeeCCCccccC
Confidence 9999999999999999988899999999999999999999997 59999999999999976554 8999999998653
Q ss_pred CCCcccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------------------
Q 018640 211 PGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII------------------- 270 (352)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~------------------- 270 (352)
.. ...+.+||+.|+|||++.+ .++.++||||+||++|||++|+.||.............
T Consensus 157 ~~-~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 157 DS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp HH-TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred CC-ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 32 2245689999999999874 59999999999999999999999997654332111000
Q ss_pred -------------------hcccccCC--CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccCCCCCCcHH
Q 018640 271 -------------------RSVLDFRR--DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGET 329 (352)
Q Consensus 271 -------------------~~~~~~~~--~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~ 329 (352)
.......+ .....++.++.+||.+||+.||++|||+.|+|+||||++... ...+++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~-~~~d~~~~ 314 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA-EEVDFAGW 314 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH-SCCCHHHH
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc-ccccHHHH
Confidence 00000000 111235789999999999999999999999999999997543 44455444
Q ss_pred HH
Q 018640 330 VK 331 (352)
Q Consensus 330 ~~ 331 (352)
++
T Consensus 315 ~~ 316 (322)
T d1s9ja_ 315 LC 316 (322)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.2e-59 Score=425.89 Aligned_cols=254 Identities=28% Similarity=0.550 Sum_probs=228.0
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+++++ +|||||++++++.+++..++|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-cCcChhheeeeEeeCCeeeeE
Confidence 4699999999999999999999999999999999765444445567899999999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCc
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (352)
|||++||+|...+.....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+.....
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~---vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH---IKITDFGFAKYVPDV-- 157 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC---EEECCCSSCEECSSC--
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCC---EEEecCccceEeccc--
Confidence 999999999999999989999999999999999999999999999999999999976554 899999999876533
Q ss_pred ccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHH
Q 018640 215 FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (352)
Q Consensus 215 ~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 293 (352)
.....||+.|+|||++.+ .++.++|||||||++|||++|+.||.+....+....+.+... ..++.+++++.++|.
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~----~~p~~~s~~~~~li~ 233 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL----RFPPFFNEDVKDLLS 233 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC----CCCTTSCHHHHHHHH
T ss_pred cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC----CCCCCCCHHHHHHHH
Confidence 345689999999999875 489999999999999999999999999888877777766533 234568999999999
Q ss_pred HhcCCCcCCCC-----CHHHHhcCcccccc
Q 018640 294 KMLDPDPKRRL-----TAQQVLEHPWLQNA 318 (352)
Q Consensus 294 ~~l~~dP~~Rp-----s~~ell~hp~f~~~ 318 (352)
+||+.||.+|| |++++++||||++.
T Consensus 234 ~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 234 RLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 99999999996 99999999999874
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-58 Score=426.97 Aligned_cols=254 Identities=28% Similarity=0.536 Sum_probs=227.6
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++++.||+|+||+||+|.++.+|+.||||++.+.........+.+.+|+.+|+.+ +|||||++++++......++|
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-CCCcEeecccccccccccccc
Confidence 5799999999999999999999999999999999765544445567899999999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCc
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (352)
|||+.+|+|.+++...+.+++..++.++.||+.||.|||++|||||||||+|||++.++ .+||+|||+|+.....
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g---~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG---YIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS---CEEECCCTTCEECSSC--
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCC---CEEeeeceeeeecccc--
Confidence 99999999999999888999999999999999999999999999999999999997655 4999999999876533
Q ss_pred ccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHH
Q 018640 215 FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (352)
Q Consensus 215 ~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 293 (352)
.....||+.|+|||++.+ .++.++|||||||++|||+||+.||.+.........+..... ..+..+++++.+||.
T Consensus 195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~----~~p~~~s~~~~~li~ 270 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV----RFPSHFSSDLKDLLR 270 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----CCCTTCCHHHHHHHH
T ss_pred cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC----CCCccCCHHHHHHHH
Confidence 345689999999999874 589999999999999999999999998888777777765533 334578999999999
Q ss_pred HhcCCCcCCCC-----CHHHHhcCcccccc
Q 018640 294 KMLDPDPKRRL-----TAQQVLEHPWLQNA 318 (352)
Q Consensus 294 ~~l~~dP~~Rp-----s~~ell~hp~f~~~ 318 (352)
+||+.||.+|+ |+.++++||||++.
T Consensus 271 ~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHhhhCHHhccccccccHHHHHcCccccCC
Confidence 99999999994 99999999999864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-59 Score=425.36 Aligned_cols=267 Identities=36% Similarity=0.668 Sum_probs=222.2
Q ss_pred ccccceece-eeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe----
Q 018640 53 IEERYELGR-ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED---- 127 (352)
Q Consensus 53 ~~~~y~~~~-~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~---- 127 (352)
+-++|.++. +||+|+||+||+|.+..+|+.||||++... ..+.+|+.++.++.+|||||+++++|++
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~ 80 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG 80 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence 456798875 599999999999999999999999998532 4677899998766589999999999875
Q ss_pred CCeEEEEEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccc
Q 018640 128 DTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (352)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~ 205 (352)
+...++||||++||+|.+++..++ .+++..++.++.||+.||+|||++||+||||||+|||++.+.....+||+|||+
T Consensus 81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccce
Confidence 467899999999999999998753 599999999999999999999999999999999999998777677799999999
Q ss_pred ceecCCCCcccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc----cCCCC
Q 018640 206 SVFFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD----FRRDP 280 (352)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~----~~~~~ 280 (352)
|+............||+.|+|||++.+ .++.++|||||||++|+|+||+.||.+.........+...... ++...
T Consensus 161 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (335)
T d2ozaa1 161 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240 (335)
T ss_dssp CEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTH
T ss_pred eeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcc
Confidence 998776666677799999999999875 5999999999999999999999999766554444444333322 22222
Q ss_pred CcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccCCCCCCc
Q 018640 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLG 327 (352)
Q Consensus 281 ~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~ 327 (352)
+..+++++.+||.+||+.||++|||+.|+++||||.+....+..++.
T Consensus 241 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~~~~~ 287 (335)
T d2ozaa1 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLH 287 (335)
T ss_dssp HHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSCCCEES
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCCCCCcC
Confidence 34689999999999999999999999999999999876665555443
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.5e-58 Score=428.18 Aligned_cols=258 Identities=28% Similarity=0.471 Sum_probs=219.1
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHH---HHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRRE---VDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E---~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
++|+++++||+|+||+||+|++..+|+.||||++.+...........+.+| +.+++.+ +|||||++++++...+..
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~-~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC-CCCcEEEEEEEEEECCEE
Confidence 469999999999999999999999999999999876544333333444444 6666677 799999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
++||||++||+|.+++.....+++..++.++.||+.||+|||++|||||||||+|||++.++. +||+|||+|+....
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~---iKl~DFGla~~~~~ 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH---VRISDLGLACDFSK 159 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSC---EEECCCTTCEECSS
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCc---EEEeeeceeeecCC
Confidence 999999999999999998889999999999999999999999999999999999999976554 89999999987654
Q ss_pred CCcccccccccccccchhcc-c-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHH
Q 018640 212 GEKFSEIVGSPYYMAPEVLK-R-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (352)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~-~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (352)
.. .....||+.|+|||++. + .++.++|||||||++|||+||+.||......... .+...........+..+++++.
T Consensus 160 ~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~ 237 (364)
T d1omwa3 160 KK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSPELR 237 (364)
T ss_dssp SC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH-HHHHHSSSCCCCCCSSSCHHHH
T ss_pred Cc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcccCCCCCCCCCCHHHH
Confidence 43 34568999999999875 3 4899999999999999999999999876543322 2333344444555667999999
Q ss_pred HHHHHhcCCCcCCCCC-----HHHHhcCcccccc
Q 018640 290 DLVRKMLDPDPKRRLT-----AQQVLEHPWLQNA 318 (352)
Q Consensus 290 ~li~~~l~~dP~~Rps-----~~ell~hp~f~~~ 318 (352)
+||.+||+.||++||| ++|+++||||++.
T Consensus 238 ~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp HHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred HHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 9999999999999999 7999999999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-58 Score=419.88 Aligned_cols=256 Identities=29% Similarity=0.471 Sum_probs=224.5
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHH-hCCCCCCeeEeeeEEEeCCeEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR-HLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
++|++++.||+|+||+||+|++..+|+.||||++.+.........+.+..|..++. .+ +|||||++++++.+++..++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~-~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-EHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHT-TCTTBCCEEEEEECSSEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhC-CCCcEEEEEEEEccCCceeE
Confidence 46999999999999999999999999999999997654433445667777877776 46 99999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC-
Q 018640 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~- 212 (352)
||||+++|+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.....
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~---~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH---IKIADFGMCKENMLGD 157 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC---EEECCCTTCBCCCCTT
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCc---eeccccchhhhccccc
Confidence 9999999999999999889999999999999999999999999999999999999976554 899999999865433
Q ss_pred Ccccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHH
Q 018640 213 EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (352)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 291 (352)
.......||+.|+|||++.+ .++.++|||||||++|||++|+.||.+.........+.... ...+..+++++.+|
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~----~~~p~~~s~~~~dl 233 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN----PFYPRWLEKEAKDL 233 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----CCCCTTSCHHHHHH
T ss_pred ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC----CCCCccCCHHHHHH
Confidence 33455689999999999874 58999999999999999999999999988887777766543 23345689999999
Q ss_pred HHHhcCCCcCCCCCHH-HHhcCcccccc
Q 018640 292 VRKMLDPDPKRRLTAQ-QVLEHPWLQNA 318 (352)
Q Consensus 292 i~~~l~~dP~~Rps~~-ell~hp~f~~~ 318 (352)
|.+||+.||++|||+. ++++||||++.
T Consensus 234 i~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 234 LVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHhcccCCCCCcCHHHHHHhCchhccC
Confidence 9999999999999995 89999999864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-58 Score=415.39 Aligned_cols=257 Identities=26% Similarity=0.387 Sum_probs=214.0
Q ss_pred eceeeeccCceEEEEEEECCCCcEEEEEEccccccCCh--hcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEE
Q 018640 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA--VDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (352)
Q Consensus 59 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e 136 (352)
.+++||+|+||+||+|.+..+|+.||||++........ ...+.+.+|+.+++++ +|||||++++++..++..++|||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTTCCEEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-CCCCEeEEEeeeccCCceeehhh
Confidence 46889999999999999999999999999976533221 1134688999999999 89999999999999999999999
Q ss_pred ecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC-cc
Q 018640 137 LCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-KF 215 (352)
Q Consensus 137 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-~~ 215 (352)
|++++++.........+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+|....... ..
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~---~KL~DFG~a~~~~~~~~~~ 157 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV---LKLADFGLAKSFGSPNRAY 157 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC---EEECCCGGGSTTTSCCCCC
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCc---cccccCccccccCCCcccc
Confidence 9998877777666677999999999999999999999999999999999999975554 8999999998664432 33
Q ss_pred cccccccccccchhcc-c-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCC-------------
Q 018640 216 SEIVGSPYYMAPEVLK-R-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP------------- 280 (352)
Q Consensus 216 ~~~~gt~~y~aPE~~~-~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~------------- 280 (352)
....||+.|+|||++. + .++.++|||||||++|||++|..||......+....+.+.........
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence 4568999999999875 3 479999999999999999999999999888887777765433221111
Q ss_pred -----------CcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 281 -----------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 281 -----------~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
.+.+++++.+||.+||+.||++|||+.|+|+||||++..
T Consensus 238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 124688999999999999999999999999999999764
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-58 Score=408.11 Aligned_cols=253 Identities=31% Similarity=0.540 Sum_probs=214.4
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChh---cHHHHHHHHHHHHhCC-CCCCeeEeeeEEEeC
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAV---DIEDVRREVDIMRHLP-KHQNIVCLKDTYEDD 128 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~E~~~l~~l~-~h~~iv~l~~~~~~~ 128 (352)
++++|++.++||+|+||+||+|.+..+|+.||||++.+....... ...++.+|+.+++++. .|||||++++++...
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 467899999999999999999999999999999999765443321 2234668999999984 389999999999999
Q ss_pred CeEEEEEEecCC-cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccce
Q 018640 129 TAVHLVMELCEG-GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (352)
Q Consensus 129 ~~~~lv~e~~~~-~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~ 207 (352)
+..++||||+.+ +++.+++..+..+++..++.++.||+.||+|||++||+||||||+|||++.+. ..+||+|||+|.
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~--~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGA 159 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT--TEEEECCCTTCE
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCC--CeEEECccccce
Confidence 999999999976 67888888888899999999999999999999999999999999999997442 348999999998
Q ss_pred ecCCCCcccccccccccccchhccc-c-CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCC
Q 018640 208 FFKPGEKFSEIVGSPYYMAPEVLKR-N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (352)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~~~~-~-~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (352)
.... .......||+.|+|||++.+ . ++.++|||||||++|||++|+.||.... .+.+.. ....+.+|
T Consensus 160 ~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~----~~~~~~~s 228 (273)
T d1xwsa_ 160 LLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ----VFFRQRVS 228 (273)
T ss_dssp ECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCC----CCCSSCCC
T ss_pred eccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcc----cCCCCCCC
Confidence 6543 33456789999999999864 3 4677999999999999999999996532 222322 22335789
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 286 ~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
+++.+||.+||+.||++|||+.|+++||||++.
T Consensus 229 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999999999999999875
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-56 Score=405.75 Aligned_cols=260 Identities=28% Similarity=0.475 Sum_probs=215.4
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++++.||+|+||+||+|.+..+|+.||||++..... .....+.+.+|+++|+++ +|||||++++++..++..++|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhC-CCCcEEEeccccccccceeEE
Confidence 479999999999999999999999999999999976532 233457889999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 135 MELCEGGELFDRIVA--RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
|||+.+ ++.+.+.. ...+++..++.++.||+.||+|||++|||||||||+|||++.++. +||+|||+|......
T Consensus 80 ~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~---~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 80 FEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVP 155 (298)
T ss_dssp EECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC---EEECSTTHHHHHCCC
T ss_pred EeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCc---ceeccCCcceeccCC
Confidence 999965 55554433 346999999999999999999999999999999999999975544 899999999876443
Q ss_pred -Ccccccccccccccchhcc--ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCC---------
Q 018640 213 -EKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP--------- 280 (352)
Q Consensus 213 -~~~~~~~gt~~y~aPE~~~--~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 280 (352)
.......||+.|+|||.+. ..++.++|||||||++|+|++|+.||.+....+....+...........
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence 3345568999999999865 3368899999999999999999999998887776666654433221111
Q ss_pred ----------------CcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 281 ----------------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 281 ----------------~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
.+.+++++.+||.+||+.||++|||+.|+++||||++...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence 1246788999999999999999999999999999998744
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.2e-57 Score=402.07 Aligned_cols=261 Identities=28% Similarity=0.425 Sum_probs=218.8
Q ss_pred ccccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC-
Q 018640 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT- 129 (352)
Q Consensus 51 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~- 129 (352)
..+.++|++.+.||+|+||+||+|.+..+|+.||||++......+....+.+.+|+.+++.+ +||||+++++++...+
T Consensus 3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-~hpniv~~~~~~~~~~~ 81 (277)
T d1o6ya_ 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETP 81 (277)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEECS
T ss_pred cCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-CCCCCCcccceeeeccC
Confidence 35778999999999999999999999999999999999876655555667899999999999 9999999999987654
Q ss_pred ---eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccc
Q 018640 130 ---AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (352)
Q Consensus 130 ---~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a 206 (352)
..++||||++|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++. ++|+|||.+
T Consensus 82 ~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~---~~l~d~~~~ 158 (277)
T d1o6ya_ 82 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA---VKVMDFGIA 158 (277)
T ss_dssp SSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSC---EEECCCTTC
T ss_pred CCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcccc---ceeehhhhh
Confidence 47899999999999999998889999999999999999999999999999999999999986655 799999998
Q ss_pred eecCCCC----cccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCC
Q 018640 207 VFFKPGE----KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281 (352)
Q Consensus 207 ~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (352)
....... ......||+.|+|||++.+ .++.++|||||||++|||+||+.||......+....+.......+....
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 238 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 238 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTS
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhc
Confidence 7653322 2345689999999999875 5899999999999999999999999988888777777666554444555
Q ss_pred cCCCHHHHHHHHHhcCCCcCCCC-CHHHHhcCcccc
Q 018640 282 PKVSENAKDLVRKMLDPDPKRRL-TAQQVLEHPWLQ 316 (352)
Q Consensus 282 ~~~~~~~~~li~~~l~~dP~~Rp-s~~ell~hp~f~ 316 (352)
+.+|+++.++|.+||+.||++|| |+++++ |+|.+
T Consensus 239 ~~~s~~l~~li~~~L~~dp~~R~~sa~~l~-~~l~r 273 (277)
T d1o6ya_ 239 EGLSADLDAVVLKALAKNPENRYQTAAEMR-ADLVR 273 (277)
T ss_dssp SSCCHHHHHHHHHHTCSSGGGSCSSHHHHH-HHHHH
T ss_pred cCCCHHHHHHHHHHccCCHhHCHhHHHHHH-HHHHH
Confidence 67999999999999999999999 566654 55543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-56 Score=404.95 Aligned_cols=263 Identities=27% Similarity=0.413 Sum_probs=215.1
Q ss_pred ccccceeceeeeccCceEEEEEEECCC-CcEEEEEEccccccCChhcHHHHHHHHHHHHhCC--CCCCeeEeeeEEEe--
Q 018640 53 IEERYELGRELGRGEFGITYLCTDREN-GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP--KHQNIVCLKDTYED-- 127 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~~iv~l~~~~~~-- 127 (352)
.+++|++++.||+|+||+||+|.+..+ ++.||||++....... .....+.+|+.+++.+. +||||++++++|..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 457899999999999999999999765 6679999987653322 22234556777766552 79999999999853
Q ss_pred ---CCeEEEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEec
Q 018640 128 ---DTAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDF 203 (352)
Q Consensus 128 ---~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Df 203 (352)
....+++|||++++++...... ...+++..++.++.|++.||+|||+++|+||||||+|||++.++. +||+||
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~---~kl~df 160 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADF 160 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC---EEECSC
T ss_pred cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCC---eeecch
Confidence 3478999999988776554443 345999999999999999999999999999999999999976554 899999
Q ss_pred ccceecCCCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC----
Q 018640 204 GLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR---- 278 (352)
Q Consensus 204 g~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---- 278 (352)
|++.............||+.|+|||++. ..++.++||||+||++|||++|+.||.+....+....+.........
T Consensus 161 g~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 161 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred hhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence 9998766555666779999999999876 55999999999999999999999999998887777766553322110
Q ss_pred -------------------CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 279 -------------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 279 -------------------~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
.....+++.+.+||.+||++||++|||+.|+|+||||++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 11235789999999999999999999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.3e-56 Score=398.97 Aligned_cols=257 Identities=32% Similarity=0.495 Sum_probs=215.0
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|+++++||+|+||+||+|.++ +|+.||||++..... .....+.+.+|+.+|+++ +|||||++++++..++..+++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSCEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhC-CCCcEEeeeeecccCCceeEE
Confidence 47999999999999999999985 789999999976543 233457899999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC-
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (352)
+||+.++.+..+......+++..++.++.||+.||+|||+.+||||||||+|||++.++. +||+|||++.......
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~---~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVR 155 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC---EEECCTTHHHHHCC---
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCC---EEecccccceecccCcc
Confidence 999988777777666778999999999999999999999999999999999999976655 8999999997654332
Q ss_pred cccccccccccccchhcc--ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC-------------
Q 018640 214 KFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR------------- 278 (352)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~--~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------------- 278 (352)
......|++.|+|||.+. ..++.++|||||||++|||++|+.||......+....+.........
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence 234457899999999875 34799999999999999999999999888777766665543322111
Q ss_pred ------------CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccc
Q 018640 279 ------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (352)
Q Consensus 279 ------------~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~ 317 (352)
...+.+++++.+||.+||+.||++|||+.|+++||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 112346889999999999999999999999999999985
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.1e-56 Score=398.15 Aligned_cols=253 Identities=20% Similarity=0.333 Sum_probs=213.7
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
.++|++.+.||+|+||+||+|.+..+|+.||||++... ....+++.+|+.+|+++ +|||||++++++.+++..++
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~----~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT----CSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc----cchHHHHHHHHHHHHhC-CCCCEecCCccEeeCCeeEE
Confidence 35799999999999999999999999999999998653 23457899999999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 134 VMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+....
T Consensus 91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~---~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL---VKVADFGLSRLMTG 167 (287)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC---EEECCCCCTTTCCS
T ss_pred EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCc---EEEccccceeecCC
Confidence 99999999999999764 45899999999999999999999999999999999999986654 89999999987654
Q ss_pred CCc--ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHH
Q 018640 212 GEK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (352)
Q Consensus 212 ~~~--~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (352)
... .....||+.|+|||++. +.++.++||||||+++|||++|..||+.............. ......+..+++.+
T Consensus 168 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~--~~~~~~~~~~~~~l 245 (287)
T d1opja_ 168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK--DYRMERPEGCPEKV 245 (287)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT--TCCCCCCTTCCHHH
T ss_pred CCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhc--CCCCCCCccchHHH
Confidence 332 23446889999999876 56999999999999999999977766555444443333333 23344556789999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 289 ~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
.+||.+||+.||++|||+.||++ +|+..
T Consensus 246 ~~li~~cl~~dP~~Rps~~ei~~--~L~~~ 273 (287)
T d1opja_ 246 YELMRACWQWNPSDRPSFAEIHQ--AFETM 273 (287)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred HHHHHHHcCCCHhHCcCHHHHHH--HHHHH
Confidence 99999999999999999999965 55544
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-56 Score=395.63 Aligned_cols=250 Identities=22% Similarity=0.390 Sum_probs=204.1
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
.++|++.+.||+|+||+||+|+.. ..||||++..... .....+.|.+|+.+++++ +|||||++++++.+ +..++
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~-~~~~l 80 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKT-RHVNILLFMGYSTA-PQLAI 80 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTC-CCTTBCCEEEEECS-SSCEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhC-CCCCEeeeeEEEec-cEEEE
Confidence 357999999999999999999753 3599999876533 344567899999999999 99999999998754 56799
Q ss_pred EEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCC
Q 018640 134 VMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~ 212 (352)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+++||||||||+|||++.++. +||+|||+|+.....
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~---~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLT---VKIGDFGLATVKSRW 157 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSS---EEECCCCCSCC----
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCC---EEEccccceeecccc
Confidence 99999999999999765 46999999999999999999999999999999999999986554 899999999765432
Q ss_pred ---Ccccccccccccccchhccc----cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC--CCCCcC
Q 018640 213 ---EKFSEIVGSPYYMAPEVLKR----NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR--RDPWPK 283 (352)
Q Consensus 213 ---~~~~~~~gt~~y~aPE~~~~----~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 283 (352)
.......||+.|+|||++.+ .++.++|||||||++|||+||+.||.+.................+ ......
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 237 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTT
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcccc
Confidence 23345689999999998752 378899999999999999999999988765554444433322111 223456
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 284 ~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
+++.+.+||.+||+.||++|||+.||+++
T Consensus 238 ~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 238 CPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 89999999999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-56 Score=395.06 Aligned_cols=247 Identities=22% Similarity=0.327 Sum_probs=205.9
Q ss_pred eeeeccCceEEEEEEEC--CCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEEEEec
Q 018640 61 RELGRGEFGITYLCTDR--ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELC 138 (352)
Q Consensus 61 ~~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~e~~ 138 (352)
++||+|+||+||+|.+. .+++.||||++.... .+....+++.+|+.+|+++ +|||||++++++..+ ..++||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l-~HpnIv~~~g~~~~~-~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQL-DNPYIVRMIGICEAE-SWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEESS-SEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhC-CCCCCceEEEEeccC-CEEEEEEcC
Confidence 46999999999999864 456789999987543 3344567899999999999 899999999998654 578999999
Q ss_pred CCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCcc---
Q 018640 139 EGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF--- 215 (352)
Q Consensus 139 ~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~--- 215 (352)
++|+|.+++.....+++..+..++.||+.||+|||+++|+||||||+|||++.++. +||+|||+++........
T Consensus 90 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~---~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 90 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE---EEECCCTTCEECCTTCSEEEC
T ss_pred CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCc---ccccchhhhhhcccccccccc
Confidence 99999999999889999999999999999999999999999999999999987665 899999999876543221
Q ss_pred -cccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHHHHH
Q 018640 216 -SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (352)
Q Consensus 216 -~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 292 (352)
....||+.|+|||.+. +.++.++||||||+++|||+| |+.||.+....+....+.+. .+...+..+|+++.+||
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~---~~~~~p~~~~~~~~~li 243 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG---ERMGCPAGCPREMYDLM 243 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT---CCCCCCTTCCHHHHHHH
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC---CCCCCCcccCHHHHHHH
Confidence 3347899999999886 558999999999999999998 89999988777666555443 23344567899999999
Q ss_pred HHhcCCCcCCCCCHHHH---hcCcccc
Q 018640 293 RKMLDPDPKRRLTAQQV---LEHPWLQ 316 (352)
Q Consensus 293 ~~~l~~dP~~Rps~~el---l~hp~f~ 316 (352)
.+||+.||++|||+.+| |+|+|+.
T Consensus 244 ~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 244 NLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp HHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 99999999999999998 5666654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-55 Score=397.23 Aligned_cols=250 Identities=24% Similarity=0.373 Sum_probs=202.6
Q ss_pred cccceeceeeeccCceEEEEEEECCCCc---EEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGD---AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 130 (352)
.++|++.++||+|+||+||+|.+..+|+ .||||.+.... .....+.|.+|+.+|+++ +|||||++++++..++.
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQF-DHPNVIHLEGVVTKSTP 101 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeCCE
Confidence 3579999999999999999999876665 58899876532 334556899999999999 89999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 131 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
.++||||+++|+|.+++... +.+++..+..++.||+.||+|||+++|+||||||+|||++.++. +||+|||+|+..
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~---~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV---CKVSDFGLSRFL 178 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC---EEECCC------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCc---EEECCcccceEc
Confidence 99999999999999988764 46999999999999999999999999999999999999976554 899999999876
Q ss_pred CCCCcc------cccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCC
Q 018640 210 KPGEKF------SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPW 281 (352)
Q Consensus 210 ~~~~~~------~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (352)
...... ....||+.|+|||.+. +.++.++|||||||++|||+| |..||......+....+.+. .....+
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~---~~~~~~ 255 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD---YRLPPP 255 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT---CCCCCC
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---CCCCCC
Confidence 443221 1235789999999986 568999999999999999998 89999988887776666543 233445
Q ss_pred cCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 282 ~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
..+++.+.+||.+||+.||++|||+.||+++
T Consensus 256 ~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 6789999999999999999999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-55 Score=393.37 Aligned_cols=252 Identities=25% Similarity=0.318 Sum_probs=212.1
Q ss_pred ccceecee-eeccCceEEEEEEECC--CCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 55 ERYELGRE-LGRGEFGITYLCTDRE--NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 55 ~~y~~~~~-lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
++|.+.+. ||+|+||+||+|.+.. ++..||||++... ......+++.+|+++|+++ +|||||++++++.. +..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~-~~~ 83 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA-EAL 83 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEES-SSE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh--cCHHHHHHHHHHHHHHHhC-CCCCEeeEeeeecc-CeE
Confidence 46888884 9999999999998754 4557999998754 2445567899999999999 89999999999865 468
Q ss_pred EEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 132 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++. +||+|||+|+...
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~---~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY---AKISDFGLSKALG 160 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE---EEECCCTTCEECT
T ss_pred EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCc---eeeccchhhhccc
Confidence 8999999999999998654 56999999999999999999999999999999999999987665 8999999998765
Q ss_pred CCCc----ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCC
Q 018640 211 PGEK----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (352)
Q Consensus 211 ~~~~----~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (352)
.... .....||+.|+|||++. +.++.++|||||||++|||+| |..||......+....+.+. .+...++.+
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~---~~~~~p~~~ 237 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG---KRMECPPEC 237 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT---CCCCCCTTC
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---CCCCCCCcC
Confidence 4332 23457899999999987 568999999999999999998 99999887776666555443 233445678
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHH---hcCcccc
Q 018640 285 SENAKDLVRKMLDPDPKRRLTAQQV---LEHPWLQ 316 (352)
Q Consensus 285 ~~~~~~li~~~l~~dP~~Rps~~el---l~hp~f~ 316 (352)
++++.+||.+||+.||++|||+.+| |+|+|++
T Consensus 238 ~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 238 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 9999999999999999999999888 6778775
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-55 Score=402.59 Aligned_cols=251 Identities=24% Similarity=0.339 Sum_probs=210.6
Q ss_pred ccceeceeeeccCceEEEEEEECCCCc-----EEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGD-----AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 129 (352)
++|++.++||+|+||+||+|++..+++ .||+|.+.... .......+.+|+.++.++.+|||||++++++...+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 579999999999999999999876544 68999886542 23345678999999999878999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCc
Q 018640 130 AVHLVMELCEGGELFDRIVARG-----------------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPEN 186 (352)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~-----------------------~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~N 186 (352)
..++||||+++|+|.+++..+. .+++..++.++.|++.||+|||+++||||||||+|
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N 194 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 194 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence 9999999999999999997542 47899999999999999999999999999999999
Q ss_pred eEeecCCCCCCEEEEecccceecCCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 018640 187 FLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAET 261 (352)
Q Consensus 187 Ill~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~ 261 (352)
||++.++. +||+|||+|+....... .....||+.|+|||++. +.++.++|||||||++|||+| |..||.+..
T Consensus 195 ill~~~~~---~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 195 VLVTHGKV---VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp EEEETTTE---EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred cccccCCe---EEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 99986654 89999999986544332 23457899999999876 569999999999999999998 899998876
Q ss_pred HHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 262 EQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
.......+.... .+...+..+++++.+||.+||+.||++|||+.||++|
T Consensus 272 ~~~~~~~~~~~~--~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 272 VDANFYKLIQNG--FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CSHHHHHHHHTT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhcC--CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 655555555543 2334456789999999999999999999999999876
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-55 Score=389.46 Aligned_cols=246 Identities=24% Similarity=0.383 Sum_probs=200.7
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++++.||+|+||+||+|.+. ++..||||++... ....+++.+|+.+++++ +|||||++++++..++..++|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~----~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREG----AMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSS----SSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCC----cCcHHHHHHHHHHHHhc-CCCCcccccceeccCCceEEE
Confidence 46999999999999999999976 5778999998753 23357899999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++. +||+|||+++......
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~---~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV---IKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGC---EEECSCC---------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCC---eEecccchheeccCCC
Confidence 9999999999998755 45899999999999999999999999999999999999986655 8999999998764433
Q ss_pred c--ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHH
Q 018640 214 K--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (352)
Q Consensus 214 ~--~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (352)
. .....||+.|+|||++. ..++.++||||||+++|||+| |.+||......+....+.... +...+...++++.
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~---~~~~p~~~~~~l~ 232 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF---RLYKPRLASTHVY 232 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTC---CCCCCTTSCHHHH
T ss_pred ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcC---CCCCccccCHHHH
Confidence 2 23457899999999987 459999999999999999999 566666666665665555432 2333456789999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcC
Q 018640 290 DLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 290 ~li~~~l~~dP~~Rps~~ell~h 312 (352)
+||..||+.||++|||++||++|
T Consensus 233 ~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 233 QIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHH
Confidence 99999999999999999999886
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-55 Score=392.75 Aligned_cols=251 Identities=23% Similarity=0.338 Sum_probs=210.3
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
.++|++.+.||+|+||+||+|.+. ++..||||++.... ...+.+.+|+.+++++ +|||||++++++.+ +..++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~-~~~~i 84 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQL-QHQRLVRLYAVVTQ-EPIYI 84 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc----CCHHHHHHHHHHHHhC-CCCCEeEEEeeecc-CCeEE
Confidence 357999999999999999999975 57889999986532 3457899999999999 99999999998755 46789
Q ss_pred EEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 134 VMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
||||+++|+|.+++... ..+++..+..|+.||+.||.|||+++|+||||||+|||++.++. +||+|||+|+....
T Consensus 85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~---~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS---CKIADFGLARLIED 161 (272)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC---EEECCCTTCEECSS
T ss_pred EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccc---eeeccccceEEccC
Confidence 99999999999977543 25999999999999999999999999999999999999976554 89999999987754
Q ss_pred CCc--ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHH
Q 018640 212 GEK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCG-VPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (352)
Q Consensus 212 ~~~--~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (352)
... .....||+.|+|||++. +.++.++||||||+++|||+|| .+|+......+....+... .+...+..++++
T Consensus 162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~---~~~~~p~~~~~~ 238 (272)
T d1qpca_ 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG---YRMVRPDNCPEE 238 (272)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT---CCCCCCTTCCHH
T ss_pred CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc---CCCCCcccChHH
Confidence 432 24457899999999987 5589999999999999999995 5555555665555555443 233344578999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhc--Cccccc
Q 018640 288 AKDLVRKMLDPDPKRRLTAQQVLE--HPWLQN 317 (352)
Q Consensus 288 ~~~li~~~l~~dP~~Rps~~ell~--hp~f~~ 317 (352)
+.+||.+||+.||++|||+.+|++ ++||..
T Consensus 239 l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 999999999999999999999998 788864
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=395.19 Aligned_cols=258 Identities=27% Similarity=0.457 Sum_probs=213.4
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe-------
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED------- 127 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~------- 127 (352)
++|+++++||+|+||+||+|++..+|+.||||++...... ......+.+|+.+|+++ +|||++++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l-~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC-------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHh-cCCCccceEeeeecccccccc
Confidence 6899999999999999999999999999999998765432 33456788999999999 89999999998754
Q ss_pred -CCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccc
Q 018640 128 -DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (352)
Q Consensus 128 -~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a 206 (352)
++..++||||+.++.+.........+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||++
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~---~kl~dfg~~ 164 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV---LKLADFGLA 164 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC---EEECCCTTC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCc---EEeeeccee
Confidence 4568999999988766665556667999999999999999999999999999999999999976554 899999999
Q ss_pred eecCCCC-----cccccccccccccchhcc--ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCC
Q 018640 207 VFFKPGE-----KFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279 (352)
Q Consensus 207 ~~~~~~~-----~~~~~~gt~~y~aPE~~~--~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 279 (352)
....... ......||+.|+|||.+. ..++.++|||||||++|||++|+.||.+.........+.+........
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 244 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 7654322 223457999999999875 358999999999999999999999999888877777766655443332
Q ss_pred CCcC----------------------------CCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccc
Q 018640 280 PWPK----------------------------VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (352)
Q Consensus 280 ~~~~----------------------------~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~ 317 (352)
.... .++.+.+||.+||++||++|||+.|+|+||||++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 2111 3677889999999999999999999999999995
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-54 Score=399.32 Aligned_cols=256 Identities=27% Similarity=0.418 Sum_probs=211.9
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe------C
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED------D 128 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~------~ 128 (352)
-+|+.+++||+|+||+||+|++..+|+.||||++..... ...+|+.+|+++ +||||++++++|.. .
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l-~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHC-CCTTBCCEEEEEEEC--CCSC
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhc-CCCCCCcEEEEEEecCccCCc
Confidence 369999999999999999999999999999999875431 223699999999 99999999999853 3
Q ss_pred CeEEEEEEecCCcchHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccc
Q 018640 129 TAVHLVMELCEGGELFDR---IVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~---l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~ 205 (352)
.+.++||||++++.+... ......+++..++.++.||+.||+|||++||+||||||+|||++.++. .+||+|||+
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~--~~kl~DFG~ 169 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA--VLKLCDFGS 169 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTC--CEEECCCTT
T ss_pred eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCC--ceeEecccc
Confidence 357899999976543332 234556999999999999999999999999999999999999975542 389999999
Q ss_pred ceecCCCCcccccccccccccchhcc--ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc-------
Q 018640 206 SVFFKPGEKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF------- 276 (352)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~------- 276 (352)
+.............||..|+|||.+. ..++.++||||+||++|||++|+.||......+....+.+.....
T Consensus 170 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 170 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred hhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 99877666666778999999999764 358999999999999999999999999888777666655432110
Q ss_pred ------------------CCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 277 ------------------RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 277 ------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
.....+..++++.+||.+||+.||++|||+.|+|+||||++...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 00112357899999999999999999999999999999997643
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.8e-54 Score=396.49 Aligned_cols=256 Identities=28% Similarity=0.523 Sum_probs=212.4
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe--CCeE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--DTAV 131 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~--~~~~ 131 (352)
.++|+++++||+|+||+||+|++..+|+.||||++... ..+.+.+|+.+|+.+.+||||+++++++.. ....
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 35799999999999999999999999999999998643 246788999999999679999999999974 4578
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
++||||+++++|.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. .+||+|||+|+....
T Consensus 108 ~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~--~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT--EEEECCGGGCEECCT
T ss_pred eEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCC--eeeecccccceeccC
Confidence 9999999999987653 46999999999999999999999999999999999999985443 389999999998776
Q ss_pred CCcccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccc-------------c
Q 018640 212 GEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVL-------------D 275 (352)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~-------------~ 275 (352)
........||+.|+|||.+.+ .++.++||||+||+++||++|+.||...... .....+..... .
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 666677789999999998753 4799999999999999999999999765432 22222211100 0
Q ss_pred --------------------cCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccccc
Q 018640 276 --------------------FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (352)
Q Consensus 276 --------------------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~ 320 (352)
........+++++.+||.+||+.||++|||++|+|+||||++...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 001112246889999999999999999999999999999997643
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-54 Score=382.50 Aligned_cols=246 Identities=22% Similarity=0.345 Sum_probs=213.5
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|++++.||+|+||+||+|+++ ++..||||++.... ...+.+.+|+.+++++ +||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~----~~~~~~~~Ev~~~~~l-~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS----MSEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSS----SCHHHHHHHHHHHHTC-CCTTBCCEEEEECCSSSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCc----CCHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEE
Confidence 47899999999999999999985 68899999987643 2357899999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC
Q 018640 135 MELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (352)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||+++......
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~---~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG---VVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTC---CEEECCCSSCCBCSSSS
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCC---cEEECcchhheeccCCC
Confidence 999999999998765 45699999999999999999999999999999999999997544 48999999998664433
Q ss_pred c--ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHH
Q 018640 214 K--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (352)
Q Consensus 214 ~--~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (352)
. .....||+.|+|||.+. ..++.++||||||+++|||+| |+.||......+....+.+.. +...+...++.+.
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~---~~~~p~~~~~~l~ 231 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL---RLYRPHLASEKVY 231 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC---CCCCCTTCCHHHH
T ss_pred ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCC---CCCCcccccHHHH
Confidence 2 23457899999999987 568999999999999999998 899999888887776665532 3344467899999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcC
Q 018640 290 DLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 290 ~li~~~l~~dP~~Rps~~ell~h 312 (352)
+||.+||+.||++|||+.+|++|
T Consensus 232 ~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 232 TIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHH
Confidence 99999999999999999999987
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-54 Score=398.72 Aligned_cols=259 Identities=26% Similarity=0.448 Sum_probs=211.6
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC--
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT-- 129 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~-- 129 (352)
.+.++|++++.||+|+||+||+|.+..+|+.||||++.... ......+.+.+|+.+|+.+ +|||||+++++|...+
T Consensus 15 ~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l-~hpniv~l~~~~~~~~~~ 92 (346)
T d1cm8a_ 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETL 92 (346)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSST
T ss_pred ecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhc-CCCCeeEEEEEeccCccc
Confidence 46789999999999999999999999999999999997643 3444567889999999999 8999999999997654
Q ss_pred ----eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEeccc
Q 018640 130 ----AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (352)
Q Consensus 130 ----~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~ 205 (352)
..++||||+ +.+|...+. +..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+
T Consensus 93 ~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~---~kl~Dfg~ 167 (346)
T d1cm8a_ 93 DDFTDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE---LKILDFGL 167 (346)
T ss_dssp TTCCCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---EEECCCTT
T ss_pred cccceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccc---cccccccc
Confidence 579999999 567777664 457999999999999999999999999999999999999976555 89999999
Q ss_pred ceecCCCCcccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc-------
Q 018640 206 SVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF------- 276 (352)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~------- 276 (352)
|+.... ......||+.|+|||.+.+ .++.++||||+||++|+|++|+.||.+.........+.......
T Consensus 168 a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 168 ARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp CEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred eeccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence 987643 3355689999999998753 47899999999999999999999998887666554444322211
Q ss_pred ----------------CC----CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccc
Q 018640 277 ----------------RR----DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (352)
Q Consensus 277 ----------------~~----~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~ 319 (352)
.. ...+.+++++.+||.+||+.||++|||+.|+|+||||++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 11 12245789999999999999999999999999999999754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=384.76 Aligned_cols=259 Identities=27% Similarity=0.480 Sum_probs=218.2
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 134 (352)
++|+++++||+|+||+||+|++..+|+.||||++.... ........+.+|+.+|+.+ +||||+++++++......++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhc-CcCCEEeeccccccccceeEE
Confidence 47999999999999999999999999999999997653 2334567899999999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCC-
Q 018640 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (352)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (352)
++++.+++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||.+.......
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~---~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE---LKLANFGLARAFGIPVR 156 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC---EEECCCTTCEECCSCCS
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCc---eeeeecchhhcccCCCc
Confidence 999999999988888888999999999999999999999999999999999999976554 8999999998765433
Q ss_pred cccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcccccCC------------
Q 018640 214 KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVLDFRR------------ 278 (352)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~------------ 278 (352)
......+++.|+|||.+.. .++.++|||||||++|||++|+.||... ...+....+.........
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence 3344467889999998763 3789999999999999999999986544 444444444332222111
Q ss_pred -------------CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 279 -------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 279 -------------~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
...+.+++.+.+||.+||++||++|||++|+|+||||++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 1123468899999999999999999999999999999875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-55 Score=397.02 Aligned_cols=261 Identities=32% Similarity=0.565 Sum_probs=221.7
Q ss_pred ccceeceeeeccCceEEEEEEE---CCCCcEEEEEEccccccC-ChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe
Q 018640 55 ERYELGRELGRGEFGITYLCTD---RENGDAFACKSISKKKLR-TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 130 (352)
++|++++.||+|+||+||+|.+ ..+|+.||||++.+.... .....+.+.+|+.+++++.+||||+++++++.....
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5799999999999999999987 446899999998765432 223346688899999999555899999999999999
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
.+++|||+.+|+|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+++...
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~---vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH---VVLTDFGLSKEFV 180 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC---EEESCSSEEEECC
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCC---EEEeeccchhhhc
Confidence 9999999999999999999888999999999999999999999999999999999999986554 8999999998754
Q ss_pred CCC--cccccccccccccchhccc---cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcCCC
Q 018640 211 PGE--KFSEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (352)
Q Consensus 211 ~~~--~~~~~~gt~~y~aPE~~~~---~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (352)
... ......|++.|+|||.+.+ .++.++|||||||+||||++|+.||...........+.+.........+..++
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s 260 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCC
Confidence 332 2345689999999998753 37889999999999999999999998776555555555554444555556799
Q ss_pred HHHHHHHHHhcCCCcCCCC-----CHHHHhcCcccccc
Q 018640 286 ENAKDLVRKMLDPDPKRRL-----TAQQVLEHPWLQNA 318 (352)
Q Consensus 286 ~~~~~li~~~l~~dP~~Rp-----s~~ell~hp~f~~~ 318 (352)
+++.+||.+||++||++|| |++|+++||||++.
T Consensus 261 ~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298 (322)
T ss_dssp HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence 9999999999999999999 58999999999874
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-54 Score=395.47 Aligned_cols=265 Identities=27% Similarity=0.457 Sum_probs=212.9
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC--
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT-- 129 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~-- 129 (352)
.++.+|++++.||+|+||+||+|.+..+|+.||||++.+.. .....+.+.+|+.+|+++ +||||+++++++....
T Consensus 5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l-~hp~iv~~~~~~~~~~~~ 81 (345)
T d1pmea_ 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIE 81 (345)
T ss_dssp CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTT
T ss_pred CcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHc-CCCCCCcEEEEEeecccc
Confidence 45678999999999999999999999999999999987542 334456788999999999 9999999999987543
Q ss_pred --eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccce
Q 018640 130 --AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (352)
Q Consensus 130 --~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~ 207 (352)
..+++++|+.+|+|.+++..+ .+++..++.++.|++.||+|||++|||||||||+|||++.++. +||+|||++.
T Consensus 82 ~~~~~~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~---~kl~DfG~a~ 157 (345)
T d1pmea_ 82 QMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLAR 157 (345)
T ss_dssp TCCCEEEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---EEECCCTTCE
T ss_pred ccceEEEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCC---EEEcccCcee
Confidence 234455666799999999754 6999999999999999999999999999999999999975554 8999999998
Q ss_pred ecCCCC----cccccccccccccchhcc--ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc-----
Q 018640 208 FFKPGE----KFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF----- 276 (352)
Q Consensus 208 ~~~~~~----~~~~~~gt~~y~aPE~~~--~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~----- 276 (352)
...... ......||+.|+|||.+. ..++.++||||+||++++|++|+.||...................
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence 654332 234557999999999875 347889999999999999999999998777655444443321111
Q ss_pred ---------------C---C----CCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccCCC
Q 018640 277 ---------------R---R----DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPN 323 (352)
Q Consensus 277 ---------------~---~----~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~~~ 323 (352)
+ . ..++.++.++.+||.+||+.||++|||+.|+|+||||+......+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~ 306 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 306 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGG
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCcc
Confidence 0 0 013357889999999999999999999999999999996655433
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=382.76 Aligned_cols=253 Identities=22% Similarity=0.306 Sum_probs=205.6
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
.++|++.+.||+|+||+||+|.+.. +..||||++.... ...+.|.+|+.+++++ +|||||++++++.+ +..++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~----~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~-~~~~l 88 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT----MSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPIYI 88 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS----SCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECccc----CCHHHHHHHHHHHHhc-ccCCEeEEEEEEec-CCeEE
Confidence 3579999999999999999999864 5679999986542 2457899999999999 99999999999854 56789
Q ss_pred EEEecCCcchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 134 VMELCEGGELFDRIVA--RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
||||+++|+|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++....
T Consensus 89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~---~kl~DfGla~~~~~ 165 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV---CKVADFGLARLIED 165 (285)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC---EEECCCCTTC----
T ss_pred EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCc---EEEcccchhhhccC
Confidence 9999999999988854 346999999999999999999999999999999999999986654 89999999987643
Q ss_pred CC--cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhcccccCCCCCcCCCHH
Q 018640 212 GE--KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPF-WAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (352)
Q Consensus 212 ~~--~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (352)
.. ......||+.|+|||++. +.++.++||||||+++|||++|..|+ ......+....+... ...+.++.++++
T Consensus 166 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~---~~~~~~~~~~~~ 242 (285)
T d1fmka3 166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPES 242 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT---CCCCCCTTSCHH
T ss_pred CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhc---CCCCCCcccCHH
Confidence 33 223457899999999886 56999999999999999999965554 444555454444432 233455678999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhc--Cccccccc
Q 018640 288 AKDLVRKMLDPDPKRRLTAQQVLE--HPWLQNAK 319 (352)
Q Consensus 288 ~~~li~~~l~~dP~~Rps~~ell~--hp~f~~~~ 319 (352)
+.++|.+||+.||++|||+.+|++ ++||....
T Consensus 243 l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 243 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred HHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 999999999999999999999988 88998654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-53 Score=380.40 Aligned_cols=248 Identities=22% Similarity=0.321 Sum_probs=199.3
Q ss_pred ccceeceeeeccCceEEEEEEECCCC----cEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENG----DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 130 (352)
+.|++.++||+|+||+||+|.+..++ ..||||++.... .......+.+|+.+++++ +|||||++++++.+.+.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l-~H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISKYKP 83 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhc-CCCCEeeeeEEEecCCc
Confidence 46899999999999999999987554 469999986542 334456789999999999 89999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 131 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
.++||||+.++++.+.+... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++. +||+|||+++..
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~---~Kl~DFGla~~~ 160 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV---CKVSDFGLSRVL 160 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC---EEECCCCC----
T ss_pred eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCe---EEEcccchhhcc
Confidence 99999999999999988755 56999999999999999999999999999999999999976554 899999999876
Q ss_pred CCCCc----ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhcccccCCCCCcC
Q 018640 210 KPGEK----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPP-FWAETEQGVAQAIIRSVLDFRRDPWPK 283 (352)
Q Consensus 210 ~~~~~----~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (352)
..... .....||+.|+|||++. +.++.++||||||+++|||+++..| +......+....+... .+...+..
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~---~~~~~~~~ 237 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG---FRLPTPMD 237 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT---CCCCCCTT
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc---CCCCCchh
Confidence 43321 23346899999999886 5689999999999999999996555 5555555454444332 23344457
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 284 VSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 284 ~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
+++.+.+||.+||+.||++|||+.||++
T Consensus 238 ~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 238 CPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp CBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 8999999999999999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-53 Score=379.40 Aligned_cols=249 Identities=27% Similarity=0.355 Sum_probs=201.8
Q ss_pred cccceeceeeeccCceEEEEEEECCC---CcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe
Q 018640 54 EERYELGRELGRGEFGITYLCTDREN---GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 130 (352)
.++|++.+.||+|+||+||+|.+..+ +..||||.+... ......+.+.+|+.+++++ +|||||++++++. ++.
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~-~~~ 81 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-ENP 81 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC-SSS
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEe-cCe
Confidence 35899999999999999999998654 346889987643 2344567899999999999 8999999999986 467
Q ss_pred EEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 131 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
.++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++++||||||+||+++.++. +||+|||+|+..
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~---~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC---VKLGDFGLSRYM 158 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE---EEECC-------
T ss_pred EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCc---EEEccchhheec
Confidence 89999999999999987654 46999999999999999999999999999999999999987665 899999999876
Q ss_pred CCCC--cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCC
Q 018640 210 KPGE--KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (352)
Q Consensus 210 ~~~~--~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (352)
.... ......||+.|+|||.+. +.++.++|||||||++|||++ |.+||......+....+.+.. ....++.++
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~---~~~~~~~~~ 235 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE---RLPMPPNCP 235 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC---CCCCCTTCC
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCC
Confidence 4332 224457899999999987 568999999999999999998 899998888877776665532 334556789
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 286 ENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 286 ~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
+.+.+||.+||+.||++|||+.||+++
T Consensus 236 ~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 236 PTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999999875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-53 Score=391.83 Aligned_cols=262 Identities=27% Similarity=0.440 Sum_probs=214.8
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC---
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--- 128 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~--- 128 (352)
.+.++|++++.||+|+||+||+|++..+|+.||||++.... .+....+.+.+|+.+|+++ +|||+|++++++...
T Consensus 15 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l-~h~~iv~~~~~~~~~~~~ 92 (348)
T d2gfsa1 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSL 92 (348)
T ss_dssp EEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSST
T ss_pred cCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeecccc
Confidence 45678999999999999999999999999999999997653 3444556788999999999 899999999998632
Q ss_pred --CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccc
Q 018640 129 --TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (352)
Q Consensus 129 --~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a 206 (352)
...+++++|+.||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +|++|||++
T Consensus 93 ~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~---~kl~dfg~a 168 (348)
T d2gfsa1 93 EEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLA 168 (348)
T ss_dssp TTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC---EEECCC---
T ss_pred ccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccc---ccccccchh
Confidence 344666778889999998854 47999999999999999999999999999999999999976654 899999999
Q ss_pred eecCCCCcccccccccccccchhccc--cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC------
Q 018640 207 VFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR------ 278 (352)
Q Consensus 207 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------ 278 (352)
.... .......||+.|+|||.+.+ .++.++|||||||++|+|++|+.||.+.........+.........
T Consensus 169 ~~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 169 RHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp -CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred cccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence 7643 33355689999999997653 3688999999999999999999999888777666666544332111
Q ss_pred -----------------C----CCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccccccC
Q 018640 279 -----------------D----PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKA 321 (352)
Q Consensus 279 -----------------~----~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~~~~ 321 (352)
. .+..+++++.+||.+||+.||++|||+.|+|+||||++....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~ 310 (348)
T d2gfsa1 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310 (348)
T ss_dssp CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCC
Confidence 0 023578999999999999999999999999999999976443
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=386.25 Aligned_cols=250 Identities=22% Similarity=0.301 Sum_probs=207.5
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcE--EEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDA--FACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
++|++.++||+|+||+||+|.+..+|.. ||||++... ......+.+.+|+.+|.++.+|||||++++++..++..+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 5799999999999999999999888875 667766433 233345679999999999867999999999999999999
Q ss_pred EEEEecCCcchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCC
Q 018640 133 LVMELCEGGELFDRIVAR----------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETA 196 (352)
Q Consensus 133 lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~ 196 (352)
+||||+++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~-- 165 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV-- 165 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc--
Confidence 999999999999999653 46899999999999999999999999999999999999976654
Q ss_pred CEEEEecccceecCCCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHHhccc
Q 018640 197 PLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGV-PPFWAETEQGVAQAIIRSVL 274 (352)
Q Consensus 197 ~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~-~p~~~~~~~~~~~~~~~~~~ 274 (352)
+||+|||+++............||..|+|||.+. +.++.++||||||+++|||++|. +||......+....+.+.
T Consensus 166 -~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~-- 242 (309)
T d1fvra_ 166 -AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-- 242 (309)
T ss_dssp -EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT--
T ss_pred -eEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc--
Confidence 8999999998655444444557899999999986 55899999999999999999965 567766666655554432
Q ss_pred ccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 275 DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 275 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
.+...+..+++++.+||.+||+.||++|||+.||+++
T Consensus 243 -~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 243 -YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp -CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3344556789999999999999999999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-53 Score=384.02 Aligned_cols=248 Identities=21% Similarity=0.284 Sum_probs=203.4
Q ss_pred ccceeceeeeccCceEEEEEEECCCCc----EEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCe
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGD----AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 130 (352)
++|+++++||+|+||+||+|.+..+|+ .||+|++.... .....+.+.+|+.+++++ +|||||++++++.++ .
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-T 84 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHC-CCTTBCCEEEEEESS-S
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC-C
Confidence 369999999999999999999988876 47888775432 333467899999999999 899999999999865 4
Q ss_pred EEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceec
Q 018640 131 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (352)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~ 209 (352)
.++++||+.+++|.+.+... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++. +||+|||+|+..
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~---~kl~DFGla~~~ 161 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH---VKITDFGLAKLL 161 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE---EEECCCSHHHHT
T ss_pred eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCC---eEeeccccceec
Confidence 67788999999999888765 46999999999999999999999999999999999999987665 899999999876
Q ss_pred CCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCC
Q 018640 210 KPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (352)
Q Consensus 210 ~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (352)
..... .....||+.|+|||++. +.++.++||||||+++|||+| |..||.+....+....+.+.. +...++.+
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~---~~~~p~~~ 238 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE---RLPQPPIC 238 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC---CCCCCTTB
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC---CCCCCccc
Confidence 44332 23346899999999876 568999999999999999998 789998877766655554432 23344578
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 285 SENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 285 ~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
++.+.+||.+||+.||++|||+.||++|
T Consensus 239 ~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 239 TIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 9999999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-53 Score=377.63 Aligned_cols=254 Identities=24% Similarity=0.349 Sum_probs=202.9
Q ss_pred ccceeceeeeccCceEEEEEEECCC-C--cEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 55 ERYELGRELGRGEFGITYLCTDREN-G--DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~-~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
++|++.+.||+|+||+||+|....+ + ..||||++...........++|.+|+.+|+++ +||||+++++++.++ ..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~~~g~~~~~-~~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLTP-PM 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSS-SC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeec-ch
Confidence 5799999999999999999986432 3 36899998876555555567899999999999 999999999999754 67
Q ss_pred EEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 132 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
++||||+++|+|.+.+..+ ..+++..+..++.||+.||.|||++||+||||||+||+++.++. +||+|||+++...
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~---vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL---VKIGDFGLMRALP 162 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE---EEECCCTTCEECC
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccc---eeeccchhhhhcc
Confidence 8999999999999877654 46999999999999999999999999999999999999987664 8999999999765
Q ss_pred CCCc----ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCC
Q 018640 211 PGEK----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (352)
Q Consensus 211 ~~~~----~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (352)
.... .....||..|+|||++. ..++.++||||||+++|||+| |..||.+....+....+.+... ..+.++.+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~ 240 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE--RLPRPEDC 240 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC--CCCCCTTC
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCC--CCCCcccc
Confidence 4432 23446788999999987 458999999999999999998 8999998888877777665532 33445678
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhcCccccc
Q 018640 285 SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (352)
Q Consensus 285 ~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~ 317 (352)
++.+.+||.+||+.||++|||+.+|++ ++++
T Consensus 241 ~~~l~~li~~cl~~dp~~RPt~~ei~~--~L~~ 271 (273)
T d1u46a_ 241 PQDIYNVMVQCWAHKPEDRPTFVALRD--FLLE 271 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHH--HHHh
Confidence 999999999999999999999999964 5443
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-53 Score=390.03 Aligned_cols=258 Identities=26% Similarity=0.389 Sum_probs=202.0
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe-----
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED----- 127 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~----- 127 (352)
+.++|+++++||+|+||+||+|.+..+|+.||||++.... .......++.+|+.+++++ +|||||+++++|..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~f~~~~~~~ 92 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLE 92 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT-SSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTT
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhh-cCHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEecccccc
Confidence 4478999999999999999999999999999999997653 3444566789999999999 89999999999953
Q ss_pred -CCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccc
Q 018640 128 -DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (352)
Q Consensus 128 -~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a 206 (352)
....|+||||+.+ ++.+.+. ..+++..++.++.|++.||+|||++||+||||||+|||++.++. ++++|||++
T Consensus 93 ~~~~~~iv~Ey~~~-~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~---~kl~df~~~ 166 (355)
T d2b1pa1 93 EFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGLA 166 (355)
T ss_dssp TCCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC---EEECCCCC-
T ss_pred cCceeEEEEeccch-HHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccc---eeeechhhh
Confidence 3688999999966 5555553 46999999999999999999999999999999999999976554 899999999
Q ss_pred eecCCCCcccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCC------
Q 018640 207 VFFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD------ 279 (352)
Q Consensus 207 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------ 279 (352)
+............||+.|+|||++.+ .++.++||||+||++++|++|+.||.+.........+..........
T Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 167 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred hccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 87766666667789999999999864 58999999999999999999999998877666555544322211000
Q ss_pred ----------------C----------------CcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccccc
Q 018640 280 ----------------P----------------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (352)
Q Consensus 280 ----------------~----------------~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~f~~~ 318 (352)
. ....++++.+||.+||+.||++|||++|+|+||||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 0 00135678999999999999999999999999999863
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=379.47 Aligned_cols=251 Identities=22% Similarity=0.331 Sum_probs=198.3
Q ss_pred ccceeceeeeccCceEEEEEEECC-----CCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC-
Q 018640 55 ERYELGRELGRGEFGITYLCTDRE-----NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD- 128 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~- 128 (352)
++|+++++||+|+||+||+|.+.. +++.||||++.... .....+.+.+|..++.++.+|+||+.+++++...
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 579999999999999999999754 45689999986542 3334567888889998887899999999987654
Q ss_pred CeEEEEEEecCCcchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecC
Q 018640 129 TAVHLVMELCEGGELFDRIVAR----------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK 192 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~ 192 (352)
...++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++||||||||+|||++.+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 170 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC
Confidence 5689999999999999999653 248899999999999999999999999999999999999766
Q ss_pred CCCCCEEEEecccceecCCCC---cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhC-CCCCCCCCHHHHHH
Q 018640 193 KETAPLKAIDFGLSVFFKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCG-VPPFWAETEQGVAQ 267 (352)
Q Consensus 193 ~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg-~~p~~~~~~~~~~~ 267 (352)
+. +||+|||+|+...... ......||+.|+|||.+. +.++.++|||||||++|||+|| ..||..........
T Consensus 171 ~~---~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~ 247 (299)
T d1ywna1 171 NV---VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247 (299)
T ss_dssp GC---EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred Cc---EEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 54 8999999998654332 234568999999999886 4589999999999999999986 56776655444443
Q ss_pred HHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 268 AIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
...... .....+..+++++.++|.+||+.||++|||+.||++|
T Consensus 248 ~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 248 RRLKEG--TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcC--CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 333332 2333445789999999999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-52 Score=377.89 Aligned_cols=249 Identities=20% Similarity=0.275 Sum_probs=210.3
Q ss_pred cccceeceeeeccCceEEEEEEEC-----CCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC
Q 018640 54 EERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 128 (352)
.++|++++.||+|+||+||+|++. .+++.||||++.... .....+++.+|+.+++++ +||||+++++++...
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~ 88 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEF-DNPNIVKLLGVCAVG 88 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhc-CCCCcccceeeeccC
Confidence 357999999999999999999975 356789999987542 333456799999999999 999999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCC
Q 018640 129 TAVHLVMELCEGGELFDRIVARG------------------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKP 184 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~------------------------~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp 184 (352)
+..+++|||+++|+|.+++.... .+++..+..|+.|++.||+|||++++|||||||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp 168 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 168 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence 99999999999999999986432 378999999999999999999999999999999
Q ss_pred CceEeecCCCCCCEEEEecccceecCCCC---cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCC-CCCCC
Q 018640 185 ENFLFANKKETAPLKAIDFGLSVFFKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGV-PPFWA 259 (352)
Q Consensus 185 ~NIll~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~-~p~~~ 259 (352)
+|||++.++. +||+|||+|+...... ......||+.|+|||.+. ..++.++||||||+++|||++|. +||..
T Consensus 169 ~NILld~~~~---~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 169 RNCLVGENMV---VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp GGEEECGGGC---EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred cceEECCCCc---EEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence 9999986554 8999999998654332 224567899999999887 45999999999999999999985 67888
Q ss_pred CCHHHHHHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 260 ETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
....+....+.... .+..+..+++++.+||..||+.||++|||+.||++
T Consensus 246 ~~~~e~~~~v~~~~---~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 246 MAHEEVIYYVRDGN---ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp SCHHHHHHHHHTTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHcCC---CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 88877776665543 23344578999999999999999999999999965
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=371.77 Aligned_cols=242 Identities=23% Similarity=0.366 Sum_probs=199.6
Q ss_pred ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe-CCeEEE
Q 018640 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED-DTAVHL 133 (352)
Q Consensus 55 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~-~~~~~l 133 (352)
++|++++.||+|+||.||+|.+. |..||||++..+ ...+.+.+|+.+++++ +||||+++++++.+ .+..++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-----~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~l 78 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYI 78 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-----C--HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CCEE
T ss_pred HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH-----HHHHHHHHHHHHHHhC-CCCCEeeEEEEEEecCCcEEE
Confidence 46999999999999999999974 789999998653 2346799999999999 89999999999854 567899
Q ss_pred EEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCC
Q 018640 134 VMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (352)
Q Consensus 134 v~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~ 211 (352)
||||+++|+|.+++..+. .+++..++.|+.||+.||.|||+++|+||||||+|||++.++. +||+|||+++....
T Consensus 79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~---~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV---AKVSDFGLTKEASS 155 (262)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC---EEECCCCC------
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCC---EeecccccceecCC
Confidence 999999999999997543 4899999999999999999999999999999999999976554 89999999986543
Q ss_pred CCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcCCCHHHH
Q 018640 212 GEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (352)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (352)
. .....+|+.|+|||++. +.++.++||||||+++|||+| |++||......+....+.+. .+++.++.+++.+.
T Consensus 156 ~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~ 230 (262)
T d1byga_ 156 T--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---YKMDAPDGCPPAVY 230 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT---CCCCCCTTCCHHHH
T ss_pred C--CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC---CCCCCCccCCHHHH
Confidence 3 23457899999999876 569999999999999999998 78888887777666665443 33445567899999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcC
Q 018640 290 DLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 290 ~li~~~l~~dP~~Rps~~ell~h 312 (352)
+||.+||+.||++|||+.+|+++
T Consensus 231 ~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 231 EVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcccCHhHCcCHHHHHHH
Confidence 99999999999999999999774
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=372.73 Aligned_cols=250 Identities=25% Similarity=0.393 Sum_probs=207.1
Q ss_pred cccceeceeeeccCceEEEEEEECCCC-------cEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENG-------DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~ 126 (352)
.++|++++.||+|+||.||+|+...++ ..||||++.... .......+.+|...+.++.+|||||++++++.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 468999999999999999999975543 479999987542 33445778889999999878999999999999
Q ss_pred eCCeEEEEEEecCCcchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEee
Q 018640 127 DDTAVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFA 190 (352)
Q Consensus 127 ~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~ 190 (352)
+++..++||||+++|+|.+++..+. .+++..++.++.||+.||+|||+.+||||||||+|||++
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 169 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeec
Confidence 9999999999999999999997542 489999999999999999999999999999999999997
Q ss_pred cCCCCCCEEEEecccceecCCCC---cccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 018640 191 NKKETAPLKAIDFGLSVFFKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGV 265 (352)
Q Consensus 191 ~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~ 265 (352)
.++. +||+|||+++...... ......||+.|+|||.+. +.++.++||||||+++|||++ |.+||........
T Consensus 170 ~~~~---~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~ 246 (299)
T d1fgka_ 170 EDNV---MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246 (299)
T ss_dssp TTCC---EEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred CCCC---eEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence 6654 8999999998764432 224457899999999876 569999999999999999998 7889888777766
Q ss_pred HHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 266 AQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
...+.+. .....+..+++++.+||.+||+.||++|||+.||++
T Consensus 247 ~~~i~~~---~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 247 FKLLKEG---HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHTT---CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcC---CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 5554432 233445678999999999999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-51 Score=371.70 Aligned_cols=251 Identities=24% Similarity=0.349 Sum_probs=211.2
Q ss_pred cccceeceeeeccCceEEEEEEEC-----CCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC
Q 018640 54 EERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 128 (352)
.++|++.+.||+|+||.||+|++. .+++.||||++.... .......+.+|+.+++++.+|||||++++++...
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 368999999999999999999863 467789999987542 3445667899999999997799999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEee
Q 018640 129 TAVHLVMELCEGGELFDRIVARG------------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFA 190 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~------------------~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~ 190 (352)
+..++||||+++|+|.+++.... .+++..+..++.||+.||+|||++++|||||||+||+++
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc
Confidence 99999999999999999987543 488999999999999999999999999999999999998
Q ss_pred cCCCCCCEEEEecccceecCCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 018640 191 NKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGV 265 (352)
Q Consensus 191 ~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~t-g~~p~~~~~~~~~ 265 (352)
.++. +|++|||+++....... .....||+.|+|||.+. +.++.++||||||+++|||+| |.+||......+.
T Consensus 180 ~~~~---~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 180 HGRI---TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp TTTE---EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred ccCc---ccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 6554 89999999987654322 24458899999999887 568999999999999999998 5666656555555
Q ss_pred HHHHHhcccccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 266 AQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
...+.... .+...+..+++.+.+||.+||+.||++|||+.+|++
T Consensus 257 ~~~~i~~~--~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 257 FYKMIKEG--FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHHT--CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcC--CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 55555442 233344568999999999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-51 Score=371.49 Aligned_cols=256 Identities=21% Similarity=0.314 Sum_probs=214.7
Q ss_pred cccceeceeeeccCceEEEEEEEC-----CCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeC
Q 018640 54 EERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 128 (352)
.++|++.+.||+|+||+||+|.+. .++..||||++... ........+.+|+.+++++ +||||+++++++..+
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~--~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQG 95 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc--cChHHHHHHHHHHHHHHHc-CCCCEeeeeeEEecC
Confidence 368999999999999999999875 23578999998754 2334456789999999999 899999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCE
Q 018640 129 TAVHLVMELCEGGELFDRIVAR----------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPL 198 (352)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~----------~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~v 198 (352)
+..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~---~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF---TV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC---CE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc---eE
Confidence 9999999999999999988642 2478999999999999999999999999999999999997554 48
Q ss_pred EEEecccceecCCCCc---ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhcc
Q 018640 199 KAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCG-VPPFWAETEQGVAQAIIRSV 273 (352)
Q Consensus 199 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg-~~p~~~~~~~~~~~~~~~~~ 273 (352)
||+|||+|+....... .....||+.|+|||.+. +.++.++||||||+++|||+|| ..||......+....+.+..
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~ 252 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 252 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC
Confidence 9999999986543322 23447899999999887 5588899999999999999998 57787777777666665432
Q ss_pred cccCCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc------Ccccccc
Q 018640 274 LDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE------HPWLQNA 318 (352)
Q Consensus 274 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~------hp~f~~~ 318 (352)
....++.+++.+.++|.+||+.||++|||+.+|++ +|+|++.
T Consensus 253 ---~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~ 300 (308)
T d1p4oa_ 253 ---LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 300 (308)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred ---CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCC
Confidence 33344678999999999999999999999999988 6777653
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.8e-51 Score=368.29 Aligned_cols=260 Identities=20% Similarity=0.267 Sum_probs=205.3
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
.+.++|++++.||+|+||+||+|.+..+|+.||||++..... .+++.+|+++++.+.+|++|+.+.+++.+.+..
T Consensus 4 ~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~ 78 (299)
T d1ckia_ 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 78 (299)
T ss_dssp EETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEE
T ss_pred eECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEE
Confidence 356789999999999999999999999999999998765421 235778999999995455566667777888899
Q ss_pred EEEEEecCCcchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecC
Q 018640 132 HLVMELCEGGELFDRIV-ARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~ 210 (352)
++||||+. ++|.+.+. ....+++..+..++.|++.||+|||++||+||||||+|||++..+....+||+|||+|+...
T Consensus 79 ~ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 79 VMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp EEEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EEEEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 99999995 46666554 44579999999999999999999999999999999999999876666779999999998764
Q ss_pred CCC--------cccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---ccc-C
Q 018640 211 PGE--------KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV---LDF-R 277 (352)
Q Consensus 211 ~~~--------~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~~~~~~~~~~~---~~~-~ 277 (352)
... ......||+.|+|||.+.+ .++.++|||||||++|||++|..||...........+.... ... .
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence 332 2245689999999999875 58999999999999999999999997765443332221111 111 1
Q ss_pred CCCCcCCCHHHHHHHHHhcCCCcCCCCCHH---HHhcCccccc
Q 018640 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTAQ---QVLEHPWLQN 317 (352)
Q Consensus 278 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~---ell~hp~f~~ 317 (352)
....+.+|+++.++|..||+.||++||++. ++|+|+|.+.
T Consensus 238 ~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 112346899999999999999999999987 5577877654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=365.20 Aligned_cols=244 Identities=21% Similarity=0.293 Sum_probs=198.1
Q ss_pred ceeeeccCceEEEEEEECCCC---cEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEe-CCeEEEEE
Q 018640 60 GRELGRGEFGITYLCTDRENG---DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED-DTAVHLVM 135 (352)
Q Consensus 60 ~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~-~~~~~lv~ 135 (352)
.++||+|+||+||+|.+..++ ..||||++... ......+++.+|+++|+++ +||||+++++++.. +...++||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEETTTEEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhC-CCCCEeEEeEEEEecCCceEEEE
Confidence 578999999999999986543 35899998643 3455567899999999999 89999999999865 56889999
Q ss_pred EecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEEecccceecCCCCc
Q 018640 136 ELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (352)
Q Consensus 136 e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (352)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+|+||||||+|||++.++ .+||+|||+++.......
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~---~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF---TVKVADFGLARDMYDKEF 185 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC---CEEECSSGGGCCTTTTTC
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCC---CEEEecccchhhcccccc
Confidence 9999999999887554 478889999999999999999999999999999999997554 489999999987643321
Q ss_pred -----ccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcccccCCCCCcCCCHH
Q 018640 215 -----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVLDFRRDPWPKVSEN 287 (352)
Q Consensus 215 -----~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 287 (352)
.....||+.|+|||.+. +.++.++||||||+++|||+||..||...... +....+... .+...++.+++.
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g---~~~~~p~~~~~~ 262 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG---RRLLQPEYCPDP 262 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT---CCCCCCTTCCHH
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC---CCCCCcccCcHH
Confidence 23357899999999876 56999999999999999999987777654332 233333332 233344568899
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 288 AKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 288 ~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
+.+||.+||+.||++|||+.||++|
T Consensus 263 l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 263 LYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999999987
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.4e-49 Score=356.39 Aligned_cols=254 Identities=20% Similarity=0.281 Sum_probs=206.8
Q ss_pred cccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeE
Q 018640 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (352)
Q Consensus 52 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 131 (352)
.+.++|++++.||+|+||+||+|++..+|+.||||++.... +.+.+.+|++.++.+.+|+|++.+++++......
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 76 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 76 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-----CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence 45678999999999999999999999999999999875432 2235778999999997779999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCC--CCCCEEEEeccccee
Q 018640 132 HLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK--ETAPLKAIDFGLSVF 208 (352)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~--~~~~vkl~Dfg~a~~ 208 (352)
++||||+ +++|.+++.... .++...+..++.|++.||+|||++||+||||||+|||++... ....+||+|||+|+.
T Consensus 77 ~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 9999999 679999887654 699999999999999999999999999999999999997532 245699999999987
Q ss_pred cCCCC--------cccccccccccccchhccc-cCCCcchHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhccccc
Q 018640 209 FKPGE--------KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQ---GVAQAIIRSVLDF 276 (352)
Q Consensus 209 ~~~~~--------~~~~~~gt~~y~aPE~~~~-~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~---~~~~~~~~~~~~~ 276 (352)
..... ......||+.|+|||++.+ .++.++||||||+++|||++|..||.+.... .....+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 64321 2245689999999999875 4999999999999999999999999754332 2222222221111
Q ss_pred -CCCCCcCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018640 277 -RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (352)
Q Consensus 277 -~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 311 (352)
.....+.+|+++.+++..|+..+|++||+.+.+.+
T Consensus 236 ~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 11123467899999999999999999999877654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-49 Score=356.00 Aligned_cols=247 Identities=21% Similarity=0.277 Sum_probs=188.2
Q ss_pred ccccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCC---
Q 018640 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT--- 129 (352)
Q Consensus 53 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~--- 129 (352)
+.++|.+.+.||+|+||+||+|++ +|+.||||++.... ......+.|+..+..+ +||||+++++++..++
T Consensus 1 ~~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~~~ 73 (303)
T d1vjya_ 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVML-RHENILGFIAADNKDNGTW 73 (303)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSS
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCCcc
Confidence 356799999999999999999986 58999999986432 1112233455555677 8999999999997654
Q ss_pred -eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------cCCEEecCCCCceEeecCCCCCCEEE
Q 018640 130 -AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK--------HGVMHRDLKPENFLFANKKETAPLKA 200 (352)
Q Consensus 130 -~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~--------~~ivH~Dikp~NIll~~~~~~~~vkl 200 (352)
..++||||+++|+|.+++... .+++..+..++.|++.||.|+|+ +||+||||||+|||++.++. +||
T Consensus 74 ~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~---~Kl 149 (303)
T d1vjya_ 74 TQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT---CCI 149 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC---EEE
T ss_pred eEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC---eEE
Confidence 679999999999999999765 69999999999999999999996 59999999999999976554 899
Q ss_pred EecccceecCCCC-----cccccccccccccchhcccc-------CCCcchHHHHHHHHHHHHhCCCCCCCCC-------
Q 018640 201 IDFGLSVFFKPGE-----KFSEIVGSPYYMAPEVLKRN-------YGPEVDVWSAGVILYILLCGVPPFWAET------- 261 (352)
Q Consensus 201 ~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-------~s~~~Di~SlG~~l~el~tg~~p~~~~~------- 261 (352)
+|||++....... ......||+.|+|||++.+. ++.++|||||||+||||+||..||....
T Consensus 150 ~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~ 229 (303)
T d1vjya_ 150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 229 (303)
T ss_dssp CCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred EecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh
Confidence 9999998764432 22346899999999987642 5668999999999999999987763211
Q ss_pred --------HHHHHHHHHhcccccCCCCCc-----CCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 018640 262 --------EQGVAQAIIRSVLDFRRDPWP-----KVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (352)
Q Consensus 262 --------~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~l~~dP~~Rps~~ell~h 312 (352)
........... ..++..+. ..+..+.+|+.+||+.||++|||+.||+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 230 DLVPSDPSVEEMRKVVCEQ--KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp TTSCSSCCHHHHHHHHTTS--CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred hcccccchHHHHHHHHhcc--ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 11111111111 11111111 123458899999999999999999999763
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.2e-46 Score=345.05 Aligned_cols=267 Identities=25% Similarity=0.435 Sum_probs=199.5
Q ss_pred ccccc-ccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCC----------CCCCe
Q 018640 50 GREIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP----------KHQNI 118 (352)
Q Consensus 50 ~~~~~-~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~----------~h~~i 118 (352)
|+.+. ++|+++++||+|+||+||+|++..+|+.||||++.+.. ...+.+.+|+.+++.+. .|+||
T Consensus 7 g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i 82 (362)
T d1q8ya_ 7 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHI 82 (362)
T ss_dssp TCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence 45554 46999999999999999999999999999999987532 23466788999988872 25789
Q ss_pred eEeeeEEEe--CCeEEEEEEecCCcchH-HHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEecCCCCceEeecC
Q 018640 119 VCLKDTYED--DTAVHLVMELCEGGELF-DRIV--ARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANK 192 (352)
Q Consensus 119 v~l~~~~~~--~~~~~lv~e~~~~~sL~-~~l~--~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dikp~NIll~~~ 192 (352)
+++++++.. ....++++++...+... .... ....+++..++.++.|++.||+|||+ .||+||||||+|||++.+
T Consensus 83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~ 162 (362)
T d1q8ya_ 83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV 162 (362)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeecc
Confidence 999998754 45666777776544332 2222 33468999999999999999999998 899999999999999765
Q ss_pred CCC---CCEEEEecccceecCCCCcccccccccccccchhcc-ccCCCcchHHHHHHHHHHHHhCCCCCCCCCHH-----
Q 018640 193 KET---APLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ----- 263 (352)
Q Consensus 193 ~~~---~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~s~~~Di~SlG~~l~el~tg~~p~~~~~~~----- 263 (352)
+.. ..++++|||.+..... ......||+.|+|||++. ..++.++||||+||++++|++|+.||......
T Consensus 163 ~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~ 240 (362)
T d1q8ya_ 163 DSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240 (362)
T ss_dssp ETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CcccccceeeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccch
Confidence 432 2389999999986543 234568999999999876 56899999999999999999999999644321
Q ss_pred -HHHHHHHhccccc--------------------------------------CCCCCcCCCHHHHHHHHHhcCCCcCCCC
Q 018640 264 -GVAQAIIRSVLDF--------------------------------------RRDPWPKVSENAKDLVRKMLDPDPKRRL 304 (352)
Q Consensus 264 -~~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rp 304 (352)
............. ........++++.+||.+||++||.+||
T Consensus 241 ~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp 320 (362)
T d1q8ya_ 241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 320 (362)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred hHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCc
Confidence 1111111111000 0001122457789999999999999999
Q ss_pred CHHHHhcCccccccccCC
Q 018640 305 TAQQVLEHPWLQNAKKAP 322 (352)
Q Consensus 305 s~~ell~hp~f~~~~~~~ 322 (352)
|++|+|+||||++.....
T Consensus 321 ta~e~L~Hp~f~~~~~~~ 338 (362)
T d1q8ya_ 321 DAGGLVNHPWLKDTLGME 338 (362)
T ss_dssp CHHHHHTCGGGTTCTTCT
T ss_pred CHHHHhcCcccCCCCCcc
Confidence 999999999999765443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=4.7e-27 Score=196.92 Aligned_cols=167 Identities=21% Similarity=0.232 Sum_probs=123.3
Q ss_pred ceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCC---------------hhcHHHHHHHHHHHHhCCCCCCeeEe
Q 018640 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT---------------AVDIEDVRREVDIMRHLPKHQNIVCL 121 (352)
Q Consensus 57 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---------------~~~~~~~~~E~~~l~~l~~h~~iv~l 121 (352)
+.+.+.||+|+||+||+|.+. +|+.||||++....... .........|...+.++ .|.+++..
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~v~~~ 79 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-QGLAVPKV 79 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-TTSSSCCE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc-cCCCcceE
Confidence 457899999999999999985 69999999875432110 01123455688899999 89999888
Q ss_pred eeEEEeCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecCCCCceEeecCCCCCCEEEE
Q 018640 122 KDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAI 201 (352)
Q Consensus 122 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dikp~NIll~~~~~~~~vkl~ 201 (352)
+++.. .+++|||+++..+.+ ++...+..++.|++.+|.|||++||+||||||+|||++.++ ++|+
T Consensus 80 ~~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~----~~li 144 (191)
T d1zara2 80 YAWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG----IWII 144 (191)
T ss_dssp EEEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE----EEEC
T ss_pred EEecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC----EEEE
Confidence 76532 379999998865532 55666788999999999999999999999999999997432 7999
Q ss_pred ecccceecCCCCccccccccccccc------chhccccCCCcchHHHHHHHH
Q 018640 202 DFGLSVFFKPGEKFSEIVGSPYYMA------PEVLKRNYGPEVDVWSAGVIL 247 (352)
Q Consensus 202 Dfg~a~~~~~~~~~~~~~gt~~y~a------PE~~~~~~s~~~Di~SlG~~l 247 (352)
|||.|........ ..|.. .+.+...|+.++|+||+.--+
T Consensus 145 DFG~a~~~~~~~~-------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGW-------REILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTH-------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCc-------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 9999976542221 11211 134456789999999986544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.76 E-value=1.6e-08 Score=86.70 Aligned_cols=89 Identities=18% Similarity=0.124 Sum_probs=64.4
Q ss_pred cccceeceeeeccCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEEE
Q 018640 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 54 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 133 (352)
-..|+.++..+.++.+.||+.. .++..+++|+........ ...+.+|...+..+..+--+++++.+...++..++
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred hhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence 3467777766656668999876 346677888776543222 23467788888888555557788888888899999
Q ss_pred EEEecCCcchHHHH
Q 018640 134 VMELCEGGELFDRI 147 (352)
Q Consensus 134 v~e~~~~~sL~~~l 147 (352)
||++++|.++.+..
T Consensus 88 v~~~l~G~~~~~~~ 101 (263)
T d1j7la_ 88 LMSEADGVLCSEEY 101 (263)
T ss_dssp EEECCSSEEHHHHT
T ss_pred EEEecccccccccc
Confidence 99999998875543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.46 E-value=2.4e-07 Score=84.19 Aligned_cols=82 Identities=18% Similarity=0.186 Sum_probs=52.3
Q ss_pred ceeeeccCceEEEEEEECCCCcEEEEEEcccccc----CChhcHHHHHHHHHHHHhCCCC--CCeeEeeeEEEeCCeEEE
Q 018640 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKL----RTAVDIEDVRREVDIMRHLPKH--QNIVCLKDTYEDDTAVHL 133 (352)
Q Consensus 60 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~E~~~l~~l~~h--~~iv~l~~~~~~~~~~~l 133 (352)
.+.||.|....||++.+..+++.|++|.-..... .-+...++...|+..|..+..+ ..+++++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4578999999999999877788999996543211 1122345666788888877443 335556544 4445678
Q ss_pred EEEecCCcch
Q 018640 134 VMELCEGGEL 143 (352)
Q Consensus 134 v~e~~~~~sL 143 (352)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987554
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.15 E-value=4.4e-06 Score=70.51 Aligned_cols=74 Identities=11% Similarity=0.112 Sum_probs=51.1
Q ss_pred eeccC-ceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCC-CCeeEeeeEEEeCCeEEEEEEecCC
Q 018640 63 LGRGE-FGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH-QNIVCLKDTYEDDTAVHLVMELCEG 140 (352)
Q Consensus 63 lG~G~-~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~~iv~l~~~~~~~~~~~lv~e~~~~ 140 (352)
+..|. .+.||+... .++..+++|...... ...+..|+..++.+..+ -.+++++.+..+.+..++||++++|
T Consensus 18 ~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp CSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred cCCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence 34444 468999874 457778888754332 23466788877776332 2256788888888899999999998
Q ss_pred cch
Q 018640 141 GEL 143 (352)
Q Consensus 141 ~sL 143 (352)
.++
T Consensus 91 ~~~ 93 (255)
T d1nd4a_ 91 QDL 93 (255)
T ss_dssp EET
T ss_pred ccc
Confidence 765
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.56 E-value=0.00014 Score=65.39 Aligned_cols=75 Identities=13% Similarity=0.083 Sum_probs=51.5
Q ss_pred ceeeeccCceEEEEEEECC-------CCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCCCeeEeeeEEEeCCeEE
Q 018640 60 GRELGRGEFGITYLCTDRE-------NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (352)
Q Consensus 60 ~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 132 (352)
++.|+.|---.+|++.... .+..|.+++.... ...-...+|..+++.+..+.-.+++++++.+ .
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-----~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-----ETESHLVAESVIFTLLSERHLGPKLYGIFSG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-----chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence 4678888899999998643 2456777765421 1223455799999988655545678887753 5
Q ss_pred EEEEecCCcch
Q 018640 133 LVMELCEGGEL 143 (352)
Q Consensus 133 lv~e~~~~~sL 143 (352)
+|+||++|.+|
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 88999987655
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.25 E-value=0.00055 Score=59.62 Aligned_cols=73 Identities=12% Similarity=0.133 Sum_probs=46.6
Q ss_pred cCceEEEEEEECCCCcEEEEEEccccccCChhcHHHHHHHHHHHHhCCCCC-CeeEeee-----EEEeCCeEEEEEEecC
Q 018640 66 GEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ-NIVCLKD-----TYEDDTAVHLVMELCE 139 (352)
Q Consensus 66 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-~iv~l~~-----~~~~~~~~~lv~e~~~ 139 (352)
+-.-.||++.. ++|..|++|+..... ...+.+..|...+..|..+. -++..+. .+...+..+.++++++
T Consensus 33 s~EN~vy~v~~-~dg~~~VlK~~rp~~----~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~ 107 (325)
T d1zyla1 33 SYENRVYQFQD-EDRRRFVVKFYRPER----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 107 (325)
T ss_dssp CSSSEEEEECC-TTCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred cccceeEEEEc-CCCCEEEEEEeCCCC----CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence 33468999985 578899999876432 13466778888888773221 1122211 2345667889999998
Q ss_pred Ccch
Q 018640 140 GGEL 143 (352)
Q Consensus 140 ~~sL 143 (352)
|..+
T Consensus 108 G~~~ 111 (325)
T d1zyla1 108 GRQF 111 (325)
T ss_dssp CEEC
T ss_pred CcCC
Confidence 7443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.98 E-value=0.0082 Score=51.36 Aligned_cols=31 Identities=32% Similarity=0.467 Sum_probs=24.9
Q ss_pred cCCEEecCCCCceEeecCCCCCCEEEEeccccee
Q 018640 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (352)
Q Consensus 175 ~~ivH~Dikp~NIll~~~~~~~~vkl~Dfg~a~~ 208 (352)
.|+||+|+.++||+++.+.. .-|+||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v---~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDEL---SGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEE---EEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccc---eeEeccccccc
Confidence 47999999999999975432 46899998864
|